Citrus Sinensis ID: 011808
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 477 | 2.2.26 [Sep-21-2011] | |||||||
| Q84TI6 | 470 | Cyclin-dependent kinase E | yes | no | 0.945 | 0.959 | 0.804 | 0.0 | |
| Q336M2 | 475 | Cyclin-dependent kinase E | yes | no | 0.966 | 0.970 | 0.745 | 0.0 | |
| Q95YH0 | 380 | Probable cyclin-dependent | yes | no | 0.681 | 0.855 | 0.554 | 1e-101 | |
| Q9VT57 | 454 | Cyclin-dependent kinase 8 | yes | no | 0.700 | 0.735 | 0.453 | 1e-82 | |
| Q9BWU1 | 502 | Cyclin-dependent kinase 1 | yes | no | 0.693 | 0.659 | 0.457 | 1e-80 | |
| Q8BWD8 | 501 | Cyclin-dependent kinase 1 | yes | no | 0.675 | 0.642 | 0.463 | 1e-80 | |
| Q17IE8 | 501 | Cyclin-dependent kinase 8 | N/A | no | 0.687 | 0.654 | 0.455 | 3e-80 | |
| Q1EBK0 | 467 | Serine/threonine-protein | N/A | no | 0.658 | 0.672 | 0.469 | 2e-79 | |
| Q8R3L8 | 464 | Cyclin-dependent kinase 8 | no | no | 0.777 | 0.799 | 0.427 | 9e-79 | |
| Q8JH47 | 464 | Cyclin-dependent kinase 8 | no | no | 0.700 | 0.719 | 0.454 | 1e-78 |
| >sp|Q84TI6|CDKE1_ARATH Cyclin-dependent kinase E-1 OS=Arabidopsis thaliana GN=CDKE-1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 748 bits (1931), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/461 (80%), Positives = 404/461 (87%), Gaps = 10/461 (2%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
EKPEWLQQYNL+GKIGEGTYGLVFLAR K R IAIKKFKQSKDGDGVSPTAIREI
Sbjct: 17 EKPEWLQQYNLVGKIGEGTYGLVFLARTKTPPKR--PIAIKKFKQSKDGDGVSPTAIREI 74
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
MLLREI+HENVVKLVNVHIN ADMSLYLAFDYAEYDLYEIIRHHRDKV H++N YTVKS+
Sbjct: 75 MLLREISHENVVKLVNVHINFADMSLYLAFDYAEYDLYEIIRHHRDKVGHSLNTYTVKSL 134
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
LWQLLNGLNYLHSNWIIHRDLKPSNILVMG+ EE G+VKIADFGLARIYQAPLK LS+NG
Sbjct: 135 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGDAEEHGIVKIADFGLARIYQAPLKPLSDNG 194
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
VVVTIWYRAPELLLG+KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS+QNPFQLDQLD
Sbjct: 195 VVVTIWYRAPELLLGSKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSSQNPFQLDQLD 254
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
KIFKILGHPT +KWPTL NLPHWQ+D HIQ KY++ GLH+VV L+ KSPAYDLLSKML
Sbjct: 255 KIFKILGHPTMDKWPTLVNLPHWQNDVQHIQAHKYDSVGLHNVVHLNQKSPAYDLLSKML 314
Query: 320 EYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFEGTTTLQ 379
EYDP KRITA+QALEHEYFR++PLPGRNA V SQP +K VNYPTRPVD+NTDFEGTT++
Sbjct: 315 EYDPLKRITASQALEHEYFRMDPLPGRNAFVASQPMEKNVNYPTRPVDTNTDFEGTTSIN 374
Query: 380 PPQP-ASGPVPGNMAGAHAVSNRNVPRPMPGVGMQRM-QAQGMMTYNFPGQAGAAGGMNP 437
PPQ A+G V GNMAGAH + +R++PRPM MQRM Q+QGMM YNFP QA G+NP
Sbjct: 375 PPQAVAAGNVAGNMAGAHGMGSRSMPRPMVAHNMQRMQQSQGMMAYNFPAQA----GLNP 430
Query: 438 AN-MPMQRGMPGQAHQQQQLRRKDPGMGLPGYPPQQKSRRL 477
+ + QRGM Q HQQQQLRRKDPGMG+ GY P KSRRL
Sbjct: 431 SVPLQQQRGM-AQPHQQQQLRRKDPGMGMSGYAPPNKSRRL 470
|
Involved in cell differentiation. Required for the specification of stamen and carpel identities and for the proper termination of stem cells in the floral meristem. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3 |
| >sp|Q336M2|CDKE1_ORYSJ Cyclin-dependent kinase E-1 OS=Oryza sativa subsp. japonica GN=CDKE-1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 706 bits (1823), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/488 (74%), Positives = 397/488 (81%), Gaps = 27/488 (5%)
Query: 1 MGDGNTSTGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIK-----AAA---N 52
MGDG R G GT+ +P WLQQY L+GKIGEGTYGLVFLAR+K AAA
Sbjct: 1 MGDG-----RVGGGTN----RPAWLQQYELVGKIGEGTYGLVFLARLKQSHPHAAAGVGR 51
Query: 53 RGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYA 112
RG IAIKKFKQSK+GDGVSPTAIREIMLLREI HENVVKLVNVHINHADMSLYLAFDYA
Sbjct: 52 RGSPIAIKKFKQSKEGDGVSPTAIREIMLLREINHENVVKLVNVHINHADMSLYLAFDYA 111
Query: 113 EYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE 172
E+DLYEIIRHHR+K+N +NPYTVKS+LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE
Sbjct: 112 EHDLYEIIRHHREKLNLPINPYTVKSLLWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE 171
Query: 173 EQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFA 232
E G++KIADFGLARIYQAPLK LS+NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFA
Sbjct: 172 EHGIIKIADFGLARIYQAPLKPLSDNGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFA 231
Query: 233 ELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGR 292
ELLTLKPLFQG EAK+T NPFQLDQLDKIFK+LGHPT EKWPTLANLP WQ+D HIQG
Sbjct: 232 ELLTLKPLFQGVEAKATPNPFQLDQLDKIFKVLGHPTVEKWPTLANLPCWQNDQQHIQGH 291
Query: 293 KYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPS 352
KYE GLH++V L KSPA+DLLSKMLEYDPRKRITAAQALEHEYFR++PLPGRNAL+PS
Sbjct: 292 KYENTGLHNIVHLPQKSPAFDLLSKMLEYDPRKRITAAQALEHEYFRMDPLPGRNALLPS 351
Query: 353 QPGDKVVNYPTRPVDSNTDFEGTTTLQPPQPASG-PVPGNMAGAHAVSNRNVPRPM--PG 409
Q G+K+V YP RPVD+ TDFEGTT+LQP Q SG PGN +V R +PR M P
Sbjct: 352 QAGEKIVQYPVRPVDTTTDFEGTTSLQPTQAPSGNAAPGN----QSVVPRPIPRQMQQPM 407
Query: 410 VGMQRMQAQGMMTYNFPGQAGAAGGMNPANMPMQRGMPGQAHQQQQLRRKDPGMGL--PG 467
VGM RM M + Q G A GMNP N+PMQRG Q+H Q R+ D GMG+ PG
Sbjct: 408 VGMSRMGGTNMAAFGAAPQGGIA-GMNPGNIPMQRGAGAQSHPHQLRRKADQGMGMQNPG 466
Query: 468 YPPQQKSR 475
YP QQK R
Sbjct: 467 YPTQQKRR 474
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q95YH0|CDK8_DICDI Probable cyclin-dependent kinase 8 OS=Dictyostelium discoideum GN=cdk8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 368 bits (945), Expect = e-101, Method: Compositional matrix adjust.
Identities = 189/341 (55%), Positives = 251/341 (73%), Gaps = 16/341 (4%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y +IG GTYG+V+ A K N +A+KKF+ +K+G+G+S TA REI LL+E+
Sbjct: 42 EKYTFSYEIGSGTYGMVYKADDKKRPNN--KVAVKKFRSTKEGEGLSLTAYREIGLLKEL 99
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
++EN+VKL++V +N D LYL FDYAE+DL+ II++HR+ +H + T+KS++WQ+LN
Sbjct: 100 SNENIVKLLDVCLNPKDKLLYLIFDYAEFDLFGIIKYHRENGSH-FSDATIKSLIWQVLN 158
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
G++YLHSNW+IHRDLKPSNILVMGEG+E G VKI DFGLARI+Q+PLK L+ENGVVVTIW
Sbjct: 159 GIHYLHSNWVIHRDLKPSNILVMGEGKECGTVKIGDFGLARIFQSPLKPLNENGVVVTIW 218
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP--FQLDQLDKIFK 263
YR+PELLLG+KHYT AVD+WA+GCIFAEL+T KPLF G E K + P FQ DQ++KI +
Sbjct: 219 YRSPELLLGSKHYTRAVDIWAIGCIFAELITTKPLFPGKE-KDPKIPSLFQDDQVEKIIR 277
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
+LG PT + WP + +LP W+ + + N L V + S AYDLLSKM+ YDP
Sbjct: 278 VLGKPTLDMWPDIKHLPEWK----RLSSMEAFPNSLAKCVGIDENSQAYDLLSKMILYDP 333
Query: 324 RKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTR 364
KRITA++AL+H YF+ PLP NA S+P + YP R
Sbjct: 334 SKRITASEALDHPYFKELPLPLPNAF--SKP----IPYPPR 368
|
Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex (By similarity). Involved in cell aggregation, but not growth. Required for starvation-induced expression of genes essential for early development of acaA and/or other genes. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9VT57|CDK8_DROME Cyclin-dependent kinase 8 OS=Drosophila melanogaster GN=Cdk8 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 307 bits (786), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 160/353 (45%), Positives = 228/353 (64%), Gaps = 19/353 (5%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
K+G GTYG V+ A+ K ++ GK A+K+ DG G+S +A REI LLRE+ H+NV+
Sbjct: 26 KVGRGTYGHVYKAKWKETSD-GKEYALKQI----DGTGLSMSACREIALLRELKHQNVIT 80
Query: 93 LVNVHINHADMSLYLAFDYAEYDLYEIIRHHR----DKVNHTMNPYTVKSILWQLLNGLN 148
L+ V ++H D ++L DYAE+DL+ II+ HR K + VKS+L+Q+L+G++
Sbjct: 81 LIRVFLSHNDRKVFLLIDYAEHDLWHIIKFHRAAKATKKQVVVPRGMVKSLLYQILDGIH 140
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE-NGVVVTIWYR 207
YLHSNW++HRDLKP+NILVMG+G E+G VKIAD G AR++ APLK L++ + VVVT WYR
Sbjct: 141 YLHSNWVLHRDLKPANILVMGDGNERGRVKIADMGFARLFNAPLKPLADLDPVVVTFWYR 200
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG-AEAKSTQNPFQLDQLDKIFKILG 266
APELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NP+ DQLD+IF ++G
Sbjct: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 260
Query: 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV---PLSPKSPAYDLLSKMLEYDP 323
P + W + +P + + + Y T L + + P S A+ LL K+L DP
Sbjct: 261 FPQDKDWEDIKKMPEHHTLTKDFKRSTYSTCSLAKYMERHKIKPDSKAFHLLQKLLLMDP 320
Query: 324 RKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFEGTT 376
KRIT+ QA++ +YF+ EP P ++ + YP R ++ D E +
Sbjct: 321 NKRITSEQAMQDQYFQEEPQPTQDVFAGCP-----IPYPKREFLTDDDQEDKS 368
|
Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. May phosphorylate the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex. Required for leg and eye development and macrochaete specification or differentiation. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9BWU1|CDK19_HUMAN Cyclin-dependent kinase 19 OS=Homo sapiens GN=CDK19 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 300 bits (769), Expect = 1e-80, Method: Compositional matrix adjust.
Identities = 160/350 (45%), Positives = 224/350 (64%), Gaps = 19/350 (5%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
K+G GTYG V+ AR K + K A+K+ +G G+S +A REI LLRE+ H NV+
Sbjct: 26 KVGRGTYGHVYKARRKDGKDE-KEYALKQI----EGTGISMSACREIALLRELKHPNVIA 80
Query: 93 LVNVHINHADMSLYLAFDYAEYDLYEIIRHHR----DKVNHTMNPYTVKSILWQLLNGLN 148
L V ++H+D ++L FDYAE+DL+ II+ HR +K + VKS+L+Q+L+G++
Sbjct: 81 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 140
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE-NGVVVTIWYR 207
YLH+NW++HRDLKP+NILVMGEG E+G VKIAD G AR++ +PLK L++ + VVVT WYR
Sbjct: 141 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 200
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG-AEAKSTQNPFQLDQLDKIFKILG 266
APELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NPF DQLD+IF ++G
Sbjct: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 260
Query: 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV---PLSPKSPAYDLLSKMLEYDP 323
P + W + +P + + + Y + L + + P S + LL K+L DP
Sbjct: 261 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDP 320
Query: 324 RKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFE 373
KRIT+ QAL+ YF+ +PLP + Q + YP R + D E
Sbjct: 321 TKRITSEQALQDPYFQEDPLPTLDVFAGCQ-----IPYPKREFLNEDDPE 365
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q8BWD8|CDK19_MOUSE Cyclin-dependent kinase 19 OS=Mus musculus GN=Cdk19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 300 bits (769), Expect = 1e-80, Method: Compositional matrix adjust.
Identities = 158/341 (46%), Positives = 221/341 (64%), Gaps = 19/341 (5%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
K+G GTYG V+ AR K + K A+K+ +G G+S +A REI LLRE+ H NV+
Sbjct: 26 KVGRGTYGHVYKARRKDGKDE-KEYALKQI----EGTGISMSACREIALLRELKHPNVIA 80
Query: 93 LVNVHINHADMSLYLAFDYAEYDLYEIIRHHR----DKVNHTMNPYTVKSILWQLLNGLN 148
L V ++H+D ++L FDYAE+DL+ II+ HR +K + VKS+L+Q+L+G++
Sbjct: 81 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 140
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE-NGVVVTIWYR 207
YLH+NW++HRDLKP+NILVMGEG E+G VKIAD G AR++ +PLK L++ + VVVT WYR
Sbjct: 141 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 200
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG-AEAKSTQNPFQLDQLDKIFKILG 266
APELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NPF DQLD+IF ++G
Sbjct: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 260
Query: 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV---PLSPKSPAYDLLSKMLEYDP 323
P + W + +P + + + Y + L + + P S + LL K+L DP
Sbjct: 261 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDP 320
Query: 324 RKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTR 364
KRIT+ QAL+ YF+ +PLP + Q + YP R
Sbjct: 321 TKRITSEQALQDPYFQEDPLPTLDVFAGCQ-----IPYPKR 356
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q17IE8|CDK8_AEDAE Cyclin-dependent kinase 8 OS=Aedes aegypti GN=Cdk8 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 299 bits (765), Expect = 3e-80, Method: Compositional matrix adjust.
Identities = 159/349 (45%), Positives = 221/349 (63%), Gaps = 21/349 (6%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
K+G GTYG V+ A K + N K A+K+ +G G+S +A REI LLRE+ H NV+
Sbjct: 26 KVGRGTYGHVYKAHRKES-NDTKDYALKQI----EGTGLSMSACREIALLRELKHPNVIN 80
Query: 93 LVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTV-----KSILWQLLNGL 147
L+ V ++H D ++L FDYAE+DL+ II+ HR T P V KS+L+Q+L+G+
Sbjct: 81 LIRVFLSHTDRKVWLLFDYAEHDLWHIIKFHR-AAKATKKPVMVPKGMVKSLLYQILDGI 139
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE-NGVVVTIWY 206
+YLHSNW++HRDLKP+NILVMGEG E+G VKIAD G AR++ APLK L++ + VVVT WY
Sbjct: 140 HYLHSNWVLHRDLKPANILVMGEGNERGRVKIADMGFARLFNAPLKPLADLDPVVVTFWY 199
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG-AEAKSTQNPFQLDQLDKIFKIL 265
RAPELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NP+ DQLD+IF ++
Sbjct: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 259
Query: 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV---PLSPKSPAYDLLSKMLEYD 322
G P + W + +P + + + Y L + + P S A+ LL K+L D
Sbjct: 260 GFPQDKDWEDIRKMPEHHTLTKDFKRSNYANCSLVKYMERHKIKPDSKAFHLLQKLLLMD 319
Query: 323 PRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTD 371
P KRIT+ QA++ YF +P+P + + YP R ++ D
Sbjct: 320 PNKRITSEQAMQDPYFSEDPMPTADVFAGCP-----IPYPKREFLTDED 363
|
Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex. Aedes aegypti (taxid: 7159) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q1EBK0|SSN3_COCIM Serine/threonine-protein kinase SSN3 OS=Coccidioides immitis (strain RS) GN=SSN3 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 164/349 (46%), Positives = 218/349 (62%), Gaps = 35/349 (10%)
Query: 17 NHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-----GV 71
++ K + ++Y ++G I GTYG V+ A+ + G AIKKFK K+G+ G+
Sbjct: 68 SYASKVKLREKYLIVGFISSGTYGRVYKAKGRDGV--GGDFAIKKFKPDKEGEKVEYTGL 125
Query: 72 SPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTM 131
S +AIREI L E+ H NVV+LV + D +Y+ F+Y E+DL +II HH H +
Sbjct: 126 SQSAIREISLCTELNHPNVVRLVETILE--DKCVYMVFEYTEHDLLQIIHHHTQPQRHAI 183
Query: 132 NPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
VKSIL+QLLNGL YLHS W++HRDLKP+NILV +G V+I D GLAR+++ P
Sbjct: 184 PAPMVKSILFQLLNGLLYLHSQWVMHRDLKPANILVT----SKGAVRIGDLGLARVFKKP 239
Query: 192 L-KFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250
L S + VVVTIWYRAPELLLGA+HYT+AVD+WAVGCIFAELL+L+P+F+G EAK
Sbjct: 240 LNSLFSGDKVVVTIWYRAPELLLGARHYTTAVDLWAVGCIFAELLSLRPIFKGEEAKMDS 299
Query: 251 N---PFQLDQLDKIFKILGHPTPEKWPTLANLP-----------------HWQSDSLHIQ 290
PFQ +Q+ KI +ILG P EKWP L+++P H S+ H
Sbjct: 300 KKTVPFQRNQMLKIIEILGLPKKEKWPGLSSMPEFPQLQAMAMAPGSGHLHKPSNLEHWY 359
Query: 291 GRKYETNGLHSVVPL-SPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338
++ G P SP +DLLS++LEYDP KRI+A +AL H YF
Sbjct: 360 HVCLKSGGYSGSSPAGSPGKEGFDLLSRLLEYDPEKRISAKEALNHPYF 408
|
Component of the SRB8-11 complex. The SRB8-11 complex is a regulatory module of the Mediator complex which is itself involved in regulation of basal and activated RNA polymerase II-dependent transcription. The SRB8-11 complex may be involved in the transcriptional repression of a subset of genes regulated by Mediator. It may inhibit the association of the Mediator complex with RNA polymerase II to form the holoenzyme complex. The SRB8-11 complex phosphorylates the C-terminal domain (CTD) of the largest subunit of RNA polymerase II. Coccidioides immitis (strain RS) (taxid: 246410) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8R3L8|CDK8_MOUSE Cyclin-dependent kinase 8 OS=Mus musculus GN=Cdk8 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 294 bits (753), Expect = 9e-79, Method: Compositional matrix adjust.
Identities = 170/398 (42%), Positives = 237/398 (59%), Gaps = 27/398 (6%)
Query: 16 SNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA 75
S+ E+ E L +Y K+G GTYG V+ + K A+K+ +G G+S +A
Sbjct: 10 SSERERVEDLFEYEGC-KVGRGTYGHVY-KAKRKDGKDDKDYALKQI----EGTGISMSA 63
Query: 76 IREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHR-DKVNHT---M 131
REI LLRE+ H NV+ L+ V ++HAD ++L FDYAE+DL+ II+ HR K N +
Sbjct: 64 CREIALLRELKHPNVISLLKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL 123
Query: 132 NPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
VKS+L+Q+L+G++YLH+NW++HRDLKP+NILVMGEG E+G VKIAD G AR++ +P
Sbjct: 124 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 183
Query: 192 LKFLSE-NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG-AEAKST 249
LK L++ + VVVT WYRAPELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T
Sbjct: 184 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 243
Query: 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV---PLS 306
NP+ DQLD+IF ++G P + W + +P + + Y L + +
Sbjct: 244 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVK 303
Query: 307 PKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRP- 365
P S A+ LL K+L DP KRIT+ QA++ YF +PLP + Q + YP R
Sbjct: 304 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQ-----IPYPKREF 358
Query: 366 -VDSNTDFEGTTTLQPPQPASGPV-----PGNMAGAHA 397
+ D +G Q Q + PGN HA
Sbjct: 359 LTEEEPDEKGDKKTQQQQQGNNHTNGTGHPGNQDSGHA 396
|
Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex. Phosphorylates CCNH leading to down-regulation of the TFIIH complex and transcriptional repression. Recruited through interaction with MAML1 to hyperphosphorylate the intracellular domain of NOTCH, leading to its degradation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8JH47|CDK8_DANRE Cyclin-dependent kinase 8 OS=Danio rerio GN=cdk8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 294 bits (752), Expect = 1e-78, Method: Compositional matrix adjust.
Identities = 161/354 (45%), Positives = 224/354 (63%), Gaps = 20/354 (5%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
E+ E L +Y K+G GTYG V+ A+ K + + A+K+ +G G+S +A REI
Sbjct: 14 ERVEDLFEYEGC-KVGRGTYGHVYKAKRKDGKD-DRDYALKQI----EGTGISMSACREI 67
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHR-DKVNHT---MNPYT 135
LLRE+ H NV+ L V ++HAD ++L FDYAE+DL+ II+ HR K N +
Sbjct: 68 ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPLQLPRGM 127
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195
VKS+L+Q+L+G++YLH+NW++HRDLKP+NILVMGEG E+G VKIAD G AR+ +PLK L
Sbjct: 128 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLSNSPLKPL 187
Query: 196 SE-NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG-AEAKSTQNPF 253
++ + VVVT WYRAPELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NP+
Sbjct: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 247
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV---PLSPKSP 310
DQLD+IF ++G P + W + +P + + Y L + + P S
Sbjct: 248 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 307
Query: 311 AYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTR 364
A+ LL K+L DP +RIT+ QA++ YF EPLP + Q + YP R
Sbjct: 308 AFHLLQKLLTMDPIRRITSEQAMQDPYFLEEPLPTSDVFAGCQ-----IPYPKR 356
|
Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 477 | ||||||
| 255555647 | 477 | cdk8, putative [Ricinus communis] gi|223 | 0.989 | 0.989 | 0.825 | 0.0 | |
| 225438347 | 481 | PREDICTED: cyclin-dependent kinase E-1 [ | 0.997 | 0.989 | 0.807 | 0.0 | |
| 356508925 | 462 | PREDICTED: cyclin-dependent kinase E-1-l | 0.962 | 0.993 | 0.814 | 0.0 | |
| 224072244 | 469 | predicted protein [Populus trichocarpa] | 0.979 | 0.995 | 0.811 | 0.0 | |
| 224058111 | 469 | predicted protein [Populus trichocarpa] | 0.979 | 0.995 | 0.805 | 0.0 | |
| 449453850 | 484 | PREDICTED: cyclin-dependent kinase E-1-l | 0.985 | 0.971 | 0.786 | 0.0 | |
| 297797359 | 469 | hypothetical protein ARALYDRAFT_919653 [ | 0.945 | 0.961 | 0.808 | 0.0 | |
| 357464813 | 474 | Cyclin-dependent kinase E-1 [Medicago tr | 0.968 | 0.974 | 0.789 | 0.0 | |
| 312282185 | 472 | unnamed protein product [Thellungiella h | 0.943 | 0.953 | 0.803 | 0.0 | |
| 15242829 | 470 | cyclin-dependent kinase E-1 [Arabidopsis | 0.945 | 0.959 | 0.804 | 0.0 |
| >gi|255555647|ref|XP_002518859.1| cdk8, putative [Ricinus communis] gi|223541846|gb|EEF43392.1| cdk8, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 786 bits (2031), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/480 (82%), Positives = 419/480 (87%), Gaps = 8/480 (1%)
Query: 1 MGDGNTS-TGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAI 59
MGDGNTS T RG T SN EKPEWLQQYNLIGKIGEGTYGLVFLA+ K+ ANRGK+IAI
Sbjct: 1 MGDGNTSNTNRGITSNSNTNEKPEWLQQYNLIGKIGEGTYGLVFLAKTKSPANRGKSIAI 60
Query: 60 KKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEI 119
KKFKQSKDGDGVSPTAIREIMLLREI+HENVVKLVNVHINHADMSLYLAFDYAE+DLYEI
Sbjct: 61 KKFKQSKDGDGVSPTAIREIMLLREISHENVVKLVNVHINHADMSLYLAFDYAEHDLYEI 120
Query: 120 IRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179
IRHHRDK H +N YTVKS+LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG+E GVVKI
Sbjct: 121 IRHHRDKGPHGINQYTVKSLLWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGDEHGVVKI 180
Query: 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKP 239
ADFGLARIYQAPLK LS+NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKP
Sbjct: 181 ADFGLARIYQAPLKPLSDNGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKP 240
Query: 240 LFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGL 299
LFQGAEAKS NPFQLDQLDKIFK+LGHPT EKWPTLANLPHWQSD HIQ KYE GL
Sbjct: 241 LFQGAEAKSMPNPFQLDQLDKIFKVLGHPTLEKWPTLANLPHWQSDLQHIQAHKYENTGL 300
Query: 300 HSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVV 359
H+VV LSPK P +DLLSKMLEYDPRKRITAAQALEHEYFRIEPLPG NALVPSQPG+KV+
Sbjct: 301 HNVVHLSPKGPPFDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGCNALVPSQPGEKVI 360
Query: 360 NYPTRPVDSNTDFEGTTTLQPPQPASG--PVPGNMAGAHAVSNRNVPRPMPGVGMQRMQA 417
NYPTRPVD+NTDFEGTT+LQPPQ S V G +AG H V+ R+ PRPMP +GMQRMQ
Sbjct: 361 NYPTRPVDTNTDFEGTTSLQPPQTVSSGNAVSGGIAGGHGVAGRSAPRPMP-MGMQRMQP 419
Query: 418 QGMMTYNFPGQAGAAGGMNPANMPMQRGMPGQAHQQQQLRRKD-PGMGLPGYPPQQKSRR 476
Q M YN QAG GGMNPA +PM RG+ Q HQQ LRRKD PG+G GY PQQKSRR
Sbjct: 420 QAMAAYNIASQAGMGGGMNPAGIPMTRGVAAQPHQQH-LRRKDPPGLGT-GY-PQQKSRR 476
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225438347|ref|XP_002273171.1| PREDICTED: cyclin-dependent kinase E-1 [Vitis vinifera] gi|296082615|emb|CBI21620.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 785 bits (2028), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/482 (80%), Positives = 420/482 (87%), Gaps = 6/482 (1%)
Query: 1 MGDGNTSTGRGGTGTSNHGE--KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIA 58
MGDG T+T G G + KP WLQQY+LIGKIGEGTYGLVFLAR K+ +NRGK+IA
Sbjct: 1 MGDGTTATSNRGGGGNGGSGSNKPAWLQQYDLIGKIGEGTYGLVFLARTKSPSNRGKSIA 60
Query: 59 IKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYE 118
IKKFKQSKDGDGVSPTAIREIMLLREI+HENVVKLVNVHINHADMSLYLAFDYAE+DLYE
Sbjct: 61 IKKFKQSKDGDGVSPTAIREIMLLREISHENVVKLVNVHINHADMSLYLAFDYAEHDLYE 120
Query: 119 IIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178
IIRHHRDKV + ++PYTVKS+LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG+EQGVVK
Sbjct: 121 IIRHHRDKVTNPIHPYTVKSLLWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGDEQGVVK 180
Query: 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK 238
IADFGLARIYQAPLK LS+NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK
Sbjct: 181 IADFGLARIYQAPLKPLSDNGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK 240
Query: 239 PLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNG 298
PLFQGAE K+T NPFQLDQLDKIF++LGHPT EKWPTL NLPHWQSD HIQG KYE G
Sbjct: 241 PLFQGAEVKATPNPFQLDQLDKIFRVLGHPTQEKWPTLVNLPHWQSDVQHIQGHKYENPG 300
Query: 299 LHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPG-DK 357
L+SVV L KS AYDLLSKMLEYDPRKRITAAQAL+HEYFR EPLPGRNALVPSQ G +K
Sbjct: 301 LYSVVHLPLKSAAYDLLSKMLEYDPRKRITAAQALDHEYFRSEPLPGRNALVPSQAGAEK 360
Query: 358 VVNYPTRPVDSNTDFEGTTTLQPPQPASG--PVPGNMAGAHAVSNRNVPRPMPGVGMQRM 415
V+NYPTRPVD+ TDFEGT +LQ QP S V G+MA H V NR+VPRPMP VGMQR+
Sbjct: 361 VMNYPTRPVDTTTDFEGTNSLQTSQPVSSGNAVSGSMAAGHVVPNRSVPRPMPVVGMQRI 420
Query: 416 QAQGMMTYNFPGQAGAAGGMNPANMPMQRGMPGQAHQQQQLRRKDPGMGLPGYPPQQKSR 475
QAQGM YN QA GGMNP ++PMQRG+ QAH QQQ+RRKDPGMG+PGYPPQQKSR
Sbjct: 421 QAQGMSAYNLTSQAAMGGGMNPGSIPMQRGVAAQAH-QQQMRRKDPGMGMPGYPPQQKSR 479
Query: 476 RL 477
R
Sbjct: 480 RF 481
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508925|ref|XP_003523203.1| PREDICTED: cyclin-dependent kinase E-1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 773 bits (1996), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/468 (81%), Positives = 407/468 (86%), Gaps = 9/468 (1%)
Query: 12 GTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV 71
G + ++ KPEWLQQY+LIGKIGEGTYGLVFLARIK++ NRGK+IAIKKFKQSKDGDGV
Sbjct: 2 GDDSGSNRSKPEWLQQYDLIGKIGEGTYGLVFLARIKSSTNRGKSIAIKKFKQSKDGDGV 61
Query: 72 SPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTM 131
SPTAIREIMLLREITHENVVKLVNVHINH DMSLYLAFDYAE+DL+EIIRHHRDKVN ++
Sbjct: 62 SPTAIREIMLLREITHENVVKLVNVHINHMDMSLYLAFDYAEHDLFEIIRHHRDKVNQSI 121
Query: 132 NPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
N YTVKS+LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE GVVKIADFGLARIYQAP
Sbjct: 122 NQYTVKSLLWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEHGVVKIADFGLARIYQAP 181
Query: 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251
LK LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAE K+T N
Sbjct: 182 LKPLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEVKATPN 241
Query: 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
PFQLDQLDKIFK+LGHPT EKWP+LANLPHWQ DS HIQG KY+ L SV+ LSPKSPA
Sbjct: 242 PFQLDQLDKIFKVLGHPTLEKWPSLANLPHWQQDSQHIQGHKYDNASLCSVLQLSPKSPA 301
Query: 312 YDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTD 371
YDLLSKMLEYDPRKRITAAQALEHEYF+IEPLPGRNALVP QPGD VNYPTRPVD+ TD
Sbjct: 302 YDLLSKMLEYDPRKRITAAQALEHEYFKIEPLPGRNALVPCQPGDTFVNYPTRPVDTTTD 361
Query: 372 FEGTTTLQPPQPAS--GPVPGNMAGAHAVSNRNVPRPMPGVGMQRMQAQGMMTYNFPGQA 429
FEGT +QP QP S V GNM G H VSNR+VPRPM GMQR+ Q M YN QA
Sbjct: 362 FEGTANMQPSQPVSSGAAVSGNMPGGH-VSNRSVPRPMNVGGMQRIPHQAMQGYNLSSQA 420
Query: 430 GAAGGMNPANMPMQRGMPGQAHQQQQLRRKDPGMGLPGYPPQQKSRRL 477
G GMNP +PMQRG+P QQQLRRKD MG+PGYPPQQKSRR+
Sbjct: 421 GMGAGMNPGGIPMQRGVP-----QQQLRRKDQ-MGMPGYPPQQKSRRI 462
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224072244|ref|XP_002303670.1| predicted protein [Populus trichocarpa] gi|222841102|gb|EEE78649.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 770 bits (1988), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/478 (81%), Positives = 417/478 (87%), Gaps = 11/478 (2%)
Query: 1 MGDGNTSTGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK 60
MGDGN + SN+ EKPEWLQQYNLIGKIGEGTYGLVFLA+ K+ ANRGK+IAIK
Sbjct: 1 MGDGNNRS-------SNNNEKPEWLQQYNLIGKIGEGTYGLVFLAKTKSPANRGKSIAIK 53
Query: 61 KFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEII 120
KFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH DMSLYLAFDYAE+DLYEII
Sbjct: 54 KFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHTDMSLYLAFDYAEHDLYEII 113
Query: 121 RHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180
RHHRDKVN+ ++ YTVKS+LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE GVVKIA
Sbjct: 114 RHHRDKVNNLIHQYTVKSLLWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEHGVVKIA 173
Query: 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL 240
DFGLARIYQAPLK LS+NGVVVTIWYRAPELLLGAKHYTSA+DMWAVGCIFAELLTLKPL
Sbjct: 174 DFGLARIYQAPLKALSDNGVVVTIWYRAPELLLGAKHYTSAIDMWAVGCIFAELLTLKPL 233
Query: 241 FQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLH 300
FQGAEAKS NPFQLDQLDKIFK+LGHPT EKWPTLA+LPHWQ+D IQ KYE GLH
Sbjct: 234 FQGAEAKSASNPFQLDQLDKIFKVLGHPTLEKWPTLASLPHWQNDVHRIQEHKYENTGLH 293
Query: 301 SVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVN 360
SVVPLSPK +DLLSKMLEYDP+KRITAAQALEH+YFR EPLPGRNALVPSQPG+KV+N
Sbjct: 294 SVVPLSPKGAPFDLLSKMLEYDPQKRITAAQALEHDYFRSEPLPGRNALVPSQPGEKVIN 353
Query: 361 YPTRPVDSNTDFEGTTTLQPPQPASG--PVPGNMAGAHAVSNRNVPRPMPGVGMQRMQAQ 418
YPTRPVD+NTDFEGTT+LQPPQP S V G + GAH V+NR+ PRPMP +G+QRMQ Q
Sbjct: 354 YPTRPVDTNTDFEGTTSLQPPQPVSSGNAVSGGIPGAHGVNNRSAPRPMP-IGLQRMQTQ 412
Query: 419 GMMTYNFPGQAGAAGGMNPANMPMQRGMPGQAHQQQQLRRKDPGMGLPGYPPQQKSRR 476
GM YN QAG GGMNP N+PM RG+ Q HQQ QLRRKDP GYPPQQKSRR
Sbjct: 413 GMTAYNLASQAGMGGGMNPGNIPMPRGV-AQPHQQHQLRRKDPPGTGTGYPPQQKSRR 469
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224058111|ref|XP_002299450.1| predicted protein [Populus trichocarpa] gi|222846708|gb|EEE84255.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 765 bits (1976), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/478 (80%), Positives = 415/478 (86%), Gaps = 11/478 (2%)
Query: 1 MGDGNTSTGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK 60
MGDGN + +N+ EKPEWLQQYNLIGKIGEGTYGLVFLA+ K+ AN GK+IAIK
Sbjct: 1 MGDGNNRS-------NNNSEKPEWLQQYNLIGKIGEGTYGLVFLAKTKSPANCGKSIAIK 53
Query: 61 KFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEII 120
KFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAE+DLYEII
Sbjct: 54 KFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEHDLYEII 113
Query: 121 RHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180
RHHRDK N +N YTVKS+LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE GVVKIA
Sbjct: 114 RHHRDKGNTMINQYTVKSLLWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEHGVVKIA 173
Query: 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL 240
DFGLARIYQAPLK LS+NGVVVTIWYRAPELLLGAKHYTSAVDMWA+GCIFAELLTLKPL
Sbjct: 174 DFGLARIYQAPLKALSDNGVVVTIWYRAPELLLGAKHYTSAVDMWALGCIFAELLTLKPL 233
Query: 241 FQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLH 300
FQGAEAKST PFQ+DQLDKIFK+LGHPT EKWPTLA+LPHW +D HIQ KYE GLH
Sbjct: 234 FQGAEAKSTSIPFQIDQLDKIFKVLGHPTLEKWPTLASLPHWHNDVQHIQEHKYENTGLH 293
Query: 301 SVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVN 360
VVPLSPKS ++DLLSKMLEYDPRKRITAAQA+EH+YFR EPLPGRNALVPSQPG+KV+N
Sbjct: 294 GVVPLSPKSASFDLLSKMLEYDPRKRITAAQAIEHDYFRSEPLPGRNALVPSQPGEKVIN 353
Query: 361 YPTRPVDSNTDFEGTTTLQPPQPASG--PVPGNMAGAHAVSNRNVPRPMPGVGMQRMQAQ 418
YPTRPVD+NTDFEGTT+LQPPQP S V G M GAH +++R+ PRPM VGMQRMQ+Q
Sbjct: 354 YPTRPVDTNTDFEGTTSLQPPQPVSSGNAVSGGMPGAHGINSRSAPRPM-SVGMQRMQSQ 412
Query: 419 GMMTYNFPGQAGAAGGMNPANMPMQRGMPGQAHQQQQLRRKDPGMGLPGYPPQQKSRR 476
GM YN QAG GGMNP N+PM RG+ Q HQQ LRRKDP GYPPQQKSRR
Sbjct: 413 GMAAYNLSSQAGMGGGMNPGNIPMPRGV-AQPHQQHHLRRKDPPGTGTGYPPQQKSRR 469
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449453850|ref|XP_004144669.1| PREDICTED: cyclin-dependent kinase E-1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 762 bits (1967), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/488 (78%), Positives = 412/488 (84%), Gaps = 18/488 (3%)
Query: 1 MGDGNTSTGRG-----------GTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKA 49
MGDGN S RG +H +KPEWLQQY+LIGKIGEGTYGLVFLA+IK
Sbjct: 1 MGDGNNSN-RGLVSANAANRNNNNNNGSHHKKPEWLQQYDLIGKIGEGTYGLVFLAKIKP 59
Query: 50 AA-NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLA 108
+ +RGK+IAIKKFKQSKDGDGVSPTAIREIMLLREI+HENVVKLVNVHINHADMSLYLA
Sbjct: 60 PSPSRGKSIAIKKFKQSKDGDGVSPTAIREIMLLREISHENVVKLVNVHINHADMSLYLA 119
Query: 109 FDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVM 168
FDYAE+DLYEIIRHHRDK NH +N YTVKS+LWQLLNGLNYLHSNWIIHRDLKPSNILVM
Sbjct: 120 FDYAEHDLYEIIRHHRDKANHPLNQYTVKSLLWQLLNGLNYLHSNWIIHRDLKPSNILVM 179
Query: 169 GEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVG 228
GEGEEQGVVKIADFGLARIYQAPLK L ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVG
Sbjct: 180 GEGEEQGVVKIADFGLARIYQAPLKPLFENGVVVTIWYRAPELLLGAKHYTSAVDMWAVG 239
Query: 229 CIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLH 288
CIFAELLTLKPLFQG E K NPFQLDQLDKIFK+LGHPT EKWPTLANLP+WQ D H
Sbjct: 240 CIFAELLTLKPLFQGQEVKGPPNPFQLDQLDKIFKVLGHPTIEKWPTLANLPNWQQDVQH 299
Query: 289 IQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNA 348
IQG KY+ GL++VV LSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR+EPLPG NA
Sbjct: 300 IQGHKYDNAGLYNVVHLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRLEPLPGYNA 359
Query: 349 LVPSQPGDKVVNYPTRPVDSNTDFEGTTTLQPPQPASGPVPGNMAGAHAVSNRNVPRPMP 408
LVP+QPG+KV+NYPTRPVD+ TDFEGTT+LQP Q + NM G H R+VPR M
Sbjct: 360 LVPNQPGEKVINYPTRPVDTTTDFEGTTSLQPSQTVTSGNAVNMQGGHMA--RSVPRAM- 416
Query: 409 GVGMQRMQAQGMMTYNFPGQAGAAGGMNPANMPMQRGMPGQAHQQQQLRRKDPGMGLPGY 468
GVGM RM Q M YN QAG GMNP +PMQRG+ QAHQQQQLRRKDPGMG+PGY
Sbjct: 417 GVGMPRMPHQSMAAYNLASQAGM--GMNPGGIPMQRGVSSQAHQQQQLRRKDPGMGMPGY 474
Query: 469 PPQQKSRR 476
PPQQK +R
Sbjct: 475 PPQQKQQR 482
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297797359|ref|XP_002866564.1| hypothetical protein ARALYDRAFT_919653 [Arabidopsis lyrata subsp. lyrata] gi|297312399|gb|EFH42823.1| hypothetical protein ARALYDRAFT_919653 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1948), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/460 (80%), Positives = 404/460 (87%), Gaps = 9/460 (1%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
EKPEWLQQYNL+GKIGEGTYGLVFLA+ KA R IAIKKFKQSKDGDGVSPTAIREI
Sbjct: 17 EKPEWLQQYNLVGKIGEGTYGLVFLAKTKAPPKR--PIAIKKFKQSKDGDGVSPTAIREI 74
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
MLLREI+HENVVKLVNVHIN ADMSLYLAFDYAEYDLYEIIRHHRDKV H++N YTVKS+
Sbjct: 75 MLLREISHENVVKLVNVHINFADMSLYLAFDYAEYDLYEIIRHHRDKVGHSINTYTVKSL 134
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE G+VKIADFGLARIYQAPLK LS+NG
Sbjct: 135 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEHGIVKIADFGLARIYQAPLKPLSDNG 194
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
VVVTIWYRAPELLLG+KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS+QNPFQLDQLD
Sbjct: 195 VVVTIWYRAPELLLGSKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSSQNPFQLDQLD 254
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
KIFKILGHPT +KWPTL NLPHWQ D HIQ KY++ GLH+VV L+ KSPAYDLLSKML
Sbjct: 255 KIFKILGHPTMDKWPTLVNLPHWQGDVQHIQAHKYDSVGLHNVVHLNQKSPAYDLLSKML 314
Query: 320 EYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFEGTTTLQ 379
EYDP KRITA+QALEHEYFR++PLPGRNA V +QP +K VNYP RPVD+NTDFEGTT++
Sbjct: 315 EYDPLKRITASQALEHEYFRVDPLPGRNAFVATQPMEKNVNYPIRPVDTNTDFEGTTSIN 374
Query: 380 PPQP-ASGPVPGNMAGAHAVSNRNVPRPMPGVGMQRMQAQGMMTYNFPGQAGAAGGMNPA 438
PPQ A+G V GNMAGAH + NR++PRPM MQRMQ QGMM YNFP QA G+NP+
Sbjct: 375 PPQAVAAGNVAGNMAGAHGMGNRSMPRPMVAHNMQRMQPQGMMAYNFPAQA----GLNPS 430
Query: 439 N-MPMQRGMPGQAHQQQQLRRKDPGMGLPGYPPQQKSRRL 477
+ QRGM Q+HQQQQLRRKDPGMG+ GY P KSRRL
Sbjct: 431 VPLQQQRGM-AQSHQQQQLRRKDPGMGMSGYAPPNKSRRL 469
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357464813|ref|XP_003602688.1| Cyclin-dependent kinase E-1 [Medicago truncatula] gi|355491736|gb|AES72939.1| Cyclin-dependent kinase E-1 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1946), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/479 (78%), Positives = 413/479 (86%), Gaps = 17/479 (3%)
Query: 1 MGDGNTSTGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK 60
M DGN S + KPEWLQQY+LIGKIGEGTYGLVFLARIK+ NRGK+IAIK
Sbjct: 1 MADGNRS----------NSNKPEWLQQYDLIGKIGEGTYGLVFLARIKSTTNRGKSIAIK 50
Query: 61 KFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEII 120
KFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH DMSLYLAFDYAE+DLYEII
Sbjct: 51 KFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHTDMSLYLAFDYAEHDLYEII 110
Query: 121 RHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180
RHHRDKVN ++N YTVKSILWQLLNGLNYLHSNWI+HRDLKPSNILVMG+GEE GVVK+A
Sbjct: 111 RHHRDKVNQSINQYTVKSILWQLLNGLNYLHSNWIVHRDLKPSNILVMGDGEEHGVVKVA 170
Query: 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL 240
DFGLARIY APLK LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL
Sbjct: 171 DFGLARIYLAPLKPLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL 230
Query: 241 FQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLH 300
FQGAE K+T NPFQLDQLDKIFK+LGHPT EKWP+LA+LPHW D+ HIQG KY+ L+
Sbjct: 231 FQGAEVKATPNPFQLDQLDKIFKVLGHPTLEKWPSLAHLPHWNQDTSHIQGHKYDNASLN 290
Query: 301 SVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVN 360
SVV LSPKSPAYDLLSKMLEYDP++RITAAQA+EHEYF++EP PGRNALVP QPG+ VN
Sbjct: 291 SVVHLSPKSPAYDLLSKMLEYDPKRRITAAQAMEHEYFKMEPQPGRNALVPCQPGEAFVN 350
Query: 361 YPTRPVDSNTDFEGTTTLQPPQPAS--GPVPGNMAGAHAVSNRNVPRPMPGVGMQRMQAQ 418
YPTRPVD+ TDFEGTT +Q QP S + GNM G HA SNR+VPRP+ VGMQRM
Sbjct: 351 YPTRPVDTTTDFEGTTNMQQSQPVSSGAAIAGNMPGGHA-SNRSVPRPI-NVGMQRMHQ- 407
Query: 419 GMMTYNFPGQAGAAGGMNPANMPMQRGMPGQAHQQQQLRRKDPGMGLPGYPPQQKSRRL 477
+ YN QAG + G+NPA +PMQRG+P QAHQQQQLRRKDP MG+PGYPPQQKSRR+
Sbjct: 408 -LQAYNLTSQAGMSSGINPAGIPMQRGVPQQAHQQQQLRRKDP-MGMPGYPPQQKSRRM 464
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|312282185|dbj|BAJ33958.1| unnamed protein product [Thellungiella halophila] | Back alignment and taxonomy information |
|---|
Score = 749 bits (1933), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/464 (80%), Positives = 406/464 (87%), Gaps = 14/464 (3%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
EKPEWLQQYNL+GKIGEGTYGLVFLAR K R IAIKKFKQSKDGDGVSPTAIREI
Sbjct: 17 EKPEWLQQYNLVGKIGEGTYGLVFLARTKTPPKR--PIAIKKFKQSKDGDGVSPTAIREI 74
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
MLLREI+HENVVKLVNVHIN ADMSLYLAFDYAEYDLYEIIRHHRDKV H++N YTVKS+
Sbjct: 75 MLLREISHENVVKLVNVHINFADMSLYLAFDYAEYDLYEIIRHHRDKVGHSLNQYTVKSL 134
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG+E G+VKIADFGLARIYQAPLK LS+NG
Sbjct: 135 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGDEHGIVKIADFGLARIYQAPLKPLSDNG 194
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
VVVTIWYRAPELLLG+KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS+QNPFQ+DQLD
Sbjct: 195 VVVTIWYRAPELLLGSKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSSQNPFQVDQLD 254
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
KIFKILGHPT EKWPTL NLPHWQ+D HIQ KY++ GLH+VV L+ KSPAYDLLSKML
Sbjct: 255 KIFKILGHPTMEKWPTLVNLPHWQADLQHIQAHKYDSAGLHNVVHLNLKSPAYDLLSKML 314
Query: 320 EYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFEGTTTLQ 379
EYDP KRITA+QALEHEYFR++PLPGRNA V SQP +K V+YPTRPVD+NTDFEGTT++
Sbjct: 315 EYDPLKRITASQALEHEYFRMDPLPGRNAFVASQPMEKNVSYPTRPVDTNTDFEGTTSIN 374
Query: 380 PPQP-ASGPVPGNMAGAHAVSNRNVPRPMPGVGMQRMQAQGMMTYNFPGQAGAAGGMNPA 438
PPQ A+G V GNMAGAH + +R++PRPM MQRMQ QGMM YNFP Q GGMNP+
Sbjct: 375 PPQAVAAGNVAGNMAGAHGMGSRSMPRPMVAHNMQRMQPQGMMAYNFPAQ----GGMNPS 430
Query: 439 NMPM-----QRGMPGQAHQQQQLRRKDPGMGLPGYPPQQKSRRL 477
+PM QRGM Q HQQQQLRRKDPGMG+ GY P K+RRL
Sbjct: 431 -VPMQQQQQQRGM-AQPHQQQQLRRKDPGMGMSGYAPPNKTRRL 472
|
Source: Thellungiella halophila Species: Eutrema halophilum Genus: Eutrema Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15242829|ref|NP_201166.1| cyclin-dependent kinase E-1 [Arabidopsis thaliana] gi|152013387|sp|Q84TI6.2|CDKE1_ARATH RecName: Full=Cyclin-dependent kinase E-1; Short=CDKE;1; AltName: Full=Cyclin-dependent kinase 8; AltName: Full=Protein HUA ENHANCER 3 gi|10177042|dbj|BAB10454.1| cdc2-like protein kinase-like protein [Arabidopsis thaliana] gi|47607488|gb|AAT36644.1| HUA enhancer 3 [Arabidopsis thaliana] gi|56382025|gb|AAV85731.1| At5g63610 [Arabidopsis thaliana] gi|332010393|gb|AED97776.1| cyclin-dependent kinase E-1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1931), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/461 (80%), Positives = 404/461 (87%), Gaps = 10/461 (2%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
EKPEWLQQYNL+GKIGEGTYGLVFLAR K R IAIKKFKQSKDGDGVSPTAIREI
Sbjct: 17 EKPEWLQQYNLVGKIGEGTYGLVFLARTKTPPKR--PIAIKKFKQSKDGDGVSPTAIREI 74
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
MLLREI+HENVVKLVNVHIN ADMSLYLAFDYAEYDLYEIIRHHRDKV H++N YTVKS+
Sbjct: 75 MLLREISHENVVKLVNVHINFADMSLYLAFDYAEYDLYEIIRHHRDKVGHSLNTYTVKSL 134
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
LWQLLNGLNYLHSNWIIHRDLKPSNILVMG+ EE G+VKIADFGLARIYQAPLK LS+NG
Sbjct: 135 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGDAEEHGIVKIADFGLARIYQAPLKPLSDNG 194
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
VVVTIWYRAPELLLG+KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS+QNPFQLDQLD
Sbjct: 195 VVVTIWYRAPELLLGSKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSSQNPFQLDQLD 254
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
KIFKILGHPT +KWPTL NLPHWQ+D HIQ KY++ GLH+VV L+ KSPAYDLLSKML
Sbjct: 255 KIFKILGHPTMDKWPTLVNLPHWQNDVQHIQAHKYDSVGLHNVVHLNQKSPAYDLLSKML 314
Query: 320 EYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFEGTTTLQ 379
EYDP KRITA+QALEHEYFR++PLPGRNA V SQP +K VNYPTRPVD+NTDFEGTT++
Sbjct: 315 EYDPLKRITASQALEHEYFRMDPLPGRNAFVASQPMEKNVNYPTRPVDTNTDFEGTTSIN 374
Query: 380 PPQP-ASGPVPGNMAGAHAVSNRNVPRPMPGVGMQRM-QAQGMMTYNFPGQAGAAGGMNP 437
PPQ A+G V GNMAGAH + +R++PRPM MQRM Q+QGMM YNFP QA G+NP
Sbjct: 375 PPQAVAAGNVAGNMAGAHGMGSRSMPRPMVAHNMQRMQQSQGMMAYNFPAQA----GLNP 430
Query: 438 AN-MPMQRGMPGQAHQQQQLRRKDPGMGLPGYPPQQKSRRL 477
+ + QRGM Q HQQQQLRRKDPGMG+ GY P KSRRL
Sbjct: 431 SVPLQQQRGM-AQPHQQQQLRRKDPGMGMSGYAPPNKSRRL 470
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 477 | ||||||
| TAIR|locus:2160609 | 470 | CDKE;1 "cyclin-dependent kinas | 0.947 | 0.961 | 0.793 | 8.1e-195 | |
| DICTYBASE|DDB_G0267442 | 380 | cdk8 "protein kinase, CMGC gro | 0.687 | 0.863 | 0.550 | 3.7e-96 | |
| UNIPROTKB|Q9BWU1 | 502 | CDK19 "Cyclin-dependent kinase | 0.758 | 0.721 | 0.449 | 2.1e-77 | |
| FB|FBgn0015618 | 454 | Cdk8 "Cyclin-dependent kinase | 0.704 | 0.740 | 0.457 | 2.7e-77 | |
| MGI|MGI:1925584 | 501 | Cdk19 "cyclin-dependent kinase | 0.752 | 0.716 | 0.451 | 3.4e-77 | |
| MGI|MGI:1196224 | 464 | Cdk8 "cyclin-dependent kinase | 0.769 | 0.790 | 0.436 | 7.1e-77 | |
| UNIPROTKB|Q17IE8 | 501 | Cdk8 "Cyclin-dependent kinase | 0.710 | 0.676 | 0.453 | 2.4e-76 | |
| UNIPROTKB|E1C2T0 | 467 | CDK8 "Uncharacterized protein" | 0.737 | 0.753 | 0.446 | 5e-76 | |
| UNIPROTKB|E2RMV5 | 464 | CDK8 "Uncharacterized protein" | 0.767 | 0.788 | 0.435 | 5e-76 | |
| UNIPROTKB|P49336 | 464 | CDK8 "Cyclin-dependent kinase | 0.767 | 0.788 | 0.435 | 5e-76 |
| TAIR|locus:2160609 CDKE;1 "cyclin-dependent kinase E;1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1887 (669.3 bits), Expect = 8.1e-195, P = 8.1e-195
Identities = 365/460 (79%), Positives = 395/460 (85%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
EKPEWLQQYNL+GKIGEGTYGLVFLAR K R IAIKKFKQSKDGDGVSPTAIREI
Sbjct: 17 EKPEWLQQYNLVGKIGEGTYGLVFLARTKTPPKR--PIAIKKFKQSKDGDGVSPTAIREI 74
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
MLLREI+HENVVKLVNVHIN ADMSLYLAFDYAEYDLYEIIRHHRDKV H++N YTVKS+
Sbjct: 75 MLLREISHENVVKLVNVHINFADMSLYLAFDYAEYDLYEIIRHHRDKVGHSLNTYTVKSL 134
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
LWQLLNGLNYLHSNWIIHRDLKPSNILVMG+ EE G+VKIADFGLARIYQAPLK LS+NG
Sbjct: 135 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGDAEEHGIVKIADFGLARIYQAPLKPLSDNG 194
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
VVVTIWYRAPELLLG+KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS+QNPFQLDQLD
Sbjct: 195 VVVTIWYRAPELLLGSKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSSQNPFQLDQLD 254
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
KIFKILGHPT +KWPTL NLPHWQ+D HIQ KY++ GLH+VV L+ KSPAYDLLSKML
Sbjct: 255 KIFKILGHPTMDKWPTLVNLPHWQNDVQHIQAHKYDSVGLHNVVHLNQKSPAYDLLSKML 314
Query: 320 EYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFEGTTTLQ 379
EYDP KRITA+QALEHEYFR++PLPGRNA V SQP +K VNYPTRPVD+NTDFEGTT++
Sbjct: 315 EYDPLKRITASQALEHEYFRMDPLPGRNAFVASQPMEKNVNYPTRPVDTNTDFEGTTSIN 374
Query: 380 PPQP-ASGPVPGNMAGAHAVSNRNVPRPMPGVGMQRMQ-AQGMMTYNFXXXXXXXXXXXX 437
PPQ A+G V GNMAGAH + +R++PRPM MQRMQ +QGMM YNF
Sbjct: 375 PPQAVAAGNVAGNMAGAHGMGSRSMPRPMVAHNMQRMQQSQGMMAYNFPAQAGLNPSVPL 434
Query: 438 XXXXXQRGMPGQAHQQQQLRRKDPGMGLPGYPPQQKSRRL 477
QRGM Q HQQQQLRRKDPGMG+ GY P KSRRL
Sbjct: 435 QQ---QRGM-AQPHQQQQLRRKDPGMGMSGYAPPNKSRRL 470
|
|
| DICTYBASE|DDB_G0267442 cdk8 "protein kinase, CMGC group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 956 (341.6 bits), Expect = 3.7e-96, P = 3.7e-96
Identities = 190/345 (55%), Positives = 254/345 (73%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y +IG GTYG+V+ A K N +A+KKF+ +K+G+G+S TA REI LL+E+
Sbjct: 42 EKYTFSYEIGSGTYGMVYKADDKKRPNN--KVAVKKFRSTKEGEGLSLTAYREIGLLKEL 99
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
++EN+VKL++V +N D LYL FDYAE+DL+ II++HR+ +H + T+KS++WQ+LN
Sbjct: 100 SNENIVKLLDVCLNPKDKLLYLIFDYAEFDLFGIIKYHRENGSH-FSDATIKSLIWQVLN 158
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
G++YLHSNW+IHRDLKPSNILVMGEG+E G VKI DFGLARI+Q+PLK L+ENGVVVTIW
Sbjct: 159 GIHYLHSNWVIHRDLKPSNILVMGEGKECGTVKIGDFGLARIFQSPLKPLNENGVVVTIW 218
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP--FQLDQLDKIFK 263
YR+PELLLG+KHYT AVD+WA+GCIFAEL+T KPLF G E K + P FQ DQ++KI +
Sbjct: 219 YRSPELLLGSKHYTRAVDIWAIGCIFAELITTKPLFPGKE-KDPKIPSLFQDDQVEKIIR 277
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
+LG PT + WP + +LP W+ + + N L V + S AYDLLSKM+ YDP
Sbjct: 278 VLGKPTLDMWPDIKHLPEWK----RLSSMEAFPNSLAKCVGIDENSQAYDLLSKMILYDP 333
Query: 324 RKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTR-PVD 367
KRITA++AL+H YF+ PLP NA S+P + YP R P++
Sbjct: 334 SKRITASEALDHPYFKELPLPLPNAF--SKP----IPYPPRLPIN 372
|
|
| UNIPROTKB|Q9BWU1 CDK19 "Cyclin-dependent kinase 19" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 779 (279.3 bits), Expect = 2.1e-77, P = 2.1e-77
Identities = 173/385 (44%), Positives = 240/385 (62%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
E+ E L +Y K+G GTYG V+ AR K + K A+K+ +G G+S +A REI
Sbjct: 14 ERVEDLFEYEGC-KVGRGTYGHVYKARRKDGKDE-KEYALKQI----EGTGISMSACREI 67
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHR-DKVNHT-MN-PYT- 135
LLRE+ H NV+ L V ++H+D ++L FDYAE+DL+ II+ HR K N M P +
Sbjct: 68 ALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSM 127
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195
VKS+L+Q+L+G++YLH+NW++HRDLKP+NILVMGEG E+G VKIAD G AR++ +PLK L
Sbjct: 128 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 187
Query: 196 SE-NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ-GAEAKSTQNPF 253
++ + VVVT WYRAPELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NPF
Sbjct: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPF 247
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP---LSPKSP 310
DQLD+IF ++G P + W + +P + + + Y + L + + P S
Sbjct: 248 HHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSK 307
Query: 311 AYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQ---PGDKVVNY--PTRP 365
+ LL K+L DP KRIT+ QAL+ YF+ +PLP + Q P + +N P
Sbjct: 308 VFLLLQKLLTMDPTKRITSEQALQDPYFQEDPLPTLDVFAGCQIPYPKREFLNEDDPEEK 367
Query: 366 VDSNTDFEGTTTLQP---PQPASGP 387
D N + QP PQ A+ P
Sbjct: 368 GDKNQQQQQNQHQQPTAPPQQAAAP 392
|
|
| FB|FBgn0015618 Cdk8 "Cyclin-dependent kinase 8" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 778 (278.9 bits), Expect = 2.7e-77, P = 2.7e-77
Identities = 163/356 (45%), Positives = 231/356 (64%)
Query: 28 YNLIG-KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+N G K+G GTYG V+ A+ K ++ GK A+K+ DG G+S +A REI LLRE+
Sbjct: 20 FNYEGCKVGRGTYGHVYKAKWKETSD-GKEYALKQI----DGTGLSMSACREIALLRELK 74
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHR----DKVNHTMNPYTVKSILWQ 142
H+NV+ L+ V ++H D ++L DYAE+DL+ II+ HR K + VKS+L+Q
Sbjct: 75 HQNVITLIRVFLSHNDRKVFLLIDYAEHDLWHIIKFHRAAKATKKQVVVPRGMVKSLLYQ 134
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE-NGVV 201
+L+G++YLHSNW++HRDLKP+NILVMG+G E+G VKIAD G AR++ APLK L++ + VV
Sbjct: 135 ILDGIHYLHSNWVLHRDLKPANILVMGDGNERGRVKIADMGFARLFNAPLKPLADLDPVV 194
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ-GAEAKSTQNPFQLDQLDK 260
VT WYRAPELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NP+ DQLD+
Sbjct: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 254
Query: 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP---LSPKSPAYDLLSK 317
IF ++G P + W + +P + + + Y T L + + P S A+ LL K
Sbjct: 255 IFNVMGFPQDKDWEDIKKMPEHHTLTKDFKRSTYSTCSLAKYMERHKIKPDSKAFHLLQK 314
Query: 318 MLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFE 373
+L DP KRIT+ QA++ +YF+ EP P ++ P + YP R ++ D E
Sbjct: 315 LLLMDPNKRITSEQAMQDQYFQEEPQPTQDVFAGC-P----IPYPKREFLTDDDQE 365
|
|
| MGI|MGI:1925584 Cdk19 "cyclin-dependent kinase 19" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 777 (278.6 bits), Expect = 3.4e-77, P = 3.4e-77
Identities = 171/379 (45%), Positives = 237/379 (62%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
E+ E L +Y K+G GTYG V+ AR K + K A+K+ +G G+S +A REI
Sbjct: 14 ERVEDLFEYEGC-KVGRGTYGHVYKARRKDGKDE-KEYALKQI----EGTGISMSACREI 67
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHR-DKVNHT-MN-PYT- 135
LLRE+ H NV+ L V ++H+D ++L FDYAE+DL+ II+ HR K N M P +
Sbjct: 68 ALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSM 127
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195
VKS+L+Q+L+G++YLH+NW++HRDLKP+NILVMGEG E+G VKIAD G AR++ +PLK L
Sbjct: 128 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 187
Query: 196 SE-NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ-GAEAKSTQNPF 253
++ + VVVT WYRAPELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NPF
Sbjct: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPF 247
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP---LSPKSP 310
DQLD+IF ++G P + W + +P + + + Y + L + + P S
Sbjct: 248 HHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSK 307
Query: 311 AYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQ---PGDKVVNY--PTRP 365
+ LL K+L DP KRIT+ QAL+ YF+ +PLP + Q P + +N P
Sbjct: 308 VFLLLQKLLTMDPTKRITSEQALQDPYFQEDPLPTLDVFAGCQIPYPKREFLNEDEPEEK 367
Query: 366 VDSNTDFEGTTTLQPPQPA 384
D N + QP PA
Sbjct: 368 GDKNQPQQQNPHQQPAAPA 386
|
|
| MGI|MGI:1196224 Cdk8 "cyclin-dependent kinase 8" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 774 (277.5 bits), Expect = 7.1e-77, P = 7.1e-77
Identities = 172/394 (43%), Positives = 238/394 (60%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
E+ E L +Y K+G GTYG V+ A+ K + K A+K+ +G G+S +A REI
Sbjct: 14 ERVEDLFEYEGC-KVGRGTYGHVYKAKRKDGKD-DKDYALKQI----EGTGISMSACREI 67
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHR-DKVNH--TMNPY-T 135
LLRE+ H NV+ L+ V ++HAD ++L FDYAE+DL+ II+ HR K N P
Sbjct: 68 ALLRELKHPNVISLLKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 127
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195
VKS+L+Q+L+G++YLH+NW++HRDLKP+NILVMGEG E+G VKIAD G AR++ +PLK L
Sbjct: 128 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 187
Query: 196 SE-NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ-GAEAKSTQNPF 253
++ + VVVT WYRAPELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NP+
Sbjct: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 247
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP---LSPKSP 310
DQLD+IF ++G P + W + +P + + Y L + + P S
Sbjct: 248 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 307
Query: 311 AYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRP--VDS 368
A+ LL K+L DP KRIT+ QA++ YF +PLP + Q + YP R +
Sbjct: 308 AFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQ-----IPYPKREFLTEE 362
Query: 369 NTDFEGTTTLQPPQPASGPV-----PGNMAGAHA 397
D +G Q Q + PGN HA
Sbjct: 363 EPDEKGDKKTQQQQQGNNHTNGTGHPGNQDSGHA 396
|
|
| UNIPROTKB|Q17IE8 Cdk8 "Cyclin-dependent kinase 8" [Aedes aegypti (taxid:7159)] | Back alignment and assigned GO terms |
|---|
Score = 769 (275.8 bits), Expect = 2.4e-76, P = 2.4e-76
Identities = 164/362 (45%), Positives = 227/362 (62%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
K+G GTYG V+ A K + N K A+K+ +G G+S +A REI LLRE+ H NV+
Sbjct: 26 KVGRGTYGHVYKAHRKES-NDTKDYALKQI----EGTGLSMSACREIALLRELKHPNVIN 80
Query: 93 LVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTV-----KSILWQLLNGL 147
L+ V ++H D ++L FDYAE+DL+ II+ HR T P V KS+L+Q+L+G+
Sbjct: 81 LIRVFLSHTDRKVWLLFDYAEHDLWHIIKFHR-AAKATKKPVMVPKGMVKSLLYQILDGI 139
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE-NGVVVTIWY 206
+YLHSNW++HRDLKP+NILVMGEG E+G VKIAD G AR++ APLK L++ + VVVT WY
Sbjct: 140 HYLHSNWVLHRDLKPANILVMGEGNERGRVKIADMGFARLFNAPLKPLADLDPVVVTFWY 199
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ-GAEAKSTQNPFQLDQLDKIFKIL 265
RAPELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NP+ DQLD+IF ++
Sbjct: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 259
Query: 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP---LSPKSPAYDLLSKMLEYD 322
G P + W + +P + + + Y L + + P S A+ LL K+L D
Sbjct: 260 GFPQDKDWEDIRKMPEHHTLTKDFKRSNYANCSLVKYMERHKIKPDSKAFHLLQKLLLMD 319
Query: 323 PRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRP--VDSNTDFEGTTTLQP 380
P KRIT+ QA++ YF +P+P + P + YP R D + D +G + Q
Sbjct: 320 PNKRITSEQAMQDPYFSEDPMPTADVFAGC-P----IPYPKREFLTDEDQDDKGESKRQQ 374
Query: 381 PQ 382
Q
Sbjct: 375 QQ 376
|
|
| UNIPROTKB|E1C2T0 CDK8 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 766 (274.7 bits), Expect = 5.0e-76, P = 5.0e-76
Identities = 167/374 (44%), Positives = 233/374 (62%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
E+ E L +Y K+G GTYG V+ A+ K + K A+K+ +G G+S +A REI
Sbjct: 14 ERVEDLFEYEGC-KVGRGTYGHVYKAKRKDGKD-DKDYALKQI----EGTGISMSACREI 67
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHR-DKVNH--TMNPY-T 135
LLRE+ H NV+ L V ++HAD ++L FDYAE+DL+ II+ HR K N P
Sbjct: 68 ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 127
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195
VKS+L+Q+L+G++YLH+NW++HRDLKP+NILVMGEG E+G VKIAD G AR++ +PLK L
Sbjct: 128 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 187
Query: 196 SE-NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ-GAEAKSTQNPF 253
++ + VVVT WYRAPELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NP+
Sbjct: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 247
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP---LSPKSP 310
DQLD+IF ++G P + W + +P + + Y L + + P S
Sbjct: 248 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 307
Query: 311 AYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRP--VDS 368
A+ LL K+L DP KRIT+ QA++ YF +PLP + Q + YP R +
Sbjct: 308 AFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQ-----IPYPKREFLTEE 362
Query: 369 NTDFEGTTTLQPPQ 382
D +G T++ Q
Sbjct: 363 EPDDKGDKTIEKNQ 376
|
|
| UNIPROTKB|E2RMV5 CDK8 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 766 (274.7 bits), Expect = 5.0e-76, P = 5.0e-76
Identities = 171/393 (43%), Positives = 237/393 (60%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
E+ E L +Y K+G GTYG V+ A+ K + K A+K+ +G G+S +A REI
Sbjct: 14 ERVEDLFEYEGC-KVGRGTYGHVYKAKRKDGKD-DKDYALKQI----EGTGISMSACREI 67
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHR-DKVNH--TMNPY-T 135
LLRE+ H NV+ L V ++HAD ++L FDYAE+DL+ II+ HR K N P
Sbjct: 68 ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 127
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195
VKS+L+Q+L+G++YLH+NW++HRDLKP+NILVMGEG E+G VKIAD G AR++ +PLK L
Sbjct: 128 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 187
Query: 196 SE-NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ-GAEAKSTQNPF 253
++ + VVVT WYRAPELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NP+
Sbjct: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 247
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP---LSPKSP 310
DQLD+IF ++G P + W + +P + + Y L + + P S
Sbjct: 248 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 307
Query: 311 AYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRP--VDS 368
A+ LL K+L DP KRIT+ QA++ YF +PLP + Q + YP R +
Sbjct: 308 AFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQ-----IPYPKREFLTEE 362
Query: 369 NTDFEGTTTLQPPQPASGPV-----PGNMAGAH 396
D +G Q Q + PGN +H
Sbjct: 363 EPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSH 395
|
|
| UNIPROTKB|P49336 CDK8 "Cyclin-dependent kinase 8" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 766 (274.7 bits), Expect = 5.0e-76, P = 5.0e-76
Identities = 171/393 (43%), Positives = 237/393 (60%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
E+ E L +Y K+G GTYG V+ A+ K + K A+K+ +G G+S +A REI
Sbjct: 14 ERVEDLFEYEGC-KVGRGTYGHVYKAKRKDGKD-DKDYALKQI----EGTGISMSACREI 67
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHR-DKVNH--TMNPY-T 135
LLRE+ H NV+ L V ++HAD ++L FDYAE+DL+ II+ HR K N P
Sbjct: 68 ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 127
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195
VKS+L+Q+L+G++YLH+NW++HRDLKP+NILVMGEG E+G VKIAD G AR++ +PLK L
Sbjct: 128 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 187
Query: 196 SE-NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ-GAEAKSTQNPF 253
++ + VVVT WYRAPELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NP+
Sbjct: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 247
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP---LSPKSP 310
DQLD+IF ++G P + W + +P + + Y L + + P S
Sbjct: 248 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 307
Query: 311 AYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRP--VDS 368
A+ LL K+L DP KRIT+ QA++ YF +PLP + Q + YP R +
Sbjct: 308 AFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQ-----IPYPKREFLTEE 362
Query: 369 NTDFEGTTTLQPPQPASGPV-----PGNMAGAH 396
D +G Q Q + PGN +H
Sbjct: 363 EPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSH 395
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q95YH0 | CDK8_DICDI | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5542 | 0.6813 | 0.8552 | yes | no |
| Q84TI6 | CDKE1_ARATH | 2, ., 7, ., 1, 1, ., 2, 3 | 0.8047 | 0.9454 | 0.9595 | yes | no |
| Q336M2 | CDKE1_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7459 | 0.9664 | 0.9705 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.22 | 0.979 |
| 3rd Layer | 2.7.11.23 | 0.979 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 477 | |||
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 0.0 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-136 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-117 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-113 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-110 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-104 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-103 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-97 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-96 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-94 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-93 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-93 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-93 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-92 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-90 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-90 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-87 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-87 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-87 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-86 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-86 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-85 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-85 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-83 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-82 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-80 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-79 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-77 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-76 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-75 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-69 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-69 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-68 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-67 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-67 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-67 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-67 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-66 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-65 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-64 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-64 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-61 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-61 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-57 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-57 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-55 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-55 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-54 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-53 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-52 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-51 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-50 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-48 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-48 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-46 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-46 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-43 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-41 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-40 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-36 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-34 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-34 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-31 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-29 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-29 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-27 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-20 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-19 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-19 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-18 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-18 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-16 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-08 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-05 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.003 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.004 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 532 bits (1373), Expect = 0.0
Identities = 180/317 (56%), Positives = 230/317 (72%), Gaps = 6/317 (1%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREI 85
+Y + G IG GTYG V+ A+ K GK AIKKFK K+ G+S +A REI LLRE+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLREL 59
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
HENVV LV V + HAD S+YL FDYAE+DL++II+ HR ++ P VKS+LWQ+LN
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK-FLSENGVVVTI 204
G++YLHSNW++HRDLKP+NILVMGEG E+GVVKI D GLAR++ APLK + VVVTI
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS-TQNPFQLDQLDKIFK 263
WYRAPELLLGA+HYT A+D+WA+GCIFAELLTL+P+F+G EAK NPFQ DQL++IF+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPL--SPKSPAYDLLSKMLEY 321
+LG PT + WP + +P + + + + Y +N L + P S +DLL K+LEY
Sbjct: 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299
Query: 322 DPRKRITAAQALEHEYF 338
DP KRITA +ALEH YF
Sbjct: 300 DPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 393 bits (1013), Expect = e-136
Identities = 146/312 (46%), Positives = 205/312 (65%), Gaps = 31/312 (9%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y + K+GEGTYG+V+ AR K G+ +A+KK + + +G+ TA+REI LL+E+ H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDK---KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH 57
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
N+VKL++V H + LYL F+Y + DL + + ++P +KSI++QLL GL
Sbjct: 58 PNIVKLLDVI--HTERKLYLVFEYCDMDLKKYLDKRPGP----LSPNLIKSIMYQLLRGL 111
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYR 207
Y HS+ I+HRDLKP NIL+ +G V+K+ADFGLAR + PL+ + VVT+WYR
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDG----VLKLADFGLARAFGIPLRTYTHE--VVTLWYR 165
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267
APE+LLG+KHY++AVD+W+VGCIFAE++T KPLF G S ++DQL KIF+ILG
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG---DS-----EIDQLFKIFQILGT 217
Query: 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYDPRKR 326
PT E WP + LP ++ K+ L V+P L P+ DLLSKML+Y+P KR
Sbjct: 218 PTEESWPGVTKLPDYKPTF-----PKFPPKDLEKVLPRLDPE--GIDLLSKMLQYNPAKR 270
Query: 327 ITAAQALEHEYF 338
I+A +AL+H YF
Sbjct: 271 ISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 344 bits (886), Expect = e-117
Identities = 138/321 (42%), Positives = 195/321 (60%), Gaps = 33/321 (10%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFK---QSKDGDGVSPTAIREIMLLR 83
+Y K+GEGTY +V+ AR K G+ +AIKK K + + DG++ TA+REI LL+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDK---ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQ 57
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
E+ H N++ L++V ++ L F++ E DL ++I+ DK + + P +KS +
Sbjct: 58 ELKHPNIIGLLDVFG--HKSNINLVFEFMETDLEKVIK---DK-SIVLTPADIKSYMLMT 111
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
L GL YLHSNWI+HRDLKP+N+L+ GV+K+ADFGLAR + +P + ++ VVT
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLI----ASDGVLKLADFGLARSFGSPNRKMTHQ--VVT 165
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
WYRAPELL GA+HY VDMW+VGCIFAELL P G + +DQL KIF+
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG------DSD--IDQLGKIFE 217
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
LG PT E WP + +LP +++ + + L + P + A DLL ++L +P
Sbjct: 218 ALGTPTEENWPGVTSLP------DYVEFKPFPPTPLKQIFPAASDD-ALDLLQRLLTLNP 270
Query: 324 RKRITAAQALEHEYFRIEPLP 344
KRITA QALEH YF +P P
Sbjct: 271 NKRITARQALEHPYFSNDPAP 291
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 334 bits (859), Expect = e-113
Identities = 132/311 (42%), Positives = 182/311 (58%), Gaps = 24/311 (7%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y I +IGEGTYG V+ AR K G+ +A+KK + + +G TAIREI LL+++ H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNK---KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH 57
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
N+V+L + + S+Y+ F+Y ++DL ++ +K + QLL GL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSP----EVKFTESQIKCYMKQLLEGL 113
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYR 207
YLHSN I+HRD+K SNIL+ GV+K+ADFGLAR Y N V+ T+WYR
Sbjct: 114 QYLHSNGILHRDIKGSNILINN----DGVLKLADFGLARPYTKRNSADYTNRVI-TLWYR 168
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267
PELLLGA Y VDMW+VGCI AEL KP+FQG+ +L+QL+KIF++ G
Sbjct: 169 PPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST--------ELEQLEKIFELCGS 220
Query: 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI 327
PT E WP ++ LP +++ + Y+ L A DLL K+L DP+KRI
Sbjct: 221 PTDENWPGVSKLPWFENLK---PKKPYK-RRLREFFKHLIDPSALDLLDKLLTLDPKKRI 276
Query: 328 TAAQALEHEYF 338
+A QAL+HEYF
Sbjct: 277 SADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 327 bits (841), Expect = e-110
Identities = 139/319 (43%), Positives = 199/319 (62%), Gaps = 40/319 (12%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y + +I EGTYG+V+ AR K G+ +A+KK K K+ +G T++REI +L ++ H
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKT---GEIVALKKLKMEKEKEGFPITSLREINILLKLQH 63
Query: 88 ENVVKL----VNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYT---VKSIL 140
N+V + V +++ +Y+ +Y E+DL ++ + P+ VK ++
Sbjct: 64 PNIVTVKEVVVGSNLDK----IYMVMEYVEHDLKSLMETMKQ-------PFLQSEVKCLM 112
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
QLL+G+ +LH NWI+HRDLK SN+L+ +G++KI DFGLAR Y +PLK ++
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLL----NNRGILKICDFGLAREYGSPLKPYTQL-- 166
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
VVT+WYRAPELLLGAK Y++A+DMW+VGCIFAELLT KPLF G KS ++DQL+K
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG---KS-----EIDQLNK 218
Query: 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA-YDLLSKML 319
IFK+LG PT + WP + LP + + KY N L P S +DLL+++L
Sbjct: 219 IFKLLGTPTEKIWPGFSELPGAKKKTF----TKYPYNQLRKKFPALSLSDNGFDLLNRLL 274
Query: 320 EYDPRKRITAAQALEHEYF 338
YDP KRI+A AL+H YF
Sbjct: 275 TYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 312 bits (801), Expect = e-104
Identities = 146/312 (46%), Positives = 198/312 (63%), Gaps = 30/312 (9%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y +GKIGEGTYG+V+ AR G+ +AIKK K + +G+ TA+REI LL+E+ H
Sbjct: 1 YQKLGKIGEGTYGVVYKAR---DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH 57
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
N++KL++V H LYL F++ + DLY++I+ + + ++ +KS L+QLL GL
Sbjct: 58 PNIIKLLDV-FRHKG-DLYLVFEFMDTDLYKLIKDRQRGLPESL----IKSYLYQLLQGL 111
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYR 207
+ HS+ I+HRDLKP N+L+ EG V+K+ADFGLAR + +P++ + VVT WYR
Sbjct: 112 AFCHSHGILHRDLKPENLLINTEG----VLKLADFGLARSFGSPVRPYTHY--VVTRWYR 165
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267
APELLLG K Y++ VD+W+VGCIFAELL+ +PLF G KS ++DQL KIF+ LG
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG---KS-----EIDQLFKIFRTLGT 217
Query: 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYDPRKR 326
P PE WP +L + K L + P SP A DLLS+ML YDP KR
Sbjct: 218 PDPEVWPKFTSLA----RNYKFSFPKKAGMPLPKLFPNASP--QALDLLSQMLHYDPHKR 271
Query: 327 ITAAQALEHEYF 338
ITA QAL H YF
Sbjct: 272 ITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 310 bits (795), Expect = e-103
Identities = 135/314 (42%), Positives = 199/314 (63%), Gaps = 34/314 (10%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y + KIGEGTYG+V+ AR K G+ +A+KK + + +GV TAIREI LL+E+ H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLT---GEIVALKKIRLETEDEGVPSTAIREISLLKELNH 57
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHT-MNPYTVKSILWQLLNG 146
N+V+L++V H++ LYL F++ + DL + + D T ++P +KS L+QLL G
Sbjct: 58 PNIVRLLDVV--HSENKLYLVFEFLDLDL----KKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK-FLSENGVVVTIW 205
+ Y HS+ ++HRDLKP N+L+ + +G +K+ADFGLAR + P++ + E VVT+W
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLI----DREGALKLADFGLARAFGVPVRTYTHE---VVTLW 164
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265
YRAPE+LLG++ Y++ VD+W++GCIFAE++ +PLF G ++DQL +IF+ L
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS--------EIDQLFRIFRTL 216
Query: 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYDPR 324
G P + WP + +LP ++ K+ L VVP L DLLSKML YDP
Sbjct: 217 GTPDEDVWPGVTSLPDYKP-----TFPKWARQDLSKVVPNLDED--GLDLLSKMLVYDPA 269
Query: 325 KRITAAQALEHEYF 338
KRI+A AL+H YF
Sbjct: 270 KRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 294 bits (755), Expect = 2e-97
Identities = 131/317 (41%), Positives = 186/317 (58%), Gaps = 36/317 (11%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT- 86
Y + +IGEG YG V+ AR N G+ +A+KK + +G+ + +REI LL+++
Sbjct: 1 YEELAEIGEGAYGTVYKARDL---NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES 57
Query: 87 --HENVVKLVNV-HINHAD--MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILW 141
H N+V+L++V H D + L L F++ + DL + + P T+K ++
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG---LPPETIKDLMR 114
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
QLL G+++LHS+ I+HRDLKP NILV +G+ VKIADFGLARIY + S VV
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ----VKIADFGLARIYSFEMALTS---VV 167
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
VT+WYRAPE+LL + Y + VDMW+VGCIFAEL +PLF+G + DQLDKI
Sbjct: 168 VTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRG--------TSEADQLDKI 218
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
F ++G P+ E+WP +LP S + S VP + DLL KML +
Sbjct: 219 FDVIGLPSEEEWPRNVSLPR---SSFPSYTPRSFK----SFVPEICEE-GLDLLKKMLTF 270
Query: 322 DPRKRITAAQALEHEYF 338
+P KRI+A +AL+H YF
Sbjct: 271 NPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 291 bits (747), Expect = 8e-96
Identities = 150/315 (47%), Positives = 210/315 (66%), Gaps = 14/315 (4%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
K+G GTYG V+ A+ K + K A+K+ +G G+S +A REI LLRE+ H NV+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDE-KEYALKQI----EGTGISMSACREIALLRELKHPNVIA 62
Query: 93 LVNVHINHADMSLYLAFDYAEYDLYEIIRHHR----DKVNHTMNPYTVKSILWQLLNGLN 148
L V ++H+D ++L FDYAE+DL+ II+ HR +K + VKS+L+Q+L+G++
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE-NGVVVTIWYR 207
YLH+NW++HRDLKP+NILVMGEG E+G VKIAD G AR++ +PLK L++ + VVVT WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ-GAEAKSTQNPFQLDQLDKIFKILG 266
APELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NPF DQLD+IF ++G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242
Query: 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV---PLSPKSPAYDLLSKMLEYDP 323
P + W + +P + + + Y + L + + P S + LL K+L DP
Sbjct: 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDP 302
Query: 324 RKRITAAQALEHEYF 338
KRIT+ QAL+ YF
Sbjct: 303 TKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 288 bits (737), Expect = 2e-94
Identities = 150/315 (47%), Positives = 209/315 (66%), Gaps = 14/315 (4%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
K+G GTYG V+ A+ K + + A+K+ +G G+S +A REI LLRE+ H NV+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKD-DRDYALKQI----EGTGISMSACREIALLRELKHPNVIS 62
Query: 93 LVNVHINHADMSLYLAFDYAEYDLYEIIRHHR-DKVNHT---MNPYTVKSILWQLLNGLN 148
L V ++HAD ++L FDYAE+DL+ II+ HR K N + VKS+L+Q+L+G++
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE-NGVVVTIWYR 207
YLH+NW++HRDLKP+NILVMGEG E+G VKIAD G AR++ +PLK L++ + VVVT WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ-GAEAKSTQNPFQLDQLDKIFKILG 266
APELLLGA+HYT A+D+WA+GCIFAELLT +P+F E T NP+ DQLD+IF ++G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242
Query: 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV---PLSPKSPAYDLLSKMLEYDP 323
P + W + +P + + Y L + + P S A+ LL K+L DP
Sbjct: 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 302
Query: 324 RKRITAAQALEHEYF 338
KRIT+ QA++ YF
Sbjct: 303 IKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 284 bits (729), Expect = 2e-93
Identities = 142/317 (44%), Positives = 201/317 (63%), Gaps = 31/317 (9%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+ QY + KIGEGTYG+V+ AR + + IA+KK + ++ +GV TAIREI LL+E
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVT---NETIALKKIRLEQEDEGVPSTAIREISLLKE 57
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKV-NHTMNPYTVKSILWQL 143
+ H N+V+L +V H++ LYL F+Y + DL + H D + NP +K+ L+Q+
Sbjct: 58 MQHGNIVRLQDV--VHSEKRLYLVFEYLDLDL----KKHMDSSPDFAKNPRLIKTYLYQI 111
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
L G+ Y HS+ ++HRDLKP N+L+ +K+ADFGLAR + P++ + VVT
Sbjct: 112 LRGIAYCHSHRVLHRDLKPQNLLI---DRRTNALKLADFGLARAFGIPVRTFTHE--VVT 166
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
+WYRAPE+LLG++HY++ VD+W+VGCIFAE++ KPLF G ++D+L KIF+
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS--------EIDELFKIFR 218
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYD 322
ILG P E WP + +LP ++S K+ L +VVP L P DLLSKML D
Sbjct: 219 ILGTPNEETWPGVTSLPDYKSAF-----PKWPPKDLATVVPTLEPA--GVDLLSKMLRLD 271
Query: 323 PRKRITAAQALEHEYFR 339
P KRITA ALEHEYF+
Sbjct: 272 PSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 284 bits (728), Expect = 2e-93
Identities = 125/317 (39%), Positives = 175/317 (55%), Gaps = 37/317 (11%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y ++G+IGEG +G+VF A+ + G+ +A+KK + G+ A+REI L+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLEGGIPNQALREIKALQACQ 57
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYT---VKSILWQL 143
H VVKL++V L +Y DL E++R P VKS + L
Sbjct: 58 HPYVVKLLDVF--PHGSGFVLVMEYMPSDLSEVLRDEE-------RPLPEAQVKSYMRML 108
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY--QAPLKFLSENGVV 201
L G+ Y+H+N I+HRDLKP+N+L+ GV+KIADFGLAR++ + P + + V
Sbjct: 109 LKGVAYMHANGIMHRDLKPANLLI----SADGVLKIADFGLARLFSEEEPRLYSHQ---V 161
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T WYRAPELL GA+ Y VD+WAVGCIFAELL PLF G ++QL +
Sbjct: 162 ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN--------DIEQLAIV 213
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
F+ LG P E WP L +LP + I + + L + P + A DLL +L Y
Sbjct: 214 FRTLGTPNEETWPGLTSLPDYNK----ITFPESKPIPLEEIFPDASPE-ALDLLKGLLVY 268
Query: 322 DPRKRITAAQALEHEYF 338
DP KR++AA+AL H YF
Sbjct: 269 DPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 283 bits (726), Expect = 8e-93
Identities = 137/334 (41%), Positives = 199/334 (59%), Gaps = 34/334 (10%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+ ++ + +IGEGTYG+V+ AR + G+ +A+KK + + DG+ +++REI LL
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTS---GEIVALKKVRMDNERDGIPISSLREITLLLN 62
Query: 85 ITHENVVKLVNVHI-NHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYT---VKSIL 140
+ H N+V+L V + H D S++L +Y E DL ++ ++ P++ VK ++
Sbjct: 63 LRHPNIVELKEVVVGKHLD-SIFLVMEYCEQDLASLL-------DNMPTPFSESQVKCLM 114
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
QLL GL YLH N+IIHRDLK SN+L+ ++G +KIADFGLAR Y P K ++
Sbjct: 115 LQLLRGLQYLHENFIIHRDLKVSNLLL----TDKGCLKIADFGLARTYGLPAKPMTPK-- 168
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
VVT+WYRAPELLLG YT+A+DMWAVGCI AELL KPL G +++QLD
Sbjct: 169 VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--------EIEQLDL 220
Query: 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLE 320
I ++LG P WP ++LP +L K N L P ++ LL+ +L
Sbjct: 221 IIQLLGTPNESIWPGFSDLPLVGKFTL----PKQPYNNLKHKFPWLSEA-GLRLLNFLLM 275
Query: 321 YDPRKRITAAQALEHEYFRIEPLPGRNALVPSQP 354
YDP+KR TA +ALE YF+ +PLP ++P+ P
Sbjct: 276 YDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 280 bits (719), Expect = 2e-92
Identities = 117/312 (37%), Positives = 162/312 (51%), Gaps = 59/312 (18%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y ++ K+GEG++G V+LAR K GK +AIK K+ K +REI +L+++ H
Sbjct: 1 YEILEKLGEGSFGKVYLARDK---KTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKH 56
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
N+V+L +V + LYL +Y E DL+++++ ++ + L Q+L+
Sbjct: 57 PNIVRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRG-----RLSEDEARFYLRQILSA 109
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
L YLHS I+HRDLKP NIL+ E G VK+ADFGLAR K V T Y
Sbjct: 110 LEYLHSKGIVHRDLKPENILLD----EDGHVKLADFGLARQLDPGEKL---TTFVGTPEY 162
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266
APE+LLG K Y AVD+W++G I ELLT KP F G DQL ++FK +G
Sbjct: 163 MAPEVLLG-KGYGKAVDIWSLGVILYELLTGKPPFPGD-----------DQLLELFKKIG 210
Query: 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326
P P P P W +SP A DL+ K+L DP KR
Sbjct: 211 KPKPPFPP-----PEW---------------------DISP--EAKDLIRKLLVKDPEKR 242
Query: 327 ITAAQALEHEYF 338
+TA +AL+H +F
Sbjct: 243 LTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 278 bits (713), Expect = 2e-90
Identities = 128/325 (39%), Positives = 177/325 (54%), Gaps = 48/325 (14%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK----FKQSKDGDGVSPTAIREIMLLR 83
Y L+ IG G YG+V A K G+ +AIKK F D + +REI LLR
Sbjct: 2 YELLKPIGSGAYGVVCSAVDK---RTGRKVAIKKISNVFDDLIDAKRI----LREIKLLR 54
Query: 84 EITHENVVKLVNVHINHADMS---LYLAFDYAEYDLYEIIRHHRDKVN-HTMNPYTVKSI 139
+ HEN++ L+++ + +Y+ + E DL+++I+ + + H ++
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDH------IQYF 108
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ---APLKFLS 196
L+Q+L GL YLHS +IHRDLKPSNILV +KI DFGLAR FL+
Sbjct: 109 LYQILRGLKYLHSANVIHRDLKPSNILV----NSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
E VVT WYRAPELLL + YT A+D+W+VGCIFAELLT KPLF G + +D
Sbjct: 165 E--YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG---RDY-----ID 214
Query: 257 QLDKIFKILGHPTPE--KWPTLANLPHWQSDSLHIQGR-KYETNGLHSVVPLSPKSPAYD 313
QL+ I ++LG P+ E K+ T ++ ++ K L + P + A D
Sbjct: 215 QLNLIVEVLGTPSEEDLKFITSEKARNY------LKSLPKKPKKPLSKLFPGASPE-AID 267
Query: 314 LLSKMLEYDPRKRITAAQALEHEYF 338
LL KML +DP+KRITA +AL H Y
Sbjct: 268 LLEKMLVFDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 275 bits (707), Expect = 4e-90
Identities = 127/330 (38%), Positives = 181/330 (54%), Gaps = 66/330 (20%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-- 85
Y +I ++G+GT+G V+LAR K G+ +AIKK K+ + E M LRE+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNK---ETGELVAIKKMKKKF-------YSWEECMNLREVKS 50
Query: 86 -----THENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSIL 140
H N+VKL V + + LY F+Y E +LY++++ + K + ++SI+
Sbjct: 51 LRKLNEHPNIVKLKEVFRENDE--LYFVFEYMEGNLYQLMKDRKGK---PFSESVIRSII 105
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR---------IYQAP 191
+Q+L GL ++H + HRDLKP N+LV G VVKIADFGLAR Y
Sbjct: 106 YQILQGLAHIHKHGFFHRDLKPENLLVSG----PEVVKIADFGLAREIRSRPPYTDY--- 158
Query: 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251
V T WYRAPE+LL + Y+S VD+WA+GCI AEL TL+PLF G+
Sbjct: 159 ---------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS------ 203
Query: 252 PFQLDQLDKIFKILGHPTPEKWP---TLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPK 308
++DQL KI +LG PT + WP LA+ L + ++ LH ++P +
Sbjct: 204 --EIDQLYKICSVLGTPTKQDWPEGYKLAS-------KLGFRFPQFAPTSLHQLIPNASP 254
Query: 309 SPAYDLLSKMLEYDPRKRITAAQALEHEYF 338
A DL+ ML +DP+KR TA+QAL+H YF
Sbjct: 255 E-AIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 269 bits (689), Expect = 1e-87
Identities = 132/313 (42%), Positives = 190/313 (60%), Gaps = 31/313 (9%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y I KIGEGTYG+V+ R K G+ +A+KK + + +GV TAIREI LL+E+ H
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNK---KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRD--KVNHTMNPYTVKSILWQLLN 145
N+V L +V + LYL F++ DL + + D M+ VKS L+Q+L
Sbjct: 59 PNIVCLQDVL--MQESRLYLIFEFLSMDL----KKYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
G+ + HS ++HRDLKP N+L+ + +GV+K+ADFGLAR + P++ + VVT+W
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLI----DNKGVIKLADFGLARAFGIPVRVYTHE--VVTLW 166
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265
YRAPE+LLG+ Y++ VD+W++G IFAE+ T KPLF G ++DQL +IF+IL
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS--------EIDQLFRIFRIL 218
Query: 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK 325
G PT + WP + +LP +++ K++ L S V + DLL KML YDP K
Sbjct: 219 GTPTEDVWPGVTSLPDYKNTF-----PKWKKGSLRSAVKNLDED-GLDLLEKMLIYDPAK 272
Query: 326 RITAAQALEHEYF 338
RI+A +AL H YF
Sbjct: 273 RISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 269 bits (689), Expect = 3e-87
Identities = 129/334 (38%), Positives = 186/334 (55%), Gaps = 49/334 (14%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
L+ Y ++GK+GEGT+G V+ AR G+ +A+KK + DG TA+REI +L++
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKT---GRVVALKKILMHNEKDGFPITALREIKILKK 63
Query: 85 ITHENVVKLVNVHINHADM------SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKS 138
+ H NVV L+++ + D S+Y+ Y ++DL ++ + K+ + +K
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES----QIKC 119
Query: 139 ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSEN 198
+ QLL G+NYLH N I+HRD+K +NIL+ + QG++KIADFGLAR Y P
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILI----DNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 199 G---------VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST 249
G +VVT WYR PELLLG + YT+AVD+W +GC+FAE+ T +P+ QG
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS---- 231
Query: 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLP-----HWQSDSLHIQGRKYETNGLHSVVP 304
+DQL IFK+ G PT E WP +LP H ++ ++ G
Sbjct: 232 ----DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLG------ 281
Query: 305 LSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338
DLLSK+L DP KR+TA+ ALEH YF
Sbjct: 282 ----PEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 267 bits (685), Expect = 9e-87
Identities = 133/316 (42%), Positives = 191/316 (60%), Gaps = 29/316 (9%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y + KIGEGTYG V+ AR K N GK +A+KK + D +G+ PTA+REI LL+ ++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDK---NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 88 EN-VVKL---VNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+V+L +V + SLYL F+Y + DL + + + + T+KS ++QL
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
L G+ + H + ++HRDLKP N+LV +++G++KIAD GL R + P+K + +VT
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADLGLGRAFSIPVKSYTHE--IVT 174
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
+WYRAPE+LLG+ HY++ VD+W+VGCIFAE+ +PLF G +L QL IFK
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS--------ELQQLLHIFK 226
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYD 322
+LG PT + WP ++ L W H +++ L VP LSP+ DLL KML YD
Sbjct: 227 LLGTPTEQVWPGVSKLRDW-----HEF-PQWKPQDLSRAVPDLSPE--GLDLLQKMLRYD 278
Query: 323 PRKRITAAQALEHEYF 338
P KRI+A AL H YF
Sbjct: 279 PAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 267 bits (683), Expect = 1e-86
Identities = 131/307 (42%), Positives = 188/307 (61%), Gaps = 30/307 (9%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
KIGEGTYG+V+ AR K G+ +A+KK + + +GV TAIREI LL+E+ H N+VK
Sbjct: 7 KIGEGTYGVVYKARNKLT---GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 63
Query: 93 LVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYT-VKSILWQLLNGLNYLH 151
L++V H + LYL F++ DL + D + P +KS L+QLL GL + H
Sbjct: 64 LLDV--IHTENKLYLVFEFLHQDL----KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPEL 211
S+ ++HRDLKP N+L+ +G +K+ADFGLAR + P++ + VVT+WYRAPE+
Sbjct: 118 SHRVLHRDLKPQNLLI----NTEGAIKLADFGLARAFGVPVRTYTHE--VVTLWYRAPEI 171
Query: 212 LLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPE 271
LLG K+Y++AVD+W++GCIFAE++T + LF G ++DQL +IF+ LG P
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--------EIDQLFRIFRTLGTPDEV 223
Query: 272 KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ 331
WP + +LP ++ K+ VVP + DLLS+ML YDP KRI+A
Sbjct: 224 VWPGVTSLPDYKPSF-----PKWARQDFSKVVPPLDED-GRDLLSQMLHYDPNKRISAKA 277
Query: 332 ALEHEYF 338
AL H +F
Sbjct: 278 ALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 266 bits (683), Expect = 1e-86
Identities = 129/314 (41%), Positives = 193/314 (61%), Gaps = 32/314 (10%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y + KIGEGTYG VF A+ + + +A+K+ + D +GV +A+REI LL+E+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNR---ETHEIVALKRVRLDDDDEGVPSSALREICLLKELK 57
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
H+N+V+L +V H+D L L F+Y + DL + + D N ++P VKS ++QLL G
Sbjct: 58 HKNIVRLYDVL--HSDKKLTLVFEYCDQDL----KKYFDSCNGDIDPEIVKSFMFQLLKG 111
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
L + HS+ ++HRDLKP N+L+ GE +K+ADFGLAR + P++ S VVT+WY
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLINKNGE----LKLADFGLARAFGIPVRCYSAE--VVTLWY 165
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKSTQNPFQLDQLDKIFKIL 265
R P++L GAK Y++++DMW+ GCIFAEL +PLF G + DQL +IF++L
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--------DDQLKRIFRLL 217
Query: 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYDPR 324
G PT E WP ++ LP ++ + T L +VVP L+ DLL +L +P
Sbjct: 218 GTPTEESWPGVSKLPDYK--PYPMYPA---TTSLVNVVPKLNST--GRDLLQNLLVCNPV 270
Query: 325 KRITAAQALEHEYF 338
+RI+A +AL+H YF
Sbjct: 271 QRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 262 bits (672), Expect = 3e-85
Identities = 116/312 (37%), Positives = 153/312 (49%), Gaps = 53/312 (16%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y L+ K+G G++G V+ A+ K GK +A+K K+ + TA REI +LR ++H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHK---GTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSH 57
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
N+V+L++ + LYL +Y E DL++ + ++ K I Q+L G
Sbjct: 58 PNIVRLIDAFEDKDH--LYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQILRG 110
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
L YLHSN IIHRDLKP NIL+ +E GVVKIADFGLA+ L V T WY
Sbjct: 111 LEYLHSNGIIHRDLKPENILL----DENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWY 164
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266
APE+LLG Y VD+W++G I ELLT KP F G LDQL I +ILG
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGEN--------ILDQLQLIRRILG 216
Query: 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326
P P S A DL+ K L DP KR
Sbjct: 217 PPLEFDEPK----------------------------WSSGSEEAKDLIKKCLNKDPSKR 248
Query: 327 ITAAQALEHEYF 338
TA + L+H +F
Sbjct: 249 PTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 265 bits (678), Expect = 3e-85
Identities = 133/344 (38%), Positives = 191/344 (55%), Gaps = 54/344 (15%)
Query: 26 QQYNLIGK-IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSP----------- 73
++Y G +GEGTYG V A GK +AIKK K + + V+
Sbjct: 8 ERYIQKGAHLGEGTYGKVEKAYDT---LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64
Query: 74 -TAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMN 132
T +RE+ ++ EI HEN++ LV+V++ ++L + D DL +++ K+ T +
Sbjct: 65 FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVM--DIMASDLKKVVD---RKIRLTES 119
Query: 133 PYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPL 192
VK IL Q+LNGLN LH + +HRDL P+NI + +G+ KIADFGLAR Y P
Sbjct: 120 --QVKCILLQILNGLNVLHKWYFMHRDLSPANIFI----NSKGICKIADFGLARRYGYPP 173
Query: 193 KFLSENGV------------VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL 240
+ + VVT+WYRAPELL+GA+ Y AVDMW+VGCIFAELLT KPL
Sbjct: 174 YSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233
Query: 241 FQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLH 300
F G ++DQL +IF++LG P + WP LP L+ + + L
Sbjct: 234 FPGEN--------EIDQLGRIFELLGTPNEDNWPQAKKLP------LYTEFTPRKPKDLK 279
Query: 301 SVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLP 344
++ P + A DLL +L+ +P +RI+A +AL+HEYF+ +PLP
Sbjct: 280 TIFPNA-SDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 259 bits (663), Expect = 1e-83
Identities = 122/316 (38%), Positives = 183/316 (57%), Gaps = 30/316 (9%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
L+ Y + K+GEG+Y V+ R K G+ +A+K+ + + +G TAIRE LL++
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLT---GQLVALKEIRLEHE-EGAPFTAIREASLLKD 59
Query: 85 ITHENVVKLVNVH-INHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+ H N+V L H I H +L L F+Y + DL + + ++ + V+ L+QL
Sbjct: 60 LKHANIVTL---HDIIHTKKTLTLVFEYLDTDLKQYMDDC----GGGLSMHNVRLFLFQL 112
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
L GL Y H ++HRDLKP N+L+ E+G +K+ADFGLAR P K S VVT
Sbjct: 113 LRGLAYCHQRRVLHRDLKPQNLLI----SERGELKLADFGLARAKSVPSKTYSNE--VVT 166
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
+WYR P++LLG+ Y++++DMW VGCIF E+ T +PLF G + + DQL KIF+
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG--STDVE-----DQLHKIFR 219
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYD 322
+LG PT E WP +++ P ++ S Y L + P L +L K L+Y+
Sbjct: 220 VLGTPTEETWPGVSSNPEFKPYSFP----FYPPRPLINHAPRLDRIPHGEELALKFLQYE 275
Query: 323 PRKRITAAQALEHEYF 338
P+KRI+AA+A++H YF
Sbjct: 276 PKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 257 bits (658), Expect = 4e-82
Identities = 134/328 (40%), Positives = 189/328 (57%), Gaps = 49/328 (14%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK----FKQSKDGDGVSPTAIREIM 80
L++Y ++ K+G+G YG+V+ A + + +A+KK F+ + D + REIM
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDR---RTKEVVALKKIFDAFRNATD----AQRTFREIM 58
Query: 81 LLREIT-HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
L+E+ H N+VKL+NV D +YL F+Y E DL+ +IR + + H + I
Sbjct: 59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH------KRYI 112
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
++QLL L Y+HS +IHRDLKPSNIL+ + VK+ADFGLAR + L+ EN
Sbjct: 113 MYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR----VKLADFGLARSL-SELEENPENP 167
Query: 200 V----VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255
V V T WYRAPE+LLG+ YT VDMW+VGCI E+L KPLF G ST L
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT---ST-----L 219
Query: 256 DQLDKIFKILGHPTPE-----KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP 310
+QL+KI +++G P+ E K P A + DSL + RK L ++P +
Sbjct: 220 NQLEKIIEVIGPPSAEDIESIKSPFAATM----LDSLPSRPRKP----LDELLPKAS-DD 270
Query: 311 AYDLLSKMLEYDPRKRITAAQALEHEYF 338
A DLL K+L ++P KR+TA +ALEH Y
Sbjct: 271 ALDLLKKLLVFNPNKRLTAEEALEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 250 bits (641), Expect = 2e-80
Identities = 124/323 (38%), Positives = 169/323 (52%), Gaps = 45/323 (13%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+Y ++G +GEG YG+V R KA G+ +AIKKFK+S+D + V TA+RE+ +LR++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKAT---GEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
HEN+V L LYL F+Y E L E++ + + P V+S +WQLL
Sbjct: 58 RHENIVNLKEAF--RRKGRLYLVFEYVERTLLELL----EASPGGLPPDAVRSYIWQLLQ 111
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV----- 200
+ Y HS+ IIHRD+KP NILV E GV+K+ DFG AR L
Sbjct: 112 AIAYCHSHNIIHRDIKPENILV----SESGVLKLCDFGFAR-------ALRARPASPLTD 160
Query: 201 -VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
V T WYRAPELL+G +Y VD+WA+GCI AELL +PLF G S +DQL
Sbjct: 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG---DS-----DIDQLY 212
Query: 260 KIFKILGHPTPEKWPTLANLPHWQS----DSLHIQGRKYETNGLHSVVPLSPKSPAYDLL 315
I K LG P ++ P + + + + G S SPA D L
Sbjct: 213 LIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVS-------SPALDFL 265
Query: 316 SKMLEYDPRKRITAAQALEHEYF 338
L DP++R+T + L+H YF
Sbjct: 266 KACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 247 bits (633), Expect = 7e-79
Identities = 121/322 (37%), Positives = 173/322 (53%), Gaps = 34/322 (10%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y + KIG+GT+G VF AR K + +A+KK + +G TA+REI +L+ +
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHK---KTKQIVALKKVLMENEKEGFPITALREIKILQLLK 69
Query: 87 HENVVKLVNVHINHADM------SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSIL 140
HENVV L+ + A S YL F++ E+DL ++ + N +K ++
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN----KNVKFTLSEIKKVM 125
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSEN-- 198
LLNGL Y+H N I+HRD+K +NIL+ + G++K+ADFGLAR + K N
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILI----TKDGILKLADFGLARAFSLS-KNSKPNRY 180
Query: 199 -GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257
VVT+WYR PELLLG + Y +DMW GCI AE+ T P+ QG + Q+ Q
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG---NTEQH-----Q 232
Query: 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP-AYDLLS 316
L I ++ G TPE WP + L ++ L ++ L V K P A DL+
Sbjct: 233 LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYV----KDPHALDLID 288
Query: 317 KMLEYDPRKRITAAQALEHEYF 338
K+L DP KRI A AL H++F
Sbjct: 289 KLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 243 bits (621), Expect = 2e-77
Identities = 124/315 (39%), Positives = 190/315 (60%), Gaps = 34/315 (10%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+ + K+GEGTY V+ R NR G+ +A+K+ + +G TAIREI L++E
Sbjct: 1 NFKQLEKLGEGTYATVYKGR-----NRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKE 54
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ HEN+V+L +V H + L L F+Y + DL + + H + ++P TVKS +QLL
Sbjct: 55 LKHENIVRLHDVI--HTENKLMLVFEYMDKDLKKYMDTHGVR--GALDPNTVKSFTYQLL 110
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPL-KFLSENGVVVT 203
G+ + H N ++HRDLKP N+L+ GE +K+ADFGLAR + P+ F +E VVT
Sbjct: 111 KGIAFCHENRVLHRDLKPQNLLINKRGE----LKLADFGLARAFGIPVNTFSNE---VVT 163
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
+WYRAP++LLG++ Y++++D+W+VGCI AE++T +PLF G T N DQL KIF+
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG-----TNNE---DQLLKIFR 215
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
I+G PT WP ++ LP ++ +Y L + P + DLL ++L+ +P
Sbjct: 216 IMGTPTESTWPGISQLPEYKPTF-----PRYPPQDLQQLFPHADPL-GIDLLHRLLQLNP 269
Query: 324 RKRITAAQALEHEYF 338
RI+A AL+H +F
Sbjct: 270 ELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 241 bits (618), Expect = 1e-76
Identities = 120/321 (37%), Positives = 179/321 (55%), Gaps = 33/321 (10%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+ ++++IG+IGEGTYG V+ AR K + G+ +A+KK + + +G TAIREI +LR+
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDK---DTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 85 ITHENVVKLVNVHINHADM--------SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTV 136
+ H N+V L + + D + YL F+Y ++DL ++ + +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED----HI 118
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
KS + QLL GLNY H +HRD+K SNIL+ +G+ +K+ADFGLAR+Y +
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ----IKLADFGLARLYNSEESRPY 174
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
N V+ T+WYR PELLLG + Y A+D+W+ GCI EL T KP+FQ + +L
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ--------ELA 225
Query: 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLS 316
QL+ I ++ G P P WP + LP++ + ++ +K L P PA DLL
Sbjct: 226 QLELISRLCGSPCPAVWPDVIKLPYFNT----MKPKKQYRRRLREEFSFIPT-PALDLLD 280
Query: 317 KMLEYDPRKRITAAQALEHEY 337
ML DP KR TA +AL +
Sbjct: 281 HMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 237 bits (608), Expect = 2e-75
Identities = 119/317 (37%), Positives = 171/317 (53%), Gaps = 41/317 (12%)
Query: 28 YNLIGKIGEGTYGLVFLAR-IKAAANRGKAIAIKKFKQS-KDGDGVSPTAIREIMLLREI 85
Y ++GKIGEGT+ V A+ K GK AIK K+ K + V +REI LR +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKT----GKYYAIKCMKKHFKSLEQV--NNLREIQALRRL 54
Query: 86 T-HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ H N+++L+ V + L L F+ + +LYE+I+ + + VKS ++QLL
Sbjct: 55 SPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRK----RPLPEKRVKSYMYQLL 110
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAP--LKFLSENGVV 201
L+++H N I HRD+KP NIL+ ++K+ADFG R IY P +++S
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIK-----DDILKLADFGSCRGIYSKPPYTEYIS----- 160
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T WYRAPE LL +Y +D+WAVGC+F E+L+L PLF G +LDQ+ KI
Sbjct: 161 -TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN--------ELDQIAKI 211
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
+LG P E L + + + +K GL ++P + DLL K+L Y
Sbjct: 212 HDVLGTPDAE---VLKKFRKSRHMNYNFPSKK--GTGLRKLLPNASA-EGLDLLKKLLAY 265
Query: 322 DPRKRITAAQALEHEYF 338
DP +RITA QAL H YF
Sbjct: 266 DPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 2e-69
Identities = 126/327 (38%), Positives = 176/327 (53%), Gaps = 50/327 (15%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y I IG G YG+V A GK +AIKK + D ++ +RE+ +LR
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDT---RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK 62
Query: 87 HENVVKLVNV-HINHADM-SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYT---VKSILW 141
H+N++ + ++ AD +Y+ D E DL+ II H+ P T ++ L+
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII--------HSDQPLTEEHIRYFLY 114
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY-QAPLK---FLSE 197
QLL GL Y+HS +IHRDLKPSN+LV + E ++I DFG+AR +P + F++E
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLVNEDCE----LRIGDFGMARGLSSSPTEHKYFMTE 170
Query: 198 NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257
V T WYRAPELLL YT+A+DMW+VGCIFAE+L + LF G + Q
Sbjct: 171 Y--VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY--------VHQ 220
Query: 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETN-GLHSVVPLS---PKS--PA 311
L I +LG P+ E + SD + RKY N VP S PK+ A
Sbjct: 221 LKLILSVLGSPSEEVLNRI------GSDRV----RKYIQNLPRKQPVPWSKIFPKASPEA 270
Query: 312 YDLLSKMLEYDPRKRITAAQALEHEYF 338
DLLS+ML++DP +RIT QAL+H +
Sbjct: 271 LDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 4e-69
Identities = 130/333 (39%), Positives = 193/333 (57%), Gaps = 50/333 (15%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
L+ Y + K+GEGTY V+ R K N +A+K+ + + +G TAIRE+ LL++
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDN---LVALKEIRLEHE-EGAPCTAIREVSLLKD 60
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ H N+V L + I H + SL L F+Y + DL + + D +++N + VK L+QLL
Sbjct: 61 LKHANIVTLHD--IIHTEKSLTLVFEYLDKDL----KQYLDDCGNSINMHNVKLFLFQLL 114
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
GLNY H ++HRDLKP N+L+ E+G +K+ADFGLAR P K S VVT+
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLI----NERGELKLADFGLARAKSIPTKTYSNE--VVTL 168
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
WYR P++LLG+ Y++ +DMW VGCIF E+ T +PLF G+ + +QL IF+I
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--------EQLHFIFRI 220
Query: 265 LGHPTPEKWPTLA--------NLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLS 316
LG PT E WP + N P +++D LH + +++G +LLS
Sbjct: 221 LGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGA-------------ELLS 267
Query: 317 KMLEYDPRKRITAAQALEHEYF-----RIEPLP 344
K+L+++ RKRI+A +A++H YF RI LP
Sbjct: 268 KLLQFEGRKRISAEEAMKHPYFHCLGERIHKLP 300
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 219 bits (558), Expect = 5e-68
Identities = 120/314 (38%), Positives = 177/314 (56%), Gaps = 29/314 (9%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
L+ Y + K+GEGTY VF R K N +A+K+ + + +G TAIRE+ LL+
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTEN---LVALKEIRLEHE-EGAPCTAIREVSLLKN 59
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ H N+V L + I H + L L F+Y + DL + + D + M+ + VK ++QLL
Sbjct: 60 LKHANIVTLHD--IIHTERCLTLVFEYLDSDL----KQYLDNCGNLMSMHNVKIFMFQLL 113
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
GL+Y H I+HRDLKP N+L+ E+G +K+ADFGLAR P K S VVT+
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLI----NEKGELKLADFGLARAKSVPTKTYSNE--VVTL 167
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
WYR P++LLG+ Y++ +DMW VGCI E+ T +P+F G+ K ++L IF++
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--------EELHLIFRL 219
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324
LG PT E WP + + ++S +Y L + P + DLLS +L Y+ +
Sbjct: 220 LGTPTEETWPGITSNEEFRSYLF----PQYRAQPLINHAP-RLDTDGIDLLSSLLLYETK 274
Query: 325 KRITAAQALEHEYF 338
RI+A AL H YF
Sbjct: 275 SRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 1e-67
Identities = 113/319 (35%), Positives = 173/319 (54%), Gaps = 39/319 (12%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y +G +GEG+YG+V + K G+ +AIKKF +S+D V A+REI +L+++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHK---ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL 57
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
HEN+V L+ V LYL F++ ++ + + + + + ++ V+ L+Q+L
Sbjct: 58 RHENLVNLIEVF--RRKKRLYLVFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILR 111
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
G+ + HS+ IIHRD+KP NILV + GVVK+ DFG AR AP + ++ V T W
Sbjct: 112 GIEFCHSHNIIHRDIKPENILV----SQSGVVKLCDFGFARTLAAPGEVYTD--YVATRW 165
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265
YRAPELL+G Y AVD+WAVGC+ E+LT +PLF G +DQL I K L
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS--------DIDQLYHIIKCL 217
Query: 266 GHPTP------EKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
G+ P +K P A + + + +++ LS DL + L
Sbjct: 218 GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPK--------LSGL--VLDLAKQCL 267
Query: 320 EYDPRKRITAAQALEHEYF 338
DP R +++Q L HE+F
Sbjct: 268 RIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 2e-67
Identities = 118/329 (35%), Positives = 177/329 (53%), Gaps = 49/329 (14%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-T 86
Y LI ++G+G YG+V AR A + + +AIKK ++ A+RE+ LLR
Sbjct: 2 YELIKELGQGAYGIVCSAR-NAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 87 HENVVKLVNVHINHADM--SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
H+N+ L ++ I LYL + E DL++IIR + +S ++Q+L
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-----GQPLTDAHFQSFIYQIL 115
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK----FLSENGV 200
GL Y+HS ++HRDLKP N+LV + E +KI DFGLAR + F++E
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCE----LKICDFGLARGFSENPGENAGFMTE--Y 169
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
V T WYRAPE++L + YT A+D+W+VGCI AELL KP+F+G + +DQL++
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY--------VDQLNQ 221
Query: 261 IFKILGHP---------TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
I ++LG P +P+ + +LP +I + +E+ P + A
Sbjct: 222 ILQVLGTPDEETLSRIGSPKAQNYIRSLP-------NIPKKPFESI-----FP-NANPLA 268
Query: 312 YDLLSKMLEYDPRKRITAAQALEHEYFRI 340
DLL K+L +DP KRI+ +ALEH Y I
Sbjct: 269 LDLLEKLLAFDPTKRISVEEALEHPYLAI 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 2e-67
Identities = 118/324 (36%), Positives = 160/324 (49%), Gaps = 46/324 (14%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+Y + +G G YG V A + +AIKK + + RE+ LL+ +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRK---VAIKKLSRPFQSAIHAKRTYRELRLLKHM 71
Query: 86 THENVVKLVNVHINHADMSL------YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
HENV+ L++V SL YL DL I++ + +H ++ +
Sbjct: 72 DHENVIGLLDVF--TPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDH------IQFL 123
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
++Q+L GL Y+HS IIHRDLKPSNI V + E +KI DFGLAR + G
Sbjct: 124 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE----LKILDFGLARHTDDEM-----TG 174
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
V T WYRAPE++L HY VD+W+VGCI AELLT K LF G++ +DQL
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD--------HIDQLK 226
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDS--LHIQGR-KYETNGLHSVVP-LSPKSPAYDLL 315
+I ++G P E L S+S +IQ + V +P A DLL
Sbjct: 227 RIMNLVGTPDEEL------LQKISSESARNYIQSLPQMPKKDFKEVFSGANPL--AIDLL 278
Query: 316 SKMLEYDPRKRITAAQALEHEYFR 339
KML DP KRITAA+AL H Y
Sbjct: 279 EKMLVLDPDKRITAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 2e-67
Identities = 119/327 (36%), Positives = 172/327 (52%), Gaps = 55/327 (16%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y + KIGEG+YG+VF R + G+ +AIKKF +S+D + A+REI +L+++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNR---ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL 57
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
H N+V L+ V L+L F+Y ++ + + +K + + +K I+WQ L
Sbjct: 58 KHPNLVNLIEVF--RRKRKLHLVFEYCDHTVL----NELEKNPRGVPEHLIKKIIWQTLQ 111
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
+N+ H + IHRD+KP NIL+ +QG +K+ DFG ARI P ++ V T W
Sbjct: 112 AVNFCHKHNCIHRDVKPENILI----TKQGQIKLCDFGFARILTGPGDDYTD--YVATRW 165
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265
YRAPELL+G Y VD+WA+GC+FAELLT +PL+ G KS +DQL I K L
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG---KS-----DVDQLYLIRKTL 217
Query: 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETN----GLH-----SVVPLSPK-----SPA 311
G P H Q + TN GL + PL K SPA
Sbjct: 218 GDLIPR----------------HQQ--IFSTNQFFKGLSIPEPETREPLESKFPNISSPA 259
Query: 312 YDLLSKMLEYDPRKRITAAQALEHEYF 338
L L+ DP +R++ + LEH YF
Sbjct: 260 LSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 2e-66
Identities = 121/328 (36%), Positives = 177/328 (53%), Gaps = 55/328 (16%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+Y I IG G YG+V +A N + +AIKK + D + +REI LLR
Sbjct: 6 KYVPIKPIGRGAYGIVC-----SAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH 60
Query: 85 ITHENVVKLVNV-HINHADM--SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILW 141
+ HENV+ + ++ H + +Y+ ++ + DL++IIR + T++ + L+
Sbjct: 61 LDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRS-----SQTLSDDHCQYFLY 115
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
QLL GL Y+HS ++HRDLKPSN+L+ + +KI DFGLAR F++E V
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARTTSEKGDFMTE--YV 169
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
VT WYRAPELLL YT+A+D+W+VGCIFAELL KPLF G + + QL I
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD--------YVHQLKLI 221
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP----------- 310
++LG P+ E +L +++ + R+Y + +P +P+
Sbjct: 222 TELLGSPSEE------DLGFIRNE----KARRYIRS-----LPYTPRQSFARLFPHANPL 266
Query: 311 AYDLLSKMLEYDPRKRITAAQALEHEYF 338
A DLL KML +DP KRIT +AL H Y
Sbjct: 267 AIDLLEKMLVFDPSKRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 213 bits (543), Expect = 2e-65
Identities = 121/315 (38%), Positives = 187/315 (59%), Gaps = 29/315 (9%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
++ Y + K+GEGTY VF R K N +A+K+ + + +G TAIRE+ LL++
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTEN---LVALKEIRLEHE-EGAPCTAIREVSLLKD 60
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ H N+V L + I H D SL L F+Y + DL + + D + M+ + VK L+Q+L
Sbjct: 61 LKHANIVTLHD--IVHTDKSLTLVFEYLDKDL----KQYMDDCGNIMSMHNVKIFLYQIL 114
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
GL Y H ++HRDLKP N+L+ E+G +K+ADFGLAR P K S VVT+
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLI----NERGELKLADFGLARAKSVPTKTYSNE--VVTL 168
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
WYR P++LLG+ Y++ +DMW VGCIF E+ + +PLF G+ + D+L IF++
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE--------DELHLIFRL 220
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324
LG PT E WP +++ +++ + KY+ L + P + +LL+K L+Y+ +
Sbjct: 221 LGTPTEETWPGISSNDEFKNYNF----PKYKPQPLINHAP-RLDTEGIELLTKFLQYESK 275
Query: 325 KRITAAQALEHEYFR 339
KRI+A +A++H YFR
Sbjct: 276 KRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 2e-64
Identities = 119/337 (35%), Positives = 174/337 (51%), Gaps = 72/337 (21%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSP--------TAIR 77
+Y + IGEG YG+V A K G +AIKK +SP +R
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKP---TGVKVAIKK---------ISPFEHQTFCQRTLR 52
Query: 78 EIMLLREITHENVVKLVNVHI--NHADMS-LYLAFDYAEYDLYEIIRHHRDKVNHTMNPY 134
EI +LR HEN++ ++++ + + +Y+ + E DLY++I+ +H
Sbjct: 53 EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH----- 107
Query: 135 TVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA---P 191
++ L+Q+L GL Y+HS ++HRDLKPSN+L+ + +KI DFGLARI
Sbjct: 108 -IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD----LKICDFGLARIADPEHDH 162
Query: 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251
FL+E V T WYRAPE++L +K YT A+D+W+VGCI AE+L+ +PLF G +
Sbjct: 163 TGFLTE--YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD------ 214
Query: 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP- 310
L QL+ I +LG P+ E + +L + R Y + S +P PK P
Sbjct: 215 --YLHQLNLILGVLGTPSQEDLNCIISL----------RARNY----IKS-LPFKPKVPW 257
Query: 311 ----------AYDLLSKMLEYDPRKRITAAQALEHEY 337
A DLL KML ++P KRIT +AL H Y
Sbjct: 258 NKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 8e-64
Identities = 128/320 (40%), Positives = 184/320 (57%), Gaps = 40/320 (12%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
QY + +IG G YG V+ AR + G +A+K + + DG+ + +RE+ LL+ +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDP---HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLE 57
Query: 87 ---HENVVKLVNVHIN---HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPY-TVKSI 139
H N+V+L++V + + L F++ + DL R + DKV P T+K +
Sbjct: 58 AFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDL----RTYLDKVPPPGLPAETIKDL 113
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
+ Q L GL++LH+N I+HRDLKP NILV G+ VK+ADFGLARIY +
Sbjct: 114 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ----VKLADFGLARIYSCQMAL---TP 166
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG-AEAKSTQNPFQLDQL 258
VVVT+WYRAPE+LL + Y + VDMW+VGCIFAE+ KPLF G +EA DQL
Sbjct: 167 VVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEA---------DQL 216
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318
KIF ++G P + WP LP + +G + + SVVP +S A LL +M
Sbjct: 217 GKIFDLIGLPPEDDWPRDVTLPR---GAFSPRGPR----PVQSVVPEIEESGA-QLLLEM 268
Query: 319 LEYDPRKRITAAQALEHEYF 338
L ++P KRI+A +AL+H +F
Sbjct: 269 LTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 202 bits (514), Expect = 2e-61
Identities = 128/320 (40%), Positives = 179/320 (55%), Gaps = 37/320 (11%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
QQY + +IGEG YG VF AR N G+ +A+K+ + +G+ + IRE+ +LR +
Sbjct: 1 QQYECVAEIGEGAYGKVFKAR--DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58
Query: 86 T---HENVVKLVNV-HINHAD--MSLYLAFDYAEYDLYEIIRHHRDKV-NHTMNPYTVKS 138
H NVV+L +V ++ D L L F++ + DL + DKV + T+K
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL----DKVPEPGVPTETIKD 114
Query: 139 ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSEN 198
+++QLL GL++LHS+ ++HRDLKP NILV G+ +K+ADFGLARIY + S
Sbjct: 115 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ----IKLADFGLARIYSFQMALTS-- 168
Query: 199 GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258
VVVT+WYRAPE+LL + Y + VD+W+VGCIFAE+ KPLF+G+ +DQL
Sbjct: 169 -VVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSS--------DVDQL 218
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318
KI ++G P E WP LP S Q + V DLL K
Sbjct: 219 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQ-------PIEKFVT-DIDELGKDLLLKC 270
Query: 319 LEYDPRKRITAAQALEHEYF 338
L ++P KRI+A AL H YF
Sbjct: 271 LTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 8e-61
Identities = 125/319 (39%), Positives = 181/319 (56%), Gaps = 28/319 (8%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y + K+GEG+Y V+ + K GK +A+K + ++ +G TAIRE LL+ + H
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKV---NGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKH 62
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
N+V L + I H +L L F+Y DL + + DK ++P VK L+QLL GL
Sbjct: 63 ANIVLLHD--IIHTKETLTLVFEYVHTDLCQ----YMDKHPGGLHPENVKLFLFQLLRGL 116
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYR 207
+Y+H +I+HRDLKP N+L+ GE +K+ADFGLAR P S VVT+WYR
Sbjct: 117 SYIHQRYILHRDLKPQNLLISDTGE----LKLADFGLARAKSVPSHTYSNE--VVTLWYR 170
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267
P++LLG+ Y++ +DMW VGCIF E++ QG A Q DQL++IF +LG
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMI------QGVAAFPGMKDIQ-DQLERIFLVLGT 223
Query: 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI 327
P + WP + +LPH++ + + K N + LS + A DL SK+L+ P+ R+
Sbjct: 224 PNEDTWPGVHSLPHFKPERFTLYSPK---NLRQAWNKLSYVNHAEDLASKLLQCFPKNRL 280
Query: 328 TAAQALEHEYFRIEPLPGR 346
+A AL HEYF LP R
Sbjct: 281 SAQAALSHEYF--SDLPPR 297
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 5e-57
Identities = 119/310 (38%), Positives = 171/310 (55%), Gaps = 34/310 (10%)
Query: 33 KIGEGTYGLVF--LARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENV 90
K+GEG+Y V+ ++RI G+ +A+K + +GV TAIRE LL+ + H N+
Sbjct: 12 KLGEGSYATVYKGISRIN-----GQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANI 65
Query: 91 VKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL 150
V L + I H +L F+Y DL + + H ++PY V+ ++QLL GL Y+
Sbjct: 66 VLLHD--IIHTKETLTFVFEYMHTDLAQYMIQHPGG----LHPYNVRLFMFQLLRGLAYI 119
Query: 151 HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPE 210
H I+HRDLKP N+L+ GE +K+ADFGLAR P + S VVT+WYR P+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGE----LKLADFGLARAKSIPSQTYSSE--VVTLWYRPPD 173
Query: 211 LLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTP 270
+LLGA Y+SA+D+W GCIF E+L +P F G +QL+KI+ +LG PT
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-------FEQLEKIWTVLGVPTE 226
Query: 271 EKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV--PLSPKSPAYDLLSKMLEYDPRKRIT 328
+ WP ++ LP+++ + VV LS A DL S+ML P+ RI+
Sbjct: 227 DTWPGVSKLPNYKPEWF-----LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS 281
Query: 329 AAQALEHEYF 338
A AL H YF
Sbjct: 282 AQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 6e-57
Identities = 82/210 (39%), Positives = 120/210 (57%), Gaps = 16/210 (7%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
+GEG +G V+LAR K GK +AIK K+ + +REI +L+++ H N+VKL
Sbjct: 1 LGEGGFGTVYLARDK---KTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKL 56
Query: 94 VNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS 152
V + LYL +Y E L ++++ + K ++ + IL Q+L GL YLHS
Sbjct: 57 YGVFEDEN--HLYLVMEYCEGGSLKDLLKENEGK----LSEDEILRILLQILEGLEYLHS 110
Query: 153 NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELL 212
N IIHRDLKP NIL+ + G VK+ADFGL+++ + L +V T Y APE+L
Sbjct: 111 NGIIHRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKSLL--KTIVGTPAYMAPEVL 165
Query: 213 LGAKHYTSAVDMWAVGCIFAELLTLKPLFQ 242
LG +Y+ D+W++G I EL LK L +
Sbjct: 166 LGKGYYSEKSDIWSLGVILYELPELKDLIR 195
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 8e-57
Identities = 124/322 (38%), Positives = 169/322 (52%), Gaps = 45/322 (13%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y + ++G G YG V A K G+ +AIKK + + + A RE+ LL+ +
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRT---GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM 71
Query: 86 THENVVKLVNVHIN----HADMSLYLAFDYAEYDLYEIIRHH--RDKVNHTMNPYTVKSI 139
HENV+ L++V + YL Y + DL +I+ H DKV + +
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY---------L 122
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
++Q+L GL Y+HS IIHRDLKP N+ V + E +KI DFGLAR A + G
Sbjct: 123 VYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE----LKILDFGLARHADAEM-----TG 173
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
VVT WYRAPE++L HY VD+W+VGCI AE+LT K LF+G + LDQL
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--------YLDQLT 225
Query: 260 KIFKILGHPTPE---KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLS 316
+I K+ G P PE K A + +S KY ++ P A DLL
Sbjct: 226 QILKVTGVPGPEFVQKLEDKAAKSYIKSLP------KYPRKDFSTLFP-KASPQAVDLLE 278
Query: 317 KMLEYDPRKRITAAQALEHEYF 338
KMLE D KR+TA +ALEH YF
Sbjct: 279 KMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 1e-55
Identities = 123/367 (33%), Positives = 187/367 (50%), Gaps = 50/367 (13%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+Y + ++G G YG V A G +AIKK + + + A RE+ LL+ +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSA---LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 71
Query: 86 THENVVKLVNVHINHADMSL------YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
HENV+ L++V D+SL YL + DL ++++H + ++ ++ +
Sbjct: 72 KHENVIGLLDVFT--PDLSLDRFHDFYLVMPFMGTDLGKLMKHEK------LSEDRIQFL 123
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
++Q+L GL Y+H+ IIHRDLKP N+ V + E +KI DFGLAR + + G
Sbjct: 124 VYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE----LKILDFGLARQTDSEM-----TG 174
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
VVT WYRAPE++L HYT VD+W+VGCI AE+LT KPLF+G + LDQL
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD--------HLDQLM 226
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSL--HIQG-RKYETNGLHSVVP-LSPKSPAYDLL 315
+I K+ G P+ E L QS+ +++ ++ S++P +P A ++L
Sbjct: 227 EIMKVTGTPSKEFVQKL------QSEDAKNYVKKLPRFRKKDFRSLLPNANPL--AVNVL 278
Query: 316 SKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDS--NTDFE 373
KML D RITAA+AL H YF E + P D + + ++ F
Sbjct: 279 EKMLVLDAESRITAAEALAHPYF--EEFHDPEDETEAPPYDDSFDEVDQSLEEWKRLTFT 336
Query: 374 GTTTLQP 380
+ QP
Sbjct: 337 EILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 2e-55
Identities = 115/311 (36%), Positives = 167/311 (53%), Gaps = 31/311 (9%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
IG G +G+V+ + + GK +A+KK RE+ +L H+NV+
Sbjct: 8 IGYGAFGVVW--SVTDPRD-GKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 94 VNV-HINHADM--SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL 150
+++ H D +Y+ + + DL++II ++ VK L+Q+L GL YL
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQSDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYL 119
Query: 151 HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPE 210
HS I+HRD+KP N+LV V+KI DFGLAR+ + P + VVT +YRAPE
Sbjct: 120 HSAGILHRDIKPGNLLV----NSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYYRAPE 174
Query: 211 LLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTP 270
+L+G++HYTSAVD+W+VGCIFAELL + LFQ Q+P Q QLD I +LG P+
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA------QSPIQ--QLDLITDLLGTPSL 226
Query: 271 EKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKS--PAYDLLSKMLEYDPRKRIT 328
E + + HI ++ L + LS ++ A LL +ML +DP KRI+
Sbjct: 227 EAMRSAC-----EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS 281
Query: 329 AAQALEHEYFR 339
AA AL H Y
Sbjct: 282 AADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 5e-54
Identities = 114/338 (33%), Positives = 165/338 (48%), Gaps = 49/338 (14%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVS-PTAIREIMLLREITHENVVK 92
+G G+ GLVF A K +A+KK + D S A+REI ++R + H+N+VK
Sbjct: 13 LGCGSNGLVFSAVDSDC---DKRVAVKKIVLT---DPQSVKHALREIKIIRRLDHDNIVK 66
Query: 93 LVNV-----HINHADM-------SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSIL 140
+ V D+ S+Y+ +Y E DL ++ H + +
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEH------ARLFM 120
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK---FLSE 197
+QLL GL Y+HS ++HRDLKP+N+ + E V+KI DFGLARI +LSE
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFI---NTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 198 NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257
+VT WYR+P LLL +YT A+DMWA GCIFAE+LT KPLF GA L+Q
Sbjct: 178 G--LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE--------LEQ 227
Query: 258 LDKIFKILGHPTPE-KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLS 316
+ I + + E + L +P + + R L ++P A D L
Sbjct: 228 MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRP-----LRDLLPGV-NPEALDFLE 281
Query: 317 KMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQP 354
++L ++P R+TA +AL H Y P + V P
Sbjct: 282 QILTFNPMDRLTAEEALMHPYMSCYSCP-FDEPVSLHP 318
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 4e-53
Identities = 120/365 (32%), Positives = 180/365 (49%), Gaps = 69/365 (18%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y + IG+G+YG+V A + G+ +AIKK + + +REI LLR +
Sbjct: 1 RYKIQEVIGKGSYGVVCSA---IDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR 57
Query: 87 HENVVKLVNVHINHADMS---LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
H ++V++ ++ + + +Y+ F+ E DL+++I K N + P + L+QL
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI-----KANDDLTPEHHQFFLYQL 112
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY---QAPLKFLSENGV 200
L L Y+H+ + HRDLKP NIL + + +KI DFGLAR+ F ++
Sbjct: 113 LRALKYIHTANVFHRDLKPKNILANADCK----LKICDFGLARVAFNDTPTAIFWTD--Y 166
Query: 201 VVTIWYRAPELLLGA--KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258
V T WYRAPEL G+ YT A+D+W++GCIFAE+LT KPLF G + QL
Sbjct: 167 VATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--------VHQL 217
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSV-----VPLSPKSP--- 310
D I +LG P+PE + N + R+Y L S+ VP S K P
Sbjct: 218 DLITDLLGTPSPETISRVRN----------EKARRY----LSSMRKKQPVPFSQKFPNAD 263
Query: 311 --AYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDS 368
A LL ++L +DP+ R TA +AL YF+ KV P+ +
Sbjct: 264 PLALRLLERLLAFDPKDRPTAEEALADPYFKGLA--------------KVEREPSAQPIT 309
Query: 369 NTDFE 373
+FE
Sbjct: 310 KLEFE 314
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 179 bits (454), Expect = 9e-52
Identities = 108/411 (26%), Positives = 167/411 (40%), Gaps = 53/411 (12%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSP-TAIREIMLLREIT 86
Y ++ K+GEG++G V+LAR + K +A+K + + +REI +L +
Sbjct: 2 YRILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLN 55
Query: 87 HE-NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
H N+VKL + + + SLYL +Y + L ++++ K ++ IL Q+L
Sbjct: 56 HPPNIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGP--LSESEALFILAQIL 111
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS----ENGV 200
+ L YLHS IIHRD+KP NIL+ +G VVK+ DFGLA++ P S +
Sbjct: 112 SALEYLHSKGIIHRDIKPENILLDRDG---RVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 201 VVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258
V T Y APE+LLG + +S+ D+W++G ELLT P F+G +N Q
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG-----EKNSSATSQT 223
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318
KI L P +L S S P A DLL K+
Sbjct: 224 LKIILELPTP---------SLASPLSPSN----------------PELISKAASDLLKKL 258
Query: 319 LEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFEGTTTL 378
L DP+ R++++ L H+ L + L D S +
Sbjct: 259 LAKDPKNRLSSSSDLSHDLLAHLKLK-ESDLSDLLKPDDSAPLRLSLPPSLEALISSLNS 317
Query: 379 QPPQPASGPVPGNMAGAHAVSNRNVPRPMPGVGMQRMQAQGMMTYNFPGQA 429
+ + + N P + A + A
Sbjct: 318 LAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASSKRSSLPKISA 368
|
Length = 384 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-51
Identities = 112/328 (34%), Positives = 165/328 (50%), Gaps = 57/328 (17%)
Query: 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLL 82
E +Y + +G G +GLV AR + G+ +AIKK + ++ RE+ LL
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQL---TGQNVAIKKIMKPFSTPVLAKRTYRELKLL 63
Query: 83 REITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQ 142
+ + HEN++ L ++ I+ + +Y + DL+ ++ + ++ L+Q
Sbjct: 64 KHLRHENIISLSDIFISPLE-DIYFVTELLGTDLHRLLTSRP------LEKQFIQYFLYQ 116
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV 202
+L GL Y+HS ++HRDLKPSNIL+ E +KI DFGLARI Q P G V
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILI----NENCDLKICDFGLARI-QDP----QMTGYVS 167
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262
T +YRAPE++L + Y VD+W+ GCIFAE+L KPLF G ++ ++Q I
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG------KDH--VNQFSIIT 219
Query: 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSV--------VPLSPKSP---- 310
+LG P + T+ + N L V VP S K
Sbjct: 220 DLLGTPPDDVINTICS-----------------ENTLRFVQSLPKREPVPFSEKFKNADP 262
Query: 311 -AYDLLSKMLEYDPRKRITAAQALEHEY 337
A DLL KML +DP+KRI+AA+AL H Y
Sbjct: 263 SAIDLLEKMLVFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-50
Identities = 87/310 (28%), Positives = 141/310 (45%), Gaps = 58/310 (18%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y +I +IG+G++G V+L R K+ GK +K+ S + A+ E+ +L+++
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN 57
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
H N++K L + +YA+ DL + I+ + K + QL
Sbjct: 58 HPNIIKYYESFE--EKGKLCIVMEYADGGDLSQKIKKQK-KEGKPFPEEQILDWFVQLCL 114
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
L YLHS I+HRD+KP NI + G+VK+ DFG++++ + + VV T +
Sbjct: 115 ALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPY 168
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265
Y +PEL K Y D+W++GC+ EL TLK F+G +N +L KIL
Sbjct: 169 YLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEG------ENLLEL-----ALKIL 216
Query: 266 -GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324
G P +P S L +L+S +L+ DP
Sbjct: 217 KGQYPP--------IPSQYSSELR------------------------NLVSSLLQKDPE 244
Query: 325 KRITAAQALE 334
+R + AQ L+
Sbjct: 245 ERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 4e-48
Identities = 111/322 (34%), Positives = 162/322 (50%), Gaps = 46/322 (14%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
++ ++G +GEG YG+V R K + +AIKKFK S++ + V T +RE+ +LR +
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKET---KEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
EN+V+L LYL F+Y E ++ E++ + V P V+S ++QL+
Sbjct: 59 QENIVELKEAFRRRG--KLYLVFEYVEKNMLELLEEMPNGVP----PEKVRSYIYQLIKA 112
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG------V 200
+++ H N I+HRD+KP N+L+ V+K+ DFG AR LSE
Sbjct: 113 IHWCHKNDIVHRDIKPENLLI----SHNDVLKLCDFGFAR-------NLSEGSNANYTEY 161
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
V T WYR+PELLLGA Y AVDMW+VGCI EL +PLF G ++DQL
Sbjct: 162 VATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGES--------EIDQLFT 212
Query: 261 IFKILGHPTPEKWPTLANLPHWQSDSL----HIQGRKYETNGLHSVVPLSPKSPAYDLLS 316
I K+LG E+ + P + H Q + G+ S V L DL+
Sbjct: 213 IQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLL-------DLMK 265
Query: 317 KMLEYDPRKRITAAQALEHEYF 338
+L+ +P R Q L H F
Sbjct: 266 NLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 7e-48
Identities = 114/317 (35%), Positives = 159/317 (50%), Gaps = 34/317 (10%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y + +G G YG V A G +A+KK + + RE+ LL+ +
Sbjct: 17 ERYQNLSPVGSGAYGSVCAA---FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73
Query: 86 THENVVKLVNVHINHADMS----LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILW 141
HENV+ L++V + +YL DL I++ + +H V+ +++
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH------VQFLIY 127
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
Q+L GL Y+HS IIHRDLKPSN+ V + E +KI DFGLAR + G V
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVNEDCE----LKILDFGLARHTDDEM-----TGYV 178
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T WYRAPE++L HY VD+W+VGCI AELLT + LF G + +DQL I
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--------HIDQLKLI 230
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
+++G P E L + +S +IQ + V + A DLL KML
Sbjct: 231 LRLVGTPGAE---LLKKISS-ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL 286
Query: 322 DPRKRITAAQALEHEYF 338
D KRITAAQAL H YF
Sbjct: 287 DSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 7e-47
Identities = 114/336 (33%), Positives = 168/336 (50%), Gaps = 54/336 (16%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
L++Y + IG G G+V A G+ +AIKK + + A RE++L++
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAA---YDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKL 71
Query: 85 ITHENVVKLVNVHINHADMS----LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSIL 140
+ H+N++ L+NV + +YL + + +L ++I D ++H Y +L
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMD-LDHERMSY----LL 124
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
+Q+L G+ +LHS IIHRDLKPSNI+V + +KI DFGLAR A F+
Sbjct: 125 YQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLART--AGTSFMMTP-Y 177
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
VVT +YRAPE++LG Y VD+W+VGCI E++ LF G + +DQ +K
Sbjct: 178 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTD--------HIDQWNK 228
Query: 261 IFKILGHPTPEKW----PT----LANLPHWQ--------SDSLHIQGRKYETNGLHSVVP 304
I + LG P+ E PT + N P + D L + N L +
Sbjct: 229 IIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSE-SHNKLKA--- 284
Query: 305 LSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340
S A DLLSKML DP KRI+ AL+H Y +
Sbjct: 285 ----SQARDLLSKMLVIDPEKRISVDDALQHPYINV 316
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 4e-46
Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 52/306 (16%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
+G G++G V+LA K + G+ +A+K + S D + REI +L + H N+V+
Sbjct: 7 LLGRGSFGSVYLALDK---DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR 63
Query: 93 LVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS 152
+ +L + + EY + K + ++ Q+L GL YLHS
Sbjct: 64 YYGSERDEEKNTLNI---FLEYVSGGSLSSLLKKFGK-LPEPVIRKYTRQILEGLAYLHS 119
Query: 153 NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELL 212
N I+HRD+K +NILV GVVK+ADFG A+ V T ++ APE++
Sbjct: 120 NGIVHRDIKGANILVDS----DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 213 LGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEK 272
G + Y A D+W++GC E+ T KP + + + ++KI P
Sbjct: 176 RGEE-YGRAADIWSLGCTVIEMATGKPPW----------SELGNPMAALYKIGSSGEP-- 222
Query: 273 WPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332
P +P S+ A D L K L DP+KR TA +
Sbjct: 223 -P---EIPEHLSEE------------------------AKDFLRKCLRRDPKKRPTADEL 254
Query: 333 LEHEYF 338
L+H +
Sbjct: 255 LQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 8e-46
Identities = 109/320 (34%), Positives = 164/320 (51%), Gaps = 40/320 (12%)
Query: 26 QQYNLIGKIGEGTYGLV---FLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLL 82
++Y + +G G YG V + R++ + +A+KK + + RE+ LL
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLR------QKVAVKKLSRPFQSLIHARRTYRELRLL 68
Query: 83 REITHENVVKLVNVHINHADMS----LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKS 138
+ + HENV+ L++V + +YL + DL I++ + H V+
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEH------VQF 122
Query: 139 ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSEN 198
+++QLL GL Y+HS IIHRDLKPSN+ V + E ++I DFGLAR +
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE----LRILDFGLARQADDEM-----T 173
Query: 199 GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258
G V T WYRAPE++L HY VD+W+VGCI AELL K LF G + +DQL
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND--------YIDQL 225
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318
+I +++G P+PE +++ H + +IQ + + A DLL KM
Sbjct: 226 KRIMEVVGTPSPEVLKKISS-EHARK---YIQSLPHMPQQDLKKIFRGANPLAIDLLEKM 281
Query: 319 LEYDPRKRITAAQALEHEYF 338
L D KRI+A++AL H YF
Sbjct: 282 LVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 4e-43
Identities = 119/359 (33%), Positives = 173/359 (48%), Gaps = 67/359 (18%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
L++Y + IG G G+V A G +A+KK + + A RE++LL+
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVL---GINVAVKKLSRPFQNQTHAKRAYRELVLLKC 76
Query: 85 ITHENVVKLVNVHINHADMS----LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSIL 140
+ H+N++ L+NV + +YL + + +L ++I H + ++H Y +L
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--HME-LDHERMSY----LL 129
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
+Q+L G+ +LHS IIHRDLKPSNI+V + +KI DFGLAR A F+
Sbjct: 130 YQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLAR--TACTNFMM-TPY 182
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
VVT +YRAPE++LG Y VD+W+VGCI EL+ +FQG + +DQ +K
Sbjct: 183 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTD--------HIDQWNK 233
Query: 261 IFKILGHPTPE----KWPTLAN----------------LPHW--QSDSLHIQGRKYETNG 298
+ + LG P+ E PT+ N P W S+S K +T
Sbjct: 234 VIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESER---DKLKT-- 288
Query: 299 LHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDK 357
S A DLLSKML DP KRI+ +AL H Y + P P Q D
Sbjct: 289 ----------SQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDA 337
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 5e-43
Identities = 91/311 (29%), Positives = 140/311 (45%), Gaps = 60/311 (19%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
+ ++ KIG+G +G V+ AR K GK +AIK K I EI +L++ H
Sbjct: 2 FEILEKIGKGGFGEVYKARHK---RTGKEVAIKVIKLESKEK--KEKIINEIQILKKCKH 56
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
N+VK ++ L++ ++ L ++++ N T+ + + +LL G
Sbjct: 57 PNIVKYYGSYLK--KDELWIVMEFCSGGSLKDLLKST----NQTLTESQIAYVCKELLKG 110
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
L YLHSN IIHRD+K +NIL+ +GE VK+ DFGL+ + N +V T ++
Sbjct: 111 LEYLHSNGIIHRDIKAANILLTSDGE----VKLIDFGLSAQLS---DTKARNTMVGTPYW 163
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266
APE++ G K Y D+W++G EL KP + +L + +FKI
Sbjct: 164 MAPEVING-KPYDYKADIWSLGITAIELAEGKPPY-----------SELPPMKALFKIAT 211
Query: 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326
+ P L N P SD D L K L+ +P KR
Sbjct: 212 NGP----PGLRN-PEKWSDEFK------------------------DFLKKCLQKNPEKR 242
Query: 327 ITAAQALEHEY 337
TA Q L+H +
Sbjct: 243 PTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 8e-41
Identities = 121/353 (34%), Positives = 176/353 (49%), Gaps = 55/353 (15%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
L++Y + IG G G+V A A +R +AIKK + + A RE++L++
Sbjct: 16 LKRYQNLKPIGSGAQGIV-CAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 85 ITHENVVKLVNVHINHADMS----LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSIL 140
+ H+N++ L+NV + +YL + + +L ++I+ D H Y +L
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD---HERMSY----LL 125
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
+Q+L G+ +LHS IIHRDLKPSNI+V + +KI DFGLAR A F+
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLAR--TAGTSFMM-TPY 178
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
VVT +YRAPE++LG Y VD+W+VGCI E++ K LF G + +DQ +K
Sbjct: 179 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRD--------YIDQWNK 229
Query: 261 IFKILGHPTPE----KWPTLAN------------LPHWQSDSLHIQGRKYETNGLHSVVP 304
+ + LG P PE PT+ N P DSL + + H+ +
Sbjct: 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL------FPADSEHNKL- 282
Query: 305 LSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDK 357
S A DLLSKML DP KRI+ +AL+H Y + P P Q DK
Sbjct: 283 --KASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDK 333
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 3e-40
Identities = 117/349 (33%), Positives = 174/349 (49%), Gaps = 47/349 (13%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
L++Y + IG G G+V A A R +AIKK + + A RE++L++
Sbjct: 23 LKRYQNLKPIGSGAQGIV-CAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 85 ITHENVVKLVNVHINHADMS----LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSIL 140
+ H+N++ L+NV + +Y+ + + +L ++I+ D H Y +L
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD---HERMSY----LL 132
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
+Q+L G+ +LHS IIHRDLKPSNI+V + +KI DFGLAR A F+
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLAR--TAGTSFMMTP-Y 185
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
VVT +YRAPE++LG Y VD+W+VGCI E++ LF G + +DQ +K
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTD--------HIDQWNK 236
Query: 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGR-KYETNGLHSVVP--LSP---------K 308
+ + LG P PE L P ++ +++ R KY + P L P
Sbjct: 237 VIEQLGTPCPEFMKKLQ--PTVRT---YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKA 291
Query: 309 SPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDK 357
S A DLLSKML D KRI+ +AL+H Y + P P + DK
Sbjct: 292 SQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK 340
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 9e-38
Identities = 91/319 (28%), Positives = 165/319 (51%), Gaps = 36/319 (11%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ Y L IG G++G+V+ A + + +AIKK Q RE+++++ +
Sbjct: 66 KSYKLGNIIGNGSFGVVYEA---ICIDTSEKVAIKKVLQDPQYKN------RELLIMKNL 116
Query: 86 THENVVKLVN------VHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
H N++ L + N ++ L + ++ +++ ++H+ + NH + + VK
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHY-ARNNHALPLFLVKLY 175
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
+QL L Y+HS +I HRDLKP N+L+ +K+ DFG A+ A + +S
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLI---DPNTHTLKLCDFGSAKNLLAGQRSVS--- 229
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
+ + +YRAPEL+LGA +YT+ +D+W++GCI AE++ P+F G + +DQL
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS--------VDQLV 281
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
+I ++LG PT ++ + P++ I+ + L V P A + +S+ L
Sbjct: 282 RIIQVLGTPTEDQLKEMN--PNYAD----IKFPDVKPKDLKKVFPKGTPDDAINFISQFL 335
Query: 320 EYDPRKRITAAQALEHEYF 338
+Y+P KR+ +AL +F
Sbjct: 336 KYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 91/317 (28%), Positives = 140/317 (44%), Gaps = 68/317 (21%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAA-ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
Y L IG G +G+V+ K G +AIK+ K + + ++EI LL+ +
Sbjct: 1 NYQLGDLIGRGAFGVVY----KGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL 56
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
H N+VK + SLY+ +YAE L +II+ V ++Q+L
Sbjct: 57 KHPNIVKYIGSIETSD--SLYIILEYAENGSLRQIIKKF-----GPFPESLVAVYVYQVL 109
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
GL YLH +IHRD+K +NIL + GVVK+ADFG+A K + VV T
Sbjct: 110 QGLAYLHEQGVIHRDIKAANILTTKD----GVVKLADFGVATKLNDVSK--DDASVVGTP 163
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
++ APE++ + ++A D+W++GC ELLT P + + L+ + +F+I
Sbjct: 164 YWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPY-----------YDLNPMAALFRI 211
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPK--SPAY-DLLSKMLEY 321
+ P PL P+ SP D L + +
Sbjct: 212 VQDDHP---------------------------------PL-PEGISPELKDFLMQCFQK 237
Query: 322 DPRKRITAAQALEHEYF 338
DP R TA Q L+H +
Sbjct: 238 DPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 90/343 (26%), Positives = 129/343 (37%), Gaps = 93/343 (27%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKF------KQSKDGDGVSPTAIRE- 78
+ IGEG++ V LA+ K K AIK K+ K E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKET---NKEYAIKILDKRQLIKEKK-----VKYVKIEK 52
Query: 79 IMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVK 137
+L R H ++KL + + +LY +YA +L + IR + Y
Sbjct: 53 EVLTRLNGHPGIIKLY--YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAA- 109
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
++L L YLHS IIHRDLKP NIL+ + +KI DFG A++ S
Sbjct: 110 ----EILLALEYLHSKGIIHRDLKPENILLD----KDMHIKITDFGTAKVLDPNSSPESN 161
Query: 198 NGV------------------VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKP 239
G V T Y +PELL K + D+WA+GCI ++LT KP
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKP 220
Query: 240 LFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGL 299
F+G N + KI K L + P +P A
Sbjct: 221 PFRG------SNEYLT--FQKILK-LEYSFPPNFPPDAK--------------------- 250
Query: 300 HSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE----HEYF 338
DL+ K+L DP+ R+ + + H +F
Sbjct: 251 -------------DLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 1e-34
Identities = 95/319 (29%), Positives = 135/319 (42%), Gaps = 83/319 (26%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK--DGDGVSPTAIREIMLLREITHENVV 91
+G+G++G V L R K GK A+K K+ K V + E +L I H +V
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEV-EHTLTERNILSRINHPFIV 56
Query: 92 KLVNVHINHA----DMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
KL H + LYL +YA +L+ + + + +++
Sbjct: 57 KL------HYAFQTEEKLYLVLEYAPGGELFSHLSKE-----GRFSEERARFYAAEIVLA 105
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE----NGVVV 202
L YLHS II+RDLKP NIL+ + G +K+ DFGLA+ SE N
Sbjct: 106 LEYLHSLGIIYRDLKPENILL----DADGHIKLTDFGLAKE------LSSEGSRTNTFCG 155
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262
T Y APE+LLG Y AVD W++G + E+LT KP F + K
Sbjct: 156 TPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE----------- 203
Query: 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYD 322
KIL P ++P LSP+ A DL+S +L+ D
Sbjct: 204 KIL--KDPLRFPE----------------------------FLSPE--ARDLISGLLQKD 231
Query: 323 PRKRITAAQALE---HEYF 338
P KR+ + A E H +F
Sbjct: 232 PTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 83/315 (26%), Positives = 133/315 (42%), Gaps = 59/315 (18%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
Y ++ IG+G++G V R K + GK + K+ + + E+ +LRE+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRK---SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
H N+V+ + I+ ++ +LY+ +Y E DL ++I+ + K + + IL QLL
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLL 116
Query: 146 GLNYLH-----SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
L H N ++HRDLKP+NI + + VK+ DFGLA+I F
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFL----DANNNVKLGDFGLAKILGHDSSFAKT--Y 170
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
V T +Y +PE L Y D+W++GC+ EL L P F N QL
Sbjct: 171 VGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTAR------NQLQLAS--- 220
Query: 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLE 320
KI +P+ S L+ +++ ML
Sbjct: 221 --KIKEGKFRR-------IPYRYSSELN------------------------EVIKSMLN 247
Query: 321 YDPRKRITAAQALEH 335
DP KR + + L+
Sbjct: 248 VDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 91/316 (28%), Positives = 134/316 (42%), Gaps = 67/316 (21%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKF-KQSKDGDGVSPTAIREIMLLREITHENVVK 92
I +G YG VFLA+ K + G AIK K + E +L + VVK
Sbjct: 1 ISKGAYGRVFLAKKK---STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
L +LYL +Y DL ++ + V +++ + + +++ L YLH
Sbjct: 58 LYYSFQG--KKNLYLVMEYLPGGDLASLLEN----VG-SLDEDVARIYIAEIVLALEYLH 110
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA------RIYQAPLKFLSENGVVVTIW 205
SN IIHRDLKP NIL+ G +K+ DFGL+ R + +V T
Sbjct: 111 SNGIIHRDLKPDNILIDSNGH----LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265
Y APE++LG + ++ VD W++GCI E L P PF + ++IF+
Sbjct: 167 YIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIP------------PFHGETPEEIFQ-- 211
Query: 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK 325
+I K E V +S + A DL+SK+L DP K
Sbjct: 212 ----------------------NILNGKIE---WPEDVEVSDE--AIDLISKLLVPDPEK 244
Query: 326 RITAAQALE---HEYF 338
R+ A E H +F
Sbjct: 245 RLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
K+GEG +G V+ ++K + +A+K K+ + ++E +++++ H NVV+
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERK-DFLKEARVMKKLGHPNVVR 60
Query: 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPY-TVK---SILWQLLNGL 147
L+ V + LYL +Y E DL + +R R ++K S Q+ G+
Sbjct: 61 LLGVCTE--EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVVVTIWY 206
YL S +HRDL N LV E VVKI+DFGL+R +Y G + W
Sbjct: 119 EYLASKKFVHRDLAARNCLV----GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
APE L +TS D+W+ G + E+ TL
Sbjct: 175 -APESLKD-GIFTSKSDVWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-32
Identities = 71/212 (33%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGK-AIAIKKFKQSKDGDGVSPTAIREIMLLREITHE 88
L K+GEG +G V+ ++K + K +A+K K+ + +RE ++R++ H
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIE-EFLREARIMRKLDHP 61
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
NVVKL+ V + LY+ +Y E DL +R +R K++ + + S Q+ G+
Sbjct: 62 NVVKLLGVCTE--EEPLYIVMEYMEGGDLLSYLRKNRPKLSLS----DLLSFALQIARGM 115
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVVVTI-W 205
YL S IHRDL N LV E VVKI+DFGL+R +Y + G + I W
Sbjct: 116 EYLESKNFIHRDLAARNCLV----GENLVVKISDFGLSRDLYDDDYY--RKRGGKLPIRW 169
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
APE L +TS D+W+ G + E+ TL
Sbjct: 170 M-APESLK-EGKFTSKSDVWSFGVLLWEIFTL 199
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 84/318 (26%), Positives = 131/318 (41%), Gaps = 86/318 (27%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFK---QSKDGDGVSPTAIREIMLLREITHENV 90
+G G++G V+ + G A+K+ + G +EI LL ++ H N+
Sbjct: 8 LGSGSFGSVYEG---LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 91 VKLVNVHINHADMSLYLAF--------DYAEYDL--YEIIRHHRDKVNHTMNPYTVKSIL 140
V+ + ++ ++L +Y +IR YT
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL-----------YTR---- 109
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
Q+L GL YLH +HRD+K +NILV + GVVK+ADFG+A+ S G
Sbjct: 110 -QILLGLEYLHDRNTVHRDIKGANILV----DTNGVVKLADFGMAKQVVEFSFAKSFKG- 163
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF-QLDQLD 259
+ ++ APE++ Y A D+W++GC E+ T KP P+ QL+ +
Sbjct: 164 --SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP------------PWSQLEGVA 209
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP--LSPKSPAYDLLSK 317
+FKI GR + +P LS + A D + K
Sbjct: 210 AVFKI--------------------------GR----SKELPPIPDHLSDE--AKDFILK 237
Query: 318 MLEYDPRKRITAAQALEH 335
L+ DP R TAA+ LEH
Sbjct: 238 CLQRDPSLRPTAAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 91/315 (28%), Positives = 147/315 (46%), Gaps = 66/315 (20%)
Query: 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI-REIMLLREITHENV 90
KIG GT+G V+ A + G+ +A+K+ + +D D + I E+ +L + H N+
Sbjct: 6 NKIGGGTFGKVYTA---VNLDTGELMAVKEIR-IQDNDPKTIKEIADEMKVLELLKHPNL 61
Query: 91 VKLVNVHINHADMSLYLAFDYAEY----DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
VK V ++ + +++ EY L E++ H R H + YT+ QLL G
Sbjct: 62 VKYYGVEVHREKVYIFM-----EYCSGGTLEELLEHGRILDEHVIRVYTL-----QLLEG 111
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE--NGVVVTI 204
L YLHS+ I+HRD+KP+NI + + GV+K+ DFG A + + E + T
Sbjct: 112 LAYLHSHGIVHRDIKPANIFL----DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167
Query: 205 WYRAPELLLGAK--HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262
Y APE++ G K + A D+W++GC+ E+ T K + + N FQ+ +F
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-----NEFQI-----MF 217
Query: 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYD 322
+ P +P S L +G D L + LE D
Sbjct: 218 HVGAGHKPP-------IP--DSLQLSPEG--------------------KDFLDRCLESD 248
Query: 323 PRKRITAAQALEHEY 337
P+KR TA++ L+H +
Sbjct: 249 PKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 88/314 (28%), Positives = 140/314 (44%), Gaps = 64/314 (20%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y + KIGEG G V+ A +A GK +AIKK + K + I EI+++++ H
Sbjct: 21 YKNLEKIGEGASGEVYKATDRAT---GKEVAIKKMRLRKQNKEL---IINEILIMKDCKH 74
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
N+V + ++ L++ +Y + L +II + ++N Y + ++L G
Sbjct: 75 PNIVDYYDSYL--VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY----VCREVLQG 128
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL-ARIYQAPLKFLSENGVVVTIW 205
L YLHS +IHRD+K NIL+ +G VK+ADFG A++ + K N VV T +
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGS----VKLADFGFAAQLTKEKSK---RNSVVGTPY 181
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP-FQLDQLDKIFKI 264
+ APE++ K Y VD+W++G + E+ +P P + L +F I
Sbjct: 182 WMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEP------------PYLREPPLRALFLI 228
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324
P L N W + D L+K L DP
Sbjct: 229 TTKGIPP----LKNPEKWSPEFK-------------------------DFLNKCLVKDPE 259
Query: 325 KRITAAQALEHEYF 338
KR +A + L+H +
Sbjct: 260 KRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 18/212 (8%)
Query: 30 LIGKIGEGTYGLVFLARIKAA-ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE 88
L K+GEG +G V+ +K + +A+K K+ + +RE ++R++ H
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIE-EFLREARIMRKLDHP 61
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
N+VKL+ V + L + +Y DL + +R +R K ++ + S Q+ G+
Sbjct: 62 NIVKLLGVCT--EEEPLMIVMEYMPGGDLLDYLRKNRPKE---LSLSDLLSFALQIARGM 116
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVVVTI-W 205
YL S IHRDL N LV E VVKI+DFGL+R +Y G + I W
Sbjct: 117 EYLESKNFIHRDLAARNCLV----GENLVVKISDFGLSRDLYDDDYY--KVKGGKLPIRW 170
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
APE L +TS D+W+ G + E+ TL
Sbjct: 171 M-APESLK-EGKFTSKSDVWSFGVLLWEIFTL 200
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 70/249 (28%), Positives = 114/249 (45%), Gaps = 25/249 (10%)
Query: 30 LIGKIGEGTYGLVFLARIKAAA-NRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITH 87
L K+GEG +G V+ +K +A+K K+ + + E ++++++H
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER--EEFLEEASIMKKLSH 60
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
N+V+L+ V LY+ +Y DL + +R H +K+ + + Q+ G
Sbjct: 61 PNIVRLLGVCTQ--GEPLYIVTEYMPGGDLLDFLRKHGEKLTLK----DLLQMALQIAKG 114
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVVVTIW 205
+ YL S +HRDL N LV E VVKI+DFGL+R IY+ G + W
Sbjct: 115 MEYLESKNFVHRDLAARNCLV----TENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW 170
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265
APE L K +TS D+W+ G + E+ TL G + + ++ L+ +
Sbjct: 171 M-APESLKDGK-FTSKSDVWSFGVLLWEIFTL-----GEQPYPGMSNEEV--LELLEDGY 221
Query: 266 GHPTPEKWP 274
P PE P
Sbjct: 222 RLPRPENCP 230
|
Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 9e-31
Identities = 90/322 (27%), Positives = 145/322 (45%), Gaps = 71/322 (22%)
Query: 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIML 81
PE + ++++ K+GEG+YG V+ A K G+ +AIK + D I+EI +
Sbjct: 1 PE--EVFDILEKLGEGSYGSVYKAIHK---ETGQVVAIKVV--PVEEDLQE--IIKEISI 51
Query: 82 LREITHENVVKLVNVHINHADMSLYLAFDYAEY----DLYEIIRHHRDKVNHTMNPYTVK 137
L++ +VK + + D L++ +Y D+ +I N T+ +
Sbjct: 52 LKQCDSPYIVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMKIT-------NKTLTEEEIA 102
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
+IL+Q L GL YLHSN IHRD+K NIL+ E+G K+ADFG++ +
Sbjct: 103 AILYQTLKGLEYLHSNKKIHRDIKAGNILL----NEEGQAKLADFGVSGQLTDTMA--KR 156
Query: 198 NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257
N V+ T ++ APE++ Y + D+W++G E+ KP + S +P +
Sbjct: 157 NTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPY------SDIHPMRA-- 207
Query: 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY-DLLS 316
IF I P P TL++ W SP + D +
Sbjct: 208 ---IFMIPNKPPP----TLSDPEKW--------------------------SPEFNDFVK 234
Query: 317 KMLEYDPRKRITAAQALEHEYF 338
K L DP +R +A Q L+H +
Sbjct: 235 KCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 83/317 (26%), Positives = 125/317 (39%), Gaps = 56/317 (17%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
Y LI IG G +V+ A + +AIK+ K V +E+ + +
Sbjct: 2 DYELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCN 57
Query: 87 HENVVKLVNVHINHADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNP-YTVKSILWQLL 144
H NVVK + L+L Y + L +I++ + ++L ++L
Sbjct: 58 HPNVVKYYTSFV--VGDELWLVMPYLSGGSLLDIMKS---SYPRGGLDEAIIATVLKEVL 112
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL-ARIYQ-APLKFLSENGVVV 202
GL YLHSN IHRD+K NIL+ E G VKIADFG+ A + V
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILL----GEDGSVKIADFGVSASLADGGDRTRKVRKTFVG 168
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262
T + APE++ Y D+W+ G EL T GA S P ++ +
Sbjct: 169 TPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT------GAAPYSKYPPMKV-----LM 217
Query: 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY-DLLSKMLEY 321
L + P ET S ++ ++S L+
Sbjct: 218 LTLQNDPP----------------------SLETG-----ADYKKYSKSFRKMISLCLQK 250
Query: 322 DPRKRITAAQALEHEYF 338
DP KR TA + L+H++F
Sbjct: 251 DPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 81/309 (26%), Positives = 139/309 (44%), Gaps = 60/309 (19%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y I +G+G +G L R + K+ ++ + A+ EI++L + H
Sbjct: 2 YIPIRVLGKGAFGEATLYR---RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH 58
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
N++ N ++ D +L + +YA LY+ I + ++ V L+Q+++
Sbjct: 59 PNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQL---FEEEMVLWYLFQIVSA 113
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
++Y+H I+HRD+K NI + + G++K+ DFG+++I + ++ VV T +Y
Sbjct: 114 VSYIHKAGILHRDIKTLNIFL----TKAGLIKLGDFGISKILGS--EYSMAETVVGTPYY 167
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL- 265
+PEL G K Y D+WA+GC+ ELLTLK F NP L + KI+
Sbjct: 168 MSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDAT------NPLNL-----VVKIVQ 215
Query: 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK 325
G+ TP ++ L S+V +L+ DP K
Sbjct: 216 GNYTPVVSVY--------------------SSELISLV------------HSLLQQDPEK 243
Query: 326 RITAAQALE 334
R TA + L+
Sbjct: 244 RPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 86/319 (26%), Positives = 133/319 (41%), Gaps = 78/319 (24%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN 89
+ +G+G+ G+V+ R K GK A+KK D + +RE+ LR
Sbjct: 5 RVKVLGQGSSGVVYKVRHKPT---GKIYALKKIHVDGDEEFRK-QLLRELKTLRSCESPY 60
Query: 90 VVKLVNVHINHADMSLYLAFDYAEY----DLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
VVK ++S+ L EY L ++++ + + I Q+L
Sbjct: 61 VVKCYGAFYKEGEISIVL-----EYMDGGSLADLLKKVG-----KIPEPVLAYIARQILK 110
Query: 146 GLNYLHSNW-IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV---- 200
GL+YLH+ IIHRD+KPSN+L+ +GE VKIADFG++++ EN +
Sbjct: 111 GLDYLHTKRHIIHRDIKPSNLLINSKGE----VKIADFGISKV--------LENTLDQCN 158
Query: 201 --VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258
V T+ Y +PE + G + Y+ A D+W++G E K F Q
Sbjct: 159 TFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPG--------QPSFF 209
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP-AYDLLSK 317
+ + I P P LP SP D +S
Sbjct: 210 ELMQAICDGPPPS-------LPA------------------------EEFSPEFRDFISA 238
Query: 318 MLEYDPRKRITAAQALEHE 336
L+ DP+KR +AA+ L+H
Sbjct: 239 CLQKDPKKRPSAAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 81/321 (25%), Positives = 130/321 (40%), Gaps = 84/321 (26%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH-----E 88
I +G +G V+LA+ ++ G AIK K+S D ++ + + R I
Sbjct: 4 ISKGAFGSVYLAKKRST---GDYFAIKVLKKS---DMIAKNQVTNVKAERAIMMIQGESP 57
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHR----DKVNHTMNPYT---VKSILW 141
V KL Y +F +Y LY ++ + + T+ K +
Sbjct: 58 YVAKL------------YYSFQSKDY-LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA 104
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
+++ G+ LH IIHRD+KP N+L+ ++ G +K+ DFGL+R KF V
Sbjct: 105 EVVLGVEDLHQRGIIHRDIKPENLLI----DQTGHLKLTDFGLSRNGLENKKF------V 154
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T Y APE +LG D W++GC+ E L P PF + D +
Sbjct: 155 GTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYP------------PFHAETPDAV 201
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
F + L+ +W + SP+ A DL++++L
Sbjct: 202 FDNI----------LSRRINWPEE---------------VKEFCSPE--AVDLINRLLCM 234
Query: 322 DPRKRITAAQALE---HEYFR 339
DP KR+ A E H +F+
Sbjct: 235 DPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 94/322 (29%), Positives = 152/322 (47%), Gaps = 81/322 (25%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFK------QSKDGDGVSPTAI-REIMLLREIT 86
IG G++G V+L A+ G+ +A+K+ + SKD A+ REI LL+E+
Sbjct: 8 IGSGSFGSVYLG---MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPY------TVKSIL 140
HEN+V+ + ++ ++++L + V +N Y V++ +
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPG------------GSVAALLNNYGAFEETLVRNFV 112
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG- 199
Q+L GLNYLH+ IIHRD+K +NILV + +G +KI+DFG+++ +A NG
Sbjct: 113 RQILKGLNYLHNRGIIHRDIKGANILV----DNKGGIKISDFGISKKLEANSLSTKTNGA 168
Query: 200 ---VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF-QL 255
+ ++++ APE ++ YT D+W++GC+ E+LT K +PF
Sbjct: 169 RPSLQGSVFWMAPE-VVKQTSYTRKADIWSLGCLVVEMLTGK------------HPFPDC 215
Query: 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLL 315
QL IFKI + +PE +P + S A D L
Sbjct: 216 TQLQAIFKIGENASPE-------------------------------IPSNISSEAIDFL 244
Query: 316 SKMLEYDPRKRITAAQALEHEY 337
K E D KR TAA+ L+H +
Sbjct: 245 EKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 82/320 (25%), Positives = 134/320 (41%), Gaps = 70/320 (21%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
+ +IG++G+G +G V+ A+ K A K Q + + + + EI +L E H
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKET----GLFAAAKIIQIESEEELEDFMV-EIDILSECKH 61
Query: 88 ENVVKLVNVHINHADMSLYLAF-DYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
N+V L + + + + F D D I+ ++ + ++ + Q+L
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALD--SIM----LELERGLTEPQIRYVCRQMLEA 115
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE----NGVVV 202
LN+LHS+ +IHRDLK NIL+ +G+ VK+ADFG++ K S + +
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGD----VKLADFGVSA------KNKSTLQKRDTFIG 165
Query: 203 TIWYRAPELLL----GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258
T ++ APE++ Y D+W++G +TL L Q NP ++
Sbjct: 166 TPYWMAPEVVACETFKDNPYDYKADIWSLG------ITLIELAQMEPPHHELNPMRV--- 216
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318
+ KIL P TL W S S + D L
Sbjct: 217 --LLKILKSEPP----TLDQPSKW-SSSFN------------------------DFLKSC 245
Query: 319 LEYDPRKRITAAQALEHEYF 338
L DP R TAA+ L+H +
Sbjct: 246 LVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 76/321 (23%), Positives = 131/321 (40%), Gaps = 75/321 (23%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIR--------EIMLLREI 85
IG+GTYG V+LA G+ +A+K+ + G + + EI L+++
Sbjct: 9 IGKGTYGRVYLA---LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY----DLYEIIRHHRDKVNHTMNPYTVKSILW 141
H N+V+ + +S++L EY + +R + V+
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFL-----EYVPGGSIGSCLRTY-----GRFEEQLVRFFTE 115
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
Q+L GL YLHS I+HRDLK N+LV + G+ KI+DFG+++ +
Sbjct: 116 QVLEGLAYLHSKGILHRDLKADNLLV----DADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 202 VTIWYRAPELL-LGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
++++ APE++ ++ Y++ VD+W++GC+ E +F G S +
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLE------MFAGRRPWSDEEAIA-----A 220
Query: 261 IFKILGH----PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLS 316
+FK+ P P NL A D L+
Sbjct: 221 MFKLGNKRSAPPIPPD--VSMNL----------------------------SPVALDFLN 250
Query: 317 KMLEYDPRKRITAAQALEHEY 337
+P R TA + L+H +
Sbjct: 251 ACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 16/218 (7%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+ ++ K+G+G+YG V+ + + + A+K+ A+ EI +L +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLS---DNQFYALKEVDLGSMSQKEREDAVNEIRILASVN 57
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
H N++ ++ L + +YA + DL + I R K + + I QLL
Sbjct: 58 HPNIISYKEAFLD--GNKLCIVMEYAPFGDLSKAISK-RKKKRKLIPEQEIWRIFIQLLR 114
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
GL LH I+HRDLK +NIL++ +VKI D G++++ LK + T
Sbjct: 115 GLQALHEQKILHRDLKSANILLV----ANDLVKIGDLGISKV----LKKNMAKTQIGTPH 166
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
Y APE+ G + Y+ D+W++GC+ E+ T P F+
Sbjct: 167 YMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 90/320 (28%), Positives = 134/320 (41%), Gaps = 66/320 (20%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+ Y LI +IG GTYG V+ AR A G+ +AIK K GD +EI +L+E
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIA---TGELVAIKVIKLE-PGDDFE-IIQQEISMLKE 56
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAE----YDLYEIIRHHRDKVNHTMNPYTVKSIL 140
H N+V + L++ +Y D+Y++ R ++ + +
Sbjct: 57 CRHPNIVAYFGSY--LRRDKLWIVMEYCGGGSLQDIYQVTRGP-------LSELQIAYVC 107
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
+ L GL YLH IHRD+K +NIL+ E G VK+ADFG++ A +
Sbjct: 108 RETLKGLAYLHETGKIHRDIKGANILL----TEDGDVKLADFGVSAQLTATIA--KRKSF 161
Query: 201 VVTIWYRAPELLLGAKH--YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP-FQLDQ 257
+ T ++ APE+ + Y D+WA+G EL L+P P F L
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP------------PMFDLHP 209
Query: 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSK 317
+ +F I P P L + W S H D + K
Sbjct: 210 MRALFLISKSNFPP--PKLKDKEKW-SPVFH------------------------DFIKK 242
Query: 318 MLEYDPRKRITAAQALEHEY 337
L DP+KR TA + L+H +
Sbjct: 243 CLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 64/227 (28%), Positives = 116/227 (51%), Gaps = 21/227 (9%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA----IREIM 80
L + + KIG+G + +V+ A G+ +A+KK + + + A ++EI
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLL---DGRVVALKKVQIF---EMMDAKARQDCLKEID 54
Query: 81 LLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSI 139
LL+++ H NV+K + I + L + + A+ DL +I+H + K + T+
Sbjct: 55 LLKQLDHPNVIKYLASFIE--NNELNIVLELADAGDLSRMIKHFK-KQKRLIPERTIWKY 111
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
QL + L ++HS I+HRD+KP+N+ + GVVK+ D GL R + + K + +
Sbjct: 112 FVQLCSALEHMHSKRIMHRDIKPANVFITA----TGVVKLGDLGLGRFFSS--KTTAAHS 165
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246
+V T +Y +PE + Y D+W++GC+ E+ L+ F G +
Sbjct: 166 LVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 77/265 (29%), Positives = 126/265 (47%), Gaps = 27/265 (10%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y I +G G +G+V L R KA K + IK+ + A E +L+ ++
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQ---KLVIIKQIPVEQMTKDERLAAQNECQVLKLLS 57
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
H N+++ + D +L + +YA L E I+ + N ++ T+ Q+L
Sbjct: 58 HPNIIEYYENFLE--DKALMIVMEYAPGGTLAEYIQ---KRCNSLLDEDTILHFFVQILL 112
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
L+++H+ I+HRDLK NIL+ + + VVKI DFG+++I + K + VV T
Sbjct: 113 ALHHVHTKLILHRDLKTQNILL---DKHKMVVKIGDFGISKILSSKSKAYT---VVGTPC 166
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAE--------AKSTQNPFQ--- 254
Y +PEL G K Y D+WA+GC+ EL +LK F+ A T P
Sbjct: 167 YISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRY 225
Query: 255 LDQLDKIFKILGHPTPEKWPTLANL 279
L ++ + + P K P L+ +
Sbjct: 226 SPDLRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 86/317 (27%), Positives = 127/317 (40%), Gaps = 64/317 (20%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKF-KQSKDGDGVSPTAIREIMLLREI 85
+ L+ IG+G +G V + + + + K A+K KQ G + E +L+E+
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKR---DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL 57
Query: 86 THENVVKLVNVHINHADMS-LYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
H LVN+ + D +YL D DL R+H + + VK + ++
Sbjct: 58 NHP---FLVNLWYSFQDEENMYLVVDLLLGGDL----RYHLSQ-KVKFSEEQVKFWICEI 109
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
+ L YLHS IIHRD+KP NIL+ +EQG V I DF +A S +G T
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNILL----DEQGHVHITDFNIATKVTPDTLTTSTSG---T 162
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
Y APE+L + AVD W++G E L K ++G DQ+ +
Sbjct: 163 PGYMAPEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIR------DQIRAKQE 215
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
P W T A D ++K+LE DP
Sbjct: 216 TADVLYPATWST----------------------------------EAIDAINKLLERDP 241
Query: 324 RKRI--TAAQALEHEYF 338
+KR+ H YF
Sbjct: 242 QKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI---REIMLLREITHENV 90
+G G +G V L ++K ++ + A+K K+ + I +EI+ E H +
Sbjct: 1 LGVGGFGRVELVKVK---SKNRTFALKCVKKRHIVETGQQEHIFSEKEILE--ECNHPFI 55
Query: 91 VKLVNVHINHADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNY 149
VKL + +Y+ +Y +L+ I+R D+ + YT + + ++ Y
Sbjct: 56 VKLYRTFKDKKY--IYMLMEYCLGGELWTILR---DRGL--FDEYTARFYIACVVLAFEY 108
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAP 209
LH+ II+RDLKP N+L+ G VK+ DFG A+ ++ K + G T Y AP
Sbjct: 109 LHNRGIIYRDLKPENLLLD----SNGYVKLVDFGFAKKLKSGQKTWTFCG---TPEYVAP 161
Query: 210 ELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAE 245
E++L K Y +VD W++G + ELLT +P F +
Sbjct: 162 EIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 81/316 (25%), Positives = 133/316 (42%), Gaps = 68/316 (21%)
Query: 32 GK-IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSP--TAIR-EIMLLREITH 87
GK +G+G +G V+L + G+ +A+K+ D A+ EI LL+ + H
Sbjct: 7 GKLLGQGAFGRVYLC---YDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEY----DLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
E +V+ + +S+++ EY + + ++ + YT Q+
Sbjct: 64 ERIVQYYGCLRDDETLSIFM-----EYMPGGSVKDQLKAYGALTETVTRKYT-----RQI 113
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA-PLKFLSENGVVV 202
L G+ YLHSN I+HRD+K +NIL + G VK+ DFG ++ Q V
Sbjct: 114 LEGVEYLHSNMIVHRDIKGANIL----RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262
T ++ +PE++ G + A D+W+VGC E+LT KP + EA + IF
Sbjct: 170 TPYWMSPEVISGEGYGRKA-DVWSVGCTVVEMLTEKPPWAEFEAMAA-----------IF 217
Query: 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYD 322
KI PT + P H D A + L + +
Sbjct: 218 KIATQPTNPQLP-----SHVSPD-------------------------ARNFLRRTFVEN 247
Query: 323 PRKRITAAQALEHEYF 338
+KR +A + L H +
Sbjct: 248 AKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 1e-23
Identities = 74/215 (34%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 30 LIGKIGEGTYGLVFLARIKAAA-NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE 88
I ++GEG +G V L R N G+ +A+K S + REI +LR + HE
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLDHE 66
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNH-TMNPYTVKSILWQLLNG 146
N+VK V SL L +Y L + ++ HRD++N + ++ Q+ G
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS-----QICKG 121
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK----FLSENGVVV 202
++YL S IHRDL NILV E + +VKI+DFGLA++ P ++ E G
Sbjct: 122 MDYLGSQRYIHRDLAARNILV----ESEDLVKISDFGLAKV--LPEDKDYYYVKEPGESP 175
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
WY APE L +K ++SA D+W+ G EL T
Sbjct: 176 IFWY-APECLRTSK-FSSASDVWSFGVTLYELFTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 8e-23
Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 22/226 (9%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y + KIGEG++G L + K GK IK+ SK + +E+ +L +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSK---EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK 57
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSIL-W--Q 142
H N+V+ + +LY+ DY E DLY+ I R + IL W Q
Sbjct: 58 HPNIVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGV------LFPEDQILDWFVQ 109
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV 202
+ L ++H I+HRD+K NI + + G +K+ DFG+AR+ + ++ +
Sbjct: 110 ICLALKHVHDRKILHRDIKSQNIFLT----KDGTIKLGDFGIARVLNSTVEL--ARTCIG 163
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248
T +Y +PE+ + Y + D+WA+GC+ E+ TLK F+ K+
Sbjct: 164 TPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-22
Identities = 84/315 (26%), Positives = 133/315 (42%), Gaps = 63/315 (20%)
Query: 34 IGEGTYGLVFLAR-IKAAANRGKAIAIKKFKQ----SKDGDGVSPTAIREIMLLREITHE 88
+G G + + AR +K G +A+K+ S + + V +EI L+ + H
Sbjct: 8 LGTGAFSSCYQARDVKT----GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 89 NVVKLV--NVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
++++++ +H ++ + E+ + H K + QLL G
Sbjct: 64 HIIRMLGATCEDSHFNL-------FVEWMAGGSVSHLLSKYGAFKEAVIINYTE-QLLRG 115
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE--NGVVVTI 204
L+YLH N IIHRD+K +N+L+ G+ ++IADFG A A E ++ TI
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQR---LRIADFGAAARLAAKGTGAGEFQGQLLGTI 172
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
+ APE+L G + Y + D+W+VGC+ E+ T KP + AE S N L IFKI
Sbjct: 173 AFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPW-NAEKHS--NHLAL-----IFKI 223
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324
T P LSP D+ + LE P
Sbjct: 224 ASATTAPSIPE----------------------------HLSPG--LRDVTLRCLELQPE 253
Query: 325 KRITAAQALEHEYFR 339
R + + L+H FR
Sbjct: 254 DRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 76/255 (29%), Positives = 107/255 (41%), Gaps = 57/255 (22%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK--DGDGVSPTAIREIMLLR 83
+ I +G G++G V L R K GK A+K ++K V + E +L+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHV-LNEKRILQ 56
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNP----YTVKSI 139
I H +V L D +LYL +Y E+ H R K P Y + +
Sbjct: 57 SIRHPFLVNLYGSF--QDDSNLYLVMEYVPGG--ELFSHLR-KSGRFPEPVARFYAAQVV 111
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
L L YLHS I++RDLKP N+L+ + G +KI DFG A K +
Sbjct: 112 L-----ALEYLHSLDIVYRDLKPENLLL----DSDGYIKITDFGFA-------KRVKGR- 154
Query: 200 VVVTIW-------YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252
+ Y APE++L K Y AVD WA+G + E+L P P
Sbjct: 155 ----TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYP------------P 197
Query: 253 FQLDQLDKIF-KILG 266
F D +I+ KIL
Sbjct: 198 FFDDNPIQIYEKILE 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 4e-22
Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 20/222 (9%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
+ ++ KIG+G++G+VF KA + A+K+ SK AI E +L ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
+++ ++ L + +YAE DL+++++ R + + V Q+L G
Sbjct: 59 SYIIRYYESFLD--KGKLNIVMEYAENGDLHKLLKMQRGR---PLPEDQVWRFFIQILLG 113
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
L +LHS I+HRD+K N+ + + VKI D G+A++ F N +V T +Y
Sbjct: 114 LAHLHSKKILHRDIKSLNLFL----DAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYY 167
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLF----QGA 244
+PE L K Y D+WA+G + E T K F QGA
Sbjct: 168 LSPE-LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 6e-22
Identities = 74/319 (23%), Positives = 132/319 (41%), Gaps = 69/319 (21%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ + L+ IG+G++G V+ A K + +AIK + D + +EI L +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRT---NQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQC 56
Query: 86 THENVVKLVNVHINHADMSLYLAFDY----AEYDLYEIIRHHRDKVNHTMNPYTVKSILW 141
+ K + L++ +Y + DL + + ++ + IL
Sbjct: 57 RSPYITKYYGSFLK--GSKLWIIMEYCGGGSCLDLLKPGK---------LDETYIAFILR 105
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
++L GL YLH IHRD+K +NIL+ EG+ VK+ADFG++ Q N V
Sbjct: 106 EVLLGLEYLHEEGKIHRDIKAANILLSEEGD----VKLADFGVSG--QLTSTMSKRNTFV 159
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T ++ APE++ + Y D+W++G EL +P L + +
Sbjct: 160 GTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSD-----------LHPMRVL 207
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY-DLLSKMLE 320
F I + P ++G K+ S + D +S L
Sbjct: 208 FLIPKNNPPS-----------------LEGNKF--------------SKPFKDFVSLCLN 236
Query: 321 YDPRKRITAAQALEHEYFR 339
DP++R +A + L+H++ +
Sbjct: 237 KDPKERPSAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 9e-22
Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 26/226 (11%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKF--------KQSKDGDGVSPTAIREI 79
Y ++ +G G +G V+ +++ N +A+K+ K ++ D + E+
Sbjct: 2 YAVLEHLGSGAFGCVY--KVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59
Query: 80 MLLRE-ITHENVVKLVNVHI-NHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTV 136
+++E + H N+V+ + N LY+ D E L E ++K +
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLEND---RLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERI 115
Query: 137 KSILWQLLNGLNYLH-SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195
+I Q++ L YLH I+HRDL P+NI+ +GE ++ V I DFGLA+ Q K
Sbjct: 116 WNIFVQMVLALRYLHKEKRIVHRDLTPNNIM-LGEDDK---VTITDFGLAKQKQPESKLT 171
Query: 196 SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLF 241
S VV TI Y PE++ Y D+WA GCI ++ TL+P F
Sbjct: 172 S---VVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 65/221 (29%), Positives = 113/221 (51%), Gaps = 21/221 (9%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y +I KIGEG++G ++LA+ K+ + + IK+ +K + +E++LL ++
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDS---EHCVIKEIDLTKMPVKEKEASKKEVILLAKMK 57
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSIL-W--Q 142
H N+V + L++ +Y + DL + I R + ++ IL W Q
Sbjct: 58 HPNIVTFFASF--QENGRLFIVMEYCDGGDLMKRINRQRGVL------FSEDQILSWFVQ 109
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV 202
+ GL ++H I+HRD+K NI + G V K+ DFG+AR ++ V
Sbjct: 110 ISLGLKHIHDRKILHRDIKSQNIFLSKNGM---VAKLGDFGIARQLNDSMELAYT--CVG 164
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
T +Y +PE+ + Y + D+W++GC+ EL TLK F+G
Sbjct: 165 TPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 77/314 (24%), Positives = 124/314 (39%), Gaps = 50/314 (15%)
Query: 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENV 90
+ ++GEG G V R+K I K + + +RE+ + + +
Sbjct: 6 LSRLGEGAGGSVTKCRLK----NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 91 VKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL 150
VK ++ + S+ +A +Y E + I K + + I +L GL+YL
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 151 HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPE 210
HS IIHRD+KPSNIL+ +G VK+ DFG++ + T +Y APE
Sbjct: 122 HSRKIIHRDIKPSNILL----TRKGQVKLCDFGVSG--ELVNSLAGT--FTGTSFYMAPE 173
Query: 211 LLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGA---EAKSTQNPFQLDQLDKIFKILGH 267
+ G K Y+ D+W++G LTL + Q + ++ L I +
Sbjct: 174 RIQG-KPYSITSDVWSLG------LTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM--- 223
Query: 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI 327
P PE N W S+ D + + LE DP +R
Sbjct: 224 PNPELKDEPGNGIKW-SEEFK------------------------DFIKQCLEKDPTRRP 258
Query: 328 TAAQALEHEYFRIE 341
T LEH + + +
Sbjct: 259 TPWDMLEHPWIKAQ 272
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-21
Identities = 72/267 (26%), Positives = 125/267 (46%), Gaps = 27/267 (10%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG-VSPTAIREIMLLR 83
L + + KIG G + V+ A G +A+KK + D I+EI LL+
Sbjct: 1 LANFRIEKKIGRGQFSEVYRA---TCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK 57
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
++ H NV+K I ++++ L A DL +I+H + K + TV QL
Sbjct: 58 QLNHPNVIKYYASFIEDNELNIVLELADAG-DLSRMIKHFK-KQKRLIPEKTVWKYFVQL 115
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
+ L ++HS ++HRD+KP+N+ + GVVK+ D GL R + + K + + +V T
Sbjct: 116 CSALEHMHSRRVMHRDIKPANVFITA----TGVVKLGDLGLGRFFSS--KTTAAHSLVGT 169
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD---- 259
+Y +PE + Y D+W++GC+ E+ L+ F G + +++Q D
Sbjct: 170 PYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 228
Query: 260 ----------KIFKILGHPTPEKWPTL 276
++ + +P PEK P +
Sbjct: 229 PSDHYSEELRQLVNMCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 31 IGKIGEGTYGLVFLARIKAAANR-GKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN 89
I +GEG +G V L R + G+ +A+K K G+ ++ +EI +LR + HEN
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRNLYHEN 67
Query: 90 VVKLVNVHINHADMSLYLAFDY-AEYDLYEIIRHHRDKVN-HTMNPYTVKSILWQLLNGL 147
+VK + + L ++ L E + +++K+N Y V Q+ G+
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV-----QICKGM 122
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKF--LSENGVVVTIW 205
+YL S +HRDL N+LV E + VKI DFGL + + ++ + ++ W
Sbjct: 123 DYLGSRQYVHRDLAARNVLV----ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
Y APE L+ +K Y A D+W+ G ELLT
Sbjct: 179 Y-APECLIQSKFYI-ASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 84/331 (25%), Positives = 130/331 (39%), Gaps = 90/331 (27%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIR-------- 77
I +G GT+G V L R + + A+K P IR
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRIS---EHYYALKVMA--------IPEVIRLKQEQHVH 49
Query: 78 -EIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYT 135
E +L+E++H +++L H LY+ +Y +L+ +R+ N T Y
Sbjct: 50 NEKRVLKEVSHPFIIRLFWTE--HDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYA 107
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195
+++ L YLHS I++RDLKP NIL+ EG +K+ DFG A K L
Sbjct: 108 S-----EIVCALEYLHSKEIVYRDLKPENILLDKEGH----IKLTDFGFA-------KKL 151
Query: 196 SENGVVV--TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253
+ + T Y APE ++ +K + AVD WA+G + E+L P F NPF
Sbjct: 152 RDRTWTLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFD------DNPF 204
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYD 313
+ + KIL ++P +L A D
Sbjct: 205 GIYE-----KILAGKL--EFPRHLDL------------------------------YAKD 227
Query: 314 LLSKMLEYDPRKRI-----TAAQALEHEYFR 339
L+ K+L D +R+ A H +F+
Sbjct: 228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 5e-21
Identities = 71/235 (30%), Positives = 114/235 (48%), Gaps = 28/235 (11%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIKKFKQSKDGDGVSPTAIREIMLL 82
L + ++GEG +G V+ + R ++AIK K++ + V +E L+
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK-VQQEFRQEAELM 62
Query: 83 REITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-IIRH--HRDKVNHTMNPYTVKS 138
++ H N+V L+ V + F+Y + DL+E ++R+ H D V TVKS
Sbjct: 63 SDLQHPNIVCLLGVCTKEQPTCML--FEYLAHGDLHEFLVRNSPHSD-VGAESGDETVKS 119
Query: 139 ILW---------QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IY 188
L Q+ G+ YL S+ +HRDL N LV GEG VKI+DFGL+R IY
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV-GEGL---TVKISDFGLSRDIY 175
Query: 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT--LKPLF 241
A + ++ W PE +L K +T+ D+W+ G + E+ + L+P +
Sbjct: 176 SADYYRVQSKSLLPVRWM-PPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-21
Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 31 IGKIGEGTYGLVFLARIKAAA-NRGKAIAIKKFKQSKDGDGVSPTAI----REIMLLREI 85
I ++G+G +G V L R N G+ +A+KK + S + + REI +L+ +
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS------TAEHLRDFEREIEILKSL 62
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNH-TMNPYTVKSILWQL 143
H+N+VK V + +L L +Y Y L + ++ HR++++H + Y Q+
Sbjct: 63 QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA-----SQI 117
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKF--LSENGVV 201
G+ YL S +HRDL NILV E + VKI DFGL ++ ++ + E G
Sbjct: 118 CKGMEYLGSKRYVHRDLATRNILV----ESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
WY APE L +K ++ A D+W+ G + EL T
Sbjct: 174 PIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 9e-21
Identities = 80/325 (24%), Positives = 144/325 (44%), Gaps = 70/325 (21%)
Query: 19 GEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKF---KQSKDGDGVSPTA 75
G+ +L + KIGEG+ G+V +A K+ G+ +A+KK KQ +
Sbjct: 15 GDPRSYLDNFV---KIGEGSTGIVCIATDKST---GRQVAVKKMDLRKQQR-----RELL 63
Query: 76 IREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPY 134
E++++R+ H N+V++ + ++ L++ ++ E L +I+ H R MN
Sbjct: 64 FNEVVIMRDYQHPNIVEMYSSYL--VGDELWVVMEFLEGGALTDIVTHTR------MNEE 115
Query: 135 TVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKF 194
+ ++ +L L++LH+ +IHRD+K +IL+ + G VK++DFG Q +
Sbjct: 116 QIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD----GRVKLSDFGFCA--QVSKEV 169
Query: 195 LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254
+V T ++ APE ++ Y + VD+W++G + E++ +P P+
Sbjct: 170 PRRKSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEP------------PYF 216
Query: 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDL 314
+ + K + P P L N H S L
Sbjct: 217 NEPPLQAMKRIRDNLP---PKLKN-LHKVSPRLR------------------------SF 248
Query: 315 LSKMLEYDPRKRITAAQALEHEYFR 339
L +ML DP +R TAA+ L H +
Sbjct: 249 LDRMLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 72/217 (33%), Positives = 106/217 (48%), Gaps = 30/217 (13%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
+G+GTYG+V+ AR + R IAIK+ + +D V P EI L + H N+V+
Sbjct: 16 LGKGTYGIVYAARDLSTQVR---IAIKEIPE-RDSRYVQPLH-EEIALHSYLKHRNIVQY 70
Query: 94 VNVHINHADMSLYLAFDYAEYDLYEIIRHH----RDKVNHTMNPYTVKSILWQLLNGLNY 149
+ + +++ L ++R +D T+ YT Q+L GL Y
Sbjct: 71 LGSDSENGFFKIFME-QVPGGSLSALLRSKWGPLKDNEQ-TIIFYTK-----QILEGLKY 123
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG----LARIYQAPLKFLSENGVVVTIW 205
LH N I+HRD+K N+LV GVVKI+DFG LA I F T+
Sbjct: 124 LHDNQIVHRDIKGDNVLV---NTYSGVVKISDFGTSKRLAGINPCTETFTG------TLQ 174
Query: 206 YRAPELL-LGAKHYTSAVDMWAVGCIFAELLTLKPLF 241
Y APE++ G + Y + D+W++GC E+ T KP F
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 69/225 (30%), Positives = 112/225 (49%), Gaps = 23/225 (10%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
QYN++ +GEG++G L + N + A+K+ + K V + +E +LL ++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHV---NSDQKYAMKEIRLPKSSSAVE-DSRKEAVLLAKMK 56
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSIL-W--Q 142
H N+V AD LY+ +Y + DL + I+ R K+ + +IL W Q
Sbjct: 57 HPNIVAFKESF--EADGHLYIVMEYCDGGDLMQKIKLQRGKL------FPEDTILQWFVQ 108
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV 202
+ G+ ++H ++HRD+K NI + + G VK+ DFG AR+ +P + V
Sbjct: 109 MCLGVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSARLLTSPGAYACT--YVG 162
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247
T +Y PE+ Y + D+W++GCI EL TLK FQ K
Sbjct: 163 TPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWK 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 71/231 (30%), Positives = 113/231 (48%), Gaps = 35/231 (15%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKF----KQS--KDGDGVSP 73
+ PE + + + +IG G++G V+ AR + +AIKK KQS K D
Sbjct: 11 DDPE--KLFTDLREIGHGSFGAVYFARDV---RTNEVVAIKKMSYSGKQSNEKWQD---- 61
Query: 74 TAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNP 133
I+E+ L+++ H N ++ ++ + + +L +Y +I+ H+ +
Sbjct: 62 -IIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWLVMEYCLGSASDILEVHKKP----LQE 114
Query: 134 YTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK 193
+ +I L GL YLHS+ IHRD+K NIL+ E G VK+ADFG A + +P
Sbjct: 115 VEIAAICHGALQGLAYLHSHERIHRDIKAGNILL----TEPGTVKLADFGSASL-VSP-- 167
Query: 194 FLSENGVVVTIWYRAPELLLGAK--HYTSAVDMWAVGCIFAELLTLK-PLF 241
N V T ++ APE++L Y VD+W++G EL K PLF
Sbjct: 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 63/220 (28%), Positives = 115/220 (52%), Gaps = 13/220 (5%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG-VSPTAIREIMLLR 83
L + + KIG G + V+ R +R K +A+KK + + D ++EI LL+
Sbjct: 1 LANFQIEKKIGRGQFSEVY--RATCLLDR-KPVALKKVQIFEMMDAKARQDCVKEIDLLK 57
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
++ H NV+K ++ I ++++ L A DL ++I++ + K + TV QL
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAG-DLSQMIKYFK-KQKRLIPERTVWKYFVQL 115
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
+ + ++HS ++HRD+KP+N+ + GVVK+ D GL R + + K + + +V T
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITA----TGVVKLGDLGLGRFFSS--KTTAAHSLVGT 169
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
+Y +PE + Y D+W++GC+ E+ L+ F G
Sbjct: 170 PYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 88/332 (26%), Positives = 150/332 (45%), Gaps = 67/332 (20%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI- 85
+ ++ ++G+G YG VFLA+ K + G+ +A+K+ K+S +R ++ R+I
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKK---DTGEIVALKRMKKSLL---FKLNEVRHVLTERDIL 55
Query: 86 ---THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILW 141
E +VKL+ + D LYLA +Y D ++ + Y +
Sbjct: 56 TTTKSEWLVKLL--YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFY-----MA 108
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS-ENGV 200
++ ++ LH IHRDLKP N L+ + G +K+ DFGL++ ++ N V
Sbjct: 109 EMFEAVDALHELGYIHRDLKPENFLI----DASGHIKLTDFGLSK------GIVTYANSV 158
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
V + Y APE+L G K Y VD W++GC+ E L P F G+
Sbjct: 159 VGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGS---------------- 201
Query: 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLE 320
TP + T NL +W+ +Q Y+ + LS + A+DL++K++
Sbjct: 202 --------TPNE--TWENLKYWKE---TLQRPVYDDPRFN----LSDE--AWDLITKLIN 242
Query: 321 YDPRKRITAAQALE-HEYFRIEPLPGRNALVP 351
DP +R + + ++ H +F+ L P
Sbjct: 243 -DPSRRFGSLEDIKNHPFFKEVDWNELRELKP 273
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-20
Identities = 65/264 (24%), Positives = 118/264 (44%), Gaps = 34/264 (12%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGK-AIAIKKFKQSKDGDGVSPTAIREIMLLREITHE 88
+ ++G G +G+V L + RGK +AIK ++ G I E ++ +++H
Sbjct: 8 FLKELGSGQFGVVHLGKW-----RGKIDVAIKMIRE---GAMSEDDFIEEAKVMMKLSHP 59
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEYD-LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
N+V+L V +++ +Y L +R + K+ + + + +
Sbjct: 60 NLVQLYGVCTKQR--PIFIVTEYMANGCLLNYLRERKGKLGTEW----LLDMCSDVCEAM 113
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYR 207
YL SN IHRDL N LV E VVK++DFGLAR Y ++ S G + +
Sbjct: 114 EYLESNGFIHRDLAARNCLV----GEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWA 168
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTLKPL----FQGAE-AKSTQNPFQLDQ----L 258
PE+ ++ ++S D+W+ G + E+ + + F +E +S ++L +
Sbjct: 169 PPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAP 227
Query: 259 DKIFKILG---HPTPEKWPTLANL 279
+++ I+ H PE P L
Sbjct: 228 TEVYTIMYSCWHEKPEDRPAFKKL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 8e-20
Identities = 79/315 (25%), Positives = 123/315 (39%), Gaps = 67/315 (21%)
Query: 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI-REIMLLREITHEN 89
+G++G G G+V + GK +A+K + + + I RE+ +L +
Sbjct: 6 LGELGAGNSGVVSKVLHRPT---GKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPY 60
Query: 90 VVKLVNVHINHADMSLYLAF-DYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLN 148
+V N+ D+S+ + + D D +V + + I +L GL
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKI------LKEVQGRIPERILGKIAVAVLKGLT 114
Query: 149 YLHSNW-IIHRDLKPSNILVMGEGEEQGVVKIADFGLAR--IYQAPLKFLSENGVVVTIW 205
YLH IIHRD+KPSNILV +G +K+ DFG++ + F V T
Sbjct: 115 YLHEKHKIIHRDVKPSNILV----NSRGQIKLCDFGVSGQLVNSLAKTF------VGTSS 164
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK-PLFQGAEAKSTQNPFQLDQLDKIFKI 264
Y APE + G Y+ D+W++G EL T + P E F + L I
Sbjct: 165 YMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPY--PPENDPPDGIF--ELLQYIVN- 218
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY-DLLSKMLEYDP 323
E P L P SP + D ++ L DP
Sbjct: 219 ------EPPPRL---------------------------PSGKFSPDFQDFVNLCLIKDP 245
Query: 324 RKRITAAQALEHEYF 338
R+R + + LEH +
Sbjct: 246 RERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 83/307 (27%), Positives = 141/307 (45%), Gaps = 61/307 (19%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
KIGEG+ G+V +A +K++ GK +A+KK K E++++R+ HENVV+
Sbjct: 27 KIGEGSTGIVCIATVKSS---GKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVE 81
Query: 93 LVNVHINHADMSLYLAFDYAEYD-LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
+ N ++ L++ ++ E L +I+ H R MN + ++ +L L+ LH
Sbjct: 82 MYNSYL--VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLKALSVLH 133
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPEL 211
+ +IHRD+K +IL+ +G VK++DFG Q + +V T ++ APE
Sbjct: 134 AQGVIHRDIKSDSILLTHDGR----VKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPE- 186
Query: 212 LLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPE 271
L+ Y VD+W++G + E++ +P P+ + K K++ P
Sbjct: 187 LISRLPYGPEVDIWSLGIMVIEMVDGEP------------PYFNEPPLKAMKMIRDNLP- 233
Query: 272 KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ 331
P L N LH V P L ++L DP +R TAA+
Sbjct: 234 --PKLKN--------------------LHKVSPS-----LKGFLDRLLVRDPAQRATAAE 266
Query: 332 ALEHEYF 338
L+H +
Sbjct: 267 LLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-19
Identities = 76/244 (31%), Positives = 123/244 (50%), Gaps = 33/244 (13%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIKKFKQSKDGDGVSPTAIREIMLL 82
L +Y +I KIG G +G VFL + K KAI+ + K+ + V E+ ++
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-----EVNVM 66
Query: 83 REITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILW 141
RE+ H+N+V+ ++ +N A+ LY+ ++ + DL I+ K+ + + + I
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITR 125
Query: 142 QLLNGLNYLHS-------NWIIHRDLKPSNILV------MGEGEEQG-------VVKIAD 181
QLL+ L Y H+ ++HRDLKP NI + +G+ Q + KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLG-AKHYTSAVDMWAVGCIFAELLTLKPL 240
FGL++ ++ ++ + V T +Y +PELLL K Y DMWA+GCI EL + K
Sbjct: 186 FGLSK--NIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
Query: 241 FQGA 244
F A
Sbjct: 243 FHKA 246
|
Length = 1021 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-19
Identities = 86/339 (25%), Positives = 147/339 (43%), Gaps = 43/339 (12%)
Query: 23 EWLQQYNLIGKIGEGTYGLVFLARIKA------------AANRGKAIAIKKF-KQSKDGD 69
E+L + +I + G +G +F+ ++A + N+GK + K+ K G
Sbjct: 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGS 204
Query: 70 GVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNH 129
+ EI+ L + HEN++K+ + + + + Y ++DLY +
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEI-LRSEANTYMITQKY-DFDLYSFMYDEAFDWKD 262
Query: 130 TMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ 189
++I+ QLL + Y+H +IHRD+K NI + +G+ + + DFG A ++
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK----IVLGDFGTAMPFE 318
Query: 190 APLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT--LKPLFQGAEAK 247
+ + G V T+ +PE+L G Y D+W+ G I ++L+ P+ G
Sbjct: 319 KE-REAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDG---- 372
Query: 248 STQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS- 306
P + QL KI L E++P + P D + + + G HSV PL
Sbjct: 373 -GGKPGK--QLLKIIDSLS-VCDEEFP---DPPCKLFDYIDSA--EIDHAG-HSVPPLIR 422
Query: 307 ----PKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341
P Y L+ KML +D R AA+ L F E
Sbjct: 423 NLGLPADFEYPLV-KMLTFDWHLRPGAAELLALPLFSAE 460
|
Length = 501 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 84/325 (25%), Positives = 136/325 (41%), Gaps = 73/325 (22%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIR-EIMLLREIT 86
+ L+ IGEGTYG V+ AR K G+ +AIK +D + I+ E +LR+ +
Sbjct: 8 FELVEVIGEGTYGKVYKARHK---KTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYS 60
Query: 87 -HENVVK-----LVNVHINHADMSLYLAFDYAE----YDLYEIIRHHRDKVNHTMNPYTV 136
H N+ + + D L+L + DL + +R K + +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDD-QLWLVMELCGGGSVTDLVKGLR----KKGKRLKEEWI 115
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
IL + L GL YLH N +IHRD+K NIL+ E VK+ DFG++ + L
Sbjct: 116 AYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE----VKLVDFGVSAQLDSTL--GR 169
Query: 197 ENGVVVTIWYRAPELLLGAK----HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252
N + T ++ APE++ + Y + D+W++G EL KP +P
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL------CDMHP 223
Query: 253 FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY 312
+ +FKI +P PTL + +W +K+
Sbjct: 224 -----MRALFKIPRNPP----PTLKSPENWS--------KKF-----------------N 249
Query: 313 DLLSKMLEYDPRKRITAAQALEHEY 337
D +S+ L + +R + LEH +
Sbjct: 250 DFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 80/320 (25%), Positives = 127/320 (39%), Gaps = 40/320 (12%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y +I + G+ G VF+A + + +K G T + E MLL+ + H
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPD---PVVLKI--------GQKGTTLIEAMLLQNVNH 116
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKS---ILWQLL 144
+V+++ + ++ A + L + DLY + P + I Q+L
Sbjct: 117 PSVIRMKDTLVSGAITCMVLP--HYSSDLYTYL-------TKRSRPLPIDQALIIEKQIL 167
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
GL YLH+ IIHRD+K NI + + V I D G A+ FL G+ T+
Sbjct: 168 EGLRYLHAQRIIHRDVKTENIFI----NDVDQVCIGDLGAAQFPVVAPAFL---GLAGTV 220
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ--LDQLDKIF 262
APE+L K Y S D+W+ G + E+L + + + L KI
Sbjct: 221 ETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279
Query: 263 KILGHPTPEKWPTLANLPHWQSDSLHIQG--RK-YETNGLHSVVPLSPKSPAYDLLSKML 319
L PE++P + R+ Y V L P + L+ KML
Sbjct: 280 STLK-VHPEEFPRDPG-SRLVRGFIEYASLERQPYTRYPCFQRVNL-PIDGEF-LVHKML 335
Query: 320 EYDPRKRITAAQALEHEYFR 339
+D R +A + L + F
Sbjct: 336 TFDAAMRPSAEEILNYPMFA 355
|
Length = 357 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 73/234 (31%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 31 IGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE 88
+ IG+G +G VF AR +A+K K+ D + RE L+ E H
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAEFDHP 68
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVK---------- 137
N+VKL+ V M L F+Y Y DL E +RH + +++ T
Sbjct: 69 NIVKLLGVCAVGKPMCLL--FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 138 -------SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQ 189
I Q+ G+ YL +HRDL N LV E VVKIADFGL+R IY
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV----GENMVVKIADFGLSRNIYS 182
Query: 190 APLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT--LKPLF 241
A SEN + W PE + + YT+ D+WA G + E+ + ++P +
Sbjct: 183 ADYYKASENDAIPIRWM-PPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYY 234
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 5e-19
Identities = 82/318 (25%), Positives = 135/318 (42%), Gaps = 66/318 (20%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y L ++G+G++G V+L + K A + +K+ + + A +E LL ++
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 87 HENVVKLVNVHINHADMSLYLAF----DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILW 141
H +VK HA AF +Y E DL + + T++ V
Sbjct: 61 HPAIVKF------HASFLERDAFCIITEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFI 113
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
QLL G++Y+H I+HRDLK NI + + ++KI DFG++R+ +
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFL-----KNNLLKIGDFGVSRLLMGSCDLATT--FT 166
Query: 202 VTIWYRAPELLLGAKH--YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
T +Y +PE L KH Y S D+W++GCI E+ L F+G + L
Sbjct: 167 GTPYYMSPEAL---KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----------NFLS 212
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
+ +I+ PTP +LP S L+ ++ ML
Sbjct: 213 VVLRIVEGPTP-------SLPETYSRQLNS------------------------IMQSML 241
Query: 320 EYDPRKRITAAQALEHEY 337
DP R +AA+ L + +
Sbjct: 242 NKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 32/232 (13%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKA--IAIKKFKQSKDGDGVSPTA----IREIMLLR 83
L ++GEG +G VFL +A+K K + S A RE LL
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-----ETASNDARKDFEREAELLT 63
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHH------RDKVNHTMNPYTV 136
HEN+VK V + F+Y E+ DL + +R H + M T+
Sbjct: 64 NFQHENIVKFYGVCTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 137 KSILW---QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPL 192
+L Q+ +G+ YL S +HRDL N LV G + VVKI DFG++R +Y
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDL-VVKIGDFGMSRDVYTTDY 177
Query: 193 KFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL--KPLFQ 242
+ ++ I + PE ++ K +T+ D+W+ G + E+ T +P +
Sbjct: 178 -YRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYG 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 78/230 (33%), Positives = 115/230 (50%), Gaps = 37/230 (16%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQS--KDGDGVSPTAIREIMLLREITHENVV 91
+G+G++G VFL R + G+ A+K K++ K D V R+I L E+ H +V
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDI--LAEVNHPFIV 61
Query: 92 KLVNVHINHA---DMSLYLAFDYAEY-DLY-----EIIRHHRDKVNHTMNPYTVKSILWQ 142
KL ++A + LYL D+ DL+ E++ D VK L +
Sbjct: 62 KL-----HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED----------VKFYLAE 106
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVV 201
L L++LHS II+RDLKP NIL+ +E+G +K+ DFGL++ K S G
Sbjct: 107 LALALDHLHSLGIIYRDLKPENILL----DEEGHIKLTDFGLSKESIDHEKKAYSFCG-- 160
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251
T+ Y APE++ H SA D W+ G + E+LT FQG + K T
Sbjct: 161 -TVEYMAPEVVNRRGHTQSA-DWWSFGVLMFEMLTGSLPFQGKDRKETMT 208
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 8e-19
Identities = 74/252 (29%), Positives = 124/252 (49%), Gaps = 34/252 (13%)
Query: 31 IGKI-GEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSP--TAIR-EIMLLREIT 86
+GK+ G+G +G V+L A+ G+ +A+K+ + + S A+ EI LL+ +
Sbjct: 6 LGKLLGQGAFGRVYLCY---DADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 87 HENVVKLVNVHINHADMSLYLAFDYA-EYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
HE +V+ + + +L + ++ + + ++ + + YT Q+L
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-----QILE 117
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG---VVV 202
G++YLHSN I+HRD+K +NIL + G VK+ DFG ++ Q LS G V
Sbjct: 118 GVSYLHSNMIVHRDIKGANIL----RDSVGNVKLGDFGASKRLQTIC--LSGTGMKSVTG 171
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262
T ++ +PE++ G + Y D+W+VGC E+LT KP + EA + IF
Sbjct: 172 TPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-----------IF 219
Query: 263 KILGHPTPEKWP 274
KI PT P
Sbjct: 220 KIATQPTNPVLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 70/235 (29%), Positives = 109/235 (46%), Gaps = 28/235 (11%)
Query: 22 PEW---LQQYNLIGKIGEGTYGLVFLARIKAAANRGK--AIAIKKFKQSKDGDGVSPTAI 76
PEW + L +GEG +G V A N + +A+K K +S +
Sbjct: 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS-DLV 63
Query: 77 REIMLLREI-THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHR---------D 125
E+ +++ I H+N++ L+ V + LY+ +YA + +L + +R R D
Sbjct: 64 SEMEMMKMIGKHKNIINLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121
Query: 126 KVNH--TMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183
T+ + S +Q+ G+ +L S IHRDL N+LV E V+KIADFG
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV----TEDHVMKIADFG 177
Query: 184 LAR-IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
LAR I+ + NG + W APE L + YT D+W+ G + E+ TL
Sbjct: 178 LARDIHHIDYYRKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLLWEIFTL 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 31 IGKIGEGTYGLVFLARIKAAAN-RGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN 89
I +GEG +G V L A + G+ +A+K K + G + +EI +L+ + HEN
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNTSGWKKEINILKTLYHEN 67
Query: 90 VVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNY 149
+VK L L +Y +R + K H +N + Q+ G+ Y
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLG---SLRDYLPK--HKLNLAQLLLFAQQICEGMAY 122
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKF-LSENGVVVTIWYR 207
LHS IHRDL N+L+ + +VKI DFGLA+ + + + + E+G WY
Sbjct: 123 LHSQHYIHRDLAARNVLL----DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY- 177
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLT 236
A E L K A D+W+ G ELLT
Sbjct: 178 AVECLKENKFSY-ASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 83/314 (26%), Positives = 132/314 (42%), Gaps = 57/314 (18%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
Y LI ++G GTYG V+ AR A+ I K + D + +EI +++E
Sbjct: 9 HDYELIQRVGSGTYGDVYKAR-NLHTGELAAVKIIKLEPGDDFSLIQ----QEIFMVKEC 63
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
H N+V +++ L++ +Y + I H V ++ + + + L
Sbjct: 64 KHCNIVAYFGSYLSRE--KLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQ 117
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
GL YLHS +HRD+K +NIL+ G+ VK+ADFG+A A + + T +
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGD----VKLADFGVAAKITATIA--KRKSFIGTPY 171
Query: 206 YRAPELLLGAKH--YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
+ APE+ K+ Y D+WAVG EL L+P F L + +F
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM-----------FDLHPMRALF- 219
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
L + + P L + W S H+ V +S L +P
Sbjct: 220 -LMSKSNFQPPKLKDKTKWSST-------------FHNFVKIS------------LTKNP 253
Query: 324 RKRITAAQALEHEY 337
+KR TA + L H +
Sbjct: 254 KKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 108/383 (28%), Positives = 157/383 (40%), Gaps = 99/383 (25%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK----DGDGVSPTAIREIMLLREITHEN 89
+G+G YG VF R A+ GK A+K K++ D A R I L + H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNI--LEAVKHPF 61
Query: 90 VVKLVNVHINHADMSLYLAFDYAEYDLYEIIRH-HRDKVNHTMNPYTVKSILWQLLNGLN 148
+V L+ + LYL +Y E+ H R+ + T L ++ L
Sbjct: 62 IVDLI--YAFQTGGKLYLILEYLSGG--ELFMHLEREGI---FMEDTACFYLSEISLALE 114
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV----TI 204
+LH II+RDLKP NIL+ + QG VK+ DFGL + + + E V TI
Sbjct: 115 HLHQQGIIYRDLKPENILL----DAQGHVKLTDFGLCK------ESIHEGTVTHTFCGTI 164
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
Y APE+L+ + H AVD W++G + ++LT P F K T +DKI K
Sbjct: 165 EYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKT--------IDKILK- 214
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324
NLP + L+P+ A DLL K+L+ +P
Sbjct: 215 ----------GKLNLPPY----------------------LTPE--ARDLLKKLLKRNPS 240
Query: 325 KRI-----TAAQALEHEYFRI---EPLPGRNALVPSQPG----DKVVNYPTR-----PVD 367
R+ AA+ H +FR + L R P +P + V + ++ PVD
Sbjct: 241 SRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVD 300
Query: 368 SNTD----------FEGTTTLQP 380
S D F G T + P
Sbjct: 301 SPDDSTLSESANQIFLGFTYVAP 323
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 70/248 (28%), Positives = 120/248 (48%), Gaps = 31/248 (12%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSP--TAIR-EIMLLREITHENV 90
+G+G +G V+L + G+ +A K+ + + S +A+ EI LL+ + HE +
Sbjct: 10 LGQGAFGRVYLCY---DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 91 VKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL 150
V+ + A+ +L + +Y + + K + + Q+L G++YL
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 151 HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG---VVVTIWYR 207
HSN I+HRD+K +NIL + G VK+ DFG ++ Q +S G V T ++
Sbjct: 123 HSNMIVHRDIKGANIL----RDSAGNVKLGDFGASKRLQTIC--MSGTGIRSVTGTPYWM 176
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267
+PE++ G + Y D+W++GC E+LT KP + EA + IFKI
Sbjct: 177 SPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-----------IFKIATQ 224
Query: 268 PTPEKWPT 275
PT + P+
Sbjct: 225 PTNPQLPS 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 24/223 (10%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS-KDGDGVSPTAIRE 78
E PE L + + +IG G++G V+ AR + +AIKK S K + I+E
Sbjct: 21 EDPEKL--FTDLREIGHGSFGAVYFAR---DVRTNEVVAIKKMSYSGKQSNEKWQDIIKE 75
Query: 79 IMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKS 138
+ L+ I H N ++ ++ + + +L +Y +++ H+ + + +
Sbjct: 76 VKFLQRIKHPNSIEYKGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEV----EIAA 129
Query: 139 ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSEN 198
I L GL YLHS+ +IHRD+K NIL+ E G VK+ADFG A I N
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSASIASPA------N 179
Query: 199 GVVVTIWYRAPELLLGAK--HYTSAVDMWAVGCIFAELLTLKP 239
V T ++ APE++L Y VD+W++G EL KP
Sbjct: 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 72/266 (27%), Positives = 113/266 (42%), Gaps = 26/266 (9%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y + +G+G+YG V L R + GK IKK A +E LL ++ H
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH 58
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
N+V D LY+ + E DLY ++ + K+ + V Q+
Sbjct: 59 PNIV-AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL---LPENQVVEWFVQIAMA 114
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
L YLH I+HRDLK N+ + ++K+ D G+AR+ + S ++ T +Y
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLT----RTNIIKVGDLGIARVLENQCDMAST--LIGTPYY 168
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGA----------EAKSTQNPFQLD 256
+PE L K Y D+WA+GC E+ TLK F E K P
Sbjct: 169 MSPE-LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYS 227
Query: 257 -QLDKIFKILGHPTPEKWPTLANLPH 281
+L ++ + PEK P++ ++
Sbjct: 228 PELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 87/340 (25%), Positives = 140/340 (41%), Gaps = 91/340 (26%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD----GDGVSPTAIREIMLLREITHEN 89
+G+G++G V LA +K +G+ A+K K KD D V T + + +L
Sbjct: 3 LGKGSFGKVLLAELKG---KGEYFAVKALK--KDVVLIDDDVECTMVEKRVL-------- 49
Query: 90 VVKLVNVHINHADMSLYLAFDYAEYDLY--------EIIRHHRDKVNHTMNPYTVKSILW 141
+ N + H LY F E+ + +++ H +DK + Y
Sbjct: 50 ALAWENPFLTH----LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAA 103
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
+++ GL +LHS II+RDLK N+++ +G +KIADFG+ + +N
Sbjct: 104 EIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH----IKIADFGMCK-----ENVFGDNRAS 154
Query: 202 V---TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258
T Y APE+L G K YT +VD W+ G + E+L Q+PF D
Sbjct: 155 TFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLI------------GQSPFHGDDE 201
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318
D++F+ + TP + P W + K D+L K+
Sbjct: 202 DELFESIRVDTP-------HYPRW--------------------ITKESK----DILEKL 230
Query: 319 LEYDPRKRITAAQALE-HEYFRI---EPLPGRNALVPSQP 354
E DP +R+ + H +F+ L R P +P
Sbjct: 231 FERDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 32/230 (13%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
Y + IG G YG V+ R K G+ +A+K D VS RE+ LL ++
Sbjct: 1 SLYQRLELIGRGAYGAVY--RGKHVPT-GRVVALKIINLDTPDDDVSDIQ-REVALLSQL 56
Query: 86 TH---ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKS---- 138
N+ K ++ L++ +YAE V M +
Sbjct: 57 RQSQPPNITKYYGSYLK--GPRLWIIMEYAE----------GGSVRTLMKAGPIAEKYIS 104
Query: 139 -ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL-ARIYQAPLKFLS 196
I+ ++L L Y+H +IHRD+K +NILV G VK+ DFG+ A + Q K +
Sbjct: 105 VIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN----VKLCDFGVAALLNQNSSKRST 160
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246
G T ++ APE++ K+Y + D+W++G E+ T P + +A
Sbjct: 161 FVG---TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 85/321 (26%), Positives = 148/321 (46%), Gaps = 64/321 (19%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y KIG+G G V+ A I A G+ +AIK+ + I EI+++RE
Sbjct: 19 KKYTRFEKIGQGASGTVYTA-IDVAT--GQEVAIKQMNLQQQPK--KELIINEILVMREN 73
Query: 86 THENVVKLVNVHINHADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
H N+V ++ ++ L++ +Y A L +++ M+ + ++ + L
Sbjct: 74 KHPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECL 125
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL-ARIYQAPLKFLSENGVVVT 203
L +LHSN +IHRD+K NIL+ +G VK+ DFG A+I K + +V T
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSK---RSTMVGT 178
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
++ APE++ K Y VD+W++G + E++ +P + +NP L ++
Sbjct: 179 PYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYL------NENP-----LRALYL 226
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
I + TPE L + + S + D L++ LE D
Sbjct: 227 IATNGTPE-------LQNPEKLSAIFR----------------------DFLNRCLEMDV 257
Query: 324 RKRITAAQALEHEYFRI-EPL 343
KR +A + L+H + +I +PL
Sbjct: 258 EKRGSAKELLQHPFLKIAKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 9e-18
Identities = 84/321 (26%), Positives = 146/321 (45%), Gaps = 65/321 (20%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
KIGEG+ G+V +AR K + G+ +A+K K E++++R+ H+NVV+
Sbjct: 28 KIGEGSTGIVCIAREK---HSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHQNVVE 82
Query: 93 LVNVHINHADMSLYLAFDYAEYD-LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
+ ++ L++ ++ + L +I+ R +N + ++ +L L YLH
Sbjct: 83 MYKSYL--VGEELWVLMEFLQGGALTDIVSQTR------LNEEQIATVCESVLQALCYLH 134
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL-ARIYQAPLKFLSENGVVVTIWYRAPE 210
S +IHRD+K +IL+ +G VK++DFG A+I + K +V T ++ APE
Sbjct: 135 SQGVIHRDIKSDSILLTLDGR----VKLSDFGFCAQISKDVPK---RKSLVGTPYWMAPE 187
Query: 211 LLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTP 270
++ Y + VD+W++G + E++ +P P+ D + K L P
Sbjct: 188 -VISRTPYGTEVDIWSLGIMVIEMVDGEP------------PYFSDSPVQAMKRLRDSPP 234
Query: 271 EKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA 330
P L N H + P+ D L +ML +P++R TA
Sbjct: 235 ---PKLKN--------------------AHKISPV-----LRDFLERMLTREPQERATAQ 266
Query: 331 QALEHEYFRIEPLPGRNALVP 351
+ L+H + LP LVP
Sbjct: 267 ELLDHPFLLQTGLP--ECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 89/329 (27%), Positives = 137/329 (41%), Gaps = 77/329 (23%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
+ L+ +G G YG VFL R + GK A+K K++ T +++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKA--------TIVQKAKTAEHTRT 53
Query: 88 ENVVK--------LVNVHIN-HADMSLYLAFDYAEYDLYEIIRH--HRDKVNHTMNPYTV 136
E V LV +H D L+L DY E+ H R+ + V
Sbjct: 54 ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGG--ELFTHLYQREHFTES----EV 107
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
+ + +++ L++LH II+RD+K NIL+ EG V + DFGL++ + A + +
Sbjct: 108 RVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH----VVLTDFGLSKEFLAEEEERA 163
Query: 197 ENGVVVTIWYRAPELLL-GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255
TI Y APE++ G+ + AVD W++G + ELLT GA +PF +
Sbjct: 164 -YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT------GA------SPFTV 210
Query: 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPK--SPAYD 313
D Q+ I R L S P + A D
Sbjct: 211 DGE------------------------QNSQSEISRRI-----LKSKPPFPKTMSAEARD 241
Query: 314 LLSKMLEYDPRKRITAAQALE---HEYFR 339
+ K+LE DP+KR+ A A E H +F+
Sbjct: 242 FIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 61/208 (29%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
KIGEG+ G+V +A K + GK +A+KK K E++++R+ HENVV
Sbjct: 29 KIGEGSTGIVCIATEK---HTGKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHENVVD 83
Query: 93 LVNVHINHADMSLYLAFDYAEYD-LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
+ N ++ L++ ++ E L +I+ H R MN + ++ +L L+YLH
Sbjct: 84 MYNSYL--VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLSVLRALSYLH 135
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPEL 211
+ +IHRD+K +IL+ +G +K++DFG Q + +V T ++ APE
Sbjct: 136 NQGVIHRDIKSDSILLTSDGR----IKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPE- 188
Query: 212 LLGAKHYTSAVDMWAVGCIFAELLTLKP 239
++ Y + VD+W++G + E++ +P
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 82/316 (25%), Positives = 137/316 (43%), Gaps = 61/316 (19%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK--KFKQSKDGDGVSPTAIREIMLLR 83
+ + LI +IG GTYG V+ AR N G+ AIK K + +D V +EI++++
Sbjct: 9 EDFELIQRIGSGTYGDVYKAR---NVNTGELAAIKVIKLEPGEDFAVVQ----QEIIMMK 61
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+ H N+V ++ L++ ++ + I H V ++ + + +
Sbjct: 62 DCKHSNIVAYFGSYLRRD--KLWICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRET 115
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
L GL YLHS +HRD+K +NIL+ + G VK+ADFG++ A + + T
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLT----DNGHVKLADFGVSAQITATIA--KRKSFIGT 169
Query: 204 IWYRAPELLLGAKH--YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
++ APE+ + Y D+WAVG EL L+P F L + +
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM-----------FDLHPMRAL 218
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
F L + + P L + W +N H V ++ L
Sbjct: 219 F--LMTKSNFQPPKLKDKMKW-------------SNSFHHFVKMA------------LTK 251
Query: 322 DPRKRITAAQALEHEY 337
+P+KR TA + L+H +
Sbjct: 252 NPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS-KDGDGVSPTAIREIMLLREITHENVV 91
+IG G++G V+ A ++ + +A+KK S K + I+E+ L+++ H N +
Sbjct: 28 EIGHGSFGAVYFA---TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 92 KLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
+ ++ + + +L +Y +++ H+ + + +I L GL YLH
Sbjct: 85 EYKGCYLK--EHTAWLVMEYCLGSASDLLEVHKKPLQEV----EIAAITHGALQGLAYLH 138
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPEL 211
S+ +IHRD+K NIL+ E G VK+ADFG A N V T ++ APE+
Sbjct: 139 SHNMIHRDIKAGNILLT----EPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEV 188
Query: 212 LLGAK--HYTSAVDMWAVGCIFAELLTLKP 239
+L Y VD+W++G EL KP
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 80/322 (24%), Positives = 125/322 (38%), Gaps = 88/322 (27%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD----GDGVSPTAIREIMLLREITHEN 89
+G+G++G V LA +K + AIK K KD D V T + +L H
Sbjct: 3 LGKGSFGKVMLAELK---GTNEFFAIKALK--KDVVLEDDDVECTMVERRVLALAWEHP- 56
Query: 90 VVKLVNVHINHADMSLYLAFDYAEYDLY--------EIIRHHRDKVNHTMNPYTVKSILW 141
+ H L+ F E+ + +++ H + + +
Sbjct: 57 -------FLTH----LFCTFQTKEHLFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAA 103
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
+++ GL +LH II+RDLK N+L+ +G +KIADFG+ + E
Sbjct: 104 EIICGLQFLHKKGIIYRDLKLDNVLLDKDGH----IKIADFGMCK-----ENMNGEGKAS 154
Query: 202 V---TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258
T Y APE+L G K Y +VD W+ G + E+L Q+PF +
Sbjct: 155 TFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLI------------GQSPFHGEDE 201
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318
D++F + + P + P W S A D LSK+
Sbjct: 202 DELFDSILNDRP-------HFPRWIS------------------------KEAKDCLSKL 230
Query: 319 LEYDPRKRI-TAAQALEHEYFR 339
E DP KR+ +H +FR
Sbjct: 231 FERDPTKRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 71/245 (28%), Positives = 113/245 (46%), Gaps = 27/245 (11%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSP--TAIR-EIMLLREITHENV 90
+G G +G V+L A+ G+ +A+K+ D S A+ EI LL+ + H+ +
Sbjct: 10 LGRGAFGEVYLCY---DADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 91 VKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL 150
V+ + + L + + EY I+ K + + Q+L G++YL
Sbjct: 67 VQYYGCLRDPEEKKLSI---FVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYL 122
Query: 151 HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA-RIYQAPLKFLSENGVVVTIWYRAP 209
HSN I+HRD+K +NIL + G VK+ DFG + RI + V T ++ +P
Sbjct: 123 HSNMIVHRDIKGANIL----RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 210 ELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPT 269
E++ G + Y D+W+V C E+LT KP + EA + IFKI PT
Sbjct: 179 EVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-----------IFKIATQPT 226
Query: 270 PEKWP 274
P
Sbjct: 227 KPMLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 77/318 (24%), Positives = 137/318 (43%), Gaps = 60/318 (18%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
+ +IG++G+G +G V+ KA +A K +K + + + EI +L H
Sbjct: 7 WEIIGELGDGAFGKVY----KAQNKETGVLAAAKVIDTKSEEELEDYMV-EIDILASCDH 61
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
N+VKL++ + + +L++ ++ + + ++ + ++ + Q L L
Sbjct: 62 PNIVKLLDAF--YYENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEAL 116
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYR 207
NYLH N IIHRDLK NIL +G+ +K+ADFG++ ++ + + T ++
Sbjct: 117 NYLHENKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQ--RRDSFIGTPYWM 170
Query: 208 APELLL----GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
APE+++ + Y D+W++G E+ ++P NP ++ L KI K
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP------PHHELNPMRV--LLKIAK 222
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
P PTLA W S+ D L K LE +
Sbjct: 223 --SEP-----PTLAQPSRWSSE-------------------------FKDFLKKCLEKNV 250
Query: 324 RKRITAAQALEHEYFRIE 341
R T Q L+H + +
Sbjct: 251 DARWTTTQLLQHPFVTVN 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 60/316 (18%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ + +IG++G+G +G V+ A+ K A+A K ++K + + + EI +L
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETG----ALAAAKVIETKSEEELEDYMV-EIEILATC 66
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
H +VKL+ + D L++ ++ + I D+ + ++ I Q+L
Sbjct: 67 NHPYIVKLLGAF--YWDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVICRQMLE 121
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
L YLHS IIHRDLK N+L+ +G+ +K+ADFG++ L+ + + T +
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQ--RRDSFIGTPY 175
Query: 206 YRAPELLLGAKH----YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
+ APE+++ Y D+W++G E+ ++P NP ++ L KI
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP------PHHELNPMRV--LLKI 227
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
K P PTL+ W + D L L+
Sbjct: 228 AK--SEP-----PTLSQPSKWSME-------------------------FRDFLKTALDK 255
Query: 322 DPRKRITAAQALEHEY 337
P R +AAQ LEH +
Sbjct: 256 HPETRPSAAQLLEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 83/326 (25%), Positives = 125/326 (38%), Gaps = 92/326 (28%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQS---KDGDGVSPTAIREIMLLREITHENV 90
+G+G++G V LA +K + A+K K+ +D D + ++ L
Sbjct: 3 LGKGSFGKVLLAELK---GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG----KH 55
Query: 91 VKLVNVHINHADMS-LYLAFDYAEY-DL-YEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
L +H L+ +Y DL + I R R Y + +L GL
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAAEIVL-----GL 109
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSEN---GVVVTI 204
+LH II+RDLK N+L+ EG +KIADFG+ + E GV +
Sbjct: 110 QFLHERGIIYRDLKLDNVLLDSEGH----IKIADFGMCK----------EGILGGVTTST 155
Query: 205 W-----YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
+ Y APE+L Y AVD WA+G + E+L + Q+PF+ D D
Sbjct: 156 FCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEML------------AGQSPFEGDDED 202
Query: 260 KIFK-ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318
++F+ IL P W S A +L
Sbjct: 203 ELFQSILEDE--------VRYPRWLSK------------------------EAKSILKSF 230
Query: 319 LEYDPRKRI----TAAQAL-EHEYFR 339
L +P KR+ T Q + H +FR
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFR 256
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 84/328 (25%), Positives = 149/328 (45%), Gaps = 64/328 (19%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y KIG+G G VF A A G+ +AIK+ K I EI++++E+
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVAT---GQEVAIKQINLQKQPK--KELIINEILVMKEL 73
Query: 86 THENVVKLVNVHINHADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ N+V ++ + L++ +Y A L +++ M+ + ++ + L
Sbjct: 74 KNPNIVNFLDSFL--VGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECL 125
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL-ARIYQAPLKFLSENGVVVT 203
L +LH+N +IHRD+K N+L+ +G VK+ DFG A+I K + +V T
Sbjct: 126 QALEFLHANQVIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSK---RSTMVGT 178
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
++ APE++ K Y VD+W++G + E++ +P + +NP L ++
Sbjct: 179 PYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYL------NENP-----LRALYL 226
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
I + TPE L + LSP D L++ LE D
Sbjct: 227 IATNGTPE---------------------------LQNPEKLSPI--FRDFLNRCLEMDV 257
Query: 324 RKRITAAQALEHEYFRI-EPLPGRNALV 350
KR +A + L+H + ++ +PL L+
Sbjct: 258 EKRGSAKELLQHPFLKLAKPLSSLTPLI 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS-KDGDGVSPTAIREIMLLREITHENVV 91
+IG G++G V+ AR + +AIKK S K + I+E+ L+++ H N +
Sbjct: 22 EIGHGSFGAVYFAR---DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 78
Query: 92 KLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
+ ++ + + +L +Y +++ H+ + + ++ L GL YLH
Sbjct: 79 QYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEV----EIAAVTHGALQGLAYLH 132
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPEL 211
S+ +IHRD+K NIL+ E G+VK+ DFG A I AP N V T ++ APE+
Sbjct: 133 SHNMIHRDVKAGNILLS----EPGLVKLGDFGSASIM-AP-----ANXFVGTPYWMAPEV 182
Query: 212 LLGAK--HYTSAVDMWAVGCIFAELLTLKP 239
+L Y VD+W++G EL KP
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 77/239 (32%), Positives = 113/239 (47%), Gaps = 30/239 (12%)
Query: 20 EKPEWLQQYN--LIGK-IGEGTYGLVFLARI----KAAANRGKAIAIKKFKQSKDGDGVS 72
E P W + ++GK +GEG +G V +A K NR +A+K K +S
Sbjct: 9 EDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLS 68
Query: 73 PTAIREIMLLREI-THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDK-VNH 129
I E+ +++ I H+N++ L+ D LY+ +YA +L E +R R + +
Sbjct: 69 -DLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEY 125
Query: 130 TMNPYTVK----------SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179
NP V S +Q+ G+ YL S IHRDL N+LV E V+KI
Sbjct: 126 CYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT----EDNVMKI 181
Query: 180 ADFGLAR-IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
ADFGLAR I+ + NG + W APE L + YT D+W+ G + E+ TL
Sbjct: 182 ADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 70/237 (29%), Positives = 109/237 (45%), Gaps = 52/237 (21%)
Query: 34 IGEGTYGLVFLARIKAAANRGKA------IAIKKFKQSKDGDGVSPTAIREIM----LLR 83
+GEG +G V +KA A R K +A+K K+ S + +R+++ LL+
Sbjct: 8 LGEGEFGKV----VKATAFRLKGRAGYTTVAVKMLKE-----NASSSELRDLLSEFNLLK 58
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKV--------------- 127
++ H +V+KL D L L +YA+Y L +R R KV
Sbjct: 59 QVNHPHVIKLYGA--CSQDGPLLLIVEYAKYGSLRSFLRESR-KVGPSYLGSDGNRNSSY 115
Query: 128 --NHTMNPYTVKSIL---WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182
N T+ ++ WQ+ G+ YL ++HRDL N+LV EG +KI+DF
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGR---KMKISDF 171
Query: 183 GLAR-IYQAPLKFLSENGVVVTIWYRAPELLLGAKH-YTSAVDMWAVGCIFAELLTL 237
GL+R +Y+ G + W A E L H YT+ D+W+ G + E++TL
Sbjct: 172 GLSRDVYEEDSYVKRSKGRIPVKWM-AIESL--FDHIYTTQSDVWSFGVLLWEIVTL 225
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 44/264 (16%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
E+P ++ L K+G G +G V+ K NR + +AIK K D +E+
Sbjct: 2 ERPRE--EFTLERKLGSGYFGEVWEGLWK---NRVR-VAIKILKS--DDLLKQQDFQKEV 53
Query: 80 MLLREITHENVVKLVNVHINHADMSL----YLAFDYAEY-DLYEIIRHHRDKVNHTMNPY 134
L+ + H++++ L A S+ Y+ + E L +R +V
Sbjct: 54 QALKRLRHKHLISL------FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV------L 101
Query: 135 TVKSIL---WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
V S++ Q+ G+ YL IHRDL NILV GE V K+ADFGLAR+ +
Sbjct: 102 PVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV-GEDL---VCKVADFGLARLIKED 157
Query: 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL-FQGAEAKSTQ 250
+ +LS + + W APE +++ D+W+ G + E+ T + + G
Sbjct: 158 V-YLSSDKKIPYKW-TAPE-AASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV- 213
Query: 251 NPFQLDQLDKIFKILGHPTPEKWP 274
DQ+ +++ P P K P
Sbjct: 214 ----YDQITAGYRM---PCPAKCP 230
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-16
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
K+G G YG V+ K +A+K K+ D V ++E +++EI H N+V+
Sbjct: 13 KLGGGQYGEVYEGVWK---KYSLTVAVKTLKE--DTMEVE-EFLKEAAVMKEIKHPNLVQ 66
Query: 93 LVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS 152
L+ V Y+ ++ Y ++ + R+ +N + + Q+ + + YL
Sbjct: 67 LLGVCTREP--PFYIITEFMTYG--NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 153 NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELL 212
IHRDL N LV E +VK+ADFGL+R+ + + G I + APE L
Sbjct: 123 KNFIHRDLAARNCLV----GENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESL 177
Query: 213 LGAKHYTSAVDMWAVGCIFAELLT 236
K ++ D+WA G + E+ T
Sbjct: 178 AYNK-FSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 28/232 (12%)
Query: 2 GDGNTSTGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK 61
++S+ +G++ K L + + +IG G G V+ + G+ A+K
Sbjct: 52 SSSSSSSSSSASGSAPSAAKS--LSELERVNRIGSGAGGTVYKVIHRPT---GRLYALKV 106
Query: 62 FKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAF-DYAEYDLYEII 120
+ + D V REI +LR++ H NVVK ++ ++ ++ + L F D + I
Sbjct: 107 IYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIA 165
Query: 121 RHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180
+ + Q+L+G+ YLH I+HRD+KPSN+L+ VKIA
Sbjct: 166 DEQF-----------LADVARQILSGIAYLHRRHIVHRDIKPSNLLI----NSAKNVKIA 210
Query: 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPEL----LLGAKHYTSAVDMWAVG 228
DFG++RI + N V TI Y +PE L + A D+W++G
Sbjct: 211 DFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLG 260
|
Length = 353 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 85/354 (24%), Positives = 123/354 (34%), Gaps = 101/354 (28%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK---KFKQSKDGDGVSPTAIREIMLL 82
+ + I +G+G G VFL R+K GK A+K K + K +EI L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEI--L 55
Query: 83 REITHENVVKLVNVHINHADMSLYLAFDYAE----YDLYEIIRHHRDKVNHTMNPYTVKS 138
+ H + L + L L DY + L + +
Sbjct: 56 ATLDHPFLPTLY--ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEV------ARF 107
Query: 139 ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL---------ARIYQ 189
++L L YLH I++RDLKP NIL+ E G + ++DF L
Sbjct: 108 YAAEVLLALEYLHLLGIVYRDLKPENILL----HESGHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 190 A------------PLKFLSE------NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIF 231
P + SE N V T Y APE++ G H SAVD W +G +
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILL 222
Query: 232 AELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPT--PEKWPTLANLPHWQSDSLHI 289
E+L F+G+ T IL P P ++
Sbjct: 223 YEMLYGTTPFKGSNRDET-----------FSNILKKEVTFPGSPPVSSS----------- 260
Query: 290 QGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI----TAAQALEHEYFR 339
A DL+ K+L DP KR+ AA+ +H +FR
Sbjct: 261 ---------------------ARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 61/249 (24%), Positives = 113/249 (45%), Gaps = 42/249 (16%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIR----EIMLLREITHEN 89
+G+G YG V+ N+G+ IA+K+ + + E+ LL+ + H N
Sbjct: 8 LGKGAYGTVYCGLT----NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 90 VVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNY 149
+V+ + ++ +S+++ F + I+ YT Q+L+G+ Y
Sbjct: 64 IVQYLGTCLDDNTISIFMEF-VPGGSISSILNRFGPLPEPVFCKYTK-----QILDGVAY 117
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG--------VV 201
LH+N ++HRD+K +N+++M G++K+ DFG AR L ++ +G +
Sbjct: 118 LHNNCVVHRDIKGNNVMLM----PNGIIKLIDFGCAR----RLAWVGLHGTHSNMLKSMH 169
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T ++ APE ++ Y D+W++GC E+ T KP +D+L +
Sbjct: 170 GTPYWMAPE-VINESGYGRKSDIWSIGCTVFEMATGKPPLA-----------SMDRLAAM 217
Query: 262 FKILGHPTP 270
F I H
Sbjct: 218 FYIGAHRGL 226
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 1e-15
Identities = 81/329 (24%), Positives = 146/329 (44%), Gaps = 62/329 (18%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y KIG+G G V+ A A G+ +AI++ + I EI+++RE
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVAT---GQEVAIRQMNLQQQPK--KELIINEILVMREN 74
Query: 86 THENVVKLVNVHINHADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ N+V ++ ++ L++ +Y A L +++ M+ + ++ + L
Sbjct: 75 KNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECL 126
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
L +LHSN +IHRD+K NIL+ +G VK+ DFG S +V T
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRST--MVGTP 180
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
++ APE++ K Y VD+W++G + E++ +P + +NP L ++ I
Sbjct: 181 YWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYL------NENP-----LRALYLI 228
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324
+ TPE L N P + D L++ L+ D
Sbjct: 229 ATNGTPE----LQN-------------------------PEKLSAIFRDFLNRCLDMDVE 259
Query: 325 KRITAAQALEHEYFRI-EPLPGRNALVPS 352
KR +A + L+H++ +I +PL L+ +
Sbjct: 260 KRGSAKELLQHQFLKIAKPLSSLTPLIAA 288
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENV 90
+ ++G G +G+V L + +A +AIK + G I E ++ +++H +
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIK----VAIKAINE---GAMSEEDFIEEAKVMMKLSHPKL 61
Query: 91 VKLVNVHINHADMSLYLAFDYAEYD-LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNY 149
V+L V LY+ ++ E L +R + K++ M + S+ + G+ Y
Sbjct: 62 VQLYGVCTQQK--PLYIVTEFMENGCLLNYLRQRQGKLSKDM----LLSMCQDVCEGMEY 115
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAP 209
L N IHRDL N LV GVVK++DFG+ R Y ++ S +G + + P
Sbjct: 116 LERNSFIHRDLAARNCLV----SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPP 170
Query: 210 ELLLGAKHYTSAVDMWAVGCIFAELLT 236
E+ +K Y+S D+W+ G + E+ T
Sbjct: 171 EVFNFSK-YSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 68/263 (25%), Positives = 122/263 (46%), Gaps = 32/263 (12%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN 89
+ ++G G +G+V + + + +AIK K+ G I E ++ +++HE
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYD----VAIKMIKE---GSMSEDEFIEEAKVMMKLSHEK 60
Query: 90 VVKLVNVHINHADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLN 148
+V+L V +Y+ +Y + L +R H P + + + G+
Sbjct: 61 LVQLYGVCTK--QRPIYIVTEYMSNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMA 114
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA 208
YL S IHRDL N LV ++QG VK++DFGL+R Y ++ S G + +
Sbjct: 115 YLESKQFIHRDLAARNCLV----DDQGCVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSP 169
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAELLTL--KPLFQGAEAKSTQNPFQLDQL-------D 259
PE+LL +K ++S D+WA G + E+ +L P + +++ + Q +L +
Sbjct: 170 PEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASE 228
Query: 260 KIFKIL---GHPTPEKWPTLANL 279
K++ I+ H E+ PT L
Sbjct: 229 KVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 78/269 (28%), Positives = 124/269 (46%), Gaps = 43/269 (15%)
Query: 22 PEW-LQQYNL-IGK-IGEGTYGLVFLARI----KAAANRGKAIAIKKFKQSKDGDGVSPT 74
P+W L + L +GK +GEG +G V +A K N+ +A+K K +S
Sbjct: 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS-D 63
Query: 75 AIREIMLLREI-THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDK------ 126
+ E+ +++ I H+N++ L+ D LY+ +YA +L E +R R
Sbjct: 64 LVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSF 121
Query: 127 -----VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181
+ + S +Q+ G+ YL S IHRDL N+LV E V+KIAD
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT----EDNVMKIAD 177
Query: 182 FGLAR-IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL 240
FGLAR ++ + NG + W APE L + YT D+W+ G + E+ TL
Sbjct: 178 FGLARDVHNIDYYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLLWEIFTLGG- 234
Query: 241 FQGAEAKSTQNPFQLDQLDKIFKIL--GH 267
+P+ ++++FK+L GH
Sbjct: 235 ----------SPYPGIPVEELFKLLKEGH 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 83/328 (25%), Positives = 149/328 (45%), Gaps = 64/328 (19%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y KIG+G G V+ A A G+ +AIK+ + I EI+++RE
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIAT---GQEVAIKQMNLQQQPK--KELIINEILVMREN 73
Query: 86 THENVVKLVNVHINHADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ N+V ++ ++ L++ +Y A L +++ M+ + ++ + L
Sbjct: 74 KNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECL 125
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL-ARIYQAPLKFLSENGVVVT 203
L++LHSN +IHRD+K NIL+ +G VK+ DFG A+I K + +V T
Sbjct: 126 QALDFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSK---RSTMVGT 178
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
++ APE++ K Y VD+W++G + E++ +P + +NP L ++
Sbjct: 179 PYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYL------NENP-----LRALYL 226
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
I + TPE L N P + D L++ LE D
Sbjct: 227 IATNGTPE----LQN-------------------------PERLSAVFRDFLNRCLEMDV 257
Query: 324 RKRITAAQALEHEYFRI-EPLPGRNALV 350
+R +A + L+H + ++ +PL L+
Sbjct: 258 DRRGSAKELLQHPFLKLAKPLSSLTPLI 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
K+G+G++G+V + + +A+K K K D + ++E ++ + HEN+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD-DFLKEAAIMHSLDHENLIR 60
Query: 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILW----QLLNGL 147
L V + H L + + A L + +R + + S L Q+ NG+
Sbjct: 61 LYGVVLTH---PLMMVTELAPLGSLLDRLRKDA-------LGHFLISTLCDYAVQIANGM 110
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVVVTIWY 206
YL S IHRDL NIL+ + + VKI DFGL R + Q ++ E + V +
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDK----VKIGDFGLMRALPQNEDHYVMEEHLKVPFAW 166
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
APE L ++ A D+W G E+ T
Sbjct: 167 CAPESLRTRT-FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 7e-15
Identities = 70/291 (24%), Positives = 120/291 (41%), Gaps = 75/291 (25%)
Query: 55 KAIAIKKFKQSKDGDGVSPTAIREIM---LLREITHENVVKLVNVHINHADMSLYLAFDY 111
K I K F AI E M L+++ + N +KL L DY
Sbjct: 47 KIIKAKNF-----------NAI-EPMVHQLMKD--NPNFIKLYYSV--TTLKGHVLIMDY 90
Query: 112 -AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE 170
+ DL+++++ K++ VK I+ QL+ LN LH + IIH D+K N+L
Sbjct: 91 IKDGDLFDLLKKE-GKLSEA----EVKKIIRQLVEALNDLHKHNIIHNDIKLENVL-YDR 144
Query: 171 GEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCI 230
+++ + + D+GL +I P + +G + Y +PE + G +Y + D WAVG +
Sbjct: 145 AKDR--IYLCDYGLCKIIGTPSCY---DGTLD---YFSPEKIKG-HNYDVSFDWWAVGVL 195
Query: 231 FAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQ 290
ELLT ++PF+ D+ +++ L +L Q L
Sbjct: 196 TYELLT------------GKHPFKEDEDEEL-------------DLESLLKRQQKKLPFI 230
Query: 291 GRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR-ITAAQALEHEYFRI 340
+S A D + ML+Y+ R + ++H + +I
Sbjct: 231 KN------------VSKN--ANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 26/211 (12%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN 89
L+ +IG G +GLV+L + +AIK ++ G I E ++ +++H
Sbjct: 8 LVQEIGSGQFGLVWLGYWL----EKRKVAIKTIRE---GAMSEEDFIEEAQVMMKLSHPK 60
Query: 90 VVKLVNVHINHADMSLYLAFDYAEYD-LYEIIRHHRDKVNHTMNPYTVKSILWQLLN--- 145
+V+L V + + L F++ E+ L + +R R K ++ +++L L+
Sbjct: 61 LVQLYGVCTERS--PICLVFEFMEHGCLSDYLRAQRGK-------FSQETLLGMCLDVCE 111
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
G+ YL S+ +IHRDL N LV GE Q VVK++DFG+ R ++ S G +
Sbjct: 112 GMAYLESSNVIHRDLAARNCLV---GENQ-VVKVSDFGMTRFVLDD-QYTSSTGTKFPVK 166
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
+ +PE+ +K Y+S D+W+ G + E+ +
Sbjct: 167 WSSPEVFSFSK-YSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 101/387 (26%), Positives = 157/387 (40%), Gaps = 92/387 (23%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
+ L+ +G G YG VFL R + GK A+K +++ + + T
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAA-------LVQKAKTVEHTRTE 54
Query: 88 ENVVKLVN-----VHINHA---DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
NV++ V V +++A + L+L DY E+ H + N + + V+
Sbjct: 55 RNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGG--EMFTHLYQRDNFSED--EVRFY 110
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSEN- 198
+++ L +LH I++RD+K NIL+ EG V + DFGL++ +FLSE
Sbjct: 111 SGEIILALEHLHKLGIVYRDIKLENILLDSEGH----VVLTDFGLSK------EFLSEEK 160
Query: 199 ----GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254
TI Y APE++ G + AVD W++G + ELLT F ++TQ+
Sbjct: 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
Query: 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDL 314
+I K P P + P+ A DL
Sbjct: 221 ----RRILK-CDPPFPSF--------------------------------IGPE--AQDL 241
Query: 315 LSKMLEYDPRKRITAA-----QALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRP-VDS 368
L K+L DP+KR+ A + EH +F+ L + VN P RP + +
Sbjct: 242 LHKLLRKDPKKRLGAGPQGASEIKEHPFFK--------GLDWEALALRKVNPPFRPSIRN 293
Query: 369 NTDF----EGTTTLQPP-QPASGPVPG 390
D E T L+P PA P G
Sbjct: 294 ELDVGNFAEEFTNLEPVYSPAGTPPSG 320
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 30/223 (13%)
Query: 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRG-KAIAIKKFKQSKDGDGVSPTAIREIM 80
PE L + + KIG+G++G VF K NR K +AIK + D + +EI
Sbjct: 2 PEEL--FTKLEKIGKGSFGEVF----KGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEIT 54
Query: 81 LLREITHENVVKLVNVHINHADMSLYLAFDY----AEYDLYEIIRHHRDKVNHTMNPYTV 136
+L + V K ++ D L++ +Y + DL E ++ +
Sbjct: 55 VLSQCDSPYVTKYYGSYLK--DTKLWIIMEYLGGGSALDLLE---------PGPLDETQI 103
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
+IL ++L GL+YLHS IHRD+K +N+L+ E G VK+ADFG+A Q +
Sbjct: 104 ATILREILKGLDYLHSEKKIHRDIKAANVLL----SEHGEVKLADFGVAG--QLTDTQIK 157
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKP 239
N V T ++ APE++ + Y S D+W++G EL +P
Sbjct: 158 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 71/239 (29%), Positives = 106/239 (44%), Gaps = 30/239 (12%)
Query: 20 EKPEW---LQQYNLIGKIGEGTYGLVFLARI----KAAANRGKAIAIKKFKQSKDGDGVS 72
E P W + L +GEG +G V +A K +A+K K +S
Sbjct: 6 EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS 65
Query: 73 PTAIREIMLLREI-THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHR------ 124
+ E+ +++ I H+N++ L+ D LY+ +YA +L E +R R
Sbjct: 66 -DLVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEY 122
Query: 125 --DKVNHTMNPYTVKSIL---WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179
D T K ++ +Q+ G+ YL S IHRDL N+LV E V+KI
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT----ENNVMKI 178
Query: 180 ADFGLAR-IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
ADFGLAR + + NG + W APE L + YT D+W+ G + E+ TL
Sbjct: 179 ADFGLARDVNNIDYYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFTL 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKF--KQSKDGDGVSPTAIREIMLLREITHENVV 91
+G+G +G V ++KA GK A KK K+ K G A+ E +L +++ +V
Sbjct: 1 LGKGGFGEVCACQVKAT---GKMYACKKLDKKRLKKRKGEQ-MALNEKKILEKVSSRFIV 56
Query: 92 KLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKV--NHTMNPYTVKSILWQLLNGLNY 149
L D+ L + DL I + + Y Q++ GL +
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGG-DLKYHIYNVGEPGFPEARAIFYAA-----QIICGLEH 110
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAP 209
LH I++RDLKP N+L+ ++ G V+I+D GLA + K G T Y AP
Sbjct: 111 LHQRRIVYRDLKPENVLL----DDHGNVRISDLGLAVELKGGKKI---KGRAGTPGYMAP 163
Query: 210 ELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ 242
E+L G + Y +VD +A+GC E++ + F+
Sbjct: 164 EVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 32/224 (14%)
Query: 30 LIGKIGEGTYGLVF--LARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIM------ 80
LI ++G+G++G+V+ LA+ +AIK V+ A +RE +
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKT---------VNENASMRERIEFLNEA 60
Query: 81 -LLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHR---DKVNHTMNPYTV 136
+++E +VV+L+ V ++ +L + A+ DL +R R + P
Sbjct: 61 SVMKEFNCHHVVRLLGV-VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 137 KSILW--QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLK 193
K I ++ +G+ YL + +HRDL N +V E VKI DFG+ R IY+
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV----AEDLTVKIGDFGMTRDIYETDYY 175
Query: 194 FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
G++ W APE L +T+ D+W+ G + E+ TL
Sbjct: 176 RKGGKGLLPVRWM-APESLKDGV-FTTKSDVWSFGVVLWEMATL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 77/312 (24%), Positives = 125/312 (40%), Gaps = 86/312 (27%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
IGEG +G V+ + N A+A+K K V ++E ++R+ H ++VK
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS-VREKFLQEAYIMRQFDHPHIVK 71
Query: 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
L+ V + +++ + A +L ++ ++ ++ ++ +QL L YL
Sbjct: 72 LIGVI---TENPVWIVMELAPLGELRSYLQVNKYSLDLA----SLILYSYQLSTALAYLE 124
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR------IYQA-----PLKFLSENGV 200
S +HRD+ N+LV VK+ DFGL+R Y+A P+K++
Sbjct: 125 SKRFVHRDIAARNVLVS----SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM----- 175
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL--KPLFQGAEAKSTQNPFQLDQL 258
APE + + +TSA D+W G E+L L KP FQG +
Sbjct: 176 -------APE-SINFRRFTSASDVWMFGVCMWEILMLGVKP-FQGVKNN----------- 215
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA--YDLLS 316
D I +I NG +P+ P P Y L++
Sbjct: 216 DVIGRI-------------------------------ENG--ERLPMPPNCPPTLYSLMT 242
Query: 317 KMLEYDPRKRIT 328
K YDP KR
Sbjct: 243 KCWAYDPSKRPR 254
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 71/268 (26%), Positives = 119/268 (44%), Gaps = 40/268 (14%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
IG+G +G V+ + + + A+K + D + V ++E +++++ +H NV+ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFSHPNVLSL 61
Query: 94 VNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSIL---WQLLNGLNYL 150
+ + + L + DL IR + T NP TVK ++ Q+ G+ YL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIR------SETHNP-TVKDLIGFGLQVAKGMEYL 114
Query: 151 HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPL-KFLSENGVVVTIWYRA 208
S +HRDL N ++ +E VK+ADFGLAR IY + G + + + A
Sbjct: 115 ASKKFVHRDLAARNCML----DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL------------- 255
E L K +T+ D+W+ G + EL+T +GA + F +
Sbjct: 171 LESLQTQK-FTTKSDVWSFGVLLWELMT-----RGAPPYPDVDSFDITVYLLQGRRLLQP 224
Query: 256 ----DQLDKIFKILGHPTPEKWPTLANL 279
D L ++ HP PE PT + L
Sbjct: 225 EYCPDPLYEVMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 83/354 (23%), Positives = 127/354 (35%), Gaps = 107/354 (30%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE-I 85
+ +I IG G +G V+L R K G+ A+K ++S M+ R I
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDT---GQVYAMKVLRKS-------------DMIKRNQI 45
Query: 86 THENVVKLVNVH-----INHADMS------LYLAFDYAEY-DLYEIIRHHRDKVNHTMNP 133
H + + I S LYL +Y DL ++ T
Sbjct: 46 AHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARF 105
Query: 134 YTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA-------- 185
Y + +L L+ +H IHRD+KP NIL+ + G +K+ADFGL
Sbjct: 106 YIAELVL-----ALDSVHKLGFIHRDIKPDNILI----DADGHIKLADFGLCKKMNKAKD 156
Query: 186 -------------------RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWA 226
R + + N V T Y APE+L G Y D W+
Sbjct: 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWS 215
Query: 227 VGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDS 286
+G I E+L P F + T N KI+ +W+
Sbjct: 216 LGVILYEMLYGFPPFYSDTLQETYN-----------KII---------------NWK--- 246
Query: 287 LHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA-QALEHEYFR 339
E+ P+SP+ A DL+ ++L DP R+ + + H +F+
Sbjct: 247 --------ESLRFPPDPPVSPE--AIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA----IREIMLLREITHEN 89
IG G +G V R+K + +AIK K G S + E ++ + H N
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLK-----AGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 90 VVKLVNVHINHADMSLYLAFDYAEY----DLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
+++L V + + EY L + +R + K + +L + +
Sbjct: 67 IIRLEGVVTKSRPVMII-----TEYMENGSLDKFLRENDGKFT----VGQLVGMLRGIAS 117
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
G+ YL +HRDL NILV V K++DFGL+R + + G + I
Sbjct: 118 GMKYLSEMNYVHRDLAARNILV----NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR 173
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
+ APE + + +TSA D+W+ G + E+++
Sbjct: 174 WTAPE-AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 28/227 (12%)
Query: 30 LIGK-IGEGTYGLVFLARI----KAAANRGKAIAIKKFK-QSKDGDGVSPTAIREIMLLR 83
++GK +GEG +G V A K+ ++ +A+K K + D D + E+M L
Sbjct: 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLI 74
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYA-EYDLYEIIRHHR--------DKVNHTMNPY 134
H+N++ L+ V + LY+ +YA + +L E +R R D
Sbjct: 75 G-KHKNIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 135 TVK---SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA 190
+ K S +Q+ G+ YL S IHRDL N+LV E V+KIADFGLAR ++
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT----EDNVMKIADFGLARGVHDI 187
Query: 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+ NG + W APE L + YT D+W+ G + E+ TL
Sbjct: 188 DYYKKTSNGRLPVKWM-APEALFD-RVYTHQSDVWSFGILMWEIFTL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 13/172 (7%)
Query: 75 AIREIMLLREITHENVVKLVNVHIN--HADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTM 131
A E+ L H +VK H + +D L L +Y DL + I+ R K +
Sbjct: 112 ARSELHCLAACDHFGIVK----HFDDFKSDDKLLLIMEYGSGGDLNKQIKQ-RLKEHLPF 166
Query: 132 NPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
Y V + +Q++ L+ +HS ++HRDLK +NI +M G++K+ DFG ++ Y
Sbjct: 167 QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM----PTGIIKLGDFGFSKQYSDS 222
Query: 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
+ + T +Y APE L K Y+ DMW++G I ELLTL F+G
Sbjct: 223 VSLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 22/201 (10%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
IG+G +G V L RG+ +A+K KD + + E ++ + H N+V+L
Sbjct: 14 IGKGEFGDVMLGDY-----RGQKVAVK---CLKDDSTAAQAFLAEASVMTTLRHPNLVQL 65
Query: 94 VNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN 153
+ V + LY+ +Y ++ + R + + + G+ YL
Sbjct: 66 LGVVLQGN--PLYIVTEYMAKG--SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 154 WIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLL 213
+HRDL N+LV E V K++DFGLA+ ++ + + + APE L
Sbjct: 122 NFVHRDLAARNVLV----SEDLVAKVSDFGLAKEAS-----QGQDSGKLPVKWTAPE-AL 171
Query: 214 GAKHYTSAVDMWAVGCIFAEL 234
K +++ D+W+ G + E+
Sbjct: 172 REKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 34/237 (14%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS-KDGDGVSPTAIREIMLLR 83
+Q+Y++I IG+G G V+LA + R +A+KK ++ + + +RE +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRR---VALKKIREDLSENPLLKKRFLREAKIAA 57
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDK------VNHTMNPYTV 136
++ H +V + + I +Y Y E Y L +++ K + +
Sbjct: 58 DLIHPGIVPVYS--ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI------YQA 190
SI ++ + Y+HS ++HRDLKP NIL+ GE V I D+G A
Sbjct: 116 LSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE----VVILDWGAAIFKKLEEEDLL 171
Query: 191 PLKFLSENG----------VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+ N +V T Y APE LLG + + D++A+G I ++LTL
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTL 227
|
Length = 932 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 67/256 (26%), Positives = 105/256 (41%), Gaps = 67/256 (26%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
+ + +G G +G V LA K G+ AIK K+ GD ++ + +M + I
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYK---KTGELYAIKALKK---GDIIARDEVESLMCEKRI-F 53
Query: 88 ENVVK-----LVNVH-INHADMSLYLAFDYAEY-DLYEIIRH-HRDKVNHTMNPYTVKSI 139
E LVN+ + + +YA DL + H H D + + +
Sbjct: 54 ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL---MMHIHTDVFSEPRAVFYAACV 110
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
+ GL YLH N I++RDLK N+L+ + +G VKIADFGL + E
Sbjct: 111 VL----GLQYLHENKIVYRDLKLDNLLL----DTEGFVKIADFGLCK----------EG- 151
Query: 200 VVVTIWYR-------------APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246
+ + APE+L YT AVD W +G + E+L
Sbjct: 152 ----MGFGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLV---------- 196
Query: 247 KSTQNPFQLDQLDKIF 262
++PF D +++F
Sbjct: 197 --GESPFPGDDEEEVF 210
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 81/318 (25%), Positives = 124/318 (38%), Gaps = 81/318 (25%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
IG+G++G V R + + + A+K +++ I+ E+TH +
Sbjct: 1 IGKGSFGKVMQVRKR---DTQRIYALKTIRKA------------HIVSRSEVTHTLAERT 45
Query: 94 VNVHINHADM-SLYLAFDYAEYDLYEIIR--------HHRDKVNHTMNPYTVKSILWQLL 144
V +N + L +F E LY ++ HH + + + +LL
Sbjct: 46 VLAQVNCPFIVPLKFSFQSPE-KLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELL 103
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
L LH +I+RDLKP NIL+ + QG + + DFGL ++ N T
Sbjct: 104 CALENLHKFNVIYRDLKPENILL----DYQGHIALCDFGLCKLNMK--DDDKTNTFCGTP 157
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF-K 263
Y APELLLG YT AVD W +G + E+LT P PF + +++++ K
Sbjct: 158 EYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLP------------PFYDENVNEMYRK 204
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
IL P P A DLL +L DP
Sbjct: 205 ILQEPL--------------------------------RFPDGFDRDAKDLLIGLLSRDP 232
Query: 324 RKRITAAQALE---HEYF 338
+R+ A E H +F
Sbjct: 233 TRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 6e-14
Identities = 49/140 (35%), Positives = 75/140 (53%), Gaps = 7/140 (5%)
Query: 107 LAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNI 165
L DYA DL + I+ R K N T + + Q+L ++++HS +IHRD+K +NI
Sbjct: 116 LVLDYANAGDLRQEIKS-RAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANI 174
Query: 166 LVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMW 225
L+ G+VK+ DFG +++Y A + T +Y APE+ K Y+ DM+
Sbjct: 175 LLC----SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR-RKPYSKKADMF 229
Query: 226 AVGCIFAELLTLKPLFQGAE 245
++G + ELLTLK F G
Sbjct: 230 SLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 80/334 (23%), Positives = 129/334 (38%), Gaps = 48/334 (14%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
QYN++ + G+ G VF+ R K I +K K REI +L+ I+
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVI-VKAVTGGKTPG-------REIDILKTIS 144
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILW---QL 143
H ++ L++ + + ++ + + DL+ + P ++ + +L
Sbjct: 145 HRAIINLIHAYRWKS--TVCMVMPKYKCDLFTYV--------DRSGPLPLEQAITIQRRL 194
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
L L YLH IIHRD+K NI + +E + DFG A A G T
Sbjct: 195 LEALAYLHGRGIIHRDVKTENIFL----DEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK-PLFQGAEAKSTQNPFQLDQLDKIF 262
+ +PE LL Y + D+W+ G + E+ LF Q QL I
Sbjct: 251 LETNSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLF------GKQVKSSSSQLRSII 303
Query: 263 KILG-HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLH--SVVPLSPKS-PAYD---LL 315
+ + HP P S +L ++Y ++ P+ K D L+
Sbjct: 304 RCMQVHP--------LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLI 355
Query: 316 SKMLEYDPRKRITAAQALEHEYFRIEPLPGRNAL 349
+KML +D R +A L F EP+ N
Sbjct: 356 AKMLTFDQEFRPSAQDILSLPLFTKEPINLLNIT 389
|
Length = 392 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ +N I +G G++G V LA K +AIK+F++SK + + + R+I
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKI---IKQKQVDHVFSERKI 84
Query: 86 THENVVK---LVNVHINHADMS-LYLAFDYA-EYDLYEIIRHHRDKVNHTMNPYTVKSIL 140
N + VN++ + D S LYL ++ + + +R ++ N Y + +L
Sbjct: 85 L--NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
YL S I++RDLKP N+L+ ++ G +K+ DFG A++ L
Sbjct: 143 I-----FEYLQSLNIVYRDLKPENLLL----DKDGFIKMTDFGFAKVVDTRTYTLCG--- 190
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAE 245
T Y APE+LL H A D W +G E+L P F E
Sbjct: 191 --TPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANE 232
|
Length = 340 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-14
Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 46/238 (19%)
Query: 20 EKPE---W-LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA 75
KP+ W L + + +G G++G V +A+ K G+ AIK K+
Sbjct: 8 TKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKK----------- 53
Query: 76 IREIMLLREITHENVVKLVNVHINHA-----------DMSLYLAFDYA-EYDLYEIIRHH 123
REI+ ++++ H K + + ++H + +Y ++ +L+ +R
Sbjct: 54 -REILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA 112
Query: 124 RDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183
N Y + +L YLHS II+RDLKP N+L+ + +G VK+ DFG
Sbjct: 113 GRFPNDVAKFYHAELVL-----AFEYLHSKDIIYRDLKPENLLL----DNKGHVKVTDFG 163
Query: 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLF 241
A+ + P + + G T Y APE ++ +K + AVD W +G + E + P F
Sbjct: 164 FAK--KVPDRTFTLCG---TPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 65/230 (28%), Positives = 111/230 (48%), Gaps = 33/230 (14%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKF--KQSKDGDGVSPTAIREIMLLR 83
+ Y ++GK G +G V +++A GK A KK K+ K G + A+ E +L
Sbjct: 3 RHYRVLGK---GGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEA-MALNEKQILE 55
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNP-YTVKSILW- 141
++ VV L + + L L DL + H + + NP + + ++
Sbjct: 56 KVNSRFVVSLAYAYETKDALCLVLTLMNGG-DL----KFH---IYNMGNPGFDEERAVFY 107
Query: 142 --QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA-RIYQA-PLKFLSE 197
++ GL LH I++RDLKP NIL+ ++ G ++I+D GLA I + ++
Sbjct: 108 AAEITCGLEDLHRERIVYRDLKPENILL----DDYGHIRISDLGLAVEIPEGETIR---- 159
Query: 198 NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247
G V T+ Y APE++ + YT + D W +GC+ E++ K F+ + K
Sbjct: 160 -GRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 67/231 (29%), Positives = 103/231 (44%), Gaps = 30/231 (12%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD----GDGVSPTAIREIMLLREITHEN 89
+G+G++G VFLA +K + AIK K KD D V T + + +L H
Sbjct: 3 LGKGSFGKVFLAELKGT---NQFFAIKALK--KDVVLMDDDVECTMVEKRVLSLAWEHPF 57
Query: 90 VVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHR-DKVNHTMNPYTVKSILWQLLNGLN 148
+ L ++ + + ++ I H+ D T Y + I GL
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIIC-----GLQ 110
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA 208
+LHS I++RDLK NIL+ + G +KIADFG+ + + L T Y A
Sbjct: 111 FLHSKGIVYRDLKLDNILL----DTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIA 164
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS------TQNPF 253
PE+LLG K Y ++VD W+ G + E+L + F G + + NP
Sbjct: 165 PEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC 214
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 31 IGKIGEGTYGLVFLARIKAAANRGK-AIAIKKFKQSKDGDGVSPTAIREIM----LLREI 85
I +G G +G V+ + K +AIK ++ SP A +EI+ ++ +
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-----SPKANKEILDEAYVMASV 66
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
H +VV+L+ + ++ L L + +R+H+D + + + Q+
Sbjct: 67 DHPHVVRLLGICLSSQVQ---LITQLMPLGCLLDYVRNHKDNIG----SQYLLNWCVQIA 119
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
G++YL ++HRDL N+LV + VKI DFGLA++ K G V I
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
+ A E +L YT D+W+ G EL+T
Sbjct: 176 KWMALESILHRI-YTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 77/333 (23%), Positives = 131/333 (39%), Gaps = 57/333 (17%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFK-QSKDGDGVSPTAI-REIMLLREI 85
LIGK E +V LA+ K +A+KK S + + + +EI+ R++
Sbjct: 3 LTLIGKCFEDL-MIVHLAKHKPT---NTLVAVKKINLDSCSKEDL--KLLQQEIITSRQL 56
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY----DLYEIIRHHRDKVNHTMNPYTVKSILW 141
H N++ V I D LY+ Y DL + H + + + IL
Sbjct: 57 QHPNILPYVTSFIV--DSELYVVSPLMAYGSCEDL--LKTHFPEGLPELAIAF----ILK 108
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY------QAPLKFL 195
+LN L+Y+HS IHR +K S+IL+ G+G+ V ++ + Q +
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSGDGK----VVLSGLRYSVSMIKHGKRQRVVHDF 164
Query: 196 SENGVVVTIWYRAPELLLGAKH-YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254
++ V W +PE+L Y D+++VG EL + PF+
Sbjct: 165 PKSSVKNLPWL-SPEVLQQNLQGYNEKSDIYSVGITACEL------------ANGHVPFK 211
Query: 255 LDQLDKIF--KILGHPTPEKWPTL---ANLPHWQSDSLHIQGRKYETNGLHSVVPLSPK- 308
++ K+ G P L + P ++ + N SV +
Sbjct: 212 DMPATQMLLEKVRGTV-----PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRT 266
Query: 309 -SPAY-DLLSKMLEYDPRKRITAAQALEHEYFR 339
S + + L+ DP R +A+Q L H +F+
Sbjct: 267 FSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
KIG+G +G V+ +K +A+K + S + ++E +L++ H N+VK
Sbjct: 2 KIGKGNFGDVYKGVLKG----NTEVAVKTCR-STLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 93 LVNVHINHADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL---NGLN 148
L+ V + +Y+ + L +R ++++ TVK +L L G+
Sbjct: 57 LIGVCVQ--KQPIYIVMELVPGGSLLTFLRKKKNRL-------TVKKLLQMSLDAAAGME 107
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA 208
YL S IHRDL N LV E V+KI+DFG++R + + +S+ + I + A
Sbjct: 108 YLESKNCIHRDLAARNCLV----GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA 163
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAELLTL 237
PE L + YTS D+W+ G + E +L
Sbjct: 164 PEALNYGR-YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 67/233 (28%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 25 LQQYNLIGK--IGEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTAIREIM 80
++++N++ K +GEG +G VFLA I A+K K + D RE
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN--ARKDFHREAE 59
Query: 81 LLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHH-RDKVNHTM-NPYT-- 135
LL + HE++VK V + L + F+Y ++ DL + +R H D V N
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAEL 117
Query: 136 ----VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
+ I Q+ G+ YL S +HRDL N LV E +VKI DFG++R +
Sbjct: 118 TQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV----GENLLVKIGDFGMSRDVYST 173
Query: 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL--KPLFQ 242
+ ++ I + PE ++ K +T+ D+W++G + E+ T +P +Q
Sbjct: 174 DYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQ 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 30/223 (13%)
Query: 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAI-AIKKFKQSKDGDGVSPTAIREIM 80
PE L + + +IG+G++G VF K NR + + AIK + D + +EI
Sbjct: 2 PEEL--FTKLERIGKGSFGEVF----KGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-QEIT 54
Query: 81 LLREITHENVVKLVNVHINHADMSLYLAFDY----AEYDLYEIIRHHRDKVNHTMNPYTV 136
+L + V K ++ L++ +Y + DL + + +
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGT--KLWIIMEYLGGGSALDLLRA---------GPFDEFQI 103
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
++L ++L GL+YLHS IHRD+K +N+L+ EQG VK+ADFG+A Q +
Sbjct: 104 ATMLKEILKGLDYLHSEKKIHRDIKAANVLL----SEQGDVKLADFGVAG--QLTDTQIK 157
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKP 239
N V T ++ APE++ + Y S D+W++G EL +P
Sbjct: 158 RNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
IGEG +G V ARIK R A AIK+ K+ D A +L + H N++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 94 VNVHINHADMSLYLAFDYAEY-DLYEIIRHHR-----------DKVNHTMNPYTVKSILW 141
+ + LYLA +YA + +L + +R R + T++ +
Sbjct: 74 LGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
+ G++YL IHRDL NILV E V KIADFGL+R + +K G +
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILV----GENYVAKIADFGLSRGQEVYVK--KTMGRL 185
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
W L YT+ D+W+ G + E+++L
Sbjct: 186 PVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSL 219
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
LQ+ L IGEG +G V G+ +A+K K D + + E ++ +
Sbjct: 5 LQKLTLGEIIGEGEFGAVL-----QGEYTGQKVAVKNIK----CDVTAQAFLEETAVMTK 55
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ H+N+V+L+ V +++ LY+ + ++ R + ++ + +
Sbjct: 56 LHHKNLVRLLGVILHNG---LYIVMELMSKG--NLVNFLRTRGRALVSVIQLLQFSLDVA 110
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
G+ YL S ++HRDL NILV E GV K++DFGLAR+ + +N +
Sbjct: 111 EGMEYLESKKLVHRDLAARNILV----SEDGVAKVSDFGLARVGSMGV----DNSKLPVK 162
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
W APE L K ++S D+W+ G + E+ +
Sbjct: 163 W-TAPEALKHKK-FSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFK----QSKDGDGVSPTAIREIMLLREITHEN 89
IG G +G VF +K + A+AIK K + + D +S +I + + +H N
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASI-----MGQFSHHN 67
Query: 90 VVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNY 149
+++L V + +Y E + ++ RD + + Y + +L + G+ Y
Sbjct: 68 IIRLEGVVTKFKPAMIIT--EYMENGALD--KYLRDH-DGEFSSYQLVGMLRGIAAGMKY 122
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA-PLKFLSENGVVVTIWYRA 208
L +HRDL NILV K++DFGL+R+ + P + +G + I + A
Sbjct: 123 LSDMNYVHRDLAARNILV----NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAELLT 236
PE + + +TSA D+W+ G + E+++
Sbjct: 179 PE-AIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 32/236 (13%)
Query: 27 QYNLIGKIGEGTYGLVFLAR-IKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIM----L 81
++ I +G G +G V+ I +AIK+ +++ SP A +EI+ +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----TSPKANKEILDEAYV 62
Query: 82 LREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKV--NHTMNPYTVKSI 139
+ + + +V +L+ + + + + L + +R H+D + + +N
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQLITQLMPFG--CLLDYVREHKDNIGSQYLLN------- 113
Query: 140 LW--QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
W Q+ G+NYL ++HRDL N+LV VKI DFGLA++ A K
Sbjct: 114 -WCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH----VKITDFGLAKLLGADEKEYHA 168
Query: 198 NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT--LKPLFQGAEAKSTQN 251
G V I + A E +L + YT D+W+ G EL+T KP + G A +
Sbjct: 169 EGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISS 222
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 76/274 (27%), Positives = 113/274 (41%), Gaps = 22/274 (8%)
Query: 78 EIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVK 137
E +LR I H ++++L + L L + DLY + R+ + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILP--RYKTDLYCYLAAKRN-----IAICDIL 185
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
+I +L + YLH N IIHRD+K NI + G+ V + DFG A + +
Sbjct: 186 AIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD----VCLGDFG-AACFPVDINANKY 240
Query: 198 NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK-PLFQ--GAEAKSTQNPFQ 254
G TI APELL Y AVD+W+ G + E+ T LF+ G + +
Sbjct: 241 YGWAGTIATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSD--- 296
Query: 255 LDQLDKIFKILG-HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYD 313
Q+ I + G HP ANL RK + L + + P Y
Sbjct: 297 -RQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEY- 354
Query: 314 LLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRN 347
L+ KML +D R +A L+ F+ P P N
Sbjct: 355 LICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPN 388
|
Length = 391 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 58/269 (21%), Positives = 117/269 (43%), Gaps = 29/269 (10%)
Query: 31 IGKIGEGTYGLVFLARIKAAANRGK--AIAIKKFKQSKDGDGVSPTAIREIMLLREITHE 88
I +G G +G VFLA+ K G + +K Q + + RE+ + R+++H+
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL-QKTKDENLQSEFRRELDMFRKLSHK 68
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHT----MNPYTVKSILWQL 143
NVV+L+ + A+ Y+ +Y + DL + +R + K ++ ++ Q+
Sbjct: 69 NVVRLLGL-CREAE-PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
G+++L + +HRDL N LV + E VK++ L++ + N ++
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQRE----VKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL----------FQGAEAKSTQNPF 253
W APE + +++ D+W+ G + E+ T L +A + P
Sbjct: 183 RWL-APEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240
Query: 254 QLDQLDKIFKILGH---PTPEKWPTLANL 279
+++K++ P+ P+ + L
Sbjct: 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 27/246 (10%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITHE 88
L+ K+G G +G V++ N +AIK KQ +SP A + E L++++ H
Sbjct: 10 LVKKLGAGQFGEVWMGYY----NGHTKVAIKSLKQGS----MSPEAFLAEANLMKQLQHP 61
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLN 148
+V+L V +Y+ +Y E ++ + + + + Q+ G+
Sbjct: 62 RLVRLYAVVTQE---PIYIITEYMENG--SLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA 208
++ IHRDL+ +NILV E KIADFGLAR+ + ++ + G I + A
Sbjct: 117 FIERKNYIHRDLRAANILV----SETLCCKIADFGLARLIEDN-EYTAREGAKFPIKWTA 171
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268
PE + +T D+W+ G + E++T + NP + L++ +++ P
Sbjct: 172 PE-AINYGTFTIKSDVWSFGILLTEIVT----YGRIPYPGMTNPEVIQNLERGYRM---P 223
Query: 269 TPEKWP 274
P+ P
Sbjct: 224 RPDNCP 229
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 75/286 (26%), Positives = 112/286 (39%), Gaps = 58/286 (20%)
Query: 77 REIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKV--NHTMNPY 134
RE L + H N+V L++ + L+ F+Y R R+ + + +
Sbjct: 27 RETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPG------RTLREVLAADGALPAG 79
Query: 135 TVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY-----Q 189
++ Q+L+ L H+ I+HRDLKP NI+V G K+ DFG+ +
Sbjct: 80 ETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH-AKVLDFGIGTLLPGVRDA 138
Query: 190 APLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST 249
V+ T Y APE L G + T D++A G IF E LT + + QGA S
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRG-EPVTPNSDLYAWGLIFLECLTGQRVVQGA---SV 194
Query: 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKS 309
+ +++ L P +LP W I G
Sbjct: 195 A--------EILYQQLS-------PVDVSLPPW------IAGH----------------- 216
Query: 310 PAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPG 355
P +L K L DPR+R +A AL E FR L ++ G
Sbjct: 217 PLGQVLRKALNKDPRQRAASAPALA-ERFRALELCALVGILRMGEG 261
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 64/216 (29%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
IGEG +G V A IK + A AIK K+ + A +L + H N++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNA-AIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 94 VNVHINHADMSLYLAFDYAEY-DLYEIIRHHR--------DKVNHTMNPYTVKSILW--- 141
+ N LY+A +YA Y +L + +R R K + T + T + +L
Sbjct: 69 LGACENRG--YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
+ G+ YL IHRDL N+LV E KIADFGL+R + +K G +
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLV----GENLASKIADFGLSRGEEVYVK--KTMGRL 180
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
W L YT+ D+W+ G + E+++L
Sbjct: 181 PVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIVSL 214
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 64/232 (27%), Positives = 112/232 (48%), Gaps = 26/232 (11%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARI--KAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLL 82
L + ++GE +G V+ + A + +A+AIK K +G + E M+
Sbjct: 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-PLREEFKHEAMMR 62
Query: 83 REITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYE--IIRHHRDKVNHTMNPYTVKS- 138
+ H N+V L+ V +S+ F Y + DL+E ++R V T + TVKS
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSM--IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 139 --------ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQ 189
I+ Q+ G+ +L S+ ++H+DL N+LV ++ VKI+D GL R +Y
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF----DKLNVKISDLGLFREVYA 176
Query: 190 APLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT--LKP 239
A L N ++ W +PE ++ K ++ D+W+ G + E+ + L+P
Sbjct: 177 ADYYKLMGNSLLPIRWM-SPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 71/283 (25%), Positives = 127/283 (44%), Gaps = 42/283 (14%)
Query: 33 KIGEGTYGLVFLARIK-------------AAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
K+GEG +G V L + + N+ +A+K ++ + + + ++EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN-DFLKEI 70
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHR-----DKVNHTMNP 133
++ + N+++L+ V I L + +Y E DL + + H +K +
Sbjct: 71 KIMSRLKDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 134 Y-TVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAP 191
Y T+ + Q+ +G+ YL S +HRDL N LV + +KIADFG++R +Y
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV----GKNYTIKIADFGMSRNLYSGD 184
Query: 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL---KPLFQGAEAKS 248
+ V+ W +LLG +T+A D+WA G E+LTL +P Q ++ +
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242
Query: 249 TQNP--FQLDQLDKIFKILGHPTPEKWPTLAN---LPHWQSDS 286
+N F DQ +++ P P P L W+ ++
Sbjct: 243 IENTGEFFRDQGRQVYL----PKPALCPDSLYKLMLSCWRRNA 281
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 36 EGTYGLVFLAR-IKAAANRGKAIAIKKFKQSKDGDGVSPTAI----REIMLLREITHENV 90
EGT+G +F I + + + +K K D S + +E LL ++H+N+
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVK-----DHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 91 VKLVNVHINHAD--MSLYLAFDYAEYDLY-EIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
+ +++V I + LY ++ L+ + R ++ + + Q+ G+
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVVVTIWY 206
+YLH +IH+D+ N ++ +E+ VKI D L+R ++ L +N W
Sbjct: 131 SYLHKRGVIHKDIAARNCVI----DEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM 186
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
A E L+ K Y+SA D+W+ G + EL+TL
Sbjct: 187 -ALESLVN-KEYSSASDVWSFGVLLWELMTL 215
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 34 IGEGTYGLVF---LARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENV 90
+G G +G V+ I + +A+K ++ D ++E L+ H N+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNI 61
Query: 91 VKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNP-YTVKSILWQLL---N 145
VKL+ V + + Y+ + E DL +R R V P T+K +L L
Sbjct: 62 VKLLGVCLLNE--PQYIIMELMEGGDLLSYLRDAR--VERFGPPLLTLKELLDICLDVAK 117
Query: 146 GLNYLHSNWIIHRDLKPSNILV-MGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVVVT 203
G YL IHRDL N LV + VVKI DFGLAR IY++ G++
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
W APE LL K +T+ D+W+ G + E+LTL
Sbjct: 178 RWM-APESLLDGK-FTTQSDVWSFGVLMWEILTL 209
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPT--AIREIMLLREI 85
+ L+ +G G YG VFL R + + GK A+K K++ T E +L I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 86 THENVVKLVNVHIN-HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
LV +H D L+L DY E+ H + + S +++
Sbjct: 62 RQSPF--LVTLHYAFQTDTKLHLILDYINGG--ELFTHLSQRERFKEQEVQIYS--GEIV 115
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
L +LH II+RD+K NIL+ + G V + DFGL++ + + + TI
Sbjct: 116 LALEHLHKLGIIYRDIKLENILL----DSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTI 170
Query: 205 WYRAPELLLGAKH-YTSAVDMWAVGCIFAELLT 236
Y AP+++ G + AVD W++G + ELLT
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 34 IGEGTYGLVFLARIKAAANR---GKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENV 90
IG+GT+G V+ R K R K ++ K+ K+ V+ T +L+R + E+
Sbjct: 1 IGKGTFGQVYQVR-KKDTRRIYAMKVLSKKEIVAKKE---VAHTIGERNILVRTLLDESP 56
Query: 91 VKLVNVHIN-HADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLN 148
+V + + D LYL DY + +L+ ++ Y + +L L
Sbjct: 57 F-IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL-----ALE 110
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA 208
+LH I++RDLKP NIL+ G + + DFGL++ K + N T Y A
Sbjct: 111 HLHKYDIVYRDLKPENILLDATGH----IALCDFGLSKANLTDNK--TTNTFCGTTEYLA 164
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAEL 234
PE+LL K YT VD W++G + E+
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 68/217 (31%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
IG+G++G V LA+ KA GK A+K ++ AI + + I E V L
Sbjct: 3 IGKGSFGKVLLAKHKA---DGKFYAVKVLQKK---------AILKKKEQKHIMAERNVLL 50
Query: 94 VNVHINHADM-SLYLAFDYAEYDLYEIIRH--------HRDKVNHTMNPYTVKSILWQLL 144
NV H + L+ +F A+ LY ++ + H + P + ++
Sbjct: 51 KNV--KHPFLVGLHYSFQTAD-KLYFVLDYVNGGELFFHLQRERSFPEPRA-RFYAAEIA 106
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
+ L YLHS II+RDLKP NIL+ + QG V + DFGL + K S T
Sbjct: 107 SALGYLHSLNIIYRDLKPENILL----DSQGHVVLTDFGLCKEGIEHSKTTST--FCGTP 160
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLF 241
Y APE+L + Y VD W +G + E+L P F
Sbjct: 161 EYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+++ L+ IG+G +G V L RG +A+K K D + + E ++ +
Sbjct: 5 MKELKLLQTIGKGEFGDVMLGD-----YRGNKVAVKCIKN----DATAQAFLAEASVMTQ 55
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+ H N+V+L+ V I LY+ +Y A+ L + +R V + + +
Sbjct: 56 LRHSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDV 111
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
+ YL +N +HRDL N+LV E V K++DFGL + + +++ +
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLV----SEDNVAKVSDFGLTKEASS-----TQDTGKLP 162
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+ + APE L K +++ D+W+ G + E+ +
Sbjct: 163 VKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSF 195
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 72/261 (27%), Positives = 114/261 (43%), Gaps = 40/261 (15%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANR-GKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+ +I IG+GTYG V+ K + G A+K D V E +L+ +
Sbjct: 24 WEIIETIGKGTYGKVY----KVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLP 76
Query: 87 -HENVVKLVNVHINHADMS---LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILW 141
H NVVK + + L+L + + E+++ ++ + IL+
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILY 135
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
L GL +LH+N IIHRD+K +NIL+ EG VK+ DFG++ Q L N V
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGG----VKLVDFGVSA--QLTSTRLRRNTSV 189
Query: 202 VTIWYRAPELLLGAKHYTSA----VDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257
T ++ APE++ + Y + D+W++G EL P F +
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL-----------FDMHP 238
Query: 258 LDKIFKILGHPT-----PEKW 273
+ +FKI +P PEKW
Sbjct: 239 VKTLFKIPRNPPPTLLHPEKW 259
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 23/226 (10%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKF--KQSKDGDGVSPTAIREIMLL 82
+QY ++GK G +G V +++A GK A K+ K+ K G S A+ E +L
Sbjct: 2 FRQYRVLGK---GGFGEVCACQVRAT---GKMYACKRLEKKRIKKRKGES-MALNEKQIL 54
Query: 83 REITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQ 142
++ + VV L + + L L + ++ H + N +
Sbjct: 55 EKVNSQFVVNLAYAYETKDALCLVLTI----MNGGDLKFHIYNMGNPGFEEERALFYAAE 110
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA-RIYQAPLKFLSENGVV 201
+L GL LH ++RDLKP NIL+ ++ G ++I+D GLA +I + G V
Sbjct: 111 ILCGLEDLHRENTVYRDLKPENILL----DDYGHIRISDLGLAVKIPEGESI----RGRV 162
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247
T+ Y APE +L + YT + D W +GC+ E++ + F+G + K
Sbjct: 163 GTVGYMAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 22/199 (11%)
Query: 76 IREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYT 135
+RE+ ++ E +V +N ++ + + F + D++ P
Sbjct: 51 LRELQIMHECRSPYIVSFYGAFLNENNICMCMEF---------MDCGSLDRIYKKGGPIP 101
Query: 136 VK---SILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
V+ I ++ GL YL++ + I+HRD+KPSNILV G+ +K+ DFG++
Sbjct: 102 VEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ----IKLCDFGVS----GE 153
Query: 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251
L + V T Y +PE + G K YT D+W++G EL K F +
Sbjct: 154 LINSIADTFVGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ 212
Query: 252 PFQLDQLDKIFKILGHPTP 270
+ LD + +I+ P P
Sbjct: 213 DDPMGILDLLQQIVQEPPP 231
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 78/320 (24%), Positives = 137/320 (42%), Gaps = 70/320 (21%)
Query: 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIML 81
PE L + + +IG+G++G V+ K NR K + K ++ + +EI +
Sbjct: 2 PEEL--FTKLERIGKGSFGEVY----KGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITV 55
Query: 82 LREITHENVVKLVNVHINHADMSLYLAFDY----AEYDLYEIIRHHRDKVNHTMNPYTVK 137
L + + + ++ L++ +Y + DL + + +
Sbjct: 56 LSQCDSPYITRYYGSYLKGT--KLWIIMEYLGGGSALDLLK---------PGPLEETYIA 104
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
+IL ++L GL+YLHS IHRD+K +N+L+ EQG VK+ADFG+A Q +
Sbjct: 105 TILREILKGLDYLHSERKIHRDIKAANVLL----SEQGDVKLADFGVAG--QLTDTQIKR 158
Query: 198 NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257
N V T ++ APE++ + Y D+W++G +T L +G S +P
Sbjct: 159 NTFVGTPFWMAPEVIKQSA-YDFKADIWSLG------ITAIELAKGEPPNSDLHPM---- 207
Query: 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSK 317
++ ++ +P PTL G +S P + +
Sbjct: 208 --RVLFLIPKNSP---PTL--------------------EGQYS-------KPFKEFVEA 235
Query: 318 MLEYDPRKRITAAQALEHEY 337
L DPR R TA + L+H++
Sbjct: 236 CLNKDPRFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 66/236 (27%), Positives = 109/236 (46%), Gaps = 37/236 (15%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAA-----------NRGKAIAIKKFKQSKDGDGVSPT 74
QQ L K+GEG +G V L + A + +A+K + V+ T
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-----VTKT 59
Query: 75 A----IREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEII--RHHRDKV 127
A ++EI ++ + + N+++L+ V ++ D L + +Y E DL + + R
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTF 117
Query: 128 NHTMNPYTV--KSILW---QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182
H N +V ++L+ Q+ +G+ YL S +HRDL N LV +KIADF
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV----GNHYTIKIADF 173
Query: 183 GLAR-IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
G++R +Y + V+ W +LLG +T+A D+WA G E+ TL
Sbjct: 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTL 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITHE 88
L K+G G +G V+ N +A+K K +SP A ++E +++++ H+
Sbjct: 10 LERKLGAGQFGEVW----MGTWNGTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLRHD 61
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHH------RDKVNHTMNPYTVKSILWQ 142
+V+L +A S Y + E + + + + + Q
Sbjct: 62 KLVQL------YAVCSEEEPI----YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQ 111
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV 202
+ G+ YL S IHRDL NILV E V KIADFGLAR+ + ++ + G
Sbjct: 112 IAEGMAYLESRNYIHRDLAARNILV----GENLVCKIADFGLARLIEDD-EYTAREGAKF 166
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
I + APE + +T D+W+ G + E++T
Sbjct: 167 PIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 67/227 (29%), Positives = 109/227 (48%), Gaps = 25/227 (11%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKF--KQSKDGDGVSPTAIREIMLL 82
+QY ++GK G +G V +++A GK A KK K+ K G S A+ E +L
Sbjct: 2 FRQYRVLGK---GGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGES-MALNEKQIL 54
Query: 83 REITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILW- 141
++ VV L + + L L DL I H + +++ +
Sbjct: 55 EKVNSRFVVSLAYAYETKDALCLVLTLMNGG-DLKFHIYHMGEA-----GFEEGRAVFYA 108
Query: 142 -QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
++ GL LH I++RDLKP NIL+ ++ G ++I+D GLA P + + G
Sbjct: 109 AEICCGLEDLHQERIVYRDLKPENILL----DDHGHIRISDLGLA--VHVP-EGQTIKGR 161
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247
V T+ Y APE++ + YT + D WA+GC+ E++ + FQ + K
Sbjct: 162 VGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 35/231 (15%)
Query: 33 KIGEGTYGLVFLARIK--AAANRGKAIAIKKFKQ-----SKDGDGVSPTAIREIMLLREI 85
++GEG +G VFLA + +A+K K KD RE LL +
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ-------REAELLTNL 64
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRD-----------KVNHTMNP 133
HE++VK V + L + F+Y ++ DL + +R H + +
Sbjct: 65 QHEHIVKFYGVCGDGD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 134 YTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK 193
+ I Q+ +G+ YL S +HRDL N LV G +VKI DFG++R +
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLV-GANL---LVKIGDFGMSRDVYSTDY 178
Query: 194 FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL--KPLFQ 242
+ ++ I + PE ++ K +T+ D+W+ G I E+ T +P FQ
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQ 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 65/299 (21%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
+IG G +G VF R++A +A+K +++ D + ++E +L++ +H N+V+
Sbjct: 2 RIGRGNFGEVFSGRLRA---DNTPVAVKSCRETLPPD-LKAKFLQEARILKQYSHPNIVR 57
Query: 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLN---GLN 148
L+ V +Y+ + + D +R ++ VK ++ + N G+
Sbjct: 58 LIGVCTQ--KQPIYIVMELVQGGDFLTFLRTEGPRLK-------VKELIQMVENAAAGME 108
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV-VVTIWYR 207
YL S IHRDL N LV E+ V+KI+DFG++R + + S G+ + + +
Sbjct: 109 YLESKHCIHRDLAARNCLVT----EKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWT 163
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267
APE L Y+S D+W+ G + E +L GA
Sbjct: 164 APE-ALNYGRYSSESDVWSFGILLWEAFSL-----GA----------------------- 194
Query: 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326
P + L+N Q R+ G+ P Y L+ + EYDP +R
Sbjct: 195 -VP--YANLSNQ----------QTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 16/216 (7%)
Query: 30 LIGKIGEGTYGLVF--LARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
L+ +G G +G V+ L R + +A+K +S S + E +++ + H
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDES-DFLMEALIMSKFNH 68
Query: 88 ENVVKLVNVHINHADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILW---QL 143
+N+V+L+ V + ++ + A DL +R +R + + T+K +L+ +
Sbjct: 69 QNIVRLIGVSFER--LPRFILLELMAGGDLKSFLRENRPRPERP-SSLTMKDLLFCARDV 125
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENG-VV 201
G YL N IHRD+ N L+ +G V KIADFG+AR IY+A + + G +
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKG-PGRVAKIADFGMARDIYRA--SYYRKGGRAM 182
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+ I + PE L +TS D+W+ G + E+ +L
Sbjct: 183 LPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSL 217
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITHE 88
LI K+G G +G V++ N +A+K K +SP + + E +++++ H+
Sbjct: 10 LIKKLGNGQFGEVWMG----TWNGNTKVAVKTLKPGT----MSPESFLEEAQIMKKLRHD 61
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLN 148
+V+L V ++ +Y+ +Y ++ +D + + + Q+ G+
Sbjct: 62 KLVQLYAVV---SEEPIYIVTEYMSKG--SLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA 208
Y+ IHRDL+ +NILV G+G V KIADFGLAR+ + ++ + G I + A
Sbjct: 117 YIERMNYIHRDLRSANILV-GDGL---VCKIADFGLARLIEDN-EYTARQGAKFPIKWTA 171
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAELLT 236
PE L + +T D+W+ G + EL+T
Sbjct: 172 PEAALYGR-FTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 63/268 (23%), Positives = 110/268 (41%), Gaps = 29/268 (10%)
Query: 32 GKI-GEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTAIREIMLLREI-TH 87
GK G G +G V A + + A+K K + + E+ ++ + H
Sbjct: 40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSE-REALMSELKIMSHLGNH 98
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
EN+V L+ + + +Y Y DL +R R+ + + S +Q+ G
Sbjct: 99 ENIVNLLGACTIGG--PILVITEYCCYGDLLNFLRRKRESFLTLED---LLSFSYQVAKG 153
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
+ +L S IHRDL N+L+ G+ +VKI DFGLAR ++ + + + +
Sbjct: 154 MAFLASKNCIHRDLAARNVLLT-HGK---IVKICDFGLARDIMNDSNYVVKGNARLPVKW 209
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTL--KP----LFQGAEAKSTQNPFQLDQ--- 257
APE + YT D+W+ G + E+ +L P K + +++ Q
Sbjct: 210 MAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268
Query: 258 -LDKIFKILG---HPTPEKWPTLANLPH 281
+I+ I+ P K PT +
Sbjct: 269 APAEIYDIMKTCWDADPLKRPTFKQIVQ 296
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 57/211 (27%), Positives = 85/211 (40%), Gaps = 65/211 (30%)
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI---------YQAPL----K 193
L YLH+ I+HRDLKP N+L+ G +K+ DFGL++I Y+ + +
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGH----IKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 194 FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253
+ V T Y APE++L + Y VD WA+G I E L PF
Sbjct: 170 EFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCV------------PF 216
Query: 254 QLDQLDKIFKILGHPTPEK--WPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
D +++F G + WP + D L A
Sbjct: 217 FGDTPEELF---GQVISDDIEWP--------EGDE-----------------ALPAD--A 246
Query: 312 YDLLSKMLEYDPRKRITAAQALE---HEYFR 339
DL+S++L +P +R+ A E H +F
Sbjct: 247 QDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 55/205 (26%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITHENVV 91
K+G+G +G V+ N +AIK K +SP A ++E +++++ HE +V
Sbjct: 13 KLGQGCFGEVW----MGTWNGTTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLV 64
Query: 92 KLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
+L V ++ +Y+ +Y ++ + ++ + + + Q+ +G+ Y+
Sbjct: 65 QLYAVV---SEEPIYIVTEYM--SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPEL 211
+HRDL+ +NILV E V K+ADFGLAR+ + ++ + G I + APE
Sbjct: 120 RMNYVHRDLRAANILV----GENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEA 174
Query: 212 LLGAKHYTSAVDMWAVGCIFAELLT 236
L + +T D+W+ G + EL T
Sbjct: 175 ALYGR-FTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 42/224 (18%)
Query: 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVV 91
++G G +G V + + +A+K KQ G +RE ++ ++ H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEF-LREASVMAQLDHPCIV 59
Query: 92 KLVNVHINHADMSLYLAFDYAEYD-LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL 150
+L+ V M L + A L + ++ R+ + +K + Q+ G+ YL
Sbjct: 60 RLIGVCKGEPLM---LVMELAPLGPLLKYLKKRRE-----IPVSDLKELAHQVAMGMAYL 111
Query: 151 HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI-------YQA------PLKFLSE 197
S +HRDL N+L+ + KI+DFG++R Y+A PLK
Sbjct: 112 ESKHFVHRDLAARNVLL----VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK---- 163
Query: 198 NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL--KP 239
WY APE + K ++S D+W+ G E + KP
Sbjct: 164 -------WY-APECINYGK-FSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 24/233 (10%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIK-AAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLR 83
L + ++GE +G ++ + + + +AIK K + +E L+
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQ-QEASLMA 62
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEYDLYE--IIRH-HRDKVNHTMNPYTVKS-- 138
E+ H N+V L+ V + + + + DL+E I+R H D + TVKS
Sbjct: 63 ELHHPNIVCLLGVVTQEQPVCMLFEY-LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSL 121
Query: 139 -------ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA 190
I Q+ G+ YL S++ +H+DL NIL+ EQ VKI+D GL+R IY A
Sbjct: 122 DHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI----GEQLHVKISDLGLSREIYSA 177
Query: 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT--LKPLF 241
+ ++ W PE ++ K ++S D+W+ G + E+ + L+P +
Sbjct: 178 DYYRVQPKSLLPIRWM-PPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-11
Identities = 57/206 (27%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITHENVV 91
K+G+G +G V++ N +AIK K + P A ++E +++++ H+
Sbjct: 13 KLGQGCFGEVWMG----TWNGTTKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHD--- 61
Query: 92 KLVNVHINHADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL 150
KLV ++ ++ +Y+ ++ + L + ++ K + P V + Q+ +G+ Y+
Sbjct: 62 KLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGK--YLKLPQLV-DMAAQIADGMAYI 118
Query: 151 HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPE 210
IHRDL+ +NILV + V KIADFGLAR+ + ++ + G I + APE
Sbjct: 119 ERMNYIHRDLRAANILV----GDNLVCKIADFGLARLIEDN-EYTARQGAKFPIKWTAPE 173
Query: 211 LLLGAKHYTSAVDMWAVGCIFAELLT 236
L + +T D+W+ G + EL+T
Sbjct: 174 AALYGR-FTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITHE 88
L+ K+G G +G V+ + N +A+K K + P + E +++++ H
Sbjct: 10 LLRKLGAGQFGEVW----EGLWNNTTPVAVKTLKP----GTMDPKDFLAEAQIMKKLRHP 61
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRH-------HRDKVNHTMNPYTVKSILW 141
+++L V + Y + E++++ P + +
Sbjct: 62 KLIQLYAVCTLEEPI----------YIVTELMKYGSLLEYLQGGAGRALKLPQLI-DMAA 110
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
Q+ +G+ YL + IHRDL N+LV GE + K+ADFGLAR+ + + + + G
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLV-GEN---NICKVADFGLARVIKEDI-YEAREGAK 165
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
I + APE L + ++ D+W+ G + E++T
Sbjct: 166 FPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 73/240 (30%), Positives = 106/240 (44%), Gaps = 45/240 (18%)
Query: 34 IGEGTYGLVFLARIKA-----AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE 88
IG+G++G V LAR KA A + AI K K+ K IM R + +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEK-----------HIMSERNVLLK 51
Query: 89 NVVK--LVNVHINHADMS-LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
NV LV +H + LY DY +L+ ++ R + Y ++
Sbjct: 52 NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-----EIA 106
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
+ L YLHS I++RDLKP NIL+ + QG + + DFGL + + + NG T
Sbjct: 107 SALGYLHSLNIVYRDLKPENILL----DSQGHIVLTDFGLCK------ENIEHNGTTSTF 156
Query: 205 W----YRAPELLLGAKHYTSAVDMWAVGCIFAELL-TLKPLFQGAEAKSTQN----PFQL 255
Y APE +L + Y VD W +G + E+L L P + A+ N P QL
Sbjct: 157 CGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL 215
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 75/274 (27%), Positives = 111/274 (40%), Gaps = 68/274 (24%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK---KFKQSKDGDGVSPTAIREIML 81
+ +++I IG G +G V L R K++ + A+K KF+ K D R+IM
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSK---QVYAMKLLSKFEMIKRSDSAFFWEERDIM- 97
Query: 82 LREITHENVVKLVNVHINHADMS-LYLAFDYAEYDLYEIIRHHRDKVNHTMN---P---- 133
H N +V +H D LY+ +Y D VN N P
Sbjct: 98 ----AHANSEWIVQLHYAFQDDKYLYMVMEYMP---------GGDLVNLMSNYDIPEKWA 144
Query: 134 --YTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
YT + +L L+ +HS IHRD+KP N+L+ ++ G +K+ADFG
Sbjct: 145 RFYTAEVVL-----ALDAIHSMGFIHRDVKPDNMLL----DKSGHLKLADFGTC------ 189
Query: 192 LKFLSENGVVV------TIWYRAPELLLGAKH---YTSAVDMWAVGCIFAELLTLKPLFQ 242
+K + NG+V T Y +PE+L Y D W+VG E+L
Sbjct: 190 MK-MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT--- 245
Query: 243 GAEAKSTQNPFQLDQLDKIF-KILGHPTPEKWPT 275
PF D L + KI+ H +P
Sbjct: 246 ---------PFYADSLVGTYSKIMDHKNSLTFPD 270
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKF--KQSKDGDGVSPTAIREIMLLREITHENVV 91
IG G +G V+ R A+ GK A+K K+ K G + IML T +
Sbjct: 2 IGRGGFGEVYGCR---KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 92 KLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL 150
+ + H L D DL+ + H M Y + IL GL ++
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL-----GLEHM 113
Query: 151 HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPE 210
H+ ++++RDLKP+NIL+ +E G V+I+D GLA + S V T Y APE
Sbjct: 114 HNRFVVYRDLKPANILL----DEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPE 165
Query: 211 LLLGAKHYTSAVDMWAVGCIFAELL 235
+L Y S+ D +++GC+ +LL
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 19/218 (8%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKF--KQSKDGDGVSPTAIREIMLLREITHENVV 91
IG G +G V+ R A+ GK A+K K+ K G + IML T +
Sbjct: 2 IGRGGFGEVYGCR---KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 92 KLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL 150
+ + H L D DL+ + H M Y + IL GL ++
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL-----GLEHM 113
Query: 151 HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPE 210
H+ ++++RDLKP+NIL+ +E G V+I+D GLA + S V T Y APE
Sbjct: 114 HNRFVVYRDLKPANILL----DEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPE 165
Query: 211 LLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248
+L Y S+ D +++GC+ +LL F+ + K
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
K+G G +G V++A N+ +A+K K G + E +++ + H+ K
Sbjct: 13 KLGAGQFGEVWMA----TYNKHTKVAVKTMKP---GSMSVEAFLAEANVMKTLQHD---K 62
Query: 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
LV +H +Y+ ++ L + ++ D+ + P + Q+ G+ ++
Sbjct: 63 LVKLHAVVTKEPIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLI-DFSAQIAEGMAFIE 119
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPEL 211
IHRDL+ +NILV V KIADFGLAR+ + ++ + G I + APE
Sbjct: 120 QRNYIHRDLRAANILV----SASLVCKIADFGLARVIEDN-EYTAREGAKFPIKWTAPE- 173
Query: 212 LLGAKHYTSAVDMWAVGCIFAELLT 236
+ +T D+W+ G + E++T
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 24/225 (10%)
Query: 33 KIGEGTYGLVFLARIK--AAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENV 90
++GEG +G VFLA +A+K K++ + RE LL + H+++
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES--ARQDFQREAELLTVLQHQHI 69
Query: 91 VKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHH-------RDKVNHTMNPYTVKSILW- 141
V+ V L + F+Y + DL +R H + T+ +L
Sbjct: 70 VRFYGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 142 --QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
Q+ +G+ YL S +HRDL N LV G+G VVKI DFG++R + +
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLV-GQGL---VVKIGDFGMSRDIYSTDYYRVGGR 183
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL--KPLFQ 242
++ I + PE +L K +T+ D+W+ G + E+ T +P +Q
Sbjct: 184 TMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQ 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 85/325 (26%), Positives = 130/325 (40%), Gaps = 62/325 (19%)
Query: 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIML 81
P+ + +I IG+GTYG VF ++ N KA A+K D D E +
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVF--KVLNKKNGSKA-AVKILDPIHDID---EEIEAEYNI 67
Query: 82 LREIT-HENVVKLVNVH----INHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTV 136
L+ ++ H NVVK ++ + + D L+L + + K M +
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGD-QLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
IL + L GL +LH N IHRD+K +NIL+ EG VK+ DFG++ Q L
Sbjct: 127 AYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG----VKLVDFGVSA--QLTSTRLR 180
Query: 197 ENGVVVTIWYRAPELLLGAKH----YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252
N V T ++ APE++ + Y + D+W++G EL P
Sbjct: 181 RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA---------- 230
Query: 253 FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY 312
L + +FKI +P PTL W ++
Sbjct: 231 -DLHPMRALFKIPRNPP----PTLHQPELWSNE-------------------------FN 260
Query: 313 DLLSKMLEYDPRKRITAAQALEHEY 337
D + K L D KR T + L+H +
Sbjct: 261 DFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 65/242 (26%), Positives = 113/242 (46%), Gaps = 38/242 (15%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVS------- 72
E P Q N + K+GEG +G V L A+ + + K F ++ + D
Sbjct: 1 EFPR--QPLNFVEKLGEGQFGEVHLCE----ADGLQDFSEKAFAENDNADAPVLVAVKVL 54
Query: 73 -PTA--------IREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRH 122
P A ++E+ +L ++ N+ +L+ V D L + +Y E DL + ++
Sbjct: 55 RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV--DPPLCMIMEYMENGDLNQFLQK 112
Query: 123 HRDK---VNHTMNPYTVKSILW---QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176
H + + + ++L+ Q+ +G+ YL S +HRDL N LV G+
Sbjct: 113 HVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV-GKNY---T 168
Query: 177 VKIADFGLAR-IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELL 235
+KIADFG++R +Y + + + + I + A E +L K +T+ D+WA G E+L
Sbjct: 169 IKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEIL 226
Query: 236 TL 237
TL
Sbjct: 227 TL 228
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN 89
L+ K+G G +G V++ N +A+K K G + E L++ + H+
Sbjct: 10 LVKKLGAGQFGEVWMGYY----NNSTKVAVKTLKP---GTMSVQAFLEEANLMKTLQHDK 62
Query: 90 VVKLVNVHINHADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLN 148
+V+L V + +Y+ +Y A+ L + ++ D+ + P + Q+ G+
Sbjct: 63 LVRLYAVVTK--EEPIYIITEYMAKGSLLDFLK--SDEGGKVLLPKLI-DFSAQIAEGMA 117
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA 208
Y+ IHRDL+ +N+LV E + KIADFGLAR+ + ++ + G I + A
Sbjct: 118 YIERKNYIHRDLRAANVLV----SESLMCKIADFGLARVIEDN-EYTAREGAKFPIKWTA 172
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAELLT 236
PE + +T D+W+ G + E++T
Sbjct: 173 PE-AINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 8e-11
Identities = 69/271 (25%), Positives = 122/271 (45%), Gaps = 43/271 (15%)
Query: 33 KIGEGTYGLVFLARIKAAAN-------------RGKAIAIKKFKQSKDGDGVSPTAIREI 79
K+GEG +G V L + + R +A+K + + + + ++E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN-DFLKEV 70
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHR-----------DKV 127
+L + N+++L+ V ++ + L + +Y E DL + + H
Sbjct: 71 KILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 128 NHTMNPYTVKSIL---WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184
H + + S+L Q+ +G+ YL S +HRDL N LV GE +KIADFG+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENL-TIKIADFGM 184
Query: 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL---KPLF 241
+R A + + V+ I + A E +L K +T+A D+WA G E+L L +P
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPYG 243
Query: 242 QGAEAKSTQNP--FQLDQLDKIFKILGHPTP 270
+ + + +N F DQ +++ L P P
Sbjct: 244 ELTDEQVIENAGEFFRDQGRQVY--LFRPPP 272
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 69/219 (31%)
Query: 146 GLNYLHSNW-IIHRDLKPSNILVMGEGEEQGVVKIADFG--------LARIYQAPLKFLS 196
L YLHS +IHRD+KPSN+L+ G VK+ DFG +A+ A K
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLI----NRNGQVKLCDFGISGYLVDSVAKTIDAGCK--- 167
Query: 197 ENGVVVTIWYRAPELL---LGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253
Y APE + L K Y D+W++G EL T + + S + PF
Sbjct: 168 --------PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----SWKTPF 214
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYD 313
Q QL ++ + P+P+ LP + S Q D
Sbjct: 215 Q--QLKQVVE---EPSPQ-------LPA-EKFSPEFQ----------------------D 239
Query: 314 LLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPS 352
++K L+ + ++R + L+H +F E +N V S
Sbjct: 240 FVNKCLKKNYKERPNYPELLQHPFF--ELHLSKNTDVAS 276
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSP--TAIREIMLLREITHENV 90
+IG G +G V L +RG + A K+ + ++E+ RE+ H NV
Sbjct: 2 EIGNGWFGKVLLGEA----HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNV 57
Query: 91 VKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNY 149
++ + I + L ++ DL +R +R V ++ + ++ +GL +
Sbjct: 58 LQCLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAP 209
LH IH DL N + + VKI D+GLA +++++ V + + AP
Sbjct: 116 LHQADFIHSDLALRNCQLTADLS----VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171
Query: 210 ELL------LGAKHYTSAVDMWAVGCIFAELLTL 237
EL+ L K T ++W++G EL T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 10/111 (9%)
Query: 131 MNPYTVKSIL---WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR- 186
+P T++ ++ +Q+ G+ +L S IHRDL NIL+ E VVKI DFGLAR
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL----SENNVVKICDFGLARD 223
Query: 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
IY+ P ++ + + + + APE + K YT+ D+W+ G + E+ +L
Sbjct: 224 IYKDP-DYVRKGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSL 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 9e-11
Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 45/226 (19%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKF--KQSKDGDGVSPTAIREIMLLREITHENVV 91
+G+G +G V +++A GK A KK K+ K G A+ E +L ++ +V
Sbjct: 1 LGKGGFGEVSACQMRAT---GKLYACKKLNKKRLKKRKGYE-GAMVEKRILAKVHSRFIV 56
Query: 92 KLVNVHINHADMSLYLAF----DYAEYDLYEIIRHHRDKVNHTMNP---------YTVKS 138
L D+ L + D +R+H V+ NP YT
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGD---------LRYHIYNVDEE-NPGFPEPRACFYTA-- 104
Query: 139 ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSEN 198
Q+++GL +LH II+RDLKP N+L+ + G V+I+D GLA LK
Sbjct: 105 ---QIISGLEHLHQRRIIYRDLKPENVLL----DNDGNVRISDLGLA----VELKDGQSK 153
Query: 199 --GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ 242
G T + APELL G + Y +VD +A+G E++ + F+
Sbjct: 154 TKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFR 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 34 IGEGTYGLVFLARIKAAAN------RGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
IG+G++G V LA+ K+ + K +KK +Q+ IM R +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQN------------HIMAERNVLL 50
Query: 88 ENVVK--LVNVHIN-HADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+N+ LV +H + LY DY +L+ ++ R + Y ++
Sbjct: 51 KNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAA-----EV 105
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
+ + YLHS II+RDLKP NIL+ + QG V + DFGL + P + S T
Sbjct: 106 ASAIGYLHSLNIIYRDLKPENILL----DSQGHVVLTDFGLCKEGVEPEETTST--FCGT 159
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLF 241
Y APE +L + Y VD W +G + E+L P F
Sbjct: 160 PEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 61/264 (23%), Positives = 108/264 (40%), Gaps = 52/264 (19%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI---REIMLLRE 84
+++ +G G +G V + R KA G A+K K+S + + R+I+ +
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSIS- 58
Query: 85 ITHENVVKLVNVHINHADM-SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQ 142
N + + D +LYL +Y DL ++ + D+ + M + L +
Sbjct: 59 ----NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAE 110
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV 202
L+ ++ +H +HRD+KP N+L+ + G +K+ADFG A L+ N +V
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLI----DRTGHIKLADFGSA-------ARLTANKMVN 159
Query: 203 ------TIWYRAPELLLGAKHYTSAV-----DMWAVGCIFAELLTLKPLFQGAEAKSTQN 251
T Y APE+L D W++G I E++ ++
Sbjct: 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY------------GRS 207
Query: 252 PFQLDQLDKIF-KILGHPTPEKWP 274
PF K + I+ K+P
Sbjct: 208 PFHEGTSAKTYNNIMNFQRFLKFP 231
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 67/216 (31%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
IGEG +G V ARIK R A AIK+ K+ D A +L + H N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 94 VNVHINHADMSLYLAFDYAEY-DLYEIIRHHR--------DKVNHTMNPYTVKSILW--- 141
+ + LYLA +YA + +L + +R R N T + + + +L
Sbjct: 62 LGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
+ G++YL IHRDL NILV E V KIADFGL+R + +K G +
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILV----GENYVAKIADFGLSRGQEVYVK--KTMGRL 173
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
W L YT+ D+W+ G + E+++L
Sbjct: 174 PVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSL 207
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 38/95 (40%), Positives = 50/95 (52%), Gaps = 10/95 (10%)
Query: 143 LLNGLNYLHSNW-IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
+L GL YL I+HRD+KPSNILV GE +K+ DFG++ L N V
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVS----GQLIDSMANSFV 159
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
T Y +PE L G HYT D+W++G E+
Sbjct: 160 GTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 37/110 (33%), Positives = 60/110 (54%), Gaps = 10/110 (9%)
Query: 132 NPYTVKSIL---WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-I 187
T++ ++ +Q+ G+ +L S IHRDL NIL+ E VVKI DFGLAR I
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL----SENNVVKICDFGLARDI 229
Query: 188 YQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
Y+ P ++ + + + + APE + + YT D+W+ G + E+ +L
Sbjct: 230 YKDP-DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 37/98 (37%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
GL +LHS II+RDLK N+++ EG +KIADFG+ + K + T
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGH----IKIADFGMCKENIFGGK--TTRTFCGTPD 166
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
Y APE++ + Y +VD WA G + E+L +P F G
Sbjct: 167 YIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 11/160 (6%)
Query: 74 TAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNP 133
+++ E LLR ++H V+ L++V + L L + DLY + +
Sbjct: 206 SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS--DLYTYLGARLRPLGLAQ-- 261
Query: 134 YTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK 193
V ++ QLL+ ++Y+H IIHRD+K N+LV G + + + DFG A +
Sbjct: 262 --VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED----ICLGDFGAACFARGSWS 315
Query: 194 FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAE 233
G+ T+ APE+L G YT +VD+W+ G + E
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 7/97 (7%)
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGV 200
Q+ G+ +L S IHRDL NIL+ E VVKI DFGLAR IY+ P ++ +
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL----SENNVVKICDFGLARDIYKDP-DYVRKGDA 235
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+ + + APE + K YT+ D+W+ G + E+ +L
Sbjct: 236 RLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSL 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFK------QSKDGDGVSPTAIREIMLLREITH 87
IG G +G V R+K R +AIK K Q +D + E ++ + H
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-------FLSEASIMGQFDH 64
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTV---KSILWQL 143
N++ L V + + +Y E L +R H + +TV +L +
Sbjct: 65 PNIIHLEGVVTKSK--PVMIVTEYMENGSLDAFLRKHDGQ-------FTVIQLVGMLRGI 115
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ-APLKFLSENGVVV 202
+G+ YL +HRDL NILV V K++DFGL+R+ + P + G +
Sbjct: 116 ASGMKYLSDMGYVHRDLAARNILV----NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
I + APE + + +TSA D+W+ G + E+++
Sbjct: 172 PIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK- 92
IG+G++G V LA+ K GK A+K ++ ++ + IM R + +NV
Sbjct: 3 IGKGSFGKVLLAKRKL---DGKCYAVKVLQKKIV---LNRKEQKHIMAERNVLLKNVKHP 56
Query: 93 -LVNVHIN-HADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNY 149
LV +H + LY D+ +L+ ++ R + + ++ + L Y
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER-----SFPEPRARFYAAEIASALGY 111
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR--IYQAPLKFLSENGVVVTIWYR 207
LHS I++RDLKP NIL+ + QG V + DFGL + I Q+ + T Y
Sbjct: 112 LHSINIVYRDLKPENILL----DSQGHVVLTDFGLCKEGIAQSD----TTTTFCGTPEYL 163
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLF 241
APE++ + Y + VD W +G + E+L P F
Sbjct: 164 APEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 68/254 (26%), Positives = 108/254 (42%), Gaps = 32/254 (12%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ Y+++ IG G +G V L R K++ + KF+ K D R+IM
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF--A 100
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
VV+L D LY+ +Y DL ++ ++ D YT + +L
Sbjct: 101 NSPWVVQLFCAF--QDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVL---- 153
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
L+ +HS +IHRD+KP N+L+ ++ G +K+ADFG + + + V T
Sbjct: 154 -ALDAIHSMGLIHRDVKPDNMLL----DKHGHLKLADFGTC-MKMDETGMVRCDTAVGTP 207
Query: 205 WYRAPELLL---GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
Y +PE+L G +Y D W+VG E+L PF D L
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV------------GDTPFYADSLVGT 255
Query: 262 F-KILGHPTPEKWP 274
+ KI+ H +P
Sbjct: 256 YSKIMDHKNSLNFP 269
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKF--KQSKDGDGVSPTAIREIMLLREITHENVV 91
+G+G +G V +++A GK A KK K+ K G + A+ E +L ++ VV
Sbjct: 8 LGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEA-MALNEKRILEKVNSRFVV 63
Query: 92 KLVNVHINHADMSLYLAFDYA---EYDLYEIIRHHRDKVNHTMNPYTVKSILW--QLLNG 146
L + + L L ++ +Y + D+ ++I + +L G
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ---------RAIFYAAELCCG 114
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
L L I++RDLKP NIL+ +++G ++I+D GLA Q P + + G V T+ Y
Sbjct: 115 LEDLQRERIVYRDLKPENILL----DDRGHIRISDLGLA--VQIP-EGETVRGRVGTVGY 167
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELL 235
APE++ K YT + D W +GC+ E++
Sbjct: 168 MAPEVINNEK-YTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
+G+G +G VF K +A+K K+ + + + E +L++ H N+VKL
Sbjct: 3 LGKGNFGEVF----KGTLKDKTPVAVKTCKEDLPQE-LKIKFLSEARILKQYDHPNIVKL 57
Query: 94 VNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLN---GLNY 149
+ V +Y+ + D +R +D++ K ++ L+ G+ Y
Sbjct: 58 IGVCTQR--QPIYIVMELVPGGDFLSFLRKKKDELK-------TKQLVKFALDAAAGMAY 108
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV-VVTIWYRA 208
L S IHRDL N LV E V+KI+DFG++R Q S +G+ + I + A
Sbjct: 109 LESKNCIHRDLAARNCLV----GENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTA 162
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAELLTL 237
PE L Y+S D+W+ G + E +L
Sbjct: 163 PE-ALNYGRYSSESDVWSYGILLWETFSL 190
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 29/126 (23%)
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW- 205
L +LH + +I+RDLK NIL+ EG K+ADFG+ + NGV T +
Sbjct: 109 LMFLHRHGVIYRDLKLDNILLDAEGH----CKLADFGMCKEGIL-------NGVTTTTFC 157
Query: 206 ----YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
Y APE+L + Y +VD WA+G + E++ +P PF+ D D +
Sbjct: 158 GTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQP------------PFEADNEDDL 204
Query: 262 FKILGH 267
F+ + H
Sbjct: 205 FESILH 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 62/233 (26%), Positives = 105/233 (45%), Gaps = 19/233 (8%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
IG G+Y V L R+K R A+ + K + D + + + + + H +V L
Sbjct: 3 IGRGSYAKVLLVRLKKT-ERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 94 VNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS 152
+ + L+ +Y DL ++ R Y+ + L LNYLH
Sbjct: 62 HSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL-----ALNYLHE 114
Query: 153 NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELL 212
II+RDLK N+L+ EG +K+ D+G+ + P + + T Y APE+L
Sbjct: 115 RGIIYRDLKLDNVLLDSEGH----IKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEIL 168
Query: 213 LGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265
G + Y +VD WA+G + E++ + F S+ NP Q + D +F+++
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGRSPFD--IVGSSDNPDQ-NTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 26/212 (12%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFK------QSKDGDGVSPTAIREIMLLREITH 87
IG G +G V R+K R +AIK K Q +D + E ++ + H
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-------FLSEASIMGQFDH 64
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
N++ L V + + ++ E + D + +L + G+
Sbjct: 65 PNIIHLEGVVTK--SRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGM 119
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ---APLKFLSENGVVVTI 204
YL +HRDL NILV V K++DFGL+R + + + S G + I
Sbjct: 120 KYLSEMNYVHRDLAARNILV----NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
+ APE + K +TSA D+W+ G + E+++
Sbjct: 176 RWTAPEAIAYRK-FTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 33 KIGEGTYGLVF--LARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENV 90
++G+G++G+V+ +A+ +AIK ++ + E +++E +V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE-RIEFLNEASVMKEFNCHHV 71
Query: 91 VKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKV--NHTMNPYTVKSILW---QLLN 145
V+L+ V ++ +L + DL +R R ++ N P ++K ++ ++ +
Sbjct: 72 VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVVVTI 204
G+ YL++N +HRDL N +V E VKI DFG+ R IY+ G++
Sbjct: 131 GMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
W L G +T+ D+W+ G + E+ TL
Sbjct: 187 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 34 IGEGTYGLVFLA-RIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIM----LLREITHE 88
+G G +G V+ I N +AIK +++ SP A +EI+ ++ +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-----TSPKANKEILDEAYVMAGVGSP 69
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEYD-LYEIIRHHRDKVNHTMNPYTVKSILW--QLLN 145
V +L+ + + ++ L Y L + +R ++D++ + + W Q+
Sbjct: 70 YVCRLLGICLTS---TVQLVTQLMPYGCLLDYVRENKDRIG------SQDLLNWCVQIAK 120
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
G++YL ++HRDL N+LV VKI DFGLAR+ +G V I
Sbjct: 121 GMSYLEEVRLVHRDLAARNVLVKSPNH----VKITDFGLARLLDIDETEYHADGGKVPIK 176
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTL--KPLFQGAEAK 247
+ A E +L + +T D+W+ G EL+T KP + G A+
Sbjct: 177 WMALESIL-HRRFTHQSDVWSYGVTVWELMTFGAKP-YDGIPAR 218
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 71/259 (27%), Positives = 107/259 (41%), Gaps = 42/259 (16%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ Y ++ IG G +G V L R K+ + KF+ K D R+IM
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
VV+L + D LY+ +Y DL ++ ++ D YT + +L
Sbjct: 103 PW--VVQLF--YAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVL---- 153
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV---- 200
L+ +HS IHRD+KP N+L+ ++ G +K+ADFG +K E V
Sbjct: 154 -ALDAIHSMGFIHRDVKPDNMLL----DKSGHLKLADFGTC------MKMNKEGMVRCDT 202
Query: 201 -VVTIWYRAPELLL---GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
V T Y +PE+L G +Y D W+VG E+L PF D
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV------------GDTPFYAD 250
Query: 257 QLDKIF-KILGHPTPEKWP 274
L + KI+ H +P
Sbjct: 251 SLVGTYSKIMNHKNSLTFP 269
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
+N + +G+G++G V LA K + AI I K D V T + + +L
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGT-DELYAIKILKKDVVIQDDDVECTMVEKRVL---ALS 57
Query: 88 ENVVKLVNVHINHADMS-LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
L +H M LY +Y DL + +V P+ V ++
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM----YQIQQVGRFKEPHAVFYAA-EIAI 112
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
GL +LHS II+RDLK N+++ EG +KIADFG+ + + ++ T
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDSEGH----IKIADFGMCK--ENMWDGVTTKTFCGTPD 166
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAE 245
Y APE ++ + Y +VD WA G + E+L + F+G +
Sbjct: 167 YIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 41/118 (34%), Positives = 61/118 (51%), Gaps = 14/118 (11%)
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR--IYQAPLKFLSENGV 200
++ GL YL S I+HRD+KPSN+LV G+ VK+ DFG++ + ++ N
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQ----VKLCDFGVSTQLVNSIAKTYVGTNA- 158
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAEL-LTLKPLFQGAEAKSTQNPFQLDQ 257
Y APE + G + Y D+W++G F EL L P Q + + + P QL Q
Sbjct: 159 -----YMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ 210
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
+Q+ NG+ +L S +HRDL N+L+ E +VKI DFGLAR ++S+
Sbjct: 246 YQVANGMEFLASKNCVHRDLAARNVLIC----EGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+ + + APE + YT+ D+W+ G + E+ TL
Sbjct: 302 FLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTL 337
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS---KDGDGVSPTAIREIMLLRE 84
+N + +G+G++G V LA K + AIK K+ +D D + ++ L++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 85 ITHENVVKLVNVHINHADMS-LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQ 142
L +H + LY +Y DL +H +V P V +
Sbjct: 59 ----KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLM----YHIQQVGKFKEPQAVFYAA-E 109
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV 202
+ GL +LH II+RDLK N+++ EG +KIADFG+ + + + ++
Sbjct: 110 ISVGLFFLHRRGIIYRDLKLDNVMLDSEGH----IKIADFGMCK--EHMVDGVTTRTFCG 163
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAE 245
T Y APE ++ + Y +VD WA G + E+L +P F G +
Sbjct: 164 TPDYIAPE-IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 52/233 (22%)
Query: 31 IGKI-GEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI----REIMLLREI 85
+GKI GEG +G V ++ +A+K K D + + I E +++
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL----DIHTYSEIEEFLSEAACMKDF 58
Query: 86 THENVVKLVNVHINHADM----SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNP--YTVKS 138
H NV+KL+ V + + + + ++ DL+ + + R P +++
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG----GLPEKLPLQT 114
Query: 139 ILWQLLN---GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR--------- 186
+L +++ G+ YL + IHRDL N ++ E V +ADFGL++
Sbjct: 115 LLKFMVDIALGMEYLSNRNFIHRDLAARNCML----REDMTVCVADFGLSKKIYSGDYYR 170
Query: 187 ---IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
I + P+K+++ L + YTS D+WA G E+ T
Sbjct: 171 QGRIAKMPVKWIAIES-------------LADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 63/260 (24%), Positives = 118/260 (45%), Gaps = 40/260 (15%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
+ L+ +G GTYG V+ R G+ AIK + D + +EI +L++ +H
Sbjct: 8 FELVELVGNGTYGQVYKGR---HVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSH 61
Query: 88 -ENVVKLVNVHINH----ADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILW 141
N+ I D L+L ++ + ++I++ + +T+ + I
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICR 118
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
++L GL++LH + +IHRD+K N+L+ E VK+ DFG++ Q N +
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAE----VKLVDFGVSA--QLDRTVGRRNTFI 172
Query: 202 VTIWYRAPELLLGAKH----YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257
T ++ APE++ ++ Y D+W++G +T + +GA +P +
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLG------ITAIEMAEGAPPLCDMHPMR--- 223
Query: 258 LDKIFKILGHPTP----EKW 273
+F I +P P +KW
Sbjct: 224 --ALFLIPRNPAPRLKSKKW 241
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKF-KQSKDGDGVSPTAIREIMLLREITHENVVK 92
+G+G +G V ++K N GK A KK K+ A+ E +L ++ +V
Sbjct: 1 LGKGGFGEVCAVQVK---NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 93 LVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS 152
L + + L ++ Y I ++ + M S Q+ G+ +LHS
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHI--YNVGERGLEMERVIHYSA--QITCGILHLHS 113
Query: 153 NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELL 212
I++RD+KP N+L+ ++QG +++D GLA + G T Y APE+L
Sbjct: 114 MDIVYRDMKPENVLL----DDQGNCRLSDLGLAVELKDGKTITQRAG---TNGYMAPEIL 166
Query: 213 LGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247
+ Y+ VD +A+GC E++ + F+ + K
Sbjct: 167 K-EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 9e-09
Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 49/277 (17%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
+G+G +G V A++K+ + +A+K K +RE ++E H NV+KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 94 VNVHINHADMS------LYLAFDYAEYDLYEIIRHHRDKVN-HTMNPYTVKSILWQLLNG 146
+ V + + L F DL+ + R T+ T+ + + +G
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPF-MKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA-----------PLKF 194
+ YL S IHRDL N ++ E V +ADFGL++ IY P+K+
Sbjct: 126 MEYLSSKNFIHRDLAARNCML----NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 195 LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKSTQNPF 253
L+ L YT+ D+WA G E++T + + G E N
Sbjct: 182 LALES-------------LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228
Query: 254 --------QLDQLDKIFKILG---HPTPEKWPTLANL 279
D L+ +++++ P P+ P+ +L
Sbjct: 229 IKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 56/240 (23%)
Query: 131 MNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190
M+ + +IL+ L GLNYLH N IHR++K S+IL+ G+G +V ++ GL+ +Y
Sbjct: 98 MSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG----LVSLS--GLSHLYS- 150
Query: 191 PLKFLSENG-------------VVVTIWYRAPELLLGAKH-YTSAVDMWAVGCIFAELLT 236
L NG V W +PELL + Y D+++VG EL
Sbjct: 151 ----LVRNGQKAKVVYDFPQFSTSVLPWL-SPELLRQDLYGYNVKSDIYSVGITACEL-- 203
Query: 237 LKPLFQGAEAKSTQNPFQ-LDQLDKIFKILGHPTPEKWPTLANLPHWQS----------- 284
+ + PFQ + + + + L P P +S
Sbjct: 204 ----------ATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT-FPCEESRMKNSQSGVDS 252
Query: 285 ---DSLHIQGRKYETNG--LHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
+S+ G L + + +L+ L+ DP KR +A+ L H +F+
Sbjct: 253 GIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 74/329 (22%), Positives = 127/329 (38%), Gaps = 77/329 (23%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
L +G+IG GT G V+ R K G +A+K+ +++ G R +M L
Sbjct: 14 LNDLENLGEIGSGTCGQVYKMRFKKT---GHVMAVKQMRRT----GNKEENKRILMDLDV 66
Query: 85 I--THE--NVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSIL 140
+ +H+ +VK I D +++ + L ++++ ++ + + +
Sbjct: 67 VLKSHDCPYIVKCYGYFI--TDSDVFICMELMSTCLDKLLK----RIQGPIPEDILGKMT 120
Query: 141 WQLLNGLNYL---HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA-RIYQAPLKFLS 196
++ L+YL H +IHRD+KPSNIL+ + G VK+ DFG++ R+ + K S
Sbjct: 121 VAIVKALHYLKEKHG--VIHRDVKPSNILL----DASGNVKLCDFGISGRLVDSKAKTRS 174
Query: 197 ENGVVVTIWYRAPELLLGAKH---YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253
Y APE + Y D+W++G EL T Q P+
Sbjct: 175 AGCAA----YMAPERIDPPDPNPKYDIRADVWSLGISLVELAT------------GQFPY 218
Query: 254 QLDQLD--KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
+ + + + KIL P LP + S
Sbjct: 219 KNCKTEFEVLTKILQEEPPS-------LPPNEGFSPDFC--------------------- 250
Query: 312 YDLLSKMLEYDPRKRITAAQALEHEYFRI 340
+ L D RKR + L+H + R
Sbjct: 251 -SFVDLCLTKDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 65/257 (25%), Positives = 103/257 (40%), Gaps = 80/257 (31%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD----GDGVSPTAIREIMLLREITHEN 89
+G+G++G V LAR+K + G+ A+K K KD D V T + +L H
Sbjct: 3 LGKGSFGKVMLARLKES---GRLYAVKVLK--KDVILQDDDVECTMTEKRILSLARNHPF 57
Query: 90 VVKL------------VNVHINHADMSLYLA----FDYAEYDLYEIIRHHRDKVNHTMNP 133
+ +L V +N D+ ++ FD A Y
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA-------------- 103
Query: 134 YTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR--IYQAP 191
++ + L +LH II+RDLK N+L+ EG K+ADFG+ + I+
Sbjct: 104 --------EITSALMFLHDKGIIYRDLKLDNVLLDHEGH----CKLADFGMCKEGIF--- 148
Query: 192 LKFLSENGVVVTIW-----YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246
NG + + Y APE +L Y +VD WA+G + E+L
Sbjct: 149 ------NGKTTSTFCGTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEML----------- 190
Query: 247 KSTQNPFQLDQLDKIFK 263
PF+ + D +F+
Sbjct: 191 -CGHAPFEAENEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 48/205 (23%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
+G G +G V+ K K G + + E +++ + H ++V+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 94 VNVHINHADMSLYLAFDYAEYD-LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS 152
+ V ++ ++ L + L + + H+D + + + + Q+ G+ YL
Sbjct: 75 LGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQL----LLNWCVQIAKGMMYLEE 127
Query: 153 NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELL 212
++HRDL N+LV VKI DFGLAR+ + K + +G + I + A E
Sbjct: 128 RRLVHRDLAARNVLVKSPNH----VKITDFGLARLLEGDEKEYNADGGKMPIKWMALE-C 182
Query: 213 LGAKHYTSAVDMWAVGCIFAELLTL 237
+ + +T D+W+ G EL+T
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ I ++G G G+V + K + I +K + + IRE+ +L E
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPS----GLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 86 THENVVKLVNVHINHADMSLYLA-FDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+V + ++S+ + D D ++++ + + ++ +L
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLD--QVLKEAKRIPEEILGKVSIA-----VL 113
Query: 145 NGLNYL-HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
GL YL + I+HRD+KPSNILV GE +K+ DFG++ L N V T
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVNSRGE----IKLCDFGVS----GQLIDSMANSFVGT 165
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAEL 234
Y +PE L G HY+ D+W++G EL
Sbjct: 166 RSYMSPERLQGT-HYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 62/228 (27%), Positives = 94/228 (41%), Gaps = 52/228 (22%)
Query: 139 ILWQLLNGLNYLHSNW-IIHRDLKPSNILVMGEGEEQGV--------------VKIADFG 183
I++Q L+Y H+ ++H DLKP NIL+ E + V V+I D G
Sbjct: 236 IIFQTGVALDYFHTELHLMHTDLKPENILM--ETSDTVVDPVTNRALPPDPCRVRICDLG 293
Query: 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
+ S +V T YR+PE++LG + + DMW++GCI EL T K L+
Sbjct: 294 GCCDERH-----SRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDT 347
Query: 244 AEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQ------------SDSLHIQG 291
+ L+ L + K LG P +W + +D H+
Sbjct: 348 HD--------NLEHLHLMEKTLGR-LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHL-A 397
Query: 292 RKYETNGLHSVV--PLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337
R + V+ L DL+ +L YD +KR+ A Q H Y
Sbjct: 398 RIARARPVREVIRDDL-----LCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 75/326 (23%), Positives = 127/326 (38%), Gaps = 86/326 (26%)
Query: 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENV 90
+ ++G+G YG V+ + G +A+K+ + D + +I++ +I H+ V
Sbjct: 6 LDELGKGNYGSVYKVLHRPT---GVTMAMKEIRLELD-----ESKFNQIIMELDILHKAV 57
Query: 91 VKLVNVHINHADMSLYLAFDYAEYDLYEIIRH----HRDKV------NHTMNPYTVKSIL 140
+ + Y AF + E +Y + + DK+ + ++ I
Sbjct: 58 SPYI--------VDFYGAF-FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRIT 108
Query: 141 WQLLNGLNYLHSNW-IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
+ ++ GL +L IIHRD+KP+N+LV G G+ VK+ DFG++ A L +
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ----VKLCDFGVSGNLVASLAKTN--- 161
Query: 200 VVVTIWYRAPELL-----LGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254
+ Y APE + YT D+W++G L++ + G P+
Sbjct: 162 -IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLG------LSILEMALGRY------PYP 208
Query: 255 LDQLDKIFKILG---HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
+ IF L P PTL P A
Sbjct: 209 PETYANIFAQLSAIVDGDP---PTL---------------------------PSGYSDDA 238
Query: 312 YDLLSKMLEYDPRKRITAAQALEHEY 337
D ++K L P +R T AQ LEH +
Sbjct: 239 QDFVAKCLNKIPNRRPTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK--DGDGVSPTAIREIMLLREITHENVV 91
+G+GT+G V L R KA GK A+K K+ D V+ T + E +L+ H +
Sbjct: 3 LGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHT-LTESRVLQNTRHPFLT 58
Query: 92 KLVNVHINHADMSLYLAFDYAEY----DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
L H L F EY +L+ + R Y ++++ L
Sbjct: 59 ALKYSFQTHD----RLCF-VMEYANGGELFFHLSRERVFSEDRARFYGA-----EIVSAL 108
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR---IYQAPLKFLSENGVVVTI 204
YLHS +++RDLK N+++ ++ G +KI DFGL + A +K T
Sbjct: 109 GYLHSCDVVYRDLKLENLML----DKDGHIKITDFGLCKEGISDGATMKTFCG-----TP 159
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELL 235
Y APE +L Y AVD W +G + E++
Sbjct: 160 EYLAPE-VLEDNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 30/227 (13%)
Query: 26 QQYNLIGKIGEGTYGLVF--LARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIRE-IMLL 82
++ L+ ++G+G++G+V+ AR +A+K +S ++RE I L
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--------ASLRERIEFL 57
Query: 83 RE------ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHR-DKVNHTMNPY- 134
E T +VV+L+ V ++ +L + A DL +R R + N+ P
Sbjct: 58 NEASVMKGFTCHHVVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 135 TVKSILW---QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA 190
T++ ++ ++ +G+ YL++ +HRDL N +V VKI DFG+ R IY+
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV----AHDFTVKIGDFGMTRDIYET 172
Query: 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
G++ W APE L +T++ DMW+ G + E+ +L
Sbjct: 173 DYYRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITSL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 23/221 (10%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
+ L+ +G GTYG V+ R G+ AIK ++D + I ML + H
Sbjct: 18 FELVEVVGNGTYGQVYKGR---HVKTGQLAAIKVMDVTEDEEEEIKLEIN--MLKKYSHH 72
Query: 88 ENVVKLVNVHINHA----DMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQ 142
N+ I + D L+L ++ + +++++ + + + + I +
Sbjct: 73 RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICRE 129
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV 202
+L GL +LH++ +IHRD+K N+L+ E VK+ DFG++ Q N +
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLTENAE----VKLVDFGVSA--QLDRTVGRRNTFIG 183
Query: 203 TIWYRAPELLLGAKH----YTSAVDMWAVGCIFAELLTLKP 239
T ++ APE++ ++ Y D+W++G E+ P
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
S +Q+ G+ +L S +HRDL N+L + +G+ +VKI DFGLAR ++S+
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVL-LAQGK---IVKICDFGLARDIMHDSNYVSK 296
Query: 198 NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+ + + APE + YT+ D+W+ G + E+ +L
Sbjct: 297 GSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSL 335
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 32/173 (18%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
++++ ++ I G +G V+L R K N K A+K K++ I + M+ +
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKK---NNSKLYAVKVVKKAD--------MINKNMVHQV 51
Query: 85 ITHENVVKLVN----VHINHADMSLYLAFDYAEY----DLYEI--IRHHRDKVNHTMNPY 134
+ + L VH+ ++ S + EY D+ + I + D+
Sbjct: 52 QAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE------EM 105
Query: 135 TVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187
VK I L L+YLH + IIHRDLKP N+L+ EG +K+ DFGL+++
Sbjct: 106 AVKYISEVAL-ALDYLHRHGIIHRDLKPDNMLISNEGH----IKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 51/220 (23%)
Query: 143 LLNGLNYL-HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
++ GL YL + I+HRD+KPSNILV GE +K+ DFG++ L N V
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVS----GQLIDSMANSFV 163
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T Y +PE L G HY+ D+W++G E+ A + P +L+ +
Sbjct: 164 GTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEM---------AIGRYPIPPPDAKELELM 213
Query: 262 F--KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS------------- 306
F + G P + P GR + G S P++
Sbjct: 214 FGCPVEGDPAESETSPRPRPP----------GRPLSSYGPDSRPPMAIFELLDYIVNEPP 263
Query: 307 PKSPA-------YDLLSKMLEYDPRKRITAAQALEHEYFR 339
PK P+ D ++K L +P +R Q + H + +
Sbjct: 264 PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK 303
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 61/263 (23%), Positives = 114/263 (43%), Gaps = 47/263 (17%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK---KFKQSKDGDGVSPTAIREIMLL 82
+ + ++ IG G +G V + ++K N K A+K K++ K + R+++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLK---NADKVFAMKILNKWEMLKRAETACFREERDVL-- 55
Query: 83 REITHENVVKLVNVHINHADMSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILW 141
+ +N + + +LYL DY DL ++ D++ M + L
Sbjct: 56 --VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM----ARFYLA 109
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV- 200
+++ ++ +H +HRD+KP NIL+ + G +++ADFG + LK + + V
Sbjct: 110 EMVIAIDSVHQLHYVHRDIKPDNILM----DMNGHIRLADFG------SCLKLMEDGTVQ 159
Query: 201 ----VVTIWYRAPELLL----GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252
V T Y +PE+L G Y D W++G E+L + P
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY------------GETP 207
Query: 253 FQLDQLDKIF-KILGHPTPEKWP 274
F + L + + KI+ H ++P
Sbjct: 208 FYAESLVETYGKIMNHKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 85/360 (23%), Positives = 141/360 (39%), Gaps = 74/360 (20%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK--DGDGVSPTAIREIMLLREITHENVV 91
+G+GT+G V L R KA+ GK A+K K+ D V+ T + E +L+ H +
Sbjct: 3 LGKGTFGKVILVREKAS---GKYYAMKILKKEVIIAKDEVAHT-LTESRVLKNTRHPFLT 58
Query: 92 KLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
L + + + + + R + T + ++++ L+YLH
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT------RFYGAEIVSALDYLH 112
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPEL 211
S I++RDLK N+++ ++ G +KI DFGL + + + T Y APE
Sbjct: 113 SGKIVYRDLKLENLML----DKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPE- 165
Query: 212 LLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPE 271
+L Y AVD W +G + E++ + PF +K+F++
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMC------------GRLPFYNQDHEKLFEL------- 206
Query: 272 KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ 331
+ ++ K+ P + + A LLS +L DP KR+
Sbjct: 207 ---------------ILMEDIKF---------PRTLSADAKSLLSGLLIKDPNKRLGGGP 242
Query: 332 ALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRP-VDSNTDFE--------GTTTLQPPQ 382
E R G N DK + P +P V S TD T T+ PP+
Sbjct: 243 DDAKEIMRHSFFTGVNW---QDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQTITITPPE 299
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 42/219 (19%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIK---KFKQSKDGDGVSPTAIREIMLL---REITH 87
IG G +G V + ++K N G+ A+K K++ K + R++++ R IT
Sbjct: 9 IGRGAFGEVAVVKMK---NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWIT- 64
Query: 88 ENVVKLVNVHINHAD-MSLYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
N+H D +LYL DY DL ++ D++ M + L +++
Sbjct: 65 -------NLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM----ARFYLAEMVL 113
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV----- 200
++ +H +HRD+KP N+L+ ++ G +++ADFG + L+ L++ V
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLL----DKNGHIRLADFG------SCLRLLADGTVQSNVA 163
Query: 201 VVTIWYRAPELLL----GAKHYTSAVDMWAVGCIFAELL 235
V T Y +PE+L G Y D W++G E+L
Sbjct: 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 37/107 (34%), Positives = 54/107 (50%), Gaps = 9/107 (8%)
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
LN+LH II+RDLK N+L+ EG +K+ D+G+ + P S T Y
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGH----IKLTDYGMCKEGIRPGDTTST--FCGTPNY 162
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ--GAEAKSTQN 251
APE+L G + Y +VD WA+G + E++ + F G QN
Sbjct: 163 IAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 54/229 (23%), Positives = 87/229 (37%), Gaps = 57/229 (24%)
Query: 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIRE-IMLLREI----- 85
G+IG G +G V K G +A+K+ + + D +E LL ++
Sbjct: 10 GEIGRGAFGTVNKMLHK---PSGTIMAVKRIRSTVDE--------KEQKRLLMDLDVVMR 58
Query: 86 --THENVVKLVNVHINHAD----MSLY-LAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKS 138
+VK D M L ++ D Y+ + + + + +
Sbjct: 59 SSDCPYIVKFYGALFREGDCWICMELMDISLD----KFYKYVY---EVLKSVIPEEILGK 111
Query: 139 ILWQLLNGLNYLHSNW-IIHRDLKPSNILVMGEGEEQGVVKIADFGL--------ARIYQ 189
I + LNYL IIHRD+KPSNIL+ + G +K+ DFG+ A+
Sbjct: 112 IAVATVKALNYLKEELKIIHRDVKPSNILL----DRNGNIKLCDFGISGQLVDSIAKTRD 167
Query: 190 APLKFLSENGVVVTIWYRAPELLL--GAKHYTSAVDMWAVGCIFAELLT 236
A + Y APE + Y D+W++G E+ T
Sbjct: 168 AGCRP-----------YMAPERIDPSARDGYDVRSDVWSLGITLYEVAT 205
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 32 GKIGEGTYGLV---FLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE 88
G++G G +G V K+ K +A+K K + + +RE +++++ +
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSE----KTVAVKILKNDNNDPALKDELLREANVMQQLDNP 56
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEYD-LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
+V+++ I A+ S L + AE L + ++ ++ + ++ Q+ G+
Sbjct: 57 YIVRMIG--ICEAE-SWMLVMELAELGPLNKFLQKNKHVTEKN-----ITELVHQVSMGM 108
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE--NGVVVTIW 205
YL +HRDL N+L++ Q KI+DFGL++ A + +G W
Sbjct: 109 KYLEETNFVHRDLAARNVLLV----TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKW 164
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLT--LKP 239
Y APE + K ++S D+W+ G + E + KP
Sbjct: 165 Y-APECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 68/267 (25%), Positives = 99/267 (37%), Gaps = 79/267 (29%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQS---KDGDGVSPTAIREIMLLREITHENV 90
IG G +G V L + K + G A+KK ++S + A R+I L E + V
Sbjct: 9 IGRGAFGEVRLVQKK---DTGHIYAMKKLRKSEMLEKEQVAHVRAERDI--LAEADNPWV 63
Query: 91 VKLVNVHINHADMSLYLAFDYAEYDLYEIIRH-----------HRDKVNHTMNP-YTVKS 138
VKL Y +F Y LY I+ + +D Y ++
Sbjct: 64 VKL------------YYSFQDENY-LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAET 110
Query: 139 ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL------------AR 186
IL ++ +H IHRD+KP N+L+ + +G +K++DFGL R
Sbjct: 111 IL-----AIDSIHKLGYIHRDIKPDNLLL----DAKGHIKLSDFGLCTGLKKSHRTEFYR 161
Query: 187 IY--QAPLKFLSEN----------------------GVVVTIWYRAPELLLGAKHYTSAV 222
I P FL V T Y APE+ L Y
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKEC 220
Query: 223 DMWAVGCIFAELLTLKPLFQGAEAKST 249
D W++G I E+L P F + T
Sbjct: 221 DWWSLGVIMYEMLVGYPPFCSDNPQET 247
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 43/150 (28%), Positives = 59/150 (39%), Gaps = 46/150 (30%)
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL---------ARIYQ--- 189
+L + +H IHRD+KP NIL+ + G +K+ DFGL ++ YQ
Sbjct: 109 ELTCAIESVHKMGFIHRDIKPDNILI----DRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164
Query: 190 ------------------APLKFLSE-----------NGVVVTIWYRAPELLLGAKHYTS 220
LK L + +V T Y APE+LL YT
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQ 223
Query: 221 AVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250
D W+VG I E+L +P F TQ
Sbjct: 224 LCDWWSVGVILYEMLVGQPPFLADTPAETQ 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG-VVKIADFGLARIYQAPLKFLS 196
S +Q+ G+++L S IHRDL NIL+ G + KI DFGLAR + ++
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLT-----HGRITKICDFGLARDIRNDSNYVV 272
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+ + + + APE + YT D+W+ G + E+ +L
Sbjct: 273 KGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSL 312
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 38/120 (31%), Positives = 62/120 (51%), Gaps = 12/120 (10%)
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
LN+LH II+RDLK N+L+ + G +K+ D+G+ + P S T
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLL----DADGHIKLTDYGMCKEGLGPGDTTST--FCGTPN 161
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265
Y APE+L G + Y +VD WA+G + E++ + F T NP ++ D +F+++
Sbjct: 162 YIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFD----IITDNP-DMNTEDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 41/146 (28%), Positives = 73/146 (50%), Gaps = 15/146 (10%)
Query: 116 LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175
L + +R HRD +++P + + Q+ G+ YL + ++HR+L NIL+ +
Sbjct: 95 LLDHVRQHRD----SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL----KSDS 146
Query: 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELL 235
+V+IADFG+A + K + I + A E +L + YT D+W+ G E++
Sbjct: 147 IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMM 205
Query: 236 TLKPLFQGAEAKSTQNPFQL-DQLDK 260
+ GAE + P ++ D L+K
Sbjct: 206 SY-----GAEPYAGMRPHEVPDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 57/262 (21%), Positives = 110/262 (41%), Gaps = 43/262 (16%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ +I IG G +G V + ++K + K++ K + R +++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLV---- 56
Query: 86 THENVVKLVNVHINHADMS-LYLAFDY-AEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+ + + +H D + LYL DY DL ++ D++ M + + ++
Sbjct: 57 -NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA----EM 111
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV--- 200
+ ++ +H +HRD+KP N+L+ + G +++ADFG + LK + V
Sbjct: 112 VLAIHSIHQLHYVHRDIKPDNVLL----DMNGHIRLADFG------SCLKMNQDGTVQSS 161
Query: 201 --VVTIWYRAPELLL----GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254
V T Y +PE+L G Y D W++G E+L + PF
Sbjct: 162 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY------------GETPFY 209
Query: 255 LDQLDKIF-KILGHPTPEKWPT 275
+ L + + KI+ H ++P+
Sbjct: 210 AESLVETYGKIMNHEERFQFPS 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK--DGDGVSPTAIREIMLLREITHENVV 91
+G+GT+G V L R KA G+ A+K ++ D V+ T + E +L+ H +
Sbjct: 3 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHPFLT 58
Query: 92 KLVNVHINHADMSLYLAFDYAEYDLYEIIRH-HRDKVNHTMNPYTVKSILWQLLNGLNYL 150
L H L +YA E+ H R++V + ++++ L YL
Sbjct: 59 ALKYAFQTHD--RLCFVMEYANGG--ELFFHLSRERV---FTEERARFYGAEIVSALEYL 111
Query: 151 HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR---IYQAPLKFLSENGVVVTIWYR 207
HS +++RD+K N+++ ++ G +KI DFGL + A +K T Y
Sbjct: 112 HSRDVVYRDIKLENLML----DKDGHIKITDFGLCKEGISDGATMKTFCG-----TPEYL 162
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELL 235
APE +L Y AVD W +G + E++
Sbjct: 163 APE-VLEDNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 42/158 (26%), Positives = 78/158 (49%), Gaps = 16/158 (10%)
Query: 81 LLREITHENVVKLVNVHINHADMSLYLAF-DYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
++R+++H+++V L V + + + F ++ DL+ HR K + P+ K +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLF----MHR-KSDVLTTPWKFK-V 110
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG---EEQGVVKIADFGLARIYQAPLKFLS 196
QL + L+YL ++H ++ NIL+ EG E +K++D G+ P+ LS
Sbjct: 111 AKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI------PITVLS 164
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAEL 234
V I + APE + +K+ + A D W+ G E+
Sbjct: 165 RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 24/50 (48%), Positives = 33/50 (66%), Gaps = 4/50 (8%)
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185
+K ++ Q+L GL LH I+HRD+KP N+LV +G+ VKI DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ----VKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 21/215 (9%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA----IREIMLLREITHE 88
+IG G +G V L + + + + +K+ + S S + E R + H
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVV-VKELRVS-----ASVQEQMKFLEEAQPYRSLQHS 55
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLN 148
N+++ + L + F DL +R R T +P T++ + ++ GL
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEF-CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL 114
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA 208
+LH N IH DL N L+ + VKI D+GL+ +++ + + V + + A
Sbjct: 115 HLHKNNFIHSDLALRNCLLTAD----LTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIA 170
Query: 209 PELL------LGAKHYTSAVDMWAVGCIFAELLTL 237
PEL+ L T ++W++G EL L
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWELFEL 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 76 IREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY---DLYEIIRHHRDKVNHTMN 132
L+ +++H+++VKL V + ++ + +Y ++ D++ HR+K N +++
Sbjct: 49 FETASLMSQLSHKHLVKLYGVCVRDENI---MVEEYVKFGPLDVF----LHREKNNVSLH 101
Query: 133 PYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG---VVKIADFGLARIYQ 189
+ QL + L+YL ++H ++ NILV G +G +K++D G+
Sbjct: 102 WKLD--VAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI----- 154
Query: 190 APLKFLSENGVVVTIWYRAPELL-LGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248
P+ LS V I + APE + G T A D W+ G E+ + + S
Sbjct: 155 -PITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213
Query: 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANL 279
+ F DQ L P P+ LANL
Sbjct: 214 EKERFYQDQ-----HRL--PMPD-CAELANL 236
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 48/191 (25%), Positives = 77/191 (40%), Gaps = 57/191 (29%)
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
+++ L+ LH I+ RDL P+NIL+ +++G +++ F + S +G
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILL----DDRGHIQLTYFSRWSEVED-----SCDGEA 143
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
V Y APE + G T A D W++G I ELLT K L +
Sbjct: 144 VENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTLVE------------------- 183
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
HP+ T N+P W S+ A LL ++L++
Sbjct: 184 ----CHPSGINTHTTLNIPEWVSE------------------------EARSLLQQLLQF 215
Query: 322 DPRKRITAAQA 332
+P +R+ A A
Sbjct: 216 NPTERLGAGVA 226
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 31 IGK-IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN 89
+GK +GEG +G V ++ + K +A+K K + + E + ++E H N
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILK-VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 90 VVKLVNVHINHADMSLYLA----FDYAEY-DLYEIIRHHR--DKVNHTMNPYTVKSILWQ 142
V++L+ V + + Y + + ++ DL+ + + R D + VK +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTD 120
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA------------RIYQA 190
+ +G+ YL S IHRDL N ++ E V +ADFGL+ RI +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCML----NENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
P+K+++ L + YT+ D+W+ G E+ T
Sbjct: 177 PVKWIAIES-------------LADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 5/96 (5%)
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
Q+ G+++L S IHRD+ N+L+ + V KI DFGLAR ++ +
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLL----TDGRVAKICDFGLARDIMNDSNYVVKGNAR 275
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+ + + APE + YT D+W+ G + E+ +L
Sbjct: 276 LPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSL 310
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 22/50 (44%), Positives = 31/50 (62%), Gaps = 3/50 (6%)
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185
+++I+ Q+L L+ LHS I+HRD+KP NI+ E G KI D G A
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIF---SEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 22/213 (10%)
Query: 46 RIKAAANRGKAIAIKKFKQSKDGDGV-SPTAIREIMLLREITHENVVKLVNVHINHAD-- 102
I K + I+ FK+ G V EI LR I N++K+ I+ D
Sbjct: 35 SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 103 --MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH-SNWIIHRD 159
+SL L + Y L E++ +D ++ T + GL L+ +++
Sbjct: 95 PRLSLILEYCTRGY-LREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNKPYKN 148
Query: 160 LKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA-KHY 218
L + LV E +KI GL +I +P F + N +V Y + ++L Y
Sbjct: 149 LTSVSFLV----TENYKLKIICHGLEKILSSP-PFKNVNFMV----YFSYKMLNDIFSEY 199
Query: 219 TSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251
T D++++G + E+ T K F+ K +
Sbjct: 200 TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD 232
|
Length = 283 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 44/154 (28%), Positives = 61/154 (39%), Gaps = 50/154 (32%)
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL---------ARIYQA-- 190
+L + +H IHRD+KP NIL+ + G +K+ DFGL ++ YQ
Sbjct: 109 ELTLAIESVHKMGFIHRDIKPDNILI----DLDGHIKLTDFGLCTGFRWTHNSKYYQKGS 164
Query: 191 -----------------------PLKFLSE-----------NGVVVTIWYRAPELLLGAK 216
LK L + + +V T Y APE+LL K
Sbjct: 165 HIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RK 223
Query: 217 HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250
YT D W+VG I E+L +P F TQ
Sbjct: 224 GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 43/154 (27%), Positives = 61/154 (39%), Gaps = 50/154 (32%)
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL---------ARIYQA-- 190
+L + +H IHRD+KP NIL+ + G +K+ DFGL ++ YQ+
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILI----DRDGHIKLTDFGLCTGFRWTHDSKYYQSGD 164
Query: 191 -----PLKFLSENG-----------------------------VVVTIWYRAPELLLGAK 216
+ F +E G +V T Y APE+LL
Sbjct: 165 HVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG 224
Query: 217 HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250
YT D W+VG I E+L +P F TQ
Sbjct: 225 -YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
+G+GT+G V L + KA R A+ I K + D V+ T + E +L+ H + L
Sbjct: 3 LGKGTFGKVILVKEKATG-RYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLTAL 60
Query: 94 VNVHINHADMSLYLAFDYAEYDLYEIIRH-HRDKVNHTMNPYTVKSILWQLLNGLNYLHS 152
H L +YA E+ H R++V + + ++++ L+YLHS
Sbjct: 61 KYSFQTHD--RLCFVMEYANGG--ELFFHLSRERV---FSEDRARFYGAEIVSALDYLHS 113
Query: 153 NW-IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPEL 211
+++RDLK N+++ ++ G +KI DFGL + + + T Y APE+
Sbjct: 114 EKNVVYRDLKLENLML----DKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEV 167
Query: 212 LLGAKHYTSAVDMWAVGCIFAELL 235
L Y AVD W +G + E++
Sbjct: 168 L-EDNDYGRAVDWWGLGVVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 44/220 (20%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTAIREIMLLREITHENV 90
++G G +G V K R K I AIK K + V +RE ++ ++ + +
Sbjct: 2 ELGSGNFGCVKKGVYKM---RKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYI 57
Query: 91 VKLVNVHINHADMSLYLAFDYAEYD-LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNY 149
V+++ V A+ +L L + A L + + +D++ + V ++ Q+ G+ Y
Sbjct: 58 VRMIGV--CEAE-ALMLVMEMASGGPLNKFLSGKKDEITVS----NVVELMHQVSMGMKY 110
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI-------YQA------PLKFLS 196
L +HRDL N+L++ Q KI+DFGL++ Y+A PLK
Sbjct: 111 LEGKNFVHRDLAARNVLLV----NQHYAKISDFGLSKALGADDSYYKARSAGKWPLK--- 163
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
WY APE + K ++S D+W+ G E +
Sbjct: 164 --------WY-APECINFRK-FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 13/27 (48%), Positives = 17/27 (62%)
Query: 309 SPAYDLLSKMLEYDPRKRITAAQALEH 335
DL+ KML+ DP KR +A + LEH
Sbjct: 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 58/244 (23%), Positives = 100/244 (40%), Gaps = 52/244 (21%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE-NVVK 92
IG G +G V L + K + G A+K +++ D + + I R+I E + +
Sbjct: 9 IGRGAFGEVRLVQKK---DTGHVYAMKILRKA---DMLEKEQVGHIRAERDILVEADSLW 62
Query: 93 LVNVHINHAD-MSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL 150
+V + + D ++LYL ++ D+ ++ Y +++L ++ +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL-----AIDSI 117
Query: 151 HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL---------ARIYQ-----APLKFLS 196
H IHRD+KP N+L+ + +G VK++DFGL Y+ P F
Sbjct: 118 HQLGFIHRDIKPDNLLL----DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 197 EN-------------------GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+N V T Y APE+ + Y D W++G I E+L
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIG 232
Query: 238 KPLF 241
P F
Sbjct: 233 YPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 28/171 (16%)
Query: 115 DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ 174
D Y ++ +++ +N + K + W L++L + H ++ N+L++ E + +
Sbjct: 87 DTY--LKKNKNLINISWKLEVAKQLAW----ALHFLEDKGLTHGNVCAKNVLLIREEDRK 140
Query: 175 G----VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCI 230
+K++D G++ I P + L E I + PE + ++ + A D W+ G
Sbjct: 141 TGNPPFIKLSDPGIS-ITVLPKEILLER-----IPWVPPECIENPQNLSLAADKWSFGTT 194
Query: 231 FAELLT--LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANL 279
E+ + KPL K Q QL P P KW LANL
Sbjct: 195 LWEIFSGGDKPLSALDSQKKLQFYEDRHQL---------PAP-KWTELANL 235
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 16/38 (42%), Positives = 21/38 (55%), Gaps = 5/38 (13%)
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187
LHS IIH DL SN+++ G + + DFGLA
Sbjct: 111 LHSAGIIHGDLTTSNMILSGGK-----IYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 38/145 (26%), Positives = 54/145 (37%), Gaps = 50/145 (34%)
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA---------RIYQAPLK------- 193
+H IHRD+KP NIL+ + G +K++DFGL+ YQ L+
Sbjct: 117 VHKLGFIHRDIKPDNILI----DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172
Query: 194 FLSENGVVV-TIW----------------------------YRAPELLLGAKHYTSAVDM 224
+ N V V +I Y APE+ L + Y D
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDW 231
Query: 225 WAVGCIFAELLTLKPLFQGAEAKST 249
W++G I E L P F + T
Sbjct: 232 WSLGAIMFECLIGWPPFCSENSHET 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 14/38 (36%), Positives = 20/38 (52%), Gaps = 5/38 (13%)
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187
LH I+H DL SNI+V + + + DFGL +
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDDK-----LYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 57/245 (23%), Positives = 95/245 (38%), Gaps = 54/245 (22%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN---- 89
IG G +G V L + K + G A+K +++ D + + I R+I E
Sbjct: 9 IGRGAFGEVRLVQKK---DTGHIYAMKILRKA---DMLEKEQVAHIRAERDILVEADGAW 62
Query: 90 VVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNY 149
VVK+ + ++ L + F D+ ++ Y +++L ++
Sbjct: 63 VVKMFYSFQDKRNLYLIMEF-LPGGDMMTLLMKKDTLSEEATQFYIAETVL-----AIDA 116
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR--------------IYQAPLKFL 195
+H IHRD+KP N+L+ + +G VK++DFGL + P F
Sbjct: 117 IHQLGFIHRDIKPDNLLL----DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 196 SEN-------------------GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
+N V T Y APE+ + Y D W++G I E+L
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLI 231
Query: 237 LKPLF 241
P F
Sbjct: 232 GYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.001
Identities = 14/38 (36%), Positives = 18/38 (47%), Gaps = 5/38 (13%)
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187
LH I+H DL SNI++ G + DFGL
Sbjct: 108 LHKAGIVHGDLTTSNIILSGGR-----IYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 20/36 (55%), Positives = 21/36 (58%), Gaps = 1/36 (2%)
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLF 241
Y APELLLG H AVD WA+G E LT P F
Sbjct: 546 YLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPF 580
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 38/166 (22%), Positives = 68/166 (40%), Gaps = 26/166 (15%)
Query: 34 IGEGTYGLVF--LARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVV 91
IG G +G V+ N I+ + T + E ++ I + +
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENE--------TIVMETLVYNNIYDIDKI 71
Query: 92 KL-VNVH-INHADMSLYLAFDYAEYD-------LYEIIRHHRDKVNHTMNPYT---VKSI 139
L N+H I+H + Y + L E + + ++ + +K+I
Sbjct: 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNI 131
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185
+ +L L Y+H + I H D+KP NI+V +G +G I D+G+A
Sbjct: 132 MKDMLTTLEYIHEHGISHGDIKPENIMV--DGNNRGY--IIDYGIA 173
|
Length = 294 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 40/202 (19%)
Query: 48 KAAANRGKAIAIK-KF--KQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104
K A+ +GK+I +F K+ D + + + I + + ++ H N+VKL+ + ++
Sbjct: 703 KGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD---MGKLQHPNIVKLIG--LCRSEKG 757
Query: 105 LYLAFDYAE-YDLYEIIR----HHRDKVNHTMNPYTVKSILWQLLNGLNYLH---SNWII 156
YL +Y E +L E++R R K I + L +LH S ++
Sbjct: 758 AYLIHEYIEGKNLSEVLRNLSWERRRK------------IAIGIAKALRFLHCRCSPAVV 805
Query: 157 HRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAK 216
+L P I++ G+ E + + P ++ ++ Y APE K
Sbjct: 806 VGNLSPEKIIIDGKDEPHLRLSL-----------PGLLCTDTKCFISSAYVAPETR-ETK 853
Query: 217 HYTSAVDMWAVGCIFAELLTLK 238
T D++ G I ELLT K
Sbjct: 854 DITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 46/207 (22%), Positives = 87/207 (42%), Gaps = 20/207 (9%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIR----EIMLLREITHEN 89
+G G +G + +K + R +AI + G S R E + L + H N
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLR-----AGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 90 VVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNY 149
+V+L V M + + + L +R H ++ + +L L +G+ Y
Sbjct: 68 IVRLEGVITRGNTMMIVTEY-MSNGALDSFLRKHEGQLVAGQ----LMGMLPGLASGMKY 122
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAP 209
L +H+ L +LV V KI+ F + ++ + + +G +W AP
Sbjct: 123 LSEMGYVHKGLAAHKVLV----NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW-AAP 177
Query: 210 ELLLGAKHYTSAVDMWAVGCIFAELLT 236
E + H++SA D+W+ G + E+++
Sbjct: 178 EAI-QYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 477 | |||
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.32 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.2 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.18 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.86 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.8 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.68 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.48 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.43 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.28 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.2 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.2 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.2 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.11 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.96 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.92 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.87 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.82 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.7 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.69 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.47 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.33 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.29 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.28 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.26 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.26 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.25 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.08 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.98 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.75 | |
| PLN02236 | 344 | choline kinase | 96.34 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.33 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.98 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.85 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.81 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.81 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.81 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.49 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.33 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.24 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 94.61 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.05 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.58 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.32 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.22 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.99 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.96 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.8 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 92.29 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 92.03 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-70 Score=500.74 Aligned_cols=420 Identities=57% Similarity=0.924 Sum_probs=337.8
Q ss_pred CCCCCCccccccceeEEeeecccCceEEEEEEEecc-cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEE
Q 011808 15 TSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAA-ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93 (477)
Q Consensus 15 ~~~~~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l 93 (477)
.+...+..+++..|++++.||+|+||.||+|..+.+ ......+|||+|+..+........+.+|+.++|.++||||+.|
T Consensus 13 ~~ser~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~L 92 (438)
T KOG0666|consen 13 LASERERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISL 92 (438)
T ss_pred hhhhhhhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhH
Confidence 334556668999999999999999999999954332 1224489999999998888899999999999999999999999
Q ss_pred EEEEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCC
Q 011808 94 VNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE 173 (477)
Q Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~ 173 (477)
..+|... +..++|++||.+.+|+.+|..++......++...++.|++||+.|+.|||++.|+||||||.|||+++++.+
T Consensus 93 v~Vfl~~-d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgpe 171 (438)
T KOG0666|consen 93 VKVFLSH-DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPE 171 (438)
T ss_pred HHHHhcc-CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCc
Confidence 9999887 678999999999999999999988777889999999999999999999999999999999999999999999
Q ss_pred cccEEEeecccceeecCCCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccC-CC
Q 011808 174 QGVVKIADFGLARIYQAPLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST-QN 251 (477)
Q Consensus 174 ~~~vkL~DFG~a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~-~~ 251 (477)
.|.|||+|||+++.+..+.... .....+.|.+|+|||++.|.++|+.++||||+|||+.||||..+.|.+.+.+.. .+
T Consensus 172 rG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~ 251 (438)
T KOG0666|consen 172 RGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKN 251 (438)
T ss_pred cCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCC
Confidence 9999999999999998876655 556778899999999999999999999999999999999999999999876655 45
Q ss_pred cccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCC--CCCchHHHHHHHhcccCCCCCCCH
Q 011808 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPL--SPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
||..+++.+|++++|.|+.+.|+++.++|+|+.....++.+.+...+++..+.. .-++.+++||.+||++||.+|+|+
T Consensus 252 Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta 331 (438)
T KOG0666|consen 252 PFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA 331 (438)
T ss_pred CchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH
Confidence 999999999999999999999999999999988877787777777777665533 234559999999999999999999
Q ss_pred HHHhcCccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCCCCCCCCCCccccccCCCCCCCCCc
Q 011808 330 AQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFEGTTTLQPPQPASGPVPGNMAGAHAVSNRNVPRPMPG 409 (477)
Q Consensus 330 ~e~L~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 409 (477)
+++|+|+||+.+++|. .+.+..++ +++....-+++ .....++...++....++.
T Consensus 332 ~qAleh~yF~~d~lpp-------~pt~~~vn-----------f~~~~~~~~~q--~~~~~~n~~~~~~~~s~~~------ 385 (438)
T KOG0666|consen 332 EQALEHPYFTEDPLPP-------LPTSDNVN-----------FEGTTPIIPPQ--AGQQQGNMAGAHGMGSRSM------ 385 (438)
T ss_pred HHHhcccccccCCCCC-------Ccccceee-----------cccccccCchH--HHHHhhhhhhhhccCCccC------
Confidence 9999999999776652 22222222 44444444443 1122233344443333332
Q ss_pred ccceec-ccccccccccCCccccCCCCCCCCCCcccCCCCChhhhhhhhhcCCCCCCCCCCCCcccCC
Q 011808 410 VGMQRM-QAQGMMTYNFPGQAGAAGGMNPANMPMQRGMPGQAHQQQQLRRKDPGMGLPGYPPQQKSRR 476 (477)
Q Consensus 410 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 476 (477)
-..||+ +.+++.++ .-+|.+|..-+.|.-.++|++||||++++++++ ||+||
T Consensus 386 ~n~q~~~~~~g~~a~-------a~~~l~~~~~~~q~~~~aq~~qq~~~~~~~~~~--------q~~rr 438 (438)
T KOG0666|consen 386 GNPQRMQQSQGMMAY-------AQGGLNPSRPLQQAAGMAQPPQQQQLRRKDPGM--------QKSRR 438 (438)
T ss_pred CChhhcccccCcccc-------cccccCCCCCcHHHhcccCCcccccccccCcch--------hhcCC
Confidence 223444 33444444 112555555455544455899999999999866 66664
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-58 Score=431.06 Aligned_cols=308 Identities=45% Similarity=0.800 Sum_probs=272.2
Q ss_pred CccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEc
Q 011808 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHIN 99 (477)
Q Consensus 20 ~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 99 (477)
..+.-+++|+.+.+|++|+||.||+|+++. +++.||+|+++.+...+..--..+|||.+|.+++|||||.+..+...
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~---t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKK---TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCC---cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 345668899999999999999999998774 78999999999988777777788999999999999999999999988
Q ss_pred CCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 100 HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 100 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
.+-..+|||||||+.+|..++.... .+++..+++.++.|++.||+|||+++|+|||||++|+|+ ...|.+||
T Consensus 147 ~~~d~iy~VMe~~EhDLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm----~~~G~lKi 218 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEHDLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL----SHKGILKI 218 (419)
T ss_pred cccceeeeeHHHHHhhHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee----ccCCcEEe
Confidence 7777899999999999999998764 579999999999999999999999999999999999999 77788999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+|+.+..+... .+..+.|.||+|||++.|.+.|+.++|+||+|||+.||+++++.|.|.. +.+|+.
T Consensus 219 aDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s--------E~dQl~ 288 (419)
T KOG0663|consen 219 ADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS--------EIDQLD 288 (419)
T ss_pred cccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc--------hHHHHH
Confidence 999999999887553 3457789999999999999999999999999999999999999999988 899999
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCC-CCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS-PKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+|+..+|.|+...|+.+..+|.|....+ .....+.++..++.. .++...||++.+|.+||.+|.||.++|.|.||
T Consensus 289 ~If~llGtPte~iwpg~~~lp~~k~~~f----~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F 364 (419)
T KOG0663|consen 289 KIFKLLGTPSEAIWPGYSELPAVKKMTF----SEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF 364 (419)
T ss_pred HHHHHhCCCccccCCCccccchhhcccc----CCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc
Confidence 9999999999999999999998874322 333445555666555 68899999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCC
Q 011808 339 RIEPLPGRNALVPS 352 (477)
Q Consensus 339 ~~~~~~~~~~~~~~ 352 (477)
...|.+-.+...|.
T Consensus 365 ~e~P~p~~P~~~Pt 378 (419)
T KOG0663|consen 365 RETPLPIDPSMFPT 378 (419)
T ss_pred ccCCCCCChhhcCC
Confidence 98777665444433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-59 Score=420.40 Aligned_cols=294 Identities=48% Similarity=0.881 Sum_probs=259.3
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
.+|..+++||+|.||.||+|++.. +|+.||||+++.....+.....++|||+.|+.++|+||+.++++|-. ...+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~--~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH--KSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC--CCce
Confidence 589999999999999999999764 79999999999988888888899999999999999999999999955 4478
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
.||+||++.+|...+++. ...++...++.|+.++++||+|||+++|+||||||.|+|+ +++|.+||+|||+|
T Consensus 77 ~lVfEfm~tdLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi----s~~g~lKiADFGLA 148 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI----SSDGQLKIADFGLA 148 (318)
T ss_pred EEEEEeccccHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE----cCCCcEEeecccch
Confidence 999999999999999875 3479999999999999999999999999999999999999 78889999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
+.+..+...... .+.|.||+|||.+.|.+.|+..+||||.|||+.||+.|.+.|.|.+ +.+|+..|+..+
T Consensus 149 r~f~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s--------DidQL~~If~~L 218 (318)
T KOG0659|consen 149 RFFGSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS--------DIDQLSKIFRAL 218 (318)
T ss_pred hccCCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc--------hHHHHHHHHHHc
Confidence 998876554333 3679999999999999999999999999999999999999999988 799999999999
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCCCCCC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPG 345 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~~~~~ 345 (477)
|.|+++.|+++..+|+|.... .+....+...++.. +.++.||+.+||.+||.+|+|+.|+|+|+||+..|.+.
T Consensus 219 GTP~~~~WP~~~~lpdY~~~~------~~P~~~~~~lf~aa-s~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 219 GTPTPDQWPEMTSLPDYVKIQ------QFPKPPLNNLFPAA-SSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred CCCCcccCccccccccHHHHh------cCCCCccccccccc-cHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 999999999999999987743 12233334445443 55679999999999999999999999999999766665
Q ss_pred CCCC
Q 011808 346 RNAL 349 (477)
Q Consensus 346 ~~~~ 349 (477)
.+..
T Consensus 292 ~~~~ 295 (318)
T KOG0659|consen 292 PPSK 295 (318)
T ss_pred Chhh
Confidence 4443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-58 Score=447.64 Aligned_cols=303 Identities=44% Similarity=0.733 Sum_probs=259.6
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..+.|+.+++||+|+||.||+|++.. +|+.||+|++..+...+.......+||.||++|+||||++|.++..+....
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~---tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLE---TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecc---cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 34679999999999999999998764 799999999999888888888899999999999999999999999887677
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+|||||||+.+|..++.... -.+++.+++.|+.||+.||+|||++||+|||||..|||| +.+|.+||+|||
T Consensus 192 siYlVFeYMdhDL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi----dn~G~LKiaDFG 263 (560)
T KOG0600|consen 192 SIYLVFEYMDHDLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI----DNNGVLKIADFG 263 (560)
T ss_pred eEEEEEecccchhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE----cCCCCEEecccc
Confidence 899999999999999987642 369999999999999999999999999999999999999 888999999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+|+++...... ..+..+.|.||+|||++.|...|+.++|+||+||||.||++|++.|.|.+ +.+|+.+|++
T Consensus 264 LAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t--------EveQl~kIfk 334 (560)
T KOG0600|consen 264 LARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT--------EVEQLHKIFK 334 (560)
T ss_pred ceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc--------HHHHHHHHHH
Confidence 99987654322 24556779999999999999999999999999999999999999999998 8999999999
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPL 343 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~~~ 343 (477)
.+|.|++..|+ ..++|.+........ |.. .+... -...+..+.+|+..||..||.+|.||.++|.|+||+..+.
T Consensus 335 lcGSP~e~~W~-~~kLP~~~~~kp~~~---y~r-~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~ 408 (560)
T KOG0600|consen 335 LCGSPTEDYWP-VSKLPHATIFKPQQP---YKR-RLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPL 408 (560)
T ss_pred HhCCCChhccc-cccCCcccccCCCCc---ccc-hHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCC
Confidence 99999999999 666774332211111 110 01111 2234678999999999999999999999999999988877
Q ss_pred CCCCCCCCC
Q 011808 344 PGRNALVPS 352 (477)
Q Consensus 344 ~~~~~~~~~ 352 (477)
+..+...|.
T Consensus 409 ~~~p~~Lp~ 417 (560)
T KOG0600|consen 409 PCDPSSLPK 417 (560)
T ss_pred CCCcccCCC
Confidence 776665555
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-57 Score=436.90 Aligned_cols=292 Identities=39% Similarity=0.738 Sum_probs=251.6
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEc
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHIN 99 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 99 (477)
...+.++|.++++||.|+||.||+|+.+. ++..||||.+++....- ....-+||++.|++|+ |||||+|.+++.+
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~---~~~~VAIK~MK~Kf~s~-ee~~nLREvksL~kln~hpniikL~Evi~d 80 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKE---TGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNPHPNIIKLKEVIRD 80 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecC---CCceeeHHHHHhhhccH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence 45578999999999999999999998664 68899999998765542 2234468999999998 9999999999988
Q ss_pred CCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 100 HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 100 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
++. .+|+|||||+++|+++++.. +..+++..++.|++||++||+|+|.+|++|||+||||||+ ..+..|||
T Consensus 81 ~~~-~L~fVfE~Md~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi----~~~~~iKi 151 (538)
T KOG0661|consen 81 NDR-ILYFVFEFMDCNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI----SGNDVIKI 151 (538)
T ss_pred cCc-eEeeeHHhhhhhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe----cccceeEe
Confidence 765 89999999999999999876 4579999999999999999999999999999999999999 44667999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+|+.+.....+ +.++-|.||+|||++.....|+.++||||+|||++|+.+.++.|.|.+ +.|++.
T Consensus 152 aDFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s--------E~Dqi~ 220 (538)
T KOG0661|consen 152 ADFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS--------EIDQIY 220 (538)
T ss_pred cccccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc--------HHHHHH
Confidence 999999987764443 346669999999999988899999999999999999999999999998 899999
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+|..++|.|....|++..++ +....++........+..++|. .+.++.+||.+||.+||.+||||.|+|+||||+
T Consensus 221 KIc~VLGtP~~~~~~eg~~L----a~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq 295 (538)
T KOG0661|consen 221 KICEVLGTPDKDSWPEGYNL----ASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQ 295 (538)
T ss_pred HHHHHhCCCccccchhHHHH----HHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence 99999999999998874322 1223344444455566667777 889999999999999999999999999999998
Q ss_pred CC
Q 011808 340 IE 341 (477)
Q Consensus 340 ~~ 341 (477)
..
T Consensus 296 ~~ 297 (538)
T KOG0661|consen 296 VG 297 (538)
T ss_pred cc
Confidence 53
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-57 Score=413.56 Aligned_cols=284 Identities=40% Similarity=0.701 Sum_probs=239.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|+.+.++|+|+||+||+|+++. +|+.||||+|..+.+.....+.++|||++|++|+|+|+|.|+++|.. ...
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~---TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krk 75 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKD---TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRK 75 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCC---cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cce
Confidence 4689999999999999999999875 79999999999888777777888999999999999999999999955 458
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
++||||||+.++++.|+... ..+++..++.+++|++.|+.|+|++++|||||||+|||+ +.++.+||||||+
T Consensus 76 lhLVFE~~dhTvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi----t~~gvvKLCDFGF 147 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI----TQNGVVKLCDFGF 147 (396)
T ss_pred eEEEeeecchHHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE----ecCCcEEeccchh
Confidence 99999999999999888764 468999999999999999999999999999999999999 7888999999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
|+.+..+.. ..+.++.|.||+|||.+.|...|+..+||||+||++.||++|.+.|.|.+ +.+++..|...
T Consensus 148 AR~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S--------DiDQLy~I~kt 217 (396)
T KOG0593|consen 148 ARTLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS--------DIDQLYLIRKT 217 (396)
T ss_pred hHhhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc--------hHHHHHHHHHH
Confidence 998875433 33457779999999999998889999999999999999999999999988 78999999999
Q ss_pred hCCCCCCCccccCCCccccccccccccccccC----CCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYET----NGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+|.-.|+...-+.. ...+.+..... ..++..+|. .+..+.||+++||+.||++|++.+|+|.|+||.
T Consensus 218 LG~L~prhq~iF~~-------N~~F~Gv~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 218 LGNLIPRHQSIFSS-------NPFFHGVRLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred HcccCHHHHHHhcc-------CCceeeeecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 99877653221111 11122222211 122223332 345788999999999999999999999999994
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-56 Score=425.53 Aligned_cols=270 Identities=32% Similarity=0.477 Sum_probs=216.1
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCC-----cHHHHHHHHHHHhcCCCCeeEEEEE
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV-----SPTAIREIMLLREITHENVVKLVNV 96 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~~Ei~il~~l~hpnIv~l~~~ 96 (477)
..+.+.|.+.+.||+|+||.|-+|..+. +|+.||||++++....... .....+|++||++|+|||||+++++
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~---tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKK---TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcc---cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence 4478889999999999999999998764 7999999999876544311 2234689999999999999999999
Q ss_pred EEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 97 HINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 97 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
|...+ ..||||||++ |+|++.+..+ +.+.+...+.+++||+.||.|||++||+||||||+|||+..+ .++-
T Consensus 245 f~~~d--s~YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~-~e~~ 316 (475)
T KOG0615|consen 245 FEVPD--SSYMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSND-AEDC 316 (475)
T ss_pred eecCC--ceEEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccC-Ccce
Confidence 97755 6799999998 6999998874 478999999999999999999999999999999999999654 4567
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAK--HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
.+||+|||+|+...... ...+.||||.|.|||++.+.. .+..++|||||||+||-+|+|.+||.+.... +-
T Consensus 317 llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~----~s 389 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD----PS 389 (475)
T ss_pred EEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC----cc
Confidence 89999999999876322 345689999999999997643 3556899999999999999999999865421 10
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
..+| |.+---..-+. ....++++++|||.+||..||++|+|++|+|
T Consensus 390 l~eQ---I~~G~y~f~p~-------------------------------~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 390 LKEQ---ILKGRYAFGPL-------------------------------QWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred HHHH---HhcCcccccCh-------------------------------hhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 1111 11110001111 2233468899999999999999999999999
Q ss_pred cCccCCCCCC
Q 011808 334 EHEYFRIEPL 343 (477)
Q Consensus 334 ~h~~f~~~~~ 343 (477)
+||||+..+.
T Consensus 436 ~hpW~~~~~~ 445 (475)
T KOG0615|consen 436 NHPWFKDAPC 445 (475)
T ss_pred cChhhhcccc
Confidence 9999986543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=427.16 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=219.2
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.+|+..+.||+|||+.||.+++.. +|..||+|++.+... ......++.+||+|++.|+|||||+++++|++.. +
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~--n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN--N 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC--c
Confidence 559999999999999999998754 799999999976433 3445678889999999999999999999998765 8
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|||+|+|. ++|.++++. .+.++|.+++.+++||+.||.|||+++|+|||||..|+|| +++.+|||+|||
T Consensus 93 VYivLELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL----~~~~~VKIgDFG 163 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL----NENMNVKIGDFG 163 (592)
T ss_pred eEEEEEecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee----cCcCcEEecccc
Confidence 999999999 677777764 3489999999999999999999999999999999999999 888899999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+|..+..+. ....+.||||.|+||||+... .++..+||||+|||+|.||+|+|||...+ +..++.
T Consensus 164 LAt~le~~~--Erk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~------------vkety~ 228 (592)
T KOG0575|consen 164 LATQLEYDG--ERKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKT------------VKETYN 228 (592)
T ss_pred eeeeecCcc--cccceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccch------------HHHHHH
Confidence 999887542 245568999999999999864 48999999999999999999999997655 333333
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEP 342 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~~ 342 (477)
.+... +..+|...+.+++|||.+||+.||.+|||++++|.|+||+..-
T Consensus 229 ~Ik~~-------------------------------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 229 KIKLN-------------------------------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred HHHhc-------------------------------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 33111 1336677889999999999999999999999999999996443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=397.97 Aligned_cols=294 Identities=44% Similarity=0.814 Sum_probs=251.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCC-eeEEEEEEEcCC--
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN-VVKLVNVHINHA-- 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~-- 101 (477)
+..|+.+++||+|+||+||+|+.+. +|+.||+|+++.....+..-...++|+.+|+.++|+| |+.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~---~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKR---TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEec---CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 7789999999999999999999875 6899999999987765556668899999999999999 999999987654
Q ss_pred --CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 102 --DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 102 --~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
...+++||||++.+|..++....... ..++...++.+++||+.||+|||+++|+||||||.|||| ++.|.+||
T Consensus 87 ~~~~~l~lvfe~~d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi----~~~G~lKl 161 (323)
T KOG0594|consen 87 RGIGKLYLVFEFLDRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI----SSSGVLKL 161 (323)
T ss_pred cccceEEEEEEeecccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE----CCCCcEee
Confidence 24799999999999999998865321 457778999999999999999999999999999999999 77889999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+|+.+.-+... ....++|.+|+|||++.|...|+..+||||+|||++||+++++.|.+.. +.+++.
T Consensus 162 aDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s--------e~~ql~ 231 (323)
T KOG0594|consen 162 ADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS--------EIDQLF 231 (323)
T ss_pred eccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc--------HHHHHH
Confidence 999999976644332 3446789999999999999889999999999999999999999999988 589999
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.|+..+|.|..+.|+....+|+|......... ...+....+. .+..+.|++.+||++||.+|.|++.+|.|+||.
T Consensus 232 ~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~----~~~l~~~~~~-~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~ 306 (323)
T KOG0594|consen 232 RIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPG----PKDLSSILPK-LDPDGIELLSKLLQYDPAKRISAKGALTHPYFS 306 (323)
T ss_pred HHHHHcCCCCccCCCCccccccccccCcCCCC----ccchHHhccc-cCccHHHHHHHHhccCcccCcCHHHHhcChhhc
Confidence 99999999999999999999999873222211 1112222222 236789999999999999999999999999997
Q ss_pred CC
Q 011808 340 IE 341 (477)
Q Consensus 340 ~~ 341 (477)
..
T Consensus 307 ~~ 308 (323)
T KOG0594|consen 307 EL 308 (323)
T ss_pred cc
Confidence 54
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-53 Score=401.23 Aligned_cols=261 Identities=28% Similarity=0.462 Sum_probs=220.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++.+.++.||+|..|+||+|+|+. +++.+|+|++.. .......+++++|+++++.++|||||.+|++|+++.+ .
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~---t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~ 152 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKP---TGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-E 152 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcC---CCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-e
Confidence 4578889999999999999999885 799999999944 3344566788999999999999999999999998765 6
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
++|+||||+ |+|..++... +.++|..+..++.+|++||.|||+ ++||||||||+|||+ +..|.||||||
T Consensus 153 isI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv----NskGeVKicDF 223 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV----NSKGEVKICDF 223 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee----ccCCCEEeccc
Confidence 999999999 5776666543 479999999999999999999995 899999999999999 78889999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|.+..+... ..++++||..|||||.+.+. .|+.++||||||++++||++|+.||..... -..+.++.+.
T Consensus 224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~------~~~~~~~Ll~ 292 (364)
T KOG0581|consen 224 GVSGILVNS----IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNP------PYLDIFELLC 292 (364)
T ss_pred cccHHhhhh----hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCC------CCCCHHHHHH
Confidence 999987654 35678999999999999985 499999999999999999999999976521 1234445555
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCC-CCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS-PKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
.++..++|. .|.. .|+++++||..||++||.+|+|+.|+|+|||++..
T Consensus 293 ~Iv~~ppP~-------------------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 293 AIVDEPPPR-------------------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHhcCCCCC-------------------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 555555544 2222 57899999999999999999999999999999743
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-53 Score=400.48 Aligned_cols=297 Identities=39% Similarity=0.637 Sum_probs=247.1
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEc---C
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHIN---H 100 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---~ 100 (477)
.-.+|..++.||+|+||.|+.|.++. ++..||||++.......-..++.++|+++|+.++|+||+.+++++.. .
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~---t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKR---TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcC---CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 34667778999999999999998775 67999999998777777777889999999999999999999999875 2
Q ss_pred CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 101 ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 101 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.-.-+|+|+|+++.+|...++.. ..+++..+..+++||+.||.|+|+.+|+||||||.|+|+ +.+..+||+
T Consensus 97 ~f~DvYiV~elMetDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~----n~~c~lKI~ 167 (359)
T KOG0660|consen 97 KFNDVYLVFELMETDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL----NADCDLKIC 167 (359)
T ss_pred ccceeEEehhHHhhHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhcccccccccchhheee----ccCCCEEec
Confidence 33458999999999999999874 359999999999999999999999999999999999999 677779999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||+|+...........+.++.|.||+|||++.....|+.++||||+|||+.|||+|++.|.|.+ ..+|+..
T Consensus 168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d--------~v~Ql~l 239 (359)
T KOG0660|consen 168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD--------YVHQLQL 239 (359)
T ss_pred cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc--------hHHHHHH
Confidence 99999988653222233567889999999999888889999999999999999999999999998 7899999
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccc-cccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQ-GRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
|...+|.|.++.+..+.+-. ...+++ ........+...+| ..++.+.|||++||..||.+|+|++|+|+||||.
T Consensus 240 I~~~lGtP~~e~l~~i~s~~----ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~ 314 (359)
T KOG0660|consen 240 ILELLGTPSEEDLQKIRSEK----ARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLA 314 (359)
T ss_pred HHHhcCCCCHHHHHHhccHH----HHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhh
Confidence 99999999887665544211 011122 11222334444555 6788999999999999999999999999999997
Q ss_pred CCCCCC
Q 011808 340 IEPLPG 345 (477)
Q Consensus 340 ~~~~~~ 345 (477)
.-..+.
T Consensus 315 ~~hdp~ 320 (359)
T KOG0660|consen 315 PYHDPE 320 (359)
T ss_pred hhcCCc
Confidence 544433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-52 Score=397.64 Aligned_cols=269 Identities=31% Similarity=0.556 Sum_probs=224.8
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
...+.+|.+.++||+|+|++||+|+++. ++..||||.+.+.....+..+.+..||.+|+.++|||||.+++++.+.+
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~---~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKK---SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD 82 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEecc---CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence 3457899999999999999999999886 5799999999887766666777889999999999999999999997755
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc--ccEE
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ--GVVK 178 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~--~~vk 178 (477)
++|||||||. |+|.++|+.+. .++|..++.++.||+.||++||+++||||||||.||||+.....+ ..+|
T Consensus 83 --~i~lVMEyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 83 --FIYLVMEYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred --eEEEEEEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEE
Confidence 8999999999 79999998854 799999999999999999999999999999999999997652222 6899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+|+.+.... .....||+|.|||||++.. ..|+.|+|+||+|+++|+|++|++||...+..
T Consensus 156 IADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~----------- 220 (429)
T KOG0595|consen 156 IADFGFARFLQPGS---MAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPK----------- 220 (429)
T ss_pred ecccchhhhCCchh---HHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHH-----------
Confidence 99999999887533 3345889999999999976 45999999999999999999999999866532
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+++..+.. .+.+....+...+.++.+|+..+|..|+..|.+..+.+.|+++
T Consensus 221 -eL~~~~~k----------------------------~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l 271 (429)
T KOG0595|consen 221 -ELLLYIKK----------------------------GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFL 271 (429)
T ss_pred -HHHHHHhc----------------------------cccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhc
Confidence 11111110 0112223445556788899999999999999999999999999
Q ss_pred CCCCCC
Q 011808 339 RIEPLP 344 (477)
Q Consensus 339 ~~~~~~ 344 (477)
...+..
T Consensus 272 ~~~p~~ 277 (429)
T KOG0595|consen 272 AANPQD 277 (429)
T ss_pred ccCccc
Confidence 866543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-52 Score=393.06 Aligned_cols=258 Identities=33% Similarity=0.518 Sum_probs=216.5
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC-CcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG-VSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
.-.++|+++++||+|+||+||.++.+ .+++.+|+|++++...-+. .......|..||..++||.||+++..|.+.+
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~---dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKK---DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEc---ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 34789999999999999999999977 4799999999987765433 4567778999999999999999999997755
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.+|+|+||+. |.|+..|.+. +.++|..++.++..|+.||.|||++|||||||||+|||| +++|+++|+
T Consensus 99 --kLylVld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL----d~~GHi~Lt 167 (357)
T KOG0598|consen 99 --KLYLVLDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL----DEQGHIKLT 167 (357)
T ss_pred --eEEEEEeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee----cCCCcEEEe
Confidence 7999999998 5999988864 479999999999999999999999999999999999999 899999999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||+++..-.... ...+.|||+.|||||++.+. .|+.++|+|||||++||||+|.+||.+.+. .+
T Consensus 168 DFgL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~------------~~ 232 (357)
T KOG0598|consen 168 DFGLCKEDLKDGD--ATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDV------------KK 232 (357)
T ss_pred ccccchhcccCCC--ccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccH------------HH
Confidence 9999985443222 23458999999999999985 599999999999999999999999987762 22
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC----CHHHHhcCc
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI----TAAQALEHE 336 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp----t~~e~L~h~ 336 (477)
+.+.+..... ...|...+.+++|||+++|.+||++|. ++.++-+||
T Consensus 233 ~~~~I~~~k~------------------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hp 282 (357)
T KOG0598|consen 233 MYDKILKGKL------------------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHP 282 (357)
T ss_pred HHHHHhcCcC------------------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCc
Confidence 2222211110 012333568899999999999999996 699999999
Q ss_pred cCC
Q 011808 337 YFR 339 (477)
Q Consensus 337 ~f~ 339 (477)
||.
T Consensus 283 fF~ 285 (357)
T KOG0598|consen 283 FFK 285 (357)
T ss_pred ccc
Confidence 997
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-52 Score=392.23 Aligned_cols=287 Identities=37% Similarity=0.655 Sum_probs=238.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC--
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD-- 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 102 (477)
.=.|.-.+++|+|+||.||.|.... ++..||||+...+.... -+|+++|+.++|||||++..+|....+
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e---~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d 93 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRE---TEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESD 93 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcC---CCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence 3468999999999999999998775 48899999987765432 279999999999999999999875443
Q ss_pred -ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 -MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.++.+||||+..+|.+.++... ..+..++...++-+.+||+.||.|||+.||+||||||.|||+. .+.+.+||||
T Consensus 94 ~~~lnlVleymP~tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD---~~tg~LKicD 169 (364)
T KOG0658|consen 94 EVYLNLVLEYMPETLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD---PDTGVLKICD 169 (364)
T ss_pred hhHHHHHHHhchHHHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc---CCCCeEEecc
Confidence 4788999999999999998642 2355789999999999999999999999999999999999993 5678999999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||.|+.+...... ..+..|..|+|||.+.|...|+.++||||.||++.||+-|++.|.|.+ ..+|+..|
T Consensus 170 FGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s--------~~dQL~eI 238 (364)
T KOG0658|consen 170 FGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS--------SVDQLVEI 238 (364)
T ss_pred CCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC--------HHHHHHHH
Confidence 9999988765433 346669999999999999999999999999999999999999999977 78999999
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
++++|.|+.+....+.. .+. ....-......+..++....++++.||+.++|.++|.+|.++.|+|.||||...
T Consensus 239 ik~lG~Pt~e~I~~mn~--~y~----~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 239 IKVLGTPTREDIKSMNP--NYT----EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred HHHhCCCCHHHHhhcCc--ccc----cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 99999999876554331 111 111112222333345667778899999999999999999999999999999754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=397.94 Aligned_cols=258 Identities=35% Similarity=0.512 Sum_probs=219.2
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
-..+|.+.+.||+|+|++|++|+.+. +++.||||++.+...- +.-..-+.+|-.+|.+| .||.|++|+..|.|.
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~---t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~- 146 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKA---TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE- 146 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecC---CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc-
Confidence 36789999999999999999998775 7999999999765432 22233455688899999 899999999999765
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+|+||+. |+|+++|.+. +.+++..++.++.+|+.||+|||++|||||||||+|||| +.++++||+
T Consensus 147 -~sLYFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL----d~dmhikIT 216 (604)
T KOG0592|consen 147 -ESLYFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL----DKDGHIKIT 216 (604)
T ss_pred -cceEEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE----cCCCcEEEe
Confidence 48999999998 8999999885 379999999999999999999999999999999999999 889999999
Q ss_pred ecccceeecCCCCc---------ccC--CCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccC
Q 011808 181 DFGLARIYQAPLKF---------LSE--NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST 249 (477)
Q Consensus 181 DFG~a~~~~~~~~~---------~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~ 249 (477)
|||.|+.+...... ... ..++||..|.+||+|.. ...+..+|||+||||||.|+.|.+||.+.+
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~N---- 291 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAAN---- 291 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCcccc----
Confidence 99999987543221 111 45899999999999987 458999999999999999999999999887
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
+...+.+|+++- ..+|...++.+.|||+++|..||.+|+|+
T Consensus 292 ----eyliFqkI~~l~-----------------------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~ 332 (604)
T KOG0592|consen 292 ----EYLIFQKIQALD-----------------------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTS 332 (604)
T ss_pred ----HHHHHHHHHHhc-----------------------------------ccCCCCCCHHHHHHHHHHHccCccccccH
Confidence 455566665542 22455556889999999999999999999
Q ss_pred HHHhcCccCC
Q 011808 330 AQALEHEYFR 339 (477)
Q Consensus 330 ~e~L~h~~f~ 339 (477)
.+|.+||||.
T Consensus 333 ~qIk~HpFF~ 342 (604)
T KOG0592|consen 333 QQIKAHPFFE 342 (604)
T ss_pred HHHhhCcccc
Confidence 9999999996
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=406.49 Aligned_cols=292 Identities=33% Similarity=0.560 Sum_probs=232.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-C-----CCeeEEEEEEE
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-H-----ENVVKLVNVHI 98 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~~~ 98 (477)
-.+|++++.||+|+||.|.+|++.. +++.||||+++.... ...+...|+.+|..|+ | -|||+++++|.
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~---T~e~VAIKIiKN~k~---f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHK---TGEIVAIKIIKNKKR---FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecC---CCcEEEEEeeccChH---HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 3489999999999999999998764 799999999987543 3456778999999996 3 49999999997
Q ss_pred cCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 99 NHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 99 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
... ++|||+|.++.+|+++++.+. ...++...++.++.||+.||.+||+.||||||||||||||..- ....||
T Consensus 259 fr~--HlciVfELL~~NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~--~r~~vK 331 (586)
T KOG0667|consen 259 FRN--HLCIVFELLSTNLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP--KRSRIK 331 (586)
T ss_pred ccc--ceeeeehhhhhhHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC--CcCcee
Confidence 654 899999999999999999876 3469999999999999999999999999999999999999653 334799
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||.|+..... ...++.+.+|+|||+|.|.. |+.++||||||||++||++|.+.|.|.+ +.+|+
T Consensus 332 VIDFGSSc~~~q~-----vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~n--------e~DQl 397 (586)
T KOG0667|consen 332 VIDFGSSCFESQR-----VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDN--------EYDQL 397 (586)
T ss_pred EEecccccccCCc-----ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCC--------HHHHH
Confidence 9999999876542 22567799999999999965 9999999999999999999999999998 78999
Q ss_pred HHHHHHhCCCCCCCccccCCCccc----------cccccccccc--------------cc----cCCCCccccCCCCCch
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHW----------QSDSLHIQGR--------------KY----ETNGLHSVVPLSPKSP 310 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~--------------~~----~~~~~~~~~p~~~s~~ 310 (477)
..|++++|.|++..+....+.-.+ .......... .+ ....+....+......
T Consensus 398 ~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~ 477 (586)
T KOG0667|consen 398 ARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKL 477 (586)
T ss_pred HHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHH
Confidence 999999998887544432221111 1111100000 00 1112222233334456
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccCCCCCC
Q 011808 311 AYDLLSKMLEYDPRKRITAAQALEHEYFRIEPL 343 (477)
Q Consensus 311 ~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~~~ 343 (477)
+.|||++||++||.+|+|+.++|+||||+....
T Consensus 478 F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 478 FIDFLKRCLEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred HHHHHHHHhccCchhcCCHHHHhcCcccccccc
Confidence 889999999999999999999999999985433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=395.99 Aligned_cols=260 Identities=30% Similarity=0.503 Sum_probs=215.8
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC---CCCcHHHHHHHHHHHhcC-CCCeeEEEEEE
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG---DGVSPTAIREIMLLREIT-HENVVKLVNVH 97 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~ 97 (477)
....++|++.+.||+|+||+|++|++.. ++..||||++...... ......+.+|+.+++.++ ||||+++++++
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~---t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRL---TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF 89 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeecc---CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence 4568899999999999999999998775 5799999987765222 234556668999999998 99999999999
Q ss_pred EcCCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc-c
Q 011808 98 INHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ-G 175 (477)
Q Consensus 98 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~-~ 175 (477)
.... .+|+||||+.| +|++++... +++.|.+++.+|+||++|++|||++||+||||||+|||+ +.+ +
T Consensus 90 ~t~~--~~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill----d~~~~ 158 (370)
T KOG0583|consen 90 ATPT--KIYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL----DGNEG 158 (370)
T ss_pred ecCC--eEEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe----cCCCC
Confidence 8766 49999999995 999999873 379999999999999999999999999999999999999 666 8
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCccc
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAK-HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~ 254 (477)
++||+|||++..... ........|||+.|+|||++.+.. +-+.++|||||||+||.|++|+.||...+
T Consensus 159 ~~Kl~DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------- 227 (370)
T KOG0583|consen 159 NLKLSDFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------- 227 (370)
T ss_pred CEEEeccccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc---------
Confidence 899999999997741 122345688999999999999866 44689999999999999999999998643
Q ss_pred HHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCC-CchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSP-KSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~-s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
...++..+... ...+|... +.++.+||++||..||.+|+|+.+++
T Consensus 228 ---~~~l~~ki~~~-------------------------------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 228 ---VPNLYRKIRKG-------------------------------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---HHHHHHHHhcC-------------------------------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 12222222111 12244445 78899999999999999999999999
Q ss_pred cCccCCC
Q 011808 334 EHEYFRI 340 (477)
Q Consensus 334 ~h~~f~~ 340 (477)
.|+||+.
T Consensus 274 ~h~w~~~ 280 (370)
T KOG0583|consen 274 EHPWFQK 280 (370)
T ss_pred hChhhcc
Confidence 9999986
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-51 Score=366.36 Aligned_cols=265 Identities=31% Similarity=0.433 Sum_probs=221.9
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
...|-++|++.++||+|.|+.|+++.++. +|+.+|+|++..........+++.+|+.|.+.|+||||++|.+.+.
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~---tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-- 80 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-- 80 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHHHhcc---chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc--
Confidence 35677899999999999999999997664 7999999999877776667788999999999999999999999874
Q ss_pred CCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
++.+.|||||++.| +|..-|-.. .-++|..+-.+++||++||.|+|.+||||||+||+|+|+-.. +...-+||
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK-~~~A~vKL 154 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASK-AKGAAVKL 154 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeec-cCCCceee
Confidence 45589999999985 666555443 247899999999999999999999999999999999999654 33456999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+|..+.. .....+.+|||.|||||++... .|+..+|||+.||+||-||.|.+||.+.+ ..+.++
T Consensus 155 ~~FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~--------~~rlye 222 (355)
T KOG0033|consen 155 ADFGLAIEVND---GEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYE 222 (355)
T ss_pred cccceEEEeCC---ccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCcc--------HHHHHH
Confidence 99999998773 2245678899999999999875 49999999999999999999999999865 444555
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.|.+---.-+++.|+. +++++++||++||..||.+|+|+.|+|+|||..
T Consensus 223 ~I~~g~yd~~~~~w~~-------------------------------is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 223 QIKAGAYDYPSPEWDT-------------------------------VTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred HHhccccCCCCcccCc-------------------------------CCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 5554443344444443 357899999999999999999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=387.92 Aligned_cols=262 Identities=29% Similarity=0.455 Sum_probs=214.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+++|+++++||+|+||.||+|+.+. +|..+|+|++++...- ...+..+..|-.+|...+++.||+|+..|.+.+
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~---Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~-- 214 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKD---TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE-- 214 (550)
T ss_pred cccchhheeeccccceeEEEEEEcc---CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC--
Confidence 6899999999999999999998764 7999999999887643 344556777999999999999999999997754
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
++||||||+. |++..+|.. .+.|++..++.++.+++.|++.||..|+|||||||+|+|| +..|++||+||
T Consensus 215 ~LYLiMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi----D~~GHiKLSDF 285 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI----DAKGHIKLSDF 285 (550)
T ss_pred eeEEEEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee----cCCCCEeeccc
Confidence 8999999998 577777776 3489999999999999999999999999999999999999 89999999999
Q ss_pred ccceeecCC---------------------CCcc-----c-------------------CCCeeeccccccchhhcCCCC
Q 011808 183 GLARIYQAP---------------------LKFL-----S-------------------ENGVVVTIWYRAPELLLGAKH 217 (477)
Q Consensus 183 G~a~~~~~~---------------------~~~~-----~-------------------~~~~~gt~~y~APE~l~~~~~ 217 (477)
|++.-+... .... . ....+|||.||||||+.+..
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg- 364 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG- 364 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-
Confidence 998533210 0000 0 12578999999999999955
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCC
Q 011808 218 YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETN 297 (477)
Q Consensus 218 ~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (477)
|+..+|+||||||+||||.|.+||.+.+.. +...+|...- .
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~--------~T~rkI~nwr-------------------------------~ 405 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQ--------ETYRKIVNWR-------------------------------E 405 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHh-------------------------------h
Confidence 999999999999999999999999987743 2333333321 0
Q ss_pred CCccccCCCCCchHHHHHHHhcccCCCCCCC---HHHHhcCccCCCC
Q 011808 298 GLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT---AAQALEHEYFRIE 341 (477)
Q Consensus 298 ~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt---~~e~L~h~~f~~~ 341 (477)
.+........+++++|||.+||. ||++|.. +.||..||||+.-
T Consensus 406 ~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 406 TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 11111223346889999999999 9999985 9999999999843
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-51 Score=373.21 Aligned_cols=253 Identities=28% Similarity=0.487 Sum_probs=211.8
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
-+.+|+++++||+|+||.||++++.. ++..+|.|.+..........+..+.|+.+|++|+|||||+++++-+.++..
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~---~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLL---DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeecc---CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 37889999999999999999998764 699999999987666666677888999999999999999999965566666
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh--CC--eecCCCCCCcEEEeccCCCcccEE
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS--NW--IIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~--~g--ivHrDikp~NILl~~~~~~~~~vk 178 (477)
.++||||||+ |+|...+...+ +....++|..+|.++.|++.||.++|+ .. |+||||||.||+| +.+|.||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl----~~~gvvK 168 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL----TANGVVK 168 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE----cCCCcee
Confidence 7999999999 78888887755 446689999999999999999999999 45 9999999999999 7888999
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+++.+..... .....+|||.||+||++.+.+ |+.++|||||||++|||+..++||.+.+ +
T Consensus 169 LGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n------------~ 233 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDN------------L 233 (375)
T ss_pred eccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCccccc------------H
Confidence 999999998876543 345689999999999998855 9999999999999999999999998764 2
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccC-CCCCchHHHHHHHhcccCCCCCCCH
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p-~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
..+.+.|....- ...| ...|..+..||..|+..||+.||+.
T Consensus 234 ~~L~~KI~qgd~------------------------------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 234 LSLCKKIEQGDY------------------------------PPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHHcCCC------------------------------CCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 223333322110 0012 3346789999999999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=363.56 Aligned_cols=254 Identities=30% Similarity=0.465 Sum_probs=216.4
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
--+++|++++.||.|+||.|.+++++. ++..+|+|++++...- -+..+...+|..+|+.+.||+++++++.|.+..
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~---~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKH---SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS 117 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEcc---CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence 457899999999999999999999875 6899999999765422 223445668999999999999999999887654
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
++||||||++ |.|+.++++. +++++..++.++.||+.||+|||+++|++|||||||||| +.+|.+||+
T Consensus 118 --~lymvmeyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl----D~~G~iKit 186 (355)
T KOG0616|consen 118 --NLYMVMEYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL----DQNGHIKIT 186 (355)
T ss_pred --eEEEEEeccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee----ccCCcEEEE
Confidence 8999999998 6999999874 479999999999999999999999999999999999999 899999999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||+|+.+... ..+.||||.|+|||++.. +.|+.++|+|||||++|||+.|.+||...+. ....++
T Consensus 187 DFGFAK~v~~r-----T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~K 252 (355)
T KOG0616|consen 187 DFGFAKRVSGR-----TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEK 252 (355)
T ss_pred eccceEEecCc-----EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHH
Confidence 99999987642 345789999999999987 5599999999999999999999999987662 223333
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h 335 (477)
|... ...+|...++.++|||+++|+.|-.+|. ...++..|
T Consensus 253 I~~~-----------------------------------~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H 297 (355)
T KOG0616|consen 253 ILEG-----------------------------------KVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNH 297 (355)
T ss_pred HHhC-----------------------------------cccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccC
Confidence 3221 1235666788999999999999999995 57899999
Q ss_pred ccCC
Q 011808 336 EYFR 339 (477)
Q Consensus 336 ~~f~ 339 (477)
|||+
T Consensus 298 ~wF~ 301 (355)
T KOG0616|consen 298 PWFK 301 (355)
T ss_pred cccc
Confidence 9997
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=376.91 Aligned_cols=285 Identities=40% Similarity=0.726 Sum_probs=228.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|+++++||+|+||.||+|+++. ++..||+|+++..... .....+.+|+.+++.++||||+++++++.+. ..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 77 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RC 77 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECC---CCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--Ce
Confidence 6789999999999999999998764 6889999998754322 2334677899999999999999999998654 47
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+|+||||+.++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 78 ~~lv~e~~~~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~----~~~~~~kl~DfG~ 149 (288)
T cd07871 78 LTLVFEYLDSDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI----NEKGELKLADFGL 149 (288)
T ss_pred EEEEEeCCCcCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----CCCCCEEECcCcc
Confidence 8999999999999888654 2357899999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
++....... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+ ..+.+..+...
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~ 219 (288)
T cd07871 150 ARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST--------VKEELHLIFRL 219 (288)
T ss_pred eeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHH
Confidence 976543221 22345679999999999876668999999999999999999999998765 45667788888
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
++.++.+.|+.+.....|...... .+...... ......+.+++|||++||++||.+|+|++|+|+||||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 220 LGTPTEETWPGITSNEEFRSYLFP----QYRAQPLI-NHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hCCCChHHhhccccchhhhccccC----ccCCCchH-HhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 898988888876554443321110 00001111 1123457789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=395.24 Aligned_cols=259 Identities=29% Similarity=0.462 Sum_probs=220.4
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccC-CCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS-KDGDGVSPTAIREIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
...++-|++.+.||+|+.|.|-+|++.. +|+.+|||++.+. .........+.+||-||+.|.||||+++++++++.
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~---TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~ 84 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAE---TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK 84 (786)
T ss_pred cccccceeccccccCCCCceehhhhccc---ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC
Confidence 4457889999999999999999998764 7999999999876 44444556778999999999999999999999765
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
. .+|+|.||+. |.|++++... +++++.++.++|+||+.|+.|||..+|+||||||+|+|| +..+++||
T Consensus 85 ~--~lylvlEyv~gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL----d~~~nIKI 153 (786)
T KOG0588|consen 85 Q--HLYLVLEYVPGGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL----DVKNNIKI 153 (786)
T ss_pred c--eEEEEEEecCCchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh----hcccCEee
Confidence 4 7999999988 7999998874 489999999999999999999999999999999999999 77777999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+|..-...... .+.||+|.|.|||++.|.++.+.++||||+|||||.||||++||++.+ +.
T Consensus 154 ADFGMAsLe~~gklL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------------ir 218 (786)
T KOG0588|consen 154 ADFGMASLEVPGKLL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------------IR 218 (786)
T ss_pred eccceeecccCCccc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------------HH
Confidence 999999865443322 346889999999999998888899999999999999999999998544 22
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+...+... .+..|..++.+++|||++||+.||++|+|.++++.|||+.
T Consensus 219 ~LLlKV~~G-------------------------------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 219 VLLLKVQRG-------------------------------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred HHHHHHHcC-------------------------------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 222222111 1235677789999999999999999999999999999987
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 268 g 268 (786)
T KOG0588|consen 268 G 268 (786)
T ss_pred c
Confidence 4
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=391.23 Aligned_cols=255 Identities=32% Similarity=0.559 Sum_probs=221.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|-+.+.||+|+||.||+|+.+. +.+.||||.+.+....+.....+.+|++|++.++||||+.++++|++.. .
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~---t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~--~ 75 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKY---TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA--H 75 (808)
T ss_pred CcchhHHHHhcCCccceeeeccccc---ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc--e
Confidence 4789999999999999999998765 6889999999988877777888999999999999999999999997754 7
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+|+|.||+.|+|..++.+. +.++|+.++.+..++++||.|||+++|+|||+||.|||+ +..+.+|+||||+
T Consensus 76 ~~vVte~a~g~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl----~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 76 LWVVTEYAVGDLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL----EKGGTLKLCDFGL 146 (808)
T ss_pred EEEEehhhhhhHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee----cCCCceeechhhh
Confidence 8999999999999999874 479999999999999999999999999999999999999 8888999999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
|+....... .....-|||.|||||++.+ ..|+..+|+||||||+|||++|++||.. ..+..+.+.
T Consensus 147 Ar~m~~~t~--vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a------------~si~~Lv~~ 211 (808)
T KOG0597|consen 147 ARAMSTNTS--VLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYA------------RSITQLVKS 211 (808)
T ss_pred hhhcccCce--eeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchH------------HHHHHHHHH
Confidence 998765332 2334678999999999986 5699999999999999999999999953 334445555
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
|.+.+.. .|...+..+.+||..+|.+||.+|+|..+++.|||.+
T Consensus 212 I~~d~v~-------------------------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k 255 (808)
T KOG0597|consen 212 ILKDPVK-------------------------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWK 255 (808)
T ss_pred HhcCCCC-------------------------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHh
Confidence 4333222 2334567899999999999999999999999999986
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-48 Score=371.85 Aligned_cols=279 Identities=27% Similarity=0.404 Sum_probs=223.4
Q ss_pred CCCCCccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEE
Q 011808 16 SNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVN 95 (477)
Q Consensus 16 ~~~~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 95 (477)
......+.-.+.|++..+||.|..++||+|+.+. .+..||||++..+..... ...+.+|++.|+.++||||++++.
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p---~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~ 91 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIP---TNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHC 91 (516)
T ss_pred cccccCCCCccceeEEEEEeccceeEeeeeeecc---cCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEE
Confidence 3344444447899999999999999999999775 579999999998877665 678889999999999999999999
Q ss_pred EEEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc
Q 011808 96 VHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ 174 (477)
Q Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~ 174 (477)
.|.... .+|+||.||. |++++++...- ...++|..+..|++++++||.|||.+|.||||||+.|||| +++
T Consensus 92 sFvv~~--~LWvVmpfMa~GS~ldIik~~~---~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi----~~d 162 (516)
T KOG0582|consen 92 SFVVDS--ELWVVMPFMAGGSLLDIIKTYY---PDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI----DSD 162 (516)
T ss_pred EEEecc--eeEEeehhhcCCcHHHHHHHHc---cccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE----cCC
Confidence 998754 8999999998 68899888754 5579999999999999999999999999999999999999 888
Q ss_pred ccEEEeecccceeecCCC-CcccC-CCeeeccccccchhhc-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCC
Q 011808 175 GVVKIADFGLARIYQAPL-KFLSE-NGVVVTIWYRAPELLL-GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251 (477)
Q Consensus 175 ~~vkL~DFG~a~~~~~~~-~~~~~-~~~~gt~~y~APE~l~-~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~ 251 (477)
|.|||+|||.+-.+.... ..... +..+||++|||||+++ ....|+.|+|||||||+..||.+|+.||....
T Consensus 163 G~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p------ 236 (516)
T KOG0582|consen 163 GTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP------ 236 (516)
T ss_pred CcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC------
Confidence 899999999886554322 11122 5568899999999954 44559999999999999999999999998543
Q ss_pred cccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHH
Q 011808 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ 331 (477)
Q Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e 331 (477)
.+..+...+...+|... ...++ .......+..++.+|..||++||.+|||+++
T Consensus 237 -----PmkvLl~tLqn~pp~~~--t~~~~--------------------~d~~k~~~ksf~e~i~~CL~kDP~kRptAsk 289 (516)
T KOG0582|consen 237 -----PMKVLLLTLQNDPPTLL--TSGLD--------------------KDEDKKFSKSFREMIALCLVKDPSKRPTASK 289 (516)
T ss_pred -----hHHHHHHHhcCCCCCcc--cccCC--------------------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHH
Confidence 34444445544443221 11000 0011122357899999999999999999999
Q ss_pred HhcCccCCC
Q 011808 332 ALEHEYFRI 340 (477)
Q Consensus 332 ~L~h~~f~~ 340 (477)
+|+|+||+.
T Consensus 290 Llkh~FFk~ 298 (516)
T KOG0582|consen 290 LLKHAFFKK 298 (516)
T ss_pred HhccHHHhh
Confidence 999999974
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=335.54 Aligned_cols=285 Identities=42% Similarity=0.809 Sum_probs=246.6
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|+-.++||+|.||+||+|+++. +++.||+|.++.+...+.+-..+++||.+|+.++|.|||+++++.. .+..+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~---t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh--sdkkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRE---THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH--SDKKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCC---ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc--cCcee
Confidence 568888999999999999998764 7899999999998888888889999999999999999999999874 45589
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
-+|+|||..+|..++... ++.++...++.++.|++.+|.++|++++.||||||.|+|+ +.+|.+||+|||++
T Consensus 77 tlvfe~cdqdlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli----n~ngelkladfgla 148 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI----NRNGELKLADFGLA 148 (292)
T ss_pred EEeHHHhhHHHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe----ccCCcEEecccchh
Confidence 999999999999888765 5679999999999999999999999999999999999999 78888999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+.++-+....+. .+.|.+|++|.++.|.+-|+.+.|+||-|||+.|+.. |++.|.+.+ ..+++.+|+..
T Consensus 149 rafgipvrcysa--evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d--------vddqlkrif~~ 218 (292)
T KOG0662|consen 149 RAFGIPVRCYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--------VDDQLKRIFRL 218 (292)
T ss_pred hhcCCceEeeec--eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc--------HHHHHHHHHHH
Confidence 988765543332 4569999999999999999999999999999999987 889999988 67899999999
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+|.++.+.|+.+.++|+|..--.+-... .+.. +-...+...+||+.++|.-+|..|++++++|+||||.
T Consensus 219 lg~p~ed~wps~t~lpdyk~yp~ypatt-----swsq-ivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~ 287 (292)
T KOG0662|consen 219 LGTPTEDQWPSMTKLPDYKPYPIYPATT-----SWSQ-IVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFS 287 (292)
T ss_pred hCCCccccCCccccCCCCcccCCccccc-----hHHH-HhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccc
Confidence 9999999999999999887532221110 1111 1123345678999999999999999999999999996
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=379.98 Aligned_cols=303 Identities=48% Similarity=0.854 Sum_probs=235.2
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEe
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFD 110 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e 110 (477)
.++||+|+||.||+|+++. ..++..||+|.+.... ....+.+|+.++++++||||+++++++....+..+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~-~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKD-GKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEcc-CCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 4689999999999998653 2457889999986543 2346778999999999999999999998777778999999
Q ss_pred ccCCCHHHHHHhhhcc----cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 111 YAEYDLYEIIRHHRDK----VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 111 ~~~~~L~~~l~~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
|++++|.+++...... ....+++..++.++.||+.||.|||++||+||||||+|||+..+++..+.+||+|||+++
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 81 YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred ccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 9999999888654311 123589999999999999999999999999999999999997665667789999999998
Q ss_pred eecCCCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc-cCCCcccHHHHHHHHHH
Q 011808 187 IYQAPLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK-STQNPFQLDQLDKIFKI 264 (477)
Q Consensus 187 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~-~~~~~~~~~~~~~i~~~ 264 (477)
.+...... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||...... ....++..+++..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 76543221 12234577999999999987666899999999999999999999999865432 33456677889999999
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCc---cccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLH---SVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
++.+....|..+..++.+...........+....+. .......+..+.|||++||++||.+|+|++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 998888888877666554332111111111111100 01122345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=376.31 Aligned_cols=289 Identities=40% Similarity=0.756 Sum_probs=227.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++++.||+|+||.||+|+++. ++..||||++...... .....+.+|+.+++.++||||+++++++.+. ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV---NGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTK--ET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC---CCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecC--Ce
Confidence 4689999999999999999998764 5889999999765432 2334667899999999999999999998764 47
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+|+||||+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 78 ~~lv~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~ 149 (303)
T cd07869 78 LTLVFEYVHTDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI----SDTGELKLADFGL 149 (303)
T ss_pred EEEEEECCCcCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEECCCCc
Confidence 89999999999998887642 358899999999999999999999999999999999999 6777899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+........ ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+... ..+.+..++..
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~ 220 (303)
T cd07869 150 ARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD-------IQDQLERIFLV 220 (303)
T ss_pred ceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc-------HHHHHHHHHHH
Confidence 975433221 223356799999999998766689999999999999999999999986542 35667777777
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccc-cCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSV-VPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
++.+....|+.....+.+....... +....+... .....+..+.|||.+||++||++|+|+.++|+||||+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 221 LGTPNEDTWPGVHSLPHFKPERFTL----YSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred hCCCChhhccchhhccccccccccc----cCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 8877777776655544433221110 011111111 11224567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=380.17 Aligned_cols=265 Identities=33% Similarity=0.437 Sum_probs=208.9
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC------------CcHHHHHHHHHHHhcCCCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG------------VSPTAIREIMLLREITHEN 89 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~Ei~il~~l~hpn 89 (477)
...+++|++++.||+|.||+|.+|++.. +++.||||++.+...... -.+...+||.||++|.|||
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~---~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEV---DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecC---CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 3457999999999999999999998664 699999999976543211 1246678999999999999
Q ss_pred eeEEEEEEEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCC-CCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEE
Q 011808 90 VVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHT-MNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILV 167 (477)
Q Consensus 90 Iv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~-l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl 167 (477)
||+|+++..+.....+|||+|||. |.+.+. . .... +++.+++.|+++++.||+|||.+|||||||||+|+||
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~-p-----~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl 243 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWC-P-----PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL 243 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccC-C-----CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE
Confidence 999999999988889999999998 333221 1 1224 8999999999999999999999999999999999999
Q ss_pred eccCCCcccEEEeecccceeecCCCC---cccCCCeeeccccccchhhcCCC---CCCchhhHHHHHHHHHHHHhCCCCC
Q 011808 168 MGEGEEQGVVKIADFGLARIYQAPLK---FLSENGVVVTIWYRAPELLLGAK---HYTSAVDMWAVGCIFAELLTLKPLF 241 (477)
Q Consensus 168 ~~~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DiwSlGvil~elltG~~PF 241 (477)
+++++|||+|||.+........ ...-...+|||.|+|||.+.+.. ..+.+.|||||||+||.|+.|+.||
T Consensus 244 ----~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 244 ----SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred ----cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 7778999999999986632210 00112378999999999997732 3467899999999999999999999
Q ss_pred CCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhccc
Q 011808 242 QGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321 (477)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~ 321 (477)
-+.. ..+.+.+|... +.. +.......+.++|||.+||++
T Consensus 320 ~~~~--------~~~l~~KIvn~----pL~-----------------------------fP~~pe~~e~~kDli~~lL~K 358 (576)
T KOG0585|consen 320 FDDF--------ELELFDKIVND----PLE-----------------------------FPENPEINEDLKDLIKRLLEK 358 (576)
T ss_pred ccch--------HHHHHHHHhcC----ccc-----------------------------CCCcccccHHHHHHHHHHhhc
Confidence 7654 34444444321 111 111112357799999999999
Q ss_pred CCCCCCCHHHHhcCccCCC
Q 011808 322 DPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 322 dP~~Rpt~~e~L~h~~f~~ 340 (477)
||++|++..++..|||...
T Consensus 359 dP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 359 DPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred Chhheeehhhheecceecc
Confidence 9999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=369.89 Aligned_cols=264 Identities=31% Similarity=0.487 Sum_probs=211.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
..+|...+.||+|+||.||++.+.. +|...|||.+....... .+.+.+|+.+|++++|||||++++.....+...
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~---~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKK---TGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecC---CCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 5679999999999999999998764 48999999987653222 566889999999999999999999754443347
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCC-cccEEEeec
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE-QGVVKIADF 182 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~-~~~vkL~DF 182 (477)
+++.|||+. |+|.+++.... + .++|..++.+.+||++||.|||++|||||||||+|||+ +. ++.+||+||
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g---~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl----~~~~~~~KlaDF 162 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYG---G-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL----DPSNGDVKLADF 162 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcC---C-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE----eCCCCeEEeccC
Confidence 899999998 68888888753 2 69999999999999999999999999999999999999 55 678999999
Q ss_pred ccceeecC-CCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQA-PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~-~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|+++.... ...........||+.|||||++........++|||||||++.||+||++||... .+....+
T Consensus 163 G~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----------~~~~~~~ 232 (313)
T KOG0198|consen 163 GLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----------FEEAEAL 232 (313)
T ss_pred ccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----------cchHHHH
Confidence 99987664 111122335778999999999985222335999999999999999999999752 1222333
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
+....... ...+|...+.++++||.+||.+||++||||+++|.|||.+..
T Consensus 233 ~~ig~~~~------------------------------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 233 LLIGREDS------------------------------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred HHHhccCC------------------------------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 33322111 112455667899999999999999999999999999998743
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=365.77 Aligned_cols=284 Identities=42% Similarity=0.757 Sum_probs=222.8
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc---CCCCeeEEEEEEEc---
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI---THENVVKLVNVHIN--- 99 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~--- 99 (477)
++|++++.||+|+||.||+|++.. .++..||||.++.............+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcC--CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 479999999999999999998753 2467899999876655444445667788877766 69999999998853
Q ss_pred CCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 100 HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 100 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
.....+++||||+.++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 79 ~~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~----~~~~~~kl 151 (290)
T cd07862 79 DRETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV----TSSGQIKL 151 (290)
T ss_pred CCCCcEEEEEccCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE----cCCCCEEE
Confidence 2345689999999999999887643 2358999999999999999999999999999999999999 66778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+ ..+.+.
T Consensus 152 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~--------~~~~~~ 219 (290)
T cd07862 152 ADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSS--------DVDQLG 219 (290)
T ss_pred ccccceEeccCCc---ccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCC--------HHHHHH
Confidence 9999998654321 22345679999999999764 48899999999999999999999998765 456777
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.+...++.+.++.|+....++...- .......+... ....+..+.+||.+||+.||++|||+.++|+||||
T Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 220 KILDVIGLPGEEDWPRDVALPRQAF-------HSKSAQPIEKF-VTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHHHHhCCCChhhchhhhcccchhc-------cCCCCCCHHHH-ccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 7888777777766654433322110 00001111111 12356788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=369.60 Aligned_cols=302 Identities=48% Similarity=0.869 Sum_probs=235.5
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEec
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
.+||+|+||.||+|+++. ..++..||+|.+.... ....+.+|+.+++.++||||+++++++....+..+|++|||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~-~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKD-GKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecC-CCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999998653 2456789999986532 23467789999999999999999999987777789999999
Q ss_pred cCCCHHHHHHhhhcc----cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 112 AEYDLYEIIRHHRDK----VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 112 ~~~~L~~~l~~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
++++|.+++...... ....+++..++.++.||+.||.|||+.||+||||||+|||+..+++.++.+||+|||+++.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 999999888643211 1235889999999999999999999999999999999999977666778899999999987
Q ss_pred ecCCCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc-cCCCcccHHHHHHHHHHh
Q 011808 188 YQAPLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK-STQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 188 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~-~~~~~~~~~~~~~i~~~~ 265 (477)
+...... .......+|+.|+|||++.+...++.++|||||||++|||+||++||...... ....++...++..++..+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 6543221 12234577999999999987666899999999999999999999999865432 335677788899999999
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCc---cccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLH---SVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+.+..+.|..+...+.+......+....+....+. .......+..+++||.+||+.||.+|||++|+|.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 98888888776665555432222211111111111 11122345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=381.98 Aligned_cols=256 Identities=28% Similarity=0.511 Sum_probs=214.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
...|....+||+|+.|.||.|+... ++..||||.+....... .+-+++|+.+|+..+|+|||++++.|... ..
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~---~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~--de 344 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKIS---TKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVG--DE 344 (550)
T ss_pred hhhhcchhhhccccccceeeeeecc---CCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhccc--ce
Confidence 4679999999999999999998664 68889999998766554 34678999999999999999999988765 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||++ |+|.+.+... .++|.++..++++++.||+|||.+||+|||||.+|||+ ..++.+||+|||
T Consensus 345 LWVVMEym~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL----~~~g~vKltDFG 414 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL----TMDGSVKLTDFG 414 (550)
T ss_pred eEEEEeecCCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe----ccCCcEEEeeee
Confidence 899999999 5777777653 59999999999999999999999999999999999999 677779999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++..+..... .....+|||+|||||++.. +.|+.++||||||++++||+-|.+||-..+ .+..+..
T Consensus 415 Fcaqi~~~~~--KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~-----------PlrAlyL 480 (550)
T KOG0578|consen 415 FCAQISEEQS--KRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----------PLRALYL 480 (550)
T ss_pred eeeccccccC--ccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCC-----------hHHHHHH
Confidence 9998776543 3456899999999999987 459999999999999999999999996533 2333333
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+-...+++ ...+..+|..++|||.+||+.|+++|++|.|+|+||||+.
T Consensus 481 Ia~ng~P~-----------------------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 481 IATNGTPK-----------------------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HhhcCCCC-----------------------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 32222222 2245566889999999999999999999999999999964
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=366.06 Aligned_cols=287 Identities=36% Similarity=0.636 Sum_probs=215.3
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|++.+.||+|+||.||+|+++. ++..||||+++...........+.+|+.+++.++|+||+++++++... ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR--GKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC---CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC--CEE
Confidence 479999999999999999998764 688999999987655555566778999999999999999999998654 478
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
|+||||+.+++++.+... ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 76 ~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~ 147 (287)
T cd07848 76 YLVFEYVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI----SHNDVLKLCDFGFA 147 (287)
T ss_pred EEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCcEEEeeccCc
Confidence 999999998887776543 2468999999999999999999999999999999999999 66778999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
........ .......|++.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+ ..+.+..+....
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~--------~~~~~~~~~~~~ 217 (287)
T cd07848 148 RNLSEGSN-ANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGES--------EIDQLFTIQKVL 217 (287)
T ss_pred cccccccc-ccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHhh
Confidence 86543221 1222356799999999998754 8999999999999999999999998654 233333344433
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+..+...+.....-+.+...... ................+..+.|||.+||++||++|||++++|+||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 218 GPLPAEQMKLFYSNPRFHGLRFP---AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CCCCHHHHHhhhccchhcccccC---cccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 33222211111111111100000 00000011111223456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=353.41 Aligned_cols=305 Identities=39% Similarity=0.710 Sum_probs=253.1
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEc--
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHIN-- 99 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 99 (477)
+...+.|+-+.+||+|.||.||+|+.+ ++++.||+|++..+......-...++|+++|..|+|+|++.++++|..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~---n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSK---NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhc---CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 344678999999999999999999865 468889999887766666666788999999999999999999987743
Q ss_pred ----CCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 100 ----HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 100 ----~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
.....+|+||++|+.+|..++... ..+++..++..++.++++||.|+|...|+|||+|++|+|| +.++
T Consensus 90 Tp~~r~r~t~ylVf~~cehDLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI----t~dg 161 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEHDLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI----TKDG 161 (376)
T ss_pred CCcccccceeeeeHHHhhhhHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE----cCCc
Confidence 233459999999999999998764 2468999999999999999999999999999999999999 7778
Q ss_pred cEEEeecccceeecCCCCc--ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 176 VVKIADFGLARIYQAPLKF--LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
.+||+|||+++.+...... ...+..+.|.+|++||.+.|.+.|+++.|||.-||++.||+|+.+.|.+.+
T Consensus 162 ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt-------- 233 (376)
T KOG0669|consen 162 ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT-------- 233 (376)
T ss_pred eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh--------
Confidence 8999999999876543221 123345669999999999999999999999999999999999999999887
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
+..++..|...+|..+++.||+..++|-|.+.+..--.......--....|..-++++.||+++||..||.+|++++++|
T Consensus 234 eqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 234 EQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred HHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 77899999999999999999999999999886443211111111111122445567899999999999999999999999
Q ss_pred cCccCCCCCCCC
Q 011808 334 EHEYFRIEPLPG 345 (477)
Q Consensus 334 ~h~~f~~~~~~~ 345 (477)
+|.||..++.|.
T Consensus 314 nh~~F~kdp~pq 325 (376)
T KOG0669|consen 314 NHDFFWKDPMPQ 325 (376)
T ss_pred chhhhhcCCcch
Confidence 999999877664
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=386.80 Aligned_cols=285 Identities=31% Similarity=0.590 Sum_probs=222.3
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH----- 100 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 100 (477)
.+|++.++||+|+||.||+|.+.. ++..||||++.... ....+|+.+|+.++|+||++++++|...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICID---TSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 579999999999999999998754 68899999885432 2345799999999999999999987532
Q ss_pred -CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 -ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 -~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
...++++||||+.++|.+++..... ....+++..++.++.||+.||.|||++||+||||||+|||+. ...+.+||
T Consensus 137 ~~~~~l~lvmE~~~~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~---~~~~~vkL 212 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID---PNTHTLKL 212 (440)
T ss_pred CCceEEEEEEecCCccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc---CCCCceee
Confidence 2346789999999999888765432 245789999999999999999999999999999999999993 13346999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+++.+..... ....++|+.|+|||++.+...|+.++|||||||++|||++|.+||.+.. ..+.+.
T Consensus 213 ~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~--------~~~~~~ 281 (440)
T PTZ00036 213 CDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS--------SVDQLV 281 (440)
T ss_pred eccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHH
Confidence 99999986643222 2235679999999999876679999999999999999999999998765 456777
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+...++.++.+.+..+. +.|... .........+...+|...+.++++||.+||++||.+|+|+.|+|.||||.
T Consensus 282 ~i~~~~~~p~~~~~~~~~--~~~~~~----~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 282 RIIQVLGTPTEDQLKEMN--PNYADI----KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred HHHHHhCCCCHHHHHHhc--hhhhcc----cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 788888776654333211 111110 00111122334445667788999999999999999999999999999997
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 356 ~ 356 (440)
T PTZ00036 356 D 356 (440)
T ss_pred h
Confidence 3
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=365.90 Aligned_cols=311 Identities=58% Similarity=1.017 Sum_probs=247.5
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCC-CCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK-DGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
+|++.+.||+|+||.||+|.++.. ..+..||||.+.... ........+.+|+.+++.++||||+++++++.+.....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 589999999999999999987541 258899999998754 223345677889999999999999999999988755689
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
|+||||++++|.+++..........+++..++.++.||+.||.|||+++|+||||||+|||+..+++.++.+||+|||++
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999999999988876654434478999999999999999999999999999999999999655455889999999999
Q ss_pred eeecCCCC-cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc-CCCcccHHHHHHHHH
Q 011808 186 RIYQAPLK-FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS-TQNPFQLDQLDKIFK 263 (477)
Q Consensus 186 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~-~~~~~~~~~~~~i~~ 263 (477)
........ ........++..|+|||++.+...++.++|||||||++|+|++|++||.+..... ...++....+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86644322 2223345678999999999876668999999999999999999999998776543 455667788888999
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCC--CCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPL--SPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.++.+.+..|..+..+++|...........+....+...... ..+..+.+||.+||..||++|||+.+++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 998888887777777766654222222222222222222222 567789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=371.44 Aligned_cols=290 Identities=36% Similarity=0.601 Sum_probs=216.5
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---c
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD---M 103 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---~ 103 (477)
+|++.+.||+|+||.||+|+++. ++..||||++............+.+|+.+++.++||||+++++++..... .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 69999999999999999998764 68899999987544333344567899999999999999999998864332 3
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+|+||||++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 78 ~~~lv~e~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll----~~~~~~kL~Dfg 148 (338)
T cd07859 78 DIYVVFELMESDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA----NADCKLKICDFG 148 (338)
T ss_pred eEEEEEecCCCCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCcEEEccCc
Confidence 58999999999999888653 368999999999999999999999999999999999999 777889999999
Q ss_pred cceeecCCCC-cccCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLK-FLSENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
+++....... .......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+ ...++..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~--------~~~~~~~~ 220 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN--------VVHQLDLI 220 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC--------hHHHHHHH
Confidence 9975432211 1112335679999999998652 458899999999999999999999998755 34455555
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
...++.+....+..+.+.. ...............+...+ ...+..+.+||.+||+.||++|||++++|.||||+.
T Consensus 221 ~~~~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 221 TDLLGTPSPETISRVRNEK---ARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred HHHhCCCCHHHHHHhhhhh---HHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 5656555443322211100 00000000000000011111 134567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=349.73 Aligned_cols=262 Identities=31% Similarity=0.483 Sum_probs=211.9
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC---C---CcHHHHHHHHHHHhc-CCCCeeEEE
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD---G---VSPTAIREIMLLREI-THENVVKLV 94 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~---~---~~~~~~~Ei~il~~l-~hpnIv~l~ 94 (477)
..+.+.|+-.+.||.|..++|-++.++. ++..+|+|++....... . ..+.-.+|+.||+++ .||||+++.
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~---t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKE---TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcc---cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 4678999999999999999999987664 68889999886543322 1 122334699999999 699999999
Q ss_pred EEEEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCC
Q 011808 95 NVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE 173 (477)
Q Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~ 173 (477)
++|+++ .++++|||.|. |.|+++|.+. -.++|...+.|++|++++++|||.++||||||||+|||+ ++
T Consensus 90 D~yes~--sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl----dd 158 (411)
T KOG0599|consen 90 DVYESD--AFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL----DD 158 (411)
T ss_pred eeccCc--chhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee----cc
Confidence 999664 48999999998 8999999874 379999999999999999999999999999999999999 88
Q ss_pred cccEEEeecccceeecCCCCcccCCCeeeccccccchhhcC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc
Q 011808 174 QGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLG-----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248 (477)
Q Consensus 174 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~ 248 (477)
+.++||+|||+++.+....+. ...||||+|+|||.+.. ...|+..+|+||+|||+|.||.|.+||....
T Consensus 159 n~~i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--- 232 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--- 232 (411)
T ss_pred ccceEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---
Confidence 889999999999988765443 45789999999999853 3458999999999999999999999996332
Q ss_pred CCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC
Q 011808 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT 328 (477)
Q Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt 328 (477)
+.--+..|++---....+.|. + .++.++|||.+||+.||.+|+|
T Consensus 233 -----QmlMLR~ImeGkyqF~speWa---------d----------------------is~~~KdLIsrlLqVdp~~Rit 276 (411)
T KOG0599|consen 233 -----QMLMLRMIMEGKYQFRSPEWA---------D----------------------ISATVKDLISRLLQVDPTKRIT 276 (411)
T ss_pred -----HHHHHHHHHhcccccCCcchh---------h----------------------ccccHHHHHHHHHeeCchhccc
Confidence 122222222222222222232 2 2577899999999999999999
Q ss_pred HHHHhcCccCC
Q 011808 329 AAQALEHEYFR 339 (477)
Q Consensus 329 ~~e~L~h~~f~ 339 (477)
+.|+|.||||.
T Consensus 277 ake~LaHpff~ 287 (411)
T KOG0599|consen 277 AKEALAHPFFI 287 (411)
T ss_pred HHHHhcChHHH
Confidence 99999999995
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=367.93 Aligned_cols=265 Identities=34% Similarity=0.570 Sum_probs=219.7
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcC-CCCeeEEEEEEEc
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREIT-HENVVKLVNVHIN 99 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 99 (477)
..+...|++.+.||+|.||.||+|+.+. +|..+|+|.+.+..... .....+.+|+.+|+++. ||||+.++++|++
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~---tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKS---TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecC---CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 4556789999999999999999998775 59999999998766543 23457788999999998 9999999999987
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
.. .+++|||+|. |.|++.+... .++|..+..++.||+.++.|||+.||+||||||+|+|+......++.+|
T Consensus 108 ~~--~~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik 179 (382)
T KOG0032|consen 108 PD--SVYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIK 179 (382)
T ss_pred CC--eEEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEE
Confidence 65 8999999999 6999988764 2999999999999999999999999999999999999976655557899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
++|||++...... ......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+. ...+
T Consensus 180 ~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~--------~~~~ 247 (382)
T KOG0032|consen 180 LIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETE--------FEIF 247 (382)
T ss_pred EeeCCCceEccCC---ceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCCh--------hHHH
Confidence 9999999987652 23456889999999999986 4499999999999999999999999988763 2222
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..+...-.....+.|+ .++..+.|||++||..||.+|+|+.++|.|||+
T Consensus 248 ~~i~~~~~~f~~~~w~-------------------------------~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 248 LAILRGDFDFTSEPWD-------------------------------DISESAKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred HHHHcCCCCCCCCCcc-------------------------------ccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 2332221122222222 235789999999999999999999999999998
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
+.
T Consensus 297 ~~ 298 (382)
T KOG0032|consen 297 KS 298 (382)
T ss_pred cC
Confidence 74
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=362.41 Aligned_cols=288 Identities=40% Similarity=0.735 Sum_probs=227.7
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.+++|.+++.||+|+||.||+|+++. ++..||||.++..... .....+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 77 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-- 77 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecC---CCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCC--
Confidence 36789999999999999999998764 5788999998765432 23346778999999999999999999987643
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill----~~~~~~kl~Dfg 149 (309)
T cd07872 78 SLTLVFEYLDKDLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI----NERGELKLADFG 149 (309)
T ss_pred eEEEEEeCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEECccc
Confidence 78999999999999888654 2358899999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+++....... ......+++.|+|||++.+...++.++|||||||++|+|+||++||.+.+ ..+.+..+..
T Consensus 150 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~--------~~~~~~~~~~ 219 (309)
T cd07872 150 LARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST--------VEDELHLIFR 219 (309)
T ss_pred cceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHH
Confidence 9976543222 12234568999999999876668999999999999999999999998765 4566777888
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.++.+..+.|+.+.....+.... ...+....+.. .....+.++++||.+||+.||.+|+|++|+|.||||+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 220 LLGTPTEETWPGISSNDEFKNYN----FPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred HhCCCCHHHHhhhcchhhhhhhh----cCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 88888877776554332222111 11111111111 12245778999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=379.05 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=215.8
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREI-THENVVKLVNVHIN 99 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 99 (477)
+--+++|.++++||+|+||+|++|..+. +++.+|||++++... ....+...+.|.+|++.. +||.+++++.+|.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~---~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT 440 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKG---TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT 440 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcC---CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc
Confidence 3347899999999999999999998775 688999999988764 345567788899999888 59999999999977
Q ss_pred CCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 100 HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 100 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
.+ ++|+||||+.|+.+..+.+ ...+++..++.|+..|+.||.|||++||||||||.+|||| +..|++||
T Consensus 441 ~~--~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL----D~eGh~ki 509 (694)
T KOG0694|consen 441 KE--HLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL----DTEGHVKI 509 (694)
T ss_pred CC--eEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE----cccCcEEe
Confidence 55 8999999998655332222 3479999999999999999999999999999999999999 88999999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+++..-.... ...+.||||.|||||++.+.. |+.++|+|||||+|||||.|..||.+.++ .+
T Consensus 510 ADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddE--------ee--- 575 (694)
T KOG0694|consen 510 ADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDE--------EE--- 575 (694)
T ss_pred cccccccccCCCCC--ccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCH--------HH---
Confidence 99999985432222 345689999999999999855 99999999999999999999999998773 22
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhc
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALE 334 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~ 334 (477)
+++.|... +...|...+.++.++++++|.+||++|+. +.++..
T Consensus 576 -~FdsI~~d-------------------------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~ 623 (694)
T KOG0694|consen 576 -VFDSIVND-------------------------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK 623 (694)
T ss_pred -HHHHHhcC-------------------------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh
Confidence 33333221 12356667789999999999999999985 689999
Q ss_pred CccCCC
Q 011808 335 HEYFRI 340 (477)
Q Consensus 335 h~~f~~ 340 (477)
||||+.
T Consensus 624 hpFFr~ 629 (694)
T KOG0694|consen 624 HPFFRS 629 (694)
T ss_pred CCcccc
Confidence 999983
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=361.04 Aligned_cols=260 Identities=27% Similarity=0.473 Sum_probs=219.0
Q ss_pred CccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC-CcHHHHHHHHHHHhcCCCCeeEEEEEEE
Q 011808 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG-VSPTAIREIMLLREITHENVVKLVNVHI 98 (477)
Q Consensus 20 ~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 98 (477)
.+-.+.-+|++.+.||+|.||+|-+|+.. ..|+.||||.++++...++ ....+.+||+||..|+||||+.++++|+
T Consensus 47 hkhnlkHRyE~~etLGkGTYGKVk~A~e~---~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE 123 (668)
T KOG0611|consen 47 HKHNLKHRYEITETLGKGTYGKVKLAYEH---KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE 123 (668)
T ss_pred cccchhhHHHHHHHhcCCcccceeehhhc---cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence 34456779999999999999999999764 3699999999998876643 3446678999999999999999999997
Q ss_pred cCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccE
Q 011808 99 NHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVV 177 (477)
Q Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~v 177 (477)
+.+ .++|||||.. |.|++++...+ .|+|.+++.+|+||.+|+.|||.++++|||||.+|||| +.++++
T Consensus 124 Nkd--KIvivMEYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL----D~N~Ni 192 (668)
T KOG0611|consen 124 NKD--KIVIVMEYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL----DQNNNI 192 (668)
T ss_pred CCc--eEEEEEEecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhccceecccchhheee----cCCCCe
Confidence 654 7899999988 79999998754 79999999999999999999999999999999999999 888999
Q ss_pred EEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 178 KIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
||+|||++..+.... ....+||+|.|.+||++.|..+-++.+|.|||||+||.|+.|..||+|.+.+
T Consensus 193 KIADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---------- 259 (668)
T KOG0611|consen 193 KIADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---------- 259 (668)
T ss_pred eeeccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH----------
Confidence 999999998776432 2345899999999999999887789999999999999999999999987732
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
.+++.|.... | +....+..+.-||+.||..||++|.|+.++-.|.|
T Consensus 260 --~lvrQIs~Ga------------------------Y--------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 260 --RLVRQISRGA------------------------Y--------REPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred --HHHHHhhccc------------------------c--------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 2222221110 0 11112356889999999999999999999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
+.+
T Consensus 306 vNw 308 (668)
T KOG0611|consen 306 VNW 308 (668)
T ss_pred eec
Confidence 864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=337.51 Aligned_cols=255 Identities=28% Similarity=0.461 Sum_probs=216.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+++|++.+.||+|-||.||+|+.+. ++..||+|++.+.... ......+.+|++|...|+||||++++++|.+. .
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekk---s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--~ 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKK---SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--K 95 (281)
T ss_pred hhhccccccccCCccccEeEeeecc---CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc--c
Confidence 7999999999999999999999774 6889999998765533 34456777899999999999999999999764 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+||++||.. |.++..|...+ ...+++..+..+++|++.||.|+|.++||||||||+|+|+ ...+.+||+||
T Consensus 96 riyLilEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl----g~~~~lkiAdf 168 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL----GSAGELKIADF 168 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc----CCCCCeeccCC
Confidence 8999999987 89999998654 4478999999999999999999999999999999999999 77788999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|-+..... ......|||..|.+||...+. .++..+|+|++|++.||++.|.+||.... ..+...+|.
T Consensus 169 GwsV~~p~----~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------~~etYkrI~ 235 (281)
T KOG0580|consen 169 GWSVHAPS----NKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQS--------HSETYKRIR 235 (281)
T ss_pred CceeecCC----CCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhh--------hHHHHHHHH
Confidence 99876432 234568999999999999884 48999999999999999999999997554 223333332
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+. +..+|..++.++.|||.+||.++|.+|.+..|++.|||..
T Consensus 236 k~-----------------------------------~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 236 KV-----------------------------------DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred Hc-----------------------------------cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 21 2335677789999999999999999999999999999975
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=364.70 Aligned_cols=269 Identities=29% Similarity=0.483 Sum_probs=232.3
Q ss_pred CCCCCCccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEE
Q 011808 15 TSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLV 94 (477)
Q Consensus 15 ~~~~~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 94 (477)
+..+.....+.+-|.+.+.||+|.|++|.+|++. .+|..||||++.+.+........+++|++-|+.++|||||+||
T Consensus 7 ~~g~i~DgkIAGLYDLekTlG~GHFAVVKLArHV---FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLY 83 (864)
T KOG4717|consen 7 KRGHIYDGKIAGLYDLEKTLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLY 83 (864)
T ss_pred ccccccccceeeeehhhhhhcCCceehhhhhhhh---cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeee
Confidence 3344455567788999999999999999999865 4799999999999888777777889999999999999999999
Q ss_pred EEEEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCC
Q 011808 95 NVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE 173 (477)
Q Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~ 173 (477)
++..+. ..+|||+|+.+ |+|+++|.++. ..+.|..++++|+||+.|+.|+|...+|||||||+||.+. ..
T Consensus 84 EViDTQ--TKlyLiLELGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF---EK 154 (864)
T KOG4717|consen 84 EVIDTQ--TKLYLILELGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF---EK 154 (864)
T ss_pred ehhccc--ceEEEEEEecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe---ee
Confidence 998554 47999999988 59999999874 4799999999999999999999999999999999999885 56
Q ss_pred cccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 174 QGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 174 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
-|.|||+|||++..+.+.... +..||+..|.|||++.|..+..+++||||||||||-|.+|++||...++
T Consensus 155 lGlVKLTDFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND------- 224 (864)
T KOG4717|consen 155 LGLVKLTDFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND------- 224 (864)
T ss_pred cCceEeeeccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-------
Confidence 778999999999988765543 4578899999999999987667799999999999999999999998773
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
.+.+..|+.+- ..+|..++.+++|||..||..||.+|.+.++|.
T Consensus 225 -SETLTmImDCK-----------------------------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 225 -SETLTMIMDCK-----------------------------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred -hhhhhhhhccc-----------------------------------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 34454444331 236777889999999999999999999999999
Q ss_pred cCccCCCC
Q 011808 334 EHEYFRIE 341 (477)
Q Consensus 334 ~h~~f~~~ 341 (477)
.|+|++..
T Consensus 269 s~~Wlq~~ 276 (864)
T KOG4717|consen 269 STSWLQAG 276 (864)
T ss_pred ccccccCC
Confidence 99999843
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=356.74 Aligned_cols=262 Identities=29% Similarity=0.394 Sum_probs=211.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+++|++++.||.|..|+||+|+.+. ++..+|+|++.+.... .....++..|-+||..++||.++.||..|++. .
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~---t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~--~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRG---TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD--K 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecC---CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc--c
Confidence 5689999999999999999998775 5689999999876543 22344556699999999999999999999764 4
Q ss_pred eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
++|++||||.| +|..++++.. +..+++..++.++..|+.||+|||..|||+|||||+|||| .++|+|.|+||
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv----redGHIMLsDF 223 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV----REDGHIMLSDF 223 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE----ecCCcEEeeec
Confidence 89999999995 7666665543 5689999999999999999999999999999999999999 78889999999
Q ss_pred ccceeecC---------------------------------CCC---------------------cccCCCeeecccccc
Q 011808 183 GLARIYQA---------------------------------PLK---------------------FLSENGVVVTIWYRA 208 (477)
Q Consensus 183 G~a~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~A 208 (477)
.++....- ... ....+.++||-.|+|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 98743210 000 011235688999999
Q ss_pred chhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccc
Q 011808 209 PELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLH 288 (477)
Q Consensus 209 PE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (477)
||++.|.. .+.++|+|+|||++||||.|..||.|.+.++ . +.++++.+..
T Consensus 304 PEvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--------T---l~NIv~~~l~------------------ 353 (459)
T KOG0610|consen 304 PEVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--------T---LRNIVGQPLK------------------ 353 (459)
T ss_pred ceeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchh--------h---HHHHhcCCCc------------------
Confidence 99999966 7999999999999999999999999887432 2 3333333211
Q ss_pred cccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC----HHHHhcCccCCC
Q 011808 289 IQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT----AAQALEHEYFRI 340 (477)
Q Consensus 289 ~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt----~~e~L~h~~f~~ 340 (477)
......++..++|||+++|.+||.+|+. |+||.+||||+.
T Consensus 354 ------------Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 354 ------------FPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred ------------CCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence 0111244678999999999999999998 999999999974
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=369.61 Aligned_cols=291 Identities=36% Similarity=0.582 Sum_probs=216.7
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+.++|++++.||+|+||.||+|.++. ++..||||++............+.+|+.+++.++||||+++++++.....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTV---LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS 94 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcC---CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence 568999999999999999999998654 68899999997654444445677899999999999999999999864432
Q ss_pred ----ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 103 ----MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 103 ----~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
..+|+||||++++|...+.. .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~----~~~~~~k 163 (359)
T cd07876 95 LEEFQDVYLVMELMDANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLK 163 (359)
T ss_pred ccccceeEEEEeCCCcCHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----CCCCCEE
Confidence 35799999999998877642 47888999999999999999999999999999999999 6777899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+ ..+.+
T Consensus 164 l~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~--------~~~~~ 231 (359)
T cd07876 164 ILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTD--------HIDQW 231 (359)
T ss_pred EecCCCccccccCc---cCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 99999997543221 12335679999999999874 48999999999999999999999998765 33455
Q ss_pred HHHHHHhCCCCCCCccccC--------CCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHH
Q 011808 259 DKIFKILGHPTPEKWPTLA--------NLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA 330 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~ 330 (477)
..+...++.+..+.+..+. +.+.+...........+ ............+..+++||.+||..||++|||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~ 310 (359)
T cd07876 232 NKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDW-IFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310 (359)
T ss_pred HHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccc-ccccccccccccchhHHHHHHHHhccCcccCCCHH
Confidence 5555555544332111100 00000000000000000 00000011223456789999999999999999999
Q ss_pred HHhcCccCCC
Q 011808 331 QALEHEYFRI 340 (477)
Q Consensus 331 e~L~h~~f~~ 340 (477)
|+|.||||..
T Consensus 311 e~l~hp~~~~ 320 (359)
T cd07876 311 EALRHPYITV 320 (359)
T ss_pred HHhcCchhhh
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=353.34 Aligned_cols=282 Identities=41% Similarity=0.745 Sum_probs=218.5
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc---CCCCeeEEEEEEEcC---
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI---THENVVKLVNVHINH--- 100 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~--- 100 (477)
+|++++.||+|+||.||+|+++. ++..||+|.++.............+|+.+++.+ +||||+++++++.+.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 69999999999999999998764 688999999876544444444566777777665 799999999988643
Q ss_pred CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 101 ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 101 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
....++++|||+.++|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 78 ~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili----~~~~~~kl~ 150 (288)
T cd07863 78 RETKVTLVFEHVDQDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV----TSGGQVKLA 150 (288)
T ss_pred CCceEEEEEcccccCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCCEEEC
Confidence 234689999999999988886543 2358999999999999999999999999999999999999 667789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||+++....... .....+|..|+|||++.+. .++.++|||||||++|+|++|++||.+.. ..+.+.+
T Consensus 151 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~--------~~~~~~~ 218 (288)
T cd07863 151 DFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNS--------EADQLGK 218 (288)
T ss_pred ccCccccccCccc---CCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCC--------HHHHHHH
Confidence 9999986643221 2234568999999999774 48999999999999999999999997654 4566777
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+...++.+....|+.....+...- .......+.. .....+..+.+||.+||++||++|||+.+++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 219 IFDLIGLPPEDDWPRDVTLPRGAF-------SPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHHHhCCCChhhCccccccccccc-------CCCCCCchHH-hCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 777777766666554332221100 0000001111 112456778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=355.06 Aligned_cols=298 Identities=44% Similarity=0.764 Sum_probs=235.2
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.-+++|++.+.||+|+||.||+|.++. ++..||+|+++.............+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTT---SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECC---CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 357899999999999999999998764 68899999997655444434456789999999999999999999887655
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..+|+||||++++|.+++.... ..+++.+++.++.||+.||.|||+.|++||||||+||++ +.++.+||+||
T Consensus 81 ~~~~lv~e~~~~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~----~~~~~~kL~df 152 (309)
T cd07845 81 DSIFLVMEYCEQDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL----TDKGCLKIADF 152 (309)
T ss_pred CeEEEEEecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCCEEECcc
Confidence 6789999999999988887642 468999999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++........ ......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+ ..+.+..+.
T Consensus 153 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--------~~~~~~~~~ 222 (309)
T cd07845 153 GLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--------EIEQLDLII 222 (309)
T ss_pred ceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence 99987654321 12223447889999999876668999999999999999999999998665 456777778
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEP 342 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~~ 342 (477)
..++.+....|+.+..++.+......... ...+... ....+..+.+||.+||+.||++|||+.+++.|+||+..+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 223 QLLGTPNESIWPGFSDLPLVGKFTLPKQP----YNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred HhcCCCChhhchhhhcccccccccccCCC----CCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 88888877777766554433221111000 0011111 112467889999999999999999999999999998665
Q ss_pred CCCC
Q 011808 343 LPGR 346 (477)
Q Consensus 343 ~~~~ 346 (477)
.+-.
T Consensus 298 ~~~~ 301 (309)
T cd07845 298 LPCE 301 (309)
T ss_pred CCCC
Confidence 5543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=366.00 Aligned_cols=293 Identities=35% Similarity=0.555 Sum_probs=221.0
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
....++|.+.+.||+|+||.||+|++.. .+..||||++............+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 20 FTVLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hchhcceeEEEEeecCCCeEEEEEEECC---CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 3568999999999999999999998764 5788999999865544445567789999999999999999999875432
Q ss_pred ----CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccE
Q 011808 102 ----DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVV 177 (477)
Q Consensus 102 ----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~v 177 (477)
...+|+||||++++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 97 ~~~~~~~~~lv~e~~~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~ 165 (364)
T cd07875 97 SLEEFQDVYIVMELMDANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTL 165 (364)
T ss_pred cccccCeEEEEEeCCCCCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE----CCCCcE
Confidence 235799999999999887753 47888999999999999999999999999999999999 667789
Q ss_pred EEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 178 KIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+ ..+.
T Consensus 166 kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~--------~~~~ 233 (364)
T cd07875 166 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTD--------HIDQ 233 (364)
T ss_pred EEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCC--------HHHH
Confidence 999999998654321 12335679999999999874 48999999999999999999999998765 3456
Q ss_pred HHHHHHHhCCCCCCCccccCCCccc-ccccccccccccc------CCCCccccCCCCCchHHHHHHHhcccCCCCCCCHH
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHW-QSDSLHIQGRKYE------TNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA 330 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~------~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~ 330 (477)
+..+...++.+.++.+..+.....+ ............. ............+..++|||.+||+.||.+|||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~ 313 (364)
T cd07875 234 WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313 (364)
T ss_pred HHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHH
Confidence 6666666666554433322211000 0000000000000 00001111222356789999999999999999999
Q ss_pred HHhcCccCCC
Q 011808 331 QALEHEYFRI 340 (477)
Q Consensus 331 e~L~h~~f~~ 340 (477)
++|.||||..
T Consensus 314 e~L~hp~~~~ 323 (364)
T cd07875 314 EALQHPYINV 323 (364)
T ss_pred HHhcCccccc
Confidence 9999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=369.86 Aligned_cols=289 Identities=23% Similarity=0.276 Sum_probs=211.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
..+|.+++.||+|+||.||+|+++. +++.||||.... ..+.+|+.++++++||||++++++|... ..
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~---~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~ 157 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNK---TCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYN--KF 157 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECC---CCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEEC--Ce
Confidence 3579999999999999999998764 688999997542 2457899999999999999999998764 37
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
.+++||++.++|..++... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+
T Consensus 158 ~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll----~~~~~vkL~DFG~ 228 (391)
T PHA03212 158 TCLILPRYKTDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI----NHPGDVCLGDFGA 228 (391)
T ss_pred eEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE----cCCCCEEEEeCCc
Confidence 8999999999999888653 368899999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
++....... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||...+..... .....++..+...
T Consensus 229 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~l~~i~~~ 305 (391)
T PHA03212 229 ACFPVDINA-NKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGD-CDSDRQIKLIIRR 305 (391)
T ss_pred ccccccccc-cccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCccccccc-CchhHHHHHHHHH
Confidence 975432111 122345789999999999774 4899999999999999999999877544322111 1134556667666
Q ss_pred hCCCCCCCccccCC-CccccccccccccccccCCCCc--cccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 265 LGHPTPEKWPTLAN-LPHWQSDSLHIQGRKYETNGLH--SVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 265 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
++..+.+...+... +.... .............. .......+.++.+||.+||++||.+|||+.|+|.||||+..
T Consensus 306 ~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 306 SGTHPNEFPIDAQANLDEIY---IGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hcCChhhcCcchhHHHHHHH---HHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 66554332111000 00000 00000000000000 00011234578999999999999999999999999999753
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=361.91 Aligned_cols=263 Identities=27% Similarity=0.394 Sum_probs=206.7
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC--CCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCc
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD--GDGVSPTAIREIMLLREI-THENVVKLVNVHINHADM 103 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 103 (477)
+|++++.||+|+||.||+|++.....++..||+|++..... .......+.+|+.+++.+ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--A 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--C
Confidence 58999999999999999998765556789999999875432 122334567899999999 599999999988654 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili----~~~~~~kl~Df 149 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL----DSEGHVVLTDF 149 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE----CCCCCEEEeeC
Confidence 7899999998 5888887653 368999999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+++.+...... .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||....... ... .+.
T Consensus 150 G~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~~---~~~ 220 (332)
T cd05614 150 GLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-----TQS---EVS 220 (332)
T ss_pred cCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-----CHH---HHH
Confidence 999865432221 12245689999999999875557889999999999999999999997543211 111 111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCcc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEY 337 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~ 337 (477)
..+.... ..++...+..+.+||.+||+.||++|+ +++++++|||
T Consensus 221 ~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 221 RRILKCD-------------------------------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred HHHhcCC-------------------------------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 1111110 112334567899999999999999999 8889999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|+.
T Consensus 270 ~~~ 272 (332)
T cd05614 270 FKG 272 (332)
T ss_pred cCC
Confidence 974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=352.82 Aligned_cols=288 Identities=41% Similarity=0.736 Sum_probs=225.2
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.+++|+++++||+|+||.||+|+++. ++..||+|.+...... .....+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~ 77 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKL---TDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE--K 77 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcC---CCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecC--C
Confidence 47899999999999999999998764 5789999998755432 2334667899999999999999999998764 4
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+|+||||+.++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~dfg 149 (301)
T cd07873 78 SLTLVFEYLDKDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI----NERGELKLADFG 149 (301)
T ss_pred eEEEEEeccccCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE----CCCCcEEECcCc
Confidence 78999999999999888654 2358899999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++........ ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+ ..+++..+..
T Consensus 150 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~--------~~~~~~~~~~ 219 (301)
T cd07873 150 LARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST--------VEEQLHFIFR 219 (301)
T ss_pred chhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHH
Confidence 9975443221 12234568999999999876668899999999999999999999998665 3456677777
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.++.+....|+.+.....|..... ..+... .........+..+.+||.+||+.||.+|||++++|.|+||+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 220 ILGTPTEETWPGILSNEEFKSYNY----PKYRAD-CLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred HcCCCChhhchhhhcccccccccc----Cccccc-cHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 777777776665433222211000 000000 001122345678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=366.15 Aligned_cols=260 Identities=26% Similarity=0.442 Sum_probs=214.3
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
...+-..|..++.||+|+||.||+|.+.. +++.||||++..+...+ ....+.+|+.+|.+++++||.++|+.|...
T Consensus 8 ~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~---t~k~vAiKii~Le~~~d-eIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 8 KIDPELLYTKLELIGRGSFGEVYKAIDNK---TKKVVAIKIIDLEEAED-EIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cCCcccccccchhccccccceeeeeeecc---ccceEEEEEechhhcch-hhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 34556789999999999999999998764 78999999998876544 345777899999999999999999999875
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
. .++++||||. |.+.++++.. ..+.|..+..++++++.||.|||..+.+|||||+.|||+ ...+.+||
T Consensus 84 ~--~LwiiMey~~gGsv~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~----s~~g~vkl 152 (467)
T KOG0201|consen 84 T--KLWIIMEYCGGGSVLDLLKSG-----NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL----SESGDVKL 152 (467)
T ss_pred c--cHHHHHHHhcCcchhhhhccC-----CCCccceeeeehHHHHHHhhhhhhcceecccccccceeE----eccCcEEE
Confidence 4 7899999999 5777777653 355889999999999999999999999999999999999 55578999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||.+..+...... ...++|||+||||||+.+ ..|+.++||||||+++|||++|.+||..... +.
T Consensus 153 ~DfgVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----------mr 218 (467)
T KOG0201|consen 153 ADFGVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHP-----------MR 218 (467)
T ss_pred Eecceeeeeechhhc--cccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCc-----------ce
Confidence 999999877665433 367899999999999996 4599999999999999999999999986543 11
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.++-+....+|. .....+..+++||..||++||+.||+|.++|.|.|.+
T Consensus 219 vlflIpk~~PP~-------------------------------L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk 267 (467)
T KOG0201|consen 219 VLFLIPKSAPPR-------------------------------LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIK 267 (467)
T ss_pred EEEeccCCCCCc-------------------------------cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHH
Confidence 111111111111 1123467899999999999999999999999999987
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 268 ~ 268 (467)
T KOG0201|consen 268 R 268 (467)
T ss_pred h
Confidence 4
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=370.88 Aligned_cols=289 Identities=37% Similarity=0.574 Sum_probs=221.6
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---c
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD---M 103 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---~ 103 (477)
+|++++.||+|+||.||+|.+.. ++..||||++............+.+|+.+++.++|+||+++++++..... .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence 58899999999999999998653 68899999987544333344577899999999999999999999865431 2
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+|+||||+.++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili----~~~~~~kL~Dfg 148 (372)
T cd07853 78 EIYVVTELMQSDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV----NSNCVLKICDFG 148 (372)
T ss_pred eEEEEeeccccCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE----CCCCCEEecccc
Confidence 6899999999999888765 3468999999999999999999999999999999999999 677889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+++........ ......+++.|+|||++.+...++.++|||||||++|||++|++||.+.+ ..+++..+..
T Consensus 149 ~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~ 219 (372)
T cd07853 149 LARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS--------PIQQLDLITD 219 (372)
T ss_pred ceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHH
Confidence 99865432211 12234568999999999886668999999999999999999999998765 4566777777
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCC--ccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGL--HSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
.++.++.+.+..... .....+.......... ........+.++.+||.+||+.||.+|||+.++|.||||...
T Consensus 220 ~~g~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 220 LLGTPSLEAMRSACE-----GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HcCCCCHHHHHHhhH-----HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 777665543321110 0000000000000000 011233446789999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=350.10 Aligned_cols=285 Identities=45% Similarity=0.806 Sum_probs=225.1
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|++++.||+|+||.||+|+++. ++..||||+++...........+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE--SRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEE
Confidence 58999999999999999998654 588999999976554444456778899999999999999999998764 4789
Q ss_pred EEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 107 LAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 107 lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
+||||+.++|.+++..... +..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 76 ~v~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~----~~~~~~~l~dfg~~~ 149 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI----DNKGVIKLADFGLAR 149 (285)
T ss_pred EEEecCCCCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE----cCCCcEEECccccee
Confidence 9999999999888865431 3468999999999999999999999999999999999999 677789999999997
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhC
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~ 266 (477)
....... ......+++.|+|||++.+...++.++|||||||++|+|+||++||.+.. ..+.+..++..++
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~--------~~~~~~~~~~~~~ 219 (285)
T cd07861 150 AFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS--------EIDQLFRIFRILG 219 (285)
T ss_pred ecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHHHhC
Confidence 6543221 12233568899999999776668899999999999999999999998654 3455666666677
Q ss_pred CCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.+....|+....++.|........ .. .........+.++.+||.+||+.||.+|||+.+++.|+||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 220 TPTEDVWPGVTSLPDYKNTFPKWK-----KG-SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred CCChhhhhcchhhHHHHhhccccC-----cc-hhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 666666665555444432211100 00 0011123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=360.35 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=205.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+++|++.+.||+|+||.||+|+++. ++..||||++..... .......+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN-- 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC--
Confidence 6899999999999999999998764 588999999875432 2233456778999999999999999999987644
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|++|||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll----~~~~~~kl~Df 162 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL----DNKGHVKVTDF 162 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----CCCCCEEEeec
Confidence 7899999987 5888888753 368899999999999999999999999999999999999 77788999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+. ......+.
T Consensus 163 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~ 228 (329)
T PTZ00263 163 GFAKKVPDR-----TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKIL 228 (329)
T ss_pred cCceEcCCC-----cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHh
Confidence 999865432 1235679999999999874 478999999999999999999999975441 11111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCcc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHEY 337 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~~ 337 (477)
... ..+|...+..+.+||.+||+.||.+|++ +++++.|||
T Consensus 229 ----~~~-------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 229 ----AGR-------------------------------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred ----cCC-------------------------------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 110 0122334577899999999999999997 799999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|..
T Consensus 274 f~~ 276 (329)
T PTZ00263 274 FHG 276 (329)
T ss_pred cCC
Confidence 974
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=366.15 Aligned_cols=292 Identities=36% Similarity=0.562 Sum_probs=220.5
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
...+++|++++.||+|+||.||+|++.. .+..||||++............+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhhhhceeEEEEeeecCCEEEEEEEecC---CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 3568999999999999999999998653 6888999999765544444567788999999999999999999986432
Q ss_pred ----CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccE
Q 011808 102 ----DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVV 177 (477)
Q Consensus 102 ----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~v 177 (477)
...+|++|||+++++.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 90 ~~~~~~~~~lv~e~~~~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill----~~~~~~ 158 (355)
T cd07874 90 SLEEFQDVYLVMELMDANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTL 158 (355)
T ss_pred cccccceeEEEhhhhcccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE----CCCCCE
Confidence 235799999999998887753 47888999999999999999999999999999999999 667789
Q ss_pred EEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 178 KIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+ ..+.
T Consensus 159 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~ 226 (355)
T cd07874 159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD--------YIDQ 226 (355)
T ss_pred EEeeCcccccCCCcc---ccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHH
Confidence 999999998654321 22335679999999999874 48999999999999999999999998765 3455
Q ss_pred HHHHHHHhCCCCCCCccccCC--------CccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 258 LDKIFKILGHPTPEKWPTLAN--------LPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
+..+...++.+.++.+..+.. .+.+........ ............+...+..+++||.+||+.||++|||+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~ 305 (355)
T cd07874 227 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL-FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305 (355)
T ss_pred HHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhh-ccccccccccccccccchHHHHHHHHHhcCCchhcCCH
Confidence 666666666655443322211 011000000000 00000000111222345678999999999999999999
Q ss_pred HHHhcCccCCC
Q 011808 330 AQALEHEYFRI 340 (477)
Q Consensus 330 ~e~L~h~~f~~ 340 (477)
.|+|.||||..
T Consensus 306 ~ell~hp~~~~ 316 (355)
T cd07874 306 DEALQHPYINV 316 (355)
T ss_pred HHHhcCcchhc
Confidence 99999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=349.98 Aligned_cols=284 Identities=41% Similarity=0.769 Sum_probs=222.1
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|++.+.||+|+||.||+|+++. ++..+++|.++...........+.+|+.+++.++|+||+++++++.+. ..+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceE
Confidence 69999999999999999998764 588999999976544444445677899999999999999999998654 4789
Q ss_pred EEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 107 LAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 107 lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
+++||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++
T Consensus 76 lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~----~~~~~~~l~dfg~~~ 147 (284)
T cd07839 76 LVFEYCDQDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI----NKNGELKLADFGLAR 147 (284)
T ss_pred EEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE----cCCCcEEECccchhh
Confidence 99999999998887653 2468999999999999999999999999999999999999 667789999999998
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhC
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~ 266 (477)
.+..... ......++..|+|||++.+...++.++|||||||++|+|+||..||..... ..+.+..++..++
T Consensus 148 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~-------~~~~~~~~~~~~~ 218 (284)
T cd07839 148 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-------VDDQLKRIFRLLG 218 (284)
T ss_pred ccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC-------HHHHHHHHHHHhC
Confidence 6543221 122345688999999998766689999999999999999999887643221 3456677777777
Q ss_pred CCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.+....|+.+...+.+..... +.............+.++.+||.+||+.||.+|||+++++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 219 TPTEESWPGVSKLPDYKPYPM------YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCChHHhHHhhhcccccccCC------CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 776666655554443321100 000000011223457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=358.88 Aligned_cols=249 Identities=27% Similarity=0.427 Sum_probs=199.1
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEe
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFD 110 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e 110 (477)
+.||+|+||.||+|+++. +++.||||+++..... ......+.+|+.+++.++||||+++++++.... .+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD--RLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC--EEEEEEe
Confidence 479999999999998764 6889999999754322 223346678999999999999999999987644 7899999
Q ss_pred ccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeec
Q 011808 111 YAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 111 ~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
|+. ++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll----~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 76 YANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML----DKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE----CCCCCEEEeeCCCCcccc
Confidence 998 5777777653 368999999999999999999999999999999999999 677789999999987532
Q ss_pred CCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCC
Q 011808 190 APLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPT 269 (477)
Q Consensus 190 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 269 (477)
... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...+. ..+...+....
T Consensus 147 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~------------~~~~~~~~~~~ 211 (323)
T cd05571 147 SDG--ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------EKLFELILMEE 211 (323)
T ss_pred cCC--CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCH------------HHHHHHHHcCC
Confidence 211 122346789999999999874 489999999999999999999999975431 11111111100
Q ss_pred CCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCccCCC
Q 011808 270 PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEYFRI 340 (477)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~f~~ 340 (477)
..++...+.++.+||++||++||++|+ ++.++++|+||..
T Consensus 212 -------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 212 -------------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred -------------------------------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 012344567899999999999999999 8999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.82 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=203.0
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++++.||+|+||.||+|+++. +++.||||++...... ......+.+|+.+++.++||||+++++++.+. ..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ--RF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC--Ce
Confidence 479999999999999999998764 5889999998654321 22344667899999999999999999987654 48
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli----~~~~~~kl~Dfg 146 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL----DKEGHIKLTDFG 146 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE----CCCCCEEEEecC
Confidence 899999987 6888888763 368999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. ......+..
T Consensus 147 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~ 212 (291)
T cd05612 147 FAKKLRDR-----TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILA 212 (291)
T ss_pred cchhccCC-----cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh
Confidence 99865432 1235679999999999874 489999999999999999999999976542 111221111
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCccC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHEYF 338 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~~f 338 (477)
.. ..++...+..+.+||++||+.||.+|++ +++++.|+||
T Consensus 213 ----~~-------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 213 ----GK-------------------------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred ----CC-------------------------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 00 0122334578999999999999999995 9999999999
Q ss_pred C
Q 011808 339 R 339 (477)
Q Consensus 339 ~ 339 (477)
.
T Consensus 258 ~ 258 (291)
T cd05612 258 K 258 (291)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=362.94 Aligned_cols=287 Identities=38% Similarity=0.614 Sum_probs=217.3
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA- 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 101 (477)
++.++|.+++.||+|+||.||+|.+.. ++..||||++............+.+|+.+++.++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTR---LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECC---CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 456899999999999999999998654 6889999998765433334456778999999999999999999875432
Q ss_pred ---CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 102 ---DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 102 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
...+|+++++++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 89 ~~~~~~~~~~~~~~~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~----~~~~~~k 158 (343)
T cd07878 89 IENFNEVYLVTNLMGADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV----NEDCELR 158 (343)
T ss_pred ccccCcEEEEeecCCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE----CCCCCEE
Confidence 135799999999998877653 358999999999999999999999999999999999999 6777899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+++..... .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+ ..+.+
T Consensus 159 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~ 225 (343)
T cd07878 159 ILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND--------YIDQL 225 (343)
T ss_pred EcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC--------HHHHH
Confidence 9999999865432 2345679999999999876668999999999999999999999997654 34555
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccc-cccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGR-KYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
..+....+.+.++.+..+..- ... ...... ......+.. .....++.+.+||.+||+.||.+|||+.++|.|||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 226 KRIMEVVGTPSPEVLKKISSE---HAR-KYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred HHHHHHhCCCCHHHHHhcchh---hHH-HHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 666666555544322221110 000 000000 000000000 01123566889999999999999999999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|..
T Consensus 301 ~~~ 303 (343)
T cd07878 301 FSQ 303 (343)
T ss_pred hhc
Confidence 974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=362.40 Aligned_cols=292 Identities=24% Similarity=0.318 Sum_probs=217.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
..+|++++.||+|+||.||+|.... ...+..|++|.+.... ...+|+.+|+.++||||+++++++... ..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~-~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~--~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHG-DEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWK--ST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcC-CccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeC--CE
Confidence 4579999999999999999997543 2456789999886432 345899999999999999999998654 47
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+|++||++.++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+
T Consensus 161 ~~lv~e~~~~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill----~~~~~~~l~DfG~ 231 (392)
T PHA03207 161 VCMVMPKYKCDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL----DEPENAVLGDFGA 231 (392)
T ss_pred EEEEehhcCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----cCCCCEEEccCcc
Confidence 899999999999998844 2468999999999999999999999999999999999999 6777899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
++.+.............||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+..... ...++..+.+.
T Consensus 232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~l~~i~~~ 305 (392)
T PHA03207 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-----SSSQLRSIIRC 305 (392)
T ss_pred ccccCcccccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-----cHHHHHHHHHH
Confidence 9766543332233346789999999999874 48999999999999999999999998765432 45666667776
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCcc-ccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCCCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHS-VVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPL 343 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~~~ 343 (477)
++..+.+....... ........+.........+.. ......+.++.+||.+||..||++|||+.++|.||||...+.
T Consensus 306 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 306 MQVHPLEFPQNGST--NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred hccCccccCCccch--hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 65444332111000 000000000000000000000 111234567899999999999999999999999999986543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=348.25 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=203.7
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
.|++.+.||+|+||.||+|.++. ++..||||.+....... .....+.+|+.+++.++|+||+++++++.+.. .+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~--~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD--AL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec---CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--eE
Confidence 38899999999999999998764 58899999987543322 22345678999999999999999999986543 78
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+++|||+. ++|...+.... ...+++..+..++.||+.||.|||++||+||||||+|||+ ++++.+||+|||+
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill----~~~~~~kl~Dfg~ 148 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL----DDRGHIRISDLGL 148 (285)
T ss_pred EEEEEecCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE----CCCCCEEEeeCCC
Confidence 99999998 57766665432 2368999999999999999999999999999999999999 6777899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+........ .....||..|+|||++.+. .++.++|||||||++|+|++|+.||.+.... .....+...
T Consensus 149 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~--------~~~~~~~~~ 216 (285)
T cd05631 149 AVQIPEGET---VRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--------VKREEVDRR 216 (285)
T ss_pred cEEcCCCCe---ecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcc--------hhHHHHHHH
Confidence 986543221 2234679999999999874 4899999999999999999999999865421 111112221
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCccCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHEYFR 339 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~~f~ 339 (477)
+.... ...+...+..+.+||++||+.||.+|++ ++++++||||.
T Consensus 217 ~~~~~-------------------------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~ 265 (285)
T cd05631 217 VKEDQ-------------------------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265 (285)
T ss_pred hhccc-------------------------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence 11110 0123344678999999999999999997 89999999997
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 266 ~ 266 (285)
T cd05631 266 N 266 (285)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=363.51 Aligned_cols=260 Identities=26% Similarity=0.377 Sum_probs=200.4
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|.+++.||+|+||.||+|+++. ++..||||++..... .......+.+|+++++.++||||++++++|.+.. .
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ--Y 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--e
Confidence 479999999999999999998764 688999999865432 2223456678999999999999999999997644 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll----~~~~~~kl~DfG 146 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI----DRGGHIKLSDFG 146 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE----CCCCCEEEeecc
Confidence 999999997 6888888653 368999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCC------------c---------------------------------ccCCCeeeccccccchhhcCCCCC
Q 011808 184 LARIYQAPLK------------F---------------------------------LSENGVVVTIWYRAPELLLGAKHY 218 (477)
Q Consensus 184 ~a~~~~~~~~------------~---------------------------------~~~~~~~gt~~y~APE~l~~~~~~ 218 (477)
+++.+..... . ......+||+.|+|||++.+. .+
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~ 225 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GY 225 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CC
Confidence 9863321000 0 000124689999999999774 48
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCC
Q 011808 219 TSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNG 298 (477)
Q Consensus 219 ~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (477)
+.++|||||||++|||++|.+||.+.+. .+.+..+.... ....+|
T Consensus 226 ~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~---------~~~~~p------------------ 270 (377)
T cd05629 226 GQECDWWSLGAIMFECLIGWPPFCSENS--------HETYRKIINWR---------ETLYFP------------------ 270 (377)
T ss_pred CCceeeEecchhhhhhhcCCCCCCCCCH--------HHHHHHHHccC---------CccCCC------------------
Confidence 9999999999999999999999975441 22222222110 000000
Q ss_pred CccccCCCCCchHHHHHHHhcccCCCCC---CCHHHHhcCccCCC
Q 011808 299 LHSVVPLSPKSPAYDLLSKMLEYDPRKR---ITAAQALEHEYFRI 340 (477)
Q Consensus 299 ~~~~~p~~~s~~~~dli~~~L~~dP~~R---pt~~e~L~h~~f~~ 340 (477)
.....+.++.+||.+||. +|.+| +|+.+++.||||+.
T Consensus 271 ----~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 271 ----DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred ----CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 011246789999999998 77765 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=357.84 Aligned_cols=255 Identities=29% Similarity=0.419 Sum_probs=206.1
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
-+++|.+++.||+|+||.||+|.++. ..+..||+|++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~- 104 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES- 104 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEEC--CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC-
Confidence 36789999999999999999998654 2346899999865432 2233456778999999999999999999987654
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 105 -~~~lv~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl----~~~~~ikL~D 174 (340)
T PTZ00426 105 -YLYLVLEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL----DKDGFIKMTD 174 (340)
T ss_pred -EEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE----CCCCCEEEec
Confidence 7899999997 6888888753 368999999999999999999999999999999999999 6778899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||++...... ....+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+. ......+
T Consensus 175 FG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i 240 (340)
T PTZ00426 175 FGFAKVVDTR-----TYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKI 240 (340)
T ss_pred CCCCeecCCC-----cceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHH
Confidence 9999865432 2345689999999999874 488999999999999999999999976542 1111111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHE 336 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~ 336 (477)
.. .. ...|...+..+.+||++||+.||++|+ ++.++++||
T Consensus 241 ~~----~~-------------------------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 241 LE----GI-------------------------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred hc----CC-------------------------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 11 00 012334467899999999999999996 899999999
Q ss_pred cCCC
Q 011808 337 YFRI 340 (477)
Q Consensus 337 ~f~~ 340 (477)
||..
T Consensus 286 ~f~~ 289 (340)
T PTZ00426 286 WFGN 289 (340)
T ss_pred CcCC
Confidence 9973
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=353.27 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=205.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcE-EEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKA-IAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.....+.+.||+|+||+||++.++ |.. ||||++............+.+|+.+|.+++|||||++++++.....
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~-----g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~- 113 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR-----GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG- 113 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC-----CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-
Confidence 345667778999999999999876 455 9999998776555556788999999999999999999999976543
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC-eecCCCCCCcEEEeccCCCcc-cEEEe
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW-IIHRDLKPSNILVMGEGEEQG-VVKIA 180 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g-ivHrDikp~NILl~~~~~~~~-~vkL~ 180 (477)
.++|||||+. |+|.+++... ....++...+..++.+|+.||+|||+++ |||||||++|||+ +.+. ++||+
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv----~~~~~~~KI~ 186 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV----DLKGKTLKIA 186 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE----cCCCCEEEEC
Confidence 6899999998 6888888763 1457999999999999999999999999 9999999999999 6665 99999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|||+++...... .......||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+... ..
T Consensus 187 DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----------~~ 253 (362)
T KOG0192|consen 187 DFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----------VQ 253 (362)
T ss_pred CCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----------HH
Confidence 999998765432 223336779999999999952 5699999999999999999999999987652 11
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.+..+... +....+|..++..+..||.+||..||.+||++.+++.-
T Consensus 254 ~~~~v~~~------------------------------~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~ 299 (362)
T KOG0192|consen 254 VASAVVVG------------------------------GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSR 299 (362)
T ss_pred HHHHHHhc------------------------------CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHH
Confidence 22222111 11122344466789999999999999999999988754
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=359.44 Aligned_cols=259 Identities=30% Similarity=0.500 Sum_probs=224.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|+.+++||+|+||.+++++++. ....+++|++......+.....+.+|+.+++++.|||||.+.+.|+.++ ..
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~---~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS---DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc---CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ce
Confidence 5789999999999999999999876 4679999999998888877788899999999999999999999997643 35
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
++|||+||+ |++.+.+...+ +.-++|..+..|+.|++.|+.|||+++|+|||||+.|||+ +.+..|||+|||
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl----tk~~~VkLgDfG 151 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL----TKDKKVKLGDFG 151 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc----cccCceeecchh
Confidence 999999999 58888887765 3468999999999999999999999999999999999999 666678999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+|+.+..... .....+||+.||.||++.+. .|+.++|||||||++|||++-+++|.+.+ ....+.+|..
T Consensus 152 laK~l~~~~~--~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--------m~~Li~ki~~ 220 (426)
T KOG0589|consen 152 LAKILNPEDS--LASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASN--------MSELILKINR 220 (426)
T ss_pred hhhhcCCchh--hhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccc--------hHHHHHHHhh
Confidence 9999876542 23457899999999999885 59999999999999999999999998776 3444555555
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+..| .|...+.+++.||+.||..+|+.||++.++|.+|.+.
T Consensus 221 ~~~~P----------------------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 221 GLYSP----------------------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ccCCC----------------------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 44333 3445578899999999999999999999999998875
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=345.82 Aligned_cols=289 Identities=47% Similarity=0.859 Sum_probs=232.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|++.+.||.|+||.||+|.++. ++..++||.++...........+.+|+.++++++||||+++++++.+.....
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKK---TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECC---CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence 5789999999999999999998764 5789999999766544444456678999999999999999999987765568
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+|++|||++++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||+
T Consensus 81 ~~lv~e~~~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili----~~~~~~~l~d~g~ 152 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL----NNRGILKICDFGL 152 (293)
T ss_pred EEEEehhcCcCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE----CCCCcEEEeecCc
Confidence 99999999999988887643 258999999999999999999999999999999999999 6778899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+..+..... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.... ..+.+.+++..
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~--------~~~~~~~~~~~ 222 (293)
T cd07843 153 AREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS--------EIDQLNKIFKL 222 (293)
T ss_pred eeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHH
Confidence 987654321 12234568899999999876667899999999999999999999998665 45667777888
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCC-CCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS-PKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
++.+....|+.+..++.+...... ......+...++.. .+..+.+||.+||+.||++|||+.|+|.|+||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 223 LGTPTEKIWPGFSELPGAKKKTFT----KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hCCCchHHHHHhhccchhcccccc----cccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 888887777766665544431111 01111122233333 57789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=370.08 Aligned_cols=288 Identities=26% Similarity=0.400 Sum_probs=206.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCC------CCeeEEEEEEE
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH------ENVVKLVNVHI 98 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~ 98 (477)
.++|+++++||+|+||+||+|++.. ++..||||+++... ........|+.+++.++| .+|++++++|.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcC---CCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3689999999999999999998764 57899999986432 122344567777777654 45889999886
Q ss_pred cCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCCCcEEEeccCC-----
Q 011808 99 NHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEGE----- 172 (477)
Q Consensus 99 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp~NILl~~~~~----- 172 (477)
.. ...+|+||++++++|++++... ..+++..++.++.||+.||.|||+ .|||||||||+|||+..++.
T Consensus 202 ~~-~~~~~iv~~~~g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NE-TGHMCIVMPKYGPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cC-CceEEEEEeccCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccc
Confidence 54 3478999999999999988764 368999999999999999999998 59999999999999954321
Q ss_pred -------CcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 011808 173 -------EQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAE 245 (477)
Q Consensus 173 -------~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~ 245 (477)
+...+||+|||.+..... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 123599999998764321 22346789999999999875 48999999999999999999999998765
Q ss_pred cccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccc---cccccccccccccCC------CCccccCCCCCchHHHHHH
Q 011808 246 AKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHW---QSDSLHIQGRKYETN------GLHSVVPLSPKSPAYDLLS 316 (477)
Q Consensus 246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~p~~~s~~~~dli~ 316 (477)
..+.+..+...++..+.+ |.......+. ........ ...... ..........++.+.|||.
T Consensus 350 --------~~~~~~~i~~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 419 (467)
T PTZ00284 350 --------NLEHLHLMEKTLGRLPSE-WAGRCGTEEARLLYNSAGQLR-PCTDPKHLARIARARPVREVIRDDLLCDLIY 419 (467)
T ss_pred --------hHHHHHHHHHHcCCCCHH-HHhhccchhHHHHhhhccccc-ccCCHHHHHhhhcccchhhhhchHHHHHHHH
Confidence 345566666666654322 2111000000 00000000 000000 0000000112456789999
Q ss_pred HhcccCCCCCCCHHHHhcCccCCC
Q 011808 317 KMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 317 ~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+||++||.+|+|++|+|.||||..
T Consensus 420 ~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 420 GLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred HhCCcChhhCCCHHHHhcCccccc
Confidence 999999999999999999999974
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=355.67 Aligned_cols=261 Identities=27% Similarity=0.417 Sum_probs=199.4
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
..-+.+|+++++||+|+||.||+|+++. +++.||||++..... ......+.+|+.+++.++|+||+++++++...
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 144 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRP---TGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHN- 144 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECC---CCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccC-
Confidence 3447889999999999999999998764 588999999865432 22345677899999999999999999998654
Q ss_pred CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 102 DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 102 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|+||||+.+..+. . ....++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 145 -~~~~lv~e~~~~~~L~---~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~~~~kL~D 211 (353)
T PLN00034 145 -GEIQVLLEFMDGGSLE---G-----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI----NSAKNVKIAD 211 (353)
T ss_pred -CeEEEEEecCCCCccc---c-----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE----cCCCCEEEcc
Confidence 4789999999864321 1 1235677889999999999999999999999999999999 6777899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA----KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
||+++.+..... ......||..|+|||++... ..++.++|||||||++|||++|+.||...... +
T Consensus 212 fG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--------~- 280 (353)
T PLN00034 212 FGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--------D- 280 (353)
T ss_pred cccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--------c-
Confidence 999987643221 12335679999999988431 23456899999999999999999999733211 1
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
...+...+.... ....+...+.++++||.+||+.||++|||+.|+|+|+|
T Consensus 281 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 281 WASLMCAICMSQ------------------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred HHHHHHHHhccC------------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 111111110000 00122344678999999999999999999999999999
Q ss_pred CCCC
Q 011808 338 FRIE 341 (477)
Q Consensus 338 f~~~ 341 (477)
|...
T Consensus 331 ~~~~ 334 (353)
T PLN00034 331 ILRA 334 (353)
T ss_pred cccC
Confidence 9743
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=342.25 Aligned_cols=286 Identities=42% Similarity=0.752 Sum_probs=230.6
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|++.+.||+|+||.||+|.+.. ++..|+||++............+.+|+.++++++|+||+++++++... ..+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeE
Confidence 69999999999999999998764 588999999987654444556788999999999999999999998764 4789
Q ss_pred EEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 107 LAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 107 lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
+||||++++|.+++.... ..+++.+++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++.
T Consensus 76 ~v~e~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~----~~~~~~~l~dfg~~~ 147 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI----SADGVLKIADFGLAR 147 (286)
T ss_pred EEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE----cCCCcEEEeeeeecc
Confidence 999999889998886542 468999999999999999999999999999999999999 667789999999998
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhC
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~ 266 (477)
....... .......++..|+|||++.+...++.++|||||||++|+|++|.++|.+.+ ....+..+...++
T Consensus 148 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~--------~~~~~~~~~~~~~ 218 (286)
T cd07832 148 LFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN--------DIEQLAIVFRTLG 218 (286)
T ss_pred cccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC--------HHHHHHHHHHHcC
Confidence 6654321 112234578999999999776667899999999999999999999997655 4566777788888
Q ss_pred CCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+....|+.+..++.|.......... ..+... ....+..+.+||.+||.+||.+|||++++|.||||.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 219 TPNEETWPGLTSLPDYNKITFPESKP----IPLEEI-FPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCChHHHhhccCcchhhcccCCCCCc----chHHHh-CCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 88888888777777664422211110 001111 123457899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=354.11 Aligned_cols=260 Identities=27% Similarity=0.469 Sum_probs=206.3
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++++.||+|+||.||+|+++. ++..||||+++..... ......+.+|+.+++.++||||+++++++.+.. .
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE--Y 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC--E
Confidence 479999999999999999998764 5889999999764322 223456778999999999999999999987644 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kL~Dfg 146 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI----DASGHIKLTDFG 146 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----CCCCCEEEEeCc
Confidence 899999997 5888888653 368999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++..... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+. .+.+..+..
T Consensus 147 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~ 212 (333)
T cd05600 147 LSKGIVT-----YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETWENLKY 212 (333)
T ss_pred CCccccc-----ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHHHHHHh
Confidence 9976543 22345689999999999875 589999999999999999999999976542 122222211
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
... ....|.+.. .....+.++.+||.+||..+|.+|+++.+++.|+||..
T Consensus 213 ~~~---------~~~~~~~~~------------------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 213 WKE---------TLQRPVYDD------------------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred ccc---------cccCCCCCc------------------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 100 000000000 01234678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=357.03 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=200.7
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++++.||+|+||+||+|+++. ++..||||++...... ......+.+|+.++++++|+||+++++++.+. ..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--Ce
Confidence 479999999999999999998764 6889999999754321 22334667799999999999999999998764 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi----~~~~~vkL~DFG 146 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL----DSKGHVKLSDFG 146 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE----CCCCCEEEeecc
Confidence 899999997 5888888653 368999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCc---------------------------------ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHH
Q 011808 184 LARIYQAPLKF---------------------------------LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCI 230 (477)
Q Consensus 184 ~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvi 230 (477)
+++.+...... ......+||+.|+|||++.+. .++.++|||||||+
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvi 225 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVI 225 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHH
Confidence 98754321100 001235789999999999874 48999999999999
Q ss_pred HHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCch
Q 011808 231 FAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP 310 (477)
Q Consensus 231 l~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~ 310 (477)
+|||++|+.||.+.+. .+....+...... . .+| .....+++
T Consensus 226 l~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~---~------~~p----------------------~~~~~s~~ 266 (363)
T cd05628 226 MYEMLIGYPPFCSETP--------QETYKKVMNWKET---L------IFP----------------------PEVPISEK 266 (363)
T ss_pred HHHHHhCCCCCCCCCH--------HHHHHHHHcCcCc---c------cCC----------------------CcCCCCHH
Confidence 9999999999976542 2222222211000 0 000 01124678
Q ss_pred HHHHHHHhcccCCC---CCCCHHHHhcCccCCC
Q 011808 311 AYDLLSKMLEYDPR---KRITAAQALEHEYFRI 340 (477)
Q Consensus 311 ~~dli~~~L~~dP~---~Rpt~~e~L~h~~f~~ 340 (477)
+.+||.+|+. +|. .||+++++++||||+.
T Consensus 267 ~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 267 AKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred HHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 9999999876 444 4589999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=343.86 Aligned_cols=296 Identities=39% Similarity=0.676 Sum_probs=223.6
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
....+++|+++++||+|+||.||+|.++. ++..||||++............+.+|+.++++++||||+++++++...
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECC---CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 34457899999999999999999998664 688999999876554444445667899999999999999999988654
Q ss_pred C------CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc
Q 011808 101 A------DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ 174 (477)
Q Consensus 101 ~------~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~ 174 (477)
. ....|+||||+.++|.+.+... ...+++.+++.++.||++||.|||++||+|+||||+||++ +.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~----~~~ 155 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCEHDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI----TKD 155 (310)
T ss_pred cccccCCCceEEEEEcCCCcCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE----CCC
Confidence 3 2357999999999998887653 2368999999999999999999999999999999999999 677
Q ss_pred ccEEEeecccceeecCCCCc--ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCc
Q 011808 175 GVVKIADFGLARIYQAPLKF--LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252 (477)
Q Consensus 175 ~~vkL~DFG~a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~ 252 (477)
+.+||+|||++..+...... .......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~------- 228 (310)
T cd07865 156 GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT------- 228 (310)
T ss_pred CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC-------
Confidence 78999999999866432211 111234568889999998776667889999999999999999999997654
Q ss_pred ccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 011808 253 FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332 (477)
Q Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~ 332 (477)
....+..+....+..+++.++....+..|...... .. ..........+...+..+.+||.+||..||.+|||++++
T Consensus 229 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~ 304 (310)
T cd07865 229 -EQHQLTLISQLCGSITPEVWPGVDKLELFKKMELP--QG-QKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304 (310)
T ss_pred -HHHHHHHHHHHhCCCChhhcccccchhhhhhccCC--Cc-cchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 23444555556666666655554433332211100 00 000000111122245678899999999999999999999
Q ss_pred hcCccC
Q 011808 333 LEHEYF 338 (477)
Q Consensus 333 L~h~~f 338 (477)
|.||||
T Consensus 305 l~h~~f 310 (310)
T cd07865 305 LNHDFF 310 (310)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=357.19 Aligned_cols=260 Identities=25% Similarity=0.395 Sum_probs=202.7
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++++.||+|+||+||+|+++. ++..||||++..... .......+.+|+.+++.++|+||+++++++.+.. .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN--Y 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--e
Confidence 479999999999999999998764 588999999975432 1223345678999999999999999999987644 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~----~~~~~~kl~Dfg 146 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL----DAKGHIKLSDFG 146 (364)
T ss_pred EEEEECCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE----CCCCCEEEeecc
Confidence 899999997 5787877653 368999999999999999999999999999999999999 777889999999
Q ss_pred cceeecCCCCc------------------------------------ccCCCeeeccccccchhhcCCCCCCchhhHHHH
Q 011808 184 LARIYQAPLKF------------------------------------LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAV 227 (477)
Q Consensus 184 ~a~~~~~~~~~------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSl 227 (477)
++..+...... ......+||+.|+|||++.+. .++.++|||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSl 225 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSL 225 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecc
Confidence 98754321100 001124689999999999774 48999999999
Q ss_pred HHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCC
Q 011808 228 GCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSP 307 (477)
Q Consensus 228 Gvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 307 (477)
||++|||++|.+||.+.+. ...+..+... ... +........
T Consensus 226 G~il~el~~G~~Pf~~~~~--------~~~~~~i~~~---~~~----------------------------~~~~~~~~~ 266 (364)
T cd05599 226 GVIMYEMLVGYPPFCSDNP--------QETYRKIINW---KET----------------------------LQFPDEVPL 266 (364)
T ss_pred hhHHHHhhcCCCCCCCCCH--------HHHHHHHHcC---CCc----------------------------cCCCCCCCC
Confidence 9999999999999976542 1122222110 000 000011134
Q ss_pred CchHHHHHHHhcccCCCCCCC---HHHHhcCccCCC
Q 011808 308 KSPAYDLLSKMLEYDPRKRIT---AAQALEHEYFRI 340 (477)
Q Consensus 308 s~~~~dli~~~L~~dP~~Rpt---~~e~L~h~~f~~ 340 (477)
++.+.+||.+||. ||.+|++ +.+++.||||+.
T Consensus 267 s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 267 SPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 6789999999997 9999998 999999999974
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=359.14 Aligned_cols=261 Identities=26% Similarity=0.360 Sum_probs=200.8
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
..|++++.||+|+||+||+|+++. ++..||||++..... .......+.+|+.+++.++|+||+++++++.+. ..
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~ 75 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVD---THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DN 75 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CE
Confidence 369999999999999999998764 688999999976432 223345677899999999999999999999764 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++++||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili----~~~~~~kL~DFG 146 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI----DLDGHIKLTDFG 146 (381)
T ss_pred EEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE----CCCCCEEEeeCc
Confidence 999999997 5888888653 368999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCC---------------------------------------------cccCCCeeeccccccchhhcCCCCC
Q 011808 184 LARIYQAPLK---------------------------------------------FLSENGVVVTIWYRAPELLLGAKHY 218 (477)
Q Consensus 184 ~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~ 218 (477)
++..+..... .......+||+.|+|||++.+. .+
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~ 225 (381)
T cd05626 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GY 225 (381)
T ss_pred CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CC
Confidence 9754311000 0001235789999999999874 48
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCC
Q 011808 219 TSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNG 298 (477)
Q Consensus 219 ~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (477)
+.++|||||||++|||++|..||...+. .+....+..... .
T Consensus 226 ~~~~DiwSlG~il~elltG~~Pf~~~~~--------~~~~~~i~~~~~---~---------------------------- 266 (381)
T cd05626 226 TQLCDWWSVGVILFEMLVGQPPFLAPTP--------TETQLKVINWEN---T---------------------------- 266 (381)
T ss_pred CCccceeehhhHHHHHHhCCCCCcCCCH--------HHHHHHHHcccc---c----------------------------
Confidence 9999999999999999999999976542 111111111000 0
Q ss_pred CccccCCCCCchHHHHHHHhccc--CCCCCCCHHHHhcCccCCC
Q 011808 299 LHSVVPLSPKSPAYDLLSKMLEY--DPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 299 ~~~~~p~~~s~~~~dli~~~L~~--dP~~Rpt~~e~L~h~~f~~ 340 (477)
+........++++.+||.+||.. ++..|+++++++.||||..
T Consensus 267 ~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 267 LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 00001123467899999996654 5556999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=350.25 Aligned_cols=253 Identities=32% Similarity=0.463 Sum_probs=200.6
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCC--CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEE
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD--GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLA 108 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv 108 (477)
++.||+|+||.||+|++......+..||||+++.... .......+.+|+.+++.++||||++++++|... ..+|+|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEE
Confidence 4689999999999998765456788999999875432 122234566899999999999999999998764 378999
Q ss_pred EeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 109 FDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 109 ~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
|||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 79 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 79 LEYLSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL----DAQGHVKLTDFGLCKE 149 (323)
T ss_pred EeCCCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCCEEEeeCcCCee
Confidence 99998 4787777653 368899999999999999999999999999999999999 6777899999999875
Q ss_pred ecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCC
Q 011808 188 YQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267 (477)
Q Consensus 188 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~ 267 (477)
...... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+. ...+..+..
T Consensus 150 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~---- 214 (323)
T cd05584 150 SIHEGT--VTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILK---- 214 (323)
T ss_pred cccCCC--cccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc----
Confidence 432221 12335679999999999774 478999999999999999999999976542 122222211
Q ss_pred CCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCccCCC
Q 011808 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEYFRI 340 (477)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~f~~ 340 (477)
.. ..++...+..+.+||.+||++||++|+ ++.+++.||||..
T Consensus 215 ~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 215 GK-------------------------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred CC-------------------------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 00 012334467899999999999999999 8999999999974
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=360.43 Aligned_cols=288 Identities=24% Similarity=0.341 Sum_probs=206.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
...|.+.+.||+|+||.||+|++.. .+..||||.... ....+|+++|++++|+||+++++++... ..
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD---YPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVG--GL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC---CCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CE
Confidence 3479999999999999999998764 578899996432 2356899999999999999999998764 37
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
.|++|+++.++|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+
T Consensus 235 ~~lv~e~~~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl----~~~~~vkL~DFGl 306 (461)
T PHA03211 235 TCLVLPKYRSDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV----NGPEDICLGDFGA 306 (461)
T ss_pred EEEEEEccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE----CCCCCEEEcccCC
Confidence 89999999999999886532 368999999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
++.+.............||+.|+|||++.+. .++.++|||||||++|||++|..++-.........++ ..++..++..
T Consensus 307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~-~~~l~~~i~~ 384 (461)
T PHA03211 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPY-DAQILRIIRQ 384 (461)
T ss_pred ceecccccccccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCc-HHHHHHHHHh
Confidence 9866433222222345689999999999874 4899999999999999999987654332222122222 2334444444
Q ss_pred hCCCCCCCccccCCCccccccccc---cccc-cccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLH---IQGR-KYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
......+ ++.... ..+...... .... .+....+ ..-...+..+.+||.+||++||.+|||+.|+|+|+||+
T Consensus 385 ~~~~~~~-~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~ 459 (461)
T PHA03211 385 AQVHVDE-FPQHAG-SRLVSQYRHRAARNRRPAYTRPAW--TRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459 (461)
T ss_pred hcccccc-CCCCcc-hHHHHHHHhhhhcccCCccCCcch--hhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence 3322211 110000 000000000 0000 0000000 00113356789999999999999999999999999996
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=342.71 Aligned_cols=284 Identities=44% Similarity=0.804 Sum_probs=223.3
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|++++.||.|+||.||+|+++. ++..|+||.++...........+.+|++++++++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC--CcEE
Confidence 48999999999999999998754 588999999976655454556788999999999999999999998654 4789
Q ss_pred EEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 107 LAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 107 lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
++|||+.++|..++.... ...+++..++.++.||+.||+|||+.+++|+||+|+||++ +.++.+||+|||++.
T Consensus 76 ~v~e~~~~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill----~~~~~~~l~dfg~~~ 148 (284)
T cd07860 76 LVFEFLHQDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI----NTEGAIKLADFGLAR 148 (284)
T ss_pred EEeeccccCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEEeeccchh
Confidence 999999988888876543 3468999999999999999999999999999999999999 677789999999987
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhC
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~ 266 (477)
.+..... ......++..|+|||++.+...++.++|||||||++|+|+||+.||.+.+ ..+.+.++....+
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~--------~~~~~~~~~~~~~ 218 (284)
T cd07860 149 AFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--------EIDQLFRIFRTLG 218 (284)
T ss_pred hcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHHHhC
Confidence 6543221 12223458899999998876657889999999999999999999997654 4456666777777
Q ss_pred CCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.+....|+....++.+........ ...+.. .....+.++++||.+||+.||.+|||++++|.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 219 TPDEVVWPGVTSLPDYKPSFPKWA-----RQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred CCChhhhhhhhHHHHHHhhccccc-----ccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 776666655444443333211110 000111 122356788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=338.25 Aligned_cols=287 Identities=39% Similarity=0.715 Sum_probs=223.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
..+|.+++.||+|+||.||+|.++. ++..|+||.+..... ......+.+|+.+++.++|+||+++++++.+. ..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~ 77 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI---NGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTK--ET 77 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC---CCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC--Ce
Confidence 3689999999999999999998764 578999999875443 23344667899999999999999999998754 47
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
.|++|||+.++++..+... ...+++..++.++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||+
T Consensus 78 ~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~----~~~~~~~l~Dfg~ 149 (291)
T cd07870 78 LTFVFEYMHTDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI----SYLGELKLADFGL 149 (291)
T ss_pred EEEEEecccCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE----cCCCcEEEecccc
Confidence 8999999999998877543 2357888899999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
++....... ......+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+. ..+.+.++...
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~-------~~~~~~~~~~~ 220 (291)
T cd07870 150 ARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD-------VFEQLEKIWTV 220 (291)
T ss_pred ccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh-------HHHHHHHHHHH
Confidence 875433221 123345689999999997655578899999999999999999999976542 34666677777
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCcc-ccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHS-VVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
++.+....++.+..++.+........... .+.. ......+..+.+||.+||+.||.+|||+.+++.||||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 221 LGVPTEDTWPGVSKLPNYKPEWFLPCKPQ----QLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cCCCChhhhhhhhhcccccchhccccCCc----chhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 77777777766666665544321111000 0000 0011235678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=356.75 Aligned_cols=260 Identities=27% Similarity=0.388 Sum_probs=201.5
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++++.||+|+||.||+|+++. +++.||||++..... .......+.+|+.+|++++|+||+++++++.+. ..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD---TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK--DN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CE
Confidence 479999999999999999998764 588999999865332 122345667899999999999999999998764 48
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill----~~~~~ikL~DFG 146 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI----DRDGHIKLTDFG 146 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE----CCCCCEEEEeCC
Confidence 999999997 6888888653 368999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCC-----------------------------------------CcccCCCeeeccccccchhhcCCCCCCchh
Q 011808 184 LARIYQAPL-----------------------------------------KFLSENGVVVTIWYRAPELLLGAKHYTSAV 222 (477)
Q Consensus 184 ~a~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~ 222 (477)
++..+.... ........+||+.|+|||++.+. .++.++
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 225 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC 225 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcce
Confidence 975321000 00011235789999999999874 489999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccc
Q 011808 223 DMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSV 302 (477)
Q Consensus 223 DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (477)
|||||||++|+|++|+.||.+.+. .+....+... ... +...
T Consensus 226 DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~---~~~----------------------------~~~~ 266 (376)
T cd05598 226 DWWSVGVILYEMLVGQPPFLADTP--------AETQLKVINW---ETT----------------------------LHIP 266 (376)
T ss_pred eeeeccceeeehhhCCCCCCCCCH--------HHHHHHHhcc---Ccc----------------------------ccCC
Confidence 999999999999999999976542 1111111110 000 0001
Q ss_pred cCCCCCchHHHHHHHhcccCCCCCC---CHHHHhcCccCCC
Q 011808 303 VPLSPKSPAYDLLSKMLEYDPRKRI---TAAQALEHEYFRI 340 (477)
Q Consensus 303 ~p~~~s~~~~dli~~~L~~dP~~Rp---t~~e~L~h~~f~~ 340 (477)
.....+.++.+||.+|+ .||.+|+ |+.+++.||||+.
T Consensus 267 ~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 267 SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 11234678899999977 5999999 9999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.88 Aligned_cols=290 Identities=44% Similarity=0.797 Sum_probs=224.1
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCC--
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHAD-- 102 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~-- 102 (477)
++|++.+.||+|+||.||+|.+.. ++..||||++............+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN---TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC---CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 479999999999999999998764 6889999998776544445567888999999995 6999999998865432
Q ss_pred -ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCC-cccEEEe
Q 011808 103 -MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE-QGVVKIA 180 (477)
Q Consensus 103 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~-~~~vkL~ 180 (477)
..+|++|||++++|.+++..........+++..++.++.||+.||.|||++||+||||||+||++ +. ++.+||+
T Consensus 78 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~----~~~~~~~kl~ 153 (295)
T cd07837 78 KPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLV----DKQKGLLKIA 153 (295)
T ss_pred CceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE----ecCCCeEEEe
Confidence 34899999999999998876543323468999999999999999999999999999999999999 44 6789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||++..+..... ......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ....+..
T Consensus 154 dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~--------~~~~~~~ 223 (295)
T cd07837 154 DLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS--------ELQQLLH 223 (295)
T ss_pred ecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHH
Confidence 9999986543221 11223458899999999776668999999999999999999999998755 3455666
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
++..++.++.+.|+.......|.... ......+.. .....+..+.+||.+||.+||.+||++.++|.||||+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 224 IFKLLGTPTEQVWPGVSKLRDWHEFP------QWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHHHhCCCChhhCcchhhccchhhcC------cccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 77777777766665444333222100 000000001 1123567899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=359.62 Aligned_cols=260 Identities=27% Similarity=0.398 Sum_probs=201.0
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.+|+++++||+|+||.||+|+++. ++..||||++..... .......+.+|+.+++.++|+||++++++|.+.. .
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~--~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVD---TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--N 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--E
Confidence 369999999999999999998764 688999999875432 1223446678999999999999999999997644 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl----~~~g~~kL~DFG 146 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI----DRDGHIKLTDFG 146 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCCEEEeECC
Confidence 999999998 5888887653 368999999999999999999999999999999999999 677889999999
Q ss_pred cceeecCCCC---------------------------------------------cccCCCeeeccccccchhhcCCCCC
Q 011808 184 LARIYQAPLK---------------------------------------------FLSENGVVVTIWYRAPELLLGAKHY 218 (477)
Q Consensus 184 ~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~ 218 (477)
++..+..... .......+||+.|+|||++.+. .|
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~ 225 (382)
T cd05625 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GY 225 (382)
T ss_pred CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CC
Confidence 9753211000 0001234689999999999874 48
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCC
Q 011808 219 TSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNG 298 (477)
Q Consensus 219 ~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (477)
+.++|||||||++|||++|++||.+.+. .+....+ +......
T Consensus 226 ~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i---~~~~~~~--------------------------- 267 (382)
T cd05625 226 TQLCDWWSVGVILYEMLVGQPPFLAQTP--------LETQMKV---INWQTSL--------------------------- 267 (382)
T ss_pred CCeeeEEechHHHHHHHhCCCCCCCCCH--------HHHHHHH---HccCCCc---------------------------
Confidence 9999999999999999999999976542 1111111 1100000
Q ss_pred CccccCCCCCchHHHHHHHhcccCCCCCCC---HHHHhcCccCCC
Q 011808 299 LHSVVPLSPKSPAYDLLSKMLEYDPRKRIT---AAQALEHEYFRI 340 (477)
Q Consensus 299 ~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt---~~e~L~h~~f~~ 340 (477)
........++++.+||.+|+ .||.+|++ +++++.||||+.
T Consensus 268 -~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 268 -HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred -CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 00011234678999999987 59999997 999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=351.25 Aligned_cols=265 Identities=26% Similarity=0.486 Sum_probs=216.1
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 104 (477)
..|+++++||+||-+.||+++.. +...||+|++............+..|+..|.+| .|.+||+|+++-.. +.+
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s----~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS----DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC----CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--Cce
Confidence 56999999999999999999743 356789998887777777788889999999999 59999999998765 559
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+||||||.+.+|..+|.+.. .-+....++.+..||+.|+.++|..||||.||||.|+|+ -.|.+||+|||+
T Consensus 435 lYmvmE~Gd~DL~kiL~k~~----~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-----VkG~LKLIDFGI 505 (677)
T KOG0596|consen 435 LYMVMECGDIDLNKILKKKK----SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-----VKGRLKLIDFGI 505 (677)
T ss_pred EEEEeecccccHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-----EeeeEEeeeech
Confidence 99999999999999998753 234556899999999999999999999999999999998 356799999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCC----------CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCccc
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAK----------HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----------~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~ 254 (477)
|..+.......-...-+||+.||+||-+.... ..+.++||||||||||+|+.|++||...
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------- 575 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------- 575 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----------
Confidence 99888777777777789999999999986422 1567999999999999999999999631
Q ss_pred HHHHHHHHHHhCCC-CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 255 LDQLDKIFKILGHP-TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 255 ~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
.....++. .|..| ....++++.+ ..++.++++.||.+||.+|||+.++|
T Consensus 576 ~n~~aKl~-aI~~P~~~Iefp~~~~-----------------------------~~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 576 INQIAKLH-AITDPNHEIEFPDIPE-----------------------------NDELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred HHHHHHHH-hhcCCCccccccCCCC-----------------------------chHHHHHHHHHHhcCcccCCCcHHHh
Confidence 12333333 33333 3233333221 13489999999999999999999999
Q ss_pred cCccCCCCCCCC
Q 011808 334 EHEYFRIEPLPG 345 (477)
Q Consensus 334 ~h~~f~~~~~~~ 345 (477)
+|||+...+++.
T Consensus 626 qhpFl~~~~i~~ 637 (677)
T KOG0596|consen 626 QHPFLQIQPIPV 637 (677)
T ss_pred cCcccccccccc
Confidence 999998655543
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=338.01 Aligned_cols=287 Identities=40% Similarity=0.742 Sum_probs=222.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|++.+.||+|+||.||+|.++. ++..||||.+....... ....+.+|+.+++.++|+||+++++++.+. ..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 77 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKL---TGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTK--KT 77 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcC---CCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecC--Ce
Confidence 6889999999999999999998653 57899999987644322 233567899999999999999999998754 47
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
.|+||||+.++|.+++.... ..+++..++.++.||++||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 78 ~~lv~e~~~~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~----~~~~~~kl~dfg~ 149 (291)
T cd07844 78 LTLVFEYLDTDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI----SERGELKLADFGL 149 (291)
T ss_pred EEEEEecCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE----cCCCCEEECcccc
Confidence 89999999999988876542 368899999999999999999999999999999999999 6777899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
++....... ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+... ..+++..+...
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~~~~ 220 (291)
T cd07844 150 ARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD-------VEDQLHKIFRV 220 (291)
T ss_pred ccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc-------HHHHHHHHHHh
Confidence 875432211 112234588899999998756688999999999999999999999975542 34566777788
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCcccc-CCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV-PLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
++.+.+..|+.....+.+........ ....+.... .......+.+||.+||+.||++|||+.++|.|+||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 221 LGTPTEETWPGVSSNPEFKPYSFPFY----PPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cCCCChhhhhhhhhcccccccccccc----CChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 88877777766554333322111100 001111111 11122678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=340.28 Aligned_cols=289 Identities=47% Similarity=0.826 Sum_probs=225.9
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC---CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG---DGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+|.+.+.||+|+||.||+|.++. ++..|+||.++..... ......+..|+.+++.++|+||+++++++.+ +.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CC
Confidence 58999999999999999998664 5889999999766543 3334456789999999999999999999976 34
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+|+||||+.++|.+++.... ..+++..++.++.||++||.|||++||+|+||||+|||+ +.++.++|+|||
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill----~~~~~~~l~dfg 147 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI----ASDGVLKLADFG 147 (298)
T ss_pred EEEEEEcccCCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE----cCCCCEEEccce
Confidence 889999999889988886532 268999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++......... .....+++.|+|||.+.+...++.++|||||||++|+|++|.++|.+.+ ..+.+..+..
T Consensus 148 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~--------~~~~~~~~~~ 217 (298)
T cd07841 148 LARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS--------DIDQLGKIFE 217 (298)
T ss_pred eeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc--------cHHHHHHHHH
Confidence 99876543221 1223457889999999776668999999999999999999999887654 3455666777
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPL 343 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~~~ 343 (477)
.++.+....|+.....+.+..... ........ .....+..+.+||.+||.+||++|||+.++|.|+||+..+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 218 ALGTPTEENWPGVTSLPDYVEFKP------FPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred HcCCCchhhhhhcccccccccccc------cCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 777776666665554443322110 00111111 12344678999999999999999999999999999986554
Q ss_pred CC
Q 011808 344 PG 345 (477)
Q Consensus 344 ~~ 345 (477)
+.
T Consensus 291 ~~ 292 (298)
T cd07841 291 PT 292 (298)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=353.43 Aligned_cols=260 Identities=28% Similarity=0.444 Sum_probs=206.5
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|.+++.||+|+||.||+|+++. ++..||||+++...... .....+.+|+.+++.++|+||+++++++.+. ..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE--EH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC--Ce
Confidence 479999999999999999998764 68899999997643322 3445677899999999999999999988664 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll----~~~~~~kL~Dfg 146 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI----DADGHIKLADFG 146 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE----CCCCCEEeecCC
Confidence 999999997 6888888763 368999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCC---------------------------CcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh
Q 011808 184 LARIYQAPL---------------------------KFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236 (477)
Q Consensus 184 ~a~~~~~~~---------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt 236 (477)
++..+.... .........||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~ 225 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLY 225 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhcc
Confidence 998654332 01122345689999999999875 58999999999999999999
Q ss_pred CCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHH
Q 011808 237 LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLS 316 (477)
Q Consensus 237 G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~ 316 (477)
|+.||...+. ......+....... .+| .....++++.+||.
T Consensus 226 g~~Pf~~~~~--------~~~~~~i~~~~~~~---------~~p----------------------~~~~~~~~~~~li~ 266 (350)
T cd05573 226 GFPPFYSDTL--------QETYNKIINWKESL---------RFP----------------------PDPPVSPEAIDLIC 266 (350)
T ss_pred CCCCCCCCCH--------HHHHHHHhccCCcc---------cCC----------------------CCCCCCHHHHHHHH
Confidence 9999976541 22222222110000 000 01114678999999
Q ss_pred HhcccCCCCCCC-HHHHhcCccCCC
Q 011808 317 KMLEYDPRKRIT-AAQALEHEYFRI 340 (477)
Q Consensus 317 ~~L~~dP~~Rpt-~~e~L~h~~f~~ 340 (477)
+||. ||.+|++ +++++.||||+.
T Consensus 267 ~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 267 RLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 9997 9999999 999999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=349.00 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=198.3
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEe
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFD 110 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e 110 (477)
+.||+|+||.||+|+++. ++..||||++...... ......+.+|+.+++.++||||+++++++.+.. .+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD--RLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--EEEEEEe
Confidence 479999999999998764 6889999999764322 233456778999999999999999999987644 7899999
Q ss_pred ccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeec
Q 011808 111 YAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 111 ~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
|+. ++|...+... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 76 y~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll----~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 76 YVNGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML----DKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE----CCCCcEEEecCcCCccCC
Confidence 998 5777776542 368999999999999999999999999999999999999 677789999999987532
Q ss_pred CCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCC
Q 011808 190 APLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPT 269 (477)
Q Consensus 190 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 269 (477)
.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. . .+...+...
T Consensus 147 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~----~~~~~~~~~- 210 (328)
T cd05593 147 TDAA--TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------E----KLFELILME- 210 (328)
T ss_pred Cccc--ccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCH--------H----HHHHHhccC-
Confidence 2111 12335689999999999874 489999999999999999999999975431 1 111111100
Q ss_pred CCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCccCCC
Q 011808 270 PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEYFRI 340 (477)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~f~~ 340 (477)
...+|...+.++.+||++||++||.+|+ ++.++++|+||..
T Consensus 211 ------------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 211 ------------------------------DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred ------------------------------CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 0113344567899999999999999997 8999999999963
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=347.51 Aligned_cols=249 Identities=26% Similarity=0.417 Sum_probs=197.8
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEe
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFD 110 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e 110 (477)
+.||+|+||.||+++++. ++..||+|+++.... .......+.+|+.+++.++||||++++++|.... .+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--EEEEEEe
Confidence 479999999999998764 688999999976432 1223446678999999999999999999987644 7899999
Q ss_pred ccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeec
Q 011808 111 YAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 111 ~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
|+. ++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 76 YANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML----DKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE----cCCCCEEecccHHhcccc
Confidence 998 5777766542 368999999999999999999999999999999999999 667789999999987532
Q ss_pred CCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCC
Q 011808 190 APLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPT 269 (477)
Q Consensus 190 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 269 (477)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+. ......+.. ..
T Consensus 147 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~----~~ 211 (323)
T cd05595 147 SDGA--TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILM----EE 211 (323)
T ss_pred CCCC--ccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhc----CC
Confidence 2111 12335679999999999774 489999999999999999999999975442 111111110 00
Q ss_pred CCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCccCCC
Q 011808 270 PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEYFRI 340 (477)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~f~~ 340 (477)
..+|...++++.+||.+||++||.+|+ ++.++++|+||..
T Consensus 212 -------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 212 -------------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred -------------------------------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 012344568899999999999999998 8999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=337.37 Aligned_cols=288 Identities=46% Similarity=0.838 Sum_probs=228.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|++.+.||+|++|.||+|.++. +++.|+||.+............+.+|+.+++.++|+||+++++++.+. ..
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 75 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRV---TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KR 75 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecC---CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC--Ce
Confidence 4789999999999999999998754 588999999876554444445678899999999999999999998764 47
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
.|+||||++++|.+.+.... ...+++..++.++.||+.||+|||+++|+||||||+||++.. .++.+||+|||+
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~---~~~~~kl~dfg~ 149 (294)
T PLN00009 76 LYLVFEYLDLDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADFGL 149 (294)
T ss_pred EEEEEecccccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC---CCCEEEEccccc
Confidence 89999999999888876533 234688899999999999999999999999999999999942 345699999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+........ ......+++.|+|||++.+...++.++|||||||++|+|+||.+||...+ ..+.+.+++..
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~--------~~~~~~~~~~~ 219 (294)
T PLN00009 150 ARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS--------EIDELFKIFRI 219 (294)
T ss_pred ccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHH
Confidence 976543211 11234568899999999776668899999999999999999999998655 34566677788
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
++.+....|.....+++|....... .. ..........+..+.+||.+||+.||++||++.++++|+||.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~ 288 (294)
T PLN00009 220 LGTPNEETWPGVTSLPDYKSAFPKW-----PP-KDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288 (294)
T ss_pred hCCCChhhccccccchhhhhhcccC-----CC-CCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence 8888888887766666653321110 00 011112334567899999999999999999999999999996
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=348.57 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=197.2
Q ss_pred ecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEecc
Q 011808 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYA 112 (477)
Q Consensus 34 lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~ 112 (477)
||+|+||.||+|+++. ++..||||+++.... .......+.+|+.+++.++||||+++++++.+. ..+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCC
Confidence 7999999999998764 588999999875432 222345667899999999999999999988664 4789999999
Q ss_pred C-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCC
Q 011808 113 E-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191 (477)
Q Consensus 113 ~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~ 191 (477)
. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 76 ~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili----~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 76 NGGELFHHLQRE-----GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL----DYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE----CCCCcEEEEECcccccCccC
Confidence 8 5888887653 368999999999999999999999999999999999999 67778999999999754322
Q ss_pred CCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCC
Q 011808 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPE 271 (477)
Q Consensus 192 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 271 (477)
.. .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. ..++..+....
T Consensus 147 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~------------~~~~~~~~~~~-- 209 (312)
T cd05585 147 DD--KTNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENV------------NEMYRKILQEP-- 209 (312)
T ss_pred CC--ccccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCH------------HHHHHHHHcCC--
Confidence 11 22345689999999999874 489999999999999999999999975431 11222111110
Q ss_pred CccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC---CHHHHhcCccCCC
Q 011808 272 KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI---TAAQALEHEYFRI 340 (477)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp---t~~e~L~h~~f~~ 340 (477)
..++...+..+.+||.+||.+||.+|+ ++.++|.||||..
T Consensus 210 -----------------------------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 210 -----------------------------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred -----------------------------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 112344567899999999999999997 5899999999974
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=364.45 Aligned_cols=266 Identities=26% Similarity=0.408 Sum_probs=212.0
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
...++|.+.+.||+|+||+||+|++.. ++..||||++............+.+|+.++..++|+||+++++.+.....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVS---DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcC---CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 345799999999999999999998764 68899999997765544445567789999999999999999887754321
Q ss_pred ------ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 103 ------MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 103 ------~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
..+++||||+. ++|.+++.... .....+++..+..++.||+.||.|||+++|+||||||+|||+ +.++
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl----~~~~ 180 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL----CSNG 180 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE----eCCC
Confidence 24789999998 68988887543 224578999999999999999999999999999999999999 6677
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccH
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~ 255 (477)
.+||+|||+++.+............+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+. .
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--------~ 251 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENM--------E 251 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------H
Confidence 8999999999876543322233446789999999999874 489999999999999999999999975441 1
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+.+..+.. .. ....+...++++.+||.+||+.||.+||++.+++.|
T Consensus 252 ~~~~~~~~----~~------------------------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 EVMHKTLA----GR------------------------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHhc----CC------------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111111 00 011234456789999999999999999999999999
Q ss_pred ccCC
Q 011808 336 EYFR 339 (477)
Q Consensus 336 ~~f~ 339 (477)
||++
T Consensus 298 p~~~ 301 (496)
T PTZ00283 298 PICK 301 (496)
T ss_pred HHHH
Confidence 9986
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=354.72 Aligned_cols=262 Identities=24% Similarity=0.348 Sum_probs=205.6
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
-.++|++++.||+|+||.||+|+++. ++..||||++...... ......+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-- 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-- 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence 35789999999999999999998764 6889999999653322 22234566899999999999999999988764
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|+||||+. ++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl----~~~~~~kL~D 185 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL----DKSGHLKLAD 185 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE----cCCCCEEEEe
Confidence 47999999997 5788777542 58899999999999999999999999999999999999 7778899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAK---HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
||++........ ......+||+.|+|||++.+.. .++.++|||||||++|||++|++||.+.+. ...+
T Consensus 186 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~ 256 (370)
T cd05596 186 FGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTY 256 (370)
T ss_pred ccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHH
Confidence 999986643221 1223456899999999987532 378899999999999999999999976542 1222
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCc
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK--RITAAQALEHE 336 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~--Rpt~~e~L~h~ 336 (477)
..+.. ......++ .....+.++.+||.+||+.+|.+ |+|+++++.||
T Consensus 257 ~~i~~---~~~~~~~~----------------------------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 257 SKIMD---HKNSLTFP----------------------------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred HHHHc---CCCcCCCC----------------------------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 22211 11000010 11234678999999999999988 99999999999
Q ss_pred cCCC
Q 011808 337 YFRI 340 (477)
Q Consensus 337 ~f~~ 340 (477)
||+.
T Consensus 306 ~~~~ 309 (370)
T cd05596 306 FFKN 309 (370)
T ss_pred ccCC
Confidence 9974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=346.27 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=198.0
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHH---HhcCCCCeeEEEEEEEcCCCc
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLL---REITHENVVKLVNVHINHADM 103 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~ 103 (477)
|++++.||+|+||.||+|.++. ++..||||+++..... ......+.+|+.++ +.++||||+++++++.+..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~-- 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED-- 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC--
Confidence 7899999999999999998764 6889999999754321 22334556666655 4668999999999987644
Q ss_pred eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+.+ +|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill----~~~~~~kL~Df 145 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL----DTEGFVKIADF 145 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE----CCCCcEEeCcc
Confidence 78999999985 66655532 368999999999999999999999999999999999999 67778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++........ .....+|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. .+.+..+.
T Consensus 146 g~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~~~~i~ 214 (324)
T cd05589 146 GLCKEGMGFGD--RTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEVFDSIV 214 (324)
T ss_pred cCCccCCCCCC--cccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence 99875332111 22346789999999999874 489999999999999999999999976542 12222221
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCcc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEY 337 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~ 337 (477)
.. . ...+...+..+.+||.+||++||.+|| ++.+++.|+|
T Consensus 215 ~~----~-------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~ 259 (324)
T cd05589 215 ND----E-------------------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259 (324)
T ss_pred hC----C-------------------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence 10 0 012334567899999999999999999 7999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|+.
T Consensus 260 f~~ 262 (324)
T cd05589 260 FRD 262 (324)
T ss_pred cCC
Confidence 974
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=345.93 Aligned_cols=284 Identities=24% Similarity=0.371 Sum_probs=206.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++++.||+|+||.||+++++. ++..+|+|.+..... ......+.+|+++++.++||||+++++++.+.. .
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP---SGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--E 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC---CCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--E
Confidence 4789999999999999999998764 688999999875432 223456788999999999999999999987644 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
+++||||+. ++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~----~~~~~~kl~Df 148 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV----NSRGEIKLCDF 148 (331)
T ss_pred EEEEeecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE----cCCCcEEEccC
Confidence 899999998 4888887653 3689999999999999999999986 69999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++..+.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.. .+ .
T Consensus 149 g~~~~~~~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~---------~~---~ 211 (331)
T cd06649 149 GVSGQLIDSM----ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAK---------EL---E 211 (331)
T ss_pred cccccccccc----cccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---------HH---H
Confidence 9987654321 2335679999999999874 4899999999999999999999999754421 11 1
Q ss_pred HHhCCCCC----CCccccCCCccccc--------cc----ccccccccc-CCCCccccCCCCCchHHHHHHHhcccCCCC
Q 011808 263 KILGHPTP----EKWPTLANLPHWQS--------DS----LHIQGRKYE-TNGLHSVVPLSPKSPAYDLLSKMLEYDPRK 325 (477)
Q Consensus 263 ~~~~~~~~----~~~~~~~~~~~~~~--------~~----~~~~~~~~~-~~~~~~~~p~~~s~~~~dli~~~L~~dP~~ 325 (477)
..++.+.. ..+......+.... .. .......+. ............+.++++||.+||++||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~ 291 (331)
T cd06649 212 AIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAE 291 (331)
T ss_pred HHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCccc
Confidence 12221110 00000000000000 00 000000000 000011112235678999999999999999
Q ss_pred CCCHHHHhcCccCCC
Q 011808 326 RITAAQALEHEYFRI 340 (477)
Q Consensus 326 Rpt~~e~L~h~~f~~ 340 (477)
|||+.++|+|+||+.
T Consensus 292 Rpt~~ell~h~~~~~ 306 (331)
T cd06649 292 RADLKMLMNHTFIKR 306 (331)
T ss_pred CCCHHHHhcChHHhh
Confidence 999999999999974
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=330.71 Aligned_cols=265 Identities=28% Similarity=0.408 Sum_probs=211.7
Q ss_pred ccccceeEEe-eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcC
Q 011808 23 EWLQQYNLIG-KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINH 100 (477)
Q Consensus 23 ~~~~~Y~i~~-~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 100 (477)
.+.++|.+-. +||-|-.|+|..+.++. +++.+|+|++... .++.+|+++.-.. .|||||.++++|++.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~---T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKR---TQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEecc---chhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 4678887754 79999999999998875 6899999998653 4677899887666 699999999999753
Q ss_pred --CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccE
Q 011808 101 --ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVV 177 (477)
Q Consensus 101 --~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~v 177 (477)
...++.+|||.++ |.|+..+.+++. ..++|.++..|++||..|+.|||+.+|.||||||+|+|.+.+ ..+..+
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t-~~na~l 203 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTT-SPNAPL 203 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecC-CCCcce
Confidence 3457899999998 699999988763 479999999999999999999999999999999999999766 456789
Q ss_pred EEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 178 KIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
||+|||+|+....... ..+.|-||+|.|||++...+ |+..+|+|||||++|-||+|.+||...... .+.-.-
T Consensus 204 KLtDfGFAK~t~~~~~---L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGyPPFYS~hg~----aispgM 275 (400)
T KOG0604|consen 204 KLTDFGFAKETQEPGD---LMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGM 275 (400)
T ss_pred EecccccccccCCCcc---ccCCcccccccCHHHhCchh-cCCCCCccchhHHHHHhhcCCCcccccCCc----cCChhH
Confidence 9999999997654332 23356699999999996644 999999999999999999999999865421 112222
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
..+|..---..+.++|.. +|+.++|+|++||..+|++|+|+.++++|||
T Consensus 276 k~rI~~gqy~FP~pEWs~-------------------------------VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 276 KRRIRTGQYEFPEPEWSC-------------------------------VSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred HhHhhccCccCCChhHhH-------------------------------HHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 233322222223333322 3578999999999999999999999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
...
T Consensus 325 i~~ 327 (400)
T KOG0604|consen 325 INQ 327 (400)
T ss_pred hcc
Confidence 863
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=350.47 Aligned_cols=253 Identities=30% Similarity=0.422 Sum_probs=202.2
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEe
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFD 110 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e 110 (477)
++.||+|+||.||++++.....++..||+|++............+.+|+.++++++||||+++++++.+. ..+|+|||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 78 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLILD 78 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEEc
Confidence 3689999999999998765556789999999976543333344667899999999999999999998764 47899999
Q ss_pred ccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeec
Q 011808 111 YAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 111 ~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
|+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 79 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 79 FLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL----DEEGHIKLTDFGLSKESI 149 (318)
T ss_pred CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE----CCCCcEEEeeccCCcccC
Confidence 997 6888877542 368999999999999999999999999999999999999 667789999999987654
Q ss_pred CCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCC
Q 011808 190 APLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPT 269 (477)
Q Consensus 190 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 269 (477)
.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. ...+..+....
T Consensus 150 ~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~~~~---- 214 (318)
T cd05582 150 DHEK--KAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMILKAK---- 214 (318)
T ss_pred CCCC--ceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHHcCC----
Confidence 3211 12235679999999999774 478999999999999999999999976541 12222221100
Q ss_pred CCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCccCCC
Q 011808 270 PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHEYFRI 340 (477)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~~f~~ 340 (477)
..++...+..+.+||++||++||++|++ +.+++.|+||..
T Consensus 215 -------------------------------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 215 -------------------------------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred -------------------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 0123344678999999999999999999 778999999974
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=340.34 Aligned_cols=291 Identities=43% Similarity=0.769 Sum_probs=225.1
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA-- 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 101 (477)
.+++|++.++||+|+||.||+|.++. ++..++||++............+.+|+++++.++|+||+++++++....
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 47999999999999999999998764 5788999998765544444456678999999999999999999876533
Q ss_pred ----CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccE
Q 011808 102 ----DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVV 177 (477)
Q Consensus 102 ----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~v 177 (477)
...+|++|+|+.+++...+... ...+++..++.++.||++||.|||++||+|+||||+|||+ +.++.+
T Consensus 83 ~~~~~~~~~lv~~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~----~~~~~~ 154 (311)
T cd07866 83 SKRKRGSVYMVTPYMDHDLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI----DNQGIL 154 (311)
T ss_pred ccccCceEEEEEecCCcCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCCE
Confidence 2368999999999988877653 2369999999999999999999999999999999999999 777889
Q ss_pred EEeecccceeecCCCCcc---------cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc
Q 011808 178 KIADFGLARIYQAPLKFL---------SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~---------~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~ 248 (477)
+|+|||++.......... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~--- 231 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS--- 231 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC---
Confidence 999999997654322111 11234568889999998776668999999999999999999999998765
Q ss_pred CCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC
Q 011808 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT 328 (477)
Q Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt 328 (477)
.......++...+.+.+..|+....++......... . ....+.. .-...+..+.+||.+||..||++|||
T Consensus 232 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t 301 (311)
T cd07866 232 -----DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFT---N-YPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLT 301 (311)
T ss_pred -----HHHHHHHHHHHhCCCChhhchhhhhcccccccccCC---C-CCccHHH-HcccCChhHHHHHHHHcccCcccCcC
Confidence 445667777777777766666544444332200000 0 0001111 11223467889999999999999999
Q ss_pred HHHHhcCccC
Q 011808 329 AAQALEHEYF 338 (477)
Q Consensus 329 ~~e~L~h~~f 338 (477)
+.+++.|+||
T Consensus 302 ~~ell~~~~f 311 (311)
T cd07866 302 ASDALEHPYF 311 (311)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=350.16 Aligned_cols=263 Identities=24% Similarity=0.335 Sum_probs=204.6
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
..++|++++.||+|+||.||+|+++. ++..+|+|++...... ......+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-- 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-- 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--
Confidence 35789999999999999999998764 6889999998653222 22234566899999999999999999998764
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|+||||+. ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl----~~~~~~kL~D 185 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL----DKHGHLKLAD 185 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE----CCCCCEEEEe
Confidence 47999999997 6888887542 58899999999999999999999999999999999999 6778899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAK---HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
||++..+..... ......+||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+. ...+
T Consensus 186 FG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~ 256 (370)
T cd05621 186 FGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTY 256 (370)
T ss_pred cccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHH
Confidence 999987643221 1223457899999999997532 378899999999999999999999976542 2222
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCc
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK--RITAAQALEHE 336 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~--Rpt~~e~L~h~ 336 (477)
..+..... ...++ .....+..+.+||.+||..++.+ |+|+.++++||
T Consensus 257 ~~i~~~~~---~~~~p----------------------------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 257 SKIMDHKN---SLNFP----------------------------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred HHHHhCCc---ccCCC----------------------------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 33222110 00000 11234677899999999866544 89999999999
Q ss_pred cCCCC
Q 011808 337 YFRIE 341 (477)
Q Consensus 337 ~f~~~ 341 (477)
||+..
T Consensus 306 ~~~~~ 310 (370)
T cd05621 306 FFKND 310 (370)
T ss_pred ccCCC
Confidence 99753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=340.36 Aligned_cols=256 Identities=29% Similarity=0.509 Sum_probs=214.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
-+-|.++.+||+|+||.||+|.++. +|..+|||.+..+. ..+++++||.|+.+++.|++|++|+.|+.+. -
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~E---sG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--D 102 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRE---SGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--D 102 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhc---cCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCC--c
Confidence 3568999999999999999998775 79999999987643 3678899999999999999999999887765 5
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+++|||||+ |+..++++.. +.+|+|.++..+++..+++|+|||...-||||||..|||| +..|+.||+|||
T Consensus 103 LWIVMEYCGAGSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL----NT~G~AKLADFG 174 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL----NTDGIAKLADFG 174 (502)
T ss_pred eEeehhhcCCCcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE----cccchhhhhhcc
Confidence 899999999 7888888765 4589999999999999999999999999999999999999 778899999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
.+..+.... ...+...|||+|||||++..-. |+.++||||||++..||..|++||.+-- .+..||-
T Consensus 175 VAGQLTDTM--AKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIH-----------PMRAIFM 240 (502)
T KOG0574|consen 175 VAGQLTDTM--AKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIH-----------PMRAIFM 240 (502)
T ss_pred ccchhhhhH--HhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCccccc-----------ccceeEe
Confidence 998776543 3456788999999999997643 9999999999999999999999997433 2333333
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+-..|+|. +..|..-|+++-|||++||.++|++|-|+.++++|+|.+.
T Consensus 241 IPT~PPPT-----------------------------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 241 IPTKPPPT-----------------------------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred ccCCCCCC-----------------------------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 33333322 1123333567889999999999999999999999999874
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=348.88 Aligned_cols=261 Identities=24% Similarity=0.328 Sum_probs=205.4
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|.+.+.||+|+||.||+|+++. ++..||||+++.... .......+.+|+.+++.++|+||+++++++.+. ..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--Ce
Confidence 479999999999999999998764 688999999976543 222344567799999999999999999998764 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll----~~~~~~kL~Dfg 147 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI----DRTGHIKLADFG 147 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE----CCCCCEEeccCC
Confidence 899999996 68888887642 368999999999999999999999999999999999999 777889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLG-----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
++..+...... ......||+.|+|||++.. ...++.++|||||||++|+|++|..||...+. ...+
T Consensus 148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~ 218 (330)
T cd05601 148 SAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTY 218 (330)
T ss_pred CCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHH
Confidence 99876543221 2223467999999999863 34578899999999999999999999976542 1222
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..+... ..... .......+..+.+||.+||. ||.+|+|+++++.||||
T Consensus 219 ~~i~~~---~~~~~----------------------------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~ 266 (330)
T cd05601 219 NNIMNF---QRFLK----------------------------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF 266 (330)
T ss_pred HHHHcC---CCccC----------------------------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence 222111 00000 00112346789999999998 99999999999999999
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
..
T Consensus 267 ~~ 268 (330)
T cd05601 267 SK 268 (330)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=346.73 Aligned_cols=291 Identities=36% Similarity=0.580 Sum_probs=218.3
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA- 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 101 (477)
.+.++|++++.||+|+||.||+|++.. ++..||||.+............+.+|+.+++.++|+||++++++|....
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTV---TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKS 89 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECC---CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCC
Confidence 457899999999999999999998764 6889999998765444444556778999999999999999999986432
Q ss_pred ---CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 102 ---DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 102 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
....|+||||+.++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 90 ~~~~~~~~lv~e~~~~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~----~~~~~~k 158 (353)
T cd07850 90 LEEFQDVYLVMELMDANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLK 158 (353)
T ss_pred ccccCcEEEEEeccCCCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE----CCCCCEE
Confidence 235799999999999887753 37888999999999999999999999999999999999 6777899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||...+ ..+..
T Consensus 159 L~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~--------~~~~~ 226 (353)
T cd07850 159 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTD--------HIDQW 226 (353)
T ss_pred EccCccceeCCCCCC---CCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCC--------HHHHH
Confidence 999999986543221 2234568899999999874 48999999999999999999999998655 34556
Q ss_pred HHHHHHhCCCCCCCccccCCCc-cccccccccccccccC-------CCCccccCCCCCchHHHHHHHhcccCCCCCCCHH
Q 011808 259 DKIFKILGHPTPEKWPTLANLP-HWQSDSLHIQGRKYET-------NGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA 330 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-------~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~ 330 (477)
..+...++.++.+.+..+.... .+...........+.. .......+...+..+.+||.+||+.||.+|||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 306 (353)
T cd07850 227 NKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306 (353)
T ss_pred HHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHH
Confidence 6666666666543322211100 0000000000000000 0000001223355689999999999999999999
Q ss_pred HHhcCccCC
Q 011808 331 QALEHEYFR 339 (477)
Q Consensus 331 e~L~h~~f~ 339 (477)
++|.||||+
T Consensus 307 eiL~~~~~~ 315 (353)
T cd07850 307 DALQHPYIN 315 (353)
T ss_pred HHhcChhHh
Confidence 999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=345.29 Aligned_cols=254 Identities=28% Similarity=0.396 Sum_probs=200.5
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCC-CeeEEEEEEEcCCCce
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHE-NVVKLVNVHINHADMS 104 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~ 104 (477)
+|++++.||+|+||.||+|+++. ++..||||++..... .......+..|+.+++.+.|+ +|+++++++.+.+ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--R 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC--E
Confidence 58999999999999999998764 578999999976432 223345677899999999765 6888888886543 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill----~~~~~~kL~Dfg 146 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML----DAEGHIKIADFG 146 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE----cCCCCEEEeecC
Confidence 899999997 5887777653 368899999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++........ .....+||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+. .+.+..+..
T Consensus 147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~ 215 (324)
T cd05587 147 MCKENIFGGK--TTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIME 215 (324)
T ss_pred cceecCCCCC--ceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHc
Confidence 9875322111 22335689999999999874 489999999999999999999999976542 122222211
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH-----HHHhcCccC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA-----AQALEHEYF 338 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~-----~e~L~h~~f 338 (477)
.. ..++...+..+.+||.+||.+||.+|++. .++++||||
T Consensus 216 ----~~-------------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~ 260 (324)
T cd05587 216 ----HN-------------------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF 260 (324)
T ss_pred ----CC-------------------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCc
Confidence 00 01233456789999999999999999976 899999999
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
..
T Consensus 261 ~~ 262 (324)
T cd05587 261 RR 262 (324)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=344.63 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=198.6
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREI-THENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
++||+|+||.||+|+++. ++..||||+++..... ......+.+|+.+++.+ +||||++++++|.+.. .+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~--~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES--RLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC--EEEEEE
Confidence 479999999999998764 6889999999765432 22334567899999988 7999999999987644 789999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili----~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 76 EFVSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL----DAEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE----CCCCCEEECcCcccccc
Confidence 9998 5787777543 369999999999999999999999999999999999999 66778999999998743
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..............+. +.+.+...
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~ 220 (329)
T cd05588 147 IRPGD--TTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY---LFQVILEK 220 (329)
T ss_pred ccCCC--ccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHH---HHHHHHcC
Confidence 22111 22345789999999999874 48999999999999999999999997433211111001111 11111100
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC------HHHHhcCccCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT------AAQALEHEYFRI 340 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt------~~e~L~h~~f~~ 340 (477)
...+|...+..+.+||++||++||.+|+| +++++.||||..
T Consensus 221 -------------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 221 -------------------------------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred -------------------------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 01134445678999999999999999997 789999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=374.20 Aligned_cols=275 Identities=28% Similarity=0.438 Sum_probs=215.6
Q ss_pred CCCccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEE
Q 011808 18 HGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVH 97 (477)
Q Consensus 18 ~~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 97 (477)
......++++|++++.||+|+||+||+|+++. ++..+|+|++............+..|+.+|+.|+||||++++++|
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f 81 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKR---TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRF 81 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECC---CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 34455678999999999999999999998764 678999999976655444556788899999999999999999999
Q ss_pred EcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-------CeecCCCCCCcEEEec
Q 011808 98 INHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-------WIIHRDLKPSNILVMG 169 (477)
Q Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-------givHrDikp~NILl~~ 169 (477)
.+.....+||||||+. ++|.++|...... ...+++..++.|+.||+.||.|||+. +||||||||+||||..
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 8776678999999998 5888888764321 34699999999999999999999984 4999999999999953
Q ss_pred cC-------------CCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHHHHH
Q 011808 170 EG-------------EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELL 235 (477)
Q Consensus 170 ~~-------------~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~ell 235 (477)
+. +....+||+|||++..+.... .....+||+.|+|||++.+. ..++.++||||||||||+|+
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 21 223469999999998654322 12335679999999998653 34889999999999999999
Q ss_pred hCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHH
Q 011808 236 TLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLL 315 (477)
Q Consensus 236 tG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli 315 (477)
||..||...+. +..++..+...+.. .....+..+.+||
T Consensus 238 TGk~PF~~~~~-----------~~qli~~lk~~p~l-------------------------------pi~~~S~eL~dLI 275 (1021)
T PTZ00266 238 SGKTPFHKANN-----------FSQLISELKRGPDL-------------------------------PIKGKSKELNILI 275 (1021)
T ss_pred HCCCCCCcCCc-----------HHHHHHHHhcCCCC-------------------------------CcCCCCHHHHHHH
Confidence 99999975431 12222222111100 0012356799999
Q ss_pred HHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 316 SKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 316 ~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
.+||..||.+||++.++|.|+|++..
T Consensus 276 ~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 276 KNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHhcCChhHCcCHHHHhccHHHhhc
Confidence 99999999999999999999999743
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=366.51 Aligned_cols=296 Identities=25% Similarity=0.396 Sum_probs=206.5
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecc---------------cCCCCCCCcHHHHHHHHHHHhcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFK---------------QSKDGDGVSPTAIREIMLLREITH 87 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~---------------~~~~~~~~~~~~~~Ei~il~~l~h 87 (477)
.+.++|+++++||+|+||+||+|.++.. .+..+++|.+. ...........+.+|+.+|+.++|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRAS--TEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEecc--chhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence 4678999999999999999999976542 22222222111 111112223456789999999999
Q ss_pred CCeeEEEEEEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEE
Q 011808 88 ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILV 167 (477)
Q Consensus 88 pnIv~l~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl 167 (477)
+||+++++++.+.. ..|++++++.++|++++...............++.++.||+.||.|||++|||||||||+|||+
T Consensus 223 pnIv~l~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl 300 (501)
T PHA03210 223 ENILKIEEILRSEA--NTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300 (501)
T ss_pred CCcCcEeEEEEECC--eeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 99999999997654 6899999999999988865433323345567888999999999999999999999999999999
Q ss_pred eccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCccc
Q 011808 168 MGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL-FQGAEA 246 (477)
Q Consensus 168 ~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~P-F~~~~~ 246 (477)
+.++.+||+|||+++.+...... .....+||..|+|||++.+. .|+.++|||||||++|||++|..+ |.....
T Consensus 301 ----~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~ 374 (501)
T PHA03210 301 ----NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374 (501)
T ss_pred ----CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence 66778999999999876543221 22345789999999999874 489999999999999999998754 432221
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCcccc-CCCcccccccccccccccc--CCCCcc-ccCCCCCchHHHHHHHhcccC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTL-ANLPHWQSDSLHIQGRKYE--TNGLHS-VVPLSPKSPAYDLLSKMLEYD 322 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~-~~p~~~s~~~~dli~~~L~~d 322 (477)
....++.+++..+.....+ +++. ..+.+| +....+. ...+.. ......+..+.++|.+||.+|
T Consensus 375 ------~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~------i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~D 441 (501)
T PHA03210 375 ------KPGKQLLKIIDSLSVCDEE-FPDPPCKLFDY------IDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD 441 (501)
T ss_pred ------CHHHHHHHHHHhcccChhh-cCCcHHHHHHH------hhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccC
Confidence 1344555555554432221 2111 000000 0000000 000101 112234567889999999999
Q ss_pred CCCCCCHHHHhcCccCCCC
Q 011808 323 PRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 323 P~~Rpt~~e~L~h~~f~~~ 341 (477)
|.+|||+.|+|.||||...
T Consensus 442 P~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 442 WHLRPGAAELLALPLFSAE 460 (501)
T ss_pred cccCcCHHHHhhChhhhcC
Confidence 9999999999999999743
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=358.56 Aligned_cols=258 Identities=26% Similarity=0.469 Sum_probs=208.2
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
+.|+|+..||.|+||+||+|.++. ++...|.|++.... .+....++-||.||..++||+||+|++.|+... .+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nke---t~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~en--kL 104 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKE---TKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYFEN--KL 104 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhccc---chhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC--ce
Confidence 568999999999999999998764 57778888885433 334567788999999999999999999887654 68
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
+|..|||+|.-.+.+.-. .+..|++.++..+++|++.||.|||+++|||||||..|||+ +.+|.|+|+|||.+
T Consensus 105 wiliEFC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~----TldGdirLADFGVS 177 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL----TLDGDIRLADFGVS 177 (1187)
T ss_pred EEEEeecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE----EecCcEeeeccccc
Confidence 999999997555544332 24589999999999999999999999999999999999999 55666999999998
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLG----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
...... ......++|||+|||||+..+ ...|+.++|||||||+|.||..+.+|.... ..+..+
T Consensus 178 AKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-----------npMRVl 244 (1187)
T KOG0579|consen 178 AKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-----------NPMRVL 244 (1187)
T ss_pred ccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-----------chHHHH
Confidence 654332 223456899999999999864 346999999999999999999999998743 345555
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.++-...+|. +. .|...+..+.|||.+||.+||..||+++++|.||||.
T Consensus 245 lKiaKSePPT----Ll-------------------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 245 LKIAKSEPPT----LL-------------------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred HHHhhcCCCc----cc-------------------------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 5554433332 11 2333356789999999999999999999999999997
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=341.07 Aligned_cols=263 Identities=22% Similarity=0.339 Sum_probs=201.4
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++++.||+|+||.||+++++. ++..||||++..... .......+.+|+.+++.++|+||+++++++.+. ..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE--NN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--Ce
Confidence 579999999999999999998764 588999999875322 122334567799999999999999999998764 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill----~~~~~~kl~Dfg 147 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL----DKNGHIRLADFG 147 (331)
T ss_pred EEEEEecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE----CCCCCEEEEECC
Confidence 999999986 6888888653 2368999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLG----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
++..+...... .....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+. .+...
T Consensus 148 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~~~ 218 (331)
T cd05597 148 SCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYG 218 (331)
T ss_pred ceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHHHH
Confidence 98765432221 1223468999999999963 24478899999999999999999999975431 12222
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCcc
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK--RITAAQALEHEY 337 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~--Rpt~~e~L~h~~ 337 (477)
.+... ..... ++ ......+..+++||++||..++.+ |+++.+++.|||
T Consensus 219 ~i~~~---~~~~~------~~---------------------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 219 KIMNH---KEHFQ------FP---------------------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred HHHcC---CCccc------CC---------------------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 22111 00000 00 011124678999999999765443 789999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|..
T Consensus 269 ~~~ 271 (331)
T cd05597 269 FEG 271 (331)
T ss_pred CCC
Confidence 964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=333.00 Aligned_cols=284 Identities=40% Similarity=0.790 Sum_probs=225.3
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|+++++||.|++|.||+|+++. ++..||||+++.... ......+.+|+.+++.++|+||+++++++.+.. .++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---TGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTEN--KLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---CCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--cEE
Confidence 59999999999999999998764 588999999976543 223456778999999999999999999987654 689
Q ss_pred EEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 107 LAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 107 lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
+||||+.++|.+++..... ...+++..+..++.||+.||.|||+.||+||||||+||++ ++++.++|+|||++.
T Consensus 75 lv~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~----~~~~~~~l~d~g~~~ 148 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI----NKRGELKLADFGLAR 148 (284)
T ss_pred EEEecCCccHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE----CCCCcEEEeecchhh
Confidence 9999999999988876432 2468999999999999999999999999999999999999 667789999999997
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhC
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~ 266 (477)
....... ......++..|++||++.+...++.++|||||||++|+|++|+.||.+.+ ..+.+..++....
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~--------~~~~~~~~~~~~~ 218 (284)
T cd07836 149 AFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN--------NEDQLLKIFRIMG 218 (284)
T ss_pred hhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------cHHHHHHHHHHhC
Confidence 5543221 12234568899999999776667899999999999999999999998665 3456667777777
Q ss_pred CCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.+....|..+...+.+......... .... ......+..+.++|.+||+.||.+||++.++++||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 219 TPTESTWPGISQLPEYKPTFPRYPP-----QDLQ-QLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChhhHHHHhcCchhcccccCCCh-----HHHH-HHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 7777777666655554432111110 0011 1112346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=335.48 Aligned_cols=259 Identities=26% Similarity=0.373 Sum_probs=203.6
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
.|++.+.||+|+||.||++.+.. ++..||||++....... .....+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeE
Confidence 48999999999999999998653 58899999987543322 2234567899999999999999999998664 379
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|++|||+. ++|.+.+.... ...+++..+..++.||+.||.|||+.||+||||||+||++ ++++.++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~~l~Dfg~ 148 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL----DDYGHIRISDLGL 148 (285)
T ss_pred EEEEeccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE----CCCCCEEEeeCCC
Confidence 99999998 57776665432 2468999999999999999999999999999999999999 6778899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+........ ....+|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.... .....+...
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~--------~~~~~~~~~ 216 (285)
T cd05605 149 AVEIPEGET---IRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK--------VKREEVERR 216 (285)
T ss_pred ceecCCCCc---cccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchh--------hHHHHHHHH
Confidence 986543221 1234679999999999774 4899999999999999999999999865421 111222222
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCccCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEYFR 339 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~f~ 339 (477)
+..... ..+...+..+.+||.+||..||.+|+ ++++++.|+||.
T Consensus 217 ~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05605 217 VKEDQE-------------------------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265 (285)
T ss_pred hhhccc-------------------------------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence 111100 12233467789999999999999999 899999999997
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 266 ~ 266 (285)
T cd05605 266 T 266 (285)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=344.32 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=196.9
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREI-THENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
+.||+|+||.||+|+++. ++..||||++..... .......+..|+.+++.+ +||||+++++++.+.. .+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~--~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD--RLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC--EEEEEE
Confidence 479999999999998764 688999999875432 223345667788888876 7999999999987644 789999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+. ++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 76 Ey~~~g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli----~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 76 EFVNGGDLMFHIQKS-----RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL----DHEGHCKLADFGMCKEG 146 (320)
T ss_pred cCCCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE----CCCCcEEEeeCCCCeec
Confidence 9998 5777777653 368999999999999999999999999999999999999 67778999999998754
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. ...+..+. ..
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~----~~ 211 (320)
T cd05590 147 IFNGK--TTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAIL----ND 211 (320)
T ss_pred CcCCC--cccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHh----cC
Confidence 22111 22345689999999999774 489999999999999999999999976542 11122221 11
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH------HHHhcCccCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA------AQALEHEYFRI 340 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~------~e~L~h~~f~~ 340 (477)
. ...+...+.++.+||++||++||.+|+++ .+++.||||..
T Consensus 212 ~-------------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 212 E-------------------------------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred C-------------------------------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 0 01223346789999999999999999998 99999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=347.03 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=197.2
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEe
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFD 110 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e 110 (477)
+.||+|+||.||+|+++. ++..||+|+++..... ......+.+|+++++.++||||+++++++.... .+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~--~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC--EEEEEEe
Confidence 479999999999998764 6889999999764322 223446678999999999999999999887644 7899999
Q ss_pred ccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 111 YAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 111 ~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
|+. ++|..++... ..+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||+++..
T Consensus 76 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll----~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 76 YANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML----DKDGHIKITDFGLCKEG 146 (325)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE----CCCCCEEEecCCCCeec
Confidence 998 5777666542 368999999999999999999997 799999999999999 67778999999998754
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+. ..+...+...
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~------------~~~~~~i~~~ 211 (325)
T cd05594 147 IKDGA--TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------EKLFELILME 211 (325)
T ss_pred CCCCc--ccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCH------------HHHHHHHhcC
Confidence 32211 12235689999999999774 489999999999999999999999975441 1111211100
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCccCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEYFRI 340 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~f~~ 340 (477)
. ..++...+.++.+||++||++||++|+ ++.++++|+||..
T Consensus 212 ~-------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 212 E-------------------------------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred C-------------------------------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 0 012344567899999999999999997 8999999999973
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=342.07 Aligned_cols=249 Identities=25% Similarity=0.395 Sum_probs=197.5
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREI-THENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
++||+|+||.||+|+++. ++..||||+++.... .......+..|+.++..+ +||||+++++++.+.. .+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~--~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD--RLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--eEEEEE
Confidence 469999999999998764 688999999876432 222334566788888866 8999999999997654 789999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+. ++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 76 E~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill----~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 76 EYVNGGDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL----DAEGHCKLADFGMCKEG 146 (321)
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE----CCCCCEEEeecccceec
Confidence 9998 5777777653 368999999999999999999999999999999999999 67788999999998754
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. .+.+..+.. .
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~----~ 211 (321)
T cd05591 147 ILNGV--TTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILH----D 211 (321)
T ss_pred ccCCc--cccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHc----C
Confidence 32221 12345689999999999774 489999999999999999999999976542 222222211 0
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-------CHHHHhcCccCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-------TAAQALEHEYFRI 340 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-------t~~e~L~h~~f~~ 340 (477)
. ...|...+.++.+||.+||++||++|+ ++.++++||||..
T Consensus 212 ~-------------------------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 212 D-------------------------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred C-------------------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 0 012333467899999999999999999 9999999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=342.63 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=201.4
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCce
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREI-THENVVKLVNVHINHADMS 104 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 104 (477)
+|++++.||+|+||.||+|+++. ++..||||+++..... .........|..++..+ .|++|+++++++.+.+ .
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD--R 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC--E
Confidence 58999999999999999998764 6789999999764322 22234556788888777 5899999999986643 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill----~~~~~~kL~DfG 146 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML----DSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE----CCCCcEEEccCC
Confidence 899999997 6888777653 368999999999999999999999999999999999999 777889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+++....... .....+||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.+. ...+..+..
T Consensus 147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~~i~~ 215 (323)
T cd05616 147 MCKENMWDGV--TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIME 215 (323)
T ss_pred CceecCCCCC--ccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHHHHHh
Confidence 9975432111 22345689999999999874 489999999999999999999999976542 122222211
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCccC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHEYF 338 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~~f 338 (477)
.. ..+|...+.++.+||.+||++||.+|++ ..++++|+||
T Consensus 216 ----~~-------------------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~ 260 (323)
T cd05616 216 ----HN-------------------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 260 (323)
T ss_pred ----CC-------------------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCc
Confidence 00 1123445678999999999999999997 4899999999
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
+.
T Consensus 261 ~~ 262 (323)
T cd05616 261 RY 262 (323)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=334.84 Aligned_cols=255 Identities=26% Similarity=0.354 Sum_probs=197.2
Q ss_pred ecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEecc
Q 011808 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYA 112 (477)
Q Consensus 34 lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~ 112 (477)
||+|+||+||++.++. +++.||||++....... .....+..|+.+++.++|+||+++.+++... ..+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEcc---CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeCC
Confidence 7999999999998764 68899999987543222 2234567899999999999999999988654 4789999999
Q ss_pred C-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCC
Q 011808 113 E-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191 (477)
Q Consensus 113 ~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~ 191 (477)
. ++|...+.... ..+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 76 ~~g~L~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 76 NGGDLRYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL----DNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEeeCccceecCCC
Confidence 8 57766664422 224568999999999999999999999999999999999999 66778999999999765432
Q ss_pred CCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCC
Q 011808 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPE 271 (477)
Q Consensus 192 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 271 (477)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ....+...+....
T Consensus 151 ~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--------~~~~~~~~~~~~~-- 217 (280)
T cd05608 151 QS--KTKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKV--------ENKELKQRILNDS-- 217 (280)
T ss_pred Cc--cccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcch--------hHHHHHHhhcccC--
Confidence 22 12235679999999999875 48899999999999999999999997543210 0111111111000
Q ss_pred CccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCccCCC
Q 011808 272 KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEYFRI 340 (477)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~f~~ 340 (477)
...+...+..+.+||.+||+.||++|+ +++++++||||+.
T Consensus 218 -----------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 218 -----------------------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred -----------------------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 012334567899999999999999999 8899999999973
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=343.35 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=197.6
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREI-THENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
+.||+|+||.||+|+++. ++..||+|+++..... ......+.+|+.++.++ +||||+++++++.+.. .+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC--EEEEEE
Confidence 479999999999998764 6889999999765332 22334566788888877 8999999999987644 789999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+. ++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 76 E~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili----~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 76 EYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL----DSEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE----CCCCCEEEeeCCccccc
Confidence 9998 5777766542 368999999999999999999999999999999999999 67778999999998753
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||................ +.+.+...
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~---~~~~i~~~ 220 (329)
T cd05618 147 LRPGD--TTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY---LFQVILEK 220 (329)
T ss_pred cCCCC--ccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHH---HHHHHhcC
Confidence 22211 12345689999999999874 48999999999999999999999996432211111111111 11111100
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC------HHHHhcCccCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT------AAQALEHEYFRI 340 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt------~~e~L~h~~f~~ 340 (477)
...+|...+..+.+||++||++||.+|++ ++++++||||+.
T Consensus 221 -------------------------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 221 -------------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred -------------------------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 01134455678999999999999999998 589999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.42 Aligned_cols=290 Identities=41% Similarity=0.731 Sum_probs=229.1
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA-- 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 101 (477)
..++|++.+.||+|+||.||+|.++. ++..|+||.++...........+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKD---TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECC---CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 46889999999999999999998764 5789999999766544444556778999999999999999999886543
Q ss_pred ------CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 102 ------DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 102 ------~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
...+|+++||+++++...+... ...+++..++.++.||+.||.|||+.||+|+||||+||++ ++++
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili----~~~~ 153 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDHDLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL----NNKG 153 (302)
T ss_pred hhccccCCcEEEEEcccCccHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCC
Confidence 2378999999999888887653 2368999999999999999999999999999999999999 7778
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccH
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~ 255 (477)
.+||+|||++..+..... .......++..|+|||++.+...++.++|||||||++|+|++|++||...+ ..
T Consensus 154 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~--------~~ 224 (302)
T cd07864 154 QIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ--------EL 224 (302)
T ss_pred cEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------hH
Confidence 899999999986643321 111223457889999998765557899999999999999999999997554 45
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+.+..+....+.+.+..|+.+...+.|.......... ..+.. .....+..+.+||.+||..||.+|||+.+++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 225 AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYR----RRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHHHHHHhCCCChhhcccccccccccccccccccc----cchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 6677777888888888887777666553321111000 00000 111246789999999999999999999999999
Q ss_pred ccC
Q 011808 336 EYF 338 (477)
Q Consensus 336 ~~f 338 (477)
+||
T Consensus 300 ~~~ 302 (302)
T cd07864 300 PWL 302 (302)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=344.76 Aligned_cols=286 Identities=24% Similarity=0.361 Sum_probs=202.9
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
.+|++++.||+|+||.||+|++.. ++..||+|+.... ....|+.++++++|+||+++++++.... ..
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~ 132 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPG---QPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGA--IT 132 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECC---CCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCC--ee
Confidence 469999999999999999998754 5788999975432 2346999999999999999999987643 78
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
|+|||++.++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++
T Consensus 133 ~lv~e~~~~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill----~~~~~~kl~DfG~a 204 (357)
T PHA03209 133 CMVLPHYSSDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI----NDVDQVCIGDLGAA 204 (357)
T ss_pred EEEEEccCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEEecCccc
Confidence 999999999999988653 3468999999999999999999999999999999999999 67778999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCcccccCCC--cccHHHHHHHH
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK-PLFQGAEAKSTQN--PFQLDQLDKIF 262 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~-~PF~~~~~~~~~~--~~~~~~~~~i~ 262 (477)
+...... ......||+.|+|||++.+. .++.++|||||||++|||+++. ++|..... .... ......+..+.
T Consensus 205 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~-~~~~~~~~~~~~l~~~~ 279 (357)
T PHA03209 205 QFPVVAP---AFLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPS-TPEEYVKSCHSHLLKII 279 (357)
T ss_pred cccccCc---ccccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCC-cHHHHHHHHHHHHHHHH
Confidence 7533221 12335679999999999874 4899999999999999999854 44543221 1000 01123334444
Q ss_pred HHhCCCCCCCccccCCCccccccccccccc-cccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGR-KYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
..++..+.. ++.-.. ............. +..............+.++.+||.+||+.||.+|||+.|+|+||||+
T Consensus 280 ~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 280 STLKVHPEE-FPRDPG-SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred HHhccChhh-cCCCCc-cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 444433222 210000 0000000000000 00000000111224566788999999999999999999999999996
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=349.57 Aligned_cols=260 Identities=29% Similarity=0.460 Sum_probs=223.2
Q ss_pred CccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEc
Q 011808 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHIN 99 (477)
Q Consensus 20 ~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 99 (477)
....-+..|.+++.||+|.|++|.+|++.. ++..||||.+.+...+....+.+.+|+++|+.|+|||||+++.+...
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~---t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t 126 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHIL---TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET 126 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecC---CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence 344567899999999999999999999775 68999999999888777666778999999999999999999999976
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
.. .+|+||||+. |.+++++..+. .+.+.+++.+|.|+.+|++|||+++|||||||.+|||| +.+.++|
T Consensus 127 ~~--~lylV~eya~~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL----~~~mnik 195 (596)
T KOG0586|consen 127 EA--TLYLVMEYASGGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL----DENMNIK 195 (596)
T ss_pred cc--eeEEEEEeccCchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc----cccccee
Confidence 54 7999999987 79999998864 67889999999999999999999999999999999999 7888899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||++..+.... .....||++.|.|||++.+..+.++.+|+||||++||.|+.|.+||.+.+.++.......
T Consensus 196 IaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~--- 269 (596)
T KOG0586|consen 196 IADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR--- 269 (596)
T ss_pred eeccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee---
Confidence 99999999887533 234578999999999999988788999999999999999999999998774433221100
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
...-+|...+.++.+||+++|..+|.+|++.++++.|.|.
T Consensus 270 ----------------------------------------gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 270 ----------------------------------------GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred ----------------------------------------eeecccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 0111344556788999999999999999999999999997
Q ss_pred C
Q 011808 339 R 339 (477)
Q Consensus 339 ~ 339 (477)
.
T Consensus 310 n 310 (596)
T KOG0586|consen 310 N 310 (596)
T ss_pred c
Confidence 4
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=343.90 Aligned_cols=261 Identities=24% Similarity=0.401 Sum_probs=198.5
Q ss_pred cceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHAD 102 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 102 (477)
++|++.++||+|+||.||+|.+.. ...++..||||+++.... ......+.+|+.+++.+ +||||+++++++... +
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTKP-N 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-C
Confidence 689999999999999999997632 223467899999875432 22345678899999999 899999999988654 3
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcc-------------------------------------------------------
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDK------------------------------------------------------- 126 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~------------------------------------------------------- 126 (477)
..++++|||+. |+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46899999998 6888888753211
Q ss_pred --cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeecc
Q 011808 127 --VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204 (477)
Q Consensus 127 --~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~ 204 (477)
....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...............++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~----~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL----SENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE----cCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 01347888899999999999999999999999999999999 667789999999998654332222222334567
Q ss_pred ccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCcccc
Q 011808 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQ 283 (477)
Q Consensus 205 ~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 283 (477)
.|+|||++.+. .++.++|||||||++|||++ |..||.+.... ..+. ..+.....
T Consensus 241 ~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--------~~~~---~~~~~~~~------------- 295 (338)
T cd05102 241 KWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--------EEFC---QRLKDGTR------------- 295 (338)
T ss_pred cccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--------HHHH---HHHhcCCC-------------
Confidence 89999999774 48999999999999999997 99999764421 1111 11111100
Q ss_pred ccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 284 SDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
...+...++.+.+||.+||..||.+|||+.++++
T Consensus 296 -----------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 296 -----------------MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0123344678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=349.54 Aligned_cols=260 Identities=24% Similarity=0.377 Sum_probs=201.6
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++++.||+|+||.||+|+++. ++..||||+++.... .......+.+|+.++..++|+||+++++.+.+. ..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD---TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CE
Confidence 479999999999999999998764 688999999975332 233345667899999999999999999998764 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli----~~~~~vkL~DfG 146 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL----DAKGHVKLSDFG 146 (360)
T ss_pred EEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE----CCCCCEEEeecc
Confidence 899999998 5888887653 368999999999999999999999999999999999999 677889999999
Q ss_pred cceeecCCCC---------------------------------cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHH
Q 011808 184 LARIYQAPLK---------------------------------FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCI 230 (477)
Q Consensus 184 ~a~~~~~~~~---------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvi 230 (477)
++..+..... .......+||+.|+|||++.+. .++.++|||||||+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvi 225 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVI 225 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccce
Confidence 9875432110 0001235789999999999874 48999999999999
Q ss_pred HHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCch
Q 011808 231 FAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP 310 (477)
Q Consensus 231 l~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~ 310 (477)
+|||++|++||.+.+. ...+..+... .... .+| .....+..
T Consensus 226 lyel~tG~~Pf~~~~~--------~~~~~~i~~~---~~~~------~~p----------------------~~~~~s~~ 266 (360)
T cd05627 226 MYEMLIGYPPFCSETP--------QETYRKVMNW---KETL------VFP----------------------PEVPISEK 266 (360)
T ss_pred eeecccCCCCCCCCCH--------HHHHHHHHcC---CCce------ecC----------------------CCCCCCHH
Confidence 9999999999976542 1222222110 0000 000 01124678
Q ss_pred HHHHHHHhcccCCCCCC---CHHHHhcCccCCC
Q 011808 311 AYDLLSKMLEYDPRKRI---TAAQALEHEYFRI 340 (477)
Q Consensus 311 ~~dli~~~L~~dP~~Rp---t~~e~L~h~~f~~ 340 (477)
+.+||.+|+. ||.+|+ ++.+++.||||..
T Consensus 267 ~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 267 AKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred HHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 9999999874 999998 4899999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=340.31 Aligned_cols=290 Identities=37% Similarity=0.642 Sum_probs=218.3
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA-- 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 101 (477)
+.++|++.+.||+|+||.||+|.++. ++..||||++.... .......+.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKP---TGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE 78 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcC---CCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence 45789999999999999999998764 68899999986432 2234456778999999999999999999875432
Q ss_pred -CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 -DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 -~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
...+|+++||++++|...+.. ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+
T Consensus 79 ~~~~~~lv~e~~~~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill----~~~~~~kl~ 148 (336)
T cd07849 79 SFNDVYIVQELMETDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTNCDLKIC 148 (336)
T ss_pred ccceEEEEehhcccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE----CCCCCEEEC
Confidence 235899999999998887754 368999999999999999999999999999999999999 677789999
Q ss_pred ecccceeecCCCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 181 DFGLARIYQAPLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 181 DFG~a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|||++.......... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+ ....+.
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~--------~~~~~~ 220 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD--------YLHQLN 220 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 999998654322211 11234678999999998765568999999999999999999999997654 344566
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccc-cCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKY-ETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.+...++.+.++.+..+....... ....... ....+.. .....+..+.+||.+||+.||++|||+.+++.||||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~ 295 (336)
T cd07849 221 LILGVLGTPSQEDLNCIISLRARN----YIKSLPFKPKVPWNK-LFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295 (336)
T ss_pred HHHHHcCCCCHHHHHHhhchhhhh----HHhhcCcCCcccHHH-HhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 666666666555443222100000 0000000 0000000 112346789999999999999999999999999999
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
+.
T Consensus 296 ~~ 297 (336)
T cd07849 296 EQ 297 (336)
T ss_pred cc
Confidence 74
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=332.45 Aligned_cols=259 Identities=36% Similarity=0.579 Sum_probs=203.8
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYL 107 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~l 107 (477)
|++++.||+|+||+||++++.. ++..+|+|++..............+|+.++++++|+||+++++++.+ +..+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC---CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--cccccc
Confidence 8999999999999999998764 67899999998765444333344569999999999999999999977 447899
Q ss_pred EEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 108 AFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 108 v~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
+||++.+ +|.+++... ..+++..++.++.||+.||.+||++||+|+||||+|||+ +.++.++|+|||.+.
T Consensus 76 v~~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~----~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL----DENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEETTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE----STTSEEEESSGTTTE
T ss_pred ccccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccc----ccccccccccccccc
Confidence 9999997 999988832 368999999999999999999999999999999999999 777889999999998
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhC
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~ 266 (477)
..... ........++..|+|||++.....++.++||||||+++|+|++|..||.... ..+....+.....
T Consensus 147 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--------~~~~~~~~~~~~~ 216 (260)
T PF00069_consen 147 KLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN--------SDDQLEIIEKILK 216 (260)
T ss_dssp ESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--------HHHHHHHHHHHHH
T ss_pred ccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccc--------chhhhhhhhhccc
Confidence 64211 1223345669999999999833558999999999999999999999998652 1122222222211
Q ss_pred CCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
......+ .........+.+||.+||+.||++|||+.++++||||
T Consensus 217 ~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 217 RPLPSSS----------------------------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp THHHHHT----------------------------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ccccccc----------------------------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0000000 0000012578999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=338.70 Aligned_cols=249 Identities=29% Similarity=0.426 Sum_probs=194.8
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREI-THENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
+.||+|+||.||+|+++. ++..||||+++..... .........|..++..+ +||||+++++++... ..+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEE
Confidence 479999999999998764 5889999999764322 22334455677777654 899999999998664 3799999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+. ++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 76 e~~~gg~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill----~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 76 EYLNGGDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL----DKDGHIKIADFGMCKEN 146 (316)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE----CCCCCEEEccCcCCeEC
Confidence 9997 5777777653 368999999999999999999999999999999999999 67778999999999764
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. ...+.. +...
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~----i~~~ 211 (316)
T cd05592 147 MNGE--GKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDS----ILND 211 (316)
T ss_pred CCCC--CccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHH----HHcC
Confidence 3322 122345789999999999874 489999999999999999999999986542 111111 1110
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH-HHHhcCccCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA-AQALEHEYFRI 340 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~-~e~L~h~~f~~ 340 (477)
. ..++...+.++.+||.+||+.||.+|+++ .+++.|+||..
T Consensus 212 ~-------------------------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 212 R-------------------------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred C-------------------------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 0 11233446788999999999999999986 58889999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=344.76 Aligned_cols=248 Identities=29% Similarity=0.486 Sum_probs=203.7
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
+.+.+++.||+|-||.||+++++. ...||+|.++..... ...+++|+++|++|+|+|||++++++.... .+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~----~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG----STKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC----CCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCC--ce
Confidence 446788999999999999999864 457999998765332 357789999999999999999999997644 79
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
||||||+. |+|+++|+... ...+...+...++.||++|++||+++++|||||-.+|||| +++..+||+|||+
T Consensus 277 yIVtE~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV----~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV----DEDLVVKISDFGL 349 (468)
T ss_pred EEEEEecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee----ccCceEEEccccc
Confidence 99999998 89999999833 4578889999999999999999999999999999999999 8888999999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
|+...... +....+.--...|.|||.+...+ |+.+||||||||+|+||+| |+.||.+.+. .+-++.+
T Consensus 350 Ar~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn--------~ev~~~l-- 417 (468)
T KOG0197|consen 350 ARLIGDDE-YTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSN--------EEVLELL-- 417 (468)
T ss_pred ccccCCCc-eeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCH--------HHHHHHH--
Confidence 99544322 22222222367899999998754 9999999999999999999 8999987762 2222222
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
..+.+-..|..+++.+++++..||+.+|++|||++.+.
T Consensus 418 --------------------------------e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 418 --------------------------------ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred --------------------------------hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 22344456888999999999999999999999998654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=337.86 Aligned_cols=293 Identities=43% Similarity=0.740 Sum_probs=226.9
Q ss_pred ccccceeEE-eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC------------CcHHHHHHHHHHHhcCCCC
Q 011808 23 EWLQQYNLI-GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG------------VSPTAIREIMLLREITHEN 89 (477)
Q Consensus 23 ~~~~~Y~i~-~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~Ei~il~~l~hpn 89 (477)
.+.++|..+ +.||.|+||.||+|+++. .+..||||+++....... ....+.+|+.+++.++|+|
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 81 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTL---TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN 81 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECC---CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence 456788754 679999999999998664 688999999865433221 1124678999999999999
Q ss_pred eeEEEEEEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEec
Q 011808 90 VVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMG 169 (477)
Q Consensus 90 Iv~l~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~ 169 (477)
|+++++++... ..+|++|||+.++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||++
T Consensus 82 iv~~~~~~~~~--~~~~lv~e~~~~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill-- 152 (335)
T PTZ00024 82 IMGLVDVYVEG--DFINLVMDIMASDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI-- 152 (335)
T ss_pred eeeeeEEEecC--CcEEEEEeccccCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE--
Confidence 99999998764 378999999999999888653 368999999999999999999999999999999999999
Q ss_pred cCCCcccEEEeecccceeecCCC------------CcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhC
Q 011808 170 EGEEQGVVKIADFGLARIYQAPL------------KFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237 (477)
Q Consensus 170 ~~~~~~~vkL~DFG~a~~~~~~~------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG 237 (477)
+.++.++|+|||++....... .........++..|+|||++.+...++.++|+|||||++|+|++|
T Consensus 153 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 153 --NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred --CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 667789999999997654110 001112234578899999998766679999999999999999999
Q ss_pred CCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHH
Q 011808 238 KPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSK 317 (477)
Q Consensus 238 ~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~ 317 (477)
.+||.+.+ ..+.+..++..++.+....|+....++.+...... ....+. ......+..+.+||.+
T Consensus 231 ~~p~~~~~--------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~-~~~~~~~~~~~~li~~ 295 (335)
T PTZ00024 231 KPLFPGEN--------EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR------KPKDLK-TIFPNASDDAIDLLQS 295 (335)
T ss_pred CCCCCCCC--------HHHHHHHHHHHhCCCchhhCcchhhcccccccCcC------CcccHH-HhCcCCChHHHHHHHH
Confidence 99998665 45677788888888887777765554433221000 000011 1122346789999999
Q ss_pred hcccCCCCCCCHHHHhcCccCCCCCCC
Q 011808 318 MLEYDPRKRITAAQALEHEYFRIEPLP 344 (477)
Q Consensus 318 ~L~~dP~~Rpt~~e~L~h~~f~~~~~~ 344 (477)
||+.||++|||++++|.|+||+..+.+
T Consensus 296 ~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 296 LLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HcCCCchhccCHHHHhcCcccCCCCCC
Confidence 999999999999999999999865443
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=328.84 Aligned_cols=286 Identities=38% Similarity=0.671 Sum_probs=210.3
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|++++.||+|+||.||+|+++. ++..||+|++............+.+|+.+++.++|+||+++++++... ..+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE---TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC---CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEE
Confidence 479999999999999999998764 588999999876554444445677899999999999999999998764 478
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
+++|||+++.++..+... ...+++..++.++.||+.+|.|||+.||+||||||+||++ +.++.++|+|||++
T Consensus 76 ~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~----~~~~~~~l~dfg~~ 147 (286)
T cd07847 76 HLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI----TKQGQIKLCDFGFA 147 (286)
T ss_pred EEEEeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE----cCCCcEEECccccc
Confidence 999999998777665442 2368999999999999999999999999999999999999 66678999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
........ ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ..+.+..+...+
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~~~~~ 217 (286)
T cd07847 148 RILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS--------DVDQLYLIRKTL 217 (286)
T ss_pred eecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHh
Confidence 87654321 12234568899999999875668899999999999999999999998655 233344443333
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+...+.... ...-..|........ ......+... -...+..+.+||.+||+.||++|||+.+++.||||
T Consensus 218 ~~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 218 GDLIPRHQQ-IFSTNQFFKGLSIPE--PETREPLESK-FPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCCChHHhh-hcccccccccccCCC--cccccCHHHH-hccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 322111000 000000000000000 0000000001 11346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=347.57 Aligned_cols=256 Identities=28% Similarity=0.429 Sum_probs=207.5
Q ss_pred eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEecc
Q 011808 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYA 112 (477)
Q Consensus 33 ~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~ 112 (477)
+||+|.||+||-|+++. +...+|||.+.... .+..+.+..||.+.++|+|.|||++++.+. ++.++-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~---tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~s--enGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---TQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVS--ENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeecccc---ceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccC--CCCeEEEEeecC
Confidence 79999999999999775 67889999986533 344668889999999999999999999974 345888899987
Q ss_pred C-CCHHHHHHhhhcccCCCC--CHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeec
Q 011808 113 E-YDLYEIIRHHRDKVNHTM--NPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 113 ~-~~L~~~l~~~~~~~~~~l--~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
. |+|..+++...+ ++ .|..+..+.+||++||.|||++.|||||||-+|||+. +-.|.+||+|||.++.+.
T Consensus 655 PGGSLSsLLrskWG----PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN---TySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWG----PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN---TYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred CCCcHHHHHHhccC----CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe---eccceEEecccccchhhc
Confidence 7 688888877543 45 7889999999999999999999999999999999994 667899999999998775
Q ss_pred CCCCcccCCCeeeccccccchhhcC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 190 APLKFLSENGVVVTIWYRAPELLLG-AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 190 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
.-... ...+.||..|||||++.. .+.|+.++|||||||++.||.||++||..... .-..+|++-.-
T Consensus 728 ginP~--TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs----------pqAAMFkVGmy- 794 (1226)
T KOG4279|consen 728 GINPC--TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS----------PQAAMFKVGMY- 794 (1226)
T ss_pred cCCcc--ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC----------hhHhhhhhcce-
Confidence 43222 234778999999999964 45699999999999999999999999974431 11223333111
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCCCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLP 344 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~~~~ 344 (477)
..+..+|...+.+++.||.+|+..||.+||+|.++|.+||++..+..
T Consensus 795 -----------------------------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 795 -----------------------------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred -----------------------------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCC
Confidence 12334566778899999999999999999999999999999866433
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=356.21 Aligned_cols=261 Identities=26% Similarity=0.429 Sum_probs=205.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
...|.+.+.||+|+||.||+|.... ..+..||+|.+.... ......+.+|+.+|+.++||||+++++++.... .
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~--~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGS--DPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDD--K 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcC--CCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC--E
Confidence 4459999999999999999998654 226778888764432 222345667999999999999999999997654 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+||||||+. ++|.+.+..... ....+++.++..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll----~~~~~~kL~DFg 214 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL----MPTGIIKLGDFG 214 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE----CCCCcEEEEeCc
Confidence 999999997 688887765321 23468999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+++.+............+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. .+.+..+..
T Consensus 215 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~ 285 (478)
T PTZ00267 215 FSKQYSDSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLY 285 (478)
T ss_pred CceecCCccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh
Confidence 99876543222223446789999999999774 589999999999999999999999975431 112222111
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+.. ...+...+..+.+||.+||..||++||++++++.|+|++
T Consensus 286 --~~~--------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~ 327 (478)
T PTZ00267 286 --GKY--------------------------------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327 (478)
T ss_pred --CCC--------------------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence 000 012334467899999999999999999999999999986
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=340.22 Aligned_cols=249 Identities=29% Similarity=0.414 Sum_probs=193.6
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHH-HHHhcCCCCeeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIM-LLREITHENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
+.||+|+||+||+|+++. ++..||||++...... ......++.|.. +++.++||||+++++++.+. ..+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEE
Confidence 479999999999998764 6889999998754322 222334455554 56789999999999998764 4789999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 76 e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll----~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 76 DYVNGGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL----DSQGHVVLTDFGLCKEG 146 (323)
T ss_pred cCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE----CCCCcEEEeccCCCccc
Confidence 9998 5787777652 368999999999999999999999999999999999999 67778999999998753
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+. .+ +...+...
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~----~~~~i~~~ 211 (323)
T cd05575 147 IEHSK--TTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AE----MYDNILNK 211 (323)
T ss_pred ccCCC--ccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCH--------HH----HHHHHHcC
Confidence 22111 22345689999999999874 489999999999999999999999976541 11 11211111
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH----HHHhcCccCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA----AQALEHEYFRI 340 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~----~e~L~h~~f~~ 340 (477)
.. ..+...+..+.+||++||++||.+|+++ .+++.||||..
T Consensus 212 ~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 212 PL-------------------------------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CC-------------------------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 10 0122346789999999999999999987 69999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=340.45 Aligned_cols=249 Identities=28% Similarity=0.448 Sum_probs=194.9
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREI-THENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
++||+|+||.||+|+++. ++..||||+++..... .........|+.++..+ +||||+++++++.+. ..+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEE
Confidence 479999999999998764 6889999999764321 22334566788888755 899999999998764 4899999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+. ++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 76 E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~----~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 76 EFLNGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML----DRDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE----CCCCCEEeCccCCCeec
Confidence 9998 5787777653 368999999999999999999999999999999999999 67778999999998743
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+. . .+...+...
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------~----~~~~~~~~~ 211 (316)
T cd05620 147 VFGDN--RASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------D----ELFESIRVD 211 (316)
T ss_pred ccCCC--ceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCH--------H----HHHHHHHhC
Confidence 22111 22345679999999999874 489999999999999999999999975542 1 112221111
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH-HHHhcCccCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA-AQALEHEYFRI 340 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~-~e~L~h~~f~~ 340 (477)
.+ ..+...+.++.+||.+||+.||.+|+++ ++++.||||..
T Consensus 212 ~~-------------------------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 212 TP-------------------------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred CC-------------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 10 1222346789999999999999999997 58999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=346.81 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=202.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++++.||+|+||.||+|+++. ++..+|+|++...... ......+.+|+.+++.++||||+++++++.+. .
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~ 116 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--R 116 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECC---CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--C
Confidence 5799999999999999999998764 6889999998653221 22234566899999999999999999998764 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll----~~~~~ikL~Df 186 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL----DKSGHLKLADF 186 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE----CCCCCEEEEeC
Confidence 7999999997 5787777542 58899999999999999999999999999999999999 67778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAK---HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|++........ ......+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+. ...+.
T Consensus 187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~ 257 (371)
T cd05622 187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYS 257 (371)
T ss_pred CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHH
Confidence 99987643221 1223467899999999997532 378899999999999999999999976542 12222
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCcc
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK--RITAAQALEHEY 337 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~--Rpt~~e~L~h~~ 337 (477)
.+.... ....+ ......+..+.+||.+||..++.+ |++++++++|+|
T Consensus 258 ~i~~~~---~~~~~----------------------------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 258 KIMNHK---NSLTF----------------------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred HHHcCC---CcccC----------------------------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 222110 00000 111234678999999999844433 789999999999
Q ss_pred CCCC
Q 011808 338 FRIE 341 (477)
Q Consensus 338 f~~~ 341 (477)
|+..
T Consensus 307 ~~~~ 310 (371)
T cd05622 307 FKND 310 (371)
T ss_pred cCCC
Confidence 9753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=330.94 Aligned_cols=283 Identities=45% Similarity=0.854 Sum_probs=221.6
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYL 107 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~l 107 (477)
|++.+.||.|++|.||+|.++. ++..|+||++............+.+|+.+++.++|+||+++++++.+. ...|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEE
Confidence 7889999999999999998764 688999999976654444456778899999999999999999998654 48899
Q ss_pred EEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 108 AFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 108 v~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
+|||++++|.+++.... ...+++..+..++.||+.||+|||+++++||||+|+||++ +.++.++|+|||++..
T Consensus 76 v~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~----~~~~~~~l~df~~~~~ 148 (283)
T cd07835 76 VFEFLDLDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI----DREGALKLADFGLARA 148 (283)
T ss_pred EEeccCcCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE----cCCCcEEEeecccccc
Confidence 99999989998887643 1368999999999999999999999999999999999999 6677899999999976
Q ss_pred ecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCC
Q 011808 188 YQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267 (477)
Q Consensus 188 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~ 267 (477)
...... ......++..|+|||++.+...++.++|+|||||++|+|++|++||...+ ..+.+..++..++.
T Consensus 149 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~ 218 (283)
T cd07835 149 FGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS--------EIDQLFRIFRTLGT 218 (283)
T ss_pred cCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhCC
Confidence 543221 11223458899999998775567899999999999999999999997654 34455556666666
Q ss_pred CCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+....|+....++++....... ..... .......+..+.+||.+||+.||++|||+.+++.|+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 219 PDEDVWPGVTSLPDYKPTFPKW-----ARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred CChHHhhhhhhchhhhhhcccc-----cccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 6666665554444333211100 00000 11233456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=340.91 Aligned_cols=291 Identities=40% Similarity=0.625 Sum_probs=220.7
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC-
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD- 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~- 102 (477)
+..+|.+.+.||+|+||.||+|++.. ++..||||.+............+.+|+.+++.++|+||+++++++.....
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSE---TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE 79 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecC---CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccc
Confidence 45789999999999999999998653 68899999987654344445567789999999999999999998764322
Q ss_pred --ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 103 --MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 103 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+++||++++|.+++... ..+++..+..++.||+.||.|||+++++||||||+|||+ +.++.+||+
T Consensus 80 ~~~~~~lv~e~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~----~~~~~~kL~ 150 (337)
T cd07858 80 AFNDVYIVYELMDTDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL----NANCDLKIC 150 (337)
T ss_pred ccCcEEEEEeCCCCCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE----cCCCCEEEC
Confidence 358999999999998888653 468999999999999999999999999999999999999 667789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||++........ ......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+ ....+..
T Consensus 151 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--------~~~~~~~ 220 (337)
T cd07858 151 DFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD--------YVHQLKL 220 (337)
T ss_pred cCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC--------hHHHHHH
Confidence 9999986543221 12234568899999998764558899999999999999999999997654 3445555
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+...++.+.++.+..+... .+.. ....................+..+.+||.+||+.||++|||+.++|+||||..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 221 ITELLGSPSEEDLGFIRNE-KARR---YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HHHHhCCCChHHhhhcCch-hhhH---HHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 6666666655444221110 0000 00000000000001112346788999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=344.91 Aligned_cols=268 Identities=27% Similarity=0.419 Sum_probs=222.7
Q ss_pred CCccccccceeEE--eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEE
Q 011808 19 GEKPEWLQQYNLI--GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNV 96 (477)
Q Consensus 19 ~~~~~~~~~Y~i~--~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 96 (477)
++..++-.-|.|. ++||+|.||+||-++++. +|+.||||++.+..........+.+|+.||..+.||.||.+.-.
T Consensus 555 qe~vd~stvYQif~devLGSGQFG~VYgg~hRk---tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M 631 (888)
T KOG4236|consen 555 QENVDISTVYQIFADEVLGSGQFGTVYGGKHRK---TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM 631 (888)
T ss_pred hhhhhHHHHHHhhhHhhccCCcceeeecceecc---cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe
Confidence 3344555567664 689999999999999875 79999999999888777777788899999999999999999999
Q ss_pred EEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc
Q 011808 97 HINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~ 176 (477)
|++.+ .+++|||-+.|++++.|.... .++|++...+.++.||+.||.|||-+||+||||||+|||+... +.-..
T Consensus 632 ~ET~e--rvFVVMEKl~GDMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~-~~FPQ 705 (888)
T KOG4236|consen 632 FETPE--RVFVVMEKLHGDMLEMILSSE---KGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA-SPFPQ 705 (888)
T ss_pred ecCCc--eEEEEehhhcchHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC-CCCCc
Confidence 87765 789999999999999987754 5689999999999999999999999999999999999999654 45567
Q ss_pred EEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHH
Q 011808 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~ 256 (477)
+||||||+|+++.... .....+|||.|+|||++++ +.|+...|+||+|||+|--|.|..||...++
T Consensus 706 vKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---------- 771 (888)
T KOG4236|consen 706 VKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---------- 771 (888)
T ss_pred eeeccccceeecchhh---hhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccc----------
Confidence 9999999999987532 3456889999999999988 4599999999999999999999999975432
Q ss_pred HHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 257 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
.-+.|.+.-..-++..|.+ ++.++.|||..+|+..-++|.|.++.|.|+
T Consensus 772 IndQIQNAaFMyPp~PW~e-------------------------------is~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 772 INDQIQNAAFMYPPNPWSE-------------------------------ISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred hhHHhhccccccCCCchhh-------------------------------cCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 1122222222223333332 357899999999999999999999999999
Q ss_pred cCCC
Q 011808 337 YFRI 340 (477)
Q Consensus 337 ~f~~ 340 (477)
|++.
T Consensus 821 Wlq~ 824 (888)
T KOG4236|consen 821 WLQD 824 (888)
T ss_pred hhhc
Confidence 9973
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=338.23 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=197.3
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREI-THENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
+.||+|+||+||+|+++. ++..||||+++..... ......+.+|+.+++.+ +||||+++++++.+.. .+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~--~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--RLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEEE
Confidence 479999999999998764 5789999999764321 22344567889999888 7999999999987644 799999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+. ++|...+... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 76 EYVNGGDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL----DSEGHIKIADFGMCKEG 146 (318)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE----CCCCcEEecccCCCeec
Confidence 9997 5777777653 368999999999999999999999999999999999999 67778999999998753
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. .. +...+...
T Consensus 147 ~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~----~~~~i~~~ 211 (318)
T cd05570 147 ILGGV--TTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DE----LFQSILED 211 (318)
T ss_pred CcCCC--cccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HH----HHHHHHcC
Confidence 22111 12335689999999999874 489999999999999999999999975542 11 11111100
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH-----HHHhcCccCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA-----AQALEHEYFRI 340 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~-----~e~L~h~~f~~ 340 (477)
. ...+...+..+.+||++||++||.+|+|+ .+++.||||+.
T Consensus 212 ~-------------------------------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 212 E-------------------------------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred C-------------------------------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 0 11233456789999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=338.78 Aligned_cols=263 Identities=21% Similarity=0.337 Sum_probs=201.1
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++++.||+|+||.||+++++. +++.||+|++...... ......+.+|+.+++.++|+||+++++++.+. ..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH---TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE--NY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CE
Confidence 579999999999999999998764 6788999998653221 22233466789999999999999999998764 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill----~~~~~~kl~DfG 147 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL----DMNGHIRLADFG 147 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE----cCCCCEEEEecc
Confidence 899999987 6888888653 2368999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGA----KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
++..+...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+. .+.+.
T Consensus 148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~ 218 (331)
T cd05624 148 SCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYG 218 (331)
T ss_pred ceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--------HHHHH
Confidence 99866433221 12235689999999998652 3478899999999999999999999975441 12222
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCcc
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK--RITAAQALEHEY 337 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~--Rpt~~e~L~h~~ 337 (477)
.+.. ......++. .....+.++.+||.+||..++.+ |+++++++.|+|
T Consensus 219 ~i~~---~~~~~~~p~---------------------------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 219 KIMN---HEERFQFPS---------------------------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred HHHc---CCCcccCCC---------------------------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 2211 000000000 01124678999999999976654 568999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|..
T Consensus 269 f~~ 271 (331)
T cd05624 269 FEG 271 (331)
T ss_pred cCC
Confidence 974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=337.17 Aligned_cols=263 Identities=21% Similarity=0.349 Sum_probs=201.1
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|+++++||+|+||.||+++++. ++..+|+|++..... .......+.+|+.++..++|+||+++++++.+. ..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE--NN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CE
Confidence 479999999999999999998764 578899999864322 122233466789999999999999999998764 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili----~~~~~~kL~DfG 147 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM----DMNGHIRLADFG 147 (332)
T ss_pred EEEEEeccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE----CCCCCEEEeecc
Confidence 899999987 6888888753 2368999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLG----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
++..+..... ......+||+.|+|||++.+ ...++.++|||||||++|||++|+.||...+. .+.+.
T Consensus 148 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--------~~~~~ 218 (332)
T cd05623 148 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYG 218 (332)
T ss_pred hheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--------HHHHH
Confidence 9976533221 11223568999999999863 34578899999999999999999999975441 12222
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCcc
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK--RITAAQALEHEY 337 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~--Rpt~~e~L~h~~ 337 (477)
.+ ........++ .....++..+++||++||..++.+ |++++++++|||
T Consensus 219 ~i---~~~~~~~~~p---------------------------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 219 KI---MNHKERFQFP---------------------------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred HH---hCCCccccCC---------------------------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 22 1111000000 011234678999999999765544 689999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|..
T Consensus 269 f~~ 271 (332)
T cd05623 269 FTG 271 (332)
T ss_pred cCC
Confidence 974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=338.01 Aligned_cols=284 Identities=23% Similarity=0.367 Sum_probs=204.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.++||+|+||.||++.++. ++..+|+|.+..... ......+.+|+++++.++|+||++++++|.+.. .
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP---SGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--E 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC---CCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEECC--E
Confidence 4789999999999999999998764 678899998875432 223456789999999999999999999997744 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili----~~~~~~kL~Df 148 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV----NSRGEIKLCDF 148 (333)
T ss_pred EEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE----cCCCCEEEeeC
Confidence 899999997 5888888653 3688999999999999999999985 79999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++..+... ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||..... ..+..++
T Consensus 149 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~---------~~~~~~~ 214 (333)
T cd06650 149 GVSGQLIDS----MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDA---------KELELMF 214 (333)
T ss_pred Ccchhhhhh----ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcch---------hHHHHHh
Confidence 998755322 12234679999999999874 489999999999999999999999975432 1111111
Q ss_pred HHhCCCCCCCccccCCCcccccccccc-----cc---------cccc-CCCCccccCCCCCchHHHHHHHhcccCCCCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHI-----QG---------RKYE-TNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI 327 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~---------~~~~-~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp 327 (477)
. ......+......+.+....... .. .... ............+.++++||.+||++||++||
T Consensus 215 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rp 291 (333)
T cd06650 215 G---CPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERA 291 (333)
T ss_pred c---CcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCc
Confidence 1 11100000000000000000000 00 0000 00000011113457789999999999999999
Q ss_pred CHHHHhcCccCCC
Q 011808 328 TAAQALEHEYFRI 340 (477)
Q Consensus 328 t~~e~L~h~~f~~ 340 (477)
|+.+++.|+||+.
T Consensus 292 t~~ell~h~~~~~ 304 (333)
T cd06650 292 DLKQLMVHAFIKR 304 (333)
T ss_pred CHHHHhhCHHHhc
Confidence 9999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=328.93 Aligned_cols=287 Identities=46% Similarity=0.791 Sum_probs=226.3
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYL 107 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~l 107 (477)
|++.+.||+|+||.||+|.+.. ++..+++|.+............+.+|+.+++.++|+|++++++++.+.....+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 7899999999999999998764 5789999999876544444567788999999999999999999987653458999
Q ss_pred EEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 108 AFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 108 v~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
+|||++++|.+++... ...+++..++.++.||+.||+|||+.|++|+||||+|||+ ++++.+||+|||++..
T Consensus 78 v~e~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~----~~~~~~~l~d~g~~~~ 149 (287)
T cd07840 78 VFEYMDHDLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI----NNDGVLKLADFGLARP 149 (287)
T ss_pred EeccccccHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE----cCCCCEEEccccceee
Confidence 9999999888887653 2368999999999999999999999999999999999999 6778899999999987
Q ss_pred ecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCC
Q 011808 188 YQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267 (477)
Q Consensus 188 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~ 267 (477)
...... .......++..|+|||.+.+...++.++|||||||++|+|++|+.||...+ ....+..+....+.
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~--------~~~~~~~~~~~~~~ 220 (287)
T cd07840 150 YTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST--------ELEQLEKIFELCGS 220 (287)
T ss_pred ccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHhCC
Confidence 654321 112233457889999988775568899999999999999999999997655 34566777777787
Q ss_pred CCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
++...|+.+..+..+...... ......+........+..+.++|++||..||.+||++.+++.|+||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 221 PTDENWPGVSKLPWFENLKPK----KPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred Cchhhccccccchhhhhcccc----ccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 877777766554322221110 0000111112222247789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=328.08 Aligned_cols=288 Identities=43% Similarity=0.745 Sum_probs=218.1
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|++.+.||+|+||.||+|.++. ++..|+||+++...........+.+|+++++.++|+||+++++++.+. ..+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA---TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK--GRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC---CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC--CEE
Confidence 479999999999999999998764 578999999987655555566788999999999999999999999764 478
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
+++|||+++++...+... ...+++.++..++.||+.||.|||+.+|+|+||+|+||++ ++++.+||+|||++
T Consensus 76 ~iv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~----~~~~~~kl~d~g~~ 147 (288)
T cd07833 76 YLVFEYVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV----SESGVLKLCDFGFA 147 (288)
T ss_pred EEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCCEEEEeeecc
Confidence 999999998877765543 2358999999999999999999999999999999999999 66788999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
........ .......++..|+|||++.+...++.++|||||||++|+|++|++||.+.. ..+.+..+...+
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~--------~~~~~~~~~~~~ 218 (288)
T cd07833 148 RALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS--------DIDQLYLIQKCL 218 (288)
T ss_pred cccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHh
Confidence 87654332 112235668899999999876468999999999999999999999997654 234444455544
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+...+........-+.+..... ........+....+...+.++++||++||..||++|||+++++.|+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 219 GPLPPSHQELFSSNPRFAGVAF---PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCCCHHHhhhcccCcccccccc---CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 4433322211111111100000 000000011112334457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=336.58 Aligned_cols=249 Identities=29% Similarity=0.461 Sum_probs=195.1
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREI-THENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
+.||+|+||.||+|+++. ++..||||+++..... .........|..++..+ +||||+++++++.+.. .+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE--NLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC--EEEEEE
Confidence 479999999999998764 5889999999764321 22334566788888764 9999999999987654 789999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 76 ey~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~----~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 76 EYLNGGDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL----DTDGHIKIADFGMCKEN 146 (316)
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE----CCCCCEEEccCCcceEC
Confidence 9997 6888887653 368899999999999999999999999999999999999 67778999999998753
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+. .+ +...+...
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~----~~~~i~~~ 211 (316)
T cd05619 147 MLGDA--KTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EE----LFQSIRMD 211 (316)
T ss_pred CCCCC--ceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HH----HHHHHHhC
Confidence 22111 12335679999999999874 489999999999999999999999976442 11 11111100
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHH-HHhcCccCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA-QALEHEYFRI 340 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~-e~L~h~~f~~ 340 (477)
.+ ..+...+.++.+||.+||++||.+|+++. +++.||||..
T Consensus 212 ~~-------------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 212 NP-------------------------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred CC-------------------------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 00 11223457789999999999999999996 9999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=339.52 Aligned_cols=296 Identities=37% Similarity=0.601 Sum_probs=223.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH--AD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 102 (477)
-++|++.+.||+|+||.||+|.++. ++..|++|++............+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC---CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 4789999999999999999998664 588999999986554445566778899999999999999999987643 33
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~----~~~~~~kl~df 151 (334)
T cd07855 81 KDVYVVMDLMESDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV----NEDCELRIGDF 151 (334)
T ss_pred ceEEEEEehhhhhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCcEEeccc
Confidence 57899999999988887754 2358999999999999999999999999999999999999 67788999999
Q ss_pred ccceeecCCCCc--ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 183 GLARIYQAPLKF--LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 183 G~a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|++......... .......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+ ...++..
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~--------~~~~~~~ 223 (334)
T cd07855 152 GMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN--------YVHQLKL 223 (334)
T ss_pred ccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC--------hHHHHHH
Confidence 999865432211 111234678999999998765568999999999999999999999998655 3455666
Q ss_pred HHHHhCCCCCCCccccCCCcccccccccccc-ccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQG-RKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+...++.++.+.+.....-. . ...... .......+. ......+..+.+||.+||+.||++|||+++++.||||.
T Consensus 224 ~~~~~g~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 224 ILSVLGSPSEEVLNRIGSDR--V--RKYIQNLPRKQPVPWS-KIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred HHHHhCCChhHhhhhhchhh--H--HHHHhhcccCCCCCHH-HHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 66667766655433221100 0 000000 000000000 01123467899999999999999999999999999997
Q ss_pred CCCCCC
Q 011808 340 IEPLPG 345 (477)
Q Consensus 340 ~~~~~~ 345 (477)
..+.+.
T Consensus 299 ~~~~~~ 304 (334)
T cd07855 299 QYHDPD 304 (334)
T ss_pred hccCCc
Confidence 544433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=336.32 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=200.2
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCce
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREIT-HENVVKLVNVHINHADMS 104 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 104 (477)
+|++.+.||+|+||.||+|+++. ++..||||++...... ......+..|+.+++.+. |++|+++++++.+.. .
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD--R 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC--E
Confidence 48899999999999999998764 6889999998764321 223445677888988885 577888998886643 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill----~~~~~ikL~Dfg 146 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML----DSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE----CCCCCEEEeccc
Confidence 899999997 5887777653 368999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+++....... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. ...+..+..
T Consensus 147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~ 215 (323)
T cd05615 147 MCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIME 215 (323)
T ss_pred cccccCCCCc--cccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh
Confidence 9875432211 12335679999999999874 489999999999999999999999976542 122222211
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCccC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHEYF 338 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~~f 338 (477)
. . ...|...+.++.+||.+||++||.+|++ ..++++|+||
T Consensus 216 ~----~-------------------------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f 260 (323)
T cd05615 216 H----N-------------------------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFF 260 (323)
T ss_pred C----C-------------------------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCccc
Confidence 0 0 0123344678999999999999999997 5799999999
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
..
T Consensus 261 ~~ 262 (323)
T cd05615 261 RR 262 (323)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=321.45 Aligned_cols=275 Identities=26% Similarity=0.395 Sum_probs=211.6
Q ss_pred ccccceeEEe-eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcC
Q 011808 23 EWLQQYNLIG-KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINH 100 (477)
Q Consensus 23 ~~~~~Y~i~~-~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 100 (477)
.|.+-|++.. .||+|+|+.|-.+... .++..||||++.+.. .....+.++|++++.++ .|+||++|+++|+++
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i---~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSI---QTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeee---ccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3666787754 6999999999999755 478999999997653 33456888999999999 699999999999764
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+|||||-+. |.|+..|.+++ .++|.++..+++.|+.||.+||.+||.||||||+|||.... +.-.-|||
T Consensus 149 --~~FYLVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~p-n~vsPvKi 220 (463)
T KOG0607|consen 149 --TRFYLVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESP-NKVSPVKI 220 (463)
T ss_pred --ceEEEEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCC-CCcCceee
Confidence 48999999988 68888888764 68999999999999999999999999999999999997433 33345999
Q ss_pred eecccceeecCCC-----CcccCCCeeeccccccchhhc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCC
Q 011808 180 ADFGLARIYQAPL-----KFLSENGVVVTIWYRAPELLL----GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250 (477)
Q Consensus 180 ~DFG~a~~~~~~~-----~~~~~~~~~gt~~y~APE~l~----~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~ 250 (477)
+||.+..-+.... ......+.+|+..|||||+.. ....|+.++|.||||||||-||.|.+||.|.-..+..
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 9999876432211 111223567899999999863 2345899999999999999999999999886543221
Q ss_pred ---CcccHHHHHHHHHHhC----CCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCC
Q 011808 251 ---NPFQLDQLDKIFKILG----HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323 (477)
Q Consensus 251 ---~~~~~~~~~~i~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP 323 (477)
......=-+++|..|. ..+.+.|.. +|.+++|||..+|.+|+
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWah-------------------------------IS~eakdlisnLlvrda 349 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAH-------------------------------ISSEAKDLISNLLVRDA 349 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHH-------------------------------hhHHHHHHHHHHHhccH
Confidence 1112222233333332 222333322 35789999999999999
Q ss_pred CCCCCHHHHhcCccCCCC
Q 011808 324 RKRITAAQALEHEYFRIE 341 (477)
Q Consensus 324 ~~Rpt~~e~L~h~~f~~~ 341 (477)
..|.++.+++.|||+...
T Consensus 350 ~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 350 KQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HhhhhhhhccCCcccccc
Confidence 999999999999999743
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=347.72 Aligned_cols=254 Identities=28% Similarity=0.522 Sum_probs=211.4
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCC-CCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK-DGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
.|.=++.||.|+||.||-|++.. +...||||++.... ...+-.+.+++|+..|++++|||+|.+.+||..+. ..
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~---n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--TA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccC---ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc--hH
Confidence 47778999999999999998764 68899999997543 23344678899999999999999999999997643 67
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
|||||||-|+-.+++.-++ .++-+.++..|..+.+.||.|||+.+.||||||..|||| .+.|.|||+|||.|
T Consensus 102 WLVMEYClGSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL----se~g~VKLaDFGSA 173 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL----SEPGLVKLADFGSA 173 (948)
T ss_pred HHHHHHHhccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe----cCCCeeeeccccch
Confidence 9999999998888887764 479999999999999999999999999999999999999 88899999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
.+..+ .+.++|||+|||||||.. ...|+-++|||||||+..||...++|+-.++ .+..++.
T Consensus 174 si~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-----------AMSALYH 236 (948)
T KOG0577|consen 174 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----------AMSALYH 236 (948)
T ss_pred hhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-----------HHHHHHH
Confidence 87654 456899999999999953 4569999999999999999999999975444 4445554
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+-.+..|. +. -++| ++.++.||..||++-|.+|||++++|.|+|...
T Consensus 237 IAQNesPt----Lq-s~eW-------------------------S~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 237 IAQNESPT----LQ-SNEW-------------------------SDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHhcCCCC----CC-Cchh-------------------------HHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 43332221 10 1222 456889999999999999999999999999863
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=349.21 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=199.2
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEE-EEc---C
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNV-HIN---H 100 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~-~~~---~ 100 (477)
-+++|.+.|.+|||+.||+|++.. .+..||+|.+... .+...+.+.+||++|+.|+ |+|||.+++. ... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~---~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVK---GGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecC---CCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 357899999999999999998653 4589999998765 3445667788999999996 9999999993 322 2
Q ss_pred C-CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC--eecCCCCCCcEEEeccCCCccc
Q 011808 101 A-DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW--IIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 101 ~-~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDikp~NILl~~~~~~~~~ 176 (477)
. ...++|.||||. +.|.+++.... ...|+|.++++||+++++|+.+||... |||||||-||||| ..+++
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl----s~~g~ 184 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL----SADGN 184 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE----cCCCC
Confidence 2 345789999999 69999998754 335999999999999999999999998 9999999999999 77778
Q ss_pred EEEeecccceeecCCCCcccC-------CCeeeccccccchhhc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 011808 177 VKIADFGLARIYQAPLKFLSE-------NGVVVTIWYRAPELLL--GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~-------~~~~gt~~y~APE~l~--~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~ 247 (477)
+||||||.+.-.......... -....|+.|+|||++. .....+.|+|||+|||+||.|+....||......
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 999999998643222110000 0123399999999984 2345899999999999999999999999765311
Q ss_pred cCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC
Q 011808 248 STQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI 327 (477)
Q Consensus 248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp 327 (477)
.+ ....|. .......+..+.+||+.||+.||.+||
T Consensus 265 aI----------------------------------------lng~Y~-----~P~~p~ys~~l~~LI~~mL~~nP~~RP 299 (738)
T KOG1989|consen 265 AI----------------------------------------LNGNYS-----FPPFPNYSDRLKDLIRTMLQPNPDERP 299 (738)
T ss_pred eE----------------------------------------Eecccc-----CCCCccHHHHHHHHHHHHhccCcccCC
Confidence 11 111111 111234567899999999999999999
Q ss_pred CHHHHhcCccC
Q 011808 328 TAAQALEHEYF 338 (477)
Q Consensus 328 t~~e~L~h~~f 338 (477)
++.|++.+-+.
T Consensus 300 nI~Qv~~~~~~ 310 (738)
T KOG1989|consen 300 NIYQVLEEIFE 310 (738)
T ss_pred CHHHHHHHHHH
Confidence 99999988653
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=335.82 Aligned_cols=248 Identities=29% Similarity=0.449 Sum_probs=192.2
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHH-HHHhcCCCCeeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIM-LLREITHENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
++||+|+||.||+|+++. ++..||||++..... .......+.+|+. +++.++||||+++++++.+.. .+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~--~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--KLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--EEEEEE
Confidence 479999999999998764 688999999865432 1222334555554 678899999999999986644 789999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+. ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 76 DYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL----DSQGHVVLTDFGLCKEG 146 (321)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE----CCCCCEEEccCCCCccC
Confidence 9998 577776654 2368899999999999999999999999999999999999 67778999999998753
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+. ..+...+...
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~~~~~i~~~ 211 (321)
T cd05603 147 VEPEE--TTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------------SQMYDNILHK 211 (321)
T ss_pred CCCCC--ccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCH------------HHHHHHHhcC
Confidence 22211 22345689999999999774 489999999999999999999999976541 1111211111
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH----HHHhcCccCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA----AQALEHEYFR 339 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~----~e~L~h~~f~ 339 (477)
. ..++...+..+.++|.+||++||.+|+++ .++++|+||.
T Consensus 212 ~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~ 255 (321)
T cd05603 212 P-------------------------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFS 255 (321)
T ss_pred C-------------------------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcC
Confidence 0 01233345778999999999999999975 5999999996
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=324.99 Aligned_cols=281 Identities=39% Similarity=0.671 Sum_probs=209.6
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCceEE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~ 106 (477)
|++++.||+|+||.||+|.++. ++..||+|+++....... .....+|+.+++++. |+||+++++++.+.....++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---TGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcC---CCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 7899999999999999998654 578999999876543322 234567999999885 99999999999876546899
Q ss_pred EEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 107 LAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 107 lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
+||||+.+++++.+.... ..+++..++.++.||+.||.|||+.||+||||||+||++ +. +.+||+|||++.
T Consensus 77 lv~e~~~~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l----~~-~~~kl~dfg~~~ 147 (282)
T cd07831 77 LVFELMDMNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KD-DILKLADFGSCR 147 (282)
T ss_pred EEEecCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE----cC-CCeEEEeccccc
Confidence 999999999998887532 368999999999999999999999999999999999999 55 889999999998
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhC
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~ 266 (477)
........ ....++..|+|||++.....++.++|||||||++|||++|.+||.+.+ ..+.+..+...++
T Consensus 148 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~--------~~~~~~~~~~~~~ 216 (282)
T cd07831 148 GIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN--------ELDQIAKIHDVLG 216 (282)
T ss_pred ccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC--------HHHHHHHHHHHcC
Confidence 66433221 224568899999987665667889999999999999999999998765 2344455555544
Q ss_pred CCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.+......... ...... ..........+. ......+..+.+||.+||.+||++|||+.++|.||||
T Consensus 217 ~~~~~~~~~~~---~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 217 TPDAEVLKKFR---KSRHMN--YNFPSKKGTGLR-KLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred CCCHHHHHhhc---cccccc--ccCcccccccHH-HHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 43331100000 000000 000000000000 0112446889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=336.84 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=198.2
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREI-THENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
+.||+|+||.||+|+++. ++..||+|+++..... ......+.+|+.+++++ +|+||+++++++.+.. .+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS--RLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC--EEEEEE
Confidence 479999999999998764 5889999999765332 22344567899999888 6999999999987644 789999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili----~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 76 EYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL----DADGHIKLTDYGMCKEG 146 (327)
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE----eCCCCEEEeccccceec
Confidence 9997 5777777543 369999999999999999999999999999999999999 66778999999998753
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.........+ ....+...+...
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~ 218 (327)
T cd05617 147 LGPGD--TTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-----TEDYLFQVILEK 218 (327)
T ss_pred cCCCC--ceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-----cHHHHHHHHHhC
Confidence 22211 22345689999999999874 48999999999999999999999997543221111 111122221111
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC------HHHHhcCccCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT------AAQALEHEYFRI 340 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt------~~e~L~h~~f~~ 340 (477)
+ ..+|...+..+.+||.+||++||.+|++ +.+++.|+||..
T Consensus 219 ~-------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 219 P-------------------------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred C-------------------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 0 1123445678899999999999999997 579999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=338.49 Aligned_cols=288 Identities=20% Similarity=0.270 Sum_probs=200.1
Q ss_pred eEEeeeccc--CceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 29 NLIGKIGEG--TYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 29 ~i~~~lG~G--~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+++++||+| +|++||+++++. ++..||||.+............+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~ 75 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKP---TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELW 75 (327)
T ss_pred ChhhhccccccceEEEEEEeecc---cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--EEE
Confidence 367899999 788999998764 6899999999776544444556677999999999999999999997654 789
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
+||||+. ++|.+++..+. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++++||+.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~----~~~~~~~l~~~~~~ 148 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI----SVDGKVYLSGLRSN 148 (327)
T ss_pred EEEeccCCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE----ecCCcEEEcccchh
Confidence 9999998 57888876543 2358999999999999999999999999999999999999 66678999999875
Q ss_pred eeecCCCCcc-----cCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 186 RIYQAPLKFL-----SENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 186 ~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
.......... ......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------- 217 (327)
T cd08227 149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ----------- 217 (327)
T ss_pred hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-----------
Confidence 4332111000 01112457789999999763 358899999999999999999999997543210
Q ss_pred HHHHHhCCCCCCCcc-------ccCCCccccccccccccccc-------cCCCCccccCCCCCchHHHHHHHhcccCCCC
Q 011808 260 KIFKILGHPTPEKWP-------TLANLPHWQSDSLHIQGRKY-------ETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK 325 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~ 325 (477)
.+...+....+..+. ++...+........+..... .............++.+.+||++||++||++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 297 (327)
T cd08227 218 MLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDA 297 (327)
T ss_pred HHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchh
Confidence 011111111110000 00000000000000000000 0000001122334678999999999999999
Q ss_pred CCCHHHHhcCccCC
Q 011808 326 RITAAQALEHEYFR 339 (477)
Q Consensus 326 Rpt~~e~L~h~~f~ 339 (477)
|||++++++||||+
T Consensus 298 Rpt~~ell~~p~f~ 311 (327)
T cd08227 298 RPSASTLLNHSFFK 311 (327)
T ss_pred cCCHHHHhcChhhh
Confidence 99999999999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=327.44 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=202.5
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC-CcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG-VSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
.|++.+.||+|+||.||++.++. +++.||||.+........ ....+.+|+.+++.++|+||+.+++.+.+. ..+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC---CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEE
Confidence 47889999999999999998764 688999999875433222 234566899999999999999999998664 378
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|++|||+. ++|.+++.... ...+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||+
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~----~~~~~~~l~Dfg~ 148 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL----DDHGHIRISDLGL 148 (285)
T ss_pred EEEEEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE----CCCCCEEEeeccc
Confidence 99999987 57777775432 2368999999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+........ .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||...... ...+....+...
T Consensus 149 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-----~~~~~~~~~~~~ 219 (285)
T cd05630 149 AVHVPEGQT---IKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-----IKREEVERLVKE 219 (285)
T ss_pred eeecCCCcc---ccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCcc-----chHHHHHhhhhh
Confidence 876543221 1234679999999999774 4899999999999999999999999754321 011111111111
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCccCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHEYFR 339 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~~f~ 339 (477)
. ....+...+.++.+||.+||+.||++|+| +.++++||||+
T Consensus 220 ~----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 220 V----------------------------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred h----------------------------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 0 00122334577999999999999999999 99999999997
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 266 ~ 266 (285)
T cd05630 266 Q 266 (285)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=340.67 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=192.9
Q ss_pred ecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhc---CCCCeeEEEEEEEcCCCceEEEEE
Q 011808 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREI---THENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 34 lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
||+|+||+||+|+++. ++..||||++..... ..........|..++..+ +||||+++++++.+.. .+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~--~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS--DLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC--eEEEEE
Confidence 7999999999998764 688999999865322 122233455677777655 6999999999987654 789999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+. ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 76 e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili----~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 76 DYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL----DATGHIALCDFGLSKAN 146 (330)
T ss_pred cCCCCChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE----CCCCCEEEecCCcCcCC
Confidence 9997 578777765 2368999999999999999999999999999999999999 67778999999998754
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+. ..+...+...
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------------~~~~~~i~~~ 212 (330)
T cd05586 147 LTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------------QQMYRNIAFG 212 (330)
T ss_pred CCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------------HHHHHHHHcC
Confidence 32211 223457899999999998766689999999999999999999999976441 1122221111
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC----CHHHHhcCccCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI----TAAQALEHEYFRI 340 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp----t~~e~L~h~~f~~ 340 (477)
... + .....+.++.+||++||++||.+|+ ++.++++||||..
T Consensus 213 ~~~-------~-----------------------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 213 KVR-------F-----------------------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred CCC-------C-----------------------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 000 0 0112357889999999999999998 7999999999974
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=336.50 Aligned_cols=249 Identities=28% Similarity=0.440 Sum_probs=192.7
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHH-HHHhcCCCCeeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIM-LLREITHENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
+.||+|+||+||+|+++. ++..||||++...... ......+..|.. +++.++||||+++++++... ..+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEE
Confidence 479999999999998764 6889999998754322 222334455554 56778999999999998764 3789999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+. ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll----~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 76 DFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL----DSQGHVVLTDFGLCKEG 146 (325)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE----CCCCCEEEeecCCcccC
Confidence 9998 577777654 3468999999999999999999999999999999999999 67778999999998753
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+. .+ ++..+...
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~----~~~~~~~~ 211 (325)
T cd05604 147 IAQSD--TTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AE----MYDNILHK 211 (325)
T ss_pred CCCCC--CcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCH--------HH----HHHHHHcC
Confidence 22111 22345689999999999874 488999999999999999999999976542 11 11111111
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH----HHHhcCccCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA----AQALEHEYFRI 340 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~----~e~L~h~~f~~ 340 (477)
.. ..+...+..+.++|++||++||.+|+++ .+++.||||..
T Consensus 212 ~~-------------------------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 212 PL-------------------------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred Cc-------------------------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 00 1122346778999999999999999976 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=326.59 Aligned_cols=286 Identities=38% Similarity=0.661 Sum_probs=210.8
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|+++++||+|+||.||+|.++. ++..||+|.+............+.+|+.+++.++|+||+++++++.+ +..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeE
Confidence 479999999999999999998653 58899999987655444345567789999999999999999999865 4478
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
|++|||+.+.+++.+... ...+++.+++.++.||+.||.|||+.||+|+||+|+||++ ++++.++|+|||++
T Consensus 76 ~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~----~~~~~~~l~dfg~~ 147 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV----SQSGVVKLCDFGFA 147 (286)
T ss_pred EEEEecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----CCCCcEEEEeeeee
Confidence 999999998666555432 2358999999999999999999999999999999999999 66778999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
..+..... ......++..|+|||++.+...++.++|||||||++|+|++|++||.... ..+.+..+...+
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~--------~~~~~~~~~~~~ 217 (286)
T cd07846 148 RTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS--------DIDQLYHIIKCL 217 (286)
T ss_pred eeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc--------hHHHHHHHHHHh
Confidence 86644322 12234568999999999875667889999999999999999999997544 234444455444
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+.............+..... .........-........+..+.+||.+||..||++||++.+++.|+||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAGM----RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred CCCchhhHHHhccchHhhcc----ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 33221110000000000000 0000000000001123456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=324.17 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=213.0
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
--+++|+++++||+|.||+|-+++-+. +++.||||++++...- ......-+.|-++|+..+||.+..|...|..++
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKa---t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKA---TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecc---cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 357899999999999999999998664 7999999999876532 223345567899999999999999998887654
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.+|+||||.. |.|+-.|... ..++|..++.+...|++||.|||+++||+||||.+|+|+ +.+|++||+
T Consensus 242 --rlCFVMeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL----DkDGHIKit 310 (516)
T KOG0690|consen 242 --RLCFVMEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL----DKDGHIKIT 310 (516)
T ss_pred --eEEEEEEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee----ccCCceEee
Confidence 8999999988 5777666553 368999999999999999999999999999999999999 888999999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||+++.--... .....+||||.|+|||++.. ..|+.++|+|.+||++|||++|++||...+. .+
T Consensus 311 DFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh------------~k 375 (516)
T KOG0690|consen 311 DFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH------------EK 375 (516)
T ss_pred ecccchhccccc--ceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccch------------hH
Confidence 999997432211 12346899999999999977 5599999999999999999999999986652 22
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h 335 (477)
++..|... +..+|...+++++.||..+|.+||.+|. .+.|+++|
T Consensus 376 LFeLIl~e-------------------------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 376 LFELILME-------------------------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHHHHHhh-------------------------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 33332111 1236777889999999999999999998 48999999
Q ss_pred ccCC
Q 011808 336 EYFR 339 (477)
Q Consensus 336 ~~f~ 339 (477)
+||.
T Consensus 425 ~FF~ 428 (516)
T KOG0690|consen 425 RFFA 428 (516)
T ss_pred hhhc
Confidence 9997
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=317.82 Aligned_cols=256 Identities=28% Similarity=0.503 Sum_probs=204.0
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|++++.||+|++|.||++.++. ++..+++|++............+.+|+.++++++|+||+++++.+.. .+..+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEE
Confidence 59999999999999999998764 57889999997655444445567889999999999999999988753 344789
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
++|||+. ++|.+.+.... ...+++.+++.++.||+.||.+||++||+|+||||+||++ +.++.++|+|||++
T Consensus 77 lv~e~~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~----~~~~~~~l~df~~~ 149 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL----TRTNIIKVGDLGIA 149 (257)
T ss_pred EEecccCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE----ecCCcEEEecccce
Confidence 9999997 58888887533 3468999999999999999999999999999999999999 66778999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
........ ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+. ......+..
T Consensus 150 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--------~~~~~~~~~-- 216 (257)
T cd08223 150 RVLENQCD--MASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDM--------NSLVYRIIE-- 216 (257)
T ss_pred EEecccCC--ccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHh--
Confidence 87643322 12234568999999999874 488899999999999999999999975431 111111111
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
...+ ..+...+..+.+||.+||+.||++|||+.+++.||||
T Consensus 217 -~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 217 -GKLP-------------------------------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -cCCC-------------------------------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 0123345789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=335.25 Aligned_cols=249 Identities=29% Similarity=0.408 Sum_probs=192.3
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHH-HHHhcCCCCeeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIM-LLREITHENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
+.||+|+||.||+|+++. ++..||+|++...... ......+..|.. +++.++|+||+++++++.... .+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~--~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC--eEEEEE
Confidence 479999999999998764 5788999998754321 122234444544 567889999999999987644 789999
Q ss_pred eccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili----~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 76 DYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL----DSQGHIVLTDFGLCKEN 146 (325)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE----CCCCCEEEccCCCCccc
Confidence 99985 777777652 368899999999999999999999999999999999999 66778999999999754
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+. .+.+..+.. .
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~----~ 211 (325)
T cd05602 147 IEHNG--TTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILN----K 211 (325)
T ss_pred ccCCC--CcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHHHHHHh----C
Confidence 32111 22345689999999999874 489999999999999999999999976542 112222211 0
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHH----HHhcCccCCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA----QALEHEYFRI 340 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~----e~L~h~~f~~ 340 (477)
.. ..+...+..+.+||.+||++||.+|+++. ++++|+||..
T Consensus 212 ~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 212 PL-------------------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred Cc-------------------------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 00 01223467899999999999999999865 8999999963
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=319.14 Aligned_cols=257 Identities=28% Similarity=0.481 Sum_probs=203.1
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC---CcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG---VSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
+.|++.+.||+|+||.||+|.+.. ++..+++|.+........ ....+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-
Confidence 469999999999999999998653 588999999875443221 2345678999999999999999999987654
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+++++||+. ++|.+.+... ..+++..++.++.|++.||.|||+.||+||||||+||++ ++++.++|+|
T Consensus 78 -~~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv----~~~~~~~l~d 147 (263)
T cd06625 78 -TLSIFMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR----DSAGNVKLGD 147 (263)
T ss_pred -eEEEEEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEee
Confidence 8999999997 5787877653 358899999999999999999999999999999999999 6677899999
Q ss_pred cccceeecCCCCccc-CCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 182 FGLARIYQAPLKFLS-ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 182 FG~a~~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
||+++.......... .....++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+. ...
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~ 215 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEA-----------MAA 215 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccch-----------HHH
Confidence 999976543211111 12345688999999998754 89999999999999999999999965331 111
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+........ ....+...+..+.+||++||..||.+|||+.++++|+||
T Consensus 216 ~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 216 IFKIATQPT------------------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHhccCC------------------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 122111110 112344456789999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=336.07 Aligned_cols=294 Identities=40% Similarity=0.688 Sum_probs=218.7
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINH 100 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 100 (477)
..+.++|++.+.||+|+||.||+|.+.. ++..++||++............+.+|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcC---CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 3567899999999999999999998653 578999998865433333345677899999999 999999999998766
Q ss_pred CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 101 ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 101 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
....+|+||||+.++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+
T Consensus 80 ~~~~~~lv~e~~~~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill----~~~~~~kl~ 149 (337)
T cd07852 80 NDKDIYLVFEYMETDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL----NSDCRVKLA 149 (337)
T ss_pred CCceEEEEecccccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCcEEEe
Confidence 66678999999999998887642 57888899999999999999999999999999999999 777889999
Q ss_pred ecccceeecCCCCc---ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 181 DFGLARIYQAPLKF---LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 181 DFG~a~~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
|||++..+...... .......++..|+|||++.+...++.++|||||||++|+|++|++||.+.. ..+.
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~--------~~~~ 221 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS--------TLNQ 221 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC--------hHHH
Confidence 99999866443221 112235678999999998776668899999999999999999999997654 3344
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
+.++....+.+..+.+..+..- ....... ..............+. .+.++.+||.+||+.||.+|||+.++++|+|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~P~~Rps~~~il~~~~ 297 (337)
T cd07852 222 LEKIIEVIGPPSAEDIESIKSP--FAATMLD-SLPSRPRKPLDELLPK-ASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297 (337)
T ss_pred HHHHHHHhCCCCHHHHHHHHhh--hHHHhhh-hcccccccchhhhccC-CCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence 4555554443332221111000 0000000 0000000011111222 5678999999999999999999999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|+.
T Consensus 298 ~~~ 300 (337)
T cd07852 298 VAQ 300 (337)
T ss_pred hhh
Confidence 974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=322.68 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=193.9
Q ss_pred ecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC-CcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEecc
Q 011808 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG-VSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYA 112 (477)
Q Consensus 34 lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~ 112 (477)
||+|+||.||+++++. ++..||+|.+........ ....+..|+++++.++||||+++++++.+. ..+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEcc---CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEecC
Confidence 7999999999998764 688999999865433221 223456799999999999999999998654 4789999999
Q ss_pred C-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCC
Q 011808 113 E-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191 (477)
Q Consensus 113 ~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~ 191 (477)
. ++|.+.+.... ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++......
T Consensus 76 ~g~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili----~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 76 NGGDLKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL----DDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCCHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE----cCCCCEEEeeceeeeecCCC
Confidence 7 57777665432 2358888999999999999999999999999999999999 66778999999999865432
Q ss_pred CCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCC
Q 011808 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPE 271 (477)
Q Consensus 192 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 271 (477)
.. .....|+..|+|||++.+.. ++.++|||||||++|+|++|+.||....... . ...+.........
T Consensus 149 ~~---~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-------~-~~~~~~~~~~~~~- 215 (277)
T cd05607 149 KT---ITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-------A-KEELKRRTLEDEV- 215 (277)
T ss_pred ce---eeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchh-------h-HHHHHHHhhcccc-
Confidence 21 12245689999999998755 8999999999999999999999997543210 0 1111111100000
Q ss_pred CccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH----HHHhcCccCCC
Q 011808 272 KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA----AQALEHEYFRI 340 (477)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~----~e~L~h~~f~~ 340 (477)
.......+.++.+||.+||++||.+|+++ .+++.|+||+.
T Consensus 216 -----------------------------~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 216 -----------------------------KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred -----------------------------ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 00112346789999999999999999999 77889999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=323.03 Aligned_cols=260 Identities=26% Similarity=0.381 Sum_probs=202.6
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
.|++.+.||+|+||+||+|.+.. +++.+|+|.+....... .....+.+|+.+++.++|+||+.+.+++... ..+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC---CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEE
Confidence 47889999999999999998764 58899999986543322 2234567899999999999999999988664 478
Q ss_pred EEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|++|||+.+ +|.+.+.... ...+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili----~~~~~~kl~Dfg~ 148 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL----DDYGHIRISDLGL 148 (285)
T ss_pred EEEEEeccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE----CCCCCEEEecCCc
Confidence 999999985 6766665432 3368999999999999999999999999999999999999 6667899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+........ .....|+..|+|||++.+. .++.++|+|||||++|+|++|..||.+... ......+...
T Consensus 149 ~~~~~~~~~---~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~--------~~~~~~~~~~ 216 (285)
T cd05632 149 AVKIPEGES---IRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKE--------KVKREEVDRR 216 (285)
T ss_pred ceecCCCCc---ccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHh
Confidence 976543211 1234679999999999774 489999999999999999999999975442 1111222111
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCccCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHEYFR 339 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~~f~ 339 (477)
+.... ...+...+.++.+||.+||+.||++|++ +++++.|+||+
T Consensus 217 ~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05632 217 VLETE-------------------------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265 (285)
T ss_pred hhccc-------------------------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhh
Confidence 11110 0122334567899999999999999999 89999999997
Q ss_pred CC
Q 011808 340 IE 341 (477)
Q Consensus 340 ~~ 341 (477)
..
T Consensus 266 ~~ 267 (285)
T cd05632 266 NM 267 (285)
T ss_pred cC
Confidence 43
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=330.22 Aligned_cols=293 Identities=38% Similarity=0.624 Sum_probs=218.7
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcC--CCc
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINH--ADM 103 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~--~~~ 103 (477)
+|++.+.||+|+||.||++++... ..+..||||++............+.+|+.+++++ +|+||+++++++... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC-CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999987642 2277899999876544443455678899999999 599999999875432 224
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+|+++++++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili----~~~~~~kl~Dfg 150 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV----NADCELKICDFG 150 (332)
T ss_pred cEEEEEecccCCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE----cCCCCEEeCcCC
Confidence 57899999999999888653 368999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCc--ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKF--LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
+++.+...... .......|+..|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ....+..+
T Consensus 151 ~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~--------~~~~~~~~ 222 (332)
T cd07857 151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD--------YVDQLNQI 222 (332)
T ss_pred CceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC--------HHHHHHHH
Confidence 99865432211 112235679999999998765568999999999999999999999998655 34566777
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccc-cccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGR-KYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+..++.++.+.+..+.....+. ..... ......+.. .....+..+.+||.+||+.||.+|||+.+++.||||+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 223 LQVLGTPDEETLSRIGSPKAQN----YIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred HHHhCCCCHHHHHhhhhhhHHH----HHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 7777665543332222110000 00000 000001111 11234678999999999999999999999999999975
Q ss_pred CC
Q 011808 341 EP 342 (477)
Q Consensus 341 ~~ 342 (477)
..
T Consensus 298 ~~ 299 (332)
T cd07857 298 WH 299 (332)
T ss_pred hc
Confidence 43
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=331.95 Aligned_cols=288 Identities=38% Similarity=0.610 Sum_probs=212.9
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC-
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD- 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~- 102 (477)
+.++|++++.||+|+||.||+|.+.. ++..||||++............+.+|+.+++.++|+||+++++++.....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECC---CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 56789999999999999999998654 68899999986544434344567789999999999999999999865432
Q ss_pred ---ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 103 ---MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 103 ---~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+++||+|++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill----~~~~~~kl 159 (343)
T cd07880 90 DRFHDFYLVMPFMGTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV----NEDCELKI 159 (343)
T ss_pred cccceEEEEEecCCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEE
Confidence 24699999998888877753 358999999999999999999999999999999999999 66778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||++...... .....+++.|+|||++.+...++.++|+|||||++|+|++|+.||.+.+ ....+.
T Consensus 160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~--------~~~~~~ 226 (343)
T cd07880 160 LDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD--------HLDQLM 226 (343)
T ss_pred eecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 999999765432 1234568899999999765558899999999999999999999998654 233444
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+.........+.+..+... .... .+..................+..+.+||.+||+.||.+|||+.+++.|+||+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~ 302 (343)
T cd07880 227 EIMKVTGTPSKEFVQKLQSE-DAKN---YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302 (343)
T ss_pred HHHHhcCCCCHHHHHhhcch-hHHH---HHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHh
Confidence 44443332221111111000 0000 0000000000000112234567899999999999999999999999999997
Q ss_pred CC
Q 011808 340 IE 341 (477)
Q Consensus 340 ~~ 341 (477)
..
T Consensus 303 ~~ 304 (343)
T cd07880 303 EF 304 (343)
T ss_pred hh
Confidence 43
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=325.13 Aligned_cols=266 Identities=23% Similarity=0.356 Sum_probs=196.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecc-------------cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCee
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAA-------------ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVV 91 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~-------------~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv 91 (477)
.++|++.++||+|+||.||+|.++.. ..++..||||.+..... ......+.+|+.+++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCCee
Confidence 36899999999999999999986431 12345799999875432 22345678899999999999999
Q ss_pred EEEEEEEcCCCceEEEEEeccC-CCHHHHHHhhhc--------------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCee
Q 011808 92 KLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRD--------------KVNHTMNPYTVKSILWQLLNGLNYLHSNWII 156 (477)
Q Consensus 92 ~l~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~qil~aL~~LH~~giv 156 (477)
++++++.+.. .++++|||+. ++|.+++..... .....+++..+..++.||+.||.|||+.||+
T Consensus 83 ~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999987643 6899999997 588888765321 1112467788999999999999999999999
Q ss_pred cCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh
Q 011808 157 HRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236 (477)
Q Consensus 157 HrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt 236 (477)
||||||+|||+ +.++.+||+|||+++.+.............++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 161 H~dlkp~Nill----~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 161 HRDLATRNCLV----GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred ccCcchhheEE----cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHH
Confidence 99999999999 66778999999999865443222222233457889999998764 48999999999999999987
Q ss_pred --CCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHH
Q 011808 237 --LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDL 314 (477)
Q Consensus 237 --G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dl 314 (477)
+..||...+. .+.+..+...+..... ......+..++..+.+|
T Consensus 236 ~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~l 280 (304)
T cd05096 236 LCKEQPYGELTD--------EQVIENAGEFFRDQGR---------------------------QVYLFRPPPCPQGLYEL 280 (304)
T ss_pred ccCCCCCCcCCH--------HHHHHHHHHHhhhccc---------------------------cccccCCCCCCHHHHHH
Confidence 5677865432 1111111111100000 00011233456789999
Q ss_pred HHHhcccCCCCCCCHHHHh
Q 011808 315 LSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 315 i~~~L~~dP~~Rpt~~e~L 333 (477)
|.+||..||.+|||+.++.
T Consensus 281 i~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 281 MLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHHHccCCchhCcCHHHHH
Confidence 9999999999999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=334.51 Aligned_cols=288 Identities=40% Similarity=0.636 Sum_probs=217.0
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+.++|++.+.||+|+||.||+|++.. ++..||||++............+.+|+.+++.++|+||+++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECC---CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 467899999999999999999998764 57889999987654333344567789999999999999999987754332
Q ss_pred ----ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 103 ----MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 103 ----~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
..+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++
T Consensus 89 ~~~~~~~~lv~e~~~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill----~~~~~~k 158 (343)
T cd07851 89 LEDFQDVYLVTHLMGADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV----NEDCELK 158 (343)
T ss_pred ccccccEEEEEecCCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCCEE
Confidence 34899999999999888864 368999999999999999999999999999999999999 6677899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||++...... .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+ ..+.+
T Consensus 159 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~--------~~~~~ 225 (343)
T cd07851 159 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD--------HIDQL 225 (343)
T ss_pred Ecccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHH
Confidence 9999999865432 2234568899999998765567899999999999999999999997654 34455
Q ss_pred HHHHHHhCCCCCCCccccCCCcccccccccccc-ccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQG-RKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
..+....+.+++..+..+.. ......... .......+... ....+..+.+||++||..||.+|||+.+++.|||
T Consensus 226 ~~i~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~ 300 (343)
T cd07851 226 KRIMNLVGTPDEELLQKISS----ESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300 (343)
T ss_pred HHHHHhcCCCCHHHHhhccc----hhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence 55555554444332221110 000000000 00000011111 1234678999999999999999999999999999
Q ss_pred CCCC
Q 011808 338 FRIE 341 (477)
Q Consensus 338 f~~~ 341 (477)
|...
T Consensus 301 ~~~~ 304 (343)
T cd07851 301 LAEY 304 (343)
T ss_pred cccc
Confidence 9743
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=332.89 Aligned_cols=285 Identities=42% Similarity=0.687 Sum_probs=213.4
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC-
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD- 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~- 102 (477)
+..+|.+.+.||+|+||.||+|++.. ++..||||++............+.+|+.+++.++|+||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCC---CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 45799999999999999999998653 58899999987654444445567899999999999999999999865422
Q ss_pred ---ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 103 ---MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 103 ---~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+|+++||+..+|...+. ..+++..+..++.||+.||.|||+.+|+||||||+|||+ +.++.+||
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll----~~~~~~kL 158 (342)
T cd07879 90 DEFQDFYLVMPYMQTDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV----NEDCELKI 158 (342)
T ss_pred CCCceEEEEecccccCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEE
Confidence 3569999999877765542 258899999999999999999999999999999999999 66778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+++.... ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+ ....+.
T Consensus 159 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~--------~~~~~~ 225 (342)
T cd07879 159 LDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--------YLDQLT 225 (342)
T ss_pred eeCCCCcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 99999875432 12335678999999998765558899999999999999999999998654 234455
Q ss_pred HHHHHhCCCCCCCccccCCCcccccccccccc-ccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQG-RKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.+....+.+.+..+..+.....+. .... .......+.... ...+..+.+||.+||+.||.+||++++++.|+||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f 300 (342)
T cd07879 226 QILKVTGVPGPEFVQKLEDKAAKS----YIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300 (342)
T ss_pred HHHHhcCCCCHHHHHHhcccchHH----HHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcch
Confidence 555555444433222221100000 0000 000000011111 2346678999999999999999999999999999
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
..
T Consensus 301 ~~ 302 (342)
T cd07879 301 DS 302 (342)
T ss_pred hh
Confidence 74
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=331.02 Aligned_cols=289 Identities=42% Similarity=0.643 Sum_probs=222.5
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---Cc
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA---DM 103 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---~~ 103 (477)
+|++.+.||.|+||.||+|++.. ++..++||++............+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 69999999999999999998653 5889999999765543445567889999999999999999999886643 23
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+|++|+|++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||
T Consensus 78 ~~~lv~e~~~~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili----~~~~~~~L~dfg 148 (330)
T cd07834 78 DVYIVTELMETDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV----NSNCDLKICDFG 148 (330)
T ss_pred ceEEEecchhhhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEcccC
Confidence 67999999998888887652 378999999999999999999999999999999999999 666889999999
Q ss_pred cceeecCCCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++......... .......++..|+|||++.+...++.++|+|||||++|+|++|.+||.+.+ ..+.+..+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~ 220 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD--------YIDQLNLIV 220 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC--------HHHHHHHHH
Confidence 99876543210 112234568999999999886468999999999999999999999998776 345666777
Q ss_pred HHhCCCCCCCccccCC--CccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 263 KILGHPTPEKWPTLAN--LPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
..++.++++.+..... ...+... ........+.. .....+..+.+||.+||++||.+|||+.+++.||||+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 221 EVLGTPSEEDLKFITSEKARNYLKS-----LPKKPKKPLSK-LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred HhcCCCChhHhhhccccchhhHHhh-----cccCCcchhHH-hcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 7777666554432110 0000000 00000000001 12235678999999999999999999999999999974
Q ss_pred C
Q 011808 341 E 341 (477)
Q Consensus 341 ~ 341 (477)
.
T Consensus 295 ~ 295 (330)
T cd07834 295 L 295 (330)
T ss_pred h
Confidence 3
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=321.24 Aligned_cols=258 Identities=19% Similarity=0.315 Sum_probs=199.5
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|++++.||+|+||.||+|++.. ++..||||++..... ......+.+|+.++++++||||+++++++.... ..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL---TRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFVEN--RI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC---CCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC--EE
Confidence 478999999999999999998654 688899999875432 223356778999999999999999999997754 78
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
+++|||+.+..+... ..+++..+..++.|++.||.|||+.||+|+||||+|||+ +.++.++|+|||++
T Consensus 75 ~lv~e~~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill----~~~~~~~l~dfg~~ 142 (279)
T cd06619 75 SICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV----NTRGQVKLCDFGVS 142 (279)
T ss_pred EEEEecCCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE----CCCCCEEEeeCCcc
Confidence 899999996544332 147888999999999999999999999999999999999 66778999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
..+.... ....+++..|+|||++.+. .++.++|+|||||++|+|++|+.||.......... ....+...+
T Consensus 143 ~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~~ 212 (279)
T cd06619 143 TQLVNSI----AKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-----MPLQLLQCI 212 (279)
T ss_pred eeccccc----ccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-----chHHHHHHH
Confidence 8654321 2335679999999999874 48999999999999999999999997543211100 001111221
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
....+.. ......+.++.+||.+||+.||++||++.+++.|+||..
T Consensus 213 ~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 213 VDEDPPV-----------------------------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred hccCCCC-----------------------------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 1111110 011223567899999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=318.41 Aligned_cols=258 Identities=24% Similarity=0.414 Sum_probs=201.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC--
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHA-- 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~-- 101 (477)
-+.|++.+.||+|+||.||+|.++. ++..+|+|.+.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcC---CCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 4679999999999999999998754 58899999986543 2234677899999998 7999999999987542
Q ss_pred --CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 102 --DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 102 --~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
...+|++|||+. ++|.+++.... ...+++..+..++.||+.||.|||+++|+|+||||+||++ +.++.++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili----~~~~~~~ 151 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL----TENAEVK 151 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE----CCCCCEE
Confidence 246899999998 58888877633 3468999999999999999999999999999999999999 6677899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCccc
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA----KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~ 254 (477)
|+|||++........ ......|+..|+|||++.+. ..++.++|||||||++|+|++|..||.....
T Consensus 152 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-------- 221 (272)
T cd06637 152 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------- 221 (272)
T ss_pred EccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH--------
Confidence 999999986543221 22345678999999998632 3478899999999999999999999964331
Q ss_pred HHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
........... .........+..+.+||.+||..||.+|||+.+++.
T Consensus 222 ---~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 222 ---MRALFLIPRNP------------------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ---HHHHHHHhcCC------------------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11111111000 000112234567899999999999999999999999
Q ss_pred CccC
Q 011808 335 HEYF 338 (477)
Q Consensus 335 h~~f 338 (477)
||||
T Consensus 269 ~~~~ 272 (272)
T cd06637 269 HPFI 272 (272)
T ss_pred CCCC
Confidence 9997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=314.54 Aligned_cols=255 Identities=28% Similarity=0.425 Sum_probs=205.1
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|.+.+.||+|+||.||+|.++. ++..|++|.+............+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEE
Confidence 58999999999999999998764 588999999876554445566778899999999999999999998764 4789
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
++|||+. ++|.+++.... ...+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++
T Consensus 76 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili----~~~~~~~l~df~~~ 148 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL----DAYDNVKIGDLGVA 148 (256)
T ss_pred EEEEeCCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE----eCCCCEEEcccccc
Confidence 9999986 68888887642 3468999999999999999999999999999999999999 66678999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
+.+...... .....+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+. ......+..
T Consensus 149 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-- 215 (256)
T cd08529 149 KLLSDNTNF--ANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKIIR-- 215 (256)
T ss_pred eeccCccch--hhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHc--
Confidence 876543221 2234578999999999874 488999999999999999999999975441 111111111
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
... ...+...+.++.++|.+||+.||++||++.+++.|||+
T Consensus 216 -~~~-------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 -GVF-------------------------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -CCC-------------------------------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 000 01122345779999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=306.19 Aligned_cols=286 Identities=30% Similarity=0.516 Sum_probs=222.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 103 (477)
.++|++++++|+|-|+.||.|.+.. ++..++||+++..+ .+.+.+|+.||+.|. ||||++|+++..+....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~---~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINIT---NNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccC---CCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 5789999999999999999997553 67889999997643 347789999999996 99999999999988877
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
...|+|||+...-+..|-. .++...++.++.++++||.|||+.||+|||+||.|+++. .+...++|+|+|
T Consensus 109 tpaLiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId---h~~rkLrlIDWG 178 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID---HELRKLRLIDWG 178 (338)
T ss_pred CchhHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec---hhhceeeeeecc
Confidence 8899999999755544432 588889999999999999999999999999999999994 456679999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLF-QGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF-~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+|.++..... .+-.+.+..|--||.+.....|+.+.|+|||||++..|++.+-|| .|.+ ..+|+.+|.
T Consensus 179 LAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d--------N~DQLVkIa 247 (338)
T KOG0668|consen 179 LAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--------NYDQLVKIA 247 (338)
T ss_pred hHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC--------CHHHHHHHH
Confidence 9998876543 233455888999999998888999999999999999999987665 5555 678999999
Q ss_pred HHhCCCCCCCccccCC--CccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 263 KILGHPTPEKWPTLAN--LPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+++|......+-.--+ ++.-..+......++.+...++.-...-+++++.|||.++|.+|-.+|+||.|++.||||.
T Consensus 248 kVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 248 KVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred HHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 9988654321110000 1111111111112222222233333334578999999999999999999999999999996
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=321.79 Aligned_cols=282 Identities=50% Similarity=0.920 Sum_probs=225.9
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYL 107 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~l 107 (477)
|++.+.||+|+||.||+|++.. ++..+++|++............+.+|+.+++.++|+||+++++++.+. ..+++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecC---CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEE
Confidence 7788999999999999998654 588999999987654455556778899999999999999999998664 47899
Q ss_pred EEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 108 AFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 108 v~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
+|||++++|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||++ ++++.++|+|||++..
T Consensus 76 v~e~~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~----~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 76 VFEYCDMDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI----NRDGVLKLADFGLARA 147 (282)
T ss_pred EecCcCcCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE----cCCCCEEEecCCcccc
Confidence 99999999999987642 368999999999999999999999999999999999999 6678899999999986
Q ss_pred ecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCC
Q 011808 188 YQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267 (477)
Q Consensus 188 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~ 267 (477)
...... ......++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+ ..+.+..+...++.
T Consensus 148 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--------~~~~~~~~~~~~~~ 217 (282)
T cd07829 148 FGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS--------EIDQLFKIFQILGT 217 (282)
T ss_pred cCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHHHhCC
Confidence 644322 11223447889999999876568999999999999999999999998765 45667777888888
Q ss_pred CCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+....|..+.+++.+...... +........++. .+..+.+||++||..||++||++.+++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 218 PTEESWPGVTKLPDYKPTFPK-----FPPKDLEKVLPR-LDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CcHHHHHhhcccccccccccc-----cCccchHHhccc-ccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 877777766655422221111 111111112222 26789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=329.89 Aligned_cols=287 Identities=39% Similarity=0.596 Sum_probs=214.1
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA-- 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 101 (477)
..++|.+.+.||+|+||.||+|.+.. ++..||+|++............+.+|+.++++++|+||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcC---CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 45899999999999999999998653 6889999999765433333456778999999999999999999886432
Q ss_pred --CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 102 --DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 102 --~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
...+|+++++++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||
T Consensus 92 ~~~~~~~lv~~~~~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll----~~~~~~kl 161 (345)
T cd07877 92 EEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKI 161 (345)
T ss_pred cccccEEEEehhcccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE----cCCCCEEE
Confidence 234789999998888877653 258899999999999999999999999999999999999 66778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||++...... .....++..|+|||++.+...++.++|||||||++|+|++|++||...+ ....+.
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~--------~~~~~~ 228 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--------HIDQLK 228 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 999998754321 2234568899999998775568899999999999999999999997544 234444
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccc-cccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGR-KYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.+....+.+.+..+..+.....+ ..+... ......+. ......+..+.+||.+||+.||.+|+++.+++.|+||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f 303 (345)
T cd07877 229 LILRLVGTPGAELLKKISSESAR----NYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303 (345)
T ss_pred HHHHHhCCCCHHHHhhcccHhHH----HHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhh
Confidence 55555444443332222110000 000000 00000000 0111346779999999999999999999999999999
Q ss_pred CCC
Q 011808 339 RIE 341 (477)
Q Consensus 339 ~~~ 341 (477)
+..
T Consensus 304 ~~~ 306 (345)
T cd07877 304 AQY 306 (345)
T ss_pred hhc
Confidence 843
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=329.89 Aligned_cols=290 Identities=36% Similarity=0.588 Sum_probs=208.9
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC-
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD- 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~- 102 (477)
+..+|.+.+.||.|+||.||+|.++. ++..|++|++..... .....+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~---~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~ 77 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSD---CDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD 77 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECC---CCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccc
Confidence 45899999999999999999998764 688999999865443 334567889999999999999999987754322
Q ss_pred -----------ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC
Q 011808 103 -----------MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 103 -----------~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~ 171 (477)
..+|++|||++++|.+++.. ..+++..++.++.||++||.|||+.||+||||||+||+++
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--- 148 (342)
T cd07854 78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--- 148 (342)
T ss_pred cccccccccccceEEEEeecccccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc---
Confidence 25799999999988877753 2588999999999999999999999999999999999993
Q ss_pred CCcccEEEeecccceeecCCCCccc-CCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCC
Q 011808 172 EEQGVVKIADFGLARIYQAPLKFLS-ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~ 250 (477)
.+++.+||+|||++..+........ .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+.
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---- 224 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE---- 224 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 2445799999999986543211111 11234688999999887656688999999999999999999999976542
Q ss_pred CcccHHHHHHHHHHhCCCCCCCccccC-CCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 251 NPFQLDQLDKIFKILGHPTPEKWPTLA-NLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 251 ~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
.+....+...+.....+.+..+. .++..... ........... .....+.++.+||.+||..||++|||+
T Consensus 225 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~ 294 (342)
T cd07854 225 ----LEQMQLILESVPVVREEDRNELLNVIPSFVRN-----DGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTA 294 (342)
T ss_pred ----HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhh-----cccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCH
Confidence 22232222222111111110000 00000000 00000000111 122456789999999999999999999
Q ss_pred HHHhcCccCCCC
Q 011808 330 AQALEHEYFRIE 341 (477)
Q Consensus 330 ~e~L~h~~f~~~ 341 (477)
.++|.|+||+.-
T Consensus 295 ~ell~h~~~~~~ 306 (342)
T cd07854 295 EEALMHPYMSCY 306 (342)
T ss_pred HHHhCCCccccc
Confidence 999999999743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=315.96 Aligned_cols=255 Identities=32% Similarity=0.548 Sum_probs=200.4
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC-------CcHHHHHHHHHHHhcCCCCeeEEEEEEEc
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG-------VSPTAIREIMLLREITHENVVKLVNVHIN 99 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 99 (477)
+|.+.+.||+|+||.||+|.+.. ++..+++|.+........ ....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Confidence 58899999999999999998653 578899998876543321 12356679999999999999999999876
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
. ...+++|||+. ++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||++ +.++.++
T Consensus 78 ~--~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~----~~~~~~~ 146 (267)
T cd06628 78 A--DHLNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV----DNKGGIK 146 (267)
T ss_pred C--CccEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE----cCCCCEE
Confidence 4 37899999997 4788888653 368889999999999999999999999999999999999 6777899
Q ss_pred EeecccceeecCCCCcc----cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCccc
Q 011808 179 IADFGLARIYQAPLKFL----SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~ 254 (477)
|+|||+++.+....... ......++..|+|||++.+. .++.++|+|||||++|+|++|+.||...+.
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------- 217 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------- 217 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccH--------
Confidence 99999998665321111 11123568899999999774 478899999999999999999999975431
Q ss_pred HHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
...+........ ...+...+..+.+||.+||+.||.+||++.++++
T Consensus 218 ---~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 218 ---LQAIFKIGENAS-------------------------------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---HHHHHHHhccCC-------------------------------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 122222211100 1123344678999999999999999999999999
Q ss_pred CccC
Q 011808 335 HEYF 338 (477)
Q Consensus 335 h~~f 338 (477)
|+||
T Consensus 264 ~~~~ 267 (267)
T cd06628 264 HPFL 267 (267)
T ss_pred CCCC
Confidence 9997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=320.47 Aligned_cols=283 Identities=50% Similarity=0.858 Sum_probs=222.0
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYL 107 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~l 107 (477)
|++.+.||+|++|.||+|.+.. ++..+++|.+............+.+|+.+++.++|+||+++++++.+. ..+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEE
Confidence 7788999999999999998653 688999999876655444456778899999999999999999988664 47899
Q ss_pred EEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 108 AFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 108 v~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
+|||+++++.+.+.... ..+++..+..++.||+.||.|||+.+|+|+||||+||++ +.++.++|+|||.+..
T Consensus 76 v~e~~~~~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili----~~~~~~~l~df~~~~~ 147 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI----NTEGVLKLADFGLARS 147 (283)
T ss_pred EEeccCCCHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE----CCCCcEEEeeeeeeEe
Confidence 99999999988887632 468999999999999999999999999999999999999 6677899999999987
Q ss_pred ecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCC
Q 011808 188 YQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267 (477)
Q Consensus 188 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~ 267 (477)
...... ......++..|+|||.+.+...++.++|+|||||++|+|++|+.||...+ ..+.+..+...++.
T Consensus 148 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~--------~~~~~~~~~~~~~~ 217 (283)
T cd05118 148 FGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS--------EIDQLFKIFRTLGT 217 (283)
T ss_pred cCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHcCC
Confidence 654331 12224468889999999876568999999999999999999999997665 45666777777777
Q ss_pred CCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+.+..|..+.+.-...... ......... .......+..+.+||.+||.+||.+||++.+++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 218 PDPEVWPKFTSLARNYKFS----FPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred CchHhcccchhhhhhhhhh----hccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 7666665544311111000 000000000 11123457789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=316.20 Aligned_cols=259 Identities=28% Similarity=0.469 Sum_probs=201.0
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC---CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD---GVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
..|++.+.||+|+||.||+|.+.. ++..|++|++....... .....+.+|+.+++.++||||+++++++.+..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD---TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC---CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence 468999999999999999998654 58899999986544322 123456779999999999999999999877656
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+++++||+. ++|.+.+... ..+++..++.++.||+.||.|||+.+|+||||||+||++ +.++.+||+|
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~----~~~~~~~l~d 149 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR----DSAGNVKLGD 149 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE----CCCCCEEEcc
Confidence 68899999997 5788887653 358899999999999999999999999999999999999 6677899999
Q ss_pred cccceeecCCCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 182 FGLARIYQAPLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 182 FG~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
||+++.+...... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||.... ....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~-----------~~~~ 217 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYE-----------AMAA 217 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccc-----------hHHH
Confidence 9998765321111 111223468899999999874 48899999999999999999999997432 1222
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+......... ..++...+..+.+|| +||..||++||+++++++||||+
T Consensus 218 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 218 IFKIATQPTN------------------------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHhcCCCC------------------------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 2222211111 112233456788898 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=313.95 Aligned_cols=259 Identities=29% Similarity=0.505 Sum_probs=208.4
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|++++.||.|+||.||+|.+.. ++..+++|.+............+.+|+.+++.++|+||+++++++....+..+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 58999999999999999998664 578899999876554444455677899999999999999999988776667899
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhh-----hCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH-----SNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH-----~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
++|||+. ++|.+++..... ....+++..++.++.||+.||.||| +.+|+|+||||+||++ +.++.+||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili----~~~~~~kl~ 152 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL----DANNNVKLG 152 (265)
T ss_pred EEehhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE----ecCCCEEEe
Confidence 9999997 588888876432 2457899999999999999999999 8999999999999999 667789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||++......... .....+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||...+. . .
T Consensus 153 d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~---~ 217 (265)
T cd08217 153 DFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQ---------L---Q 217 (265)
T ss_pred cccccccccCCccc--ccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCH---------H---H
Confidence 99999876543221 22345789999999997744 88999999999999999999999975431 1 1
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+...+..... ..++...+..+.+||.+||..||.+|||+.++++|||+
T Consensus 218 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 218 LASKIKEGKF------------------------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHhcCCC------------------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 1122111110 11233446789999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=319.02 Aligned_cols=262 Identities=23% Similarity=0.428 Sum_probs=201.9
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHH-HHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIML-LREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++++.||+|+||.||+|+++. ++..||||.++....... ...+..|+.+ ++.++||||+++++++.... .
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~--~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---TGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREG--D 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---CCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCC--c
Confidence 479999999999999999998764 689999999876543322 3355566665 56679999999999987644 6
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|++|||++++|.+++...... ...+++..++.++.||+.||.|||++ +++||||||+|||+ +.++.+||+|||
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~----~~~~~~kl~dfg 149 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI----NRNGQVKLCDFG 149 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE----CCCCCEEEeecc
Confidence 8999999999998888764322 35689999999999999999999997 99999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGA---KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
++....... ......++..|+|||++.+. ..++.++|+|||||++|+|++|+.||..... ..+.+.
T Consensus 150 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~- 218 (283)
T cd06617 150 ISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-------PFQQLK- 218 (283)
T ss_pred ccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-------CHHHHH-
Confidence 998654321 12224568899999998652 3368899999999999999999999964221 111221
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
..+....+. ......+.++.+||.+||..||.+||++.+++.|+||..
T Consensus 219 --~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 219 --QVVEEPSPQ------------------------------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred --HHHhcCCCC------------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 211111100 001123577999999999999999999999999999975
Q ss_pred C
Q 011808 341 E 341 (477)
Q Consensus 341 ~ 341 (477)
.
T Consensus 267 ~ 267 (283)
T cd06617 267 H 267 (283)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=323.44 Aligned_cols=292 Identities=28% Similarity=0.492 Sum_probs=215.6
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCC--C----CeeEEEEE
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH--E----NVVKLVNV 96 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~h--p----nIv~l~~~ 96 (477)
.+.++|.+++.+|+|+||.|..++++. ++..||||+++.-. ...+.++-|+++|.++.+ | -++.+.++
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~---~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRE---TKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecC---CCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 346899999999999999999999875 48899999997543 223455669999999932 2 36667777
Q ss_pred EEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC-----
Q 011808 97 HINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG----- 171 (477)
Q Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~----- 171 (477)
|.... .+|||+|.++-++++++..+. -.+++...++.+.+||++++++||+.+++|-||||+|||+.++.
T Consensus 160 Fdyrg--hiCivfellG~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 160 FDYRG--HICIVFELLGLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhccC--ceEEEEeccChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence 75544 789999999999999998754 34788999999999999999999999999999999999995421
Q ss_pred -----------CCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 011808 172 -----------EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL 240 (477)
Q Consensus 172 -----------~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~P 240 (477)
..+..|+|+|||.|...... ....+.|..|+|||++.+-. ++..+||||+||||+||.||...
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccC-cCCccCceeeeeEEEEeecccee
Confidence 12346999999999865432 23456699999999999965 99999999999999999999999
Q ss_pred CCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCC--------Cccccccccccccccc--cCCCCccccC--CCCC
Q 011808 241 FQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLAN--------LPHWQSDSLHIQGRKY--ETNGLHSVVP--LSPK 308 (477)
Q Consensus 241 F~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~--~~~~~~~~~p--~~~s 308 (477)
|++.+ ..+.+..+..++| |.|..+..... --+|......-+.+.. ....+..... ...-
T Consensus 309 FqtHe--------n~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~ 379 (415)
T KOG0671|consen 309 FQTHE--------NLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH 379 (415)
T ss_pred cccCC--------cHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence 99877 5677766666677 44433322210 0112111110000000 0011111111 1112
Q ss_pred chHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 309 SPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 309 ~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.++.|||++||.+||.+|+|+.|+|.||||..
T Consensus 380 ~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 380 VQLFDLLRRMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred hHHHHHHHHHHccCccccccHHHHhcCHHhhc
Confidence 34789999999999999999999999999973
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=319.98 Aligned_cols=252 Identities=30% Similarity=0.461 Sum_probs=204.1
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|.+.+.||+|+||.||++.+.. ++..+|+|++...... ......+.+|++++++++||||+++++++.+. ..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--Ce
Confidence 479999999999999999998764 5789999998754322 22345677899999999999999999998764 47
Q ss_pred EEEEEecc-CCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYA-EYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~-~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|++|||+ +++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+|||+ +.++.+||+|||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili----~~~~~~kl~dfg 146 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL----DSDGYIKITDFG 146 (290)
T ss_pred EEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE----CCCCCEEEeeCC
Confidence 89999999 47888888663 368999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++...... ....++++.|+|||.+.+. .++.++||||||+++|+|++|..||...+. ......+.
T Consensus 147 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~- 211 (290)
T cd05580 147 FAKRVKGR-----TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKIL- 211 (290)
T ss_pred CccccCCC-----CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHh-
Confidence 99866443 2234578999999999764 478899999999999999999999975441 11111111
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCccC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEYF 338 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~f 338 (477)
. .. ..++...+..++++|.+||..||.+|+ ++++++.||||
T Consensus 212 --~-~~-------------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 257 (290)
T cd05580 212 --E-GK-------------------------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257 (290)
T ss_pred --c-CC-------------------------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccc
Confidence 0 00 012333467899999999999999999 89999999999
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
..
T Consensus 258 ~~ 259 (290)
T cd05580 258 AG 259 (290)
T ss_pred cc
Confidence 63
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.46 Aligned_cols=235 Identities=29% Similarity=0.495 Sum_probs=199.4
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEe
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFD 110 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e 110 (477)
++-||+|+-|.||+++.+ ++.||||+++.-+ .-+|+-||+|+|+||+.|.++|... .++|||||
T Consensus 129 LeWlGSGaQGAVF~Grl~-----netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqs--PcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-----NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQS--PCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeeecc-----CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCC--ceeEEeee
Confidence 456899999999999854 6789999986432 2489999999999999999999654 48999999
Q ss_pred ccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeec
Q 011808 111 YAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 111 ~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
||. |-|+++|+.. ..++......|..+|+.++.|||.+.|||||||.-|||| ..+..|||+|||.++.+.
T Consensus 193 fCa~GqL~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI----s~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAG-----RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI----SYDDVVKISDFGTSKELS 263 (904)
T ss_pred ccccccHHHHHhcc-----CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe----eccceEEeccccchHhhh
Confidence 998 7999999874 478999999999999999999999999999999999999 445569999999998765
Q ss_pred CCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCC
Q 011808 190 APLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPT 269 (477)
Q Consensus 190 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 269 (477)
.. .+.-.++||..|||||+|.+. ..+.++|||||||+|||||||..||.+-+.. .-|
T Consensus 264 ~~---STkMSFaGTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----------AII-------- 320 (904)
T KOG4721|consen 264 DK---STKMSFAGTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----------AII-------- 320 (904)
T ss_pred hh---hhhhhhhhhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchh-----------eeE--------
Confidence 43 234458899999999999885 4899999999999999999999999754311 101
Q ss_pred CCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 270 PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
| ..-.+.|+..+|..+++.++-||+.||+-.|..||++.++|.|
T Consensus 321 ------------w----------GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 321 ------------W----------GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ------------E----------eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 0 1124567788999999999999999999999999999999999
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=313.00 Aligned_cols=264 Identities=29% Similarity=0.399 Sum_probs=205.3
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|++.+.||.|+||+||+|.+.. ++..+++|++....... ....+.+|+.+++.++|+||+++++.+... ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---CCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEE
Confidence 479999999999999999998653 57889999987654433 456778899999999999999999988664 478
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|++||++. ++|.+++..... ...+++..++.++.||+.||.|||+.||+|+||||+||++ ++++.++|+|||+
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~----~~~~~~~l~df~~ 148 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL----GEDGSVKIADFGV 148 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE----cCCCCEEEcccch
Confidence 99999997 578888765321 2368999999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcc--cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 185 ARIYQAPLKFL--SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 185 a~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+..+....... ......++..|+|||++.....++.++|+|||||++|+|++|+.||...+.. .. ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~---~~ 217 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KV---LM 217 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------hh---HH
Confidence 87665432221 1233457899999999987656899999999999999999999999754321 11 11
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+.+...++ .+.... .....+..+.+||.+||..||++|||+.+++.||||
T Consensus 218 ~~~~~~~~-~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 218 LTLQNDPP-SLETGA-------------------------DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHhcCCCC-CcCCcc-------------------------ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 11111111 000000 012335678999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=321.72 Aligned_cols=261 Identities=29% Similarity=0.451 Sum_probs=204.7
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++.+.||+|+||.||+|.+.. ++..+|||.+....... .....+.+|+++++.++|+||+++++++.+. ..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE--TY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC--CE
Confidence 479999999999999999998664 68899999997654332 2445677899999999999999999998654 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|++|||+. ++|.+++.... +..+++..++.++.||+.||.|||+.|++|+||||+||++ +.++.++|+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~~l~dfg 148 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL----HESGHIMLSDFD 148 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE----cCCCCEEEeecc
Confidence 899999987 58888776432 3468999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCc---------------------------ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh
Q 011808 184 LARIYQAPLKF---------------------------LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236 (477)
Q Consensus 184 ~a~~~~~~~~~---------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt 236 (477)
++......... .......|+..|+|||++.+. .++.++|||||||++|+|++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhh
Confidence 98754321110 011234678899999999874 47899999999999999999
Q ss_pred CCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHH
Q 011808 237 LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLS 316 (477)
Q Consensus 237 G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~ 316 (477)
|+.||.+.+. ...+..+. .... .++ .....+..+.+||.
T Consensus 228 g~~pf~~~~~--------~~~~~~~~---~~~~--~~~----------------------------~~~~~~~~~~~li~ 266 (316)
T cd05574 228 GTTPFKGSNR--------DETFSNIL---KKEV--TFP----------------------------GSPPVSSSARDLIR 266 (316)
T ss_pred CCCCCCCCch--------HHHHHHHh---cCCc--cCC----------------------------CccccCHHHHHHHH
Confidence 9999976542 12222211 1000 000 01113578999999
Q ss_pred HhcccCCCCCCC----HHHHhcCccCCC
Q 011808 317 KMLEYDPRKRIT----AAQALEHEYFRI 340 (477)
Q Consensus 317 ~~L~~dP~~Rpt----~~e~L~h~~f~~ 340 (477)
+||..||++||| ++++|.|+||+.
T Consensus 267 ~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 267 KLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 999999999999 999999999974
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.25 Aligned_cols=258 Identities=27% Similarity=0.452 Sum_probs=199.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.+.|+++++||.|+||.||+|++.. ++..+++|.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 83 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKE---TGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWD--GK 83 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECC---CCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--Ce
Confidence 3669999999999999999998654 57899999986532 22345677899999999999999999998764 37
Q ss_pred EEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+.+ +|..++.+. ...+++..+..++.||+.+|.|||+.||+||||||+||++ +.++.+||+|||
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~kl~dfg 155 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL----TLDGDIKLADFG 155 (292)
T ss_pred EEEEEecCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE----cCCCCEEEccCc
Confidence 8999999986 555555432 2368999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLG----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
++....... .......+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+. ..
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----------~~ 222 (292)
T cd06644 156 VSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------MR 222 (292)
T ss_pred cceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----------HH
Confidence 987543321 12233456889999999853 23478899999999999999999999965431 11
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+........+. ...+...+.++.+||.+||..||++||++.++++||||.
T Consensus 223 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 273 (292)
T cd06644 223 VLLKIAKSEPPT-----------------------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVS 273 (292)
T ss_pred HHHHHhcCCCcc-----------------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 111111111000 011233456789999999999999999999999999996
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=312.62 Aligned_cols=255 Identities=28% Similarity=0.506 Sum_probs=203.0
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|++.+.||+|+||.||++++.. ++..+++|.+............+.+|+.+++.++|+||+++++++... ...|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN--GNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--CeEE
Confidence 69999999999999999998654 578999999876544444455778899999999999999999998654 4789
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
+||||+. ++|.+.+.... ...+++..+..++.||+.||.|||+++++|+||+|+|||+ +.++.++|+|||++
T Consensus 76 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~----~~~~~~~l~d~~~~ 148 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL----TKDGTIKLGDFGIA 148 (256)
T ss_pred EEEecCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE----cCCCCEEEeeccce
Confidence 9999997 58888876532 2357899999999999999999999999999999999999 66677999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
..+...... .....+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+. .+.+..+ +
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~---~ 214 (256)
T cd08218 149 RVLNSTVEL--ARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKI---I 214 (256)
T ss_pred eecCcchhh--hhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHH---h
Confidence 866442211 1224568889999999774 478899999999999999999999964331 1112111 1
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.... ...+...+.++.++|.+||+.||.+||++.++|.|+||
T Consensus 215 ~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 215 RGSY-------------------------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred cCCC-------------------------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 1000 01233345779999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=311.65 Aligned_cols=259 Identities=27% Similarity=0.480 Sum_probs=201.9
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC---CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD---GVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+|++.+.||+|+||.||++++.. ++..|+||.+....... .....+.+|+.+++.++|+||+++++++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD---TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC---CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 579999999999999999998653 68899999886543222 123466779999999999999999999876655
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..++++|||+. ++|.+++... ..+++..+..++.||+.||.|||+++|+|+||||+|||+ +.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~----~~~~~~~l~D 149 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR----DSVGNVKLGD 149 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe----cCCCCEEECc
Confidence 67899999997 5788887653 257889999999999999999999999999999999999 6677899999
Q ss_pred cccceeecCCCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 182 FGLARIYQAPLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 182 FG~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
||++......... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||.... ....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~-----------~~~~ 217 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFE-----------AMAA 217 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccc-----------hHHH
Confidence 9998765432111 112234568899999999774 48899999999999999999999996432 1122
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+......+.. ...+...+..+.++|.+||. +|.+||++++++.|+|+.
T Consensus 218 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 218 IFKIATQPTN------------------------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHhcCCCC------------------------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 2222211110 11233445678899999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=318.93 Aligned_cols=261 Identities=23% Similarity=0.394 Sum_probs=201.8
Q ss_pred ccceeEEeeecccCceEEEEEEEeccc--CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAA--NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
+++|++.+.||+|+||.||+|.+.... .....|++|.++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-- 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE-- 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--
Confidence 468999999999999999999875432 2346799999875432 22344677899999999999999999998654
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhccc-----------CCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKV-----------NHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~ 170 (477)
...|++|||+. ++|.+++....... ...+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~--- 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV--- 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---
Confidence 36899999997 68888887643211 1468889999999999999999999999999999999999
Q ss_pred CCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccC
Q 011808 171 GEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKST 249 (477)
Q Consensus 171 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~ 249 (477)
+.++.++|+|||++................+++.|+|||++.+. .++.++|||||||++|||++ |..||.+...
T Consensus 158 -~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~--- 232 (283)
T cd05048 158 -GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--- 232 (283)
T ss_pred -cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 66778999999999865433222222334567889999998764 48999999999999999998 9999976542
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
.+ +...+..... ...+..++.++.+||.+||+.||.+||++
T Consensus 233 -----~~----~~~~i~~~~~------------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~ 273 (283)
T cd05048 233 -----QE----VIEMIRSRQL------------------------------LPCPEDCPARVYALMIECWNEIPARRPRF 273 (283)
T ss_pred -----HH----HHHHHHcCCc------------------------------CCCcccCCHHHHHHHHHHccCChhhCcCH
Confidence 11 1222111110 01234456889999999999999999999
Q ss_pred HHHhcC
Q 011808 330 AQALEH 335 (477)
Q Consensus 330 ~e~L~h 335 (477)
.+++++
T Consensus 274 ~~i~~~ 279 (283)
T cd05048 274 KDIHTR 279 (283)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=332.67 Aligned_cols=260 Identities=22% Similarity=0.370 Sum_probs=196.8
Q ss_pred cceeEEeeecccCceEEEEEEEecc--cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAA--ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHAD 102 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 102 (477)
++|++.+.||+|+||.||+|++... ..+...||||+++..... .....+.+|+.+++.+ +|+||+++++++....
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~- 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTHGG- 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecCCC-
Confidence 5799999999999999999986432 234567999999764332 2345677899999999 8999999999986643
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcc-------------------------------------------------------
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDK------------------------------------------------------- 126 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~------------------------------------------------------- 126 (477)
.+|+||||+. ++|.+++......
T Consensus 116 -~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 116 -PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred -CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 7899999998 6888888653210
Q ss_pred ----------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCccc
Q 011808 127 ----------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196 (477)
Q Consensus 127 ----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 196 (477)
....+++..++.++.||+.||.|||++||+||||||+|||+ ++++.+||+|||+++.+........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~----~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL----TDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE----eCCCeEEEeeceeeeeccCCcceee
Confidence 11347888999999999999999999999999999999999 6677899999999986543322212
Q ss_pred CCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccc
Q 011808 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPT 275 (477)
Q Consensus 197 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 275 (477)
.....++..|+|||++.+. .++.++|||||||++|+|++ |+.||...... ..+..+... .
T Consensus 271 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--------~~~~~~~~~---~------- 331 (374)
T cd05106 271 KGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--------SKFYKMVKR---G------- 331 (374)
T ss_pred ccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCcccccc--------HHHHHHHHc---c-------
Confidence 2222345679999999764 48999999999999999997 99999754311 111111110 0
Q ss_pred cCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 276 LANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.....+...+.++.+||.+||+.||.+|||+.++++
T Consensus 332 -----------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 332 -----------------------YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -----------------------cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001122234578999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=314.92 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=199.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|.+.+.||+|+||.||+|++.. ++..||+|+++.... .....+.+|+.+++.++||||+++++++... ..
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~~ 80 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVN---TGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--DK 80 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcC---CCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CE
Confidence 4689999999999999999998654 588999999875432 2234567899999999999999999998764 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|++|||++ ++|.+++... +.+++.+++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili----~~~~~~~l~dfg 151 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL----TDNGHVKLADFG 151 (267)
T ss_pred EEEEEeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEECcce
Confidence 899999998 5888877653 368999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
++....... .......|+..|+|||++.. ...++.++|+|||||++|+|++|..||..... ...+..+
T Consensus 152 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~--------~~~~~~~ 221 (267)
T cd06645 152 VSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP--------MRALFLM 221 (267)
T ss_pred eeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc--------hhhHHhh
Confidence 987654321 12234567999999999842 23478899999999999999999999864331 1111111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
.. ....+..+. .....+..+.+||.+||..||++|||+++++.|||
T Consensus 222 ~~--~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 222 TK--SNFQPPKLK----------------------------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred hc--cCCCCCccc----------------------------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00 000000000 01123567899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=322.06 Aligned_cols=290 Identities=36% Similarity=0.592 Sum_probs=214.9
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
...++|++++.||.|+||.||+|+++. ++..||||++............+.+|+.+++.++||||++++++|....
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 82 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQL---TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL- 82 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECC---CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-
Confidence 456889999999999999999998664 6889999998765444444567778999999999999999999986533
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
...|+++||++++|..++.. ..+++..+..++.||++||.|||+++|+||||||.|||+ +.++.++|+||
T Consensus 83 ~~~~lv~e~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili----~~~~~~~l~df 152 (328)
T cd07856 83 EDIYFVTELLGTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI----NENCDLKICDF 152 (328)
T ss_pred CcEEEEeehhccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE----CCCCCEEeCcc
Confidence 36789999999988877753 257888899999999999999999999999999999999 67778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++...... .....++..|+|||++.+...++.++|||||||++|+|++|++||...+ ....+..+.
T Consensus 153 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~--------~~~~~~~~~ 219 (328)
T cd07856 153 GLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD--------HVNQFSIIT 219 (328)
T ss_pred ccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence 998754321 1234558889999998765568999999999999999999999997654 233344444
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEP 342 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~~ 342 (477)
+.++.++.+.+..+.. .................... .....+..+.++|.+||+.||++|||+++++.|+||....
T Consensus 220 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 220 DLLGTPPDDVINTICS---ENTLRFVQSLPKREPVPFSE-KFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HHhCCCCHHHHHhccc---hhhHHHHhhccccCCCcHHH-HcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 5555443322111000 00000000000000000000 1123467899999999999999999999999999997543
Q ss_pred C
Q 011808 343 L 343 (477)
Q Consensus 343 ~ 343 (477)
.
T Consensus 296 ~ 296 (328)
T cd07856 296 D 296 (328)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=320.59 Aligned_cols=284 Identities=23% Similarity=0.371 Sum_probs=203.2
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|++.+.||+|+||.||++.+.. ++..+++|.+..... ......+.+|++++++++||||+++++++.+.. .+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~---~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP---SGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG--EI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC---CCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--EE
Confidence 479999999999999999998664 578899998875422 223446778999999999999999999997644 78
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
|++|||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||
T Consensus 75 ~lv~ey~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~----~~~~~~~l~dfg 145 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV----NSRGEIKLCDFG 145 (308)
T ss_pred EEEeeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE----ecCCcEEEccCC
Confidence 99999998 5888887653 368999999999999999999998 599999999999999 666789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++....... .....++..|+|||++.+. .++.++|+|||||++|+|++|+.||...+.. .+..++.
T Consensus 146 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---------~~~~~~~ 211 (308)
T cd06615 146 VSGQLIDSM----ANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---------ELEAMFG 211 (308)
T ss_pred Ccccccccc----cccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchh---------hHHHhhc
Confidence 987543221 2335678999999998764 4889999999999999999999999754321 1111111
Q ss_pred HhCCCCC-CCcc---c--cCCCccccccccccccccccCCCCccccC-CCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 264 ILGHPTP-EKWP---T--LANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 264 ~~~~~~~-~~~~---~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~p-~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
....... .... . ....+.+...... ............+ ...+.++.+||.+||..||++|||+.+++.||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 212 RPVSEGEAKESHRPVSGHPPDSPRPMAIFEL---LDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CccccccccCCcccccCCCCCccchhhHHHH---HHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1000000 0000 0 0000000000000 0000000001111 12466799999999999999999999999999
Q ss_pred cCCCC
Q 011808 337 YFRIE 341 (477)
Q Consensus 337 ~f~~~ 341 (477)
||...
T Consensus 289 ~~~~~ 293 (308)
T cd06615 289 FIKRA 293 (308)
T ss_pred hhhhc
Confidence 99743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=309.62 Aligned_cols=255 Identities=29% Similarity=0.513 Sum_probs=205.7
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|++++.||.|+||.||++++.. ++..+++|.+............+.+|+.++++++|+||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEE
Confidence 69999999999999999998654 688899999876655555566788999999999999999999999764 4789
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
++|||+. ++|.+++.... ...+++..+..++.|++.+|.|||+.|++|+||||+||++ +.++.+||+|||++
T Consensus 76 ~~~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~----~~~~~~kl~d~~~~ 148 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL----TKAGLIKLGDFGIS 148 (256)
T ss_pred EEEEecCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE----eCCCCEEECcCcce
Confidence 9999997 58888887643 3468999999999999999999999999999999999999 66678999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
........ ......+++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+. .+....+..
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~-- 215 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIVQ-- 215 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHc--
Confidence 86644321 223356799999999997744 78899999999999999999999975431 122222211
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.... ..+...+..+.+||.+||..||.+||++.++|+|+|+
T Consensus 216 --~~~~------------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 216 --GNYT------------------------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred --CCCC------------------------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 1000 0112335678999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=314.31 Aligned_cols=254 Identities=18% Similarity=0.284 Sum_probs=196.4
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
.+|++.+.||+|+||.||+|.++.....+..||+|.++..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CCc
Confidence 5799999999999999999987655556789999999765332 2335678899999999999999999998754 478
Q ss_pred EEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
++||||+++ +|.+++... ...+++..++.++.||+.||+|||++|++||||||+|||+ +.++.+||+|||.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili----~~~~~~~l~dfg~ 153 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV----NSDLVCKISGFRR 153 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE----cCCCcEEECCCcc
Confidence 999999985 666676543 2368999999999999999999999999999999999999 6677899999998
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+......... ......++..|+|||++.+. .++.++|||||||++||+++ |..||...+. .+.+..+
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~-- 221 (266)
T cd05064 154 LQEDKSEAIY-TTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDVIKAV-- 221 (266)
T ss_pred cccccccchh-cccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHH--
Confidence 7653222111 11122346789999999774 48999999999999999775 9999976542 1111111
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.... ....+..++..+.++|.+||..||.+|||++++++
T Consensus 222 --~~~~------------------------------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 222 --EDGF------------------------------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred --HCCC------------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 1100 00123344577899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=314.14 Aligned_cols=281 Identities=44% Similarity=0.803 Sum_probs=211.4
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc---CCCCeeEEEEEEEcCCC--
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI---THENVVKLVNVHINHAD-- 102 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~-- 102 (477)
|++.+.||+|+||.||+|.++. ++..||||.++...........+.+|+.+++++ +|+||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 7899999999999999998764 588999999976554443344566788777666 59999999999876542
Q ss_pred -ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 -MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..++++|||+.++|.+++.... ...+++..++.++.||+.||.|||+.+++|+||+|+||++ +.++.+||+|
T Consensus 78 ~~~~~l~~e~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili----~~~~~~~l~d 150 (287)
T cd07838 78 ELKLTLVFEHVDQDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV----TSDGQVKIAD 150 (287)
T ss_pred CceeEEEehhcccCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE----ccCCCEEEec
Confidence 3489999999999988886543 2358999999999999999999999999999999999999 6668899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||++..+..... .....++..|+|||++.+.. ++.++|+|||||++|+|++|++||.+.+ ..+.+.++
T Consensus 151 fg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~--------~~~~~~~~ 218 (287)
T cd07838 151 FGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTS--------EADQLDKI 218 (287)
T ss_pred cCcceeccCCcc---cccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCC--------hHHHHHHH
Confidence 999987643321 12334688899999998744 8899999999999999999999998655 34556666
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+.....+....|+.....+... + ........ .......+..+.+||.+||+.||.+||++.+++.|+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~-----~--~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 219 FDVIGLPSEEEWPRNVSLPRSS-----F--PSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred HHHcCCCChHhcCCCcccchhh-----c--ccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 6665544433333211100000 0 00000000 00112335678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=317.37 Aligned_cols=259 Identities=27% Similarity=0.467 Sum_probs=203.8
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
....+|++++.||+|+||.||++.+.. ++..||||.+...... ....+.+|+.+++.++|+||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-- 88 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIA---TGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG-- 88 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECC---CCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 345899999999999999999998653 5889999998654332 235677899999999999999999998764
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.++|+|
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili----~~~~~~~l~D 158 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL----GMDGSVKLTD 158 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEECc
Confidence 37899999997 577777754 257889999999999999999999999999999999999 6677899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||++........ ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.... +..+
T Consensus 159 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--------~~~~ 227 (297)
T cd06656 159 FGFCAQITPEQS--KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLI 227 (297)
T ss_pred CccceEccCCcc--CcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--------eeee
Confidence 999976543221 1223456889999999977 4488999999999999999999999975442110 0000
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
...+.+ ....+...+..+.+||.+||..||.+||++.+++.||||+..
T Consensus 228 -~~~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 228 -ATNGTP-------------------------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred -ccCCCC-------------------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 000000 001223345678999999999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=331.28 Aligned_cols=261 Identities=24% Similarity=0.394 Sum_probs=197.4
Q ss_pred cceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHAD 102 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 102 (477)
++|++.+.||+|+||.||+|.+.. ...++..||||+++..... .....+.+|+.+++.+ +||||+++++++.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~- 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHINIVNLLGACTVGG- 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-HHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence 479999999999999999997532 2245678999999754322 2345678899999999 8999999999986644
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcc-------------------------------------------------------
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDK------------------------------------------------------- 126 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~------------------------------------------------------- 126 (477)
..++||||+. |+|.+++......
T Consensus 113 -~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 113 -PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred -cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 6899999998 6888888653210
Q ss_pred ---------------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCC
Q 011808 127 ---------------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191 (477)
Q Consensus 127 ---------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~ 191 (477)
....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill----~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL----THGRITKICDFGLARDIRND 267 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE----ECCCcEEEecCccceeccCc
Confidence 01247888899999999999999999999999999999999 56677999999999866443
Q ss_pred CCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCCCC
Q 011808 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTP 270 (477)
Q Consensus 192 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 270 (477)
..........++..|+|||++.+. .++.++|||||||++|+|++ |..||..... ...+. +.+....
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--------~~~~~---~~~~~~~- 334 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPV--------DSKFY---KMIKEGY- 334 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--------hHHHH---HHHHhCc-
Confidence 222222223346679999999774 48999999999999999998 8999975431 11111 1111000
Q ss_pred CCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 271 EKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
....+...+.++++||.+||+.||++|||+.++++.
T Consensus 335 -----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 335 -----------------------------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -----------------------------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 001122335679999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=318.20 Aligned_cols=259 Identities=29% Similarity=0.464 Sum_probs=202.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++++.||.|+||.||++.++. ++..+++|.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE---TGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYE--NK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC---CCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--Ce
Confidence 4679999999999999999998764 57899999986542 22334677899999999999999999998764 47
Q ss_pred EEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+++ +|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||++ +.++.++|+|||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili----~~~~~~~l~d~g 148 (280)
T cd06611 77 LWILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL----TLDGDVKLADFG 148 (280)
T ss_pred EEEEeeccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE----CCCCCEEEccCc
Confidence 8999999985 777776653 2368999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLG----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
++........ ......+++.|+|||++.. ...++.++|+|||||++|+|++|++||...+. ..
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--------~~--- 215 (280)
T cd06611 149 VSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--------MR--- 215 (280)
T ss_pred cchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--------HH---
Confidence 9875433211 2233567899999999853 23467899999999999999999999975431 11
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+........+ ....+...+.++.+||.+||+.||.+||++.++|+|+||.
T Consensus 216 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 266 (280)
T cd06611 216 VLLKILKSEPP-----------------------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS 266 (280)
T ss_pred HHHHHhcCCCC-----------------------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhc
Confidence 11111111100 0011233457899999999999999999999999999997
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 267 ~ 267 (280)
T cd06611 267 D 267 (280)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=324.83 Aligned_cols=261 Identities=26% Similarity=0.397 Sum_probs=211.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.+.|+.-++||+|+||.||-++.+. +|+.||+|++.+..... .....+++|-.||.+++.+.||.+-..|++.+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvra---TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd-- 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRA---TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD-- 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEec---chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC--
Confidence 4678889999999999999998775 79999999886544332 23345678999999999999999999887755
Q ss_pred eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+|+..|.| +|.-.|-.+. +..+++..++.++.+|+.||++||..+||+|||||+|||| ++.|+++|+|+
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL----Dd~GhvRISDL 331 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL----DDHGHVRISDL 331 (591)
T ss_pred ceEEEEEeecCCceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee----ccCCCeEeecc
Confidence 78999999984 6665565544 3579999999999999999999999999999999999999 89999999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+|..+..... ..+.+||.+|||||++.+.. |+...|+|||||++|||+.|+.||.....+... +++-
T Consensus 332 GLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--------eEvd 399 (591)
T KOG0986|consen 332 GLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--------EEVD 399 (591)
T ss_pred ceEEecCCCCc---cccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--------HHHH
Confidence 99987765433 23348899999999999866 999999999999999999999999876543221 1121
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCcc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEY 337 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~ 337 (477)
+.+... + ...+...|+++++|.+.+|.+||.+|. +++++.+|||
T Consensus 400 rr~~~~-~------------------------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hpf 448 (591)
T KOG0986|consen 400 RRTLED-P------------------------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPF 448 (591)
T ss_pred HHHhcc-h------------------------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcc
Confidence 111111 1 113445578999999999999999998 5889999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|+.
T Consensus 449 Fk~ 451 (591)
T KOG0986|consen 449 FKD 451 (591)
T ss_pred ccc
Confidence 984
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=319.22 Aligned_cols=265 Identities=21% Similarity=0.339 Sum_probs=202.1
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 104 (477)
.+|...+.||+|+||.||++.+.. ++..+|||.+...... .....+.+|+.++.++. |+||+++++++.... .
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~--~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKP---SGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG--D 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECC---CCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC--c
Confidence 467788899999999999998764 5889999998754433 23446778999999995 999999999887643 6
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+++|||+..++.++...........+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~----~~~~~~kl~dfg 153 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL----DRNGNIKLCDFG 153 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE----ccCCcEEEeecc
Confidence 7899999988776654432222235789999999999999999999975 99999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGA--KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
+++.+..... .....++..|+|||++.+. ..++.++|||||||++|+|++|++||.... .....+
T Consensus 154 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----------~~~~~~ 220 (288)
T cd06616 154 ISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----------SVFDQL 220 (288)
T ss_pred hhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----------hHHHHH
Confidence 9976543221 1223568899999999775 358999999999999999999999996432 111222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
........+. +....+...+.++.+||.+||.+||++|||+++++.|+||+.
T Consensus 221 ~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 221 TQVVKGDPPI---------------------------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred hhhcCCCCCc---------------------------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 2222111111 001112335678999999999999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=317.02 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=199.0
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
-|++++.||+|+||.||++.+.. ++..+++|.+.... ......+.+|+.+++.++|+||+++++++... ...|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~ 78 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLW 78 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECC---CCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEE
Confidence 37899999999999999998654 57889999986432 22345677899999999999999999998764 4789
Q ss_pred EEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
++|||+.+ +|..++... ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 79 ~v~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili----~~~~~~kl~dfg~~ 150 (282)
T cd06643 79 ILIEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF----TLDGDIKLADFGVS 150 (282)
T ss_pred EEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE----ccCCCEEEcccccc
Confidence 99999985 555555432 2468999999999999999999999999999999999999 66778999999998
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLG----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
....... .......++..|+|||++.. ...++.++|||||||++|+|++|.+||...+. ......+
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~ 220 (282)
T cd06643 151 AKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKI 220 (282)
T ss_pred ccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHH
Confidence 7543321 12233567899999999842 23477899999999999999999999975431 1122211
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.. ...+. ...+...+..+.+||.+||..||.+|||+++++.||||+.
T Consensus 221 ~~---~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 221 AK---SEPPT-----------------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred hh---cCCCC-----------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 11 10000 0122334578999999999999999999999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=317.29 Aligned_cols=257 Identities=28% Similarity=0.485 Sum_probs=202.4
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
...+|++++.||+|+||.||++.++. ++..|++|.+...... ....+.+|+.+++.++|+||+++++.+... .
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~--~ 90 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG--D 90 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECC---CCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC--C
Confidence 35799999999999999999998653 5789999998754432 235677899999999999999999998764 3
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..|+||||+. ++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+|||+ +.++.+||+||
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill----~~~~~~kl~df 160 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL----GMDGSVKLTDF 160 (296)
T ss_pred EEEEeecccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----cCCCCEEECcc
Confidence 7899999997 578887754 257889999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++........ ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+. ...+ .
T Consensus 161 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--------~~~~---~ 226 (296)
T cd06654 161 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRAL---Y 226 (296)
T ss_pred ccchhcccccc--ccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCH--------HHhH---H
Confidence 99876543221 12234568999999999764 478999999999999999999999975431 1111 1
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.......+. ...+...+..+.+||.+||.+||++|||+.+++.|+||..
T Consensus 227 ~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 227 LIATNGTPE-----------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHhcCCCCC-----------------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 111000000 0012234567899999999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=311.30 Aligned_cols=256 Identities=24% Similarity=0.407 Sum_probs=198.7
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC----CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD----GVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
+|.+.+.||+|+||.||+|.+. ++..+|||.+....... .....+.+|+.+++.++|+||+++++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-- 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--
Confidence 5889999999999999999642 57889999987543321 1224567899999999999999999998764
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..++++|||+. ++|.+++... ..+++..+..++.||+.||+|||+.+|+|+||||+||++ ++++.++|+|
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~----~~~~~~~l~d 145 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML----MPNGIIKLID 145 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE----CCCCeEEecc
Confidence 48899999997 5888887653 358899999999999999999999999999999999999 6777899999
Q ss_pred cccceeecCCCCc----ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 182 FGLARIYQAPLKF----LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 182 FG~a~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
||++......... .......++..|+|||++.+. .++.++|+|||||++|+|++|..||...+. ...
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~ 216 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDR--------LAA 216 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCCh--------HHH
Confidence 9998754321110 011234568899999999774 488999999999999999999999975431 111
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
...+.... . .....+...+.++.+||++||..||.+||++.+++.|||
T Consensus 217 ~~~~~~~~--~------------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 217 MFYIGAHR--G------------------------------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred HHHhhhcc--C------------------------------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 11110000 0 001123345678999999999999999999999999999
Q ss_pred C
Q 011808 338 F 338 (477)
Q Consensus 338 f 338 (477)
|
T Consensus 265 ~ 265 (265)
T cd06631 265 L 265 (265)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=316.55 Aligned_cols=259 Identities=23% Similarity=0.402 Sum_probs=201.2
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcC--
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINH-- 100 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~-- 100 (477)
-.+.|++.+.||+|+||.||+|+++. ++..+|+|++.... .....+..|+.+++++ +|+||+++++++...
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcC---CCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 35799999999999999999998764 57899999986542 1234667799999988 799999999998642
Q ss_pred --CCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccE
Q 011808 101 --ADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVV 177 (477)
Q Consensus 101 --~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~v 177 (477)
....+|++|||+.+ +|.+++.... ...+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili----~~~~~~ 160 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL----TENAEV 160 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCE
Confidence 24578999999985 8888876643 3458889999999999999999999999999999999999 667789
Q ss_pred EEeecccceeecCCCCcccCCCeeeccccccchhhcC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 178 KIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLG----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
+|+|||++........ ......+++.|+|||++.. ...++.++|+|||||++|+|++|..||.....
T Consensus 161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~------- 231 (282)
T cd06636 161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP------- 231 (282)
T ss_pred EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-------
Confidence 9999999875532211 1233567899999999853 23478899999999999999999999965431
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
...+..... .... .......+..+.+||++||..||.+|||+.++|
T Consensus 232 ----~~~~~~~~~-~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 232 ----MRALFLIPR-NPPP-----------------------------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred ----HhhhhhHhh-CCCC-----------------------------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 111111110 0000 011123457899999999999999999999999
Q ss_pred cCccC
Q 011808 334 EHEYF 338 (477)
Q Consensus 334 ~h~~f 338 (477)
.||||
T Consensus 278 ~~~~~ 282 (282)
T cd06636 278 KHPFI 282 (282)
T ss_pred cCCCC
Confidence 99997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=308.26 Aligned_cols=255 Identities=31% Similarity=0.471 Sum_probs=203.7
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|++.+.||+|+||.||+|.+.. ++..++||.+............+.+|+.+++.++|+||+++++.+... ..++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEE
Confidence 69999999999999999998764 688999999976655555566788899999999999999999988653 4789
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
+||||+. ++|.+++.... ...+++..+..++.+++.+|.|||++||+|+||||+||++. ..+..+||+|||++
T Consensus 76 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~---~~~~~~~l~d~~~~ 149 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD---KHKMVVKIGDFGIS 149 (256)
T ss_pred EEEecCCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEEccCCCc
Confidence 9999997 58888887643 33589999999999999999999999999999999999993 23456899999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
........ .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+. ......+...
T Consensus 150 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~~- 216 (256)
T cd08220 150 KILSSKSK---AYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMSG- 216 (256)
T ss_pred eecCCCcc---ccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHhc-
Confidence 87654321 2234568899999999774 478899999999999999999999975442 1111111110
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
. ....+...+..+.+||.+||..||.+|||+.+++.||||
T Consensus 217 ---~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 217 ---T------------------------------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ---C------------------------------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0 001223346789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=301.22 Aligned_cols=262 Identities=25% Similarity=0.368 Sum_probs=199.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC---C
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH---A 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---~ 101 (477)
-+||+|.+.||+|||+.||+++.. .++..||+|++.-.. .+..+..++|++..++++||||++++++.... .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~---s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGL---STGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred CceEEEeeeecCCCceeeeeeccc---Ccccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 368999999999999999999744 478899999997665 34567889999999999999999999876432 3
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC--eecCCCCCCcEEEeccCCCcccEE
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW--IIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDikp~NILl~~~~~~~~~vk 178 (477)
....||+++|.. |+|.+.++....+ +..++|.++..|+.+|++||++||+.. ++||||||.|||+ .+.+.++
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl----s~~~~~v 169 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL----SDSGLPV 169 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe----cCCCceE
Confidence 456899999876 8899999887654 457999999999999999999999998 9999999999999 5567799
Q ss_pred EeecccceeecCCCCcccC-------CCeeeccccccchhhcCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccccC
Q 011808 179 IADFGLARIYQAPLKFLSE-------NGVVVTIWYRAPELLLGAK--HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST 249 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~-------~~~~gt~~y~APE~l~~~~--~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~ 249 (477)
|.|||.++...-....... ..-..|..|+|||.+.-.. ..+.++|||||||+||+|+.|..||.......+
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 9999998643211110000 0112288999999986432 367899999999999999999999963221000
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
.+. +.+. ...+........++.+.+||+.||+.||.+||++
T Consensus 250 --Sla--------------------------------LAv~-----n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i 290 (302)
T KOG2345|consen 250 --SLA--------------------------------LAVQ-----NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTI 290 (302)
T ss_pred --eEE--------------------------------Eeee-----ccccccCCCCCccHHHHHHHHHHhcCCcccCCCH
Confidence 000 0000 0001111122357889999999999999999999
Q ss_pred HHHhcC
Q 011808 330 AQALEH 335 (477)
Q Consensus 330 ~e~L~h 335 (477)
.+++.+
T Consensus 291 ~~ll~~ 296 (302)
T KOG2345|consen 291 PELLSK 296 (302)
T ss_pred HHHHHH
Confidence 999876
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=318.70 Aligned_cols=261 Identities=24% Similarity=0.418 Sum_probs=202.1
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|++++.||+|+||.||+|++.. ++..||+|.++.... ......+.+|+.++++++|+||+++++++... ..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP---TGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC---CCcEEEEEEeecccC-HHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeE
Confidence 479999999999999999998764 588999999875422 22345778899999999999999999988764 478
Q ss_pred EEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 106 YLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 106 ~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
|+||||+.+ +|..++.... ....+++..+..++.||+.||.|||+ .+|+|+||||+||++ +.++.+||+|||
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~----~~~~~~~l~dfg 148 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV----NGNGQVKLCDFG 148 (286)
T ss_pred EEEEeecCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE----CCCCCEEEeecC
Confidence 999999985 7766665431 12368999999999999999999997 599999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAK-----HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-----~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
++..+.... .....++..|+|||++.+.. .++.++|+|||||++|+|++|+.||..... ....
T Consensus 149 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~~ 216 (286)
T cd06622 149 VSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--------ANIF 216 (286)
T ss_pred CcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--------hhHH
Confidence 987653321 12234688899999985432 357899999999999999999999965431 1111
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..+........+ ..+...+.++.+||.+||..||.+||++.+++.|+||
T Consensus 217 ~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~ 265 (286)
T cd06622 217 AQLSAIVDGDPP-------------------------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265 (286)
T ss_pred HHHHHHhhcCCC-------------------------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhh
Confidence 222222111111 1223346789999999999999999999999999999
Q ss_pred CCC
Q 011808 339 RIE 341 (477)
Q Consensus 339 ~~~ 341 (477)
...
T Consensus 266 ~~~ 268 (286)
T cd06622 266 VKY 268 (286)
T ss_pred hhc
Confidence 643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=311.80 Aligned_cols=257 Identities=29% Similarity=0.430 Sum_probs=198.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
..+|++.+.||+|+||.||+|+++. ++..||+|++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~ 80 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH---TGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EK 80 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC---CCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CE
Confidence 4579999999999999999998754 578999999865432 2234567899999999999999999998764 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||++ ++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||
T Consensus 81 ~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill----~~~~~~~l~dfg 151 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL----TDNGDVKLADFG 151 (267)
T ss_pred EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----CCCCCEEECcCc
Confidence 899999998 577777754 2368999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
++..+..... ......++..|+|||.+.+ ...++.++|+|||||++|+|++|..||........ ...+
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--------~~~~ 221 (267)
T cd06646 152 VAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------LFLM 221 (267)
T ss_pred cceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--------heee
Confidence 9986643221 1233567889999999853 23477899999999999999999999964331100 0000
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
... ...+.. .......+..+.+||++||..||++|||++++|+|.|
T Consensus 222 ~~~--~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 222 SKS--NFQPPK----------------------------LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ecC--CCCCCC----------------------------CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000 000000 0011234568999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=327.51 Aligned_cols=262 Identities=24% Similarity=0.404 Sum_probs=199.3
Q ss_pred cceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHAD 102 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 102 (477)
++|++.+.||+|+||.||+|++.. ...+++.||+|+++.... ......+.+|+.+++++ +|+||+++++++... +
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 489999999999999999997533 223567899999875432 22335677899999999 899999999988654 3
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcc-------------------------------------------------------
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDK------------------------------------------------------- 126 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~------------------------------------------------------- 126 (477)
..++++|||+. ++|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 47899999998 5888887643211
Q ss_pred -cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccc
Q 011808 127 -VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205 (477)
Q Consensus 127 -~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~ 205 (477)
....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.............++..
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill----~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL----SENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE----eCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 01367889999999999999999999999999999999999 5667899999999987643322222233445678
Q ss_pred cccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccc
Q 011808 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQS 284 (477)
Q Consensus 206 y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 284 (477)
|+|||++.+. .++.++|||||||++|||++ |..||.+.... +.+...... ..
T Consensus 241 y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~---~~--------------- 293 (337)
T cd05054 241 WMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------EEFCRRLKE---GT--------------- 293 (337)
T ss_pred ccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--------HHHHHHHhc---cC---------------
Confidence 9999999874 48999999999999999998 99999754321 111111110 00
Q ss_pred cccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 285 DSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
....+...+.++.+++.+||+.+|++||++.++++|
T Consensus 294 ---------------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 294 ---------------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ---------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 001223345789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=303.49 Aligned_cols=259 Identities=22% Similarity=0.412 Sum_probs=204.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 103 (477)
+++.+++..||+|+.|+||+++++. +|..+|||.+......+ ..++++..+.++-.. ++|+||+.+++|..+.+
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs---~~~iiAVK~M~rt~Nke-e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d- 165 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRS---TGHIIAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD- 165 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcc---cceEEEEEeecccCCHH-HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-
Confidence 4556678899999999999999875 68999999998765544 345666667665544 69999999999988664
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
+++.||.+...+..+++.. .++++|..+-++...+++||.||-++ +|+|||+||+|||+ ++.|++|||||
T Consensus 166 -V~IcMelMs~C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl----De~GniKlCDF 236 (391)
T KOG0983|consen 166 -VFICMELMSTCAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL----DERGNIKLCDF 236 (391)
T ss_pred -HHHHHHHHHHHHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE----ccCCCEEeecc
Confidence 5677888886666666554 34799999999999999999999975 89999999999999 89999999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|++-.+..... .....|-+.|||||.+.- ...|+.++||||||++++||.||..||.+.+. + ++.
T Consensus 237 GIsGrlvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-------d---Fe~ 303 (391)
T KOG0983|consen 237 GISGRLVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-------D---FEV 303 (391)
T ss_pred cccceeecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-------c---HHH
Confidence 99987654332 233456899999999853 24589999999999999999999999988653 2 333
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+.+++...+ ..++. ....|+.+++|+..||.+|+.+||...++|+|||.+
T Consensus 304 ltkvln~eP-P~L~~----------------------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~ 353 (391)
T KOG0983|consen 304 LTKVLNEEP-PLLPG----------------------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK 353 (391)
T ss_pred HHHHHhcCC-CCCCc----------------------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence 444443322 22111 111367899999999999999999999999999986
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=316.36 Aligned_cols=256 Identities=28% Similarity=0.487 Sum_probs=202.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
..+|++++.||.|+||.||++.+.. ++..|+||.+..... .....+.+|+.+++.++|+||+++++++... ..
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 90 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVA---TGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVG--DE 90 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcC---CCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecC--ce
Confidence 4679999999999999999998654 688999999865432 2345677899999999999999999998764 47
Q ss_pred EEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+|+||+.+ +|.+++.. ..+++.++..++.|++.||.|||++|++|+||||+||++ +.++.+||+|||
T Consensus 91 ~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili----~~~~~~kl~dfg 160 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL----GMDGSVKLTDFG 160 (296)
T ss_pred EEEEEEecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEccCc
Confidence 8999999985 66666643 258999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++........ ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+. ...+..+..
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~--------~~~~~~~~~ 229 (296)
T cd06655 161 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIAT 229 (296)
T ss_pred cchhcccccc--cCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh
Confidence 9876543221 12234568899999999764 488999999999999999999999976542 112211111
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
. ..+. ...+..++..+.+||++||..||.+|||+.+++.|+||+.
T Consensus 230 ~-~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 230 N-GTPE-------------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred c-CCcc-------------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 0 0000 0122334577999999999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=353.87 Aligned_cols=263 Identities=24% Similarity=0.334 Sum_probs=212.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC-CcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG-VSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|+|+++||+|+||.|.+++++. +++.||+|++++-..-+. ....|..|-.+|-.-+.+=|+.+...|.++ .
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~---t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~--~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKS---TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE--R 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeec---cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc--c
Confidence 3689999999999999999999885 689999999987433222 233555688888888899999999988765 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
++|+||||+. |+|..++.+.. .+++..++.|+..|..||.-||+.|+|||||||+|||| +..|+|||+||
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl----d~~GHikLADF 219 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL----DKSGHIKLADF 219 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe----cccCcEeeccc
Confidence 8999999977 68888887642 69999999999999999999999999999999999999 89999999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLG----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|.+-.+...... .....+|||.|++||++.. ...|+..+|+|||||++|||+.|..||...+ ..+..
T Consensus 220 GsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--------lveTY 290 (1317)
T KOG0612|consen 220 GSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--------LVETY 290 (1317)
T ss_pred hhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--------HHHHH
Confidence 999877755443 3456789999999999952 2458999999999999999999999997544 22333
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccC--CCCCchHHHHHHHhcccCCCCCCC---HHHHh
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP--LSPKSPAYDLLSKMLEYDPRKRIT---AAQAL 333 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~s~~~~dli~~~L~~dP~~Rpt---~~e~L 333 (477)
.+|+.. ...- .+| ..+|..++|||+++|. +|+.|.. ++++.
T Consensus 291 ~KIm~h---k~~l------------------------------~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 291 GKIMNH---KESL------------------------------SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred HHHhch---hhhc------------------------------CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 333322 1111 122 3468899999999887 4889998 99999
Q ss_pred cCccCCCCCCC
Q 011808 334 EHEYFRIEPLP 344 (477)
Q Consensus 334 ~h~~f~~~~~~ 344 (477)
.||||......
T Consensus 337 ~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 337 NHPFFEGIDWD 347 (1317)
T ss_pred hCccccCCChh
Confidence 99999865553
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=312.18 Aligned_cols=262 Identities=29% Similarity=0.464 Sum_probs=203.2
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC-
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHA- 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~- 101 (477)
-.++|++.+.||+|+||.||+|.++. ++..+++|++..... ....+.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECC---CCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 35899999999999999999998754 578899999875432 235677899999999 7999999999987643
Q ss_pred ---CceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccE
Q 011808 102 ---DMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVV 177 (477)
Q Consensus 102 ---~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~v 177 (477)
...+|++|||+.+ +|.+++.... .....+++..++.++.||+.||.|||+.+++|+||+|+||++ +.++.+
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~----~~~~~~ 152 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL----TKNAEV 152 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE----ccCCeE
Confidence 4568999999995 7777765533 123578999999999999999999999999999999999999 667789
Q ss_pred EEeecccceeecCCCCcccCCCeeeccccccchhhcCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 178 KIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA----KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
||+|||++........ ......++..|+|||++... ..++.++|||||||++|+|++|++||.....
T Consensus 153 ~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------- 223 (275)
T cd06608 153 KLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP------- 223 (275)
T ss_pred EECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-------
Confidence 9999999876543221 12335578999999998542 3467899999999999999999999964331
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
. ..+........+ .+ ..+...+..+.+||.+||..||.+|||+.+++
T Consensus 224 -~---~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll 270 (275)
T cd06608 224 -M---RALFKIPRNPPP-TL----------------------------KSPENWSKKFNDFISECLIKNYEQRPFMEELL 270 (275)
T ss_pred -H---HHHHHhhccCCC-CC----------------------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 1 112222111110 00 01122356789999999999999999999999
Q ss_pred cCccC
Q 011808 334 EHEYF 338 (477)
Q Consensus 334 ~h~~f 338 (477)
.|||+
T Consensus 271 ~~~~~ 275 (275)
T cd06608 271 EHPFI 275 (275)
T ss_pred cCCCC
Confidence 99996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=313.81 Aligned_cols=263 Identities=27% Similarity=0.423 Sum_probs=202.3
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC-
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHA- 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~- 101 (477)
..++|.+.+.||+|+||.||+|.++. ++..+|+|.+.... .....+.+|+.+++++ +||||+++++++...+
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~---~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 36889999999999999999998653 68899999986532 1234566899999999 8999999999987543
Q ss_pred --CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 102 --DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 102 --~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
...+|+||||+. ++|.+++..... ....+++..++.++.|++.||.|||+.+|+||||||+||++ +.++.+|
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili----~~~~~~k 168 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL----TTEGGVK 168 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE----cCCCCEE
Confidence 246899999997 578777764321 23468999999999999999999999999999999999999 6667799
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCccc
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAK----HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~ 254 (477)
|+|||++........ ......++..|+|||++.... .++.++|||||||++|+|++|++||...+.
T Consensus 169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-------- 238 (291)
T cd06639 169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------- 238 (291)
T ss_pred Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--------
Confidence 999999876543221 122345688999999986432 267899999999999999999999975431
Q ss_pred HHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
...+........+. ...+...+..+.+||.+||+.||++||++.+++.
T Consensus 239 ---~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 239 ---VKTLFKIPRNPPPT-----------------------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ---HHHHHHHhcCCCCC-----------------------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11122221111100 0012223457899999999999999999999999
Q ss_pred CccCC
Q 011808 335 HEYFR 339 (477)
Q Consensus 335 h~~f~ 339 (477)
||||+
T Consensus 287 ~~~~~ 291 (291)
T cd06639 287 HPFIK 291 (291)
T ss_pred CcccC
Confidence 99984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=313.25 Aligned_cols=254 Identities=26% Similarity=0.454 Sum_probs=203.6
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|++.+.||.|+||.||+|++.. ++..+++|.+..... ......+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC---CCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeE
Confidence 479999999999999999998764 688999999876532 22345677899999999999999999998765 488
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|+++||+. ++|.+++... .+++..++.++.|++.||.|||+.+++|+||+|+||++ ++++.++|+|||+
T Consensus 75 ~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i----~~~~~~~l~d~g~ 144 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL----SEEGDVKLADFGV 144 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----CCCCCEEEccccc
Confidence 99999998 4788777642 68999999999999999999999999999999999999 6777899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+........ ......+++.|+|||++.+.. ++.++|||||||++|+|++|.+||...+. ..... .
T Consensus 145 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~~----~ 209 (274)
T cd06609 145 SGQLTSTMS--KRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLF----L 209 (274)
T ss_pred ceeeccccc--ccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHHH----H
Confidence 987754321 223356688999999998755 89999999999999999999999965431 11111 1
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCC-CCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS-PKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+....+.. .+.. .+.++.++|.+||..||++|||+++++.|+||..
T Consensus 210 ~~~~~~~~------------------------------~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 210 IPKNNPPS------------------------------LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred hhhcCCCC------------------------------CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 11000000 1111 4567999999999999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=310.90 Aligned_cols=260 Identities=27% Similarity=0.456 Sum_probs=200.8
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC----CcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG----VSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
+|+..+.||+|+||.||++.+.. ++..+|+|++........ ....+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC-
Confidence 58889999999999999998653 688999999875443221 2356778999999999999999999986543
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc-ccEEEe
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ-GVVKIA 180 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~-~~vkL~ 180 (477)
.++++|||+. ++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||++ +.+ ..+||+
T Consensus 77 -~~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~----~~~~~~~~l~ 146 (268)
T cd06630 77 -HFNLFVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI----DSTGQRLRIA 146 (268)
T ss_pred -eEEEEEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEEc
Confidence 7899999988 4777777653 368899999999999999999999999999999999999 443 359999
Q ss_pred ecccceeecCCCCcc--cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 181 DFGLARIYQAPLKFL--SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 181 DFG~a~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|||++..+....... ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+. ....
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~ 217 (268)
T cd06630 147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKH--------SNHL 217 (268)
T ss_pred ccccccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC--------cchH
Confidence 999997665432111 1123456889999999976 4488999999999999999999999964331 1111
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..+....... .....+...+.++.+||.+||..||.+|||+.+++.||||
T Consensus 218 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~ 267 (268)
T cd06630 218 ALIFKIASAT------------------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267 (268)
T ss_pred HHHHHHhccC------------------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence 1121111000 0011233446789999999999999999999999999998
Q ss_pred C
Q 011808 339 R 339 (477)
Q Consensus 339 ~ 339 (477)
+
T Consensus 268 ~ 268 (268)
T cd06630 268 R 268 (268)
T ss_pred C
Confidence 4
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=312.64 Aligned_cols=269 Identities=25% Similarity=0.408 Sum_probs=204.9
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|+..+.||.|++|.||+|.+.. ++..+|+|.+...... .....+.+|+++++.++||||++++++|.+.....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN---TGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC---CCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 479999999999999999998764 5889999998754332 334567899999999999999999999877666689
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|+||||++ ++|.+++..... ....+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||+
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~----~~~~~~~l~dfg~ 151 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL----TRKGQVKLCDFGV 151 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----ecCCeEEEeeccc
Confidence 99999997 578777654332 24468999999999999999999999999999999999999 6667799999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+........ ....++..|+|||.+.+. .++.++|||||||++|+|++|..||...... ... ..+ +...
T Consensus 152 ~~~~~~~~~----~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~--~~~----~~~~ 219 (287)
T cd06621 152 SGELVNSLA----GTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLG--PIE----LLSY 219 (287)
T ss_pred ccccccccc----ccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCC--hHH----HHHH
Confidence 875443211 123458889999999764 4899999999999999999999999765321 000 111 1121
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+............ ......++.+.+||.+||.+||.+|||+.|++.|+||+
T Consensus 220 ~~~~~~~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~ 270 (287)
T cd06621 220 IVNMPNPELKDEP------------------------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270 (287)
T ss_pred HhcCCchhhccCC------------------------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccc
Confidence 1111111000000 00011235688999999999999999999999999996
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=310.86 Aligned_cols=261 Identities=27% Similarity=0.471 Sum_probs=199.8
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC--------CcHHHHHHHHHHHhcCCCCeeEEEEEEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG--------VSPTAIREIMLLREITHENVVKLVNVHI 98 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 98 (477)
+|.+.+.||+|+||.||+|.+.. ++..+|||.++....... ..+.+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET 78 (272)
T ss_pred ceeecceecccCceEEEEEeecC---CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec
Confidence 68999999999999999998653 588999998864322111 1234567999999999999999999886
Q ss_pred cCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccE
Q 011808 99 NHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVV 177 (477)
Q Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~v 177 (477)
.. ..+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++++|+||+|+||++ +.++.+
T Consensus 79 ~~--~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~----~~~~~~ 147 (272)
T cd06629 79 TE--EYLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV----DADGIC 147 (272)
T ss_pred cC--CceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE----cCCCeE
Confidence 54 47899999997 5888887653 368899999999999999999999999999999999999 677889
Q ss_pred EEeecccceeecCCCCcccCCCeeeccccccchhhcCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHH
Q 011808 178 KIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAK-HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~ 256 (477)
+|+|||++................++..|+|||++.+.. .++.++|+||||+++|+|++|..||...+
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----------- 216 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----------- 216 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-----------
Confidence 999999997654322111222345688999999987643 47889999999999999999999996432
Q ss_pred HHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 257 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
....+++.........++ .......+..+.+||.+||.+||.+|||++++|+||
T Consensus 217 ~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (272)
T cd06629 217 AIAAMFKLGNKRSAPPIP--------------------------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270 (272)
T ss_pred hHHHHHHhhccccCCcCC--------------------------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence 122222221111000000 001122457899999999999999999999999999
Q ss_pred cC
Q 011808 337 YF 338 (477)
Q Consensus 337 ~f 338 (477)
||
T Consensus 271 ~~ 272 (272)
T cd06629 271 FI 272 (272)
T ss_pred CC
Confidence 96
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=311.99 Aligned_cols=261 Identities=24% Similarity=0.331 Sum_probs=199.9
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC----c
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD----M 103 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~----~ 103 (477)
|.+.+.||+|+||.||+|.+..+...+..||||.++...........+.+|+.+++.++|+||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678999999999999999877554456889999997654444444577889999999999999999998765332 3
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcc-cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDK-VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+++|||+. ++|..++...... ....+++..+..++.|++.||.|||+++|+||||||+||++ ++++.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML----REDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE----CCCCeEEECC
Confidence 4799999988 5888777553211 12368999999999999999999999999999999999999 6677899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
||+++.+.............++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+... .+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~---- 223 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HE---- 223 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HH----
Confidence 999986644322222222233678999999866 458999999999999999999 8899965431 11
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+...+..... ...+...+..+.++|.+||+.||.+|||+.+++.+
T Consensus 224 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 224 IYDYLRHGNR------------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHcCCC------------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222211110 01233456789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=313.06 Aligned_cols=264 Identities=29% Similarity=0.445 Sum_probs=202.3
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEc-
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHIN- 99 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~- 99 (477)
+...++|++++.||+|+||.||+|.++. ++..+++|++..... ....+.+|+.+++.+ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECC---CCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3457899999999999999999998764 578999998764321 234567899999999 79999999998753
Q ss_pred --CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc
Q 011808 100 --HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 100 --~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~ 176 (477)
..+..+|++|||++ ++|.+++.... .....+++..++.++.|++.||.|||+.+|+||||||+||++ +.++.
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili----~~~~~ 162 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL----TTEGG 162 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE----CCCCC
Confidence 23457899999997 57877776432 123468899999999999999999999999999999999999 66677
Q ss_pred EEEeecccceeecCCCCcccCCCeeeccccccchhhcCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCc
Q 011808 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA----KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~ 252 (477)
+||+|||++..+.... .......|++.|+|||++... ..++.++|||||||++|+|++|..||.....
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~------ 234 (286)
T cd06638 163 VKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP------ 234 (286)
T ss_pred EEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch------
Confidence 9999999998654321 122334578999999998532 3478899999999999999999999975431
Q ss_pred ccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 011808 253 FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332 (477)
Q Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~ 332 (477)
...+........+ ....+...+..+.+||.+||..||++|||+.++
T Consensus 235 -----~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 280 (286)
T cd06638 235 -----MRALFKIPRNPPP-----------------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280 (286)
T ss_pred -----hHHHhhccccCCC-----------------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHH
Confidence 1111111100000 001122335679999999999999999999999
Q ss_pred hcCccC
Q 011808 333 LEHEYF 338 (477)
Q Consensus 333 L~h~~f 338 (477)
++|+||
T Consensus 281 l~~~~~ 286 (286)
T cd06638 281 LQHVFI 286 (286)
T ss_pred hhcccC
Confidence 999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=308.72 Aligned_cols=253 Identities=32% Similarity=0.544 Sum_probs=201.8
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|++.+.||+|+||.||+|.++. ++..+++|.+..... ...+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---TGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKN--TDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---CCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcE
Confidence 689999999999999999998764 578899999875432 46788899999999999999999998765 478
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|+++||+. ++|.+++... ...+++..++.++.||+.||.|||+.+|+|+||+|+||++ +.++.+||+|||+
T Consensus 74 ~l~~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~----~~~~~~~l~dfg~ 145 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL----NEEGQAKLADFGV 145 (256)
T ss_pred EEEEecCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE----CCCCcEEEccccc
Confidence 99999998 4777777653 2468999999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+........ ......++..|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+...
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-----------~~~~~~ 211 (256)
T cd06612 146 SGQLTDTMA--KRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPM-----------RAIFMI 211 (256)
T ss_pred chhcccCcc--ccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchh-----------hhhhhh
Confidence 986654321 12234468899999999774 4889999999999999999999999754321 111111
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.... .. ....+...+..+.+||.+||+.||.+|||+.++|.|+||
T Consensus 212 ~~~~-~~----------------------------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 212 PNKP-PP----------------------------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ccCC-CC----------------------------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0000 00 000122345678999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=314.75 Aligned_cols=244 Identities=22% Similarity=0.240 Sum_probs=192.0
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC-CcHHHHHHHHHHHhcCCCCeeEEEEEEEc--CCCceEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG-VSPTAIREIMLLREITHENVVKLVNVHIN--HADMSLYLA 108 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~~~lv 108 (477)
..||+|+++.||+|.+ +++.||||+++....... ....+.+|+.+|++++||||+++++++.+ .....++++
T Consensus 26 ~~i~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv 100 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI 100 (283)
T ss_pred eEEeeCCceEEEEEEE-----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEE
Confidence 5789999999999975 478999999976543222 23566689999999999999999999876 444578999
Q ss_pred EeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 109 FDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 109 ~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
|||+. ++|.+++... ..+++.....++.+++.||.|||+. +++||||||+|||+ +.++.+||+|||+++
T Consensus 101 ~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill----~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 101 LEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV----TENYKLKIICHGLEK 171 (283)
T ss_pred EEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE----CCCCcEEEcccchHh
Confidence 99999 5788888653 3688889999999999999999985 99999999999999 677889999999998
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
.+.... ....++..|+|||++.+. ..++.++|||||||++|||++|+.||.+.+. .+....+...
T Consensus 172 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--------~~~~~~i~~~- 237 (283)
T PHA02988 172 ILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--------KEIYDLIINK- 237 (283)
T ss_pred hhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhc-
Confidence 654321 224568999999999752 3589999999999999999999999976542 1111111110
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.. ....+..++..+.+||.+||+.||.+|||+++++..
T Consensus 238 -~~-------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 238 -NN-------------------------------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred -CC-------------------------------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 00 011233456789999999999999999999999853
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=313.19 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=204.5
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|++.+.||+|+||.||+|.++. ++..+++|.+...... .....+.+|++++++++||||+++++++... ..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP---TGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC---CCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEE
Confidence 478999999999999999998764 6889999998765432 3445678899999999999999999998765 478
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
++++||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .|++|+||||+||++ +.++.++|+|||
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~----~~~~~~~l~d~g 146 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV----NSRGQIKLCDFG 146 (265)
T ss_pred EEEEEecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE----CCCCCEEEeecc
Confidence 99999999 68888887642 468999999999999999999999 999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
.+......... ...++..|+|||.+.+. .++.++|||||||++|+|++|..||...... .......+..
T Consensus 147 ~~~~~~~~~~~----~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~ 215 (265)
T cd06605 147 VSGQLVNSLAK----TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDP------PDGIFELLQY 215 (265)
T ss_pred cchhhHHHHhh----cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccc------cccHHHHHHH
Confidence 98765432111 15568899999999774 5899999999999999999999999754321 0011111111
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCC-CCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS-PKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.+....+. .+.. .+..+.+||.+||..||++|||+.+++.||||+.
T Consensus 216 ~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 216 IVNEPPPR-------------------------------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HhcCCCCC-------------------------------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 11111110 1111 4577999999999999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=314.75 Aligned_cols=282 Identities=43% Similarity=0.759 Sum_probs=215.7
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCceEE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~ 106 (477)
|.+.+.||+|+||.||+|.+.. ++..|+||.+....... ......+|+..+++++ |+||+++++++.+ +...|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---TGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---CCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEE
Confidence 7899999999999999998653 57889999987644322 2234457999999998 9999999999876 44789
Q ss_pred EEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 107 LAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 107 lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
+||||+.++|.+.+.... ...+++.++..++.||+.+|.|||++|++|+||+|+||++ +.++.++|+|||++.
T Consensus 75 lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i----~~~~~~~l~d~~~~~ 147 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV----SGPEVVKIADFGLAR 147 (283)
T ss_pred EEEecCCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE----cCCCCEEEeecccce
Confidence 999999999998887643 2468999999999999999999999999999999999999 677889999999998
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhC
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~ 266 (477)
....... .....++..|+|||++.+...++.++|+||||+++++|++|++||...+ ..+.+.++...++
T Consensus 148 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~--------~~~~~~~~~~~~~ 216 (283)
T cd07830 148 EIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS--------EIDQLYKICSVLG 216 (283)
T ss_pred eccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC--------hHHHHHHHHHhcC
Confidence 6654322 1234568899999998765668899999999999999999999998765 4456666667776
Q ss_pred CCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.+....|.+...+-.... ..........+....+.. +..+.+||++||..||++|||+.|++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 217 TPTKQDWPEGYKLASKLG----FRFPQFAPTSLHQLIPNA-SPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred CCChhhhhhHhhhhcccc----ccccccccccHHHHcccC-CHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 666554443221110000 000000001111112222 5779999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=314.08 Aligned_cols=260 Identities=27% Similarity=0.407 Sum_probs=201.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecc--cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAA--ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++|.+.+.||+|+||.||+|.+... ...+..||||.++.... ......+.+|+++++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG-- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC--
Confidence 46799999999999999999986532 23467899999875433 22345778899999999999999999998765
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhc---------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCC
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRD---------KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE 172 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~ 172 (477)
..+|++|||+. ++|.+++..... .....+++..+..++.||+.||.|||++||+||||||+|||+ +
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili----~ 156 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV----G 156 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE----c
Confidence 47899999987 688888876431 123457888999999999999999999999999999999999 6
Q ss_pred CcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCC
Q 011808 173 EQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQN 251 (477)
Q Consensus 173 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~ 251 (477)
.++.+||+|||++..+.............+++.|+|||++.+. .++.++|||||||++|+|++ |..||...+.
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~----- 230 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSN----- 230 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence 6788999999999765432222222333457889999999874 48999999999999999998 9999975442
Q ss_pred cccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHH
Q 011808 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ 331 (477)
Q Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e 331 (477)
.+....+. ... ....+...+..+.+||.+||..||.+|||+.|
T Consensus 231 ---~~~~~~~~----~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 273 (280)
T cd05049 231 ---EEVIECIT----QGR------------------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKD 273 (280)
T ss_pred ---HHHHHHHH----cCC------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 11111111 100 00122334678999999999999999999999
Q ss_pred Hhc
Q 011808 332 ALE 334 (477)
Q Consensus 332 ~L~ 334 (477)
+++
T Consensus 274 il~ 276 (280)
T cd05049 274 IHE 276 (280)
T ss_pred HHH
Confidence 985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=306.83 Aligned_cols=257 Identities=32% Similarity=0.465 Sum_probs=200.7
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|++.+.||.|+||.||+|.+.. ++..+++|++...... ....+.+|+.+++.++||||+++++++.+.. .+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~ 75 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIA---TGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRD--KL 75 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecC---CCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCC--EE
Confidence 689999999999999999998754 5778999999765432 4567888999999999999999999987644 78
Q ss_pred EEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|++|||+++ +|.+++... ...+++.++..++.|++.||.|||+++|+|+||||+||++ +.++.+||+|||+
T Consensus 76 ~l~~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i----~~~~~~~l~d~g~ 147 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL----TEDGDVKLADFGV 147 (262)
T ss_pred EEEEeCCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE----CCCCCEEECcccc
Confidence 999999985 777776653 2468999999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGA--KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+..+..... ......++..|+|||++.+. ..++.++|+|||||++|+|++|.+||...+. ......+.
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--------~~~~~~~~ 217 (262)
T cd06613 148 SAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--------MRALFLIS 217 (262)
T ss_pred chhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence 876543211 12234568899999998764 2478899999999999999999999975431 11111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
.. . ..+.. ...+...+.++.+||++||..||.+|||+.+++.|+|
T Consensus 218 ~~-~-~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 218 KS-N-FPPPK----------------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hc-c-CCCcc----------------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 10 0 00000 0011223467899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=342.45 Aligned_cols=258 Identities=28% Similarity=0.446 Sum_probs=212.7
Q ss_pred cceeEEeeecccCceEEEEEEEeccc--CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAA--NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.+-.+.+.||+|+||+||+|+.-... .....||||.++.... ....+.|.+|++++..|+|||||+|++++... .
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--~ 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLLGVCREG--D 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEccC--C
Confidence 45677889999999999999754333 4566899999986543 33567899999999999999999999999654 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCC---------CCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCC
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHT---------MNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE 173 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~---------l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~ 173 (477)
.+||||||+. |+|.++|+.+..+.... |+..+...|+.||+.|+.||-++.+|||||-.+|+|| .+
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV----ge 638 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV----GE 638 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee----cc
Confidence 8999999999 89999998876544333 8899999999999999999999999999999999999 88
Q ss_pred cccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCc
Q 011808 174 QGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNP 252 (477)
Q Consensus 174 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~ 252 (477)
+..|||+|||+++.+...+.+.......-...|||||.|.-.+ |+.+|||||+||+|||+++ |+-||.+....
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~----- 712 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ----- 712 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchH-----
Confidence 9999999999999766655554444556688999999998755 9999999999999999998 89999887632
Q ss_pred ccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 011808 253 FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332 (477)
Q Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~ 332 (477)
+-++.+.+. .+ ...|.+++.++++|+..||+.+|.+||++.||
T Consensus 713 ---EVIe~i~~g---------------------------------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 713 ---EVIECIRAG---------------------------------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred ---HHHHHHHcC---------------------------------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 222222110 01 23678889999999999999999999999987
Q ss_pred h
Q 011808 333 L 333 (477)
Q Consensus 333 L 333 (477)
-
T Consensus 756 ~ 756 (774)
T KOG1026|consen 756 H 756 (774)
T ss_pred H
Confidence 3
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=328.79 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=200.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++..+...||+|.||+||+|++-. .||||+++......+..+.+.+|+.++++-+|.||+-+.+++....
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~--- 461 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP--- 461 (678)
T ss_pred HHHhhccceeccccccceeeccccc------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---
Confidence 4677889999999999999998764 3999999988877777888899999999999999999999986654
Q ss_pred EEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+.||..+|+| +|+.+|.... .++.....+.|++||+.|+.|||.++|||||||..||+| .+++.|||+|||
T Consensus 462 ~AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl----~~~~kVkIgDFG 533 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL----HEDLKVKIGDFG 533 (678)
T ss_pred eeeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE----ccCCcEEEeccc
Confidence 4899999997 6676665543 468888999999999999999999999999999999999 777889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
++..-.............|...|||||+++. ...|+..+|||||||++|||+||..||.....+.+
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI------------ 601 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI------------ 601 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe------------
Confidence 9965332211112223456889999999963 23589999999999999999999999984432111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
+-.+| +.|..+. .......++.++++|+..||.+++++||.+.+||.
T Consensus 602 ifmVG-------------------------rG~l~pd-~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 602 IFMVG-------------------------RGYLMPD-LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred EEEec-------------------------ccccCcc-chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 00000 1111100 01122344568999999999999999999999987
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=318.43 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=197.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccC-CCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAAN-RGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..+|++.+.||+|+||.||+|++..+.. ....||||+++.... ......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---
Confidence 3579999999999999999998754321 233589999864322 23345677899999999999999999998653
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..+++++|+. ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill----~~~~~~kl~Df 153 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV----KTPQHVKITDF 153 (316)
T ss_pred CceeeeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe----cCCCcEEEccc
Confidence 3578888877 68888887642 357888999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|+++.+.............++..|+|||++.+. .++.++|||||||++|||++ |..||.+... ..+..+
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~---------~~~~~~ 223 (316)
T cd05108 154 GLAKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---------SEISSI 223 (316)
T ss_pred cccccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHH
Confidence 999876543332222233346789999999774 48999999999999999997 9999975431 122222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
... .. ....+..++..+.++|.+||..||.+|||+.+++.+
T Consensus 224 ~~~---~~------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 224 LEK---GE------------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HhC---CC------------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 211 00 001123345678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=330.74 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=206.9
Q ss_pred cce-eEEeeecccCceEEEEEEEecccCCCcEEEEEecccCC--CCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 26 QQY-NLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK--DGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 26 ~~Y-~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
++| ++..+||+|+|-+||+|.|. .+|..||=-.++... ...+..+++..|+.+|+.|+||||+++++.+.+...
T Consensus 39 gRy~k~~evLGrGafKtVYka~De---~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDE---EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN 115 (632)
T ss_pred Cceeehhhhcccccceeeeecccc---ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence 566 56778999999999999864 357766643333222 223445788999999999999999999999998888
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC--eecCCCCCCcEEEeccCCCcccEEE
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW--IIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+.+|.|++. |+|..|+++++ .++...++.|++||++||.|||++. |||||||.+||+|+ ...|.|||
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin---G~~G~VKI 187 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN---GNLGEVKI 187 (632)
T ss_pred ceeeeeeecccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc---CCcCceee
Confidence 88999999887 89999999876 6889999999999999999999995 99999999999996 34578999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|+|+|...... .....+|||.|||||++- ..|+..+||||||+++.||+|+.+||.... .-.
T Consensus 188 GDLGLAtl~r~s----~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----------n~A 250 (632)
T KOG0584|consen 188 GDLGLATLLRKS----HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----------NPA 250 (632)
T ss_pred cchhHHHHhhcc----ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhC-----------CHH
Confidence 999999876532 233478999999999996 459999999999999999999999997544 223
Q ss_pred HHHHHhCC-CCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 260 KIFKILGH-PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 260 ~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.|++.+-. ..|..+ ...-.+++++||.+||.. ..+|+|+.|+|.|+||
T Consensus 251 QIYKKV~SGiKP~sl------------------------------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff 299 (632)
T KOG0584|consen 251 QIYKKVTSGIKPAAL------------------------------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFF 299 (632)
T ss_pred HHHHHHHcCCCHHHh------------------------------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhh
Confidence 34443321 111111 122247899999999999 9999999999999999
Q ss_pred CCC
Q 011808 339 RIE 341 (477)
Q Consensus 339 ~~~ 341 (477)
..+
T Consensus 300 ~~d 302 (632)
T KOG0584|consen 300 DED 302 (632)
T ss_pred ccc
Confidence 865
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=311.49 Aligned_cols=265 Identities=21% Similarity=0.353 Sum_probs=199.7
Q ss_pred ccceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++|++.++||+|+||.||+|.++. ....+..||+|.++..... .....+.+|+.+++.++|+||+++++++.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ- 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 4789999999999999999997653 2234568999988654322 22335678999999999999999999986543
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhccc-----CCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKV-----NHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~ 176 (477)
..|++|||+. ++|.+++....... ...++...+..++.||+.||.|||+++|+||||||+|||+ +.++.
T Consensus 83 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili----~~~~~ 157 (288)
T cd05061 83 -PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV----AHDFT 157 (288)
T ss_pred -CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE----cCCCc
Confidence 6899999987 69998887643111 1234667889999999999999999999999999999999 66778
Q ss_pred EEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccH
Q 011808 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~ 255 (477)
++|+|||+++...............++..|+|||.+.+. .++.++|+|||||++|||++ |..||.+... .
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~ 228 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------E 228 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 999999999865432222222223346789999999764 48999999999999999998 7889975431 1
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc-
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE- 334 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~- 334 (477)
+ +.+.+..... ...+...+..+.+||.+||+.||.+|||+.++++
T Consensus 229 ~----~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 274 (288)
T cd05061 229 Q----VLKFVMDGGY------------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNL 274 (288)
T ss_pred H----HHHHHHcCCC------------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1 1111110000 0012233567999999999999999999999987
Q ss_pred -----CccCC
Q 011808 335 -----HEYFR 339 (477)
Q Consensus 335 -----h~~f~ 339 (477)
||||+
T Consensus 275 l~~~~~~~~~ 284 (288)
T cd05061 275 LKDDLHPSFP 284 (288)
T ss_pred HHhhcCCCCC
Confidence 88875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=308.29 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=199.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||+|+++....+...|+||.++.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--RP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--Cc
Confidence 3579999999999999999998875444567899999875432 22345677899999999999999999988654 36
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
++++|||+. ++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||+ ++++.++|+|||
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili----~~~~~~~l~dfg 151 (266)
T cd05033 80 VMIITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV----NSNLVCKVSDFG 151 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE----cCCCCEEECccc
Confidence 899999997 58888876542 368999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+++.+.............++..|+|||.+.+. .++.++|||||||++|+|++ |..||..... .. +.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--------~~----~~ 218 (266)
T cd05033 152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSN--------QD----VI 218 (266)
T ss_pred hhhcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCH--------HH----HH
Confidence 99876522221122222336789999999764 48999999999999999998 9999964331 11 11
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..+.... ....+...+..+.+||.+||+.||++||++.+++++
T Consensus 219 ~~~~~~~------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 219 KAVEDGY------------------------------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1111100 001123345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=310.09 Aligned_cols=254 Identities=31% Similarity=0.457 Sum_probs=203.9
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
+|++.+.||.|+||.||+|++.. ++..|++|++....... .....+.+|++++++++||||+++++++.+. ..+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE--ENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC--CeE
Confidence 59999999999999999998653 58889999997654332 3456778899999999999999999988654 478
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|+++||+. ++|.+.+... ..+++..+..++.||++||.|||++|++|+||+|+||++ ++++.++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~----~~~~~~~l~d~~~ 146 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL----DEQGHVHITDFNI 146 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE----cCCCCEEEeeccc
Confidence 99999997 5788777653 368999999999999999999999999999999999999 6777899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+....... ......++..|+|||++.+.. ++.++|+|||||++|+|++|..||...+.. ..+.+. ..
T Consensus 147 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~---~~ 213 (258)
T cd05578 147 ATKVTPDT---LTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIR---AK 213 (258)
T ss_pred ccccCCCc---cccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHH---HH
Confidence 88654332 123345688999999997744 899999999999999999999999765421 111111 11
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH--HHHhcCccC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA--AQALEHEYF 338 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~--~e~L~h~~f 338 (477)
.... ....+...+..+.++|.+||..||.+|+++ .++++||||
T Consensus 214 ~~~~-------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 214 QETA-------------------------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred hccc-------------------------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 1100 011233445789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.65 Aligned_cols=251 Identities=28% Similarity=0.481 Sum_probs=198.8
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|++.+.||+|+||.||++.++. ++..+++|.++.... ......+.+|+.+++.++|+||+++++.+.+. ..+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---SDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---CCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEE
Confidence 58999999999999999998764 688899999865433 22345677899999999999999999998764 4889
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
++|||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+|+||||+||++ ++++.++|+|||++
T Consensus 75 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili----~~~~~~~l~dfg~~ 147 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL----TQNGKVKLGDFGSA 147 (255)
T ss_pred EEEeeCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE----CCCCcEEEcccCcc
Confidence 9999997 58888876533 3458899999999999999999999999999999999999 66778999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
........ ......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+. ......+ .
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~---~ 213 (255)
T cd08219 148 RLLTSPGA--YACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLILKV---C 213 (255)
T ss_pred eeeccccc--ccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCH--------HHHHHHH---h
Confidence 86643222 122345788999999997744 89999999999999999999999975431 1111111 1
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.... ...+...+..+.+||.+||+.||++|||+.+++.-
T Consensus 214 -~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 214 -QGSY------------------------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -cCCC------------------------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0000 01223345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.74 Aligned_cols=260 Identities=27% Similarity=0.386 Sum_probs=199.8
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++++.||+|+||.||++.++. ++..|+||.+...... ......+.+|+.+++.++||||+++++.+... ..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE---TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK--RH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC---CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--CE
Confidence 479999999999999999998764 5789999998754321 22334667899999999999999999998654 47
Q ss_pred EEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|++|||+.+ +|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||++ +.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll----~~~~~~~l~dfg 146 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI----TSMGHIKLTDFG 146 (305)
T ss_pred EEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE----CCCCCEEEeeCC
Confidence 8999999984 787787653 368999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCC-------------cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCC
Q 011808 184 LARIYQAPLK-------------FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250 (477)
Q Consensus 184 ~a~~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~ 250 (477)
+++....... ........++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~---- 221 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTP---- 221 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 9864211100 0011123467889999998764 489999999999999999999999975431
Q ss_pred CcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC--
Q 011808 251 NPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-- 328 (477)
Q Consensus 251 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-- 328 (477)
.+.+..+.... ...+ ......+.++.+||.+||+.||++||+
T Consensus 222 ----~~~~~~~~~~~-~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 265 (305)
T cd05609 222 ----EELFGQVISDD-IEWP-------------------------------EGDEALPADAQDLISRLLRQNPLERLGTG 265 (305)
T ss_pred ----HHHHHHHHhcc-cCCC-------------------------------CccccCCHHHHHHHHHHhccChhhccCcc
Confidence 11111111100 0000 001134577899999999999999998
Q ss_pred -HHHHhcCccCCC
Q 011808 329 -AAQALEHEYFRI 340 (477)
Q Consensus 329 -~~e~L~h~~f~~ 340 (477)
+.++|+||||..
T Consensus 266 ~~~~ll~~~~~~~ 278 (305)
T cd05609 266 GAFEVKQHRFFLG 278 (305)
T ss_pred CHHHHHhCccccC
Confidence 799999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=314.56 Aligned_cols=257 Identities=28% Similarity=0.482 Sum_probs=203.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..+|.+.+.||+|+||.||+|.+.. ++..|++|++...... ......+.+|+.+++.++||||+++++++.+..
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-- 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-- 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC--
Confidence 4679999999999999999998654 5889999998654322 223346778999999999999999999997644
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
..|+||||+.+++.+++.... ..+++..+..++.||+.||.|||+.||+||||+|+||++ +.++.++|+|||
T Consensus 89 ~~~lv~e~~~g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~----~~~~~~kL~dfg 160 (307)
T cd06607 89 TAWLVMEYCLGSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL----TEPGTVKLADFG 160 (307)
T ss_pred eEEEEHHhhCCCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE----CCCCCEEEeecC
Confidence 689999999999988876542 368999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
++...... ....++..|+|||++.+ ...++.++|||||||++|+|++|.+||...+. ...+
T Consensus 161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-----------~~~~ 223 (307)
T cd06607 161 SASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSAL 223 (307)
T ss_pred cceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-----------HHHH
Confidence 98765432 22456889999999853 34588899999999999999999999975441 1111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
........+. ..+...+..+.+||.+||..||.+||++.+++.|+||...
T Consensus 224 ~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 224 YHIAQNDSPT------------------------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHhcCCCCC------------------------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 1111111000 0011234678999999999999999999999999999743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=311.59 Aligned_cols=266 Identities=23% Similarity=0.349 Sum_probs=202.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++++.||+|+||+||++.+.. ++..||+|++..... ......+.+|+++++.++||||+++++++... ..
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 77 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP---TGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NN 77 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC---CCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CE
Confidence 3679999999999999999998654 588999998865432 33456778899999999999999999998765 47
Q ss_pred EEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 105 LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 105 ~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
+|+||||+.+ +|.+++... +.+++..+..++.+++.+|.|||+ .+|+||||||+||++ +.++.++|+||
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~----~~~~~~~l~d~ 148 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV----NSRGQIKLCDF 148 (284)
T ss_pred EEEEEecCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE----CCCCcEEEccC
Confidence 8999999985 676666542 368999999999999999999997 589999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++....... .....++..|+|||++.+. .++.++|||||||++|+|++|..||........... ....+..+.
T Consensus 149 gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~ 222 (284)
T cd06620 149 GVSGELINSI----ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD-DPMGILDLL 222 (284)
T ss_pred Ccccchhhhc----cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh-hhhHHHHHH
Confidence 9986543221 1234678999999998764 588899999999999999999999986543211100 111111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
..+....+... .....+..+.+||.+||++||.+|||+.+++.|+||..
T Consensus 223 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 223 QQIVQEPPPRL-----------------------------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHhhccCCCC-----------------------------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 11111110000 00113467899999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=309.81 Aligned_cols=261 Identities=20% Similarity=0.340 Sum_probs=196.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecc--cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAA--ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++|++.+.||+|+||.||+|.++.. ...+..||||++..... ......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-- 81 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 81 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 46799999999999999999987532 23456899999864322 12234577899999999999999999998543
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhccc-----CCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKV-----NHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~ 176 (477)
...++||||+. ++|.+++....... ...++...+..++.|++.||.|||+.|++||||||+|||+ ++++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~----~~~~~ 157 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDFT 157 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE----cCCCC
Confidence 47899999988 68888886643211 1245777889999999999999999999999999999999 66778
Q ss_pred EEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccH
Q 011808 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~ 255 (477)
++|+|||+++...............++..|+|||++.+. .++.++|||||||++|||++ |..||.+... .
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~ 228 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------E 228 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999998755432222222223447789999999764 48999999999999999999 7899975431 1
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..+..+.. . .. ...+...+..+.+||.+||+.||++|||+.+++++
T Consensus 229 ~~~~~~~~-~--~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 229 QVLRFVME-G--GL-------------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHHHc-C--Cc-------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11111110 0 00 01123345679999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=309.22 Aligned_cols=250 Identities=27% Similarity=0.403 Sum_probs=190.8
Q ss_pred eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCC-cHHHHHHHHHHH---hcCCCCeeEEEEEEEcCCCceEEEE
Q 011808 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV-SPTAIREIMLLR---EITHENVVKLVNVHINHADMSLYLA 108 (477)
Q Consensus 33 ~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~~~lv 108 (477)
.||+|+||.||++++.. ++..+|||.+......... .....+|..+++ ..+|+||+.+++++...+ .+|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECC---CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEEEE
Confidence 48999999999998653 6889999998765433222 223344544443 347999999999987644 78999
Q ss_pred EeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 109 FDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 109 ~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
|||+. ++|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.++|+|||++..
T Consensus 76 ~e~~~~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~----~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 76 LDLMNGGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL----DEHGHVRISDLGLACD 146 (279)
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE----CCCCCEEEccCCccee
Confidence 99998 5777777653 368999999999999999999999999999999999999 6777899999999875
Q ss_pred ecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCC
Q 011808 188 YQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267 (477)
Q Consensus 188 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~ 267 (477)
..... .....|+..|+|||++.+...++.++|||||||++|+|++|..||...... ....+......
T Consensus 147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~--- 213 (279)
T cd05633 147 FSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK------DKHEIDRMTLT--- 213 (279)
T ss_pred ccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc------CHHHHHHHhhc---
Confidence 54321 123457999999999875455889999999999999999999999754321 11111111000
Q ss_pred CCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCccCCC
Q 011808 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEYFRI 340 (477)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~f~~ 340 (477)
.....+...+.++.+||++||..||.+|+ |+.++++||||+.
T Consensus 214 -------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 214 -------------------------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred -------------------------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 00113344567899999999999999999 6999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=303.88 Aligned_cols=258 Identities=28% Similarity=0.472 Sum_probs=203.4
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC---CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG---DGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+|++.+.||+|+||.||+|.++. ++..|++|.+...... ......+.+|+.++++++|+||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 579999999999999999998763 6889999987543221 2233466789999999999999999999877666
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+++++||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||++ +.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i----~~~~~~~l~d 149 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR----DSAGNVKLGD 149 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE----cCCCCEEECc
Confidence 67899999997 5788887653 358899999999999999999999999999999999999 6667899999
Q ss_pred cccceeecCCCC-cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 182 FGLARIYQAPLK-FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 182 FG~a~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
||+++....... ........++..|+|||++.+. .++.++|+|||||++|+|++|+.||.... ....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~-----------~~~~ 217 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYE-----------AMAA 217 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccC-----------HHHH
Confidence 999986543111 1111234568899999999874 47889999999999999999999997432 2223
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+.+....+... .+|...++.+.++|.+||. +|.+||++.+++.|||.
T Consensus 218 ~~~~~~~~~~~------------------------------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 218 IFKIATQPTKP------------------------------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHcCCCCC------------------------------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 33333222211 1344556789999999999 47999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=304.06 Aligned_cols=254 Identities=29% Similarity=0.465 Sum_probs=200.9
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC---CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG---DGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+|+..+.||+|+||.||+|.++. ++..|++|.+...... ......+.+|+.+++.++|+||+++++++.+. .
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--D 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--C
Confidence 58888999999999999998653 5789999998654322 22345677899999999999999999988654 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+++||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+||++ +.++.+||+||
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~----~~~~~~kl~d~ 146 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV----DTNGVVKLADF 146 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEccC
Confidence 7899999997 5888887653 358899999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++....... ......++..|+|||.+.....++.++|+|||||++|+|++|..||.... ..... .
T Consensus 147 ~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~~~~---~ 212 (258)
T cd06632 147 GMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAV---F 212 (258)
T ss_pred ccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HHHHH---H
Confidence 9988654332 12234568899999998764447889999999999999999999996533 11111 1
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
....... ...++...+..+.+||.+||..||.+||++.+++.|||+
T Consensus 213 ~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 213 KIGRSKE------------------------------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHhccc------------------------------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 1111000 001233446789999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=305.30 Aligned_cols=259 Identities=30% Similarity=0.523 Sum_probs=202.2
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|.+.+.||+|+||.||++.+.. ++..|++|.++...........+.+|+.+++.++|+||+++++++.+. ..++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEE
Confidence 69999999999999999998653 578999999977655444566788999999999999999999987654 4789
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
+++||+. ++|.+++... ..+++..++.++.|++.||.|||+.||+|+||+|+||++ +.++.+||+|||++
T Consensus 76 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~----~~~~~~kl~d~g~~ 146 (264)
T cd06626 76 IFMEYCSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL----DHNGVIKLGDFGCA 146 (264)
T ss_pred EEEecCCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEcccccc
Confidence 9999998 5777777652 357889999999999999999999999999999999999 66778999999999
Q ss_pred eeecCCCCccc--CCCeeeccccccchhhcCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 186 RIYQAPLKFLS--ENGVVVTIWYRAPELLLGAK--HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 186 ~~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~--~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
........... .....++..|+|||++.+.. .++.++|||||||++|+|++|..||...+. . ....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--------~--~~~~ 216 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--------E--FQIM 216 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--------h--HHHH
Confidence 87654322111 11245688999999997643 378899999999999999999999975431 0 1111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+.... ..... +|. ...++..+.+||.+||+.||.+|||+.+++.|||+
T Consensus 217 ~~~~~-~~~~~------~~~----------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 217 FHVGA-GHKPP------IPD----------------------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHhc-CCCCC------CCc----------------------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 11111 11111 110 11225678999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=315.44 Aligned_cols=262 Identities=28% Similarity=0.493 Sum_probs=202.0
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..+.|.....||+|+||.||++.+.. ++..||||.+.... ......+.+|+.+++.++|+||+++++.+... .
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~ 92 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKH---TGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--D 92 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECC---CCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--C
Confidence 34667778889999999999998653 57899999986432 22344677899999999999999999988764 3
Q ss_pred eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..|++|||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+||
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill----~~~~~~kL~df 162 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL----TSDGRIKLSDF 162 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE----cCCCCEEEccC
Confidence 78999999985 56565532 258899999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++........ ......++..|+|||++.+. .++.++|+|||||++|||++|+.||...+. ...+..+.
T Consensus 163 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~ 231 (292)
T cd06658 163 GFCAQVSKEVP--KRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--------LQAMRRIR 231 (292)
T ss_pred cchhhcccccc--cCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence 99875433221 22335678999999999764 488999999999999999999999975431 11122111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEP 342 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~~ 342 (477)
..+ +.... .....+..+.+||.+||..||.+|||+.++++|+||+...
T Consensus 232 ~~~----~~~~~----------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 232 DNL----PPRVK----------------------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred hcC----CCccc----------------------------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 111 00000 1112356788999999999999999999999999998654
Q ss_pred CCC
Q 011808 343 LPG 345 (477)
Q Consensus 343 ~~~ 345 (477)
.+.
T Consensus 280 ~~~ 282 (292)
T cd06658 280 PPS 282 (292)
T ss_pred Ccc
Confidence 443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=309.45 Aligned_cols=261 Identities=21% Similarity=0.378 Sum_probs=198.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecc-cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAA-ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+.+|++.+.||+|+||+||+|.+... ...+..+++|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 80 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ-- 80 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC--
Confidence 46899999999999999999986432 23567899999875332 223346778999999999999999999986643
Q ss_pred eEEEEEeccC-CCHHHHHHhhhc------------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRD------------KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~------------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~ 170 (477)
..|++|||+. ++|.+++..... .....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili--- 157 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI--- 157 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---
Confidence 6899999998 588888754321 012347888999999999999999999999999999999999
Q ss_pred CCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccC
Q 011808 171 GEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKST 249 (477)
Q Consensus 171 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~ 249 (477)
+.++.+||+|||+++...............++..|+|||++.+. .++.++|||||||++|||++ |.+||.+...
T Consensus 158 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--- 232 (283)
T cd05090 158 -GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--- 232 (283)
T ss_pred -cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 66678999999999865433222222233446789999999764 48999999999999999998 9999975431
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
.+ +...+..... ...+..++..+.+||.+||+.||++||++
T Consensus 233 -----~~----~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 273 (283)
T cd05090 233 -----QE----VIEMVRKRQL------------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRF 273 (283)
T ss_pred -----HH----HHHHHHcCCc------------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCH
Confidence 11 1111110000 01223345789999999999999999999
Q ss_pred HHHhcC
Q 011808 330 AQALEH 335 (477)
Q Consensus 330 ~e~L~h 335 (477)
.+++++
T Consensus 274 ~~i~~~ 279 (283)
T cd05090 274 KDIHTR 279 (283)
T ss_pred HHHHHH
Confidence 999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=324.28 Aligned_cols=262 Identities=22% Similarity=0.373 Sum_probs=197.7
Q ss_pred ccceeEEeeecccCceEEEEEEEeccc--CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAA--NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 101 (477)
.++|.+.++||+|+||.||+|.+.... ..+..||||+++.... ......+++|+.+++++. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~- 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKS- 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence 467889999999999999999864321 2345799999975432 233457788999999996 99999999998654
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcc------------------------------------------------------
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDK------------------------------------------------------ 126 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~------------------------------------------------------ 126 (477)
..+||||||+. ++|.+++......
T Consensus 114 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 114 -GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred -CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 47899999998 6888887653210
Q ss_pred -------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEec
Q 011808 127 -------------------------------------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMG 169 (477)
Q Consensus 127 -------------------------------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~ 169 (477)
....+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill-- 270 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL-- 270 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE--
Confidence 01347888899999999999999999999999999999999
Q ss_pred cCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccc
Q 011808 170 EGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKS 248 (477)
Q Consensus 170 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~ 248 (477)
+.++.+||+|||+++.+.............++..|+|||++.+. .++.++|||||||++|+|++ |..||.....
T Consensus 271 --~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~-- 345 (400)
T cd05105 271 --AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIV-- 345 (400)
T ss_pred --eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccch--
Confidence 66678999999999866443332233334567889999999774 48999999999999999997 9999975431
Q ss_pred CCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC
Q 011808 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT 328 (477)
Q Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt 328 (477)
...+. ..+... .....+...+..+.+||.+||..||++|||
T Consensus 346 ------~~~~~---~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 386 (400)
T cd05105 346 ------DSTFY---NKIKSG------------------------------YRMAKPDHATQEVYDIMVKCWNSEPEKRPS 386 (400)
T ss_pred ------hHHHH---HHHhcC------------------------------CCCCCCccCCHHHHHHHHHHCccCHhHCcC
Confidence 11111 111100 001122334577999999999999999999
Q ss_pred HHHHhcC
Q 011808 329 AAQALEH 335 (477)
Q Consensus 329 ~~e~L~h 335 (477)
+.++.+.
T Consensus 387 ~~~l~~~ 393 (400)
T cd05105 387 FLHLSDI 393 (400)
T ss_pred HHHHHHH
Confidence 9887653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=319.78 Aligned_cols=286 Identities=21% Similarity=0.290 Sum_probs=197.9
Q ss_pred Eeeeccc--CceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEE
Q 011808 31 IGKIGEG--TYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLA 108 (477)
Q Consensus 31 ~~~lG~G--~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv 108 (477)
...||+| +||+||+|++.. ++..||||++..........+.+.+|+.+++.++||||++++++|.... .+|++
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~~v 77 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTP---TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLWVI 77 (328)
T ss_pred HHHhCCcccCceeEEEEEEcC---CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceEEE
Confidence 4567777 999999998754 6899999998765444334456778999999999999999999997644 78999
Q ss_pred EeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 109 FDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 109 ~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
|||+. +++.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++++||+.+..
T Consensus 78 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill----~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 78 SPFMAYGSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI----SGDGLVSLSGLSHLYS 150 (328)
T ss_pred EecccCCCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----eCCCcEEEechHHHhh
Confidence 99988 58888877643 2358999999999999999999999999999999999999 5667899999986543
Q ss_pred ecCCCCcc-----cCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 188 YQAPLKFL-----SENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 188 ~~~~~~~~-----~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
........ ......++..|+|||++.+. ..++.++|||||||++|+|++|.+||..... . ..+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~--------~---~~~ 219 (328)
T cd08226 151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR--------T---QML 219 (328)
T ss_pred hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh--------H---HHH
Confidence 32111100 00111235679999999764 3478999999999999999999999976431 1 112
Q ss_pred HHHhCCCCCCCccccCCCcc----cccccccc----ccc--------cccCCCCccccCCCCCchHHHHHHHhcccCCCC
Q 011808 262 FKILGHPTPEKWPTLANLPH----WQSDSLHI----QGR--------KYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK 325 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----~~~--------~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~ 325 (477)
...+..+....+. ....+. +....... ... ......+....+...+..+.+||++||+.||++
T Consensus 220 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 298 (328)
T cd08226 220 LQKLKGPPYSPLD-ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEK 298 (328)
T ss_pred HHHhcCCCCCCcc-ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCccc
Confidence 2222221111110 000000 00000000 000 000001111122345667899999999999999
Q ss_pred CCCHHHHhcCccCCC
Q 011808 326 RITAAQALEHEYFRI 340 (477)
Q Consensus 326 Rpt~~e~L~h~~f~~ 340 (477)
|||++++|+|+||+.
T Consensus 299 Rpta~e~l~~~~~~~ 313 (328)
T cd08226 299 RPSASSLLSHAFFKQ 313 (328)
T ss_pred CCCHHHHhhCHHHHH
Confidence 999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=309.52 Aligned_cols=270 Identities=25% Similarity=0.376 Sum_probs=198.3
Q ss_pred ccce-eEEeeecccCceEEEEEEEec-ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQY-NLIGKIGEGTYGLVFLARIKA-AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y-~i~~~lG~G~~g~Vy~a~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++| ++++.||+|+||+||++..+. ...++..||+|.++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 4567 999999999999999876432 234677899999875432 2234567789999999999999999999877666
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..++++|||+. ++|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~~l~d 150 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL----DNDRLVKIGD 150 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE----cCCCcEEEee
Confidence 67899999998 5777777542 58999999999999999999999999999999999999 6677899999
Q ss_pred cccceeecCCCCccc-CCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 182 FGLARIYQAPLKFLS-ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 182 FG~a~~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
||+++.+........ .....++..|+|||++.+. .++.++|||||||++|+|++|..||...... +..
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~----------~~~ 219 (283)
T cd05080 151 FGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK----------FEE 219 (283)
T ss_pred cccccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch----------hhh
Confidence 999986543222111 1112346679999998764 4889999999999999999999998643311 111
Q ss_pred HHHHhC-CCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 261 IFKILG-HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 261 i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
+..... ......+ ............+...+..+.+||.+||+.||++|||+++++.
T Consensus 220 ~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 220 MIGPKQGQMTVVRL------------------IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhcccccccchhhh------------------hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 100000 0000000 0000001111234456678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=305.27 Aligned_cols=259 Identities=25% Similarity=0.441 Sum_probs=198.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+++|++.+.||+|+||.||+|+++. ++..||||.++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLL---DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-- 75 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeC---CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC--
Confidence 4689999999999999999998764 578999998865332 2233446778999999999999999999987653
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+++++||+. ++|.+++..... ....+++..+..++.||+.||.|||+++|+|+||||+||++ +.++.++|+||
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~----~~~~~~~l~d~ 150 (267)
T cd08228 76 ELNIVLELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI----TATGVVKLGDL 150 (267)
T ss_pred eEEEEEEecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE----cCCCCEEECcc
Confidence 7899999998 477777765332 23458899999999999999999999999999999999999 66678999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++..+..... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||..... ... .+.
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~-------~~~---~~~ 217 (267)
T cd08228 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKM-------NLF---SLC 217 (267)
T ss_pred ccceeccchhH--HHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccc-------cHH---HHH
Confidence 99886643221 11234568899999999774 478999999999999999999999964321 111 111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..+...... .......+..+.+||.+||..||++||++.++++.
T Consensus 218 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 218 QKIEQCDYP-----------------------------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHhcCCCC-----------------------------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 211110000 00111234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=357.91 Aligned_cols=262 Identities=29% Similarity=0.451 Sum_probs=211.9
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.--+|.-...||.|.||.||.|.+. .+|...|+|.++.............+|..++..|+|||+|+++++-...+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~---~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-- 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNL---DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-- 1307 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecC---CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH--
Confidence 3457778889999999999999754 58999999999877666667777889999999999999999999866544
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.++|.||||+ |+|.++++.. ...+|...+.+..|++.||.|||+.|||||||||+||+| +.+|.+|++||
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~g-----ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L----d~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHG-----RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL----DFNGLIKYGDF 1378 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhc-----chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee----ecCCcEEeecc
Confidence 5789999999 5777776653 256777888899999999999999999999999999999 78889999999
Q ss_pred ccceeecCCCCc--ccCCCeeeccccccchhhcCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 183 GLARIYQAPLKF--LSENGVVVTIWYRAPELLLGAK--HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 183 G~a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~--~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|.|..+...... ......+||+.|||||++.+.+ ....+.|||||||++.||+||+.||...+ .-
T Consensus 1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-----------ne 1447 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-----------NE 1447 (1509)
T ss_pred cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-----------ch
Confidence 999877654211 1224578999999999998754 35668999999999999999999997544 22
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..|+-.++... ...+|...+.+.+|||.+||+.||++|.++.|+|+|.|-
T Consensus 1448 ~aIMy~V~~gh------------------------------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1448 WAIMYHVAAGH------------------------------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred hHHHhHHhccC------------------------------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 22332222111 112455578899999999999999999999999999997
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
+.
T Consensus 1498 ~~ 1499 (1509)
T KOG4645|consen 1498 KS 1499 (1509)
T ss_pred cc
Confidence 63
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=303.44 Aligned_cols=255 Identities=27% Similarity=0.492 Sum_probs=200.6
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|.+.+.||+|+||.||++.++. ++..+|+|.+............+.+|+.+++.++|+||+++++.+... ..+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN--GRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC--CeEE
Confidence 58999999999999999998764 578899999876544444455677899999999999999999988654 4789
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc-ccEEEeeccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ-GVVKIADFGL 184 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~-~~vkL~DFG~ 184 (477)
+++||+. ++|.+++.... ...+++..+..++.||+.||.|||+.+|+|+||||+||++ +++ ..+||+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~----~~~~~~~~l~d~~~ 148 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFL----SKNGMVAKLGDFGI 148 (257)
T ss_pred EEEecCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE----cCCCCeEEeccccc
Confidence 9999997 58888876532 2357899999999999999999999999999999999999 444 3579999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+......... .....|++.|+|||++.+. .++.++|+|||||++|+|++|..||...+. .+.+. ..
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~---~~ 214 (257)
T cd08225 149 ARQLNDSMEL--AYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNL--------HQLVL---KI 214 (257)
T ss_pred chhccCCccc--ccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHH---HH
Confidence 9766432211 1223568899999998764 488999999999999999999999965431 11111 11
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..... ...+...+..+.++|.+||..||++|||+.+++.||||
T Consensus 215 ~~~~~-------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 215 CQGYF-------------------------------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred hcccC-------------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 11000 00122345679999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.78 Aligned_cols=261 Identities=28% Similarity=0.441 Sum_probs=199.7
Q ss_pred ccceeEEeeecccCceEEEEEEEeccc--CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAA--NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
.++|++.+.||+|+||.||++.++... .....+|+|.+..... ......+.+|+.+++++ +|+||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE- 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC-
Confidence 468999999999999999999876432 3457899999875433 22335677899999999 899999999988654
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhc-----------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEec
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRD-----------KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMG 169 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~ 169 (477)
..++++|||+. ++|.+++..... .....+++..++.++.||+.||.|||+++|+||||||+|||+
T Consensus 89 -~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~-- 165 (293)
T cd05053 89 -GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV-- 165 (293)
T ss_pred -CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE--
Confidence 46899999987 688888865321 224468899999999999999999999999999999999999
Q ss_pred cCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccc
Q 011808 170 EGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKS 248 (477)
Q Consensus 170 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~ 248 (477)
+.++.+||+|||+++.+.............++..|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus 166 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 240 (293)
T cd05053 166 --TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 240 (293)
T ss_pred --cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence 66778999999999866543222112222335679999998764 48899999999999999997 9999975431
Q ss_pred CCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC
Q 011808 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT 328 (477)
Q Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt 328 (477)
..++..+.... ....+...+..+.+||.+||..||.+|||
T Consensus 241 ----------~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps 280 (293)
T cd05053 241 ----------EELFKLLKEGY------------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPT 280 (293)
T ss_pred ----------HHHHHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcC
Confidence 11122211110 00123344678999999999999999999
Q ss_pred HHHHhcC
Q 011808 329 AAQALEH 335 (477)
Q Consensus 329 ~~e~L~h 335 (477)
+.+++++
T Consensus 281 ~~eil~~ 287 (293)
T cd05053 281 FKQLVED 287 (293)
T ss_pred HHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=312.23 Aligned_cols=261 Identities=23% Similarity=0.381 Sum_probs=197.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecc--cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAA--ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
+.+|++++.||+|+||.||+|.+..+ ...+..||||+++.... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~- 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ- 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC-
Confidence 45789999999999999999986532 23457899999975432 222345678999999999999999999986654
Q ss_pred ceEEEEEeccC-CCHHHHHHhhh-----------cccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHR-----------DKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~ 170 (477)
.+++++||+. ++|.+++.... ......+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 82 -~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~--- 157 (283)
T cd05091 82 -PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV--- 157 (283)
T ss_pred -ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---
Confidence 6899999988 57777775321 0112357888899999999999999999999999999999999
Q ss_pred CCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccC
Q 011808 171 GEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKST 249 (477)
Q Consensus 171 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~ 249 (477)
++++.+||+|||+++...............+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+...
T Consensus 158 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--- 232 (283)
T cd05091 158 -FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--- 232 (283)
T ss_pred -cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 666779999999988654332221222334478899999997644 8999999999999999998 8889876431
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
.+.+ ..+...... ..+..++..+.+||.+||+.||.+||++
T Consensus 233 -----~~~~----~~i~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~ 273 (283)
T cd05091 233 -----QDVI----EMIRNRQVL------------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRF 273 (283)
T ss_pred -----HHHH----HHHHcCCcC------------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence 1222 222111110 1233456778999999999999999999
Q ss_pred HHHhcC
Q 011808 330 AQALEH 335 (477)
Q Consensus 330 ~e~L~h 335 (477)
++++..
T Consensus 274 ~~i~~~ 279 (283)
T cd05091 274 KDIHSR 279 (283)
T ss_pred HHHHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=307.14 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=194.7
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----Cc
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA----DM 103 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 103 (477)
|.+.++||+|+||.||+|++... .....+|+|.++...........+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQD-DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccC-CCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 45788999999999999987542 12236999998765444444567788999999999999999999765321 22
Q ss_pred eEEEEEeccC-CCHHHHHHhhhc-ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRD-KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+++|||+. ++|.+++...+. .....+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~D 155 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML----NENMNVCVAD 155 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE----cCCCCEEECC
Confidence 4689999998 688777654321 123458899999999999999999999999999999999999 6677899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
||+++.+.............+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+... ..
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~---- 222 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SE---- 222 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HH----
Confidence 9999876443221112223346789999999774 48999999999999999999 8999975431 11
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+...+..... ...+...+..+.++|.+||+.||++|||+.+++++
T Consensus 223 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 223 IYDYLRQGNR------------------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHcCCC------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1111111100 00122345678999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=299.87 Aligned_cols=259 Identities=31% Similarity=0.507 Sum_probs=207.4
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|.+.+.||+|++|.||+|.++. ++..+++|++............+.+|+.++++++|+||+++++++.......++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 58899999999999999998764 688999999977655444566778899999999999999999998765335889
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
+++||+. ++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+
T Consensus 78 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i----~~~~~~~l~d~~~~ 148 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV----DSDGVVKLADFGCA 148 (260)
T ss_pred EEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----cCCCCEEEcccccE
Confidence 9999995 68888877532 78999999999999999999999999999999999999 66778999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
................++..|+|||.+.+.. ++.++||||||+++|+|++|..||.... +....+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~----------~~~~~~~~~~ 217 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELG----------NPMAALYKIG 217 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC----------chHHHHHhcc
Confidence 8766543211122345688999999997754 8899999999999999999999997554 1111111111
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
... .....+...+..+.+||.+||..||.+||++.+++.||||
T Consensus 218 ~~~------------------------------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 218 SSG------------------------------EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ccC------------------------------CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000 0011233446789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=300.79 Aligned_cols=257 Identities=30% Similarity=0.539 Sum_probs=207.3
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|.+.+.||+|+||.||++.+.. ++..+++|++............+.+|+++++.++|+|++++++.+... ..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEE
Confidence 69999999999999999998753 588999999987655445566788899999999999999999998765 5889
Q ss_pred EEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
+++|++++ +|.+.+..... ....+++..+..++.+|+.||.|||+.|++|+||+|+||++ +.++.++|+|||++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~----~~~~~~~l~d~~~~ 150 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL----TSNGLVKLGDFGIS 150 (258)
T ss_pred EEEEecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE----cCCCcEEECCccce
Confidence 99999984 88888876432 13578999999999999999999999999999999999999 66778999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
........ ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+. ..+...+
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------------~~~~~~~ 215 (258)
T cd08215 151 KVLSSTVD--LAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENL------------LELALKI 215 (258)
T ss_pred eecccCcc--eecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcH------------HHHHHHH
Confidence 87654321 223356789999999987644 88899999999999999999999965431 1111111
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..... ...+...+..+.++|.+||..||++|||+.++|.||||
T Consensus 216 ~~~~~------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 216 LKGQY------------------------------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred hcCCC------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 11100 01222445789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=302.48 Aligned_cols=248 Identities=25% Similarity=0.421 Sum_probs=192.8
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|++.+.||+|+||.||++.++. +..+|+|.+..... ....+.+|+.++++++||||+++++++... ..+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----QIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----CceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccC--CCE
Confidence 579999999999999999997653 56799998864332 235778899999999999999999998654 468
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+++|||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i----~~~~~~kl~d~g~ 146 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV----SSTGVVKVSDFGM 146 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE----cCCCeEEECCCCC
Confidence 99999997 68888876532 358899999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++....... .......++..|+|||++.+. .++.++|+|||||++|+|++ |+.||...+. .+.+..+..
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~~ 216 (256)
T cd05114 147 TRYVLDDEY-TSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMISR 216 (256)
T ss_pred ccccCCCce-eccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHC
Confidence 876533221 111222345679999999764 48899999999999999999 8999975441 112222111
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.... ..+...+..+.+||.+||..||.+|||+++++.
T Consensus 217 ----~~~~------------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 217 ----GFRL------------------------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ----CCCC------------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0000 012223467899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=302.09 Aligned_cols=257 Identities=30% Similarity=0.496 Sum_probs=206.6
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|++.+.||+|++|.||+|.++. ++..++||++...... .....+.+|+.++..++|+||+++++++... ..+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeE
Confidence 479999999999999999998764 6889999998765432 3456788899999999999999999998764 478
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+++|||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+++|+||+|+||++ +.++.++|+|||
T Consensus 75 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~----~~~~~~~l~df~ 145 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI----NSKGEVKIADFG 145 (264)
T ss_pred EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE----CCCCCEEEccCc
Confidence 99999999 6888888753 468999999999999999999999 999999999999999 677889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++......... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... ....+..
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---------~~~~~~~ 213 (264)
T cd06623 146 ISKVLENTLDQ--CNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQP---------SFFELMQ 213 (264)
T ss_pred cceecccCCCc--ccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccccc---------CHHHHHH
Confidence 99876543221 1234568999999998774 5889999999999999999999999765420 1111122
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCC-CCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS-PKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+...... ..+.. .+..+.++|.+||..+|.+|||+.++++||||+
T Consensus 214 ~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~ 260 (264)
T cd06623 214 AICDGPPP------------------------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIK 260 (264)
T ss_pred HHhcCCCC------------------------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHH
Confidence 21111110 01222 457899999999999999999999999999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=310.55 Aligned_cols=267 Identities=22% Similarity=0.349 Sum_probs=198.5
Q ss_pred ccceeEEeeecccCceEEEEEEEeccc-------------CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCee
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAA-------------NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVV 91 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~-------------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv 91 (477)
.++|+++++||+|+||.||+|.+.... ..+..||+|.+...... .....+.+|++++++++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEe
Confidence 468999999999999999999875421 12356899998765432 2345677899999999999999
Q ss_pred EEEEEEEcCCCceEEEEEeccC-CCHHHHHHhhhccc------CCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCc
Q 011808 92 KLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKV------NHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSN 164 (477)
Q Consensus 92 ~l~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~N 164 (477)
++++++... ..++++||++. ++|.+++....... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 999998664 47899999987 68888887653211 2268999999999999999999999999999999999
Q ss_pred EEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 011808 165 ILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT--LKPLFQ 242 (477)
Q Consensus 165 ILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt--G~~PF~ 242 (477)
|++ +.++.++|+|||+++...............++..|+|||++.+. .++.++|||||||++|+|++ +..||.
T Consensus 161 ili----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 161 CLV----GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred eee----cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999 66678999999999865433222222233457789999998774 48999999999999999998 678886
Q ss_pred CcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccC
Q 011808 243 GAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYD 322 (477)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~d 322 (477)
..+. .+.+..+......... ......+...+.++.+||.+||..|
T Consensus 236 ~~~~--------~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~l~~li~~cl~~~ 280 (296)
T cd05051 236 HLTD--------QQVIENAGHFFRDDGR---------------------------QIYLPRPPNCPKDIYELMLECWRRD 280 (296)
T ss_pred CcCh--------HHHHHHHHhccccccc---------------------------cccCCCccCCCHHHHHHHHHHhccC
Confidence 4331 1111111111000000 0001122344578999999999999
Q ss_pred CCCCCCHHHHhc
Q 011808 323 PRKRITAAQALE 334 (477)
Q Consensus 323 P~~Rpt~~e~L~ 334 (477)
|.+|||+.+++.
T Consensus 281 p~~Rpt~~el~~ 292 (296)
T cd05051 281 EEDRPTFREIHL 292 (296)
T ss_pred hhcCCCHHHHHH
Confidence 999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=306.59 Aligned_cols=264 Identities=22% Similarity=0.390 Sum_probs=198.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecc--cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAA--ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++|.+.+.||+|+||.||+|.+... ......|++|.+..... ......+.+|+.+++.++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFNHQNIVRLIGVSFERL- 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-
Confidence 46799999999999999999987641 12467899998865432 222346788999999999999999999886643
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhccc--CCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKV--NHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+++|||+. ++|.+++...+... ...+++..+..++.||+.||.|||+++++||||||+|||+..++ ....+||
T Consensus 83 -~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~-~~~~~kl 160 (277)
T cd05036 83 -PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG-PGRVAKI 160 (277)
T ss_pred -CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC-CCcceEe
Confidence 6789999996 68888887653211 12588999999999999999999999999999999999995432 2346999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~ 258 (477)
+|||+++.+..............+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~----------- 228 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----------- 228 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------
Confidence 9999998653322111112223356799999997744 8999999999999999997 99999765421
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.+...+..... ...+...+..+.+||.+||+.||++|||+.++++|
T Consensus 229 -~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 229 -EVMEFVTGGGR------------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -HHHHHHHcCCc------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11111111000 01233446789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=307.73 Aligned_cols=252 Identities=28% Similarity=0.394 Sum_probs=195.6
Q ss_pred ecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEecc
Q 011808 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYA 112 (477)
Q Consensus 34 lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~ 112 (477)
||+|+||+||+|.++. +++.+++|++...... ......+.+|+.+++.++||||+++++++... ..+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKA---TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcC---CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecC
Confidence 6999999999998664 5889999998654322 22234557899999999999999999998664 3789999999
Q ss_pred C-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCC
Q 011808 113 E-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191 (477)
Q Consensus 113 ~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~ 191 (477)
. ++|.+++.... ...+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++......
T Consensus 76 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~----~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 76 NGGDLKYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL----DDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred CCCcHHHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----CCCCCEEEccCcchhhhccC
Confidence 8 58887776543 2368999999999999999999999999999999999999 66778999999998765432
Q ss_pred CCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCC
Q 011808 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPE 271 (477)
Q Consensus 192 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 271 (477)
. ......++..|+|||++.+.. ++.++|||||||++|+|++|+.||....... .... +......
T Consensus 149 ~---~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~---~~~~~~~---- 212 (277)
T cd05577 149 K---KIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-----EKEE---LKRRTLE---- 212 (277)
T ss_pred C---ccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccc-----cHHH---HHhcccc----
Confidence 1 112344578899999998755 8899999999999999999999997654211 1111 1111000
Q ss_pred CccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCccCCC
Q 011808 272 KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEYFRI 340 (477)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~f~~ 340 (477)
.....+...++.+.+||++||+.||.+|| ++.+++.||||+.
T Consensus 213 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 213 ---------------------------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred ---------------------------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 00112333467899999999999999999 8999999999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=310.66 Aligned_cols=296 Identities=30% Similarity=0.437 Sum_probs=221.1
Q ss_pred cc-cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC--------CCCeeEEE
Q 011808 24 WL-QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT--------HENVVKLV 94 (477)
Q Consensus 24 ~~-~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l~ 94 (477)
|. +||-++++||.|.|++||+|++.. ..+.||+|+.+... ...+.++.||++|++++ -.+||+|+
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq---~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQ---NKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeecc---CCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 44 799999999999999999999875 57889999987543 23457789999999883 25899999
Q ss_pred EEEEc--CCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEecc-
Q 011808 95 NVHIN--HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGE- 170 (477)
Q Consensus 95 ~~~~~--~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~- 170 (477)
+.|.. ....++|||||+++.+|+.+|.... -..++...++.|++|||.||.|||.. ||||-||||+|||++.+
T Consensus 149 D~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e 225 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTE 225 (590)
T ss_pred ccceecCCCCcEEEEEehhhhhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccc
Confidence 99863 4567899999999999999998865 34799999999999999999999975 99999999999999110
Q ss_pred --------------------------------------------------------------------------------
Q 011808 171 -------------------------------------------------------------------------------- 170 (477)
Q Consensus 171 -------------------------------------------------------------------------------- 170 (477)
T Consensus 226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~ 305 (590)
T KOG1290|consen 226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN 305 (590)
T ss_pred cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 011808 171 -------------------------------------------------------------------------------- 170 (477)
Q Consensus 171 -------------------------------------------------------------------------------- 170 (477)
T Consensus 306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~ 385 (590)
T KOG1290|consen 306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP 385 (590)
T ss_pred ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence
Q ss_pred -CCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccC
Q 011808 171 -GEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST 249 (477)
Q Consensus 171 -~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~ 249 (477)
......+||+|||.|+-+.... +..+.|..|+||||+.|.. |+..+||||++|++|||+||...|...+-..
T Consensus 386 ~~~~di~vKIaDlGNACW~~khF-----T~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~- 458 (590)
T KOG1290|consen 386 LPECDIRVKIADLGNACWVHKHF-----TEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGEN- 458 (590)
T ss_pred CCccceeEEEeeccchhhhhhhh-----chhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCC-
Confidence 0001136667777665433211 1234588999999999965 9999999999999999999999998766443
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccc--------------cCCCCCchHHHHH
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSV--------------VPLSPKSPAYDLL 315 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~p~~~s~~~~dli 315 (477)
..-+.+.+..|++.+|.-+..... -..+.++.++.++. ...++.+ ++.....++.|||
T Consensus 459 -Y~rDEDHiA~i~ELLG~iPr~ia~----~Gk~SRdFFnr~G~---LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL 530 (590)
T KOG1290|consen 459 -YSRDEDHIALIMELLGKIPRKIAL----GGKYSRDFFNRRGE---LRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFL 530 (590)
T ss_pred -CCccHHHHHHHHHHHhhccHHHHh----cCcchHhhhccccc---eecccccCCCcHHHHHHHHhCCCHHHHHHHHHHH
Confidence 344788999999999876653211 11122222221111 1111111 2222334577999
Q ss_pred HHhcccCCCCCCCHHHHhcCccCCCCCC
Q 011808 316 SKMLEYDPRKRITAAQALEHEYFRIEPL 343 (477)
Q Consensus 316 ~~~L~~dP~~Rpt~~e~L~h~~f~~~~~ 343 (477)
.-||+.+|++|+||.++|+|||+...+.
T Consensus 531 ~PmLef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 531 SPMLEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred HHHHhcCccccccHHHHhcCccccCCCC
Confidence 9999999999999999999999974433
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=307.42 Aligned_cols=255 Identities=24% Similarity=0.466 Sum_probs=200.7
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC---CCCeeEEEEEEEcCCCc
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT---HENVVKLVNVHINHADM 103 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~ 103 (477)
.|++++.||+|+||.||+|.+.. ++..++||.+..... ......+.+|+.+++.++ ||||+++++++... .
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---TGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--P 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---CCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--C
Confidence 58899999999999999998754 588999999875432 233456778999999996 99999999998654 4
Q ss_pred eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..|++|||+.+ +|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||++ +..+.++|+||
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i----~~~~~~~l~df 145 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV----TNTGNVKLCDF 145 (277)
T ss_pred EEEEEEecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE----cCCCCEEEccC
Confidence 78999999974 77777653 268899999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++..+..... ......|+..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.. . ..
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~----~~ 211 (277)
T cd06917 146 GVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------R----AM 211 (277)
T ss_pred CceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--------h----hh
Confidence 99987654321 1233457889999999876566789999999999999999999999754321 0 00
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
..+....+.. ......+.++.+||.+||+.||.+||++.+++.|+||+.
T Consensus 212 ~~~~~~~~~~-----------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 212 MLIPKSKPPR-----------------------------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred hccccCCCCC-----------------------------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 1110000000 001113567999999999999999999999999999974
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=304.82 Aligned_cols=288 Identities=37% Similarity=0.579 Sum_probs=229.7
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA-- 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 101 (477)
...||.-++.+|.|+- .|..|.+. -.++.||||++..........+++.+|+.++..+.|+||++++.+|.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~---v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQ---VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchh---hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 4578999999999998 66667544 46889999999887766667788899999999999999999999985321
Q ss_pred --CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 102 --DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 102 --~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
...+|+|||++..+|.+.+.. .++-..+..++.|++.|+.|||+.||+||||||+||++ .....+||
T Consensus 91 ~~~~e~y~v~e~m~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv----~~~~~lKi 159 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV----NSDCTLKI 159 (369)
T ss_pred HHHHhHHHHHHhhhhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee----cchhheee
Confidence 234799999999999988863 36677899999999999999999999999999999999 77778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
.|||+|+.-... ...+.++.|..|.|||++.+.. |...+||||+||++.||++|+..|.|.+ ..++..
T Consensus 160 ~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d--------~idQ~~ 227 (369)
T KOG0665|consen 160 LDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKD--------HIDQWN 227 (369)
T ss_pred ccchhhcccCcc---cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCch--------HHHHHH
Confidence 999999865432 2445677899999999999977 9999999999999999999999999877 899999
Q ss_pred HHHHHhCCCCCCCccccCC--------CccccccccccccccccCCCCccc--cCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 260 KIFKILGHPTPEKWPTLAN--------LPHWQSDSLHIQGRKYETNGLHSV--VPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~--~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
++.+.+|++.+.++..+.. .|.+....+. +.+....+... .+......++||+.+||..||++|.++
T Consensus 228 ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~---~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv 304 (369)
T KOG0665|consen 228 KIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFS---ELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV 304 (369)
T ss_pred HHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchh---hhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH
Confidence 9999999999876655432 2222221110 00000000000 111223458899999999999999999
Q ss_pred HHHhcCccCCCC
Q 011808 330 AQALEHEYFRIE 341 (477)
Q Consensus 330 ~e~L~h~~f~~~ 341 (477)
+++|.|||++..
T Consensus 305 ~daL~HPY~~vw 316 (369)
T KOG0665|consen 305 DDALRHPYIKVW 316 (369)
T ss_pred HHHhcCCeeeee
Confidence 999999999743
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=313.08 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=200.9
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
..|...+.||+|+||.||++++.. ++..+|+|++..... .......+.+|+.+++.++|+|++++++++.+.. .
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH--T 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcC---CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--e
Confidence 458899999999999999998754 578999999865432 2233456778999999999999999999987644 6
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
.|+||||+.+++.+.+.... ..+++.++..++.||+.||.|||++||+||||+|+||++ +.++.+||+|||+
T Consensus 100 ~~lv~e~~~g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~----~~~~~~kl~dfg~ 171 (317)
T cd06635 100 AWLVMEYCLGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL----TEPGQVKLADFGS 171 (317)
T ss_pred EEEEEeCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE----CCCCCEEEecCCC
Confidence 89999999999988876542 358999999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+...... ....++..|+|||++.. ...++.++|||||||++|+|++|..||...+ ....+..+.
T Consensus 172 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~ 237 (317)
T cd06635 172 ASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIA 237 (317)
T ss_pred ccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHH
Confidence 8754321 23456889999999842 2447889999999999999999999996533 111121111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
. ...+ .......+..+.+||.+||+.||.+||++.+++.|+|+..
T Consensus 238 ~---~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 238 Q---NESP------------------------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred h---ccCC------------------------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 1 1000 0011223467899999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=298.54 Aligned_cols=253 Identities=34% Similarity=0.550 Sum_probs=204.9
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|++.+.||+|++|.||++.+.. ++..|++|.+............+.+|++++++++|+|++++++++.+. ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEE
Confidence 58999999999999999998653 578899999987655444556788999999999999999999998764 4789
Q ss_pred EEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
++|||+.+ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++
T Consensus 76 ~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i----~~~~~~~l~d~~~~ 146 (254)
T cd06627 76 IILEYAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT----TKDGVVKLADFGVA 146 (254)
T ss_pred EEEecCCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE----CCCCCEEEeccccc
Confidence 99999985 787777653 368999999999999999999999999999999999999 56778999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
......... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+. ...+....
T Consensus 147 ~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----------~~~~~~~~ 212 (254)
T cd06627 147 TKLNDVSKD--DASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNP-----------MAALFRIV 212 (254)
T ss_pred eecCCCccc--ccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHHHHh
Confidence 876543221 22345688999999987754 88999999999999999999999974331 11111111
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
... ....+...+..+.++|.+||..||++|||+.+++.|+||
T Consensus 213 ~~~-------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 213 QDD-------------------------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ccC-------------------------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 100 011234456789999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=302.22 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=194.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|+++++||+|+||.||+|.+. .+..|++|.+..... ....+.+|+.+++.++|+||+++++++.+. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~----~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN----NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec----CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CC
Confidence 468999999999999999999754 356799998765322 245778899999999999999999988654 46
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+++|||+. ++|.+++.... ...+++..+..++.||+.||+|||+.+++||||||+||++ +.++.++|+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili----~~~~~~~l~dfg 148 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV----SESLMCKIADFG 148 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe----cCCCcEEECCCc
Confidence 899999986 68888886543 3468888999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++......... ......++..|+|||++.+. .++.++|||||||++|+|++ |..||..... ......+.
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~ 218 (261)
T cd05072 149 LARVIEDNEYT-AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--------SDVMSALQ 218 (261)
T ss_pred cceecCCCcee-ccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCH--------HHHHHHHH
Confidence 99876432211 11223346789999998764 48889999999999999998 9999975431 11111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
... . .......+.++.+||.+||..||++|||++++++
T Consensus 219 ~~~---~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 219 RGY---R-------------------------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred cCC---C-------------------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 100 0 0011234567899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=305.68 Aligned_cols=261 Identities=22% Similarity=0.365 Sum_probs=199.9
Q ss_pred ccceeEEeeecccCceEEEEEEEeccc--CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAA--NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++|.+.+.||+|+||.||++.++... ..+..|++|.+..... ......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--
Confidence 468999999999999999999876432 3457899999865432 12234677899999999999999999998664
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcc-----cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDK-----VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~ 176 (477)
...|++|||+. ++|.+++...... ....+++..+..++.||+.||.|||+.+|+||||||+|||+ +.++.
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill----~~~~~ 157 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV----AEDLT 157 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE----cCCCC
Confidence 47899999997 6888888654321 12247888999999999999999999999999999999999 67778
Q ss_pred EEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccH
Q 011808 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~ 255 (477)
+||+|||+++.+.............++..|+|||.+.+. .++.++|||||||++|||++ |..||.+.+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------- 227 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------- 227 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCH---------
Confidence 999999999765433222222234457889999999764 48899999999999999998 9999975442
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.. +.+.+.... ....+...+..+.+||.+||+.||++|||+.++++.
T Consensus 228 ~~---~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 228 EE---VLKFVIDGG------------------------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred HH---HHHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 11 111111110 011233346789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=303.83 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=194.2
Q ss_pred CccccccceeEEeee--cccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEE
Q 011808 20 EKPEWLQQYNLIGKI--GEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNV 96 (477)
Q Consensus 20 ~~~~~~~~Y~i~~~l--G~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 96 (477)
+...+.++|++.+.+ |+|+||.||++.++. ++..+++|.+....... .|+.+...+ +|+||++++++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~ 77 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKP---TQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYS 77 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcC---CCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEE
Confidence 344567788888887 999999999998764 58889999986543211 133333323 79999999999
Q ss_pred EEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 97 HINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 97 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
|.... .+|+||||+. ++|.+++... ..+++.+++.++.||+.||.|||+.|++||||||+||++ +.++
T Consensus 78 ~~~~~--~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~----~~~~ 146 (267)
T PHA03390 78 VTTLK--GHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY----DRAK 146 (267)
T ss_pred EecCC--eeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE----eCCC
Confidence 97654 7899999997 6898888753 278999999999999999999999999999999999999 4444
Q ss_pred -cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCccc
Q 011808 176 -VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254 (477)
Q Consensus 176 -~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~ 254 (477)
.++|+|||++....... ...++..|+|||++.+. .++.++|||||||++|+|++|..||....... +.
T Consensus 147 ~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~----~~ 215 (267)
T PHA03390 147 DRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE----LD 215 (267)
T ss_pred CeEEEecCccceecCCCc------cCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcch----hh
Confidence 79999999987654321 23468899999999774 48899999999999999999999997543211 11
Q ss_pred HHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-HHHHh
Q 011808 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-AAQAL 333 (477)
Q Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-~~e~L 333 (477)
... +..... .. ...+...+..+++||.+||+.||.+|++ ++++|
T Consensus 216 ~~~---~~~~~~-~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 216 LES---LLKRQQ-KK-------------------------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred HHH---HHHhhc-cc-------------------------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 111 111110 00 0012234678999999999999999996 59999
Q ss_pred cCccCC
Q 011808 334 EHEYFR 339 (477)
Q Consensus 334 ~h~~f~ 339 (477)
+|+||+
T Consensus 261 ~h~~~~ 266 (267)
T PHA03390 261 KHPFLK 266 (267)
T ss_pred cCCccc
Confidence 999996
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=302.54 Aligned_cols=247 Identities=21% Similarity=0.372 Sum_probs=190.4
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEec
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
++||+|+||.||+|.++. ..++..+|+|+++...........+.+|+.+++.++|+||+++++++.. ...+++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~ 76 (257)
T cd05116 1 GELGSGNFGTVKKGMYKM-KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMEL 76 (257)
T ss_pred CcCCCcCCcceEEeEEec-CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEec
Confidence 368999999999997653 2467889999987654444445677889999999999999999998743 256899999
Q ss_pred cC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 112 AE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 112 ~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||.|||+ +.++.+||+|||+++.+..
T Consensus 77 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill----~~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 77 AELGPLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL----VTQHYAKISDFGLSKALGA 147 (257)
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE----cCCCeEEECCCccccccCC
Confidence 88 5788887653 368999999999999999999999999999999999999 6677899999999986644
Q ss_pred CCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 191 PLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 191 ~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||..... .+. ...+...
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~----~~~i~~~ 214 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEV----TQMIESG 214 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH----HHHHHCC
Confidence 32211 1112233578999999865 348889999999999999998 9999975432 111 1111110
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
. ....+...+.++.+||.+||+.||.+||+++++..
T Consensus 215 ~------------------------------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 215 E------------------------------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred C------------------------------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0 01123445678999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=307.08 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=200.8
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
+.|+.++.||.|+||.||+|.++. ++..||||.+..... ......+.+|+.+++.++|+||+++++++.+.. .+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT--KL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc---CCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--EE
Confidence 568899999999999999998764 578999999875432 223456778999999999999999999987643 79
Q ss_pred EEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|+||||+++ +|.+++.. ..+++..+..++.|++.||+|||+++++|+||+|+||++ +.++.++|+|||+
T Consensus 78 ~lv~e~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~----~~~~~~~l~dfg~ 147 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL----SEQGDVKLADFGV 147 (277)
T ss_pred EEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE----cCCCCEEEccccc
Confidence 999999984 78777753 258889999999999999999999999999999999999 6667899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+........ ......++..|+|||++.+. .++.++|+|||||++|+|++|..||...+.. ... ..
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~----~~ 212 (277)
T cd06640 148 AGQLTDTQI--KRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVL----FL 212 (277)
T ss_pred ceeccCCcc--ccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hHh----hh
Confidence 976543221 12234568889999999764 4889999999999999999999999754421 000 00
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+.... ....+...+.++.+||.+||+.||.+||++.+++.|+||..
T Consensus 213 ~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 213 IPKNN------------------------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred hhcCC------------------------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence 00000 00112233567889999999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=300.96 Aligned_cols=254 Identities=29% Similarity=0.474 Sum_probs=200.1
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEec
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
+.||+|+||.||+|.+......+..+++|.+....... ....+.+|+.+++.++|+||+++++++.+ +..++++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 47999999999999876433447889999997665433 45677889999999999999999999876 4578999999
Q ss_pred cC-CCHHHHHHhhhcc----cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 112 AE-YDLYEIIRHHRDK----VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 112 ~~-~~L~~~l~~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
+. ++|.+++...... ....+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||.+.
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili----~~~~~~~l~dfg~~~ 153 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV----GEDLVVKISDFGLSR 153 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE----CCCCcEEEccccccc
Confidence 94 7898888764211 12478999999999999999999999999999999999999 667889999999998
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
...............++..|+|||.+.+. .++.++|||||||++|+|++ |..||..... .+.. ..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~----~~~ 220 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVL----EYL 220 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHH----HHH
Confidence 76543322233345568899999999775 58999999999999999999 6999976531 1111 111
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
... .....+...+..+.++|.+||+.||.+|||+.+++.+
T Consensus 221 ~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 221 RKG------------------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HcC------------------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 110 0011233446789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=309.62 Aligned_cols=257 Identities=27% Similarity=0.460 Sum_probs=202.0
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
+.+.|...++||+|+||.||+|++.. ++..|+||++...... ......+.+|+.+++.++|+|++++++++.+..
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 94 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSH---TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH- 94 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECC---CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-
Confidence 34568888999999999999998653 6889999998754332 223346778999999999999999999987653
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..|++|||+.+++.+.+... ...+++..+..++.||+.||.|||++||+|+||||+||++ +.++.+||+||
T Consensus 95 -~~~lv~e~~~~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili----~~~~~~kL~df 165 (313)
T cd06633 95 -TAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL----TEPGQVKLADF 165 (313)
T ss_pred -EEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE----CCCCCEEEeec
Confidence 78999999999998887653 2368899999999999999999999999999999999999 66678999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|++..... .....++..|+|||++.. ...++.++|||||||++|+|++|..||...+. ...+..
T Consensus 166 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--------~~~~~~ 231 (313)
T cd06633 166 GSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYH 231 (313)
T ss_pred CCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHH
Confidence 99864321 223567889999999853 24478899999999999999999999975431 111211
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+ .....+. ......+..+.+||.+||++||.+||++.+++.|+||+.
T Consensus 232 ~---~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 232 I---AQNDSPT------------------------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred H---HhcCCCC------------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 1 1111000 011123456899999999999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=301.59 Aligned_cols=246 Identities=24% Similarity=0.440 Sum_probs=187.1
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEec
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
+.||+|+||.||+|+++. ++..+|+|.+..... ......+.+|+.+++.++||||+++++++... ..+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~---~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---DNTPVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEec---CCceEEEEecCccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEee
Confidence 479999999999998764 588899998864332 22345678899999999999999999998664 378999999
Q ss_pred cC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 112 AE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 112 ~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 75 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~----~~~~~~kl~dfg~~~~~~~ 146 (252)
T cd05084 75 VQGGDFLTFLRTE----GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV----TEKNVLKISDFGMSREEED 146 (252)
T ss_pred ccCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE----cCCCcEEECccccCccccc
Confidence 87 5888877643 2358899999999999999999999999999999999999 6667899999999875443
Q ss_pred CCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCCC
Q 011808 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPT 269 (477)
Q Consensus 191 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 269 (477)
............+..|+|||.+.+.. ++.++|||||||++|+|++ |.+||..... .. ...... ..
T Consensus 147 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~-~~~~~~---~~- 212 (252)
T cd05084 147 GVYASTGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQ-TREAIE---QG- 212 (252)
T ss_pred ccccccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCH--------HH-HHHHHH---cC-
Confidence 21111111112245699999997744 8999999999999999998 8899964431 11 111111 00
Q ss_pred CCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 270 PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.....+...+..+.+||.+||+.||++|||+.+++.
T Consensus 213 -----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 213 -----------------------------VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -----------------------------CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001123334678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=311.47 Aligned_cols=260 Identities=27% Similarity=0.483 Sum_probs=201.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
...|+....||+|+||.||+|.+.. ++..||||.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~ 92 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKH---SGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EE 92 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcC---CCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeC--Ce
Confidence 3456667789999999999998653 578999999865432 2345677899999999999999999988764 37
Q ss_pred EEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.|++|||+.+ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||
T Consensus 93 ~~iv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill----~~~~~~kL~dfg 162 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL----TLDGRVKLSDFG 162 (297)
T ss_pred EEEEEecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE----ccCCcEEEeech
Confidence 8999999985 66665543 258899999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++..+.... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||...+. ...+..
T Consensus 163 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~--- 228 (297)
T cd06659 163 FCAQISKDV--PKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--------VQAMKR--- 228 (297)
T ss_pred hHhhccccc--ccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH---
Confidence 987554322 122345679999999999774 489999999999999999999999975431 112211
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPL 343 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~~~ 343 (477)
+.......+. .....+..+.+||.+||+.||.+||++.+++.|+||.....
T Consensus 229 -~~~~~~~~~~----------------------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 229 -LRDSPPPKLK----------------------------NAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred -HhccCCCCcc----------------------------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 1111111000 11223567899999999999999999999999999985544
Q ss_pred C
Q 011808 344 P 344 (477)
Q Consensus 344 ~ 344 (477)
+
T Consensus 280 ~ 280 (297)
T cd06659 280 P 280 (297)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=300.75 Aligned_cols=250 Identities=25% Similarity=0.425 Sum_probs=193.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||++.+.. +..+|||.+..... ....+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~----~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC----CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CC
Confidence 3579999999999999999997642 44699998875432 235678899999999999999999998654 36
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili----~~~~~~kl~d~g 145 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV----DDQGCVKVSDFG 145 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE----cCCCCEEECCCc
Confidence 799999997 57888876532 258999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
.++....... .......++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+. .+....+.
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~ 215 (256)
T cd05113 146 LSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEKVS 215 (256)
T ss_pred cceecCCCce-eecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHh
Confidence 9886543221 1122233467799999997644 8899999999999999998 9999965441 11111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
. ... ...+...+..++++|.+||+.||.+|||+.+++.+
T Consensus 216 ~----~~~------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 216 Q----GLR------------------------------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred c----CCC------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 1 000 00122235789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=301.88 Aligned_cols=251 Identities=25% Similarity=0.433 Sum_probs=196.3
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
.+|.+.+.||+|+||.||+|.++. .+..+++|.+.... .....+.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 77 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPF 77 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---CCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCc
Confidence 569999999999999999998764 57889999986432 2245678899999999999999999988654 478
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+++|||+. ++|.+++.... ...+++..++.++.||+.||.|||++|++||||||+|||+ ++++.+||+|||+
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~----~~~~~~kl~df~~ 150 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV----GENHLVKVADFGL 150 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE----cCCCcEEeCCCcc
Confidence 99999987 68888886533 3358889999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+......... ......++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+. + .+..
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---------~---~~~~ 216 (263)
T cd05052 151 SRLMTGDTYT-AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------S---QVYE 216 (263)
T ss_pred ccccccceee-ccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---------H---HHHH
Confidence 9866542211 11122235679999998764 48899999999999999998 9999975431 1 1111
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.+... .....+...+..+.+||.+||..||++|||+.++++.
T Consensus 217 ~~~~~------------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 217 LLEKG------------------------------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHCC------------------------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 11110 0011234456789999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=306.25 Aligned_cols=263 Identities=27% Similarity=0.414 Sum_probs=203.0
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC--CCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCc
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG--DGVSPTAIREIMLLREI-THENVVKLVNVHINHADM 103 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 103 (477)
.|++.+.||+|+||.||+|++.....++..||+|+++..... ......+.+|+.+++++ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--T 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--C
Confidence 489999999999999999987654457889999998754321 12234567899999999 699999999988654 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||+ +.++.+||+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~----~~~~~~kl~df 149 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL----DSNGHVVLTDF 149 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE----CCCCCEEEeeC
Confidence 7899999998 5888888653 368899999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|++........ .......++..|+|||.+.+. ..++.++|||||||++|+|++|..||...... .....+
T Consensus 150 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~~~ 220 (290)
T cd05613 150 GLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--------NSQAEI 220 (290)
T ss_pred ccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--------ccHHHH
Confidence 99986543211 112234578899999998653 24678999999999999999999999643211 111222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHE 336 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~ 336 (477)
...+....+ ..+...+..+.+||.+||..||++|+ ++.+++.|+
T Consensus 221 ~~~~~~~~~-------------------------------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~ 269 (290)
T cd05613 221 SRRILKSEP-------------------------------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHP 269 (290)
T ss_pred HHHhhccCC-------------------------------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCc
Confidence 222111110 12233456789999999999999997 899999999
Q ss_pred cCCC
Q 011808 337 YFRI 340 (477)
Q Consensus 337 ~f~~ 340 (477)
||..
T Consensus 270 ~~~~ 273 (290)
T cd05613 270 FFQK 273 (290)
T ss_pred cccc
Confidence 9974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=300.06 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=194.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||+|.+. .+..||||.++.... ....+.+|+.++++++|+||+++++++.... .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN----NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE--P 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec----CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCC--C
Confidence 367999999999999999999754 356799999875432 2456788999999999999999999886543 6
Q ss_pred EEEEEecc-CCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYA-EYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~-~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|++|||+ +++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||++ ++++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~~l~dfg 148 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV----GENNICKVADFG 148 (261)
T ss_pred eeeeeecccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE----cCCCCEEECCcc
Confidence 89999999 478988887643 3468999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++..+...... ...+...+..|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+. ...+..+.
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~ 218 (261)
T cd05068 149 LARVIKEDIYE-AREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQVD 218 (261)
T ss_pred eEEEccCCccc-ccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHH
Confidence 99876532111 11122224579999998764 48999999999999999999 9999976441 11111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.. . ....+...+..+.+||.+||+.||.+||++.+++.
T Consensus 219 ~~---~-------------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 219 QG---Y-------------------------------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred cC---C-------------------------------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 10 0 00112334578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=303.94 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=194.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCC-CcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANR-GKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..+|++++.||+|+||+||+|++..+... ...||+|+++.... ......+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLTS--- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---
Confidence 46899999999999999999987643111 22589999865432 22345677899999999999999999988643
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..+++++|+. ++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+||
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~----~~~~~~kL~df 153 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV----KSPNHVKITDF 153 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE----cCCCcEEECCC
Confidence 4678999887 6888888653 2368999999999999999999999999999999999999 56677999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|+++.+.............++..|+|||.+.+. .++.++|||||||++|||++ |..||..... ..+..+
T Consensus 154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---------~~~~~~ 223 (279)
T cd05109 154 GLARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---------REIPDL 223 (279)
T ss_pred CceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHH
Confidence 999876543222122223346789999999764 48999999999999999998 8999965431 122222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
....... ..+...+..+.++|.+||+.||++||++.+++..
T Consensus 224 ~~~~~~~---------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 224 LEKGERL---------------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHCCCcC---------------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2111000 0122345678999999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=308.40 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=201.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||++.+.. ++..|++|.+..... .....+.+|+.+++.++||||+++++++.... .
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA---TGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGD--E 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC---CCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCC--c
Confidence 5799999999999999999997653 578899999864332 23456788999999999999999999987644 6
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.|+|+||+. ++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili----~~~~~~kL~dfg 160 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL----GMDGSVKLTDFG 160 (293)
T ss_pred EEEEEecCCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE----cCCCCEEEccCc
Confidence 899999997 5887777542 47888999999999999999999999999999999999 666789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++........ ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.. ..+. .
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--------~~~~---~ 226 (293)
T cd06647 161 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALY---L 226 (293)
T ss_pred ceeccccccc--ccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChh--------hhee---e
Confidence 9876543222 12234578899999998764 4889999999999999999999999754421 0100 0
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
......+ ....+...+..+.+||++||..||.+||++.+++.|+||+.
T Consensus 227 ~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 227 IATNGTP-----------------------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred hhcCCCC-----------------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 0000000 00012223567899999999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=303.41 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=190.0
Q ss_pred eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCC-cHHHHHHH---HHHHhcCCCCeeEEEEEEEcCCCceEEEE
Q 011808 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV-SPTAIREI---MLLREITHENVVKLVNVHINHADMSLYLA 108 (477)
Q Consensus 33 ~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~Ei---~il~~l~hpnIv~l~~~~~~~~~~~~~lv 108 (477)
.||+|+||.||+|++.. +++.||||.+......... ......|. .+++...||||+++++++.+.. .+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEec---CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--EEEEE
Confidence 48999999999998653 5889999998765433211 11223343 3445568999999999987644 78999
Q ss_pred EeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 109 FDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 109 ~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
|||+. ++|.+++.. ...+++..++.++.|++.||.|||+.+|+||||||+||++ +.++.+||+|||++..
T Consensus 76 ~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili----~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 76 LDLMNGGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL----DEHGHVRISDLGLACD 146 (278)
T ss_pred EecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE----CCCCCEEEccCcCccc
Confidence 99998 467666654 2368999999999999999999999999999999999999 6677899999999875
Q ss_pred ecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCC
Q 011808 188 YQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267 (477)
Q Consensus 188 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~ 267 (477)
+.... .....|+..|+|||++.+...++.++|||||||++|+|++|+.||....... ..... .....
T Consensus 147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~------~~~~~---~~~~~ 213 (278)
T cd05606 147 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------KHEID---RMTLT 213 (278)
T ss_pred cCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc------hHHHH---HHhhc
Confidence 54321 2234679999999999765558899999999999999999999997653211 01111 11100
Q ss_pred CCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCccCCC
Q 011808 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEYFRI 340 (477)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~f~~ 340 (477)
. ....+...+..+.+||.+||..||.+|+ ++.++++||||+.
T Consensus 214 ~-------------------------------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 214 M-------------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred c-------------------------------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 0 0112333467899999999999999999 9999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=309.98 Aligned_cols=253 Identities=25% Similarity=0.429 Sum_probs=198.8
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
+.|.+++.||+|+||.||+|.+.. ++..||+|.+...... .....+.+|+.+++.++|+||+++++++... ..+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR---TKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYGSYLKG--TKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC---CCeEEEEEEeccccch-HHHHHHHHHHHHHHcCCCCccHhhhcccccC--Cce
Confidence 468888999999999999998653 5788999998754322 2345677899999999999999999998764 378
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||+
T Consensus 78 ~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i----~~~~~~~l~dfg~ 147 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL----SEQGDVKLADFGV 147 (277)
T ss_pred EEEEEccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE----eCCCCEEEccccc
Confidence 99999998 477776643 358899999999999999999999999999999999999 6667899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+..+..... ......++..|+|||++.+. .++.++|+|||||++|+|++|..||...... ... ..
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~----~~ 212 (277)
T cd06642 148 AGQLTDTQI--KRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPM--------RVL----FL 212 (277)
T ss_pred cccccCcch--hhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchh--------hHH----hh
Confidence 976543221 12224568899999999774 4889999999999999999999999643311 000 01
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+..... ...+...+.++.+||.+||..||.+|||+.+++.|+||.
T Consensus 213 ~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 213 IPKNSP------------------------------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred hhcCCC------------------------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence 100000 011223456789999999999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=309.16 Aligned_cols=261 Identities=28% Similarity=0.433 Sum_probs=198.4
Q ss_pred ccceeEEeeecccCceEEEEEEEeccc----CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAA----NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHIN 99 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 99 (477)
.++|.+.+.||+|+||.||+|++.... .....+|+|.++.... ......+.+|+.+++.+ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 478999999999999999999865321 2345799999975432 22345677899999999 79999999999866
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRDK-----------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILV 167 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl 167 (477)
.. .+|+||||+. ++|.+++...... ....++..+++.++.||+.||+|||++|++||||||+|||+
T Consensus 96 ~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 96 DG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred CC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 44 7899999998 6899998764321 12358888999999999999999999999999999999999
Q ss_pred eccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 011808 168 MGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEA 246 (477)
Q Consensus 168 ~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~ 246 (477)
+.++.+||+|||+++...............++..|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus 174 ----~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 174 ----TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred ----cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 66678999999998765432111111112235689999999774 48999999999999999998 8899865431
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
..++..+..... ...+...+.++.+||.+||..+|.+|
T Consensus 249 ------------~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R 286 (307)
T cd05098 249 ------------EELFKLLKEGHR------------------------------MDKPSNCTNELYMMMRDCWHAVPSQR 286 (307)
T ss_pred ------------HHHHHHHHcCCC------------------------------CCCCCcCCHHHHHHHHHHcccChhhC
Confidence 122222211100 01233446789999999999999999
Q ss_pred CCHHHHhcC
Q 011808 327 ITAAQALEH 335 (477)
Q Consensus 327 pt~~e~L~h 335 (477)
||+.+++++
T Consensus 287 ps~~evl~~ 295 (307)
T cd05098 287 PTFKQLVED 295 (307)
T ss_pred cCHHHHHHH
Confidence 999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=305.59 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=196.7
Q ss_pred cceeEEeeecccCceEEEEEEEecc--cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAA--ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.+|.+.+.||+|+||.||++.+... ..++..+++|.+.... ......+.+|+.++++++|+||+++++++... .
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEG--D 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence 4699999999999999999975431 2345678999886532 22345678899999999999999999998654 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhc--------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRD--------KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ 174 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~ 174 (477)
.++++|||+. ++|.+++..... .....+++..++.++.||+.||+|||++||+||||||+|||+ +++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili----~~~ 156 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV----GEN 156 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE----ccC
Confidence 7899999997 688888875431 112348999999999999999999999999999999999999 677
Q ss_pred ccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcc
Q 011808 175 GVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 175 ~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~ 253 (477)
+.+||+|||+++...............++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.....
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~------- 228 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------- 228 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------
Confidence 7899999999986543322222223344778999999977 458999999999999999998 9999975441
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
.+.+..+.. ... ...+...+.++.+||.+||+.||.+|||+.+++
T Consensus 229 -~~~~~~i~~----~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 229 -NEVIECITQ----GRV------------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred -HHHHHHHHc----CCc------------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 111111111 000 001223456799999999999999999999985
Q ss_pred c
Q 011808 334 E 334 (477)
Q Consensus 334 ~ 334 (477)
.
T Consensus 274 ~ 274 (288)
T cd05093 274 S 274 (288)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=302.05 Aligned_cols=258 Identities=23% Similarity=0.355 Sum_probs=187.8
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEec
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
++||+|+||.||+|.... ......+++|.+..... ......+.+|+.+++.++|+||+++++.+... ..+|+||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~-~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHR-GMSKARVVVKELRASAT-PDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEec-CCCCeEEEEeecCccCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEEe
Confidence 469999999999997543 23456789998764332 22334677899999999999999999988654 468999999
Q ss_pred cC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 112 AE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 112 ~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
+. ++|.+++...........++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill----~~~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL----TADLSVKIGDYGLALEQYP 152 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe----cCCCcEEEecccccccccc
Confidence 98 588888877654333445678889999999999999999999999999999999 6677899999999875432
Q ss_pred CCCcccCCCeeeccccccchhhcC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 191 PLKFLSENGVVVTIWYRAPELLLG------AKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 191 ~~~~~~~~~~~gt~~y~APE~l~~------~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
...........++..|+|||++.. ...++.++|||||||++|||++ |..||..... .+.+..+..
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~ 224 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--------EQVLKQVVR 224 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhh
Confidence 221112233345678999999753 2346889999999999999999 7888865431 122222211
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..... ++ ....+...+..+.+++..|+ .||++|||++++++-
T Consensus 225 ~~~~~----~~-------------------------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 225 EQDIK----LP-------------------------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred ccCcc----CC-------------------------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 11000 00 00122334567788999998 599999999998753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=338.65 Aligned_cols=262 Identities=26% Similarity=0.393 Sum_probs=197.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+++|+++++||+|+||.||+|++.. +++.||||++....... .....+.+|+.+++.++||||+++++++.+. .
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~---tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~ 75 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPV---CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--D 75 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECC---CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--C
Confidence 4799999999999999999998754 68899999997643322 2345678899999999999999999998764 3
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcc------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDK------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~ 176 (477)
..|++|||++ ++|.+++...... ....++...+..++.||+.||+|||++||+||||||+|||+ +.++.
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL----d~dg~ 151 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL----GLFGE 151 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE----cCCCC
Confidence 7899999998 5888887653211 12345667788999999999999999999999999999999 67778
Q ss_pred EEEeecccceeecCCCC----------------cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 011808 177 VKIADFGLARIYQAPLK----------------FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL 240 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~----------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~P 240 (477)
+||+|||+++....... .......+||+.|+|||++.+. .++.++|||||||++|||+||..|
T Consensus 152 vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 152 VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCC
Confidence 99999999986621100 0111234689999999999874 489999999999999999999999
Q ss_pred CCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcc
Q 011808 241 FQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLE 320 (477)
Q Consensus 241 F~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~ 320 (477)
|........ .. ...+..+ ..+ ......+..+.+++.+||.
T Consensus 231 F~~~~~~ki--------~~--~~~i~~P--~~~----------------------------~p~~~iP~~L~~LI~rcL~ 270 (932)
T PRK13184 231 YRRKKGRKI--------SY--RDVILSP--IEV----------------------------APYREIPPFLSQIAMKALA 270 (932)
T ss_pred CCCcchhhh--------hh--hhhccCh--hhc----------------------------cccccCCHHHHHHHHHHcc
Confidence 975332100 00 0000000 000 0011335678899999999
Q ss_pred cCCCCCCCHHHHhcCc
Q 011808 321 YDPRKRITAAQALEHE 336 (477)
Q Consensus 321 ~dP~~Rpt~~e~L~h~ 336 (477)
.||.+|++..+.+.+.
T Consensus 271 ~DP~kR~ss~eeLl~~ 286 (932)
T PRK13184 271 VDPAERYSSVQELKQD 286 (932)
T ss_pred CChhhCcCHHHHHHHH
Confidence 9999999877766553
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=300.45 Aligned_cols=249 Identities=24% Similarity=0.421 Sum_probs=193.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|+++++||+|+||.||+|.+. .+..+++|.+...... ...+.+|+.++++++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~----~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN----GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE---EP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec----CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC---CC
Confidence 568999999999999999999754 3567999998764332 3467889999999999999999998743 34
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.|++|||+. ++|.+++.... ...+++..++.++.|++.||.|||+++|+||||||+||++ ++++.++|+|||
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili----~~~~~~~l~dfg 147 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV----GDGLVCKIADFG 147 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE----eCCceEEeCCce
Confidence 789999997 58888886532 3458899999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++..+...... ......++..|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+ ..+.+..+.
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~ 217 (260)
T cd05070 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMN--------NREVLEQVE 217 (260)
T ss_pred eeeeccCcccc-cccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHH
Confidence 99865432211 11223345679999998764 48899999999999999999 899997543 122222221
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
... ....+...+..+.+||.+||.+||.+|||++++++
T Consensus 218 ~~~----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 218 RGY----------------------------------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred cCC----------------------------------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 100 00122334577999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=302.05 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=194.4
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYL 107 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~l 107 (477)
......||+|+||.||+|.++. ++..|++|.+..... .....+.+|+.+++.++|+||+++++++... ..+++
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~---~~~~v~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 82 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLS---TQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKI 82 (268)
T ss_pred CCceEEEecCCceEEEEeEecC---CCcEEEEEEecCCCH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEE
Confidence 3445689999999999998654 578899998865432 2345677899999999999999999998664 47899
Q ss_pred EEeccC-CCHHHHHHhhhcccCCCC--CHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 108 AFDYAE-YDLYEIIRHHRDKVNHTM--NPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 108 v~e~~~-~~L~~~l~~~~~~~~~~l--~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
++||+. ++|.+.+.... ..+ ++..+..++.||+.||.|||++||+||||||+||++. ...+.++|+|||+
T Consensus 83 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~---~~~~~~~l~dfg~ 155 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN---TYSGVVKISDFGT 155 (268)
T ss_pred EEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCeEEEecchh
Confidence 999987 58888887542 234 7888999999999999999999999999999999993 2256799999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+........ ......+++.|+|||++.+. ..++.++|+|||||++|+|++|..||...... .. .+..
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-------~~---~~~~ 223 (268)
T cd06624 156 SKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-------QA---AMFK 223 (268)
T ss_pred heecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-------hh---hHhh
Confidence 876543211 11223468899999998653 34788999999999999999999999643210 00 0000
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
... ......++...+.++.+||.+||..+|.+|||+.+++.||||
T Consensus 224 ~~~------------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 224 VGM------------------------------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred hhh------------------------------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 000 000111334456789999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=305.92 Aligned_cols=255 Identities=32% Similarity=0.486 Sum_probs=203.0
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCc
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREIT-HENVVKLVNVHINHADM 103 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 103 (477)
++|.+.+.||+|+||.||+|.++. ++..|++|++...... ......+.+|+.+++++. |+||+++++++.+. .
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--E 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--c
Confidence 479999999999999999998764 6889999998764322 223356678999999998 99999999988654 4
Q ss_pred eEEEEEecc-CCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYA-EYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.++++||++ +++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||++ +.++.++|+||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i----~~~~~~~l~df 146 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL----DKDMHIKITDF 146 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE----CCCCCEEecCC
Confidence 789999999 57888888763 268999999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCc------------------ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 011808 183 GLARIYQAPLKF------------------LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGA 244 (477)
Q Consensus 183 G~a~~~~~~~~~------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~ 244 (477)
|++......... .......++..|+|||++.+. .++.++|+|||||+++++++|..||...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 999865443211 112234568899999998764 4888999999999999999999999855
Q ss_pred ccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCC
Q 011808 245 EAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324 (477)
Q Consensus 245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~ 324 (477)
+. ...+..+.. . ....+...+..+.+||.+||+.||.
T Consensus 226 ~~--------~~~~~~~~~-~----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~ 262 (280)
T cd05581 226 NE--------YLTFQKILK-L----------------------------------EYSFPPNFPPDAKDLIEKLLVLDPQ 262 (280)
T ss_pred cH--------HHHHHHHHh-c----------------------------------CCCCCCccCHHHHHHHHHHhcCCHh
Confidence 41 111121111 0 0112333457789999999999999
Q ss_pred CCCCH----HHHhcCccC
Q 011808 325 KRITA----AQALEHEYF 338 (477)
Q Consensus 325 ~Rpt~----~e~L~h~~f 338 (477)
+|||+ .++|.||||
T Consensus 263 ~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 263 DRLGVNEGYDELKAHPFF 280 (280)
T ss_pred hCCCcccCHHHHhcCCCC
Confidence 99999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=306.54 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=195.8
Q ss_pred ceeEEeeecccCceEEEEEEEeccc--CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAA--NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+|++.+.||+|+||.||+|.+.... .....+++|.+...... .....+.+|+.+++.++||||+++++.+... ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-SELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CC
Confidence 5889999999999999999865321 23357899988754322 2235677899999999999999999988654 36
Q ss_pred EEEEEeccC-CCHHHHHHhhhc-------------------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRD-------------------KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSN 164 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~N 164 (477)
.|++|||+. ++|.+++..... +....+++..++.++.|++.||.|||+++|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 799999998 688888765321 112357888999999999999999999999999999999
Q ss_pred EEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 011808 165 ILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQG 243 (477)
Q Consensus 165 ILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~ 243 (477)
||+ ++++.+||+|||+++...............++..|+|||++.+. .++.++|||||||++|+|++ |..||.+
T Consensus 158 ill----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 158 VLV----AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred EEE----cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999 66778999999999865433222222233446789999998764 48999999999999999998 9999975
Q ss_pred cccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCC
Q 011808 244 AEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323 (477)
Q Consensus 244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP 323 (477)
... .++...+.... ....+...+.++.+||.+||+.||
T Consensus 233 ~~~------------~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~i~~cl~~~P 270 (290)
T cd05045 233 IAP------------ERLFNLLKTGY------------------------------RMERPENCSEEMYNLMLTCWKQEP 270 (290)
T ss_pred CCH------------HHHHHHHhCCC------------------------------CCCCCCCCCHHHHHHHHHHccCCc
Confidence 432 11222221110 011233456789999999999999
Q ss_pred CCCCCHHHHhc
Q 011808 324 RKRITAAQALE 334 (477)
Q Consensus 324 ~~Rpt~~e~L~ 334 (477)
.+||+++++++
T Consensus 271 ~~Rp~~~~i~~ 281 (290)
T cd05045 271 DKRPTFADISK 281 (290)
T ss_pred ccCCCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=301.27 Aligned_cols=250 Identities=29% Similarity=0.480 Sum_probs=197.1
Q ss_pred ecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEecc
Q 011808 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYA 112 (477)
Q Consensus 34 lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~ 112 (477)
||.|+||.||+|++.. ++..+++|++...... ......+.+|+.+++.++|+||+++++++.+. ..+|++|||+
T Consensus 1 lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKS---KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecC
Confidence 7999999999998754 5889999999765432 23345677899999999999999999988654 3789999998
Q ss_pred C-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCC
Q 011808 113 E-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191 (477)
Q Consensus 113 ~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~ 191 (477)
. ++|.+++... ..+++..+..++.||+.||.|||+++++|+||||+||++ +.++.++|+|||++......
T Consensus 76 ~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv----~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 76 LGGELWTILRDR-----GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL----DSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred CCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE----cCCCCEEEeeCCcccccCcc
Confidence 7 6888888653 258999999999999999999999999999999999999 66778999999999866543
Q ss_pred CCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCC
Q 011808 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPE 271 (477)
Q Consensus 192 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 271 (477)
. ......++..|++||.+.+. .++.++|+|||||++|+|++|..||..... +.............
T Consensus 147 ~---~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~~-- 211 (262)
T cd05572 147 Q---KTWTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDE---------DPMEIYNDILKGNG-- 211 (262)
T ss_pred c---ccccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCC---------CHHHHHHHHhccCC--
Confidence 2 12234568899999998764 488999999999999999999999976542 01111111110000
Q ss_pred CccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCccCCC
Q 011808 272 KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHEYFRI 340 (477)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~~f~~ 340 (477)
....|...+..+++||.+||..||.+|++ +.|+++||||+.
T Consensus 212 ----------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 212 ----------------------------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred ----------------------------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 01123333578999999999999999999 999999999973
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=306.58 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=197.3
Q ss_pred ccceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
.++|.+.+.||+|+||.||++.+.. ....+..+|||+++.... ......+.+|+.+++++ +|+||+++++++....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 4689999999999999999997532 123456899999875432 22234677899999999 7999999999986644
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.+|++|||+. ++|.+++.... ...+++.++..++.||+.||.|||+++|+|+||||+|||+ +.++.++|+
T Consensus 113 --~~~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~~l~ 183 (302)
T cd05055 113 --PILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL----THGKIVKIC 183 (302)
T ss_pred --ceEEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE----cCCCeEEEC
Confidence 6899999987 68888886533 2248999999999999999999999999999999999999 666789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|||+++.+.............++..|+|||++.+.. ++.++|||||||++|+|++ |..||..... .+.+.
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~--------~~~~~ 254 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPV--------DSKFY 254 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--------hHHHH
Confidence 999998654332211122234477899999997744 8999999999999999998 9999975542 11121
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
+.... .. ....+...+..+.+||.+||.+||++|||+.+++.
T Consensus 255 ~~~~~---~~------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 255 KLIKE---GY------------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHc---CC------------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11110 00 00112233567999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=307.06 Aligned_cols=256 Identities=26% Similarity=0.362 Sum_probs=192.9
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++.+.||+|+||.||+|+++.+ .....+++|.++... .....+.+.+|+.+++++ +||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKD-GLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCC-CCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Cc
Confidence 6899999999999999999987642 223457888876422 222345677899999999 799999999998654 36
Q ss_pred EEEEEeccC-CCHHHHHHhhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCC
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDK-----------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE 172 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~ 172 (477)
+|++|||+. ++|.+++...... ....+++..++.++.||+.||+|||++||+||||||+|||+ +
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill----~ 153 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV----G 153 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE----C
Confidence 899999987 6888888653210 12358889999999999999999999999999999999999 6
Q ss_pred CcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCC
Q 011808 173 EQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQN 251 (477)
Q Consensus 173 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~ 251 (477)
.++.+||+|||++....... .......+..|+|||++.+. .++.++|||||||++|||++ |..||.+...
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~----- 224 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC----- 224 (297)
T ss_pred CCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence 67789999999986432111 11111224579999998764 48999999999999999997 9999975542
Q ss_pred cccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHH
Q 011808 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ 331 (477)
Q Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e 331 (477)
.+....+... .....+..++..+.+||.+||..||.+|||+++
T Consensus 225 ---~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 267 (297)
T cd05089 225 ---AELYEKLPQG----------------------------------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQ 267 (297)
T ss_pred ---HHHHHHHhcC----------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 1111111100 001123345678999999999999999999999
Q ss_pred HhcC
Q 011808 332 ALEH 335 (477)
Q Consensus 332 ~L~h 335 (477)
++..
T Consensus 268 i~~~ 271 (297)
T cd05089 268 ISVQ 271 (297)
T ss_pred HHHH
Confidence 9766
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=315.12 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=196.8
Q ss_pred cceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHAD 102 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 102 (477)
++|++.+.||+|+||.||+|++.. ...+++.||||+++.... ......+.+|+.++.++ +|+||+++++++... +
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence 589999999999999999998642 224578999999975432 22345677899999999 689999999987654 3
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcc-------------------------------------------------------
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDK------------------------------------------------------- 126 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~------------------------------------------------------- 126 (477)
..++++|||+. ++|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 46899999998 6888888653210
Q ss_pred -------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCC
Q 011808 127 -------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199 (477)
Q Consensus 127 -------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 199 (477)
....++...+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL----SENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE----cCCCcEEEEecccccccccCcchhhcCC
Confidence 01236778889999999999999999999999999999999 6677899999999986543222222222
Q ss_pred eeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCC
Q 011808 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLAN 278 (477)
Q Consensus 200 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 278 (477)
..++..|+|||++.+. .++.++|||||||++|+|++ |..||...... ..+.. .+.....
T Consensus 241 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~---~~~~~~~-------- 300 (343)
T cd05103 241 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCR---RLKEGTR-------- 300 (343)
T ss_pred CCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--------HHHHH---HHhccCC--------
Confidence 3346779999999764 48999999999999999997 99999754310 11111 1110000
Q ss_pred CccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 279 LPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
...+...++.+.+++.+||+.||.+|||+.++++|
T Consensus 301 ----------------------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 301 ----------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01122235678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=305.70 Aligned_cols=266 Identities=23% Similarity=0.364 Sum_probs=195.2
Q ss_pred cceeEEeeecccCceEEEEEEEec-------------ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKA-------------AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~-------------~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 92 (477)
++|++.+.||+|+||.||++++.. ...+...+|+|++..... ......+.+|+.+++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999986532 112345799999875432 223456788999999999999999
Q ss_pred EEEEEEcCCCceEEEEEeccC-CCHHHHHHhhhcc------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcE
Q 011808 93 LVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDK------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNI 165 (477)
Q Consensus 93 l~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NI 165 (477)
+++++.... ..+++|||+. ++|.+++...... ....+++..+..++.||+.||+|||++||+||||||+||
T Consensus 84 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999986644 6899999987 6888888764321 112477888999999999999999999999999999999
Q ss_pred EEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 011808 166 LVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT--LKPLFQG 243 (477)
Q Consensus 166 Ll~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt--G~~PF~~ 243 (477)
|+ +.++.++|+|||+++.+.............++..|+|||++.+. .++.++|||||||++|||++ |..||..
T Consensus 162 li----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 162 LV----GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EE----cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99 66778999999999865433222112223346789999988764 48999999999999999998 7788865
Q ss_pred cccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCC
Q 011808 244 AEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323 (477)
Q Consensus 244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP 323 (477)
.+... .+........... .......+..++..+.+||.+||+.||
T Consensus 237 ~~~~~--------~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~li~~cl~~~p 281 (296)
T cd05095 237 LSDEQ--------VIENTGEFFRDQG---------------------------RQVYLPKPALCPDSLYKLMLSCWRRNA 281 (296)
T ss_pred cChHH--------HHHHHHHHHhhcc---------------------------ccccCCCCCCCCHHHHHHHHHHcCCCc
Confidence 44211 1111111000000 000011223345788999999999999
Q ss_pred CCCCCHHHHhc
Q 011808 324 RKRITAAQALE 334 (477)
Q Consensus 324 ~~Rpt~~e~L~ 334 (477)
.+||++.++++
T Consensus 282 ~~Rp~~~~i~~ 292 (296)
T cd05095 282 KERPSFQEIHA 292 (296)
T ss_pred ccCCCHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=321.71 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=199.6
Q ss_pred CccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 011808 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHI 98 (477)
Q Consensus 20 ~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 98 (477)
....+.+.|++...+|.|+|+.|-.+.+.. ++...++|++...... .-+|+.++... +||||+++.+++.
T Consensus 316 ~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~---t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 316 VTAPFTESYEFREELGEGSFSAVKYCESSP---TDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred ccCCcchhhccccccCCCCccceeeeeccc---cccchhheeccccccc------cccccchhhhhcCCCcceeecceec
Confidence 345688999999999999999999997664 6788999999876221 22567665555 8999999999986
Q ss_pred cCCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccE
Q 011808 99 NHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVV 177 (477)
Q Consensus 99 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~v 177 (477)
+ ....|+|||.+.| .+++.+... +....++..|+++|+.|+.|||++|||||||||+|||+. ++.+++
T Consensus 387 ~--~~~~~~v~e~l~g~ell~ri~~~------~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~---~~~g~l 455 (612)
T KOG0603|consen 387 D--GKEIYLVMELLDGGELLRRIRSK------PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD---GSAGHL 455 (612)
T ss_pred C--CceeeeeehhccccHHHHHHHhc------chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec---CCCCcE
Confidence 5 4589999999985 555655543 233367888999999999999999999999999999994 366789
Q ss_pred EEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 178 KIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
+|+|||.++..... ....+-|..|.|||++.. ..|+.++||||||++||+||+|+.||......
T Consensus 456 rltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---------- 519 (612)
T KOG0603|consen 456 RLTYFGFWSELERS-----CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---------- 519 (612)
T ss_pred EEEEechhhhCchh-----hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch----------
Confidence 99999999866543 223455889999999985 55999999999999999999999999866531
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
..+...++.+. +...+|++++|||.+||+.||.+|+++.+++.|+|
T Consensus 520 -~ei~~~i~~~~---------------------------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 520 -IEIHTRIQMPK---------------------------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred -HHHHHhhcCCc---------------------------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 23333333221 12456889999999999999999999999999999
Q ss_pred C
Q 011808 338 F 338 (477)
Q Consensus 338 f 338 (477)
|
T Consensus 566 ~ 566 (612)
T KOG0603|consen 566 F 566 (612)
T ss_pred h
Confidence 9
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=340.65 Aligned_cols=264 Identities=30% Similarity=0.464 Sum_probs=200.1
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC--
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH-- 100 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 100 (477)
.++.+|+.++.||+||||.||+|+++. +|+.||||++.... ......++.+|+.+|.+|+|||||+++..+...
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKl---DGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKL---DGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecc---cchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 467888999999999999999999886 59999999998876 566677889999999999999999998543100
Q ss_pred ----------------------------------------------------C---------------------------
Q 011808 101 ----------------------------------------------------A--------------------------- 101 (477)
Q Consensus 101 ----------------------------------------------------~--------------------------- 101 (477)
.
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence 0
Q ss_pred ----------------------------C--------ceEEEEEeccCCCHHHHHHhhhcccCCCC-CHHHHHHHHHHHH
Q 011808 102 ----------------------------D--------MSLYLAFDYAEYDLYEIIRHHRDKVNHTM-NPYTVKSILWQLL 144 (477)
Q Consensus 102 ----------------------------~--------~~~~lv~e~~~~~L~~~l~~~~~~~~~~l-~~~~~~~i~~qil 144 (477)
+ ..+||-||||+.+++..+.... ... ....++++|++|+
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDEAWRLFREIL 707 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHHHHHHHHHHH
Confidence 0 3478999999976665554432 122 4678999999999
Q ss_pred HHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeec----C------------CCCcccCCCeeecccccc
Q 011808 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ----A------------PLKFLSENGVVVTIWYRA 208 (477)
Q Consensus 145 ~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~----~------------~~~~~~~~~~~gt~~y~A 208 (477)
+||.|+|++|||||||||.||+| +++..|||+|||+|.... . .......++.+||..|+|
T Consensus 708 EGLaYIH~~giIHRDLKP~NIFL----d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 708 EGLAYIHDQGIIHRDLKPRNIFL----DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHhCceeeccCCcceeEE----cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 99999999999999999999999 788889999999997621 0 011113456789999999
Q ss_pred chhhcCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccc
Q 011808 209 PELLLGAK--HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDS 286 (477)
Q Consensus 209 PE~l~~~~--~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (477)
||++.+.. .|+.|+|+|||||++|||+. ||....+ . ..+...+..+.-+.-+++.
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME----------R-a~iL~~LR~g~iP~~~~f~--------- 840 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME----------R-ASILTNLRKGSIPEPADFF--------- 840 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH----------H-HHHHHhcccCCCCCCcccc---------
Confidence 99998766 69999999999999999985 5764321 1 1122223222111101100
Q ss_pred cccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 287 LHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 287 ~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
..--+.-..+|++||+.||.+||||.|+|.+.||.
T Consensus 841 ------------------~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 841 ------------------DPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred ------------------cccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 00113355899999999999999999999999996
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=303.18 Aligned_cols=256 Identities=27% Similarity=0.491 Sum_probs=199.2
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
.+|...+.||+|++|.||++.+.. ++..++||++..... .....+.+|+.+++.++|+||+++++++.... ..
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~--~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKS---TGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD--EL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECC---CCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCC--eE
Confidence 356667899999999999998653 578899998864322 22346778999999999999999999987643 78
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
++++||+. ++|.+++.. ..+++..+..++.||+.||+|||++||+||||+|+||++ +.++.++|+|||+
T Consensus 92 ~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~~l~d~g~ 161 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL----TSDGRVKLSDFGF 161 (285)
T ss_pred EEEEeccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE----cCCCcEEEccccc
Confidence 99999997 588777765 258899999999999999999999999999999999999 6677899999998
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+........ ......+++.|+|||++.+. .++.++|||||||++|+|++|..||...+. ...+..+...
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~~~~ 230 (285)
T cd06648 162 CAQVSKEVP--RRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRIRDN 230 (285)
T ss_pred chhhccCCc--ccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHhc
Confidence 875433211 12234578999999999774 488999999999999999999999975431 1112111110
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
.+... ..+...+..+.+||.+||..||.+|||+.++++|+||+..
T Consensus 231 ----~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 231 ----LPPKL----------------------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred ----CCCCC----------------------------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 00000 0112245679999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.52 Aligned_cols=262 Identities=22% Similarity=0.381 Sum_probs=199.3
Q ss_pred ccceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 101 (477)
.++|.+.+.||+|+||.||+|+++. ....+..||||+++..... .....+.+|+.+|.++. ||||+++++++....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 4578899999999999999998753 2234568999999764322 23346788999999997 999999999987644
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcc------------------------------------------------------
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDK------------------------------------------------------ 126 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~------------------------------------------------------ 126 (477)
.+++||||+. |+|.+++......
T Consensus 115 --~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 115 --PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred --CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 6899999998 6998888654210
Q ss_pred ---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEE
Q 011808 127 ---------------------------------------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILV 167 (477)
Q Consensus 127 ---------------------------------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl 167 (477)
....+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 01246777889999999999999999999999999999999
Q ss_pred eccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 011808 168 MGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEA 246 (477)
Q Consensus 168 ~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~ 246 (477)
++.+.+||+|||+++.+.............++..|+|||++.+. .++.++|||||||++|||++ |..||.....
T Consensus 273 ----~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 273 ----CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ----eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 56678999999999865432222222334567889999999774 48899999999999999998 8899965431
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
.+.+.. .+... .....+..++..+.+||.+||..||.+|
T Consensus 348 --------~~~~~~---~~~~~------------------------------~~~~~p~~~~~~l~~li~~cl~~~P~~R 386 (401)
T cd05107 348 --------NEQFYN---AIKRG------------------------------YRMAKPAHASDEIYEIMQKCWEEKFEIR 386 (401)
T ss_pred --------hHHHHH---HHHcC------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhHC
Confidence 111111 11100 0011233456789999999999999999
Q ss_pred CCHHHHhcC
Q 011808 327 ITAAQALEH 335 (477)
Q Consensus 327 pt~~e~L~h 335 (477)
|++++++..
T Consensus 387 Ps~~ell~~ 395 (401)
T cd05107 387 PDFSQLVHL 395 (401)
T ss_pred cCHHHHHHH
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=299.33 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=192.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.++||+|+||.||+|.+.. ...|+||+++.... ....+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----CceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC---CC
Confidence 4689999999999999999997643 34699999875332 23467889999999999999999998643 35
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.|++|||+. ++|.+++.... ...+++..+..++.|++.||.|||+.+|+||||||+||++ +.++.++|+|||
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill----~~~~~~~L~dfg 147 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV----GENLVCKVADFG 147 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE----cCCCcEEeccCC
Confidence 799999998 58888887542 2357889999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
.+..+...... ......++..|+|||++.+. .++.++|||||||++|+|++ |..||.+... ......+.
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~~ 217 (262)
T cd05071 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVE 217 (262)
T ss_pred ceeeccccccc-cccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHHh
Confidence 99866433221 12223456789999998764 48999999999999999999 8899975432 11111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
. ... ...+...+..+.+||.+||++||++||+++++++
T Consensus 218 ~----~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 218 R----GYR------------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred c----CCC------------------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0 000 0012234567899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=309.08 Aligned_cols=257 Identities=27% Similarity=0.481 Sum_probs=201.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
...|...+.||+|+||.||+|+++. ++..++||.+..... .......+.+|+.+++.++|+|++++++++... .
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--H 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcC---CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--C
Confidence 4568899999999999999998764 578899999865322 222344677899999999999999999998764 3
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
..++||||+.+++.+.+... ...+++..+..++.|++.||.|||+++++||||||+|||+ +.++.++|+|||
T Consensus 89 ~~~lv~e~~~~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~----~~~~~~kl~dfg 160 (308)
T cd06634 89 TAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL----SEPGLVKLGDFG 160 (308)
T ss_pred eeEEEEEccCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE----CCCCcEEECCcc
Confidence 78999999999988877653 2358899999999999999999999999999999999999 666789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
++...... ....++..|+|||++.+ ...++.++|||||||++|+|++|..||...+. ... +
T Consensus 161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~---~ 223 (308)
T cd06634 161 SASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSA---L 223 (308)
T ss_pred cceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH--------HHH---H
Confidence 98765432 23456889999999853 23478899999999999999999999865331 111 1
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
........+ .......+..+.+||++||..+|.+||++.+++.|+|+...
T Consensus 224 ~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 224 YHIAQNESP------------------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHhhcCCC------------------------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 111110000 01122345678999999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=310.03 Aligned_cols=279 Identities=22% Similarity=0.291 Sum_probs=192.2
Q ss_pred CceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEeccC-CCH
Q 011808 38 TYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAE-YDL 116 (477)
Q Consensus 38 ~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~-~~L 116 (477)
+++.||+++.+. ++..||||+++...........+.+|+.+++.++|+||+++++++.... ..|++|||+. ++|
T Consensus 12 ~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~--~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKP---TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS--ELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecC---CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC--eEEEEEeccCCCCH
Confidence 445566665443 6889999999876444445567889999999999999999999987644 6899999998 577
Q ss_pred HHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCc--
Q 011808 117 YEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKF-- 194 (477)
Q Consensus 117 ~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~-- 194 (477)
.+++.... ...+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||.+..+......
T Consensus 87 ~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili----~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 87 EDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL----SGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE----ecCCceEEecCccceeecccccccc
Confidence 77777543 3368899999999999999999999999999999999999 66678999999998755322110
Q ss_pred ---ccCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCC
Q 011808 195 ---LSENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTP 270 (477)
Q Consensus 195 ---~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 270 (477)
.......++..|+|||++.+. ..++.++|+|||||++|+|++|+.||...... ...+.. +....+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-------~~~~~~----~~~~~~ 228 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-------QMLLEK----VRGTVP 228 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHH----HhccCc
Confidence 011223457789999999763 34888999999999999999999999754321 111111 111111
Q ss_pred CCccccCCCcccccccccc---ccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 271 EKWPTLANLPHWQSDSLHI---QGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
..+.. ...+......... ..................+..+.+||.+||.+||++|||+.++|+||||+.
T Consensus 229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 229 CLLDK-STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred ccccc-CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 10000 0000000000000 000000001111122233467889999999999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=297.62 Aligned_cols=256 Identities=29% Similarity=0.510 Sum_probs=199.2
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++.+.||+|+||.||+|.+.. ++..|++|.++...... .....+.+|+.++++++|+||+++++++... ..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--Ce
Confidence 689999999999999999998763 68899999987543332 2355778899999999999999999998764 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+++|||+. ++|.+++.... .....+++..++.++.+|+.||.|||+.||+|+||||+||++ +.++.++|+|||
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~----~~~~~~~l~d~~ 151 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI----TATGVVKLGDLG 151 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE----CCCCcEEEeccc
Confidence 899999998 58888886532 223468999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++..+..... ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..... ....+..
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~~~~~~~ 218 (267)
T cd08224 152 LGRFFSSKTT--AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKM----------NLYSLCK 218 (267)
T ss_pred eeeeccCCCc--ccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCc----------cHHHHHh
Confidence 9876543221 12234568899999999764 488999999999999999999999965431 1111111
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCC-CCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPL-SPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~-~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.+..... ...+. ..+..+.++|.+||..||.+|||+.++++
T Consensus 219 ~~~~~~~------------------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 219 KIEKCDY------------------------------PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred hhhcCCC------------------------------CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1110000 00111 33567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=307.08 Aligned_cols=261 Identities=27% Similarity=0.427 Sum_probs=199.6
Q ss_pred ccceeEEeeecccCceEEEEEEEec----ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA----AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHIN 99 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 99 (477)
..+|.+.+.||+|+||.||+|++.. ....+..|++|.+..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 5789999999999999999997542 223456799999875432 23345778899999999 89999999999866
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRDK-----------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILV 167 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl 167 (477)
. ..+|++|||+. ++|.+++...... ....++...+..++.||+.||.|||++||+||||||+|||+
T Consensus 93 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 93 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred C--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 4 37899999998 5888888764311 12357788899999999999999999999999999999999
Q ss_pred eccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 011808 168 MGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEA 246 (477)
Q Consensus 168 ~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~ 246 (477)
+.++.+||+|||+++.+.............++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus 171 ----~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 171 ----TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ----cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 66678999999999876443222222223346789999999774 48999999999999999998 7888865431
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
..+...+..... ...+..++..+.+||.+||..+|.+|
T Consensus 246 ------------~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~cl~~~p~~R 283 (304)
T cd05101 246 ------------EELFKLLKEGHR------------------------------MDKPANCTNELYMMMRDCWHAIPSHR 283 (304)
T ss_pred ------------HHHHHHHHcCCc------------------------------CCCCCCCCHHHHHHHHHHcccChhhC
Confidence 122222211100 01233456789999999999999999
Q ss_pred CCHHHHhcC
Q 011808 327 ITAAQALEH 335 (477)
Q Consensus 327 pt~~e~L~h 335 (477)
||+.+++..
T Consensus 284 ps~~e~l~~ 292 (304)
T cd05101 284 PTFKQLVED 292 (304)
T ss_pred CCHHHHHHH
Confidence 999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=302.89 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=196.4
Q ss_pred cceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.+|.+.++||+|+||.||++.... ...++..+++|.+.... ......+.+|+++++.++|+||+++++++.+. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEG--R 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--C
Confidence 578899999999999999997542 22356689999876432 22345677899999999999999999988664 3
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcc----------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCC
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDK----------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE 172 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~ 172 (477)
..+++|||+. ++|.+++...... ....+++..++.++.||+.||.|||+.||+||||||+|||+ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~----~ 156 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV----G 156 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE----c
Confidence 6899999987 6888888764310 11357889999999999999999999999999999999999 6
Q ss_pred CcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCC
Q 011808 173 EQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQN 251 (477)
Q Consensus 173 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~ 251 (477)
+++.+||+|||++................+++.|+|||++.+. .++.++|||||||++|+|++ |.+||.....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 230 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSN----- 230 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCH-----
Confidence 6778999999999765432221122233446789999999774 48999999999999999998 9999965431
Q ss_pred cccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHH
Q 011808 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ 331 (477)
Q Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e 331 (477)
.+.+..+.. .. ....+..+++.+.+||.+||+.||.+||++.+
T Consensus 231 ---~~~~~~~~~----~~------------------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 273 (280)
T cd05092 231 ---TEAIECITQ----GR------------------------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKD 273 (280)
T ss_pred ---HHHHHHHHc----Cc------------------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 111211111 00 00122344678999999999999999999999
Q ss_pred Hhc
Q 011808 332 ALE 334 (477)
Q Consensus 332 ~L~ 334 (477)
++.
T Consensus 274 l~~ 276 (280)
T cd05092 274 IHS 276 (280)
T ss_pred HHH
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=299.31 Aligned_cols=249 Identities=22% Similarity=0.391 Sum_probs=193.4
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
.+|++.+.||+|+||.||+++++ .+..+++|.+..... ....+.+|+.+++.++|+||+++++++... ..+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 74 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR----GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPI 74 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec----CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--Cce
Confidence 46899999999999999999764 356799999864332 234677899999999999999999988654 378
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|++|||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i----~~~~~~kl~dfg~ 146 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV----GEDNVVKVSDFGL 146 (256)
T ss_pred EEEEecCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE----CCCCcEEECCccc
Confidence 99999997 58888886542 268899999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++........ ......++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+.. +....+.
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~- 215 (256)
T cd05059 147 ARYVLDDQYT-SSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------EVVESVS- 215 (256)
T ss_pred ceeccccccc-ccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------HHHHHHH-
Confidence 9765432211 11112234579999999874 48999999999999999999 89999754321 1111111
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.. .....+...+..+.+||.+||..+|++|||+.++++.
T Consensus 216 ---~~------------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 216 ---AG------------------------------YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ---cC------------------------------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00 0011233456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=301.79 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=199.4
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
+-|++++.||+|+||.||+|.+.. ++..+|||.+...... .....+.+|+.++++++|+||+++++++... ..+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~---~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 77 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKL 77 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECC---CCcEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeE
Confidence 347889999999999999997653 5789999998654332 2345677899999999999999999998764 378
Q ss_pred EEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|+||||+++ +|.+++.. ..+++..+..++.|++.+|.|||+.|++|+||||+||++ +.++.++|+|||+
T Consensus 78 ~lv~e~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i----~~~~~~~l~dfg~ 147 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL----SEHGEVKLADFGV 147 (277)
T ss_pred EEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE----CCCCCEEEeeccc
Confidence 999999984 77777653 358899999999999999999999999999999999999 6667899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+..+..... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||..... .... ..
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~----~~ 212 (277)
T cd06641 148 AGQLTDTQI--KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVL----FL 212 (277)
T ss_pred ceecccchh--hhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHH----HH
Confidence 876543221 12234568899999998764 478899999999999999999999964331 1111 11
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+..... ...+...+.++.++|.+||..||.+||++.+++.|+||..
T Consensus 213 ~~~~~~------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 213 IPKNNP------------------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred HhcCCC------------------------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 110000 0012234567899999999999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=302.25 Aligned_cols=253 Identities=31% Similarity=0.513 Sum_probs=192.4
Q ss_pred eEEeeecccCceEEEEEEEe-cccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEE
Q 011808 29 NLIGKIGEGTYGLVFLARIK-AAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYL 107 (477)
Q Consensus 29 ~i~~~lG~G~~g~Vy~a~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~l 107 (477)
.+.+.||.|.||.||+|.++ .....+..|+||.++... .......+.+|++++++++||||+++++++.... .+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-ccccceeeeecccccccccccccccccccccccc--cccc
Confidence 57889999999999999988 445567889999996532 2223568889999999999999999999998433 4899
Q ss_pred EEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 108 AFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 108 v~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
|+||+. ++|.+++.... ...+++..+..|+.||+.||.|||+++|+|+||+++|||+ ++++.+||+|||++.
T Consensus 79 v~e~~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill----~~~~~~Kl~~f~~~~ 151 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL----DSNGQVKLSDFGLSR 151 (259)
T ss_dssp EEE--TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE----ETTTEEEEESTTTGE
T ss_pred cccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc----ccccccccccccccc
Confidence 999998 68999998752 2468999999999999999999999999999999999999 667789999999998
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
...................|+|||++.+.. ++.++||||||+++|||++ |+.||...+. .+....+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~~- 221 (259)
T PF07714_consen 152 PISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQG- 221 (259)
T ss_dssp ETTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHTT-
T ss_pred cccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccc--------cccccccccc-
Confidence 763322222233344578899999997744 8999999999999999999 7899865431 1212222110
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.....+..++..+.++|.+||..||.+|||+.++++
T Consensus 222 ---------------------------------~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 222 ---------------------------------QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---------------------------------EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---------------------------------ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 001133445678999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=300.57 Aligned_cols=256 Identities=23% Similarity=0.368 Sum_probs=196.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||+|.++.....+..+|+|.++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--KP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--Cc
Confidence 4689999999999999999998765444556899999875432 22345678899999999999999999998654 37
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|++|||+. ++|.+++... ...+++.++..++.||+.||.|||++|++||||||+|||+ +.++.++|+|||
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili----~~~~~~~l~dfg 151 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV----NSNLVCKVSDFG 151 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE----CCCCeEEeCCCC
Confidence 899999997 5788887653 2358899999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
++..+....... ......++..|+|||++.+. .++.++|+|||||++|++++ |..||...+. .+....+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~ 222 (267)
T cd05066 152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QDVIKAI 222 (267)
T ss_pred cccccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HHHHHHH
Confidence 998664322111 11112225679999999774 48999999999999999886 9999975442 1111111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.+.. . ...+...+..+.+||.+||+++|.+||++.++++
T Consensus 223 ~~~~--~--------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 223 EEGY--R--------------------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred hCCC--c--------------------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 1100 0 0112234567899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=301.58 Aligned_cols=256 Identities=29% Similarity=0.511 Sum_probs=193.7
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEeccc---CCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQ---SKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+|.+.+.||+|+||.||++++... +..+++|+++. ..........+..|+.+++.++||||+++++++.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA---VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC---CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--
Confidence 699999999999999999987643 34444554443 2222233345667999999999999999999886543
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..+++|||+. ++|.+++..... ....+++..++.++.|++.||.|||+.|++|+||||+||++. . +.++|+||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~-~~~~l~d~ 149 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----N-NLLKIGDF 149 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----c-CCEeeccc
Confidence 6899999998 477777765332 245789999999999999999999999999999999999993 2 35999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||..... . ..+.
T Consensus 150 g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~---~~~~ 215 (260)
T cd08222 150 GVSRLLMGSCD--LATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------L---SVVL 215 (260)
T ss_pred CceeecCCCcc--cccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------H---HHHH
Confidence 99976643222 11224468899999998763 478899999999999999999999964331 1 1111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.......+ ..+...+.++.+||.+||..||++||++.+++.||||
T Consensus 216 ~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 216 RIVEGPTP-------------------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHcCCCC-------------------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 11111110 1223345688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=307.49 Aligned_cols=261 Identities=29% Similarity=0.432 Sum_probs=196.8
Q ss_pred ccceeEEeeecccCceEEEEEEEec----ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA----AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHIN 99 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 99 (477)
.++|.+.+.||+|+||.||+|++.. .......+|+|.++.... ......+.+|+.+++.+ +||||+++++++.+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4689999999999999999997632 123456799999875432 22345677899999999 69999999999865
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhc-----------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRD-----------KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILV 167 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl 167 (477)
. ..+|++|||+. ++|.+++..... .....++..++..++.||+.||.|||++||+||||||+|||+
T Consensus 90 ~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 90 E--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred C--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 4 46899999997 688888876431 112458888999999999999999999999999999999999
Q ss_pred eccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 011808 168 MGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEA 246 (477)
Q Consensus 168 ~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~ 246 (477)
+.++.+||+|||+++...............++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 168 ----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 168 ----TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred ----cCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 6667899999999986543211111111223567999999977 458999999999999999999 8999965431
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
..++..+..... ...+..++.++.+||.+||..||.+|
T Consensus 243 ------------~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~cl~~~p~~R 280 (314)
T cd05099 243 ------------EELFKLLREGHR------------------------------MDKPSNCTHELYMLMRECWHAVPTQR 280 (314)
T ss_pred ------------HHHHHHHHcCCC------------------------------CCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 112222111100 01233445689999999999999999
Q ss_pred CCHHHHhcC
Q 011808 327 ITAAQALEH 335 (477)
Q Consensus 327 pt~~e~L~h 335 (477)
||+.++++.
T Consensus 281 ps~~~ll~~ 289 (314)
T cd05099 281 PTFKQLVEA 289 (314)
T ss_pred cCHHHHHHH
Confidence 999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=305.00 Aligned_cols=266 Identities=23% Similarity=0.345 Sum_probs=193.1
Q ss_pred cceeEEeeecccCceEEEEEEEeccc-----------CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAA-----------NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLV 94 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 94 (477)
++|++.++||+|+||.||+|++.... .....||+|.++.... ......+.+|++++++++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 58999999999999999999764321 1234689999875432 22334677899999999999999999
Q ss_pred EEEEcCCCceEEEEEeccC-CCHHHHHHhhhcc-------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEE
Q 011808 95 NVHINHADMSLYLAFDYAE-YDLYEIIRHHRDK-------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNIL 166 (477)
Q Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NIL 166 (477)
+++... ..+++||||+. ++|.+++...... ....+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 84 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 998654 46899999998 5888877543210 0113678889999999999999999999999999999999
Q ss_pred EeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCc
Q 011808 167 VMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT--LKPLFQGA 244 (477)
Q Consensus 167 l~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt--G~~PF~~~ 244 (477)
+ +.++.+||+|||++..+.............++..|+|||++.+.. ++.++|||||||++|+|++ +..||...
T Consensus 162 l----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 162 V----GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred E----cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 9 566779999999997654322221222233467899999987744 8999999999999999998 66788654
Q ss_pred ccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCC
Q 011808 245 EAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324 (477)
Q Consensus 245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~ 324 (477)
+. .+.+..+.......... .....+...+..+.+||.+||..||.
T Consensus 237 ~~--------~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~~l~~~p~ 281 (295)
T cd05097 237 SD--------EQVIENTGEFFRNQGRQ---------------------------IYLSQTPLCPSPVFKLMMRCWSRDIK 281 (295)
T ss_pred Ch--------HHHHHHHHHhhhhcccc---------------------------ccCCCCCCCCHHHHHHHHHHcCCCch
Confidence 32 11111111111000000 00011223457899999999999999
Q ss_pred CCCCHHHHhc
Q 011808 325 KRITAAQALE 334 (477)
Q Consensus 325 ~Rpt~~e~L~ 334 (477)
+|||++++++
T Consensus 282 ~RPs~~~i~~ 291 (295)
T cd05097 282 DRPTFNKIHH 291 (295)
T ss_pred hCcCHHHHHH
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=304.02 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=198.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecc--cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAA--ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
..+|.+.+.||+|+||.||+|.+... ..+...+++|.+..... .....+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQHEHIVKFYGVCGDG-- 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH--HHHHHHHHHHHHHhcCCCCCcceEEEEEccC--
Confidence 35799999999999999999976432 23456788998864332 2234677899999999999999999998654
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhc-----------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRD-----------KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~ 170 (477)
..+++||||+. ++|.+++..+.. .....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~--- 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV--- 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---
Confidence 47899999997 688888876431 112358899999999999999999999999999999999999
Q ss_pred CCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccC
Q 011808 171 GEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKST 249 (477)
Q Consensus 171 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~ 249 (477)
+.++.++|+|||++................++..|+|||++.+. .++.++|||||||++|+|++ |..||.....
T Consensus 157 -~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~--- 231 (291)
T cd05094 157 -GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSN--- 231 (291)
T ss_pred -ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 66778999999999765443222222334457889999999874 48899999999999999999 9999965432
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
.+ +...+...... ..+...+..+.+||.+||+.||.+|||+
T Consensus 232 -----~~----~~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 272 (291)
T cd05094 232 -----TE----VIECITQGRVL------------------------------ERPRVCPKEVYDIMLGCWQREPQQRLNI 272 (291)
T ss_pred -----HH----HHHHHhCCCCC------------------------------CCCccCCHHHHHHHHHHcccChhhCcCH
Confidence 11 11111111000 0122235678999999999999999999
Q ss_pred HHHhcC
Q 011808 330 AQALEH 335 (477)
Q Consensus 330 ~e~L~h 335 (477)
.++++.
T Consensus 273 ~~v~~~ 278 (291)
T cd05094 273 KEIYKI 278 (291)
T ss_pred HHHHHH
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=308.13 Aligned_cols=258 Identities=28% Similarity=0.404 Sum_probs=193.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 103 (477)
+++|++.+.||+|+||.||+|.++.+ .....+++|.++... .......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~-~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~ 81 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--G 81 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccC-CceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--C
Confidence 46899999999999999999987642 122356777765432 222334667899999999 899999999998654 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDK-----------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~ 171 (477)
.+|++|||+. ++|.+++...... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---- 157 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---- 157 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe----
Confidence 7899999997 6888888654311 12357899999999999999999999999999999999999
Q ss_pred CCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCC
Q 011808 172 EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQ 250 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~ 250 (477)
+.++.+||+|||++....... ......++..|+|||++.+. .++.++|||||||++|+|+| |..||.+.+.
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~---- 229 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---- 229 (303)
T ss_pred cCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCCh----
Confidence 667789999999986432111 11112235679999998764 48899999999999999998 9999975442
Q ss_pred CcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHH
Q 011808 251 NPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA 330 (477)
Q Consensus 251 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~ 330 (477)
.+ ++..+... .....+...+.++.+||.+||+.||++||+++
T Consensus 230 ----~~----~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 271 (303)
T cd05088 230 ----AE----LYEKLPQG------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 271 (303)
T ss_pred ----HH----HHHHHhcC------------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 11 11111000 00011223457789999999999999999999
Q ss_pred HHhcCc
Q 011808 331 QALEHE 336 (477)
Q Consensus 331 e~L~h~ 336 (477)
+++.+-
T Consensus 272 ~il~~l 277 (303)
T cd05088 272 QILVSL 277 (303)
T ss_pred HHHHHH
Confidence 999873
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=301.35 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=197.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
..+|++.++||.|+||.||+|+++. +..+++|++..... .....+.+|+.+++.++|+||+++++++.+.. .
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~----~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~ 76 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN----RVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGE--P 76 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC----CCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCC--C
Confidence 3579999999999999999998653 77899999876432 22456778999999999999999999886644 6
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
++++|||+. ++|.+++.... ...+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv----~~~~~~kl~d~g 149 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV----GEDLVCKVADFG 149 (261)
T ss_pred eEEEEeecccCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE----cCCceEEEcccc
Confidence 899999998 59999887643 3468899999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++......... .....++..|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+. .+.+..+.
T Consensus 150 ~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~ 218 (261)
T cd05148 150 LARLIKEDVYL--SSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQIT 218 (261)
T ss_pred chhhcCCcccc--ccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHH
Confidence 99765432211 1123346789999998764 58899999999999999998 8999975541 12222221
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.. .....+...+..+.++|.+||+.||.+|||+.++++
T Consensus 219 ~~----------------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 219 AG----------------------------------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred hC----------------------------------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 10 001123344678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=299.04 Aligned_cols=257 Identities=21% Similarity=0.318 Sum_probs=187.5
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEec
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
+.||+|+||.||+|.+.. ..++..+++|.++..... .....+.+|+.++++++||||+++++++.+. ..+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS-GYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcC-CCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEEC
Confidence 469999999999997653 345678999988765432 2234677899999999999999999988654 367999999
Q ss_pred cC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 112 AE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 112 ~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
+. ++|.+++...........++..+..++.|++.||.|||+++++||||||+||++ +.++.+||+|||++.....
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~----~~~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL----TADLTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE----cCCCcEEECCccccccccC
Confidence 98 688888876443223346677888999999999999999999999999999999 6677899999999875433
Q ss_pred CCCcccCCCeeeccccccchhhcCCC------CCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 191 PLKFLSENGVVVTIWYRAPELLLGAK------HYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 191 ~~~~~~~~~~~gt~~y~APE~l~~~~------~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
...........++..|+|||++.+.. .++.++|||||||++|||++ |..||..... .+.......
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~ 224 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--------EQVLTYTVR 224 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHhh
Confidence 22222233345678899999986421 25789999999999999996 9999965431 111111110
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
... ..++ ........+..+.++|.+|+ .||++|||+++++.
T Consensus 225 --~~~--~~~~-------------------------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 225 --EQQ--LKLP-------------------------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --ccc--CCCC-------------------------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000 0000 00011233567889999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=297.57 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=194.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
-++|+++++||+|+||.||+|..+ ++..||+|.+..... ....+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~----~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 74 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN----GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EP 74 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC----CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CC
Confidence 467999999999999999999754 467899999875433 23577889999999999999999998643 35
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+++|||+. ++|.+++.... +..+++.++..++.|++.||+|||+.|++||||||+||++ +.++.++|+|||
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i----~~~~~~~l~dfg 147 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV----SETLCCKIADFG 147 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE----cCCCCEEEccCc
Confidence 799999987 68888876533 3468899999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++........ .......++..|+|||++.+. .++.++|||||||++|+|++ |++||.+.+. .+....+.
T Consensus 148 ~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~ 217 (260)
T cd05067 148 LARLIEDNEY-TAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------PEVIQNLE 217 (260)
T ss_pred ceeecCCCCc-ccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHH
Confidence 9976653221 111223346789999998764 48889999999999999999 9999976542 11111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
. .. ....+...+.++.+||.+||+.||++|||++++++
T Consensus 218 ~----~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 218 R----GY------------------------------RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred c----CC------------------------------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 00 00112334567999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=309.58 Aligned_cols=262 Identities=27% Similarity=0.422 Sum_probs=197.9
Q ss_pred ccceeEEeeecccCceEEEEEEEeccc----CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAA----NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHIN 99 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 99 (477)
..+|.+.+.||+|+||.||+|++.... .....||+|.++... .......+.+|+.+++++ +|+||+++++++..
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 357999999999999999999864321 223478999887532 223345778899999999 89999999999865
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhc-----------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRD-----------KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILV 167 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl 167 (477)
. ..+|++|||+. ++|.+++..... .....++...+..++.||+.||.|||++||+||||||+|||+
T Consensus 90 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 90 D--GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred C--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 4 37899999997 588888876321 112357788899999999999999999999999999999999
Q ss_pred eccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 011808 168 MGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEA 246 (477)
Q Consensus 168 ~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~ 246 (477)
+.++.+||+|||+++...............++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+.
T Consensus 168 ----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 168 ----TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred ----cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 66678999999999865432221112222335679999999774 48899999999999999998 8899975441
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
..++..+..... ...+...+..+.+||.+||+.+|.+|
T Consensus 243 ------------~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~cl~~~p~~R 280 (334)
T cd05100 243 ------------EELFKLLKEGHR------------------------------MDKPANCTHELYMIMRECWHAVPSQR 280 (334)
T ss_pred ------------HHHHHHHHcCCC------------------------------CCCCCCCCHHHHHHHHHHcccChhhC
Confidence 112222211100 01223445679999999999999999
Q ss_pred CCHHHHhcCc
Q 011808 327 ITAAQALEHE 336 (477)
Q Consensus 327 pt~~e~L~h~ 336 (477)
||+.+++.+-
T Consensus 281 ps~~ell~~l 290 (334)
T cd05100 281 PTFKQLVEDL 290 (334)
T ss_pred cCHHHHHHHH
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=291.89 Aligned_cols=252 Identities=33% Similarity=0.531 Sum_probs=200.8
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|++.+.||+|++|.||++.+.. ++..+++|++..... .....+.+|+.+++.++|+||+++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---CCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEE
Confidence 58999999999999999998653 578999999976543 2445778899999999999999999998765 4789
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
+++||++ ++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+
T Consensus 74 l~~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i----~~~~~~~l~d~~~~ 145 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL----TSDGEVKLIDFGLS 145 (253)
T ss_pred EEEecCCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE----ccCCeEEEeecccc
Confidence 9999999 68877776532 468999999999999999999999999999999999999 66778999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+. ...+....
T Consensus 146 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~ 210 (253)
T cd05122 146 AQLSDTKA---RNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPP-----------MKALFKIA 210 (253)
T ss_pred cccccccc---ccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCch-----------HHHHHHHH
Confidence 87654321 23355688999999997744 88899999999999999999999975431 11111111
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
.... ... ..+...+..+.+||.+||..||.+|||+.++|.|||
T Consensus 211 ~~~~-~~~----------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 211 TNGP-PGL----------------------------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred hcCC-CCc----------------------------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 1000 000 001112567899999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=296.31 Aligned_cols=250 Identities=25% Similarity=0.419 Sum_probs=195.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|.+.++||+|+||.||+|.++ .+..++||.+..... ....+.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~----~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN----GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EP 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc----CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecC--Cc
Confidence 578999999999999999999754 356799999875433 235778899999999999999999988653 46
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
++++|||+. ++|.+++.... ...+++..+..++.||+.||.|||++||+|+||||+||++ +.++.+||+|||
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili----~~~~~~~l~d~g 148 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV----GENLVCKIADFG 148 (261)
T ss_pred eEEEEeccCCCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE----cCCCCEEECccc
Confidence 899999987 58888887643 3468999999999999999999999999999999999999 667889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++..+..... ........+..|+|||.+.+. .++.++|+|||||++|+|++ |+.||.+.+ ....+..+.
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~--------~~~~~~~~~ 218 (261)
T cd05034 149 LARLIEDDEY-TAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMT--------NREVLEQVE 218 (261)
T ss_pred cceeccchhh-hhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHH
Confidence 9986543211 111122235689999999864 48999999999999999998 999997544 122222221
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
... ....+...+.++.++|.+||..||.+||+++++++
T Consensus 219 ~~~----------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 219 RGY----------------------------------RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred cCC----------------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 110 01122233567999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=297.80 Aligned_cols=255 Identities=25% Similarity=0.473 Sum_probs=203.3
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+|++.+.||+|+||.||++.++. ++..+++|.+............+.+|+.+++.++|+||+++++++.+. ...|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEE
Confidence 58999999999999999998654 578999999976554444456777899999999999999999998764 4789
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
++|||+. ++|.+++.... .....+++..++.++.||+.||.|||+.|++|+||+|+||++ +.++.+||+|||++
T Consensus 76 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~----~~~~~~kl~d~g~~ 150 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL----VANDLVKIGDLGIS 150 (256)
T ss_pred EEehhcCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE----ecCCcEEEeeccch
Confidence 9999986 58888876633 223568999999999999999999999999999999999999 55677999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
....... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.. .+ ...+
T Consensus 151 ~~~~~~~----~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---------~~---~~~~ 213 (256)
T cd08530 151 KVLKKNM----AKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---------DL---RYKV 213 (256)
T ss_pred hhhccCC----cccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HH---HHHH
Confidence 8765431 1224568899999999774 4888999999999999999999999754421 11 1111
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
.... + ...+...+.++.++|.+||..||.+|||+.+++.||++
T Consensus 214 ~~~~---~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 214 QRGK---Y---------------------------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred hcCC---C---------------------------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 1100 0 00122335679999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=301.07 Aligned_cols=258 Identities=27% Similarity=0.462 Sum_probs=197.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+++|.+.+.||+|+||.||+|+++. ++..++||.+...... ......+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-- 75 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecC---CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC--
Confidence 4689999999999999999998654 5889999988654322 223356778999999999999999999987643
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.++++|||+. ++|.+++.... .....+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+||
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili----~~~~~~~l~df 150 (267)
T cd08229 76 ELNIVLELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI----TATGVVKLGDL 150 (267)
T ss_pred eEEEEEEecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCCEEECcc
Confidence 7899999998 58888776432 223468999999999999999999999999999999999999 66678999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++..+..... ......++..|+|||++.+. .++.++|+|||||++|+|++|..||.+.... ...+.
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------~~~~~ 217 (267)
T cd08229 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----------LYSLC 217 (267)
T ss_pred hhhhccccCCc--ccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccch----------HHHHh
Confidence 99876543221 12234578899999999764 4888999999999999999999999654311 11111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
+.+..... ....+...+..+.+||.+||..||.+|||+.++++
T Consensus 218 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 218 KKIEQCDY-----------------------------PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred hhhhcCCC-----------------------------CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 11110000 00011234568999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=303.08 Aligned_cols=263 Identities=28% Similarity=0.416 Sum_probs=201.1
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC--CCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCc
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG--DGVSPTAIREIMLLREI-THENVVKLVNVHINHADM 103 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 103 (477)
+|++.+.||+|+||.||++++.....++..||||+++..... ......+.+|+.+++++ +|+||+++++++... .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--T 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--C
Confidence 589999999999999999987655567889999998754321 22334567899999999 699999999988654 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|.+.+... ..+++..++.++.|++.+|.|||+.+++||||||+||++ +.++.++|+||
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~----~~~~~~~l~df 149 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL----DSEGHVVLTDF 149 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE----CCCCCEEEEEC
Confidence 7899999998 5888777642 368899999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAK-HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|+++.+...... ......++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||....... ....+
T Consensus 150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~ 220 (288)
T cd05583 150 GLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--------SQSEI 220 (288)
T ss_pred cccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--------hHHHH
Confidence 998765433221 122345788999999986643 36789999999999999999999996432110 01111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC---HHHHhcCccC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT---AAQALEHEYF 338 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt---~~e~L~h~~f 338 (477)
...+... ....+...+..+.+||.+||+.||++||| +.++|+|+||
T Consensus 221 ~~~~~~~-------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 221 SRRILKS-------------------------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred HHHHHcc-------------------------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 1111000 00122334577899999999999999998 5788999999
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
+.
T Consensus 270 ~~ 271 (288)
T cd05583 270 QG 271 (288)
T ss_pred cc
Confidence 73
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=296.96 Aligned_cols=251 Identities=27% Similarity=0.381 Sum_probs=194.4
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEec
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
+.||+|++|.||+|.+.........+|||.+...... .....+.+|+.++++++|+||+++++++.+ ..++++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 4689999999999988654334457999999876543 445677889999999999999999999876 478999999
Q ss_pred cC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 112 AE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 112 ~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
+. ++|.+.+..... ..+++..++.++.|++.||.|||++|++|+||||+||++ +.++.+||+|||++..+..
T Consensus 77 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~----~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 77 APLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL----ASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred cCCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE----ecCCEEEeccccccccccc
Confidence 96 689888876431 468999999999999999999999999999999999999 6667899999999987654
Q ss_pred CCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 191 PLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 191 ~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... ......++..|+|||.+.+. .++.++|||||||++|+|++ |+.||...+. .+.+..+... .
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~---~ 217 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILKKIDKE---G 217 (257)
T ss_pred cccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhc---C
Confidence 22211 11123457789999998764 48999999999999999998 9999965431 1112211110 0
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
. ....+...+..+.+||.+||..+|++|||+.++++.
T Consensus 218 --~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 254 (257)
T cd05040 218 --E----------------------------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREF 254 (257)
T ss_pred --C----------------------------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHH
Confidence 0 001122345679999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=295.69 Aligned_cols=245 Identities=22% Similarity=0.411 Sum_probs=192.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
..+|.+.+.||+|+||.||++... +..+++|.++... ....+.+|+.++++++|+||+++++++... +..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~ 74 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGG 74 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-----CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCc
Confidence 468999999999999999999643 6789999986432 245678899999999999999999976543 346
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.|++|||+. ++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~----~~~~~~kl~dfg 147 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV----SEDNVAKVSDFG 147 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE----cCCCcEEecCCc
Confidence 899999998 58888887643 2357889999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+++...... ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||...+. ..+.
T Consensus 148 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------------~~~~ 209 (256)
T cd05082 148 LTKEASSTQ-----DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------------KDVV 209 (256)
T ss_pred cceeccccC-----CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------------HHHH
Confidence 988654321 122336679999998764 48899999999999999997 9999964331 1122
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
..+..... ...+..++..+.+||.+||+.||++|||+.++++
T Consensus 210 ~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 210 PRVEKGYK------------------------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHhcCCC------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 21111000 0122334678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=298.19 Aligned_cols=248 Identities=29% Similarity=0.438 Sum_probs=188.3
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHH-HhcCCCCeeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLL-REITHENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
+.||+|+||.||+|.+.. ++..||||++...... .........|..++ ..++|+||+++++++... ..+|+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecC---CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEE
Confidence 579999999999998654 5789999998754321 11122334454443 455899999999998654 4789999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||+|+||++ +.++.+||+|||++...
T Consensus 77 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~----~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 77 EYLNGGDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI----DQTGHLKLTDFGLSRNG 147 (260)
T ss_pred eccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCcEEEeecccceec
Confidence 9997 5787777653 368999999999999999999999999999999999999 66778999999998754
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
.. .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+. ......+....
T Consensus 148 ~~------~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~--- 209 (260)
T cd05611 148 LE------NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDNILSRR--- 209 (260)
T ss_pred cc------cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcc---
Confidence 32 22345688899999998754 89999999999999999999999975432 11111111100
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC---HHHHhcCccCC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT---AAQALEHEYFR 339 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt---~~e~L~h~~f~ 339 (477)
. .| ........+..+.+||.+||..||++||+ +.|+|.||||+
T Consensus 210 -~----------~~-----------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~ 255 (260)
T cd05611 210 -I----------NW-----------------PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255 (260)
T ss_pred -c----------CC-----------------CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhh
Confidence 0 00 00112234678999999999999999994 57999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=298.98 Aligned_cols=257 Identities=23% Similarity=0.350 Sum_probs=195.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.+.|++.+.||+|+||.||+|.++.+...+..|+||.++.... ......+..|+.+++.++||||+++++++.+. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~ 79 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--RP 79 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--Cc
Confidence 4679999999999999999999876544556899999875432 22345778899999999999999999998553 47
Q ss_pred EEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
++++|||+.+ +|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||++ +.++.+||+|||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili----~~~~~~kl~dfg 151 (269)
T cd05065 80 VMIITEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV----NSNLVCKVSDFG 151 (269)
T ss_pred eEEEEecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE----cCCCcEEECCCc
Confidence 8999999985 777777653 2358899999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCccc---CCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHH
Q 011808 184 LARIYQAPLKFLS---ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 184 ~a~~~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
++..+........ ......+..|+|||.+.+. .++.++|||||||++|||++ |..||...+. .+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--------~~~~~ 222 (269)
T cd05065 152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVIN 222 (269)
T ss_pred cccccccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCH--------HHHHH
Confidence 9876543221111 1111124579999999764 48999999999999999886 9999965431 11111
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.+.... ....+..++..+.++|.+||..||.+||++.+++..
T Consensus 223 ~i~~~~----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 223 AIEQDY----------------------------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHcCC----------------------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111000 001122345678999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=294.89 Aligned_cols=249 Identities=24% Similarity=0.400 Sum_probs=192.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||+|.+.. +..+++|.+..... ....+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNG----TTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcC----CceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CC
Confidence 3679999999999999999997643 34689998765332 33567889999999999999999998743 35
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.|++|||+. ++|.+++.... ...+++..+..++.||+.||.|||+.||+|+||||+||++ ++++.++|+|||
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill----~~~~~~~l~dfg 147 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV----GDNLVCKIADFG 147 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE----cCCCeEEECCCc
Confidence 789999998 58988887532 3357889999999999999999999999999999999999 677889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++........ .......++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+... .+....+.
T Consensus 148 ~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~ 217 (260)
T cd05069 148 LARLIEDNEY-TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLEQVE 217 (260)
T ss_pred cceEccCCcc-cccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence 9986543221 112223346789999998764 48999999999999999999 8999976442 11111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
. ... ...+...+..+.+||++||.+||.+||+++++++
T Consensus 218 ~---~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 218 R---GYR-------------------------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred c---CCC-------------------------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1 000 0112234567999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=308.43 Aligned_cols=275 Identities=28% Similarity=0.422 Sum_probs=213.0
Q ss_pred CCCccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-----CCCcHHHHHHHHHHHhcCCCCeeE
Q 011808 18 HGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-----DGVSPTAIREIMLLREITHENVVK 92 (477)
Q Consensus 18 ~~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~ 92 (477)
.-+.+.+-++|-++.+||+|+|+.||+|.+.. ..+.||||+-...+.- +...+.+.+|..|.+.|+||-||+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~---EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK 531 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLT---EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK 531 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccc---hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence 45667778999999999999999999998653 5788999986544322 234456678999999999999999
Q ss_pred EEEEEEcCCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC--eecCCCCCCcEEEec
Q 011808 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW--IIHRDLKPSNILVMG 169 (477)
Q Consensus 93 l~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDikp~NILl~~ 169 (477)
+|++|.-..+ .+|.|+|||+| +|.-+|.+++ .++|.+++.|+.||+.||.||.... |||.||||.||||..
T Consensus 532 lYDyfslDtd-sFCTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~ 605 (775)
T KOG1151|consen 532 LYDYFSLDTD-SFCTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVN 605 (775)
T ss_pred eeeeeeeccc-cceeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEec
Confidence 9999865443 68999999998 4555565543 6999999999999999999999874 999999999999854
Q ss_pred cCCCcccEEEeecccceeecCCCCcc-----cCCCeeeccccccchhhcCC---CCCCchhhHHHHHHHHHHHHhCCCCC
Q 011808 170 EGEEQGVVKIADFGLARIYQAPLKFL-----SENGVVVTIWYRAPELLLGA---KHYTSAVDMWAVGCIFAELLTLKPLF 241 (477)
Q Consensus 170 ~~~~~~~vkL~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~---~~~~~~~DiwSlGvil~elltG~~PF 241 (477)
|+..|.+||+|||++++++...... -.....||.||++||+|.-. ...+.++||||+|||+|.++.|+.||
T Consensus 606 -GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPF 684 (775)
T KOG1151|consen 606 -GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPF 684 (775)
T ss_pred -CcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCC
Confidence 4677899999999999886543221 11235689999999998543 34788999999999999999999999
Q ss_pred CCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhccc
Q 011808 242 QGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321 (477)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~ 321 (477)
..... +.+.+.. ..|... ....+.....+++++.+||++||.+
T Consensus 685 Ghnqs-------QQdILqe--NTIlkA----------------------------tEVqFP~KPvVsseAkaFIRRCLaY 727 (775)
T KOG1151|consen 685 GHNQS-------QQDILQE--NTILKA----------------------------TEVQFPPKPVVSSEAKAFIRRCLAY 727 (775)
T ss_pred CCchh-------HHHHHhh--hchhcc----------------------------eeccCCCCCccCHHHHHHHHHHHHh
Confidence 64321 1221111 001000 1112223345678999999999999
Q ss_pred CCCCCCCHHHHhcCccCC
Q 011808 322 DPRKRITAAQALEHEYFR 339 (477)
Q Consensus 322 dP~~Rpt~~e~L~h~~f~ 339 (477)
--++|....++-.||||.
T Consensus 728 RKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 728 RKEDRIDVQQLACDPYLL 745 (775)
T ss_pred hhhhhhhHHHHccCcccc
Confidence 999999999999999996
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=296.01 Aligned_cols=247 Identities=21% Similarity=0.351 Sum_probs=190.8
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEec
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
++||+|+||.||+|.+......+..+|+|.+...... .....+.+|+.+++.++|+||+++++++... ..+++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKGE---PLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC---ceEEEEEe
Confidence 4799999999999987654335578999999765543 3345678899999999999999999987532 57999999
Q ss_pred cC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 112 AE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 112 ~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
+. ++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+|||+ +.++.+||+|||+++.+..
T Consensus 77 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili----~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 77 APLGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL----VNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE----cCCCcEEeccccccceeec
Confidence 87 6898888763 268999999999999999999999999999999999999 6677899999999986644
Q ss_pred CCCccc-CCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 191 PLKFLS-ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 191 ~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
...... .....++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+. ..+. ..+...
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---------~~~~---~~~~~~ 214 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---------AEVI---AMLESG 214 (257)
T ss_pred CCcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCH---------HHHH---HHHHcC
Confidence 332211 1112224679999999764 48999999999999999998 9999965431 1111 111110
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.. ...+...+..+++||.+||..||.+||++.+++.
T Consensus 215 ~~------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 215 ER------------------------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred Cc------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 0123344577899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=302.44 Aligned_cols=269 Identities=25% Similarity=0.418 Sum_probs=196.8
Q ss_pred cceeEEeeecccCceEEEEEEEec-ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKA-AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++++.||+|+||.||++..+. ...++..|+||.+.... ......+.+|+++++.++||||+++++++...+...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 479999999999999999997542 23468899999986543 223456778999999999999999999887666667
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili----~~~~~~~l~dfg 153 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV----ESENRVKIGDFG 153 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE----CCCCeEEECCCc
Confidence 899999997 68888886532 358899999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCccc-CCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccC----CCcccHHHH
Q 011808 184 LARIYQAPLKFLS-ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST----QNPFQLDQL 258 (477)
Q Consensus 184 ~a~~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~----~~~~~~~~~ 258 (477)
++........... .....++..|+|||++.+. .++.++|||||||++|||++|..++........ .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05081 154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV 232 (284)
T ss_pred ccccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccch
Confidence 9986543222111 1111224569999999764 489999999999999999998776643221000 000000000
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..+...+.. ......+...+..+.+||.+||..||++|||+.+++..
T Consensus 233 ~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 233 YHLIELLKN------------------------------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HHHHHHHhc------------------------------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 001111100 00111234456789999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=303.32 Aligned_cols=260 Identities=23% Similarity=0.397 Sum_probs=199.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++.+.||+|+||.||+|.++. ++..||||.++...... ....+.+|+.++.++ .|+||+++++++.+. .
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~ 87 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITD--S 87 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECC---CCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecC--C
Confidence 6889999999999999999998763 58899999997543322 234566677766666 599999999998764 4
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|++|||+.+.+..++... ...+++..+..++.||+.||.|||+ .||+||||+|+||++ +.++.+||+||
T Consensus 88 ~~~~v~e~~~~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill----~~~~~~kL~df 159 (296)
T cd06618 88 DVFICMELMSTCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL----DASGNVKLCDF 159 (296)
T ss_pred eEEEEeeccCcCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE----cCCCCEEECcc
Confidence 78999999998887776653 2368999999999999999999997 599999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGA---KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|++..+...... ....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||..... ...
T Consensus 160 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~ 226 (296)
T cd06618 160 GISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT----------EFE 226 (296)
T ss_pred ccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh----------HHH
Confidence 998765432211 223457889999998753 2378899999999999999999999964321 111
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+...+....+ .++ .....+.++.+||.+||..||.+||++.+++.|+||.
T Consensus 227 ~~~~~~~~~~~-~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 277 (296)
T cd06618 227 VLTKILQEEPP-SLP----------------------------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277 (296)
T ss_pred HHHHHhcCCCC-CCC----------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 11122211100 000 0112356789999999999999999999999999997
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 278 ~ 278 (296)
T cd06618 278 R 278 (296)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=299.03 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=196.6
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC----c
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD----M 103 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~----~ 103 (477)
|.+.+.||+|+||.||+|.++....++..+|||++............+.+|+++++.++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999887665678899999997665444445567889999999999999999998865322 1
Q ss_pred eEEEEEeccC-CCHHHHHHhhh-cccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHR-DKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+++++|+. ++|.+++.... ......+++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili----~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML----NENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE----cCCCCEEECc
Confidence 3477888887 67777664322 1112357889999999999999999999999999999999999 6677899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
||+++...............+++.|++||.+.+. .++.++|||||||++|+|++ |++||.+.+. .+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~---- 223 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SE---- 223 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HH----
Confidence 9999865432221122223346789999998764 48889999999999999999 8999975431 11
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+...+..... ...+...+..+.+|+.+||..+|.+|||+.+++.+
T Consensus 224 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 224 IYNYLIKGNR------------------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHHHHcCCc------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111110000 00112335678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=296.41 Aligned_cols=256 Identities=23% Similarity=0.387 Sum_probs=194.9
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|+..+.||+|+||.||+|+++.+......+++|.++.... ......+.+|+.+++.++|+||+++++++.+.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK--PA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC--Cc
Confidence 578999999999999999998875444455899999865432 223456778999999999999999999986543 68
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|++|||+. ++|.+++... ...+++.++..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||+
T Consensus 82 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili----~~~~~~kl~dfg~ 153 (268)
T cd05063 82 MIITEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV----NSNLECKVSDFGL 153 (268)
T ss_pred EEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE----cCCCcEEECCCcc
Confidence 99999998 4777777543 2468899999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCccc-CCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 185 ARIYQAPLKFLS-ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 185 a~~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+........... ......+..|+|||++.+. .++.++|||||||++|+|++ |+.||...+. .+....+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~ 224 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAIN 224 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHh
Confidence 986643221111 1111224579999999774 48999999999999999997 9999965431 12222221
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
... . ...+...+..+.+||.+||..||.+||++.++++.
T Consensus 225 ~~~--~--------------------------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 225 DGF--R--------------------------------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred cCC--C--------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 100 0 00122335678999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=300.97 Aligned_cols=260 Identities=27% Similarity=0.381 Sum_probs=196.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecc--cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAA--ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++|++++.||+|+||.||+|.+... ..++..+|+|++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~-- 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAVG-- 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--
Confidence 36799999999999999999986421 23567899999875432 22334677899999999999999999988654
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcc-----------------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCc
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDK-----------------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSN 164 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~-----------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~N 164 (477)
..++++|||+. ++|.+++...... ....+++.+++.++.||+.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 36899999988 5898888754211 11246788899999999999999999999999999999
Q ss_pred EEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 011808 165 ILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQG 243 (477)
Q Consensus 165 ILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~ 243 (477)
||+ +.++.++|+|||++..+..............+..|+|||++.+. .++.++|||||||++|+|++ |..||.+
T Consensus 161 il~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 161 CLV----GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred eEe----cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999 66778999999998765433222122223346679999998774 48999999999999999997 8888865
Q ss_pred cccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCC
Q 011808 244 AEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323 (477)
Q Consensus 244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP 323 (477)
... .+ +...+..... ...+...+..+.+||.+||..||
T Consensus 236 ~~~--------~~----~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p 273 (288)
T cd05050 236 MAH--------EE----VIYYVRDGNV------------------------------LSCPDNCPLELYNLMRLCWSKLP 273 (288)
T ss_pred CCH--------HH----HHHHHhcCCC------------------------------CCCCCCCCHHHHHHHHHHcccCc
Confidence 432 11 1111111000 00122345779999999999999
Q ss_pred CCCCCHHHHhc
Q 011808 324 RKRITAAQALE 334 (477)
Q Consensus 324 ~~Rpt~~e~L~ 334 (477)
.+|||+.|++.
T Consensus 274 ~~Rpt~~el~~ 284 (288)
T cd05050 274 SDRPSFASINR 284 (288)
T ss_pred ccCCCHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=297.98 Aligned_cols=256 Identities=21% Similarity=0.329 Sum_probs=192.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccC-CCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAAN-RGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++++.||+|+||+||+|.+..+.. ....+++|.+.... .......+..|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---A 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC---C
Confidence 3689999999999999999998754211 11247888875332 22233456678888999999999999998743 2
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..++++||+. ++|.+++.... ..+++..+..++.||+.||.|||+++++||||||+|||+ +.++.+||+||
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili----~~~~~~kl~Df 153 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL----KSDSIVQIADF 153 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE----cCCCcEEEcCC
Confidence 4678899887 79988887542 368999999999999999999999999999999999999 67788999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|+++.+.............++..|+|||++.+. .++.++|||||||++|||++ |..||.+... ..+..+
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---------~~~~~~ 223 (279)
T cd05111 154 GVADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---------HEVPDL 223 (279)
T ss_pred ccceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHH
Confidence 999866433222222234457789999999764 48999999999999999998 9999976431 112222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
... ... ...+..++.++.++|.+||..||.+|||+.+++..
T Consensus 224 ~~~---~~~------------------------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 224 LEK---GER------------------------------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHC---CCc------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 111 000 00112234678899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=332.38 Aligned_cols=148 Identities=26% Similarity=0.425 Sum_probs=126.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+++|.++++||+|+||.||+|++.. ++..||||+++..... ......+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA--N 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC--C
Confidence 6899999999999999999998764 6889999999754322 22235667899999999999999999988654 3
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+||||||+. ++|.+++... ..+++..++.|+.||+.||.|||.++||||||||+|||| +.++.+||+||
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl----~~~g~vkL~DF 148 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI----SNEGHIKLTDF 148 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE----cCCCCEEEEeC
Confidence 7899999996 6888888653 358899999999999999999999999999999999999 66678999999
Q ss_pred ccce
Q 011808 183 GLAR 186 (477)
Q Consensus 183 G~a~ 186 (477)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=300.69 Aligned_cols=293 Identities=38% Similarity=0.625 Sum_probs=230.5
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
|..-.+-+-.+.||-|+||.||.+.+. .+|+.|++|++......-...+.+++|+++|.-++|.|++..+++..-..
T Consensus 49 Pqqq~Di~PDRPIGYGAFGVVWsVTDP---RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph 125 (449)
T KOG0664|consen 49 PQQQQDIQPDRPIGYGAFGVVWSVTDP---RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPAN 125 (449)
T ss_pred ccccccCCCCCcccccceeEEEeccCC---CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCC
Confidence 444556677889999999999999754 57999999999876665556678889999999999999999998764322
Q ss_pred C---ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 102 D---MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 102 ~---~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
- ..+|++.|++..+|..++-. ...++.+.++-+++||+.||+|||+.+|.||||||.|+|+ +++-.+|
T Consensus 126 ~dfFqEiYV~TELmQSDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV----NSNCvLK 196 (449)
T KOG0664|consen 126 PSFFQELYVLTELMQSDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV----NSNCILK 196 (449)
T ss_pred chHHHHHHHHHHHHHhhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe----ccCceEE
Confidence 1 12688889999999888865 4478999999999999999999999999999999999999 8888999
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|||||+++....... ...+..+.|.+|+|||+++|.+.|+.++||||+|||+.|||-.+..|...+ ...++
T Consensus 197 ICDFGLARvee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~--------PiqQL 267 (449)
T KOG0664|consen 197 ICDFGLARTWDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG--------PIEQL 267 (449)
T ss_pred ecccccccccchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC--------hHHHH
Confidence 999999997654322 223334569999999999999999999999999999999999999998776 57899
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCcc----ccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHS----VVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
+.|.+.+|.|+.|.+..-.+ ....++-........+.. ..+.....+..+++.+||..||++|.+.++++.
T Consensus 268 ~lItdLLGTPs~EaMr~ACE-----GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 268 QMIIDLLGTPSQEAMKYACE-----GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred HHHHHHhCCCcHHHHHHHhh-----hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 99999999998775442211 011111111111111111 123344456889999999999999999999999
Q ss_pred CccCCC
Q 011808 335 HEYFRI 340 (477)
Q Consensus 335 h~~f~~ 340 (477)
|+++..
T Consensus 343 ~~~~~e 348 (449)
T KOG0664|consen 343 HRYLEE 348 (449)
T ss_pred cccccc
Confidence 999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=313.47 Aligned_cols=260 Identities=27% Similarity=0.370 Sum_probs=207.1
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCC-CCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK-DGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.-|..++.||-|+||.|.+++... +..+||+|.+++.. .....+.....|-.||..-+++-||+||..|.+.+ .
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvD---T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd--n 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVD---TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--N 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecc---hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC--c
Confidence 457889999999999999997543 68899999986543 23334445567999999999999999999997754 8
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. |++..+|.+.. -+.|..++.++..|.+|+++.|+.|+|||||||+|||| +.+|+|||+|||
T Consensus 704 LYFVMdYIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI----DrdGHIKLTDFG 774 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI----DRDGHIKLTDFG 774 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE----ccCCceeeeecc
Confidence 999999998 68888887643 68999999999999999999999999999999999999 888999999999
Q ss_pred cceeec---------CCCC-------------------------------cccCCCeeeccccccchhhcCCCCCCchhh
Q 011808 184 LARIYQ---------APLK-------------------------------FLSENGVVVTIWYRAPELLLGAKHYTSAVD 223 (477)
Q Consensus 184 ~a~~~~---------~~~~-------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~D 223 (477)
++.-+. .... .+.....+||+.|+|||+|.... |+..+|
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cd 853 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCD 853 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccch
Confidence 985321 1100 00113568899999999998744 999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCcccc
Q 011808 224 MWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV 303 (477)
Q Consensus 224 iwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (477)
+||.|||||||+.|++||...+..+.... ...+.+.|+...
T Consensus 854 wws~gvil~em~~g~~pf~~~tp~~tq~k---------------------------------------v~nw~~~l~~~~ 894 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADTPGETQYK---------------------------------------VINWRNFLHIPY 894 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCCCCcceee---------------------------------------eeehhhcccccc
Confidence 99999999999999999987665433210 112233455556
Q ss_pred CCCCCchHHHHHHHhcccCCCCCCC---HHHHhcCccCCC
Q 011808 304 PLSPKSPAYDLLSKMLEYDPRKRIT---AAQALEHEYFRI 340 (477)
Q Consensus 304 p~~~s~~~~dli~~~L~~dP~~Rpt---~~e~L~h~~f~~ 340 (477)
..+.+.++.+||.++.. +++.|+. ++++..||||+.
T Consensus 895 ~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 895 QGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred ccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 67788999999998765 5788884 788999999973
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=300.42 Aligned_cols=265 Identities=17% Similarity=0.195 Sum_probs=185.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCc---------HHHHHHHHHHHhcCCCCeeEEEE
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVS---------PTAIREIMLLREITHENVVKLVN 95 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~~~Ei~il~~l~hpnIv~l~~ 95 (477)
-++|++.++||+|+||.||+|.+..+...+..+++|+........... .....+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 368999999999999999999876532235667777654332211000 11123334456678999999998
Q ss_pred EEEcCCC--ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCC
Q 011808 96 VHINHAD--MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE 173 (477)
Q Consensus 96 ~~~~~~~--~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~ 173 (477)
++..... ...+++++++..++.+.+... ...++..++.++.||+.||.|||+++|+||||||+|||+ +.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill----~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV----DG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cC
Confidence 7654322 245788888887877766543 235788899999999999999999999999999999999 66
Q ss_pred cccEEEeecccceeecCCCCc-----ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc
Q 011808 174 QGVVKIADFGLARIYQAPLKF-----LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248 (477)
Q Consensus 174 ~~~vkL~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~ 248 (477)
++.++|+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.....
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 778999999999876432111 111234679999999999874 48999999999999999999999998653211
Q ss_pred CCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC
Q 011808 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT 328 (477)
Q Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt 328 (477)
. .+.... ......+... .......+..+.++++.|+..+|++||+
T Consensus 241 ~--~~~~~~-~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~ 285 (294)
T PHA02882 241 N--LIHAAK-CDFIKRLHEG--------------------------------KIKIKNANKFIYDFIECVTKLSYEEKPD 285 (294)
T ss_pred H--HHHHhH-HHHHHHhhhh--------------------------------hhccCCCCHHHHHHHHHHHhCCCCCCCC
Confidence 0 000000 0111111000 0011223467899999999999999999
Q ss_pred HHHHhc
Q 011808 329 AAQALE 334 (477)
Q Consensus 329 ~~e~L~ 334 (477)
++++++
T Consensus 286 ~~~l~~ 291 (294)
T PHA02882 286 YDALIK 291 (294)
T ss_pred HHHHHH
Confidence 999874
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=302.78 Aligned_cols=256 Identities=27% Similarity=0.383 Sum_probs=208.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREI-THENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 102 (477)
..+|.++.+||+|+||+|.+|..+. +.+.||||+++++..- +...+--+.|-++|... +-|.++++..+|.+-+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkg---tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD- 423 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD- 423 (683)
T ss_pred ecccceEEEeccCccceeeeecccC---cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh-
Confidence 5689999999999999999997553 6789999999887532 22233445677787766 5779999999987654
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+|+||||+. |+|...+++. +++.|..+..++..|+-||-+||++|||+||||.+|||| +..|++||+|
T Consensus 424 -RLyFVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL----d~eGHiKi~D 493 (683)
T KOG0696|consen 424 -RLYFVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML----DSEGHIKIAD 493 (683)
T ss_pred -heeeEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe----ccCCceEeee
Confidence 7999999998 5888777764 367788899999999999999999999999999999999 8889999999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+++.---. ..+....||||.|+|||++.- ..|+.++|+||+||+|||||.|.+||.+.++ .+.+..|
T Consensus 494 FGmcKEni~~--~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--------~elF~aI 562 (683)
T KOG0696|consen 494 FGMCKENIFD--GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQAI 562 (683)
T ss_pred cccccccccC--CcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHH
Confidence 9999743222 223456899999999999976 4599999999999999999999999998873 3344444
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHE 336 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~ 336 (477)
.+.- ...|...|.++.++++.+|.+.|.+|+. -.++-.||
T Consensus 563 ~ehn-----------------------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~ 607 (683)
T KOG0696|consen 563 MEHN-----------------------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHP 607 (683)
T ss_pred HHcc-----------------------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCc
Confidence 3321 1256677889999999999999999985 46899999
Q ss_pred cCCC
Q 011808 337 YFRI 340 (477)
Q Consensus 337 ~f~~ 340 (477)
||+.
T Consensus 608 FFR~ 611 (683)
T KOG0696|consen 608 FFRR 611 (683)
T ss_pred chhh
Confidence 9973
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=299.45 Aligned_cols=259 Identities=32% Similarity=0.491 Sum_probs=205.0
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
...+.|++.+.||+|+||.||++.+.. ++..+++|++..... ....+.+|+.+++.++|+||+++++++...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 87 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG-- 87 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEcc---CCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--
Confidence 456779999999999999999998764 578899999976443 345678899999999999999999998775
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
...|+++||+. ++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i----~~~~~~~l~d 159 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL----SKDGSVKLAD 159 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE----cCCCCEEECc
Confidence 47899999999 68888887643 368999999999999999999999999999999999999 6677899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||++........ ......++..|+|||++.+. .++.++|+|||||++|+|++|+.||...+. ......+
T Consensus 160 ~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--------~~~~~~~ 228 (286)
T cd06614 160 FGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPP--------LRALFLI 228 (286)
T ss_pred cchhhhhccchh--hhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence 999875543221 11223457889999998764 489999999999999999999999975431 1111111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.. ... ... ..+...+..+.+||.+||+.||.+|||+.++++|+||+.
T Consensus 229 ~~---~~~-~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 229 TT---KGI-PPL----------------------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred Hh---cCC-CCC----------------------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 10 000 000 011123567899999999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=301.49 Aligned_cols=255 Identities=29% Similarity=0.504 Sum_probs=196.8
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYL 107 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~l 107 (477)
|+...+||+|+||.||++.++. ++..||||++.... ......+.+|+.+++.++|+||+++++++...+ ..|+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 94 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKS---SGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWV 94 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcC---CCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC--EEEE
Confidence 4445789999999999998654 68899999885432 223456778999999999999999999987644 7899
Q ss_pred EEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 108 AFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 108 v~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
+|||+.+ +|.+++.. ..+++..++.++.|++.||+|||+.|++|+||||+||++ +.++.++|+|||++.
T Consensus 95 v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv----~~~~~~~l~dfg~~~ 164 (292)
T cd06657 95 VMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL----THDGRVKLSDFGFCA 164 (292)
T ss_pred EEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEEcccccce
Confidence 9999985 66665532 257899999999999999999999999999999999999 667789999999987
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhC
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~ 266 (477)
....... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+... ...+..+...+
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~~~~~~~~- 232 (292)
T cd06657 165 QVSKEVP--RRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNL- 232 (292)
T ss_pred ecccccc--cccccccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhhC-
Confidence 5543211 12334578999999998764 478899999999999999999999975431 11111111110
Q ss_pred CCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCCC
Q 011808 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEP 342 (477)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~~ 342 (477)
+..+. .....+..+.++|.+||..||.+||++.+++.|+||....
T Consensus 233 ---~~~~~----------------------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 233 ---PPKLK----------------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ---CcccC----------------------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 11000 1122356789999999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=297.20 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=195.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccC-CCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAAN-RGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..+|++.+.||+|+||.||+|.++.+.. ....+++|.+..... ......+.+|+.+++.++|+||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec---C
Confidence 3689999999999999999998764321 133689998875543 2234567789999999999999999999876 3
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..+++|||+. ++|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.+||+||
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~----~~~~~~kL~df 153 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV----KTPQHVKITDF 153 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE----cCCCeEEECCC
Confidence 6899999987 68888887642 358999999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|+++.+.............++..|+|||.+.. ..++.++|+|||||++||+++ |+.||.+... ..+.
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---------~~~~-- 221 (279)
T cd05057 154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---------VEIP-- 221 (279)
T ss_pred cccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---------HHHH--
Confidence 99987654322222222223567999999865 448899999999999999998 9999975432 1111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
..+.... ....+...+..+.++|.+||..||.+|||+.++++
T Consensus 222 -~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 222 -DLLEKGE------------------------------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -HHHhCCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111100 01122334567899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=294.09 Aligned_cols=247 Identities=21% Similarity=0.346 Sum_probs=188.1
Q ss_pred eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEecc
Q 011808 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYA 112 (477)
Q Consensus 33 ~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~ 112 (477)
.||+|+||.||+|.++.. ..+..||+|++..... ......+.+|+.++++++|+||+++++++.. ..+++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~-~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecC-CCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeC
Confidence 489999999999987532 3466799999875432 3334567889999999999999999998743 2579999999
Q ss_pred C-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCC
Q 011808 113 E-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191 (477)
Q Consensus 113 ~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~ 191 (477)
. ++|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||+ +.++.+||+|||++..+...
T Consensus 77 ~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~----~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 77 SGGPLNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL----VNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred CCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE----cCCCcEEeccCCccccccCC
Confidence 7 5788777643 2368999999999999999999999999999999999999 66678999999999765433
Q ss_pred CCccc-CCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCCC
Q 011808 192 LKFLS-ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPT 269 (477)
Q Consensus 192 ~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 269 (477)
..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||..... .+. ...+...
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~----~~~~~~~- 214 (257)
T cd05115 149 DSYYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEV----MSFIEQG- 214 (257)
T ss_pred ccceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHH----HHHHHCC-
Confidence 22111 1112225689999998764 48899999999999999996 9999976542 111 1111110
Q ss_pred CCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 270 PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.....+..+++++.+||.+||..||++||++.++++.
T Consensus 215 -----------------------------~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 215 -----------------------------KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred -----------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0011234456789999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=330.03 Aligned_cols=259 Identities=24% Similarity=0.412 Sum_probs=207.7
Q ss_pred cceeEEeeecccCceEEEEEEEecccCC--CcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..-.+.+.||+|+||.||.|........ ...||||.++.... ......+++|..+|+.++|||||++++++.+. .
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--G 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--C
Confidence 3567889999999999999988754333 34589998876543 34456889999999999999999999999884 3
Q ss_pred eEEEEEeccC-CCHHHHHHhhhccc--CCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKV--NHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|++|||. |+|+.+|++.+... ...++..+...++.+|++|++||+++++|||||..+|+|| ++...|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL----~~~r~VKIa 844 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL----DERRVVKIA 844 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee----cccCcEEEc
Confidence 6789999998 79999999863221 3468899999999999999999999999999999999999 777999999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|||+|+.+.....+.......-...|||||.+.. ..|+.++|||||||+|||++| |..||.+.+. .+
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----------~~ 912 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----------FE 912 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcch-----------HH
Confidence 9999995544333333322233678999999987 459999999999999999999 8899986552 22
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.+..++.. -+...|..+++.+++|+..||+.+|++||++..+++
T Consensus 913 v~~~~~~g-------------------------------gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 913 VLLDVLEG-------------------------------GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHHHHhC-------------------------------CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 22212111 123357778899999999999999999999999997
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=292.94 Aligned_cols=246 Identities=24% Similarity=0.411 Sum_probs=195.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||.|+||.||+|.. .++.|+||.++.... ....+.+|+.+++.++|+||+++++++.+ +..
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-----~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-----RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-----cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCC
Confidence 46799999999999999999974 368899999976543 34678889999999999999999999876 347
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+++|||+. ++|.+++.... ...+++..++.++.|++.||.|||++||+|+||||+||++ +.++.+||+|||
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili----~~~~~~~l~d~g 147 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV----SEDLVAKVSDFG 147 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE----eCCCCEEEcccc
Confidence 899999998 69988887542 2368999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+++....... ....+..|+|||.+.+. .++.++|||||||++|+|++ |..||..... . .+.
T Consensus 148 ~~~~~~~~~~-----~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~---~~~ 209 (256)
T cd05039 148 LAKEASQGQD-----SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------K---DVV 209 (256)
T ss_pred cccccccccc-----cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---------H---HHH
Confidence 9986632211 12235679999998764 48899999999999999997 9999964431 1 111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..+.... ....+...++.+.+||.+||..||++|||+.+++..
T Consensus 210 ~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 210 PHVEKGY------------------------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HHHhcCC------------------------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 2111100 001223346789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=295.89 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=195.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
..+|.+.+.||+|+||.||+|.+.........++||.+..... ......+.+|+.+++.++|+||+++++++.+. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---P 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---C
Confidence 3569999999999999999998764333445799998865432 22345678899999999999999999988643 4
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.|++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+.|++||||||+|||+ +..+.+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili----~~~~~~~l~d~g 152 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV----SSPDCVKLGDFG 152 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE----ecCCCeEEccCc
Confidence 689999997 68888886532 358899999999999999999999999999999999999 666789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+++........ ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||..... .+.+..+.
T Consensus 153 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~~ 222 (270)
T cd05056 153 LSRYLEDESYY-KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKN--------NDVIGRIE 222 (270)
T ss_pred eeeecccccce-ecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHH
Confidence 99866443211 12222335679999998764 48999999999999999986 9999976542 11111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
. . .....+..++..+.+||.+||..||.+|||+.+++..
T Consensus 223 ~----~------------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 223 N----G------------------------------ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred c----C------------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0 0001233446789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=298.76 Aligned_cols=269 Identities=26% Similarity=0.429 Sum_probs=197.0
Q ss_pred ceeEEeeecccCceEEEEEEEec-ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKA-AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
-|.+++.||+|+||.||+|++.. ...++..||+|.++.... ......+.+|+.+++.++|+||+++++++.......+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 37899999999999999997542 234678999999875432 2334567889999999999999999999877655678
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+++|||+. ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+
T Consensus 84 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~----~~~~~~~l~dfg~ 155 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV----ESEHQVKIGDFGL 155 (284)
T ss_pred EEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE----cCCCCEEECCCcc
Confidence 99999997 6888877553 2358899999999999999999999999999999999999 6667899999999
Q ss_pred ceeecCCCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccC--CCc-ccHHHHHH
Q 011808 185 ARIYQAPLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST--QNP-FQLDQLDK 260 (477)
Q Consensus 185 a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~--~~~-~~~~~~~~ 260 (477)
++.+....... ......++..|+|||++.+. .++.++|||||||++|+|+++..|+........ ..+ ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR 234 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence 98664332211 11223456789999998774 488999999999999999998766532110000 000 00000000
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
....+. .+.....+...+..+.+||.+||+.||.+|||+.+++.+
T Consensus 235 ~~~~~~------------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 235 LVRVLE------------------------------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHH------------------------------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 111100 001111233456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=296.40 Aligned_cols=250 Identities=34% Similarity=0.556 Sum_probs=194.9
Q ss_pred ecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEecc
Q 011808 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYA 112 (477)
Q Consensus 34 lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~ 112 (477)
||+|+||.||++.+.. ++..+++|.+...... ......+.+|++++++++|+||+++++.+.. +..+|++|||+
T Consensus 1 lg~g~~~~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecC
Confidence 6899999999998653 5889999998754332 2344567789999999999999999998865 34789999999
Q ss_pred C-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCC
Q 011808 113 E-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191 (477)
Q Consensus 113 ~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~ 191 (477)
. ++|.+++... ..+++..+..++.||+.||.|||+++++|+||+|+||++ +.++.++|+|||++......
T Consensus 76 ~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~----~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 76 PGGDLASLLENV-----GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI----DSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE----cCCCCEEEEecccchhcccC
Confidence 7 5888887653 268999999999999999999999999999999999999 67778999999998754332
Q ss_pred CC------cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 192 LK------FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 192 ~~------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
.. ........++..|+|||++.+.. ++.++|+|||||++|+|++|..||..... .. ++..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~----~~~~~ 213 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP--------EE----IFQNI 213 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HH----HHHHH
Confidence 11 11223345688999999997754 78899999999999999999999975441 11 11111
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH---HHHhcCccCC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA---AQALEHEYFR 339 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~---~e~L~h~~f~ 339 (477)
.... ..++ .....+..+.+||.+||+.||.+|||+ .++|+||||+
T Consensus 214 ~~~~-~~~~----------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 214 LNGK-IEWP----------------------------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred hcCC-cCCC----------------------------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence 1100 0000 001125778999999999999999999 9999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.64 Aligned_cols=261 Identities=25% Similarity=0.438 Sum_probs=217.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEc---C
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHIN---H 100 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~---~ 100 (477)
.+-|+|+++||.|.+|.||+++++. +++..|+|++....+.+ .++..|.++|+.+ .|||++.++++|.- .
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~---~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVK---TGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeee---cCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 5679999999999999999998775 68888999887766544 3556688899888 79999999999863 2
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
.+..+|||||||+ |+.-+++.... +..+.|..+..|++.++.||.+||.+.++|||||-.|||+ +.++.|||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL----T~e~~VKL 164 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL----TENAEVKL 164 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE----eccCcEEE
Confidence 3457999999999 57778877654 6689999999999999999999999999999999999999 77778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAK----HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~ 255 (477)
+|||++..++.... ..+..+|||+|||||++.... .|+..+|+||||++..||.-|.+|+.+.-
T Consensus 165 vDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH---------- 232 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH---------- 232 (953)
T ss_pred eeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc----------
Confidence 99999998876443 456688999999999997643 47889999999999999999999997443
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.+..+|.+...|+|... .|..-+..+.|||..||.+|-++||+..++|.|
T Consensus 233 -PmraLF~IpRNPPPkLk-----------------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 233 -PMRALFLIPRNPPPKLK-----------------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -hhhhhccCCCCCCcccc-----------------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 45567777766665422 122224568899999999999999999999999
Q ss_pred ccCCC
Q 011808 336 EYFRI 340 (477)
Q Consensus 336 ~~f~~ 340 (477)
||.+.
T Consensus 283 pFi~e 287 (953)
T KOG0587|consen 283 PFITE 287 (953)
T ss_pred Ccccc
Confidence 99974
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=297.81 Aligned_cols=261 Identities=20% Similarity=0.332 Sum_probs=197.4
Q ss_pred ccceeEEeeecccCceEEEEEEEeccc-CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAA-NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++.+.||+|+||.||+|.+..+. ..+..|++|.+.... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 468999999999999999999876421 236789999886432 223345677899999999999999999987654 34
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcc---cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDK---VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+++++|+. ++|.+++...... ....+++..++.++.||+.||.|||+++++||||||+||++ ++++.+||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~----~~~~~~kl 158 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI----DEELQVKI 158 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE----cCCCcEEE
Confidence 6789999987 6888888664321 01458899999999999999999999999999999999999 66678999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~ 258 (477)
+|||+++.+.............++..|+|||++.+. .++.++|||||||++|++++ |+.||...+. .
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~--- 226 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------F--- 226 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------H---
Confidence 999999865432211111223346779999999774 48999999999999999999 9999975431 1
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.+...+.... ....+..+++.+.++|.+||..||++|||+.+++.
T Consensus 227 -~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 227 -EMAAYLKDGY------------------------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -HHHHHHHcCC------------------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111111100 00012233567999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=289.74 Aligned_cols=250 Identities=24% Similarity=0.445 Sum_probs=193.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
..+|++.+.||+|+||.||++.+. .+..+++|.+..... ....+.+|++++++++||||+++++++.... .
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~----~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL----EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS--P 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe----CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC--c
Confidence 358999999999999999999764 256799998865432 2346788999999999999999999886543 6
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.|++|||+. ++|.+++.... ..+++..++.++.|++.+|.|||+.+++|+||||+||++ +.++.+||+|||
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i----~~~~~~~l~d~g 145 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV----GENQVVKVSDFG 145 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE----cCCCeEEECCCc
Confidence 899999998 57777776432 357889999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++........ .......++..|+|||++.+. .++.++|||||||++|+|++ |..||..... .. +.
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~----~~ 211 (256)
T cd05112 146 MTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SE----VV 211 (256)
T ss_pred ceeecccCcc-cccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HH----HH
Confidence 9876543211 112223346789999999764 48899999999999999998 9999975431 11 11
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..+... .....+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 212 ~~~~~~------------------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 212 ETINAG------------------------------FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHhCC------------------------------CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 111100 0001122235779999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=292.68 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=186.1
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEec
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
+.||+|+||.||+|.+.........+|||.+..... ......+.+|+.+++.++||||+++++++...+ ...+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEEec
Confidence 468999999999998765444567899998854322 223456778999999999999999999776433 357899999
Q ss_pred cC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 112 AE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 112 ~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
+. ++|.+++.... ..+++..+..++.||++||.|||+.+|+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 79 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili----~~~~~~kl~dfg~~~~~~~ 150 (262)
T cd05058 79 MKHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML----DESFTVKVADFGLARDIYD 150 (262)
T ss_pred CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE----cCCCcEEECCccccccccC
Confidence 87 68888886532 246777888999999999999999999999999999999 6677899999999975533
Q ss_pred CCC--cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCC
Q 011808 191 PLK--FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267 (477)
Q Consensus 191 ~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~ 267 (477)
... ........++..|+|||.+.+. .++.++|||||||++|||++ |.+||...+. .+ +...+..
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~----~~~~~~~ 217 (262)
T cd05058 151 KEYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------FD----ITVYLLQ 217 (262)
T ss_pred CcceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HH----HHHHHhc
Confidence 211 1111223446789999998764 48999999999999999999 5677754321 11 1111111
Q ss_pred CCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
... ...+...+..+.++|.+||..||++||++.+++..
T Consensus 218 ~~~------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 218 GRR------------------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CCC------------------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 000 00122235678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=291.90 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=193.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||++.+. .+..+++|.+.... .....+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~----~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~ 74 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EP 74 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec----CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CC
Confidence 578999999999999999999754 35669999886532 224567889999999999999999998865 36
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+++|||+. ++|.+++.... ...++...+..++.||+.||.|||+.|++|+||||+||++ +..+.+||+|||
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i----~~~~~~~l~d~~ 147 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV----SASLVCKIADFG 147 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE----cCCCcEEECCCc
Confidence 799999997 68988887642 3457888999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++......... ......++..|+|||++.+ ..++.++|+|||||++|++++ |+.||.+.+. .+....+.
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~ 217 (260)
T cd05073 148 LARVIEDNEYT-AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALE 217 (260)
T ss_pred ceeeccCCCcc-cccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHh
Confidence 99765432211 1122334677999999976 448889999999999999999 9999975441 11111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.... ...+...+..+.++|.+||+.||++||++.++++
T Consensus 218 ---~~~~-------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 218 ---RGYR-------------------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ---CCCC-------------------------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0000 0012233567999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=295.18 Aligned_cols=246 Identities=18% Similarity=0.303 Sum_probs=181.7
Q ss_pred eeecccCceEEEEEEEeccc---------CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 32 GKIGEGTYGLVFLARIKAAA---------NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
+.||+|+||.||+|+..... .....+++|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 46899999999999753211 123468888876533 223446678899999999999999999987643
Q ss_pred ceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCC---CcccEE
Q 011808 103 MSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE---EQGVVK 178 (477)
Q Consensus 103 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~---~~~~vk 178 (477)
..+++|||+++ .|..++... ...+++..++.++.||+.||.|||+++|+||||||+|||+..++. ....++
T Consensus 78 -~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 78 -ENIMVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred -CCEEEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeE
Confidence 57899999985 555555432 236899999999999999999999999999999999999954321 122489
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCcccccCCCcccHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELL-TLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ell-tG~~PF~~~~~~~~~~~~~~~~ 257 (477)
++|||++..... .....++..|+|||++.+...++.++|||||||++|+|+ +|..||...... .
T Consensus 153 l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---------~ 217 (262)
T cd05077 153 LSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA---------E 217 (262)
T ss_pred eCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh---------H
Confidence 999999875432 122446888999999875566899999999999999998 588888654311 1
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
...+... .. ......+.++.+||.+||+.||.+||++.+++.+
T Consensus 218 ~~~~~~~---~~--------------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 218 KERFYEG---QC--------------------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHhc---Cc--------------------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 1111100 00 0011123568899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.79 Aligned_cols=290 Identities=30% Similarity=0.444 Sum_probs=212.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC------CCCeeEEEEEEE
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT------HENVVKLVNVHI 98 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~------hpnIv~l~~~~~ 98 (477)
-.+|.+....|+|-|++|..|++.. .+..||||+|...... ...-++|++||++|. --|+++|+..|.
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~---r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQA---RGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred cceeEEEeccccceeeeeeeccccC---CCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 3689999999999999999998764 5779999999876543 345568999999995 358899998886
Q ss_pred cCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 99 NHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 99 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
... ++|||||.+.-+|.++|..... +-.|....++.|..||+.||..|-..||+|+||||+|||+. .....+|
T Consensus 505 hkn--HLClVFE~LslNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN---E~k~iLK 577 (752)
T KOG0670|consen 505 HKN--HLCLVFEPLSLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN---ESKNILK 577 (752)
T ss_pred hcc--eeEEEehhhhchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec---cCcceee
Confidence 644 8999999999999999998764 34688889999999999999999999999999999999994 4567899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|||||.|....... .+.+..+.+|.|||++.|.. |+...|+||+||+||||.||+..|.|.+. ..-+
T Consensus 578 LCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TN--------N~ML 644 (752)
T KOG0670|consen 578 LCDFGSASFASENE----ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTN--------NQML 644 (752)
T ss_pred eccCcccccccccc----ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCc--------HHHH
Confidence 99999998765432 22355588999999999955 99999999999999999999999999873 2333
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccc---cccCCC----CccccC---------C--CCC-------chHHH
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGR---KYETNG----LHSVVP---------L--SPK-------SPAYD 313 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~----~~~~~p---------~--~~s-------~~~~d 313 (477)
...+.+-|..+...+..-.-+....+..+++-.. +..... +..+.| . ..+ ..+.|
T Consensus 645 rl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rd 724 (752)
T KOG0670|consen 645 RLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRD 724 (752)
T ss_pred HHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHH
Confidence 3333433333322111111111111111111111 000000 001111 0 011 12779
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 314 LLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 314 li~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
||.+||..||++|.|..++|.||||..
T Consensus 725 LLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 725 LLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHHhccChhhcCCHHHHhcCCcccC
Confidence 999999999999999999999999963
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=319.59 Aligned_cols=210 Identities=28% Similarity=0.415 Sum_probs=178.1
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC----
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA---- 101 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 101 (477)
.-|...+.||+|+||.||+++++. +|+.||||.++... ...-.....+|+++|++|+|+|||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnke---tG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKE---TGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred cceeehhhhcCCccceeeeecccc---cccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 457788899999999999999775 79999999998755 3344567788999999999999999999754443
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
...-+++||||. |+|+..+++-. ....|+|.+++.++..+..||.|||++|||||||||.||++-...+..-..||+
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 334689999998 68888887633 234799999999999999999999999999999999999997655566789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGA 244 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~ 244 (477)
|||.|+.++.... -...+||..|++||++-..+.|+..+|.|||||++|+++||..||...
T Consensus 167 DfG~Arel~d~s~---~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 167 DFGAARELDDNSL---FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cccccccCCCCCe---eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9999998876542 345789999999999975567999999999999999999999999644
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=293.03 Aligned_cols=260 Identities=23% Similarity=0.411 Sum_probs=197.6
Q ss_pred cceeEEeeecccCceEEEEEEEeccc--CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAA--NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
++|++++.||+|+||.||+|+.+... .....+++|.+..... ......+.+|+.++++++|+||+++++++.+. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREA--E 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCC--C
Confidence 67999999999999999999876432 2456799998865332 22345678899999999999999999988553 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhccc----CCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKV----NHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
..|+||||+. ++|.+++....... ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili----~~~~~~~ 157 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV----SSQREVK 157 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE----eCCCcEE
Confidence 7899999998 68888887643211 1258999999999999999999999999999999999999 6667899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~ 257 (477)
|+|||++....... ........++..|+|||.+.+.. ++.++|||||||++|+|++ |..||..... ..
T Consensus 158 l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~- 226 (275)
T cd05046 158 VSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EE- 226 (275)
T ss_pred EcccccccccCccc-ccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccch--------HH-
Confidence 99999987543221 11223345678899999987644 7889999999999999998 8889965431 11
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+...+.... +....+...+..+.++|.+||..||.+|||+.+++.+
T Consensus 227 ---~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 227 ---VLNRLQAGK-----------------------------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ---HHHHHHcCC-----------------------------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 111111000 0011223345789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=295.05 Aligned_cols=270 Identities=30% Similarity=0.438 Sum_probs=201.1
Q ss_pred cceeEEeeecccCceEEEEEEEecc-cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAA-ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.+|++.+.||+|+||.||+|.+... ..++..+|||++...... .....+.+|+.+++.++|+||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 5688999999999999999986532 345789999999765443 23557788999999999999999999987766668
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+++|||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~----~~~~~~~l~dfg 154 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV----ESEDLVKISDFG 154 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE----cCCCCEEEcccc
Confidence 999999997 68888886542 258899999999999999999999999999999999999 666889999999
Q ss_pred cceeecCCCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCC---cccHHHHH
Q 011808 184 LARIYQAPLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN---PFQLDQLD 259 (477)
Q Consensus 184 ~a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~---~~~~~~~~ 259 (477)
++.......... ......++..|+|||.+.+. .++.++|||||||++|+|++|..||.......... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05038 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233 (284)
T ss_pred cccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence 998765322111 11112335679999999764 48889999999999999999999986543211000 00000011
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.+...+... .....+..++..+.+||.+||..||.+|||+.++++.
T Consensus 234 ~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05038 234 RLLELLKEG------------------------------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279 (284)
T ss_pred HHHHHHHcC------------------------------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 111111100 0111223345679999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=290.36 Aligned_cols=244 Identities=26% Similarity=0.466 Sum_probs=191.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|++.+.||+|+||.||++.. ++..+|+|.++... ....+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~ 72 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-----TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN---G 72 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-----CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---C
Confidence 47899999999999999999852 46789999986532 235678899999999999999999998643 3
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+++|||+. ++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||++ +.++.+||+|||
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili----~~~~~~kl~Dfg 145 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV----SEDGVAKVSDFG 145 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE----cCCCcEEECCCc
Confidence 689999988 69988887643 3358899999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++....... .....+..|+|||.+.+. .++.++|+|||||++|+|++ |++||...+.. + +.
T Consensus 146 ~~~~~~~~~-----~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~----~~ 207 (254)
T cd05083 146 LARVGSMGV-----DNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--------E----VK 207 (254)
T ss_pred cceeccccC-----CCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--------H----HH
Confidence 997643221 112235679999998764 48899999999999999998 99999755421 1 11
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..+.... ....+...+..+.+||.+||+.+|.+||++++++..
T Consensus 208 ~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 208 ECVEKGY------------------------------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred HHHhCCC------------------------------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111000 000122345778999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=288.23 Aligned_cols=246 Identities=25% Similarity=0.427 Sum_probs=188.7
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEec
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
++||+|+||.||+|.+. . +..|++|.+...... .....+.+|+++++.++|+||+++++++.+.. ..+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~---~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK---G-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--PIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEe---C-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--CeEEEEEc
Confidence 47999999999999754 2 788999998765433 23457788999999999999999999986644 78999999
Q ss_pred cC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 112 AE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 112 ~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
+. ++|.+++... ...+++..+..++.+++.+|.|||+++++||||||+|||+ +.++.+||+|||++.....
T Consensus 74 ~~~~~l~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili----~~~~~~~l~d~g~~~~~~~ 145 (251)
T cd05041 74 VPGGSLLTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV----GENNVLKISDFGMSREEEG 145 (251)
T ss_pred CCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE----cCCCcEEEeeccccccccC
Confidence 86 6788887653 2357889999999999999999999999999999999999 6677899999999976542
Q ss_pred CCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCCC
Q 011808 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPT 269 (477)
Q Consensus 191 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 269 (477)
............+..|+|||.+.+. .++.++|+|||||++|+|++ |..||..... .. .. ..+....
T Consensus 146 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~-~~---~~~~~~~ 212 (251)
T cd05041 146 GIYTVSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQ-TR---ERIESGY 212 (251)
T ss_pred CcceeccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HH-HH---HHHhcCC
Confidence 2211111122235679999998764 48999999999999999999 8899975542 11 11 1111000
Q ss_pred CCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 270 PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
....+...+..+.+||.+||..+|.+|||+.++++.
T Consensus 213 ------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~ 248 (251)
T cd05041 213 ------------------------------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNE 248 (251)
T ss_pred ------------------------------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 001223345689999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=306.84 Aligned_cols=248 Identities=27% Similarity=0.442 Sum_probs=203.5
Q ss_pred EeeecccCceEEEEEEEecc-cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEE
Q 011808 31 IGKIGEGTYGLVFLARIKAA-ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~ 109 (477)
.++||.|-||.||+|.+... ....-.||||..+.+...+. .+.++.|..+|+.++||||++|++++... ..+|||
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIGv~~e~---P~Wivm 469 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIGVCVEQ---PMWIVM 469 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheeeeeecc---ceeEEE
Confidence 34789999999999987654 33344799999988666554 67899999999999999999999999654 589999
Q ss_pred eccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 110 DYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 110 e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
|++. |.|..+|+... ..++......+.+||+.||.|||+.++|||||-.+|||+ .+.-.|||+|||+++.+
T Consensus 470 EL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV----sSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV----SSPQCVKLADFGLSRYL 541 (974)
T ss_pred ecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee----cCcceeeecccchhhhc
Confidence 9998 89999998864 468888899999999999999999999999999999999 55557999999999988
Q ss_pred cCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCC
Q 011808 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGH 267 (477)
Q Consensus 189 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~ 267 (477)
.....+... ...-..-|||||.+.- +.++.++|||.|||++||++. |..||.+-...+. |
T Consensus 542 ed~~yYkaS-~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV---------------I-- 602 (974)
T KOG4257|consen 542 EDDAYYKAS-RGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV---------------I-- 602 (974)
T ss_pred cccchhhcc-ccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccce---------------E--
Confidence 765444333 2333678999999965 459999999999999999886 8999987653211 1
Q ss_pred CCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 268 PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
...+++.+...|..+++.++.|+.+||.+||.+||++.++..
T Consensus 603 -------------------------~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 603 -------------------------GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred -------------------------EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 112344555678899999999999999999999999887653
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=292.15 Aligned_cols=250 Identities=29% Similarity=0.415 Sum_probs=185.6
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCceEEEEEe
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHADMSLYLAFD 110 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~lv~e 110 (477)
+.||+|+||.||+|+++.+ .....+++|.++.... ......+.+|+.++.++ +||||+++++++... ..+|++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~-~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCC-CCeeEEEEEEccccCC-HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEE
Confidence 4689999999999987642 1223578888864322 22334677899999999 899999999998664 36899999
Q ss_pred ccC-CCHHHHHHhhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 111 YAE-YDLYEIIRHHRDK-----------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 111 ~~~-~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
|+. ++|.+++...... ....+++..++.++.||+.||+|||++|++||||||+|||+ ++++.+|
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili----~~~~~~k 152 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV----GENYVAK 152 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE----cCCCeEE
Confidence 987 6898888754311 11247889999999999999999999999999999999999 6777899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~ 257 (477)
|+|||++....... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+. .+
T Consensus 153 l~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~- 219 (270)
T cd05047 153 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AE- 219 (270)
T ss_pred ECCCCCccccchhh---hccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HH-
Confidence 99999986332111 1111222567999999876 448999999999999999997 9999965431 11
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.+..+.... ....+...+.++.+||.+||..||.+|||+.+++..
T Consensus 220 ---~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 220 ---LYEKLPQGY------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred ---HHHHHhCCC------------------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 111110000 000122345678999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=310.33 Aligned_cols=257 Identities=27% Similarity=0.440 Sum_probs=211.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+++.+++..||-|+||.|=+++.+. ....+|+|++++...- ......+..|-+||..++.|.||++|..|.+. .
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~---~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~--k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNS---QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS--K 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecc---cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc--h
Confidence 5788899999999999999997653 2335888888765433 33455677899999999999999999998664 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
++|+.||-|- |.++..+++. +.+.+..++.++..+++|++|||++|||+|||||+|+|| +.+|.+||.||
T Consensus 494 yvYmLmEaClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL----d~~Gy~KLVDF 564 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL----DNRGYLKLVDF 564 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee----ccCCceEEeeh
Confidence 8999999764 7888888874 468899999999999999999999999999999999999 88999999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+|+.+....+ ..++||||.|.|||++.+.. .+.++|.||||+++||||+|.+||.+.+.. ...+.|.
T Consensus 565 GFAKki~~g~K---TwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpm--------ktYn~IL 632 (732)
T KOG0614|consen 565 GFAKKIGSGRK---TWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPM--------KTYNLIL 632 (732)
T ss_pred hhHHHhccCCc---eeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchH--------HHHHHHH
Confidence 99998876543 34589999999999999854 789999999999999999999999987732 2223333
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCcc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHEY 337 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~~ 337 (477)
+-+. ...+|..++..+.+||+++...+|.+|.. +.++..|.|
T Consensus 633 kGid---------------------------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 633 KGID---------------------------------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred hhhh---------------------------------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 2221 01145556678999999999999999985 899999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|..
T Consensus 680 f~g 682 (732)
T KOG0614|consen 680 FEG 682 (732)
T ss_pred hhc
Confidence 963
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=290.18 Aligned_cols=256 Identities=20% Similarity=0.316 Sum_probs=185.2
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEec
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
++||+|+||.||++.... ......+++|.+..... ......+.+|+.+++.++||||+++++++.+. ..+|+||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~-~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 76 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYT-DTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFEY 76 (268)
T ss_pred CcCCCCcCceEEEEEEEc-CCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEec
Confidence 369999999999997543 23445677787765432 22345778899999999999999999998754 478999999
Q ss_pred cC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 112 AE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 112 ~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
+. ++|.+++...... ...+++..++.++.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||++.....
T Consensus 77 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~----~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 77 CELGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL----TSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred CCCCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE----cCCccEEecccccccccCc
Confidence 98 5888888764322 2356777889999999999999999999999999999999 6677899999999864322
Q ss_pred CCCcccCCCeeeccccccchhhcCC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 191 PLKFLSENGVVVTIWYRAPELLLGA------KHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 191 ~~~~~~~~~~~gt~~y~APE~l~~~------~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
..........+++..|+|||++... ..++.++|||||||++|||++ |..||...+. .+.+..+..
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~ 223 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVIK 223 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHh
Confidence 2111222345668899999998531 235778999999999999997 5778865431 222222211
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
. ..... .....+...++.+.++|..|| .||++||+++++++
T Consensus 224 ~---~~~~~--------------------------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 224 D---QQVKL--------------------------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred h---ccccc--------------------------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 1 00000 001122234567889999999 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=293.61 Aligned_cols=245 Identities=18% Similarity=0.297 Sum_probs=182.3
Q ss_pred eecccCceEEEEEEEecc---------------------cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCee
Q 011808 33 KIGEGTYGLVFLARIKAA---------------------ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVV 91 (477)
Q Consensus 33 ~lG~G~~g~Vy~a~~~~~---------------------~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv 91 (477)
.||+|+||.||++..... ......|++|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 699999999999975321 1123468888886432 22234667889999999999999
Q ss_pred EEEEEEEcCCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc
Q 011808 92 KLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 92 ~l~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~ 170 (477)
++++++.+.. ..++||||+++ +|..++... ...+++..+..++.||+.||+|||+++|+||||||+|||+...
T Consensus 80 ~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 80 FVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARL 153 (274)
T ss_pred eEEEEEEeCC--ceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEecc
Confidence 9999987644 67999999995 565565442 2368899999999999999999999999999999999999643
Q ss_pred CC---CcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCccc
Q 011808 171 GE---EQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELL-TLKPLFQGAEA 246 (477)
Q Consensus 171 ~~---~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ell-tG~~PF~~~~~ 246 (477)
+. ....+||+|||++...... ....++..|+|||++.+...++.++|||||||++|||+ +|..||.....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 22 2345899999988643221 12345788999999976566899999999999999985 69999975432
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
. .....+... ...+......+.+||.+||+.||++|
T Consensus 228 ~---------~~~~~~~~~-----------------------------------~~~~~~~~~~~~~li~~cl~~~p~~R 263 (274)
T cd05076 228 S---------EKERFYEKK-----------------------------------HRLPEPSCKELATLISQCLTYEPTQR 263 (274)
T ss_pred H---------HHHHHHHhc-----------------------------------cCCCCCCChHHHHHHHHHcccChhhC
Confidence 1 111111100 00111223568899999999999999
Q ss_pred CCHHHHhcC
Q 011808 327 ITAAQALEH 335 (477)
Q Consensus 327 pt~~e~L~h 335 (477)
||+.++|++
T Consensus 264 ps~~~il~~ 272 (274)
T cd05076 264 PSFRTILRD 272 (274)
T ss_pred cCHHHHHHh
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=286.61 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=194.6
Q ss_pred eeEEeeecccCceEEEEEEEeccc-CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAA-NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
+.+.+.||.|+||.||++.+.... ..+..+|+|++...... .....+..|+.+++.++|+||+++++++.+. ...|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcCC--CeeE
Confidence 357889999999999999876421 12488999999654332 1445777899999999999999999998765 4789
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
++|||+. ++|.+++..... ..+++..+..++.||+.||.|||+.+++|+||||+||++ +.++.++|+|||++
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~----~~~~~~~l~dfg~~ 150 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV----GENLVVKISDFGLS 150 (258)
T ss_pred EEEeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE----ccCCeEEEcccCCc
Confidence 9999997 588888766431 128999999999999999999999999999999999999 66778999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
............ ...++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+. .+ +...
T Consensus 151 ~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~----~~~~ 216 (258)
T smart00219 151 RDLYDDDYYKKK-GGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EE----VLEY 216 (258)
T ss_pred eecccccccccc-cCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HH----HHHH
Confidence 876544222211 2225788999999965 458999999999999999998 8899875331 11 1111
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
+..... ...+...+..+.++|.+||..||++|||+.++++
T Consensus 217 ~~~~~~------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 217 LKKGYR------------------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HhcCCC------------------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 111000 0112234678999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=288.21 Aligned_cols=245 Identities=33% Similarity=0.507 Sum_probs=195.1
Q ss_pred ecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEecc
Q 011808 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYA 112 (477)
Q Consensus 34 lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~ 112 (477)
||.|+||.||++.+.. ++..+++|.+....... .....+..|+.+++.++|+||+++++.+.+. ..+|++|||+
T Consensus 1 lg~G~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE--EKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC--CeeEEEEecC
Confidence 6999999999998653 57899999987654332 2344677899999999999999999988653 4789999999
Q ss_pred -CCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCC
Q 011808 113 -EYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191 (477)
Q Consensus 113 -~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~ 191 (477)
+++|.+++... ..+++..+..++.||+.||.|||+.+++|+||+|+||++ +.++.++|+|||++......
T Consensus 76 ~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~----~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 76 PGGELFSHLSKE-----GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL----DADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE----cCCCcEEEeecCcceecccC
Confidence 57888888763 268999999999999999999999999999999999999 66678999999999865442
Q ss_pred CCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCC
Q 011808 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPE 271 (477)
Q Consensus 192 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 271 (477)
.. ......++..|++||.+.+.. .+.++|+||||+++|+|++|..||...+. ..+...+...
T Consensus 147 ~~--~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~------------~~~~~~~~~~--- 208 (250)
T cd05123 147 GS--RTNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDR------------KEIYEKILKD--- 208 (250)
T ss_pred CC--cccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHhcC---
Confidence 11 123345688999999997744 78899999999999999999999965431 1111111100
Q ss_pred CccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH---HHHhcCccC
Q 011808 272 KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA---AQALEHEYF 338 (477)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~---~e~L~h~~f 338 (477)
...++...+..+.+||++||..||++||++ .+++.||||
T Consensus 209 ----------------------------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 209 ----------------------------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ----------------------------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 011233345789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=285.88 Aligned_cols=245 Identities=24% Similarity=0.406 Sum_probs=186.7
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEec
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
++||+|+||.||+|.+. ++..+|+|.++.... ......+.+|+.+++.++||||+++++++.... ..+++|||
T Consensus 1 ~~ig~g~~g~vy~~~~~----~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec----CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEEEC
Confidence 47999999999999743 477899999875432 222346778999999999999999999986643 68999999
Q ss_pred cC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 112 AE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 112 ~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
+. ++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++.....
T Consensus 74 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili----~~~~~~~l~d~g~~~~~~~ 145 (250)
T cd05085 74 VPGGDFLSFLRKK----KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV----GENNVLKISDFGMSRQEDD 145 (250)
T ss_pred CCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE----cCCCeEEECCCccceeccc
Confidence 87 6887777543 2357899999999999999999999999999999999999 6677899999999875433
Q ss_pred CCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCCC
Q 011808 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPT 269 (477)
Q Consensus 191 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 269 (477)
.... ......++..|+|||++.+. .++.++|||||||++|++++ |..||.+... .... ..+....
T Consensus 146 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--------~~~~----~~~~~~~ 211 (250)
T cd05085 146 GIYS-SSGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTN--------QQAR----EQVEKGY 211 (250)
T ss_pred cccc-cCCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--------HHHH----HHHHcCC
Confidence 2111 11112335679999999764 48899999999999999998 9999975432 1111 1111000
Q ss_pred CCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 270 PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
....+...+..+.+||.+||..||++||++.++++.
T Consensus 212 ------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 212 ------------------------------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred ------------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 001223345789999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=293.59 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=190.5
Q ss_pred eeecccCceEEEEEEEeccc---CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAA---NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLA 108 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv 108 (477)
+.||+|+||.||+|+++... ..+..++||.+..... ......+.+|+.+++.++||||+++++++.... ..+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE--PQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--CeEEE
Confidence 46999999999999875421 2346799998865432 233457788999999999999999999986643 68999
Q ss_pred EeccC-CCHHHHHHhhhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC-CCcccEEEeeccc
Q 011808 109 FDYAE-YDLYEIIRHHRDK--VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG-EEQGVVKIADFGL 184 (477)
Q Consensus 109 ~e~~~-~~L~~~l~~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~-~~~~~vkL~DFG~ 184 (477)
|||+. ++|.+++...... ....+++..+..++.||+.||.|||+.+++|+||||+||++..++ +....++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99987 6888888764321 123478899999999999999999999999999999999995432 1223799999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+................++..|+|||++.+. .++.++|||||||++|+|++ |+.||...+. .+ +..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------~~----~~~ 224 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------QE----VLQ 224 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCH--------HH----HHH
Confidence 9765433222222223446789999999874 48999999999999999998 9999975431 11 111
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.+.... ....+...+..+.+||.+||..+|.+||+++++++
T Consensus 225 ~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 225 HVTAGG------------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHhcCC------------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 111000 00122234567899999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=290.31 Aligned_cols=263 Identities=20% Similarity=0.315 Sum_probs=203.6
Q ss_pred eEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHh-cCCCCeeEEEEEEEcCCCceEEE
Q 011808 29 NLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE-ITHENVVKLVNVHINHADMSLYL 107 (477)
Q Consensus 29 ~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~~~l 107 (477)
+-+..||.|+||+|++..++. .|+..|||.++.... +....+++.|.....+ -+.||||++++..+.+.+ -||
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~---sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--cWi 140 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKP---SGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--CWI 140 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCc---cCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc--eee
Confidence 335689999999999998775 799999999987665 3344577778875544 479999999999887664 588
Q ss_pred EEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 108 AFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 108 v~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
.||+++-++..+...-.......++|..+-.|..-...||+||-.. .||||||||+|||+ +..|.|||||||++-
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl----dr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL----DRHGDVKLCDFGICG 216 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE----ecCCCEeeecccchH
Confidence 8999997766554443333355799999999999999999999965 89999999999999 777889999999997
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKH-YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
.+.... ..+...|-..|||||.+..... |+.++|+||||++|||+.||+.||.+.+. .++.+-.+.
T Consensus 217 qLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----------vfeql~~Vv 283 (361)
T KOG1006|consen 217 QLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----------VFEQLCQVV 283 (361)
T ss_pred hHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----------HHHHHHHHH
Confidence 665422 2334566888999999976544 99999999999999999999999987652 344444433
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
...+|...... -....+.++..||.-||.+|-..||...+++.++|++.
T Consensus 284 ~gdpp~l~~~~--------------------------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 284 IGDPPILLFDK--------------------------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred cCCCCeecCcc--------------------------cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 22222211100 11234678999999999999999999999999999874
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=293.68 Aligned_cols=246 Identities=15% Similarity=0.293 Sum_probs=184.1
Q ss_pred eeecccCceEEEEEEEecccC----CCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAAN----RGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYL 107 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~l 107 (477)
+.||+|+||.||+|.++.... ....+++|.+.... ......+.+|+.+++.++||||+++++++.... ..++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--CcEE
Confidence 469999999999998754321 23457888775432 223446678999999999999999999987644 5789
Q ss_pred EEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCC----CcccEEEeec
Q 011808 108 AFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE----EQGVVKIADF 182 (477)
Q Consensus 108 v~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~----~~~~vkL~DF 182 (477)
||||+. ++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||+..++. ..+.++|+||
T Consensus 77 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEecCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999998 57878876542 25888999999999999999999999999999999999964432 1234899999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|++...... ....++..|+|||++.+...++.++|||||||++|+|++| .+||...+. ....
T Consensus 153 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~~--- 215 (258)
T cd05078 153 GISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKL--- 215 (258)
T ss_pred ccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHHH---
Confidence 998754321 2244588899999998756689999999999999999998 466654331 1111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
...... ...+...+..+.+||.+||+.||.+|||++++++.
T Consensus 216 -~~~~~~--------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 216 -QFYEDR--------------------------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -HHHHcc--------------------------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 111000 01222334678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=302.80 Aligned_cols=204 Identities=27% Similarity=0.435 Sum_probs=168.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.+.|.-...||+|+||.||+|... ++..||||.+....... ..++.+|+.++.+++|||+|+|+++|.+.++ .
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~----~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~ 146 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLS----DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-H 146 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEEC----CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-e
Confidence 357777889999999999999754 35899999876654432 4569999999999999999999999987654 5
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC---eecCCCCCCcEEEeccCCCcccEEEe
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW---IIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.+||+||+. |+|.+.|...... .++.....+|+.+++.||+|||... |||||||++|||| ++++..||+
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL----D~~~~aKls 219 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL----DEDFNAKLS 219 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE----CCCCCEEcc
Confidence 899999999 7988888654321 7899999999999999999999854 9999999999999 889999999
Q ss_pred ecccceeecCCCCcccCCCe-eeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 011808 181 DFGLARIYQAPLKFLSENGV-VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAE 245 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~-~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~ 245 (477)
|||+|+....... ..... .||.+|+|||.+.. ...+.++|||||||+|.||+||+.+.....
T Consensus 220 DFGLa~~~~~~~~--~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 220 DFGLAKLGPEGDT--SVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred CccCcccCCcccc--ceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCC
Confidence 9999965432111 11112 67999999999976 448999999999999999999998876543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=286.79 Aligned_cols=228 Identities=26% Similarity=0.364 Sum_probs=179.3
Q ss_pred cCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEeccC-CC
Q 011808 37 GTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAE-YD 115 (477)
Q Consensus 37 G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~-~~ 115 (477)
|.||.||+|+++. +++.||+|.++.... ..+|...+....||||+++++++.+. ...|++|||+. ++
T Consensus 4 g~~~~v~~~~~~~---~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTR---TQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEcc---CCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCC
Confidence 8999999998764 688999999976432 22455555566799999999998764 47899999998 58
Q ss_pred HHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcc
Q 011808 116 LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195 (477)
Q Consensus 116 L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~ 195 (477)
|.+++.... .+++..+..++.|+++||.|||++||+||||||+||++ +.++.++|+|||.+.......
T Consensus 72 L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~~l~df~~~~~~~~~~--- 139 (237)
T cd05576 72 LWSHISKFL-----NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL----DDRGHIQLTYFSRWSEVEDSC--- 139 (237)
T ss_pred HHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE----cCCCCEEEecccchhcccccc---
Confidence 888886532 58999999999999999999999999999999999999 667779999999886554321
Q ss_pred cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccc
Q 011808 196 SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPT 275 (477)
Q Consensus 196 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 275 (477)
....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...... +...
T Consensus 140 --~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------~~~~------- 192 (237)
T cd05576 140 --DGEAVENMYCAPEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSG-----------------INTH------- 192 (237)
T ss_pred --ccCCcCccccCCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------cccc-------
Confidence 223447789999998664 4788999999999999999999887532110 0000
Q ss_pred cCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH-----HHHhcCccC
Q 011808 276 LANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA-----AQALEHEYF 338 (477)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~-----~e~L~h~~f 338 (477)
.....+...+..+++||++||+.||.+|+++ ++++.||||
T Consensus 193 -----------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 193 -----------------------TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred -----------------------cccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0001233346789999999999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=308.99 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=198.8
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcE-EEEEecccCC-CCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKA-IAIKKFKQSK-DGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~-vaiK~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
++-.+.++||+|+||.||+|+.+........ ||||..+... ........+++|+++|+.++|||||+++|+.... .
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~--~ 234 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE--E 234 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--C
Confidence 4455678999999999999998764321223 8999988633 4455677889999999999999999999998664 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.++||||+|. |+|.++|++.. ..++..+...++.+.+.||+|||++++|||||-.+|+|+ ..++.+||+||
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~----~~~~~vKISDF 306 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY----SKKGVVKISDF 306 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee----cCCCeEEeCcc
Confidence 7999999999 59999998753 258999999999999999999999999999999999999 66667899999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|+++.-.... ......-....|+|||.+... .|+.++|||||||++||+++ |..||.+.... +....+
T Consensus 307 GLs~~~~~~~--~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI 375 (474)
T KOG0194|consen 307 GLSRAGSQYV--MKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKI 375 (474)
T ss_pred ccccCCccee--eccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHH
Confidence 9987543111 011011236789999999875 69999999999999999998 78899877632 222222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.. .+.....|...+..+..++.+|+..||++|+|+.++.+.
T Consensus 376 ~~---------------------------------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~ 416 (474)
T KOG0194|consen 376 VK---------------------------------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKK 416 (474)
T ss_pred Hh---------------------------------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHH
Confidence 11 111122334445778899999999999999999987653
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=294.48 Aligned_cols=256 Identities=21% Similarity=0.333 Sum_probs=193.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCC-CcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANR-GKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++.+.||+|+||.||+|.+..+... ...+|+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 35789999999999999999987643111 13578888865432 22233567899999999999999999988653
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..+++++|+. ++|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+||
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill----~~~~~~kL~Df 153 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV----KSPNHVKITDF 153 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee----cCCCceEEccc
Confidence 3578899987 68888886542 357888999999999999999999999999999999999 56677999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|+++.+.............++..|+|||++.+. .++.++|||||||++|||++ |..||.+... .....+
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---------~~~~~~ 223 (303)
T cd05110 154 GLARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------REIPDL 223 (303)
T ss_pred cccccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHH
Confidence 999866533222222233447789999999764 48999999999999999997 8999965431 112222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
...... ...+...+..+.++|.+||..||++||++++++..
T Consensus 224 ~~~~~~---------------------------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 224 LEKGER---------------------------------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHCCCC---------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 211000 00112234678899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.57 Aligned_cols=283 Identities=24% Similarity=0.365 Sum_probs=177.3
Q ss_pred cccceeEEeeecccCceEEEEEEEecc-cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEE----
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAA-ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHI---- 98 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~---- 98 (477)
..++|++.++||+|+||.||+|++..+ ...+..||||++..... ......| .++...+.++..++..+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 367899999999999999999987641 11278899998764321 1111111 122222233333222211
Q ss_pred cCCCceEEEEEeccC-CCHHHHHHhhhcc---------------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCC
Q 011808 99 NHADMSLYLAFDYAE-YDLYEIIRHHRDK---------------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKP 162 (477)
Q Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp 162 (477)
...+..+++||||++ ++|.+++...... ......+..+..++.||+.||.|||+++|+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 133457899999998 5787877643210 001122345678999999999999999999999999
Q ss_pred CcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCC---------------------CCCch
Q 011808 163 SNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAK---------------------HYTSA 221 (477)
Q Consensus 163 ~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---------------------~~~~~ 221 (477)
+|||+. .+.+.+||+|||+++.+...... .....++++.|+|||++.... .++.+
T Consensus 284 ~NILl~---~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 284 QNIIFS---EGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred HHEEEe---CCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999993 23567999999999865433222 223467799999999764321 23456
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCc-
Q 011808 222 VDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLH- 300 (477)
Q Consensus 222 ~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 300 (477)
+|||||||++|||+++..++.. ...++..++...+.. +..|...... . ....+.
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~----------~~~~~~~~l~~~~~~----------~~~~~~~~~~---~--~~~~~~~ 414 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS----------NLIQFNRQLKRNDYD----------LVAWRKLVEP---R--ASPDLRR 414 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch----------HHHHHHHHHHhcCCc----------HHHHHHhhcc---c--cchhhhh
Confidence 7999999999999997665432 223333333322211 0111110000 0 000000
Q ss_pred -cccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 301 -SVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 301 -~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
..........++|||.+||++||++|||+.++|+||||...
T Consensus 415 ~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 415 GFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDRE 456 (566)
T ss_pred hhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCC
Confidence 00111123456799999999999999999999999999743
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=285.75 Aligned_cols=243 Identities=19% Similarity=0.318 Sum_probs=182.0
Q ss_pred eeecccCceEEEEEEEeccc-------CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 32 GKIGEGTYGLVFLARIKAAA-------NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+.||+|+||.||+|.++... .....+++|.+...... ...+.+|+.+++.++|+||+++++++.. . .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~--~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-D--E 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-C--C
Confidence 46999999999999886531 01135778877654322 4677889999999999999999998876 2 4
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCC---CcccEEEe
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE---EQGVVKIA 180 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~---~~~~vkL~ 180 (477)
.++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+..++. ....+||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeC
Confidence 689999998 57777776542 26889999999999999999999999999999999999954321 12269999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|||++..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+.. . .
T Consensus 151 Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--------~-~ 215 (259)
T cd05037 151 DPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--------E-K 215 (259)
T ss_pred CCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--------h-H
Confidence 9999986543 1123446789999999775 358899999999999999999 57888654311 0 0
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
...+.. . ...+......+.+||.+||..||.+|||+.++++
T Consensus 216 ~~~~~~---~--------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 216 ERFYQD---Q--------------------------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHhc---C--------------------------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 001000 0 0011111257889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=283.45 Aligned_cols=263 Identities=27% Similarity=0.442 Sum_probs=206.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREI-THENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 102 (477)
+++|+++++||+|+|++|.+++++. +.+.||+|++++.-.++ +...-...|-.+..+- +||.+|-+..+|.++.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~---t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes- 324 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKK---TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES- 324 (593)
T ss_pred cccceeeeeecCcchhhhhheehcc---cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc-
Confidence 6899999999999999999998764 68899999998765443 3333444577777666 7999999999997654
Q ss_pred ceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+++|.||+.| +|.-.+.+.+ +++|..++.+...|+.||.|||++|||+||||.+|||+ +..|++||+|
T Consensus 325 -rlffvieyv~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~rgiiyrdlkldnvll----daeghikltd 394 (593)
T KOG0695|consen 325 -RLFFVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL----DAEGHIKLTD 394 (593)
T ss_pred -eEEEEEEEecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE----ccCCceeecc
Confidence 78999999884 6665555543 69999999999999999999999999999999999999 8889999999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
+|+++.--.+.. ....+||||.|.|||+++|.. |+.++|+|+|||+++||+.|+.||.--... ++ +.+.-.-+
T Consensus 395 ygmcke~l~~gd--~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~---n~-d~ntedyl 467 (593)
T KOG0695|consen 395 YGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMD---NP-DMNTEDYL 467 (593)
T ss_pred cchhhcCCCCCc--ccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCC---Cc-ccchhHHH
Confidence 999985443333 234589999999999999854 999999999999999999999999743211 11 11222223
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC------CHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI------TAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp------t~~e~L~h 335 (477)
++++.... ..+|...|-.+..+|+..|++||.+|. .++++..|
T Consensus 468 fqvilekq-------------------------------iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h 516 (593)
T KOG0695|consen 468 FQVILEKQ-------------------------------IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSH 516 (593)
T ss_pred HHHHhhhc-------------------------------ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcc
Confidence 44432110 113444455577899999999999997 48899999
Q ss_pred ccCC
Q 011808 336 EYFR 339 (477)
Q Consensus 336 ~~f~ 339 (477)
+||+
T Consensus 517 ~ffr 520 (593)
T KOG0695|consen 517 AFFR 520 (593)
T ss_pred hhhh
Confidence 9997
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=286.44 Aligned_cols=255 Identities=28% Similarity=0.480 Sum_probs=194.1
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC--------CCCCcHHHHHHHHHHHh-cCCCCeeEEEEEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD--------GDGVSPTAIREIMLLRE-ITHENVVKLVNVH 97 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~ 97 (477)
.|++.+.||+|+||.||++.++. ..+..+|+|.+..... .......+.+|+.++++ ++|+||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN--NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC--CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE
Confidence 48899999999999999998764 2567899998864321 12233456678888865 7999999999998
Q ss_pred EcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCCCcEEEeccCCCcc
Q 011808 98 INHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp~NILl~~~~~~~~ 175 (477)
... ...+++|||+. ++|.+++..... ....+++..++.++.|++.+|.|||+ .+|+|+||||+|||+ +.++
T Consensus 79 ~~~--~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~----~~~~ 151 (269)
T cd08528 79 LEN--DRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML----GEDD 151 (269)
T ss_pred ccC--CeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE----CCCC
Confidence 654 47899999998 478777755322 13468999999999999999999996 689999999999999 6677
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccH
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~ 255 (477)
.+||+|||++....... ......++..|+|||++.+. .++.++|+|||||++|+|++|++||...+. .
T Consensus 152 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--------~ 219 (269)
T cd08528 152 KVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNM--------L 219 (269)
T ss_pred cEEEecccceeeccccc---ccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCH--------H
Confidence 89999999998765432 22334568899999999874 489999999999999999999999964431 1
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.....+......+ ......+..+.+||.+||..||++||++.++.++
T Consensus 220 ~~~~~~~~~~~~~---------------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 220 SLATKIVEAVYEP---------------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHhhccCCc---------------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 1111111110000 0011235679999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=308.59 Aligned_cols=259 Identities=22% Similarity=0.363 Sum_probs=210.3
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++..+.++||+|+||.|++|.|.....+...||||+++.+.... ....|++|+.+|.+|+|+|+++||++..+. .+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q---p~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc---hh
Confidence 56788899999999999999998765566689999998776654 567899999999999999999999999763 57
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
.||||++. |+|++.|++.. ...|-......|+.||+.||.||.++++|||||-..|||| .....|||+|||+
T Consensus 186 mMV~ELaplGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll----asprtVKI~DFGL 258 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL----ASPRTVKICDFGL 258 (1039)
T ss_pred hHHhhhcccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee----cccceeeeecccc
Confidence 89999999 79999998722 3467888899999999999999999999999999999999 5566799999999
Q ss_pred ceeecCCCCcccCC-CeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 185 ARIYQAPLKFLSEN-GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 185 a~~~~~~~~~~~~~-~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
.+.+.......... ..-....|+|||.|...+ ++.++|+|++||++|||+| |..||.|... .. |.
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~q----IL 325 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------IQ----IL 325 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCH--------HH----HH
Confidence 99876544332211 112256799999998855 9999999999999999998 7899988762 11 22
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
+.+. .+.....|..++..+++++..||..+|++|||+..|.+.-++
T Consensus 326 ~~iD------------------------------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 326 KNID------------------------------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred Hhcc------------------------------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 2221 112233577888999999999999999999999998755443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=296.88 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=206.4
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
+...+.++||+|-||.|.+|... .+.+||+|+++.....+ ....+.+||++|.+|+||||++|+++|...+ .+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve----g~lkVAVK~Lr~~a~~~-~r~~F~kEIkiLsqLkhPNIveLvGVC~~De--Pi 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE----GPLKVAVKILRPDATKN-ARNDFLKEIKILSRLKHPNIVELLGVCVQDD--PL 610 (807)
T ss_pred hheehhhhhcCcccceeEEEEec----CceEEEEeecCcccchh-HHHHHHHHHHHHhccCCCCeeEEEeeeecCC--ch
Confidence 45788999999999999999643 36899999998765433 4568899999999999999999999997644 78
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
++++||++ |+|.+++..+... .+.-.....++.||++||+||.+.++|||||.+.|+|+ +.++++||+|||+
T Consensus 611 cmI~EYmEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv----~~e~~iKiadfgm 683 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV----DGEFTIKIADFGM 683 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhchhhccccccceee----cCcccEEecCccc
Confidence 99999999 8999999887422 23444566799999999999999999999999999999 8889999999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT--LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt--G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++.+.....+......+-...|||+|.+...+ ++.++|+|+||+++||+++ ..-||....++ .-.+..-
T Consensus 684 sR~lysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--------~vven~~ 754 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--------QVVENAG 754 (807)
T ss_pred ccccccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--------HHHHhhh
Confidence 99776666666666667789999999988755 9999999999999999865 56788655421 1111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..+.+.... .-...|..++..+++||.+||.+|-++||+++++..|
T Consensus 755 ~~~~~~~~~---------------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 755 EFFRDQGRQ---------------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred hhcCCCCcc---------------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 111111111 1123567778899999999999999999999998543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=300.35 Aligned_cols=280 Identities=22% Similarity=0.394 Sum_probs=185.5
Q ss_pred ccceeEEeeecccCceEEEEEEEec-------------ccCCCcEEEEEecccCCCCC------------CCcHHHHHHH
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA-------------AANRGKAIAIKKFKQSKDGD------------GVSPTAIREI 79 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~-------------~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~Ei 79 (477)
.++|++.++||+|+||.||+|.+.. ....++.||||.+....... ......+.|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 5789999999999999999996421 12345689999986543210 1122334577
Q ss_pred HHHHhcCCCCe-----eEEEEEEEcC------CCceEEEEEeccC-CCHHHHHHhhhcc-------------------cC
Q 011808 80 MLLREITHENV-----VKLVNVHINH------ADMSLYLAFDYAE-YDLYEIIRHHRDK-------------------VN 128 (477)
Q Consensus 80 ~il~~l~hpnI-----v~l~~~~~~~------~~~~~~lv~e~~~-~~L~~~l~~~~~~-------------------~~ 128 (477)
.++.+++|.++ ++++++|... .+...+|||||+. ++|.+++...... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 6666766432 1235799999998 5887777542110 01
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeecccccc
Q 011808 129 HTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA 208 (477)
Q Consensus 129 ~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~A 208 (477)
..+++..++.++.||+.+|.|||+.+|+||||||+|||+ +.++.+||+|||++......... ......+|+.|+|
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl----~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV----TVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE----CCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 234567789999999999999999999999999999999 66678999999999755432211 1112234789999
Q ss_pred chhhcCCCC-------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCcccccCCCcccHHHHHHHHHHhC
Q 011808 209 PELLLGAKH-------------------Y--TSAVDMWAVGCIFAELLTLKP-LFQGAEAKSTQNPFQLDQLDKIFKILG 266 (477)
Q Consensus 209 PE~l~~~~~-------------------~--~~~~DiwSlGvil~elltG~~-PF~~~~~~~~~~~~~~~~~~~i~~~~~ 266 (477)
||++..... | ..+.||||+||++|+|++|.. ||.+... +........
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~-----------f~~~~~~~~ 447 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRL-----------FNTELRQYD 447 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhh-----------hhhHHhhcc
Confidence 999864221 1 124799999999999999875 7753221 000000000
Q ss_pred CCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCC---CCCCCHHHHhcCccCC
Q 011808 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP---RKRITAAQALEHEYFR 339 (477)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP---~~Rpt~~e~L~h~~f~ 339 (477)
.. +..|. .+.............++.++|||.+||.++| .+|+|++|+|+||||.
T Consensus 448 -~~---------~~~~r---------~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 448 -ND---------LNRWR---------MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred -ch---------HHHHH---------hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 00 00000 0000111111233456789999999999876 7899999999999995
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=293.06 Aligned_cols=247 Identities=26% Similarity=0.435 Sum_probs=201.2
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYL 107 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~l 107 (477)
.....+||-|.||.||.+.|+.. .-.||||.++.+.. ...++++|+.+|+.++|||+|+|+++|..+ ..+||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKky---slTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~E--pPFYI 340 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKY---SLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--PPFYI 340 (1157)
T ss_pred eeeeeccCCCcccceeeeeeecc---ceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccC--CCeEE
Confidence 44567899999999999999863 55699999976543 356899999999999999999999999654 47899
Q ss_pred EEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 108 AFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 108 v~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
|.|||. |+|+++|+.... ..++.-....++.||.+|++||..+++|||||-..|+|+ .++..|||+|||+++
T Consensus 341 iTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV----gEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV----GENHIVKVADFGLSR 413 (1157)
T ss_pred EEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc----cccceEEeeccchhh
Confidence 999987 899999998753 346667788899999999999999999999999999999 888899999999999
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
.+.... ++...+.--..-|.|||.+.-. .++.++|||+|||+|||+.| |-.||.+.+ +.++..+.+
T Consensus 414 lMtgDT-YTAHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGid---------lSqVY~LLE-- 480 (1157)
T KOG4278|consen 414 LMTGDT-YTAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGID---------LSQVYGLLE-- 480 (1157)
T ss_pred hhcCCc-eecccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCcc---------HHHHHHHHh--
Confidence 876532 2222222336789999998653 48999999999999999998 778887754 344444332
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
++++-..|..|++.+++|++.||++.|.+||+++++-
T Consensus 481 -------------------------------kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 481 -------------------------------KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred -------------------------------ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 2233346788899999999999999999999988763
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.83 Aligned_cols=253 Identities=32% Similarity=0.435 Sum_probs=191.7
Q ss_pred EeeecccCceE-EEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCceEEEE
Q 011808 31 IGKIGEGTYGL-VFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHADMSLYLA 108 (477)
Q Consensus 31 ~~~lG~G~~g~-Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~lv 108 (477)
.+++|.|+-|+ ||+|.. .++.||||.+-... ...+.+||..|+.- +|||||+++..- .++.++||+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-----e~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-----EGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEEee-----CCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEE
Confidence 45789999886 899875 47899999886543 23567899999998 699999998754 446699999
Q ss_pred EeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc-CCCcccEEEeeccccee
Q 011808 109 FDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE-GEEQGVVKIADFGLARI 187 (477)
Q Consensus 109 ~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~-~~~~~~vkL~DFG~a~~ 187 (477)
.|.|.++|.++++..... .........+.++.|+++||++||+.+||||||||.||||... .+....++|+|||+++.
T Consensus 582 lELC~~sL~dlie~~~~d-~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLD-VEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHhhhhHHHHHhccccc-hhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 999999999999885111 1112224568899999999999999999999999999999653 23456899999999998
Q ss_pred ecCCCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 188 YQAPLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 188 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
+...... ....+..||-+|+|||++.... -+.++|||||||++|+.++| ..||...-. +-.+++
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~-------------R~~NIl 726 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-------------RQANIL 726 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHH-------------hhhhhh
Confidence 8654332 2345677899999999998755 56799999999999999996 899975331 111111
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
... + .+....+... .++.|||.+||++||..||+|.++|.||||+
T Consensus 727 ~~~-------------------------~---~L~~L~~~~d-~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 727 TGN-------------------------Y---TLVHLEPLPD-CEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred cCc-------------------------c---ceeeeccCch-HHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 000 0 0001111111 1789999999999999999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.40 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=211.7
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
.-.|.++||.|.||.|++++.+...+....||||.++.... ++....|+.|+.||-+++||||++|.++.... ..+.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks--~PvM 706 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS--KPVM 706 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcccCCCCcEEEEEEEEecC--ceeE
Confidence 34788999999999999999988777788999999987554 44567899999999999999999999998553 3678
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
|+.|||+ |.|..+|+.+. +.++..++..+++.|+.|++||-+.|+|||||-.+|||+ +.+...|++|||++
T Consensus 707 IiTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV----NsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV----NSNLVCKVSDFGLS 778 (996)
T ss_pred EEhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee----ccceEEEeccccce
Confidence 9999999 79999998875 357888999999999999999999999999999999999 89999999999999
Q ss_pred eeecCCC-CcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 186 RIYQAPL-KFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 186 ~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+.+.... ...+..+.--...|.|||.|.-.+ ++.++||||+||++||.++ |..||.+.+ ..+-+..|.+
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmS--------NQdVIkaIe~ 849 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMS--------NQDVIKAIEQ 849 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccc--------hHHHHHHHHh
Confidence 9875433 211222222268899999998755 9999999999999999876 888887766 3333433332
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+++...|.+++..++.|+..||++|-.+||.++||+.+
T Consensus 850 ----------------------------------gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 850 ----------------------------------GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred ----------------------------------ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 23344577888999999999999999999999999876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=282.28 Aligned_cols=295 Identities=28% Similarity=0.452 Sum_probs=211.1
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHIN 99 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 99 (477)
.+...+.|.++++||+|+|++||++.+.......+.||+|.+...... ..+..|+++|..+ .+.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 445667899999999999999999987653346789999999765543 3678999999999 59999999999866
Q ss_pred CCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 100 HADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 100 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
++ ..++|+||++. ...+++. .++..+++.+++.++.||.++|.+|||||||||.|+|.+ ...+.-.
T Consensus 107 nd--~v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n---~~t~rg~ 173 (418)
T KOG1167|consen 107 ND--QVAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN---RRTQRGV 173 (418)
T ss_pred CC--eeEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc---cccCCce
Confidence 54 78999999995 4445544 367889999999999999999999999999999999995 4556678
Q ss_pred EeecccceeecCC---------------------------------CCc---------ccCCCeeeccccccchhhcCCC
Q 011808 179 IADFGLARIYQAP---------------------------------LKF---------LSENGVVVTIWYRAPELLLGAK 216 (477)
Q Consensus 179 L~DFG~a~~~~~~---------------------------------~~~---------~~~~~~~gt~~y~APE~l~~~~ 216 (477)
|+|||+|...+.. ... .......||++|+|||++....
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 9999998621100 000 0001346899999999998877
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccC---------CCcccccccc
Q 011808 217 HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLA---------NLPHWQSDSL 287 (477)
Q Consensus 217 ~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 287 (477)
..++++||||.|||+..+++++.||-...+ +.+.+.+|..+.|...-++...+. +++.......
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a~d-------d~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~ 326 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKD-------DADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRV 326 (418)
T ss_pred CcCCccceeeccceeehhhccccccccCcc-------ccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHh
Confidence 789999999999999999999999865443 445555555555443322211111 1111110000
Q ss_pred cccccc----ccCC--CCc-cccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 288 HIQGRK----YETN--GLH-SVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 288 ~~~~~~----~~~~--~~~-~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+.... +... +.. .......+..++||+++||+.||.+|+|++++|.||||.
T Consensus 327 ~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 327 NFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred chhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 000000 0000 011 112223344789999999999999999999999999997
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=260.39 Aligned_cols=243 Identities=43% Similarity=0.684 Sum_probs=191.0
Q ss_pred CceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEeccCC-CH
Q 011808 38 TYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DL 116 (477)
Q Consensus 38 ~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~-~L 116 (477)
+||.||+|.+.. ++..+++|++........ ...+.+|++++++++|+||+++++++... ...++++|++++ +|
T Consensus 1 ~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKK---TGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECC---CCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCH
Confidence 589999998753 578999999876543321 46778899999999999999999988664 478999999996 88
Q ss_pred HHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCccc
Q 011808 117 YEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196 (477)
Q Consensus 117 ~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 196 (477)
.+++.... .++...+..++.+++.+|.+||+.+|+|+||+|.||++ +.++.++|+|||.+....... .
T Consensus 75 ~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~----~~~~~~~l~d~~~~~~~~~~~---~ 142 (244)
T smart00220 75 FDLLKKRG-----RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL----DEDGHVKLADFGLARQLDPGG---L 142 (244)
T ss_pred HHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE----CCCCcEEEccccceeeecccc---c
Confidence 88876532 38899999999999999999999999999999999999 666789999999998765432 1
Q ss_pred CCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCcccc
Q 011808 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTL 276 (477)
Q Consensus 197 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 276 (477)
.....++..|++||.+.+. .++.++||||||+++|+|++|..||.... ....+...+..........
T Consensus 143 ~~~~~~~~~~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~-----------~~~~~~~~~~~~~~~~~~~- 209 (244)
T smart00220 143 LTTFVGTPEYMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDD-----------QLLELFKKIGKPKPPFPPP- 209 (244)
T ss_pred cccccCCcCCCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------cHHHHHHHHhccCCCCccc-
Confidence 2234568899999999763 47889999999999999999999996532 1122233222211110000
Q ss_pred CCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 277 ANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
....+..+.++|.+||..||.+||++.++++|+||
T Consensus 210 ---------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 210 ---------------------------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ---------------------------cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 00034678999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=281.35 Aligned_cols=206 Identities=29% Similarity=0.439 Sum_probs=174.3
Q ss_pred CCccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCC------cHHHHHHHHHHHhcC---CCC
Q 011808 19 GEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV------SPTAIREIMLLREIT---HEN 89 (477)
Q Consensus 19 ~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~Ei~il~~l~---hpn 89 (477)
.....-+..|..++.||+|+||.|++|.++. +...|+||.+.+.+.-... .-..-.||+||..++ |+|
T Consensus 554 e~~~~k~s~yttlq~lG~GAyGkV~lai~K~---n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N 630 (772)
T KOG1152|consen 554 EKEYKKFSDYTTLQPLGEGAYGKVNLAIHKE---NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN 630 (772)
T ss_pred eeeecccccceeeeeccccccceEEEeeecc---cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence 3344456789999999999999999999885 4788999999876532211 112335999999996 999
Q ss_pred eeEEEEEEEcCCCceEEEEEeccC-C-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEE
Q 011808 90 VVKLVNVHINHADMSLYLAFDYAE-Y-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILV 167 (477)
Q Consensus 90 Iv~l~~~~~~~~~~~~~lv~e~~~-~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl 167 (477)
|++++++|++.+ ++||+||--+ + +|+++|+.+ ..++|.++..||+||..|+++||+.||||||||-+||++
T Consensus 631 IlKlLdfFEddd--~yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv 703 (772)
T KOG1152|consen 631 ILKLLDFFEDDD--YYYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV 703 (772)
T ss_pred hhhhhheeecCC--eeEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhccccccccCceecccccccEEE
Confidence 999999997754 8999999766 3 899999864 379999999999999999999999999999999999999
Q ss_pred eccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011808 168 MGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ 242 (477)
Q Consensus 168 ~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~ 242 (477)
+.+|-+||+|||.+....... -..++||..|.|||++.|.++.+..-|||+||++||.++....||.
T Consensus 704 ----d~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 704 ----DSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ----ecCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 888899999999997654432 2347899999999999998888899999999999999999888875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=289.57 Aligned_cols=259 Identities=29% Similarity=0.473 Sum_probs=203.5
Q ss_pred eeEEeeecccCceEEEEEEEecccCC----CcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANR----GKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHAD 102 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 102 (477)
..+.+.||+|.||.|++|..+..... ...||||.++..... .....+..|+++|+.+ .|+||+.+++++.. .
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~--~ 374 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ--D 374 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc--C
Confidence 35677999999999999975533222 567999999876665 5567888999999999 69999999999876 5
Q ss_pred ceEEEEEeccC-CCHHHHHHhhh---------cccCC--CCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHR---------DKVNH--TMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~---------~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~ 170 (477)
..+++|+||+. |+|.++++..+ ..... .++..+...+.+||+.|++||++..+|||||-.+|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi--- 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI--- 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe---
Confidence 57899999998 89999999877 22222 28899999999999999999999999999999999999
Q ss_pred CCCcccEEEeecccceeecCCCCcccCCCe-eeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccc
Q 011808 171 GEEQGVVKIADFGLARIYQAPLKFLSENGV-VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKS 248 (477)
Q Consensus 171 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~-~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~ 248 (477)
..+..+||+|||+|+............+. .-...|||||.+.. ..|+.++||||+||+||||++ |..||.+...
T Consensus 452 -~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-- 527 (609)
T KOG0200|consen 452 -TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-- 527 (609)
T ss_pred -cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCc--
Confidence 77788999999999965443333212110 12456999999988 569999999999999999998 7899876220
Q ss_pred CCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC
Q 011808 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT 328 (477)
Q Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt 328 (477)
... +++.+ ..+.....|..++.+++++++.||+.+|++||+
T Consensus 528 ------~~~---l~~~l------------------------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~ 568 (609)
T KOG0200|consen 528 ------TEE---LLEFL------------------------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPT 568 (609)
T ss_pred ------HHH---HHHHH------------------------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCC
Confidence 111 11111 112233457778899999999999999999999
Q ss_pred HHHHhcC
Q 011808 329 AAQALEH 335 (477)
Q Consensus 329 ~~e~L~h 335 (477)
+.++.+.
T Consensus 569 F~~~~~~ 575 (609)
T KOG0200|consen 569 FSECVEF 575 (609)
T ss_pred HHHHHHH
Confidence 9988743
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=242.74 Aligned_cols=203 Identities=24% Similarity=0.392 Sum_probs=167.7
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCceEE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~ 106 (477)
..-+..||+|+||.|-+.++.. +|...|+|.+...... ....++++|+.+..+. .+|.+|.+++.++... .++
T Consensus 48 L~~i~elGrGayG~vekmrh~~---sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg--dvw 121 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQ---SGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG--DVW 121 (282)
T ss_pred hhhhhhhcCCccchhhheeecc---CCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhccc--cEE
Confidence 4456789999999999988775 7999999999876553 3445777888877666 7999999999887655 578
Q ss_pred EEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
+.||.+..+|..+.++.. +.+..++|..+-+++..++.||.|||++ .+||||+||+|||+ +..|+||+||||++
T Consensus 122 IcME~M~tSldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI----n~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI----NYDGQVKICDFGIS 196 (282)
T ss_pred EeHHHhhhhHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE----ccCCcEEEcccccc
Confidence 999999988877766644 3367899999999999999999999987 89999999999999 78889999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLG---AKHYTSAVDMWAVGCIFAELLTLKPLFQGA 244 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~~DiwSlGvil~elltG~~PF~~~ 244 (477)
-.+..... .+...|-..|||||.+.. .+.|+.++||||||++++||.+++.||...
T Consensus 197 G~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 197 GYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 88765332 222345678999999853 235899999999999999999999999753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=284.35 Aligned_cols=252 Identities=26% Similarity=0.364 Sum_probs=204.0
Q ss_pred eeEEeeecccCceEEEEEEEeccc-CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAA-NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
.+..++||+|+||+||++.+.... +-..+||||++.... ......++++|+-+|..++|||+++|++++.... +-
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST---LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---HH
Confidence 455679999999999999875432 224579999986544 3444568899999999999999999999987653 77
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
||.+|+. |.|+++++.+++ .+-......|..||++||.|||++++|||||-.+|||| .+-.++||.|||++
T Consensus 774 lvtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV----ksP~hvkitdfgla 845 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV----KSPNHVKITDFGLA 845 (1177)
T ss_pred HHHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee----cCCCeEEEEecchh
Confidence 8899998 899999999864 57888999999999999999999999999999999999 77778999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+.+..........+....+-|||-|.+... .|+.++||||+||++||++| |..|+.+...+++ -+.
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI------------~dl 912 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI------------PDL 912 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh------------hHH
Confidence 988766554444444447789999999874 49999999999999999998 8888877653322 111
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
+ +.+.+...|..++-+++-++.+||..|+..||+++++..
T Consensus 913 l------------------------------e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 913 L------------------------------EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred H------------------------------hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 1 112223357778889999999999999999999887654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-34 Score=285.95 Aligned_cols=261 Identities=30% Similarity=0.488 Sum_probs=203.7
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
--++|+++.++|+|+||.||+|+++. +++..|+|+++.....+ ...+.+|+-+++.++||||+.+++.+...+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~---s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~d-- 85 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKR---SGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-- 85 (829)
T ss_pred CccchhheeeecCCcccchhhhcccc---cCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhhc--
Confidence 35789999999999999999999775 68999999998765432 445668999999999999999999887654
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.++++||||+++.++.+-. ..++++|.++..+.+..+.+|+|||+.|-+|||||-.|||+ ++.+.+||+|||
T Consensus 86 klwicMEycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill----td~gDvklaDfg 157 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL----TDEGDVKLADFG 157 (829)
T ss_pred CcEEEEEecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee----cccCceeecccC
Confidence 6899999999655544433 36689999999999999999999999999999999999999 677779999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
.+-.+..... ....+.||++|||||+..- ...|...+|||++|++..|+-..++|.- ++.++..+
T Consensus 158 vsaqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf-----------dlhpmr~l 224 (829)
T KOG0576|consen 158 VSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF-----------DLHPMRAL 224 (829)
T ss_pred chhhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc-----------ccchHHHH
Confidence 9876654332 3456889999999998742 2348999999999999999998887753 22222222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+-- ......-+.+.+.-.| ++.+.+|++.+|.++|.+|||++.+|.|+|..
T Consensus 225 ~Lm--TkS~~qpp~lkDk~kw-------------------------s~~fh~fvK~altknpKkRptaeklL~h~fvs 275 (829)
T KOG0576|consen 225 FLM--TKSGFQPPTLKDKTKW-------------------------SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVS 275 (829)
T ss_pred HHh--hccCCCCCcccCCccc-------------------------hHHHHHHHHHHhcCCCccCCChhhheeceeec
Confidence 211 1111111112221112 35688999999999999999999999999985
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=265.35 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=191.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHh--cCCCCeeEEEEEEEcC--
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE--ITHENVVKLVNVHINH-- 100 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~-- 100 (477)
+....++++||+|.||.||+|+.. ++.||||+|.... .+.+..|-.|.+. ++|+||+++++.-...
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-----~~~VAVKifp~~~-----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-----NRLVAVKIFPEQE-----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-----CceeEEEecCHHH-----HHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 556788999999999999999753 6899999997532 3456667666664 5899999999864322
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh---------CCeecCCCCCCcEEEecc
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS---------NWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~---------~givHrDikp~NILl~~~ 170 (477)
....++||++|-. |+|.++|..+ .++.....+++..|+.||+|||+ ..|+|||||..||||
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv--- 349 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV--- 349 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---
Confidence 2456899999977 8999999875 58999999999999999999996 249999999999999
Q ss_pred CCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCC-----chhhHHHHHHHHHHHHhCCCCCCCcc
Q 011808 171 GEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYT-----SAVDMWAVGCIFAELLTLKPLFQGAE 245 (477)
Q Consensus 171 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~-----~~~DiwSlGvil~elltG~~PF~~~~ 245 (477)
..++...|+|||+|..+..........+-+||..|||||++.|.-.+. .+.||||+|.+||||++...-+....
T Consensus 350 -K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~ 428 (534)
T KOG3653|consen 350 -KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP 428 (534)
T ss_pred -ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCC
Confidence 777889999999999988665554555678999999999998765554 37899999999999999776554333
Q ss_pred cccCCCccc--------HHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHH
Q 011808 246 AKSTQNPFQ--------LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSK 317 (477)
Q Consensus 246 ~~~~~~~~~--------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~ 317 (477)
..+..-+|+ .+.+..++-. +.-.+.|++ .|. ....-..+++.|+.
T Consensus 429 vp~Yqlpfe~evG~hPt~e~mq~~VV~--kK~RP~~p~-----~W~--------------------~h~~~~~l~et~Ee 481 (534)
T KOG3653|consen 429 VPEYQLPFEAEVGNHPTLEEMQELVVR--KKQRPKIPD-----AWR--------------------KHAGMAVLCETIEE 481 (534)
T ss_pred CCcccCchhHHhcCCCCHHHHHHHHHh--hccCCCChh-----hhh--------------------cCccHHHHHHHHHH
Confidence 333333443 1222221111 010111110 010 00112458899999
Q ss_pred hcccCCCCCCCHH
Q 011808 318 MLEYDPRKRITAA 330 (477)
Q Consensus 318 ~L~~dP~~Rpt~~ 330 (477)
||+.|++-|+|+.
T Consensus 482 CWDhDaeARLTA~ 494 (534)
T KOG3653|consen 482 CWDHDAEARLTAG 494 (534)
T ss_pred HcCCchhhhhhhH
Confidence 9999999999975
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=303.30 Aligned_cols=255 Identities=20% Similarity=0.294 Sum_probs=179.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
...|...++||+|+||.||+|+++. ++..||||++..... ...+|++++++++||||+++++++.+.. .
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~--~ 757 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIK---NGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEK--G 757 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECC---CCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCC--C
Confidence 3556777899999999999998754 588999999864332 1235788999999999999999997654 6
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhh---hCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH---SNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.|+||||++ ++|.+++. .+++..+..++.||+.||+||| +.+|+||||||+||++ +.++..++.
T Consensus 758 ~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~----~~~~~~~~~ 825 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII----DGKDEPHLR 825 (968)
T ss_pred CEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE----CCCCceEEE
Confidence 799999998 68888774 3778889999999999999999 6699999999999999 444555554
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|+....... .....+|+.|+|||++.+. .++.++|||||||++|||+||+.||....... ..+.+
T Consensus 826 -~~~~~~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-------~~~~~ 890 (968)
T PLN00113 826 -LSLPGLLCT------DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVH-------GSIVE 890 (968)
T ss_pred -ecccccccc------CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCC-------CcHHH
Confidence 555443221 1223568999999999874 48999999999999999999999995332110 11111
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
......... ....|.+.... .....+.....++.+++.+||+.||++|||+.|+++.
T Consensus 891 ~~~~~~~~~--------~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 891 WARYCYSDC--------HLDMWIDPSIR----------GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHhcCcc--------chhheeCcccc----------CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 111100000 00000000000 0000011112356789999999999999999999876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=255.67 Aligned_cols=202 Identities=29% Similarity=0.423 Sum_probs=160.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHH--hcCCCCeeEEEEEEEcC--
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLR--EITHENVVKLVNVHINH-- 100 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~~~-- 100 (477)
-.+-.+++.||+|-||.||+|+++ |..||||+|.... .....+|.+|.. .|+|+||+.+++.=...
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-----Ge~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-----GEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hheeEEEEEecCccccceeecccc-----CCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 356899999999999999999986 7899999997543 235566666665 55999999998753222
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-----C---CeecCCCCCCcEEEeccC
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-----N---WIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-----~---givHrDikp~NILl~~~~ 171 (477)
.-..++||.+|-+ |+|+++|... .++.....+++..+++||++||. + .|.|||||..|||+
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---- 349 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---- 349 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE----
Confidence 2246999999988 8999999863 68999999999999999999994 2 39999999999999
Q ss_pred CCcccEEEeecccceeecCCC--CcccCCCeeeccccccchhhcCCCC---CC--chhhHHHHHHHHHHHHhC-------
Q 011808 172 EEQGVVKIADFGLARIYQAPL--KFLSENGVVVTIWYRAPELLLGAKH---YT--SAVDMWAVGCIFAELLTL------- 237 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~---~~--~~~DiwSlGvil~elltG------- 237 (477)
..++..-|+|+|+|....... .....+..+||..|||||++...-. +. ..+||||||+++||++..
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ 429 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV 429 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence 788889999999997665432 2334456789999999999965322 21 278999999999998753
Q ss_pred ---CCCCCCccc
Q 011808 238 ---KPLFQGAEA 246 (477)
Q Consensus 238 ---~~PF~~~~~ 246 (477)
.+||.+..+
T Consensus 430 eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 430 EEYQLPYYDVVP 441 (513)
T ss_pred hhhcCCcccCCC
Confidence 377776543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=245.21 Aligned_cols=270 Identities=24% Similarity=0.338 Sum_probs=200.3
Q ss_pred CCCCCCccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEE
Q 011808 15 TSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKL 93 (477)
Q Consensus 15 ~~~~~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l 93 (477)
+..+.++..+.+.|.|.+.||+|.||.+.+|.++. +...+++|.+..... ....+.+|..---.| .|.||+.-
T Consensus 13 ~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~---s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~t 86 (378)
T KOG1345|consen 13 PMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQ---SKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDT 86 (378)
T ss_pred ccccccccchhhhhhHHHHhcccceeeEEeeeccC---CceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHH
Confidence 33456677888999999999999999999999885 678899999876543 346777887655555 58999999
Q ss_pred EEEEEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCC
Q 011808 94 VNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE 172 (477)
Q Consensus 94 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~ 172 (477)
|++.+...+ .+++++||+. |+|..-+.. ..+-|...+.++.|+++||.|+|++++||||||.+||||...+
T Consensus 87 Y~vaFqt~d-~YvF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d- 158 (378)
T KOG1345|consen 87 YEVAFQTSD-AYVFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD- 158 (378)
T ss_pred HHHHhhcCc-eEEEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-
Confidence 887554443 7889999999 788776654 2588899999999999999999999999999999999996543
Q ss_pred CcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCccccc
Q 011808 173 EQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA----KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248 (477)
Q Consensus 173 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~ 248 (477)
...|||||||+.+..+........ +..|.+||++... -...+.+|||.||+++|.+|||++||+.....+
T Consensus 159 -f~rvKlcDFG~t~k~g~tV~~~~~-----~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d 232 (378)
T KOG1345|consen 159 -FYRVKLCDFGLTRKVGTTVKYLEY-----VNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD 232 (378)
T ss_pred -ccEEEeeecccccccCceehhhhh-----hcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC
Confidence 337999999999876554333222 5678999987432 125678999999999999999999998443211
Q ss_pred CCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC--
Q 011808 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR-- 326 (477)
Q Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R-- 326 (477)
....+..+..+...+. .|+. + ...++.+..+.++-|..++.+|
T Consensus 233 -------~~Y~~~~~w~~rk~~~-~P~~--------------------------F-~~fs~~a~r~Fkk~lt~~~~drck 277 (378)
T KOG1345|consen 233 -------KPYWEWEQWLKRKNPA-LPKK--------------------------F-NPFSEKALRLFKKSLTPRFKDRCK 277 (378)
T ss_pred -------chHHHHHHHhcccCcc-Cchh--------------------------h-cccCHHHHHHHHHhcCCcccccch
Confidence 1122222332222221 0100 0 1125678899999999999999
Q ss_pred -CCHHHHhcCccCC
Q 011808 327 -ITAAQALEHEYFR 339 (477)
Q Consensus 327 -pt~~e~L~h~~f~ 339 (477)
.+++......|..
T Consensus 278 i~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 278 IWTAKKMRKCLWKE 291 (378)
T ss_pred hHHHHHHHHHHHHH
Confidence 6777777777753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=222.64 Aligned_cols=213 Identities=42% Similarity=0.694 Sum_probs=176.9
Q ss_pred ecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEeccC
Q 011808 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAE 113 (477)
Q Consensus 34 lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~ 113 (477)
||+|++|.||++.+.. ++..+++|++....... ....+.+|+++++.++|++|+++++++... ...+++||++.
T Consensus 1 l~~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecC---CCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCC
Confidence 6899999999998653 58899999997654322 245788999999999999999999998664 47899999999
Q ss_pred -CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCC-cccEEEeecccceeecCC
Q 011808 114 -YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE-QGVVKIADFGLARIYQAP 191 (477)
Q Consensus 114 -~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~-~~~vkL~DFG~a~~~~~~ 191 (477)
++|.+++.... ..++...++.++.+++.+|.+||+.|++|+||+|.||++ +. .+.++|+|||.+......
T Consensus 75 ~~~l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~----~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 75 GGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL----DSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred CCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE----eCCCCcEEEecCCceEEccCC
Confidence 78888876532 358899999999999999999999999999999999999 44 678999999999866543
Q ss_pred CCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCC
Q 011808 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPE 271 (477)
Q Consensus 192 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 271 (477)
.. ......+...|++||.+.....++.+.|+|+||+++++| .
T Consensus 147 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------~-------------------------- 188 (215)
T cd00180 147 KS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------P-------------------------- 188 (215)
T ss_pred cc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------H--------------------------
Confidence 21 122244578899999997653578899999999999999 0
Q ss_pred CccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 272 KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
.+.++|.+||..||.+||++.++++|+
T Consensus 189 --------------------------------------~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 189 --------------------------------------ELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------------------------------------HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 256899999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=282.78 Aligned_cols=208 Identities=18% Similarity=0.281 Sum_probs=148.2
Q ss_pred hcCC-CCeeEEEEEEEcC-----CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeec
Q 011808 84 EITH-ENVVKLVNVHINH-----ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIH 157 (477)
Q Consensus 84 ~l~h-pnIv~l~~~~~~~-----~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH 157 (477)
.++| .||++++++|... ....++++||+++++|.+++... ...+++.+++.+++||+.||.|||++||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 4455 5777788776211 12368889999999999998643 235899999999999999999999999999
Q ss_pred CCCCCCcEEEeccC---------------CCcccEEEeecccceeecCCCC--------------cccCCCeeecccccc
Q 011808 158 RDLKPSNILVMGEG---------------EEQGVVKIADFGLARIYQAPLK--------------FLSENGVVVTIWYRA 208 (477)
Q Consensus 158 rDikp~NILl~~~~---------------~~~~~vkL~DFG~a~~~~~~~~--------------~~~~~~~~gt~~y~A 208 (477)
|||||+||||...+ +..+.+||+|||+++....... .......+||++|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999994311 2345678888888764321000 001112457899999
Q ss_pred chhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccc
Q 011808 209 PELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLH 288 (477)
Q Consensus 209 PE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (477)
||++.+.. |+.++|||||||+||||++|.+||.... ..+..+..... + +.
T Consensus 184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~~~~~~-~-~~----------------- 233 (793)
T PLN00181 184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSLRHRVL-P-PQ----------------- 233 (793)
T ss_pred hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHHHHhhc-C-hh-----------------
Confidence 99998754 8999999999999999999988875321 11111111110 0 00
Q ss_pred cccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 289 IQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 289 ~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.......+.+++.+||++||.+||++.|+|.||||..
T Consensus 234 ---------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 234 ---------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred ---------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 0001234678999999999999999999999999964
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-28 Score=224.89 Aligned_cols=201 Identities=43% Similarity=0.677 Sum_probs=166.3
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYL 107 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~l 107 (477)
|.+.+.||+|++|.||++.+.. ++..+++|.+...... .....+.+|+..++.++|+|++++++++... ...++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---TGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---CCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEE
Confidence 6789999999999999998653 5788999999765433 2355777899999999999999999987654 47899
Q ss_pred EEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 108 AFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 108 v~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
++|++.+ +|.+++..... .+++..+..++.+++.+|.+||+.+++|+||+|.||++ +.++.++|+|||++.
T Consensus 75 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v----~~~~~~~l~d~g~~~ 146 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL----GMDGLVKLADFGLAR 146 (225)
T ss_pred EEeccCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEeeCceee
Confidence 9999997 88888876431 17889999999999999999999999999999999999 666789999999998
Q ss_pred eecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 011808 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243 (477)
Q Consensus 187 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~ 243 (477)
........ ......++..|++||.+.+...++.++|+|+||+++++|++|+.||..
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 147 FIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 76543200 123355688899999984334578899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=238.81 Aligned_cols=260 Identities=21% Similarity=0.325 Sum_probs=202.7
Q ss_pred cceeEEeeecccCceEEEEEEEecc--cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAA--ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.|+++...+-+|.||.||.|.++.. -++.+.|.+|.++... +.-....++.|..++..+.|||+..+.++..... .
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~-~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY-A 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc-C
Confidence 4677778899999999999977642 2345567888887543 3334456778999999999999999999987643 3
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcc---cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDK---VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..++++.+.+ |+|..++...+.. ....++..+...++.|++.|++|||+.||||.||-.+|+++ ++...+||
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI----dd~LqVkl 437 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI----DDQLQVKL 437 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee----hhheeEEe
Confidence 5677788887 8999999855422 12346677888999999999999999999999999999999 88899999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~ 258 (477)
+|=.+++.+.+.....-..+......||++|-+.+ ..|+.++|+|||||++|||+| |+.|+..-+ ||+...
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeID------PfEm~~- 509 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEID------PFEMEH- 509 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccC------HHHHHH-
Confidence 99999997765443332223333778999999987 459999999999999999998 889986443 222211
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
+...+.+...|.++++++..++..||..+|++||+++|+..
T Consensus 510 -----------------------------------ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 510 -----------------------------------YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -----------------------------------HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 11223444578899999999999999999999999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-29 Score=261.04 Aligned_cols=273 Identities=26% Similarity=0.445 Sum_probs=197.5
Q ss_pred Cccccccce-eEEeeecccCceEEEEEEEecccCCCcEEEEEecc----cCCCCCCCcHHHHHHHHHHHhcCCCCeeEEE
Q 011808 20 EKPEWLQQY-NLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFK----QSKDGDGVSPTAIREIMLLREITHENVVKLV 94 (477)
Q Consensus 20 ~~~~~~~~Y-~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~----~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 94 (477)
....+.+.| ...+++|.|++|.|+.+.... .....+.|.+. ...........+..|+.+-..++|+|++..+
T Consensus 311 ~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~---~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l 387 (601)
T KOG0590|consen 311 SPIGFSEKYGKPGRVLGSGAYGSVRIAKRRS---DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETL 387 (601)
T ss_pred CccccccccCCccceeeecccCceEEEEecC---CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhH
Confidence 334556778 678899999999888876553 34445555443 2222122222355688888889999998877
Q ss_pred EEEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc
Q 011808 95 NVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ 174 (477)
Q Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~ 174 (477)
..+.... ..+-+||||.++|+.++... ..++..++..++.|++.||+|||+.||.|||||++|+++ ..+
T Consensus 388 ~~~~~~~--~~~~~mE~~~~Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~----~~~ 456 (601)
T KOG0590|consen 388 DIVQEID--GILQSMEYCPYDLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV----TEN 456 (601)
T ss_pred HHHhhcc--cchhhhhcccHHHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE----ecC
Confidence 7665433 23334999999888888763 368888999999999999999999999999999999999 777
Q ss_pred ccEEEeecccceeecCCCCc--ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCc
Q 011808 175 GVVKIADFGLARIYQAPLKF--LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252 (477)
Q Consensus 175 ~~vkL~DFG~a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~ 252 (477)
+.+||+|||.+..+..+... ....+.+|+..|+|||++.+........||||.|++++.|.+|+.||.-....+...
T Consensus 457 g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~- 535 (601)
T KOG0590|consen 457 GILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF- 535 (601)
T ss_pred CceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-
Confidence 79999999999877655444 556778999999999999987755668999999999999999999997654321110
Q ss_pred ccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 011808 253 FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332 (477)
Q Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~ 332 (477)
.. .....|... ..+ ...+-...+...+.+|.+||+.||.+|.|+++|
T Consensus 536 ------~~----------------~~~~~~~~~----------~~~-~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i 582 (601)
T KOG0590|consen 536 ------KT----------------NNYSDQRNI----------FEG-PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQI 582 (601)
T ss_pred ------hh----------------hcccccccc----------ccC-hHHHHHhchhhHHHHHHHHccCChhheecHHHH
Confidence 00 000000000 000 000111223457799999999999999999999
Q ss_pred hcCccCCC
Q 011808 333 LEHEYFRI 340 (477)
Q Consensus 333 L~h~~f~~ 340 (477)
++.+||+.
T Consensus 583 ~~d~W~~~ 590 (601)
T KOG0590|consen 583 LNDEWIRS 590 (601)
T ss_pred hhChHhhh
Confidence 99999973
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=212.79 Aligned_cols=167 Identities=21% Similarity=0.269 Sum_probs=124.5
Q ss_pred CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCC
Q 011808 114 YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK 193 (477)
Q Consensus 114 ~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~ 193 (477)
|+|.+++... +..+++.+++.++.||+.||.|||+++ ||+|||+ +.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~----~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL----TWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE----cCccceee--ccceEeecccc-
Confidence 5788888753 236999999999999999999999998 9999999 67778888 99998764321
Q ss_pred cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCc
Q 011808 194 FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKW 273 (477)
Q Consensus 194 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 273 (477)
..||+.|+|||++.+. .|+.++|||||||++|||+||+.||..... ....+..+........+..
T Consensus 64 ------~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~- 128 (176)
T smart00750 64 ------SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERE-------LSAILEILLNGMPADDPRD- 128 (176)
T ss_pred ------CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccch-------hcHHHHHHHHHhccCCccc-
Confidence 2568999999999874 489999999999999999999999965431 1122222222111110000
Q ss_pred cccCCCccccccccccccccccCCCCccccCCCCCc--hHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 274 PTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKS--PAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~--~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
. ..+...+. .+.+||.+||..||.+||++.+++.|+|+.
T Consensus 129 --~-------------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 129 --R-------------------------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred --c-------------------------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0 00011112 588999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=217.91 Aligned_cols=211 Identities=27% Similarity=0.303 Sum_probs=167.3
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCC----CCeeEEEEEEEcCCC
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH----ENVVKLVNVHINHAD 102 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~~~~~~ 102 (477)
+|.+.+.||+|+||.||+|.+.... ...+|+|........... .+..|+.++..+.. .++..+++... ..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCC
Confidence 8999999999999999999876432 467888887765433221 45678888888862 68999998874 234
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC-CCcccEEEee
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG-EEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~-~~~~~vkL~D 181 (477)
.+-|+||+.++.+|.++..... ...++...+..++.|++.+|++||+.|++||||||+|+++.... .....+.|.|
T Consensus 94 ~~~~iVM~l~G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 94 DFNFIVMSLLGPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred ceeEEEEeccCccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 5789999999999999886654 46899999999999999999999999999999999999994332 1225799999
Q ss_pred cccce--eecCCCC-----ccc-CCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 011808 182 FGLAR--IYQAPLK-----FLS-ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246 (477)
Q Consensus 182 FG~a~--~~~~~~~-----~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~ 246 (477)
||+++ .+..... ... .....||..|.++.+..+. ..+.+.|+||++.++.+|+.|..||.+...
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 99998 4322211 111 2345589999999999884 489999999999999999999999976653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-23 Score=206.40 Aligned_cols=268 Identities=35% Similarity=0.558 Sum_probs=199.9
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC-CcHHHHHHHHHHHhcCCC-CeeEEEEEEEcCCCceE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG-VSPTAIREIMLLREITHE-NVVKLVNVHINHADMSL 105 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~~ 105 (477)
|.+.+.||.|+|+.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+++++++.... ..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--SL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC--EE
Confidence 889999999999999999754 6789999987666553 566788999999999988 7999999995433 47
Q ss_pred EEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc-cEEEeecc
Q 011808 106 YLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG-VVKIADFG 183 (477)
Q Consensus 106 ~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~-~vkL~DFG 183 (477)
+++++++.+ .+.+++...... ..+.+..+..++.|++.+|.|+|+.+++||||||+||++ +... .++++|||
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~----~~~~~~~~l~dfg 147 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL----DRDGRVVKLIDFG 147 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee----cCCCCeEEEeccC
Confidence 999999995 666455442110 268899999999999999999999999999999999999 5555 69999999
Q ss_pred cceeecCCCCcc----cCCCeeeccccccchhhcCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 184 LARIYQAPLKFL----SENGVVVTIWYRAPELLLGA--KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 184 ~a~~~~~~~~~~----~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
+++.+....... ......+|..|+|||++.+. ..+....|+||+|++++++++|..||...... .....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~ 222 (384)
T COG0515 148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQ 222 (384)
T ss_pred cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHH
Confidence 998655433221 23557789999999999874 45888999999999999999999998655421 11222
Q ss_pred HHHHHHHhCCC-CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 258 LDKIFKILGHP-TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 258 ~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
....+.....+ ....... .........+.+++.+|+..+|..|.+..+...++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~ 276 (384)
T COG0515 223 TLKIILELPTPSLASPLSP--------------------------SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276 (384)
T ss_pred HHHHHHhcCCcccccccCc--------------------------cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhch
Confidence 33322222211 0000000 00011124578999999999999999999999997
Q ss_pred cCCC
Q 011808 337 YFRI 340 (477)
Q Consensus 337 ~f~~ 340 (477)
|...
T Consensus 277 ~~~~ 280 (384)
T COG0515 277 LLAH 280 (384)
T ss_pred HhhC
Confidence 7653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-26 Score=232.46 Aligned_cols=241 Identities=29% Similarity=0.432 Sum_probs=192.9
Q ss_pred eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCceEEEEEec
Q 011808 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 33 ~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
++|+|+||.|++++.......+..+++|+.++.............|..++..++ ||.++++...|+.+. .+++++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG--KLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc--chhHhhhh
Confidence 479999999999976555567889999998876655444334455888888886 999999999987654 67889998
Q ss_pred cCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 112 AEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 112 ~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
..+ .|...+.. ...+.+..+..+...++.+++++|+.+|+|||+|++||++ +.+|++++.|||+++....
T Consensus 79 ~rgg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill----d~~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 79 LRGGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL----LLEGHIKLTDFGLSKEAVK 149 (612)
T ss_pred cccchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee----cccCccccCCchhhhHhHh
Confidence 875 66655443 3357788889999999999999999999999999999999 8889999999999986543
Q ss_pred CCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCC
Q 011808 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTP 270 (477)
Q Consensus 191 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 270 (477)
.. ..|||..|||||++.+ ...++|.||+|+++|+|+||..||.+ +.+..|.+.
T Consensus 150 ~~------~~cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~------ 202 (612)
T KOG0603|consen 150 EK------IACGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKA------ 202 (612)
T ss_pred hh------hcccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhh------
Confidence 22 1288999999999984 67789999999999999999999975 222222221
Q ss_pred CCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCccCCC
Q 011808 271 EKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHEYFRI 340 (477)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~~f~~ 340 (477)
....|...+..+++++..|+.++|.+|.- +.++++|+||..
T Consensus 203 -----------------------------~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 203 -----------------------------ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred -----------------------------ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence 11234455678999999999999999985 579999999973
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=195.46 Aligned_cols=213 Identities=24% Similarity=0.327 Sum_probs=169.8
Q ss_pred CccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCC-CCeeEEEEEEE
Q 011808 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH-ENVVKLVNVHI 98 (477)
Q Consensus 20 ~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~ 98 (477)
++--..+.|+++++||+|+||.+|+|.... .|..||||+-+.... ...+..|..+.+.|++ ..|..+..++.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~---~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISIT---SGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeecc---CCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 334457899999999999999999998654 799999998654332 3466789999999964 56666666553
Q ss_pred cCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 99 NHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 99 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
. ..+-++|||+++.+|.+++.-+ +..++...+.-++.|++.-++|+|.+++|||||||+|+|+. -+.....+.
T Consensus 82 e--~~ynvlVMdLLGPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMG-lgrh~~kl~ 154 (341)
T KOG1163|consen 82 E--KDYNVLVMDLLGPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMG-LGRHCNKLY 154 (341)
T ss_pred c--cccceeeeeccCccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeec-cccccceEE
Confidence 3 3467999999999998888654 44789999999999999999999999999999999999973 335566799
Q ss_pred EeecccceeecCCC-----CcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 011808 179 IADFGLARIYQAPL-----KFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247 (477)
Q Consensus 179 L~DFG~a~~~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~ 247 (477)
|+|||+|+.+.... .........||..|.+---..+.. .+.+.|+-|+|.+|.++.-|..||++....
T Consensus 155 LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 155 LIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred EEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 99999998765422 223344567899999887666533 577899999999999999999999987754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=201.99 Aligned_cols=211 Identities=25% Similarity=0.364 Sum_probs=173.3
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
-.--.|++.++||+|+||..|++.+.. ++..||||.-.... ...++..|.+..+.| ..++|..++.+. ..
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~---nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFG--qe 95 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLY---NNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFG--QE 95 (449)
T ss_pred EecccceeccccccCcceeeecccccc---cCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeec--cc
Confidence 345689999999999999999997654 68999999765432 345777899888888 578998887644 45
Q ss_pred CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC-CCcccEEEe
Q 011808 102 DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG-EEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~-~~~~~vkL~ 180 (477)
..+-.||+|+++.+|.+++.-+ +..++...+.-++.||+.-++|+|++.+|.|||||+|+||..-+ .....|.|+
T Consensus 96 G~~NiLVidLLGPSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 96 GKYNILVIDLLGPSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred cchhhhhhhhhCcCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEE
Confidence 5677899999999999988765 45799999999999999999999999999999999999995332 344569999
Q ss_pred ecccceeecCCCC-----cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 011808 181 DFGLARIYQAPLK-----FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247 (477)
Q Consensus 181 DFG~a~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~ 247 (477)
|||+|+.+..+.+ ........||..||+--...|.. -+.+.|+-|||-+++++|-|.+||.|....
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 9999998765432 22334567899999999988854 788999999999999999999999997643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=217.34 Aligned_cols=183 Identities=20% Similarity=0.214 Sum_probs=132.2
Q ss_pred CccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC---CCCCcHHHHHHHHHHHhcCCCCeeE-EEE
Q 011808 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD---GDGVSPTAIREIMLLREITHENVVK-LVN 95 (477)
Q Consensus 20 ~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~-l~~ 95 (477)
..+.+.++|.+.++||+|+||+||+|+++. .++..+|||++..... .......+.+|+++|+.++|+||+. +++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAG--DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcC--CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence 345678899999999999999999998764 2467789998753211 1223445778999999999999985 443
Q ss_pred EEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCC-CCCcEEEeccCCCc
Q 011808 96 VHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDL-KPSNILVMGEGEEQ 174 (477)
Q Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDi-kp~NILl~~~~~~~ 174 (477)
+ ...|+||||+.|..+..+. ... ...++.+++++|.|||++||+|||| ||+|||+ +.+
T Consensus 90 ~------~~~~LVmE~~~G~~L~~~~--------~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv----~~~ 148 (365)
T PRK09188 90 T------GKDGLVRGWTEGVPLHLAR--------PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM----GPD 148 (365)
T ss_pred c------CCcEEEEEccCCCCHHHhC--------ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE----cCC
Confidence 2 1469999999864443221 111 1467899999999999999999999 9999999 556
Q ss_pred ccEEEeecccceeecCCCCccc------CCCeeeccccccchhhcCC-----CCCCchhhHH
Q 011808 175 GVVKIADFGLARIYQAPLKFLS------ENGVVVTIWYRAPELLLGA-----KHYTSAVDMW 225 (477)
Q Consensus 175 ~~vkL~DFG~a~~~~~~~~~~~------~~~~~gt~~y~APE~l~~~-----~~~~~~~Diw 225 (477)
+.+||+|||+|+.+........ ....++++.|+|||.+.-. ...+...|-|
T Consensus 149 ~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 149 GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 7899999999987654321111 1245668889999988532 1233446666
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-24 Score=202.41 Aligned_cols=257 Identities=26% Similarity=0.359 Sum_probs=178.5
Q ss_pred cccceeEEeeecccCceEEEEEEEecccC--------------------------------CCcEEEEEecccCCCCCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAAN--------------------------------RGKAIAIKKFKQSKDGDGV 71 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~--------------------------------~~~~vaiK~~~~~~~~~~~ 71 (477)
-+++|+|...||+|.-..||.|+...+.. .--+.|||.+..-.....
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~- 233 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG- 233 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc-
Confidence 36789999999999999999998654210 111346666543222211
Q ss_pred cHHHH----HHH------HHH--------H-------hc-CCCCeeEEEEEEEcC-------------------------
Q 011808 72 SPTAI----REI------MLL--------R-------EI-THENVVKLVNVHINH------------------------- 100 (477)
Q Consensus 72 ~~~~~----~Ei------~il--------~-------~l-~hpnIv~l~~~~~~~------------------------- 100 (477)
...++ +|+ ..+ + +| +|||||++..+|.++
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 11222 121 011 1 12 599999999887543
Q ss_pred CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 101 ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 101 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
....+|+||-....+|.+++... ..+....+-++.|+++|+.|||.+||.|||+|.+|||+.-++|+-..+.|+
T Consensus 314 ~~~tlylvMkrY~~tLr~yl~~~------~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQTLREYLWTR------HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred CCceEEEehhcchhhHHHHHhcC------CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 23458999999999999999764 467788899999999999999999999999999999998888888899999
Q ss_pred ecccceeecCC---CCccc-CCCeeeccccccchhhcCCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCcccccC-C
Q 011808 181 DFGLARIYQAP---LKFLS-ENGVVVTIWYRAPELLLGAKH-----YTSAVDMWAVGCIFAELLTLKPLFQGAEAKST-Q 250 (477)
Q Consensus 181 DFG~a~~~~~~---~~~~~-~~~~~gt~~y~APE~l~~~~~-----~~~~~DiwSlGvil~elltG~~PF~~~~~~~~-~ 250 (477)
|||.+-..+.. ..+.+ .-..-|....||||+...... .-.++|.|+.|.+.||++....||.+..+... .
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~ 467 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT 467 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech
Confidence 99987533221 11111 112234677899999864321 12378999999999999999999986332110 0
Q ss_pred CcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 251 NPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 251 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
..++.+++ ...|..+++.+++||..+|+.||.+|+++
T Consensus 468 r~Yqe~qL------------------------------------------Palp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 468 RTYQESQL------------------------------------------PALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred hhhhhhhC------------------------------------------CCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 00111111 12456677889999999999999999984
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-25 Score=231.27 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=178.9
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC--CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG--DGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+|...+.||++-|=+|.+|+++. |. |+||+|-+.... -....+.++|++ ...+++||++.+..+... +..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHH
Confidence 78999999999999999998653 44 899998654422 223334455666 566699999999877544 335
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
-|||-+|...+|++.+.... -+..-+.+.|+.||+.||..+|..||+|+|||.+|||| +..+.+.|+||..
T Consensus 96 AylvRqyvkhnLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi----TSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI----TSWNWLYLTDFAS 166 (1431)
T ss_pred HHHHHHHHhhhhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE----eeechhhhhcccc
Confidence 68888999999999886532 46777889999999999999999999999999999999 8888999999987
Q ss_pred ceeecCCCCcccCCCe-----eeccccccchhhcCC----------CCCCchhhHHHHHHHHHHHHh-CCCCCCCccccc
Q 011808 185 ARIYQAPLKFLSENGV-----VVTIWYRAPELLLGA----------KHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKS 248 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~-----~gt~~y~APE~l~~~----------~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~ 248 (477)
-+...-+...-..-.+ ..-.+|+|||.+... ...+++.||||+||+++||++ |++||.-
T Consensus 167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----- 241 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----- 241 (1431)
T ss_pred cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----
Confidence 6533211111111111 113579999988531 125779999999999999998 7899952
Q ss_pred CCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC
Q 011808 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT 328 (477)
Q Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt 328 (477)
.|+-..-.. +.-.+ ..+...-.+..++.+|..|++.||++|.+
T Consensus 242 -------SQL~aYr~~-~~~~~-----------------------------e~~Le~Ied~~~Rnlil~Mi~rdPs~RlS 284 (1431)
T KOG1240|consen 242 -------SQLLAYRSG-NADDP-----------------------------EQLLEKIEDVSLRNLILSMIQRDPSKRLS 284 (1431)
T ss_pred -------HHHHhHhcc-CccCH-----------------------------HHHHHhCcCccHHHHHHHHHccCchhccC
Confidence 222111000 00000 00011111346899999999999999999
Q ss_pred HHHHhcC
Q 011808 329 AAQALEH 335 (477)
Q Consensus 329 ~~e~L~h 335 (477)
|++.|.-
T Consensus 285 AedyL~~ 291 (1431)
T KOG1240|consen 285 AEDYLQK 291 (1431)
T ss_pred HHHHHHh
Confidence 9999986
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=193.91 Aligned_cols=243 Identities=20% Similarity=0.261 Sum_probs=150.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcC----------CCCeeEE
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREIT----------HENVVKL 93 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~----------hpnIv~l 93 (477)
...+...+.||.|+++.||.+.+. .+++.+|+|++...... ....+.+.+|.-....+. |-.++..
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~---~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDV---ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEET---TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred ceEEEEccccccCCceEEEEEEEc---cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 345678889999999999999865 47999999998765533 223344444443333321 2222222
Q ss_pred EEEEE---------cC---CCc---eEEEEEeccCCCHHHHHHhhhcccCC--CCCHHHHHHHHHHHHHHHHHhhhCCee
Q 011808 94 VNVHI---------NH---ADM---SLYLAFDYAEYDLYEIIRHHRDKVNH--TMNPYTVKSILWQLLNGLNYLHSNWII 156 (477)
Q Consensus 94 ~~~~~---------~~---~~~---~~~lv~e~~~~~L~~~l~~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~giv 156 (477)
++... .. ... ..+++|+-+.++|.+++......... .+.......+..|++..+++||+.||+
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence 22221 11 111 24788888999998886643221111 122223345569999999999999999
Q ss_pred cCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCC-------CCCCchhhHHHHHH
Q 011808 157 HRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA-------KHYTSAVDMWAVGC 229 (477)
Q Consensus 157 HrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-------~~~~~~~DiwSlGv 229 (477)
|+||||+|+++ +.+|.++|+||+.....+..... ...+..|.+||..... -.++.+.|.|+||+
T Consensus 168 Hgdi~~~nfll----~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 168 HGDIKPENFLL----DQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp EST-SGGGEEE-----TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred ecccceeeEEE----cCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 99999999999 77888999999988765432211 1225779999987442 23788999999999
Q ss_pred HHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCc
Q 011808 230 IFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKS 309 (477)
Q Consensus 230 il~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~ 309 (477)
++|.|+++..||........... .|.. .. +.++
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~~-------------------~f~~---------------------------C~-~~Pe 271 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPEW-------------------DFSR---------------------------CR-DMPE 271 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSGG-------------------GGTT---------------------------SS----H
T ss_pred HHHHHHHccCCCCCCCccccccc-------------------cchh---------------------------cC-CcCH
Confidence 99999999999986654322110 0100 11 4467
Q ss_pred hHHHHHHHhcccCCCCC
Q 011808 310 PAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 310 ~~~dli~~~L~~dP~~R 326 (477)
.+++||+.||++||++|
T Consensus 272 ~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 272 PVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHccCCcccC
Confidence 89999999999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=218.94 Aligned_cols=228 Identities=30% Similarity=0.468 Sum_probs=157.9
Q ss_pred CccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEc
Q 011808 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHIN 99 (477)
Q Consensus 20 ~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 99 (477)
.....-.+|+.++.|-.|+||.||+++|+. +...+|+|+-++.. +++- ++....+|.+|
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~---trqrfa~kiNkq~l--------ilRn--ilt~a~npfvv-------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKE---TRQRFAMKINKQNL--------ILRN--ILTFAGNPFVV-------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccc---cccchhhcccccch--------hhhc--cccccCCccee--------
Confidence 344456789999999999999999999875 46678884433211 1111 22222333333
Q ss_pred CCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 100 HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 100 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
|+-...+.. -+.++. +++.+++|||+.||+|||+||+|++| +.-|++|+
T Consensus 136 --------------gDc~tllk~-----~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllI----T~mGhiKl 184 (1205)
T KOG0606|consen 136 --------------GDCATLLKN-----IGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLI----TSMGHIKL 184 (1205)
T ss_pred --------------chhhhhccc-----CCCCcc--------hhhHHhHhhccCCeecCCCCCCccee----eecccccc
Confidence 222222222 123433 23789999999999999999999999 78889999
Q ss_pred eecccceeecCCCC-------------cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 011808 180 ADFGLARIYQAPLK-------------FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246 (477)
Q Consensus 180 ~DFG~a~~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~ 246 (477)
+|||+++....... -......||||.|.||||+... .|+..+|+|++|+|+||++.|+.||.+.+.
T Consensus 185 TDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 185 TDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred cchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 99999864321110 0112356899999999999764 499999999999999999999999988764
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
++ .+..++... ..|++- .....++++|+|.++|+.+|..|
T Consensus 264 ee--------lfg~visd~-----i~wpE~---------------------------dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 264 EE--------LFGQVISDD-----IEWPEE---------------------------DEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred HH--------HHhhhhhhh-----cccccc---------------------------CcCCCHHHHHHHHHHHHhChHhh
Confidence 32 222222111 111111 11234789999999999999999
Q ss_pred C---CHHHHhcCccCCC
Q 011808 327 I---TAAQALEHEYFRI 340 (477)
Q Consensus 327 p---t~~e~L~h~~f~~ 340 (477)
. .+.++..|.||+.
T Consensus 304 lgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 304 LGTGGALEVKQHGFFQL 320 (1205)
T ss_pred cccchhhhhhhccceee
Confidence 6 5789999999973
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=181.66 Aligned_cols=174 Identities=14% Similarity=0.139 Sum_probs=128.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCC-cHH------HHHHHHHHHhcCCCCeeEEEEEE
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV-SPT------AIREIMLLREITHENVVKLVNVH 97 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~------~~~Ei~il~~l~hpnIv~l~~~~ 97 (477)
-++|+++++||.|+||.||++.+ ++..+|||++......... ... +.+|+..+.++.|++|..+.+++
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 47899999999999999998642 2557999999765433321 112 46899999999999999999987
Q ss_pred EcCC------CceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc
Q 011808 98 INHA------DMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 98 ~~~~------~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~ 170 (477)
.... ....+|+|||++| +|.+.. .+++ ..+.+|+.+|..||..|++||||||+||++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~---------~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili--- 168 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP---------EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIV--- 168 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh---------hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEE---
Confidence 6543 2347999999997 554432 1333 346699999999999999999999999999
Q ss_pred CCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh
Q 011808 171 GEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236 (477)
Q Consensus 171 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt 236 (477)
+.++ ++|+|||......... |-+.+.-...|+.++|+||||+++..+..
T Consensus 169 -~~~g-i~liDfg~~~~~~e~~---------------a~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 169 -SKNG-LRIIDLSGKRCTAQRK---------------AKDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred -eCCC-EEEEECCCcccccchh---------------hHHHHHHHhHhcccccccceeEeehHHHH
Confidence 4455 9999999886542211 11112222447789999999998876643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=178.53 Aligned_cols=141 Identities=18% Similarity=0.199 Sum_probs=104.7
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCC------------------------cHHHHHHHHHHHhcC
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV------------------------SPTAIREIMLLREIT 86 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~------------------------~~~~~~Ei~il~~l~ 86 (477)
...||+|+||.||+|.+. +|+.||||+++........ .....+|+.++.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05147 2 NGCISTGKEANVYHATTA----NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV 77 (190)
T ss_pred CCccccccceEEEEEECC----CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 568999999999999753 5899999999765322111 012234999999998
Q ss_pred CCCeeEEEEEEEcCCCceEEEEEeccCCCHH-HHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHh-hhCCeecCCCCCCc
Q 011808 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLY-EIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL-HSNWIIHRDLKPSN 164 (477)
Q Consensus 87 hpnIv~l~~~~~~~~~~~~~lv~e~~~~~L~-~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~L-H~~givHrDikp~N 164 (477)
++++.....+... . .+|||||++++.+ ..+.. ...+++..+..++.|++.+|.+| |+.||+||||||+|
T Consensus 78 ~~~v~~p~~~~~~-~---~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~N 148 (190)
T cd05147 78 TAGIPCPEPILLK-S---HVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYN 148 (190)
T ss_pred HCCCCCCcEEEec-C---CEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 7776443332222 1 2899999997533 22222 23688999999999999999999 79999999999999
Q ss_pred EEEeccCCCcccEEEeecccceeec
Q 011808 165 ILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 165 ILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
||+. ++.++|+|||+|....
T Consensus 149 Ili~-----~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 149 LLYH-----DGKLYIIDVSQSVEHD 168 (190)
T ss_pred EEEE-----CCcEEEEEccccccCC
Confidence 9993 2569999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=171.76 Aligned_cols=193 Identities=18% Similarity=0.093 Sum_probs=137.5
Q ss_pred eEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC--CcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCceE
Q 011808 29 NLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG--VSPTAIREIMLLREIT-HENVVKLVNVHINHADMSL 105 (477)
Q Consensus 29 ~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~ 105 (477)
.+...|++|+||+||++.. .+..++.+.+.....-.. ....+.+|+++|++|. |++|++++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec-----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CE
Confidence 4678899999999997742 467788777765443211 1124568999999995 58899998852 35
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCC-CCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDL-KPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDi-kp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|++|+|+.|..+.... .. ....++.|++.+|.++|++||+|||| ||+|||+ +.++.++|+|||+
T Consensus 74 ~lvmeyI~G~~L~~~~----------~~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv----~~~g~i~LIDFG~ 138 (218)
T PRK12274 74 HLDRSYLAGAAMYQRP----------PR-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV----QEDGSPAVIDFQL 138 (218)
T ss_pred EEEEeeecCccHHhhh----------hh-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE----cCCCCEEEEECCC
Confidence 9999999875432111 11 12357889999999999999999999 7999999 5667799999999
Q ss_pred ceeecCCCCc----cc-------CCCeeeccccccchhhcCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCcccc
Q 011808 185 ARIYQAPLKF----LS-------ENGVVVTIWYRAPELLLGAKHYT-SAVDMWAVGCIFAELLTLKPLFQGAEAK 247 (477)
Q Consensus 185 a~~~~~~~~~----~~-------~~~~~gt~~y~APE~l~~~~~~~-~~~DiwSlGvil~elltG~~PF~~~~~~ 247 (477)
+......... .. ..-...++.|+.|+...-....+ .+.++++.|+.+|.++|+..++.+..+.
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 9855432210 00 00112478888888654332233 5678889999999999999988765543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-22 Score=179.61 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=190.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+....++-+|.+...|..|++++. |..+++|+++......+..+.+..|.-.|+.+.||||+.+++.+... ..
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwq-----gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp--pn 261 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQ-----GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP--PN 261 (448)
T ss_pred hhhhhhhhhhccCCCccccccccc-----CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC--CC
Confidence 455667888999999999999875 55688888887776666677788899999999999999999998665 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC--eecCCCCCCcEEEeccCCCcccEEE--
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW--IIHRDLKPSNILVMGEGEEQGVVKI-- 179 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDikp~NILl~~~~~~~~~vkL-- 179 (477)
++++..|+. ++|+..+.... +--.+..++.+++.+|+.++.|||+.. |.---|....|++ +++.+.+|
T Consensus 262 lv~isq~mp~gslynvlhe~t---~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi----dedltarism 334 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI----DEDLTARISM 334 (448)
T ss_pred ceEeeeeccchHHHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe----cchhhhheec
Confidence 899999999 68888886643 334677789999999999999999974 4445688899999 55555444
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCC--CchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHY--TSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~--~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
+|--++.. ..+..-+|.||+||.+...... -.++|+|||.++++||.|...||......+
T Consensus 335 ad~kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme--------- 396 (448)
T KOG0195|consen 335 ADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME--------- 396 (448)
T ss_pred ccceeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh---------
Confidence 44333321 1122338999999999764332 347899999999999999999997654321
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
-+.+....++...+|...+.....|+.-|++.||.+||.++.++
T Consensus 397 --------------------------------cgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 397 --------------------------------CGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred --------------------------------hhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 12344556777888999999999999999999999999988764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=171.94 Aligned_cols=141 Identities=21% Similarity=0.214 Sum_probs=107.5
Q ss_pred EEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCC------------------------cHHHHHHHHHHHhc
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV------------------------SPTAIREIMLLREI 85 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~------------------------~~~~~~Ei~il~~l 85 (477)
+.+.||+|+||.||+|.+. +|+.||||+++........ .....+|+..+.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 76 (190)
T cd05145 1 INGCISTGKEANVYHARTG----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL 76 (190)
T ss_pred CCceeecCCCcEEEEEEcC----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 3578999999999999754 5899999999865321100 11224688999999
Q ss_pred CCCCeeEEEEEEEcCCCceEEEEEeccCCC-HHH-HHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCC
Q 011808 86 THENVVKLVNVHINHADMSLYLAFDYAEYD-LYE-IIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKP 162 (477)
Q Consensus 86 ~hpnIv~l~~~~~~~~~~~~~lv~e~~~~~-L~~-~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp 162 (477)
.|++|.....+.... .||||||++|. +.. .+.. ..+++..+..++.|++.+|.+||+ .||+||||||
T Consensus 77 ~~~~i~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP 146 (190)
T cd05145 77 YEAGVPVPEPILLKK----NVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSE 146 (190)
T ss_pred HhCCCCCceEEEecC----CEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCh
Confidence 999875544443322 38999999975 332 2322 257888999999999999999999 9999999999
Q ss_pred CcEEEeccCCCcccEEEeecccceeec
Q 011808 163 SNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 163 ~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
+|||+ + ++.++|+|||++....
T Consensus 147 ~NIll----~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 147 YNILY----H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred hhEEE----E-CCCEEEEEcccceecC
Confidence 99999 4 4679999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-19 Score=168.08 Aligned_cols=140 Identities=20% Similarity=0.201 Sum_probs=106.1
Q ss_pred EEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-----CCCCeeEEEEEEEcCCC-c
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-----THENVVKLVNVHINHAD-M 103 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~~-~ 103 (477)
-.+.||+|+|+.||. +.. +.. .+||++..... .....+.+|+.+++.+ +||||+++++++.+..+ .
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~---~~~-k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPE---DAQ-RCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred CcceecCCCceEEEE--CCC---CcC-eEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 356899999999995 442 333 36998865432 2345788999999999 57999999999987642 2
Q ss_pred e-EEEEEeccC---CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHH-HHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 104 S-LYLAFDYAE---YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL-NYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 104 ~-~~lv~e~~~---~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL-~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
. +.+|+||++ ++|.+++.+. .+++. ..++.+++.++ +|||+++|+||||||+|||+...++....++
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEE
Confidence 3 347899955 6999998652 35554 35688888888 9999999999999999999965544556899
Q ss_pred Eeecccc
Q 011808 179 IADFGLA 185 (477)
Q Consensus 179 L~DFG~a 185 (477)
|+||+.+
T Consensus 150 LiDg~G~ 156 (210)
T PRK10345 150 VCDNIGE 156 (210)
T ss_pred EEECCCC
Confidence 9995444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=193.29 Aligned_cols=198 Identities=23% Similarity=0.316 Sum_probs=150.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC---CCCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT---HENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~ 101 (477)
...|.|.+.||+|+||+||+|... +++.||||+-+....-+ ++--.+++.+|+ -+.|..+..++...+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~----~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHS----NGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecC----CCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 467999999999999999999754 39999999977654332 222334555555 233444444333333
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc---CCCcccE
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE---GEEQGVV 177 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~---~~~~~~v 177 (477)
.-+||++|.. |+|++++.. ++-+++..+..++.||+..+++||..+|||+||||+|+||+.. +.+..-+
T Consensus 768 --~S~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 768 --ASVLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred --cceeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccce
Confidence 2488999988 799999873 4579999999999999999999999999999999999999632 2334569
Q ss_pred EEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCC
Q 011808 178 KIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKP 239 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~ 239 (477)
+|+|||.+-.+.--.....-...++|-.+-.+|+..|. .+++.+|.|.|.-+++.||+|+.
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHHH
Confidence 99999998755332222233446678999999999884 59999999999999999999874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8e-20 Score=181.91 Aligned_cols=259 Identities=26% Similarity=0.379 Sum_probs=165.7
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEE-------
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVN------- 95 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~------- 95 (477)
.....+.+.+..+..+++.++..+.........-++-+....+ .........+++-.+....|-+..-+.+
T Consensus 241 ~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d--~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~ 318 (516)
T KOG1033|consen 241 EESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD--SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFE 318 (516)
T ss_pred cccccccccccccccccCCchhhhhcccchhhhhccchhhhcc--chhhhhhhhhhhhheeccccCCcccccCCCCchhh
Confidence 3345677777788888887776543322111222332222221 1123344455666665554444333333
Q ss_pred EEEcC---CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC
Q 011808 96 VHINH---ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 96 ~~~~~---~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~ 171 (477)
.+..+ ...++||.|++|. .+|.+.|+..+ .....+......++.|+..+++| +|.+|||+||.||++
T Consensus 319 ~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---- 389 (516)
T KOG1033|consen 319 SSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---- 389 (516)
T ss_pred hccccccccccchhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh---ccchhhhcccccccc----
Confidence 11111 1236899999999 56666665432 24456777899999999999999 999999999999999
Q ss_pred CCcccEEEeecccceeecCCC----CcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 011808 172 EEQGVVKIADFGLARIYQAPL----KFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEA 246 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~ 246 (477)
..+..+||.|||+........ .......-+||.+||+||.|.+. .|+.++||||||++|+|++. -...|.
T Consensus 390 ~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~e---- 464 (516)
T KOG1033|consen 390 SDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQFE---- 464 (516)
T ss_pred ccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHHH----
Confidence 555579999999987665433 22234456789999999999984 59999999999999999997 222221
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
....+..+.. +.-+++.+. ..+.-++||.+||...|.+|
T Consensus 465 -------r~~t~~d~r~--g~ip~~~~~--------------------------------d~p~e~~ll~~lls~~p~~R 503 (516)
T KOG1033|consen 465 -------RIATLTDIRD--GIIPPEFLQ--------------------------------DYPEEYTLLQQLLSPSPEER 503 (516)
T ss_pred -------HHHhhhhhhc--CCCChHHhh--------------------------------cCcHHHHHHHHhcCCCcccC
Confidence 0111111110 000111110 01345699999999999999
Q ss_pred CCHHHHhcCccC
Q 011808 327 ITAAQALEHEYF 338 (477)
Q Consensus 327 pt~~e~L~h~~f 338 (477)
|++.+.-.|.|.
T Consensus 504 P~~~~~~~~~~~ 515 (516)
T KOG1033|consen 504 PSAIEVALHEFL 515 (516)
T ss_pred chHHHHhhhhhc
Confidence 988888777764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-20 Score=196.83 Aligned_cols=266 Identities=27% Similarity=0.398 Sum_probs=199.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 103 (477)
...|.+.+.||+|+|+.|-++.... .....+|+|.+.............-.|..+-+.+. |.|++.+++...+..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~--~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~-- 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSR--DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR-- 94 (601)
T ss_pred cccccccccccccccchhhhhhhcC--CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc--
Confidence 6779999999999999998876433 34567777777665433333344445888888886 999999999875543
Q ss_pred eEEEEEeccC-CCHHHHH-HhhhcccCCCCCHHHHHHHHHHHHHHHHHhh-hCCeecCCCCCCcEEEeccCCCcc-cEEE
Q 011808 104 SLYLAFDYAE-YDLYEII-RHHRDKVNHTMNPYTVKSILWQLLNGLNYLH-SNWIIHRDLKPSNILVMGEGEEQG-VVKI 179 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l-~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~givHrDikp~NILl~~~~~~~~-~vkL 179 (477)
..++.+++.. +++++.+ ... ....+...+..++.|+..+|.|+| ..++.||||||+|.++ +..+ .+++
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~----~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l----~~s~~~l~~ 166 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPD----STGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL----DESGSALKI 166 (601)
T ss_pred ccccccCcccccccccccccCC----ccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh----ccCCCcccC
Confidence 6788888876 4666655 221 125677788999999999999999 9999999999999999 5555 8999
Q ss_pred eecccceeecC-CCCcccCCCeee-ccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 180 ADFGLARIYQA-PLKFLSENGVVV-TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 180 ~DFG~a~~~~~-~~~~~~~~~~~g-t~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
.|||+|..+.. ..........+| ++.|+|||...+........|+||+|+++..+++|..||..........
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------ 240 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------ 240 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc------
Confidence 99999987665 444444556678 9999999999886667889999999999999999999997655322110
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
-.|.... ...........+..+.+++.++|..+|..|.+..++..++|
T Consensus 241 ----------------------~~~~~~~----------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~ 288 (601)
T KOG0590|consen 241 ----------------------SSWKSNK----------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNW 288 (601)
T ss_pred ----------------------eeecccc----------cccccCccccCChhhhhcccccccCCchhcccccccccccc
Confidence 0010000 00111122334567889999999999999999999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
+..
T Consensus 289 ~~~ 291 (601)
T KOG0590|consen 289 LSS 291 (601)
T ss_pred ccc
Confidence 975
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-18 Score=162.39 Aligned_cols=145 Identities=21% Similarity=0.141 Sum_probs=106.7
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC----------------------CcHHHHHHHHHHHh
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG----------------------VSPTAIREIMLLRE 84 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~----------------------~~~~~~~Ei~il~~ 84 (477)
-|.+.+.||+|+||.||+|.+.. .+|..||||+++....... ....+.+|+.++++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~--~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFD--GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecC--CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999997321 3689999999875432100 00124579999999
Q ss_pred cCC--CCeeEEEEEEEcCCCceEEEEEeccCCCHH-HHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC-eecCCC
Q 011808 85 ITH--ENVVKLVNVHINHADMSLYLAFDYAEYDLY-EIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW-IIHRDL 160 (477)
Q Consensus 85 l~h--pnIv~l~~~~~~~~~~~~~lv~e~~~~~L~-~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g-ivHrDi 160 (477)
+.+ ..+.++++. . ..|+||||+++..+ ..+.. ...+.+.++..++.||+.+|.+||+.| |+||||
T Consensus 107 L~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Di 175 (237)
T smart00090 107 LYEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDL 175 (237)
T ss_pred HHhcCCCCCeeeEe---c---CceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCC
Confidence 975 334444442 1 24899999998433 32211 224566678899999999999999999 999999
Q ss_pred CCCcEEEeccCCCcccEEEeecccceeec
Q 011808 161 KPSNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 161 kp~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
||+||++ + .+.++|+|||.+....
T Consensus 176 kp~NIli----~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 176 SEYNILV----H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred ChhhEEE----E-CCCEEEEEChhhhccC
Confidence 9999999 4 5679999999987543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=169.76 Aligned_cols=210 Identities=24% Similarity=0.382 Sum_probs=151.9
Q ss_pred HHhcCCCCeeEEEEEEEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCe-ecCC
Q 011808 82 LREITHENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWI-IHRD 159 (477)
Q Consensus 82 l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~gi-vHrD 159 (477)
|+.+.|.|+.++++.+.+. ..+++|.+||. |+|.+.+... .-.++......++++|+.||.|||..-| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCcceeeee
Confidence 4678999999999999886 47899999999 7999988764 3357788889999999999999998865 9999
Q ss_pred CCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCC------CCchhhHHHHHHHHHH
Q 011808 160 LKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKH------YTSAVDMWAVGCIFAE 233 (477)
Q Consensus 160 ikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~------~~~~~DiwSlGvil~e 233 (477)
++..|+++ +....+||+|||+.................-..-|.|||.+.+... .+.+.||||+|++++|
T Consensus 75 l~s~nClv----d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 75 LKSSNCLV----DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred ecccccee----eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 99999999 8899999999999876642111111111122567999999977421 3667999999999999
Q ss_pred HHhCCCCCCCcccccCCCcccHHHHHHHHHHhCC-CCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHH
Q 011808 234 LLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH-PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY 312 (477)
Q Consensus 234 lltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~ 312 (477)
+++..-||........ . .+++..+.. ......|.+.. .. ...+++.
T Consensus 151 i~~r~~~~~~~~~~~~-------~-~eii~~~~~~~~~~~rP~i~~-----------------------~~--e~~~~l~ 197 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVED-------P-DEIILRVKKGGSNPFRPSIEL-----------------------LN--ELPPELL 197 (484)
T ss_pred HHhccCccccccccCC-------h-HHHHHHHHhcCCCCcCcchhh-----------------------hh--hcchHHH
Confidence 9999999986543221 1 112221211 11111111110 00 2234688
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 011808 313 DLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 313 dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.+++.||..+|.+||+++++-.
T Consensus 198 ~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 198 LLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred HHHHHhcccChhhCccHHHHHh
Confidence 9999999999999999887643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-16 Score=147.44 Aligned_cols=136 Identities=21% Similarity=0.281 Sum_probs=105.4
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCC------cHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV------SPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++.||+|++|.||+|++ .+..+++|+.......... ...+.+|+.++..+.|++|.....++.+.. .
T Consensus 1 ~~~l~~G~~~~vy~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~ 73 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF-----LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--N 73 (211)
T ss_pred CcccccCceEEEEEEee-----CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--C
Confidence 36799999999999975 3667899986543322111 124567999999999998877666655443 4
Q ss_pred EEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+++|||++| +|.+.+... .. ....++.+|+.+|.+||+.+++|||++|.|||+ + .+.++|+|||
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~----~-~~~~~liDf~ 139 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL----S-GGKIYLIDFG 139 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE----E-CCCEEEEECC
Confidence 6899999985 777766532 11 778999999999999999999999999999999 3 4569999999
Q ss_pred ccee
Q 011808 184 LARI 187 (477)
Q Consensus 184 ~a~~ 187 (477)
.+..
T Consensus 140 ~a~~ 143 (211)
T PRK14879 140 LAEF 143 (211)
T ss_pred cccC
Confidence 9864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=147.76 Aligned_cols=138 Identities=22% Similarity=0.218 Sum_probs=102.6
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC--------------------CcHHHHHHHHHHHhcCC
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG--------------------VSPTAIREIMLLREITH 87 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~--------------------~~~~~~~Ei~il~~l~h 87 (477)
|.+.+.||+|+||.||++.+. ++..||||++........ ......+|+.++..+.|
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred hhcCCccccCcceEEEEEEcC----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 888999999999999999753 588999998765431100 01124568888988877
Q ss_pred C--CeeEEEEEEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcE
Q 011808 88 E--NVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNI 165 (477)
Q Consensus 88 p--nIv~l~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NI 165 (477)
. .+...++. ...+++|||+.+..+..+.. ......++.+++.++.++|..||+||||||+||
T Consensus 93 ~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Ni 156 (198)
T cd05144 93 EGFPVPKPIDW------NRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNI 156 (198)
T ss_pred cCCCCCceeec------CCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccE
Confidence 7 44444432 13489999999743322211 024567889999999999999999999999999
Q ss_pred EEeccCCCcccEEEeecccceeec
Q 011808 166 LVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 166 Ll~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
++ ++++.++|+|||.+....
T Consensus 157 ll----~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 157 LV----DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EE----cCCCcEEEEECCccccCC
Confidence 99 667789999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=4e-16 Score=143.78 Aligned_cols=131 Identities=23% Similarity=0.321 Sum_probs=97.2
Q ss_pred eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCC------cHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV------SPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 33 ~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
.||+|+||.||++.+ .+..+++|........... ...+.+|+.+++.+.|+++....-++.... ..+
T Consensus 1 ~ig~G~~~~vy~~~~-----~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKT 73 (199)
T ss_pred CCCCCceEEEEEeec-----CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCE
Confidence 489999999999973 3677999986543222111 234567999999998876544433333332 458
Q ss_pred EEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
++|||++| +|.+.+.... ..++.+++.+|.+||+.|++|+|++|+||++ + .+.++|+|||++
T Consensus 74 lv~e~~~g~~l~~~~~~~~------------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~----~-~~~~~liDfg~a 136 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN------------DELLREIGRLVGKLHKAGIVHGDLTTSNIIV----R-DDKLYLIDFGLG 136 (199)
T ss_pred EEEEEECCccHHHHHhhcH------------HHHHHHHHHHHHHHHHCCeecCCCCcceEEE----E-CCcEEEEECCCC
Confidence 99999985 6666554311 0789999999999999999999999999999 4 567999999998
Q ss_pred ee
Q 011808 186 RI 187 (477)
Q Consensus 186 ~~ 187 (477)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 65
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.8e-16 Score=163.51 Aligned_cols=137 Identities=20% Similarity=0.212 Sum_probs=102.0
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-C-----CCcHHHHHHHHHHHhcCCCCeeEEEEEEEc
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-D-----GVSPTAIREIMLLREITHENVVKLVNVHIN 99 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 99 (477)
..|...+.||+|+||+||++.+.. ..+++|+....... . .....+.+|+++++.++|++|+....++.+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG-----RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC-----ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 345678899999999999987542 23444432211111 1 112356789999999999999887766555
Q ss_pred CCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 100 HADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 100 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
.. ..++||||+++ +|.+++. ....++.+++.+|.+||+.||+||||||+|||+ + ++.++
T Consensus 408 ~~--~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~-~~~~~ 467 (535)
T PRK09605 408 PE--EKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----R-DDRLY 467 (535)
T ss_pred CC--CCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----E-CCcEE
Confidence 33 46899999985 6666553 246789999999999999999999999999999 2 34699
Q ss_pred Eeeccccee
Q 011808 179 IADFGLARI 187 (477)
Q Consensus 179 L~DFG~a~~ 187 (477)
|+|||+++.
T Consensus 468 liDFGla~~ 476 (535)
T PRK09605 468 LIDFGLGKY 476 (535)
T ss_pred EEeCccccc
Confidence 999999975
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.8e-16 Score=140.36 Aligned_cols=137 Identities=23% Similarity=0.284 Sum_probs=95.9
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHH----------------------HHHHHHHHhcCCC
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA----------------------IREIMLLREITHE 88 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~----------------------~~Ei~il~~l~hp 88 (477)
.+.||+|+||+||+|.+. ++..||||+++............ ..|...+..+.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECC----CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 568999999999999754 57899999987643321111111 2466666666433
Q ss_pred --CeeEEEEEEEcCCCceEEEEEeccCCC-HH-HHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCCC
Q 011808 89 --NVVKLVNVHINHADMSLYLAFDYAEYD-LY-EIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPS 163 (477)
Q Consensus 89 --nIv~l~~~~~~~~~~~~~lv~e~~~~~-L~-~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp~ 163 (477)
.+.+++.+. ..+++|||+.+. +. ..+.... . ...++.++.+++.++.++|. .||+|+||||+
T Consensus 78 ~~~~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~------~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~ 144 (187)
T cd05119 78 GVPVPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVR------L-LEDPEELYDQILELMRKLYREAGLVHGDLSEY 144 (187)
T ss_pred CCCCCceEecC------CCEEEEEEeCCCCccChhhhhhh------h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChh
Confidence 344454431 248999999972 11 1121111 1 15678999999999999999 99999999999
Q ss_pred cEEEeccCCCcccEEEeecccceeec
Q 011808 164 NILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 164 NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
||++ + ++.++|+|||.+....
T Consensus 145 Nili----~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 145 NILV----D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hEEE----E-CCcEEEEECccccccc
Confidence 9999 4 5679999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.5e-15 Score=140.57 Aligned_cols=137 Identities=15% Similarity=0.250 Sum_probs=99.0
Q ss_pred eeec-ccCceEEEEEEEecccCCCcEEEEEecccCCC-----------CCCCcHHHHHHHHHHHhcCCCCe--eEEEEEE
Q 011808 32 GKIG-EGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-----------GDGVSPTAIREIMLLREITHENV--VKLVNVH 97 (477)
Q Consensus 32 ~~lG-~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~ 97 (477)
..|| .|+.|+||.+.. .+..++||.+..... .......+.+|+.++..|.|++| ++.+++.
T Consensus 37 ~~lg~~~g~gtv~~v~~-----~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~ 111 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-----PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR 111 (239)
T ss_pred ceeecCCCCccEEEEEe-----CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence 4576 788888888753 266789998853211 01223467789999999988775 6677664
Q ss_pred EcCCCc--eEEEEEeccCC--CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCC
Q 011808 98 INHADM--SLYLAFDYAEY--DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE 173 (477)
Q Consensus 98 ~~~~~~--~~~lv~e~~~~--~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~ 173 (477)
...... ..++|||++.| +|.+++.. ..+++. .+.+|+.+|.+||+.||+||||||+|||+ +.
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv----~~ 177 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL----DP 177 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE----cC
Confidence 433222 23599999985 77777643 235543 36789999999999999999999999999 55
Q ss_pred cccEEEeeccccee
Q 011808 174 QGVVKIADFGLARI 187 (477)
Q Consensus 174 ~~~vkL~DFG~a~~ 187 (477)
++.++|+|||.+..
T Consensus 178 ~~~v~LIDfg~~~~ 191 (239)
T PRK01723 178 DGKFWLIDFDRGEL 191 (239)
T ss_pred CCCEEEEECCCccc
Confidence 55799999998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.1e-15 Score=149.86 Aligned_cols=260 Identities=25% Similarity=0.255 Sum_probs=190.5
Q ss_pred ccceeEEeeecc--cCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGE--GTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~--G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
-+.+.+.+.+|. |.+|.||.++... ...+..+|+|.-+...........-++|+.-.+.+ .|+|.++.+..++..
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~- 190 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS- 190 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCc-ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC-
Confidence 456888999999 9999999997621 34688899998655544444444556788877777 599999987777554
Q ss_pred CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHH----HHHHhhhCCeecCCCCCCcEEEeccCCCc-cc
Q 011808 102 DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN----GLNYLHSNWIIHRDLKPSNILVMGEGEEQ-GV 176 (477)
Q Consensus 102 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~----aL~~LH~~givHrDikp~NILl~~~~~~~-~~ 176 (477)
..+|+-.|+|+..|..+...- ...+++..++..+.+... ||.++|+.+|+|-|+||+||++ ..+ ..
T Consensus 191 -~~lfiqtE~~~~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~----~~~~~s 261 (524)
T KOG0601|consen 191 -GILFIQTELCGESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFT----TSDWTS 261 (524)
T ss_pred -CcceeeeccccchhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheec----ccccce
Confidence 478999999998888776653 234788899999999999 9999999999999999999999 444 67
Q ss_pred EEEeecccceeecCCCCcccC---CCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 177 VKIADFGLARIYQAPLKFLSE---NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
.+++|||+...+....-.... ....+...|++||++.+ -++...|+|+||.++.+..++-.++.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------- 332 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKN------- 332 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCC-------
Confidence 999999999877654311111 11245677999999976 378999999999999998887665543210
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
..|...+... +...+-...+..+...+..|++.||..|+++..++
T Consensus 333 --------------------------~~W~~~r~~~---------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 333 --------------------------SSWSQLRQGY---------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred --------------------------CCcccccccc---------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 1121111000 00111112234566699999999999999999999
Q ss_pred cCccCC
Q 011808 334 EHEYFR 339 (477)
Q Consensus 334 ~h~~f~ 339 (477)
+|.+..
T Consensus 378 ~l~~i~ 383 (524)
T KOG0601|consen 378 ALNVIH 383 (524)
T ss_pred cccccc
Confidence 999976
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.9e-14 Score=124.18 Aligned_cols=132 Identities=23% Similarity=0.276 Sum_probs=104.4
Q ss_pred EEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCC--CCeeEEEEEEEcCCCceEEE
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH--ENVVKLVNVHINHADMSLYL 107 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~~~l 107 (477)
+++.||.|.++.||++... +..+++|.+..... ...+.+|+.+++.+.| .++++++.++... ...++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD--GWSYL 70 (155)
T ss_pred cceecccccccceEEEEec-----CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEE
Confidence 5688999999999999753 36799999865433 3467789999999976 5899998876543 46799
Q ss_pred EEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC---CeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 108 AFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN---WIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 108 v~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+|||+.+..... ++......++.+++.+|.+||.. +++|+||+|+|||+ +..+.++|+|||.
T Consensus 71 v~e~~~g~~~~~-----------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~----~~~~~~~l~Df~~ 135 (155)
T cd05120 71 LMEWIEGETLDE-----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV----DDGKILGIIDWEY 135 (155)
T ss_pred EEEecCCeeccc-----------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE----ECCcEEEEEeccc
Confidence 999998643321 13455677889999999999985 79999999999999 4467799999998
Q ss_pred cee
Q 011808 185 ARI 187 (477)
Q Consensus 185 a~~ 187 (477)
+..
T Consensus 136 ~~~ 138 (155)
T cd05120 136 AGY 138 (155)
T ss_pred ccC
Confidence 863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.3e-14 Score=149.51 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=180.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.+.+.+.+-+-+|+++.++.+.-.. .+...++|+...... .....+....+-.++-...+|-++....-+ .-..
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~---sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAG---SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccc---cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCCC
Confidence 5678889999999999999986443 455555555433221 111122222333333333456665544432 2234
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.++|+++|.+ ++|...+... ...++..++.++..+..++++||+..++|+|++|.|+|. ...++.++.||
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~----~~~gh~~l~~~ 948 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNS-----GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI----AYDGHRPLTDF 948 (1205)
T ss_pred CcchhhHHhccCCchhhhhcC-----CCcccccccchhHHHHhhhhccccchhhcccccccchhh----cccCCcccCcc
Confidence 6899999987 4666665542 357778889999999999999999999999999999999 77788999999
Q ss_pred ccceeecCC-----------------------------CCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHH
Q 011808 183 GLARIYQAP-----------------------------LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAE 233 (477)
Q Consensus 183 G~a~~~~~~-----------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~e 233 (477)
+........ ..........+|+.|.+||.+.+.. ....+|+|++|++++|
T Consensus 949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen 949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFE 1027 (1205)
T ss_pred ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhh
Confidence 843321100 0001123456799999999999865 6778899999999999
Q ss_pred HHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHH
Q 011808 234 LLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYD 313 (477)
Q Consensus 234 lltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~d 313 (477)
.++|.+||..... .++++.+.... ..|+. .+...+..+++
T Consensus 1028 ~l~g~pp~na~tp------------q~~f~ni~~~~-~~~p~---------------------------g~~~~s~~aq~ 1067 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETP------------QQIFENILNRD-IPWPE---------------------------GPEEGSYEAQD 1067 (1205)
T ss_pred hhcCCCCCCCcch------------hhhhhccccCC-CCCCC---------------------------CccccChhhhh
Confidence 9999999976553 22333332211 11221 23334677899
Q ss_pred HHHHhcccCCCCCCCHH---HHhcCccCCC
Q 011808 314 LLSKMLEYDPRKRITAA---QALEHEYFRI 340 (477)
Q Consensus 314 li~~~L~~dP~~Rpt~~---e~L~h~~f~~ 340 (477)
++.++|..+|.+|..+. ++-.|+||+.
T Consensus 1068 ~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~ 1097 (1205)
T KOG0606|consen 1068 LINRLLTEEPTQRLGAKGAAEVKGHPFFQD 1097 (1205)
T ss_pred hhhhhhccCchhccCcccccccccCCccCC
Confidence 99999999999999877 9999999973
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=8.3e-13 Score=124.61 Aligned_cols=207 Identities=21% Similarity=0.243 Sum_probs=137.4
Q ss_pred HHHHhcCCCCeeEEEEEEEcC---CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC-
Q 011808 80 MLLREITHENVVKLVNVHINH---ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW- 154 (477)
Q Consensus 80 ~il~~l~hpnIv~l~~~~~~~---~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g- 154 (477)
..|-++.|-||++++.++.+. +.....++.||+. +.+..+|++.+ +....+.....++|+.||++||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 344556799999999887653 2345778889998 78888887754 33557888899999999999999999984
Q ss_pred -eecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCC---cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHH
Q 011808 155 -IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK---FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCI 230 (477)
Q Consensus 155 -ivHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvi 230 (477)
|+|+++..+.|++ ..++-+|+.---.. ....... ........+-++|.+||.=.-. ..+.++|||++|..
T Consensus 198 piihgnlTc~tifi----q~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFI----QHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMC 271 (458)
T ss_pred ccccCCcchhheee----cCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhHH
Confidence 9999999999999 56666665321111 1110000 0001112336789999965432 35778999999999
Q ss_pred HHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCch
Q 011808 231 FAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP 310 (477)
Q Consensus 231 l~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~ 310 (477)
..+|..+..--...+.... .... +...+ -.-...-
T Consensus 272 AlemailEiq~tnseS~~~----~ee~---ia~~i--------------------------------------~~len~l 306 (458)
T KOG1266|consen 272 ALEMAILEIQSTNSESKVE----VEEN---IANVI--------------------------------------IGLENGL 306 (458)
T ss_pred HHHHHHheeccCCCcceee----hhhh---hhhhe--------------------------------------eeccCcc
Confidence 9999887653222111000 0000 11100 0000111
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 311 AYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 311 ~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
-+++|.+||+-.|..||++.++|.||.+
T Consensus 307 qr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 307 QRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred ccCcCcccccCCCCCCcchhhhhcCcee
Confidence 2479999999999999999999999985
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.5e-13 Score=139.50 Aligned_cols=156 Identities=16% Similarity=0.275 Sum_probs=98.9
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-----------------------C---------
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-----------------------D--------- 69 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-----------------------~--------- 69 (477)
.+++..|+. +.||+|++|.||+|+.+. +|+.||||+.+..... .
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~---~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~ 191 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKD---NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA 191 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECC---CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence 356778887 899999999999998763 4899999999754210 0
Q ss_pred CCcHHH------HHHHHHHHhc----CCCCeeEEEEEEEcCCCceEEEEEeccCC-CHHHH--HHhhhcccCCCCCHHHH
Q 011808 70 GVSPTA------IREIMLLREI----THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEI--IRHHRDKVNHTMNPYTV 136 (477)
Q Consensus 70 ~~~~~~------~~Ei~il~~l----~hpnIv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~--l~~~~~~~~~~l~~~~~ 136 (477)
+....+ .+|+..+.++ .+.+.+.+-.++.+- ....+|||||+.| .+.++ +.... .....+.+..+
T Consensus 192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v 269 (537)
T PRK04750 192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGV 269 (537)
T ss_pred HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHH
Confidence 011112 2344434333 244444444444332 1245899999997 55442 22211 00112445555
Q ss_pred HHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 137 ~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
..++.||+ ..|++|+|+||.||+++.++...+.++++|||++..+..
T Consensus 270 ~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 56666655 589999999999999965554455899999999987643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.3e-11 Score=125.22 Aligned_cols=163 Identities=20% Similarity=0.379 Sum_probs=121.9
Q ss_pred CCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCC
Q 011808 53 RGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMN 132 (477)
Q Consensus 53 ~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~ 132 (477)
++..|.|..++.... .....+.+-++.|+.++||||+++++.++... .+|||.|.+.. |..++.. +.
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ylvTErV~P-l~~~lk~--------l~ 102 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TLYLVTERVRP-LETVLKE--------LG 102 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccC--ceEEEeecccc-HHHHHHH--------hH
Confidence 577888888876544 34456677889999999999999999886544 89999998774 3344443 33
Q ss_pred HHHHHHHHHHHHHHHHHhh-hCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchh
Q 011808 133 PYTVKSILWQLLNGLNYLH-SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPEL 211 (477)
Q Consensus 133 ~~~~~~i~~qil~aL~~LH-~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~ 211 (477)
...+...++||+.||.||| +.+++|++|.-..|+| +..|..||++|.++........ ......---.|..|+.
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV----n~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV----NESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE 176 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE----cCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence 6678889999999999998 5689999999999999 7888899999999875443221 0111111234667776
Q ss_pred hcCCCCCCchhhHHHHHHHHHHHHhC
Q 011808 212 LLGAKHYTSAVDMWAVGCIFAELLTL 237 (477)
Q Consensus 212 l~~~~~~~~~~DiwSlGvil~elltG 237 (477)
+... +-..|.|-|||++++++.|
T Consensus 177 ~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCcc---ccchhhhhHHHHHHHHhCc
Confidence 5432 2357999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.2e-12 Score=133.36 Aligned_cols=254 Identities=22% Similarity=0.248 Sum_probs=176.2
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 102 (477)
...+|-++..||.|.|+.|+.+..+ ..++..|++|...............+.|+.+...+ .|.+++.++..+....
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r--~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r- 339 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKR--PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR- 339 (524)
T ss_pred ecCCcceeEEccCCccccceeeeec--CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc-
Confidence 4678899999999999999998643 24688999998877665544434455677777776 5888888777664433
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..|+-.|||.+....+-.. ....+.+...+.+..|++.++.++|+..++|+|+||+||++..++ +..++.||
T Consensus 340 -~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~---~~~~~~~~ 411 (524)
T KOG0601|consen 340 -QGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG---FFSKLGDF 411 (524)
T ss_pred -cccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch---hhhhcccc
Confidence 4568889997533322221 122577888999999999999999999999999999999995432 77899999
Q ss_pred ccceeecCCCCcccCCCeeeccccc-cchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYR-APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~-APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|.+..+.-.. ......-++. ..|++.....+..+.|++|||..+++.+++.+.-.... +
T Consensus 412 ~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----------~---- 471 (524)
T KOG0601|consen 412 GCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----------Q---- 471 (524)
T ss_pred ccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-----------c----
Confidence 9986422111 1111234455 36767666668889999999999999999875322111 0
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
|. .+..... ...+. ....+..+.+.++..|+..|+.+.++..|.-|.
T Consensus 472 --------------------~~----~i~~~~~------p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 472 --------------------SL----TIRSGDT------PNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred --------------------ce----eeecccc------cCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 00 0000000 00111 124577899999999999999999998887653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.9e-11 Score=111.19 Aligned_cols=142 Identities=20% Similarity=0.217 Sum_probs=98.6
Q ss_pred EeeecccCceEEEEEEEecc---cCCCcEEEEEecccCCCC----------C-C---------CcHHH----HHHHHHHH
Q 011808 31 IGKIGEGTYGLVFLARIKAA---ANRGKAIAIKKFKQSKDG----------D-G---------VSPTA----IREIMLLR 83 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~---~~~~~~vaiK~~~~~~~~----------~-~---------~~~~~----~~Ei~il~ 83 (477)
...||.|--+.||.|..... ...+..+|||+++..... + . ....+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 35799999999999964310 013578999988643211 0 0 01112 26999999
Q ss_pred hcC--CCCeeEEEEEEEcCCCceEEEEEeccCCC-HH-HHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHh-hhCCeecC
Q 011808 84 EIT--HENVVKLVNVHINHADMSLYLAFDYAEYD-LY-EIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL-HSNWIIHR 158 (477)
Q Consensus 84 ~l~--hpnIv~l~~~~~~~~~~~~~lv~e~~~~~-L~-~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~L-H~~givHr 158 (477)
++. .-++.+++++. .-+|||||++++ +. ..+.. ..+++..+..++.+++.+|..| |..||||+
T Consensus 82 rl~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECNLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 884 35677777642 238999999863 21 12222 1355567788899999999998 89999999
Q ss_pred CCCCCcEEEeccCCCcccEEEeecccceeec
Q 011808 159 DLKPSNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 159 Dikp~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
||++.|||+. ++.+.|+|||.+...+
T Consensus 150 DLs~~NIL~~-----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-----CCcEEEEECCCceeCC
Confidence 9999999993 2459999999887544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.4e-11 Score=125.06 Aligned_cols=148 Identities=20% Similarity=0.285 Sum_probs=93.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC----------------------C--CcH-------
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD----------------------G--VSP------- 73 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~----------------------~--~~~------- 73 (477)
+..|+ .+.||+|++|.||+|+.+ +|+.||||+.+...... . ...
T Consensus 117 F~~fd-~~plasaSigQVh~A~l~----~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 117 FAEFE-EKPLAAASIAQVHRARLV----DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred HhhCC-CcceeeeehhheEEEEec----CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 34444 367999999999999865 58999999986532100 0 000
Q ss_pred -------HHHHHHHHHHhc----CCCCeeEEEEEEEcCCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHH
Q 011808 74 -------TAIREIMLLREI----THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILW 141 (477)
Q Consensus 74 -------~~~~Ei~il~~l----~hpnIv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~ 141 (477)
.+.+|+..++++ +|.+-+.+-.++.+.. ...+|||||++| +|.+...... .... ...++.
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~----~~~~---~~~ia~ 263 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDE----AGLD---RKALAE 263 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHh----cCCC---HHHHHH
Confidence 122355544444 2333344444443222 235999999986 4444443211 0121 234555
Q ss_pred HHHH-HHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeec
Q 011808 142 QLLN-GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 142 qil~-aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
.++. .+..+|..|++|+|+||.||++ +.++.++|+|||++..+.
T Consensus 264 ~~~~~~l~ql~~~g~~H~D~hPgNilv----~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 264 NLARSFLNQVLRDGFFHADLHPGNIFV----LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHhCCceeCCCCcccEEE----CCCCcEEEEeCCCeeECC
Confidence 5555 4788999999999999999999 666789999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.5e-11 Score=107.64 Aligned_cols=127 Identities=17% Similarity=0.160 Sum_probs=90.7
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCCceEEEEE
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENV-VKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~~~lv~ 109 (477)
++.|+.|.++.||+++. .+..|++|........ .....+|+.+++.+.+.++ .+++.+.. . .-++||
T Consensus 3 ~~~l~~G~~~~vy~~~~-----~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~--~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-----ANKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFDP--E--TGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEE-----CCeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEeC--C--CCeEEE
Confidence 56789999999999874 2678999998654321 1234679999998865443 45555432 1 237999
Q ss_pred eccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCe-----ecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 110 DYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWI-----IHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 110 e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~gi-----vHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
||++|...... ......++.+++.+|..||..++ +|+|++|.||++ + ++.++|+||+.
T Consensus 71 e~i~G~~l~~~------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~----~-~~~~~liDf~~ 133 (170)
T cd05151 71 EFIEGSELLTE------------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL----D-DGRLWLIDWEY 133 (170)
T ss_pred EecCCCccccc------------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE----E-CCeEEEEeccc
Confidence 99997432211 01123457899999999999885 999999999999 3 34699999998
Q ss_pred ce
Q 011808 185 AR 186 (477)
Q Consensus 185 a~ 186 (477)
+.
T Consensus 134 a~ 135 (170)
T cd05151 134 AG 135 (170)
T ss_pred cc
Confidence 75
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.1e-10 Score=99.59 Aligned_cols=147 Identities=20% Similarity=0.222 Sum_probs=105.0
Q ss_pred EEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC------CcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG------VSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.+..|-+|+-+.|+++.+ .|+.+.||.-........ ...+..+|+++|.++.--.|.--.-+|.+...
T Consensus 11 ~l~likQGAEArv~~~~~-----~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~- 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG- 84 (229)
T ss_pred cceeeeccceeeEeeecc-----CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC-
Confidence 678899999999999975 478888886433222221 12344579999988864444444334444433
Q ss_pred eEEEEEeccCC--CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 104 SLYLAFDYAEY--DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 104 ~~~lv~e~~~~--~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
-.|.|||++| ++.+++..... ..........+++.|-+.+.-||.++|||+||..+||+|..++ ....+.|+|
T Consensus 85 -~~i~ME~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~-~~~~~~lId 159 (229)
T KOG3087|consen 85 -GQIYMEFIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG-NQITPILID 159 (229)
T ss_pred -CeEEEEeccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC-CcCceEEEe
Confidence 3678899998 88888877542 2333334478999999999999999999999999999997553 444568999
Q ss_pred ccccee
Q 011808 182 FGLARI 187 (477)
Q Consensus 182 FG~a~~ 187 (477)
||++..
T Consensus 160 fgls~~ 165 (229)
T KOG3087|consen 160 FGLSSV 165 (229)
T ss_pred ecchhc
Confidence 999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.8e-10 Score=110.08 Aligned_cols=170 Identities=22% Similarity=0.295 Sum_probs=127.9
Q ss_pred eEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEc--CCCceEEEEEeccC--CC
Q 011808 40 GLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHIN--HADMSLYLAFDYAE--YD 115 (477)
Q Consensus 40 g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~~~lv~e~~~--~~ 115 (477)
.+.|+|.... +|..|++|.+....... -.....-+++++++.|.|||++.++|.+ -.+..+++|++|.. .+
T Consensus 290 ~Ttyk~~s~~---DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 290 ITTYKATSNV---DGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ceeEeeeecc---CCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 5688887654 68999999995443221 1133356789999999999999999863 35678999999987 47
Q ss_pred HHHHHHhhhcc----------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 116 LYEIIRHHRDK----------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 116 L~~~l~~~~~~----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
|+++.-..... .+..++|..+|.++.||..||.++|+.|+..+-|.+.+||+ +.+.+++|...|+.
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv----~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV----TGKMRIRISGCGIM 440 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe----eCcceEEEecccce
Confidence 77765332211 24457889999999999999999999999999999999999 55557999999988
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCC
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK 238 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~ 238 (477)
..+.... . |-+.+ -.+-|.=.||.+++.|.||.
T Consensus 441 Dvl~~d~--------------~--~~le~----~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 441 DVLQEDP--------------T--EPLES----QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred eeecCCC--------------C--cchhH----HhhhhHHHHHHHHHHHhhcc
Confidence 7665432 0 11222 12568899999999999985
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2e-09 Score=94.95 Aligned_cols=130 Identities=22% Similarity=0.327 Sum_probs=88.2
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCC------cHHHHHHHHHHHhcCCC--CeeEEEEEEEcCCCc
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV------SPTAIREIMLLREITHE--NVVKLVNVHINHADM 103 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~~~ 103 (477)
..|++|+-+.+|.+.+. +..+++|.-......... ..+..+|+.++.++.-- ++..++++ +..
T Consensus 2 ~~i~~GAEa~i~~~~~~-----g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~-- 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPD-- 72 (204)
T ss_pred chhhCCcceeEEeeecc-----CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCC--
Confidence 45789999999998543 444666643222211111 12334699999888533 44445554 333
Q ss_pred eEEEEEeccCCCHHH-HHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEYDLYE-IIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~-~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
...|+|||++|.++. .+... ...+++.|-.-+.-||..||||+||.++||++.++ .+.++||
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-----~i~~IDf 135 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-----RIYFIDF 135 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-----cEEEEEC
Confidence 347999999986654 55442 14567777788889999999999999999999432 2999999
Q ss_pred cccee
Q 011808 183 GLARI 187 (477)
Q Consensus 183 G~a~~ 187 (477)
|++..
T Consensus 136 GLg~~ 140 (204)
T COG3642 136 GLGEF 140 (204)
T ss_pred Ccccc
Confidence 99974
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.3e-08 Score=97.70 Aligned_cols=131 Identities=15% Similarity=0.123 Sum_probs=89.3
Q ss_pred CCcEEEEEecccCCCCC---------CCcHHHHHHHHHHHhcCC--CCeeEEEEEEEcCC---CceEEEEEeccCC--CH
Q 011808 53 RGKAIAIKKFKQSKDGD---------GVSPTAIREIMLLREITH--ENVVKLVNVHINHA---DMSLYLAFDYAEY--DL 116 (477)
Q Consensus 53 ~~~~vaiK~~~~~~~~~---------~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~---~~~~~lv~e~~~~--~L 116 (477)
.|+.|.||........+ .-...+.+|...+.+|.. -.+..++.+++... ...-++|+|++++ +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 36789999764332110 011136688888877732 22333444443221 2346899999997 67
Q ss_pred HHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc---CCCcccEEEeecccce
Q 011808 117 YEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE---GEEQGVVKIADFGLAR 186 (477)
Q Consensus 117 ~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~---~~~~~~vkL~DFG~a~ 186 (477)
.+++.... ....++.....++.+|+..+.-||..||+|+|+++.|||+..+ +.+...+.|+||+.+.
T Consensus 124 ~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 124 EDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 77775422 1245667788999999999999999999999999999999642 2345679999999885
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.5e-09 Score=96.90 Aligned_cols=127 Identities=24% Similarity=0.283 Sum_probs=79.6
Q ss_pred EEEEEEEecccCCCcEEEEEecccCCCC-----------CC--------C-----cHHHHHHHHHHHhcCCC--CeeEEE
Q 011808 41 LVFLARIKAAANRGKAIAIKKFKQSKDG-----------DG--------V-----SPTAIREIMLLREITHE--NVVKLV 94 (477)
Q Consensus 41 ~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-----------~~--------~-----~~~~~~Ei~il~~l~hp--nIv~l~ 94 (477)
.||.|... ++..+|||+.+..... .. . .....+|.+.|.++..- ++.+++
T Consensus 1 ~Vy~~~~~----~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~ 76 (188)
T PF01163_consen 1 DVYHAIDP----DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPY 76 (188)
T ss_dssp EEEEEEEC----TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EE
T ss_pred CEEEEECC----CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEE
Confidence 48888643 4779999988654211 00 0 11334699999999655 577777
Q ss_pred EEEEcCCCceEEEEEeccC--CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHH-hhhCCeecCCCCCCcEEEeccC
Q 011808 95 NVHINHADMSLYLAFDYAE--YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNY-LHSNWIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 95 ~~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~-LH~~givHrDikp~NILl~~~~ 171 (477)
++. .. +|||||++ |.....+.... ++......++.+++..+.. +|+.||+|+||.+.|||+.
T Consensus 77 ~~~--~~----~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~--- 141 (188)
T PF01163_consen 77 DYN--RN----VIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD--- 141 (188)
T ss_dssp EEE--TT----EEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE---
T ss_pred EEe--CC----EEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee---
Confidence 653 22 89999999 64444443321 2234567788888885555 6799999999999999993
Q ss_pred CCcccEEEeecccceee
Q 011808 172 EEQGVVKIADFGLARIY 188 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~ 188 (477)
++ .+.|+|||.+...
T Consensus 142 -~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 142 -DG-KVYIIDFGQAVDS 156 (188)
T ss_dssp -TT-CEEE--GTTEEET
T ss_pred -cc-eEEEEecCcceec
Confidence 33 6999999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.5e-09 Score=97.45 Aligned_cols=143 Identities=19% Similarity=0.284 Sum_probs=93.4
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCC--CCeeEEEEEEEcCC-CceEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH--ENVVKLVNVHINHA-DMSLYLA 108 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~-~~~~~lv 108 (477)
+.|+.|.++.||++... +|..+++|........ .....+.+|+.+++.+.+ .++.+++.+..... ....+++
T Consensus 4 ~~l~~G~~n~~~~v~~~----~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred eecCCCccceEEEEEec----CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence 67899999999998643 2578999998654332 233467789999999965 34566776653321 1246899
Q ss_pred EeccCCC-HHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-----------------------------------
Q 011808 109 FDYAEYD-LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS----------------------------------- 152 (477)
Q Consensus 109 ~e~~~~~-L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~----------------------------------- 152 (477)
|||++|. +.+.+. ...+++.....++.+++.+|..||+
T Consensus 79 ~e~i~G~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (223)
T cd05154 79 MERVDGRVLRDRLL------RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD 152 (223)
T ss_pred EEEeCCEecCCCCC------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence 9999873 222110 0124444445555555555555552
Q ss_pred ---------------------CCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 153 ---------------------NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 153 ---------------------~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
..++|+|+++.|||+..+ ..+.+.|+||+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~--~~~~~~iID~e~~~~ 206 (223)
T cd05154 153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD--EPRVVAVLDWELATL 206 (223)
T ss_pred ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC--CCcEEEEEecccccc
Confidence 347999999999999431 145689999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=7.5e-08 Score=89.20 Aligned_cols=110 Identities=25% Similarity=0.269 Sum_probs=81.0
Q ss_pred cHHHHHHHHHHHhcC--CCCeeEEEEEEEcCC--CceEEEEEeccCC--CHHHHHHhhhcccCCCCCHHHHHHHHHHHHH
Q 011808 72 SPTAIREIMLLREIT--HENVVKLVNVHINHA--DMSLYLAFDYAEY--DLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145 (477)
Q Consensus 72 ~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~--~~~~~lv~e~~~~--~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~ 145 (477)
.....+|...+..|. .-.+.+.+.+.+... ...-++++|++++ +|.+++.... .++......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence 346677888777773 223444555444322 1345899999986 6777776532 2566678899999999
Q ss_pred HHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 146 aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
.+.-||..||+|+|+++.|||+..++ ....+.|+||+-++.
T Consensus 130 ~i~~lH~~gi~H~Dl~~~NILv~~~~-~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 130 LIAKLHDAGIYHGDLNPSNILVDPDD-GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHCcCCCCCCCcccEEEeCCC-CceeEEEEcchhcee
Confidence 99999999999999999999996543 345799999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.1e-09 Score=111.37 Aligned_cols=155 Identities=24% Similarity=0.341 Sum_probs=108.7
Q ss_pred HHHHHHHHhhhC-CeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCc-ccCC------Ceeeccccccchhhc
Q 011808 142 QLLNGLNYLHSN-WIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKF-LSEN------GVVVTIWYRAPELLL 213 (477)
Q Consensus 142 qil~aL~~LH~~-givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~-~~~~------~~~gt~~y~APE~l~ 213 (477)
++..||.|+|.. ++||+.|.|++|.+ +..+.+||+.|+++.....+... .... ...-...|.|||++.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~----na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVV----NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred cccchhhhhccCcceeecccchhheee----ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 445999999976 89999999999999 77778999999998654432111 0000 011256799999998
Q ss_pred CCCCCCchhhHHHHHHHHHHHH-hCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccc
Q 011808 214 GAKHYTSAVDMWAVGCIFAELL-TLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGR 292 (477)
Q Consensus 214 ~~~~~~~~~DiwSlGvil~ell-tG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (477)
+ ...+.++|+|||||++|.+. .|+..|........ ..+....
T Consensus 183 ~-~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~~~~~~----------------------------------- 225 (700)
T KOG2137|consen 183 G-TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YSFSRNL----------------------------------- 225 (700)
T ss_pred c-ccccccccceeeeeEEEEEecCCcchhhccCCcch-hhhhhcc-----------------------------------
Confidence 8 45788999999999999998 56666654431110 0000000
Q ss_pred cccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 293 KYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 293 ~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.+.-....+..++.++++=|.++|..|...||++.+++.-+||..
T Consensus 226 ---~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 226 ---LNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSD 270 (700)
T ss_pred ---cccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence 000011123455688999999999999999999999999999974
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.7e-07 Score=82.78 Aligned_cols=143 Identities=17% Similarity=0.133 Sum_probs=100.0
Q ss_pred cccCceEEEEEEEecccCCCcEEEEEecccCCCC----CCCcHHHHHHHHHHHhcCC--CCeeEEEE--EEEcCCCceEE
Q 011808 35 GEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG----DGVSPTAIREIMLLREITH--ENVVKLVN--VHINHADMSLY 106 (477)
Q Consensus 35 G~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~Ei~il~~l~h--pnIv~l~~--~~~~~~~~~~~ 106 (477)
|+||-+.|+..... |..+-+|.-...... ..-...+.+|+..|++|.. -.+.+++. .........-+
T Consensus 27 ~rgG~SgV~r~~~~-----g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~ 101 (216)
T PRK09902 27 RRNGMSGVQCVERN-----GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRAL 101 (216)
T ss_pred CCCCcceEEEEEeC-----CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEE
Confidence 56899999987532 446888865421111 2245688899999988842 22444442 11223344578
Q ss_pred EEEeccC--CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 107 LAFDYAE--YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 107 lv~e~~~--~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
||+|-++ -+|.+.+.... -.+.++.....++.+|+.+|.-||+.|+.|+|+-+.|||+..++ ...++++||.-
T Consensus 102 LVTe~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g--~~~v~lIDlEk 176 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG--KAEAGFLDLEK 176 (216)
T ss_pred EEEEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC--CeeEEEEEhhc
Confidence 9999888 48877775532 22457777889999999999999999999999999999994322 23499999997
Q ss_pred cee
Q 011808 185 ARI 187 (477)
Q Consensus 185 a~~ 187 (477)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 763
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=6e-08 Score=90.74 Aligned_cols=137 Identities=24% Similarity=0.244 Sum_probs=100.2
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC--------------------CCCcHHHHHHHHHHHhcCC
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG--------------------DGVSPTAIREIMLLREITH 87 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--------------------~~~~~~~~~Ei~il~~l~h 87 (477)
+.+...||.|--+.||.|.+. .|..+|||.-+....+ ......+.+|.++|.+|..
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred HhhccccccCccceEEEEECC----CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 456789999999999999754 5889999965332111 0112345679999999965
Q ss_pred C--CeeEEEEEEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcE
Q 011808 88 E--NVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNI 165 (477)
Q Consensus 88 p--nIv~l~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NI 165 (477)
. .|.+.+++- .-++|||+++|..+.-+ +++......++..|+.-+..+-..||||+|+++-||
T Consensus 169 ~G~~VP~P~~~n------RHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNI 233 (304)
T COG0478 169 EGVKVPKPIAWN------RHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNI 233 (304)
T ss_pred cCCCCCCccccc------cceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheE
Confidence 4 777777642 34899999998443222 223455667777888888777799999999999999
Q ss_pred EEeccCCCcccEEEeeccccee
Q 011808 166 LVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 166 Ll~~~~~~~~~vkL~DFG~a~~ 187 (477)
|+ ++++.+.++||--+..
T Consensus 234 lV----~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 234 LV----TEDGDIVVIDWPQAVP 251 (304)
T ss_pred EE----ecCCCEEEEeCccccc
Confidence 99 6667799999987653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.7e-06 Score=85.18 Aligned_cols=198 Identities=13% Similarity=0.059 Sum_probs=125.1
Q ss_pred EEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEE----EE-cCCCc
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNV----HI-NHADM 103 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~----~~-~~~~~ 103 (477)
..+.||+|+-+.+|..- .-...+.|++....-.. . .+-+..|... .||-+-.-+.+ .. .+...
T Consensus 15 ~gr~LgqGgea~ly~l~------e~~d~VAKIYh~Pppa~----~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 15 PGRPLGQGGEADLYTLG------EVRDQVAKIYHAPPPAA----Q-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CCccccCCccceeeecc------hhhchhheeecCCCchH----H-HHHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 45679999999999652 23335667776544221 1 1222233333 46544331111 11 12222
Q ss_pred eEEEEEeccCC--CHHHHHHh-hhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 104 SLYLAFDYAEY--DLYEIIRH-HRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 104 ~~~lv~e~~~~--~L~~~l~~-~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.+-+.|..+.+ ....++.- .+...........+....+.|+.+...||..|.+-+|+.++|+|+ .+++.|.|.
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV----sd~~~V~LV 159 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV----SDDSKVVLV 159 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee----ecCceEEEE
Confidence 36677777665 33333321 111112235667788999999999999999999999999999999 666678898
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcC----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCcc
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLG----AKHYTSAVDMWAVGCIFAELLTL-KPLFQGAE 245 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG-~~PF~~~~ 245 (477)
|-..-.+..+. +...+.+|.+.|.+||.-.- ...-+...|.|.||+++|++|.| +.||.|-.
T Consensus 160 dsDsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 160 DSDSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred cccceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 86544333222 12234677999999997541 12246688999999999999997 99998754
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.5e-06 Score=80.64 Aligned_cols=144 Identities=19% Similarity=0.194 Sum_probs=96.6
Q ss_pred ccceeEEe---eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCC-----------------cH-----HHHHHH
Q 011808 25 LQQYNLIG---KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV-----------------SP-----TAIREI 79 (477)
Q Consensus 25 ~~~Y~i~~---~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~-----------------~~-----~~~~Ei 79 (477)
.++..|.. .|.+|--+.||+|.. ..+..+|+|+++........ .. -..+|+
T Consensus 44 ~~rg~i~~~~g~istGKEA~Vy~a~~----~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf 119 (268)
T COG1718 44 LSRGVITELVGCISTGKEANVYLAET----GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEF 119 (268)
T ss_pred hcCCceeeeEeeecCCcceEEEeecc----CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHH
Confidence 34444444 555677778999863 35889999999755322111 11 113588
Q ss_pred HHHHhcC--CCCeeEEEEEEEcCCCceEEEEEeccCCCH--HHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CC
Q 011808 80 MLLREIT--HENVVKLVNVHINHADMSLYLAFDYAEYDL--YEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NW 154 (477)
Q Consensus 80 ~il~~l~--hpnIv~l~~~~~~~~~~~~~lv~e~~~~~L--~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~g 154 (477)
..|+++. +-.+.+-+.++. -+|+|||++... .-.|.. -.+...++..+..+++..+.-|-. .+
T Consensus 120 ~NL~R~~eAGVrvP~Pi~~~~------nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 120 RNLKRAYEAGVRVPEPIAFRN------NVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred HHHHHHHHcCCCCCCceeecC------CeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 8888873 455666666542 289999998541 111111 123344688889999999998877 89
Q ss_pred eecCCCCCCcEEEeccCCCcccEEEeecccceeec
Q 011808 155 IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 155 ivHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
+||+||+.-|||+ . .+.+.|+||+-|....
T Consensus 188 LVHgDLSEyNiL~----~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 LVHGDLSEYNILV----H-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cccccchhhheEE----E-CCeEEEEECccccccC
Confidence 9999999999999 4 5569999999886544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.8e-08 Score=100.43 Aligned_cols=249 Identities=18% Similarity=0.160 Sum_probs=161.8
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCC-eeEEEEEEEcCCCceE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN-VVKLVNVHINHADMSL 105 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~~ 105 (477)
-|.....+++++++++++.+... .+....+.+... ....-++++|.+++||| .+..++- ...+.+.
T Consensus 243 ws~~fh~fvK~altknpKkRpta----eklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d--~~~E~~~ 309 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTA----EKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLED--YDGEDYL 309 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCCh----hhheeceeeccc-------hhhHHHHHHHHHccCCCCccccccc--CCccccc
Confidence 36677888999999999987432 233345555443 13334889999999999 4444443 3445678
Q ss_pred EEEEeccCCC--HHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 106 YLAFDYAEYD--LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 106 ~lv~e~~~~~--L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+++++++++. ...... .....+.+.+...+.+.-+.+|++||+.--+|+| ||+.+ ....++.||+
T Consensus 310 ~i~~~i~s~~rs~~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-----~~~~~~~~~~ 376 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMT----VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-----EEEVKLLDFA 376 (829)
T ss_pred chhhhhhcCCccccccCC----hhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-----cccccccccc
Confidence 9999998854 111100 0011244455666777788899999998778998 88863 3558999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
....+.... ..+...+++.++|||+..... +....|+|++++-..++.-|.+|-..-.... .
T Consensus 377 v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~--------------~ 438 (829)
T KOG0576|consen 377 VPPQLTRTM---KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPPAVL--------------P 438 (829)
T ss_pred CCcccCccc---ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCcccc--------------C
Confidence 988766543 344567799999999997754 8889999999998788887777654311000 0
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPL 343 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~~~ 343 (477)
.++..+ ..+.+...-.|.. ..-.++...|+...|..|+....++-|.+|...++
T Consensus 439 ~~g~~p--~s~~L~~~~aw~~------------------------~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 439 MIGNGP--NSPMLTDKSAWSP------------------------VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred CCCCCC--CccccchhhhcCc------------------------ccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 000000 0000000001111 00115888999999999999999999999986665
Q ss_pred CC
Q 011808 344 PG 345 (477)
Q Consensus 344 ~~ 345 (477)
.-
T Consensus 493 ~i 494 (829)
T KOG0576|consen 493 RI 494 (829)
T ss_pred cc
Confidence 43
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=6.1e-06 Score=85.74 Aligned_cols=146 Identities=19% Similarity=0.249 Sum_probs=89.4
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-----------------------------CCcHHH------
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-----------------------------GVSPTA------ 75 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-----------------------------~~~~~~------ 75 (477)
.+.||.-+.|.||+|+.+ +|+.||||+-+..-... +..+.+
T Consensus 166 ~~piaaASlaQVhrA~L~----~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLK----NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred cchhhhcchhheEEEEec----CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 357999999999999876 39999999876441110 001111
Q ss_pred HHHHHHHH----hcCCCC---eeEEEEEEEcCCCceEEEEEeccCC---CHHHHHHhhhcccCCCCCHHHHHHHHHHHHH
Q 011808 76 IREIMLLR----EITHEN---VVKLVNVHINHADMSLYLAFDYAEY---DLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145 (477)
Q Consensus 76 ~~Ei~il~----~l~hpn---Iv~l~~~~~~~~~~~~~lv~e~~~~---~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~ 145 (477)
.+|++..+ .+.|-+ -|.+=.++.+-. ..-+|+|||++| +-.+.+++. .++...+..-+.+..
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s-t~RVLtME~~~G~~i~Dl~~i~~~------gi~~~~i~~~l~~~~- 313 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDLS-TKRVLTMEYVDGIKINDLDAIDKR------GISPHDILNKLVEAY- 313 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhhcC-cceEEEEEecCCccCCCHHHHHHc------CCCHHHHHHHHHHHH-
Confidence 23333332 334555 122223333221 245999999997 334555553 455554433333322
Q ss_pred HHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeec
Q 011808 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 146 aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
++-|=..|++|+|=+|.||+++.+...+..+.+.|||+...+.
T Consensus 314 -~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 314 -LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred -HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 2223356899999999999997655557789999999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.6e-05 Score=73.06 Aligned_cols=136 Identities=21% Similarity=0.226 Sum_probs=83.2
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHH---------HHHHHHHHhcCCC---CeeEE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA---------IREIMLLREITHE---NVVKL 93 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~---------~~Ei~il~~l~hp---nIv~l 93 (477)
.+|.+++++-......|.+.. -++..+++|..+..... ..+.+ .+++..+..+... .+..+
T Consensus 31 ~~~~~~kv~k~~~r~~ValIe-----i~~~kyIlK~pr~~~~r--~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIE-----IDGKKYILKEPREENRR--PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred CCceEEEeecCCCccEEEEEE-----ECCcEEEEeccchhhhh--HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 578889999887777676553 24788999988653211 11111 2334434444322 22222
Q ss_pred EEEEEc---CCCceEEEEEeccCCC-HHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEec
Q 011808 94 VNVHIN---HADMSLYLAFDYAEYD-LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMG 169 (477)
Q Consensus 94 ~~~~~~---~~~~~~~lv~e~~~~~-L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~ 169 (477)
+-+..- .--...+|+|||++|. |.+.. .+++ .+...|.+++.-||+.|++|+|..|.|++++.
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~---------~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIE---------DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccch---------hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC
Confidence 222111 1112457899999984 33221 1222 24456778899999999999999999999943
Q ss_pred cCCCcccEEEeecccce
Q 011808 170 EGEEQGVVKIADFGLAR 186 (477)
Q Consensus 170 ~~~~~~~vkL~DFG~a~ 186 (477)
+.++++||+..+
T Consensus 171 -----~~i~iID~~~k~ 182 (229)
T PF06176_consen 171 -----NGIRIIDTQGKR 182 (229)
T ss_pred -----CcEEEEECcccc
Confidence 239999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.9e-05 Score=72.97 Aligned_cols=71 Identities=15% Similarity=0.141 Sum_probs=49.2
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCC--eeEEEEEEEcCCCceEEEEE
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN--VVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~~~lv~ 109 (477)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++..+.+ ...++|
T Consensus 7 ~~i~~G~t~~~y~~-------~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~--~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH-------KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGG--RLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe-------cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCC--eeeeee
Confidence 57899999999974 14457889886432 2235678999998885332 456666654433 467899
Q ss_pred eccCCC
Q 011808 110 DYAEYD 115 (477)
Q Consensus 110 e~~~~~ 115 (477)
|+++|.
T Consensus 74 e~i~G~ 79 (226)
T TIGR02172 74 ELIVGK 79 (226)
T ss_pred eecCCc
Confidence 999984
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.9e-06 Score=87.39 Aligned_cols=141 Identities=20% Similarity=0.261 Sum_probs=84.6
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCC---------------------C---C----Cc----HH-----
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG---------------------D---G----VS----PT----- 74 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~---------------------~---~----~~----~~----- 74 (477)
..|+.++-|.||+|+.+ +|+.||||+.+..-.. . - .. +.
T Consensus 131 ~PiAsASIaQVH~A~L~----sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 131 EPIASASIAQVHRAVLK----SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred CchhhhhHhhheeEEec----CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 57899999999999876 4999999998654110 0 0 00 01
Q ss_pred -HHHHHHHHHhc----CCCCeeEEEEEEEcCCCceEEEEEeccCC-CHHHH--HHhhhcccCCCCCHHHHHHHHHHHHHH
Q 011808 75 -AIREIMLLREI----THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEI--IRHHRDKVNHTMNPYTVKSILWQLLNG 146 (477)
Q Consensus 75 -~~~Ei~il~~l----~hpnIv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~--l~~~~~~~~~~l~~~~~~~i~~qil~a 146 (477)
+.+|...+.++ ++..-+++=.++.+-. ..-+|+|||++| .+.+. +... .++...+. ..++.+
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t-~~~VLtmE~i~Gi~i~d~~~l~~~------g~d~k~ia---~~~~~~ 276 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYT-TRRVLTMEWIDGIKISDIAALKSA------GIDRKELA---ELLVRA 276 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhcc-CCcEEEEEeeCCEecccHHHHHhc------CCCHHHHH---HHHHHH
Confidence 12344444444 2333333334443211 134899999998 33333 3321 23322222 222222
Q ss_pred -HHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 147 -LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 147 -L~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
+..+=..|++|+|.+|.||++ ..++.+.+.|||+...+..
T Consensus 277 f~~q~~~dgffHaDpHpGNi~v----~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 277 FLRQLLRDGFFHADPHPGNILV----RSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHhcCccccCCCccceEE----ecCCcEEEEcCcceecCCH
Confidence 233334899999999999999 6678899999999876653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=8e-06 Score=71.93 Aligned_cols=127 Identities=22% Similarity=0.299 Sum_probs=87.1
Q ss_pred eEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCee-EEEEEEEcCCCceEEE
Q 011808 29 NLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVV-KLVNVHINHADMSLYL 107 (477)
Q Consensus 29 ~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~~~l 107 (477)
+..+.|++|.+|.||++.++ +..+|+|+-+.+.. ...+..|+++|..+.--++. +++.+- . .++
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-----~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg--~----~~i 89 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-----GGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYG--E----DFI 89 (201)
T ss_pred hhhhhhhcccccEEEEeecc-----CceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEec--h----hhh
Confidence 45678999999999999865 56899998765432 45777899999998755554 344432 2 255
Q ss_pred EEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCC-CC-cEEEeccCCCcccEEEeeccc
Q 011808 108 AFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLK-PS-NILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 108 v~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDik-p~-NILl~~~~~~~~~vkL~DFG~ 184 (477)
.|||+.| .|.+.... .+ ++-+..++++..-|-..||-|..|. |. ||++ .++.+.|+||..
T Consensus 90 ~me~i~G~~L~~~~~~--------~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv-----~~~~~~iIDFd~ 152 (201)
T COG2112 90 RMEYIDGRPLGKLEIG--------GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV-----NDRDVYIIDFDS 152 (201)
T ss_pred hhhhhcCcchhhhhhc--------cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe-----cCCcEEEEEccc
Confidence 6999998 55443321 11 3334556666666778899999987 44 4554 233699999999
Q ss_pred cee
Q 011808 185 ARI 187 (477)
Q Consensus 185 a~~ 187 (477)
|+.
T Consensus 153 At~ 155 (201)
T COG2112 153 ATF 155 (201)
T ss_pred hhh
Confidence 874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.11 E-value=7.7e-05 Score=68.27 Aligned_cols=136 Identities=16% Similarity=0.221 Sum_probs=92.3
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCC--------------CCCCCcHHHHHHHHHHHhcC------CCCee
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK--------------DGDGVSPTAIREIMLLREIT------HENVV 91 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~Ei~il~~l~------hpnIv 91 (477)
..||+|+.=.||.- . .....+||+..... ..........+|+.-...+. +.+|.
T Consensus 7 ~~i~~G~~R~cy~H--P----~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P----DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred cccccCCCceEEEC--C----CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence 47899999999953 2 34567899887665 11122345566776665555 89999
Q ss_pred EEEEEEEcCCCceEEEEEeccC---C----CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCc
Q 011808 92 KLVNVHINHADMSLYLAFDYAE---Y----DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSN 164 (477)
Q Consensus 92 ~l~~~~~~~~~~~~~lv~e~~~---~----~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~N 164 (477)
+++++..++. .+-+|+|.+. | +|.+++... .+++ . +...+-+-..||-+.+|+.+||+|.|
T Consensus 81 r~~G~veT~~--G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~N 148 (199)
T PF10707_consen 81 RFYGFVETNL--GLGLVVELIRDADGNISPTLEDYLKEG------GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHN 148 (199)
T ss_pred cEeEEEecCC--ceEEEEEEEECCCCCcCccHHHHHHcC------CccH-H---HHHHHHHHHHHHHHcCCeecCCCccc
Confidence 9999987754 4566776542 3 677777542 3554 3 33334445567888999999999999
Q ss_pred EEEeccCCCcccEEEee-cccc
Q 011808 165 ILVMGEGEEQGVVKIAD-FGLA 185 (477)
Q Consensus 165 ILl~~~~~~~~~vkL~D-FG~a 185 (477)
|++...++....+.|+| ||..
T Consensus 149 Iv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EEEEecCCCceEEEEEeCCCCc
Confidence 99977655554688887 5644
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.98 E-value=7.3e-05 Score=69.90 Aligned_cols=76 Identities=16% Similarity=0.250 Sum_probs=51.0
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCC--CeeEEEEEEEcC-CCceEEE
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE--NVVKLVNVHINH-ADMSLYL 107 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~-~~~~~~l 107 (477)
++.|+.|..+.||++... +..+++|..... .....+.+|+.+++.+... .+.+++...... .....++
T Consensus 2 i~~l~~G~~n~~~~v~~~-----~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~ 72 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD-----DGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL 72 (239)
T ss_dssp EEEEEESSSSEEEEEEET-----TSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred CccCCCCCeeeEEEEEEC-----CcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence 578999999999998632 358999997553 2234666888888888432 356666644322 2335799
Q ss_pred EEeccCCC
Q 011808 108 AFDYAEYD 115 (477)
Q Consensus 108 v~e~~~~~ 115 (477)
+|+++.|.
T Consensus 73 ~~~~i~g~ 80 (239)
T PF01636_consen 73 LMEYIPGR 80 (239)
T ss_dssp EEEEESSE
T ss_pred EEEEeccc
Confidence 99999873
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.96 E-value=3.1e-05 Score=85.26 Aligned_cols=203 Identities=22% Similarity=0.274 Sum_probs=127.6
Q ss_pred HHHHHHHHhcCCCCeeEEEEEEEcCCCc--eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh
Q 011808 76 IREIMLLREITHENVVKLVNVHINHADM--SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS 152 (477)
Q Consensus 76 ~~Ei~il~~l~hpnIv~l~~~~~~~~~~--~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~ 152 (477)
.-|+..+..+.|+|++.++.+....... .+.+..++|.. ++...+... ..++...++.+..+++++|.|+|+
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-----~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-----GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-----cccCHHHHHHHHHHHhhhHHHHHH
Confidence 3466777788999999999886543221 22333456663 666666543 368888999999999999999999
Q ss_pred CCeecCCCCCCcEEEeccCCCcccEEEe--ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCc--hhhHHHHH
Q 011808 153 NWIIHRDLKPSNILVMGEGEEQGVVKIA--DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTS--AVDMWAVG 228 (477)
Q Consensus 153 ~givHrDikp~NILl~~~~~~~~~vkL~--DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~--~~DiwSlG 228 (477)
....|.-|...-..- .+.+..+.+.++ ||+.+..+....... ...-+..+.++|...... +.. ..|+|.+|
T Consensus 305 ~~l~~v~L~~s~~~~-~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKE-STVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENT-AKKSRLTDLWCLG 379 (1351)
T ss_pred hccceeEEecccccc-cccCccceeecchhhhcccccCCCcccch---hhcCcccccccccccccc-chhhhhhHHHHHH
Confidence 844433332221111 111334445555 888877654332211 122256678888775532 333 46999999
Q ss_pred HHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCC
Q 011808 229 CIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPK 308 (477)
Q Consensus 229 vil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s 308 (477)
.++..+..|..+-.... .+... .+....
T Consensus 380 ll~~~~~~~~~i~~~~~--------------~~~~~--------------------------------------l~~~~~ 407 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSA--------------VPVSL--------------------------------------LDVLST 407 (1351)
T ss_pred HHHhhhhhcCccccccc--------------chhhh--------------------------------------hccccc
Confidence 99999887653221000 00000 011111
Q ss_pred chHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 309 SPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 309 ~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.+..+++.+|+.-|.++|+++.+++.|+|.+.
T Consensus 408 ~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 408 SELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 25779999999999999999999999999864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00018 Score=68.38 Aligned_cols=71 Identities=14% Similarity=0.089 Sum_probs=46.0
Q ss_pred eecccCc-eEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCceEEEEEe
Q 011808 33 KIGEGTY-GLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHADMSLYLAFD 110 (477)
Q Consensus 33 ~lG~G~~-g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~lv~e 110 (477)
.|-.|.. ..||++.. .+..++||...... ...+.+|+.+++.+. +--+.+++.+.... ...++||+
T Consensus 5 ~~~~g~~~~~v~~~~~-----~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e 72 (244)
T cd05150 5 RVTEGQSGATVYRLDG-----KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTS 72 (244)
T ss_pred ecCCCCCcCeEEEEcC-----CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEE
Confidence 3444555 78998842 23578888875432 234567999888883 44466777765443 35688999
Q ss_pred ccCCC
Q 011808 111 YAEYD 115 (477)
Q Consensus 111 ~~~~~ 115 (477)
++.|.
T Consensus 73 ~i~G~ 77 (244)
T cd05150 73 AVPGV 77 (244)
T ss_pred eeCCc
Confidence 99873
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00039 Score=63.28 Aligned_cols=129 Identities=23% Similarity=0.279 Sum_probs=88.5
Q ss_pred cceeEEeeecccCc-eEEEEEEEecccCCCcEEEEEeccc---CCC-------C-C--------CCcHHHHHHHHHHHhc
Q 011808 26 QQYNLIGKIGEGTY-GLVFLARIKAAANRGKAIAIKKFKQ---SKD-------G-D--------GVSPTAIREIMLLREI 85 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~-g~Vy~a~~~~~~~~~~~vaiK~~~~---~~~-------~-~--------~~~~~~~~Ei~il~~l 85 (477)
..++.++.||.|.- |.||+++. .|..||||+++. ... . . .....+..|-+..-+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-----~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRL 111 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-----DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRL 111 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-----CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHH
Confidence 68999999999999 99999975 378999999432 110 0 0 1122344566655555
Q ss_pred ---CCCCe--eEEEEEEEcC----------------CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHH
Q 011808 86 ---THENV--VKLVNVHINH----------------ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144 (477)
Q Consensus 86 ---~hpnI--v~l~~~~~~~----------------~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil 144 (477)
.+.++ +++++++.-. ......||.||+...- .+ ...-+.+|+
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~----~~~~~~~~~ 174 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL----QIRDIPQML 174 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc----chhHHHHHH
Confidence 45566 8999887422 1112467777766432 12 223356788
Q ss_pred HHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 145 ~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
+-|..+|..||+-+|+++.|..= =||+|||.+
T Consensus 175 ~dl~~~~k~gI~~~Dv~~~ny~~---------G~lvDfs~~ 206 (207)
T PF13095_consen 175 RDLKILHKLGIVPRDVKPRNYRG---------GKLVDFSSS 206 (207)
T ss_pred HHHHHHHHCCeeeccCccccccC---------CEEEecccC
Confidence 88999999999999999999872 479999964
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=4.2e-06 Score=93.70 Aligned_cols=205 Identities=14% Similarity=0.008 Sum_probs=135.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCC---CCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK---DGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
++.|++.--|+.+.++. +++...... -+.+|+.+... ..+...+..+.|...++...|+++.....-....+
T Consensus 1228 ~e~~EV~l~i~~~~~~R---~k~Lr~kid--~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~ 1302 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFR---NKWLRSKID--WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSE 1302 (2724)
T ss_pred hhhhheeeecccceeec---cchHhhhhc--eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCC
Confidence 34556655566555543 322211111 23445443222 11222223344555666778999988877665556
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC-----eecCCCCCCcEEEeccCCCcc
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW-----IIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g-----ivHrDikp~NILl~~~~~~~~ 175 (477)
....|..++|+. |.++..+.+...+ ...+.+.-+.....+.+.+..-+|+.. .+|+++|+-|.+| ..+.
T Consensus 1303 s~ee~~r~~~~~~g~~f~iIikg~ee-~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI----Vtny 1377 (2724)
T KOG1826|consen 1303 STEEYIRSLYVEFGKLFSIIIKGLEE-SPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI----VTNY 1377 (2724)
T ss_pred ChHHHHHHHHHHHhHHHHHHHhcccc-CCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce----ecCC
Confidence 667789999988 7888888776543 334555555555555578888877642 7999999999999 6677
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ 242 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~ 242 (477)
.+|+.++|+.++...... ......+++.|+.+++...-+ ++.++|+|.+++.+|+...|..+|.
T Consensus 1378 ~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1378 NVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred cccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHHHHhcccHHHH
Confidence 799999999985433222 123355688899999886644 7878999999999999998887773
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.0006 Score=76.29 Aligned_cols=84 Identities=19% Similarity=0.245 Sum_probs=55.3
Q ss_pred EEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCe--eEEEEEEEcCC-CceE
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENV--VKLVNVHINHA-DMSL 105 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~~-~~~~ 105 (477)
-++.|+.|.+..+|+...... .....+++|+....... .....+.+|+++|+.+. |.+| .+++.++.+.. ....
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~-~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNG-GSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCC-CcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 367789999999999864321 11146778876543221 12246778999999995 6655 77777765432 1346
Q ss_pred EEEEeccCCC
Q 011808 106 YLAFDYAEYD 115 (477)
Q Consensus 106 ~lv~e~~~~~ 115 (477)
|+||||++|.
T Consensus 120 flVME~v~G~ 129 (822)
T PLN02876 120 FYIMEYLEGR 129 (822)
T ss_pred eEEEEecCCc
Confidence 8999999874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0002 Score=67.63 Aligned_cols=72 Identities=11% Similarity=0.103 Sum_probs=42.3
Q ss_pred EeeecccCce-EEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCC---CeeEEEEEEEcCCC-ceE
Q 011808 31 IGKIGEGTYG-LVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE---NVVKLVNVHINHAD-MSL 105 (477)
Q Consensus 31 ~~~lG~G~~g-~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~~~-~~~ 105 (477)
++.|+.|+.. .||+. +..+++|..+... ....+.+|.++++.+... -+.+++......+. ...
T Consensus 2 ~~~~~~gG~~n~vy~~--------~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~ 69 (235)
T cd05155 2 IEPVDSGGTDNATFRL--------GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP 69 (235)
T ss_pred ceeccCCCcccceEEc--------CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence 3567777776 48875 1247778755321 234677899999887532 34444443222111 234
Q ss_pred EEEEeccCC
Q 011808 106 YLAFDYAEY 114 (477)
Q Consensus 106 ~lv~e~~~~ 114 (477)
+++|++++|
T Consensus 70 ~~l~~~i~G 78 (235)
T cd05155 70 WSVYRWLEG 78 (235)
T ss_pred eEEEEeecC
Confidence 788999876
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00042 Score=67.96 Aligned_cols=141 Identities=20% Similarity=0.259 Sum_probs=94.5
Q ss_pred EEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC----CC--------------------CcHHHHHHHHHHHhc
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG----DG--------------------VSPTAIREIMLLREI 85 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~----~~--------------------~~~~~~~Ei~il~~l 85 (477)
|-.+|..|--+.||.|. ..+|..+|||+++.+..- +. ..--+.+|++-|++|
T Consensus 148 inGCiSTGKEANVYHat----~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl 223 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT----EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL 223 (520)
T ss_pred cccccccCccceeEeee----cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH
Confidence 34467778888899985 346888999998654110 00 001224688888888
Q ss_pred CCCCeeEEEEEEEcCCCceEEEEEeccCCCHH--HHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhh-hCCeecCCCCC
Q 011808 86 THENVVKLVNVHINHADMSLYLAFDYAEYDLY--EIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH-SNWIIHRDLKP 162 (477)
Q Consensus 86 ~hpnIv~l~~~~~~~~~~~~~lv~e~~~~~L~--~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~givHrDikp 162 (477)
..-.|.----+..- .-+|||++++.+-+ ..|. ...++...+..+-.+++.-+.-|- ..++||.||.=
T Consensus 224 ~~aGIP~PePIlLk----~hVLVM~FlGrdgw~aPkLK------d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSE 293 (520)
T KOG2270|consen 224 NNAGIPCPEPILLK----NHVLVMEFLGRDGWAAPKLK------DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSE 293 (520)
T ss_pred HhcCCCCCCceeee----cceEeeeeccCCCCcCcccc------cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhh
Confidence 65544332222222 23899999985322 1222 235777888888888888888765 46999999999
Q ss_pred CcEEEeccCCCcccEEEeecccceeec
Q 011808 163 SNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 163 ~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
-|+|+ ..|.+.|+|.+-+...+
T Consensus 294 fN~Ly-----hdG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 294 FNLLY-----HDGKLYIIDVSQSVEHD 315 (520)
T ss_pred hhheE-----ECCEEEEEEccccccCC
Confidence 99998 35679999999876444
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0024 Score=63.17 Aligned_cols=30 Identities=33% Similarity=0.416 Sum_probs=24.5
Q ss_pred CCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 153 NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 153 ~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
.++||+|+.+.|||+ +.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~----~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLF----EGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEE----ECCceEEEEeccccc
Confidence 479999999999999 433445799999875
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0039 Score=58.69 Aligned_cols=73 Identities=11% Similarity=0.153 Sum_probs=44.5
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCCceEEEEE
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH-ENVVKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~~~lv~ 109 (477)
++.|..|-...+|++.... ..+..|++|+....... .....+|+.+++.+.. --+.+++..+ .. .++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~--~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~ 71 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKE--DNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIY 71 (235)
T ss_pred EEEcCCcccceEEEEEcCC--CCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEE
Confidence 5677778888999885321 02467889987543211 1133468888888843 3344454432 21 4799
Q ss_pred eccCC
Q 011808 110 DYAEY 114 (477)
Q Consensus 110 e~~~~ 114 (477)
||++|
T Consensus 72 e~i~G 76 (235)
T cd05157 72 EFIPG 76 (235)
T ss_pred EeeCC
Confidence 99886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.001 Score=60.51 Aligned_cols=98 Identities=23% Similarity=0.274 Sum_probs=74.4
Q ss_pred HHHHHHHhcCC-CCeeEEEEEEEcCCCceEEEEEeccCC-CHHHH---HHhhhcccCCCCCHHHHHHHHHHHHHHHHHhh
Q 011808 77 REIMLLREITH-ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEI---IRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151 (477)
Q Consensus 77 ~Ei~il~~l~h-pnIv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~---l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH 151 (477)
.|.-+++.+.+ +++.++++.|- -+++.||.+. .++.. +.+ -...+.....+|+.++++.+.+|+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~-----~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQ-----FLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCcccccccccccc-----ccccCHHHHHHHHHHHHHHHHHHh
Confidence 48888888865 69999999882 2667888884 44321 111 113567788999999999999999
Q ss_pred h---CCeecCCCCCCcEEEeccCCCcccEEEeecccceeec
Q 011808 152 S---NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 152 ~---~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
. ..+.-+|++++|+-+ ++++++|++|...+....
T Consensus 77 ~~~~~~~~lcDv~~~nfgv----~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGV----NDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cCCCCcEEEeecchHHeEE----eCCCcEEEEechhcchhH
Confidence 7 347889999999999 666779999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0013 Score=64.24 Aligned_cols=142 Identities=13% Similarity=0.132 Sum_probs=76.8
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCC--CeeEEEEEE----EcCCCce
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE--NVVKLVNVH----INHADMS 104 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~----~~~~~~~ 104 (477)
++.|..|....+|++.. .+..+++|++.. . ....+..|+.+++.+.+- .+.+++... .......
T Consensus 19 i~~i~~G~~n~~y~v~~-----~~~~~vLr~~~~-~----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 19 FEGISAGIENTNYFVTT-----DSGRYVLTLFEK-V----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred eecccCccccceEEEEe-----CCCcEEEEEcCC-C----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 55677787789998752 234689998764 1 123455688888877432 244444311 0011234
Q ss_pred EEEEEeccCCCHH------------HHHHh-hh--cccCCC----CCHHHHH------------HHHHHHHHHHHHhhh-
Q 011808 105 LYLAFDYAEYDLY------------EIIRH-HR--DKVNHT----MNPYTVK------------SILWQLLNGLNYLHS- 152 (477)
Q Consensus 105 ~~lv~e~~~~~L~------------~~l~~-~~--~~~~~~----l~~~~~~------------~i~~qil~aL~~LH~- 152 (477)
.++++++++|... ..+.. |. ...... ....... .....+..++.++..
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 6889999986221 11111 00 000000 0000000 011112333444443
Q ss_pred ------CCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 153 ------NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 153 ------~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
.++||+|+.|.|||+ +++..+.|+||+.+.
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~----~~~~~~~iIDfe~a~ 204 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLF----DGDELSGVIDFYFAC 204 (296)
T ss_pred hhhcCCCcCCccCcCcccEEE----eCCceEEEeehhhhc
Confidence 479999999999999 555556899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.00015 Score=69.91 Aligned_cols=135 Identities=17% Similarity=0.286 Sum_probs=91.4
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC---------------CC-----CcHHHHHHHHHHHhcC-
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG---------------DG-----VSPTAIREIMLLREIT- 86 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~---------------~~-----~~~~~~~Ei~il~~l~- 86 (477)
|.+.+.||-|--+.||++-+. .|...++|.-+....+ .. ..-.+.+|+..|+.|.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~----~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE----EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE 169 (465)
T ss_pred hhhccccccccccceEEEecC----CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence 567889999999999999654 4888888854322111 00 0113357898888884
Q ss_pred CC-CeeEEEEEEEcCCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCc
Q 011808 87 HE-NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSN 164 (477)
Q Consensus 87 hp-nIv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~N 164 (477)
|- -|.+.+++. .-++|||++.| .|.. +++ ...+..+...+..-+.-|..+|+||+|+.=-|
T Consensus 170 ~gfpVPkpiD~~------RH~Vvmelv~g~Pl~~-v~~----------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFN 232 (465)
T KOG2268|consen 170 RGFPVPKPIDHN------RHCVVMELVDGYPLRQ-VRH----------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFN 232 (465)
T ss_pred cCCCCCCccccc------ceeeHHHhhcccceee-eee----------cCChHHHHHHHHHHHHHHHHcCceecccchhe
Confidence 32 344455532 45899999886 3332 111 11244556666777778899999999999999
Q ss_pred EEEeccCCCcccEEEeeccccee
Q 011808 165 ILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 165 ILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
|++ +++..++++||--...
T Consensus 233 imv----~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 233 IMV----KDDDKIVVIDFPQMVS 251 (465)
T ss_pred eEE----ecCCCEEEeechHhhc
Confidence 999 5667799999986543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.002 Score=63.40 Aligned_cols=152 Identities=19% Similarity=0.252 Sum_probs=81.4
Q ss_pred cccccceeE-----EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCC--CeeEEE
Q 011808 22 PEWLQQYNL-----IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE--NVVKLV 94 (477)
Q Consensus 22 ~~~~~~Y~i-----~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~ 94 (477)
..++++|.+ ++.|+.|....+|++.. ++..+++|++..... ...+..|+.+++.|... .+.+++
T Consensus 13 ~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t-----~~~~~vLK~~~~~~~----~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 13 SSFLDGYDLGELLSLKGIAEGVENSNYLLTT-----DVGRYILTLYEKRVK----AEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred HHHHHhcCCCCceeccccCCccccceEEEEe-----CCCcEEEEEecCCCC----HHHHHHHHHHHHHHHHCCCCCCccc
Confidence 345667755 45677777788998752 133588898754221 23455677777777422 244444
Q ss_pred EEE----EcCCCceEEEEEeccCCCH-----H-------HHHHh-hh--cccCCC------CCHHH---HH---------
Q 011808 95 NVH----INHADMSLYLAFDYAEYDL-----Y-------EIIRH-HR--DKVNHT------MNPYT---VK--------- 137 (477)
Q Consensus 95 ~~~----~~~~~~~~~lv~e~~~~~L-----~-------~~l~~-~~--~~~~~~------l~~~~---~~--------- 137 (477)
... ....+...+++|+|++|.. . ..+.. |. ...... +.... ..
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 321 1111335689999988621 1 11111 10 000000 01000 00
Q ss_pred -HHHHHHHHHHHHhh-------hCCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 138 -SILWQLLNGLNYLH-------SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 138 -~i~~qil~aL~~LH-------~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
.....+...++++. ..++||+|+.+.||++ +.++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~----~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLF----DGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEE----ECCceEEEeeccccc
Confidence 01112333455553 2689999999999999 444556899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00053 Score=69.88 Aligned_cols=172 Identities=20% Similarity=0.288 Sum_probs=104.0
Q ss_pred HHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh
Q 011808 73 PTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS 152 (477)
Q Consensus 73 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~ 152 (477)
..++-..++++.+.|+|.+.++++..... ....+|+|++.-+|.+++..+..+ ...+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~-~r~IVV~e~~~~Sled~~~~~~l~---------~~s~~------------ 84 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKH-ERVIVVMEHYTMSLEDILKTGNLK---------DESLL------------ 84 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCcc-ceEEEEehhhccchHHHHHhcccc---------hhhhc------------
Confidence 35566788999999999999999875543 458999999999999988764311 00000
Q ss_pred CCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHH
Q 011808 153 NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFA 232 (477)
Q Consensus 153 ~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ 232 (477)
+|+ +-+-|| ++.+| -++. . | |- ...+++||||+|.++.
T Consensus 85 ---~~~-~~~~~~-----------~~~td-~~~t----------~--------~--~~------~~~pKsdVwsl~~i~~ 122 (725)
T KOG1093|consen 85 ---AHG-VLHLNI-----------IYITD-HFLT----------K--------Y--PS------PIGPKSDVWSLGFIIL 122 (725)
T ss_pred ---ccc-cceehh-----------hhccc-cccc----------c--------C--CC------CCCcchhhhhHHHHHH
Confidence 222 111222 23344 0000 0 0 10 1224899999999999
Q ss_pred HHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHH
Q 011808 233 ELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY 312 (477)
Q Consensus 233 elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~ 312 (477)
++.-|...|.... ..+.+..+.+....+ .+... ++ ....+-..++.-..
T Consensus 123 el~L~~~l~~~~~--------~s~~l~~i~k~~~~d-~~~~~-~a---------------------~e~~~~~~~d~~~~ 171 (725)
T KOG1093|consen 123 ELYLGISLEAELT--------ESEYLEILLKYYTDD-QELLS-TA---------------------MEHLIQLLADKKRL 171 (725)
T ss_pred HHHHhhHHHHHHH--------HHHHHHHHHHhccCc-hhHHH-HH---------------------HHHHHHHhhhHhHH
Confidence 9999887765433 233333333322111 10000 00 00012223345577
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 313 DLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 313 dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+++.+|+-..|..||...++++++-|.
T Consensus 172 ~~~~~c~~~~~~ir~l~~~~~k~~i~~ 198 (725)
T KOG1093|consen 172 PLLKKCLWLEPIIRPLPMELSKRCSFT 198 (725)
T ss_pred HHhccCCccccccccchhHHhcCccHH
Confidence 999999999999999999999999885
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0039 Score=59.66 Aligned_cols=137 Identities=17% Similarity=0.238 Sum_probs=72.8
Q ss_pred eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCCceEEEEEec
Q 011808 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENV-VKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 33 ~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~~~lv~e~ 111 (477)
.+..|-...+|+.. .++..+++|.......... . ...+|..+++.+..-.+ .+++... .. ++||||
T Consensus 3 ~~~~G~tn~~y~~~-----~~~~~~vlR~~~~~~~~~~-~-~r~~E~~~l~~l~~~g~~P~~i~~~--~~----~~v~e~ 69 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-----HPGISFVWRPQSPVCKALG-V-DRQREYQILQALSALGLAPKPILVN--EH----WLLVEW 69 (256)
T ss_pred cCCCcCcCCeEEEE-----eCCccEEEeeCCccccccc-C-cHHHHHHHHHHHHhcCCCCceEEEe--CC----EEEEEe
Confidence 34567778899875 2366788887654322110 1 24578889988853323 3444432 21 688999
Q ss_pred cCCCHH---------------HHHHh-hhccc-CCCCCHH-HHHHHHHHH---------HHHHHHhhh--------CCee
Q 011808 112 AEYDLY---------------EIIRH-HRDKV-NHTMNPY-TVKSILWQL---------LNGLNYLHS--------NWII 156 (477)
Q Consensus 112 ~~~~L~---------------~~l~~-~~~~~-~~~l~~~-~~~~i~~qi---------l~aL~~LH~--------~giv 156 (477)
++|... +.+.+ |.... ...++.. .+..+..++ ...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 887321 11111 11111 1112211 112221111 111222211 2589
Q ss_pred cCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 157 HRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 157 HrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
|+|+.|.|||+. +++ +.|+||..+..
T Consensus 150 H~Dl~~~Nil~~----~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVT----PQG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEe----CCC-CEEEeccccCc
Confidence 999999999994 333 78999998854
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.022 Score=57.84 Aligned_cols=77 Identities=19% Similarity=0.156 Sum_probs=50.4
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCC--C---CCCcHHHHHHHHHHHhcC---CCCeeEEEEEEEcCCC
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD--G---DGVSPTAIREIMLLREIT---HENVVKLVNVHINHAD 102 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~---~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~ 102 (477)
.+.||.|.+..||++.... .++.++||.-..... . .....+...|...|+.+. -.++.+++.+- .+
T Consensus 31 ~~elggGn~N~VyrV~~~~---g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~- 104 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTE---GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EE- 104 (401)
T ss_pred eeEcCCCceEEEEEEEeCC---CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CC-
Confidence 4689999999999997532 225799998532111 1 123345667888888762 34677777753 22
Q ss_pred ceEEEEEeccCC
Q 011808 103 MSLYLAFDYAEY 114 (477)
Q Consensus 103 ~~~~lv~e~~~~ 114 (477)
.-++|||++++
T Consensus 105 -~~~lVME~L~~ 115 (401)
T PRK09550 105 -LAVTVMEDLSD 115 (401)
T ss_pred -CCEEEEecCCC
Confidence 35899999874
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.016 Score=56.86 Aligned_cols=75 Identities=15% Similarity=0.220 Sum_probs=43.6
Q ss_pred EeeecccCceEEEEEEEecc---cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCC-eeEEEEEEEcCCCceEE
Q 011808 31 IGKIGEGTYGLVFLARIKAA---ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN-VVKLVNVHINHADMSLY 106 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~~~ 106 (477)
++.|..|-...||++..... ...+..+++|+....... .....+|+.+++.+...+ ..+++.++. . .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~----~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---LIDRERELVVFARLSERNLGPKLYGIFP--N----G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---eechHHHHHHHHHHHhCCCCCceEEEeC--C----C
Confidence 45666677778998863210 112578999997654321 224457888888884322 345555442 1 3
Q ss_pred EEEeccCC
Q 011808 107 LAFDYAEY 114 (477)
Q Consensus 107 lv~e~~~~ 114 (477)
+|++|++|
T Consensus 74 ~v~e~i~G 81 (302)
T cd05156 74 RIEEFIPS 81 (302)
T ss_pred chhheeCC
Confidence 47788765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.055 Score=54.23 Aligned_cols=77 Identities=10% Similarity=0.079 Sum_probs=44.5
Q ss_pred eEEeeecccCceEEEEEEEecc-cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCC-eeEEEEEEEcCCCceEE
Q 011808 29 NLIGKIGEGTYGLVFLARIKAA-ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN-VVKLVNVHINHADMSLY 106 (477)
Q Consensus 29 ~i~~~lG~G~~g~Vy~a~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~~~ 106 (477)
.-+..|..|-.-.+|++..... ...+..|++|+..... .... ...+|+.+++.+..-+ -.++++.+.. .
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~------g 109 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN------G 109 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceee-chHHHHHHHHHHHHcCCCCceEEEECC------c
Confidence 3445565578888999864321 1234689999886543 2222 2357888888885333 3355555422 1
Q ss_pred EEEeccCC
Q 011808 107 LAFDYAEY 114 (477)
Q Consensus 107 lv~e~~~~ 114 (477)
.+.+|+++
T Consensus 110 ~v~efi~g 117 (344)
T PLN02236 110 RVEEFIHA 117 (344)
T ss_pred eEEEeeCC
Confidence 35667664
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.04 Score=54.88 Aligned_cols=77 Identities=16% Similarity=0.248 Sum_probs=43.9
Q ss_pred eEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCCceEEE
Q 011808 29 NLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENV-VKLVNVHINHADMSLYL 107 (477)
Q Consensus 29 ~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~~~l 107 (477)
.-++.|..|=...+|++.......++..|++|+...... .. -...+|+.+++.+..-++ .++++++ .. .+
T Consensus 17 i~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~-IdR~~E~~il~~l~~~gl~P~~l~~~--~~----G~ 87 (330)
T PLN02421 17 FSVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YV-IDRERELQAIKYLSAAGFGAKLLGVF--GN----GM 87 (330)
T ss_pred eEEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eE-echHHHHHHHHHHHhcCCCCceeEEe--CC----cE
Confidence 344555557778899886432212234789998765322 11 233468888888854444 3555554 22 13
Q ss_pred EEeccCC
Q 011808 108 AFDYAEY 114 (477)
Q Consensus 108 v~e~~~~ 114 (477)
+.+|+.+
T Consensus 88 i~~fi~g 94 (330)
T PLN02421 88 IQSFINA 94 (330)
T ss_pred eehhhcC
Confidence 6677665
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.13 Score=52.21 Aligned_cols=76 Identities=20% Similarity=0.258 Sum_probs=50.0
Q ss_pred EEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC--C---CCCcHHHHHHHHHHHhcC---CCCeeEEEEEEEcCC
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD--G---DGVSPTAIREIMLLREIT---HENVVKLVNVHINHA 101 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~---~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~ 101 (477)
-.+.||.|....||+..+. +..++||.-..... + .....+...|...|+.+. -.++.+++.+..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~-----~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded-- 108 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-----SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT-- 108 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-----CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--
Confidence 4678899999999998642 34588987642111 1 113345556777777663 2478888887643
Q ss_pred CceEEEEEeccCC
Q 011808 102 DMSLYLAFDYAEY 114 (477)
Q Consensus 102 ~~~~~lv~e~~~~ 114 (477)
.-+++||++++
T Consensus 109 --~~vlvME~L~~ 119 (418)
T PLN02756 109 --MALIGMRYLEP 119 (418)
T ss_pred --CCEEEEeecCC
Confidence 24788999965
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.15 Score=50.87 Aligned_cols=75 Identities=15% Similarity=0.088 Sum_probs=46.4
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccC-----CCCCCCcHHHHHHHHHHHhcC--CC-CeeEEEEEEEcCCCc
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS-----KDGDGVSPTAIREIMLLREIT--HE-NVVKLVNVHINHADM 103 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~ 103 (477)
+.||-|....||++.+. ..+..++||.-... ..-.-...+..-|...|+... -| ++.+++.+ +.+
T Consensus 1 ~EigdGnlN~VfrV~~~---~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e-- 73 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQ---EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTE-- 73 (370)
T ss_pred CcCCCCceEEEEEEEcC---CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccc--
Confidence 36899999999999742 22357999864311 111233445566888887763 34 56666553 222
Q ss_pred eEEEEEeccC
Q 011808 104 SLYLAFDYAE 113 (477)
Q Consensus 104 ~~~lv~e~~~ 113 (477)
...+|||+++
T Consensus 74 ~~~~vMEdL~ 83 (370)
T TIGR01767 74 MAVTVMEDLS 83 (370)
T ss_pred cceehHhhCc
Confidence 4578999886
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.032 Score=55.07 Aligned_cols=74 Identities=28% Similarity=0.452 Sum_probs=59.1
Q ss_pred CCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEeccCCCcccEE
Q 011808 100 HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 100 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~~~~~~~vk 178 (477)
.+..++|++|++-++.+.-. ......++..++++.+..|.-+.++ ..-|||+.-.|||| + .|+|.
T Consensus 296 de~~y~yl~~kdhgt~is~i---------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI----d-~Gnvt 361 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII---------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI----D-EGNVT 361 (488)
T ss_pred CCceEEEEEEecCCceeeee---------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee----e-cCceE
Confidence 34568899998877765321 1234567889999999999888876 69999999999999 6 78899
Q ss_pred Eeeccccee
Q 011808 179 IADFGLARI 187 (477)
Q Consensus 179 L~DFG~a~~ 187 (477)
|+||-+++.
T Consensus 362 LIDfklsRl 370 (488)
T COG5072 362 LIDFKLSRL 370 (488)
T ss_pred EEEeeeeec
Confidence 999999984
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.066 Score=52.72 Aligned_cols=30 Identities=23% Similarity=0.271 Sum_probs=25.8
Q ss_pred CeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 154 WIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 154 givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
++||+|+.+.|||+ +.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~----~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLY----DETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEE----cCCCCEEEEEhhhccc
Confidence 79999999999999 5556689999998853
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.049 Score=52.75 Aligned_cols=30 Identities=33% Similarity=0.695 Sum_probs=23.7
Q ss_pred CeecCCCCCCcEEEeccCCCcc-cEEEeeccccee
Q 011808 154 WIIHRDLKPSNILVMGEGEEQG-VVKIADFGLARI 187 (477)
Q Consensus 154 givHrDikp~NILl~~~~~~~~-~vkL~DFG~a~~ 187 (477)
.++|+|+++.|||+ +.++ ..-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv----~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILI----DEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEE----eCCCCEEEEECcHhccc
Confidence 48999999999999 3323 456999998853
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.18 Score=51.26 Aligned_cols=77 Identities=14% Similarity=0.106 Sum_probs=42.6
Q ss_pred eEEeeecccCceEEEEEEEecccCC---CcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCC-CeeEEEEEEEcCCCce
Q 011808 29 NLIGKIGEGTYGLVFLARIKAAANR---GKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE-NVVKLVNVHINHADMS 104 (477)
Q Consensus 29 ~i~~~lG~G~~g~Vy~a~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~ 104 (477)
..++.|..|-...+|++........ .+.|.++.... .....-...+|+.+++.+... --.++++.+. .
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~--~--- 124 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG--D--- 124 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEeccHHHHHHHHHHHhCCCCCeEEEecC--C---
Confidence 3455666688889999864321100 01244444321 111112334689999999544 4455666552 1
Q ss_pred EEEEEeccCC
Q 011808 105 LYLAFDYAEY 114 (477)
Q Consensus 105 ~~lv~e~~~~ 114 (477)
+++.||++|
T Consensus 125 -g~l~efIeG 133 (383)
T PTZ00384 125 -FTIQEWVEG 133 (383)
T ss_pred -EEEEEEecc
Confidence 688888886
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.2 Score=49.30 Aligned_cols=32 Identities=22% Similarity=0.450 Sum_probs=25.5
Q ss_pred CeecCCCCCCcEEEeccCCCcccEEEeecccceeec
Q 011808 154 WIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ 189 (477)
Q Consensus 154 givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~ 189 (477)
.++|+|+.+.||++. ...-+=|+||+.+..-+
T Consensus 199 ~lvHGD~~~gNlii~----~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIID----PGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEe----CCCeeEEEeccccccCC
Confidence 489999999999994 33348899999986543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.17 Score=51.21 Aligned_cols=76 Identities=14% Similarity=0.078 Sum_probs=49.0
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecc----cCCCCCCCcHHHHHHHHHHHhcC--CC-CeeEEEEEEEcCCCc
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFK----QSKDGDGVSPTAIREIMLLREIT--HE-NVVKLVNVHINHADM 103 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~----~~~~~~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~ 103 (477)
++.||-|--..||++.+.. .+..++||.-. ....-.-...+..-|...|+.+. .| ++.+++.+ ++ .
T Consensus 34 ~~eigdGnlN~VfrV~~~~---~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~--e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DS--V 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--Cc--H
Confidence 6788999999999997531 24568888642 11122334456667888888763 34 56666653 22 2
Q ss_pred eEEEEEeccC
Q 011808 104 SLYLAFDYAE 113 (477)
Q Consensus 104 ~~~lv~e~~~ 113 (477)
...+|||++.
T Consensus 107 ~~~~vMEdL~ 116 (409)
T PRK12396 107 MNCCVMEDLS 116 (409)
T ss_pred HhhHHHHhCc
Confidence 4578888885
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.41 Score=46.90 Aligned_cols=106 Identities=13% Similarity=0.019 Sum_probs=67.7
Q ss_pred EEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCC---CCeeEEEEEEEcC-CCceE
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH---ENVVKLVNVHINH-ADMSL 105 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~~-~~~~~ 105 (477)
-.+.||.|..+.||..... +..+++|..+... ....+..|...|+.|.. -.+.++++++.+. ....-
T Consensus 18 ~~~~i~~G~~~~vy~~~~~-----~~~~~~k~~~~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 18 RVECISEQPYAALWALYDS-----QGNPMPLMARSFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred eeeecCCccceeEEEEEcC-----CCCEEEEEecccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 4567999999999987422 2246777754311 12366789999988842 4678888776543 22357
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN 153 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~ 153 (477)
+||||++++...... ..+......+..+++.+|.-||..
T Consensus 89 ~LVmE~i~G~~~~~~---------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 89 VLLLERLRGVSVEAP---------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EEEEeccCCEecCCC---------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 999999997422100 123334556667777888888864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.05 E-value=0.84 Score=45.31 Aligned_cols=28 Identities=32% Similarity=0.386 Sum_probs=23.1
Q ss_pred CCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 153 NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 153 ~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
.++||+|+.+.|||+ ++ .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~----~d--~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILW----RD--GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhccc----cC--CcEEEeCCCCC
Confidence 469999999999999 32 26799999774
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.58 E-value=0.15 Score=49.79 Aligned_cols=65 Identities=20% Similarity=0.256 Sum_probs=37.9
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHh---h-hCCeecCCCCCCcEEEecc
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL---H-SNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~L---H-~~givHrDikp~NILl~~~ 170 (477)
.+||.+..++-.++-.......+-.--..-++.++.||+.-.-.+ - ..+.+|-||||+|||+-++
T Consensus 251 IIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 251 IIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred EEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 577776655332221111111111222345778888887665333 2 3479999999999999655
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.32 E-value=1.1 Score=51.61 Aligned_cols=33 Identities=33% Similarity=0.422 Sum_probs=24.7
Q ss_pred CCeecCCCCCCcEEEeccCCCcccEE-Eeeccccee
Q 011808 153 NWIIHRDLKPSNILVMGEGEEQGVVK-IADFGLARI 187 (477)
Q Consensus 153 ~givHrDikp~NILl~~~~~~~~~vk-L~DFG~a~~ 187 (477)
.++||.|+.+.|||+..++. ..+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~--~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDG--ERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCC--cceEEEEECccccc
Confidence 47999999999999954321 1444 999998753
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.22 E-value=0.14 Score=50.21 Aligned_cols=83 Identities=23% Similarity=0.272 Sum_probs=48.3
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHH---Hhh-hCCeecCCCCCCcEEEeccCCC--------
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLN---YLH-SNWIIHRDLKPSNILVMGEGEE-------- 173 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~---~LH-~~givHrDikp~NILl~~~~~~-------- 173 (477)
.+||.++.++..++-.....+.+-..-..-++.++.||+.-.- .|- ..+.+|-||||+|||+-++...
T Consensus 247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~ 326 (434)
T PF05445_consen 247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR 326 (434)
T ss_pred EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence 5788776664433322222222222233456777888765542 232 3479999999999999654211
Q ss_pred ------cccEEEeecccceee
Q 011808 174 ------QGVVKIADFGLARIY 188 (477)
Q Consensus 174 ------~~~vkL~DFG~a~~~ 188 (477)
.-..+|.||.+|.+.
T Consensus 327 ~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 327 NYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred EEEecccceeeecccCHHHhc
Confidence 123567788877654
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.99 E-value=0.19 Score=49.30 Aligned_cols=29 Identities=28% Similarity=0.390 Sum_probs=24.1
Q ss_pred CCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 153 NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 153 ~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
.+++|+|+.+.||++. . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~----~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK----D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe----C-CcEEEEECcccc
Confidence 5799999999999993 3 358899999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.96 E-value=1.7 Score=45.02 Aligned_cols=76 Identities=12% Similarity=0.191 Sum_probs=43.9
Q ss_pred EEeeecccCceEEEEEEEeccc-----CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCee-EEEEEEEcCCCc
Q 011808 30 LIGKIGEGTYGLVFLARIKAAA-----NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVV-KLVNVHINHADM 103 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~ 103 (477)
-++.|..|=.-.+|++...... ..++.|.+++.-.... ... ....|..+++.+..-+|. ++++.+. .
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te--~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~--g-- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD--ELY-NPISEFEVYKTMSKYRIAPQLLNTFS--G-- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc--cee-CHHHHHHHHHHHHHCCCCCceEEEeC--C--
Confidence 5666766777889988643211 1146788888754332 122 334688888777543333 4555542 1
Q ss_pred eEEEEEeccCC
Q 011808 104 SLYLAFDYAEY 114 (477)
Q Consensus 104 ~~~lv~e~~~~ 114 (477)
+.+.+|++|
T Consensus 182 --g~I~efi~g 190 (442)
T PTZ00296 182 --GRIEEWLYG 190 (442)
T ss_pred --CEEEEeeCC
Confidence 446777775
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.80 E-value=2.6 Score=40.96 Aligned_cols=74 Identities=16% Similarity=0.169 Sum_probs=43.6
Q ss_pred eEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc---CCCCeeEEEEEEEcCCCceE
Q 011808 29 NLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI---THENVVKLVNVHINHADMSL 105 (477)
Q Consensus 29 ~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~ 105 (477)
+-.+.|+.|....+|+.. .++..+.||+-.... ...+..|..-|+.| .--.+.+++.+....+. -
T Consensus 20 ~~~~~v~GG~i~~a~~~~-----~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~ 87 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-----TDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--A 87 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-----TTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--C
T ss_pred eeeEecCCCChhheEEEE-----CCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--c
Confidence 345678889999999875 357789999876221 12556788877777 34467788887765443 3
Q ss_pred EEEEeccCC
Q 011808 106 YLAFDYAEY 114 (477)
Q Consensus 106 ~lv~e~~~~ 114 (477)
||+|||++.
T Consensus 88 fLlle~l~~ 96 (288)
T PF03881_consen 88 FLLLEFLEM 96 (288)
T ss_dssp EEEEE----
T ss_pred eEEEEeecC
Confidence 899999764
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.29 E-value=0.4 Score=48.31 Aligned_cols=62 Identities=23% Similarity=0.267 Sum_probs=40.9
Q ss_pred EEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHH-hhhCCeecCCCCCCcEEEeccCC
Q 011808 105 LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNY-LHSNWIIHRDLKPSNILVMGEGE 172 (477)
Q Consensus 105 ~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~-LH~~givHrDikp~NILl~~~~~ 172 (477)
.+|+-+|..| .+..++... ..+|..++.+..-...||.- |--.+++|.|+.|.||++....+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~------~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~t 383 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK------SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNKT 383 (565)
T ss_pred ceeeeeccccccHHhhhhcc------cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecCC
Confidence 4566667766 555555432 34555666666666666554 44568999999999999965433
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.03 E-value=0.27 Score=47.40 Aligned_cols=47 Identities=26% Similarity=0.428 Sum_probs=34.9
Q ss_pred HHHHHHHHHHHHHhhhC--CeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 137 KSILWQLLNGLNYLHSN--WIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 137 ~~i~~qil~aL~~LH~~--givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
...+..+-.++.-++.. -++|+|+.|+|+|. ++.+.++|+||..|..
T Consensus 135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~----t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLL----TDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHhhhcCCCceeeecCCCCccceEE----cCCCcEEEEecccCCC
Confidence 33444555555555554 59999999999999 5567799999998864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 477 | ||||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-78 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-63 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-63 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-62 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-62 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-62 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-62 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-62 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-61 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-61 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-60 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-60 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-60 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-60 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-60 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-60 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-60 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-60 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-60 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-60 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-60 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-60 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-60 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-60 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-60 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-60 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-60 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-60 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-60 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-60 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-60 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-60 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-60 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-60 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-60 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-60 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-60 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-60 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-60 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-60 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-60 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-59 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-59 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-59 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-56 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-53 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-53 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-53 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-53 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-51 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-50 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-50 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-50 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-49 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-49 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-48 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-48 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-47 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-46 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-46 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-45 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-42 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-42 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-42 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-41 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-41 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-41 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-41 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-41 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-41 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-41 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-41 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-41 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-41 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-41 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-40 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-40 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-40 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-40 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-40 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-40 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-40 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-40 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-40 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-40 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-40 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-40 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-40 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-40 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-40 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-40 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-40 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-40 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-40 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-40 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-40 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-40 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-40 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-40 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-40 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-40 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-40 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-40 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-40 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-40 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-40 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-40 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-40 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-40 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-40 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-40 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-40 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-40 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-40 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-40 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-40 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-40 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-40 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-40 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-40 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-40 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-40 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-40 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-40 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-40 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-40 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-40 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-40 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-40 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-40 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-40 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-40 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-40 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-40 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-40 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-40 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-40 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-40 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-40 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-39 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-39 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-39 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-39 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-39 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-39 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-39 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-39 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-39 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-38 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-38 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-38 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-38 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-38 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-38 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-38 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-38 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-38 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-38 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-38 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-38 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-38 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-37 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-37 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-37 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-37 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-37 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-37 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-37 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-37 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-37 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-37 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-37 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-37 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-37 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-37 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-37 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-37 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-37 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-37 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-37 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-37 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-36 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-36 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-36 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-36 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-36 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-36 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-36 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-36 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-36 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-36 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-36 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-35 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-35 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-35 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-35 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-35 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-35 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-35 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-35 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-35 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-35 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-35 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-35 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-35 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-35 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-34 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-34 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-34 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-33 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-33 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-33 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-33 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-33 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-33 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-32 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-29 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-27 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-27 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-27 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-26 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-26 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-26 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-26 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-26 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-26 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-25 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-25 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-24 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-24 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-24 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-24 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-24 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-24 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-24 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-24 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-24 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-24 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-24 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-24 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 7e-24 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-24 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-24 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-23 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-23 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-23 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-23 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-23 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-23 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-23 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-23 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-23 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-23 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-23 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 9e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-20 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-20 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-20 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-20 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-20 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-20 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-20 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-20 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-20 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-20 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-20 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-20 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-20 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-20 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-19 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-19 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-19 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-19 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-19 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-19 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-19 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-19 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-19 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-18 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-18 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-18 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-18 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-18 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-18 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-18 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-18 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-18 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-18 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-18 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-18 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-18 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-18 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-18 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-18 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-17 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-17 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-17 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-17 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-17 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-17 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-17 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-17 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-17 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-16 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-16 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-16 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-16 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-16 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-16 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-15 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-15 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-10 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-10 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 4e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-08 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-08 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-08 |
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 483 bits (1246), Expect = e-170
Identities = 165/404 (40%), Positives = 235/404 (58%), Gaps = 22/404 (5%)
Query: 15 TSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPT 74
S+ E+ E L +Y K+G GTYG V+ A+ K + K A+K+ + G+S +
Sbjct: 11 LSSERERVEDLFEY-EGCKVGRGTYGHVYKAKRKDGKD-DKDYALKQIEG----TGISMS 64
Query: 75 AIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHT---- 130
A REI LLRE+ H NV+ L V ++HAD ++L FDYAE+DL+ II+ HR +
Sbjct: 65 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ 124
Query: 131 MNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190
+ VKS+L+Q+L+G++YLH+NW++HRDLKP+NILVMGEG E+G VKIAD G AR++ +
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 191 PLKFLS-ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG-AEAKS 248
PLK L+ + VVVT WYRAPELLLGA+HYT A+D+WA+GCIFAELLT +P+F E
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244
Query: 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP---L 305
T NP+ DQLD+IF ++G P + W + +P + + Y L + +
Sbjct: 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304
Query: 306 SPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRP 365
P S A+ LL K+L DP KRIT+ QA++ YF +PLP + Q YP R
Sbjct: 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQI-----PYPKRE 359
Query: 366 VDSNTDFEGTTTLQPPQPASG--PVPGNMAGAHAVSNRNVPRPM 407
+ + + + Q G G + S+ P+
Sbjct: 360 FLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPL 403
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 410 bits (1055), Expect = e-142
Identities = 125/321 (38%), Positives = 189/321 (58%), Gaps = 26/321 (8%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+ +Y I K+GEGTYG V+ A + +AIK+ + + +GV TAIRE+ LL+E
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTV---TNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ H N+++L +V H + L+L F+YAE DL + + + D ++ +KS L+QL+
Sbjct: 90 LQHRNIIELKSVI--HHNHRLHLIFEYAENDLKKYMDKNPD-----VSMRVIKSFLYQLI 142
Query: 145 NGLNYLHSNWIIHRDLKPSNILV-MGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
NG+N+ HS +HRDLKP N+L+ + + E V+KI DFGLAR + P++ + ++T
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE--IIT 200
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
+WYR PE+LLG++HY+++VD+W++ CI+AE+L PLF G ++DQL KIF+
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS--------EIDQLFKIFE 252
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
+LG P WP + LP W+ K+ L V+ DLL+ MLE DP
Sbjct: 253 VLGLPDDTTWPGVTALPDWKQSFP-----KFRGKTLKRVLGALLDDEGLDLLTAMLEMDP 307
Query: 324 RKRITAAQALEHEYFRIEPLP 344
KRI+A ALEH YF
Sbjct: 308 VKRISAKNALEHPYFSHNDFD 328
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 403 bits (1037), Expect = e-140
Identities = 128/316 (40%), Positives = 189/316 (59%), Gaps = 32/316 (10%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+++Y+ + KIGEGTYG+V+ A+ G+ A+KK + K+ +G+ T IREI +L+E
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKEDEGIPSTTIREISILKE 56
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ H N+VKL +V H L L F++ + DL +++ + T KS L QLL
Sbjct: 57 LKHSNIVKLYDVI--HTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLL 110
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
NG+ Y H ++HRDLKP N+L+ +G +KIADFGLAR + P++ + +VT+
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLI----NREGELKIADFGLARAFGIPVRKYTHE--IVTL 164
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
WYRAP++L+G+K Y++ +D+W+VGCIFAE++ PLF G S + DQL +IF+I
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG---VS-----EADQLMRIFRI 216
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYDP 323
LG P + WP + LP + + YE S + L DLLSKML+ DP
Sbjct: 217 LGTPNSKNWPNVTELPKYDPNFT-----VYEPLPWESFLKGLDES--GIDLLSKMLKLDP 269
Query: 324 RKRITAAQALEHEYFR 339
+RITA QALEH YF+
Sbjct: 270 NQRITAKQALEHAYFK 285
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 401 bits (1032), Expect = e-139
Identities = 114/331 (34%), Positives = 169/331 (51%), Gaps = 29/331 (8%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+++Y IGKIGEG+YG+VF R + + G+ +AIKKF +S+D + A+REI +L++
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNR---DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQ 58
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ H N+V L+ V L+L F+Y ++ + + D+ + + VKSI WQ L
Sbjct: 59 LKHPNLVNLLEVF--RRKRRLHLVFEYCDHTVLHEL----DRYQRGVPEHLVKSITWQTL 112
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
+N+ H + IHRD+KP NIL+ +K+ DFG AR+ P + + V T
Sbjct: 113 QAVNFCHKHNCIHRDVKPENILITKHSV----IKLCDFGFARLLTGPSDYYDDE--VATR 166
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
WYR+PELL+G Y VD+WA+GC+FAELL+ PL+ G KS +DQL I K
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPG---KS-----DVDQLYLIRKT 218
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYDP 323
LG P + ++ + + L P +S A LL L DP
Sbjct: 219 LGDLIPRHQQVFSTNQYFSGVKIP---DPEDMEPLELKFPNISYP--ALGLLKGCLHMDP 273
Query: 324 RKRITAAQALEHEYFRIEPLPGRNALVPSQP 354
+R+T Q L H YF A +P
Sbjct: 274 TERLTCEQLLHHPYFENIREIEDLAKEHDKP 304
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 398 bits (1026), Expect = e-138
Identities = 115/334 (34%), Positives = 169/334 (50%), Gaps = 29/334 (8%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+++Y +G +GEG+YG+V R K G+ +AIKKF +S D V A+REI LL++
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDT---GRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ HEN+V L+ V YL F++ ++ + + + + + ++ V+ L+Q++
Sbjct: 81 LRHENLVNLLEVC--KKKKRWYLVFEFVDHTILDDL----ELFPNGLDYQVVQKYLFQII 134
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
NG+ + HS+ IIHRD+KP NILV G VK+ DFG AR AP + + V T
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQSGV----VKLCDFGFARTLAAPGEVYDDE--VATR 188
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
WYRAPELL+G Y AVD+WA+GC+ E+ +PLF G S +DQL I
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPG---DS-----DIDQLYHIMMC 240
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYDP 323
LG+ P P + L E L P LS DL K L DP
Sbjct: 241 LGNLIPRHQELFNKNPVFAGVRLP---EIKEREPLERRYPKLSEV--VIDLAKKCLHIDP 295
Query: 324 RKRITAAQALEHEYFRIEPLPGRNALVPSQPGDK 357
KR A+ L H++F+++ R + K
Sbjct: 296 DKRPFCAELLHHDFFQMDGFAERFSQELQLKVQK 329
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 396 bits (1020), Expect = e-137
Identities = 123/316 (38%), Positives = 196/316 (62%), Gaps = 31/316 (9%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+++Y + K+GEGTYG+V+ A+ +G+ +A+K+ + + +G+ TAIREI LL+E
Sbjct: 20 MEKYQKLEKVGEGTYGVVYKAKDS----QGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ H N+V L++V H++ L L F++ E DL +++ ++ + +K L+QLL
Sbjct: 76 LHHPNIVSLIDVI--HSERCLTLVFEFMEKDLKKVLDENKTG----LQDSQIKIYLYQLL 129
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
G+ + H + I+HRDLKP N+L+ G +K+ADFGLAR + P++ + VVT+
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLI----NSDGALKLADFGLARAFGIPVRSYTHE--VVTL 183
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
WYRAP++L+G+K Y+++VD+W++GCIFAE++T KPLF G + DQL KIF I
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG---VT-----DDDQLPKIFSI 235
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYDP 323
LG P P +WP + LP W+ + + +E S++P + DLLS ML +DP
Sbjct: 236 LGTPNPREWPQVQELPLWKQRTF----QVFEKKPWSSIIPGFCQE--GIDLLSNMLCFDP 289
Query: 324 RKRITAAQALEHEYFR 339
KRI+A A+ H YF+
Sbjct: 290 NKRISARDAMNHPYFK 305
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 395 bits (1017), Expect = e-137
Identities = 127/322 (39%), Positives = 191/322 (59%), Gaps = 32/322 (9%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+Q+Y + KIGEGTYG VF A+ + + +A+K+ + D +GV +A+REI LL+E
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRVRLDDDDEGVPSSALREICLLKE 57
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ H+N+V+L +V H+D L L F++ + DL + ++P VKS L+QLL
Sbjct: 58 LKHKNIVRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSCNGD----LDPEIVKSFLFQLL 111
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
GL + HS ++HRDLKP N+L+ G +K+A+FGLAR + P++ S VVT+
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLI----NRNGELKLANFGLARAFGIPVRCYSAE--VVTL 165
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKSTQNPFQLDQLDKIFK 263
WYR P++L GAK Y++++DMW+ GCIFAEL +PLF G DQL +IF+
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG---ND-----VDDQLKRIFR 217
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYD 322
+LG PT E+WP++ LP ++ T L +VVP L+ DLL +L+ +
Sbjct: 218 LLGTPTEEQWPSMTKLPDYKPYP-----MYPATTSLVNVVPKLNAT--GRDLLQNLLKCN 270
Query: 323 PRKRITAAQALEHEYFRIEPLP 344
P +RI+A +AL+H YF P
Sbjct: 271 PVQRISAEEALQHPYFSDFCPP 292
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 394 bits (1014), Expect = e-136
Identities = 131/378 (34%), Positives = 197/378 (52%), Gaps = 44/378 (11%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFK---QSKDGDGVSPTAI 76
+ ++Y + +GEG + V+ AR K N + +AIKK K +S+ DG++ TA+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDK---NTNQIVAIKKIKLGHRSEAKDGINRTAL 60
Query: 77 REIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTV 136
REI LL+E++H N++ L++ ++ L FD+ E DL II+ + + P +
Sbjct: 61 REIKLLQELSHPNIIGLLDAF--GHKSNISLVFDFMETDLEVIIKDNSLV----LTPSHI 114
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
K+ + L GL YLH +WI+HRDLKP+N+L+ +E GV+K+ADFGLA+ + +P + +
Sbjct: 115 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLL----DENGVLKLADFGLAKSFGSPNRAYT 170
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
VVT WYRAPELL GA+ Y VDMWAVGCI AELL P G S LD
Sbjct: 171 HQ--VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG---DS-----DLD 220
Query: 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLL 315
QL +IF+ LG PT E+WP + +LP + + + + LH + DL+
Sbjct: 221 QLTRIFETLGTPTEEQWPDMCSLPDYVTF------KSFPGIPLHHIFSAAGDD--LLDLI 272
Query: 316 SKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFEGT 375
+ ++P RITA QAL+ +YF P P +P P PV++ +
Sbjct: 273 QGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR---------PNCPVETLKEQSNP 323
Query: 376 TTLQPPQPASGPVPGNMA 393
+ G +
Sbjct: 324 ALAIKRKRTEALEQGGLP 341
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 387 bits (997), Expect = e-133
Identities = 113/333 (33%), Positives = 175/333 (52%), Gaps = 30/333 (9%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
Q+ + K+G GTY V+ K G +A+K+ K + +G TAIREI L++E+
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTT---GVYVALKEVKLDSE-EGTPSTAIREISLMKELK 61
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHT-MNPYTVKSILWQLLN 145
HEN+V+L +V H + L L F++ + DL + + + VK WQLL
Sbjct: 62 HENIVRLYDVI--HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
GL + H N I+HRDLKP N+L+ ++G +K+ DFGLAR + P+ S VVT+W
Sbjct: 120 GLAFCHENKILHRDLKPQNLLI----NKRGQLKLGDFGLARAFGIPVNTFSSE--VVTLW 173
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265
YRAP++L+G++ Y++++D+W+ GCI AE++T KPLF G + +QL IF I+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG---TN-----DEEQLKLIFDIM 225
Query: 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP----AYDLLSKMLEY 321
G P WP++ LP + + ++ L V+ K P D L +L+
Sbjct: 226 GTPNESLWPSVTKLPKYNPNI-----QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQL 280
Query: 322 DPRKRITAAQALEHEYFRIEPLPGRNALVPSQP 354
+P R++A QAL H +F S
Sbjct: 281 NPDMRLSAKQALHHPWFAEYYHHASMGGSRSHH 313
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 386 bits (993), Expect = e-132
Identities = 117/337 (34%), Positives = 176/337 (52%), Gaps = 32/337 (9%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y + KIG+GT+G VF AR + G+ +A+KK + +G TA+REI +L+ +
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKT---GQKVALKKVLMENEKEGFPITALREIKILQLLK 74
Query: 87 HENVVKLVNV------HINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSIL 140
HENVV L+ + N S+YL FD+ E+DL ++ V +K ++
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL----SNVLVKFTLSEIKRVM 130
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSEN-- 198
LLNGL Y+H N I+HRD+K +N+L+ GV+K+ADFGLAR +
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLI----TRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 199 GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258
VVT+WYR PELLLG + Y +D+W GCI AE+ T P+ QG + + QL
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NT-----EQHQL 238
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP-AYDLLSK 317
I ++ G TPE WP + N ++ L K + + + + P A DL+ K
Sbjct: 239 ALISQLCGSITPEVWPNVDNYELYEKLEL----VKGQKRKVKDRLKAYVRDPYALDLIDK 294
Query: 318 MLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQP 354
+L DP +RI + AL H++F +P+P + S
Sbjct: 295 LLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTH 331
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 382 bits (983), Expect = e-131
Identities = 120/336 (35%), Positives = 185/336 (55%), Gaps = 36/336 (10%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
++ Y + K+GEGTY V+ + K +A+K+ + + +G TAIRE+ LL++
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLT---DNLVALKEIRLEHE-EGAPCTAIREVSLLKD 56
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ H N+V L ++ H + SL L F+Y + DL + + + +N + VK L+QLL
Sbjct: 57 LKHANIVTLHDII--HTEKSLTLVFEYLDKDLKQYLDDCGNI----INMHNVKLFLFQLL 110
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
GL Y H ++HRDLKP N+L+ E+G +K+ADFGLAR P K VVT+
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLI----NERGELKLADFGLARAKSIPTKTYDNE--VVTL 164
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
WYR P++LLG+ Y++ +DMW VGCIF E+ T +PLF G + +QL IF+I
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG---ST-----VEEQLHFIFRI 216
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYDP 323
LG PT E WP + + +++ + KY L S P L DLL+K+L+++
Sbjct: 217 LGTPTEETWPGILSNEEFKTYNY----PKYRAEALLSHAPRLDSD--GADLLTKLLQFEG 270
Query: 324 RKRITAAQALEHEYFR-----IEPLPGRNALVPSQP 354
R RI+A A++H +F I LP ++ +
Sbjct: 271 RNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKE 306
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 379 bits (976), Expect = e-130
Identities = 122/326 (37%), Positives = 173/326 (53%), Gaps = 37/326 (11%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
QQY + +IGEG YG VF AR N G+ +A+K+ + +G+ + IRE+ +LR +
Sbjct: 11 QQYECVAEIGEGAYGKVFKAR--DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 86 ---THENVVKLVNV---HINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
H NVV+L +V + L L F++ + DL + + + T+K +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDM 125
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
++QLL GL++LHS+ ++HRDLKP NILV G +K+ADFGLARIY + S
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILV----TSSGQIKLADFGLARIYSFQMALTSV-- 179
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
VVT+WYRAPE+LL + Y + VD+W+VGCIFAE+ KPLF+G S +DQL
Sbjct: 180 -VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRG---SS-----DVDQLG 229
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKM 318
KI ++G P E WP LP + V + DLL K
Sbjct: 230 KILDVIGLPGEEDWPRDVALPRQAF-------HSKSAQPIEKFVTDIDEL--GKDLLLKC 280
Query: 319 LEYDPRKRITAAQALEHEYFRIEPLP 344
L ++P KRI+A AL H YF+
Sbjct: 281 LTFNPAKRISAYSALSHPYFQDLERC 306
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 373 bits (960), Expect = e-128
Identities = 121/329 (36%), Positives = 173/329 (52%), Gaps = 42/329 (12%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFK--QSKDG-DGVSPTAIREIMLLR 83
+Y + +IG G YG V+ AR + G +A+K + G G+ + +RE+ LLR
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHS---GHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 84 EI---THENVVKLVNV---HINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVK 137
+ H NVV+L++V ++ + L F++ + DL + + T+K
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPP---GLPAETIK 123
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
++ Q L GL++LH+N I+HRDLKP NILV G VK+ADFGLARIY +
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILV----TSGGTVKLADFGLARIYSYQMALTPV 179
Query: 198 NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257
VVT+WYRAPE+LL + Y + VDMW+VGCIFAE+ KPLF G S + DQ
Sbjct: 180 ---VVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCG---NS-----EADQ 227
Query: 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLS 316
L KIF ++G P + WP +LP + SVVP + LL
Sbjct: 228 LGKIFDLIGLPPEDDWPRDVSLPRGAF-------PPRGPRPVQSVVPEMEES--GAQLLL 278
Query: 317 KMLEYDPRKRITAAQALEHEYFR-IEPLP 344
+ML ++P KRI+A +AL+H Y E P
Sbjct: 279 EMLTFNPHKRISAFRALQHSYLHKDEGNP 307
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 330 bits (847), Expect = e-109
Identities = 120/425 (28%), Positives = 189/425 (44%), Gaps = 60/425 (14%)
Query: 3 DGNTSTGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKF 62
D + S T G Y IG G++G+V+ A++ + G+ +AIKK
Sbjct: 31 DKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLC---DSGELVAIKKV 87
Query: 63 KQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHI----NHADMSLYLAFDYAEYDLYE 118
Q K RE+ ++R++ H N+V+L ++ L L DY +Y
Sbjct: 88 LQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR 141
Query: 119 IIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178
+ RH+ + T+ VK ++QL L Y+HS I HRD+KP N+L+ + V+K
Sbjct: 142 VARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLK 197
Query: 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK 238
+ DFG A+ +S + + +YRAPEL+ GA YTS++D+W+ GC+ AELL +
Sbjct: 198 LCDFGSAKQLVRGEPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
Query: 239 PLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTL------ANLPHWQSDSLHIQGR 292
P+F G S +DQL +I K+LG PT E+ + P ++
Sbjct: 255 PIFPG---DSG-----VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV-- 304
Query: 293 KYETNGLHSVVPLSPKSP--AYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALV 350
P++P A L S++LEY P R+T +A H +F + L N +
Sbjct: 305 ------------FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELRDPNVKL 350
Query: 351 PS-QPGDKVVNYPTRPVDSNTDFEGTTTLQPP-----QPASGPVPGNMAGAHAVSNRNVP 404
P+ + + N+ T+ + SN T L PP AS P A +R
Sbjct: 351 PNGRDTPALFNFTTQELSSNPPLA--TILIPPHARIQAAASTPTNATAASDANTGDRGQT 408
Query: 405 RPMPG 409
Sbjct: 409 NNAAS 413
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 326 bits (837), Expect = e-108
Identities = 110/358 (30%), Positives = 172/358 (48%), Gaps = 40/358 (11%)
Query: 1 MGDGNTSTGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK 60
+ D N + ++ Y IG G++G+VF A++ +AIK
Sbjct: 18 LDDPNKVIKVLASDGKTGEQREI---AYTNCKVIGNGSFGVVFQAKLV----ESDEVAIK 70
Query: 61 KFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNV----HINHADMSLYLAFDYAEYDL 116
K Q K RE+ ++R + H NVV L ++ L L +Y +
Sbjct: 71 KVLQDKRFKN------RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124
Query: 117 YEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176
Y RH+ K+ TM +K ++QLL L Y+HS I HRD+KP N+L+ GV
Sbjct: 125 YRASRHYA-KLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD---PPSGV 180
Query: 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
+K+ DFG A+I A +S + + +YRAPEL+ GA +YT+ +D+W+ GC+ AEL+
Sbjct: 181 LKLIDFGSAKILIAGEPNVSY---ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237
Query: 237 LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYET 296
+PLF G +DQL +I K+LG P+ E+ T+ P++ +
Sbjct: 238 GQPLFPGESG--------IDQLVEIIKVLGTPSREQIKTM--NPNYMEHKF----PQIRP 283
Query: 297 NGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQP 354
+ V A DL+S++LEY P R+TA +AL H +F + L A +P+
Sbjct: 284 HPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF--DELRTGEARMPNGR 339
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-103
Identities = 99/353 (28%), Positives = 168/353 (47%), Gaps = 51/353 (14%)
Query: 2 GDGNTSTGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK 61
G G+ + + + + ++ + G+GT+G V L + K + G ++AIKK
Sbjct: 1 GPGSMMSLN--AAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEK---STGMSVAIKK 55
Query: 62 FKQSKDGDGVSPTAIREIMLLREIT---HENVVKLVNVHI-----NHADMSLYLAFDYAE 113
Q RE+ +++++ H N+V+L + + D+ L + +Y
Sbjct: 56 VIQDP------RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP 109
Query: 114 YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH--SNWIIHRDLKPSNILVMGEG 171
L+ R++ + P +K L+QL+ + LH S + HRD+KP N+LV
Sbjct: 110 DTLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV---N 165
Query: 172 EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIF 231
E G +K+ DFG A+ ++ + + +YRAPEL+ G +HYT+AVD+W+VGCIF
Sbjct: 166 EADGTLKLCDFGSAKKLSPSEPNVAY---ICSRYYRAPELIFGNQHYTTAVDIWSVGCIF 222
Query: 232 AELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLAN------LPHWQSD 285
AE++ +P+F+G ++ QL +I ++LG P+ E L L + +
Sbjct: 223 AEMMLGEPIFRG---DNS-----AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGI 274
Query: 286 SLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338
N K AYDLLS +L+Y P +R+ +AL H YF
Sbjct: 275 PWS--------NVFSDHSLKDAKE-AYDLLSALLQYLPEERMKPYEALCHPYF 318
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = 9e-99
Identities = 91/392 (23%), Positives = 168/392 (42%), Gaps = 85/392 (21%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y+L +G G++G+V + GK A+KK Q RE+ +++ +
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIES---GKRFALKKVLQDP------RYKNRELDIMKVL 57
Query: 86 THENVVKLVNVHINHADMS------------------------------------LYLAF 109
H N++KLV+ D L +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 110 DYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMG 169
+Y L+++++ + ++ + ++QL + ++HS I HRD+KP N+LV
Sbjct: 118 EYVPDTLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV-- 174
Query: 170 EGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGC 229
+ +K+ DFG A+ P + + + +YRAPEL+LGA YT ++D+W++GC
Sbjct: 175 -NSKDNTLKLCDFGSAKKL-IPSEPSVA--YICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 230 IFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLAN------LPHWQ 283
+F EL+ KPLF G +++ +DQL +I +I+G PT E+ + P +
Sbjct: 231 VFGELILGKPLFSG---ETS-----IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK 282
Query: 284 SDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPL 343
+ ++P S A DLL ++L Y+P RI +A+ H +F + L
Sbjct: 283 AKD------------WRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF--DHL 328
Query: 344 --PGRNALVPSQPGDKVVNYPTRPVDSNTDFE 373
+ + + + + +F
Sbjct: 329 RNSYES---EVKNNSNFPHGVNQNIPQLFNFS 357
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 302 bits (774), Expect = 4e-98
Identities = 110/375 (29%), Positives = 161/375 (42%), Gaps = 87/375 (23%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+Y + IG G+YG V A K + +AIKK + + +REI +L +
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDK---LEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 86 THENVVKLVNV---HINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQ 142
H++VVK++++ LY+ + A+ D ++ R + +K++L+
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-----PVYLTELHIKTLLYN 164
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV-- 200
LL G+ Y+HS I+HRDLKP+N LV + VK+ DFGLAR P S+ +
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQDCS----VKVCDFGLARTVDYPENGNSQLPISP 220
Query: 201 -----------------------VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
VVT WYRAPEL+L ++YT A+D+W++GCIFAELL +
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280
Query: 238 -----------KPLFQG------------AEAKSTQNPFQLDQLDKIFKILGHPTPEKWP 274
PLF G DQL+ IF ILG P+ E
Sbjct: 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIE 340
Query: 275 TLAN---------LPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLEYDPR 324
L P + L P S A LL +ML ++P
Sbjct: 341 ALEKEDAKRYIRIFPKREGTD------------LAERFPASSAD--AIHLLKRMLVFNPN 386
Query: 325 KRITAAQALEHEYFR 339
KRIT + L H +F+
Sbjct: 387 KRITINECLAHPFFK 401
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 1e-97
Identities = 97/332 (29%), Positives = 153/332 (46%), Gaps = 52/332 (15%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPT---------AI 76
Y + I G+YG V + G +AIK+ + +
Sbjct: 22 SPYTVQRFISSGSYGAV----CAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 77 REIMLLREITHENVVKLVNVHINHADMS---LYLAFDYAEYDLYEIIRHHRDKVNHTMNP 133
REI LL H N++ L ++ ++ + + LYL + DL ++I R ++P
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRI----VISP 133
Query: 134 YTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK 193
++ ++ +L GL+ LH ++HRDL P NIL+ + + I DF LAR A
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND----ITICDFNLAREDTAD-A 188
Query: 194 FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253
+ V WYRAPEL++ K +T VDMW+ GC+ AE+ K LF+G +
Sbjct: 189 NKTHY--VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG---STF---- 239
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSV--VPLSPKSP- 310
+QL+KI +++G P E ++ R Y N L +V + P
Sbjct: 240 -YNQLNKIVEVVGTPKIEDVVMFSSP----------SARDYLRNSLSNVPARAWTAVVPT 288
Query: 311 ----AYDLLSKMLEYDPRKRITAAQALEHEYF 338
A DL++KMLE++P++RI+ QAL H YF
Sbjct: 289 ADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 2e-96
Identities = 105/334 (31%), Positives = 160/334 (47%), Gaps = 54/334 (16%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK---FKQSKDGDGVSPTAIREIML 81
+ L +GEG YG+V A K G+ +AIKK F + +REI +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHK---PTGEIVAIKKIEPFDKPLFALR----TLREIKI 62
Query: 82 LREITHENVVKLVNVHI---NHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKS 138
L+ HEN++ + N+ +Y+ + + DL+ +I +H ++
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH------IQY 116
Query: 139 ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSEN 198
++Q L + LH + +IHRDLKPSN+L+ + +K+ DFGLARI SE
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD----LKVCDFGLARIIDESAADNSEP 172
Query: 199 GV--------VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250
V T WYRAPE++L + Y+ A+D+W+ GCI AEL +P+F G +
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG---RDY- 228
Query: 251 NPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKY-ETNGLHSVVPLSPKS 309
QL IF I+G P + +L +S + R+Y ++ ++ PL
Sbjct: 229 ----RHQLLLIFGIIGTPHSD-----NDLRCIESP----RAREYIKSLPMYPAAPLEKMF 275
Query: 310 P-----AYDLLSKMLEYDPRKRITAAQALEHEYF 338
P DLL +ML +DP KRITA +ALEH Y
Sbjct: 276 PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 9e-96
Identities = 116/351 (33%), Positives = 181/351 (51%), Gaps = 61/351 (17%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK----FKQSKDGDGVSPTAIREIM 80
L++Y L+ K+G+G YG+V+ + + G+ +A+KK F+ S D + REIM
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDR---RTGEVVAVKKIFDAFQNSTD----AQRTFREIM 60
Query: 81 LLREI-THENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
+L E+ HEN+V L+NV D +YL FDY E DL+ +IR + + H + +
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH------KQYV 114
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
++QL+ + YLHS ++HRD+KPSNIL+ E VK+ADFGL+R + + +
Sbjct: 115 VYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH----VKVADFGLSRSFVNIRRVTNNIP 170
Query: 200 V-------------------VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL 240
+ V T WYRAPE+LLG+ YT +DMW++GCI E+L KP+
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
Query: 241 FQGAEAKSTQNPFQLDQLDKIFKILGHPTPEK---------WPTLANLPHWQ--SDSLHI 289
F G ST ++QL++I ++ P+ E + +L S
Sbjct: 231 FPG---SST-----MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKR 282
Query: 290 QGRKYETNGLHSVVPLSPKSP-AYDLLSKMLEYDPRKRITAAQALEHEYFR 339
N L + P + + A DLL K+L+++P KRI+A AL+H +
Sbjct: 283 DIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 3e-94
Identities = 87/320 (27%), Positives = 149/320 (46%), Gaps = 43/320 (13%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT- 86
Y L+ K+G G Y VF A + + +K K K REI +L +
Sbjct: 38 YQLVRKLGRGKYSEVFEAINI---TNNEKVVVKILKPVKK-----KKIKREIKILENLRG 89
Query: 87 HENVVKLVNVHINHADMSLYLAFDYA-EYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
N++ L ++ + + L F++ D ++ + T+ Y ++ ++++L
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILK 141
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
L+Y HS I+HRD+KP N+++ E +++ D+GLA Y P + N V + +
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH-PGQEY--NVRVASRY 195
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK-PLFQGAEAKSTQNPFQLDQLDKIFKI 264
++ PELL+ + Y ++DMW++GC+ A ++ K P F G + DQL +I K+
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--------NYDQLVRIAKV 247
Query: 265 LGHPTPEKWPTLANLPHWQS--DSLHIQGRKYETNGLHSVVPLSPK---SP-AYDLLSKM 318
LG + N+ D L ++ V + SP A D L K+
Sbjct: 248 LGTEDLYDYIDKYNIELDPRFNDIL----GRHSRKRWERFVHSENQHLVSPEALDFLDKL 303
Query: 319 LEYDPRKRITAAQALEHEYF 338
L YD + R+TA +A+EH YF
Sbjct: 304 LRYDHQSRLTAREAMEHPYF 323
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 4e-94
Identities = 105/339 (30%), Positives = 152/339 (44%), Gaps = 64/339 (18%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIKK--FKQSKDGDGVSPTAIREIM 80
+Y + +G G GLVF +A + K +AIKK + A+REI
Sbjct: 10 GSRYMDLKPLGCGGNGLVF-----SAVDNDCDKRVAIKKIVLTDPQS----VKHALREIK 60
Query: 81 LLREITHENVVKLVNVHINHADMS------------LYLAFDYAEYDLYEIIRHHRDKVN 128
++R + H+N+VK+ + +Y+ +Y E DL ++
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 129 HTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188
H + ++QLL GL Y+HS ++HRDLKP+N+ + E +KI DFGLARI
Sbjct: 121 H------ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV---LKIGDFGLARIM 171
Query: 189 QAPLK---FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAE 245
LSE +VT WYR+P LLL +YT A+DMWA GCIFAE+LT K LF G
Sbjct: 172 DPHYSHKGHLSEG--LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG-- 227
Query: 246 AKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKY-ETNGLHSVVP 304
L+Q+ I + + E L + Y + P
Sbjct: 228 -AHE-----LEQMQLILESIPVVHEEDRQELLS-----------VIPVYIRNDMTEPHKP 270
Query: 305 LSPKSP-----AYDLLSKMLEYDPRKRITAAQALEHEYF 338
L+ P A D L ++L + P R+TA +AL H Y
Sbjct: 271 LTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 1e-93
Identities = 114/328 (34%), Positives = 165/328 (50%), Gaps = 52/328 (15%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK---FKQSKDGDGVSPTAIREIMLL 82
+Y + IGEG YG+V A +AIKK F+ +REI +L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDN---LNKVRVAIKKISPFEHQTYCQR----TLREIKIL 79
Query: 83 REITHENVVKLVNVHI---NHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
HEN++ + ++ +Y+ D E DLY++++ +H +
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH------ICYF 133
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK---FLS 196
L+Q+L GL Y+HS ++HRDLKPSN+L+ + +KI DFGLAR+ FL+
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD----LKICDFGLARVADPDHDHTGFLT 189
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
E V T WYRAPE++L +K YT ++D+W+VGCI AE+L+ +P+F G K LD
Sbjct: 190 EY--VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHY-----LD 239
Query: 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKY-ETNGLHSVVPLSPKSP----- 310
QL+ I ILG P+ E + NL + R Y + + VP + P
Sbjct: 240 QLNHILGILGSPSQEDLNCIINL----------KARNYLLSLPHKNKVPWNRLFPNADSK 289
Query: 311 AYDLLSKMLEYDPRKRITAAQALEHEYF 338
A DLL KML ++P KRI QAL H Y
Sbjct: 290 ALDLLDKMLTFNPHKRIEVEQALAHPYL 317
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 2e-92
Identities = 116/318 (36%), Positives = 165/318 (51%), Gaps = 37/318 (11%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ Y +G G YG V A K G+ +AIKK + + + A RE++LL+ +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDK---RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 86 THENVVKLVNVHINHADMS----LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILW 141
HENV+ L++V + + YL + + DL +I+ + ++ +++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK-------FSEEKIQYLVY 133
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
Q+L GL Y+HS ++HRDLKP N+ V + E +KI DFGLAR A + G V
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE----LKILDFGLARHADAEMT-----GYV 184
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
VT WYRAPE++L HY VD+W+VGCI AE+LT K LF+G K LDQL +I
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG---KDY-----LDQLTQI 236
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP-LSPKSPAYDLLSKMLE 320
K+ G P E + L + S + + P SP+ A DLL KMLE
Sbjct: 237 LKVTGVPGTE---FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQ--AADLLEKMLE 291
Query: 321 YDPRKRITAAQALEHEYF 338
D KR+TAAQAL H +F
Sbjct: 292 LDVDKRLTAAQALTHPFF 309
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 7e-92
Identities = 110/324 (33%), Positives = 157/324 (48%), Gaps = 46/324 (14%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y + +G G YG V A G +A+KK + + RE+ LL+ +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKT---GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 86 THENVVKLVNVHINHADMS----LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILW 141
HENV+ L++V + +YL DL I++ + +H V+ +++
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH------VQFLIY 139
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
Q+L GL Y+HS IIHRDLKPSN+ V + E +KI DFGLAR ++ V
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCE----LKILDFGLARHTAD---EMTGY--V 190
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T WYRAPE++L HY VD+W+VGCI AELLT + LF G +DQL I
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDH-----IDQLKLI 242
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKY-ETNGLHSVVPLSPKSP-----AYDLL 315
+++G P E +++ R Y ++ + + A DLL
Sbjct: 243 LRLVGTPGAELLKKISSE----------SARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 316 SKMLEYDPRKRITAAQALEHEYFR 339
KML D KRITAAQAL H YF
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFA 316
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 2e-91
Identities = 110/361 (30%), Positives = 163/361 (45%), Gaps = 67/361 (18%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK----FKQSKDGDGVSPTAIREIM 80
Y + IG G+YG V+LA K N K +AIKK F+ D +REI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDK---NTEKNVAIKKVNRMFEDLID----CKRILREIT 77
Query: 81 LLREITHENVVKLVNVHI---NHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVK 137
+L + + +++L ++ I LY+ + A+ DL ++ + + +K
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-----PIFLTEEHIK 132
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
+IL+ LL G N++H + IIHRDLKP+N L+ + VK+ DFGLAR +
Sbjct: 133 TILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS----VKVCDFGLARTINSEKDTNIV 188
Query: 198 NGV--------------------VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
N + VVT WYRAPEL+L ++YT ++D+W+ GCIFAELL +
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 238 -----------KPLFQGAEAKSTQNPFQ---------LDQLDKIFKILGHPTPEKWPTLA 277
PLF G+ DQL+ IF I+G PT + L
Sbjct: 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTED---DLK 305
Query: 278 NLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337
N+ + + L P +LL ML+++P KRIT QAL+H Y
Sbjct: 306 NINKPEVIKYIKLFPHRKPINLKQKYPSISDD-GINLLESMLKFNPNKRITIDQALDHPY 364
Query: 338 F 338
Sbjct: 365 L 365
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 3e-91
Identities = 107/327 (32%), Positives = 156/327 (47%), Gaps = 54/327 (16%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK----FKQSKDGDGVSPTAIREIML 81
Y + +G G YG V A G +AIKK F+ A RE+ L
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRT---GAKVAIKKLYRPFQSELFAKR----AYRELRL 77
Query: 82 LREITHENVVKLVNVHINHADMS----LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVK 137
L+ + HENV+ L++V + YL + DL ++++H + + ++
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR------IQ 131
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
+++Q+L GL Y+H+ IIHRDLKP N+ V + E +KI DFGLAR + +
Sbjct: 132 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE----LKILDFGLARQADSEM----- 182
Query: 198 NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257
G VVT WYRAPE++L YT VD+W+VGCI AE++T K LF+G LDQ
Sbjct: 183 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG---SDH-----LDQ 234
Query: 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKY-ETNGLHSVVPLSPKSP-----A 311
L +I K+ G P E L + + + Y + + A
Sbjct: 235 LKEIMKVTGTPPAEFVQRLQSD----------EAKNYMKGLPELEKKDFASILTNASPLA 284
Query: 312 YDLLSKMLEYDPRKRITAAQALEHEYF 338
+LL KML D +R+TA +AL H YF
Sbjct: 285 VNLLEKMLVLDAEQRVTAGEALAHPYF 311
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 2e-88
Identities = 101/332 (30%), Positives = 159/332 (47%), Gaps = 51/332 (15%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK----FKQSKDGDGVSPTAIREIM 80
L++Y + IG G G+V A + +AIKK F+ A RE++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAKR----AYRELV 76
Query: 81 LLREITHENVVKLVNVHINHADMS----LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTV 136
L++ + H+N++ L+NV + +Y+ + + +L ++I+ ++ +
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-------LDHERM 129
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
+L+Q+L G+ +LHS IIHRDLKPSNI+V + +KI DFGLAR ++
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLARTA-GTSFMMT 184
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
VVT +YRAPE++LG Y VD+W+VGCI E++ LF G +D
Sbjct: 185 PY--VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPG---TDH-----ID 233
Query: 257 QLDKIFKILGHPTPEKWPT--------LANLPHWQSDSLHIQGRKYETNGLHSVVPLSPK 308
Q +K+ + LG P PE + N P + S + + + +
Sbjct: 234 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFE---KLFPDVLFPADSEHNKL 290
Query: 309 SP--AYDLLSKMLEYDPRKRITAAQALEHEYF 338
A DLLSKML D KRI+ +AL+H Y
Sbjct: 291 KASQARDLLSKMLVIDASKRISVDEALQHPYI 322
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 3e-86
Identities = 105/330 (31%), Positives = 159/330 (48%), Gaps = 47/330 (14%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK----FKQSKDGDGVSPTAIREIM 80
L++Y + IG G G+V A + +AIKK F+ A RE++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVL---DRNVAIKKLSRPFQNQTHAKR----AYRELV 113
Query: 81 LLREITHENVVKLVNVHINHADMS----LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTV 136
L++ + H+N++ L+NV + +YL + + +L ++I+ ++ +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-------LDHERM 166
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
+L+Q+L G+ +LHS IIHRDLKPSNI+V + +KI DFGLAR ++
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTA-GTSFMMT 221
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
VVT +YRAPE++LG Y VD+W+VGCI E++ K LF G + +D
Sbjct: 222 PY--VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPG---RDY-----ID 270
Query: 257 QLDKIFKILGHPTPEKWPT--------LANLPHWQSDSLHIQGRKYETNGLHSVVPLSPK 308
Q +K+ + LG P PE + N P + + L
Sbjct: 271 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA- 329
Query: 309 SPAYDLLSKMLEYDPRKRITAAQALEHEYF 338
S A DLLSKML DP KRI+ AL+H Y
Sbjct: 330 SQARDLLSKMLVIDPAKRISVDDALQHPYI 359
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 8e-63
Identities = 69/360 (19%), Positives = 136/360 (37%), Gaps = 68/360 (18%)
Query: 5 NTSTGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQ 64
++S GT + Y+++ +IG G VF + + AIK
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVL----NEKKQIYAIKYVNL 62
Query: 65 SKDGDGVSPTAIREIMLLREITH--ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRH 122
+ + + EI L ++ + +++L + I +Y+ + DL ++
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLKK 120
Query: 123 HRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182
+ +++P+ KS +L ++ +H + I+H DLKP+N L+ G++K+ DF
Sbjct: 121 KK-----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-----VDGMLKLIDF 170
Query: 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKH----------YTSAVDMWAVGCIFA 232
G+A Q + ++ V T+ Y PE + + D+W++GCI
Sbjct: 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230
Query: 233 ELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGR 292
+ K FQ +Q+ K+ I+ ++P +
Sbjct: 231 YMTYGKTPFQQII----------NQISKLHAIIDPNHEIEFPDI---------------- 264
Query: 293 KYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPS 352
D+L L+ DP++RI+ + L H Y +I+ P +
Sbjct: 265 ------------PEKD--LQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 310
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-62
Identities = 79/342 (23%), Positives = 130/342 (38%), Gaps = 79/342 (23%)
Query: 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLR 83
+ + I +G+G +G V AR + AIKK + +++ T + E+MLL
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALD---SRYYAIKKIRHTEEKL---STILSEVMLLA 57
Query: 84 EITHENVVKLVNVHINHADMS-----------LYLAFDYAEY-DLYEIIRHHRDKVNHTM 131
+ H+ VV+ + + L++ +Y E LY++I N
Sbjct: 58 SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH----SENLNQ 113
Query: 132 NPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
+ Q+L L+Y+HS IIHRDLKP NI + +E VKI DFGLA+
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI----DESRNVKIGDFGLAKNVHRS 169
Query: 192 LKFLSENGVVV------------TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKP 239
L L + + T Y A E+L G HY +DM+++G IF E++ P
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--P 227
Query: 240 LFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGL 299
G E + L K+ + P +
Sbjct: 228 FSTGMERVNI--------LKKLRSVSIEFPP---------DFDDNKM------------- 257
Query: 300 HSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341
++ ++++DP KR A L + ++
Sbjct: 258 ---------KVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 2e-61
Identities = 71/370 (19%), Positives = 139/370 (37%), Gaps = 69/370 (18%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ Y+++ +IG G VF + + AIK + + + EI L ++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVL----NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL 64
Query: 86 TH--ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+ +++L + I +Y+ + DL ++ + +++P+ KS +
Sbjct: 65 QQHSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLKKKK-----SIDPWERKSYWKNM 117
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
L ++ +H + I+H DLKP+N L+ G++K+ DFG+A Q + ++ V T
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLI-----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 204 IWYRAPELLLGAKH----------YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253
+ Y PE + + D+W++GCI + K FQ
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------- 224
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYD 313
+Q+ K+ I+ ++P + D
Sbjct: 225 --NQISKLHAIIDPNHEIEFPDI----------------------------PEKD--LQD 252
Query: 314 LLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDK-VVNYPTRPVDSNTDF 372
+L L+ DP++RI+ + L H Y +I+ P + K V+ N+
Sbjct: 253 VLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSIL 312
Query: 373 EGTTTLQPPQ 382
+ TL
Sbjct: 313 KAAKTLYEHY 322
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 6e-61
Identities = 80/325 (24%), Positives = 132/325 (40%), Gaps = 61/325 (18%)
Query: 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIML 81
P + Y ++ IG G+YG R K+ GK + K+ + + E+ L
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEAEKQMLVSEVNL 58
Query: 82 LREITHENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSIL 140
LRE+ H N+V+ + I+ + +LY+ +Y E DL +I K ++ V ++
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGT-KERQYLDEEFVLRVM 117
Query: 141 WQLLNGLNYLHS-----NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195
QL L H + ++HRDLKP+N+ + G+ VK+ DFGLARI F
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ----NVKLGDFGLARILNHDTSFA 173
Query: 196 SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255
V T +Y +PE + Y D+W++GC+ EL L P F + +L
Sbjct: 174 KT--FVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTA------FSQKEL 224
Query: 256 DQLDKIFKIL-GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDL 314
KI G +P+ SD L+ ++
Sbjct: 225 -----AGKIREGKFRR--------IPYRYSDELN------------------------EI 247
Query: 315 LSKMLEYDPRKRITAAQALEHEYFR 339
+++ML R + + LE+
Sbjct: 248 ITRMLNLKDYHRPSVEEILENPLIL 272
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-60
Identities = 72/328 (21%), Positives = 122/328 (37%), Gaps = 37/328 (11%)
Query: 19 GEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK---KFKQSKDGDGVSPTA 75
G + + L +G+G VF R K G AIK + D
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHK---KTGDLFAIKVFNNISFLRPVDVQ---- 54
Query: 76 IREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPY 134
+RE +L+++ H+N+VKL + L ++ LY ++ + +
Sbjct: 55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPES 112
Query: 135 TVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKF 194
+L ++ G+N+L N I+HR++KP NI+ + + Q V K+ DFG AR + +F
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 195 LSENGVVVTIWYRAPELLLGA-------KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247
+S G T Y P++ A K Y + VD+W++G F T F+ E
Sbjct: 173 VSLYG---TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 248 STQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSP 307
+ + KI N P S + + +
Sbjct: 230 RRNK----EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV----------SCSLSRGL 275
Query: 308 KSPAYDLLSKMLEYDPRKRITAAQALEH 335
+ +L+ +LE D K Q
Sbjct: 276 QVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 9e-60
Identities = 83/336 (24%), Positives = 135/336 (40%), Gaps = 72/336 (21%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+G G+ G V +G+ +A+K+ A+ EI LL E
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSF----QGRPVAVKRMLIDFC-----DIALMEIKLLTES 65
Query: 86 T-HENVVKLVNVHINHADMSLYLAFDYAEYDLYEII--RHHRDKVNHTMNPYTVKSILWQ 142
H NV++ D LY+A + +L +++ ++ D+ Y S+L Q
Sbjct: 66 DDHPNVIRYYCSE--TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILV---------MGEGEEQGVVKIADFGLARIYQAPLK 193
+ +G+ +LHS IIHRDLKP NILV G E + I+DFGL + +
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 194 FLSE--NGVVVTIWYRAPELLLGA------KHYTSAVDMWAVGCIFAELLTLKPLFQGAE 245
N T +RAPELL + + T ++D++++GC+F +L+
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH----- 238
Query: 246 AKSTQNPF--QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV 303
PF + + I + + K H +S
Sbjct: 239 ------PFGDKYSRESNIIRGIFSLDEMKC------LHDRSLI----------------- 269
Query: 304 PLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
+ A DL+S+M+++DP KR TA + L H F
Sbjct: 270 -----AEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-59
Identities = 91/355 (25%), Positives = 149/355 (41%), Gaps = 49/355 (13%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y L+ K+G G + V+LA+ +A+K + K + A EI LL+ +
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDM---VNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVN 73
Query: 87 -----------HENVVKLVN--VHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNP 133
+++KL++ H + + + F+ +L +I+ + + +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG---IPL 130
Query: 134 YTVKSILWQLLNGLNYLHSNW-IIHRDLKPSNILVMGEGEEQG--VVKIADFGLARIYQA 190
VK I QLL GL+Y+H IIH D+KP N+L+ + +KIAD G A
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---- 186
Query: 191 PLKFLSEN--GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248
+ E+ + T YR+PE+LLGA + D+W+ C+ EL+T LF+ E S
Sbjct: 187 ---WYDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHS 242
Query: 249 TQNPFQLDQLDKIFKILGHPTP---EKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPL 305
D + +I ++LG + S L K + L V+
Sbjct: 243 YTK--DDDHIAQIIELLGELPSYLLRNGKYTRT--FFNSRGLLRNISKLKFWPLEDVLTE 298
Query: 306 SPKSPA------YDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQP 354
K D LS ML+ DPRKR A + H + + + L VP +
Sbjct: 299 KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK-DTLGMEEIRVPDRE 352
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 5e-59
Identities = 79/342 (23%), Positives = 131/342 (38%), Gaps = 69/342 (20%)
Query: 12 GTGTSNHGEKPEWLQQYNLIGKI--------GEGTYGLVFLARIKAAANRGKAIAIKKFK 63
G+ S + + ++GKI G G G + + + +A+K+
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMF----DNRDVAVKRIL 57
Query: 64 QSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRH 122
A RE+ LLRE H NV++ + Y+A + L E +
Sbjct: 58 PECF-----SFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIAIELCAATLQEYVEQ 110
Query: 123 HRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV-VKIAD 181
+ ++L Q +GL +LHS I+HRDLKP NIL+ + I+D
Sbjct: 111 K----DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD 166
Query: 182 FGLARIYQAP-LKFLSENGVVVTIWYRAPELLLGA--KHYTSAVDMWAVGCIFAELLTL- 237
FGL + F +GV T + APE+L ++ T VD+++ GC+F +++
Sbjct: 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG 226
Query: 238 KPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETN 297
PF L + IL +L L + + +
Sbjct: 227 SH------------PFG-KSLQRQANIL-----LGACSLDCLHPEKHEDVI--------- 259
Query: 298 GLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
A +L+ KM+ DP+KR +A L+H +F
Sbjct: 260 -------------ARELIEKMIAMDPQKRPSAKHVLKHPFFW 288
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 5e-59
Identities = 68/359 (18%), Positives = 134/359 (37%), Gaps = 68/359 (18%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
Y+++ +IG G VF + + AIK + + + EI L ++
Sbjct: 57 IYSILKQIGSGGSSKVFQVL----NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112
Query: 87 H--ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ +++L + I +Y+ + DL ++ + +++P+ KS +L
Sbjct: 113 QHSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLKKKK-----SIDPWERKSYWKNML 165
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
++ +H + I+H DLKP+N L+ G++K+ DFG+A Q + ++ V +
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLI-----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 205 WYRAPELLLGAKH----------YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254
Y PE + + D+W++GCI + K FQ
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--------- 271
Query: 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDL 314
+Q+ K+ I+ ++P + D+
Sbjct: 272 -NQISKLHAIIDPNHEIEFPDI----------------------------PEKD--LQDV 300
Query: 315 LSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFE 373
L L+ DP++RI+ + L H Y +I+ P + K V ++S
Sbjct: 301 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSIL 359
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-57
Identities = 84/384 (21%), Positives = 150/384 (39%), Gaps = 64/384 (16%)
Query: 12 GTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV 71
G + +++Y + KIGEG++G L + G+ IK+ S+
Sbjct: 10 GVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTED---GRQYVIKEINISRMSSKE 66
Query: 72 SPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHT 130
+ RE+ +L + H N+V+ + SLY+ DY E DL++ I +
Sbjct: 67 REESRREVAVLANMKHPNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQK---GVL 121
Query: 131 MNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190
+ Q+ L ++H I+HRD+K NI + + G V++ DFG+AR+ +
Sbjct: 122 FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT----KDGTVQLGDFGIARVLNS 177
Query: 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250
++ + T +Y +PE+ K Y + D+WA+GC+ EL TLK F+
Sbjct: 178 TVELA--RACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEA------G 228
Query: 251 NPFQLDQLDKIFKIL-GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKS 309
+ L + KI+ G P + S L
Sbjct: 229 SMKNL-----VLKIISGSFPP--------VSLHYSYDLR--------------------- 254
Query: 310 PAYDLLSKMLEYDPRKRITAAQALEHEYF--RIEPLPGRNALVPSQPGDKVVNYPTRPVD 367
L+S++ + +PR R + LE + RIE + + ++P+
Sbjct: 255 ---SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIP 311
Query: 368 SNTDFEGTT--TLQPPQPASGPVP 389
+ G ++ P Q + P
Sbjct: 312 AKRPASGQNSISVMPAQKITKPAA 335
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 4e-57
Identities = 72/328 (21%), Positives = 122/328 (37%), Gaps = 37/328 (11%)
Query: 19 GEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK---KFKQSKDGDGVSPTA 75
G + + L +G+G VF R K G AIK + D
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHK---KTGDLFAIKVFNNISFLRPVDVQ---- 54
Query: 76 IREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPY 134
+RE +L+++ H+N+VKL + L ++ LY ++ + +
Sbjct: 55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPES 112
Query: 135 TVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKF 194
+L ++ G+N+L N I+HR++KP NI+ + + Q V K+ DFG AR + +F
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 195 LSENGVVVTIWYRAPELLLGA-------KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247
+S G T Y P++ A K Y + VD+W++G F T F+ E
Sbjct: 173 VSLYG---TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 248 STQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSP 307
+ + KI N P S + + +
Sbjct: 230 RRNK----EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV----------SCSLSRGL 275
Query: 308 KSPAYDLLSKMLEYDPRKRITAAQALEH 335
+ +L+ +LE D K Q
Sbjct: 276 QVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-57
Identities = 70/338 (20%), Positives = 117/338 (34%), Gaps = 82/338 (24%)
Query: 17 NHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI 76
H + + I IG G +G VF A+ + GK IK+ K + + A
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRID---GKTYVIKRVKYNNE------KAE 52
Query: 77 REIMLLREITHENVVKL--------------VNVHINHADMSLYLAFDYAE-YDLYEIIR 121
RE+ L ++ H N+V L++ ++ + L + I
Sbjct: 53 REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112
Query: 122 HHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181
R ++ + Q+ G++Y+HS +I+RDLKPSNI ++ + VKI D
Sbjct: 113 KRR---GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV----DTKQVKIGD 165
Query: 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLF 241
FGL + K G T+ Y +PE + + Y VD++A+G I AELL +
Sbjct: 166 FGLVTSLKNDGKRTRSKG---TLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCD-- 219
Query: 242 QGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHS 301
F+ + + + +
Sbjct: 220 ---------TAFETSKF--FTDLRDGIISDIF----------DKKEK------------- 245
Query: 302 VVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
LL K+L P R ++ L
Sbjct: 246 -----------TLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-56
Identities = 70/328 (21%), Positives = 111/328 (33%), Gaps = 63/328 (19%)
Query: 13 TGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVS 72
G + + Q + + ++G G+YG VF R K G+ A+K+ G
Sbjct: 44 PGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSK---EDGRLYAVKRSMSPFRGPKDR 100
Query: 73 PTAIREIMLLREIT-HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTM 131
+ E+ ++ H V+L LYL + L + ++
Sbjct: 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYLQTELCGPSLQQHCE----AWGASL 154
Query: 132 NPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
V L L L +LHS ++H D+KP+NI + +G K+ DFGL
Sbjct: 155 PEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG----PRGRCKLGDFGLLVELGTA 210
Query: 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251
+ G Y APELL G+ Y +A D++++G E+ L
Sbjct: 211 GAGEVQEG---DPRYMAPELLQGS--YGTAADVFSLGLTILEVACNMEL----------- 254
Query: 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
P + ++ + P S L
Sbjct: 255 PHGGEGWQQLRQGYLPPE---------FTAGLSSELR----------------------- 282
Query: 312 YDLLSKMLEYDPRKRITAAQALEHEYFR 339
+L MLE DP+ R TA L R
Sbjct: 283 -SVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-54
Identities = 75/314 (23%), Positives = 126/314 (40%), Gaps = 56/314 (17%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVS-PTAIREIMLLR 83
L + + KIG G + V+ A G +A+KK + D + I+EI LL+
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACL---LDGVPVALKKVQIFDLMDAKARADCIKEIDLLK 87
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQ 142
++ H NV+K I D L + + A+ DL +I+H + + + TV Q
Sbjct: 88 QLNHPNVIKYYASFI--EDNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQ 144
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV 202
L + L ++HS ++HRD+KP+N+ + GVVK+ D GL R + + + +V
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAA--HSLVG 198
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262
T +Y +PE + Y D+W++GC+ E+ L+ F G N + L
Sbjct: 199 TPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSL-----CK 248
Query: 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY-DLLSKMLEY 321
KI + +P S L++ +
Sbjct: 249 KIE-------------------------------QCDYPPLPSDHYSEELRQLVNMCINP 277
Query: 322 DPRKRITAAQALEH 335
DP KR +
Sbjct: 278 DPEKRPDVTYVYDV 291
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 186 bits (472), Expect = 1e-54
Identities = 48/342 (14%), Positives = 92/342 (26%), Gaps = 74/342 (21%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI-REIMLLRE 84
++ L+ + G +VFL R R + A+K F + +
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVE---RLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 85 ITHEN------------------------VVKLVNVHINHADMSLYLAFDYAEYDLYEII 120
+ E+ +L ++A + L A DL +
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 121 R--HHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178
+ + QL+ L S ++H P N+ +M +G +
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR----LM 234
Query: 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKH-YTSAVDMWAVGCIFAELLTL 237
+ D V + Y E L + +T A++ W +G + L
Sbjct: 235 LGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289
Query: 238 KPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETN 297
F P + + + + LP
Sbjct: 290 FLPFGL------VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP----------------- 326
Query: 298 GLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
L+ + L +D R+R+ +A+E F
Sbjct: 327 -----------DFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-53
Identities = 95/368 (25%), Positives = 157/368 (42%), Gaps = 74/368 (20%)
Query: 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLR 83
+Y ++ IG+G++G V A + +A+K + K A EI +L
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNEKR---FHRQAAEEIRILE 148
Query: 84 EITHE------NVVKLVN--VHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYT 135
+ + NV+ ++ NH + + F+ +LYE+I+ ++ +
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNH----ICMTFELLSMNLYELIKKNK---FQGFSLPL 201
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA-----RIYQA 190
V+ +L L+ LH N IIH DLKP NIL+ +G + +K+ DFG + R+Y
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG--RSGIKVIDFGSSCYEHQRVYT- 258
Query: 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250
+ + +YRAPE++LGA+ Y +DMW++GCI AELLT PL G +
Sbjct: 259 ---------YIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGED----- 303
Query: 251 NPFQLDQLDKIFKILGHPTPE------------------KWPTLANLPHWQSDSLHIQGR 292
+ DQL + ++LG P+ + ++ T+ L + R
Sbjct: 304 ---EGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSR 360
Query: 293 KYETNGLHSVVPLSPKSPAY------DLLSKMLEYDPRKRITAAQALEHEYFR---IEPL 343
+ + G D L + LE+DP R+T QAL H + R +P
Sbjct: 361 RGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPP 420
Query: 344 PGRNALVP 351
G V
Sbjct: 421 TGEKTSVK 428
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-52
Identities = 75/346 (21%), Positives = 118/346 (34%), Gaps = 76/346 (21%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
L + I +G G +G+VF A+ K AIK+ + +RE+ L +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVD---DCNYAIKRIRLPNRELARE-KVMREVKALAK 59
Query: 85 ITHENVVKLVNVHI----------NHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNP 133
+ H +V+ N + + + LY+ +L + +
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI--EERER 117
Query: 134 YTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI------ 187
I Q+ + +LHS ++HRDLKPSNI VVK+ DFGL
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT----MDDVVKVGDFGLVTAMDQDEE 173
Query: 188 ----YQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
+ G V T Y +PE + G Y+ VD++++G I ELL P
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PFSTQ 230
Query: 244 AEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV 303
E T L + K+P P +
Sbjct: 231 MERVRT--------LTDVRN-------LKFP-----PLFTQKY----------------- 253
Query: 304 PLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNAL 349
Y ++ ML P +R A +E+ F PG+ L
Sbjct: 254 -----PCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVL 294
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-52
Identities = 85/322 (26%), Positives = 144/322 (44%), Gaps = 70/322 (21%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ Y + K+G G YG V L R K AIK +++ + + E+ +L+ +
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVT---HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYT---VKSILW 141
H N++KL + + + YL + + +L++ I H + I+
Sbjct: 94 DHPNIMKLYDFFED--KRNYYLVMECYKGGELFDEIIHR--------MKFNEVDAAVIIK 143
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
Q+L+G+ YLH + I+HRDLKP N+L+ + E+ ++KI DFGL+ +++ K +
Sbjct: 144 QVLSGVTYLHKHNIVHRDLKPENLLLESK-EKDALIKIVDFGLSAVFENQKKM---KERL 199
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T +Y APE+L K Y D+W++G I LL P PF +I
Sbjct: 200 GTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYP------------PFGGQTDQEI 245
Query: 262 F-KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSK 317
K+ G T +W + S+ A DL+ +
Sbjct: 246 LRKVEKGKYTFDSPEWKNV-------SEG------------------------AKDLIKQ 274
Query: 318 MLEYDPRKRITAAQALEHEYFR 339
ML++D ++RI+A QALEH + +
Sbjct: 275 MLQFDSQRRISAQQALEHPWIK 296
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-52
Identities = 87/358 (24%), Positives = 148/358 (41%), Gaps = 80/358 (22%)
Query: 14 GTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK----KFKQSKDGD 69
G N + + ++YN++ +G+G++G V + + + A+K ++KD
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRIT---QQEYAVKVINKASAKNKDTS 66
Query: 70 GVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVN 128
+ +RE+ LL+++ H N++KL + + S Y+ + +L++ I
Sbjct: 67 TI----LREVELLKKLDHPNIMKLFEILED--SSSFYIVGELYTGGELFDEIIKR----- 115
Query: 129 HTMNPYT---VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185
++ I+ Q+ +G+ Y+H + I+HRDLKP NIL+ + E+ +KI DFGL+
Sbjct: 116 ---KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK-EKDCDIKIIDFGLS 171
Query: 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAE 245
+Q K + T +Y APE+L G Y D+W+ G I LL+ P
Sbjct: 172 TCFQQNTKM---KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTP------ 220
Query: 246 AKSTQNPFQLDQLDKIF-KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGRKYETNGLHS 301
PF I ++ G +W T+ SD
Sbjct: 221 ------PFYGKNEYDILKRVETGKYAFDLPQWRTI-------SDD--------------- 252
Query: 302 VVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVV 359
A DL+ KML + P RITA Q LEH + + P +
Sbjct: 253 ---------AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTI--SDLPSLESA 299
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-52
Identities = 86/335 (25%), Positives = 142/335 (42%), Gaps = 71/335 (21%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI-REIMLLRE 84
+Y +G+G++G V L + K G+ A+K + + ++ RE+ LL++
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKIT---GQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYT---VKSIL 140
+ H N++KL + YL + +L++ I ++ I+
Sbjct: 83 LDHPNIMKLYEFFED--KGYFYLVGEVYTGGELFDEIISR--------KRFSEVDAARII 132
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
Q+L+G+ Y+H N I+HRDLKP N+L+ + + ++I DFGL+ ++A K
Sbjct: 133 RQVLSGITYMHKNKIVHRDLKPENLLLESK-SKDANIRIIDFGLSTHFEASKKM---KDK 188
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
+ T +Y APE+L G Y D+W+ G I LL+ P PF
Sbjct: 189 IGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCP------------PFNGANEYD 234
Query: 261 IF-KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLS 316
I K+ G T +W + S+S A DL+
Sbjct: 235 ILKKVEKGKYTFELPQWKKV-------SES------------------------AKDLIR 263
Query: 317 KMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVP 351
KML Y P RI+A AL+HE+ + + VP
Sbjct: 264 KMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-52
Identities = 85/369 (23%), Positives = 144/369 (39%), Gaps = 76/369 (20%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAI----AIKKFKQSKDGDGVSPTAIREIMLL 82
+Y ++G +GEGT+G V A A+ + K++++ A EI +L
Sbjct: 20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA---------ARLEINVL 70
Query: 83 REITHE------NVVKLVN--VHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPY 134
++I + V + + H + +AF+ + +E ++ +
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGH----MCIAFELLGKNTFEFLKENN---FQPYPLP 123
Query: 135 TVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV---------------VKI 179
V+ + +QL + L +LH N + H DLKP NIL + E +++
Sbjct: 124 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 180 ADFGLA-----RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAEL 234
ADFG A +V T YR PE++L + D+W++GCI E
Sbjct: 184 ADFGSATFDHEHHTT----------IVATRHYRPPEVILELG-WAQPCDVWSIGCILFEY 232
Query: 235 LTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPE--------KWPTLANLPHWQSDS 286
LFQ E + L + KILG K+ L ++ S
Sbjct: 233 YRGFTLFQTHE--------NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSS 284
Query: 287 LHIQGRKYETNGLHSVVPLSPKSPAY-DLLSKMLEYDPRKRITAAQALEHEYFRIEPLPG 345
++ ++ S + DL+ +MLE+DP +RIT A+AL H +F
Sbjct: 285 DGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344
Query: 346 RNALVPSQP 354
R+ P
Sbjct: 345 RSFHTSRNP 353
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-51
Identities = 82/337 (24%), Positives = 137/337 (40%), Gaps = 72/337 (21%)
Query: 13 TGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK---KFKQSKDGD 69
+G N + + K+G G +G V L +++ G IK K + +
Sbjct: 9 SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSS---GLERVIKTINKDRSQVPME 65
Query: 70 GVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVN 128
+ EI +L+ + H N++K+ V ++ ++Y+ + E +L E I + +
Sbjct: 66 QIE----AEIEVLKSLDHPNIIKIFEVFEDY--HNMYIVMETCEGGELLERIVSAQARGK 119
Query: 129 HTMNPYT---VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185
+ V ++ Q++N L Y HS ++H+DLKP NIL +KI DFGLA
Sbjct: 120 A----LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDT-SPHSPIKIIDFGLA 174
Query: 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAE 245
++++ T Y APE+ + T D+W+ G + LLT
Sbjct: 175 ELFKSDEHS---TNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCL------ 223
Query: 246 AKSTQNPFQLDQLDKIF-KIL-GHPT-PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSV 302
PF L+++ K P +
Sbjct: 224 ------PFTGTSLEEVQQKATYKEPNYAVEC--------R-------------------- 249
Query: 303 VPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
PL+P+ A DLL +ML DP +R +AAQ L HE+F+
Sbjct: 250 -PLTPQ--AVDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-51
Identities = 98/363 (26%), Positives = 153/363 (42%), Gaps = 81/363 (22%)
Query: 23 EWLQ-QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIML 81
E +Y + IG+G++G V A + + +AIK K K A E+ L
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNKKA---FLNQAQIEVRL 103
Query: 82 LREITHE------NVVKLVN--VHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNP 133
L + +V L + NH L L F+ Y+LY+++R+ ++
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNH----LCLVFEMLSYNLYDLLRNTN---FRGVSL 156
Query: 134 YTVKSILWQLLNGLNYLHSNW--IIHRDLKPSNILVMGEGEEQGVVKIADFGLA-----R 186
+ Q+ L +L + IIH DLKP NIL+ + +KI DFG + R
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK--RSAIKIVDFGSSCQLGQR 214
Query: 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246
IYQ + + +YR+PE+LLG Y A+DMW++GCI E+ T +PLF GA
Sbjct: 215 IYQ----------YIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGAN- 262
Query: 247 KSTQNPFQLDQLDKIFKILGHPTPE-------------KWPTLANLPHWQSDSLHIQGRK 293
++DQ++KI ++LG P K P D
Sbjct: 263 -------EVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 315
Query: 294 YETNGLHSVVPLSPKSPA-----------------YDLLSKMLEYDPRKRITAAQALEHE 336
LH+++ + P DL+ +ML+YDP+ RI AL+H
Sbjct: 316 GTRK-LHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHS 374
Query: 337 YFR 339
+F+
Sbjct: 375 FFK 377
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-51
Identities = 68/334 (20%), Positives = 118/334 (35%), Gaps = 64/334 (19%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK-FKQSKDGDGVSPTAIREIMLLRE 84
+ Y I K+GEG + V L + G A+K+ + A RE + R
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGL---HDGHFYALKRILCHEQQD---REEAQREADMHRL 82
Query: 85 ITHENVVKLVNVHINHADMS--LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILW 141
H N+++LV + +L + + L+ I +DK + + + +L
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLL 141
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
+ GL +H+ HRDLKP+NIL+ ++G + D G ++ + +
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLG----DEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 202 V-------TIWYRAPELLLGAKH--YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252
TI YRAPEL H D+W++GC+ ++ + + K
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---- 253
Query: 253 FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY 312
D + + + + P S +L
Sbjct: 254 ---DSVALA--VQNQLSIPQSPRH-------SSALW------------------------ 277
Query: 313 DLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGR 346
LL+ M+ DP +R L P PG+
Sbjct: 278 QLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-51
Identities = 87/341 (25%), Positives = 142/341 (41%), Gaps = 69/341 (20%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI------REI 79
+Y + +G G G V LA + K +AI+ + K G + A EI
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKT---CKKVAIRIISKRKFAIGSAREADPALNVETEI 191
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-IIRHHRDKVNHTMNPYTVK 137
+L+++ H ++K+ N Y+ + E +L++ ++ + R + T K
Sbjct: 192 EILKKLNHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKR------LKEATCK 242
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
+Q+L + YLH N IIHRDLKP N+L+ + EE ++KI DFG ++I +
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ-EEDCLIKITDFGHSKILG-ETSLMRT 300
Query: 198 NGVVVTIWYRAPELLLGAKH--YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255
+ T Y APE+L+ Y AVD W++G I L+ P F Q+
Sbjct: 301 --LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR-------TQV 351
Query: 256 DQLDKIFKILGHPT--PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYD 313
D+I G PE W + S+ A D
Sbjct: 352 SLKDQITS--GKYNFIPEVWAEV-------SEK------------------------ALD 378
Query: 314 LLSKMLEYDPRKRITAAQALEHEYFRIEPLPGR-NALVPSQ 353
L+ K+L DP+ R T +AL H + + E + + L+ +
Sbjct: 379 LVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 419
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-51
Identities = 88/351 (25%), Positives = 133/351 (37%), Gaps = 80/351 (22%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK---KFKQSKDGDGVSPTAI------ 76
+ Y + K+G G YG V L + K AIK K + K I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNG---HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 77 --REIMLLREITHENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNP 133
EI LL+ + H N++KL +V + YL ++ E +L+E I + +
Sbjct: 93 IYNEISLLKSLDHPNIIKLFDVFED--KKYFYLVTEFYEGGELFEQIINR--------HK 142
Query: 134 YT---VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190
+ +I+ Q+L+G+ YLH + I+HRD+KP NIL+ + +KI DFGL+ +
Sbjct: 143 FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK-NSLLNIKIVDFGLSSFFSK 201
Query: 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250
K + T +Y APE+L Y D+W+ G I LL P
Sbjct: 202 DYKL---RDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYP----------- 245
Query: 251 NPFQLDQLDKIF-KIL-GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPK 308
PF I K+ G + W++ S
Sbjct: 246 -PFGGQNDQDIIKKVEKGKYYFDFND-------WKNIS---------------------- 275
Query: 309 SPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVV 359
A +L+ ML YD KR TA +AL + + N Q
Sbjct: 276 DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY---ANNINKSDQKTLCGA 323
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 7e-51
Identities = 83/372 (22%), Positives = 140/372 (37%), Gaps = 49/372 (13%)
Query: 14 GTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSP 73
G + + + + ++G G +G V + + G+ +AIK+ +Q
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQ---DTGEQVAIKQCRQELSPKNRE- 57
Query: 74 TAIREIMLLREITHENVVKLVNVHINHADMS----LYLAFDYAE-YDLYEIIRHHRDKVN 128
EI +++++ H NVV V ++ LA +Y E DL + + +
Sbjct: 58 RWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN--C 115
Query: 129 HTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188
+ ++++L + + L YLH N IIHRDLKP NI+ + G ++ + KI D G A+
Sbjct: 116 CGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIV-LQPGPQRLIHKIIDLGYAKEL 174
Query: 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248
G T+ Y APELL K YT VD W+ G + E +T F
Sbjct: 175 DQGELCTEFVG---TLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPN---- 226
Query: 249 TQNPFQLDQL------DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSV 302
P Q + I K+ ++ P+ S L + +
Sbjct: 227 -WQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLER--------- 276
Query: 303 VPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI--EPLPGRNALVPSQPGDKVVN 360
L ML + R+R T Q F+ L + V + +V
Sbjct: 277 -----------WLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHT 325
Query: 361 YPTRPVDSNTDF 372
YP ++ +
Sbjct: 326 YPVTENENLQNL 337
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-51
Identities = 71/368 (19%), Positives = 124/368 (33%), Gaps = 96/368 (26%)
Query: 18 HGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK---KFKQSKDGDGVSPT 74
G E ++Y+L G IG+G+YG+V +A AIK K K +
Sbjct: 18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQT---RAIRAIKIMNKNKIRQINPKDVER 74
Query: 75 AIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEII------------- 120
E+ L++++ H N+ +L V+ + + + L + L + +
Sbjct: 75 IKTEVRLMKKLHHPNIARLYEVYED--EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 121 -------------------RHHRDKVNHTMNPYT---VKSILWQLLNGLNYLHSNWIIHR 158
+ +I+ Q+ + L+YLH+ I HR
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 159 DLKPSNILVMGEGEEQGVVKIADFGLARIYQA--PLKFLSENGVVVTIWYRAPELLLGA- 215
D+KP N L + +K+ DFGL++ + ++ T ++ APE+L
Sbjct: 193 DIKPENFLF--STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250
Query: 216 KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF-KIL-GHPT--PE 271
+ Y D W+ G + LL PF ++L
Sbjct: 251 ESYGPKCDAWSAGVLLHLLLMGAV------------PFPGVNDADTISQVLNKKLCFENP 298
Query: 272 KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ 331
+ L S A DLLS +L + +R A +
Sbjct: 299 NYNVL-------SPL------------------------ARDLLSNLLNRNVDERFDAMR 327
Query: 332 ALEHEYFR 339
AL+H +
Sbjct: 328 ALQHPWIS 335
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-50
Identities = 69/345 (20%), Positives = 117/345 (33%), Gaps = 80/345 (23%)
Query: 14 GTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIKKFKQSKDGDGV 71
G + +++ + KIG G +G VF R G AIK+ K+ G
Sbjct: 1 GAMGMKSRYT--TEFHELEKIGSGEFGSVFKCV-----KRLDGCIYAIKRSKKPLAGSVD 53
Query: 72 SPTAIREIMLLREIT-HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNH 129
A+RE+ + H +VV+ + D + + +Y L + I + ++
Sbjct: 54 EQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHMLIQNEYCNGGSLADAISENY-RIMS 110
Query: 130 TMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE---------------EQ 174
+K +L Q+ GL Y+HS ++H D+KPSNI + +
Sbjct: 111 YFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170
Query: 175 GVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAEL 234
+ KI D G +P E G + A E+L + D++A+
Sbjct: 171 VMFKIGDLGHVTRISSPQ---VEEG---DSRFLANEVLQENYTHLPKADIFALALTVVCA 224
Query: 235 LTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKY 294
+PL P DQ +I + G +P S
Sbjct: 225 AGAEPL-----------PRNGDQWHEIRQ--GRLPR--------IPQVLSQEFT------ 257
Query: 295 ETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
+LL M+ DP +R +A ++H
Sbjct: 258 ------------------ELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-50
Identities = 83/347 (23%), Positives = 135/347 (38%), Gaps = 74/347 (21%)
Query: 7 STGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKA-----AANRGKAIAIKK 61
+G GG + + Y L IG+G + +V + A K + + K
Sbjct: 5 ISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAV---KIVDVAK 61
Query: 62 FKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-I 119
F S RE + + H ++V+L+ + + D LY+ F++ + DL I
Sbjct: 62 FTSSPGLSTED--LKREASICHMLKHPHIVELLETYSS--DGMLYMVFEFMDGADLCFEI 117
Query: 120 IRHHRDKVNHTMNPYT---VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176
++ Y+ + Q+L L Y H N IIHRD+KP +L+ + E
Sbjct: 118 VKR-----ADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASK-ENSAP 171
Query: 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
VK+ FG+A G V T + APE++ + Y VD+W G I LL+
Sbjct: 172 VKLGGFGVAIQLGESGLVA--GGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLS 228
Query: 237 LKPLFQGAEAKSTQNPFQLDQLDKIF-KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGR 292
F G + +++F I+ G P +W + S+S
Sbjct: 229 GCLPFYGTK-------------ERLFEGIIKGKYKMNPRQWSHI-------SES------ 262
Query: 293 KYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
A DL+ +ML DP +RIT +AL H + +
Sbjct: 263 ------------------AKDLVRRMLMLDPAERITVYEALNHPWLK 291
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-50
Identities = 85/335 (25%), Positives = 148/335 (44%), Gaps = 72/335 (21%)
Query: 14 GTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSP 73
G N + + ++YN++ +G+G++G V + + + A+K ++ + +
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRIT---QQEYAVKVINKASAKNKDTS 66
Query: 74 TAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-IIRHHRDKVNHTM 131
T +RE+ LL+++ H N++KL + + S Y+ + +L++ II+ R
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDS--SSFYIVGELYTGGELFDEIIKRKR------- 117
Query: 132 NPYT---VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188
++ I+ Q+ +G+ Y+H + I+HRDLKP NIL+ + ++ +KI DFGL+ +
Sbjct: 118 --FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDC-DIKIIDFGLSTCF 174
Query: 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248
Q K + T +Y APE+L Y D+W+ G I LL+ P
Sbjct: 175 QQNTKM---KDRIGTAYYIAPEVL--RGTYDEKCDVWSAGVILYILLSGTP--------- 220
Query: 249 TQNPFQLDQLDKIF-KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP 304
PF I ++ G +W T+ SD
Sbjct: 221 ---PFYGKNEYDILKRVETGKYAFDLPQWRTI-------SDD------------------ 252
Query: 305 LSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
A DL+ KML + P RITA Q LEH + +
Sbjct: 253 ------AKDLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 3e-50
Identities = 84/324 (25%), Positives = 131/324 (40%), Gaps = 73/324 (22%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
Y++ ++G+G + +V K G A K K RE + R++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTT---GLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-IIRHHRDKVNHTMNPYTVK---SIL 140
H N+V+L + + YL FD +L+E I+ Y+ +
Sbjct: 63 QHPNIVRLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREF---------YSEADASHCI 111
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
Q+L + Y HSN I+HR+LKP N+L+ + + VK+ADFGLA + +G
Sbjct: 112 QQILESIAYCHSNGIVHRNLKPENLLLASK-AKGAAVKLADFGLAIEVNDSEAW---HGF 167
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
T Y +PE+L Y+ VD+WA G I LL P PF + +
Sbjct: 168 AGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYP------------PFWDEDQHR 214
Query: 261 IF-KIL-GH---PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLL 315
++ +I G P+PE W T+ + A L+
Sbjct: 215 LYAQIKAGAYDYPSPE-WDTV-------TPE------------------------AKSLI 242
Query: 316 SKMLEYDPRKRITAAQALEHEYFR 339
ML +P+KRITA QAL+ +
Sbjct: 243 DSMLTVNPKKRITADQALKVPWIC 266
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-49
Identities = 90/331 (27%), Positives = 141/331 (42%), Gaps = 86/331 (25%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
+ + + + +G G + VFL + + GK A+K K+S + EI
Sbjct: 3 QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLT---GKLFALKCIKKSPAFR--DSSLENEI 57
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEII--RHHRDKVNHTMNPYTV 136
+L++I HEN+V L +++ + YL +L++ I R YT
Sbjct: 58 AVLKKIKHENIVTLEDIY--ESTTHYYLVMQLVSGGELFDRILERGV----------YTE 105
Query: 137 K---SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK 193
K ++ Q+L+ + YLH N I+HRDLKP N+L + E + I DFGL+++
Sbjct: 106 KDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEEN-SKIMITDFGLSKME----- 159
Query: 194 FLSENGVVVTI----WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST 249
+NG++ T Y APE+L K Y+ AVD W++G I LL P
Sbjct: 160 ---QNGIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYP---------- 205
Query: 250 QNPFQLDQLDKIF-KIL-GH---PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP 304
PF + K+F KI G+ +P W + S+S
Sbjct: 206 --PFYEETESKLFEKIKEGYYEFESPF-WDDI-------SES------------------ 237
Query: 305 LSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335
A D + +LE DP +R T +AL H
Sbjct: 238 ------AKDFICHLLEKDPNERYTCEKALSH 262
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-49
Identities = 83/335 (24%), Positives = 135/335 (40%), Gaps = 76/335 (22%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK-----KFKQSKDGDGVSPTAI-REI 79
+Y + +G G G V LA + K +AIK KF + + EI
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKT---CKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-IIRHHRDKVNHTMNPYTVK 137
+L+++ H ++K+ N Y+ + E +L++ ++ + R + T K
Sbjct: 67 EILKKLNHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKR------LKEATCK 117
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
+Q+L + YLH N IIHRDLKP N+L+ + EE ++KI DFG ++I +
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ-EEDCLIKITDFGHSKILG-ETSLMRT 175
Query: 198 NGVVVTIWYRAPELLLGAKH--YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255
+ T Y APE+L+ Y AVD W++G I L+ P PF
Sbjct: 176 --LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP------------PFSE 221
Query: 256 DQLD-KIF-KIL-GH---PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKS 309
+ + +I G W + S+
Sbjct: 222 HRTQVSLKDQITSGKYNFIPEV-WAEV-------SEK----------------------- 250
Query: 310 PAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLP 344
A DL+ K+L DP+ R T +AL H + + E +
Sbjct: 251 -ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 284
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 79/357 (22%), Positives = 138/357 (38%), Gaps = 72/357 (20%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAI----AIKKFKQSKDGDGVSPTAIREIMLL 82
+Y ++ +GEG +G V A R A+ + ++ ++ A EI +L
Sbjct: 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA---------ARSEIQVL 65
Query: 83 REITHE------NVVKLVN--VHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPY 134
+ V+++ H H + + F+ Y+ I+ +
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGH----ICIVFELLGLSTYDFIKENG---FLPFRLD 118
Query: 135 TVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV---------------VKI 179
++ + +Q+ +N+LHSN + H DLKP NIL + + +K+
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 180 ADFGLARIYQAPLKFLSEN--GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
DFG A + E+ +V T YRAPE++L ++ D+W++GCI E
Sbjct: 179 VDFGSA-------TYDDEHHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLG 230
Query: 238 KPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLA--------NLPHWQSDSLHI 289
+F + + L + +ILG P+ + W S
Sbjct: 231 FTVFPTHD--------SKEHLAMMERILGPL-PKHMIQKTRKRKYFHHDRLDWDEHSSAG 281
Query: 290 QGRKYETNGLHSVVPLSPK--SPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLP 344
+ L + +DL+ KMLEYDP KRIT +AL+H +F +
Sbjct: 282 RYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-48
Identities = 79/327 (24%), Positives = 131/327 (40%), Gaps = 71/327 (21%)
Query: 18 HGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIR 77
H ++ Y + IG G+Y + KA A+K +SK
Sbjct: 14 HRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKAT---NMEFAVKIIDKSKR------DPTE 64
Query: 78 EI-MLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYT 135
EI +LLR H N++ L +V+ +Y+ + + +L + I + ++
Sbjct: 65 EIEILLRYGQHPNIITLKDVY--DDGKYVYVVTELMKGGELLDKILRQK--------FFS 114
Query: 136 ---VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPL 192
++L+ + + YLH+ ++HRDLKPSNIL + E ++I DFG A+ +A
Sbjct: 115 EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 193 KFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252
L T + APE+L + Y +A D+W++G + +LT F + +
Sbjct: 175 GLLMT--PCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
Query: 253 FQLDQLDKIFKIL-GH---PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPK 308
+I G W ++ SD+
Sbjct: 232 LA--------RIGSGKFSLSGGY-WNSV-------SDT---------------------- 253
Query: 309 SPAYDLLSKMLEYDPRKRITAAQALEH 335
A DL+SKML DP +R+TAA L H
Sbjct: 254 --AKDLVSKMLHVDPHQRLTAALVLRH 278
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-48
Identities = 83/320 (25%), Positives = 131/320 (40%), Gaps = 72/320 (22%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y L ++G+G + +V A G+ A K RE + R +
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLA---GQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-IIRHHRDKVNHTMNPYTVK---SIL 140
H N+V+L + + YL FD +L+E I+ Y+ +
Sbjct: 68 KHPNIVRLHDSI--SEEGHHYLIFDLVTGGELFEDIVAREY---------YSEADASHCI 116
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
Q+L + + H ++HR+LKP N+L+ + + VK+ADFGLA + + G
Sbjct: 117 QQILEAVLHCHQMGVVHRNLKPENLLLASK-LKGAAVKLADFGLAIEVEGEQQAWF--GF 173
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
T Y +PE+L Y VD+WA G I LL P PF + +
Sbjct: 174 AGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYP------------PFWDEDQHR 220
Query: 261 IF-KIL-GH---PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLL 315
++ +I G P+PE W T+ + A DL+
Sbjct: 221 LYQQIKAGAYDFPSPE-WDTV-------TPE------------------------AKDLI 248
Query: 316 SKMLEYDPRKRITAAQALEH 335
+KML +P KRITAA+AL+H
Sbjct: 249 NKMLTINPSKRITAAEALKH 268
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-48
Identities = 79/330 (23%), Positives = 130/330 (39%), Gaps = 78/330 (23%)
Query: 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK--DGDGVSPTAIRE 78
K + Q Y L IG G++G V +A K A KK + D D +E
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGT---RIRRAAKKIPKYFVEDVDRF----KQE 56
Query: 79 IMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-IIRHHRDKVNHTMNPYT- 135
I +++ + H N+++L ++ +YL + +L+E ++ +
Sbjct: 57 IEIMKSLDHPNIIRLYETFEDN--TDIYLVMELCTGGELFERVVHKRV---------FRE 105
Query: 136 --VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK 193
I+ +L+ + Y H + HRDLKP N L + + +K+ DFGLA ++ P K
Sbjct: 106 SDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD-SPDSPLKLIDFGLAARFK-PGK 163
Query: 194 FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253
+ V T +Y +P++L Y D W+ G + LL P PF
Sbjct: 164 MMRT--KVGTPYYVSPQVL--EGLYGPECDEWSAGVMMYVLLCGYP------------PF 207
Query: 254 QLDQLDKIF-KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKS 309
++ KI G T + W + S
Sbjct: 208 SAPTDSEVMLKIREGTFTFPEKDWLNV-------SPQ----------------------- 237
Query: 310 PAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
A L+ ++L P++RIT+ QALEHE+F
Sbjct: 238 -AESLIRRLLTKSPKQRITSLQALEHEWFE 266
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-48
Identities = 84/364 (23%), Positives = 143/364 (39%), Gaps = 92/364 (25%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK------KFKQSKDGDGVSPTAIREIM 80
+ +I K+G+GT+G V L + K A+K K+ +S A E
Sbjct: 36 AFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNIKKYTRS---------AKIEAD 83
Query: 81 LLREITHE-----NVVKLVN--VHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNP 133
+L++I ++ N+VK ++ +H + L F+ LYEII + + +
Sbjct: 84 ILKKIQNDDINNNNIVKYHGKFMYYDH----MCLIFEPLGPSLYEIITRNN---YNGFHI 136
Query: 134 YTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV----------------- 176
+K ++L LNYL + H DLKP NIL+ E+ +
Sbjct: 137 EDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 177 ----VKIADFGLA-----RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAV 227
+K+ DFG A ++ T YRAPE++L + + DMW+
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGS----------IINTRQYRAPEVILNLG-WDVSSDMWSF 245
Query: 228 GCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPH------ 281
GC+ AEL T LF+ E ++ L + I+ P+ A +
Sbjct: 246 GCVLAELYTGSLLFRTHE--------HMEHLAMMESIIQPI-PKNMLYEATKTNGSKYVN 296
Query: 282 -------WQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334
W ++ I K+ L + + D L +L+ DP R + A+ L+
Sbjct: 297 KDELKLAWPENASSINSIKHVKKCL-PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355
Query: 335 HEYF 338
H++
Sbjct: 356 HKFL 359
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 8e-48
Identities = 76/338 (22%), Positives = 128/338 (37%), Gaps = 90/338 (26%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK-------DGDGVSPTAIRE 78
+ Y +G G +V K K A+K + + + ++E
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 79 IMLLREIT-HENVVKLVNVHINHADMSLYLAFDYAE----YDLYEIIRHHRDKVNHTMNP 133
+ +LR+++ H N+++L + + + +L FD + +D +
Sbjct: 74 VDILRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFD--YLTEKVT--------- 120
Query: 134 YT---VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190
+ + I+ LL + LH I+HRDLKP NIL+ ++ +K+ DFG +
Sbjct: 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL----DDDMNIKLTDFGFSCQLD- 175
Query: 191 PLKFLSENGVVVTIWYRAPELLLGA-----KHYTSAVDMWAVGCIFAELLTLKPLFQGAE 245
P + L E V T Y APE++ + Y VDMW+ G I LL P
Sbjct: 176 PGEKLRE--VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------ 227
Query: 246 AKSTQNPFQLDQLDKIF-KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGRKYETNGLHS 301
PF + + I+ G+ +W SD+
Sbjct: 228 ------PFWHRKQMLMLRMIMSGNYQFGSPEWDDY-------SDT--------------- 259
Query: 302 VVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
DL+S+ L P+KR TA +AL H +F+
Sbjct: 260 ---------VKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 8e-48
Identities = 84/320 (26%), Positives = 130/320 (40%), Gaps = 73/320 (22%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
Y++ ++G+G + +V K G A K K RE + R++
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTT---GLEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-IIRHHRDKVNHTMNPYTVK---SIL 140
H N+V+L + + YL FD +L+E I+ Y+ +
Sbjct: 86 QHPNIVRLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREF---------YSEADASHCI 134
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
Q+L + Y HSN I+HR+LKP N+L+ + + VK+ADFGLA + +G
Sbjct: 135 QQILESIAYCHSNGIVHRNLKPENLLLASK-AKGAAVKLADFGLAIEVNDSEAW---HGF 190
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
T Y +PE+L Y+ VD+WA G I LL P PF + +
Sbjct: 191 AGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYP------------PFWDEDQHR 237
Query: 261 IF-KIL-GH---PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLL 315
++ +I G P+PE W T+ + A L+
Sbjct: 238 LYAQIKAGAYDYPSPE-WDTV-------TPE------------------------AKSLI 265
Query: 316 SKMLEYDPRKRITAAQALEH 335
ML +P+KRITA QAL+
Sbjct: 266 DSMLTVNPKKRITADQALKV 285
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 9e-48
Identities = 66/355 (18%), Positives = 131/355 (36%), Gaps = 72/355 (20%)
Query: 13 TGTSNHGEKPEW-LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK-----KFKQSK 66
+ + ++ + + Y +I + +G + + L K A+K ++ +
Sbjct: 17 IYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-----KDNKFYALKKYEKSLLEKKR 71
Query: 67 DGDGVSPTAI----------REIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-D 115
D + I E+ ++ +I +E + + N+ + +Y+ ++Y E
Sbjct: 72 DFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDS 129
Query: 116 LYEIIRHH---RDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEG 171
+ + + + +K I+ +LN +Y+H+ I HRD+KPSNIL+
Sbjct: 130 ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---- 185
Query: 172 EEQGVVKIADFGLARIYQAPLKFLSENGVVVTI----WYRAPELLLGAKHY-TSAVDMWA 226
++ G VK++DFG + + + + PE Y + VD+W+
Sbjct: 186 DKNGRVKLSDFGESEY--------MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 227 VGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ-LDKIF-KILGHPTPEKWPTLANLPHWQS 284
+G + PF L L ++F I ++P N +
Sbjct: 238 LGICLYVMFYNVV------------PFSLKISLVELFNNIRTKNI--EYPLDRNHFLYPL 283
Query: 285 DSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
+ LS D L L +P +RIT+ AL+HE+
Sbjct: 284 TNKKSTCSNNF---------LSN--EDIDFLKLFLRKNPAERITSEDALKHEWLA 327
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-47
Identities = 77/323 (23%), Positives = 130/323 (40%), Gaps = 74/323 (22%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKA-----AANRGKAIAIKKFKQSKDGDGVSPTAIREIM 80
Y + ++G G + +V R K AA K I ++ S+ G RE+
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAA---KFIKKRRLSSSRRGVSR-EEIEREVN 60
Query: 81 LLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYT---V 136
+LREI H N++ L ++ N D+ L + +L++ + T
Sbjct: 61 ILREIRHPNIITLHDIFENKTDV--VLILELVSGGELFDFLAEK--------ESLTEDEA 110
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
L Q+L+G++YLHS I H DLKP NI+++ + +K+ DFG+A +A +F
Sbjct: 111 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-- 168
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
+ T + APE++ + DMW++G I LL+ PF +
Sbjct: 169 -KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS------------PFLGE 214
Query: 257 QLDKIF-KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY 312
+ I + E + S+ A
Sbjct: 215 TKQETLTNISAVNYDFDEEYFSNT-------SEL------------------------AK 243
Query: 313 DLLSKMLEYDPRKRITAAQALEH 335
D + ++L DP++R+T AQ+LEH
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEH 266
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-47
Identities = 76/323 (23%), Positives = 129/323 (39%), Gaps = 74/323 (22%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIA---IKKFKQSKDGDGVSPTAI-REIML 81
Y++ ++G G + +V R K+ G A IKK + GV I RE+ +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 82 LREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYT---VK 137
LR++ H N++ L +V+ N D+ L + +L++ + +
Sbjct: 69 LRQVLHPNIITLHDVYENRTDV--VLILELVSGGELFDFLA--------QKESLSEEEAT 118
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
S + Q+L+G+NYLH+ I H DLKP NI+++ + +K+ DFGLA + ++F
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175
Query: 198 NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257
+ T + APE++ + DMW++G I LL+ PF D
Sbjct: 176 KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS------------PFLGDT 222
Query: 258 LDKIF-KIL-GH---PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY 312
+ I + S+ A
Sbjct: 223 KQETLANITAVSYDFDEEF-FSQT-------SEL------------------------AK 250
Query: 313 DLLSKMLEYDPRKRITAAQALEH 335
D + K+L + RKR+T +AL H
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRH 273
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 7e-47
Identities = 79/324 (24%), Positives = 126/324 (38%), Gaps = 76/324 (23%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKA-----AANRGKAIAIKKFKQSKDGDGVSPTAIREIM 80
Y+ ++G G + +V R K+ AA K I ++ K S+ G RE+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAA---KFIKKRRTKSSRRGVSR-EDIEREVS 66
Query: 81 LLREITHENVVKLVNVHINHADMSLYLAFDYAE-YDLYE-IIRHHRDKVNHTMNPYT--- 135
+L+EI H NV+ L V+ N D+ L + +L++ + T
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDV--ILILELVAGGELFDFLAEK---------ESLTEEE 115
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195
L Q+LNG+ YLHS I H DLKP NI+++ + +KI DFGLA +F
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 174
Query: 196 SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255
+ T + APE++ + DMW++G I LL+ PF
Sbjct: 175 --KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS------------PFLG 219
Query: 256 DQLDKIF-KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
D + + + E + S A
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNT-------SAL------------------------A 248
Query: 312 YDLLSKMLEYDPRKRITAAQALEH 335
D + ++L DP+KR+T +L+H
Sbjct: 249 KDFIRRLLVKDPKKRMTIQDSLQH 272
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-47
Identities = 84/321 (26%), Positives = 135/321 (42%), Gaps = 78/321 (24%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ + ++G G +V+ + K K A+K K++ D V EI +L +
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGT---QKPYALKVLKKTVDKKIV----RTEIGVLLRL 105
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-IIRHHRDKVNHTMNPYTVK---SIL 140
+H N++KL + + L + +L++ I+ Y+ + +
Sbjct: 106 SHPNIIKLKEIF--ETPTEISLVLELVTGGELFDRIVEKGY---------YSERDAADAV 154
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
Q+L + YLH N I+HRDLKP N+L + +KIADFGL++I + + V
Sbjct: 155 KQILEAVAYLHENGIVHRDLKPENLLYATPAPDA-PLKIADFGLSKIVEHQVLM---KTV 210
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
T Y APE+L G Y VDMW+VG I LL PF ++ D+
Sbjct: 211 CGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFE------------PFYDERGDQ 257
Query: 261 -IF-KIL-GH---PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDL 314
+F +IL +P W + S + A DL
Sbjct: 258 FMFRRILNCEYYFISPW-WDEV-------SLN------------------------AKDL 285
Query: 315 LSKMLEYDPRKRITAAQALEH 335
+ K++ DP+KR+T QAL+H
Sbjct: 286 VRKLIVLDPKKRLTTFQALQH 306
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-46
Identities = 75/347 (21%), Positives = 128/347 (36%), Gaps = 79/347 (22%)
Query: 4 GNTSTGRGGTGTSNHGEKPEWLQQYNLIGK-IGEGTYGLVFLARIKAAANRGKAIAIKKF 62
+ S+G +K Y L + +G G G V + G+ A+K
Sbjct: 6 HHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRT---GQKCALKLL 62
Query: 63 KQSKDGDGVSPTAIREI-MLLREITHENVVKLVNVH--INHADMSLYLAFDYAEY-DLYE 118
S A +E+ + ++V +++V+ ++H L + + E +L+
Sbjct: 63 YDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS 115
Query: 119 IIRHHRDKVNHTMNPYT---VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175
I +T I+ + + +LHS+ I HRD+KP N+L + ++
Sbjct: 116 RI------QERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKD-A 168
Query: 176 VVKIADFGLARIYQAPLKFLSENGVVVTIW----YRAPELLLGAKHYTSAVDMWAVGCIF 231
V+K+ DFG A+ + T Y APE +LG + Y + DMW++G I
Sbjct: 169 VLKLTDFGFAKET--------TQNALQTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIM 219
Query: 232 AELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGH---PTPEKWPTLANLPHWQSDSLH 288
LL P F +T +I G P PE W + S+
Sbjct: 220 YILLCGFPPFYS----NTGQAISPGMKRRIRL--GQYGFPNPE-WSEV-------SED-- 263
Query: 289 IQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335
A L+ +L+ DP +R+T Q + H
Sbjct: 264 ----------------------AKQLIRLLLKTDPTERLTITQFMNH 288
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 75/323 (23%), Positives = 128/323 (39%), Gaps = 74/323 (22%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKA-----AANRGKAIAIKKFKQSKDGDGVSPTAIREIM 80
Y++ ++G G + +V R K+ AA K I ++ + S+ G RE+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAA---KFIKKRQSRASRRGVSR-EEIEREVS 67
Query: 81 LLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYT---V 136
+LR++ H NV+ L +V+ N D+ L + +L++ + +
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDV--VLILELVSGGELFDFLAQ--------KESLSEEEA 117
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
S + Q+L+G+NYLH+ I H DLKP NI+++ + +K+ DFGLA +
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFK 176
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
+ T + APE++ + DMW++G I LL+ PF D
Sbjct: 177 N--IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS------------PFLGD 221
Query: 257 QLDKIF-KIL-GHP--TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY 312
+ I E + S+ A
Sbjct: 222 TKQETLANITSVSYDFDEEFFSHT-------SEL------------------------AK 250
Query: 313 DLLSKMLEYDPRKRITAAQALEH 335
D + K+L + RKR+T +AL H
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRH 273
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 47/275 (17%), Positives = 93/275 (33%), Gaps = 30/275 (10%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIKKFKQSKDGDGVSPTAIREIMLLR 83
+ + +GEG + V+ A + + +K K + + T + E L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMER--LK 122
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQ 142
+K + H+ L + Y L I +++ M V S +
Sbjct: 123 PSMQHMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVM-------GEGEEQGVVKIADFGLARIYQAPLKFL 195
+L + +H IIH D+KP N ++ E + + + D G + +K
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID----MKLF 236
Query: 196 SENGVVVTIW----YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAE------ 245
+ + ++ E+L K + +D + V +L + E
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295
Query: 246 AKSTQNPFQLDQLDKIF-KILGHPTPEKWPTLANL 279
+ LD ++ F +L P P+L L
Sbjct: 296 EGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLL 330
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 76/333 (22%), Positives = 121/333 (36%), Gaps = 72/333 (21%)
Query: 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK-KFKQSKDGDGVSPTAIREI 79
P ++Y +G+G + F + A K K EI
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADT---KEVFAGKIVPKSLLLKPHQREKMSMEI 66
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKS 138
+ R + H++VV + +++ + L E+ + + + +
Sbjct: 67 SIHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRRRSLLELHKRRK-----ALTEPEARY 119
Query: 139 ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL--- 195
L Q++ G YLH N +IHRDLK N+ + E VKI DFGLA + +
Sbjct: 120 YLRQIVLGCQYLHRNRVIHRDLKLGNLFL----NEDLEVKIGDFGLATKVEYDGERKKVL 175
Query: 196 --SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253
+ N Y APE+L K ++ VD+W++GCI LL KP PF
Sbjct: 176 CGTPN-------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKP------------PF 215
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYD 313
+ L + + I+ +Y +P A
Sbjct: 216 ETSCLKETYL------------------------RIKKNEYS-------IPKHINPVAAS 244
Query: 314 LLSKMLEYDPRKRITAAQALEHEYFRIEPLPGR 346
L+ KML+ DP R T + L E+F +P R
Sbjct: 245 LIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 277
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 82/351 (23%), Positives = 131/351 (37%), Gaps = 79/351 (22%)
Query: 14 GTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLAR---------IK-----------AAANR 53
G+S L QY L +IG+G+YG+V LA +K R
Sbjct: 1 GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRR 60
Query: 54 GKAIAIKKFKQSKDGDGVSPTAI-REIMLLREITHENVVKLVNVHINHADMSLYLAFDYA 112
+ + +EI +L+++ H NVVKLV V + + LY+ F+
Sbjct: 61 PPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELV 120
Query: 113 EY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG 171
+ E+ ++ + L+ G+ YLH IIHRD+KPSN+LV
Sbjct: 121 NQGPVMEVPTLKP------LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---- 170
Query: 172 EEQGVVKIADFGLARIYQAPLKFLSEN-GVVVTIWYRAPELLLGA-KHYT-SAVDMWAVG 228
E G +KIADFG++ ++ LS G T + APE L K ++ A+D+WA+G
Sbjct: 171 GEDGHIKIADFGVSNEFKGSDALLSNTVG---TPAFMAPESLSETRKIFSGKALDVWAMG 227
Query: 229 CIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLH 288
+ + F + L KI P
Sbjct: 228 VTLYCFVFGQCPFMD------ERIMCL--HSKIKS--QALE---------FPDQPD---- 264
Query: 289 IQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
++ DL+++ML+ +P RI + H +
Sbjct: 265 ----------------IAE--DLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 76/333 (22%), Positives = 121/333 (36%), Gaps = 72/333 (21%)
Query: 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK-KFKQSKDGDGVSPTAIREI 79
P ++Y +G+G + F + A K K EI
Sbjct: 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADT---KEVFAGKIVPKSLLLKPHQREKMSMEI 92
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKS 138
+ R + H++VV + +++ + L E+ + + + +
Sbjct: 93 SIHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRRRSLLELHKRRK-----ALTEPEARY 145
Query: 139 ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL--- 195
L Q++ G YLH N +IHRDLK N+ + E VKI DFGLA + +
Sbjct: 146 YLRQIVLGCQYLHRNRVIHRDLKLGNLFL----NEDLEVKIGDFGLATKVEYDGERKKVL 201
Query: 196 --SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253
+ N Y APE+L K ++ VD+W++GCI LL KP PF
Sbjct: 202 CGTPN-------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKP------------PF 241
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYD 313
+ L + + I+ +Y +P A
Sbjct: 242 ETSCLKETYL------------------------RIKKNEYS-------IPKHINPVAAS 270
Query: 314 LLSKMLEYDPRKRITAAQALEHEYFRIEPLPGR 346
L+ KML+ DP R T + L E+F +P R
Sbjct: 271 LIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 303
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 68/336 (20%), Positives = 132/336 (39%), Gaps = 71/336 (21%)
Query: 16 SNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK-FKQSKDGDGVSPT 74
S E ++ + + +G+G++ V+ A G +AIK K++ G+
Sbjct: 1 SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHT---GLEVAIKMIDKKAMYKAGMVQR 57
Query: 75 AIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNP 133
E+ + ++ H ++++L N +YL + ++ +++ +
Sbjct: 58 VQNEVKIHCQLKHPSILELYNYF--EDSNYVYLVLEMCHNGEMNRYLKNRV----KPFSE 111
Query: 134 YTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK 193
+ + Q++ G+ YLHS+ I+HRDL SN+L+ +KIADFGLA + P +
Sbjct: 112 NEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL----TRNMNIKIADFGLATQLKMPHE 167
Query: 194 FL-----SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248
+ N Y +PE+ + D+W++GC+F LL +P F K+
Sbjct: 168 KHYTLCGTPN-------YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219
Query: 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPK 308
T L+K+ +P + S
Sbjct: 220 T--------LNKVVLA-----------DYEMPSFLS------------------------ 236
Query: 309 SPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLP 344
A DL+ ++L +P R++ + L+H +
Sbjct: 237 IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-45
Identities = 77/320 (24%), Positives = 123/320 (38%), Gaps = 69/320 (21%)
Query: 26 QQYNLIGK-IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
Y L K +G G + +V K+ G+ A K K+ + G + EI +L
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKST---GQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 85 ITH-ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYT---VKSI 139
V+ L V+ N +++ L +YA +++ + + + V +
Sbjct: 85 AKSCPRVINLHEVYENTSEI--ILILEYAAGGEIFSLC------LPELAEMVSENDVIRL 136
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
+ Q+L G+ YLH N I+H DLKP NIL+ G +KI DFG++R +
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSI-YPLGDIKIVDFGMSRKIGHACEL---RE 192
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
++ T Y APE+L T+A DMW +G I LLT PF +
Sbjct: 193 IMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTS------------PFVGEDNQ 239
Query: 260 KIF-KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLL 315
+ + I + E + ++ S A D +
Sbjct: 240 ETYLNISQVNVDYSEETFSSV-------SQL------------------------ATDFI 268
Query: 316 SKMLEYDPRKRITAAQALEH 335
+L +P KR TA L H
Sbjct: 269 QSLLVKNPEKRPTAEICLSH 288
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-45
Identities = 80/342 (23%), Positives = 137/342 (40%), Gaps = 89/342 (26%)
Query: 17 NHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK------DGDG 70
+ E+ Q+Y+ IG G +V +A G A+K + + +
Sbjct: 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT---GHEFAVKIMEVTAERLSPEQLEE 141
Query: 71 VSPTAIREIMLLREIT-HENVVKLVNVHINHADMSLYLAFDYAE----YDLYEIIRHHRD 125
V RE +LR++ H +++ L++ + + ++L FD +D +
Sbjct: 142 VREATRRETHILRQVAGHPHIITLIDSY--ESSSFMFLVFDLMRKGELFD--YLTEKVA- 196
Query: 126 KVNHTMNPYT---VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182
+ +SI+ LL +++LH+N I+HRDLKP NIL+ ++ ++++DF
Sbjct: 197 --------LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL----DDNMQIRLSDF 244
Query: 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGA-----KHYTSAVDMWAVGCIFAELLTL 237
G + + P + L E + T Y APE+L + Y VD+WA G I LL
Sbjct: 245 GFSCHLE-PGEKLRE--LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
Query: 238 KPLFQGAEAKSTQNPFQLDQLDKIF-KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGRK 293
P PF + + I+ G +W S +
Sbjct: 302 SP------------PFWHRRQILMLRMIMEGQYQFSSPEWDDR-------SST------- 335
Query: 294 YETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335
DL+S++L+ DP R+TA QAL+H
Sbjct: 336 -----------------VKDLISRLLQVDPEARLTAEQALQH 360
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-45
Identities = 59/314 (18%), Positives = 111/314 (35%), Gaps = 66/314 (21%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
+IG G++ V+ +A + + K E +L+ + H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDT---ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 93 LVNVHINHADMSLYLAFDYAEY----DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLN 148
+ + + E L ++ + M ++S Q+L GL
Sbjct: 90 FYDSWESTVKGKKCIVL-VTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQ 143
Query: 149 YLHSN--WIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
+LH+ IIHRDLK NI + G G VKI D GLA + +A V+ T +
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGP---TGSVKIGDLGLATLKRAS----FAKAVIGTPEF 196
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF-QLDQLDKIFKIL 265
APE+ + Y +VD++A G E+ T + P+ + +I++ +
Sbjct: 197 MAPEM--YEEKYDESVDVYAFGMCMLEMATSEY------------PYSECQNAAQIYRRV 242
Query: 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK 325
A+ + +++ + + +
Sbjct: 243 TSGVKP-----ASFDKVAIPEVK------------------------EIIEGCIRQNKDE 273
Query: 326 RITAAQALEHEYFR 339
R + L H +F+
Sbjct: 274 RYSIKDLLNHAFFQ 287
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-45
Identities = 72/324 (22%), Positives = 127/324 (39%), Gaps = 74/324 (22%)
Query: 26 QQYNLIG---KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLL 82
Q Y+L +GEG++ + K + +A A+K + + + +EI L
Sbjct: 8 QHYDLDLKDKPLGEGSFSICRKCVHKKS---NQAFAVKIISKRMEAN-----TQKEITAL 59
Query: 83 REIT-HENVVKLVNVHINHADMSLYLAFDYAE----YDLYEIIRHHRDKVNHTMNPYTVK 137
+ H N+VKL V H + +L + ++ I + ++
Sbjct: 60 KLCEGHPNIVKLHEVF--HDQLHTFLVMELLNGGELFE--RIKKKKH---------FSET 106
Query: 138 ---SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKF 194
I+ +L++ ++++H ++HRDLKP N+L E + +KI DFG AR+ +
Sbjct: 107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDN-LEIKIIDFGFARLKPPDNQP 165
Query: 195 LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254
L T+ Y APE LL Y + D+W++G I +L+ + FQ +S
Sbjct: 166 LKT--PCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQS-HDRSLTCTSA 221
Query: 255 LDQLDKIFKILGH---PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
++ + KI K G W + S A
Sbjct: 222 VEIMKKIKK--GDFSFEGEA-WKNV-------SQE------------------------A 247
Query: 312 YDLLSKMLEYDPRKRITAAQALEH 335
DL+ +L DP KR+ + +
Sbjct: 248 KDLIQGLLTVDPNKRLKMSGLRYN 271
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 65/316 (20%), Positives = 119/316 (37%), Gaps = 67/316 (21%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
Y+++ ++G G +G+V KA G+ K D + EI ++ ++
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKAT---GRVFVAKFINTPYPLDKYT--VKNEISIMNQL 105
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAE-YDLYE-IIRHHRDKVNHTMNPYTVKSILWQL 143
H ++ L + + +M L ++ +L++ I ++ M+ V + + Q
Sbjct: 106 HHPKLINLHDAFEDKYEM--VLILEFLSGGELFDRIAAE-----DYKMSEAEVINYMRQA 158
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
GL ++H + I+H D+KP NI+ + VKI DFGLA T
Sbjct: 159 CEGLKHMHEHSIVHLDIKPENIMCETKKASS--VKIIDFGLATKLNPDEIVKVTTA---T 213
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF- 262
+ APE++ + DMWA+G + LL+ PF + +
Sbjct: 214 AEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLS------------PFAGEDDLETLQ 260
Query: 263 KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
+ + + ++ S A D + +L
Sbjct: 261 NVKRCDWEFDEDAFSSV-------SPE------------------------AKDFIKNLL 289
Query: 320 EYDPRKRITAAQALEH 335
+ +PRKR+T ALEH
Sbjct: 290 QKEPRKRLTVHDALEH 305
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 67/324 (20%), Positives = 120/324 (37%), Gaps = 74/324 (22%)
Query: 25 LQQYNLIGK-IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLR 83
+ Y + + +G G G V K + A+K + A RE+ L
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQDCPK-------ARREVELHW 109
Query: 84 EIT-HENVVKLVNVH--INHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYT---V 136
+ ++V++V+V+ + L + + + +L+ I + +T
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI------QDRGDQAFTEREA 163
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
I+ + + YLHS I HRD+KP N+L + ++K+ DFG A+ +
Sbjct: 164 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSL-- 220
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
T +Y APE +LG + Y + DMW++G I LL P F +
Sbjct: 221 -TTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------ 272
Query: 257 QLDKIF-KIL-GH---PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
+ +I G P PE W + S+
Sbjct: 273 --PGMKTRIRMGQYEFPNPE-WSEV-------SEE------------------------V 298
Query: 312 YDLLSKMLEYDPRKRITAAQALEH 335
L+ +L+ +P +R+T + + H
Sbjct: 299 KMLIRNLLKTEPTQRMTITEFMNH 322
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 77/323 (23%), Positives = 137/323 (42%), Gaps = 65/323 (20%)
Query: 20 EKPEW-LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK-FKQSKDGDGVSPTAIR 77
+K +W L+ + + +G+G +G V+LAR K + +A+K FK + GV R
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQS---KFILALKVLFKAQLEKAGVEHQLRR 58
Query: 78 EIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTV 136
E+ + + H N+++L H +YL +YA +Y ++ +
Sbjct: 59 EVEIQSHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRT 111
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
+ + +L N L+Y HS +IHRD+KP N+L+ G +KIADFG +
Sbjct: 112 ATYITELANALSYCHSKRVIHRDIKPENLLL----GSAGELKIADFGWS----VHAPSSR 163
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
+ T+ Y PE++ G + + VD+W++G + E L KP PF+ +
Sbjct: 164 RTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKP------------PFEAN 210
Query: 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLS 316
+ +K I ++ P A DL+S
Sbjct: 211 TYQETYK------------------------RISRVEFT-------FPDFVTEGARDLIS 239
Query: 317 KMLEYDPRKRITAAQALEHEYFR 339
++L+++P +R + LEH +
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWIT 262
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-43
Identities = 65/320 (20%), Positives = 120/320 (37%), Gaps = 76/320 (23%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKF-KQSKDGDGVSPTAIREIMLLRE 84
++Y + +G G +G+V ++ K K + D V +EI +L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSS---KKTYMAKFVKVKGTDQVLV----KKEISILNI 57
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAE-YDLYE-IIRHHRDKVNHTMNPYT---VKSI 139
H N++ L + ++ + F++ D++E I + S
Sbjct: 58 ARHRNILHLHESFESMEEL--VMIFEFISGLDIFERIN----TSAFE----LNEREIVSY 107
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
+ Q+ L +LHS+ I H D++P NI+ + +KI +FG AR + P
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIY--QTRRSSTIKIIEFGQARQLK-PGDNFRL-- 162
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
+ Y APE+ ++A DMW++G + LL+ PF +
Sbjct: 163 LFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGIN------------PFLAETNQ 209
Query: 260 KIF-KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLL 315
+I I+ T E + + S A D +
Sbjct: 210 QIIENIMNAEYTFDEEAFKEI-------SIE------------------------AMDFV 238
Query: 316 SKMLEYDPRKRITAAQALEH 335
++L + + R+TA++AL+H
Sbjct: 239 DRLLVKERKSRMTASEALQH 258
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-43
Identities = 60/339 (17%), Positives = 118/339 (34%), Gaps = 76/339 (22%)
Query: 16 SNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA 75
+ E+ W+ +G+ G++G V + K G A+KK + +
Sbjct: 51 YEYREEVHWMTHQPRVGR---GSFGEVHRMKDK---QTGFQCAVKKVR-------LEVFR 97
Query: 76 IREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY----DLYEIIRHHRDKVNHTM 131
+ E++ ++ +V L +++++ E L ++I+ +
Sbjct: 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFM-----ELLEGGSLGQLIKQMG-----CL 147
Query: 132 NPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI---Y 188
L Q L GL YLH+ I+H D+K N+L+ +G + DFG A
Sbjct: 148 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG---SRAALCDFGHALCLQPD 204
Query: 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248
L+ + + T + APE+++G K + VD+W+ C+ +L
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCH--------- 254
Query: 249 TQNPF-QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSP 307
P+ Q + KI P P + +P +
Sbjct: 255 ---PWTQYFRGPLCLKIASEPPPIR-----EIPPSCAPLTA------------------- 287
Query: 308 KSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGR 346
+ + L +P R +A + ++ + G
Sbjct: 288 -----QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 80/332 (24%), Positives = 132/332 (39%), Gaps = 70/332 (21%)
Query: 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK--DGDGVSPTAIREIM 80
+ + +Y + +GEG+YG V + A+K K+ K +EI
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVL---DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQ 58
Query: 81 LLREITHENVVKLVNVHINHADMSLYLAFDYAE---YDLYEIIRHHRDKVNHTMNPYTVK 137
LLR + H+NV++LV+V N +Y+ +Y ++ + + R
Sbjct: 59 LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR------FPVCQAH 112
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
QL++GL YLHS I+H+D+KP N+L+ G +KI+ G+A +
Sbjct: 113 GYFCQLIDGLEYLHSQGIVHKDIKPGNLLL----TTGGTLKISALGVAEALHP----FAA 164
Query: 198 NGVVVTI----WYRAPELLLGAKHYT-SAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252
+ T ++ PE+ G ++ VD+W+ G + T F+G N
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG------DNI 218
Query: 253 FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY 312
++L + I K G +P P P
Sbjct: 219 YKL--FENIGK--GSYA---------IPGD----------------------CGP--PLS 241
Query: 313 DLLSKMLEYDPRKRITAAQALEHEYFRIEPLP 344
DLL MLEY+P KR + Q +H +FR + P
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 64/349 (18%), Positives = 116/349 (33%), Gaps = 101/349 (28%)
Query: 25 LQQYNLIGK-IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLR 83
+ Y + + +G G G V K + A+K + A RE+ L
Sbjct: 16 IDDYKVTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQDCPK-------ARREVELHW 65
Query: 84 EIT-HENVVKLVNVH--INHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYT---V 136
+ ++V++V+V+ + L + + + +L+ I + +T
Sbjct: 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI------QDRGDQAFTEREA 119
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
I+ + + YLHS I HRD+KP N+L + ++K+ DFG
Sbjct: 120 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGF------------ 166
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
A E + Y + DMW++G I LL P F +
Sbjct: 167 -----------AKETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------ 207
Query: 257 QLDKIF-KIL-GH---PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
+ +I G P PE W + S+
Sbjct: 208 --PGMKTRIRMGQYEFPNPE-WSEV-------SEE------------------------V 233
Query: 312 YDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVN 360
L+ +L+ +P +R+T + + H + ++ VP P
Sbjct: 234 KMLIRNLLKTEPTQRMTITEFMNHPWIM------QSTKVPQTPLHTSRV 276
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 3e-43
Identities = 72/336 (21%), Positives = 123/336 (36%), Gaps = 71/336 (21%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
Y++ ++G G +G+V +A G A K + D T +EI + +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERAT---GNNFAAKFVMTPHESD--KETVRKEIQTMSVL 211
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYT---VKSILW 141
H +V L + + +M + +++ +L+ +KV N + +
Sbjct: 212 RHPTLVNLHDAFEDDNEM--VMIYEFMSGGELF-------EKVADEHNKMSEDEAVEYMR 262
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
Q+ GL ++H N +H DLKP NI+ + + +K+ DFGL
Sbjct: 263 QVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE--LKLIDFGLTAHLDPKQSV---KVTT 317
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T + APE+ G K DMW+VG + LL+ PF + D+
Sbjct: 318 GTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLS------------PFGGENDDET 364
Query: 262 F-KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSK 317
+ + + S+ D + K
Sbjct: 365 LRNVKSCDWNMDDSAFSGI-------SED------------------------GKDFIRK 393
Query: 318 MLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQ 353
+L DP R+T QALEH + PGR++ +PS
Sbjct: 394 LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 429
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-42
Identities = 67/380 (17%), Positives = 114/380 (30%), Gaps = 117/380 (30%)
Query: 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLR 83
+L + I +G G +G+VF A+ K AIK+ + + +RE+ L
Sbjct: 4 YLTDFEPIQCMGRGGFGVVFEAKNKV---DDCNYAIKRIRLPNR-ELAREKVMREVKALA 59
Query: 84 EITHENVVKLVNVHINHADMSLY----------------LAFDYAEYDLYEIIRHHRDKV 127
++ H +V+ N + L+ IR
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119
Query: 128 NHTMNPY--------------------------------------TVKSILWQLLNGLNY 149
I Q+ + +
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ----------APLKFLSENG 199
LHS ++HRDLKPSNI + VVK+ DFGL + + G
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMD----DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
V T Y +PE + G +Y+ VD++++G I ELL F
Sbjct: 236 QVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLY---------------SFS----- 274
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
E+ + ++ R + ++ + ++ ML
Sbjct: 275 --------TQMERVRIITDV------------RNLK----FPLLFTQKYPQEHMMVQDML 310
Query: 320 EYDPRKRITAAQALEHEYFR 339
P +R A +E+ F
Sbjct: 311 SPSPTERPEATDIIENAIFE 330
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-42
Identities = 78/325 (24%), Positives = 136/325 (41%), Gaps = 69/325 (21%)
Query: 20 EKPEW-LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK-FKQSKDGDGVSPTAIR 77
K ++ + +++ +G+G +G V+LAR K +A+K FK + +GV R
Sbjct: 7 PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQN---KFIMALKVLFKSQLEKEGVEHQLRR 63
Query: 78 EIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTV 136
EI + + H N++++ N H +YL ++A +LY+ ++ H +
Sbjct: 64 EIEIQSHLRHPNILRMYNYF--HDRKRIYLMLEFAPRGELYKELQKHG-----RFDEQRS 116
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
+ + +L + L+Y H +IHRD+KP N+L+ +G +KIADFG + AP
Sbjct: 117 ATFMEELADALHYCHERKVIHRDIKPENLLM----GYKGELKIADFGWSV--HAPSLRRR 170
Query: 197 EN-GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255
G T+ Y PE++ G K + VD+W G + E L P PF
Sbjct: 171 TMCG---TLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMP------------PFDS 214
Query: 256 DQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDL 314
+ +I+ P + S + DL
Sbjct: 215 PSHTETHRRIVNVDL--------KFPPFLS------------------------DGSKDL 242
Query: 315 LSKMLEYDPRKRITAAQALEHEYFR 339
+SK+L Y P +R+ +EH + +
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVK 267
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-42
Identities = 73/337 (21%), Positives = 123/337 (36%), Gaps = 71/337 (21%)
Query: 26 QQYNLIGK-IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
Y L +GEG + V + A+K ++ RE+ +L +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLIT---SQEYAVKIIEKQPGHI--RSRVFREVEMLYQ 66
Query: 85 IT-HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVK---SI 139
H NV++L+ + YL F+ + I R + +
Sbjct: 67 CQGHRNVLELIEFF--EEEDRFYLVFEKMRGGSILSHIHKRR--------HFNELEASVV 116
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
+ + + L++LH+ I HRDLKP NIL + VKI DF L + +
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQV-SPVKICDFDLGSGIKLNGDCSPIST 175
Query: 200 -----VVVTIWYRAPELLLG----AKHYTSAVDMWAVGCIFAELLTLKPLFQG---AEAK 247
+ Y APE++ A Y D+W++G I LL+ P F G ++
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235
Query: 248 STQNPFQLDQLDKIF-KIL-GH---PTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSV 302
+ + +F I G P + W + S +
Sbjct: 236 WDRGEACPACQNMLFESIQEGKYEFPDKD-WAHI-------SCA---------------- 271
Query: 303 VPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
A DL+SK+L D ++R++AAQ L+H + +
Sbjct: 272 --------AKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-42
Identities = 77/320 (24%), Positives = 131/320 (40%), Gaps = 73/320 (22%)
Query: 26 QQYNLIGK--IGEGTYGLVFLARIKAAANRGKAIAIK--KFKQSKDGDGVSPTAIREIML 81
Y + +G G +G V A G +A K K + KD + V EI +
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETAT---GLKLAAKIIKTRGMKDKEEV----KNEISV 139
Query: 82 LREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-IIRHHRDKVNHTMNPYTVKSI 139
+ ++ H N+++L + + D+ L +Y + +L++ II ++ +
Sbjct: 140 MNQLDHANLIQLYDAFESKNDI--VLVMEYVDGGELFDRII-----DESYNLTELDTILF 192
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
+ Q+ G+ ++H +I+H DLKP NIL + +Q +KI DFGLAR Y+ K G
Sbjct: 193 MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ--IKIIDFGLARRYKPREKLKVNFG 250
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
T + APE++ + DMW+VG I LL+ PF D
Sbjct: 251 ---TPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLS------------PFLGDNDA 294
Query: 260 KIF-KIL-GHPT--PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLL 315
+ IL E++ + S+ A + +
Sbjct: 295 ETLNNILACRWDLEDEEFQDI-------SEE------------------------AKEFI 323
Query: 316 SKMLEYDPRKRITAAQALEH 335
SK+L + RI+A++AL+H
Sbjct: 324 SKLLIKEKSWRISASEALKH 343
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 90/389 (23%), Positives = 146/389 (37%), Gaps = 106/389 (27%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y++I K+G G + V+L+ K +A+K K ++ + TA+ EI LL+ +
Sbjct: 38 RYHVIRKLGWGHFSTVWLSWDI---QGKKFVAMKVVKSAEHY---TETALDEIRLLKSVR 91
Query: 87 --------HENVVKLVN------VHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMN 132
E VV+L++ V+ H + + F+ + L + I + +
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTH----ICMVFEVLGHHLLKWIIKSNYQG---LP 144
Query: 133 PYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGE--------------------- 170
VK I+ Q+L GL+YLH+ IIH D+KP NIL+
Sbjct: 145 LPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204
Query: 171 ------------------------GEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
E+ VKIAD G A + T Y
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQY 259
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266
R+ E+L+G+ Y + D+W+ C+ EL T LF+ + D + I ++LG
Sbjct: 260 RSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDE--DHIALIIELLG 316
Query: 267 HPTPE----------------KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP 310
+ + L W + ++ KYE + +
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE--KYEWSQ-------EEAAG 367
Query: 311 AYDLLSKMLEYDPRKRITAAQALEHEYFR 339
D L MLE P KR TAA+ L H +
Sbjct: 368 FTDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 74/329 (22%), Positives = 126/329 (38%), Gaps = 76/329 (23%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK---KFKQSKDG---DGVSP 73
+ E+ Q+Y+ + +G G +G V+ A K K + +K K K +D D
Sbjct: 18 CEGEYSQKYSTMSPLGSGAFGFVWTAVDKEK---NKEVVVKFIKKEKVLEDCWIEDPKLG 74
Query: 74 TAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY--DLYE-IIRHHRDKVNHT 130
EI +L + H N++K++++ N L + DL+ I RH R
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDIFENQGF--FQLVMEKHGSGLDLFAFIDRHPR------ 126
Query: 131 MNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190
++ I QL++ + YL IIHRD+K NI++ E +K+ DFG A +
Sbjct: 127 LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI----AEDFTIKLIDFGSAAYLE- 181
Query: 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250
K TI Y APE+L+G + ++MW++G L+
Sbjct: 182 RGKLFYT--FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF------EE------ 227
Query: 251 NPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP 310
NPF +L++ + P P+ S
Sbjct: 228 NPF--CELEETVE--AAIHP---------PYLVSKE------------------------ 250
Query: 311 AYDLLSKMLEYDPRKRITAAQALEHEYFR 339
L+S +L+ P +R T + + +
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVT 279
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
+G G +G+V A+ R K +AIK+ + + I E+ L + H N+VK
Sbjct: 15 VVGRGAFGVVCKAKW-----RAKDVAIKQIESESERK----AFIVELRQLSRVNHPNIVK 65
Query: 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
L +N + L +YAE LY ++ H + S Q G+ YLH
Sbjct: 66 LYGACLNP----VCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 152 S---NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA 208
S +IHRDLKP N+L+ V+KI DFG A Q + G + + A
Sbjct: 120 SMQPKALIHRDLKPPNLLL---VAGGTVLKICDFGTACDIQT--HMTNNKG---SAAWMA 171
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
PE+ G +Y+ D+++ G I E++T + F
Sbjct: 172 PEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDE 205
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 66/350 (18%), Positives = 123/350 (35%), Gaps = 83/350 (23%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK-FKQSKDGDGVSPTAIREIMLLREI 85
+ + + EG + V+ A+ G+ A+K+ ++ + I+E+ ++++
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDV---GSGREYALKRLLSNEEEK---NRAIIQEVCFMKKL 82
Query: 86 T-HENVVKLVNVHINHADMS------LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKS 138
+ H N+V+ + + S L + + L E ++ + ++ TV
Sbjct: 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR--GPLSCDTVLK 140
Query: 139 ILWQLLNGLNYLHSN--WIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
I +Q + ++H IIHRDLK N+L+ QG +K+ DFG A +
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS----NQGTIKLCDFGSATTISHYPDYSW 196
Query: 197 ----------ENGVVVTIWYRAPEL--LLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGA 244
E T YR PE+ L D+WA+GCI L + F+
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256
Query: 245 EAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP 304
N + I H T Q H
Sbjct: 257 AKLRIVN--------GKYSIPPHDT-------------QYTVFH---------------- 279
Query: 305 LSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQP 354
L+ ML+ +P +R++ A+ + ++ + + P P
Sbjct: 280 --------SLIRAMLQVNPEERLSIAEVVHQ----LQEIAAARNVNPKSP 317
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-40
Identities = 47/373 (12%), Positives = 98/373 (26%), Gaps = 100/373 (26%)
Query: 6 TSTGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS 65
TS G E E + +G+ A + G++ + +
Sbjct: 53 TSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET---GESFEVHVPYFT 109
Query: 66 KDGDGVSPTAIRE--------------------------IMLLREITHENVVKLVNVHIN 99
+ + ++E L+++ + ++++ +
Sbjct: 110 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 169
Query: 100 HADMSLYLAFDYAEYDLYEIIR--HHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIH 157
+S + + + +L + ++ + + Q++ L LH ++H
Sbjct: 170 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229
Query: 158 RDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELL----- 212
L+P +I++ G V + F A + V+ + PEL
Sbjct: 230 TYLRPVDIVLDQRGG----VFLTGFEHLVRDGARVVS------SVSRGFEPPELEARRAT 279
Query: 213 -----LGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF-KILG 266
T + D WA+G + + P D I
Sbjct: 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADL------------PITKDAALGGSEWIFR 327
Query: 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326
N+P P LL L Y R
Sbjct: 328 SC--------KNIP----------------------------QPVRALLEGFLRYPKEDR 351
Query: 327 ITAAQALEHEYFR 339
+ QA+E +
Sbjct: 352 LLPLQAMETPEYE 364
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-39
Identities = 79/314 (25%), Positives = 128/314 (40%), Gaps = 68/314 (21%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93
+G+GTYG+V+ R + IAIK+ + +D P EI L + + H+N+V+
Sbjct: 30 LGKGTYGIVYAGR---DLSNQVRIAIKEIPE-RDSRYSQPL-HEEIALHKHLKHKNIVQY 84
Query: 94 VNVHINHADMSLYLAFDYAEY----DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNY 149
+ + + +++ E L ++R + T+ Q+L GL Y
Sbjct: 85 LGSFSENGFIKIFM-----EQVPGGSLSALLRSKWGPLKDNEQ--TIGFYTKQILEGLKY 137
Query: 150 LHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAP 209
LH N I+HRD+K N+L+ GV+KI+DFG ++ T+ Y AP
Sbjct: 138 LHDNQIVHRDIKGDNVLIN---TYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAP 192
Query: 210 ELLLGAKH-YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF-QLDQ-LDKIFKI-L 265
E++ Y A D+W++GC E+ T KP PF +L + +FK+ +
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKP------------PFYELGEPQAAMFKVGM 240
Query: 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK 325
PE +P +S A + K E DP K
Sbjct: 241 FKVHPE-------IPES----------------------MSA--EAKAFILKCFEPDPDK 269
Query: 326 RITAAQALEHEYFR 339
R A L E+ +
Sbjct: 270 RACANDLLVDEFLK 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 55/246 (22%), Positives = 94/246 (38%), Gaps = 29/246 (11%)
Query: 11 GGTGTSNHGEKPEWLQQYN---LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD 67
G G S + N +IG+G +GLV R+ +AIK
Sbjct: 1 GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLV---KDKSVVAIKSLILGDS 57
Query: 68 GDGVSPTAI-----REIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIR 121
RE+ ++ + H N+VKL + N + ++ DLY +
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN----PPRMVMEFVPCGDLYHRLL 113
Query: 122 HHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN--WIIHRDLKPSNILVMGEGEEQGV-VK 178
H + ++ + G+ Y+ + I+HRDL+ NI + E V K
Sbjct: 114 DK----AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169
Query: 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELLTL 237
+ADFGL++ S +G++ + APE + + YT D ++ I +LT
Sbjct: 170 VADFGLSQQ-----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224
Query: 238 KPLFQG 243
+ F
Sbjct: 225 EGPFDE 230
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 82/341 (24%), Positives = 137/341 (40%), Gaps = 74/341 (21%)
Query: 11 GGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIKKFKQSKDG 68
G + S E+P + Y L+ IG+G + V LAR + G+ +AIK +++
Sbjct: 1 GNSIASCADEQPH-IGNYRLLKTIGKGNFAKVKLAR-----HILTGREVAIKIIDKTQLN 54
Query: 69 DGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-IIRHHRDK 126
RE+ +++ + H N+VKL V I LYL +YA ++++ ++ H R
Sbjct: 55 PTSLQKLFREVRIMKILNHPNIVKLFEV-IETEKT-LYLIMEYASGGEVFDYLVAHGR-- 110
Query: 127 VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186
M +S Q+++ + Y H I+HRDLK N+L+ + +KIADFG +
Sbjct: 111 ----MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL----DADMNIKIADFGFSN 162
Query: 187 IYQAPLKFLSEN-GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAE 245
+ L G Y APEL G K+ VD+W++G I L++
Sbjct: 163 EFT-VGGKLDAFCG---APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL------ 212
Query: 246 AKSTQNPFQLDQLDKIF-KIL-GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV 303
PF L ++ ++L G +P + S
Sbjct: 213 ------PFDGQNLKELRERVLRGKYR---------IPFYMSTD----------------- 240
Query: 304 PLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLP 344
+LL + L +P KR T Q ++ +
Sbjct: 241 -------CENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-38
Identities = 79/337 (23%), Positives = 133/337 (39%), Gaps = 89/337 (26%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIK-----KFKQSKDGDGVS 72
+ Y + +GEG++G V LA + + +A+K K+S V
Sbjct: 3 ISKRHIGPYIIRETLGEGSFGKVKLAT-----HYKTQQKVALKFISRQLLKKSDMHMRVE 57
Query: 73 PTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYE-IIRHHRDKVNHTM 131
REI L+ + H +++KL +V D + + +YA +L++ I+ R M
Sbjct: 58 ----REISYLKLLRHPHIIKLYDVITTPTD--IVMVIEYAGGELFDYIVEKKR------M 105
Query: 132 NPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
+ Q++ + Y H + I+HRDLKP N+L+ ++ VKIADFGL+ I
Sbjct: 106 TEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL----DDNLNVKIADFGLSNIMT-D 160
Query: 192 LKFL-----SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246
FL S N Y APE++ G + VD+W+ G + +L G
Sbjct: 161 GNFLKTSCGSPN-------YAAPEVINGKLYAGPEVDVWSCGIVLYVMLV------GRL- 206
Query: 247 KSTQNPFQLDQLDKIF-KIL-GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP 304
PF + + +F K+ +P + S
Sbjct: 207 -----PFDDEFIPNLFKKVNSCVYV---------MPDFLSPG------------------ 234
Query: 305 LSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341
A L+ +M+ DP +RIT + +F +
Sbjct: 235 ------AQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-38
Identities = 66/362 (18%), Positives = 129/362 (35%), Gaps = 76/362 (20%)
Query: 4 GNTSTGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK--- 60
T + EK QY + +G G +G V+ + +AIK
Sbjct: 21 MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSD---NLPVAIKHVE 77
Query: 61 KFKQSKDGDGVSPTAI-REIMLLREITHE--NVVKLVNVHINHADMSLYLAFDYAEY--D 115
K + S G+ + T + E++LL++++ V++L++ S L + E D
Sbjct: 78 KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--PDSFVLILERPEPVQD 135
Query: 116 LYE-IIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ 174
L++ I + +S WQ+L + + H+ ++HRD+K NIL+ +
Sbjct: 136 LFDFITERGA------LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNR 186
Query: 175 GVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAEL 234
G +K+ DFG + + + + +G T Y PE + +++ + +W++G + ++
Sbjct: 187 GELKLIDFGSGALLKDTV-YTDFDG---TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 242
Query: 235 LTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKY 294
+ G PF + ++I + G S
Sbjct: 243 VC------GD------IPF--EHDEEIIR--GQVF---------FRQRVSSE-------- 269
Query: 295 ETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQP 354
L+ L P R T + H + + LP A +
Sbjct: 270 ----------------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHS 313
Query: 355 GD 356
Sbjct: 314 LS 315
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 7e-38
Identities = 58/394 (14%), Positives = 107/394 (27%), Gaps = 102/394 (25%)
Query: 34 IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIRE----IMLLREITHEN 89
+G+ A + G++ + ++ + ++E + LLR I ++
Sbjct: 86 LGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142
Query: 90 VVKLVNVHINHAD----------------------MSLYLAFDYAEYDLYEIIR--HHRD 125
K+ I D +S + + + +L
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 126 KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185
+ ++ + + Q++ L LH ++H L+P +I++ ++G V + F
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD----QRGGVFLTGFEHL 258
Query: 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKH----YTSAVDMWAVGCIFAELLTLKPLF 241
A A +L +H T A D W +G +
Sbjct: 259 VRDGASAVSPI-GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317
Query: 242 QGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHS 301
A + IF+ S
Sbjct: 318 TDDAALGG--------SEWIFR-------------------------------------S 332
Query: 302 VVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNY 361
+ P LL L Y R+ QA+E + R L + P +
Sbjct: 333 CKNIPQ--PVRALLEGFLRYPKEDRLLPLQAMETPEYE----QLRTELSAALPLYQTDGE 386
Query: 362 PTRPVDSNTDFEGTTTLQPPQPASGPVPGNMAGA 395
PTR + PP S P A A
Sbjct: 387 PTREGGA-----------PPSGTSQPDEAGAAEA 409
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 40/220 (18%), Positives = 76/220 (34%), Gaps = 24/220 (10%)
Query: 29 NLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE 88
N + K+ E G ++ R +G I +K K S E LR +H
Sbjct: 13 NFLTKLNENHSGELWKGRW-----QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
NV+ ++ + L + Y LY ++ + V ++ + G+
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV---VDQSQAVKFALDMARGM 124
Query: 148 NYLHS--NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
+LH+ I L ++++ +E +I+ + G +
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMI----DEDMTARISMADVKF-------SFQSPGRMYAPA 173
Query: 206 YRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
+ APE L + DMW+ + EL+T + F
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 77/321 (23%), Positives = 129/321 (40%), Gaps = 52/321 (16%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
Y L IG G +V A + + +AIK+ K + ++EI + +
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCH 71
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAE----YDLYEIIRHHRDKVNHTMNPYTVKSILWQ 142
H N+V + L+L D+ + I + + ++ T+ +IL +
Sbjct: 72 HPNIVSYYTSFVV--KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL-ARIYQAPLKFLSE--NG 199
+L GL YLH N IHRD+K NIL+ E G V+IADFG+ A + ++
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILL----GEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
V T + APE++ + Y D+W+ G EL T + P ++
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY------HKYPPMKV---- 235
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY-DLLSKM 318
+ L + P+L +KY ++ ++S
Sbjct: 236 -LMLTLQNDP----PSLET-----GVQDKEMLKKY--------------GKSFRKMISLC 271
Query: 319 LEYDPRKRITAAQALEHEYFR 339
L+ DP KR TAA+ L H++F+
Sbjct: 272 LQKDPEKRPTAAELLRHKFFQ 292
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
KIG G++G V A G +A+K + +RE+ +++ + H N+V
Sbjct: 44 KIGAGSFGTVHRAEW-----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
+ + L + +Y LY ++ H+ ++ S+ + + G+NYLH
Sbjct: 99 FMGAVTQPPN--LSIVTEYLSRGSLYRLL--HKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 152 SN--WIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAP 209
+ I+HR+LK N+LV +++ VK+ DFGL+R+ + FLS T + AP
Sbjct: 155 NRNPPIVHRNLKSPNLLV----DKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAP 208
Query: 210 ELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
E+L + D+++ G I EL TL+ +
Sbjct: 209 EVLRD-EPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 28/221 (12%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA--IREIMLLREITHENV 90
IG G +G V+ A G +A+K + D D +E L + H N+
Sbjct: 14 IIGIGGFGKVYRAFW-----IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 91 VKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNY 149
+ L V + +L L ++A L ++ + P + + Q+ G+NY
Sbjct: 69 IALRGVCLKE--PNLCLVMEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNY 120
Query: 150 LHSN---WIIHRDLKPSNILV----MGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV 202
LH IIHRDLK SNIL+ ++KI DFGLAR + K +S G
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAG--- 176
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
+ APE++ ++ D+W+ G + ELLT + F+G
Sbjct: 177 AYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-37
Identities = 82/336 (24%), Positives = 134/336 (39%), Gaps = 86/336 (25%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK-----KFKQSKDGDGVSPT 74
+ + Y L +G GT+G V + + G +A+K K + +
Sbjct: 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLT---GHKVAVKILNRQKIRSLDVVGKIK-- 59
Query: 75 AIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-IIRHHRDKVNHTMN 132
REI L+ H +++KL V D ++ +Y +L++ I +H R +
Sbjct: 60 --REIQNLKLFRHPHIIKLYQVISTPTD--FFMVMEYVSGGELFDYICKHGR------VE 109
Query: 133 PYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPL 192
+ + Q+L+ ++Y H + ++HRDLKP N+L+ + KIADFGL+ +
Sbjct: 110 EMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL----DAHMNAKIADFGLSNMMS-DG 164
Query: 193 KFL-----SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247
+FL S N Y APE++ G + VD+W+ G I LL G
Sbjct: 165 EFLRTSCGSPN-------YAAPEVISGRLYAGPEVDIWSCGVILYALLC------GTL-- 209
Query: 248 STQNPFQLDQLDKIF-KIL-GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPL 305
PF + + +F KI G +P + + S
Sbjct: 210 ----PFDDEHVPTLFKKIRGGVFY---------IPEYLNRS------------------- 237
Query: 306 SPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341
LL ML+ DP KR T EHE+F+ +
Sbjct: 238 -----VATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 63/336 (18%), Positives = 119/336 (35%), Gaps = 46/336 (13%)
Query: 27 QYNLIGKIGEG--TYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
Y L+ IG+G V LAR K G+ + +++ + + E+ + +
Sbjct: 26 CYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
H N+V I D L++ + Y ++I H MN + IL +
Sbjct: 83 FNHPNIVPYRATFIA--DNELWVVTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGV 137
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG-LARIYQAPLK----FLSEN 198
L L+Y+H +HR +K S+IL+ +G+ V ++ + +
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILISVDGK----VYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 199 GVVVTIWYRAPELLLGAKH-YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257
V + + +PE+L Y + D+++VG EL F Q+
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF------KDMPATQM-- 245
Query: 258 LDKIFKILGHPTP------EKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
+ + L P + +S + T+ SP P
Sbjct: 246 ---LLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY 302
Query: 312 Y--------DLLSKMLEYDPRKRITAAQALEHEYFR 339
+ + + L+ +P R +A+ L H +F+
Sbjct: 303 HRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-37
Identities = 60/253 (23%), Positives = 101/253 (39%), Gaps = 39/253 (15%)
Query: 22 PEWLQ---QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIRE 78
L+ G +G V+ A++ + +A+K F D S E
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQL-----LNEYVAVKIFP---IQDKQSWQNEYE 68
Query: 79 IMLLREITHENVVKLV--NVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYT 135
+ L + HEN+++ + D+ L+L + E L + ++ + ++
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK------ANVVSWNE 122
Query: 136 VKSILWQLLNGLNYLHSNW----------IIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185
+ I + GL YLH + I HRD+K N+L+ + IADFGLA
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL----KNNLTACIADFGLA 178
Query: 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGA----KHYTSAVDMWAVGCIFAELLTLKPLF 241
++A +G V T Y APE+L GA + +DM+A+G + EL +
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 242 QGAEAKSTQNPFQ 254
G PF+
Sbjct: 239 DG-PVDEYMLPFE 250
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 80/375 (21%), Positives = 136/375 (36%), Gaps = 91/375 (24%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIK---KFKQSKDGDGVSPTAIREI 79
++ ++L+ +GEG YG V LA NR +A+A+K + + + +EI
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAV-----NRVTEEAVAVKIVDMKRAVDCPENIK----KEI 56
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAE----YDLYEIIRHHRDKVNHTMNPYT 135
+ + + HENVVK YL +Y +D I M
Sbjct: 57 CINKMLNHENVVKFYGHRREGNI--QYLFLEYCSGGELFD--RIEPDIG------MPEPD 106
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ--APLK 193
+ QL+ G+ YLH I HRD+KP N+L+ +E+ +KI+DFGLA +++ +
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRER 162
Query: 194 FL-----SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248
L + Y APELL + + VD+W+ G + +L G
Sbjct: 163 LLNKMCGTLP-------YVAPELLKRREFHAEPVDVWSCGIVLTAMLA------GEL--- 206
Query: 249 TQNPF--QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS 306
P+ D + + + Y +
Sbjct: 207 ---PWDQPSDSCQEYSDW------------------------KEKKTYLNPWKK----ID 235
Query: 307 PKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE-PLPGRNALVPSQPGDKVVNYPTRP 365
LL K+L +P RIT + ++ + V S + + ++
Sbjct: 236 S--APLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKH 293
Query: 366 VDSNTDFEGTTTLQP 380
+ SN DF +
Sbjct: 294 IQSNLDFSPVNSASR 308
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 63/247 (25%), Positives = 101/247 (40%), Gaps = 38/247 (15%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ L+ +G+G YG V+ +G+ +A+K F D S E+ +
Sbjct: 8 RDITLLECVGKGRYGEVWRGSW-----QGENVAVKIFS---SRDEKSWFRETELYNTVML 59
Query: 86 THENVVKLV--NVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQ 142
HEN++ + ++ H+ L+L Y E LY+ ++ T++ + I+
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLS 113
Query: 143 LLNGLNYLHSNW--------IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY--QAPL 192
+ +GL +LH I HRDLK NILV ++ G IAD GLA ++
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV----KKNGQCCIADLGLAVMHSQSTNQ 169
Query: 193 KFLSENGVVVTIWYRAPELLLGA-----KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247
+ N V T Y APE+L VD+WA G + E+ E
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE-- 227
Query: 248 STQNPFQ 254
+ PF
Sbjct: 228 DYKPPFY 234
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 20/217 (9%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN 89
+ +IG G++G V+ + G +A+K + E+ +LR+ H N
Sbjct: 28 VGQRIGSGSFGTVYKGKW-----HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 90 VVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLN 148
++ + L + + E LY + K + I Q G++
Sbjct: 82 ILLFMGYSTAP---QLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTARGMD 134
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA 208
YLH+ IIHRDLK +NI + E VKI DFGLA + +I + A
Sbjct: 135 YLHAKSIIHRDLKSNNIFL----HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 209 PELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
PE++ + Y+ D++A G + EL+T + +
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 82/365 (22%), Positives = 138/365 (37%), Gaps = 62/365 (16%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKF-KQSKDGDGVSPTAIREIMLLR 83
+Y+ + IG G +G+ L R K + +A+K + + + V REI+ R
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLT---KELVAVKYIERGAAIDENVQ----REIINHR 71
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-IIRHHRDKVNHTMNPYTVKSILW 141
+ H N+V+ V + L + +YA +LYE I R + +
Sbjct: 72 SLRHPNIVRFKEVILTPTH--LAIIMEYASGGELYERICNAGR------FSEDEARFFFQ 123
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
QLL+G++Y HS I HRDLK N L+ +G +KI DFG ++ + S G
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVG-- 179
Query: 202 VTIWYRAPELLLGAKHYT-SAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
T Y APE+LL + Y D+W+ G +L GA PF+ + +
Sbjct: 180 -TPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLV------GAY------PFEDPEEPR 225
Query: 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLE 320
++ I KY + + +SP L+S++
Sbjct: 226 DYRKTIQ--------------------RILSVKYS---IPDDIRISP--ECCHLISRIFV 260
Query: 321 YDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFEGTTTLQP 380
DP RI+ + H +F + + P + +D+ T+
Sbjct: 261 ADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPA 320
Query: 381 PQPAS 385
+
Sbjct: 321 VRNRC 325
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-36
Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
IG+G +G V+ R G+ +AI+ +D + RE+M R+ HENVV
Sbjct: 40 LIGKGRFGQVYHGR-----WHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
+ ++ L + + LY ++R + ++ + I +++ G+ YLH
Sbjct: 94 FMGACMS--PPHLAIITSLCKGRTLYSVVRDAKIV----LDVNKTRQIAQEIVKGMGYLH 147
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV---TIWYRA 208
+ I+H+DLK N+ + G V I DFGL I E+ + + + + A
Sbjct: 148 AKGILHKDLKSKNVFY-----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 209 PELL--------LGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
PE++ ++ D++A+G I+ EL + F+
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 64/365 (17%), Positives = 121/365 (33%), Gaps = 82/365 (22%)
Query: 13 TGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK---KFKQSKDGD 69
T ++ + +Y L +G+G +G VF +AIK + +
Sbjct: 18 TPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTD---RLQVAIKVIPRNRVLGWSP 74
Query: 70 GVSPTAI-REIMLLR----EITHENVVKLVNVHINHADMSLYLAFDYAEY--DLYEIIRH 122
E+ LL H V++L++ L + DL++ I
Sbjct: 75 LSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET--QEGFMLVLERPLPAQDLFDYITE 132
Query: 123 HRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182
+ + Q++ + + HS ++HRD+K NIL+ +G K+ DF
Sbjct: 133 KG-----PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI---DLRRGCAKLIDF 184
Query: 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ 242
G + + +G T Y PE + +++ +W++G + +++
Sbjct: 185 GSGALLH-DEPYTDFDG---TRVYSPPEWISRHQYHALPATVWSLGILLYDMVC------ 234
Query: 243 GAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSV 302
G PF+ DQ +IL + P S
Sbjct: 235 GD------IPFERDQ-----EILEAEL--------HFPAHVSPD---------------- 259
Query: 303 VPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI--EPLPGRNALVPSQPGDKVVN 360
L+ + L P R + + L + + E +P L PS+ G +
Sbjct: 260 --------CCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVP----LNPSKGGPAPLA 307
Query: 361 YPTRP 365
+ P
Sbjct: 308 WSLLP 312
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 83/347 (23%), Positives = 138/347 (39%), Gaps = 90/347 (25%)
Query: 11 GGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIK-----KFK 63
G + + Y L +G GT+G V + + + G +A+K K +
Sbjct: 1 GPMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGK-----HELTGHKVAVKILNRQKIR 55
Query: 64 QSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYE-IIR 121
+ REI L+ H +++KL V +D +++ +Y +L++ I +
Sbjct: 56 SLDVVGKIR----REIQNLKLFRHPHIIKLYQVISTPSD--IFMVMEYVSGGELFDYICK 109
Query: 122 HHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181
+ R ++ + + Q+L+G++Y H + ++HRDLKP N+L+ + KIAD
Sbjct: 110 NGR------LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL----DAHMNAKIAD 159
Query: 182 FGLARIYQAPLKFL-----SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
FGL+ + +FL S N Y APE++ G + VD+W+ G I LL
Sbjct: 160 FGLSNMMS-DGEFLRTSCGSPN-------YAAPEVISGRLYAGPEVDIWSSGVILYALLC 211
Query: 237 LKPLFQGAEAKSTQNPFQLDQLDKIF-KIL-GHPTPEKWPTLANLPHWQSDSLHIQGRKY 294
G PF D + +F KI G P + +
Sbjct: 212 ------GTL------PFDDDHVPTLFKKICDGIFY---------TPQYLN---------- 240
Query: 295 ETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341
LL ML+ DP KR T EHE+F+ +
Sbjct: 241 --------------PSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 63/248 (25%), Positives = 107/248 (43%), Gaps = 38/248 (15%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+Q ++ +IG+G YG V++ + RG+ +A+K F + S EI
Sbjct: 36 AKQIQMVKQIGKGRYGEVWMGKW-----RGEKVAVKVFF---TTEEASWFRETEIYQTVL 87
Query: 85 ITHENVVKLV--NVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILW 141
+ HEN++ + ++ + LYL DY E LY+ ++ + T++ ++ + +
Sbjct: 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAY 141
Query: 142 QLLNGLNYLHSNW--------IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK 193
++GL +LH+ I HRDLK NILV ++ G IAD GLA + +
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV----KKNGTCCIADLGLAVKFISDTN 197
Query: 194 --FLSENGVVVTIWYRAPELLLGA-----KHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246
+ N V T Y PE+L + DM++ G I E+ E
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE- 256
Query: 247 KSTQNPFQ 254
Q P+
Sbjct: 257 -EYQLPYH 263
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 62/248 (25%), Positives = 102/248 (41%), Gaps = 38/248 (15%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+ L IG+G +G V+ + RG+ +A+K F + S EI
Sbjct: 41 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFS---SREERSWFREAEIYQTVM 92
Query: 85 ITHENVVKLV--NVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILW 141
+ HEN++ + + N L+L DY E+ L++ + + T+ + +
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLAL 146
Query: 142 QLLNGLNYLHSNW--------IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA--P 191
+GL +LH I HRDLK NILV ++ G IAD GLA + +
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV----KKNGTCCIADLGLAVRHDSATD 202
Query: 192 LKFLSENGVVVTIWYRAPELLLGA-----KHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246
++ N V T Y APE+L + D++A+G +F E+ + E
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE- 261
Query: 247 KSTQNPFQ 254
Q P+
Sbjct: 262 -DYQLPYY 268
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 74/334 (22%), Positives = 123/334 (36%), Gaps = 90/334 (26%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIK---KFKQSKDGDGVSPTAIREI 79
++ ++L+ +GEG YG V LA NR +A+A+K + + + +EI
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAV-----NRVTEEAVAVKIVDMKRAVDCPENIK----KEI 56
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAE----YDLYEIIRHHRDKVNHTMNPYT 135
+ + + HENVVK YL +Y +D I M
Sbjct: 57 CINKMLNHENVVKFYGHRREGNI--QYLFLEYCSGGELFD--RIEPDIG------MPEPD 106
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ--APLK 193
+ QL+ G+ YLH I HRD+KP N+L+ +E+ +KI+DFGLA +++ +
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRER 162
Query: 194 FL-----SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248
L + Y APELL + + VD+W+ G + +L G
Sbjct: 163 LLNKMCGTLP-------YVAPELLKRREFHAEPVDVWSCGIVLTAMLA------GEL--- 206
Query: 249 TQNPF--QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS 306
P+ D + + + Y +
Sbjct: 207 ---PWDQPSDSCQEYSDW------------------------KEKKTYLNPWKK----ID 235
Query: 307 PKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340
LL K+L +P RIT + ++
Sbjct: 236 S--APLALLHKILVENPSARITIPDIKKDRWYNK 267
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-35
Identities = 79/318 (24%), Positives = 139/318 (43%), Gaps = 67/318 (21%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ KIGEG+ G+V LAR K + G+ +A+K K E++++R+
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHS---GRQVAVKMMDLRKQQR--RELLFNEVVIMRDY 99
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
H NVV++ ++ + L++ ++ + L +I+ R +N + ++ +L
Sbjct: 100 QHFNVVEMYKSYLVGEE--LWVLMEFLQGGALTDIVSQVR------LNEEQIATVCEAVL 151
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL-ARIYQAPLKFLSENGVVVT 203
L YLH+ +IHRD+K +IL+ G VK++DFG A+I + K +V T
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLT----LDGRVKLSDFGFCAQISKDVPK---RKSLVGT 204
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFA-ELLTLKPLFQGAEAKSTQNP-FQLDQLDKI 261
++ APE++ Y + VD+W++G I E++ +P P F + +
Sbjct: 205 PYWMAPEVISR-SLYATEVDIWSLG-IMVIEMVDGEP------------PYFSDSPVQAM 250
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
++ P P L N S L D L +ML
Sbjct: 251 KRLRDSPP----PKLKNSHKV-SPVLR------------------------DFLERMLVR 281
Query: 322 DPRKRITAAQALEHEYFR 339
DP++R TA + L+H +
Sbjct: 282 DPQERATAQELLDHPFLL 299
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-35
Identities = 79/318 (24%), Positives = 139/318 (43%), Gaps = 67/318 (21%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y KIG+G G V+ A A G+ +AI++ + I EI+++RE
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVAT---GQEVAIRQMNLQQQPK--KELIINEILVMREN 74
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ N+V ++ ++ + L++ +Y L +++ M+ + ++ + L
Sbjct: 75 KNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECL 126
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL-ARIYQAPLKFLSENGVVVT 203
L +LHSN +IHRD+K NIL+ G VK+ DFG A+I K + +V T
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFCAQITPEQSK---RSTMVGT 179
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFA-ELLTLKPLFQGAEAKSTQNP-FQLDQLDKI 261
++ APE++ K Y VD+W++G I A E++ +P P + L +
Sbjct: 180 PYWMAPEVVTR-KAYGPKVDIWSLG-IMAIEMIEGEP------------PYLNENPLRAL 225
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
+ I + T P L N S D L++ LE
Sbjct: 226 YLIATNGT----PELQNPEKL-SAIFR------------------------DFLNRCLEM 256
Query: 322 DPRKRITAAQALEHEYFR 339
D KR +A + L+H++ +
Sbjct: 257 DVEKRGSAKELLQHQFLK 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 73/320 (22%), Positives = 137/320 (42%), Gaps = 69/320 (21%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK--FKQSKDGDGVSPTAIREIMLLR 83
+ ++ + +IG G++G V+ AR + +AIKK + + + I+E+ L+
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRN---SEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQ 109
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
++ H N ++ ++ + + +L +Y +++ H + + ++
Sbjct: 110 KLRHPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGA 163
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
L GL YLHS+ +IHRD+K NIL+ E G+VK+ DFG A + + N V T
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSA----SIMA--PANSFVGT 213
Query: 204 IWYRAPELLLGAK--HYTSAVDMWAVGCIFA-ELLTLKPLFQGAEAKSTQNP-FQLDQLD 259
++ APE++L Y VD+W++G I EL KP P F ++ +
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKP------------PLFNMNAMS 260
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
++ I + + P L + HW S+ + + L
Sbjct: 261 ALYHIAQNES----PALQS-GHW-SEYFR------------------------NFVDSCL 290
Query: 320 EYDPRKRITAAQALEHEYFR 339
+ P+ R T+ L+H +
Sbjct: 291 QKIPQDRPTSEVLLKHRFVL 310
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 74/325 (22%), Positives = 135/325 (41%), Gaps = 74/325 (22%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ + ++G++G+G +G V+ A+ K G A K + + + I EI +L
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKET---GALAAAKVIETKSEEE--LEDYIVEIEILATC 73
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAE----YDLYEIIRHHRDKVNHTMNPYTVKSILW 141
H +VKL+ + + D L++ ++ + + + + ++ +
Sbjct: 74 DHPYIVKLLGAYYH--DGKLWIMIEFCPGGAVDAIMLEL-------DRGLTEPQIQVVCR 124
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL-ARIYQAPLKFLSENGV 200
Q+L LN+LHS IIHRDLK N+L+ +G +++ADFG+ A+ + K +
Sbjct: 125 QMLEALNFLHSKRIIHRDLKAGNVLMT----LEGDIRLADFGVSAKNLKTLQK---RDSF 177
Query: 201 VVTIWYRAPELLLGA----KHYTSAVDMWAVGCIFA-ELLTLKPLFQGAEAKSTQNP-FQ 254
+ T ++ APE+++ Y D+W++G I E+ ++P P +
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP------------PHHE 224
Query: 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDL 314
L+ + + KI PTL W S D
Sbjct: 225 LNPMRVLLKIAKSDP----PTLLTPSKW-SVEFR------------------------DF 255
Query: 315 LSKMLEYDPRKRITAAQALEHEYFR 339
L L+ +P R +AAQ LEH +
Sbjct: 256 LKIALDKNPETRPSAAQLLEHPFVS 280
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 86/327 (26%), Positives = 141/327 (43%), Gaps = 75/327 (22%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
++PE + ++++ K+GEG+YG V+ A K G+ +AIK+ D + I+EI
Sbjct: 25 KQPE--EVFDVLEKLGEGSYGSVYKAIHKET---GQIVAIKQVPVESDLQEI----IKEI 75
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAE----YDLYEIIRHHRDKVNHTMNPYT 135
++++ +VVK + + D L++ +Y D+ + N T+
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTD--LWIVMEYCGAGSVSDIIRLR-------NKTLTEDE 126
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL-ARIYQAPLKF 194
+ +IL L GL YLH IHRD+K NIL+ +G K+ADFG+ ++ K
Sbjct: 127 IATILQSTLKGLEYLHFMRKIHRDIKAGNILLN----TEGHAKLADFGVAGQLTDTMAK- 181
Query: 195 LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFA-ELLTLKPLFQGAEAKSTQNP- 252
N V+ T ++ APE++ Y D+W++G I A E+ KP P
Sbjct: 182 --RNTVIGTPFWMAPEVIQE-IGYNCVADIWSLG-ITAIEMAEGKP------------PY 225
Query: 253 FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY 312
+ + IF I +P PT W SD+
Sbjct: 226 ADIHPMRAIFMIPTNPP----PTFRKPELW-SDNFT------------------------ 256
Query: 313 DLLSKMLEYDPRKRITAAQALEHEYFR 339
D + + L P +R TA Q L+H + R
Sbjct: 257 DFVKQCLVKSPEQRATATQLLQHPFVR 283
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-33
Identities = 92/361 (25%), Positives = 136/361 (37%), Gaps = 93/361 (25%)
Query: 3 DGNTSTGRGGTGTSNHGEKPEWLQQYNL----IGK-IGEGTYGLVFLARIKAAANRGKAI 57
DG + R G G+ H + P ++ GK +GEG++ V LAR A +
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELAT---SREY 58
Query: 58 AIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH-----------ADMSLY 106
AIK ++ R I+ ++ + + V ++H D LY
Sbjct: 59 AIKILEK------------RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 106
Query: 107 LAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNI 165
YA+ +L + IR YT ++++ L YLH IIHRDLKP NI
Sbjct: 107 FGLSYAKNGELLKYIRKIGSFDETCTRFYTA-----EIVSALEYLHGKGIIHRDLKPENI 161
Query: 166 LVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMW 225
L+ E ++I DFG A++ K N V T Y +PELL K + D+W
Sbjct: 162 LL----NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLW 216
Query: 226 AVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQS 284
A+GCI +L+ P PF+ IF KI+ + P
Sbjct: 217 ALGCIIYQLVAGLP------------PFRAGNEYLIFQKIIKLEY--------DFPEK-- 254
Query: 285 DSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA------LEHEYF 338
PK A DL+ K+L D KR+ + H +F
Sbjct: 255 --------------------FFPK--ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292
Query: 339 R 339
Sbjct: 293 E 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-33
Identities = 76/437 (17%), Positives = 138/437 (31%), Gaps = 83/437 (18%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
QY + G I G G ++LA + R + +K S D + + A+ E L E+
Sbjct: 81 QYEVKGCIAHGGLGWIYLALDRNVNGR--PVVLKGLVHSGDAEAQA-MAMAERQFLAEVV 137
Query: 87 HENVVKLVNV---HINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQ 142
H ++V++ N H D Y+ +Y L + + L +
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-------LPVAEAIAYLLE 190
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV 202
+L L+YLHS +++ DLKP NI++ E +K+ D G ++ G +
Sbjct: 191 ILPALSYLHSIGLVYNDLKPENIMLTEEQ-----LKLIDLGAVSR-------INSFGYLY 238
Query: 203 -TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T ++APE++ T A D++ VG A L P G
Sbjct: 239 GTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED--------- 287
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
P + + + LL + ++
Sbjct: 288 -----DPVLKTYDSY-----------------------------------GRLLRRAIDP 307
Query: 322 DPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFEGTTTLQPP 381
DPR+R T A+ + + + +PG + P+R +
Sbjct: 308 DPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSRST---FGVDLLVAHTDV 364
Query: 382 QPASGPVPGNMAGAHAVSNRNVPRPMPGVGMQRMQAQGMMTYNFPGQAGAAGGMNPANMP 441
+ V+ +VP P + +++ P Q +
Sbjct: 365 YLDGQVHAEKLTANEIVTALSVPLVDPTDVAASVLQATVLSQ--PVQTLDSLRAARHGAL 422
Query: 442 MQRGMPGQAHQQQQLRR 458
G+ + L
Sbjct: 423 DADGVDFSESVELPLME 439
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 29/224 (12%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
+G+G +G + G+ + +K+ + + T ++E+ ++R + H NV+K
Sbjct: 17 VLGKGCFGQAIKVTHR---ETGEVMVMKELI--RFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
+ V D L +Y + L II+ + S + +G+ YLH
Sbjct: 72 FIGVLYK--DKRLNFITEYIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLH 125
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ------------APLKFLSENG 199
S IIHRDL N LV E V +ADFGLAR+
Sbjct: 126 SMNIIHRDLNSHNCLV----RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
VV ++ APE++ G + Y VD+++ G + E++
Sbjct: 182 VVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 80/321 (24%), Positives = 135/321 (42%), Gaps = 74/321 (23%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ + + KIG+G++G VF K +AIK + D + +EI +L +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQC 77
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAE----YDLYEIIRHHRDKVNHTMNPYTVKSILW 141
V K ++ D L++ +Y DL E ++ + +IL
Sbjct: 78 DSPYVTKYYGSYLK--DTKLWIIMEYLGGGSALDLLE---------PGPLDETQIATILR 126
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL-ARIYQAPLKFLSENGV 200
++L GL+YLHS IHRD+K +N+L+ E G VK+ADFG+ ++ +K N
Sbjct: 127 EILKGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIK---RNTF 179
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFA-ELLTLKPLFQGAEAKSTQNP-FQLDQL 258
V T ++ APE++ + Y S D+W++G I A EL +P P +L +
Sbjct: 180 VGTPFWMAPEVIKQSA-YDSKADIWSLG-ITAIELARGEP------------PHSELHPM 225
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318
+F I + PTL ++ S L + +
Sbjct: 226 KVLFLIPKNNP----PTLEG--NY-SKPLK------------------------EFVEAC 254
Query: 319 LEYDPRKRITAAQALEHEYFR 339
L +P R TA + L+H++
Sbjct: 255 LNKEPSFRPTAKELLKHKFIL 275
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 69/330 (20%), Positives = 129/330 (39%), Gaps = 78/330 (23%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ L+ +G GTYG V+ R G+ AIK + D + +EI +L++
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKT---GQLAAIKVMDVTGDEE---EEIKQEINMLKKY 77
Query: 86 -THENVVKL----VNVHINHADMSLYLAFDYAE----YDLYEIIRHHRDKVNHTMNPYTV 136
H N+ + + D L+L ++ DL + + +T+ +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK------GNTLKEEWI 131
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
I ++L GL++LH + +IHRD+K N+L+ E VK+ DFG++ Q
Sbjct: 132 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE----VKLVDFGVSA--QLDRTVGR 185
Query: 197 ENGVVVTIWYRAPELLLGAKH----YTSAVDMWAVGCIFA-ELLTLKPLFQGAEAKSTQN 251
N + T ++ APE++ ++ Y D+W++G I A E+ P
Sbjct: 186 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAP------------ 232
Query: 252 P-FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP 310
P + + +F I +P P ++ +K+ S
Sbjct: 233 PLCDMHPMRALFLIPRNPAPR-----------------LKSKKW--------------SK 261
Query: 311 AY-DLLSKMLEYDPRKRITAAQALEHEYFR 339
+ + L + +R Q ++H + R
Sbjct: 262 KFQSFIESCLVKNHSQRPATEQLMKHPFIR 291
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-31
Identities = 70/324 (21%), Positives = 120/324 (37%), Gaps = 35/324 (10%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+ I ++G G G+VF K + G +A K + IRE+ +L E
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLEIKPAIRN-QIIRELQVLHE 87
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEY-------DLYEIIRHHRDKVNHTMNPYTVK 137
+V + ++S+ + E+ + K + +
Sbjct: 88 CNSPYIVGFYGAFYSDGEISICM-----EHMDGGSLDQVL--------KKAGRIPEQILG 134
Query: 138 SILWQLLNGLNYLHSNW-IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
+ ++ GL YL I+HRD+KPSNILV GE +K+ DFG++ +
Sbjct: 135 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMA--- 187
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
N V T Y +PE L G HY+ D+W++G E+ + +AK + F
Sbjct: 188 -NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 245
Query: 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY-DLL 315
+ P P + + Y N +P S + D +
Sbjct: 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 305
Query: 316 SKMLEYDPRKRITAAQALEHEYFR 339
+K L +P +R Q + H + +
Sbjct: 306 NKCLIKNPAERADLKQLMVHAFIK 329
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 63/262 (24%), Positives = 96/262 (36%), Gaps = 47/262 (17%)
Query: 22 PEW---LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIRE 78
E L L+ IG G YG V+ + + +A+K F + + +
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL-----DERPVAVKVFSF---ANRQNFINEKN 57
Query: 79 IMLLREITHENVVKLV---NVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPY 134
I + + H+N+ + + M L +Y L + + HT +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWV 111
Query: 135 TVKSILWQLLNGLNYLHSNW---------IIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185
+ + + GL YLH+ I HRDL N+LV + G I+DFGL+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV----KNDGTCVISDFGLS 167
Query: 186 RIYQAPLKFLSE------NGVVVTIWYRAPELLLGA------KHYTSAVDMWAVGCIFAE 233
V TI Y APE+L GA + VDM+A+G I+ E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227
Query: 234 LLT-LKPLFQGAEAKSTQNPFQ 254
+ LF G Q FQ
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQ 249
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 30/218 (13%)
Query: 30 LIGKIGEGTYGLVFLARIKAAA-NRGKAIAIKKFKQSKDGDGVSPTA--IREIMLLREIT 86
+ ++G+G +G V + R N G+ +A+KK + S + REI +L+ +
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE----EHLRDFEREIEILKSLQ 69
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
H+N+VK V + +L L +Y Y L + ++ H+++++H + Q+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI----KLLQYTSQICK 125
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI-------YQAPLKFLSEN 198
G+ YL + IHRDL NILV E + VKI DFGL ++ ++ E
Sbjct: 126 GMEYLGTKRYIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEFFKV-----KEP 176
Query: 199 GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
G WY APE L +K ++ A D+W+ G + EL T
Sbjct: 177 GESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 30/218 (13%)
Query: 30 LIGKIGEGTYGLVFLARIKAAA-NRGKAIAIKKFKQSKDGDGVSPTA--IREIMLLREIT 86
+ ++G+G +G V + R N G+ +A+KK + S + REI +L+ +
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE----EHLRDFEREIEILKSLQ 100
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
H+N+VK V + +L L +Y Y L + ++ H+++++H + Q+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI----KLLQYTSQICK 156
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI-------YQAPLKFLSEN 198
G+ YL + IHRDL NILV E + VKI DFGL ++ Y+ E
Sbjct: 157 GMEYLGTKRYIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEYYKV-----KEP 207
Query: 199 GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
G WY APE L +K ++ A D+W+ G + EL T
Sbjct: 208 GESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 33/221 (14%)
Query: 30 LIGKIGEGTYGLVFLARIKAAA-NRGKAIAIKKFKQSKDGDGVSPTA----IREIMLLRE 84
I +GEG +G V L R N G+ +A+K K +EI +LR
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEILRN 79
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+ HEN+VK + + L ++ L E + +++K+N Q+
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLK----QQLKYAVQI 135
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI-------YQAPLKFLS 196
G++YL S +HRDL N+LV E + VKI DFGL + Y
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLV----ESEHQVKIGDFGLTKAIETDKEYYTV-----K 186
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
++ WY APE L+ +K + A D+W+ G ELLT
Sbjct: 187 DDRDSPVFWY-APECLMQSK-FYIASDVWSFGVTLHELLTY 225
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 40/224 (17%)
Query: 30 LIGKIGEGTYGLVFLARIKAAA-NRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITH 87
I ++G+G +G V L R N G +A+K+ + REI +L+ +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHS 83
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
+ +VK V SL L +Y L + ++ HR +++ + + Q+ G
Sbjct: 84 DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS----RLLLYSSQICKG 139
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI-------YQA------PLK 193
+ YL S +HRDL NILV E + VKIADFGLA++ Y P+
Sbjct: 140 MEYLGSRRCVHRDLAARNILV----ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 194 FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
WY APE L ++ D+W+ G + EL T
Sbjct: 196 -----------WY-APESLSDNI-FSRQSDVWSFGVVLYELFTY 226
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-28
Identities = 74/327 (22%), Positives = 126/327 (38%), Gaps = 72/327 (22%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS--KDGDGVSPTAIREIMLL 82
+ +++ IG G +G V+ R GK A+K + K G + A+ E ++L
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGET-LALNERIML 243
Query: 83 REITHENVVKLVNVH-INHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSIL 140
++ + +V + H L D DL+ + H M Y
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA---- 299
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE--- 197
+++ GL ++H+ ++++RDLKP+NIL+ +E G V+I+D GLA S+
Sbjct: 300 -EIILGLEHMHNRFVVYRDLKPANILL----DEHGHVRISDLGLA-------CDFSKKKP 347
Query: 198 NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257
+ V T Y APE+L Y S+ D +++GC+ +LL F+ + K +
Sbjct: 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--- 404
Query: 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSK 317
L LP SP LL
Sbjct: 405 -----MTLTMAVE--------LPDS----------------------FSP--ELRSLLEG 427
Query: 318 MLEYDPRKRI-----TAAQALEHEYFR 339
+L+ D +R+ A + E +FR
Sbjct: 428 LLQRDVNRRLGCLGRGAQEVKESPFFR 454
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 73/322 (22%), Positives = 128/322 (39%), Gaps = 66/322 (20%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK--DGDGVSPTAIREIMLL 82
+ ++ IG+G++G V + + K A+K + K + + V +E+ ++
Sbjct: 14 FDHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNV-FKELQIM 69
Query: 83 REITHENVVKLVNVHINHADMS-LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSIL 140
+ + H LVN+ + D +++ D DL R+H + H TVK +
Sbjct: 70 QGLEH---PFLVNLWYSFQDEEDMFMVVDLLLGGDL----RYHLQQNVHFKEE-TVKLFI 121
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
+L+ L+YL + IIHRD+KP NIL+ +E G V I DF +A + + + G
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILL----DEHGHVHITDFNIAAMLPRETQITTMAG- 176
Query: 201 VVTIWYRAPELLL--GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258
T Y APE+ Y+ AVD W++G ELL + + +S+ + ++
Sbjct: 177 --TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY---HIRSSTSSKEIVH- 230
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318
T +P W + LL K+
Sbjct: 231 ----TFE--TTVVTYP-----SAWSQE-------------------------MVSLLKKL 254
Query: 319 LEYDPRKRITAAQAL-EHEYFR 339
LE +P +R + + Y
Sbjct: 255 LEPNPDQRFSQLSDVQNFPYMN 276
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 29/218 (13%)
Query: 30 LIGKIGEGTYGLVFLARIK-AAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITH 87
I +GEG +G V L G+ +A+K K + +EI +LR + H
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEIDILRTLYH 92
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
E+++K + SL L +Y L + + H + + Q+ G
Sbjct: 93 EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL------FAQQICEG 146
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI-------YQAPLKFLSENG 199
+ YLH+ IHRDL N+L+ + +VKI DFGLA+ Y+ E+G
Sbjct: 147 MAYLHAQHYIHRDLAARNVLL----DNDRLVKIGDFGLAKAVPEGHEYYRV-----REDG 197
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
WY APE L K + A D+W+ G ELLT
Sbjct: 198 DSPVFWY-APECLKEYK-FYYASDVWSFGVTLYELLTH 233
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 64/355 (18%), Positives = 127/355 (35%), Gaps = 84/355 (23%)
Query: 2 GDGNTSTGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKK 61
G +S + G T + +G++G GT G V+ R + G IA+K+
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKT---GHVIAVKQ 57
Query: 62 FKQSKDGDGVSPTAIREI-MLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLY--- 117
++S + + + ++ ++L+ +V+ + F D++
Sbjct: 58 MRRSGNKEENK-RILMDLDVVLKSHDCPYIVQ------------CFGTF-ITNTDVFIAM 103
Query: 118 --------EIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW-IIHRDLKPSNILVM 168
++ + ++ + + + ++ L YL +IHRD+KPSNIL+
Sbjct: 104 ELMGTCAEKLKK----RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD 159
Query: 169 GEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPE----LLLGAKHYTSAVDM 224
G+ +K+ DFG++ +++ Y APE Y D+
Sbjct: 160 ERGQ----IKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADV 212
Query: 225 WAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQS 284
W++G EL T + ++ + + F++ + K+L P P L + S
Sbjct: 213 WSLGISLVELATGQFPYK-----NCKTDFEV-----LTKVLQEE-P---PLLPGHMGF-S 257
Query: 285 DSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339
+ L D RKR + LEH + +
Sbjct: 258 GDFQ------------------------SFVKDCLTKDHRKRPKYNKLLEHSFIK 288
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-27
Identities = 64/328 (19%), Positives = 126/328 (38%), Gaps = 75/328 (22%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI-MLLR 83
I ++G G YG+V R + G+ +A+K+ + + + + ++ + +R
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPS---GQIMAVKRIRATVNSQ-EQKRLLMDLDISMR 61
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEY------DLYEIIRHHRDKVNHTMNPYTVK 137
+ V D+ + + E Y+ + T+ +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICM-----ELMDTSLDKFYKQVI----DKGQTIPEDILG 112
Query: 138 SILWQLLNGLNYLHSNW-IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
I ++ L +LHS +IHRD+KPSN+L+ G+ VK+ DFG++ ++
Sbjct: 113 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ----VKMCDFGISGYLVDD---VA 165
Query: 197 ENGVVVTIWYRAPELLLG---AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253
++ Y APE + K Y+ D+W++G EL L+ + S PF
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD-----SWGTPF 220
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLP--HWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
Q + +++ P+P+ LP + S
Sbjct: 221 QQ-----LKQVVEEPSPQ-------LPADKF-SAEFV----------------------- 244
Query: 312 YDLLSKMLEYDPRKRITAAQALEHEYFR 339
D S+ L+ + ++R T + ++H +F
Sbjct: 245 -DFTSQCLKKNSKERPTYPELMQHPFFT 271
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 62/343 (18%), Positives = 114/343 (33%), Gaps = 98/343 (28%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+ ++ IG G + V + ++K G+ A+K K +++ E
Sbjct: 60 RDDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMN--KW----------DMLKRGE 104
Query: 85 ITHENVVKLVNVHINH-----------ADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMN 132
++ + V V+ + + LYL +Y DL K +
Sbjct: 105 VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL----TLLSKFGERIP 160
Query: 133 PYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPL 192
+ L +++ ++ +H +HRD+KP NIL+ + G +++ADFG
Sbjct: 161 AEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL----DRCGHIRLADFGSC------- 209
Query: 193 KFLSENGVVV------TIWYRAPELLLG------AKHYTSAVDMWAVGCIFAELLTLKPL 240
L +G V T Y +PE+L Y D WA+G E+ +
Sbjct: 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT- 268
Query: 241 FQGAEAKSTQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGL 299
PF D + + KI+ + P
Sbjct: 269 -----------PFYADSTAETYGKIVHYKEHLSLPL------------------------ 293
Query: 300 HSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE---HEYFR 339
+ + A D + ++L P R+ A + H +F
Sbjct: 294 -VDEGVPEE--ARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 81/376 (21%), Positives = 142/376 (37%), Gaps = 86/376 (22%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS--KDGDGVSPTAIREIMLL 82
+ +G+G +G V +++A GK A KK ++ K G + + E +L
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMA-LNEKQIL 238
Query: 83 REITHENVVKLVNVHINHADMSLYLAFDYAEY-DL-YEIIRHHRDKVN-HTMNPYTVKSI 139
++ VV L + +L L DL + I + Y
Sbjct: 239 EKVNSRFVVSLAYAY--ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA--- 293
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE-- 197
++ GL LH I++RDLKP NIL+ ++ G ++I+D GLA + E
Sbjct: 294 --EICCGLEDLHRERIVYRDLKPENILL----DDHGHIRISDLGLA-------VHVPEGQ 340
Query: 198 --NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255
G V T+ Y APE++ + YT + D WA+GC+ E++ + FQ + K +
Sbjct: 341 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----- 394
Query: 256 DQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDL 314
+++ + P SP+ A L
Sbjct: 395 ---EEVERLVKEVP--------EEYSER----------------------FSPQ--ARSL 419
Query: 315 LSKMLEYDPRKRI-----TAAQALEHEYFRI---EPLPGRNALVPSQPGDKVVNYPTRPV 366
S++L DP +R+ +A + EH F+ + L P +P + +
Sbjct: 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYC----- 474
Query: 367 DSNTDFEGTTTLQPPQ 382
D E +T++ +
Sbjct: 475 KDVLDIEQFSTVKGVE 490
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 59/321 (18%), Positives = 118/321 (36%), Gaps = 57/321 (17%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI-MLLR 83
+ +G+IG G YG V K + G+ +A+K+ + + D + ++ +++R
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPS---GQIMAVKRIRSTVDEK-EQKQLLMDLDVVMR 76
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+V+ D ++ + + ++ ++ + + I
Sbjct: 77 SSDCPYIVQFYGALFREGD--CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 144 LNGLNYLHSNW-IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV 202
+ LN+L N IIHRD+KPSNIL+ G +K+ DFG++ +++
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRSGN----IKLCDFGISGQLVDS---IAKTRDAG 187
Query: 203 TIWYRAPELLLGAKH---YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
Y APE + + Y D+W++G EL T + + + F
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY-----PKWNSVFDQ---- 238
Query: 260 KIFKILGHPTPEKWPTLANLPHWQ-SDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318
+ +++ P L+N + S S + ++
Sbjct: 239 -LTQVVKGDP----PQLSNSEEREFSPSFI------------------------NFVNLC 269
Query: 319 LEYDPRKRITAAQALEHEYFR 339
L D KR + L+H +
Sbjct: 270 LTKDESKRPKYKELLKHPFIL 290
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 71/341 (20%), Positives = 122/341 (35%), Gaps = 96/341 (28%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+ + ++ IG G +G V + ++K A K A+K K E++ E
Sbjct: 73 REDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILN--KW----------EMLKRAE 117
Query: 85 ITHENVVKLVNVHINH-----------ADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMN 132
+ V V+ + D +LYL DY DL K +
Sbjct: 118 TACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL----TLLSKFEDRLP 173
Query: 133 PYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPL 192
+ L +++ ++ +H +HRD+KP NIL+ + G +++ADFG
Sbjct: 174 EEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM----DMNGHIRLADFGSC------- 222
Query: 193 KFLSENGVVV------TIWYRAPELLL----GAKHYTSAVDMWAVGCIFAELLTLKPLFQ 242
L E+G V T Y +PE+L G Y D W++G E+L +
Sbjct: 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET--- 279
Query: 243 GAEAKSTQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHS 301
PF + L + + KI+ H ++PT
Sbjct: 280 ---------PFYAESLVETYGKIMNHKERFQFPT-------------------------Q 305
Query: 302 VVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE---HEYFR 339
V +S A DL+ +++ R+ + H +F
Sbjct: 306 VTDVSEN--AKDLIRRLIC-SREHRLGQNGIEDFKKHPFFS 343
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 55/355 (15%), Positives = 101/355 (28%), Gaps = 82/355 (23%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSP------TAIREI 79
++ KIGEG +G VF +AIK + EI
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTI-----ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 80 MLLREIT---------HENVVKLVNVHINHADMSLYLAFDYAEYD--------------- 115
++ +E++ E + L +VH L + Y+
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 116 --LYEII------RHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW-IIHRDLKPSNIL 166
L+ ++ + T KSIL QL L ++ HRDL N+L
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 167 VMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWA 226
+ ++ + K+ + P G+ V+I YT +
Sbjct: 195 L----KKTSLKKLHYTLNGKSSTIPSC-----GLQVSII-----------DYTLSRLERD 234
Query: 227 VGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLP--HWQS 284
+F ++ + LF G D I++++ +W W
Sbjct: 235 GIVVFCDVSMDEDLFTG----------DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLH 284
Query: 285 DSLH-IQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338
+ + ++ K + ML + +A L
Sbjct: 285 YLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 77/403 (19%), Positives = 136/403 (33%), Gaps = 115/403 (28%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+ Y ++ IG G +G V L R K+ K A+K + E++ +
Sbjct: 68 AEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKF------------EMIKRSD 112
Query: 85 ITHENVVKLVNVHINH-----------ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMN 132
+ + N D LY+ +Y DL ++ ++ +
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD------VP 166
Query: 133 PYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPL 192
+ +++ L+ +HS IHRD+KP N+L+ ++ G +K+ADFG
Sbjct: 167 EKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL----DKSGHLKLADFGTC------- 215
Query: 193 KFLSENGVVV------TIWYRAPELLL---GAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
+++ G+V T Y +PE+L G +Y D W+VG E+L
Sbjct: 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT---- 271
Query: 244 AEAKSTQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSV 302
PF D L + KI+ H +P ++
Sbjct: 272 --------PFYADSLVGTYSKIMNHKNSLTFPDDNDIS---------------------- 301
Query: 303 VPLSPKSPAYDLLSKMLEYDPRKRITAAQALE---HEYFRI---EPLPGRNALVPSQPGD 356
A +L+ L D R+ E H +F+ R+ + P P
Sbjct: 302 ------KEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVP-- 352
Query: 357 KVVNYPTRPVDSNTD---FEGTTTLQPPQPASGPVPGNMAGAH 396
+ S+ D F+ + + P+P G
Sbjct: 353 --------DLSSDIDTSNFDDLEEDKGE-EETFPIPKAFVGNQ 386
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 55/229 (24%), Positives = 96/229 (41%), Gaps = 30/229 (13%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI--- 76
+ IG G +G V+ + + A+K +
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-----RITDIGEVSQF 73
Query: 77 -REIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPY 134
E +++++ +H NV+ L+ + ++ S + Y ++ DL IR+
Sbjct: 74 LTEGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP------- 125
Query: 135 TVK---SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA 190
TVK Q+ G+ YL S +HRDL N ++ +E+ VK+ADFGLAR +Y
Sbjct: 126 TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDK 181
Query: 191 -PLKFLSENGVVVTI-WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
++ G + + W A E L K +T+ D+W+ G + EL+T
Sbjct: 182 EYYSVHNKTGAKLPVKWM-ALESLQTQK-FTTKSDVWSFGVLLWELMTR 228
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 77/338 (22%), Positives = 131/338 (38%), Gaps = 102/338 (30%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
LQ + ++ +G G++G V L R + G+ A+K K K+ ++ L++
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLK--KE----------IVVRLKQ 49
Query: 85 ITHENVVKLVNVHINH-----------ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMN 132
+ H N +L+ + H +++ DY E +L+ ++R + N
Sbjct: 50 VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK 109
Query: 133 PYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPL 192
Y ++ L YLHS II+RDLKP NIL+ ++ G +KI DFG A
Sbjct: 110 FYAA-----EVCLALEYLHSKDIIYRDLKPENILL----DKNGHIKITDFGFA------- 153
Query: 193 KFLSEN-----GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247
K++ + G T Y APE++ K Y ++D W+ G + E+L
Sbjct: 154 KYVPDVTYTLCG---TPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYT-------- 201
Query: 248 STQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS 306
PF K + KIL ++P P +
Sbjct: 202 ----PFYDSNTMKTYEKILNAEL--RFP-----PF-----------------------FN 227
Query: 307 PKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEYFR 339
DLLS+++ D +R+ H +F+
Sbjct: 228 ED--VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 62/250 (24%), Positives = 96/250 (38%), Gaps = 29/250 (11%)
Query: 2 GDGNTSTGRGGTGTSNHGEKP-EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIK 60
+ RG + Y L +G G G V+ A R + +A+K
Sbjct: 9 HHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAE---DTVRERIVALK 65
Query: 61 KFKQSKDGDGVSPTAI----REIMLLREITHENVVKLVNVH-INHADMSLYLAFDYAE-Y 114
++ D P RE + +VV +H D LY+
Sbjct: 66 LMSETLSSD---PVFRTRMQREARTAGRLQEPHVV---PIHDFGEIDGQLYVDMRLINGV 119
Query: 115 DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ 174
DL ++R + P +I+ Q+ + L+ H+ HRD+KP NILV
Sbjct: 120 DLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV----SAD 170
Query: 175 GVVKIADFGLARIYQAPLKFLSENGVVV-TIWYRAPELLLGAKHYTSAVDMWAVGCIFAE 233
+ DFG+A L++ G V T++Y APE H T D++A+ C+ E
Sbjct: 171 DFAYLVDFGIASATTDEK--LTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYE 227
Query: 234 LLTLKPLFQG 243
LT P +QG
Sbjct: 228 CLTGSPPYQG 237
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 78/333 (23%), Positives = 131/333 (39%), Gaps = 92/333 (27%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
L Q++ I +G G++G V L + K + G A+K ++++ L++
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILD------------KQKVVKLKQ 84
Query: 85 ITHENVVKLVNVHINH-----------ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMN 132
I H K + +N + +LY+ +Y +++ +R
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 133 PYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPL 192
Y Q++ YLHS +I+RDLKP N+L+ ++QG +++ DFG A+ +
Sbjct: 145 FYAA-----QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRT 195
Query: 193 KFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252
L G T APE++L K Y AVD WA+G + E+ P P
Sbjct: 196 WTLC--G---TPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP------------P 237
Query: 253 FQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
F DQ +I+ KI+ ++P H+ SD
Sbjct: 238 FFADQPIQIYEKIVSGKV--RFP-----SHFSSD-------------------------L 265
Query: 312 YDLLSKMLEYDPRKRITAAQA-----LEHEYFR 339
DLL +L+ D KR + H++F
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 58/226 (25%), Positives = 88/226 (38%), Gaps = 35/226 (15%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN 89
L +G+G +G V A++K +A+K K +RE ++E H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 90 VVKLVNV----HINHADMSLYLAFDYAEY-DLYEIIRHHRDKVN-HTMNPYTVKSILWQL 143
V KLV V + + ++ DL+ + R N + T+ + +
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA-----------P 191
G+ YL S IHRDL N ++ E V +ADFGL+R IY P
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCML----AEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+K W A E L YT D+WA G E++T
Sbjct: 203 VK-----------WL-ALESLADNL-YTVHSDVWAFGVTMWEIMTR 235
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 38/223 (17%), Positives = 88/223 (39%), Gaps = 35/223 (15%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKA----IAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+G+GT+ +F + + G+ + +K K S + ++ ++
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD--KAHRNYSESFFEAASMMSKL 69
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+H+++V V + L ++ ++ L ++ +++ +N + QL
Sbjct: 70 SHKHLVLNYGVCVC--GDENILVQEFVKFGSLDTYLKKNKNCINIL----WKLEVAKQLA 123
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGE----EQGVVKIADFGLAR------IYQAPLKF 194
+++L N +IH ++ NIL++ E + +K++D G++ I Q +
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP- 182
Query: 195 LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
W PE + K+ A D W+ G E+ +
Sbjct: 183 ----------WV-PPECIENPKNLNLATDKWSFGTTLWEICSG 214
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANR-GKAIAIKKFKQSKDGDGVSPTAI----REIMLL 82
Y ++ K+G G V+LA +AIK + RE+
Sbjct: 13 YKIVDKLGGGGMSTVYLAE----DTILNIKVAIKAIFIPPREK---EETLKRFEREVHNS 65
Query: 83 REITHENVVKLVNVH-INHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSIL 140
+++H+N+V ++ ++ D YL +Y E L E I H ++ T +
Sbjct: 66 SQLSHQNIV---SMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-----GPLSVDTAINFT 117
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
Q+L+G+ + H I+HRD+KP NIL+ +KI DFG+A+ L++
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILID----SNKTLKIFDFGIAKALSETS--LTQTNH 171
Query: 201 VV-TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
V+ T+ Y +PE G + D++++G + E+L +P F G
Sbjct: 172 VLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNG 214
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 85/395 (21%), Positives = 138/395 (34%), Gaps = 97/395 (24%)
Query: 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS--KDGDGVSPTAIREI 79
+W + ++G+ G +G VF ++KA GK A KK + K G + E
Sbjct: 184 EDWFLDFRVLGR---GGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGA-MVEK 236
Query: 80 MLLREITHENVVKLVNVHINHA----DMSLYLAFDYAE-----YDLYEIIRHHRDKVNHT 130
+L ++ +V L L L Y +Y + +
Sbjct: 237 KILAKVHSRFIVSL------AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290
Query: 131 MNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190
YT Q+++GL +LH II+RDLKP N+L+ ++ G V+I+D GLA +
Sbjct: 291 AIFYTA-----QIVSGLEHLHQRNIIYRDLKPENVLL----DDDGNVRISDLGLAV--EL 339
Query: 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250
G T + APELLLG + Y +VD +A+G E++ + F+ K
Sbjct: 340 KAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398
Query: 251 NPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP 310
+L + ++L P SP
Sbjct: 399 -----KELKQ--RVLEQA--------VTYPDK----------------------FSPA-- 419
Query: 311 AYDLLSKMLEYDPRKRI-----TAAQALEHEYFR-----------IEP--LPGRNALVPS 352
+ D +L+ DP KR+ + H FR + P +P +
Sbjct: 420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAK 479
Query: 353 QPGDKVVNYPTRPVD-SNTD---FEGTTTLQPPQP 383
D + V D F+ + P P
Sbjct: 480 NIQDVGAFSTVKGVAFEKADTEFFQEFASGTCPIP 514
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 42/229 (18%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI----REIMLLREI 85
L +GEG +G V +K +A+K K D S I E +++
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL----DNSSQREIEEFLSEAACMKDF 93
Query: 86 THENVVKLVNV---HINHADMSLYLAFDYAEY-DLYEIIRHHRDKVN-HTMNPYTVKSIL 140
+H NV++L+ V + + + +Y DL+ + + R + + T+ +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA--------- 190
+ G+ YL + +HRDL N ++ + V +ADFGL++ IY
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCML----RDDMTVCVADFGLSKKIYSGDYYRQGRIA 209
Query: 191 --PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
P+K W A E L YTS D+WA G E+ T
Sbjct: 210 KMPVK-----------WI-AIESLADRV-YTSKSDVWAFGVTMWEIATR 245
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 54/229 (23%), Positives = 96/229 (41%), Gaps = 30/229 (13%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI--- 76
+ IG G +G V+ + + A+K +
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-----RITDIGEVSQF 137
Query: 77 -REIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPY 134
E +++++ +H NV+ L+ + ++ S + Y ++ DL IR+
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP------- 189
Query: 135 TVK---SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA 190
TVK Q+ G+ +L S +HRDL N ++ +E+ VK+ADFGLAR +Y
Sbjct: 190 TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDK 245
Query: 191 -PLKFLSENGVVVTI-WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
++ G + + W A E L K +T+ D+W+ G + EL+T
Sbjct: 246 EFDSVHNKTGAKLPVKWM-ALESLQTQK-FTTKSDVWSFGVLLWELMTR 292
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 86/344 (25%), Positives = 139/344 (40%), Gaps = 85/344 (24%)
Query: 13 TGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS--KDGDG 70
T G + Q+ L+ +G+G++G VFL + + ++ + A+K K++ K D
Sbjct: 11 THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 70
Query: 71 VSPTAIREIMLLREITHENVVKLVNVHINHA----DMSLYLAFDYAEY-DLYEIIRHHRD 125
V R+I L E+ H +VKL H + LYL D+ DL+ +
Sbjct: 71 VRTKMERDI--LVEVNHPFIVKL------HYAFQTEGKLYLILDFLRGGDLFTRLSKEV- 121
Query: 126 KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185
VK L +L L++LHS II+RDLKP NIL+ +E+G +K+ DFGL+
Sbjct: 122 ----MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL----DEEGHIKLTDFGLS 173
Query: 186 RIYQAPLKFLSENGVVV----TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLF 241
+ + + T+ Y APE++ + +T + D W+ G + E+LT
Sbjct: 174 K------ESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTL-- 224
Query: 242 QGAEAKSTQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLH 300
PFQ + IL +P +
Sbjct: 225 ----------PFQGKDRKETMTMILKAK--------LGMPQF------------------ 248
Query: 301 SVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ--ALE---HEYFR 339
LSP+ A LL + + +P R+ A E H +F
Sbjct: 249 ----LSPE--AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 26/225 (11%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANR-GKAIAIKKFKQSKDGDGVSPTAI----REIMLL 82
Y L +G G V LAR R + +A+K + D P+ RE
Sbjct: 14 YELGEILGFGGMSEVHLAR----DLRDHRDVAVKVLRADLARD---PSFYLRFRREAQNA 66
Query: 83 REITHENVVKL--VNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSI 139
+ H +V + A Y+ +Y + L +I+ M P +
Sbjct: 67 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEV 121
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
+ LN+ H N IIHRD+KP+NI++ VK+ DFG+AR +++
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 200 VVV-TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243
V+ T Y +PE G + D++++GC+ E+LT +P F G
Sbjct: 178 AVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTG 221
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGK-AIAIKKFKQSKDGDGVSPTAIREIM----LLRE 84
I +G G +G V+ + K +AIK+ + + SP A +EI+ ++
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATSPKANKEILDEAYVMAS 73
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+ + +V +L+ + + ++ L + L + +R H+D + + + Q+
Sbjct: 74 VDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQI 126
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
G+NYL ++HRDL N+LV + VKI DFGLA++ A K G V
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 204 I-WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
I W A E +L YT D+W+ G EL+T
Sbjct: 183 IKWM-ALESILHRI-YTHQSDVWSYGVTVWELMTF 215
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 40/217 (18%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITHE 88
L+ IG+G +G V L + G +A+K K + + A + E ++ ++ H
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-----GNKVAVKCIK-----NDATAQAFLAEASVMTQLRHS 74
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
N+V+L+ V I LY+ +Y L + +R + + + +
Sbjct: 75 NLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAM 130
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA------PLKFLSENGV 200
YL N +HRDL N+LV E V K++DFGL + P+K
Sbjct: 131 EYLEGNNFVHRDLAARNVLV----SEDNVAKVSDFGLTKEASSTQDTGKLPVK------- 179
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
W APE L K +++ D+W+ G + E+ +
Sbjct: 180 ----WT-APEALREKK-FSTKSDVWSFGILLWEIYSF 210
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 92/348 (26%), Positives = 142/348 (40%), Gaps = 87/348 (25%)
Query: 12 GTGTSNHGEKPE--WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS---K 66
G+ ++ PE + + L+ +G+G YG VF R AN GK A+K K++ +
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 67 DGDGVSPTAIREIMLLREITHENVVKLVNVHINHA----DMSLYLAFDYAEY-DLYEIIR 121
+ + T E +L E+ H +V L LYL +Y +L+
Sbjct: 61 NAKDTAHT-KAERNILEEVKHPFIVDL------IYAFQTGGKLYLILEYLSGGELF---- 109
Query: 122 HHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181
++ M T L ++ L +LH II+RDLKP NI++ QG VK+ D
Sbjct: 110 MQLEREGIFMED-TACFYLAEISMALGHLHQKGIIYRDLKPENIML----NHQGHVKLTD 164
Query: 182 FGLARIYQAPLKFLSENGVVV----TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
FGL + + + + V TI Y APE+L+ + AVD W++G + ++LT
Sbjct: 165 FGLCK------ESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTG 217
Query: 238 KPLFQGAEAKSTQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYET 296
P PF + K KIL NLP +
Sbjct: 218 AP------------PFTGENRKKTIDKILKCK--------LNLPPY-------------- 243
Query: 297 NGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ--ALE---HEYFR 339
L+ + A DLL K+L+ + R+ A A E H +FR
Sbjct: 244 --------LTQE--ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 74/334 (22%), Positives = 125/334 (37%), Gaps = 94/334 (28%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
++ + L +G+G++G VFLA K + AIK K KD +++ +
Sbjct: 16 IEDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALK--KD----------VVLMDDD 60
Query: 85 ITH--------ENVVK---LVNVHINHADMS-LYLAFDYAEY-DLYEIIRHHRDKVNHTM 131
+ + L ++ L+ +Y DL +H +
Sbjct: 61 VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM----YHIQSCHKFD 116
Query: 132 NPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
+++ GL +LHS I++RDLK NIL+ ++ G +KIADFG+ +
Sbjct: 117 LS-RATFYAAEIILGLQFLHSKGIVYRDLKLDNILL----DKDGHIKIADFGMCK----- 166
Query: 192 LKFLSENGVVV----TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247
+ + + T Y APE+LLG + Y +VD W+ G + E+L +
Sbjct: 167 -ENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQS-------- 216
Query: 248 STQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS 306
PF +++F I P W L
Sbjct: 217 ----PFHGQDEEELFHSIRMDN--------PFYPRW----------------------LE 242
Query: 307 PKSPAYDLLSKMLEYDPRKRITAAQAL-EHEYFR 339
+ A DLL K+ +P KR+ + +H FR
Sbjct: 243 KE--AKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 48/232 (20%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTA----IREIMLLR 83
+ ++G+G++G+V+ K AIK + S + E +++
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-----EAASMRERIEFLNEASVMK 83
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKV--NHTMNPYTVKSIL 140
E +VV+L+ V + + DL +R R + N + P ++ ++
Sbjct: 84 EFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 141 ---WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA------ 190
++ +G+ YL++N +HRDL N +V E VKI DFG+ R IY+
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 191 -----PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
P++ W +PE L +T+ D+W+ G + E+ TL
Sbjct: 198 GKGLLPVR-----------WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATL 236
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 51/230 (22%), Positives = 92/230 (40%), Gaps = 44/230 (19%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTA----IREIMLLR 83
LI +G G +G V+ ++ N + A+K + S + E +++
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-----EVCSEQDELDFLMEALIIS 88
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKV--NHTMNPYTVKSIL 140
+ H+N+V+ + V + + ++ + DL +R R + ++ + +
Sbjct: 89 KFNHQNIVRCIGVSLQ--SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENG 199
+ G YL N IHRD+ N L+ G + V KI DFG+AR IY+
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYR---------- 195
Query: 200 VVVTIWYR------------APELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+YR PE + +TS D W+ G + E+ +L
Sbjct: 196 ---ASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSL 241
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 81/337 (24%), Positives = 136/337 (40%), Gaps = 85/337 (25%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQ----SKDGDGVSPTAIREIM 80
++ + L+ +G G YG VFL R + + GK A+K K+ K R++
Sbjct: 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV- 111
Query: 81 LLREITHEN-VVKLVNVHINHA----DMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPY 134
L I +V L H + L+L DY +L+ + +
Sbjct: 112 -LEHIRQSPFLVTL------HYAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEH 159
Query: 135 TVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKF 194
V+ + +++ L +LH II+RD+K NIL+ + G V + DFGL++ +F
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILL----DSNGHVVLTDFGLSK------EF 209
Query: 195 LSENGVVV-----TIWYRAPELLLGAKH-YTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248
+++ TI Y AP+++ G + AVD W++G + ELLT F K+
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269
Query: 249 TQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSP 307
+Q +I +IL P P +S
Sbjct: 270 SQ--------AEISRRILKSEPP--------YPQE----------------------MSA 291
Query: 308 KSPAYDLLSKMLEYDPRKRI-----TAAQALEHEYFR 339
A DL+ ++L DP+KR+ A + EH +F+
Sbjct: 292 L--AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGK-AIAIKKFKQSKDGDGVSPTAIREIM----LLRE 84
I +G G +G V+ + K +AIK+ + + SP A +EI+ ++
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATSPKANKEILDEAYVMAS 73
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+ + +V +L+ + + ++ L + L + +R H+D + + + Q+
Sbjct: 74 VDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQI 126
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
G+NYL ++HRDL N+LV + VKI DFGLA++ A K G V
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 204 I-WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
I W A E +L YT D+W+ G EL+T
Sbjct: 183 IKWM-ALESILHRI-YTHQSDVWSYGVTVWELMTF 215
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITHE 88
+ K+G G YG V+ K +A+K K+ D + ++E +++EI H
Sbjct: 224 MKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 276
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
N+V+L+ V + Y+ ++ Y +L + +R + ++ + + Q+ + +
Sbjct: 277 NLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAM 331
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYR 207
YL IHR+L N LV E +VK+ADFGL+R+ W
Sbjct: 332 EYLEKKNFIHRNLAARNCLV----GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT- 386
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTL 237
APE L ++ D+WA G + E+ T
Sbjct: 387 APESLA-YNKFSIKSDVWAFGVLLWEIATY 415
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 51/230 (22%), Positives = 92/230 (40%), Gaps = 44/230 (19%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTA----IREIMLLR 83
LI +G G +G V+ ++ N + A+K + S + E +++
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-----EVCSEQDELDFLMEALIIS 129
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKV--NHTMNPYTVKSIL 140
+ H+N+V+ + V + + ++ + DL +R R + ++ + +
Sbjct: 130 KFNHQNIVRCIGVSLQ--SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENG 199
+ G YL N IHRD+ N L+ G + V KI DFG+AR IY+
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYR---------- 236
Query: 200 VVVTIWYR------------APELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+YR PE + +TS D W+ G + E+ +L
Sbjct: 237 ---AGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSL 282
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 40/217 (18%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITHE 88
L+ IG+G +G V L + G +A+K K + + A + E ++ ++ H
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-----GNKVAVKCIK-----NDATAQAFLAEASVMTQLRHS 246
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
N+V+L+ V I LY+ +Y L + +R + + + +
Sbjct: 247 NLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAM 302
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA------PLKFLSENGV 200
YL N +HRDL N+LV E V K++DFGL + P+K
Sbjct: 303 EYLEGNNFVHRDLAARNVLV----SEDNVAKVSDFGLTKEASSTQDTGKLPVK------- 351
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
W APE L K +++ D+W+ G + E+ +
Sbjct: 352 ----WT-APEALREKK-FSTKSDVWSFGILLWEIYSF 382
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-23
Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 26/235 (11%)
Query: 14 GTSNHGEKPEWLQQY-------NLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK 66
G++ GE P L+ K+G+G++G+V A + + ++A+K K
Sbjct: 1 GSA--GEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV 58
Query: 67 DGDGVSPTA-IREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHR 124
+ IRE+ + + H N+++L V + + + + A L + +R H+
Sbjct: 59 LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQ 115
Query: 125 DKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184
T+ Q+ G+ YL S IHRDL N+L+ + +VKI DFGL
Sbjct: 116 GHFL----LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL----ATRDLVKIGDFGL 167
Query: 185 AR-IYQAPLKFLSENGVVVTI-WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
R + Q ++ + V W APE L ++ A D W G E+ T
Sbjct: 168 MRALPQNDDHYVMQEHRKVPFAWC-APESLKTRT-FSHASDTWMFGVTLWEMFTY 220
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIM----LLREI 85
L IGEG +G V + N A+AIK K + S + + + +R+
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-----NCTSDSVREKFLQEALTMRQF 448
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
H ++VKL+ V + +++ + +L ++ + ++ ++ +QL
Sbjct: 449 DHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKFSLDLA----SLILYAYQLS 501
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
L YL S +HRD+ N+LV VK+ DFGL+R + + + G +
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVS----SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
W APE + + +TSA D+W G E+L
Sbjct: 558 WM-APESIN-FRRFTSASDVWMFGVCMWEILMH 588
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITHE 88
+ K+G G YG V+ K +A+K K+ D + ++E +++EI H
Sbjct: 17 MKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 69
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
N+V+L+ V + Y+ ++ Y +L + +R + ++ + + Q+ + +
Sbjct: 70 NLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAM 124
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYR 207
YL IHRDL N LV E +VK+ADFGL+R+ W
Sbjct: 125 EYLEKKNFIHRDLAARNCLV----GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT- 179
Query: 208 APELLLGAKHYTSAVDMWAVGCIFAELLTL 237
APE L K ++ D+WA G + E+ T
Sbjct: 180 APESLAYNK-FSIKSDVWAFGVLLWEIATY 208
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 74/361 (20%), Positives = 126/361 (34%), Gaps = 101/361 (27%)
Query: 4 GNTSTGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFK 63
G + + G G + + + I +G+G++G V LAR+K G A+K K
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKET---GDLYAVKVLK 57
Query: 64 QSKDGDGVSPTAIREIMLLREITH----ENVVKLVNVH---IN-HA----DMSLYLAFDY 111
KD I+ ++ + ++ L H L+ ++
Sbjct: 58 --KD----------VILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEF 105
Query: 112 AEY-DL-YEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMG 169
DL + I + R + ++++ L +LH II+RDLK N+L+
Sbjct: 106 VNGGDLMFHIQKSRRFDEARA------RFYAAEIISALMFLHDKGIIYRDLKLDNVLL-- 157
Query: 170 EGEEQGVVKIADFGLARIYQAPLKFLSENGVVV----TIWYRAPELLLGAKHYTSAVDMW 225
+ +G K+ADFG+ + + + T Y APE+L Y AVD W
Sbjct: 158 --DHEGHCKLADFGMCK------EGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWW 208
Query: 226 AVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQS 284
A+G + E+L PF+ + D +F IL P W
Sbjct: 209 AMGVLLYEMLCGHA------------PFEAENEDDLFEAILNDE--------VVYPTW-- 246
Query: 285 DSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQAL-EHEYF 338
L A +L + +P R+ A+ H +F
Sbjct: 247 --------------------LHED--ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
Query: 339 R 339
+
Sbjct: 285 K 285
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 24/215 (11%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA----IREIMLLREI 85
+ IG G G V R++ R +AIK K G + + E ++ +
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-----AGYTERQRRDFLSEASIMGQF 107
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
H N+++L V + +Y E L +R H + + +L +
Sbjct: 108 DHPNIIRLEGVVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFT----IMQLVGMLRGVG 161
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVVVT 203
G+ YL +HRDL N+LV + V K++DFGL+R + P + G +
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLV----DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 204 I-WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
I W APE + + ++SA D+W+ G + E+L
Sbjct: 218 IRWT-APEAIA-FRTFSSASDVWSFGVVMWEVLAY 250
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-23
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA----IREIMLLREI 85
L IGEG +G V + N A+AIK K + S + ++E + +R+
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-----NCTSDSVREKFLQEALTMRQF 73
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
H ++VKL+ V + +++ + +L ++ + ++ ++ +QL
Sbjct: 74 DHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLS 126
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
L YL S +HRD+ N+LV VK+ DFGL+R + + + G +
Sbjct: 127 TALAYLESKRFVHRDIAARNVLV----SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
W APE + + +TSA D+W G E+L
Sbjct: 183 WM-APESIN-FRRFTSASDVWMFGVCMWEILMH 213
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 73/338 (21%), Positives = 129/338 (38%), Gaps = 99/338 (29%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+ ++ + +G+GT+G V L R KA G+ A+K + K+ I+ E
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILR--KE----------VIIAKDE 48
Query: 85 ITHENVVKLVNVHINH-----------ADMSLYLAFDYAEY-DL-YEIIRHHRDKVNHTM 131
+ H V + H L +YA +L + + R
Sbjct: 49 VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR 108
Query: 132 NPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
Y ++++ L YLHS +++RD+K N+++ ++ G +KI DFGL +
Sbjct: 109 F-YGA-----EIVSALEYLHSRDVVYRDIKLENLML----DKDGHIKITDFGLCK----- 153
Query: 192 LKFLSENGVVV----TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247
+ +S+ + T Y APE+L Y AVD W +G + E++ +
Sbjct: 154 -EGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRL-------- 203
Query: 248 STQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS 306
PF +++F IL P LS
Sbjct: 204 ----PFYNQDHERLFELILMEE--------IRFPRT----------------------LS 229
Query: 307 PKSPAYDLLSKMLEYDPRKRITAAQA-----LEHEYFR 339
P+ A LL+ +L+ DP++R+ + +EH +F
Sbjct: 230 PE--AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-22
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 44/221 (19%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITHE 88
+ +IG G +GLV L +AIK ++ +S I E ++ +++H
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDK----VAIKTIRE----GAMSEEDFIEEAEVMMKLSHP 63
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
+V+L V + + L ++ E+ L + +R R T+ + + G+
Sbjct: 64 KLVQLYGVCLE--QAPICLVTEFMEHGCLSDYLRTQRGLFA----AETLLGMCLDVCEGM 117
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI-----YQA------PLKFLS 196
YL +IHRDL N LV E V+K++DFG+ R Y + P+K
Sbjct: 118 AYLEEACVIHRDLAARNCLV----GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--- 170
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
W +PE+ ++ Y+S D+W+ G + E+ +
Sbjct: 171 --------WA-SPEVFSFSR-YSSKSDVWSFGVLMWEVFSE 201
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 46/227 (20%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI----REIMLLREI 85
IG+G +G+V+ A AIK + RE +L+R +
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-----RITEMQQVEAFLREGLLMRGL 79
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
H NV+ L+ + + + ++ Y + DL + IR + + S Q+
Sbjct: 80 NHPNVLALIGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVA 134
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA------------- 190
G+ YL +HRDL N ++ +E VK+ADFGLAR I
Sbjct: 135 RGMEYLAEQKFVHRDLAARNCML----DESFTVKVADFGLARDILDREYYSVQQHRHARL 190
Query: 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
P+K W A E L + +T+ D+W+ G + ELLT
Sbjct: 191 PVK-----------WT-ALESLQTYR-FTTKSDVWSFGVLLWELLTR 224
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 61/241 (25%), Positives = 92/241 (38%), Gaps = 58/241 (24%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTAIREIMLLREI-- 85
L +G G +G V A A+K K +G + + R L+ E+
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-----EGATHSEHRA--LMSELKI 83
Query: 86 -----THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVK-- 137
H NVV L+ L + ++ ++ +L +R R++
Sbjct: 84 LIHIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 138 ---------SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-I 187
+Q+ G+ +L S IHRDL NIL+ E+ VVKI DFGLAR I
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDI 198
Query: 188 YQA-----------PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
Y+ PLK W APE + YT D+W+ G + E+ +
Sbjct: 199 YKDPDYVRKGDARLPLK-----------WM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 245
Query: 237 L 237
L
Sbjct: 246 L 246
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 48/224 (21%), Positives = 90/224 (40%), Gaps = 45/224 (20%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA----IREIMLLREI 85
L +GEG +G V+ +A+K K + + E ++++ +
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-----KDCTLDNKEKFMSEAVIMKNL 70
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
H ++VKL+ + ++ + Y +L + +++ + T+ Q+
Sbjct: 71 DHPHIVKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLK----VLTLVLYSLQIC 123
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI------YQA-----PLK 193
+ YL S +HRD+ NILV VK+ DFGL+R Y+A P+K
Sbjct: 124 KAMAYLESINCVHRDIAVRNILV----ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 179
Query: 194 FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
W +PE + + +T+A D+W E+L+
Sbjct: 180 -----------WM-SPESINFRR-FTTASDVWMFAVCMWEILSF 210
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 19/212 (8%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGK-AIAIKKFKQSKDGDGVSPTA-IREIMLLREITH 87
+ +G G +G V K + IK + S A ++ + + H
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIED--KSGRQSFQAVTDHMLAIGSLDH 74
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
++V+L+ + SL L Y L + +R HR + P + + Q+ G
Sbjct: 75 AHIVRLLGLCP---GSSLQLVTQYLPLGSLLDHVRQHRGALG----PQLLLNWGVQIAKG 127
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI-W 205
+ YL + ++HR+L N+L+ + V++ADFG+A + K L + I W
Sbjct: 128 MYYLEEHGMVHRNLAARNVLL----KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
A E + K YT D+W+ G EL+T
Sbjct: 184 M-ALESIHFGK-YTHQSDVWSYGVTVWELMTF 213
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 58/232 (25%), Positives = 83/232 (35%), Gaps = 39/232 (16%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTAIREIMLLREI-- 85
+G G +G V A A+ A+K K T L+ E+
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-----PSAHLTEREA--LMSELKV 79
Query: 86 -----THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVK-- 137
H N+V L+ + +Y Y DL +R RD + +
Sbjct: 80 LSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 138 -----------SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186
S +Q+ G+ +L S IHRDL NIL+ + KI DFGLAR
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL----THGRITKICDFGLAR 193
Query: 187 -IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
I + N + W APE + YT D+W+ G EL +L
Sbjct: 194 DIKNDSNYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGIFLWELFSL 243
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 79/333 (23%), Positives = 122/333 (36%), Gaps = 89/333 (26%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS---KDGDGVSPTAIREIML 81
++ + IG+G++G V LAR KA A+K ++ K + + R + L
Sbjct: 37 PSDFHFLKVIGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERNV-L 92
Query: 82 LREITHENVVKLVNVHINHA----DMSLYLAFDYAEY-DL-YEIIRHHRDKVNHTMNPYT 135
L+ + H +V L H LY DY +L Y + R Y
Sbjct: 93 LKNVKHPFLVGL------HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YA 145
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195
++ + L YLHS I++RDLKP NIL+ + QG + + DFGL + + +
Sbjct: 146 A-----EIASALGYLHSLNIVYRDLKPENILL----DSQGHIVLTDFGLCK------ENI 190
Query: 196 SENGVVV----TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251
N T Y APE+L + Y VD W +G + E+L P
Sbjct: 191 EHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLP------------ 237
Query: 252 PFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP 310
PF +++ IL P L ++
Sbjct: 238 PFYSRNTAEMYDNILNKP--------LQLKPN----------------------ITNS-- 265
Query: 311 AYDLLSKMLEYDPRKRITAAQALE----HEYFR 339
A LL +L+ D KR+ A H +F
Sbjct: 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 3e-22
Identities = 75/333 (22%), Positives = 125/333 (37%), Gaps = 88/333 (26%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS--KDGDGVSPTAIREIMLL 82
L +N + +G+G++G V L+ K + A+K K+ D V T + + +L
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 83 REITHENVVKLVNVHINHA----DMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVK 137
+ +L H+ LY +Y DL +H +V P
Sbjct: 397 LPGKPPFLTQL------HSCFQTMDRLYFVMEYVNGGDLM----YHIQQVGRFKEP-HAV 445
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
++ GL +L S II+RDLK N+++ + +G +KIADFG+ K
Sbjct: 446 FYAAEIAIGLFFLQSKGIIYRDLKLDNVML----DSEGHIKIADFGMC-------KENIW 494
Query: 198 NGVVV-----TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252
+GV T Y APE++ + Y +VD WA G + E+L + P
Sbjct: 495 DGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQA------------P 541
Query: 253 FQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
F+ + D++F I+ H P +S + A
Sbjct: 542 FEGEDEDELFQSIMEHN--------VAYPKS----------------------MSKE--A 569
Query: 312 YDLLSKMLEYDPRKRITAAQA-----LEHEYFR 339
+ ++ P KR+ EH +FR
Sbjct: 570 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 67/236 (28%), Positives = 99/236 (41%), Gaps = 55/236 (23%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT--- 86
IGEG +G V ARIK R AIK+ K + S R+ E+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLR-MDAAIKRMK-----EYASKDDHRD--FAGELEVLC 80
Query: 87 ----HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHR--------DKVNHTMNP 133
H N++ L+ + LYLA +YA + +L + +R R N T +
Sbjct: 81 KLGHHPNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 134 YTVK---SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR---I 187
+ + + G++YL IHRDL NILV E V KIADFGL+R +
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV----GENYVAKIADFGLSRGQEV 194
Query: 188 YQA------PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
Y P++ W A E L + YT+ D+W+ G + E+++L
Sbjct: 195 YVKKTMGRLPVR-----------WM-AIESLNYSV-YTTNSDVWSYGVLLWEIVSL 237
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 71/338 (21%), Positives = 124/338 (36%), Gaps = 98/338 (28%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
L +N + +G+G++G V L+ K + A+K K KD ++ +
Sbjct: 19 LTDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILK--KD----------VVIQDDD 63
Query: 85 ITH----ENVVKLVNVH---IN-HA----DMSLYLAFDYAEY-DLYEIIRHHRDKVNHTM 131
+ + V+ L H+ LY +Y DL +H +V
Sbjct: 64 VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM----YHIQQVGRFK 119
Query: 132 NPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
P ++ GL +L S II+RDLK N+++ + +G +KIADFG+ +
Sbjct: 120 EP-HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML----DSEGHIKIADFGMCK----- 169
Query: 192 LKFLSENGVVV----TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247
+ + + T Y APE++ + Y +VD WA G + E+L +
Sbjct: 170 -ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQA-------- 219
Query: 248 STQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS 306
PF+ + D++F I+ H P +S
Sbjct: 220 ----PFEGEDEDELFQSIMEHN--------VAYPKS----------------------MS 245
Query: 307 PKSPAYDLLSKMLEYDPRKRITAAQA-----LEHEYFR 339
+ A + ++ P KR+ EH +FR
Sbjct: 246 KE--AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-22
Identities = 56/238 (23%), Positives = 94/238 (39%), Gaps = 54/238 (22%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTA----IREIMLLR 83
+ ++GE +G V+ + A + AIK K D E ML
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-----DKAEGPLREEFRHEAMLRA 67
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVK----- 137
+ H NVV L+ V D L + F Y + DL+E + +
Sbjct: 68 RLQHPNVVCLLGVVTK--DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 138 ------SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA 190
++ Q+ G+ YL S+ ++H+DL N+LV ++ VKI+D GL R +Y A
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV----YDKLNVKISDLGLFREVYAA 181
Query: 191 -----------PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
P++ W APE ++ K ++ D+W+ G + E+ +
Sbjct: 182 DYYKLLGNSLLPIR-----------WM-APEAIMYGK-FSIDSDIWSYGVVLWEVFSY 226
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 9e-22
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN 89
L K+G+G +G V+ N +AIK K G ++E +++++ HE
Sbjct: 188 LEVKLGQGCFGEVW----MGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEK 240
Query: 90 VVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLN 148
+V+L V +Y+ +Y L + ++ K + + + Q+ +G+
Sbjct: 241 LVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMA 294
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA 208
Y+ +HRDL+ +NILV E V K+ADFGLAR+ + + W A
Sbjct: 295 YVERMNYVHRDLRAANILV----GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-A 349
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAELLTL 237
PE L +T D+W+ G + EL T
Sbjct: 350 PEAAL-YGRFTIKSDVWSFGILLTELTTK 377
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 33/227 (14%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTA----IREIMLLR 83
L ++GEG +G VFLA + + A+K K + A RE LL
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP------TLAARKDFQREAELLT 72
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVK----- 137
+ HE++VK V + L + F+Y ++ DL + +R H ++ +
Sbjct: 73 NLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 138 ------SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA 190
I Q+ +G+ YL S +HRDL N LV +VKI DFG++R +Y
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV----GANLLVKIGDFGMSRDVYST 186
Query: 191 PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+ + ++ W PE ++ K +T+ D+W+ G I E+ T
Sbjct: 187 DYYRVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFGVILWEIFTY 231
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 62/237 (26%), Positives = 96/237 (40%), Gaps = 54/237 (22%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTA----IREIMLLR 83
L ++GEG +G VFLA + A+K K++ S +A RE LL
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESARQDFQREAELLT 98
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVK----- 137
+ H+++V+ V L + F+Y + DL +R H V
Sbjct: 99 MLQHQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 138 -----SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQA- 190
++ Q+ G+ YL +HRDL N LV + VVKI DFG++R IY
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV----GQGLVVKIGDFGMSRDIYSTD 212
Query: 191 ----------PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
P++ W PE +L K +T+ D+W+ G + E+ T
Sbjct: 213 YYRVGGRTMLPIR-----------WM-PPESILYRK-FTTESDVWSFGVVLWEIFTY 256
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA----IREIMLLREI 85
+ +G G +G V R+K + + ++AIK K G + + E ++ +
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-----VGYTEKQRRDFLGEASIMGQF 103
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
H N+++L V + + +Y E L +R H + + +L +
Sbjct: 104 DHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKHDAQFT----VIQLVGMLRGIA 157
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVVVT 203
+G+ YL +HRDL NIL+ V K++DFGL R + P + G +
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 204 I-WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
I W +PE + K +TSA D+W+ G + E+++
Sbjct: 214 IRWT-SPEAIAYRK-FTSASDVWSYGIVLWEVMSY 246
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 81/340 (23%), Positives = 135/340 (39%), Gaps = 92/340 (27%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
LQ ++L+ IG G+Y V L R+K + A+K K K+ + +
Sbjct: 8 LQDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKVVK--KE----------LVNDDED 52
Query: 85 ITH----ENVVKLVNVH---IN-HA----DMSLYLAFDYAEY-DL-YEIIRHHRDKVNHT 130
I ++V + + H + H+ + L+ +Y DL + + R + H
Sbjct: 53 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA 112
Query: 131 MNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190
Y+ ++ LNYLH II+RDLK N+L+ + +G +K+ D+G+ +
Sbjct: 113 RF-YSA-----EISLALNYLHERGIIYRDLKLDNVLL----DSEGHIKLTDYGMCK---- 158
Query: 191 PLKFLSENGVVV----TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246
+ L T Y APE+L G + Y +VD WA+G + E++ + F
Sbjct: 159 --EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVG- 214
Query: 247 KSTQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPL 305
S+ NP Q + D +F IL +P L
Sbjct: 215 -SSDNPDQNTE-DYLFQVILEKQ--------IRIPRS----------------------L 242
Query: 306 SPKSPAYDLLSKMLEYDPRKRI-----TAAQAL-EHEYFR 339
S K A +L L DP++R+ T + H +FR
Sbjct: 243 SVK--AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 21 KPEWL---QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIR 77
K +W+ + L +IG G +G VF R++ +A+K +++ D + ++
Sbjct: 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLR---ADNTLVAVKSCRETLPPDLKA-KFLQ 161
Query: 78 EIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTV 136
E +L++ +H N+V+L+ V +Y+ + + D +R ++ T+
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQGGDFLTFLRTEGARLR----VKTL 215
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
++ G+ YL S IHRDL N LV E+ V+KI+DFG++R + S
Sbjct: 216 LQMVGDAAAGMEYLESKCCIHRDLAARNCLV----TEKNVLKISDFGMSREEADGVYAAS 271
Query: 197 ENGVVVTI-WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
V + W APE L + Y+S D+W+ G + E +L
Sbjct: 272 GGLRQVPVKWT-APEALNYGR-YSSESDVWSFGILLWETFSL 311
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 76/340 (22%), Positives = 132/340 (38%), Gaps = 92/340 (27%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
LQ ++L+ IG G+Y V L R+K + A++ K K+ + +
Sbjct: 51 LQDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMRVVK--KE----------LVNDDED 95
Query: 85 ITH----ENVVKLVNVH---IN-HA----DMSLYLAFDYAEY-DL-YEIIRHHRDKVNHT 130
I ++V + + H + H+ + L+ +Y DL + + R + H
Sbjct: 96 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA 155
Query: 131 MNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190
Y+ ++ LNYLH II+RDLK N+L+ + +G +K+ D+G+ +
Sbjct: 156 RF-YSA-----EISLALNYLHERGIIYRDLKLDNVLL----DSEGHIKLTDYGMCK---- 201
Query: 191 PLKFLSENGVVV----TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246
+ L T Y APE+L G + Y +VD WA+G + E++ + F
Sbjct: 202 --EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVG- 257
Query: 247 KSTQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPL 305
+ + + D +F IL +P L
Sbjct: 258 --SSDNPDQNTEDYLFQVILEKQ--------IRIPRS----------------------L 285
Query: 306 SPKSPAYDLLSKMLEYDPRKRI-----TAAQAL-EHEYFR 339
S K A +L L DP++R+ T + H +FR
Sbjct: 286 SVK--AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITHENVV 91
++G G +G V + + +AIK KQ + +RE ++ ++ + +V
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQID-VAIKVLKQ--GTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 92 KLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL 150
+L+ V +L L + A L++ + R+++ V +L Q+ G+ YL
Sbjct: 74 RLIGVCQ---AEALMLVMEMAGGGPLHKFLVGKREEIP----VSNVAELLHQVSMGMKYL 126
Query: 151 HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVVVTI-WYRA 208
+HRDL N+L+ + KI+DFGL++ + + + + + WY A
Sbjct: 127 EEKNFVHRDLAARNVLL----VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-A 181
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAELLTL 237
PE + K ++S D+W+ G E L+
Sbjct: 182 PECINFRK-FSSRSDVWSYGVTMWEALSY 209
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 48/219 (21%), Positives = 95/219 (43%), Gaps = 40/219 (18%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
++G G +G V + K +A+K K + + + E +++++ + +V+
Sbjct: 24 ELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
++ + S L + AE L + ++ +R + + ++ Q+ G+ YL
Sbjct: 83 MIGICEAE---SWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYLE 134
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI-------YQA------PLKFLSEN 198
+ +HRDL N+L+ Q KI+DFGL++ Y+A P+K
Sbjct: 135 ESNFVHRDLAARNVLL----VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK----- 185
Query: 199 GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
WY APE + K ++S D+W+ G + E +
Sbjct: 186 ------WY-APECINYYK-FSSKSDVWSFGVLMWEAFSY 216
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 64/235 (27%), Positives = 97/235 (41%), Gaps = 40/235 (17%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTA----IREIMLLR 83
L +GEG +G V A R A+K K + SP+ + E +L+
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-----ENASPSELRDLLSEFNVLK 81
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVK----- 137
++ H +V+KL D L L +YA+Y L +R R + +
Sbjct: 82 QVNHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 138 --------------SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183
S WQ+ G+ YL ++HRDL NILV E +KI+DFG
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV----AEGRKMKISDFG 195
Query: 184 LAR-IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
L+R +Y+ G + W A E L YT+ D+W+ G + E++TL
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVTL 248
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 44/221 (19%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITHE 88
L+ ++G G +G+V L + +A+K K+ +S +E + +++H
Sbjct: 12 LLKELGSGQFGVVKLGK----WKGQYDVAVKMIKE----GSMSEDEFFQEAQTMMKLSHP 63
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
+VK V + +Y+ +Y L +R H + P + + + + G+
Sbjct: 64 KLVKFYGVCSK--EYPIYIVTEYISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGM 117
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI-----YQA------PLKFLS 196
+L S+ IHRDL N LV + VK++DFG+ R Y + P+K
Sbjct: 118 AFLESHQFIHRDLAARNCLV----DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK--- 170
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
W APE+ K Y+S D+WA G + E+ +L
Sbjct: 171 --------WS-APEVFHYFK-YSSKSDVWAFGILMWEVFSL 201
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 63/248 (25%), Positives = 93/248 (37%), Gaps = 66/248 (26%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTAIREIMLLREI-- 85
+G G +G V A + G +I A+K K + + L+ E+
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-----EKADSSEREA--LMSELKM 101
Query: 86 -----THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVK-- 137
+HEN+V L+ +YL F+Y Y DL +R R+K + Y +
Sbjct: 102 MTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 138 ----------------SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181
+Q+ G+ +L +HRDL N+LV VVKI D
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV----THGKVVKICD 215
Query: 182 FGLAR-IYQA-----------PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGC 229
FGLAR I P+K W APE L YT D+W+ G
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVK-----------WM-APESLFEGI-YTIKSDVWSYGI 262
Query: 230 IFAELLTL 237
+ E+ +L
Sbjct: 263 LLWEIFSL 270
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 67/246 (27%), Positives = 95/246 (38%), Gaps = 62/246 (25%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTA----IREIMLLR 83
+ IGEG +G VF AR A+K K + S RE L+
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-----EEASADMQADFQREAALMA 105
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVK----- 137
E + N+VKL+ V + L F+Y Y DL E +R +++ +
Sbjct: 106 EFDNPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 138 --------------SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183
I Q+ G+ YL +HRDL N LV E VVKIADFG
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV----GENMVVKIADFG 219
Query: 184 LAR-IYQA-----------PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIF 231
L+R IY A P++ W PE + + YT+ D+WA G +
Sbjct: 220 LSRNIYSADYYKADGNDAIPIR-----------WM-PPESIFYNR-YTTESDVWAYGVVL 266
Query: 232 AELLTL 237
E+ +
Sbjct: 267 WEIFSY 272
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 75/358 (20%), Positives = 134/358 (37%), Gaps = 98/358 (27%)
Query: 5 NTSTGRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQ 64
+ S + + + ++ + +G+GT+G V L + KA G+ A+K K
Sbjct: 127 DNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILK- 182
Query: 65 SKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH-----------ADMSLYLAFDYAE 113
K+ I+ E+ H V + H L +YA
Sbjct: 183 -KE----------VIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 231
Query: 114 YDLYEIIRH-HRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEG 171
E+ H R++V + + ++++ L+YLHS +++RDLK N+++
Sbjct: 232 GG--ELFFHLSRERV---FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---- 282
Query: 172 EEQGVVKIADFGLARIYQAPLKFLSENGVVV----TIWYRAPELLLGAKHYTSAVDMWAV 227
++ G +KI DFGL + + + + + T Y APE+L Y AVD W +
Sbjct: 283 DKDGHIKITDFGLCK------EGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGL 335
Query: 228 GCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF-KILGHPTPEKWPTLANLPHWQSDS 286
G + E++ + PF +K+F IL P
Sbjct: 336 GVVMYEMMCGRL------------PFYNQDHEKLFELILMEE--------IRFPRT---- 371
Query: 287 LHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA-----LEHEYFR 339
L P+ A LLS +L+ DP++R+ ++H +F
Sbjct: 372 ------------------LGPE--AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 9e-21
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN 89
L K+G+G +G V+ N +AIK K G ++E +++++ HE
Sbjct: 271 LEVKLGQGCFGEVW----MGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEK 323
Query: 90 VVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLN 148
+V+L V +Y+ +Y L + ++ K + + + Q+ +G+
Sbjct: 324 LVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMA 377
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA 208
Y+ +HRDL+ +NILV E V K+ADFGLAR+ + + W A
Sbjct: 378 YVERMNYVHRDLRAANILV----GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-A 432
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAELLTL 237
PE L + +T D+W+ G + EL T
Sbjct: 433 PEAALYGR-FTIKSDVWSFGILLTELTTK 460
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 68/243 (27%), Positives = 95/243 (39%), Gaps = 61/243 (25%)
Query: 30 LIGKIGEGTYGLVFLAR----IKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
L +GEG +G V +A K +A+K K D + + + L+ E+
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDLSD--LVSEM 137
Query: 86 -------THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVK 137
H+N++ L+ D LY+ +YA +L E +R R
Sbjct: 138 EMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 138 -----------SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186
S +QL G+ YL S IHRDL N+LV E V+KIADFGLAR
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLAR 251
Query: 187 -IYQA-----------PLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAEL 234
I P+K W APE L YT D+W+ G + E+
Sbjct: 252 DINNIDYYKKTTNGRLPVK-----------WM-APEALFDRV-YTHQSDVWSFGVLMWEI 298
Query: 235 LTL 237
TL
Sbjct: 299 FTL 301
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 66/244 (27%), Positives = 94/244 (38%), Gaps = 63/244 (25%)
Query: 30 LIGKIGEGTYGLVFLAR----IKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
L +GEG +G V +A K +A+K K D + + + L+ E+
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDLSD--LVSEM 91
Query: 86 -------THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVK 137
H+N++ L+ D LY+ +YA +L E +R R
Sbjct: 92 EMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 138 -----------SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186
S +QL G+ YL S IHRDL N+LV E V+KIADFGLAR
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLAR 205
Query: 187 -IYQAPLKFLSENGVVVTIWYR------------APELLLGAKHYTSAVDMWAVGCIFAE 233
I +Y+ APE L YT D+W+ G + E
Sbjct: 206 DINN-------------IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWE 251
Query: 234 LLTL 237
+ TL
Sbjct: 252 IFTL 255
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 44/221 (19%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA-IREIMLLREITHE 88
+ ++G G +G+V + +AIK K+ +S I E ++ ++HE
Sbjct: 28 FLKELGTGQFGVVKYGK----WRGQYDVAIKMIKE----GSMSEDEFIEEAKVMMNLSHE 79
Query: 89 NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
+V+L V +++ +Y L +R R + + + + +
Sbjct: 80 KLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKDVCEAM 133
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI-----YQA------PLKFLS 196
YL S +HRDL N LV +QGVVK++DFGL+R Y + P++
Sbjct: 134 EYLESKQFLHRDLAARNCLV----NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR--- 186
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
W PE+L+ +K ++S D+WA G + E+ +L
Sbjct: 187 --------WS-PPEVLMYSK-FSSKSDIWAFGVLMWEIYSL 217
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN 89
L K+G G +G V++A N+ +A+K K G + E +++ + H+
Sbjct: 192 LEKKLGAGQFGEVWMAT----YNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDK 244
Query: 90 VVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLN 148
+VKL V +Y+ ++ L + ++ + Q+ G+
Sbjct: 245 LVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMA 298
Query: 149 YLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA 208
++ IHRDL+ +NILV V KIADFGLAR+ + E W A
Sbjct: 299 FIEQRNYIHRDLRAANILV----SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT-A 353
Query: 209 PELLLGAKHYTSAVDMWAVGCIFAELLTL 237
PE + +T D+W+ G + E++T
Sbjct: 354 PEAINFGS-FTIKSDVWSFGILLMEIVTY 381
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 66/244 (27%), Positives = 102/244 (41%), Gaps = 63/244 (25%)
Query: 30 LIGKIGEGTYGLVFLAR----IKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
L +GEG +G V LA K NR +A+K K + + + L+ E+
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-----SDATEKDLSD--LISEM 125
Query: 86 -------THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHR--------DKVNH 129
H+N++ L+ D LY+ +YA +L E ++ R + ++
Sbjct: 126 EMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 130 TMNPYTVKSIL---WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186
+ K ++ +Q+ G+ YL S IHRDL N+LV E V+KIADFGLAR
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV----TEDNVMKIADFGLAR 239
Query: 187 -IYQAPLKFLSENGVVVTIWYR------------APELLLGAKHYTSAVDMWAVGCIFAE 233
I+ +Y+ APE L YT D+W+ G + E
Sbjct: 240 DIHH-------------IDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWE 285
Query: 234 LLTL 237
+ TL
Sbjct: 286 IFTL 289
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 3e-20
Identities = 48/208 (23%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
++G G +G V + + +AIK KQ + + +RE ++ ++ + +V+
Sbjct: 343 ELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVR 400
Query: 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
L+ V +L L + A L++ + R+++ V +L Q+ G+ YL
Sbjct: 401 LIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIP----VSNVAELLHQVSMGMKYLE 453
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVVVTI-WYRAP 209
+HR+L N+L+ + KI+DFGL++ + + + + + WY AP
Sbjct: 454 EKNFVHRNLAARNVLL----VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-AP 508
Query: 210 ELLLGAKHYTSAVDMWAVGCIFAELLTL 237
E + K ++S D+W+ G E L+
Sbjct: 509 ECINFRK-FSSRSDVWSYGVTMWEALSY 535
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 53/228 (23%), Positives = 81/228 (35%), Gaps = 35/228 (15%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAI--AIKKFKQSKDGDGVSPTAIREIMLLREI-- 85
+G G +G V A + A+K K L+ E+
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-----STAHADEKEA--LMSELKI 102
Query: 86 -----THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSI 139
HEN+V L+ + + + +Y Y DL +R + S
Sbjct: 103 MSHLGQHENIVNLLGACTH--GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 140 L---------WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQ 189
Q+ G+ +L S IHRD+ N+L+ V KI DFGLAR I
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL----TNGHVAKIGDFGLARDIMN 216
Query: 190 APLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+ N + W APE + YT D+W+ G + E+ +L
Sbjct: 217 DSNYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFSL 262
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 25/223 (11%)
Query: 20 EKPEW---LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA- 75
+ EW + L+ ++G G +G V++ N +A+K KQ +SP A
Sbjct: 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGY----YNGHTKVAVKSLKQ----GSMSPDAF 55
Query: 76 IREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPY 134
+ E L++++ H+ +V+L V +Y+ +Y E L + ++ +
Sbjct: 56 LAEANLMKQLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGI---KLTIN 109
Query: 135 TVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKF 194
+ + Q+ G+ ++ IHRDL+ +NILV + KIADFGLAR+ +
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILV----SDTLSCKIADFGLARLIEDNEYT 165
Query: 195 LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
E W APE + +T D+W+ G + E++T
Sbjct: 166 AREGAKFPIKWT-APEAINYGT-FTIKSDVWSFGILLTEIVTH 206
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGK-AIAIKKFKQSKDGDGVSPTA----IREIMLLRE 84
IG G +G V+ +K ++ + + +AIK K G + + E ++ +
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-----AGYTEKQRVDFLGEAGIMGQ 102
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+H N+++L V + + +Y E L + +R + + + +L +
Sbjct: 103 FSHHNIIRLEGVIS--KYKPMMIITEYMENGALDKFLREKDGEFS----VLQLVGMLRGI 156
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVVV 202
G+ YL + +HRDL NILV V K++DFGL+R + P + +G +
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILV----NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 203 TI-WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
I W APE + + +TSA D+W+ G + E++T
Sbjct: 213 PIRWT-APEAIS-YRKFTSASDVWSFGIVMWEVMTY 246
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 36/214 (16%), Positives = 72/214 (33%), Gaps = 38/214 (17%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAAN--RGKAIAIKKFKQSKDGDGVSPTAIREIMLLR 83
+ + IG+G +G ++LA + ++ + +K + E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD------NGPLFTELKFYQ 88
Query: 84 EITHENVVKLVN-----------------VHINHADMSLYLAFDYAEYDLYEIIRHHRDK 126
++ +H + ++ D DL +I +
Sbjct: 89 RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIY----EA 144
Query: 127 VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186
+ TV + ++L+ L Y+H + +H D+K SN+L + V + D+GLA
Sbjct: 145 NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL-LNYKNPD-QVYLVDYGLAY 202
Query: 187 IYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTS 220
Y GV G +TS
Sbjct: 203 RYCPE-------GVHKAYAADPKRCHDGTIEFTS 229
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 53/204 (25%), Positives = 78/204 (38%), Gaps = 64/204 (31%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIR----EIMLLREITHE 88
IG G +G V+ + G +A+K+ S I EI L H
Sbjct: 46 LIGHGVFGKVYKGVL----RDGAKVALKRRTPE------SSQGIEEFETEIETLSFCRHP 95
Query: 89 NVVKLVNVHINHADMSL-YLAFDYAEY----DLYEIIRHH---RDKVNHTMNPYTVKSIL 140
++V L+ +M L Y +Y +L + H D +M+
Sbjct: 96 HLVSLIGFCDERNEMILIY------KYMENGNL----KRHLYGSDLPTMSMS-------- 137
Query: 141 W-QLLN-------GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPL 192
W Q L GL+YLH+ IIHRD+K NIL+ +E V KI DFG+++
Sbjct: 138 WEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL----DENFVPKITDFGISKK----- 188
Query: 193 KFLSENG------VVVTIWYRAPE 210
+ V T+ Y PE
Sbjct: 189 -GTELDQTHLSTVVKGTLGYIDPE 211
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 20/194 (10%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y L KIG G++G ++L G+ +AIK P E + + +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDI---AAGEEVAIKLECVKTK----HPQLHIESKIYKMMQ 62
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
+ + D + + + L ++ + + + TV + Q+++
Sbjct: 63 GGVGIPTIRWCGAEGDYN-VMVMELLGPSLEDL----FNFCSRKFSLKTVLLLADQMISR 117
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
+ Y+HS IHRD+KP N L MG G++ +V I DFGLA+ Y+ I Y
Sbjct: 118 IEYIHSKNFIHRDVKPDNFL-MGLGKKGNLVYIIDFGLAKKYRDA-----RTHQH--IPY 169
Query: 207 RAPELLLGAKHYTS 220
R + L G Y S
Sbjct: 170 RENKNLTGTARYAS 183
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 33/163 (20%), Positives = 64/163 (39%), Gaps = 13/163 (7%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
Y + +IGEG++G++F + +AIK + D +P E + +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNL---LNNQQVAIKFEPRRSD----APQLRDEYRTYKLLA 63
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
+ V + L D L ++ D + TV Q+L
Sbjct: 64 GCTGIPNVYYFGQEGLHN-VLVIDLLGPSLEDL----LDLCGRKFSVKTVAMAAKQMLAR 118
Query: 147 LNYLHSNWIIHRDLKPSNILV-MGEGEEQGVVKIADFGLARIY 188
+ +H +++RD+KP N L+ + ++ + DFG+ + Y
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 22/210 (10%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
+G G +G V+ R+ G +A+K+ K + G E+ ++ H N+++
Sbjct: 37 ILGRGGFGKVYKGRLA----DGTLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLR 91
Query: 93 LVN--VHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYL 150
L + L + Y R + ++ + I GL YL
Sbjct: 92 LRGFCMTPTE----RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 147
Query: 151 HSNW---IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYR 207
H + IIHRD+K +NIL+ +E+ + DFGLA++ ++ V TI +
Sbjct: 148 HDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHI 202
Query: 208 APE-LLLGAKHYTSAVDMWAVGCIFAELLT 236
APE L G + D++ G + EL+T
Sbjct: 203 APEYLSTG--KSSEKTDVFGYGVMLLELIT 230
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 42/212 (19%), Positives = 78/212 (36%), Gaps = 37/212 (17%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
Q+ L KIG G +GL++LA A + K + + + E+ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAF-PTNKPEKDARHVVKVEYQE-----NGPLFSELKFYQRV 90
Query: 86 THENVVKLVNVHINHADMSL-----------------YLAFDYAEYDLYEIIRHHRDKVN 128
++ +K + + ++ + DL +I +
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG---- 146
Query: 129 HTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188
T TV + ++L+ L Y+H N +H D+K +N+L +G V +AD+GL+ Y
Sbjct: 147 -TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLL-LGYKNPD-QVYLADYGLSYRY 203
Query: 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTS 220
NG + G +TS
Sbjct: 204 -------CPNGNHKQYQENPRKGHNGTIEFTS 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 29/178 (16%), Positives = 62/178 (34%), Gaps = 23/178 (12%)
Query: 26 QQYNLIGKIGEGTYGLVFLAR-----IKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIM 80
+Q+ L G+++ A + + + ++K +KDG +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL--DAKDGRLFNEQNF---- 95
Query: 81 LLREITHENVVKLVNVH-INHADMSLYLAFDYAEYDLYEII---------RHHRDKVNHT 130
R V K ++ + + F + ++ H
Sbjct: 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHV 155
Query: 131 MNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188
++ +V + +LL+ L +LH N +H ++ NI + +Q V +A +G A Y
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF-VDPE-DQSQVTLAGYGFAFRY 211
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 6/91 (6%)
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
G+N+LH N IHRD+K +NIL+ +E KI+DFGLAR + + + + +V T
Sbjct: 145 GINFLHENHHIHRDIKSANILL----DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTA 200
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236
Y APE L G T D+++ G + E++T
Sbjct: 201 YMAPEALRG--EITPKSDIYSFGVVLLEIIT 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 28/225 (12%), Positives = 51/225 (22%), Gaps = 50/225 (22%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI-REIMLLREIT 86
Y L+ G + A A + +A+ + L I
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTA---LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 87 HENVVKLVNVH-INHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
V V + H + ++ L E+ +P + L
Sbjct: 90 KPGVA---RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLA 139
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
+ H + PS + V +G+ V +A
Sbjct: 140 AAADAAHRAGVALSIDHPSRVRVSIDGD----VVLAYPA--------------------- 174
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST 249
D+ +G LL + A +S
Sbjct: 175 -TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSG 210
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 37/101 (36%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLS 196
+Q+ G+ +L S IHRDL NIL+ E+ VVKI DFGLAR IY+ P
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL 237
+ + W APE + YT D+W+ G + E+ +L
Sbjct: 253 GDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSL 291
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 30/145 (20%), Positives = 53/145 (36%), Gaps = 15/145 (10%)
Query: 30 LIGKIGEGTYGLVFLARIK--AAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-T 86
L +G G +G V A + +A+K K+ + E+ +L I
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR-ALMSELKILIHIGH 84
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
H NVV L+ L + ++ ++ +L +R R + PY K +
Sbjct: 85 HLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKR----NEFVPYKTKG--ARFRQ 137
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGE 170
G +Y+ + I DLK +
Sbjct: 138 GKDYVGA---IPVDLKRRLDSITSS 159
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 58/251 (23%), Positives = 97/251 (38%), Gaps = 38/251 (15%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+ + KIG G +G + L + + +AIK P E +++
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNL---YTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLG 62
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
+ + V + + + L ++ D + T + TV I QL++
Sbjct: 63 SGDGIPQVYYFGPCGKYN-AMVLELLGPSLEDL----FDLCDRTFSLKTVLMIAIQLISR 117
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGE--EQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
+ Y+HS +I+RD+KP N L +G Q V+ I DF LA+ Y P E I
Sbjct: 118 MEYVHSKNLIYRDVKPENFL-IGRPGNKTQQVIHIIDFALAKEYIDP-----ETKKH--I 169
Query: 205 WYRAPELLLGAKHYTS-----------AVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253
YR + L G Y S D+ A+G +F L +QG +A + +
Sbjct: 170 PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK--- 226
Query: 254 QLDQLDKIFKI 264
++ KI
Sbjct: 227 --ERYQKIGDT 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 74/468 (15%), Positives = 140/468 (29%), Gaps = 67/468 (14%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
++ L KIG G++G ++L + +AIK P + E + R +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTK----HPQLLYESKIYRILQ 60
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
+ V D + L D L ++ + + ++ TV + Q++N
Sbjct: 61 GGTGIPNVRWFGVEGDYN-VLVMDLLGPSLEDL----FNFCSRKLSLKTVLMLADQMINR 115
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
+ ++HS +HRD+KP N L MG G V I DFGLA+ Y+ I Y
Sbjct: 116 VEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKKYRDTSTH-------QHIPY 167
Query: 207 RAPELLLGAKHYTSAV-----------DMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255
R + L G Y S D+ ++G + L +QG +A + +
Sbjct: 168 RENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK----- 222
Query: 256 DQLDKIFKILGHPTPEKWPTLANLPH-WQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDL 314
+ +KI + + E P + S + + +++ P Y
Sbjct: 223 QKYEKISEKKVATSIEA--LCRGYPTEFASYFHYCRSLRFDDK------------PDYSY 268
Query: 315 LSKMLE-------------YD--PRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVV 359
L ++ +D K + A P+ D+
Sbjct: 269 LKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQS 328
Query: 360 NYPTRPVDSNTDFEGTTTLQPPQPASGPVPGNMAGAHAVS-NRNVPRPMPGVGMQRMQAQ 418
+ + P + S ++ + +
Sbjct: 329 GVDEGRTSGWSSMDRRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSS 388
Query: 419 GMMTYNFPGQAGAAGGMNPANMPMQRGMPGQAHQQQQLRRKDPGMGLP 466
+ P+ PG + ++ P
Sbjct: 389 RRPAVSSSRDVMPIDTSEPSRTRATDASPGAFRRTSGPQKSSPVNSAE 436
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 1e-04
Identities = 54/346 (15%), Positives = 114/346 (32%), Gaps = 99/346 (28%)
Query: 55 KAIAIKKFKQSKDGDGVSPTAIREI-MLLRE--ITHENVVKLVNVHINHA-DMSLYLAFD 110
K + + ++ +P + I +R+ T +N + + + SL +
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL-NVLE 367
Query: 111 YAEY-DLYE---IIRHHRDKVNHTMNPYTVKSILWQLLNG------LNYLHSNWIIHRDL 160
AEY +++ + + P + S++W + +N LH ++ +
Sbjct: 368 PAEYRKMFDRLSVFP---PSAH---IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQP 421
Query: 161 KPSNILVMG-------EGEEQGVV--KIADFGLARIYQAPLKFLSENGVVVTI-----WY 206
K S I + + E + + I D Y P F S++ + + +
Sbjct: 422 KESTISIPSIYLELKVKLENEYALHRSIVDH-----YNIPKTFDSDDLIPPYLDQYFYSH 476
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKP-LFQGAEAKSTQNPFQLDQLDKIF--- 262
+G H+ ++ E +TL +F LD F
Sbjct: 477 ------IG--HHLKNIEH-------PERMTLFRMVF----------------LDFRFLEQ 505
Query: 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYD-LLSKMLEY 321
KI T W N ++L Q + Y+ + + P Y+ L++ +L++
Sbjct: 506 KIRHDSTA--W----NASGSILNTLQ-QLKFYKP---Y----ICDNDPKYERLVNAILDF 551
Query: 322 DPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVD 367
P+ + +Y + R AL + + + V
Sbjct: 552 LPK---IEENLICSKYTDLL----RIAL--MAEDEAIFEEAHKQVQ 588
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 9e-04
Identities = 11/94 (11%), Positives = 18/94 (19%), Gaps = 6/94 (6%)
Query: 379 QPPQPASGPVPGNMAGAHAVSNRNVPRPMPGVGMQRMQAQGMMTYNFPGQAGAAGGMNPA 438
Q P P P GM G + PA
Sbjct: 12 AQLQYGQNATPLQQPAQFM------PPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPA 65
Query: 439 NMPMQRGMPGQAHQQQQLRRKDPGMGLPGYPPQQ 472
+ + + + + + P Q
Sbjct: 66 QEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQP 99
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 477 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.43 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.19 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.1 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.09 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.95 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.87 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.72 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.46 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.34 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.22 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.2 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.98 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.93 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.83 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.8 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.77 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.66 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.3 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.16 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.14 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.88 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.7 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 90.2 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.82 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-61 Score=468.91 Aligned_cols=258 Identities=30% Similarity=0.461 Sum_probs=217.2
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
..++|+++++||+|+||+||+|+++. +++.||||++.+... .......+.+|+++|+.++|||||+++++|.+..
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~- 105 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE- 105 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred CccccEEEEEEecccCeEEEEEEECC---CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 35789999999999999999998764 689999999975432 2334567889999999999999999999997754
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+|||||||. |+|.+++... +.++|.+++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|
T Consensus 106 -~~yivmEy~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl----~~~g~vKl~D 175 (311)
T 4aw0_A 106 -KLYFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL----NEDMHIQITD 175 (311)
T ss_dssp -EEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTSCEEECC
T ss_pred -EEEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE----cCCCCEEEEE
Confidence 8999999998 5999999764 379999999999999999999999999999999999999 7778899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+|+.+............+||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+ ..+.+..+
T Consensus 176 FGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i 246 (311)
T 4aw0_A 176 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGLIFAKI 246 (311)
T ss_dssp CTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH
T ss_pred cCCceecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH
Confidence 9999987654444445668999999999999874 48999999999999999999999998655 22333333
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHH------HhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ------ALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e------~L~h 335 (477)
... . ..+|...+++++|||.+||++||++|+|++| +++|
T Consensus 247 ~~~----~-------------------------------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~H 291 (311)
T 4aw0_A 247 IKL----E-------------------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 291 (311)
T ss_dssp HHT----C-------------------------------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred HcC----C-------------------------------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCC
Confidence 221 0 0134455788999999999999999999988 5899
Q ss_pred ccCC
Q 011808 336 EYFR 339 (477)
Q Consensus 336 ~~f~ 339 (477)
|||+
T Consensus 292 p~F~ 295 (311)
T 4aw0_A 292 PFFE 295 (311)
T ss_dssp GGGT
T ss_pred CCcC
Confidence 9997
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-61 Score=460.14 Aligned_cols=257 Identities=27% Similarity=0.460 Sum_probs=200.0
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+++|++++.||+|+||+||+|+++. +++.||||++++.... ......+.+|+.+|+.++|||||+++++|.+.+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~- 86 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD- 86 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTT---TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-
Confidence 36899999999999999999998654 6899999999765543 334557889999999999999999999997654
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||++|+|++++.+. ..+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 87 -~~~ivmEy~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl----~~~~~vkl~DF 156 (275)
T 3hyh_A 87 -EIIMVIEYAGNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL----DEHLNVKIADF 156 (275)
T ss_dssp -EEEEEEECCCEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE----CTTCCEEECCS
T ss_pred -EEEEEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE----CCCCCEEEeec
Confidence 79999999999999999763 479999999999999999999999999999999999999 77788999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+|+...... .....+||+.|||||++.+..+++.++|||||||++|+|+||++||.+.+. ...+..+.
T Consensus 157 Gla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i~ 225 (275)
T 3hyh_A 157 GLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNIS 225 (275)
T ss_dssp SCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH
T ss_pred CCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH
Confidence 9998765432 233578999999999999876567899999999999999999999976542 12222221
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
. ... .+|..+++++++||.+||++||++|||++|+|+||||+.
T Consensus 226 ~----~~~-------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 226 N----GVY-------------------------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp H----TCC-------------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred c----CCC-------------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 1 110 123445788999999999999999999999999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-61 Score=478.54 Aligned_cols=259 Identities=28% Similarity=0.505 Sum_probs=210.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|+++++||+|+||+||+|+++. +++.||||+++...........+.+|+.+|++|+|||||+++++|.+.. .
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~--~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTE---DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG--S 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETT---TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--E
T ss_pred ccceEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC--E
Confidence 5799999999999999999998764 6899999999876655555667889999999999999999999998754 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|||||||+ |+|.++|.... ...+++.+++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl----~~~g~vKl~DFG 170 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL----TKDGTVQLGDFG 170 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE----CTTCCEEECSTT
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE----CCCCCEEEcccc
Confidence 999999998 69999997643 3468999999999999999999999999999999999999 677889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+|+.+..... .....+||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+ ..+.+..+..
T Consensus 171 la~~~~~~~~--~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~ 239 (350)
T 4b9d_A 171 IARVLNSTVE--LARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIIS 239 (350)
T ss_dssp EESCCCHHHH--HHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHH
T ss_pred cceeecCCcc--cccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHc
Confidence 9987653221 12346799999999999884 59999999999999999999999998765 2233333322
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
. ..+. .+..+++++.+||.+||++||.+|||++|+|+||||+.
T Consensus 240 ~---~~~~-------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 240 G---SFPP-------------------------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp T---CCCC-------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred C---CCCC-------------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 1 1111 23345688999999999999999999999999999963
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=464.24 Aligned_cols=256 Identities=29% Similarity=0.495 Sum_probs=212.4
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
+.|+++++||+|+||+||+|+++. +|+.||||++...... ....+.+|+.+|+.++|||||+++++|.+.+ .+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~ 146 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGD--EL 146 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred HhcEEeEEeecCcCeEEEEEEECC---CCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EE
Confidence 569999999999999999998764 6899999999765432 3456789999999999999999999998754 79
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|||||||+ |+|.+++.. ..+++.+++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+
T Consensus 147 ~ivmEy~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl----~~~g~vKl~DFGl 216 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL----THDGRVKLSDFGF 216 (346)
T ss_dssp EEEECCCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCCTT
T ss_pred EEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE----CCCCCEEEecCcC
Confidence 99999998 588888764 259999999999999999999999999999999999999 7778899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
|+.+..... .....+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+ ..+.+..+...
T Consensus 217 a~~~~~~~~--~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~ 285 (346)
T 4fih_A 217 CAQVSKEVP--RRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRDN 285 (346)
T ss_dssp CEECCSSSC--CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHS
T ss_pred ceecCCCCC--cccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcC
Confidence 997765332 23457899999999999774 59999999999999999999999998655 23333333321
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
. .+... .+..++++++|||.+||++||++|||++|+|+||||+..
T Consensus 286 ~-~~~~~-------------------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 286 L-PPRLK-------------------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp S-CCCCS-------------------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred C-CCCCC-------------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 1 00001 112346789999999999999999999999999999753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-59 Score=473.92 Aligned_cols=292 Identities=36% Similarity=0.602 Sum_probs=233.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC----
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH---- 100 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 100 (477)
.++|+++++||+|+||+||+|+++. +|+.||||+++...........+++|+++|+.|+|||||++++++...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRL---TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECC---CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 3689999999999999999998764 689999999987655444456778999999999999999999998643
Q ss_pred CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 101 ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 101 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
+...+|||||||+|+|.+++.. ...+++..++.|++||+.||.|||++|||||||||+|||+ +.++.+||+
T Consensus 130 ~~~~~~ivmE~~~g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~----~~~~~~Ki~ 200 (398)
T 4b99_A 130 EFKSVYVVLDLMESDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV----NENCELKIG 200 (398)
T ss_dssp TCCCEEEEEECCSEEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTCCEEEC
T ss_pred cCCEEEEEEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc----CCCCCEEEe
Confidence 2357999999999999998865 3479999999999999999999999999999999999999 777889999
Q ss_pred ecccceeecCCC--CcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 181 DFGLARIYQAPL--KFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 181 DFG~a~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|||+|+.+.... ........+||+.|||||++.+...|+.++|||||||++|||++|++||.+.+ ..+++
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~--------~~~~l 272 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--------YVHQL 272 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS--------HHHHH
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC--------HHHHH
Confidence 999998764321 12233457899999999999987778999999999999999999999999877 67889
Q ss_pred HHHHHHhCCCCCCCccccCCCcccccccccccc-ccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQG-RKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
..|+...+.++...|........+. .+.. .......+.. .....+++++|||.+||++||.+|+|++|+|+|||
T Consensus 273 ~~I~~~~g~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~-~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 273 QLIMMVLGTPSPAVIQAVGAERVRA----YIQSLPPRQPVPWET-VYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347 (398)
T ss_dssp HHHHHHHCCCCGGGTC-----CHHH----HHHSSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhh----hhhcCCCcCCCCHHH-hCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence 9999999988876655432211000 0000 0000011111 12345788999999999999999999999999999
Q ss_pred CCCC
Q 011808 338 FRIE 341 (477)
Q Consensus 338 f~~~ 341 (477)
|+..
T Consensus 348 f~~~ 351 (398)
T 4b99_A 348 LAKY 351 (398)
T ss_dssp GTTT
T ss_pred hCcC
Confidence 9854
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=458.09 Aligned_cols=259 Identities=29% Similarity=0.423 Sum_probs=209.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++++.||+|+||+||+|++..+..+++.||||+++...........+.+|+.+|++++|||||+++++|.+.. .
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~ 100 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG--K 100 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT--E
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--E
Confidence 47899999999999999999998765667899999999765433333346778999999999999999999998754 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|||||||. |+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl----~~~g~vKl~DFG 171 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL----DEEGHIKLTDFG 171 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE----CTTSCEEEESSE
T ss_pred EEEEEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE----cCCCCEEecccc
Confidence 999999998 6999998764 379999999999999999999999999999999999999 777889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+|+....... .....+||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+ ..+.+..+.+
T Consensus 172 la~~~~~~~~--~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~ 240 (304)
T 3ubd_A 172 LSKESIDHEK--KAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKD--------RKETMTMILK 240 (304)
T ss_dssp EEEC-----C--CCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH
T ss_pred cceeccCCCc--cccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcC--------HHHHHHHHHc
Confidence 9986543322 23457899999999999874 59999999999999999999999998765 2233333322
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCccC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHEYF 338 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~~f 338 (477)
. . ..+|..+++++.+||.+||++||++||| ++|+++||||
T Consensus 241 ~----~-------------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 241 A----K-------------------------------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp C----C-------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred C----C-------------------------------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 1 0 0123445789999999999999999998 5799999999
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
+.
T Consensus 286 ~~ 287 (304)
T 3ubd_A 286 ST 287 (304)
T ss_dssp TT
T ss_pred cC
Confidence 73
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=466.89 Aligned_cols=256 Identities=29% Similarity=0.492 Sum_probs=213.3
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
+.|+++++||+|+||+||+|+++. +|+.||||++..... .....+.+|+.+|+.++|||||+++++|.+.+ .+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~ 223 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--EL 223 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred HhcEeeeEeccCcCcEEEEEEECC---CCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECC--EE
Confidence 579999999999999999998764 689999999976543 33456889999999999999999999998754 79
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|||||||+ |+|.+++.. ..+++.+++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+
T Consensus 224 ~iVmEy~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl----~~~g~vKl~DFGl 293 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL----THDGRVKLSDFGF 293 (423)
T ss_dssp EEEEECCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE----CTTCCEEECCCTT
T ss_pred EEEEeCCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE----cCCCCEEEecCcc
Confidence 99999998 588888764 259999999999999999999999999999999999999 7778899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
|+.+..... .....+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+ ..+.+..+...
T Consensus 294 a~~~~~~~~--~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~ 362 (423)
T 4fie_A 294 CAQVSKEVP--RRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRDN 362 (423)
T ss_dssp CEECCSSCC--CBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHS
T ss_pred ceECCCCCc--cccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcC
Confidence 997765332 23457999999999999874 59999999999999999999999998655 23333333221
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
. .+.. ..+..++++++|||.+||++||++|+|++|+|+||||+..
T Consensus 363 ~-~~~~-------------------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 363 L-PPRL-------------------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp C-CCCC-------------------------------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred C-CCCC-------------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 1 0000 0123456889999999999999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-58 Score=446.82 Aligned_cols=258 Identities=22% Similarity=0.343 Sum_probs=209.5
Q ss_pred cce-eEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CC
Q 011808 26 QQY-NLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH--AD 102 (477)
Q Consensus 26 ~~Y-~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 102 (477)
++| ++.++||+|+||+||+|+++. ++..||||++............+.+|+.+|++|+|||||+++++|.+. .+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred CceEEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence 455 788899999999999998764 688999999976655544556788999999999999999999998752 34
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC--eecCCCCCCcEEEeccCCCcccEEE
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW--IIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+|||||||. |+|.+++... ..+++..++.|+.||+.||+|||++| ||||||||+||||+ ..++.+||
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~---~~~g~vKl 173 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT---GPTGSVKI 173 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES---STTSCEEE
T ss_pred cEEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE---CCCCCEEE
Confidence 57899999998 6999998764 37999999999999999999999998 99999999999993 23678999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||++||.+.+. ..
T Consensus 174 ~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----------~~ 236 (290)
T 3fpq_A 174 GDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQN-----------AA 236 (290)
T ss_dssp CCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----------HH
T ss_pred EeCcCCEeCCCC----ccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----------HH
Confidence 999999864332 2234689999999999975 399999999999999999999999975431 12
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.++..+...... ...+...++++.+||.+||++||.+|||++|+|+||||+
T Consensus 237 ~~~~~i~~~~~~-----------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~ 287 (290)
T 3fpq_A 237 QIYRRVTSGVKP-----------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp HHHHHHTTTCCC-----------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHcCCCC-----------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 233333222110 012233467899999999999999999999999999997
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 288 ~ 288 (290)
T 3fpq_A 288 E 288 (290)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-57 Score=445.77 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=205.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++.|++.++||+|+||+||+|+++. +++.||||+++..... .+|+.+|+.++|||||+++++|.+.. .
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~---~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~--~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGP--W 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETT--E
T ss_pred hhheEeCcEeccCCCeEEEEEEECC---CCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECC--E
Confidence 4679999999999999999998764 6899999999764322 37999999999999999999998754 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc-cEEEeec
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG-VVKIADF 182 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~-~vkL~DF 182 (477)
+|||||||+ |+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||| +.++ ++||+||
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl----~~~g~~vKl~DF 195 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL----SSDGSRAALCDF 195 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE----CTTSCCEEECCC
T ss_pred EEEEEeccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE----eCCCCEEEEeeC
Confidence 999999998 6999999764 379999999999999999999999999999999999999 5554 6999999
Q ss_pred ccceeecCCCC---cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 183 GLARIYQAPLK---FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 183 G~a~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|+|+.+..... .......+||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+... .+.
T Consensus 196 Gla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~ 266 (336)
T 4g3f_A 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--------LCL 266 (336)
T ss_dssp TTCEEC------------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--------CHH
T ss_pred CCCeEccCCCcccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HHH
Confidence 99997754321 1223446899999999999884 59999999999999999999999998765321 122
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHH-------
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA------- 332 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~------- 332 (477)
.+.. .+.+ ...++..+++.+.+||.+||++||.+|||+.|+
T Consensus 267 ~i~~---~~~~-----------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 267 KIAS---EPPP-----------------------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp HHHH---SCCG-----------------------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHc---CCCC-----------------------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 2221 1100 011345567889999999999999999999997
Q ss_pred ------hcCccCCCC
Q 011808 333 ------LEHEYFRIE 341 (477)
Q Consensus 333 ------L~h~~f~~~ 341 (477)
|.|||+...
T Consensus 315 l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 315 LQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHTTSSCSCSSSSC
T ss_pred HhhhhhccCCCcCCC
Confidence 679998644
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=446.81 Aligned_cols=296 Identities=27% Similarity=0.380 Sum_probs=220.5
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHIN 99 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 99 (477)
.|.+.++|+++++||+|+||+||+|+++....+++.||||++.... ....+.+|+++|+.+ +||||++++++|.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 4567789999999999999999999987655678899999986542 245678999999998 69999999999987
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
.+ .+|+||||++ ++|.+++. .+++.+++.+++||+.||+|||++|||||||||+|||++ ...+.+|
T Consensus 92 ~~--~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~---~~~~~~k 158 (361)
T 4f9c_A 92 ND--HVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN---RRLKKYA 158 (361)
T ss_dssp TT--EEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---TTTTEEE
T ss_pred CC--EEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe---CCCCeEE
Confidence 54 8999999998 68888773 489999999999999999999999999999999999994 2236899
Q ss_pred EeecccceeecCCCCc--------------------------ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHH
Q 011808 179 IADFGLARIYQAPLKF--------------------------LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFA 232 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~--------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ 232 (477)
|+|||+|+........ ......+||+.|+|||++.+...|+.++|||||||++|
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 9999999865432110 01124579999999999988777999999999999999
Q ss_pred HHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCcccc--------CCCcccc--cccccccccccc-------
Q 011808 233 ELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTL--------ANLPHWQ--SDSLHIQGRKYE------- 295 (477)
Q Consensus 233 elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~--------~~~~~~~--~~~~~~~~~~~~------- 295 (477)
||+||+.||...+. ..+++..|+..+|.+....+... ..+|... .....+......
T Consensus 239 ell~G~~Pf~~~~~-------~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~ 311 (361)
T 4f9c_A 239 SLLSGRYPFYKASD-------DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSD 311 (361)
T ss_dssp HHHHTCSSSSCCSS-------HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------
T ss_pred HHHHCCCCCCCCCC-------HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccc
Confidence 99999999965443 56788888877764321111000 0000000 000000000000
Q ss_pred --CCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 296 --TNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 296 --~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
...........++++++|||++||++||.+|+|++|+|+||||+.
T Consensus 312 ~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 312 IQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 000011122356788999999999999999999999999999974
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-56 Score=434.21 Aligned_cols=262 Identities=26% Similarity=0.430 Sum_probs=195.9
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA-- 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 101 (477)
++++|++++.||+|+||+||+|+++. +++.||||+++.... ....+.+.+|+.+|++|+|||||+++++|.+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKV---DDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETT---TCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred cchhCEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence 56789999999999999999998764 689999999976432 223456789999999999999999999987543
Q ss_pred --------CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCC
Q 011808 102 --------DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE 172 (477)
Q Consensus 102 --------~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~ 172 (477)
+.++|+|||||. ++|.+++..... .....+..++.++.||++||+|||++|||||||||+|||| +
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl----~ 152 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF----T 152 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----C
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE----C
Confidence 235899999998 689998876431 1234566789999999999999999999999999999999 6
Q ss_pred CcccEEEeecccceeecCCCCc----------ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011808 173 EQGVVKIADFGLARIYQAPLKF----------LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ 242 (477)
Q Consensus 173 ~~~~vkL~DFG~a~~~~~~~~~----------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~ 242 (477)
.++.+||+|||+|+.+...... ....+.+||+.|||||++.+. .|+.++|||||||++|||++ ||.
T Consensus 153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCC
Confidence 7778999999999876543211 112346899999999999874 59999999999999999996 775
Q ss_pred CcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccC
Q 011808 243 GAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYD 322 (477)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~d 322 (477)
+.. +....+........+..+ ...++.+.+||.+||++|
T Consensus 229 ~~~----------~~~~~~~~~~~~~~p~~~-------------------------------~~~~~~~~~li~~~L~~d 267 (299)
T 4g31_A 229 TQM----------ERVRTLTDVRNLKFPPLF-------------------------------TQKYPCEYVMVQDMLSPS 267 (299)
T ss_dssp SHH----------HHHHHHHHHHTTCCCHHH-------------------------------HHHCHHHHHHHHHHTCSS
T ss_pred Ccc----------HHHHHHHHHhcCCCCCCC-------------------------------cccCHHHHHHHHHHcCCC
Confidence 422 222223332221111110 011356789999999999
Q ss_pred CCCCCCHHHHhcCccCCC
Q 011808 323 PRKRITAAQALEHEYFRI 340 (477)
Q Consensus 323 P~~Rpt~~e~L~h~~f~~ 340 (477)
|.+|||+.|+|+||||+.
T Consensus 268 P~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 268 PMERPEAINIIENAVFED 285 (299)
T ss_dssp GGGSCCHHHHHTSGGGCC
T ss_pred hhHCcCHHHHhcCHhhCC
Confidence 999999999999999974
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=428.89 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=199.7
Q ss_pred cceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
++|.+.++||+|+||+||+|+++. ...++..||||+++... ....+.+.+|+.+|++++|||||++++++.+..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-- 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGR-- 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 568999999999999999998753 23468899999997532 334567889999999999999999999997643
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcc----------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCC
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDK----------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE 172 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~ 172 (477)
.+|||||||. |+|.+++..+... ...++++.++..|+.||+.||.|||+++||||||||+|||| +
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl----~ 192 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV----G 192 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----E
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE----C
Confidence 6899999998 6999998765321 13469999999999999999999999999999999999999 7
Q ss_pred CcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCC
Q 011808 173 EQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQN 251 (477)
Q Consensus 173 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~ 251 (477)
+++.+||+|||+|+.+............+||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~----- 266 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN----- 266 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCH-----
Confidence 7788999999999876554433344456789999999999874 49999999999999999999 8999986552
Q ss_pred cccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHH
Q 011808 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ 331 (477)
Q Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e 331 (477)
.+.+..+... . ....|..+++++.+||.+||+.||++|||++|
T Consensus 267 ---~~~~~~i~~g--~--------------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~e 309 (329)
T 4aoj_A 267 ---TEAIDCITQG--R--------------------------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKD 309 (329)
T ss_dssp ---HHHHHHHHHT--C--------------------------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred ---HHHHHHHHcC--C--------------------------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHH
Confidence 2222222211 0 01134556788999999999999999999999
Q ss_pred HhcC
Q 011808 332 ALEH 335 (477)
Q Consensus 332 ~L~h 335 (477)
++++
T Consensus 310 i~~~ 313 (329)
T 4aoj_A 310 VHAR 313 (329)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=422.10 Aligned_cols=257 Identities=23% Similarity=0.316 Sum_probs=199.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.++||+|+||+||+|+++ ..||||+++.........+.+.+|+.+|++++|||||++++++.. ..
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---Ce
Confidence 468899999999999999999743 248999998665554555678899999999999999999998743 24
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|||||||+ |+|.++|... ...+++.++..|+.||+.||.|||+++||||||||+|||| ++++.+||+|||
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl----~~~~~~Ki~DFG 177 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL----HEGLTVKIGDFG 177 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE----ETTEEEEECCCS
T ss_pred EEEEEEcCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE----CCCCcEEEeecc
Confidence 799999998 6999988754 3469999999999999999999999999999999999999 777899999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGA--KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
+|+..............+||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+. ...+..+
T Consensus 178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--------~~~~~~~ 249 (307)
T 3omv_A 178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--------RDQIIFM 249 (307)
T ss_dssp SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHH
T ss_pred CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--------HHHHHHH
Confidence 99876543333334456899999999999753 3489999999999999999999999986542 2222222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.... ...+. + ...+..++..+.+||.+||+.||++|||++|++++
T Consensus 250 ~~~~-~~~p~----~------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 250 VGRG-YASPD----L------------------------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHTT-CCCCC----S------------------------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HhcC-CCCCC----c------------------------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 2211 00000 0 11234567889999999999999999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=421.20 Aligned_cols=261 Identities=26% Similarity=0.410 Sum_probs=208.0
Q ss_pred cceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
++|.+.++||+|+||+||+|+++. ...++..||||+++... ....+.+.+|+++|++++|||||++++++.+..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-- 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-- 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC--
Confidence 679999999999999999998753 22457899999997532 334567889999999999999999999997644
Q ss_pred eEEEEEeccC-CCHHHHHHhhhc--------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRD--------KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ 174 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~ 174 (477)
.+|||||||. |+|.++|..... .....+++.++..++.||+.||.|||+++||||||||+|||| +++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl----~~~ 164 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV----GEN 164 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE----CCC
Confidence 6899999998 799999976431 123479999999999999999999999999999999999999 778
Q ss_pred ccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcc
Q 011808 175 GVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 175 ~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~ 253 (477)
+.+||+|||+|+..............+||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------- 236 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------- 236 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence 88999999999876554444444557789999999999874 49999999999999999998 8999987552
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
.+.+..+... . ....|..+++++++||.+||+.||++|||++++
T Consensus 237 -~~~~~~i~~~--~--------------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i- 280 (299)
T 4asz_A 237 -NEVIECITQG--R--------------------------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI- 280 (299)
T ss_dssp -HHHHHHHHHT--C--------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH-
T ss_pred -HHHHHHHHcC--C--------------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH-
Confidence 2222222211 0 011345567889999999999999999999998
Q ss_pred cCccCC
Q 011808 334 EHEYFR 339 (477)
Q Consensus 334 ~h~~f~ 339 (477)
|.|++
T Consensus 281 -~~~L~ 285 (299)
T 4asz_A 281 -HTLLQ 285 (299)
T ss_dssp -HHHHH
T ss_pred -HHHHH
Confidence 45654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=418.08 Aligned_cols=261 Identities=24% Similarity=0.366 Sum_probs=208.6
Q ss_pred ccceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++++++++||+|+||+||+|++.. +..++..||||+++... .....+.+.+|+.+|++++|||||++++++.+..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~- 102 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ- 102 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC-
Confidence 5789999999999999999998743 23457899999997543 3344568889999999999999999999997643
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhc-----------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRD-----------KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~ 170 (477)
.+|||||||. |+|.++|..... .....+++.++..|+.||+.||.|||+++||||||||+||||
T Consensus 103 -~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl--- 178 (308)
T 4gt4_A 103 -PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--- 178 (308)
T ss_dssp -SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred -EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---
Confidence 6899999998 699999975421 113468999999999999999999999999999999999999
Q ss_pred CCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccC
Q 011808 171 GEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKST 249 (477)
Q Consensus 171 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~ 249 (477)
++++.+||+|||+|+.+............+||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.+.
T Consensus 179 -~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--- 253 (308)
T 4gt4_A 179 -YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--- 253 (308)
T ss_dssp -CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---
T ss_pred -CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCH---
Confidence 77889999999999876554433344556789999999999875 49999999999999999998 8999987652
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
.+.+..+.. .. ....|..++..+++||.+||+.||++|||+
T Consensus 254 -----~~~~~~i~~---~~-------------------------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~ 294 (308)
T 4gt4_A 254 -----QDVVEMIRN---RQ-------------------------------VLPCPDDCPAWVYALMIECWNEFPSRRPRF 294 (308)
T ss_dssp -----HHHHHHHHT---TC-------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----HHHHHHHHc---CC-------------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCH
Confidence 122222211 00 011345567889999999999999999999
Q ss_pred HHHhcC
Q 011808 330 AQALEH 335 (477)
Q Consensus 330 ~e~L~h 335 (477)
.+++++
T Consensus 295 ~ei~~~ 300 (308)
T 4gt4_A 295 KDIHSR 300 (308)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999876
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=451.56 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=210.5
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHH---HHHHHHhcCCCCeeEEEEEEE
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIR---EIMLLREITHENVVKLVNVHI 98 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~---Ei~il~~l~hpnIv~l~~~~~ 98 (477)
--+++|+++++||+|+||+||+|+++. +++.||||++.+.... ........+ ++.+++.++|||||+++++|.
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~---tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CchHHeEEEEEEecccCeEEEEEEECC---CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 347899999999999999999999764 6999999999654321 112223333 456667789999999999998
Q ss_pred cCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccE
Q 011808 99 NHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVV 177 (477)
Q Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~v 177 (477)
+.. .+|||||||. |+|..+|... +.+++..++.|+.||+.||+|||++|||||||||+|||| +.++++
T Consensus 263 ~~~--~lylVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl----d~~G~v 331 (689)
T 3v5w_A 263 TPD--KLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL----DEHGHV 331 (689)
T ss_dssp CSS--EEEEEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE----CTTSCE
T ss_pred ECC--EEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE----eCCCCE
Confidence 754 8999999998 6999999764 379999999999999999999999999999999999999 778899
Q ss_pred EEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 178 KIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
||+|||+|+.+.... ....+||+.|||||++.+...|+.++|||||||++|||++|++||.+.+... .
T Consensus 332 KL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~------~-- 399 (689)
T 3v5w_A 332 RISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------K-- 399 (689)
T ss_dssp EECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC------H--
T ss_pred EecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------H--
Confidence 999999998765432 3457899999999999765569999999999999999999999998654321 1
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHH
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQA 332 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~ 332 (477)
..+...+.... ..+|...++++++||.+||++||.+|++ ++|+
T Consensus 400 -~~i~~~i~~~~-------------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei 447 (689)
T 3v5w_A 400 -HEIDRMTLTMA-------------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 447 (689)
T ss_dssp -HHHHHHHHHCC-------------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHH
T ss_pred -HHHHHhhcCCC-------------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHH
Confidence 12222221111 1134456789999999999999999998 7999
Q ss_pred hcCccCCC
Q 011808 333 LEHEYFRI 340 (477)
Q Consensus 333 L~h~~f~~ 340 (477)
++||||+.
T Consensus 448 ~~HpfF~~ 455 (689)
T 3v5w_A 448 KESPFFRS 455 (689)
T ss_dssp TTSGGGTT
T ss_pred hcCccccC
Confidence 99999973
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=451.73 Aligned_cols=269 Identities=25% Similarity=0.374 Sum_probs=218.0
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
..+++|++++.||+|+||.||+|+++. +|+.||||++..... .....+.+|+.+|+.|+|||||+++++|.+.
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~---tg~~~AiK~i~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 226 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-- 226 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEECS--
T ss_pred cCccccEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEeccch--hhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--
Confidence 457899999999999999999998764 689999999976432 2245677899999999999999999999764
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|||||||. |+|+++|... ...+++.+++.+++||+.||.|||++||+||||||+|||+.. +..+.+||+|
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~--~~~~~vKl~D 300 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT--KRSNELKLID 300 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS--SSCCCEEECC
T ss_pred CEEEEEEeecCCCcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC--CCCCCEEEee
Confidence 48999999998 5999888643 246999999999999999999999999999999999999943 2346899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+|+.+..... ....+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+ ..+.+..+
T Consensus 301 FG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~--------~~~~~~~i 368 (573)
T 3uto_A 301 FGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNV 368 (573)
T ss_dssp CSSCEECCTTSE---EEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHH
T ss_pred ccceeEccCCCc---eeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHH
Confidence 999998765332 2346789999999999884 59999999999999999999999998765 23333333
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
.......+. .....++++++|||++||++||.+|||+.|+|+||||+..
T Consensus 369 ~~~~~~~~~-------------------------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 369 KSCDWNMDD-------------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp HTTCCCCCS-------------------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HhCCCCCCc-------------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 221111111 1123456889999999999999999999999999999865
Q ss_pred CCCCCC
Q 011808 342 PLPGRN 347 (477)
Q Consensus 342 ~~~~~~ 347 (477)
..+...
T Consensus 418 ~~~~~~ 423 (573)
T 3uto_A 418 NAPGRD 423 (573)
T ss_dssp CCTTTT
T ss_pred CCCCch
Confidence 555443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=410.51 Aligned_cols=292 Identities=42% Similarity=0.803 Sum_probs=238.8
Q ss_pred CccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEc
Q 011808 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHIN 99 (477)
Q Consensus 20 ~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 99 (477)
....+.++|++++.||+|+||+||+|++. +++.||||++............+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS----QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET----TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC----CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 44568899999999999999999999863 48899999998765555555678899999999999999999999865
Q ss_pred CCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 100 HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 100 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
. ..+|+||||++++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 91 ~--~~~~lv~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~----~~~~~~kl 160 (311)
T 3niz_A 91 E--RCLTLVFEFMEKDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI----NSDGALKL 160 (311)
T ss_dssp S--SCEEEEEECCSEEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEE
T ss_pred C--CEEEEEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE----CCCCCEEE
Confidence 4 4789999999999999887642 358999999999999999999999999999999999999 66778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+++....... .....++|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.. ..+.+.
T Consensus 161 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~ 230 (311)
T 3niz_A 161 ADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT--------DDDQLP 230 (311)
T ss_dssp CCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------TTTHHH
T ss_pred ccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC--------hHHHHH
Confidence 99999987654322 22335679999999999876678999999999999999999999998766 456788
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+...++.+.+..|+....++.|........ ... .........+.++.+||.+||++||.+|||++|+|+||||+
T Consensus 231 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 305 (311)
T 3niz_A 231 KIFSILGTPNPREWPQVQELPLWKQRTFQVF----EKK-PWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305 (311)
T ss_dssp HHHHHHCCCCTTTSGGGTTSHHHHSCCCCCC----CCC-CHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHHHCCCChHHhhhhhccchhhhcccccc----cCC-cHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 8999999999999998887776654322111 111 11122345678899999999999999999999999999997
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 306 ~ 306 (311)
T 3niz_A 306 D 306 (311)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=417.69 Aligned_cols=263 Identities=24% Similarity=0.378 Sum_probs=211.8
Q ss_pred ccceeEEeeecccCceEEEEEEEeccc--CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCC-CCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAA--NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH-ENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~ 101 (477)
.++|++.++||+|+||+||+|+++... ..++.||||+++.... ....+.+.+|+.+|++++| ||||+++++|....
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 368999999999999999999887532 2456899999975433 2234568899999999965 89999999986543
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEec
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDK-----------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMG 169 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~ 169 (477)
..+|||||||. |+|.++|+..... ....+++..+..++.||+.||.|||+++||||||||+|||+
T Consensus 142 -~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl-- 218 (353)
T 4ase_A 142 -GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 218 (353)
T ss_dssp -SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred -CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee--
Confidence 36899999998 6999999875432 13458999999999999999999999999999999999999
Q ss_pred cCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccc
Q 011808 170 EGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKS 248 (477)
Q Consensus 170 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~ 248 (477)
++++.+||+|||+|+.+............+||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+.
T Consensus 219 --~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~-- 293 (353)
T 4ase_A 219 --SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-- 293 (353)
T ss_dssp --CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC--
T ss_pred --CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCH--
Confidence 77888999999999977655444455667899999999999874 49999999999999999998 9999987542
Q ss_pred CCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC
Q 011808 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT 328 (477)
Q Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt 328 (477)
...+..+...- .....|..+++++++||.+||+.||++|||
T Consensus 294 ------~~~~~~~i~~g---------------------------------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt 334 (353)
T 4ase_A 294 ------DEEFCRRLKEG---------------------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 334 (353)
T ss_dssp ------SHHHHHHHHHT---------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ------HHHHHHHHHcC---------------------------------CCCCCCccCCHHHHHHHHHHcCcChhHCcC
Confidence 11222222111 011234456788999999999999999999
Q ss_pred HHHHhcC
Q 011808 329 AAQALEH 335 (477)
Q Consensus 329 ~~e~L~h 335 (477)
++++++|
T Consensus 335 ~~eil~~ 341 (353)
T 4ase_A 335 FSELVEH 341 (353)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999988
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=413.16 Aligned_cols=302 Identities=40% Similarity=0.743 Sum_probs=234.8
Q ss_pred CCCCCCCccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEE
Q 011808 14 GTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKL 93 (477)
Q Consensus 14 ~~~~~~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l 93 (477)
...........+++|+++++||+|+||+||+|+++. +++.||||+++...........+.+|+.+++.++||||+++
T Consensus 22 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 98 (329)
T 3gbz_A 22 MSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTV---TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98 (329)
T ss_dssp ----------CGGGEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCE
T ss_pred ceeccCCcccchhhEEEEEEEEecCCeEEEEEEECC---CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceE
Confidence 333444556678999999999999999999998664 68999999998766555555667799999999999999999
Q ss_pred EEEEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC-C
Q 011808 94 VNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG-E 172 (477)
Q Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~-~ 172 (477)
++++.+.. .+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..++ +
T Consensus 99 ~~~~~~~~--~~~lv~e~~~~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~ 171 (329)
T 3gbz_A 99 KSVIHHNH--RLHLIFEYAENDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDAS 171 (329)
T ss_dssp EEEEEETT--EEEEEEECCSEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC----
T ss_pred EEEEecCC--EEEEEEecCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCC
Confidence 99997654 78999999999999998764 3689999999999999999999999999999999999996554 4
Q ss_pred CcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCc
Q 011808 173 EQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252 (477)
Q Consensus 173 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~ 252 (477)
..+.+||+|||+++.+..... .....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------- 242 (329)
T 3gbz_A 172 ETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS------- 242 (329)
T ss_dssp -CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------
T ss_pred ccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC-------
Confidence 566799999999986643322 22345679999999999886668999999999999999999999998766
Q ss_pred ccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 011808 253 FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332 (477)
Q Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~ 332 (477)
..+.+..++..++.+....|+....++.|...... +....+....+...+.++.+||.+||++||.+|||++|+
T Consensus 243 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 316 (329)
T 3gbz_A 243 -EIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPK-----FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316 (329)
T ss_dssp -HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC-----CCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -HHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhh-----hccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 56788889999999999999888877777653222 122223333444567889999999999999999999999
Q ss_pred hcCccCCC
Q 011808 333 LEHEYFRI 340 (477)
Q Consensus 333 L~h~~f~~ 340 (477)
|+||||+.
T Consensus 317 l~hp~f~~ 324 (329)
T 3gbz_A 317 LEHPYFSH 324 (329)
T ss_dssp HTSGGGSS
T ss_pred hCCcccCC
Confidence 99999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=395.64 Aligned_cols=287 Identities=40% Similarity=0.767 Sum_probs=238.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|++++.||+|+||+||+|+++. +++.||||++............+.+|+.++++++||||+++++++.+.. .
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 75 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--K 75 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--E
T ss_pred CCCceeeeEecCCCCeEEEEEEECC---CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC--E
Confidence 4789999999999999999998764 6889999999877665555678889999999999999999999997654 7
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+|+||||+++++.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 76 ~~lv~e~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~----~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 76 LTLVFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI----NRNGELKLANFGL 147 (292)
T ss_dssp EEEEEECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCCTT
T ss_pred EEEEEecCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEeeccc
Confidence 8999999999999888764 3469999999999999999999999999999999999999 6777899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCcccccCCCcccHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLF-QGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF-~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++....... ......||+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+ ..+.+..++.
T Consensus 148 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--------~~~~~~~i~~ 217 (292)
T 3o0g_A 148 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--------VDDQLKRIFR 217 (292)
T ss_dssp CEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--------HHHHHHHHHH
T ss_pred ceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--------HHHHHHHHHH
Confidence 987654322 2234567999999999988666899999999999999999887774 4433 5677888999
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.++.+..+.|+....++.+...... .............+..+.+||.+||+.||++|||++|+|+||||+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 218 LLGTPTEEQWPSMTKLPDYKPYPMY------PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp HHCCCCTTTCTTGGGSTTCCCCCCC------CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HhCCCChhhhhhhcccccccccccc------cCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 9999999988887776655432111 1111111233456788999999999999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=418.82 Aligned_cols=319 Identities=46% Similarity=0.836 Sum_probs=240.8
Q ss_pred ccccceeEE-eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLI-GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~-~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
.+.+.|++. ++||+|+||.||+|+++. ..++..||||++.... ....+.+|+.+|+.++||||+++++++....
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKD-GKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESS-SSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEcc-CCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 455678884 479999999999998763 2467899999997543 3457889999999999999999999998777
Q ss_pred CceEEEEEeccCCCHHHHHHhhhcc----cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccE
Q 011808 102 DMSLYLAFDYAEYDLYEIIRHHRDK----VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVV 177 (477)
Q Consensus 102 ~~~~~lv~e~~~~~L~~~l~~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~v 177 (477)
+..+|+||||++++|.+++...... ....+++..++.++.||+.||.|||++||+||||||+||||..+++.++.+
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 92 DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 7789999999999999988764421 122489999999999999999999999999999999999997666677899
Q ss_pred EEeecccceeecCCCC-cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc-cCCCcccH
Q 011808 178 KIADFGLARIYQAPLK-FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK-STQNPFQL 255 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~-~~~~~~~~ 255 (477)
||+|||+++.+..... .......+||+.|+|||++.+...|+.++|||||||++|+|++|++||.+.... ....++..
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 9999999987654321 122344678999999999988667999999999999999999999999876533 33566778
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCcc---ccCCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHS---VVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~ 332 (477)
+++..++..++.+....|..+..++.+......+....+....+.. ......+..+.+||.+||++||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 9999999999999999999888777665443333222222211111 1123346789999999999999999999999
Q ss_pred hcCccCCCCCCCCC
Q 011808 333 LEHEYFRIEPLPGR 346 (477)
Q Consensus 333 L~h~~f~~~~~~~~ 346 (477)
|+||||...+.+..
T Consensus 332 L~hp~f~~~~~~~~ 345 (405)
T 3rgf_A 332 MQDPYFLEDPLPTS 345 (405)
T ss_dssp HTSGGGTSSSCCCS
T ss_pred hcChhhccCCCCcc
Confidence 99999997766654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=393.40 Aligned_cols=286 Identities=43% Similarity=0.796 Sum_probs=233.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|++++.||+|+||.||+|++. ++..||||++............+.+|+.+++.++||||+++++++.+.. .
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 74 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--R 74 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--C
T ss_pred CccchhhhhcccCCCEEEEEEEcC----CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC--e
Confidence 478999999999999999999862 5889999999776555555678889999999999999999999997643 7
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+|+||||+.++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 75 ~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 75 LVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI----NREGELKIADFGL 146 (288)
T ss_dssp EEEEEECCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEECCTTH
T ss_pred EEEEEEecCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCCEEEeECcc
Confidence 8999999999999988764 2468999999999999999999999999999999999999 6777899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+ ..+.+..++..
T Consensus 147 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~ 216 (288)
T 1ob3_A 147 ARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--------EADQLMRIFRI 216 (288)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHH
T ss_pred ccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHH
Confidence 986543221 12335679999999999876668999999999999999999999998765 56777888888
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
++.+....|+....++.+....... .. ..........+..+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 217 LGTPNSKNWPNVTELPKYDPNFTVY-----EP-LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCC-----CC-CCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HCCCChhhchhhhcccccccccccc-----cC-ccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 9998888888776655543321110 00 0011223456788999999999999999999999999999973
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=415.05 Aligned_cols=295 Identities=36% Similarity=0.676 Sum_probs=222.8
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 101 (477)
.+.++|++++.||+|+||.||+|.++. +++.||||++............+.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETT---TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECC---CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 467899999999999999999998764 6889999999765544445567789999999997 999999999998766
Q ss_pred CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 102 DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 102 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
...+|+||||++++|..++... .+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|
T Consensus 83 ~~~~~lv~e~~~~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll----~~~~~~kl~D 152 (388)
T 3oz6_A 83 DRDVYLVFDYMETDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL----NAECHVKVAD 152 (388)
T ss_dssp SSCEEEEEECCSEEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECC
T ss_pred CCEEEEEecccCcCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE----cCCCCEEecC
Confidence 6689999999999999988752 68999999999999999999999999999999999999 6778899999
Q ss_pred cccceeecCCCC-------------------cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011808 182 FGLARIYQAPLK-------------------FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQ 242 (477)
Q Consensus 182 FG~a~~~~~~~~-------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~ 242 (477)
||+++.+..... .......+||++|+|||++.+...|+.++|||||||++|||++|++||.
T Consensus 153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 999987643111 1112345789999999999876679999999999999999999999998
Q ss_pred CcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccc-cc-cccccCCCCcc------------ccCCCCC
Q 011808 243 GAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLH-IQ-GRKYETNGLHS------------VVPLSPK 308 (477)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~------------~~p~~~s 308 (477)
+.+ ..+++..++..++.+..+.+..+..- +...... .. ........... ..+...+
T Consensus 233 ~~~--------~~~~~~~i~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (388)
T 3oz6_A 233 GSS--------TMNQLERIIGVIDFPSNEDVESIQSP--FAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302 (388)
T ss_dssp CSS--------HHHHHHHHHHHHCCCCHHHHHTSCCS--SHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCC
T ss_pred CCC--------HHHHHHHHHHhcCCCCHHHHHhccCH--HHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCC
Confidence 876 67888889888887766544322210 0000000 00 00000000000 1123567
Q ss_pred chHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 309 SPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 309 ~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+.+.+||++||+.||.+|||++|+|+||||+.
T Consensus 303 ~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSI 334 (388)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTT
T ss_pred HHHHHHHHHhhccCcccCCCHHHHhCCHHHHH
Confidence 88999999999999999999999999999974
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=396.19 Aligned_cols=295 Identities=37% Similarity=0.702 Sum_probs=224.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++++.||+|+||.||+|+++ .++..||||+++.... ......+.+|+.+++.++||||+++++++.+. ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNK---TTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTE--NK 77 (317)
T ss_dssp ---------------CEEEEEECS---SSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT--TE
T ss_pred ccceeEeeEECCCCCEEEEEEEEC---CCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEEC--Ce
Confidence 578999999999999999999865 3689999999976543 33456788999999999999999999998664 47
Q ss_pred EEEEEeccCCCHHHHHHhhhc-ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRD-KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||++++|.+++..... .....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~----~~~~~~kl~Dfg 153 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI----NKRGQLKLGDFG 153 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCCS
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE----cCCCCEEECcCc
Confidence 899999999999999876532 112358999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+++....... .....++|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+ ..+.+..++.
T Consensus 154 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~ 223 (317)
T 2pmi_A 154 LARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN--------DEEQLKLIFD 223 (317)
T ss_dssp SCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHH
T ss_pred cceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHH
Confidence 9987653322 22345679999999999876668999999999999999999999998766 5677888889
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.++.+....|+....++.+........... ....+....+...+.++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 224 IMGTPNESLWPSVTKLPKYNPNIQQRPPRD-LRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp HHCSCCTTTCGGGGGCTTCCTTCCCCCCCC-SHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred HhCCCChhHhhhhhhhhhcccccccccchh-HHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 999998888887776665543211100000 0000112233456788999999999999999999999999999974
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=394.47 Aligned_cols=264 Identities=27% Similarity=0.463 Sum_probs=215.8
Q ss_pred CCCCccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEE
Q 011808 17 NHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNV 96 (477)
Q Consensus 17 ~~~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 96 (477)
...+....+++|++++.||+|+||.||+|++.. ++..||||++............+.+|+.+++.++||||++++++
T Consensus 6 s~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 82 (328)
T 3fe3_A 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHIL---TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82 (328)
T ss_dssp -----CCEETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccCCccCCEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 344555678999999999999999999998764 68899999997765544455677899999999999999999999
Q ss_pred EEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 97 HINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 97 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
+.+. ..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 83 ~~~~--~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll----~~~~ 151 (328)
T 3fe3_A 83 IETE--KTLYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL----DADM 151 (328)
T ss_dssp EECS--SEEEEEECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTS
T ss_pred EEEC--CEEEEEEECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE----cCCC
Confidence 9764 47899999996 6999988764 369999999999999999999999999999999999999 7778
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccH
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~ 255 (477)
.+||+|||+++....... ....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+. .
T Consensus 152 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~ 220 (328)
T 3fe3_A 152 NIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------K 220 (328)
T ss_dssp CEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred CEEEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------H
Confidence 899999999986544322 23457899999999999866556899999999999999999999987552 2
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.....+.... ...|...+.++.+||++||..||.+|||++|+|+|
T Consensus 221 ~~~~~i~~~~-----------------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 221 ELRERVLRGK-----------------------------------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHHHCC-----------------------------------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHhCC-----------------------------------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2222222110 01234457889999999999999999999999999
Q ss_pred ccCCC
Q 011808 336 EYFRI 340 (477)
Q Consensus 336 ~~f~~ 340 (477)
|||..
T Consensus 266 ~~~~~ 270 (328)
T 3fe3_A 266 RWINA 270 (328)
T ss_dssp TTTTT
T ss_pred HhhcC
Confidence 99974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=418.48 Aligned_cols=302 Identities=37% Similarity=0.578 Sum_probs=218.2
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA- 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 101 (477)
.+.++|++++.||+|+||+||+|+++. +++.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKL---EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC-----CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECC---CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 345889999999999999999998764 6889999999765444444567789999999999999999999986432
Q ss_pred --CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 102 --DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 102 --~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
...+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||
T Consensus 127 ~~~~~~~lv~e~~~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl----~~~~~~kl 197 (458)
T 3rp9_A 127 EKFDELYVVLEIADSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV----NQDCSVKV 197 (458)
T ss_dssp TTCCCEEEEECCCSEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTCCEEE
T ss_pred ccCceEEEEEeccccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE----CCCCCEee
Confidence 2468999999999999998753 469999999999999999999999999999999999999 67778999
Q ss_pred eecccceeecCCCCc-------------------------ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHH
Q 011808 180 ADFGLARIYQAPLKF-------------------------LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAEL 234 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~el 234 (477)
+|||+++.+...... ......+||++|+|||++.....|+.++|||||||++|||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999876432211 1223467899999999986656799999999999999999
Q ss_pred Hh-----------CCCCCCCccccc------------CCCcccHHHHHHHHHHhCCCCCCCccccCCCcccccccccccc
Q 011808 235 LT-----------LKPLFQGAEAKS------------TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQG 291 (477)
Q Consensus 235 lt-----------G~~PF~~~~~~~------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (477)
++ |+++|.+...-. .......+++..++..++.++.+.+..+.... ....+..
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~----~~~~~~~ 353 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED----AKRYIRI 353 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHH----HHHHHTT
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHH----HHHHHHh
Confidence 99 777887654210 00111367888899999988766544332200 0000000
Q ss_pred -ccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 292 -RKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 292 -~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
.......+... ....+.++.+||++||.+||.+|||++|+|+||||+..
T Consensus 354 ~~~~~~~~~~~~-~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 354 FPKREGTDLAER-FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp SCCCCCCCGGGG-STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred cCCCCCCCHHHH-CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 00011111112 23457889999999999999999999999999999853
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=397.12 Aligned_cols=301 Identities=38% Similarity=0.677 Sum_probs=239.2
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
+..+++|++++.||+|+||.||+|+++. ++..||||++............+.+|+.+++.++||||+++++++.+..
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 13 CDEVSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp SCBGGGEEEEEECSSCSTTSEEEEEETT---TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred cccccceeEEEEEecCCCcEEEEEEECC---CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 4568999999999999999999998764 6889999999877666666778889999999999999999999987643
Q ss_pred ------CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 102 ------DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 102 ------~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
...+|+||||++++|.+.+.... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~----~~~~ 161 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI----TRDG 161 (351)
T ss_dssp -------CEEEEEEECCSEEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTS
T ss_pred cccccCCceEEEEEeccCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE----cCCC
Confidence 34689999999999998887642 369999999999999999999999999999999999999 6777
Q ss_pred cEEEeecccceeecCCCC--cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 176 VVKIADFGLARIYQAPLK--FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
.+||+|||+++.+..... .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+
T Consensus 162 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------- 233 (351)
T 3mi9_A 162 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-------- 233 (351)
T ss_dssp CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------
T ss_pred CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC--------
Confidence 899999999987653221 1122345679999999999876678999999999999999999999998766
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCc-cccCCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLH-SVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~ 332 (477)
..+.+..+....+..+++.|+.......+....... .....+. .......++.+.+||.+||++||.+|||++|+
T Consensus 234 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 309 (351)
T 3mi9_A 234 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVK----GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309 (351)
T ss_dssp HHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCS----SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hHHHHHHHHHHhCCCChhhccccccchhhccccccc----ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHH
Confidence 567778888888888888777655433222111000 0000000 00001125678999999999999999999999
Q ss_pred hcCccCCCCCCCC
Q 011808 333 LEHEYFRIEPLPG 345 (477)
Q Consensus 333 L~h~~f~~~~~~~ 345 (477)
|+||||+..+.+.
T Consensus 310 l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 310 LNHDFFWSDPMPS 322 (351)
T ss_dssp HTSGGGGSSSCCC
T ss_pred hCCCCcCCCCCcc
Confidence 9999998655543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=409.86 Aligned_cols=316 Identities=33% Similarity=0.497 Sum_probs=233.3
Q ss_pred CCCCCCCCCCCCccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCC
Q 011808 9 GRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE 88 (477)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hp 88 (477)
++++....-..+...+.++|++++.||+|+||.||+|+++. +++.||||++............+.+|+.+|+.++||
T Consensus 9 ~~~~~~~~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 85 (432)
T 3n9x_A 9 SGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85 (432)
T ss_dssp --CCCCCTTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCT
T ss_pred ccchhhhhcCCCcceecCCEEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCC
Confidence 33344444444556678999999999999999999998764 689999999976554444456788999999999999
Q ss_pred CeeEEEEEEEcCCC---ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcE
Q 011808 89 NVVKLVNVHINHAD---MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNI 165 (477)
Q Consensus 89 nIv~l~~~~~~~~~---~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NI 165 (477)
||+++++++..... ..+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 86 nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NI 160 (432)
T 3n9x_A 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANC 160 (432)
T ss_dssp TBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHe
Confidence 99999999876432 468999999999999998753 4699999999999999999999999999999999999
Q ss_pred EEeccCCCcccEEEeecccceeecCCCCc--------------------ccCCCeeeccccccchhhcCCCCCCchhhHH
Q 011808 166 LVMGEGEEQGVVKIADFGLARIYQAPLKF--------------------LSENGVVVTIWYRAPELLLGAKHYTSAVDMW 225 (477)
Q Consensus 166 Ll~~~~~~~~~vkL~DFG~a~~~~~~~~~--------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~Diw 225 (477)
|+ +.++.+||+|||+++........ ......+||++|+|||++.....|+.++|||
T Consensus 161 Ll----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~Diw 236 (432)
T 3n9x_A 161 LL----NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIW 236 (432)
T ss_dssp EE----CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHH
T ss_pred EE----CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccc
Confidence 99 67778999999999876543211 1124567899999999986667799999999
Q ss_pred HHHHHHHHHHhCCCC-----------CCCcccc---------cCCCcccHHHHHHHHHHhCCCCCCCccccCCCcccccc
Q 011808 226 AVGCIFAELLTLKPL-----------FQGAEAK---------STQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSD 285 (477)
Q Consensus 226 SlGvil~elltG~~P-----------F~~~~~~---------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 285 (477)
||||++|||++|..| |.+.+.- ........+++..++..++.++.+.+..+.... .
T Consensus 237 SlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~----~ 312 (432)
T 3n9x_A 237 STGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPE----V 312 (432)
T ss_dssp HHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHH----H
T ss_pred hHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHH----H
Confidence 999999999985444 4433210 001112478889999999988766544332200 0
Q ss_pred ccccccccc-cCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 286 SLHIQGRKY-ETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 286 ~~~~~~~~~-~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
...+..... ....+.. .....++.+.+||++||++||.+|||++|+|+||||+..
T Consensus 313 ~~~~~~~~~~~~~~~~~-~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 313 IKYIKLFPHRKPINLKQ-KYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 000000000 0001111 113467889999999999999999999999999999853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=416.48 Aligned_cols=287 Identities=37% Similarity=0.601 Sum_probs=222.7
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA- 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 101 (477)
.+.++|++++.||+|+||+||+|+++. +++.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence 457899999999999999999998764 6889999999765444444567789999999999999999999996543
Q ss_pred ---CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 102 ---DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 102 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
...+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 136 ~~~~~~~~lv~E~~~~~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll----~~~~~~k 204 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLK 204 (464)
T ss_dssp TTTCCEEEEEEECCSEEHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEE
T ss_pred cccCCeEEEEEeCCCCCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE----eCCCCEE
Confidence 246899999999998887742 48999999999999999999999999999999999999 6777899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+++...... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+ ..+++
T Consensus 205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~--------~~~~~ 272 (464)
T 3ttj_A 205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD--------YIDQW 272 (464)
T ss_dssp ECCCCCC-----CC---CC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 99999998765432 23446789999999999885 59999999999999999999999998876 67889
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccc-cccccCCCCccccCCC-----------CCchHHHHHHHhcccCCCCC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQ-GRKYETNGLHSVVPLS-----------PKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~p~~-----------~s~~~~dli~~~L~~dP~~R 326 (477)
..+++.++.+.++.+..+.. ... .... ...+....+...++.. .++.++|||.+||++||.+|
T Consensus 273 ~~i~~~lg~p~~~~~~~~~~---~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 347 (464)
T 3ttj_A 273 NKVIEQLGTPCPEFMKKLQP---TVR--NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347 (464)
T ss_dssp HHHHHHHCSCCHHHHTTSCH---HHH--HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHhcCCCCHHHHHHcch---hhh--hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhC
Confidence 99999999887765543321 000 0000 0000000111111111 13568999999999999999
Q ss_pred CCHHHHhcCccCCC
Q 011808 327 ITAAQALEHEYFRI 340 (477)
Q Consensus 327 pt~~e~L~h~~f~~ 340 (477)
||++|+|+||||..
T Consensus 348 ~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 348 ISVDDALQHPYINV 361 (464)
T ss_dssp CCHHHHHTSTTTGG
T ss_pred CCHHHHhcChhhhh
Confidence 99999999999974
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=392.35 Aligned_cols=287 Identities=39% Similarity=0.713 Sum_probs=224.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|++++.||+|+||.||+|+++. ++..||||++....... ....+.+|+.+++.++||||+++++++.+.. .
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 74 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKL---TDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEK--S 74 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS--C
T ss_pred CCceEEEEEEcCCCCEEEEEEEECC---CCcEEEEEEEecccccc-cchhHHHHHHHHHhcCCCCCCeeeeEEeeCC--E
Confidence 4789999999999999999998764 68899999997544322 1123347999999999999999999997644 7
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 75 ~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~----~~~~~~kl~Dfg~ 146 (324)
T 3mtl_A 75 LTLVFEYLDKDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI----NERGELKLADFGL 146 (324)
T ss_dssp EEEEEECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE----CTTCCEEECSSSE
T ss_pred EEEEecccccCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE----CCCCCEEEccCcc
Confidence 8999999999999998764 2368999999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
++....... .....++|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+ ..+.+..+...
T Consensus 147 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~ 216 (324)
T 3mtl_A 147 ARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST--------VEEQLHFIFRI 216 (324)
T ss_dssp EECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHH
T ss_pred cccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHH
Confidence 986543322 22345679999999999876678999999999999999999999998766 56788889999
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
++.+..+.|+.......+.... ...+.... ........+..+.+||.+||++||.+|||++|+|+||||..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 217 LGTPTEETWPGILSNEEFKTYN----YPKYRAEA-LLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp HCCCCTTTSTTGGGCHHHHHTC----CCCCCCCC-HHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hCCCChHhchhhhcchhhcccc----cccccchh-hhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 9999998887654432221110 00011111 11123456788999999999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=383.67 Aligned_cols=287 Identities=40% Similarity=0.719 Sum_probs=227.4
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC---CCCCcHHHHHHHHHHHhcC---CCCeeEEEEEE
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD---GDGVSPTAIREIMLLREIT---HENVVKLVNVH 97 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~ 97 (477)
+.++|++++.||+|+||+||+|+++ .+++.||||++..... .........+|+.+++.++ ||||+++++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDP---HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECT---TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEEC---CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 4679999999999999999999865 3688999999875432 2233456778888887774 99999999998
Q ss_pred EcCCC---ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc
Q 011808 98 INHAD---MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ 174 (477)
Q Consensus 98 ~~~~~---~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~ 174 (477)
..... ..++++|||++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~----~~~ 156 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVDQDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV----TSG 156 (308)
T ss_dssp EECCSSSEEEEEEEEECCCCBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE----CTT
T ss_pred eccCCCCceeEEEEehhhhcCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----cCC
Confidence 76432 2589999999999999987643 2349999999999999999999999999999999999999 667
Q ss_pred ccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCccc
Q 011808 175 GVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254 (477)
Q Consensus 175 ~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~ 254 (477)
+.+||+|||+++....... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+ .
T Consensus 157 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~--------~ 224 (308)
T 3g33_A 157 GTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNS--------E 224 (308)
T ss_dssp SCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSS--------H
T ss_pred CCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCC--------H
Confidence 7899999999986543322 23456799999999998754 8999999999999999999999998766 5
Q ss_pred HHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.+.+..++..++.++...|+....++...-. ..... .........++.+.+||.+||++||.+|||+.|+|+
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 225 ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFP-------PRGPR-PVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHHHHHCCCCTTTSCSSCSSCGGGSC-------CCCCC-CHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHhCCCChhhccchhhccccccC-------CCCCC-cHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 6778889999998888887765544321100 00000 111123456788999999999999999999999999
Q ss_pred CccCCC
Q 011808 335 HEYFRI 340 (477)
Q Consensus 335 h~~f~~ 340 (477)
||||+.
T Consensus 297 h~~~~~ 302 (308)
T 3g33_A 297 HSYLHK 302 (308)
T ss_dssp STTC--
T ss_pred CccccC
Confidence 999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=390.12 Aligned_cols=293 Identities=42% Similarity=0.759 Sum_probs=229.4
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC---CCCcHHHHHHHHHHHhcCCCCeeEEEEEEE
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG---DGVSPTAIREIMLLREITHENVVKLVNVHI 98 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 98 (477)
....++|++++.||+|+||.||+|+++. ++..||||++...... ......+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG 82 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECC---CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe
Confidence 3457899999999999999999998653 6889999999754332 223346789999999999999999999986
Q ss_pred cCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 99 NHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 99 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
+. ..+++||||++++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 83 ~~--~~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~----~~~~~~k 152 (346)
T 1ua2_A 83 HK--SNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL----DENGVLK 152 (346)
T ss_dssp CT--TCCEEEEECCSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCEE
T ss_pred eC--CceEEEEEcCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE----cCCCCEE
Confidence 54 368999999999998888653 2368889999999999999999999999999999999999 6777899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+++.+..... .....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ..+.+
T Consensus 153 l~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~--------~~~~~ 222 (346)
T 1ua2_A 153 LADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--------DLDQL 222 (346)
T ss_dssp ECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred EEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC--------HHHHH
Confidence 999999987643322 22345679999999999876668999999999999999999999998766 56778
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..++..++.+..+.|+....++++.... ......+ .......+..+.+||.+||+.||.+|||++|+|+|+||
T Consensus 223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 223 TRIFETLGTPTEEQWPDMCSLPDYVTFK------SFPGIPL-HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp HHHHHHHCCCCTTTSSSTTSSTTCCCCC------CCCCCCH-HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHHcCCCChhhhhhhccCccccccc------ccCCCCh-HHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 8899999999999998877766553211 0000000 01124557889999999999999999999999999999
Q ss_pred CCCCCC
Q 011808 339 RIEPLP 344 (477)
Q Consensus 339 ~~~~~~ 344 (477)
+..+.+
T Consensus 296 ~~~~~~ 301 (346)
T 1ua2_A 296 SNRPGP 301 (346)
T ss_dssp TSSSCC
T ss_pred hcCCCC
Confidence 855433
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=397.48 Aligned_cols=289 Identities=37% Similarity=0.615 Sum_probs=224.5
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
-.+.++|++++.||+|+||.||+|+++. ++..||||++............+.+|+.+++.++||||+++++++....
T Consensus 21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred eeecceEEEeEEeeecCCeEEEEEEECC---CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 3457899999999999999999998754 6899999999765544444567789999999999999999999987643
Q ss_pred C----ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccE
Q 011808 102 D----MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVV 177 (477)
Q Consensus 102 ~----~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~v 177 (477)
. ..+|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~ 167 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFMGTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCEL 167 (367)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCE
T ss_pred ccccCceEEEEEecCCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE----cCCCCE
Confidence 2 35699999999899988875 258999999999999999999999999999999999999 677789
Q ss_pred EEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 178 KIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
||+|||+++..... ....++|++|+|||++.+...++.++|||||||++|+|++|++||.+.+ ..++
T Consensus 168 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~ 234 (367)
T 1cm8_A 168 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--------HLDQ 234 (367)
T ss_dssp EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH
T ss_pred EEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC--------HHHH
Confidence 99999999876532 2345679999999999886669999999999999999999999998776 5678
Q ss_pred HHHHHHHhCCCCCCCccccCCCcccccccccccc-ccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQG-RKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
+..+...++.++.+.+..+..-. ....+.. .......+. ......++.+.+||.+||..||.+|||++++|+||
T Consensus 235 l~~i~~~~g~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 235 LKEIMKVTGTPPAEFVQRLQSDE----AKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp HHHHHHHHCCCCHHHHHTCSCHH----HHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHHHhcCCCCHHHHHHhhhHH----HHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 88899988887665443322100 0000000 000111111 12235678899999999999999999999999999
Q ss_pred cCCCC
Q 011808 337 YFRIE 341 (477)
Q Consensus 337 ~f~~~ 341 (477)
||...
T Consensus 310 ~f~~~ 314 (367)
T 1cm8_A 310 YFESL 314 (367)
T ss_dssp GGTTT
T ss_pred HHHhh
Confidence 99743
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=390.73 Aligned_cols=266 Identities=26% Similarity=0.404 Sum_probs=213.9
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC----CcHHHHHHHHHHHhcCCCCeeEEEEE
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG----VSPTAIREIMLLREITHENVVKLVNV 96 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~ 96 (477)
...+.++|++.+.||+|+||.||+|+++. ++..||||+++....... ....+.+|+.+|+.++||||++++++
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 83 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV 83 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECC---CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence 34567889999999999999999998764 688999999976554322 34577899999999999999999999
Q ss_pred EEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 97 HINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 97 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
+.+. ..+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..++....
T Consensus 84 ~~~~--~~~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 84 YENR--TDVVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp EECS--SEEEEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSC
T ss_pred EEeC--CEEEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCcc
Confidence 9764 47899999996 789888865 246999999999999999999999999999999999999954433334
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccH
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~ 255 (477)
.+||+|||++..+..... ....+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+ ..
T Consensus 157 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------~~ 224 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDT--------KQ 224 (361)
T ss_dssp CEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HH
T ss_pred CEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCC--------HH
Confidence 799999999987654322 2346789999999999874 48999999999999999999999998654 22
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+.+..+....... ........+..+.+||.+||.+||.+|||+.|+|+|
T Consensus 225 ~~~~~i~~~~~~~-------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 225 ETLANITAVSYDF-------------------------------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHHHHTTCCCC-------------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhcCCCC-------------------------------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2232222111000 001123346789999999999999999999999999
Q ss_pred ccCC
Q 011808 336 EYFR 339 (477)
Q Consensus 336 ~~f~ 339 (477)
|||+
T Consensus 274 p~~~ 277 (361)
T 2yab_A 274 PWIT 277 (361)
T ss_dssp TTTS
T ss_pred cCcC
Confidence 9997
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=389.28 Aligned_cols=264 Identities=24% Similarity=0.329 Sum_probs=192.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHH--HHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI--REIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~--~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
..+|.+.++||+|+||+||+|++ +|+.||||+++... ...+. .|+.++..++|||||++++++.....
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-----~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-----TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence 35799999999999999999975 37899999996532 22333 45666678899999999999976543
Q ss_pred --ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC--------CeecCCCCCCcEEEeccC
Q 011808 103 --MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN--------WIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 103 --~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------givHrDikp~NILl~~~~ 171 (477)
..+|||||||+ |+|.+++... .+++..+..++.|++.||.|||++ +||||||||+||||
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---- 141 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---- 141 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE----
T ss_pred CceEEEEEecCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE----
Confidence 36899999998 6999988653 588999999999999999999987 99999999999999
Q ss_pred CCcccEEEeecccceeecCCCCcc--cCCCeeeccccccchhhcCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 011808 172 EEQGVVKIADFGLARIYQAPLKFL--SENGVVVTIWYRAPELLLGAK-----HYTSAVDMWAVGCIFAELLTLKPLFQGA 244 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~-----~~~~~~DiwSlGvil~elltG~~PF~~~ 244 (477)
+.++++||+|||+|+......... .....+||+.|||||++.+.. .|+.++|||||||++|||+||.+||...
T Consensus 142 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred CCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 778899999999998776543221 223467999999999997642 2677999999999999999999988654
Q ss_pred ccccCCCccc-----HHHHHHHHHHhCCC-CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHh
Q 011808 245 EAKSTQNPFQ-----LDQLDKIFKILGHP-TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318 (477)
Q Consensus 245 ~~~~~~~~~~-----~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~ 318 (477)
..... ++. ......+...+... .... +|.. ..+......+.+||.+|
T Consensus 222 ~~~~~--p~~~~~~~~~~~~~~~~~~~~~~~rp~------~p~~-------------------~~~~~~~~~l~~li~~c 274 (303)
T 3hmm_A 222 EDYQL--PYYDLVPSDPSVEEMRKVVCEQKLRPN------IPNR-------------------WQSCEALRVMAKIMREC 274 (303)
T ss_dssp CCCCC--TTTTTSCSSCCHHHHHHHHTTSCCCCC------CCGG-------------------GGSSHHHHHHHHHHHTT
T ss_pred ccccc--cchhcccccchHHHHHHHHhcccCCCC------CCcc-------------------ccchHHHHHHHHHHHHH
Confidence 42211 110 00111222221110 0000 0000 00011123578999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 011808 319 LEYDPRKRITAAQALEH 335 (477)
Q Consensus 319 L~~dP~~Rpt~~e~L~h 335 (477)
|+.||++|||+.|+++.
T Consensus 275 l~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 275 WYANGAARLTALRIKKT 291 (303)
T ss_dssp CCSSGGGSCCHHHHHHH
T ss_pred cccCHhHCcCHHHHHHH
Confidence 99999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=395.13 Aligned_cols=271 Identities=25% Similarity=0.405 Sum_probs=206.2
Q ss_pred CCCCCCCCCCCccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhc-CC
Q 011808 10 RGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREI-TH 87 (477)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~h 87 (477)
..+.+.........-+++|+++++||+|+||+||+|+++. +++.||||+++.... .......+.+|+.+++.+ +|
T Consensus 7 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~h 83 (353)
T 3txo_A 7 KEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83 (353)
T ss_dssp ----------------CCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTC
T ss_pred cCCCCCCCCCcCCCchhheEEEEEEeeCCCEEEEEEEEcC---CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCC
Confidence 3333333334444557999999999999999999998764 688999999975421 123345677899999988 79
Q ss_pred CCeeEEEEEEEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEE
Q 011808 88 ENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNIL 166 (477)
Q Consensus 88 pnIv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NIL 166 (477)
|||+++++++.+.. .+|+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 84 p~Iv~l~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIL 156 (353)
T 3txo_A 84 PFLTQLFCCFQTPD--RLFFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVL 156 (353)
T ss_dssp TTBCCEEEEEECSS--EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred CceeeEEEEEEeCC--EEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEE
Confidence 99999999997654 7999999998 5888888764 36999999999999999999999999999999999999
Q ss_pred EeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 011808 167 VMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246 (477)
Q Consensus 167 l~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~ 246 (477)
+ +.++++||+|||+++...... ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+
T Consensus 157 l----~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~- 228 (353)
T 3txo_A 157 L----DHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAEN- 228 (353)
T ss_dssp E----CTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred E----CCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCC-
Confidence 9 777889999999998543221 123456789999999999874 48999999999999999999999998765
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
..+.+..+.... ..+|...+..+.+||++||++||.+|
T Consensus 229 -------~~~~~~~i~~~~-----------------------------------~~~p~~~~~~~~~li~~lL~~dP~~R 266 (353)
T 3txo_A 229 -------EDDLFEAILNDE-----------------------------------VVYPTWLHEDATGILKSFMTKNPTMR 266 (353)
T ss_dssp -------HHHHHHHHHHCC-----------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred -------HHHHHHHHHcCC-----------------------------------CCCCCCCCHHHHHHHHHHhhhCHHHc
Confidence 223333332210 11233456789999999999999999
Q ss_pred CCH------HHHhcCccCCC
Q 011808 327 ITA------AQALEHEYFRI 340 (477)
Q Consensus 327 pt~------~e~L~h~~f~~ 340 (477)
+++ .++++||||+.
T Consensus 267 ~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 267 LGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp TTSGGGTCTHHHHTSGGGTT
T ss_pred cCCcccCCHHHHhhCCcccC
Confidence 998 89999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=399.96 Aligned_cols=287 Identities=34% Similarity=0.587 Sum_probs=226.3
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEc----
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHIN---- 99 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---- 99 (477)
...+|++++.||+|+||.||+|+++. ++..||||++...... ..+|+++|+.++||||++++++|..
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~~~------~~~E~~il~~l~hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECC---CCcEEEEEEecccchh------HHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence 34579999999999999999998764 6889999998754322 2379999999999999999999854
Q ss_pred CCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 100 HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 100 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
....++++||||+.+++.+.+..... ....+++..++.++.||+.||.|||++||+||||||+||||.. +.+.+||
T Consensus 123 ~~~~~~~lv~e~~~~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~~kl 198 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP---DTAVLKL 198 (420)
T ss_dssp TTEEEEEEEEECCCEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET---TTTEEEE
T ss_pred CcceeEEeehhcccccHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC---CCCeEEe
Confidence 23446889999999998888765432 2457999999999999999999999999999999999999932 3457899
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+++.+..... ....++|+.|+|||++.+...|+.++|||||||++|||++|++||.+.+ ..+++.
T Consensus 199 ~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~--------~~~~l~ 267 (420)
T 1j1b_A 199 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--------GVDQLV 267 (420)
T ss_dssp CCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred ccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 99999987654322 2345679999999999876679999999999999999999999998766 567888
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
++++.++.++.+.+..+. +.+.. +.........+...++...+.++.+||.+||++||.+|||+.|+|+||||.
T Consensus 268 ~i~~~lg~p~~~~~~~~~--~~~~~----~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 268 EIIKVLGTPTREQIREMN--PNYTE----FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp HHHHHHCSCCHHHHHHHC--SCCCC----CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HHHHHhCCCCHHHHHhhC--hhhhh----hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 899988877655443221 01100 000111112223334556788999999999999999999999999999997
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 342 ~ 342 (420)
T 1j1b_A 342 E 342 (420)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=393.12 Aligned_cols=286 Identities=30% Similarity=0.573 Sum_probs=227.9
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC---
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH--- 100 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--- 100 (477)
..++|++++.||+|+||.||+|++.. ++..||||++....... .+|+.+++.++||||++++++|...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~~~~~------~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPRYK------NRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETT---TCCEEEEEEEECCTTSC------CHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccceEEEEEEEEeccCEEEEEEEECC---CCCEEEEEEEecCcchH------HHHHHHHHHcCCCCccchhheeeecCcc
Confidence 35789999999999999999998764 68999999987543222 2799999999999999999998653
Q ss_pred ---------------------------------CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHH
Q 011808 101 ---------------------------------ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147 (477)
Q Consensus 101 ---------------------------------~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL 147 (477)
...++++||||++++|.+.+..... ....+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHH
Confidence 2345899999999999888876432 245799999999999999999
Q ss_pred HHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHH
Q 011808 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAV 227 (477)
Q Consensus 148 ~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSl 227 (477)
.|||++||+||||||+|||+. ..++.+||+|||+++.+..... .....+|+.|+|||++.+...++.++|||||
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~---~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVN---SKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEE---TTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEc---CCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 999999999999999999993 2467899999999987654332 2345679999999999886679999999999
Q ss_pred HHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCC
Q 011808 228 GCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSP 307 (477)
Q Consensus 228 Gvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 307 (477)
||++|+|++|++||.+.+ ..+++..+...++.++.+.+..... .+.. ..........+...++...
T Consensus 229 G~il~ell~g~~pf~~~~--------~~~~~~~i~~~~g~p~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~~~~ 294 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGET--------SIDQLVRIIQIMGTPTKEQMIRMNP--HYTE----VRFPTLKAKDWRKILPEGT 294 (383)
T ss_dssp HHHHHHHHHSSCSSCCSS--------HHHHHHHHHHHHCCCCHHHHHHHCT--TC------CCCCCCCCCCHHHHSCTTC
T ss_pred HHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHhCCCCHHHHHHhCc--cccc----ccCCccCcccHHhhCCCCC
Confidence 999999999999998766 6778888999888877654332211 1100 0011112223444566778
Q ss_pred CchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 308 KSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 308 s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+..+.+||.+||++||.+|||+.|+|+||||+
T Consensus 295 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (383)
T 3eb0_A 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFD 326 (383)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCHHHH
Confidence 88999999999999999999999999999996
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=391.79 Aligned_cols=266 Identities=26% Similarity=0.413 Sum_probs=209.3
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
-+++|+++++||+|+||+||+|+++. +++.||||++++.... ......+.+|+.+++++ +||||++++++|.+.
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~- 125 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE- 125 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-
Confidence 36899999999999999999998764 6889999999765432 23344677899999887 899999999999764
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 126 -~~~~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl----~~~g~ikL~ 195 (396)
T 4dc2_A 126 -SRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL----DSEGHIKLT 195 (396)
T ss_dssp -SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEEC
T ss_pred -CEEEEEEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE----CCCCCEEEe
Confidence 47999999998 5888888764 369999999999999999999999999999999999999 777889999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||..............+.
T Consensus 196 DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~--- 269 (396)
T 4dc2_A 196 DYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY--- 269 (396)
T ss_dssp CCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHH---
T ss_pred ecceeeecccCCC--ccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHH---
Confidence 9999985332221 23457889999999999874 48999999999999999999999997543221111111111
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH------HHHhc
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA------AQALE 334 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~------~e~L~ 334 (477)
+...+.... ..+|...+..+.+||++||++||.+|+++ +++++
T Consensus 270 ~~~~i~~~~-------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 270 LFQVILEKQ-------------------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp HHHHHHHCC-------------------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred HHHHHhccc-------------------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 111111000 11344567889999999999999999985 89999
Q ss_pred CccCCC
Q 011808 335 HEYFRI 340 (477)
Q Consensus 335 h~~f~~ 340 (477)
||||+.
T Consensus 319 Hpff~~ 324 (396)
T 4dc2_A 319 HPFFRN 324 (396)
T ss_dssp STTTTT
T ss_pred CccccC
Confidence 999973
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=399.65 Aligned_cols=267 Identities=28% Similarity=0.385 Sum_probs=213.8
Q ss_pred CccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEc
Q 011808 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHIN 99 (477)
Q Consensus 20 ~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 99 (477)
....+.++|++++.||+|+||.||+|.++. ++..+|+|++............+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~---~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 81 (444)
T 3soa_A 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 81 (444)
T ss_dssp --CHHHHHEEEEEEEEEC--CEEEEEEETT---TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC
T ss_pred ccccccCCeEEEEEeccCCCeEEEEEEECC---CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE
Confidence 345678999999999999999999998764 68999999998765444445567899999999999999999999976
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
. ..+|+||||+. ++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+..+ ..++.+|
T Consensus 82 ~--~~~~lv~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~-~~~~~vk 153 (444)
T 3soa_A 82 E--GHHYLIFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASK-LKGAAVK 153 (444)
T ss_dssp S--SEEEEEECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBS-STTCCEE
T ss_pred C--CEEEEEEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecc-CCCCcEE
Confidence 4 47899999997 5888888763 369999999999999999999999999999999999999533 2457899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||++........ .....+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+ ..+.+
T Consensus 154 L~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~--------~~~~~ 222 (444)
T 3soa_A 154 LADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDED--------QHRLY 222 (444)
T ss_dssp ECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHH
T ss_pred EccCceeEEecCCCc--eeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCcc--------HHHHH
Confidence 999999987654322 22346789999999999874 48999999999999999999999997654 22333
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..+.......+...| ..+++++.+||.+||+.||.+|||+.|+|+||||
T Consensus 223 ~~i~~~~~~~~~~~~-------------------------------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~ 271 (444)
T 3soa_A 223 QQIKAGAYDFPSPEW-------------------------------DTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271 (444)
T ss_dssp HHHHHTCCCCCTTTT-------------------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred HHHHhCCCCCCcccc-------------------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 333322111111111 2346789999999999999999999999999999
Q ss_pred C
Q 011808 339 R 339 (477)
Q Consensus 339 ~ 339 (477)
+
T Consensus 272 ~ 272 (444)
T 3soa_A 272 S 272 (444)
T ss_dssp H
T ss_pred c
Confidence 6
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=382.67 Aligned_cols=256 Identities=25% Similarity=0.422 Sum_probs=210.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+++|++++.||+|+||+||+|+++. +++.||||+++.... .......+.+|+.+|+.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-- 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-- 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS--
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC--
Confidence 6799999999999999999998764 688999999975421 2234567788999999999999999999997654
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~vkL~DF 149 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML----DKDGHIKITDF 149 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE----CCCCCEEEeec
Confidence 7999999998 5888888763 368999999999999999999999999999999999999 77788999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+++....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+. ......+.
T Consensus 150 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~ 218 (337)
T 1o6l_A 150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELIL 218 (337)
T ss_dssp TTCBCSCCTTC--CBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH
T ss_pred cchhhcccCCC--cccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHH
Confidence 99985433221 23457899999999999874 589999999999999999999999976542 12222221
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCcc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEY 337 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~ 337 (477)
.. . ..+|...++++.+||.+||++||.+|+ +++++++|||
T Consensus 219 ~~----~-------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 219 ME----E-------------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp HC----C-------------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred cC----C-------------------------------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 10 0 012344578899999999999999999 9999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|+.
T Consensus 264 f~~ 266 (337)
T 1o6l_A 264 FLS 266 (337)
T ss_dssp GTT
T ss_pred cCC
Confidence 973
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=388.58 Aligned_cols=270 Identities=27% Similarity=0.388 Sum_probs=211.5
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCC---CCCCCcHHHHHHHHHHHhcCCCCeeEEEEEE
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK---DGDGVSPTAIREIMLLREITHENVVKLVNVH 97 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 97 (477)
...+.++|++.+.||+|+||.||+|+++. +++.||||++.... ........+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 95 (351)
T 3c0i_A 19 DVLFEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY 95 (351)
T ss_dssp -CCHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCccccceEEeeEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34456889999999999999999998764 68899999986432 1122356788999999999999999999999
Q ss_pred EcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc
Q 011808 98 INHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~ 176 (477)
.+. ..+|+||||+. ++|.+.+..... ....+++..++.++.||+.||.|||++||+||||||+|||+..+ .....
T Consensus 96 ~~~--~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~-~~~~~ 171 (351)
T 3c0i_A 96 SSD--GMLYMVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASK-ENSAP 171 (351)
T ss_dssp EET--TEEEEEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSS-STTCC
T ss_pred EeC--CEEEEEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecC-CCCCc
Confidence 774 47899999998 688877765432 23468999999999999999999999999999999999999543 22345
Q ss_pred EEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHH
Q 011808 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~ 256 (477)
+||+|||++........ .....+||+.|+|||++.+. .|+.++|||||||++|+|++|..||.+.. ..
T Consensus 172 vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~ 239 (351)
T 3c0i_A 172 VKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK---------ER 239 (351)
T ss_dssp EEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HH
T ss_pred EEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HH
Confidence 99999999987654322 23346789999999999874 48999999999999999999999997643 12
Q ss_pred HHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 257 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
.+..+........+. .....+..+.+||.+||+.||.+|||+.++|+||
T Consensus 240 ~~~~i~~~~~~~~~~-------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 240 LFEGIIKGKYKMNPR-------------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp HHHHHHHTCCCCCHH-------------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHcCCCCCCcc-------------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 222222211000000 1123467899999999999999999999999999
Q ss_pred cCCC
Q 011808 337 YFRI 340 (477)
Q Consensus 337 ~f~~ 340 (477)
||+.
T Consensus 289 ~~~~ 292 (351)
T 3c0i_A 289 WLKE 292 (351)
T ss_dssp HHHT
T ss_pred hhcC
Confidence 9973
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=387.07 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=213.2
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
..+++|++.+.||+|+||.||+|++.. ++..||||++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYK---TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT 82 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 468999999999999999999998754 688999999865321 1234467889999999999999999999997654
Q ss_pred CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 102 DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 102 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+|+||||++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 83 --~~~lv~E~~~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll----~~~~~~kl~D 151 (336)
T 3h4j_B 83 --DIVMVIEYAGGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL----DDNLNVKIAD 151 (336)
T ss_dssp --EEEEEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE----CTTCCEEECC
T ss_pred --EEEEEEECCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE----cCCCCEEEEE
Confidence 78999999999999998764 369999999999999999999999999999999999999 6777899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||++........ ....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........
T Consensus 152 FG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~--------- 219 (336)
T 3h4j_B 152 FGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK--------- 219 (336)
T ss_dssp SSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------
T ss_pred eccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------
Confidence 999986554322 23456899999999998865457899999999999999999999976442111000
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
........|...++.+.+||++||+.||.+|||++|+++||||+.
T Consensus 220 ----------------------------------i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 220 ----------------------------------VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp ----------------------------------CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred ----------------------------------HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 000112245556788999999999999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=391.47 Aligned_cols=286 Identities=36% Similarity=0.619 Sum_probs=225.0
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC---
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH--- 100 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--- 100 (477)
...+|+++++||+|+||.||+|++.. +..+|+|++....... .+|+.+++.++||||++++++|...
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~----~~~~aikk~~~~~~~~------~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVE----SDEVAIKKVLQDKRFK------NRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETT----TEEEEEEEEECCTTSC------CHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECC----CCeEEEEEEecCcchH------HHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 45789999999999999999998753 3448888876543222 2799999999999999999998653
Q ss_pred -CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 -ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 -~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
...++|+||||+.++++..+.... .....+++..++.++.||+.||.|||++||+||||||+|||+. ..++.+||
T Consensus 108 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~~kL 183 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPETVYRASRHYA-KLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD---PPSGVLKL 183 (394)
T ss_dssp SSCEEEEEEEECCSEEHHHHHHHHH-HTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---TTTTEEEE
T ss_pred CCceEEEEEeeccCccHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc---CCCCcEEE
Confidence 234589999999998887776533 2245799999999999999999999999999999999999993 15778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+++.+..... ....++|+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+ ..+++.
T Consensus 184 ~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--------~~~~l~ 252 (394)
T 4e7w_A 184 IDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES--------GIDQLV 252 (394)
T ss_dssp CCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred eeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 99999987654332 2345679999999999886679999999999999999999999998876 567888
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+.+.++.++.+.+.... +.|.. ..........+...++...++++.+||.+||++||.+|||+.++|.||||+
T Consensus 253 ~i~~~~g~p~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (394)
T 4e7w_A 253 EIIKVLGTPSREQIKTMN--PNYME----HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326 (394)
T ss_dssp HHHHHHCCCCHHHHHHHC--GGGSS----SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred HHHHHhCCCCHHHHHhhC--hhhhh----hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence 888888877655433211 01100 000111122233345566788999999999999999999999999999997
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 327 ~ 327 (394)
T 4e7w_A 327 E 327 (394)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=374.19 Aligned_cols=258 Identities=28% Similarity=0.474 Sum_probs=210.8
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
...++|++++.||+|+||+||+|++. .++..||||++...... ....+.+|+.+++.++||||+++++++.+..
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDV---ATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGD- 90 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBT---TTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred ChhhceeeeeeeccCCCeEEEEEEEC---CCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-
Confidence 35689999999999999999999865 46889999998755432 3456788999999999999999999997754
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 91 -~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~----~~~~~~kl~D 159 (297)
T 3fxz_A 91 -ELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL----GMDGSVKLTD 159 (297)
T ss_dssp -EEEEEEECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECC
T ss_pred -EEEEEEECCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE----CCCCCEEEee
Confidence 7899999996 6888888653 58999999999999999999999999999999999999 6677899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||++........ .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+ ....+..+
T Consensus 160 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~~ 228 (297)
T 3fxz_A 160 FGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLI 228 (297)
T ss_dssp CTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHH
T ss_pred CCCceecCCccc--ccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH
Confidence 999987654332 23346789999999999874 48999999999999999999999997654 22222222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
... ..+.. ..+...+..+.+||.+||+.||++|||++++|+||||+.
T Consensus 229 ~~~-~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 229 ATN-GTPEL-------------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp HHH-CSCCC-------------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HhC-CCCCC-------------------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 221 11100 112334677999999999999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=382.00 Aligned_cols=264 Identities=27% Similarity=0.410 Sum_probs=208.2
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
..|+++|++++.||+|+||.||+|+++. +++.||||++...... .....+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~- 77 (323)
T 3tki_A 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREG- 77 (323)
T ss_dssp CTTTTCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred CcHhhhceeeeEEecCCCEEEEEEEECC---CCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecC-
Confidence 3578999999999999999999998764 6889999998654432 2234677899999999999999999998764
Q ss_pred CceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
...|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 78 -~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll----~~~~~~kl~ 147 (323)
T 3tki_A 78 -NIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL----DERDNLKIS 147 (323)
T ss_dssp -SEEEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEEC
T ss_pred -CeEEEEEEcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE----eCCCCEEEE
Confidence 478999999975 77777644 3369999999999999999999999999999999999999 677789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||+++.+............+||+.|+|||++.+...++.++|||||||++|+|++|+.||...... ...+..
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~ 220 (323)
T 3tki_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-------CQEYSD 220 (323)
T ss_dssp CCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-------SHHHHH
T ss_pred EeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHH
Confidence 9999987654333333345678999999999988665578999999999999999999999765421 011111
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+... .... + .....+..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 221 ~~~~--~~~~---------~----------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 221 WKEK--KTYL---------N----------------------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp HHTT--CTTS---------T----------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred Hhcc--cccC---------C----------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 1100 0000 0 01223578899999999999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=397.08 Aligned_cols=290 Identities=30% Similarity=0.524 Sum_probs=223.0
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc------CCCCeeEEEE
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI------THENVVKLVN 95 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~ 95 (477)
..+..+|+++++||+|+||.||+|++.. ++..||||+++... .....+.+|+.+++.+ +|+||+++++
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~---~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETT---TTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECC---CCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 3456789999999999999999998764 68899999997532 2234566788888877 5779999999
Q ss_pred EEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 96 VHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
++.... .+|+||||++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 167 ~~~~~~--~~~lv~e~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl----~~~~ 237 (429)
T 3kvw_A 167 NFTFRN--HICMTFELLSMNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL----KQQG 237 (429)
T ss_dssp EEEETT--EEEEEECCCCCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE----SSTT
T ss_pred ecccCC--eEEEEEeccCCCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----ccCC
Confidence 997654 789999999999999998754 2358999999999999999999999999999999999999 5554
Q ss_pred c--EEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 176 V--VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 176 ~--vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
. +||+|||+++..... ....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+
T Consensus 238 ~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~-------- 303 (429)
T 3kvw_A 238 RSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGED-------- 303 (429)
T ss_dssp SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS--------
T ss_pred CcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCC--------
Confidence 4 999999999764432 23457799999999998854 8999999999999999999999998776
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCC---------Cccccccccc------cccc---------cccCCCCccccCCCCCc
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLAN---------LPHWQSDSLH------IQGR---------KYETNGLHSVVPLSPKS 309 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~---------~~~~~~~~~~------~~~~---------~~~~~~~~~~~p~~~s~ 309 (477)
..+.+..+...++.++.+.+..... .|.|...... .... ......+....+...++
T Consensus 304 ~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 383 (429)
T 3kvw_A 304 EGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383 (429)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCH
T ss_pred HHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchH
Confidence 5677888888888776543322111 1111110000 0000 00011112223344577
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 310 PAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 310 ~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.+.+||++||++||++|||++|+|+||||+.
T Consensus 384 ~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414 (429)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSTTTC-
T ss_pred HHHHHHHHHCCCChhhCCCHHHHhCChhhcc
Confidence 8999999999999999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=387.26 Aligned_cols=265 Identities=29% Similarity=0.413 Sum_probs=212.6
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
...+.++|++.+.||+|+||.||+|.++. ++..||||++............+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 100 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE 100 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 34567899999999999999999998764 688999999987655444456778899999999999999999999764
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ ...+.+||
T Consensus 101 --~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~-~~~~~~kl 172 (362)
T 2bdw_A 101 --SFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK-AKGAAVKL 172 (362)
T ss_dssp --SEEEEEECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCS-STTCCEEE
T ss_pred --CEEEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC-CCCCCEEE
Confidence 47899999998 5888887653 368999999999999999999999999999999999999543 23456999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||++....... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+ ....+.
T Consensus 173 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~--------~~~~~~ 240 (362)
T 2bdw_A 173 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYA 240 (362)
T ss_dssp CCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred eecCcceEecCCc---ccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHH
Confidence 9999998765432 22346789999999999874 48999999999999999999999997654 222222
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+.......+...| ..+++++.+||.+||+.||.+|||+.++|+||||.
T Consensus 241 ~i~~~~~~~~~~~~-------------------------------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 289 (362)
T 2bdw_A 241 QIKAGAYDYPSPEW-------------------------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289 (362)
T ss_dssp HHHHTCCCCCTTGG-------------------------------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred HHHhCCCCCCcccc-------------------------------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence 22221111111111 12357899999999999999999999999999996
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=387.05 Aligned_cols=296 Identities=35% Similarity=0.595 Sum_probs=228.9
Q ss_pred CCccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEE
Q 011808 19 GEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHI 98 (477)
Q Consensus 19 ~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 98 (477)
++...+.++|++++.||+|+||.||+|++.. ++..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 20 g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 95 (364)
T 3qyz_A 20 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIR 95 (364)
T ss_dssp -CBCCCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred cEeccccccEEEEEEeecCCCeEEEEEEECC---CCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEe
Confidence 4444556799999999999999999998754 68899999997532 2223456788999999999999999999986
Q ss_pred cCC---CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 99 NHA---DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 99 ~~~---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
... ...+|+||||++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 96 ~~~~~~~~~~~iv~e~~~~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~----~~~~ 165 (364)
T 3qyz_A 96 APTIEQMKDVYIVQDLMETDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTC 165 (364)
T ss_dssp CSSTTTCCCEEEEEECCSEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTC
T ss_pred cCCccccceEEEEEcccCcCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE----CCCC
Confidence 542 2468999999999999988652 59999999999999999999999999999999999999 6777
Q ss_pred cEEEeecccceeecCCCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCccc
Q 011808 176 VVKIADFGLARIYQAPLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~ 254 (477)
.+||+|||+++......... .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+ .
T Consensus 166 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~ 237 (364)
T 3qyz_A 166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH--------Y 237 (364)
T ss_dssp CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS--------G
T ss_pred CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC--------h
Confidence 89999999998765432211 12345789999999998776668999999999999999999999998766 5
Q ss_pred HHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.+.+..+...++.+..+.+..+.+..... ............+ .......+..+.+||.+||++||.+|||++++|+
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 238 LDQLNHILGILGSPSQEDLNCIINLKARN---YLLSLPHKNKVPW-NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp GGHHHHHHHHHCSCCHHHHHTCCCHHHHH---HHHTSCCCCCCCH-HHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHH---HHHhcCCccCCCH-HHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 56778888888777665443322211000 0000000000000 1122345788999999999999999999999999
Q ss_pred CccCCC
Q 011808 335 HEYFRI 340 (477)
Q Consensus 335 h~~f~~ 340 (477)
||||+.
T Consensus 314 hp~~~~ 319 (364)
T 3qyz_A 314 HPYLEQ 319 (364)
T ss_dssp SGGGTT
T ss_pred Ccchhh
Confidence 999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=376.47 Aligned_cols=289 Identities=38% Similarity=0.668 Sum_probs=212.9
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
++++|++++.||+|+||.||+|+++. ++..||||++............+.+|+.+++.++||||+++++++.+..
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 75 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR-- 75 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred CcccceEeeEEeecCCeEEEEEEeCC---CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC--
Confidence 46899999999999999999998754 6889999999766544434556778999999999999999999997644
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+++||||+++.++..+... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg 147 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI----TKHSVIKLCDFG 147 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCCT
T ss_pred eEEEEEEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE----cCCCCEEEeeCC
Confidence 78999999997655544432 3468999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++......... ....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+..+..
T Consensus 148 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~ 217 (311)
T 4agu_A 148 FARLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS--------DVDQLYLIRK 217 (311)
T ss_dssp TCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHH
T ss_pred CchhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHH
Confidence 99876543221 2345679999999999876678999999999999999999999998766 4455666666
Q ss_pred HhCCCCCCCccccCCCcccccccccccccccc-CCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYE-TNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.++...+......... .|.... ...... ...+. ......+.++.+||.+||+.||.+|||++++|+||||+.
T Consensus 218 ~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 218 TLGDLIPRHQQVFSTN-QYFSGV---KIPDPEDMEPLE-LKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp HHCSCCHHHHHHHHTC-GGGTTC---CCCCCSSCCCHH-HHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred Hhcccccccccccccc-cccccC---cCCCccccchhh-hhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 5554432211100000 000000 000000 00000 111346778999999999999999999999999999973
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=392.70 Aligned_cols=288 Identities=39% Similarity=0.606 Sum_probs=212.1
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA- 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 101 (477)
.+.++|++++.||+|+||.||+|++.. ++..||||++............+.+|+.+++.++||||+++++++....
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETT---TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECC---CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 446899999999999999999998654 6899999999765444344567789999999999999999999986531
Q ss_pred ---CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 102 ---DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 102 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
...+|+++|+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll----~~~~~~k 172 (367)
T 2fst_X 103 LEEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELK 172 (367)
T ss_dssp GGGCCCCEEEEECCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCEE
T ss_pred cccCCeEEEEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE----CCCCCEE
Confidence 245799999999888887754 369999999999999999999999999999999999999 6777899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+++..... ....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+ ..+++
T Consensus 173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~l 239 (367)
T 2fst_X 173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--------HIDQL 239 (367)
T ss_dssp ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHH
T ss_pred Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 9999999865432 2345779999999999876669999999999999999999999998776 57888
Q ss_pred HHHHHHhCCCCCCCccccCCCcccccccccccc-ccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQG-RKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
..+.+.++.+..+.+..+..-. . ...+.. .......+.. .....++.+.+||.+||..||.+|||++++|+|||
T Consensus 240 ~~i~~~~g~p~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 240 KLILRLVGTPGAELLKKISSES---A-RNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp HHHHHHHCSCCHHHHTTCCCHH---H-HHHHHTSCCCCCCCHHH-HTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHhCCCCHHHHHHhhhHH---H-HHHHhccCCCCCCCHHH-HCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 8899998887765444332100 0 000000 0000011111 12345778999999999999999999999999999
Q ss_pred CCCC
Q 011808 338 FRIE 341 (477)
Q Consensus 338 f~~~ 341 (477)
|...
T Consensus 315 ~~~~ 318 (367)
T 2fst_X 315 FAQY 318 (367)
T ss_dssp GTTT
T ss_pred hhhc
Confidence 9753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=376.00 Aligned_cols=262 Identities=29% Similarity=0.418 Sum_probs=203.1
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC------------------------CCcHHHHH
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD------------------------GVSPTAIR 77 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~------------------------~~~~~~~~ 77 (477)
...+++|++.+.||+|+||.||+|+++. ++..||||++....... .....+.+
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNEN---DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ 85 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETT---TTEEEEEEEEECC-------------------------------CHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECC---CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence 3457999999999999999999998654 68899999997653211 12346788
Q ss_pred HHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCee
Q 011808 78 EIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWII 156 (477)
Q Consensus 78 Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~giv 156 (477)
|+.+++.++||||+++++++.+.....+|+||||+.+ +|.+++. ...+++..++.++.||+.||.|||++||+
T Consensus 86 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 159 (298)
T 2zv2_A 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHYQKII 159 (298)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 9999999999999999999987666789999999985 5544321 34699999999999999999999999999
Q ss_pred cCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCC--CCchhhHHHHHHHHHHH
Q 011808 157 HRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKH--YTSAVDMWAVGCIFAEL 234 (477)
Q Consensus 157 HrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~--~~~~~DiwSlGvil~el 234 (477)
||||||+|||+ +.++.+||+|||+++.+...... .....||+.|+|||++.+... ++.++|||||||++|+|
T Consensus 160 H~Dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 160 HRDIKPSNLLV----GEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp CCCCCGGGEEE----CTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred ccCCCHHHEEE----CCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 99999999999 66778999999999876543221 234568999999999976442 47789999999999999
Q ss_pred HhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHH
Q 011808 235 LTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDL 314 (477)
Q Consensus 235 ltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dl 314 (477)
++|+.||.+... ......+.... . ........+..+.+|
T Consensus 234 ~~g~~pf~~~~~--------~~~~~~~~~~~--~-------------------------------~~~~~~~~~~~l~~l 272 (298)
T 2zv2_A 234 VFGQCPFMDERI--------MCLHSKIKSQA--L-------------------------------EFPDQPDIAEDLKDL 272 (298)
T ss_dssp HHSSCSSCCSSH--------HHHHHHHHHCC--C-------------------------------CCCSSSCCCHHHHHH
T ss_pred HHCCCCCCCccH--------HHHHHHHhccc--C-------------------------------CCCCccccCHHHHHH
Confidence 999999975431 11111111100 0 000112346789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccCC
Q 011808 315 LSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 315 i~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
|.+||+.||.+|||+.|+|+||||+
T Consensus 273 i~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 273 ITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHhhcChhhCCCHHHHhcCcccc
Confidence 9999999999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=377.09 Aligned_cols=265 Identities=27% Similarity=0.394 Sum_probs=212.6
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC----CcHHHHHHHHHHHhcCCCCeeEEEEEE
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG----VSPTAIREIMLLREITHENVVKLVNVH 97 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~ 97 (477)
..+.++|++.+.||+|+||.||+|+++. ++..||||++........ ....+.+|+.+|+.++||||+++++++
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 83 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 83 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECC---CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4567889999999999999999998764 688999999976543321 345778999999999999999999999
Q ss_pred EcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc
Q 011808 98 INHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~ 176 (477)
.+. ..+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..++.....
T Consensus 84 ~~~--~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 156 (326)
T 2y0a_A 84 ENK--TDVILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPR 156 (326)
T ss_dssp ECS--SEEEEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCC
T ss_pred EeC--CEEEEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCC
Confidence 764 47899999996 689888864 2469999999999999999999999999999999999999554434448
Q ss_pred EEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHH
Q 011808 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~ 256 (477)
+||+|||+++....... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. ..+
T Consensus 157 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~ 224 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDT--------KQE 224 (326)
T ss_dssp EEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHH
T ss_pred EEEEECCCCeECCCCCc---cccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCC--------HHH
Confidence 99999999987654322 2345689999999999764 48999999999999999999999997654 222
Q ss_pred HHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 257 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
.+..+....... ........+..+.+||.+||+.||.+|||+.++|+||
T Consensus 225 ~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 225 TLANVSAVNYEF-------------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HHHHHHHTCCCC-------------------------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred HHHHHHhcCCCc-------------------------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 333322211000 0011223467899999999999999999999999999
Q ss_pred cCC
Q 011808 337 YFR 339 (477)
Q Consensus 337 ~f~ 339 (477)
||+
T Consensus 274 ~~~ 276 (326)
T 2y0a_A 274 WIK 276 (326)
T ss_dssp TTS
T ss_pred Ccc
Confidence 997
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=375.88 Aligned_cols=253 Identities=26% Similarity=0.446 Sum_probs=210.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+++|++++.||+|+||.||+|+++. +++.||||+++.... .......+.+|+.+++.++||||+++++++.+. .
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--Q 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--S
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC--C
Confidence 6899999999999999999998764 688999999975422 123345677899999999999999999999764 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~~kL~Df 150 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL----DKNGHIKITDF 150 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE----CTTSCEEECCC
T ss_pred EEEEEEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE----cCCCCEEEeec
Confidence 7999999998 5899888763 368999999999999999999999999999999999999 67788999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+++..... ....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+ ....+..+.
T Consensus 151 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~ 216 (318)
T 1fot_A 151 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKIL 216 (318)
T ss_dssp SSCEECSSC-----BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH
T ss_pred CcceecCCc-----cccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence 999875432 2346789999999999874 48999999999999999999999997654 222333332
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCcc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEY 337 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~ 337 (477)
... ..+|...+.++.+||.+||..||.+|+ +++++++|||
T Consensus 217 ~~~-----------------------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 217 NAE-----------------------------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp HCC-----------------------------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred hCC-----------------------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 210 012334567899999999999999999 8999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|+.
T Consensus 262 f~~ 264 (318)
T 1fot_A 262 FKE 264 (318)
T ss_dssp GSS
T ss_pred ccC
Confidence 973
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=393.43 Aligned_cols=285 Identities=36% Similarity=0.599 Sum_probs=212.6
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+.++|++++.||+|+||.||+|+++. ++..||||++............+.+|+.+++.++||||+++++++.....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred chhhheeEeeeeEecCCEEEEEEEECC---CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence 467899999999999999999998754 68899999997654444445567889999999999999999999875432
Q ss_pred ----ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 103 ----MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 103 ----~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
..+|+||||++++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 99 ~~~~~~~~lv~e~~~~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~----~~~~~~k 167 (371)
T 2xrw_A 99 LEEFQDVYIVMELMDANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLK 167 (371)
T ss_dssp TTTCCEEEEEEECCSEEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEE
T ss_pred cccccceEEEEEcCCCCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE----cCCCCEE
Confidence 37899999999999888752 58999999999999999999999999999999999999 6677899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+++...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+ ..+.+
T Consensus 168 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~ 235 (371)
T 2xrw_A 168 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTD--------HIDQW 235 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred EEEeeccccccccc---ccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 99999998654322 22345789999999999874 48999999999999999999999998766 45666
Q ss_pred HHHHHHhCCCCCCCccccCC--------CccccccccccccccccCCCCccccCCC------CCchHHHHHHHhcccCCC
Q 011808 259 DKIFKILGHPTPEKWPTLAN--------LPHWQSDSLHIQGRKYETNGLHSVVPLS------PKSPAYDLLSKMLEYDPR 324 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~p~~------~s~~~~dli~~~L~~dP~ 324 (477)
..+...++.+.++.+..+.. .+.+....... ..-...++.. .+..+++||.+||+.||.
T Consensus 236 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 308 (371)
T 2xrw_A 236 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK-------LFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 308 (371)
T ss_dssp HHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHH-------HSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGG
T ss_pred HHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhh-------hcccccCcccccccccccHHHHHHHHHHCcCChh
Confidence 77777666665543332210 01110000000 0000001111 145689999999999999
Q ss_pred CCCCHHHHhcCccCCC
Q 011808 325 KRITAAQALEHEYFRI 340 (477)
Q Consensus 325 ~Rpt~~e~L~h~~f~~ 340 (477)
+|||++|+|+||||+.
T Consensus 309 ~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 309 KRISVDEALQHPYINV 324 (371)
T ss_dssp GSCCHHHHHHSHHHHT
T ss_pred hCCCHHHHhCCcchhh
Confidence 9999999999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=376.45 Aligned_cols=262 Identities=31% Similarity=0.443 Sum_probs=204.0
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC--CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEc
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG--DGVSPTAIREIMLLREITHENVVKLVNVHIN 99 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 99 (477)
.-..++|++++.||+|+||.||+|++.....++..||||+++..... ......+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 34468999999999999999999988655567899999999765321 2233456789999999999999999999976
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
. ..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 93 ~--~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill----~~~~~~k 161 (327)
T 3a62_A 93 G--GKLYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML----NHQGHVK 161 (327)
T ss_dssp S--SCEEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE----CTTSCEE
T ss_pred C--CEEEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE----CCCCcEE
Confidence 4 37899999997 6888888763 368999999999999999999999999999999999999 6777899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+ ....+
T Consensus 162 l~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~ 230 (327)
T 3a62_A 162 LTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGEN--------RKKTI 230 (327)
T ss_dssp ECCCSCC------------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHH
T ss_pred EEeCCcccccccCCc--cccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCC--------HHHHH
Confidence 999999975433221 12345689999999999874 48999999999999999999999998654 22333
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHh
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQAL 333 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L 333 (477)
..+.... ..++...+..+.+||.+||..||.+|| ++.+++
T Consensus 231 ~~i~~~~-----------------------------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l 275 (327)
T 3a62_A 231 DKILKCK-----------------------------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275 (327)
T ss_dssp HHHHHTC-----------------------------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHH
T ss_pred HHHHhCC-----------------------------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHH
Confidence 3333211 012334567899999999999999999 899999
Q ss_pred cCccCCC
Q 011808 334 EHEYFRI 340 (477)
Q Consensus 334 ~h~~f~~ 340 (477)
.||||+.
T Consensus 276 ~hp~f~~ 282 (327)
T 3a62_A 276 AHPFFRH 282 (327)
T ss_dssp HSGGGSS
T ss_pred cCCcccC
Confidence 9999973
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=387.06 Aligned_cols=306 Identities=19% Similarity=0.216 Sum_probs=210.9
Q ss_pred ccccceeEEeeeccc--CceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 011808 23 EWLQQYNLIGKIGEG--TYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G--~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
.-.++|+++++||+| +||.||+|+++. ++..||||++............+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcC---CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 347899999999999 999999998764 689999999987655544556777899999999999999999999875
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
. .+|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 99 ~--~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll----~~~~~~kl 169 (389)
T 3gni_B 99 N--ELWVVTSFMAYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI----SVDGKVYL 169 (389)
T ss_dssp T--EEEEEEECCTTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEE
T ss_pred C--EEEEEEEccCCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEE
Confidence 4 7899999998 68888887643 3469999999999999999999999999999999999999 67778999
Q ss_pred eecccceeecCCCC-----cccCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 180 ADFGLARIYQAPLK-----FLSENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 180 ~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
+|||++........ .......+||+.|+|||++.+. ..|+.++|||||||++|+|++|+.||.+.+........
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred cccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999865432111 1111234679999999999874 45899999999999999999999999875532110000
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCc---cccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHH
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLP---HWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA 330 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~ 330 (477)
....+..+......+............ .+.....................+...++.+.+||++||++||.+|||++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 000000000000000000000000000 00000000000000000011123455678899999999999999999999
Q ss_pred HHhcCccCCC
Q 011808 331 QALEHEYFRI 340 (477)
Q Consensus 331 e~L~h~~f~~ 340 (477)
|+|+||||+.
T Consensus 330 ell~hp~f~~ 339 (389)
T 3gni_B 330 TLLNHSFFKQ 339 (389)
T ss_dssp HHTTSGGGGG
T ss_pred HHhcCHHHHH
Confidence 9999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=378.48 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=212.7
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
...+++|++++.||+|+||.||+|+++. ++..||||++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 113 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 3457899999999999999999998764 688999999865432 223456778899999999999999999999764
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 114 --~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~~kL 182 (350)
T 1rdq_E 114 --SNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQV 182 (350)
T ss_dssp --SEEEEEEECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEE
T ss_pred --CEEEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE----CCCCCEEE
Confidence 47999999996 6999988764 369999999999999999999999999999999999999 67788999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+ ....+.
T Consensus 183 ~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~ 248 (350)
T 1rdq_E 183 TDFGFAKRVKGR-----TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYE 248 (350)
T ss_dssp CCCTTCEECSSC-----BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred cccccceeccCC-----cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHH
Confidence 999999876432 2346889999999999874 48999999999999999999999997654 222222
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhc
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALE 334 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~ 334 (477)
.+... . ..+|...+..+.+||.+||+.||.+|++ ++++++
T Consensus 249 ~i~~~----~-------------------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 249 KIVSG----K-------------------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHC----C-------------------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHcC----C-------------------------------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 22221 0 0123445788999999999999999998 999999
Q ss_pred CccCCC
Q 011808 335 HEYFRI 340 (477)
Q Consensus 335 h~~f~~ 340 (477)
||||+.
T Consensus 294 h~~f~~ 299 (350)
T 1rdq_E 294 HKWFAT 299 (350)
T ss_dssp SGGGTT
T ss_pred CcCcCC
Confidence 999973
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=377.55 Aligned_cols=266 Identities=26% Similarity=0.418 Sum_probs=209.2
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
-+++|++++.||+|+||.||+|+++. +++.||||+++...... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~- 82 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE- 82 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-
T ss_pred chhheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-
Confidence 47899999999999999999998764 68999999998654332 2334567899999988 899999999999764
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 83 -~~~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~~kL~ 152 (345)
T 3a8x_A 83 -SRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL----DSEGHIKLT 152 (345)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEEC
T ss_pred -CEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE----CCCCCEEEE
Confidence 47999999997 5888888763 369999999999999999999999999999999999999 677889999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.......... ......
T Consensus 153 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~~ 226 (345)
T 3a8x_A 153 DYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD---QNTEDY 226 (345)
T ss_dssp CGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------CHHH
T ss_pred eccccccccCCCC--cccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc---cccHHH
Confidence 9999985432221 23446789999999999874 48999999999999999999999997533211100 011111
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH------HHHhc
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA------AQALE 334 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~------~e~L~ 334 (477)
+...+.... ..+|...+..+.+||.+||++||.+|+++ ++++.
T Consensus 227 ~~~~i~~~~-------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 227 LFQVILEKQ-------------------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp HHHHHHHCC-------------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred HHHHHHcCC-------------------------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 121111000 11344557889999999999999999995 89999
Q ss_pred CccCCC
Q 011808 335 HEYFRI 340 (477)
Q Consensus 335 h~~f~~ 340 (477)
||||+.
T Consensus 276 hp~f~~ 281 (345)
T 3a8x_A 276 HPFFRN 281 (345)
T ss_dssp SGGGTT
T ss_pred CCccCC
Confidence 999973
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=380.30 Aligned_cols=292 Identities=26% Similarity=0.403 Sum_probs=214.8
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-----CCCeeEEEEEE
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-----HENVVKLVNVH 97 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~~~ 97 (477)
.+.++|+++++||+|+||.||+|++.. ++..||||+++... ........|+.+++.+. ||||+++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSCH---HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECC---CCeEEEEEEeccch---hhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 456899999999999999999998764 68899999996422 22345667999999996 99999999999
Q ss_pred EcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC------
Q 011808 98 INHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG------ 171 (477)
Q Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~------ 171 (477)
.... .+|+||||++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+....
T Consensus 106 ~~~~--~~~lv~e~~~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 106 MYYD--HMCLIFEPLGPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EETT--EEEEEECCCCCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred eECC--eeEEEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 7754 789999999999999998754 23589999999999999999999999999999999999994311
Q ss_pred ---------------CCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh
Q 011808 172 ---------------EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236 (477)
Q Consensus 172 ---------------~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt 236 (477)
...+.+||+|||+++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHH
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHH
Confidence 12678999999999865432 2345679999999999875 48999999999999999999
Q ss_pred CCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCC--cccc-ccccccccccccC--------CCCccccCC
Q 011808 237 LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANL--PHWQ-SDSLHIQGRKYET--------NGLHSVVPL 305 (477)
Q Consensus 237 G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~--------~~~~~~~p~ 305 (477)
|+.||.+.+ ..+.+..+...++..+...+...... ..+. ............. .......+.
T Consensus 255 g~~pf~~~~--------~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 255 GSLLFRTHE--------HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp SSCSCCCSS--------HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred CCCCCCCCc--------HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence 999998765 34555555555543332211110000 0000 0000000000000 000001111
Q ss_pred CCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 306 SPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 306 ~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
..++.+.+||.+||+.||.+|||++|+|+||||+
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred chHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 2346688999999999999999999999999995
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=381.02 Aligned_cols=291 Identities=37% Similarity=0.641 Sum_probs=217.3
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
..+++|++++.||+|+||.||+|+++. ++..||||++............+.+|+.+++.++||||+++++++.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 97 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK- 97 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETT---TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECC---CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC-
Confidence 347899999999999999999998764 6889999999765544444456678999999999999999999997644
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+++.++..+... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 98 -~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~----~~~~~~kl~Df 168 (331)
T 4aaa_A 98 -RWYLVFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV----SQSGVVKLCDF 168 (331)
T ss_dssp -EEEEEEECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEECCC
T ss_pred -EEEEEEecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE----cCCCcEEEEeC
Confidence 78999999998776665443 3469999999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+++.+..... ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+ ..+.+..+.
T Consensus 169 g~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~ 238 (331)
T 4aaa_A 169 GFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS--------DIDQLYHIM 238 (331)
T ss_dssp TTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHH
T ss_pred CCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC--------cHHHHHHHH
Confidence 99986554322 12335679999999999876568999999999999999999999998766 455666666
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
..++...+.....+...+.+.... .................+..+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 239 MCLGNLIPRHQELFNKNPVFAGVR----LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHCSCCHHHHHHHHHCGGGTTCC----CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred HHhCCCChhhhhHhhhcccccccc----CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 666554332111111101000000 00000000011112345788999999999999999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=378.35 Aligned_cols=261 Identities=23% Similarity=0.347 Sum_probs=210.1
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+.++|++.+.||+|+||.||+|.++. ++..||+|.+.... .....+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 74 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESME- 74 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-
T ss_pred chhhceEeeeEEecCCCeEEEEEEECC---CCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-
Confidence 467899999999999999999998764 68899999987432 22345678999999999999999999997754
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+..+ .++.+||+|
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~--~~~~~kl~D 147 (321)
T 1tki_A 75 -ELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKIIE 147 (321)
T ss_dssp -EEEEEECCCCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECC
T ss_pred -EEEEEEEeCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC--CCCCEEEEE
Confidence 7899999998 4888888543 2368999999999999999999999999999999999999431 267899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||++..+..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+ ....+..+
T Consensus 148 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i 215 (321)
T 1tki_A 148 FGQARQLKPGDN---FRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENI 215 (321)
T ss_dssp CTTCEECCTTCE---EEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHH
T ss_pred CCCCeECCCCCc---cccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHH
Confidence 999987654322 2335679999999999874 48999999999999999999999998654 22333333
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.......+. ......+.++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 216 ~~~~~~~~~-------------------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 216 MNAEYTFDE-------------------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHTCCCCCH-------------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HcCCCCCCh-------------------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 322111000 011234678999999999999999999999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=379.63 Aligned_cols=258 Identities=29% Similarity=0.427 Sum_probs=209.7
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREI-THENVVKLVNVHINH 100 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 100 (477)
.-+++|++++.||+|+||.||+|+++. +++.||||+++.... .......+..|..+++.+ +||||+++++++.+.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 347899999999999999999998764 689999999976421 123345677899999877 999999999999764
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
. .+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 91 ~--~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~vkL 159 (345)
T 1xjd_A 91 E--NLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL----DKDGHIKI 159 (345)
T ss_dssp S--EEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEE
T ss_pred C--EEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE----CCCCCEEE
Confidence 4 7999999997 6898888763 368999999999999999999999999999999999999 67778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.+. .+.+.
T Consensus 160 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~ 228 (345)
T 1xjd_A 160 ADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFH 228 (345)
T ss_dssp CCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH
T ss_pred eEChhhhhcccCCC--cccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHH
Confidence 99999985432221 23456789999999999874 489999999999999999999999986542 22222
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHH-HHhcCccC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA-QALEHEYF 338 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~-e~L~h~~f 338 (477)
.+... . ..+|...+.++.+||.+||+.||.+||++. ++++||||
T Consensus 229 ~i~~~----~-------------------------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f 273 (345)
T 1xjd_A 229 SIRMD----N-------------------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273 (345)
T ss_dssp HHHHC----C-------------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred HHHhC----C-------------------------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence 22210 0 012334568899999999999999999998 99999999
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
+.
T Consensus 274 ~~ 275 (345)
T 1xjd_A 274 RE 275 (345)
T ss_dssp TT
T ss_pred cC
Confidence 73
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=379.46 Aligned_cols=265 Identities=28% Similarity=0.418 Sum_probs=208.1
Q ss_pred CccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 011808 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHI 98 (477)
Q Consensus 20 ~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 98 (477)
+...+.++|++.+.||+|+||.||+|+++. ++..||||++...... ..+|+.++.++ +||||+++++++.
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp ---CHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccCccccEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 345678999999999999999999998764 6899999999765422 24688888888 7999999999997
Q ss_pred cCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccE
Q 011808 99 NHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVV 177 (477)
Q Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~v 177 (477)
+. ..+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+..++...+.+
T Consensus 87 ~~--~~~~lv~E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~ 159 (342)
T 2qr7_A 87 DG--KYVYVVTELMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESI 159 (342)
T ss_dssp CS--SEEEEEECCCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGE
T ss_pred cC--CEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeE
Confidence 64 48999999997 5898888753 3699999999999999999999999999999999999996554445679
Q ss_pred EEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 178 KIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
||+|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|..||.+.... .
T Consensus 160 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---------~ 227 (342)
T 2qr7_A 160 RICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDD---------T 227 (342)
T ss_dssp EECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS---------C
T ss_pred EEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcC---------C
Confidence 9999999987654322 22345779999999999764 3889999999999999999999999754311 1
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
...++..+...... +........++++.+||++||..||++|||++++|+|||
T Consensus 228 ~~~~~~~i~~~~~~---------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 228 PEEILARIGSGKFS---------------------------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp HHHHHHHHHHCCCC---------------------------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHHHccCCcc---------------------------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 11222222111100 000112345688999999999999999999999999999
Q ss_pred CC
Q 011808 338 FR 339 (477)
Q Consensus 338 f~ 339 (477)
|.
T Consensus 281 ~~ 282 (342)
T 2qr7_A 281 IV 282 (342)
T ss_dssp HH
T ss_pred ec
Confidence 95
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=384.16 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=210.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|+++++||+|+||+||+|+++. ++..||||+++.... .......+.+|+.+++.++||||++++++|.+. .
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~ 142 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--R 142 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred ccccEEEEEEEcCCCEEEEEEEECC---CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--C
Confidence 5789999999999999999998764 688999999865321 112233567899999999999999999999764 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++++||+||
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl----~~~g~ikL~DF 212 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL----DKSGHLKLADF 212 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE----CCCCCEEEecc
Confidence 7999999996 6888887642 58999999999999999999999999999999999999 77788999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCC---CCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKH---YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~---~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|+++....... ......+||+.|+|||++.+... |+.++|||||||++|||++|++||.+.+ ....+.
T Consensus 213 G~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~ 283 (410)
T 3v8s_A 213 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYS 283 (410)
T ss_dssp TTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHH
T ss_pred ceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--------hhhHHH
Confidence 99987654321 22345688999999999986432 7889999999999999999999998655 233333
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCcc
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK--RITAAQALEHEY 337 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~--Rpt~~e~L~h~~ 337 (477)
.+........ + ......+.++++||++||..+|.+ |++++++++|||
T Consensus 284 ~i~~~~~~~~---------~----------------------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 284 KIMNHKNSLT---------F----------------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp HHHTHHHHCC---------C----------------------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred HHHhcccccc---------C----------------------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 3332110000 0 011234688999999999999988 999999999999
Q ss_pred CCCC
Q 011808 338 FRIE 341 (477)
Q Consensus 338 f~~~ 341 (477)
|+..
T Consensus 333 f~~~ 336 (410)
T 3v8s_A 333 FKND 336 (410)
T ss_dssp GCCS
T ss_pred ccCC
Confidence 9743
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=378.81 Aligned_cols=259 Identities=25% Similarity=0.361 Sum_probs=209.9
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREI-THENVVKLVNVHIN 99 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 99 (477)
..-+++|++++.||+|+||.||+|+++. +++.||||+++.... .......+.+|..+++.+ +||||+++++++.+
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~ 92 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 92 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETT---EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc
Confidence 3457899999999999999999998764 588999999976432 123455677899999988 89999999999976
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
.. .+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 93 ~~--~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll----~~~g~vk 161 (353)
T 2i0e_A 93 MD--RLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML----DSEGHIK 161 (353)
T ss_dssp SS--EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEE
T ss_pred CC--EEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE----cCCCcEE
Confidence 44 7999999997 5898888764 369999999999999999999999999999999999999 7778899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+. .+.+
T Consensus 162 L~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~ 230 (353)
T 2i0e_A 162 IADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELF 230 (353)
T ss_dssp ECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH
T ss_pred EEeCCcccccccCCc--ccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHH
Confidence 999999985432221 23456789999999999874 489999999999999999999999986542 2223
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHh
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQAL 333 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L 333 (477)
..+... . ..+|...+.++.+||.+||.+||.+|+ ++++++
T Consensus 231 ~~i~~~----~-------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~ 275 (353)
T 2i0e_A 231 QSIMEH----N-------------------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 275 (353)
T ss_dssp HHHHHC----C-------------------------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred HHHHhC----C-------------------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 333221 0 012344578899999999999999999 479999
Q ss_pred cCccCCC
Q 011808 334 EHEYFRI 340 (477)
Q Consensus 334 ~h~~f~~ 340 (477)
+||||+.
T Consensus 276 ~h~~f~~ 282 (353)
T 2i0e_A 276 EHAFFRY 282 (353)
T ss_dssp TSGGGTT
T ss_pred cCccccC
Confidence 9999973
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=383.13 Aligned_cols=287 Identities=40% Similarity=0.627 Sum_probs=220.9
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+.++|.+.+.||+|+||.||+|+++. +++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cccccEEEEeEEecCCCeEEEEEEECC---CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 345899999999999999999998764 68999999998765444445677899999999999999999999976543
Q ss_pred c----eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 103 M----SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 103 ~----~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
. .+|+||||+.++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 116 ~~~~~~~~lv~e~~~~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll----~~~~~~k 184 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQTDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELK 184 (371)
T ss_dssp STTCCCCEEEEECCCEEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEE
T ss_pred cccceeEEEEEccccccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE----CCCCCEE
Confidence 2 349999999998887663 258999999999999999999999999999999999999 6777899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+++..... ....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+ ..+.+
T Consensus 185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~ 251 (371)
T 4exu_A 185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--------YLDQL 251 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHH
T ss_pred EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHH
Confidence 9999999865432 2335679999999999876669999999999999999999999998766 56677
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..+....+.+..+.+..+... .. ...+..................++.+.+||.+||+.||.+|||++|+|+||||
T Consensus 252 ~~i~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 327 (371)
T 4exu_A 252 TQILKVTGVPGTEFVQKLNDK---AA-KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327 (371)
T ss_dssp HHHHHHHCCCCHHHHTTCSCH---HH-HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHHHhCCCcHHHHHHhhhh---hh-hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence 777777776654433322110 00 00000000000000011234567889999999999999999999999999999
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
+.
T Consensus 328 ~~ 329 (371)
T 4exu_A 328 EP 329 (371)
T ss_dssp TT
T ss_pred cc
Confidence 74
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=379.41 Aligned_cols=261 Identities=25% Similarity=0.465 Sum_probs=204.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCC--CCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH--ENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~ 102 (477)
.++|++++.||+|+||.||+|.+. ++..||||++............+.+|+.+|+.++| +||+++++++.+.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-- 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-- 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT----TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC----CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC--
Confidence 467999999999999999999753 48899999998765544445677889999999976 9999999998764
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..+|+|||+.+++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+. ++.+||+||
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-----~~~~kl~DF 151 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDF 151 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-----TTEEEECCC
T ss_pred CEEEEEEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-----CCcEEEeec
Confidence 489999998889999999763 3689999999999999999999999999999999999993 356999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCc
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLG----------AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~----------~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~ 252 (477)
|+++.+............+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||....
T Consensus 152 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------- 224 (343)
T 3dbq_A 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------- 224 (343)
T ss_dssp SSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------
T ss_pred ccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-------
Confidence 99987654433333345678999999999864 2458899999999999999999999997533
Q ss_pred ccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 011808 253 FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332 (477)
Q Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~ 332 (477)
+....+...+...... .++...+..+.+||.+||+.||.+|||+.++
T Consensus 225 ---~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~ 271 (343)
T 3dbq_A 225 ---NQISKLHAIIDPNHEI------------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271 (343)
T ss_dssp ---SHHHHHHHHHCTTSCC------------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ---hHHHHHHHHhcCCccc------------------------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 1222233333211111 1233345679999999999999999999999
Q ss_pred hcCccCCCC
Q 011808 333 LEHEYFRIE 341 (477)
Q Consensus 333 L~h~~f~~~ 341 (477)
|+||||+..
T Consensus 272 l~hp~~~~~ 280 (343)
T 3dbq_A 272 LAHPYVQIQ 280 (343)
T ss_dssp HTSHHHHSC
T ss_pred HhCcccccc
Confidence 999999754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=384.78 Aligned_cols=260 Identities=25% Similarity=0.461 Sum_probs=204.6
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC--CCCeeEEEEEEEcCCCc
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT--HENVVKLVNVHINHADM 103 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~ 103 (477)
.+|++++.||+|+||.||+|.+. .+..||||++............+.+|+.+|+.+. ||||+++++++....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~-- 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-- 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--
T ss_pred CceEEEEEEccCCCeEEEEEEcC----CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC--
Confidence 56999999999999999999753 3789999999876554444567789999999996 599999999987654
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+|+|||+.+++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll----~-~~~~kl~DFG 199 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----V-DGMLKLIDFG 199 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE----S-SSCEEECCCS
T ss_pred EEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----E-CCeEEEEecC
Confidence 79999998888999998764 368999999999999999999999999999999999999 3 2579999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGA----------KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----------~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
+++.+............+||+.|+|||++.+. ..|+.++|||||||++|+|++|+.||.....
T Consensus 200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------- 272 (390)
T 2zmd_A 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------- 272 (390)
T ss_dssp SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------
T ss_pred ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------
Confidence 99876543333233456789999999999752 3589999999999999999999999975431
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
....+...+...... .++...+..+.+||.+||+.||.+|||+.++|
T Consensus 273 ---~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 319 (390)
T 2zmd_A 273 ---QISKLHAIIDPNHEI------------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319 (390)
T ss_dssp ---HHHHHHHHHCTTSCC------------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ---HHHHHHHHhCccccC------------------------------CCCccchHHHHHHHHHHcccChhhCCCHHHHh
Confidence 122222332211111 12233356799999999999999999999999
Q ss_pred cCccCCCC
Q 011808 334 EHEYFRIE 341 (477)
Q Consensus 334 ~h~~f~~~ 341 (477)
+||||+..
T Consensus 320 ~hp~~~~~ 327 (390)
T 2zmd_A 320 AHPYVQIQ 327 (390)
T ss_dssp TSHHHHSC
T ss_pred hCcCcccc
Confidence 99999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=366.45 Aligned_cols=290 Identities=41% Similarity=0.717 Sum_probs=229.3
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc---CCCCeeEEEEEEE
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI---THENVVKLVNVHI 98 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~ 98 (477)
....++|++++.||+|+||.||+|++.. .++..||||+++...........+.+|+.+++.+ +||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecC--CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 3456899999999999999999998742 3578999999976554444444566788877766 8999999999986
Q ss_pred c---CCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 99 N---HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 99 ~---~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
. .....+++||||++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili----~~~~ 157 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV----TSSG 157 (326)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTC
T ss_pred ecccCCCceEEEEEecCCCCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE----cCCC
Confidence 2 2445789999999999999987753 2358999999999999999999999999999999999999 6677
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccH
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~ 255 (477)
.+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+ ..
T Consensus 158 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~ 225 (326)
T 1blx_A 158 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSS--------DV 225 (326)
T ss_dssp CEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HH
T ss_pred CEEEecCcccccccCCC---CccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCC--------HH
Confidence 89999999998654322 22345679999999999874 48999999999999999999999998766 45
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+.+..+...++.+....|+.....+...- ... ............+..+.+||.+||+.||.+|||+.++|+|
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-------~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 226 DQLGKILDVIGLPGEEDWPRDVALPRQAF-------HSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHHHHHHHHHCCCCGGGSCTTCSSCGGGS-------CCC-CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHcCCCCcccCccccccchhhh-------ccc-CcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 67778888888777766654333221100 000 0011122344567889999999999999999999999999
Q ss_pred ccCCC
Q 011808 336 EYFRI 340 (477)
Q Consensus 336 ~~f~~ 340 (477)
|||+.
T Consensus 298 p~~~~ 302 (326)
T 1blx_A 298 PYFQD 302 (326)
T ss_dssp GGGTT
T ss_pred ccccc
Confidence 99973
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=378.52 Aligned_cols=294 Identities=32% Similarity=0.534 Sum_probs=215.1
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
....+++|++.+.||+|+||.||+|+++. ++..||||++..... ......+|++.++.++||||+++++++...
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETT---TCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 34558999999999999999999998764 688999999865432 233667788889999999999999998653
Q ss_pred -----CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhh--hCCeecCCCCCCcEEEeccCCC
Q 011808 101 -----ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH--SNWIIHRDLKPSNILVMGEGEE 173 (477)
Q Consensus 101 -----~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH--~~givHrDikp~NILl~~~~~~ 173 (477)
...++++||||+.++|...+..... ....+++..++.++.||+.||.||| ++||+||||||+|||++ ..
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~---~~ 167 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPDTLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN---EA 167 (360)
T ss_dssp CSSCTTCEEEEEEEECCSCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE---TT
T ss_pred ccccccceeEEEEeecccccHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe---CC
Confidence 2335899999999998887765332 2457899999999999999999999 99999999999999993 23
Q ss_pred cccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 174 QGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 174 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
++.+||+|||+++.+..... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-------- 236 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN-------- 236 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------
T ss_pred CCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC--------
Confidence 67899999999987654332 2335679999999999876668999999999999999999999998766
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCc---cccCCCCCchHHHHHHHhcccCCCCCCCHH
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLH---SVVPLSPKSPAYDLLSKMLEYDPRKRITAA 330 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~ 330 (477)
....+..+...++.++.+.+..+.... .. ..........+. ...+...+..+.+||.+||++||.+|||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 310 (360)
T 3e3p_A 237 SAGQLHEIVRVLGCPSREVLRKLNPSH--TD----VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310 (360)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHHCTTC--CC----GGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hHHHHHHHHHHcCCCCHHHHHhcccch--hh----ccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHH
Confidence 556777777777766554333221100 00 000000000000 112233567899999999999999999999
Q ss_pred HHhcCccCCCC
Q 011808 331 QALEHEYFRIE 341 (477)
Q Consensus 331 e~L~h~~f~~~ 341 (477)
|+|+||||+..
T Consensus 311 e~l~hp~f~~~ 321 (360)
T 3e3p_A 311 EALCHPYFDEL 321 (360)
T ss_dssp HHTTSGGGGGG
T ss_pred HHhcCcccccc
Confidence 99999999854
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=377.86 Aligned_cols=263 Identities=26% Similarity=0.384 Sum_probs=197.9
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
...++|++++.||+|+||.||+|+++. +++.||||++..... ....+.+|+.+++.++||||+++++++.+..
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 89 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKL---TKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPT- 89 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETT---TCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC-
Confidence 346899999999999999999998764 688999999976432 3457889999999999999999999997644
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ ..+.+||+|
T Consensus 90 -~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~--~~~~~kl~D 161 (361)
T 3uc3_A 90 -HLAIIMEYASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS--PAPRLKICD 161 (361)
T ss_dssp -EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS--SSCCEEECC
T ss_pred -EEEEEEEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC--CCceEEEee
Confidence 7899999996 6888888663 369999999999999999999999999999999999999322 233599999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+++...... .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+..... .+..+
T Consensus 162 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~~ 230 (361)
T 3uc3_A 162 FGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--------DYRKT 230 (361)
T ss_dssp CCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--------CHHHH
T ss_pred cCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--------HHHHH
Confidence 99997543221 22345789999999999886644455999999999999999999998655321 11222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
...+..... ........++.+.+||.+||++||.+|||+.++|+||||..
T Consensus 231 ~~~~~~~~~-----------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 231 IQRILSVKY-----------------------------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp HHHHHTTCC-----------------------------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred HHHHhcCCC-----------------------------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 221111000 00011234678999999999999999999999999999963
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=386.41 Aligned_cols=264 Identities=21% Similarity=0.333 Sum_probs=210.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|+++++||+|+||+||+|+++. +++.||||+++.... .......+.+|+.+++.++||||++++++|.+. .
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD--N 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS--S
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcC---CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--C
Confidence 4789999999999999999998764 688999999865221 111223467899999999999999999999764 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+||
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl----~~~g~vkL~DF 219 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM----DMNGHIRLADF 219 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE----cCCCCEEEcch
Confidence 7999999996 6999988763 2469999999999999999999999999999999999999 77788999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLL----GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~----~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+++....... ......+||+.|+|||++. +...|+.++|||||||++|||++|++||.+.+ ..+.+
T Consensus 220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--------~~~~~ 290 (437)
T 4aw2_A 220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETY 290 (437)
T ss_dssp TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHH
T ss_pred hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--------hhHHH
Confidence 99987654322 2233467899999999997 23458999999999999999999999998765 23334
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCc
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK--RITAAQALEHE 336 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~--Rpt~~e~L~h~ 336 (477)
..+........ +|. .....++++++||++||..+|.+ |++++++++||
T Consensus 291 ~~i~~~~~~~~---------~p~---------------------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 291 GKIMNHKERFQ---------FPT---------------------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HHHHTHHHHCC---------CCS---------------------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred Hhhhhcccccc---------CCc---------------------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 44432110000 000 11234688999999999999888 99999999999
Q ss_pred cCCC
Q 011808 337 YFRI 340 (477)
Q Consensus 337 ~f~~ 340 (477)
||+.
T Consensus 341 ff~~ 344 (437)
T 4aw2_A 341 FFSG 344 (437)
T ss_dssp GGTT
T ss_pred ccCC
Confidence 9974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=367.94 Aligned_cols=254 Identities=27% Similarity=0.343 Sum_probs=202.4
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 102 (477)
+.++|+++++||+|+||+||+|+++. +++.||||++.............+.|+..+..+ +|+||+++++++.+.
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-- 129 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKE---DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-- 129 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred hhhheeeeheeccCCCeEEEEEEECC---CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--
Confidence 34789999999999999999998764 689999999876544433344555666666655 899999999999764
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..+|+||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 130 ~~~~lv~e~~~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll----~~~~~~kl~DF 201 (311)
T 3p1a_A 130 GILYLQTELCGPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL----GPRGRCKLGDF 201 (311)
T ss_dssp TEEEEEEECCCCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CGGGCEEECCC
T ss_pred CEEEEEEeccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE----CCCCCEEEccc
Confidence 4789999999999999887652 469999999999999999999999999999999999999 67778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++........ .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+.. ....+.
T Consensus 202 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~-----------~~~~~~ 265 (311)
T 3p1a_A 202 GLLVELGTAGA---GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGE-----------GWQQLR 265 (311)
T ss_dssp TTCEECC---------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----------HHHHHT
T ss_pred eeeeecccCCC---CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHh
Confidence 99987654322 233567999999999986 48999999999999999999976665322 111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
. .. +....+...+..+.+||.+||+.||++|||++++|+||||+
T Consensus 266 ~---~~------------------------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (311)
T 3p1a_A 266 Q---GY------------------------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309 (311)
T ss_dssp T---TC------------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred c---cC------------------------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence 0 00 00112334568899999999999999999999999999997
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=359.56 Aligned_cols=264 Identities=29% Similarity=0.381 Sum_probs=212.1
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+.++|++.+.||+|+||.||+|.++. ++..||+|++............+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 77 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-- 77 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcC---CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--
Confidence 577899999999999999999998764 688999999977655444456778899999999999999999998654
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
...|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ ...+.+||+|
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~~~kl~D 151 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK-AKGAAVKLAD 151 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSS-STTCCEEECC
T ss_pred CEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecC-CCCCcEEEee
Confidence 47899999998 4888887664 368999999999999999999999999999999999999543 2234599999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+ .......+
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~ 219 (284)
T 3kk8_A 152 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQI 219 (284)
T ss_dssp CTTCEECCSSCB---CCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH
T ss_pred ceeeEEcccCcc---ccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCc--------hhHHHHHH
Confidence 999987654322 2345679999999999874 48999999999999999999999997654 22222222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.......+.. .....++.+.+||.+||+.||.+|||++++|+||||+.
T Consensus 220 ~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 220 KAGAYDYPSP-------------------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp HHTCCCCCTT-------------------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred HhccccCCch-------------------------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 2211111111 11234578999999999999999999999999999973
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=377.41 Aligned_cols=261 Identities=25% Similarity=0.399 Sum_probs=211.5
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
-.+++|++++.||+|+||.||+|+++. ++..||||++..... .......+.+|+.+|+.++||||++++++|.+..
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 347899999999999999999998764 688999999865431 2334567889999999999999999999997654
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.+|+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 89 --~~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll----~~~g~vkL~ 157 (384)
T 4fr4_A 89 --DMFMVVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL----DEHGHVHIT 157 (384)
T ss_dssp --EEEEEECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEEC
T ss_pred --EEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE----CCCCCEEEe
Confidence 7899999997 5888888653 469999999999999999999999999999999999999 777889999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA--KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|||+++.+.... .....+||+.|+|||++.+. ..|+.++|||||||++|+|++|+.||...... ....+
T Consensus 158 DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~------~~~~~ 228 (384)
T 4fr4_A 158 DFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST------SSKEI 228 (384)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS------CHHHH
T ss_pred ccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc------cHHHH
Confidence 999998765432 23456789999999999752 34889999999999999999999999754421 11122
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-HHHHhcCcc
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-AAQALEHEY 337 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-~~e~L~h~~ 337 (477)
...+.... ...|...+..+.+||.+||++||.+||+ +++++.|||
T Consensus 229 ~~~~~~~~----------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~ 274 (384)
T 4fr4_A 229 VHTFETTV----------------------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274 (384)
T ss_dssp HHHHHHCC----------------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGG
T ss_pred HHHHhhcc----------------------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChh
Confidence 11111110 1123445688999999999999999998 999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|..
T Consensus 275 f~~ 277 (384)
T 4fr4_A 275 MND 277 (384)
T ss_dssp GTT
T ss_pred hhc
Confidence 973
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=377.82 Aligned_cols=262 Identities=25% Similarity=0.382 Sum_probs=209.6
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+.++|++++.||+|+||.||+|.++. ++..||+|++..... .....+.+|+.+|+.++||||+++++++.+.
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-- 120 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDK-- 120 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--
T ss_pred ccccceEEEEEEecCCCEEEEEEEECC---CCCEEEEEEecccch--hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--
Confidence 456899999999999999999998764 688999999875432 1234677899999999999999999999764
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~~~vkL~D 194 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET--KKASSVKIID 194 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS--TTCCCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec--CCCCceEEEe
Confidence 47899999997 5888877543 236899999999999999999999999999999999999942 1346799999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+++.+..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+ ..+.+..+
T Consensus 195 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~i 262 (387)
T 1kob_A 195 FGLATKLNPDEI---VKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNV 262 (387)
T ss_dssp CTTCEECCTTSC---EEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHH
T ss_pred cccceecCCCcc---eeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCC--------HHHHHHHH
Confidence 999987654322 1234679999999999874 48999999999999999999999998654 22333333
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
......... ......+.++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 263 ~~~~~~~~~-------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 263 KRCDWEFDE-------------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp HHCCCCCCS-------------------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HhCCCCCCc-------------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence 221111100 112234678999999999999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=389.88 Aligned_cols=262 Identities=31% Similarity=0.524 Sum_probs=207.9
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+.++|++++.||+|+||+||+|+++. ++..||||++............+.+|+.+++.++||||+++++++.+.
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 108 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKV---THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-- 108 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETT---TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECC---CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--
Confidence 456789999999999999999998764 688999999987665555567889999999999999999999999764
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+... ...+.+||+|
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~~~~kl~D 182 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK-EKDALIKIVD 182 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS-STTCCEEECC
T ss_pred CEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCC-CCCCcEEEEE
Confidence 47899999998 5888888764 368999999999999999999999999999999999999543 2345699999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||++..+..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+. .+.+..+
T Consensus 183 fG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i 249 (494)
T 3lij_A 183 FGLSAVFENQKK---MKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEILRKV 249 (494)
T ss_dssp CTTCEECBTTBC---BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred CCCCeECCCCcc---ccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence 999987764332 234578999999999864 489999999999999999999999987652 2333333
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
........... ...++..+.+||++||++||.+|||+.++|+||||+
T Consensus 250 ~~~~~~~~~~~-------------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 296 (494)
T 3lij_A 250 EKGKYTFDSPE-------------------------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296 (494)
T ss_dssp HHTCCCCCSGG-------------------------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred HhCCCCCCchh-------------------------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence 32211111111 123467899999999999999999999999999996
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=368.22 Aligned_cols=266 Identities=28% Similarity=0.436 Sum_probs=210.8
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC--CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG--DGVSPTAIREIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
.++++|++.+.||+|+||.||+|++. .++..||||+++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDS---ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBT---TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred ccccceeEeeEEecCCCeEEEEEEEC---CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 46789999999999999999999865 46889999999754311 23346778999999999999999999998766
Q ss_pred CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 101 ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 101 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
....+|+||||+.++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 79 ~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~----~~~~~~kl~ 151 (305)
T 2wtk_C 79 EKQKMYMVMEYCVCGMQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL----TTGGTLKIS 151 (305)
T ss_dssp ---CEEEEEECCSEEHHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEEC
T ss_pred CCCeEEEEehhccCCHHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE----cCCCcEEee
Confidence 666899999999988888887643 3479999999999999999999999999999999999999 667789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAK-HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|||++................||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+. ...+.
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~ 223 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--------YKLFE 223 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHH
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--------HHHHH
Confidence 999998765432222333456799999999997643 247799999999999999999999976441 11222
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+.. .. ...+..++..+.+||.+||+.||.+|||++++++|+||+
T Consensus 224 ~i~~----~~-------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 268 (305)
T 2wtk_C 224 NIGK----GS-------------------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268 (305)
T ss_dssp HHHH----CC-------------------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHH
T ss_pred HHhc----CC-------------------------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence 2211 00 012334567899999999999999999999999999997
Q ss_pred CC
Q 011808 340 IE 341 (477)
Q Consensus 340 ~~ 341 (477)
..
T Consensus 269 ~~ 270 (305)
T 2wtk_C 269 KK 270 (305)
T ss_dssp SC
T ss_pred cC
Confidence 54
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=392.37 Aligned_cols=264 Identities=31% Similarity=0.552 Sum_probs=212.8
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
..+.++|+++++||+|+||+||+|+++. ++..||||++............+.+|+.++++++||||+++++++.+.
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 93 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS- 93 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETT---TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECC---CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-
Confidence 4578999999999999999999998764 688999999976544444567888999999999999999999999764
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+
T Consensus 94 -~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~-~~~~~~kl~ 166 (486)
T 3mwu_A 94 -SSFYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK-EKDCDIKII 166 (486)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSS-STTCCEEEC
T ss_pred -CEEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC-CCCCCEEEE
Confidence 47899999997 5888888764 369999999999999999999999999999999999999543 245679999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||+++.+..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+ ..+.+..
T Consensus 167 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~ 233 (486)
T 3mwu_A 167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKR 233 (486)
T ss_dssp SCSCTTTBCCC-------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred ECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH
Confidence 9999986654322 234567999999999986 38999999999999999999999998765 2233333
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+........ .+.| ..+++.+++||.+||+.||.+|||+.++|+||||+.
T Consensus 234 i~~~~~~~~---------~~~~----------------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 234 VETGKYAFD---------LPQW----------------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp HHHTCCCSC---------SGGG----------------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred HHhCCCCCC---------Cccc----------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 322111110 1111 123678999999999999999999999999999974
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=378.27 Aligned_cols=265 Identities=28% Similarity=0.418 Sum_probs=207.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC--CCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD--GDGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
+++|++++.||+|+||.||+|++.....++..||||+++.... .......+.+|+.+++.+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 4799999999999999999999865445789999999875431 112233455799999999 7999999999987654
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 133 --~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~ 201 (355)
T 1vzo_A 133 --KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL----DSNGHVVLT 201 (355)
T ss_dssp --EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEES
T ss_pred --eEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCcEEEe
Confidence 7899999998 5898888764 368999999999999999999999999999999999999 677789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|||+++.+..... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||....... . ..
T Consensus 202 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~---~~ 272 (355)
T 1vzo_A 202 DFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-----S---QA 272 (355)
T ss_dssp CSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-----C---HH
T ss_pred eCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-----h---HH
Confidence 9999986543222 123345789999999999863 347899999999999999999999997544221 1 11
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhc
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALE 334 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~ 334 (477)
.+...+.... ...+...+..+.+||.+||..||.+|| |++++++
T Consensus 273 ~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 273 EISRRILKSE-------------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp HHHHHHHHCC-------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHHhccC-------------------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 1111111000 012334467899999999999999999 9999999
Q ss_pred CccCCC
Q 011808 335 HEYFRI 340 (477)
Q Consensus 335 h~~f~~ 340 (477)
|+||..
T Consensus 322 h~~f~~ 327 (355)
T 1vzo_A 322 HLFFQK 327 (355)
T ss_dssp SGGGTT
T ss_pred Ccchhc
Confidence 999973
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=373.03 Aligned_cols=262 Identities=29% Similarity=0.395 Sum_probs=194.1
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
..+.++|++.+.||+|+||.||+|+++. +++.||||+++.... ...+.+|+.++++++||||+++++++.+.
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 120 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKG---TQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEIFETP- 120 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECS-
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECC---CCcEEEEEEeccchh----HHHHHHHHHHHHhCCCCCCcceeeeEecC-
Confidence 4456789999999999999999998764 578999999976432 23566899999999999999999999764
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+||||+. ++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+... +.++.+||+
T Consensus 121 -~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~-~~~~~~kl~ 193 (349)
T 2w4o_A 121 -TEISLVLELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP-APDAPLKIA 193 (349)
T ss_dssp -SEEEEEECCCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSS-STTCCEEEC
T ss_pred -CeEEEEEEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecC-CCCCCEEEc
Confidence 37899999997 5888888653 368999999999999999999999999999999999999432 236789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||+++...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ....+..
T Consensus 194 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~ 262 (349)
T 2w4o_A 194 DFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERG-------DQFMFRR 262 (349)
T ss_dssp CCC-------------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-------HHHHHHH
T ss_pred cCccccccCccc---ccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcc-------cHHHHHH
Confidence 999998664322 12345689999999999874 489999999999999999999999975442 1112222
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+......... ......+..+.+||++||+.||++|||+.++|+||||..
T Consensus 263 i~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 263 ILNCEYYFIS-------------------------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp HHTTCCCCCT-------------------------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHhCCCccCC-------------------------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 2111000000 011234678999999999999999999999999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=359.92 Aligned_cols=265 Identities=28% Similarity=0.463 Sum_probs=206.4
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
-.+.++|.+.+.||+|+||.||+|+++. ++..+|+|++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 92 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY- 92 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred CChhhheeecceeccCCCeEEEEEEEcc---CCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecC-
Confidence 3567899999999999999999998754 688999999976543 23356788999999999999999999999764
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+||||+. ++|.+.+...... ...+++..++.++.||+.||.|||++||+||||||+|||+..+ +..+.+||+
T Consensus 93 -~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~-~~~~~~kl~ 169 (285)
T 3is5_A 93 -HNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDT-SPHSPIKII 169 (285)
T ss_dssp -SEEEEEECCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSS-STTCCEEEC
T ss_pred -CeEEEEEEeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecC-CCCCCEEEE
Confidence 47899999998 4888888664322 3579999999999999999999999999999999999999543 345679999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||++..+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+... ..+..
T Consensus 170 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~---------~~~~~ 235 (285)
T 3is5_A 170 DFGLAELFKSDEH---STNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---------EEVQQ 235 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHH
T ss_pred eeecceecCCccc---CcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCH---------HHHHh
Confidence 9999986554322 234567999999999864 489999999999999999999999986542 11111
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.... ..+.. .......++.+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 236 ~~~~-~~~~~------------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~ 283 (285)
T 3is5_A 236 KATY-KEPNY------------------------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283 (285)
T ss_dssp HHHH-CCCCC------------------------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred hhcc-CCccc------------------------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence 1111 00000 001122457899999999999999999999999999997
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=376.31 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=201.9
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHH-HHhcCCCCeeEEEEEEEcC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIML-LREITHENVVKLVNVHINH 100 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~ 100 (477)
.-.++|++++.||+|+||.||+|+++. ++..||||+++..... ......+.+|..+ ++.++||||++++++|.+.
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETT---TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 347899999999999999999998764 6889999999765432 2233455667776 5678999999999999764
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
. .+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++++||
T Consensus 112 ~--~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll----~~~g~ikL 180 (373)
T 2r5t_A 112 D--KLYFVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL----DSQGHIVL 180 (373)
T ss_dssp S--EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEE
T ss_pred C--EEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE----CCCCCEEE
Confidence 4 8999999998 5888888763 368999999999999999999999999999999999999 77788999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+. .+.+.
T Consensus 181 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~ 249 (373)
T 2r5t_A 181 TDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYD 249 (373)
T ss_dssp CCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHH
T ss_pred eeCccccccccCCC--ccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHH
Confidence 99999985432211 23456789999999999874 489999999999999999999999986542 22233
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH----HHHhcC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA----AQALEH 335 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~----~e~L~h 335 (477)
.+... . ..++...+..+.+||.+||++||.+|+++ .+++.|
T Consensus 250 ~i~~~---~--------------------------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 250 NILNK---P--------------------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp HHHHS---C--------------------------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred HHHhc---c--------------------------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 33221 0 01233456789999999999999999986 699999
Q ss_pred ccCCC
Q 011808 336 EYFRI 340 (477)
Q Consensus 336 ~~f~~ 340 (477)
+||+.
T Consensus 295 ~~f~~ 299 (373)
T 2r5t_A 295 VFFSL 299 (373)
T ss_dssp GGGTT
T ss_pred ccccC
Confidence 99973
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=369.70 Aligned_cols=294 Identities=33% Similarity=0.549 Sum_probs=221.8
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA- 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 101 (477)
.+.++|++.+.||+|+||.||+|+++. ++..||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECC---CCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 456899999999999999999998753 68899999996432 2223446678999999999999999999876431
Q ss_pred --CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 102 --DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 102 --~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
...+|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 84 ~~~~~~~lv~e~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~----~~~~~~kl 153 (353)
T 2b9h_A 84 ENFNEVYIIQELMQTDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKV 153 (353)
T ss_dssp TTCCCEEEEECCCSEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTCCEEE
T ss_pred CccceEEEEEeccCccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----cCCCcEEE
Confidence 257899999999999988875 268999999999999999999999999999999999999 66778999
Q ss_pred eecccceeecCCCCcc--------cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCC
Q 011808 180 ADFGLARIYQAPLKFL--------SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~ 251 (477)
+|||+++......... .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+
T Consensus 154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------ 227 (353)
T 2b9h_A 154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD------ 227 (353)
T ss_dssp CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------
T ss_pred EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC------
Confidence 9999998765322111 11234679999999998765668999999999999999999999998766
Q ss_pred cccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHH
Q 011808 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ 331 (477)
Q Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e 331 (477)
..+.+..++..++.+...........+.... .......+....+ .......+..+.+||.+||+.||.+|||+++
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (353)
T 2b9h_A 228 --YRHQLLLIFGIIGTPHSDNDLRCIESPRARE--YIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302 (353)
T ss_dssp --HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHH--HHHTSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred --cHHHHHHHHHHhCCCchhccccccccchhhH--HhhcccCCCCcch-hhhcccCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 4566777777777665332211110000000 0000000000111 1122356788999999999999999999999
Q ss_pred HhcCccCCCC
Q 011808 332 ALEHEYFRIE 341 (477)
Q Consensus 332 ~L~h~~f~~~ 341 (477)
+|+||||+..
T Consensus 303 ll~hp~~~~~ 312 (353)
T 2b9h_A 303 ALEHPYLQTY 312 (353)
T ss_dssp HHTSGGGTTT
T ss_pred HhcCcccccc
Confidence 9999999743
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=366.08 Aligned_cols=266 Identities=26% Similarity=0.409 Sum_probs=212.3
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC----CcHHHHHHHHHHHhcCCCCeeEEEEE
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG----VSPTAIREIMLLREITHENVVKLVNV 96 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~ 96 (477)
...+.++|++.+.||+|+||.||+|+++. ++..||||++........ ....+.+|+.+++.++||||++++++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 83 (321)
T 2a2a_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV 83 (321)
T ss_dssp CSCHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhhhccEEEeeEeeecCCEEEEEEEECC---CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34567899999999999999999998764 688999999976544322 34577899999999999999999999
Q ss_pred EEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 97 HINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 97 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
+.+. ..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..++....
T Consensus 84 ~~~~--~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 84 YENR--TDVVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp EECS--SEEEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSC
T ss_pred EecC--CEEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcC
Confidence 8764 47899999996 6898888653 36899999999999999999999999999999999999954433333
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccH
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~ 255 (477)
.+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... .
T Consensus 157 ~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~ 224 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTK--------Q 224 (321)
T ss_dssp CEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------H
T ss_pred CEEEccCccceecCcccc---ccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCH--------H
Confidence 799999999987654322 2345679999999999874 489999999999999999999999976542 2
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+.+..+...... +........+..+.+||.+||..||.+|||+.++|+|
T Consensus 225 ~~~~~i~~~~~~-------------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 225 ETLANITSVSYD-------------------------------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHHTTCCC-------------------------------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhcccc-------------------------------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 222222211000 0001123346789999999999999999999999999
Q ss_pred ccCC
Q 011808 336 EYFR 339 (477)
Q Consensus 336 ~~f~ 339 (477)
|||.
T Consensus 274 p~~~ 277 (321)
T 2a2a_A 274 PWIT 277 (321)
T ss_dssp TTTS
T ss_pred cccc
Confidence 9996
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=374.77 Aligned_cols=286 Identities=40% Similarity=0.633 Sum_probs=219.4
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+.++|.+.+.||+|+||.||+|+++. ++..||||++............+.+|+.+++.++||||+++++++.....
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECC---CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 346899999999999999999998764 68999999997655444445677889999999999999999999876543
Q ss_pred ----ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 103 ----MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 103 ----~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
..+|+||||++++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~----~~~~~~k 166 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQTDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELK 166 (353)
T ss_dssp GGGCCCCEEEEECCSEEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE----CTTCCEE
T ss_pred cccceeEEEEeccccCCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE----CCCCcEE
Confidence 2469999999998776552 258999999999999999999999999999999999999 6777899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+++..... .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+ ..+.+
T Consensus 167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~~~~ 233 (353)
T 3coi_A 167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--------YLDQL 233 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC--------HHHHH
T ss_pred EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 9999999865432 2335679999999999876668999999999999999999999998765 45667
Q ss_pred HHHHHHhCCCCCCCccccCCCcccccccccccccc-ccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRK-YETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
..+....+.+..+.+..+.... . ...+.... .....+ .......+..+.+||.+||+.||.+|||++++|+|||
T Consensus 234 ~~i~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 234 TQILKVTGVPGTEFVQKLNDKA---A-KSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp HHHHHHHCBCCHHHHTTCSCHH---H-HHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHhCCCCHHHHHHHhhHH---H-HHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 7777777665543332221100 0 00000000 000011 1122355788999999999999999999999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|+.
T Consensus 309 f~~ 311 (353)
T 3coi_A 309 FEP 311 (353)
T ss_dssp GTT
T ss_pred hhh
Confidence 974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=375.19 Aligned_cols=291 Identities=32% Similarity=0.563 Sum_probs=217.2
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCC---------cHHHHHHHHHHHhcCCCCeeEE
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV---------SPTAIREIMLLREITHENVVKL 93 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~---------~~~~~~Ei~il~~l~hpnIv~l 93 (477)
.+.++|++++.||+|+||.||+|.+. .+..||||++......... ...+.+|+.+++.++||||+++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS----EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT----TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred HhccceEEeEEeccCCCEEEEEEECC----CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 45689999999999999999999753 4889999999765443322 2678899999999999999999
Q ss_pred EEEEEcC---CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc
Q 011808 94 VNVHINH---ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 94 ~~~~~~~---~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~ 170 (477)
++++... ....+|+||||++++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~--- 167 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--- 167 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCSEEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---
T ss_pred eeeEEeccCCCcceEEEEEccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---
Confidence 9998653 33478999999999999988753 3468999999999999999999999999999999999999
Q ss_pred CCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCC
Q 011808 171 GEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250 (477)
Q Consensus 171 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~ 250 (477)
+.++.+||+|||+++...... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+
T Consensus 168 -~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----- 238 (362)
T 3pg1_A 168 -ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST----- 238 (362)
T ss_dssp -CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----
T ss_pred -cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC-----
Confidence 667789999999997544322 22345679999999999876669999999999999999999999998765
Q ss_pred CcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccc-cccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 251 NPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQ-GRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 251 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
..+.+..+...++.+..+.+..... +.+. ..+. .................++.+.+||.+||+.||.+|||+
T Consensus 239 ---~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 311 (362)
T 3pg1_A 239 ---FYNQLNKIVEVVGTPKIEDVVMFSS-PSAR---DYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311 (362)
T ss_dssp ---HHHHHHHHHHHHCCCCHHHHHHTSC-HHHH---HHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ---HHHHHHHHHHHcCCCChHHhhhccc-hhhh---HHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence 4566777777776654332211100 0000 0000 000000001112234557789999999999999999999
Q ss_pred HHHhcCccCCC
Q 011808 330 AQALEHEYFRI 340 (477)
Q Consensus 330 ~e~L~h~~f~~ 340 (477)
.++|+||||+.
T Consensus 312 ~ell~hp~f~~ 322 (362)
T 3pg1_A 312 EQALRHPYFES 322 (362)
T ss_dssp HHHHTSGGGTT
T ss_pred HHHHcCchhhh
Confidence 99999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=375.70 Aligned_cols=255 Identities=27% Similarity=0.469 Sum_probs=207.7
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++++.||+|+||.||+|++.. ++..||||++...... ......+.+|+.+++.++||||+++++++.+.. .
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--T 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--E
T ss_pred hheeeeeEEccCCCEEEEEEEEcc---CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--e
Confidence 569999999999999999998653 6899999999764322 222346778999999999999999999997754 7
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+|+||||+.|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 129 ~~lv~e~~~g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL----SEPGLVKLGDFGS 200 (348)
T ss_dssp EEEEEECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE----ETTTEEEECCCTT
T ss_pred EEEEEecCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE----CCCCCEEEeeccC
Confidence 89999999999998886542 468999999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++.... ....+||+.|+|||++.+ ...++.++|||||||++|||++|++||.+.+ ....+..+.
T Consensus 201 a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--------~~~~~~~~~ 266 (348)
T 1u5q_A 201 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIA 266 (348)
T ss_dssp CBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHH
T ss_pred ceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHH
Confidence 986543 233567999999999863 3458999999999999999999999997654 222222222
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.. ..+. ..+...+..+.+||.+||+.||.+|||++++|+|+||..
T Consensus 267 ~~---~~~~------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 267 QN---ESPA------------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp HS---CCCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred hc---CCCC------------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 21 1100 112234678999999999999999999999999999964
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=377.96 Aligned_cols=266 Identities=23% Similarity=0.344 Sum_probs=200.8
Q ss_pred cccccceeEE-eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHH-hcCCCCeeEEEEEEEc
Q 011808 22 PEWLQQYNLI-GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLR-EITHENVVKLVNVHIN 99 (477)
Q Consensus 22 ~~~~~~Y~i~-~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~ 99 (477)
..++++|.+. ++||+|+||+||+|+++. ++..||||++.. ...+.+|+.++. .++||||++++++|..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~---~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CcccccceeccceeeeccCeEEEEEEECC---CCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence 4567889888 689999999999998764 688999999863 246778999875 4589999999999864
Q ss_pred --CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc
Q 011808 100 --HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 100 --~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~ 176 (477)
.+...+||||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+ ..++.
T Consensus 127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~~~ 202 (400)
T 1nxk_A 127 LYAGRKCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK-RPNAI 202 (400)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-STTCC
T ss_pred cccCCcEEEEEEEeCCCCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecC-CCCcc
Confidence 33457999999997 59999987643 2369999999999999999999999999999999999999432 12678
Q ss_pred EEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHH
Q 011808 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~ 256 (477)
+||+|||+++...... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.........
T Consensus 203 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---- 274 (400)
T 1nxk_A 203 LKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---- 274 (400)
T ss_dssp EEECCCTTCEECC--------------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS----
T ss_pred EEEEecccccccCCCC---ccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH----
Confidence 9999999998654322 22346789999999999764 589999999999999999999999986553222111
Q ss_pred HHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 257 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
....+.......+.. ....++.++.+||++||+.||.+|||+.++|+||
T Consensus 275 ~~~~i~~~~~~~~~~-------------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 275 MKTRIRMGQYEFPNP-------------------------------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp HHHHHHHTCCCCCTT-------------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHcCcccCCCc-------------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 111111110000000 1123467899999999999999999999999999
Q ss_pred cCCC
Q 011808 337 YFRI 340 (477)
Q Consensus 337 ~f~~ 340 (477)
||..
T Consensus 324 ~~~~ 327 (400)
T 1nxk_A 324 WIMQ 327 (400)
T ss_dssp HHHT
T ss_pred cccC
Confidence 9974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=381.72 Aligned_cols=299 Identities=29% Similarity=0.394 Sum_probs=219.2
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC--------CCCeeEEEE
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT--------HENVVKLVN 95 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l~~ 95 (477)
+.++|+++++||+|+||+||+|++.. +++.||||+++... .....+.+|+.+++.++ |+||+++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecC---CCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 46889999999999999999998654 68899999996432 23456778999999985 788999999
Q ss_pred EEEcC--CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEeccCC
Q 011808 96 VHINH--ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGEGE 172 (477)
Q Consensus 96 ~~~~~--~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~~~ 172 (477)
++... ....+|+||||++++|++.+.... ...+++..++.++.||+.||.|||++ ||+||||||+|||+..++.
T Consensus 109 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVLGHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEEETTEEEEEEEECCCCCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred ceeecCCCCceEEEEEeccCccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence 98632 345799999999999999887643 24699999999999999999999998 9999999999999953320
Q ss_pred ---------------------------------------------CcccEEEeecccceeecCCCCcccCCCeeeccccc
Q 011808 173 ---------------------------------------------EQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYR 207 (477)
Q Consensus 173 ---------------------------------------------~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 207 (477)
....+||+|||++...... ....+||+.|+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~ 260 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCccc
Confidence 1237999999999876532 23356799999
Q ss_pred cchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCcccccccc
Q 011808 208 APELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSL 287 (477)
Q Consensus 208 APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (477)
|||++.+.. ++.++|||||||++|+|++|+.||.+.+..... ...+.+..+...++..+...+........+.....
T Consensus 261 aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 261 SLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYT--RDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp CHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSC--HHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred CChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccC--chHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 999998854 899999999999999999999999876543322 24566777777777654322111000000000000
Q ss_pred cccc-ccccCCCC------ccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 288 HIQG-RKYETNGL------HSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 288 ~~~~-~~~~~~~~------~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.... .......+ ....+...+..+.+||.+||++||++|||++|+|+||||+
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0000 00000000 0001122245688999999999999999999999999996
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=372.72 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=208.0
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC------CcHHHHHHHHHHHhcCCCCeeEEEEE
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG------VSPTAIREIMLLREITHENVVKLVNV 96 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~Ei~il~~l~hpnIv~l~~~ 96 (477)
.+.++|++++.||+|+||.||+|+++. ++..||||+++....... ....+.+|+.+++.++||||++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 97 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKE---KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI 97 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETT---TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECC---CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 467899999999999999999998764 689999999987653322 22345679999999999999999999
Q ss_pred EEcCCCceEEEEEeccC-C-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc
Q 011808 97 HINHADMSLYLAFDYAE-Y-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ 174 (477)
Q Consensus 97 ~~~~~~~~~~lv~e~~~-~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~ 174 (477)
+.+. ..+++||||+. + +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 98 ~~~~--~~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll----~~~ 166 (335)
T 3dls_A 98 FENQ--GFFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI----AED 166 (335)
T ss_dssp EECS--SEEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTT
T ss_pred EeeC--CEEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE----cCC
Confidence 9764 47899999886 4 888888753 369999999999999999999999999999999999999 667
Q ss_pred ccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCccc
Q 011808 175 GVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254 (477)
Q Consensus 175 ~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~ 254 (477)
+.+||+|||++........ ....+||+.|+|||++.+...++.++|||||||++|+|++|..||........
T Consensus 167 ~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----- 238 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE----- 238 (335)
T ss_dssp SCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-----
T ss_pred CcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-----
Confidence 7899999999987654322 23456899999999998866558899999999999999999999975331000
Q ss_pred HHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.....+...+.++.+||.+||++||.+|||++++|+
T Consensus 239 --------------------------------------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 239 --------------------------------------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp --------------------------------------------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------------------------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000123345788999999999999999999999999
Q ss_pred CccCC
Q 011808 335 HEYFR 339 (477)
Q Consensus 335 h~~f~ 339 (477)
||||+
T Consensus 275 hp~~~ 279 (335)
T 3dls_A 275 DPWVT 279 (335)
T ss_dssp CTTTT
T ss_pred Ccccc
Confidence 99997
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=369.73 Aligned_cols=262 Identities=25% Similarity=0.414 Sum_probs=202.9
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++++|++++.||+|+||.||+|+++. ++..||||+++... .......+.+|+.++++++||||+++++++.+...
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKV---DDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETT---TCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcC---CCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 478899999999999999999998764 68899999997654 23345678899999999999999999999865432
Q ss_pred -------------------------------------------------------ceEEEEEeccCC-CHHHHHHhhhcc
Q 011808 103 -------------------------------------------------------MSLYLAFDYAEY-DLYEIIRHHRDK 126 (477)
Q Consensus 103 -------------------------------------------------------~~~~lv~e~~~~-~L~~~l~~~~~~ 126 (477)
.++|+||||+.+ +|.+++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~- 157 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS- 157 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-
Confidence 248999999984 88888876432
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCC----------ccc
Q 011808 127 VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK----------FLS 196 (477)
Q Consensus 127 ~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~----------~~~ 196 (477)
....++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... ...
T Consensus 158 -~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T 3qd2_B 158 -LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF----TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232 (332)
T ss_dssp -GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCCTTCEECSCC--------------C
T ss_pred -ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE----eCCCCEEEeecCcccccccchhhcccccccccccc
Confidence 2345667789999999999999999999999999999999 6677899999999987654321 112
Q ss_pred CCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCcccc
Q 011808 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTL 276 (477)
Q Consensus 197 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 276 (477)
....+||+.|+|||++.+. .++.++|||||||++|+|++|..|+.. ....+........+.
T Consensus 233 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-------------~~~~~~~~~~~~~~~----- 293 (332)
T 3qd2_B 233 HTGQVGTKLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-------------RVRIITDVRNLKFPL----- 293 (332)
T ss_dssp CCSCC-CGGGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-------------HHHHHHHHHTTCCCH-----
T ss_pred ccccCCCcCccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-------------HHHHHHHhhccCCCc-----
Confidence 2345789999999999874 489999999999999999998776531 111111111111000
Q ss_pred CCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 277 ANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.....++.+.+||.+||+.||.+|||++++|+||||+
T Consensus 294 --------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~ 330 (332)
T 3qd2_B 294 --------------------------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330 (332)
T ss_dssp --------------------------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCC
T ss_pred --------------------------ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhh
Confidence 0011235678999999999999999999999999996
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=386.51 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=200.3
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
..++|++++.||+|+||.||+|+++. ++..||||++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~- 221 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD- 221 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcC---CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-
Confidence 36889999999999999999998764 689999999975421 2233456678999999999999999999997754
Q ss_pred ceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 103 MSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 103 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+ +||+||||||+|||| +.++.+||+
T Consensus 222 -~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll----~~~~~~kl~ 291 (446)
T 4ejn_A 222 -RLCFVMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML----DKDGHIKIT 291 (446)
T ss_dssp -EEEEEECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE----CSSSCEEEC
T ss_pred -EEEEEEeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE----CCCCCEEEc
Confidence 78999999984 888887653 368999999999999999999998 999999999999999 677789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+. ...+..
T Consensus 292 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~ 360 (446)
T 4ejn_A 292 DFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFEL 360 (446)
T ss_dssp CCCCCCTTCC-------CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred cCCCceeccCCCc--ccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHH
Confidence 9999975432221 23346789999999999874 489999999999999999999999976542 222222
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h 335 (477)
+.... ..+|...++.+.+||.+||++||.+|| |++++|+|
T Consensus 361 i~~~~-----------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 361 ILMEE-----------------------------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHCC-----------------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHhCC-----------------------------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 22110 012344568899999999999999999 99999999
Q ss_pred ccCCC
Q 011808 336 EYFRI 340 (477)
Q Consensus 336 ~~f~~ 340 (477)
|||..
T Consensus 406 p~f~~ 410 (446)
T 4ejn_A 406 RFFAG 410 (446)
T ss_dssp GGGTT
T ss_pred ccccC
Confidence 99973
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=368.36 Aligned_cols=278 Identities=28% Similarity=0.390 Sum_probs=215.6
Q ss_pred CCCCCCCCCCccccccceeEE-eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCC
Q 011808 11 GGTGTSNHGEKPEWLQQYNLI-GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THE 88 (477)
Q Consensus 11 ~~~~~~~~~~~~~~~~~Y~i~-~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hp 88 (477)
.++..........|.++|.+. +.||+|+||.||+|+++. ++..||||++............+.+|+.+++.+ .||
T Consensus 13 ~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 89 (327)
T 3lm5_A 13 LGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89 (327)
T ss_dssp ---CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCT
T ss_pred ccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCC
Confidence 344445566666788899998 899999999999998764 688999999987665555567888999999999 569
Q ss_pred CeeEEEEEEEcCCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEE
Q 011808 89 NVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILV 167 (477)
Q Consensus 89 nIv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl 167 (477)
||+++++++.+. ..+|+||||+.+ +|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 90 ~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~ 164 (327)
T 3lm5_A 90 RVINLHEVYENT--SEIILILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILL 164 (327)
T ss_dssp TBCCEEEEEECS--SEEEEEEECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CEEEEEEEEEeC--CeEEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEE
Confidence 999999999764 478999999985 777766432 23579999999999999999999999999999999999999
Q ss_pred eccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 011808 168 MGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247 (477)
Q Consensus 168 ~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~ 247 (477)
... ...+.+||+|||+++....... ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+
T Consensus 165 ~~~-~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-- 237 (327)
T 3lm5_A 165 SSI-YPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGED-- 237 (327)
T ss_dssp SCB-TTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred ecC-CCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence 432 1267899999999987654322 2335679999999999874 48999999999999999999999997655
Q ss_pred cCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC
Q 011808 248 STQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI 327 (477)
Q Consensus 248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp 327 (477)
..+.+..+.........+ ....++..+.+||.+||+.||.+||
T Consensus 238 ------~~~~~~~i~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~L~~dP~~Rp 280 (327)
T 3lm5_A 238 ------NQETYLNISQVNVDYSEE-------------------------------TFSSVSQLATDFIQSLLVKNPEKRP 280 (327)
T ss_dssp ------HHHHHHHHHHTCCCCCTT-------------------------------TTTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred ------chHHHHHHHhcccccCch-------------------------------hhcccCHHHHHHHHHHcCCChhhCc
Confidence 223333333322111111 1223467899999999999999999
Q ss_pred CHHHHhcCccCCC
Q 011808 328 TAAQALEHEYFRI 340 (477)
Q Consensus 328 t~~e~L~h~~f~~ 340 (477)
|++++|+||||+.
T Consensus 281 t~~~ll~h~~~~~ 293 (327)
T 3lm5_A 281 TAEICLSHSWLQQ 293 (327)
T ss_dssp CHHHHTTCGGGCC
T ss_pred CHHHHhCCHhhcc
Confidence 9999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=370.16 Aligned_cols=268 Identities=26% Similarity=0.414 Sum_probs=191.1
Q ss_pred cccccceeEE---eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEE
Q 011808 22 PEWLQQYNLI---GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVH 97 (477)
Q Consensus 22 ~~~~~~Y~i~---~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~ 97 (477)
..|.++|++. +.||+|+||.||+|+++. ++..||||++... ......+|+.+++.+. ||||+++++++
T Consensus 4 ~~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~ 75 (325)
T 3kn6_A 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVF 75 (325)
T ss_dssp CHHHHHEEECTTSCCSEEETTEEEEEEEETT---TCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CcchhccccccCCCccccCCCeEEEEEEECC---CCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEE
Confidence 4578899997 789999999999998764 6889999999653 2356778999999996 99999999999
Q ss_pred EcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc
Q 011808 98 INHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~ 176 (477)
.+. ..+|+||||+. ++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+..+ +....
T Consensus 76 ~~~--~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~ 147 (325)
T 3kn6_A 76 HDQ--LHTFLVMELLNGGELFERIKKK-----KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE-NDNLE 147 (325)
T ss_dssp ECS--SEEEEEECCCCSCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----CE
T ss_pred EcC--CEEEEEEEccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecC-CCccc
Confidence 764 47899999997 4898888763 369999999999999999999999999999999999999543 22347
Q ss_pred EEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHH
Q 011808 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~ 256 (477)
+||+|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..... .
T Consensus 148 ~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----~ 219 (325)
T 3kn6_A 148 IKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-----T 219 (325)
T ss_dssp EEECCCTTCEECCC------------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------C-----C
T ss_pred EEEeccccceecCCCCC--cccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-----c
Confidence 99999999986544322 22345679999999999774 4899999999999999999999999865532111 1
Q ss_pred HHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 257 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
....+...+....... .......++.++.+||.+||+.||.+|||+++++.||
T Consensus 220 ~~~~~~~~i~~~~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 220 SAVEIMKKIKKGDFSF---------------------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp CHHHHHHHHTTTCCCC---------------------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred cHHHHHHHHHcCCCCC---------------------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 1122223222111100 0001123467899999999999999999999999999
Q ss_pred cCCC
Q 011808 337 YFRI 340 (477)
Q Consensus 337 ~f~~ 340 (477)
||+.
T Consensus 273 w~~~ 276 (325)
T 3kn6_A 273 WLQD 276 (325)
T ss_dssp GGCT
T ss_pred hhcc
Confidence 9974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=378.11 Aligned_cols=263 Identities=23% Similarity=0.343 Sum_probs=208.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|+++++||+|+||+||+|+++. +++.||||++++... .......+.+|+.++..++||||++++++|.+..
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~---~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-- 134 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN-- 134 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS--
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC--
Confidence 5789999999999999999998764 689999999865321 1112234678999999999999999999997644
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++++||+||
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl----d~~g~vkL~DF 206 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL----DRCGHIRLADF 206 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCC
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee----cCCCCEEEeec
Confidence 7999999996 7999988764 2369999999999999999999999999999999999999 77788999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcC------CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLG------AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~ 256 (477)
|+++....... ......+||+.|+|||++.+ ...|+.++|||||||++|||++|+.||.+.+ ..+
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~ 277 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--------TAE 277 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHH
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--------HHH
Confidence 99987654322 12234678999999999972 2458999999999999999999999998755 223
Q ss_pred HHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC---CCHHHHh
Q 011808 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR---ITAAQAL 333 (477)
Q Consensus 257 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R---pt~~e~L 333 (477)
.+..+........ +| ..+...+.++++||++||+ ||.+| +++++++
T Consensus 278 ~~~~i~~~~~~~~---------~p---------------------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~ 326 (412)
T 2vd5_A 278 TYGKIVHYKEHLS---------LP---------------------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR 326 (412)
T ss_dssp HHHHHHTHHHHCC---------CC-------------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH
T ss_pred HHHHHHhcccCcC---------CC---------------------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 3333332110000 00 0123457889999999999 99998 4999999
Q ss_pred cCccCCC
Q 011808 334 EHEYFRI 340 (477)
Q Consensus 334 ~h~~f~~ 340 (477)
+||||+.
T Consensus 327 ~Hpff~~ 333 (412)
T 2vd5_A 327 THPFFFG 333 (412)
T ss_dssp TSGGGTT
T ss_pred cCCCcCC
Confidence 9999974
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=373.86 Aligned_cols=286 Identities=24% Similarity=0.357 Sum_probs=210.6
Q ss_pred CCCCCCCCCCCCccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCC---CCCCCcHHHHHHHHHHHhc
Q 011808 9 GRGGTGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK---DGDGVSPTAIREIMLLREI 85 (477)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~Ei~il~~l 85 (477)
+++..+..-.++...+.++|++.+.||+|+||.||+|+++. ++..||||++.... ........+.+|+.+++.+
T Consensus 9 ~~~~~~~~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l 85 (345)
T 3hko_A 9 SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQ---TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85 (345)
T ss_dssp -----CCCCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC
T ss_pred CCCccccccCchhhhhhhheeecceeeecCCeEEEEEEECC---CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC
Confidence 33333444455666788999999999999999999998654 68899999986542 1234456788999999999
Q ss_pred CCCCeeEEEEEEEcCCCceEEEEEeccC-CCHHHHHHhhhcc-----------------------------------cCC
Q 011808 86 THENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDK-----------------------------------VNH 129 (477)
Q Consensus 86 ~hpnIv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-----------------------------------~~~ 129 (477)
+||||+++++++.+. ..+|+||||+. ++|.+++...... ...
T Consensus 86 ~hpniv~~~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (345)
T 3hko_A 86 HHPNIARLYEVYEDE--QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDF 163 (345)
T ss_dssp CCTTBCCEEEEEECS--SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCH
T ss_pred CCCCcceeehhhccC--CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999764 47999999996 6888877421100 011
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCC--cccCCCeeeccccc
Q 011808 130 TMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK--FLSENGVVVTIWYR 207 (477)
Q Consensus 130 ~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~~gt~~y~ 207 (477)
.+++..++.++.||+.||.|||++||+||||||+|||+..+ ....+||+|||+++.+..... ........||+.|+
T Consensus 164 ~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~ 241 (345)
T 3hko_A 164 VQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN--KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV 241 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCS--SSCCEEECCCTTCEEGGGTTCC--------CCCGGGC
T ss_pred cccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecC--CCceEEEeeccccccccccCccccccccccCCCcccc
Confidence 24677889999999999999999999999999999999422 223799999999987643221 11223456899999
Q ss_pred cchhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccc
Q 011808 208 APELLLGA-KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDS 286 (477)
Q Consensus 208 APE~l~~~-~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (477)
|||++.+. ..++.++|||||||++|+|++|+.||.+.+ ..+.+..+..........
T Consensus 242 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~--------------- 298 (345)
T 3hko_A 242 APEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN--------DADTISQVLNKKLCFENP--------------- 298 (345)
T ss_dssp CHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCTTSG---------------
T ss_pred CchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------hHHHHHHHHhcccccCCc---------------
Confidence 99999753 458999999999999999999999998665 223333332211100000
Q ss_pred cccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 287 LHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 287 ~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.....+..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 299 ----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 299 ----------------NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp ----------------GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred ----------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence 01123578999999999999999999999999999973
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=357.67 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=210.6
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHIN 99 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 99 (477)
...+.++|++++.||+|+||.||+|+++. ++..||||++............+.+|+.++..+ +||||+++++++.+
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~ 82 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRL---DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE 82 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcC---CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 34578899999999999999999998764 688999999987655555566788899999999 99999999999976
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC-------
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG------- 171 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~------- 171 (477)
.. .+|+||||+. ++|.+++...... ...+++..++.++.||+.||.|||++||+||||||+|||+..++
T Consensus 83 ~~--~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~ 159 (289)
T 1x8b_A 83 DD--HMLIQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 159 (289)
T ss_dssp TT--EEEEEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------
T ss_pred CC--eEEEEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccc
Confidence 54 7899999997 4999998765321 34689999999999999999999999999999999999995432
Q ss_pred --------CCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 011808 172 --------EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQG 243 (477)
Q Consensus 172 --------~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~ 243 (477)
.....+||+|||++....... ...||+.|+|||++.+...++.++|||||||++|+|++|.++|..
T Consensus 160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 160 EGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp ----------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred ccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 144579999999998765422 234799999999998765677899999999999999999988753
Q ss_pred cccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCC
Q 011808 244 AEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323 (477)
Q Consensus 244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP 323 (477)
.. ....+... . ....+...+..+.+||.+||+.||
T Consensus 234 ~~-----------~~~~~~~~---~-------------------------------~~~~~~~~~~~~~~li~~~l~~dp 268 (289)
T 1x8b_A 234 GD-----------QWHEIRQG---R-------------------------------LPRIPQVLSQEFTELLKVMIHPDP 268 (289)
T ss_dssp SH-----------HHHHHHTT---C-------------------------------CCCCSSCCCHHHHHHHHHHTCSSG
T ss_pred hh-----------HHHHHHcC---C-------------------------------CCCCCcccCHHHHHHHHHHhCCCc
Confidence 32 11211110 0 011234456889999999999999
Q ss_pred CCCCCHHHHhcCccCCC
Q 011808 324 RKRITAAQALEHEYFRI 340 (477)
Q Consensus 324 ~~Rpt~~e~L~h~~f~~ 340 (477)
.+|||+.++|+||||..
T Consensus 269 ~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 269 ERRPSAMALVKHSVLLS 285 (289)
T ss_dssp GGSCCHHHHHTCTTC--
T ss_pred ccCCCHHHHhhChHhhh
Confidence 99999999999999973
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=368.22 Aligned_cols=286 Identities=29% Similarity=0.507 Sum_probs=210.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 103 (477)
.++|++++.||+|+||.||+|++.. +++.||||+++.. ....+.+|+.+++.++ ||||+++++++.+....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCceEEEEEecccCCeEEEEEEECC---CCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 4789999999999999999998764 6889999998642 2457889999999997 99999999999886667
Q ss_pred eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..++||||+.+ +|.+++. .+++..++.++.||+.||.|||++||+||||||+|||+.. +...+||+||
T Consensus 107 ~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~---~~~~~kl~Df 175 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH---EHRKLRLIDW 175 (330)
T ss_dssp CEEEEEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTTEEEECCC
T ss_pred ceEEEEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC---CCCEEEEEeC
Confidence 89999999984 6666552 3889999999999999999999999999999999999932 2337999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+++.+..... .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||..... ..+.+..+.
T Consensus 176 g~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~-------~~~~l~~~~ 245 (330)
T 3nsz_A 176 GLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-------NYDQLVRIA 245 (330)
T ss_dssp TTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS-------HHHHHHHHH
T ss_pred CCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc-------hHHHHHHHH
Confidence 99987654332 23456799999999998766799999999999999999999999954332 334444444
Q ss_pred HHhCCCCCCCccccCC---CccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 263 KILGHPTPEKWPTLAN---LPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
..++.+....+..... .+.+... .................+...+..+.+||.+||++||.+|||++|+|+||||+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~ 324 (330)
T 3nsz_A 246 KVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324 (330)
T ss_dssp HHHCHHHHHHHHHHTTCCCCTHHHHH-HCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred HhcCCchhhhHHHHhccccccchhhh-hhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence 4332211000000000 0000000 00000000000011112233578899999999999999999999999999997
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 325 ~ 325 (330)
T 3nsz_A 325 T 325 (330)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=365.71 Aligned_cols=292 Identities=22% Similarity=0.307 Sum_probs=218.7
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+.++|++.+.||+|+||.||+|+++. +++.||||++...... .....+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECC---CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 346789999999999999999998764 6889999999754432 234677899999999999999999999987776
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|+||||+. ++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||+..+.+..+.+||+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred ceEEEEEeCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 68899999997 689888876532 234899999999999999999999999999999999999865556677899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCccc
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLG-------AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~ 254 (477)
||+++....... ....+||+.|+|||++.. ...++.++|||||||++|+|++|+.||......
T Consensus 160 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------- 229 (319)
T 4euu_A 160 FGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP------- 229 (319)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG-------
T ss_pred CCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-------
Confidence 999987655432 233567999999999862 245899999999999999999999999754421
Q ss_pred HHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
......+...+...++..+..+....... ..... ........+...+..+.+||++||+.||++|||++|+|+
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~---~~~~~----~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~ 302 (319)
T 4euu_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGP---IDWSG----DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (319)
T ss_dssp GGCHHHHHHHHHHCCTTCCEEEECSTTCC---EEEES----SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred chhHHHHHHHhcCCCcccchhhhcccCCc---cccCc----cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence 12222333333334444333322211100 00000 000001112223456889999999999999999999999
Q ss_pred Ccc
Q 011808 335 HEY 337 (477)
Q Consensus 335 h~~ 337 (477)
||=
T Consensus 303 h~~ 305 (319)
T 4euu_A 303 ETS 305 (319)
T ss_dssp HHH
T ss_pred ccH
Confidence 974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=387.84 Aligned_cols=265 Identities=32% Similarity=0.546 Sum_probs=213.6
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEc
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHIN 99 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 99 (477)
...+.++|++.++||+|+||.||+|+++. ++..||||++...... ......+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 97 (484)
T 3nyv_A 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED 97 (484)
T ss_dssp CCCHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCcccCceEEeeEEecCCCEEEEEEEECC---CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34567899999999999999999998764 6889999999765443 3345678899999999999999999999976
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
. ..+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+... +.++.+|
T Consensus 98 ~--~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~~~~k 169 (484)
T 3nyv_A 98 K--GYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK-SKDANIR 169 (484)
T ss_dssp S--SEEEEEECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS-STTCCEE
T ss_pred C--CEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecC-CCCCcEE
Confidence 4 48899999987 6888888653 369999999999999999999999999999999999999533 3457899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+++.+..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+ ..+.+
T Consensus 170 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~ 236 (484)
T 3nyv_A 170 IIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--------EYDIL 236 (484)
T ss_dssp ECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred EEeeeeeEEcccccc---cccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCC--------HHHHH
Confidence 999999987654322 123467999999999986 48999999999999999999999998765 22333
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..+........ .+.| ..++..+++||++||++||.+|||+.++|+||||
T Consensus 237 ~~i~~~~~~~~---------~~~~----------------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 237 KKVEKGKYTFE---------LPQW----------------------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp HHHHHCCCCCC---------SGGG----------------------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHcCCCCCC---------Cccc----------------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 33322111110 1111 1235789999999999999999999999999999
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
+.
T Consensus 286 ~~ 287 (484)
T 3nyv_A 286 QT 287 (484)
T ss_dssp HH
T ss_pred cc
Confidence 73
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=355.41 Aligned_cols=261 Identities=28% Similarity=0.408 Sum_probs=209.8
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
..+.++|++.+.||+|+||.||+|.++. ++..+|+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 78 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKG---TRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDN- 78 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCC---CCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 3567899999999999999999998764 678899999876543 2356788999999999999999999999764
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +.++.+||+
T Consensus 79 -~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~~~~l~ 151 (277)
T 3f3z_A 79 -TDIYLVMELCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD-SPDSPLKLI 151 (277)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS-STTCCEEEC
T ss_pred -CeEEEEEeccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC-CCCCcEEEE
Confidence 47899999997 5888888763 368999999999999999999999999999999999999543 456789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||++..+..... .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||...+. .+....
T Consensus 152 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~ 218 (277)
T 3f3z_A 152 DFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SEVMLK 218 (277)
T ss_dssp CCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred ecccceeccCccc---hhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence 9999987654332 2345679999999999763 89999999999999999999999976542 222222
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+.......+. ......++.+.+||.+||+.||.+|||+.++|+||||+
T Consensus 219 ~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~ 266 (277)
T 3f3z_A 219 IREGTFTFPE-------------------------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266 (277)
T ss_dssp HHHCCCCCCH-------------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred HHhCCCCCCc-------------------------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 2221100000 00113467899999999999999999999999999996
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=392.22 Aligned_cols=262 Identities=27% Similarity=0.390 Sum_probs=211.6
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
-.++|+++++||+|+||.||+|+++. ++..||||++..... .......+.+|+.+|+.++||||+++++++.+..
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~- 257 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD- 257 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cccceEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC-
Confidence 35789999999999999999998764 689999999865422 1233456788999999999999999999997644
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 258 -~l~lVmEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl----d~~g~vKL~D 329 (576)
T 2acx_A 258 -ALCLVLTLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL----DDHGHIRISD 329 (576)
T ss_dssp -EEEEEECCCCSCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTSCEEECC
T ss_pred -EEEEEEEcCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE----eCCCCeEEEe
Confidence 7999999996 68888886543 2359999999999999999999999999999999999999 7778899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+++.+..... ....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+..... ....+...
T Consensus 330 FGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-----~~~~i~~~ 400 (576)
T 2acx_A 330 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERL 400 (576)
T ss_dssp CTTCEECCTTCC---EECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-----CHHHHHHH
T ss_pred cccceecccCcc---ccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccch-----hHHHHHHH
Confidence 999987654322 2235789999999999874 48999999999999999999999998654221 11222222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHE 336 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~ 336 (477)
... ... .++...+.++.+||.+||++||.+|+ +++++++||
T Consensus 401 i~~---~~~-------------------------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 401 VKE---VPE-------------------------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp HHH---CCC-------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred hhc---ccc-------------------------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 111 110 12334568899999999999999999 899999999
Q ss_pred cCCC
Q 011808 337 YFRI 340 (477)
Q Consensus 337 ~f~~ 340 (477)
||+.
T Consensus 447 fF~~ 450 (576)
T 2acx_A 447 LFKK 450 (576)
T ss_dssp GGTT
T ss_pred hhcc
Confidence 9974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=386.41 Aligned_cols=259 Identities=28% Similarity=0.445 Sum_probs=212.6
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
...+++|.+.+.||+|+||.||+|+++. ++..||||++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHEL---TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETT---TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3457999999999999999999998764 689999999965432 123345778999999999999999999999765
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
. .+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 89 ~--~~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll----~~~~~vkL 157 (476)
T 2y94_A 89 S--DIFMVMEYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL----DAHMNAKI 157 (476)
T ss_dssp S--EEEEEEECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE----CTTCCEEE
T ss_pred C--EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE----ecCCCeEE
Confidence 4 7899999996 689888864 3469999999999999999999999999999999999999 67778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+++....... ....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+. ...+.
T Consensus 158 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~ 226 (476)
T 2y94_A 158 ADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLFK 226 (476)
T ss_dssp CCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHHH
T ss_pred Eeccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHHH
Confidence 99999987654321 23457899999999998866557899999999999999999999976542 22222
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+.... ...|...++++.+||.+||+.||.+|||+.++++||||+
T Consensus 227 ~i~~~~-----------------------------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~ 271 (476)
T 2y94_A 227 KICDGI-----------------------------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271 (476)
T ss_dssp HHHTTC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred HHhcCC-----------------------------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence 222110 012334567899999999999999999999999999997
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 272 ~ 272 (476)
T 2y94_A 272 Q 272 (476)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=373.07 Aligned_cols=293 Identities=32% Similarity=0.577 Sum_probs=217.7
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CC-----CeeEEE
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HE-----NVVKLV 94 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~ 94 (477)
...+.++|++++.||+|+||+||+|+++. +++.||||+++... .....+.+|+.+++.++ |+ +|++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcC---CCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 34568999999999999999999998764 68899999997432 22345667888888884 55 499999
Q ss_pred EEEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhh--hCCeecCCCCCCcEEEeccCC
Q 011808 95 NVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH--SNWIIHRDLKPSNILVMGEGE 172 (477)
Q Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH--~~givHrDikp~NILl~~~~~ 172 (477)
+++.... .+|+||||++++|.+++.... ...+++..++.++.||+.||.||| +.||+||||||+|||+.. +
T Consensus 123 ~~~~~~~--~~~lv~e~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~--~ 195 (382)
T 2vx3_A 123 RHFMFRN--HLCLVFEMLSYNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN--P 195 (382)
T ss_dssp EEEEETT--EEEEEEECCCCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS--T
T ss_pred eeeccCC--ceEEEEecCCCCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec--C
Confidence 9987754 789999999999999998753 236899999999999999999999 579999999999999943 2
Q ss_pred CcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCc
Q 011808 173 EQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252 (477)
Q Consensus 173 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~ 252 (477)
.++.+||+|||+++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+
T Consensus 196 ~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~------- 262 (382)
T 2vx3_A 196 KRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGAN------- 262 (382)
T ss_dssp TSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------
T ss_pred CCCcEEEEeccCceecccc-----cccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------
Confidence 3567999999999876432 2345679999999999885 48999999999999999999999998766
Q ss_pred ccHHHHHHHHHHhCCCCCCCccccCC-------Cc--cccccccccccccccCC---CCccccCC---------------
Q 011808 253 FQLDQLDKIFKILGHPTPEKWPTLAN-------LP--HWQSDSLHIQGRKYETN---GLHSVVPL--------------- 305 (477)
Q Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~~~-------~~--~~~~~~~~~~~~~~~~~---~~~~~~p~--------------- 305 (477)
..+.+..+...++.++...+..... ++ .|.-.........+... .+......
T Consensus 263 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 341 (382)
T 2vx3_A 263 -EVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGH 341 (382)
T ss_dssp -HHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTC
T ss_pred -HHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccc
Confidence 5667778888777665433222111 11 01000000000000000 00000000
Q ss_pred --CCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 306 --SPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 306 --~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
..+..+++||.+||++||++|||++|+|+||||+.
T Consensus 342 ~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~ 378 (382)
T 2vx3_A 342 TVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378 (382)
T ss_dssp CHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC
T ss_pred cchhhHHHHHHHHHhcCCChhhCCCHHHHhcCccccc
Confidence 00136889999999999999999999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=367.65 Aligned_cols=270 Identities=24% Similarity=0.370 Sum_probs=205.8
Q ss_pred CCccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEE
Q 011808 19 GEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVH 97 (477)
Q Consensus 19 ~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 97 (477)
.....+.++|++.+.||+|+||.||+|+++. +++.||||+++...... .....+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLR---DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp CCCSEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred CCcceecCcEEEEEEEccCCCEEEEEEEECC---CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 3445678899999999999999999998754 68899999997654332 2234667899999999999999999998
Q ss_pred EcCCC--ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc
Q 011808 98 INHAD--MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ 174 (477)
Q Consensus 98 ~~~~~--~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~ 174 (477)
..... ..+|+||||++ ++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~----~~~ 152 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI----SAT 152 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ETT
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE----cCC
Confidence 75432 35699999997 6998888763 368999999999999999999999999999999999999 566
Q ss_pred ccEEEeecccceeecCCCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 175 GVVKIADFGLARIYQAPLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 175 ~~vkL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
+.+||+|||+++.+...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...
T Consensus 153 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------- 224 (311)
T 3ork_A 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSP------- 224 (311)
T ss_dssp SCEEECCCSCC------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------
T ss_pred CCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------
Confidence 77999999999866543221 222345689999999999875 489999999999999999999999976542
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
......+... ...+ ........+.++.+||.+||+.||.+||++.++|
T Consensus 225 -~~~~~~~~~~--~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l 272 (311)
T 3ork_A 225 -VSVAYQHVRE--DPIP-----------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272 (311)
T ss_dssp -HHHHHHHHHC--CCCC-----------------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred -HHHHHHHhcC--CCCC-----------------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHH
Confidence 1222111111 0000 0011234567899999999999999999999999
Q ss_pred cCccCCC
Q 011808 334 EHEYFRI 340 (477)
Q Consensus 334 ~h~~f~~ 340 (477)
.|+|++.
T Consensus 273 ~~~l~~~ 279 (311)
T 3ork_A 273 RADLVRV 279 (311)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=359.50 Aligned_cols=263 Identities=22% Similarity=0.397 Sum_probs=195.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++++.||+|+||.||+|+++. +++.||||+++...........+.++...++.++||||+++++++.+.. .
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~--~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVP---SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG--D 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--S
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecC---CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC--C
Confidence 5899999999999999999998754 6899999999765433322333344555678889999999999997644 6
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||++++|.+++...... ...+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg 155 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI----NALGQVKMCDFG 155 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE----CTTCCEEBCCC-
T ss_pred EEEEEehhccchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE----CCCCCEEEeecC
Confidence 8999999999998888764322 45799999999999999999999998 99999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhc---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLL---GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
++........ .....||+.|+|||++. ....++.++|||||||++|+|++|+.||..... ....+..
T Consensus 156 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~ 225 (290)
T 3fme_A 156 ISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-------PFQQLKQ 225 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-------HHHHHHH
T ss_pred Cccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-------hHHHHHH
Confidence 9986654322 22346799999999973 335589999999999999999999999975331 1222222
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
... ...+. ..+...+..+.+||.+||+.||.+|||+.++++||||+.
T Consensus 226 ~~~---~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 226 VVE---EPSPQ------------------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HHH---SCCCC------------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred Hhc---cCCCC------------------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 221 11110 012234678999999999999999999999999999973
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=385.50 Aligned_cols=263 Identities=32% Similarity=0.468 Sum_probs=207.6
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-----------CCcHHHHHHHHHHHhcCCCCee
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-----------GVSPTAIREIMLLREITHENVV 91 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~Ei~il~~l~hpnIv 91 (477)
.+.++|+++++||+|+||+||+|+++. ++..||||++....... .....+.+|+.+++.++||||+
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 109 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKN---GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred CcccceEEEeEecccCCeEEEEEEECC---CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 457899999999999999999998764 68899999997654321 3456778999999999999999
Q ss_pred EEEEEEEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc
Q 011808 92 KLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 92 ~l~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~ 170 (477)
++++++.+. ..+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+..+
T Consensus 110 ~~~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 110 KLFDVFEDK--KYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK 182 (504)
T ss_dssp CEEEEEECS--SEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESST
T ss_pred eEEEEEEcC--CEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecC
Confidence 999999764 47899999997 5888888764 369999999999999999999999999999999999999533
Q ss_pred CCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCC
Q 011808 171 GEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250 (477)
Q Consensus 171 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~ 250 (477)
+ ....+||+|||++..+..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+.
T Consensus 183 ~-~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~---- 252 (504)
T 3q5i_A 183 N-SLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQND---- 252 (504)
T ss_dssp T-CCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred C-CCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 1 224699999999987654322 234568999999999875 489999999999999999999999987652
Q ss_pred CcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHH
Q 011808 251 NPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA 330 (477)
Q Consensus 251 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~ 330 (477)
.+.+..+........ ......++..+.+||++||++||.+|||++
T Consensus 253 ----~~~~~~i~~~~~~~~-------------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ 297 (504)
T 3q5i_A 253 ----QDIIKKVEKGKYYFD-------------------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAE 297 (504)
T ss_dssp ----HHHHHHHHHCCCCCC-------------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred ----HHHHHHHHcCCCCCC-------------------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHH
Confidence 223333322110000 001123467899999999999999999999
Q ss_pred HHhcCccCCC
Q 011808 331 QALEHEYFRI 340 (477)
Q Consensus 331 e~L~h~~f~~ 340 (477)
|+|+||||+.
T Consensus 298 e~l~h~~~~~ 307 (504)
T 3q5i_A 298 EALNSRWIKK 307 (504)
T ss_dssp HHHTSHHHHH
T ss_pred HHhcCHhhhh
Confidence 9999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=363.01 Aligned_cols=262 Identities=27% Similarity=0.359 Sum_probs=211.4
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
...++|.+.+.||+|+||.||+|++.. ++..||+|++....... .....+.+|+.+++.++||||+++++++.+.
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 113 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN- 113 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-
Confidence 345789999999999999999998754 68899999987654322 2345677899999999999999999999764
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+||||+. ++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 114 -~~~~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~----~~~~~~kl~ 183 (335)
T 2owb_A 114 -DFVFVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL----NEDLEVKIG 183 (335)
T ss_dssp -SEEEEEECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTCCEEEC
T ss_pred -CeEEEEEecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE----cCCCCEEEe
Confidence 47899999998 5888877653 368999999999999999999999999999999999999 667789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... .+.+..
T Consensus 184 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~ 252 (335)
T 2owb_A 184 DFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLR 252 (335)
T ss_dssp CCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHH
T ss_pred eccCceecccCcc--cccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHH
Confidence 9999987653222 22345679999999999874 489999999999999999999999976541 122222
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+.... ...+...+..+.+||.+||+.||.+|||++++|+|+||..
T Consensus 253 ~~~~~-----------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 253 IKKNE-----------------------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp HHHTC-----------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HhcCC-----------------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 21110 0123344678999999999999999999999999999985
Q ss_pred CCCC
Q 011808 341 EPLP 344 (477)
Q Consensus 341 ~~~~ 344 (477)
...+
T Consensus 298 ~~~~ 301 (335)
T 2owb_A 298 GYIP 301 (335)
T ss_dssp SCCC
T ss_pred CCcc
Confidence 5433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=359.18 Aligned_cols=255 Identities=27% Similarity=0.488 Sum_probs=205.5
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEE
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 106 (477)
.|+..+.||+|+||.||+|+++. +++.||||++.... ......+.+|+.+++.++||||+++++++.... .+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE--ELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEE
T ss_pred hhhccEEeccCCCeEEEEEEECC---CCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEE
Confidence 48889999999999999998753 68899999997543 234567889999999999999999999997754 789
Q ss_pred EEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 107 LAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 107 lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
+||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 119 lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~~ 188 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL----TLDGRVKLSDFGFC 188 (321)
T ss_dssp EEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCcEEEeeeeee
Confidence 9999997 577776643 368999999999999999999999999999999999999 66778999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
........ ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. ...+..+...
T Consensus 189 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~--------~~~~~~~~~~- 256 (321)
T 2c30_A 189 AQISKDVP--KRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSP--------VQAMKRLRDS- 256 (321)
T ss_dssp EECCSSSC--CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHS-
T ss_pred eecccCcc--ccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC-
Confidence 87654322 22346789999999999774 489999999999999999999999976542 2222222211
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
..+. +. .+...+..+.+||.+||+.||++|||+.++|+||||...
T Consensus 257 --~~~~-~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 257 --PPPK-LK----------------------------NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp --SCCC-CT----------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred --CCCC-cC----------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 1100 00 112235779999999999999999999999999999743
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=362.23 Aligned_cols=278 Identities=24% Similarity=0.327 Sum_probs=203.2
Q ss_pred ccccceeEE-eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcC
Q 011808 23 EWLQQYNLI-GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINH 100 (477)
Q Consensus 23 ~~~~~Y~i~-~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 100 (477)
.+.++|++. +.||+|+||.||+|+++ .++..||||++.... ......+.+|+.+++++ +||||+++++++.+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINL---ITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE 83 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECS---SSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred ccceeEEecCceecCCceEEEEEEEEc---CCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 467899996 78999999999999865 368899999997643 33456788999999985 799999999999775
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
. .+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..++ ....+||
T Consensus 84 ~--~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~~~kl 155 (316)
T 2ac3_A 84 D--RFYLVFEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN-QVSPVKI 155 (316)
T ss_dssp T--EEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSS-SSCSEEE
T ss_pred C--EEEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCC-CcCceEE
Confidence 4 7899999997 6999988764 3689999999999999999999999999999999999994331 2234999
Q ss_pred eecccceeecCCCC-----cccCCCeeeccccccchhhcCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCC
Q 011808 180 ADFGLARIYQAPLK-----FLSENGVVVTIWYRAPELLLGA----KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250 (477)
Q Consensus 180 ~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~ 250 (477)
+|||++........ .......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.......
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 235 (316)
T 2ac3_A 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235 (316)
T ss_dssp CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence 99999876532111 1112234589999999999641 23788999999999999999999999876533211
Q ss_pred Ccc---cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC
Q 011808 251 NPF---QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI 327 (477)
Q Consensus 251 ~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp 327 (477)
... .......+...+...... +........+..+.+||.+||+.||.+||
T Consensus 236 ~~~~~~~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 288 (316)
T 2ac3_A 236 WDRGEACPACQNMLFESIQEGKYE---------------------------FPDKDWAHISCAAKDLISKLLVRDAKQRL 288 (316)
T ss_dssp C----CCHHHHHHHHHHHHHCCCC---------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred ccccccchhHHHHHHHHHhccCcc---------------------------cCchhcccCCHHHHHHHHHHhhCChhhCC
Confidence 100 000011111111100000 00000123467899999999999999999
Q ss_pred CHHHHhcCccCCC
Q 011808 328 TAAQALEHEYFRI 340 (477)
Q Consensus 328 t~~e~L~h~~f~~ 340 (477)
|++++|+||||+.
T Consensus 289 s~~e~l~hp~~~~ 301 (316)
T 2ac3_A 289 SAAQVLQHPWVQG 301 (316)
T ss_dssp CHHHHHHSTTCC-
T ss_pred CHHHHhcChhhcC
Confidence 9999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=355.36 Aligned_cols=266 Identities=27% Similarity=0.466 Sum_probs=212.7
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
+...++|++++.||+|+||.||+|+++. +++.||+|++............+.+|+.+++.++||||+++++++.+..
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 78 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred CCchhheeeehhccCCCCcEEEEEEECC---CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence 3457899999999999999999998764 6889999999876554444567788999999999999999999987666
Q ss_pred CceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC-----eecCCCCCCcEEEeccCCCcc
Q 011808 102 DMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW-----IIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 102 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g-----ivHrDikp~NILl~~~~~~~~ 175 (477)
...+|+||||+++ +|.+++..... ....+++..++.++.||+.||.|||++| |+||||||+|||+ +.++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~----~~~~ 153 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL----DGKQ 153 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE----CSSS
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE----cCCC
Confidence 6689999999985 99999876542 2345899999999999999999999999 9999999999999 6777
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccH
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~ 255 (477)
.+||+|||++......... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+. .
T Consensus 154 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~ 222 (279)
T 2w5a_A 154 NVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------K 222 (279)
T ss_dssp CEEECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred CEEEecCchheeecccccc--ccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCH--------H
Confidence 8999999999865432211 1224578999999999875 489999999999999999999999976541 1
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+....+.... . ...+...+..+.+||.+||+.||.+|||+.++|+|
T Consensus 223 ~~~~~i~~~~--~--------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 223 ELAGKIREGK--F--------------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp HHHHHHHHTC--C--------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhcc--c--------------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 2222221110 0 01233456789999999999999999999999999
Q ss_pred ccCCC
Q 011808 336 EYFRI 340 (477)
Q Consensus 336 ~~f~~ 340 (477)
+|+..
T Consensus 269 ~~~~~ 273 (279)
T 2w5a_A 269 PLILE 273 (279)
T ss_dssp TTCCG
T ss_pred hhhhh
Confidence 99974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=387.45 Aligned_cols=265 Identities=27% Similarity=0.350 Sum_probs=212.0
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
-.++|+++++||+|+||.||+|+++. +++.||||++...... ......+.+|+.+++.++||||++++++|.+.
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-- 257 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-- 257 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--
Confidence 35789999999999999999998764 6899999999654321 23345778899999999999999999998764
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|+||||+. ++|.+++..... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl----~~~g~vkL~D 332 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL----DDDGNVRISD 332 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTSCEEECC
T ss_pred CEEEEEEEeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE----eCCCCEEEee
Confidence 47999999998 588888765431 23469999999999999999999999999999999999999 7778899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+++.+..... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+..... ... .+
T Consensus 333 FGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-----~~~---~~ 401 (543)
T 3c4z_A 333 LGLAVELKAGQT--KTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKV-----ENK---EL 401 (543)
T ss_dssp CTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-----CHH---HH
T ss_pred cceeeeccCCCc--ccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccch-----hHH---HH
Confidence 999987654322 12345789999999999874 58999999999999999999999998654211 111 12
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHE 336 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~ 336 (477)
...+.... ..+|...+..+.+||.+||++||.+||+ +++++.||
T Consensus 402 ~~~i~~~~-------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hp 450 (543)
T 3c4z_A 402 KQRVLEQA-------------------------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450 (543)
T ss_dssp HHHHHHCC-------------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred HHHHhhcc-------------------------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCc
Confidence 11111000 0123445788999999999999999996 58999999
Q ss_pred cCCC
Q 011808 337 YFRI 340 (477)
Q Consensus 337 ~f~~ 340 (477)
||+.
T Consensus 451 ff~~ 454 (543)
T 3c4z_A 451 LFRD 454 (543)
T ss_dssp GGTT
T ss_pred cccC
Confidence 9974
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=353.67 Aligned_cols=263 Identities=27% Similarity=0.426 Sum_probs=208.9
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++++|++++.||+|+||.||+|+++. ++..||||++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 77 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG-- 77 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--
T ss_pred ceecceEEEEEeecCCCcEEEEEEECC---CCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--
Confidence 367899999999999999999998754 688999999875443 23346778899999999999999999998764
Q ss_pred ceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
...|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl~d 148 (276)
T 2yex_A 78 NIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL----DERDNLKISD 148 (276)
T ss_dssp TEEEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEECC
T ss_pred CEEEEEEEecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE----ccCCCEEEee
Confidence 478999999985 88776643 2368999999999999999999999999999999999999 6677899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||++..+.............||+.|+|||++.+...++.++|||||||++|+|++|..||...... ...+..+
T Consensus 149 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~ 221 (276)
T 2yex_A 149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-------CQEYSDW 221 (276)
T ss_dssp CTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT-------SHHHHHH
T ss_pred CCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHHh
Confidence 999986643322222344667999999999987554578999999999999999999999765421 1111111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.. .... .+ .....+..+.+||.+||+.||.+|||++++++|+||+.
T Consensus 222 ~~---~~~~--------~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (276)
T 2yex_A 222 KE---KKTY--------LN----------------------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (276)
T ss_dssp HT---TCTT--------ST----------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred hh---cccc--------cC----------------------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence 11 0000 00 01123578999999999999999999999999999974
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=353.66 Aligned_cols=262 Identities=27% Similarity=0.447 Sum_probs=207.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC----CcHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG----VSPTAIREIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
.++|++++.||+|+||.||+|+++. ++..||||+++....... ....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 80 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC---CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence 4689999999999999999998764 688999999876543322 346778999999999999999999999764
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++..++.....+||
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl 153 (283)
T 3bhy_A 81 --TDVVLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 153 (283)
T ss_dssp --SEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred --CeEEEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEE
Confidence 47899999996 6898888753 368999999999999999999999999999999999999655444558999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+... .+.+.
T Consensus 154 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~ 221 (283)
T 3bhy_A 154 IDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETK--------QETLT 221 (283)
T ss_dssp CCCTTCEECC-----------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH
T ss_pred EecccceeccCCCc---ccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHHHH
Confidence 99999987654322 2234679999999999774 489999999999999999999999976542 22222
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+..... . .........+..+.+||.+||..||.+|||+.++|+||||+
T Consensus 222 ~~~~~~~----~---------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 270 (283)
T 3bhy_A 222 NISAVNY----D---------------------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270 (283)
T ss_dssp HHHTTCC----C---------------------------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHH
T ss_pred HhHhccc----C---------------------------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHH
Confidence 2211100 0 00011233467899999999999999999999999999996
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=354.59 Aligned_cols=256 Identities=27% Similarity=0.473 Sum_probs=205.6
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
-+++|++.+.||+|+||.||+|+++. ++..||||++...... ......+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-- 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred ecccEEEeeEEecCCCeEEEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--
Confidence 37899999999999999999998764 6889999998653221 22345677899999999999999999999764
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+++||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili----~~~~~~~l~D 152 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL----GSAGELKIAD 152 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE----CTTSCEEECS
T ss_pred CEEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE----cCCCCEEEEe
Confidence 47899999998 5888888764 368999999999999999999999999999999999999 6777899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+. .+....+
T Consensus 153 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~ 219 (279)
T 3fdn_A 153 FGWSVHAPSSR----RTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRI 219 (279)
T ss_dssp CCEESCC------------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH
T ss_pred ccccccCCccc----ccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcH--------HHHHHHH
Confidence 99986543321 2335679999999999874 488999999999999999999999976542 2222222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
... . ...+...+..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 220 ~~~-~----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 220 SRV-E----------------------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HHT-C----------------------------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HhC-C----------------------------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 211 0 11233446789999999999999999999999999999743
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=370.77 Aligned_cols=259 Identities=26% Similarity=0.380 Sum_probs=202.3
Q ss_pred cceeE--EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 26 QQYNL--IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 26 ~~Y~i--~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..|.+ .+.||+|+||.||+|+++. ++..||||+++.... .....+.+|+.++++++||||+++++++.+. .
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETA---TGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESK--N 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETT---TCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--S
T ss_pred cceeeecceEEecCcCEEEEEEEEcC---CCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--C
Confidence 44555 6789999999999998654 688999999976432 2345678899999999999999999999764 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+||
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~~~kl~DF 233 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDES----YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN--RDAKQIKIIDF 233 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE--TTTTEEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec--CCCCcEEEEeC
Confidence 7899999997 58888876542 35899999999999999999999999999999999999953 23467999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+++.+..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+ ..+.+..+.
T Consensus 234 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~ 301 (373)
T 2x4f_A 234 GLARRYKPREK---LKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDN--------DAETLNNIL 301 (373)
T ss_dssp SSCEECCTTCB---CCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH
T ss_pred CCceecCCccc---cccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence 99987654332 2335689999999999764 48999999999999999999999998765 334444444
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
........+ .....++++.+||.+||++||.+|||+.++|+||||+.
T Consensus 302 ~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 302 ACRWDLEDE-------------------------------EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HTCCCSCSG-------------------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred hccCCCChh-------------------------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 322111111 11234678999999999999999999999999999973
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=396.33 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=211.1
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
-+++|+++++||+|+||.||+|+++. +++.||||+++.... .......+..|..++..+ +||||++++++|.+.
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~- 414 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM- 414 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESS---SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS-
T ss_pred cccceEEEEEEccCCCEEEEEEEECC---CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC-
Confidence 36789999999999999999998764 688999999875421 233456778899999988 799999999998654
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+||||||+. ++|.+++... ..+++..++.|+.||+.||.|||++|||||||||+|||| +.++++||+
T Consensus 415 -~~~~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl----~~~g~ikL~ 484 (674)
T 3pfq_A 415 -DRLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML----DSEGHIKIA 484 (674)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE----CSSSCEEEC
T ss_pred -CEEEEEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE----cCCCcEEEe
Confidence 47999999998 5888888764 369999999999999999999999999999999999999 777889999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+. .+.+..
T Consensus 485 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~ 553 (674)
T 3pfq_A 485 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQS 553 (674)
T ss_dssp CCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred ecceeeccccCCc--ccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHH
Confidence 9999986433222 23457889999999999874 589999999999999999999999987552 222332
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH-----HHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA-----AQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~-----~e~L~h 335 (477)
|.. .. ..+|...+.++.+||++||++||.+|+++ +++++|
T Consensus 554 i~~----~~-------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 554 IME----HN-------------------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHS----SC-------------------------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHh----CC-------------------------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 221 10 11344567889999999999999999997 999999
Q ss_pred ccCCC
Q 011808 336 EYFRI 340 (477)
Q Consensus 336 ~~f~~ 340 (477)
|||+.
T Consensus 599 ~ff~~ 603 (674)
T 3pfq_A 599 AFFRY 603 (674)
T ss_dssp GGGSS
T ss_pred ccccC
Confidence 99973
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=365.09 Aligned_cols=293 Identities=35% Similarity=0.562 Sum_probs=211.1
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC-
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH- 100 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 100 (477)
..+.++|++++.||+|+||.||+|+++. +++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETT---TTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECC---CCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 4567899999999999999999998753 68899999986542 23345678899999999999999999987432
Q ss_pred -----------CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEec
Q 011808 101 -----------ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMG 169 (477)
Q Consensus 101 -----------~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~ 169 (477)
....+|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~- 154 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN- 154 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE-
T ss_pred cccccccccccccCceeEEeeccCCCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc-
Confidence 2357899999999999988853 3689999999999999999999999999999999999993
Q ss_pred cCCCcccEEEeecccceeecCCCC-cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc
Q 011808 170 EGEEQGVVKIADFGLARIYQAPLK-FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248 (477)
Q Consensus 170 ~~~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~ 248 (477)
..++.+||+|||+++....... ........+|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+
T Consensus 155 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--- 229 (320)
T 2i6l_A 155 --TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH--- 229 (320)
T ss_dssp --TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred --CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC---
Confidence 2456899999999986643211 1112234568999999999876668999999999999999999999998765
Q ss_pred CCCcccHHHHHHHHHHhCCCCCCCccccCC-CccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC
Q 011808 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLAN-LPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI 327 (477)
Q Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp 327 (477)
..+.+..+...+.....+.+..+.. ++.+.... ......-........+..+.+||.+||+.||.+||
T Consensus 230 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 298 (320)
T 2i6l_A 230 -----ELEQMQLILESIPVVHEEDRQELLSVIPVYIRND------MTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298 (320)
T ss_dssp -----HHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHH------TTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSC
T ss_pred -----HHHHHHHHHHhcCCCchhhhhhhhhcCccccccc------ccCCCCChhHhcchhhHHHHHHHHHHcCCCccccC
Confidence 3344444544432221111111000 00000000 00000000112345678899999999999999999
Q ss_pred CHHHHhcCccCCCCC
Q 011808 328 TAAQALEHEYFRIEP 342 (477)
Q Consensus 328 t~~e~L~h~~f~~~~ 342 (477)
|++++|+||||+...
T Consensus 299 t~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 299 TAEEALSHPYMSIYS 313 (320)
T ss_dssp CHHHHHTSHHHHTTC
T ss_pred CHHHHhCCccccccc
Confidence 999999999997543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=350.83 Aligned_cols=264 Identities=28% Similarity=0.410 Sum_probs=208.6
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-------CCcHHHHHHHHHHHhcC-CCCeeE
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-------GVSPTAIREIMLLREIT-HENVVK 92 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~Ei~il~~l~-hpnIv~ 92 (477)
...+.++|++.+.||+|+||.||+|+++. +++.||||++....... .....+.+|+.+++++. ||||++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ 88 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcC---cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence 45688999999999999999999998754 68899999997654221 11345668999999995 999999
Q ss_pred EEEEEEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC
Q 011808 93 LVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 93 l~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~ 171 (477)
+++++.+. ..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---- 157 (298)
T 1phk_A 89 LKDTYETN--TFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---- 157 (298)
T ss_dssp EEEEEECS--SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----
T ss_pred eeeeeccC--CeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE----
Confidence 99998664 47899999998 6999988763 368999999999999999999999999999999999999
Q ss_pred CCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 011808 172 EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLL-----GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~ 246 (477)
+.++.+||+|||++........ .....+|+.|+|||++. ....++.++|||||||++|+|++|..||...+
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~- 233 (298)
T 1phk_A 158 DDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK- 233 (298)
T ss_dssp CTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred cCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-
Confidence 6677899999999987654322 23356799999999985 23458899999999999999999999997654
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
.......+.......... .....+..+.+||.+||+.||.+|
T Consensus 234 -------~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~dp~~R 275 (298)
T 1phk_A 234 -------QMLMLRMIMSGNYQFGSP-------------------------------EWDDYSDTVKDLVSRFLVVQPQKR 275 (298)
T ss_dssp -------HHHHHHHHHHTCCCCCTT-------------------------------TGGGSCHHHHHHHHHHCCSSGGGS
T ss_pred -------HHHHHHHHhcCCcccCcc-------------------------------cccccCHHHHHHHHHHccCCcccC
Confidence 222222222211111000 011235779999999999999999
Q ss_pred CCHHHHhcCccCCC
Q 011808 327 ITAAQALEHEYFRI 340 (477)
Q Consensus 327 pt~~e~L~h~~f~~ 340 (477)
||++++|+||||+.
T Consensus 276 ps~~~ll~h~~~~~ 289 (298)
T 1phk_A 276 YTAEEALAHPFFQQ 289 (298)
T ss_dssp CCHHHHTTSGGGCT
T ss_pred CCHHHHHhChHhhh
Confidence 99999999999973
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=379.59 Aligned_cols=265 Identities=29% Similarity=0.432 Sum_probs=197.7
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC------CCCcHHHHHHHHHHHhcCCCCeeEEEEE
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG------DGVSPTAIREIMLLREITHENVVKLVNV 96 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 96 (477)
.+.++|.+.+.||+|+||.||+|+++. ++..||||++...... ......+.+|+.+|++++||||++++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 208 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECC---CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 346889999999999999999998764 6889999998764321 1112246789999999999999999999
Q ss_pred EEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 97 HINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 97 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
+... .+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..+ +...
T Consensus 209 ~~~~---~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~-~~~~ 279 (419)
T 3i6u_A 209 FDAE---DYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ-EEDC 279 (419)
T ss_dssp EESS---EEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS-SSSC
T ss_pred EecC---ceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecC-CCcc
Confidence 7543 4799999997 577776643 3479999999999999999999999999999999999999543 2345
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
.+||+|||+++...... .....+||+.|+|||++.+ ...|+.++|||||||++|+|++|.+||.......
T Consensus 280 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----- 351 (419)
T 3i6u_A 280 LIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----- 351 (419)
T ss_dssp CEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-----
T ss_pred eEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-----
Confidence 69999999998765422 2234678999999999864 3457889999999999999999999997644211
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
.+....... .... ........+..+.+||.+||+.||.+|||++++|
T Consensus 352 ---~~~~~i~~~---~~~~---------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 398 (419)
T 3i6u_A 352 ---SLKDQITSG---KYNF---------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398 (419)
T ss_dssp ---CHHHHHHTT---CCCC---------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ---HHHHHHhcC---CCCC---------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 111111100 0000 0001123467899999999999999999999999
Q ss_pred cCccCCC
Q 011808 334 EHEYFRI 340 (477)
Q Consensus 334 ~h~~f~~ 340 (477)
+||||+.
T Consensus 399 ~hp~~~~ 405 (419)
T 3i6u_A 399 RHPWLQD 405 (419)
T ss_dssp HSGGGCC
T ss_pred CCcccCC
Confidence 9999973
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=366.25 Aligned_cols=301 Identities=28% Similarity=0.397 Sum_probs=217.5
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-----------CCCee
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-----------HENVV 91 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv 91 (477)
...++|++++.||+|+||.||+|+++. ++..||||++.... .....+.+|+.+++++. |+||+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecC---CCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 346799999999999999999998754 68899999997432 12346678999998886 89999
Q ss_pred EEEEEEEcC--CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEe
Q 011808 92 KLVNVHINH--ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVM 168 (477)
Q Consensus 92 ~l~~~~~~~--~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~ 168 (477)
++++++... ....++++||+++++|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||+.
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred HHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence 999998753 334789999999999999998754 34699999999999999999999998 999999999999996
Q ss_pred ccC--CCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 011808 169 GEG--EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246 (477)
Q Consensus 169 ~~~--~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~ 246 (477)
.++ +..+.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 544 44568999999999876532 23356799999999998854 89999999999999999999999986653
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCcccccccccccc-ccccCCCC------ccccCCCCCchHHHHHHHhc
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQG-RKYETNGL------HSVVPLSPKSPAYDLLSKML 319 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~------~~~~p~~~s~~~~dli~~~L 319 (477)
.... ...+.+..+...++..+...+........+......... .......+ ...++...+..+.+||.+||
T Consensus 241 ~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 241 HSYT--KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccC--ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 3222 245667777777776543211110000000000000000 00000000 00122233567889999999
Q ss_pred ccCCCCCCCHHHHhcCccCCC
Q 011808 320 EYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 320 ~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+.||.+|||++|+|+||||+.
T Consensus 319 ~~dP~~Rpt~~ell~hp~f~~ 339 (373)
T 1q8y_A 319 QLDPRKRADAGGLVNHPWLKD 339 (373)
T ss_dssp CSSTTTCBCHHHHHTCGGGTT
T ss_pred ccCccccCCHHHHhhChhhhc
Confidence 999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=364.78 Aligned_cols=260 Identities=30% Similarity=0.486 Sum_probs=207.1
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC------CcHHHHHHHHHHHhc-CCCCeeEEEEE
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG------VSPTAIREIMLLREI-THENVVKLVNV 96 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~Ei~il~~l-~hpnIv~l~~~ 96 (477)
+.++|++.+.||+|+||.||+|+++. +|..||||++........ ....+.+|+.+++++ +||||++++++
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRA---TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhcccceEEecCCCEEEEEEEECC---CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 45789999999999999999998753 588999999876542211 134566899999999 89999999999
Q ss_pred EEcCCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 97 HINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 97 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
+... ..+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++
T Consensus 169 ~~~~--~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~----~~~~ 237 (365)
T 2y7j_A 169 YESS--SFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL----DDNM 237 (365)
T ss_dssp EEBS--SEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTC
T ss_pred EeeC--CEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCC
Confidence 8764 478999999985 888888753 368999999999999999999999999999999999999 6778
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCC
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA-----KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQ 250 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~ 250 (477)
.+||+|||++..+..... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+
T Consensus 238 ~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----- 309 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR----- 309 (365)
T ss_dssp CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----
T ss_pred CEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-----
Confidence 899999999987654322 2346789999999998632 347889999999999999999999997644
Q ss_pred CcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHH
Q 011808 251 NPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA 330 (477)
Q Consensus 251 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~ 330 (477)
....+..+......... + .....+..+.+||.+||+.||.+|||++
T Consensus 310 ---~~~~~~~i~~~~~~~~~---------~----------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ 355 (365)
T 2y7j_A 310 ---QILMLRMIMEGQYQFSS---------P----------------------EWDDRSSTVKDLISRLLQVDPEARLTAE 355 (365)
T ss_dssp ---HHHHHHHHHHTCCCCCH---------H----------------------HHSSSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred ---HHHHHHHHHhCCCCCCC---------c----------------------ccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 22222222221100000 0 0122357799999999999999999999
Q ss_pred HHhcCccCC
Q 011808 331 QALEHEYFR 339 (477)
Q Consensus 331 e~L~h~~f~ 339 (477)
++|+||||+
T Consensus 356 ell~hp~f~ 364 (365)
T 2y7j_A 356 QALQHPFFE 364 (365)
T ss_dssp HHHHSGGGC
T ss_pred HHhcCcccC
Confidence 999999996
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=370.25 Aligned_cols=265 Identities=17% Similarity=0.189 Sum_probs=189.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhc--CCCCeeEEE-------
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREI--THENVVKLV------- 94 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l--~hpnIv~l~------- 94 (477)
..+|++.+.||+|+||.||+|+++. ++..||||++....... .....+.+|+.+++.| +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVE---RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECC---CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 3459999999999999999998764 68899999998765422 2233455675444444 699988865
Q ss_pred EEEEcCCC---------------ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHH------HHHHHHHHHHHHHhhhC
Q 011808 95 NVHINHAD---------------MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTV------KSILWQLLNGLNYLHSN 153 (477)
Q Consensus 95 ~~~~~~~~---------------~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~------~~i~~qil~aL~~LH~~ 153 (477)
+++..... ..+|+||||++++|.+++..... .+.+..+ ..++.||+.||.|||++
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~ 213 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSK 213 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence 55543322 45899999999999999987532 2344444 56779999999999999
Q ss_pred CeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHH
Q 011808 154 WIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFA 232 (477)
Q Consensus 154 givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~ 232 (477)
||+||||||+|||+ +.++.+||+|||+++...... ....+|+.|+|||++.+. ..|+.++|||||||++|
T Consensus 214 ~ivHrDikp~NIll----~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ 284 (371)
T 3q60_A 214 GLVHGHFTPDNLFI----MPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY 284 (371)
T ss_dssp TEEETTCSGGGEEE----CTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEE----CCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHH
Confidence 99999999999999 677789999999998654321 124457999999999752 34899999999999999
Q ss_pred HHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHH
Q 011808 233 ELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY 312 (477)
Q Consensus 233 elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~ 312 (477)
+|++|+.||.+....... .+.... ........+.......++..+.
T Consensus 285 elltg~~Pf~~~~~~~~~---------------------~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~ 330 (371)
T 3q60_A 285 RVWCLFLPFGLVTPGIKG---------------------SWKRPS-------------LRVPGTDSLAFGSCTPLPDFVK 330 (371)
T ss_dssp HHHHSSCSTTBCCTTCTT---------------------CCCBCC-------------TTSCCCCSCCCTTSSCCCHHHH
T ss_pred HHHhCCCCCCCcCccccc---------------------chhhhh-------------hhhccccccchhhccCCCHHHH
Confidence 999999999866422110 000000 0000001111122345678999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 313 DLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 313 dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+||.+||+.||++|||++++|+||||+
T Consensus 331 ~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 331 TLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp HHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 999999999999999999999999996
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=351.74 Aligned_cols=259 Identities=22% Similarity=0.334 Sum_probs=207.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH--AD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 102 (477)
...|++.+.||+|+||.||+|.+.. ++..||+|++............+.+|+.+++.++||||+++++++... .+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ceeEEeeeeccCCCCeEEEEeEecC---CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 3568999999999999999998654 688999999987655544556778899999999999999999998653 34
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC--eecCCCCCCcEEEeccCCCcccEEE
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW--IIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..++.+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~---~~~~~~kl 173 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT---GPTGSVKI 173 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES---STTSCEEE
T ss_pred ceEEEEEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE---CCCCCEEE
Confidence 57899999997 5998888764 36899999999999999999999999 99999999999993 25678999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ...
T Consensus 174 ~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~-- 237 (290)
T 1t4h_A 174 GDLGLATLKRASF----AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQN--------AAQ-- 237 (290)
T ss_dssp CCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--------HHH--
T ss_pred eeCCCcccccccc----cccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCc--------HHH--
Confidence 9999997544321 123457999999999875 389999999999999999999999975431 111
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+...+..... ....+...++.+.+||.+||+.||.+|||++++|+||||+
T Consensus 238 -~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~ 287 (290)
T 1t4h_A 238 -IYRRVTSGVK-----------------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp -HHHHHTTTCC-----------------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -HHHHHhccCC-----------------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccc
Confidence 2222211100 0112233457799999999999999999999999999997
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 288 ~ 288 (290)
T 1t4h_A 288 E 288 (290)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=352.10 Aligned_cols=263 Identities=27% Similarity=0.375 Sum_probs=211.6
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
+...++|++.+.||+|+||.||+|+++. ++..+|+|++....... .....+.+|+.+++.++||||+++++++.+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 87 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 87 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECC---CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 3456899999999999999999998754 68899999987654322 2345667899999999999999999998764
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 88 --~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl 156 (294)
T 2rku_A 88 --DFVFVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL----NEDLEVKI 156 (294)
T ss_dssp --SEEEEEEECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEE
T ss_pred --CEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE----cCCCCEEE
Confidence 47899999998 5888877653 368999999999999999999999999999999999999 66778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... .+...
T Consensus 157 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~ 225 (294)
T 2rku_A 157 GDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYL 225 (294)
T ss_dssp CCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH
T ss_pred EeccCceecccCcc--ccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH
Confidence 99999987653222 22335679999999999774 489999999999999999999999976542 11111
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+.. .. ...+...+..+.+||.+||+.||++|||++++++|+||.
T Consensus 226 ~~~~---~~--------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~ 270 (294)
T 2rku_A 226 RIKK---NE--------------------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270 (294)
T ss_dssp HHHT---TC--------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred HHhh---cc--------------------------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence 1111 00 012334567899999999999999999999999999998
Q ss_pred CCCCC
Q 011808 340 IEPLP 344 (477)
Q Consensus 340 ~~~~~ 344 (477)
....+
T Consensus 271 ~~~~~ 275 (294)
T 2rku_A 271 SGYIP 275 (294)
T ss_dssp TSCCC
T ss_pred cCCcC
Confidence 55443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=351.99 Aligned_cols=259 Identities=25% Similarity=0.437 Sum_probs=189.1
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
..+++|++.+.||+|+||.||+|++.. ++..||||++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 83 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS- 83 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-
T ss_pred cccccceeeeeecCCCceEEEEEEEcc---CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-
Confidence 347899999999999999999998653 688999999865432 123346778899999999999999999998764
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 84 -~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili----~~~~~~kl~ 154 (278)
T 3cok_A 84 -NYVYLVLEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL----TRNMNIKIA 154 (278)
T ss_dssp -SEEEEEEECCTTEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE----CTTCCEEEC
T ss_pred -CeEEEEEecCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCCEEEE
Confidence 47899999997 5888887653 2468999999999999999999999999999999999999 667789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ +.
T Consensus 155 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~- 222 (278)
T 3cok_A 155 DFGLATQLKMPHE--KHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------LN- 222 (278)
T ss_dssp CCTTCEECC-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------
T ss_pred eecceeeccCCCC--cceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------HH-
Confidence 9999987653221 12235679999999999774 488999999999999999999999976542211 00
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.+.. .....+...+.++.+||.+||+.||.+|||++++|+||||..
T Consensus 223 ---~~~~-------------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 223 ---KVVL-------------------------------ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp ----CCS-------------------------------SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred ---HHhh-------------------------------cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 0000 001123445678999999999999999999999999999974
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=361.10 Aligned_cols=295 Identities=26% Similarity=0.454 Sum_probs=214.8
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCC------CeeEEEE
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE------NVVKLVN 95 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv~l~~ 95 (477)
..+.++|++++.||+|+||.||+|.+.. .++..||||+++... .....+.+|+.+++.++|+ +|+++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecC--CCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 3456899999999999999999998632 368899999996432 2335677899999988665 4999999
Q ss_pred EEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCC--
Q 011808 96 VHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE-- 173 (477)
Q Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~-- 173 (477)
++.+.. .+|+||||++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+..++..
T Consensus 85 ~~~~~~--~~~lv~e~~~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 85 WFEHHG--HICIVFELLGLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp EEEETT--EEEEEEECCCCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred ccccCC--cEEEEEcCCCCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 987654 889999999999999997753 2368999999999999999999999999999999999999532211
Q ss_pred -------------cccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 011808 174 -------------QGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL 240 (477)
Q Consensus 174 -------------~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~P 240 (477)
++.+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCC
Confidence 567999999999865432 2345679999999999874 489999999999999999999999
Q ss_pred CCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCC-------ccccccccccccccccCCCCcc--ccCCCCCchH
Q 011808 241 FQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANL-------PHWQSDSLHIQGRKYETNGLHS--VVPLSPKSPA 311 (477)
Q Consensus 241 F~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~--~~p~~~s~~~ 311 (477)
|...+ ..+.+..+...++..+...+...... ..|................+.. ..+...++.+
T Consensus 234 f~~~~--------~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 305 (339)
T 1z57_A 234 FPTHD--------SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305 (339)
T ss_dssp CCCSC--------HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHH
T ss_pred CCCCC--------hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHH
Confidence 98765 34445555555554332211111000 0111000000000000000000 1112234568
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 312 YDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 312 ~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.+||.+||+.||.+|||++|+|+||||+.
T Consensus 306 ~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 306 FDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred HHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 89999999999999999999999999973
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=350.77 Aligned_cols=257 Identities=27% Similarity=0.482 Sum_probs=209.4
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
.-.+++|++.+.||+|+||.||+|++.. ++..||||++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 86 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR 86 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcC---CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence 3447899999999999999999998653 688999999865322 122345778899999999999999999998764
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 87 --~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl 155 (284)
T 2vgo_A 87 --KRIYLMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM----GYKGELKI 155 (284)
T ss_dssp --SEEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE----CTTCCEEE
T ss_pred --CEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE----cCCCCEEE
Confidence 47899999997 5999888764 368999999999999999999999999999999999999 66778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||++...... ......|++.|+|||++.+. .++.++|||||||++|+|++|..||..... .+...
T Consensus 156 ~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~ 222 (284)
T 2vgo_A 156 ADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------TETHR 222 (284)
T ss_dssp CCCTTCEECSSS----CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH
T ss_pred ecccccccCccc----ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCH--------hHHHH
Confidence 999999765432 12345679999999999874 489999999999999999999999976541 22222
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+... . ..++...+..+.+||.+||+.||.+|||++++++||||+
T Consensus 223 ~~~~~----~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~ 267 (284)
T 2vgo_A 223 RIVNV----D-------------------------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267 (284)
T ss_dssp HHHTT----C-------------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred HHhcc----c-------------------------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence 22110 0 012334567899999999999999999999999999997
Q ss_pred C
Q 011808 340 I 340 (477)
Q Consensus 340 ~ 340 (477)
.
T Consensus 268 ~ 268 (284)
T 2vgo_A 268 A 268 (284)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=376.30 Aligned_cols=255 Identities=16% Similarity=0.176 Sum_probs=195.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHH---HHHhcCCCCeeEEE------
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIM---LLREITHENVVKLV------ 94 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~---il~~l~hpnIv~l~------ 94 (477)
.++|++.+.||+|+||.||+|+++. ++..||||++..... .......+.+|+. +++.++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CceEEEcceeecCCCEEEEEEEECC---CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 4789999999999999999998653 688999999976533 2334567778994 55556899999998
Q ss_pred -EEEEcCCC---------------ceEEEEEeccCCCHHHHHHhhhcccC--CCCCHHHHHHHHHHHHHHHHHhhhCCee
Q 011808 95 -NVHINHAD---------------MSLYLAFDYAEYDLYEIIRHHRDKVN--HTMNPYTVKSILWQLLNGLNYLHSNWII 156 (477)
Q Consensus 95 -~~~~~~~~---------------~~~~lv~e~~~~~L~~~l~~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~giv 156 (477)
+++.+... ...|+||||++|+|.+++........ ..+++..++.++.||+.||.|||++||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 77655421 13799999999999999987531100 1233478888999999999999999999
Q ss_pred cCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCC----------CCCCchhhHHH
Q 011808 157 HRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA----------KHYTSAVDMWA 226 (477)
Q Consensus 157 HrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----------~~~~~~~DiwS 226 (477)
||||||+|||+ +.++.+||+|||+++.... .....+| +.|+|||++.+. ..|+.++||||
T Consensus 229 HrDikp~NIll----~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 229 HTYLRPVDIVL----DQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp CSCCCGGGEEE----CTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred cCCCCHHHEEE----cCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 99999999999 6677899999999986432 1223566 999999999875 25899999999
Q ss_pred HHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCC
Q 011808 227 VGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLS 306 (477)
Q Consensus 227 lGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 306 (477)
|||++|||++|+.||.+........ .+ ......
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~~~-----------------------~~------------------------~~~~~~ 331 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGGSE-----------------------WI------------------------FRSCKN 331 (377)
T ss_dssp HHHHHHHHHHSSCCC------CCSG-----------------------GG------------------------GSSCCC
T ss_pred HHHHHHHHHHCCCCCcccccccchh-----------------------hh------------------------hhhccC
Confidence 9999999999999997654211100 00 001134
Q ss_pred CCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 307 PKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 307 ~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+++.+.+||.+||+.||.+|||+.++|+||||+
T Consensus 332 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 364 (377)
T 3byv_A 332 IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence 467899999999999999999999999999996
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=353.65 Aligned_cols=262 Identities=30% Similarity=0.438 Sum_probs=207.6
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
..+.++|++.+.||+|+||.||+|+++. +++.||||+++..... ....+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 78 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRL---TGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYEST- 78 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred cchhccceeeeeccCCCCceEEEEEECC---CCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhcccC-
Confidence 3567899999999999999999998764 6889999999764322 234677899999999999999999998764
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +.++.+||+
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~-~~~~~~kl~ 151 (304)
T 2jam_A 79 -THYYLVMQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP-EENSKIMIT 151 (304)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSS-STTCCEEBC
T ss_pred -CEEEEEEEcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecC-CCCCCEEEc
Confidence 47899999997 5898888764 368999999999999999999999999999999999999533 356679999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ....+..
T Consensus 152 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~ 218 (304)
T 2jam_A 152 DFGLSKMEQNGI----MSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEET--------ESKLFEK 218 (304)
T ss_dssp SCSTTCCCCCBT----THHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHH
T ss_pred cCCcceecCCCc----cccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHH
Confidence 999997543321 1234579999999999874 48999999999999999999999997654 2222333
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+........ .......+..+.+||.+||..||.+|||++++|+||||..
T Consensus 219 i~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 219 IKEGYYEFE-------------------------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp HHHCCCCCC-------------------------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHcCCCCCC-------------------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 322111000 1122344678999999999999999999999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=358.94 Aligned_cols=268 Identities=24% Similarity=0.319 Sum_probs=190.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc-
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM- 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~- 103 (477)
.++|++.+.||+|+||.||+|+++.+......||||+++...........+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 5789999999999999999998765433334899999987655555567788999999999999999999998765422
Q ss_pred ---eEEEEEeccCC-CHHHHHHhhhccc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 104 ---SLYLAFDYAEY-DLYEIIRHHRDKV-NHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 104 ---~~~lv~e~~~~-~L~~~l~~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
..+++|||+.+ +|.+++....... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli----~~~~~~k 177 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML----AEDMTVC 177 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTSCEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE----cCCCCEE
Confidence 24899999985 8888887654221 2258999999999999999999999999999999999999 6677899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~ 257 (477)
|+|||+++...............+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.. +.
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~ 248 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--------EI 248 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChH--------HH
Confidence 9999999876544333333344568899999999874 48999999999999999999 99999875521 22
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-------HH
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-------AA 330 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-------~~ 330 (477)
...+.. .. ....+...+..+.+||.+||+.||.+||| +.
T Consensus 249 ~~~~~~---~~-------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 294 (323)
T 3qup_A 249 YNYLIG---GN-------------------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294 (323)
T ss_dssp HHHHHT---TC-------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhc---CC-------------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 222211 00 01123345678999999999999999999 88
Q ss_pred HHhcCccCC
Q 011808 331 QALEHEYFR 339 (477)
Q Consensus 331 e~L~h~~f~ 339 (477)
+++.|+|+.
T Consensus 295 ~~l~~~~~~ 303 (323)
T 3qup_A 295 NILGHLSVL 303 (323)
T ss_dssp HHHHC----
T ss_pred HHHHHhhhc
Confidence 999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=363.91 Aligned_cols=261 Identities=27% Similarity=0.412 Sum_probs=206.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecc----cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAA----ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHIN 99 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 99 (477)
.++|++.+.||+|+||.||+|++... ..++..||||+++.... ......+.+|+.+++.+ +||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 47899999999999999999987532 23566899999976432 22345678999999999 89999999999865
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhc-----------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRD-----------KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILV 167 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl 167 (477)
. ..+|+||||+. ++|.+++..... .....+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 159 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 159 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred C--CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 4 36899999998 599999987531 112358899999999999999999999999999999999999
Q ss_pred eccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 011808 168 MGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEA 246 (477)
Q Consensus 168 ~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~ 246 (477)
+.++.+||+|||+++.+.............+|+.|+|||++.+. .|+.++|||||||++|||++ |..||.+...
T Consensus 237 ----~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 237 ----TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp ----CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred ----CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 67788999999999876544333333344568899999999874 48999999999999999999 9999986542
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
. +.+..+ . .. .....+..++..+.+||.+||+.||.+|
T Consensus 312 ~--------~~~~~~-~---~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~R 349 (370)
T 2psq_A 312 E--------ELFKLL-K---EG------------------------------HRMDKPANCTNELYMMMRDCWHAVPSQR 349 (370)
T ss_dssp G--------GHHHHH-H---TT------------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred H--------HHHHHH-h---cC------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 1 111111 1 00 0011334556789999999999999999
Q ss_pred CCHHHHhcC
Q 011808 327 ITAAQALEH 335 (477)
Q Consensus 327 pt~~e~L~h 335 (477)
||+.+++++
T Consensus 350 pt~~ell~~ 358 (370)
T 2psq_A 350 PTFKQLVED 358 (370)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=350.90 Aligned_cols=264 Identities=31% Similarity=0.527 Sum_probs=211.4
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
..+.++|++++.||+|+||.||+|+++. +++.||||++............+.+|+.++++++||||+++++++.+.
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 93 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS- 93 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcC---CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-
Confidence 3567899999999999999999998753 688999999977655555667888999999999999999999998764
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ .....+||+
T Consensus 94 -~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~-~~~~~~kL~ 166 (287)
T 2wei_A 94 -SSFYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK-EKDCDIKII 166 (287)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS-STTCCEEEC
T ss_pred -CeEEEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecC-CCcccEEEe
Confidence 47899999997 6888887653 368999999999999999999999999999999999999543 234579999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||++........ .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+. .+.+..
T Consensus 167 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~ 233 (287)
T 2wei_A 167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKR 233 (287)
T ss_dssp STTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred ccCcceeecCCCc---cccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 9999986543321 233457999999999976 389999999999999999999999976542 222222
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+.... .... .+ .....+.++.+||.+||..||.+|||+.++|+||||+.
T Consensus 234 ~~~~~---~~~~------~~----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 234 VETGK---YAFD------LP----------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHCC---CCCC------SG----------------------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHcCC---CCCC------ch----------------------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 22110 0000 00 11234678999999999999999999999999999963
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=355.86 Aligned_cols=264 Identities=25% Similarity=0.451 Sum_probs=203.9
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC--CCCeeEEEEEEEc
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT--HENVVKLVNVHIN 99 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~ 99 (477)
....++|++++.||+|+||.||+|++. ++..||||++............+.+|+.+++.++ |+||+++++++.+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC----CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 334567999999999999999999753 4788999999776554444567788999999997 5999999999876
Q ss_pred CCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 100 HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 100 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
.. .+|++||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+. ++.+||
T Consensus 100 ~~--~~~lv~e~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-----~~~~kL 167 (313)
T 3cek_A 100 DQ--YIYMVMECGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKL 167 (313)
T ss_dssp SS--EEEEEECCCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-----TTEEEE
T ss_pred CC--EEEEEEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-----CCeEEE
Confidence 44 78999998889999999863 3689999999999999999999999999999999999993 267999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccC
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA----------KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST 249 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----------~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~ 249 (477)
+|||++..+.............||+.|+|||++.+. ..++.++|||||||++|+|++|..||.....
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--- 244 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--- 244 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS---
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH---
Confidence 999999876543332233345689999999999752 3588899999999999999999999975431
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
....+...+.... ...++...+..+.+||.+||+.||.+|||+
T Consensus 245 -------~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 287 (313)
T 3cek_A 245 -------QISKLHAIIDPNH------------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287 (313)
T ss_dssp -------HHHHHHHHHCTTS------------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred -------HHHHHHHHHhccc------------------------------ccCCcccchHHHHHHHHHHccCCcccCcCH
Confidence 1122222221111 011233345789999999999999999999
Q ss_pred HHHhcCccCCCC
Q 011808 330 AQALEHEYFRIE 341 (477)
Q Consensus 330 ~e~L~h~~f~~~ 341 (477)
+++|+||||+..
T Consensus 288 ~ell~h~~~~~~ 299 (313)
T 3cek_A 288 PELLAHPYVQIQ 299 (313)
T ss_dssp HHHHTSHHHHCC
T ss_pred HHHhcCccccCC
Confidence 999999999754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=354.09 Aligned_cols=265 Identities=24% Similarity=0.405 Sum_probs=205.2
Q ss_pred CccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 011808 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHI 98 (477)
Q Consensus 20 ~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 98 (477)
+.....++|++++.||+|+||.||+|++.. ++..||||++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECC---CCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 334457899999999999999999998753 688999999875432 346788999999999 8999999999997
Q ss_pred cCC----CceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCC
Q 011808 99 NHA----DMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE 173 (477)
Q Consensus 99 ~~~----~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~ 173 (477)
... ...+|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~----~~ 164 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL----TE 164 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----CT
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE----cC
Confidence 643 4578999999985 9999987653 2468999999999999999999999999999999999999 66
Q ss_pred cccEEEeecccceeecCCCCcccCCCeeeccccccchhhcC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccC
Q 011808 174 QGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLG----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST 249 (477)
Q Consensus 174 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~ 249 (477)
++.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+...
T Consensus 165 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--- 239 (326)
T 2x7f_A 165 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--- 239 (326)
T ss_dssp TCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---
T ss_pred CCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---
Confidence 77899999999986643221 2234567999999999963 24588999999999999999999999975441
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
...+..+ ...+.+. ..+...+..+.+||.+||..||.+|||+
T Consensus 240 -----~~~~~~~---~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~ 281 (326)
T 2x7f_A 240 -----MRALFLI---PRNPAPR------------------------------LKSKKWSKKFQSFIESCLVKNHSQRPAT 281 (326)
T ss_dssp -----HHHHHHH---HHSCCCC------------------------------CSCSCSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred -----HHHHHHh---hcCcccc------------------------------CCccccCHHHHHHHHHHhccChhhCCCH
Confidence 1222211 1111110 1123346789999999999999999999
Q ss_pred HHHhcCccCCC
Q 011808 330 AQALEHEYFRI 340 (477)
Q Consensus 330 ~e~L~h~~f~~ 340 (477)
+++++||||+.
T Consensus 282 ~~ll~hp~~~~ 292 (326)
T 2x7f_A 282 EQLMKHPFIRD 292 (326)
T ss_dssp HHHHTSHHHHC
T ss_pred HHHhhChHHhh
Confidence 99999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=357.38 Aligned_cols=294 Identities=28% Similarity=0.454 Sum_probs=214.5
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCC------eeEEEEE
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN------VVKLVNV 96 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~~ 96 (477)
.+.++|++++.||+|+||.||+|+++.+ .+..||||+++... .....+.+|+.+++.++|++ ++.++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHAR--GKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCC--CceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 3568999999999999999999987542 34789999996432 23346677999999987665 8999998
Q ss_pred EEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC-----
Q 011808 97 HINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG----- 171 (477)
Q Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~----- 171 (477)
+.... .+|+||||+++++++.+.... ...+++..++.++.||+.||.|||++||+||||||+|||+..++
T Consensus 91 ~~~~~--~~~lv~e~~~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 91 FNFHG--HMCIAFELLGKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp EEETT--EEEEEEECCCCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eeeCC--eEEEEEeccCCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence 87644 789999999999999887643 24689999999999999999999999999999999999995432
Q ss_pred ----------CCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 011808 172 ----------EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLF 241 (477)
Q Consensus 172 ----------~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF 241 (477)
+..+.+||+|||+++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCC
Confidence 34678999999999864432 2345679999999999874 4899999999999999999999999
Q ss_pred CCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCc-------cccccccccccccccCCCCcc--ccCCCCCchHH
Q 011808 242 QGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLP-------HWQSDSLHIQGRKYETNGLHS--VVPLSPKSPAY 312 (477)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~--~~p~~~s~~~~ 312 (477)
.+.+ ..+.+..+...++..+...+....... .|................+.. ......+..+.
T Consensus 240 ~~~~--------~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 311 (355)
T 2eu9_A 240 QTHE--------NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 311 (355)
T ss_dssp CCSS--------HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred CCCC--------HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHH
Confidence 8765 344555565655544332111111000 000000000000000000000 01111234688
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 313 DLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 313 dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+||.+||+.||++|||++++|+||||+.
T Consensus 312 ~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 312 DLMRRMLEFDPAQRITLAEALLHPFFAG 339 (355)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcC
Confidence 9999999999999999999999999973
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=353.47 Aligned_cols=258 Identities=23% Similarity=0.401 Sum_probs=197.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||+||+|++ ++..||||++............+.+|+.++++++||||+++++++.+.. .
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP--N 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--C
T ss_pred hhHceeeeEeecCCCeEEEEEEE-----CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--c
Confidence 57999999999999999999974 3778999999766544444557789999999999999999999986644 6
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC--eecCCCCCCcEEEeccCCCcccEEEee
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW--IIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
+++||||+. ++|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll----~~~~~~kL~D 182 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV----DKKYTVKVCD 182 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE----CTTCCEEECC
T ss_pred eEEEEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE----eCCCcEEECC
Confidence 799999997 589888875321 123899999999999999999999999 9999999999999 6777899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. .+....+
T Consensus 183 fg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~~~~~ 251 (309)
T 3p86_A 183 FGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQVVAAV 251 (309)
T ss_dssp CC-------------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHHH
T ss_pred CCCCccccccc--cccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence 99997654322 123346789999999999874 489999999999999999999999976542 1111111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc--CccCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE--HEYFR 339 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~--h~~f~ 339 (477)
.... . ....+...++.+.+||.+||+.||.+|||++++++ +.+++
T Consensus 252 -~~~~-~-------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 252 -GFKC-K-------------------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp -HHSC-C-------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -HhcC-C-------------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1100 0 01134455788999999999999999999999987 45554
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=358.41 Aligned_cols=264 Identities=30% Similarity=0.445 Sum_probs=201.7
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC------CCCcHHHHHHHHHHHhcCCCCeeEEEEE
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG------DGVSPTAIREIMLLREITHENVVKLVNV 96 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 96 (477)
.+.++|++.+.||+|+||.||+|+++. ++..||||++...... ......+.+|+.+++.++||||++++++
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 83 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcC---CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeE
Confidence 456899999999999999999998764 6889999998754321 1223356789999999999999999999
Q ss_pred EEcCCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 97 HINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 97 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
+... .+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..+ ....
T Consensus 84 ~~~~---~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-~~~~ 154 (322)
T 2ycf_A 84 FDAE---DYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ-EEDC 154 (322)
T ss_dssp EESS---SEEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS-SSSC
T ss_pred EcCC---ceEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecC-CCCC
Confidence 8654 37999999974 88887754 3479999999999999999999999999999999999999533 2234
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLL--GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
.+||+|||+++....... .....||+.|+|||++. +...++.++|||||||++|+|++|..||.......
T Consensus 155 ~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----- 226 (322)
T 2ycf_A 155 LIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----- 226 (322)
T ss_dssp CEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-----
T ss_pred eEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-----
Confidence 599999999987643211 12345799999999984 33558999999999999999999999997654211
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
.....+....... ........+..+.+||.+||..||.+|||++++|
T Consensus 227 --~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 227 --SLKDQITSGKYNF-------------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp --CHHHHHHHTCCCC-------------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred --HHHHHHHhCcccc-------------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 1111111100000 0001123467899999999999999999999999
Q ss_pred cCccCC
Q 011808 334 EHEYFR 339 (477)
Q Consensus 334 ~h~~f~ 339 (477)
+||||+
T Consensus 274 ~h~~~~ 279 (322)
T 2ycf_A 274 RHPWLQ 279 (322)
T ss_dssp TSGGGC
T ss_pred hCcCcC
Confidence 999997
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=348.23 Aligned_cols=258 Identities=28% Similarity=0.431 Sum_probs=201.9
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
-..++|++.+.||+|+||.||+|.++. +++.||||++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 83 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQL---TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP- 83 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECC---CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-
Confidence 357899999999999999999998753 688999999865432 223455778899999999999999999998764
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 84 -~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~~l~ 153 (276)
T 2h6d_A 84 -TDFFMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL----DAHMNAKIA 153 (276)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE----CTTSCEEEC
T ss_pred -CeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE----CCCCCEEEe
Confidence 47899999997 5999988764 368999999999999999999999999999999999999 667789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||++........ .....+|+.|+|||++.+....+.++|||||||++|+|++|..||..... ...+..
T Consensus 154 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~ 222 (276)
T 2h6d_A 154 DFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PTLFKK 222 (276)
T ss_dssp CCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred ecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHHHHH
Confidence 9999986644221 22356799999999998755457899999999999999999999975431 111222
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+.... ...+...+..+.+||.+||+.||.+|||++++++||||+.
T Consensus 223 ~~~~~-----------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 223 IRGGV-----------------------------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp HHHCC-----------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhcCc-----------------------------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 21100 0123334678999999999999999999999999999974
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=362.84 Aligned_cols=287 Identities=23% Similarity=0.351 Sum_probs=206.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++++.||+|+||.||+|+++. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+.. .
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 105 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--E 105 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT--E
T ss_pred cccceeeeeecCCCCeEEEEEEECC---CCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC--E
Confidence 5789999999999999999998764 68899999997643 2223456788999999999999999999997644 7
Q ss_pred EEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 105 LYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 105 ~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
+|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~----~~~~~~kl~Df 176 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV----NSRGEIKLCDF 176 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE----CTTCCEEECCC
T ss_pred EEEEEECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE----CCCCCEEEEEC
Confidence 8999999975 998888764 3689999999999999999999996 99999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+. ..+..++
T Consensus 177 g~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~ 242 (360)
T 3eqc_A 177 GVSGQLIDS----MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDA---------KELELMF 242 (360)
T ss_dssp CCCHHHHHH----C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCH---------HHHHHHH
T ss_pred CCCcccccc----cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHh
Confidence 998755322 12335679999999999874 489999999999999999999999976542 1222221
Q ss_pred HHhCCCCCCCccccC-----CCccccccccc----cc-cccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 011808 263 KILGHPTPEKWPTLA-----NLPHWQSDSLH----IQ-GRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~----~~-~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~ 332 (477)
...........+... .+..+...... .. .................+..+.+||.+||+.||++|||++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 322 (360)
T 3eqc_A 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322 (360)
T ss_dssp C------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred cccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHH
Confidence 111000000000000 00000000000 00 000000001111223457789999999999999999999999
Q ss_pred hcCccCCC
Q 011808 333 LEHEYFRI 340 (477)
Q Consensus 333 L~h~~f~~ 340 (477)
|+||||+.
T Consensus 323 l~hp~~~~ 330 (360)
T 3eqc_A 323 MVHAFIKR 330 (360)
T ss_dssp HTSHHHHH
T ss_pred hhChHhhc
Confidence 99999973
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=348.88 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=204.0
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
.+.++|++++.||+|+||.||+|++.. ++..||||++....... .....+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~- 83 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTI---LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED- 83 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETT---TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECC---CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-
Confidence 356889999999999999999998654 68899999986544332 2345677899999999999999999998654
Q ss_pred CceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 84 -~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~----~~~~~~kl~ 153 (294)
T 4eqm_A 84 -DCYYLVMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI----DSNKTLKIF 153 (294)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEEC
T ss_pred -CeEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEE
Confidence 478999999974 898888764 368999999999999999999999999999999999999 677789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||+++....... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. ...
T Consensus 154 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----------~~~ 220 (294)
T 4eqm_A 154 DFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETA-----------VSI 220 (294)
T ss_dssp CCSSSTTC--------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-----------HHH
T ss_pred eCCCccccccccc-cccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----------HHH
Confidence 9999986543221 123345689999999999884 489999999999999999999999986542 111
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
....+....+. .....+...+..+.++|.+||++||.+||+..+.+.+.|...
T Consensus 221 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 221 AIKHIQDSVPN---------------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHHHSSCCCC---------------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred HHHHhhccCCC---------------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 22222111111 011123345678999999999999999997777788887653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=353.21 Aligned_cols=263 Identities=22% Similarity=0.378 Sum_probs=189.3
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
...+++|++++.||+|+||.||+|+++. +++.||||++............+.++..+++.++||||+++++++.+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRK---TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETT---TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhccccccceeeecCCeeEEEEEEec---CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 3347899999999999999999998764 6889999999765433322233334555778889999999999997644
Q ss_pred CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.+|+||||+++.+..++... ...+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+
T Consensus 98 --~~~lv~e~~~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~----~~~~~~kl~ 167 (318)
T 2dyl_A 98 --DVFIAMELMGTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL----DERGQIKLC 167 (318)
T ss_dssp --EEEEEECCCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE----CTTSCEEEC
T ss_pred --cEEEEEeccCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE----CCCCCEEEE
Confidence 78999999976665555432 34689999999999999999999996 99999999999999 677789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLG----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~ 256 (477)
|||++........ .....+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||..... ..+
T Consensus 168 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~ 237 (318)
T 2dyl_A 168 DFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------DFE 237 (318)
T ss_dssp CCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHH
T ss_pred ECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------cHH
Confidence 9999976543221 223567999999999952 34588999999999999999999999975331 122
Q ss_pred HHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 257 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
.+..+... .. ..++ .....+..+.+||.+||+.||.+|||++++++||
T Consensus 238 ~~~~~~~~---~~-~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 238 VLTKVLQE---EP-PLLP----------------------------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp HHHHHHHS---CC-CCCC----------------------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred HHHHHhcc---CC-CCCC----------------------------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 22222221 10 1000 1123467899999999999999999999999999
Q ss_pred cCC
Q 011808 337 YFR 339 (477)
Q Consensus 337 ~f~ 339 (477)
||+
T Consensus 286 ~~~ 288 (318)
T 2dyl_A 286 FIK 288 (318)
T ss_dssp HHH
T ss_pred HHH
Confidence 996
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=359.46 Aligned_cols=263 Identities=24% Similarity=0.388 Sum_probs=207.9
Q ss_pred ccceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
.++|++.+.||+|+||.||+|++.. ...+++.||||+++.... ......+.+|+.+++++ +||||+++++++.+..
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC-HHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 5789999999999999999998754 345678999999975432 22335678999999999 7999999999987643
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhccc-----------------------------------------------------
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKV----------------------------------------------------- 127 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~----------------------------------------------------- 127 (477)
..+++||||+. ++|.+++.......
T Consensus 100 -~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 100 -GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp -SCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred -CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 35799999998 59999987653210
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCC
Q 011808 128 --------NHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199 (477)
Q Consensus 128 --------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 199 (477)
...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+...........
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE----cCCCcEEEEeccceeeecccccchhccc
Confidence 1228899999999999999999999999999999999999 6777899999999987655444444455
Q ss_pred eeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCC
Q 011808 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLAN 278 (477)
Q Consensus 200 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 278 (477)
..||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.... ..+........
T Consensus 255 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~~~~~------------ 313 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCRRLKEGT------------ 313 (359)
T ss_dssp CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--------HHHHHHHHHTC------------
T ss_pred cCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchh--------HHHHHHHHcCC------------
Confidence 6789999999999874 48999999999999999998 99999865421 12222221110
Q ss_pred CccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 279 LPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
....+...++++.+||.+||+.||.+|||+.++++|
T Consensus 314 ---------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 314 ---------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 011233456789999999999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=347.91 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=202.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||+||+|.++. ++..||+|++... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~---~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 81 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE---TGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KR 81 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TE
T ss_pred hhHeeccceecCCCCEEEEEEEECC---CCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--Ce
Confidence 5799999999999999999998764 6889999988542 233455778999999999999999999999765 47
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+++||||+. ++|.+++... ...+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg 153 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV----RENKNVVVADFG 153 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE----CTTSCEEECCCT
T ss_pred eEEEEEecCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE----CCCCCEEEeecc
Confidence 899999997 5888888763 3468999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcc------------cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCC
Q 011808 184 LARIYQAPLKFL------------SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251 (477)
Q Consensus 184 ~a~~~~~~~~~~------------~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~ 251 (477)
+++......... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~ 232 (310)
T 3s95_A 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232 (310)
T ss_dssp TCEECC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS
T ss_pred cceecccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH
Confidence 998764432211 1114568999999999987 458999999999999999999999997654332221
Q ss_pred cccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHH
Q 011808 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ 331 (477)
Q Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e 331 (477)
....... .. ...+..+++.+.+||.+||+.||++|||+.+
T Consensus 233 ~~~~~~~---~~-------------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 272 (310)
T 3s95_A 233 GLNVRGF---LD-------------------------------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVK 272 (310)
T ss_dssp SBCHHHH---HH-------------------------------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhhhhcc---cc-------------------------------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 1111111 00 1124455678999999999999999999999
Q ss_pred Hhc
Q 011808 332 ALE 334 (477)
Q Consensus 332 ~L~ 334 (477)
+++
T Consensus 273 l~~ 275 (310)
T 3s95_A 273 LEH 275 (310)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=365.57 Aligned_cols=268 Identities=20% Similarity=0.359 Sum_probs=208.2
Q ss_pred ccceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++|++++.||+|+||.||+|++.. ...++..||||+++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQSL- 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-
Confidence 5789999999999999999998653 234678999999965332 223446778999999999999999999986643
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDK--VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..|+||||+. ++|.+++...... ....+++.+++.++.||+.||.|||++||+||||||+|||+..++ ....+||
T Consensus 148 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~~~~kL 225 (367)
T 3l9p_A 148 -PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG-PGRVAKI 225 (367)
T ss_dssp -SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS-TTCCEEE
T ss_pred -CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC-CCceEEE
Confidence 5799999996 5999999875421 123589999999999999999999999999999999999994332 3446999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~ 258 (477)
+|||+++.+.............+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+. .+.+
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~ 296 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVL 296 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH
Confidence 999999865433333333445678999999999874 48999999999999999998 9999976542 1112
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..+.. .. ....+..++..+.+||.+||+.||.+|||++++++|.|+
T Consensus 297 ~~i~~----~~------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 297 EFVTS----GG------------------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HHHHT----TC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHc----CC------------------------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11111 00 011233456789999999999999999999999999886
Q ss_pred C
Q 011808 339 R 339 (477)
Q Consensus 339 ~ 339 (477)
.
T Consensus 343 ~ 343 (367)
T 3l9p_A 343 C 343 (367)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=353.20 Aligned_cols=275 Identities=28% Similarity=0.382 Sum_probs=190.4
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
-..++|++.+.||+|+||.||+|++.. ++..||||++...... .....+.+|+.+++.++||||+++++++....
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 86 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD- 86 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC-------CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS-
T ss_pred cchhhhhhhheeccccceEEEEEEECC---CCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-
Confidence 346899999999999999999998653 5789999998764332 23456778999999999999999999997654
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcc---cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDK---VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
.+|+||||+. ++|.+++...... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 87 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~k 161 (303)
T 2vwi_A 87 -ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL----GEDGSVQ 161 (303)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----CTTCCEE
T ss_pred -CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE----cCCCCEE
Confidence 6899999996 6888888753211 13468999999999999999999999999999999999999 6677899
Q ss_pred EeecccceeecCCCCc---ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccH
Q 011808 179 IADFGLARIYQAPLKF---LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~ 255 (477)
|+|||++......... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||......
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------- 233 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-------- 233 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--------
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--------
Confidence 9999999765432111 11233567999999999976445899999999999999999999999765421
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..+. ..+....+. ... ...........+..+.+||.+||+.||.+|||+.++++|
T Consensus 234 ~~~~---~~~~~~~~~-~~~---------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 234 KVLM---LTLQNDPPS-LET---------------------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp GHHH---HHHTSSCCC-TTC--------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hHHH---HHhccCCCc-ccc---------------------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111 111111110 000 000011223456789999999999999999999999999
Q ss_pred ccCCC
Q 011808 336 EYFRI 340 (477)
Q Consensus 336 ~~f~~ 340 (477)
|||+.
T Consensus 289 ~~~~~ 293 (303)
T 2vwi_A 289 KFFQK 293 (303)
T ss_dssp TTC--
T ss_pred hhhhc
Confidence 99974
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=354.30 Aligned_cols=258 Identities=22% Similarity=0.341 Sum_probs=203.6
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..++|++.+.||+|+||.||+|+++.+...+..||||+++.... ......+.+|+.+++.++||||+++++++.+. .
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG--R 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG--G
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--C
Confidence 35789999999999999999999876655677899999975432 22345678899999999999999999998654 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Df 195 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV----DSNLVCKVSDF 195 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEECCC
T ss_pred ccEEEeeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE----CCCCCEEECCC
Confidence 6899999997 5888888654 2469999999999999999999999999999999999999 67788999999
Q ss_pred ccceeecCCCC-cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHH
Q 011808 183 GLARIYQAPLK-FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 183 G~a~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|+++.+..... ........+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+... .+....
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~ 266 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVISS 266 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHH
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHH
Confidence 99987654321 1122234457889999999874 48999999999999999999 9999976542 122222
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+... .....+..++..+.+||.+||..||.+|||+.++++.
T Consensus 267 ~~~~----------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 267 VEEG----------------------------------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHTT----------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcC----------------------------------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2111 0111234556789999999999999999999999865
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=347.98 Aligned_cols=262 Identities=26% Similarity=0.454 Sum_probs=203.1
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
....++|++++.||+|+||.||+|+++. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 89 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETT---TCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred cCCccceeecceeccCCCeEEEEEEEcC---CCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence 3457899999999999999999998764 68899999987543 334567889999999999999999999997643
Q ss_pred CceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.+|+||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 90 --~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~ 159 (302)
T 2j7t_A 90 --KLWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM----TLEGDIRLA 159 (302)
T ss_dssp --CEEEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----CTTSCEEEC
T ss_pred --eEEEEEEeCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE----CCCCCEEEE
Confidence 78999999985 777777653 2468999999999999999999999999999999999999 667789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLL----GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~----~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~ 256 (477)
|||++....... .......||+.|+|||++. ....++.++|||||||++|+|++|..||...+. ..
T Consensus 160 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~ 229 (302)
T 2j7t_A 160 DFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MR 229 (302)
T ss_dssp CCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HH
T ss_pred ECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HH
Confidence 999975432111 1123356799999999984 334588999999999999999999999976542 22
Q ss_pred HHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 257 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
.+..+... ..+. ...+...+..+.+||.+||..||.+|||++++++||
T Consensus 230 ~~~~~~~~---~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 230 VLLKIAKS---DPPT-----------------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp HHHHHHHS---CCCC-----------------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred HHHHHhcc---CCcc-----------------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 22222111 1000 011223457799999999999999999999999999
Q ss_pred cCCC
Q 011808 337 YFRI 340 (477)
Q Consensus 337 ~f~~ 340 (477)
||+.
T Consensus 278 ~~~~ 281 (302)
T 2j7t_A 278 FVSS 281 (302)
T ss_dssp TTTT
T ss_pred HHhh
Confidence 9973
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=346.38 Aligned_cols=258 Identities=29% Similarity=0.492 Sum_probs=202.5
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
...++|++++.||+|+||.||+|.++. ++..||||++.... ....+.+|+.+++.++||||+++++++....
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 97 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT- 97 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETT---TCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred cchhhhhhheeeccCCCeEEEEEEECC---CCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-
Confidence 346789999999999999999998753 68899999997643 3467889999999999999999999997644
Q ss_pred ceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|
T Consensus 98 -~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl~d 168 (314)
T 3com_A 98 -DLWIVMEYCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL----NTEGHAKLAD 168 (314)
T ss_dssp -EEEEEEECCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECC
T ss_pred -EEEEEeecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE----CCCCCEEEee
Confidence 78999999985 888888643 3468999999999999999999999999999999999999 6677899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... .....
T Consensus 169 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~-- 235 (314)
T 3com_A 169 FGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHP--------MRAIF-- 235 (314)
T ss_dssp CTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHH--
T ss_pred cccchhhhhhcc--ccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCh--------HHHHH--
Confidence 999987654322 22345679999999999874 489999999999999999999999975441 11111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.......+. + ..+...+..+.+||.+||..||.+|||+.++|+|+||+.
T Consensus 236 -~~~~~~~~~-~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 236 -MIPTNPPPT-F----------------------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp -HHHHSCCCC-C----------------------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred -HHhcCCCcc-c----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence 111111100 0 012223578999999999999999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=343.98 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=208.7
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
...++|++++.||+|+||.||+|++.. ++..||||++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 93 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT- 93 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECC---CCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 345779999999999999999998653 6889999999765433 34567889999999999999999999997644
Q ss_pred ceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+|+||||+++ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 94 -~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl~D 162 (303)
T 3a7i_A 94 -KLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL----SEHGEVKLAD 162 (303)
T ss_dssp -EEEEEEECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECC
T ss_pred -eEEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE----CCCCCEEEee
Confidence 78999999985 88877753 368999999999999999999999999999999999999 6677899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ......+
T Consensus 163 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~ 231 (303)
T 3a7i_A 163 FGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHP--------MKVLFLI 231 (303)
T ss_dssp CTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHH
T ss_pred cccceecCcccc--ccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHHHHHh
Confidence 999987654321 22345679999999999874 488999999999999999999999975431 1111111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
... .. ...+...+..+.+||.+||+.||.+|||+.++++|+||..
T Consensus 232 ~~~---~~-------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 232 PKN---NP-------------------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp HHS---CC-------------------------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred hcC---CC-------------------------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 110 00 0122344678999999999999999999999999999963
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=345.14 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=193.4
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
....++|++.+.||+|+||.||+|++..+...+..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-- 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--
Confidence 345789999999999999999999987655567789999987543 22334567889999999999999999999743
Q ss_pred CceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
..+|+||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~ 158 (281)
T 1mp8_A 88 -NPVWIIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV----SSNDCVKLG 158 (281)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEEC
T ss_pred -CccEEEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE----CCCCCEEEC
Confidence 357899999985 898888754 2368999999999999999999999999999999999999 566789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|||+++........ ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.... +.+.
T Consensus 159 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--------~~~~ 228 (281)
T 1mp8_A 159 DFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIG 228 (281)
T ss_dssp C--------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHH
T ss_pred ccccccccCccccc-ccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--------HHHH
Confidence 99999876543221 12234457899999999764 48999999999999999997 99999865421 2222
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.+... . ....+..++..+.+||.+||..||++|||+.+++++
T Consensus 229 ~i~~~---~-------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 229 RIENG---E-------------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHTT---C-------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcC---C-------------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22110 0 011234456889999999999999999999999865
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=354.62 Aligned_cols=253 Identities=21% Similarity=0.359 Sum_probs=205.7
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC----CCcHHHHHHHHHHHhcC--CCCeeEEEE
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD----GVSPTAIREIMLLREIT--HENVVKLVN 95 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~il~~l~--hpnIv~l~~ 95 (477)
..+.++|++.+.||+|+||.||+|+++. ++..||||++....... .....+.+|+.+++.++ |+||+++++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETT---TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 3567899999999999999999998654 68999999997654332 12234567999999996 599999999
Q ss_pred EEEcCCCceEEEEEeccC--CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCC
Q 011808 96 VHINHADMSLYLAFDYAE--YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE 173 (477)
Q Consensus 96 ~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~ 173 (477)
++.... .++++||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ..
T Consensus 116 ~~~~~~--~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~ 185 (320)
T 3a99_A 116 WFERPD--SFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID---LN 185 (320)
T ss_dssp EEECSS--EEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TT
T ss_pred EEecCC--cEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe---CC
Confidence 997644 7899999987 6899988763 3689999999999999999999999999999999999993 15
Q ss_pred cccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 174 QGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 174 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
++.+||+|||+++...... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.....
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------- 254 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------- 254 (320)
T ss_dssp TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------
Confidence 6789999999998765432 22356799999999998766557899999999999999999999964321
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
+... . ...+...+..+.+||.+||+.||.+|||+++++
T Consensus 255 -------~~~~--~---------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 292 (320)
T 3a99_A 255 -------IIRG--Q---------------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 292 (320)
T ss_dssp -------HHHC--C---------------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -------hhcc--c---------------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1110 0 012234567899999999999999999999999
Q ss_pred cCccCCC
Q 011808 334 EHEYFRI 340 (477)
Q Consensus 334 ~h~~f~~ 340 (477)
+||||+.
T Consensus 293 ~hp~~~~ 299 (320)
T 3a99_A 293 NHPWMQD 299 (320)
T ss_dssp TSGGGSS
T ss_pred cCHhhcC
Confidence 9999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=347.91 Aligned_cols=263 Identities=29% Similarity=0.474 Sum_probs=199.1
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC--
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH-- 100 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 100 (477)
.+.++|++++.||+|+||.||+|++.. ++..||||++.... .....+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNAL---DSRYYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEEEH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred cccccchhhheeccCCcEEEEEEEEcC---CCeEEEEEEEeccH---HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 467899999999999999999998654 68899999996432 2345677899999999999999999988653
Q ss_pred ---------CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc
Q 011808 101 ---------ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 101 ---------~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~ 170 (477)
....+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~--- 149 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI--- 149 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---
Confidence 2457899999997 59999987642 357888999999999999999999999999999999999
Q ss_pred CCCcccEEEeecccceeecCCCC------------cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCC
Q 011808 171 GEEQGVVKIADFGLARIYQAPLK------------FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK 238 (477)
Q Consensus 171 ~~~~~~vkL~DFG~a~~~~~~~~------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~ 238 (477)
+.++.+||+|||++........ ........||+.|+|||++.+...++.++|||||||++|+|++
T Consensus 150 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-- 226 (303)
T 1zy4_A 150 -DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226 (303)
T ss_dssp -CTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--
T ss_pred -cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--
Confidence 6677899999999976542210 1112345679999999999876568999999999999999998
Q ss_pred CCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHh
Q 011808 239 PLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318 (477)
Q Consensus 239 ~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~ 318 (477)
||.... ....+...+...... +....+...+..+.+||.+|
T Consensus 227 -p~~~~~-----------~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~ 267 (303)
T 1zy4_A 227 -PFSTGM-----------ERVNILKKLRSVSIE---------------------------FPPDFDDNKMKVEKKIIRLL 267 (303)
T ss_dssp -CCSSHH-----------HHHHHHHHHHSTTCC---------------------------CCTTCCTTTSHHHHHHHHHH
T ss_pred -ccCCch-----------hHHHHHHhccccccc---------------------------cCccccccchHHHHHHHHHH
Confidence 554221 111111211111000 00112233456789999999
Q ss_pred cccCCCCCCCHHHHhcCccCCC
Q 011808 319 LEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 319 L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
|+.||.+|||+.++++||||+.
T Consensus 268 l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 268 IDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp TCSSGGGSCCHHHHHHSSCSCC
T ss_pred HhcCcccCcCHHHHhCCCCcCC
Confidence 9999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=354.11 Aligned_cols=268 Identities=25% Similarity=0.374 Sum_probs=183.7
Q ss_pred CCccccccceeEEe-eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHH-HHHhcCCCCeeEEEEE
Q 011808 19 GEKPEWLQQYNLIG-KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIM-LLREITHENVVKLVNV 96 (477)
Q Consensus 19 ~~~~~~~~~Y~i~~-~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~ 96 (477)
.+...+.++|.+++ .||+|+||.||+|+++. +++.||||++... ....+|+. .++.+.||||++++++
T Consensus 21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~ 90 (336)
T 3fhr_A 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRR---TGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDV 90 (336)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred CCCccccceeEecceeeeeCCCeEEEEEEECC---CCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHH
Confidence 33445679999966 59999999999998764 6889999998642 23334444 4567799999999999
Q ss_pred EEc--CCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCC
Q 011808 97 HIN--HADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE 173 (477)
Q Consensus 97 ~~~--~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~ 173 (477)
+.. ..+..+|+||||+.+ +|.+++.... ...+++.+++.++.||+.||.|||++||+||||||+|||+..+ +.
T Consensus 91 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~-~~ 166 (336)
T 3fhr_A 91 YENMHHGKRCLLIIMECMEGGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSK-EK 166 (336)
T ss_dssp EEEEETTEEEEEEEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS-ST
T ss_pred HhhccCCCceEEEEEeccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEec-CC
Confidence 865 234568999999985 9999987643 3469999999999999999999999999999999999999543 23
Q ss_pred cccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 174 QGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 174 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
.+.+||+|||+++...... ....++|+.|+|||++.+. .++.++|||||||++|+|++|..||..........
T Consensus 167 ~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-- 239 (336)
T 3fhr_A 167 DAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-- 239 (336)
T ss_dssp TCCEEECCCTTCEEC--------------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred CceEEEeccccceeccccc----cccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--
Confidence 5669999999998654321 2345679999999999764 48899999999999999999999997654321100
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
.....+.... ..+........+..+.+||.+||+.||.+|||++++|
T Consensus 240 --~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 286 (336)
T 3fhr_A 240 --GMKRRIRLGQ-------------------------------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFM 286 (336)
T ss_dssp --------------------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred --hHHHhhhccc-------------------------------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0000000000 0000111234567899999999999999999999999
Q ss_pred cCccCCC
Q 011808 334 EHEYFRI 340 (477)
Q Consensus 334 ~h~~f~~ 340 (477)
+||||+.
T Consensus 287 ~hp~~~~ 293 (336)
T 3fhr_A 287 NHPWINQ 293 (336)
T ss_dssp HSHHHHT
T ss_pred cCccccc
Confidence 9999973
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=353.25 Aligned_cols=265 Identities=20% Similarity=0.332 Sum_probs=187.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHH-HHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIM-LLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++++.||+|+||.||+|.++. ++..||||+++..... .....+.+|+. +++.++||||+++++++.+..
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~-- 94 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP---SGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG-- 94 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT---TTEEEEEEEEECCCCH-HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS--
T ss_pred HHHhhehheeccCCCEEEEEEEEcC---CCCEEEEEEeecccCc-hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC--
Confidence 5899999999999999999998754 6889999999765322 22334555665 677789999999999997653
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC-CeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN-WIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..|+||||+.++|.+++..........+++..+..++.|++.||.|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll----~~~~~~kl~Df 170 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL----DRSGNIKLCDF 170 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE----ETTTEEEECCC
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE----cCCCCEEEccC
Confidence 78999999999998888764443456799999999999999999999999 99999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhc---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLL---GAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|+++....... .....||+.|+|||++. ....++.++|||||||++|+|++|..||.+.... ..
T Consensus 171 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------~~ 237 (327)
T 3aln_A 171 GISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV----------FD 237 (327)
T ss_dssp SSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------
T ss_pred CCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH----------HH
Confidence 99986644321 22346799999999984 2244899999999999999999999999754310 00
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.+...+. . ....+........+..+.+||.+||..||.+|||+.++++||||.
T Consensus 238 ~~~~~~~-~--------------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 290 (327)
T 3aln_A 238 QLTQVVK-G--------------------------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290 (327)
T ss_dssp --CCCCC-S--------------------------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred HHHHHhc-C--------------------------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence 0000000 0 000011112234567899999999999999999999999999996
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=357.18 Aligned_cols=279 Identities=23% Similarity=0.384 Sum_probs=210.0
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCc---------------HHHHHHHHHHHhc
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVS---------------PTAIREIMLLREI 85 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~---------------~~~~~Ei~il~~l 85 (477)
...+.++|++++.||+|+||.||+|++ ++..||||++.......... ..+.+|+.+++.+
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 100 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence 345578999999999999999999986 58999999987543322211 6888999999999
Q ss_pred CCCCeeEEEEEEEcCCCceEEEEEeccCC-CHHHH------HHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeec
Q 011808 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEI------IRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIH 157 (477)
Q Consensus 86 ~hpnIv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~------l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH 157 (477)
+||||+++++++.+. ..+|+||||+.+ +|.++ +... ....+++..++.++.||+.||.|||+ +||+|
T Consensus 101 ~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H 175 (348)
T 2pml_X 101 KNEYCLTCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH 175 (348)
T ss_dssp CCTTBCCCSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred CCCCcceEEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccCCEee
Confidence 999999999999765 478999999986 77766 3321 14579999999999999999999999 99999
Q ss_pred CCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCc-hhhHHHHHHHHHHHHh
Q 011808 158 RDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTS-AVDMWAVGCIFAELLT 236 (477)
Q Consensus 158 rDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-~~DiwSlGvil~ellt 236 (477)
|||||+|||+ +.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++
T Consensus 176 ~dl~p~Nil~----~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 247 (348)
T 2pml_X 176 RDVKPSNILM----DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247 (348)
T ss_dssp CCCCGGGEEE----CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred cCCChHhEEE----cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999999999 67778999999999876443 2234567999999999987645666 9999999999999999
Q ss_pred CCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHH
Q 011808 237 LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLS 316 (477)
Q Consensus 237 G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~ 316 (477)
|..||...... .+ +...+............ .|.. ..............+..+.+||.
T Consensus 248 g~~pf~~~~~~-------~~----~~~~i~~~~~~~~~~~~---~~~~---------~~~~~~~~~~~~~~~~~l~~li~ 304 (348)
T 2pml_X 248 NVVPFSLKISL-------VE----LFNNIRTKNIEYPLDRN---HFLY---------PLTNKKSTCSNNFLSNEDIDFLK 304 (348)
T ss_dssp SSCSSCCSSCS-------HH----HHHHHTSCCCCCCCSSS---SSTT---------TTCC--------CCCHHHHHHHH
T ss_pred CCCCCCCCCcH-------HH----HHHHHhccCcCCccchh---hhhc---------cccccccccchhhcCHHHHHHHH
Confidence 99999865421 12 22222221111000000 0000 00000011123456788999999
Q ss_pred HhcccCCCCCCCHHHHhcCccCCC
Q 011808 317 KMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 317 ~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+||+.||.+|||++++|+||||+.
T Consensus 305 ~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 305 LFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHccCChhhCCCHHHHhcCccccC
Confidence 999999999999999999999974
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=353.84 Aligned_cols=267 Identities=25% Similarity=0.346 Sum_probs=201.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--C
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA--D 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~ 102 (477)
.++|+++++||+|+||.||+|++. +..||||++.... .......+|+.+++.++||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-----NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-----TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred hhhchhhheecccCceEEEEEEEC-----CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 578999999999999999999753 6899999996542 12234556899999999999999999997654 4
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC----------CeecCCCCCCcEEEeccC
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN----------WIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~----------givHrDikp~NILl~~~~ 171 (477)
..+|+||||+. ++|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---- 164 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---- 164 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE----
T ss_pred ceEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE----
Confidence 46899999997 4999988653 589999999999999999999999 99999999999999
Q ss_pred CCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 011808 172 EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA----KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~elltG~~PF~~~~~~ 247 (477)
+.++.+||+|||+++.+............+||+.|+|||++.+. ..++.++|||||||++|||+||+.||.+....
T Consensus 165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 67778999999999887654444344456789999999999863 23556889999999999999999999875532
Q ss_pred cCCCcccHH-----HHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCcc-ccCCCCCchHHHHHHHhccc
Q 011808 248 STQNPFQLD-----QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHS-VVPLSPKSPAYDLLSKMLEY 321 (477)
Q Consensus 248 ~~~~~~~~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~p~~~s~~~~dli~~~L~~ 321 (477)
.. .++... ....+...+...... ..+.. ......+..+.+||.+||+.
T Consensus 245 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (322)
T 3soc_A 245 YM-LPFEEEIGQHPSLEDMQEVVVHKKKR-------------------------PVLRDYWQKHAGMAMLCETIEECWDH 298 (322)
T ss_dssp CC-CTTHHHHCSSCCHHHHHHHHTTSCCC-------------------------CCCCGGGGSSHHHHHHHHHHHHHTCS
T ss_pred hc-cchhhhhccCCchhhhhhhhhcccCC-------------------------CCccccccccchHHHHHHHHHHHccC
Confidence 21 111110 111111111110000 00000 00111224588999999999
Q ss_pred CCCCCCCHHHHhcC
Q 011808 322 DPRKRITAAQALEH 335 (477)
Q Consensus 322 dP~~Rpt~~e~L~h 335 (477)
||++|||+.++++.
T Consensus 299 dP~~Rps~~ell~~ 312 (322)
T 3soc_A 299 DAEARLSAGCVGER 312 (322)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=347.31 Aligned_cols=264 Identities=21% Similarity=0.286 Sum_probs=198.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc-
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM- 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~- 103 (477)
.++|++.+.||+|+||.||+|++.....++..||||+++...........+.+|+.+++.++||||+++++++.+....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4689999999999999999998876656677999999987655444456788999999999999999999998765432
Q ss_pred --eEEEEEeccC-CCHHHHHHhhhc-ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 104 --SLYLAFDYAE-YDLYEIIRHHRD-KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 104 --~~~lv~e~~~-~~L~~~l~~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+++|||+. ++|.+++..... .....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli----~~~~~~kl 188 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML----RDDMTVCV 188 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE----CTTSCEEE
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE----cCCCcEEE
Confidence 4699999998 588888865432 223569999999999999999999999999999999999999 66778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~ 258 (477)
+|||++................+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.... ...
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~ 259 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--------EMY 259 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHH--------HHH
Confidence 999999876543322233334568899999999874 58999999999999999999 89999765421 111
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..+... . ....+..++..+.+||.+||..||.+|||+.+++++
T Consensus 260 ~~~~~~---~-------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 260 DYLLHG---H-------------------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHTT---C-------------------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcC---C-------------------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111110 0 011234456789999999999999999999999876
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=340.85 Aligned_cols=262 Identities=28% Similarity=0.435 Sum_probs=201.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|.....||+|+||.||+|++.. ++..||||++.... ......+.+|+.+++.++||||+++++++.... .
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~ 93 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLS---NQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG--F 93 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETT---TCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT--E
T ss_pred ccCCCCcEEEeecCcEEEEEEEECC---CCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC--c
Confidence 3445555599999999999998754 68899999987643 334567889999999999999999999997644 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+++||||+. ++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||+.. .++.+||+|||
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~~kl~Dfg 168 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT---YSGVLKISDFG 168 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTCCEEECCTT
T ss_pred EEEEEEeCCCCCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC---CCCCEEEeecc
Confidence 899999996 688888876432 235678899999999999999999999999999999999932 26789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++........ ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...... .......
T Consensus 169 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~- 238 (295)
T 2clq_A 169 TSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP-------QAAMFKV- 238 (295)
T ss_dssp TCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH-------HHHHHHH-
T ss_pred cccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch-------hHHHHhh-
Confidence 9987643221 12345679999999999653 23788999999999999999999999754311 1111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
..... ....+...+..+.+||.+||+.||++|||++++|.|+||+.
T Consensus 239 ~~~~~--------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 239 GMFKV--------------------------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp HHHCC--------------------------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred ccccc--------------------------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 01100 01123445678999999999999999999999999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=350.48 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=186.0
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEc-----
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHIN----- 99 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~----- 99 (477)
.+|++.++||+|+||.||+|+++. ++..||||++.... ......+.+|+.+++++. ||||+++++++..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVG---SGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECC---CCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 489999999999999999998754 68899999985542 223456778999999995 9999999999852
Q ss_pred -CCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC--eecCCCCCCcEEEeccCCCccc
Q 011808 100 -HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW--IIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 100 -~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDikp~NILl~~~~~~~~~ 176 (477)
.....++++|||++++|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.
T Consensus 103 ~~~~~~~~lv~e~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~----~~~~~ 176 (337)
T 3ll6_A 103 DTGQAEFLLLTELCKGQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL----SNQGT 176 (337)
T ss_dssp TTSSEEEEEEEECCSEEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE----CTTSC
T ss_pred ccCCceEEEEEEecCCCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE----CCCCC
Confidence 33456899999999999999876432 346999999999999999999999999 9999999999999 66778
Q ss_pred EEEeecccceeecCCCCcc----------cCCCeeeccccccchhhc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 011808 177 VKIADFGLARIYQAPLKFL----------SENGVVVTIWYRAPELLL--GAKHYTSAVDMWAVGCIFAELLTLKPLFQGA 244 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~----------~~~~~~gt~~y~APE~l~--~~~~~~~~~DiwSlGvil~elltG~~PF~~~ 244 (477)
+||+|||+++......... ......+|+.|+|||++. ....++.++|||||||++|+|++|+.||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998765422211 111345799999999984 2345888999999999999999999999754
Q ss_pred ccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCC
Q 011808 245 EAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324 (477)
Q Consensus 245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~ 324 (477)
.... +.... .....+...+..+.+||++||+.||.
T Consensus 257 ~~~~------------~~~~~---------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~ 291 (337)
T 3ll6_A 257 AKLR------------IVNGK---------------------------------YSIPPHDTQYTVFHSLIRAMLQVNPE 291 (337)
T ss_dssp ------------------------------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGG
T ss_pred hHHH------------hhcCc---------------------------------ccCCcccccchHHHHHHHHHccCChh
Confidence 3210 00000 00111233356789999999999999
Q ss_pred CCCCHHHHhcCcc
Q 011808 325 KRITAAQALEHEY 337 (477)
Q Consensus 325 ~Rpt~~e~L~h~~ 337 (477)
+|||+.++++|-+
T Consensus 292 ~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 292 ERLSIAEVVHQLQ 304 (337)
T ss_dssp GSCCHHHHHHHHH
T ss_pred hCcCHHHHHHHHH
Confidence 9999999999865
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=356.37 Aligned_cols=261 Identities=28% Similarity=0.440 Sum_probs=207.6
Q ss_pred ccceeEEeeecccCceEEEEEEEeccc----CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAA----NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHIN 99 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 99 (477)
.++|.+.+.||+|+||.||+|++.... ..+..||||+++.... ......+.+|+.+++.+ +||||+++++++.+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC-HHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 478999999999999999999875421 3456899999976432 23345678999999999 99999999999866
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRDK-----------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILV 167 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl 167 (477)
.. .+|+||||+. ++|.+++...... ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 147 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 147 DG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp SS--SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CC--ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 43 6899999997 5999999875421 12358999999999999999999999999999999999999
Q ss_pred eccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 011808 168 MGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEA 246 (477)
Q Consensus 168 ~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~ 246 (477)
+.++.+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus 225 ----~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 225 ----TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp ----CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ----cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 66778999999999876554333334445668999999999874 48999999999999999999 9999976542
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
.. +...+.... ....+..++..+.+||.+||+.||.+|
T Consensus 300 ---------~~---~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R 337 (382)
T 3tt0_A 300 ---------EE---LFKLLKEGH------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQR 337 (382)
T ss_dssp ---------HH---HHHHHHTTC------------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGS
T ss_pred ---------HH---HHHHHHcCC------------------------------CCCCCccCCHHHHHHHHHHcCCChhhC
Confidence 11 222211110 011234456889999999999999999
Q ss_pred CCHHHHhcC
Q 011808 327 ITAAQALEH 335 (477)
Q Consensus 327 pt~~e~L~h 335 (477)
||+.+++++
T Consensus 338 ps~~ell~~ 346 (382)
T 3tt0_A 338 PTFKQLVED 346 (382)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999987
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=348.90 Aligned_cols=257 Identities=21% Similarity=0.222 Sum_probs=200.6
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 102 (477)
+.++|++.+.||+|+||.||+|++.. +++.||||++...... ..+.+|+.+++.+ +||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-- 77 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCG-- 77 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETT---TTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEET--
T ss_pred EcCCeEEEEEeeccCCceEEEEEECC---CCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecC--
Confidence 45789999999999999999998654 6899999998754332 2567899999999 999999999998774
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc-----E
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV-----V 177 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~-----v 177 (477)
...|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++. +
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill----~~~~~~~~~~~ 149 (330)
T 2izr_A 78 KYNAMVLELLGPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI----GRPGNKTQQVI 149 (330)
T ss_dssp TEEEEEEECCCCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CCGGGTCTTSE
T ss_pred CccEEEEEeCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee----ccCCCCCCceE
Confidence 478999999988999998764 2479999999999999999999999999999999999999 44444 9
Q ss_pred EEeecccceeecCCCCcc-----cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCc
Q 011808 178 KIADFGLARIYQAPLKFL-----SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~ 252 (477)
||+|||+++.+....... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.....
T Consensus 150 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~---- 224 (330)
T 2izr_A 150 HIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADT---- 224 (330)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS----
T ss_pred EEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCcccccccc----
Confidence 999999998765432211 12456789999999999874 48999999999999999999999998754221
Q ss_pred ccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 011808 253 FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332 (477)
Q Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~ 332 (477)
..+.+..+.......+. ....... +++.+||.+||..||.+||+++++
T Consensus 225 -~~~~~~~i~~~~~~~~~------------------------------~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l 272 (330)
T 2izr_A 225 -LKERYQKIGDTKRATPI------------------------------EVLCENF-PEMATYLRYVRRLDFFEKPDYDYL 272 (330)
T ss_dssp -HHHHHHHHHHHHHHSCH------------------------------HHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred -HHHHHHHHHhhhccCCH------------------------------HHHhccC-hHHHHHHHHHHhCCCCCCCCHHHH
Confidence 11122222111000000 0001112 278999999999999999999988
Q ss_pred hc
Q 011808 333 LE 334 (477)
Q Consensus 333 L~ 334 (477)
++
T Consensus 273 ~~ 274 (330)
T 2izr_A 273 RK 274 (330)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=349.63 Aligned_cols=264 Identities=23% Similarity=0.389 Sum_probs=206.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecc--cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAA--ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
.++|++.+.||+|+||.||+|++... ..++..||||++.... .......+.+|+.+++++ +||||+++++++....
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 47899999999999999999987432 2356789999997543 233456888999999999 8999999999987643
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhccc------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCC
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKV------------------NHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKP 162 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~------------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp 162 (477)
.+|+||||+. ++|.+++....... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 123 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 123 --PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp --SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred --ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 6899999997 59999997653211 12478999999999999999999999999999999
Q ss_pred CcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 011808 163 SNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLF 241 (477)
Q Consensus 163 ~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF 241 (477)
+|||+ +.++.+||+|||++................+|+.|+|||++.+. .++.++|||||||++|+|+| |..||
T Consensus 201 ~NIll----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 201 RNVLV----THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp GGEEE----ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred hhEEE----cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999 66678999999999876554433344456778999999999774 48999999999999999998 99999
Q ss_pred CCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhccc
Q 011808 242 QGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321 (477)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~ 321 (477)
.+... ...+..+.... .....+...+..+.+||.+||..
T Consensus 276 ~~~~~--------~~~~~~~~~~~---------------------------------~~~~~~~~~~~~l~~li~~~l~~ 314 (344)
T 1rjb_A 276 PGIPV--------DANFYKLIQNG---------------------------------FKMDQPFYATEEIYIIMQSCWAF 314 (344)
T ss_dssp TTCCC--------SHHHHHHHHTT---------------------------------CCCCCCTTCCHHHHHHHHHHTCS
T ss_pred ccCCc--------HHHHHHHHhcC---------------------------------CCCCCCCCCCHHHHHHHHHHcCC
Confidence 76542 11222222110 01112344567899999999999
Q ss_pred CCCCCCCHHHHhcCcc
Q 011808 322 DPRKRITAAQALEHEY 337 (477)
Q Consensus 322 dP~~Rpt~~e~L~h~~ 337 (477)
||.+|||+.++++|-.
T Consensus 315 dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 315 DSRKRPSFPNLTSFLG 330 (344)
T ss_dssp SGGGSCCHHHHHHHHH
T ss_pred CchhCcCHHHHHHHHH
Confidence 9999999999998854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=338.58 Aligned_cols=250 Identities=23% Similarity=0.428 Sum_probs=200.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++++.||+|+||.||+|++. ++..||||++..... ....+.+|+.++++++||||+++++++.+. ..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 79 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--AP 79 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET----TTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SS
T ss_pred hhhceeeheecCCCccEEEEEEec----CCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Cc
Confidence 478999999999999999999865 367799999976443 235788999999999999999999998664 36
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~kl~Dfg 151 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV----GENQVIKVSDFG 151 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CGGGCEEECCTT
T ss_pred eEEEEEeCCCCcHHHHHHhc----CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE----cCCCCEEecccc
Confidence 899999997 5888888654 2368999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++....... ........+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+... .+....+.
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~ 221 (269)
T 4hcu_A 152 MTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDIS 221 (269)
T ss_dssp GGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHH
T ss_pred ccccccccc-cccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHh
Confidence 998654321 11223345578899999998744 8999999999999999999 9999976542 12222221
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.. .....+...+..+.+||.+||+.||.+|||+.++++|
T Consensus 222 ~~----------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 222 TG----------------------------------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TT----------------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC----------------------------------ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 11 0111233446789999999999999999999999976
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=351.17 Aligned_cols=261 Identities=26% Similarity=0.364 Sum_probs=204.0
Q ss_pred ccceeEEeeecccCceEEEEEEEeccc--CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAA--NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++|++++.||+|+||.||+|+++... .++..||||+++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 122 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAVG-- 122 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC--
Confidence 478999999999999999999886421 3468999999975432 22345678899999999999999999998664
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhccc-------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCC
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKV-------------------NHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKP 162 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~-------------------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp 162 (477)
..+|+||||+. ++|.+++....... ...+++.+++.++.||+.||.|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 36899999998 59999987743110 14689999999999999999999999999999999
Q ss_pred CcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 011808 163 SNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLF 241 (477)
Q Consensus 163 ~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF 241 (477)
+|||+ +.++.+||+|||+++...............+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||
T Consensus 203 ~NIl~----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 203 RNCLV----GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp GGEEE----CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ceEEE----CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999 677789999999998664433222333456789999999998744 8999999999999999999 99999
Q ss_pred CCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhccc
Q 011808 242 QGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321 (477)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~ 321 (477)
.+... .+....+.. ... ...+..++..+.+||.+||+.
T Consensus 278 ~~~~~--------~~~~~~~~~----~~~------------------------------~~~~~~~~~~l~~li~~~l~~ 315 (343)
T 1luf_A 278 YGMAH--------EEVIYYVRD----GNI------------------------------LACPENCPLELYNLMRLCWSK 315 (343)
T ss_dssp TTSCH--------HHHHHHHHT----TCC------------------------------CCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCh--------HHHHHHHhC----CCc------------------------------CCCCCCCCHHHHHHHHHHccc
Confidence 76542 111111111 000 012344567899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 011808 322 DPRKRITAAQALEH 335 (477)
Q Consensus 322 dP~~Rpt~~e~L~h 335 (477)
||.+|||+.+++++
T Consensus 316 ~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 316 LPADRPSFCSIHRI 329 (343)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CcccCCCHHHHHHH
Confidence 99999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=346.15 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=206.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecc--cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAA--ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++|++.+.||+|+||.||+|.+... ..++..||||++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG- 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC-
Confidence 57899999999999999999987532 2356889999997543 2233456788999999999999999999986543
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcc-------------------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCC
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDK-------------------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKP 162 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp 162 (477)
.+|+||||+. ++|.+++...... ....+++..++.++.||+.||.|||++||+||||||
T Consensus 100 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 100 -PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp -SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred -ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 6899999998 6999998875321 113488999999999999999999999999999999
Q ss_pred CcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 011808 163 SNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLF 241 (477)
Q Consensus 163 ~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF 241 (477)
+|||+ +.++.+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|+|++ |..||
T Consensus 179 ~NIli----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 179 RNILV----AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp GGEEE----ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred heEEE----cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999 66678999999999877554433334445568899999999874 48999999999999999999 99999
Q ss_pred CCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhccc
Q 011808 242 QGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321 (477)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~ 321 (477)
.+.... .+...... .. ....+..+++.+.+||.+||+.
T Consensus 254 ~~~~~~---------~~~~~~~~---~~------------------------------~~~~~~~~~~~~~~li~~~l~~ 291 (314)
T 2ivs_A 254 PGIPPE---------RLFNLLKT---GH------------------------------RMERPDNCSEEMYRLMLQCWKQ 291 (314)
T ss_dssp TTCCGG---------GHHHHHHT---TC------------------------------CCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCHH---------HHHHHhhc---CC------------------------------cCCCCccCCHHHHHHHHHHccC
Confidence 765421 11111111 00 0112344568899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 011808 322 DPRKRITAAQALEH 335 (477)
Q Consensus 322 dP~~Rpt~~e~L~h 335 (477)
||.+|||+.+++++
T Consensus 292 dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 292 EPDKRPVFADISKD 305 (314)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=343.65 Aligned_cols=262 Identities=25% Similarity=0.390 Sum_probs=207.7
Q ss_pred ccceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
.++|++.+.||+|+||.||+|.+.. ...++..||||+++.... ......+.+|+.+++++ +||||+++++++.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 4789999999999999999998643 234678999999975432 22345678899999999 9999999999986644
Q ss_pred CceEEEEEeccCC-CHHHHHHhhhcc-------------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEE
Q 011808 102 DMSLYLAFDYAEY-DLYEIIRHHRDK-------------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILV 167 (477)
Q Consensus 102 ~~~~~lv~e~~~~-~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl 167 (477)
..++||||+.+ +|.+++...... ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 101 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 101 --PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp --SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 67999999974 999998875421 12258999999999999999999999999999999999999
Q ss_pred eccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 011808 168 MGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEA 246 (477)
Q Consensus 168 ~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~ 246 (477)
+.++.+||+|||++................+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus 179 ----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 179 ----THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp ----ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ----cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 66778999999999876654443334456678999999999774 48999999999999999999 9999976542
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
...+..+..... ....+...+..+.+||.+||+.||.+|
T Consensus 254 --------~~~~~~~~~~~~---------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~R 292 (313)
T 1t46_A 254 --------DSKFYKMIKEGF---------------------------------RMLSPEHAPAEMYDIMKTCWDADPLKR 292 (313)
T ss_dssp --------SHHHHHHHHHTC---------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred --------hhHHHHHhccCC---------------------------------CCCCcccCCHHHHHHHHHHcCCCchhC
Confidence 122222222110 011233446789999999999999999
Q ss_pred CCHHHHhcC
Q 011808 327 ITAAQALEH 335 (477)
Q Consensus 327 pt~~e~L~h 335 (477)
||+.+++++
T Consensus 293 ps~~ell~~ 301 (313)
T 1t46_A 293 PTFKQIVQL 301 (313)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=343.07 Aligned_cols=271 Identities=24% Similarity=0.385 Sum_probs=201.9
Q ss_pred cccceeEEeeecccCceEEEEEEEec-ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKA-AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
..++|++++.||+|+||.||+|++.. +..++..||||++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 35789999999999999999998532 33568899999987532 2234567789999999999999999999876555
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~----~~~~~~kl~D 157 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV----ENENRVKIGD 157 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEECC
T ss_pred CceEEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE----cCCCeEEEcc
Confidence 56899999996 59999987753 258999999999999999999999999999999999999 6667899999
Q ss_pred cccceeecCCCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc----CCCcccHH
Q 011808 182 FGLARIYQAPLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS----TQNPFQLD 256 (477)
Q Consensus 182 FG~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~----~~~~~~~~ 256 (477)
||+++........ .......++..|+|||++.+. .++.++|||||||++|+|+||..||....... ........
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence 9999876543221 112223457889999999874 48999999999999999999999986533110 00000111
Q ss_pred HHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 257 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
....+...+. .......+..+++++.+||.+||+.||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 237 IVFHLIELLK------------------------------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHHHHHHH------------------------------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHh------------------------------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1111111110 011122345667889999999999999999999999853
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=340.31 Aligned_cols=258 Identities=23% Similarity=0.305 Sum_probs=190.7
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..++|++.+.||+|+||.||+|++. ..+|||+++...........+.+|+.+++.++||||++++++... .
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~ 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---P 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---S
T ss_pred CccceeeeeEecCCCCeEEEEEEEc------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC---C
Confidence 3578999999999999999999743 349999998766555455678899999999999999999997533 3
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~----~~~~~~kl~Df 164 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL----HEDNTVKIGDF 164 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----ETTTEEEECCC
T ss_pred ccEEEEEecCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE----CCCCCEEEccc
Confidence 5799999998 6888877543 3468999999999999999999999999999999999999 66678999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|++................||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.. ..+.+..
T Consensus 165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~ 236 (289)
T 3og7_A 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--------NRDQIIE 236 (289)
T ss_dssp C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC--------CHHHHHH
T ss_pred eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc--------hHHHHHH
Confidence 99986553322223334568999999999962 2457889999999999999999999997654 2233333
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+.......+. + ......++..+.+||.+||+.||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~--~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 237 MVGRGSLSPD--L---------------------------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp HHHHTSCCCC--T---------------------------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcccccCcc--h---------------------------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 3222111100 0 01223456789999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=350.08 Aligned_cols=255 Identities=20% Similarity=0.332 Sum_probs=195.6
Q ss_pred CccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC----CCcHHHHHHHHHHHhc----CCCCee
Q 011808 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD----GVSPTAIREIMLLREI----THENVV 91 (477)
Q Consensus 20 ~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~il~~l----~hpnIv 91 (477)
+...+.++|++.+.||+|+||.||+|+++ .++..||||++....... .....+.+|+.+++++ +|+||+
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~ 101 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRL---TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECT---TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEc---cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCee
Confidence 34456789999999999999999999765 368899999997654321 1112334699999998 899999
Q ss_pred EEEEEEEcCCCceEEEEEec-cC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEec
Q 011808 92 KLVNVHINHADMSLYLAFDY-AE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMG 169 (477)
Q Consensus 92 ~l~~~~~~~~~~~~~lv~e~-~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~ 169 (477)
++++++.+.. ..++|||+ +. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 102 ~~~~~~~~~~--~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~- 173 (312)
T 2iwi_A 102 RLLDWFETQE--GFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID- 173 (312)
T ss_dssp CEEEEC-------CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE-
T ss_pred eEEEEEecCC--eEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe-
Confidence 9999986643 67889998 44 7999998763 3689999999999999999999999999999999999993
Q ss_pred cCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccC
Q 011808 170 EGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST 249 (477)
Q Consensus 170 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~ 249 (477)
..++.+||+|||++....... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||....
T Consensus 174 --~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---- 243 (312)
T 2iwi_A 174 --LRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---- 243 (312)
T ss_dssp --TTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred --CCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----
Confidence 156789999999998765432 2335679999999999875544568999999999999999999996432
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
.+.... ..++...+..+.+||.+||+.||++|||+
T Consensus 244 ----------~~~~~~-----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 278 (312)
T 2iwi_A 244 ----------EILEAE-----------------------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSL 278 (312)
T ss_dssp ----------HHHHTC-----------------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred ----------HHhhhc-----------------------------------cCCcccCCHHHHHHHHHHccCChhhCcCH
Confidence 111100 01233456789999999999999999999
Q ss_pred HHHhcCccCCC
Q 011808 330 AQALEHEYFRI 340 (477)
Q Consensus 330 ~e~L~h~~f~~ 340 (477)
+++++|+||+.
T Consensus 279 ~e~l~~~~~~~ 289 (312)
T 2iwi_A 279 EEILLDPWMQT 289 (312)
T ss_dssp HHHHHSTTTCC
T ss_pred HHHhcChhhcC
Confidence 99999999974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=338.37 Aligned_cols=264 Identities=17% Similarity=0.221 Sum_probs=205.9
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
.+.++|++.+.||+|+||.||+|++.. ++..||||++...... ..+.+|+.+++.+ +|+||+++++++.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~- 78 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG- 78 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEET-
T ss_pred ccccceEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCC-
Confidence 356789999999999999999998653 6899999998654332 2567899999999 899999999998654
Q ss_pred CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC-CCcccEEEe
Q 011808 102 DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG-EEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~-~~~~~vkL~ 180 (477)
...|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+..++ .....+||+
T Consensus 79 -~~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 79 -LHNVLVIDLLGPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp -TEEEEEEECCCCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred -ceeEEEEEecCCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 478999999988999999764 23699999999999999999999999999999999999995543 234459999
Q ss_pred ecccceeecCCCCc-----ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccH
Q 011808 181 DFGLARIYQAPLKF-----LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 181 DFG~a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~ 255 (477)
|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..... ..
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~ 227 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NK 227 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-----HH
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccc-----cH
Confidence 99999876543221 123456789999999999874 48999999999999999999999998754221 12
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..+..+.......+. ......++..+.+||.+||+.||.+|||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 228 QKYERIGEKKQSTPL------------------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHHHHHHHSCH------------------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHHHHhhccCccH------------------------------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 222222221100000 00122346789999999999999999999998765
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=346.00 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=196.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCC-CcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANR-GKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++++.||+|+||+||+|++..+... ...||+|.+.... .......+.+|+.++++++||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS--
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 57899999999999999999987643211 2246888886543 2344567889999999999999999999997643
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+++++|+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll----~~~~~~kl~Df 161 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV----KTPQHVKITDF 161 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----EETTEEEECCT
T ss_pred -eEEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE----CCCCCEEEccC
Confidence 677888877 68999887643 468999999999999999999999999999999999999 66678999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|+++.+.............+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.... .+..+
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------~~~~~ 231 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------EISSI 231 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---------GHHHH
T ss_pred cceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---------HHHHH
Confidence 999877654443334445568899999999874 48999999999999999999 99999865421 12222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..... ....+...+..+.+||.+||+.||.+|||+.+++.+
T Consensus 232 ~~~~~---------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 232 LEKGE---------------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHTTC---------------------------------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHcCC---------------------------------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 21110 011233446789999999999999999999999987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=335.76 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=201.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++++.||+|+||.||+|+++ ++..||||+++.... ....+.+|+.+++.++||||+++++++.+. ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 77 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK----GQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE--YP 77 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SS
T ss_pred hhheeeeeeeccCCCceEEEEEec----CceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccC--Cc
Confidence 578999999999999999999764 467799999976443 235688999999999999999999998654 46
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~~l~Dfg 149 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV----DRDLCVKVSDFG 149 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE----CTTCCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE----CCCCCEEEccCc
Confidence 899999997 57888887643 358999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||..... .+....+.
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~ 219 (268)
T 3sxs_A 150 MTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTN--------SEVVLKVS 219 (268)
T ss_dssp CEEECCTTCE-EECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHH
T ss_pred cceecchhhh-hcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccCh--------HHHHHHHH
Confidence 9987654322 2233445578899999998744 8899999999999999999 9999976542 11221111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.. . ....+...++.+.+||.+||+.||.+|||+.+++++
T Consensus 220 ~~---~-------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 220 QG---H-------------------------------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TT---C-------------------------------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cC---C-------------------------------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 0 011233346789999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=339.59 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=198.9
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
-.++|++++.||+|+||.||+|.++ ++..||||+++.... ....+.+|+.+++.++||||+++++++.+. .
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 92 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--R 92 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET----TTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--S
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc----CCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecC--C
Confidence 3679999999999999999999764 467899999976433 235788999999999999999999998654 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili----~~~~~~kl~Df 164 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV----NDQGVVKVSDF 164 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE----CTTSCEEECST
T ss_pred CeEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE----cCCCCEEEccc
Confidence 6899999996 68888887642 369999999999999999999999999999999999999 67778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|+++...... ........+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||...+. .+....+
T Consensus 165 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~ 234 (283)
T 3gen_A 165 GLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHI 234 (283)
T ss_dssp TGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHH
T ss_pred cccccccccc-cccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccCh--------hHHHHHH
Confidence 9998654321 11222344578899999998744 8999999999999999998 9999976542 2222222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.... ....+...++.+.+||.+||+.||.+|||+.++++|
T Consensus 235 ~~~~----------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 235 AQGL----------------------------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HTTC----------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hccc----------------------------------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1111 111233446789999999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.77 Aligned_cols=290 Identities=23% Similarity=0.316 Sum_probs=214.9
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
...++|++.++||+|+||.||+|+++. ++..||||++...... .....+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECC---CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 346789999999999999999998764 6889999999754332 234577899999999999999999999987766
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|+||||+. ++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||+..+.+.++.+||+|
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred CeeEEEEecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence 68899999997 588888865432 234999999999999999999999999999999999999866556677899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCccc
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGA-------KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-------~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~ 254 (477)
||+++....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.......
T Consensus 160 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~------ 230 (396)
T 4eut_A 160 FGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR------ 230 (396)
T ss_dssp GGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT------
T ss_pred CCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc------
Confidence 999987654322 2335679999999998641 347789999999999999999999997544211
Q ss_pred HHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.....+...+...++..+..+....... ...... .......+...+..+.+||++||+.||++|+|++++++
T Consensus 231 -~~~~~~~~~~~~~p~~~~~~~~~~~~~~---~~~~~~----~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 231 -RNKEVMYKIITGKPSGAISGVQKAENGP---IDWSGD----MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp -TCHHHHHHHHHSCCTTCCEEEECSTTCC---EEEESS----CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred -chHHHHHHHhcCCCcccchhheeccCCC---cccCcc----CCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 1223344444444444333322211000 000000 00001112223456789999999999999999999865
Q ss_pred C
Q 011808 335 H 335 (477)
Q Consensus 335 h 335 (477)
+
T Consensus 303 ~ 303 (396)
T 4eut_A 303 E 303 (396)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=336.23 Aligned_cols=252 Identities=19% Similarity=0.259 Sum_probs=202.9
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
-+++|++.+.||+|+||.||+|+++ +..||||+++...........+.+|+.++++++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-----GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-----TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-----CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 3689999999999999999999863 77899999987655544556788999999999999999999999877556
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC--eecCCCCCCcEEEeccCCCcccEEEe
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW--IIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.+++||||+. ++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.++|+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~----~~~~~~~l~ 155 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI----DEDMTARIS 155 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE----CTTSCEEEE
T ss_pred CeEeeecccCCCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE----cCCcceeEE
Confidence 8899999998 59999987643 235899999999999999999999999 9999999999999 667789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKH--YTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~--~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|||++.... .....+|+.|+|||++.+... ++.++|||||||++|+|++|+.||.+.+. .+..
T Consensus 156 ~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~ 220 (271)
T 3kmu_A 156 MADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEIG 220 (271)
T ss_dssp GGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HHHH
T ss_pred eccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HHHH
Confidence 988875422 233567999999999987432 33489999999999999999999976542 1222
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..+... . .....+...+..+.+||.+||+.||.+|||++++++.
T Consensus 221 ~~~~~~---~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 221 MKVALE---G------------------------------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHHS---C------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhc---C------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 221111 0 1111334557889999999999999999999999853
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=356.84 Aligned_cols=253 Identities=24% Similarity=0.401 Sum_probs=200.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||+|+++. ++..||||+++.... ......+.+|+.+++.++||||+++++++.+. ..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRA---DNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEec---CCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC--CC
Confidence 4789999999999999999998764 588999999875422 11223466899999999999999999998654 36
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~----~~~~~~kl~DfG 258 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV----TEKNVLKISDFG 258 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEECCGG
T ss_pred cEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE----cCCCcEEECcCC
Confidence 899999997 69999887643 358999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+++...............+++.|+|||++.+. .++.++|||||||++|||++ |..||.+... ..+....
T Consensus 259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~---------~~~~~~~ 328 (377)
T 3cbl_A 259 MSREEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSN---------QQTREFV 328 (377)
T ss_dssp GCEECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---------HHHHHHH
T ss_pred CceecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHH
Confidence 99865433222222223457889999999864 48999999999999999998 9999976542 1111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
... .....+..++..+.+||.+||+.||++|||++++++
T Consensus 329 ~~~---------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 329 EKG---------------------------------GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HTT---------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcC---------------------------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 110 011133445678999999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=361.98 Aligned_cols=259 Identities=27% Similarity=0.372 Sum_probs=191.6
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 104 (477)
.+|.+.++||+|+||+||... . .+++.||||++..... ..+.+|+.+|+.+ +||||+++++++.+. ..
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~-~---~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~ 92 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRG-M---FDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDR--QF 92 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEE-E---SSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEET--TE
T ss_pred EEEecCCeeecCcCEEEEEEE-E---eCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecC--CE
Confidence 469999999999999976432 2 3588999999865332 2345899999999 799999999998764 47
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC-CCcccEEEeecc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG-EEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~-~~~~~vkL~DFG 183 (477)
+|+||||++++|.+++.... ..+.+..++.++.||+.||.|||++||+||||||+|||+..++ +....+||+|||
T Consensus 93 ~~lv~E~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 93 QYIAIELCAATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred EEEEEECCCCCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 89999999999999997643 2355556789999999999999999999999999999996432 334568999999
Q ss_pred cceeecCCCC-cccCCCeeeccccccchhhcC--CCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHH
Q 011808 184 LARIYQAPLK-FLSENGVVVTIWYRAPELLLG--AKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 184 ~a~~~~~~~~-~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+++.+..... .......+||+.|+|||++.+ ...++.++|||||||++|+|++ |..||..... ....
T Consensus 169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---------~~~~ 239 (432)
T 3p23_A 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---------RQAN 239 (432)
T ss_dssp EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---------HHHH
T ss_pred ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---------HHHH
Confidence 9987653321 122334678999999999974 2447889999999999999999 9999954321 1111
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
..++........ .....+..+.+||.+||+.||.+|||++++|+||||+
T Consensus 240 ---~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~ 288 (432)
T 3p23_A 240 ---ILLGACSLDCLH----------------------------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288 (432)
T ss_dssp ---HHTTCCCCTTSC----------------------------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTC
T ss_pred ---HHhccCCccccC----------------------------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcccc
Confidence 111111111000 0011134578999999999999999999999999996
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=346.05 Aligned_cols=279 Identities=25% Similarity=0.361 Sum_probs=207.6
Q ss_pred CCCCCCCccccccce-eEEeeecccCceEEEEEEEe-cccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCee
Q 011808 14 GTSNHGEKPEWLQQY-NLIGKIGEGTYGLVFLARIK-AAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVV 91 (477)
Q Consensus 14 ~~~~~~~~~~~~~~Y-~i~~~lG~G~~g~Vy~a~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv 91 (477)
.....++...+.++| ++++.||+|+||+||++.++ .+..++..||||+++... .......+.+|+.+++.++||||+
T Consensus 18 ~~~~pg~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv 96 (318)
T 3lxp_A 18 LFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHII 96 (318)
T ss_dssp ------CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred eecCCCCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchh
Confidence 334455556677777 99999999999999998654 234478899999997643 222345678899999999999999
Q ss_pred EEEEEEEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc
Q 011808 92 KLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 92 ~l~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~ 170 (477)
++++++.+.....+++||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~--- 167 (318)
T 3lxp_A 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL--- 167 (318)
T ss_dssp CEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---
T ss_pred hEEEEEecCCCceEEEEEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---
Confidence 9999998876678999999997 5888887542 48999999999999999999999999999999999999
Q ss_pred CCCcccEEEeecccceeecCCCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccC
Q 011808 171 GEEQGVVKIADFGLARIYQAPLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST 249 (477)
Q Consensus 171 ~~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~ 249 (477)
+.++.+||+|||++......... .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||........
T Consensus 168 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~ 245 (318)
T 3lxp_A 168 -DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFL 245 (318)
T ss_dssp -CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH
T ss_pred -cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhh
Confidence 67778999999999876543221 1223345688899999998744 88999999999999999999999975431100
Q ss_pred ---CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 250 ---QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 250 ---~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
...........+...+. .......+..++..+.+||++||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 295 (318)
T 3lxp_A 246 ELIGIAQGQMTVLRLTELLE------------------------------RGERLPRPDKCPAEVYHLMKNCWETEASFR 295 (318)
T ss_dssp HHHCSCCHHHHHHHHHHHHH------------------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hhhcccccchhHHHHHHHHh------------------------------cccCCCCCccccHHHHHHHHHHcCCCcccC
Confidence 00000111111111111 011122345567889999999999999999
Q ss_pred CCHHHHhc
Q 011808 327 ITAAQALE 334 (477)
Q Consensus 327 pt~~e~L~ 334 (477)
||+.++++
T Consensus 296 ps~~ell~ 303 (318)
T 3lxp_A 296 PTFENLIP 303 (318)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=335.62 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=200.4
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC-----CcHHHHHHHHHHHhcCCCCeeEEEEEEE
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG-----VSPTAIREIMLLREITHENVVKLVNVHI 98 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 98 (477)
..++|++.+.||+|+||.||+|+++. ++..||||++........ ....+.+|+.+++.++||||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETT---TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhccceehhccccCCceeEEEEEEcC---CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 35789999999999999999998764 688999999976544332 2267789999999999999999999985
Q ss_pred cCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC--eecCCCCCCcEEEeccC-CCc
Q 011808 99 NHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW--IIHRDLKPSNILVMGEG-EEQ 174 (477)
Q Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDikp~NILl~~~~-~~~ 174 (477)
+.. ++||||+. ++|.+.+... ...+++..++.++.||+.||.|||++| |+||||||+|||+..++ +..
T Consensus 94 ~~~----~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~ 165 (287)
T 4f0f_A 94 NPP----RMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP 165 (287)
T ss_dssp TTT----EEEEECCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCS
T ss_pred CCC----eEEEEecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCc
Confidence 543 79999998 6888888654 346899999999999999999999999 99999999999995433 222
Q ss_pred ccEEEeecccceeecCCCCcccCCCeeeccccccchhhcC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 175 GVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLG-AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 175 ~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
..+||+|||+++..... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||......
T Consensus 166 ~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------ 234 (287)
T 4f0f_A 166 VCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------ 234 (287)
T ss_dssp CCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC------
T ss_pred eeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc------
Confidence 34999999999754332 223567999999999843 234788999999999999999999999765421
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
.......+.. .+ .....+..+++.+.+||.+||+.||.+|||+++++
T Consensus 235 ~~~~~~~~~~-~~--------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 281 (287)
T 4f0f_A 235 KIKFINMIRE-EG--------------------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281 (287)
T ss_dssp HHHHHHHHHH-SC--------------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhc-cC--------------------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 1111111111 10 11123445568899999999999999999999998
Q ss_pred cC
Q 011808 334 EH 335 (477)
Q Consensus 334 ~h 335 (477)
+.
T Consensus 282 ~~ 283 (287)
T 4f0f_A 282 KE 283 (287)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=334.75 Aligned_cols=264 Identities=19% Similarity=0.207 Sum_probs=204.5
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+.++|++.+.||+|+||.||+|++.. +++.||||++..... ...+.+|+.+++.++|++++..+..+... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~ 77 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAE-G 77 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEE-T
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcC---CCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCC-C
Confidence 457899999999999999999998754 689999999876443 23678999999999998877777665443 3
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
...++||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.++.+||+||
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-~~~~~~kl~Df 152 (296)
T 3uzp_A 78 DYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG-KKGNLVYIIDF 152 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG-GGTTCEEECCC
T ss_pred CceEEEEEecCCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecC-CCCCeEEEeeC
Confidence 478999999988999998754 2469999999999999999999999999999999999999432 25567999999
Q ss_pred ccceeecCCCCc-----ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 183 GLARIYQAPLKF-----LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 183 G~a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
|++......... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+........ .
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~ 226 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-----K 226 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-----H
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh-----h
Confidence 999876553321 1123457899999999998754 8999999999999999999999998755332221 1
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+..+.......+ ........++.+.+||.+||+.||.+|||++++++.
T Consensus 227 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 227 YERISEKKMSTP------------------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHHHHHHHHHSC------------------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred hhhhcccccCCc------------------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 112111100000 001123346789999999999999999999988764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=349.99 Aligned_cols=275 Identities=22% Similarity=0.238 Sum_probs=206.9
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
...++|++.+.||+|+||.||+|+++ ++..||||++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR----DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDER-- 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT----TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT--
T ss_pred HHHhccCccceeecCCCeeEEEEEEC----CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--
Confidence 45689999999999999999999743 47899999886543 33456778999999999999999999998654
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|+||||+. ++|.+++.... .....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~D 182 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL----DENFVPKITD 182 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE----CTTCCEEECC
T ss_pred CeEEEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE----CCCCCEEEee
Confidence 46899999998 58877765432 113358999999999999999999999999999999999999 6778899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+++...............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+........... ..
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~-----~~ 256 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE-----WA 256 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH-----HT
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH-----Hh
Confidence 99998755433333334567899999999997744 8999999999999999999999998765433222110 00
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
.......... . .....+....+...+..+.+||.+||+.||++|||+.++++|-.
T Consensus 257 ~~~~~~~~~~---~------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 257 VESHNNGQLE---Q------------------IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp HHHHTTTCCC---S------------------SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhccccccHH---H------------------hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 0111000000 0 00001111122223456889999999999999999999998754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=342.61 Aligned_cols=263 Identities=24% Similarity=0.388 Sum_probs=207.4
Q ss_pred ccceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
.++|++.+.||+|+||.||+|++.. ...++..||||+++.... ......+.+|+.+++.+ +||||+++++++....
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC-cHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 5789999999999999999998753 234678999999975432 22334677899999999 7999999999986543
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhccc-----------CCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEec
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKV-----------NHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMG 169 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~ 169 (477)
..+|++|||+. ++|.+++....... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 105 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~-- 181 (316)
T 2xir_A 105 -GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 181 (316)
T ss_dssp -SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred -CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE--
Confidence 45899999998 59999987653210 1238899999999999999999999999999999999999
Q ss_pred cCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccc
Q 011808 170 EGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKS 248 (477)
Q Consensus 170 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~ 248 (477)
+.++.+||+|||+++.+.............+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....
T Consensus 182 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~- 257 (316)
T 2xir_A 182 --SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID- 257 (316)
T ss_dssp --CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-
T ss_pred --CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchh-
Confidence 67778999999999876554433344556779999999999874 48999999999999999998 99999765421
Q ss_pred CCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC
Q 011808 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT 328 (477)
Q Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt 328 (477)
..+........ ....+...+..+.+||.+||+.||.+|||
T Consensus 258 -------~~~~~~~~~~~---------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps 297 (316)
T 2xir_A 258 -------EEFCRRLKEGT---------------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPT 297 (316)
T ss_dssp -------HHHHHHHHHTC---------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -------HHHHHHhccCc---------------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 11211111110 01123334678999999999999999999
Q ss_pred HHHHhcC
Q 011808 329 AAQALEH 335 (477)
Q Consensus 329 ~~e~L~h 335 (477)
+.++++|
T Consensus 298 ~~ell~~ 304 (316)
T 2xir_A 298 FSELVEH 304 (316)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=335.71 Aligned_cols=263 Identities=19% Similarity=0.195 Sum_probs=198.9
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+.++|++.+.||+|+||.||+|++.. +++.||||++....... .+.+|+.+++.++|++++..+..+... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~~~~~i~~~~~~~~~-~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAE-G 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEC---CC----CHHHHHHHHHHHTTSTTCCCEEEEEEE-T
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcC---CCceEEEEeecccccch----HHHHHHHHHHHhcCCCCCCeeeeecCC-C
Confidence 456899999999999999999998654 68899999876544332 467899999999988888777766543 3
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
...++||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+..+ +.++.+||+||
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-~~~~~~kL~Df 152 (296)
T 4hgt_A 78 DYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG-KKGNLVYIIDF 152 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCG-GGTTCEEECCC
T ss_pred CceEEEEEccCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeecc-CCCCeEEEecC
Confidence 478999999999999998754 2369999999999999999999999999999999999999432 35567999999
Q ss_pred ccceeecCCCCc-----ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 183 GLARIYQAPLKF-----LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 183 G~a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
|+++........ .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........
T Consensus 153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----- 226 (296)
T 4hgt_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK----- 226 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH-----
T ss_pred ccceeccCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh-----
Confidence 999876543321 1223467899999999998754 89999999999999999999999987654332221
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
+..+.......+ ........++.+.+||.+||+.||++|||++++++
T Consensus 227 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 227 YERISEKKMSTP------------------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHHHSC------------------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhcccccch------------------------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 111111100000 00012334678999999999999999999999886
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=345.09 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=198.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCC-CcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANR-GKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++++.||+|+||.||+|+++.+... ...|++|.+..... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---S 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---S
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---C
Confidence 57899999999999999999987653211 22478888754432 2233456689999999999999999998853 3
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~----~~~~~~kl~Df 159 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL----KSPSQVQVADF 159 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE----SSSSCEEECSC
T ss_pred ccEEEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE----CCCCeEEECCC
Confidence 5889999998 68888887642 358889999999999999999999999999999999999 67778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|+++.+.............+|..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.... .+...
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---------~~~~~ 229 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---------EVPDL 229 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---------HHHHH
T ss_pred CcccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHH---------HHHHH
Confidence 9998765544333344456788999999998744 8999999999999999999 99999865421 11111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.... .....+..++.++.+||.+||..||.+|||+.++++|
T Consensus 230 ~~~~---------------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 230 LEKG---------------------------------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHTT---------------------------------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHcC---------------------------------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1110 0011233345678899999999999999999999988
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=348.60 Aligned_cols=269 Identities=20% Similarity=0.349 Sum_probs=202.7
Q ss_pred cccceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
..++|++++.||+|+||.||+|++.. +..++..||||++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 35799999999999999999998542 23467899999996432 2233456788999999999999999999987643
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDK--VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
.+|+||||+. ++|.+++...... ....+++..++.++.||+.||.|||++||+||||||+|||+..++ ....+|
T Consensus 107 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~-~~~~~k 183 (327)
T 2yfx_A 107 --PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG-PGRVAK 183 (327)
T ss_dssp --SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS-TTCCEE
T ss_pred --CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC-CcceEE
Confidence 6799999995 6999999875421 113589999999999999999999999999999999999995332 345799
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~ 257 (477)
|+|||++................+|+.|+|||++.+. .++.++|||||||++|+|++ |..||..... .+.
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~ 254 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEV 254 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHH
Confidence 9999999865443333333445668999999999774 48999999999999999998 9999976541 111
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
+..+... . ....+..++..+.+||.+||+.||.+|||++++++|.|
T Consensus 255 ~~~~~~~---~-------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 255 LEFVTSG---G-------------------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp HHHHHTT---C-------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcC---C-------------------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 1111110 0 01123345678999999999999999999999999988
Q ss_pred CC
Q 011808 338 FR 339 (477)
Q Consensus 338 f~ 339 (477)
+.
T Consensus 301 ~~ 302 (327)
T 2yfx_A 301 YC 302 (327)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=342.17 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=193.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCC-CcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANR-GKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++++.||+|+||.||+|+++.+... ...|++|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--
Confidence 57899999999999999999987653221 1246778776433 3345568889999999999999999999997643
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+++++++. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~----~~~~~~kL~Df 161 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV----KTPQHVKITDF 161 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----EETTEEEECCT
T ss_pred -ceEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE----cCCCCEEEccC
Confidence 677888777 68999887643 468999999999999999999999999999999999999 66678999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|+++.+.............+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.... .+..+
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---------~~~~~ 231 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------EISSI 231 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---------GHHHH
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---------HHHHH
Confidence 999876554433333445568899999999874 48999999999999999999 99999865422 12222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..... ....+...+..+.+||.+||..||.+|||+.++++.
T Consensus 232 ~~~~~---------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 232 LEKGE---------------------------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHTTC---------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCC---------------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11110 011233446789999999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=360.90 Aligned_cols=266 Identities=29% Similarity=0.400 Sum_probs=191.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 103 (477)
-+.|.+.+.||+|+||+||.+. . .+++.||||++.... ...+.+|+.+++++ +||||+++++++.+. .
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~---~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~ 82 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-S---FQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTD--R 82 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-E---SSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECS--S
T ss_pred hheeeccCeEeeCCCeEEEEEE-E---ECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecC--C
Confidence 4557778999999999998753 2 358999999986532 34667899999886 899999999998654 4
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccC--CCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC---------C
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVN--HTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG---------E 172 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~---------~ 172 (477)
.+|+||||++++|.+++........ ...++..++.++.||+.||.|||++||+||||||+|||++.++ +
T Consensus 83 ~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 83 FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred eEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 7999999999999999976432110 0113335678999999999999999999999999999996532 3
Q ss_pred CcccEEEeecccceeecCCCCcc--cCCCeeeccccccchhhcC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 011808 173 EQGVVKIADFGLARIYQAPLKFL--SENGVVVTIWYRAPELLLG------AKHYTSAVDMWAVGCIFAELLT-LKPLFQG 243 (477)
Q Consensus 173 ~~~~vkL~DFG~a~~~~~~~~~~--~~~~~~gt~~y~APE~l~~------~~~~~~~~DiwSlGvil~ellt-G~~PF~~ 243 (477)
.+..+||+|||+++.+....... .....+||+.|+|||++.+ ...++.++|||||||++|||++ |..||..
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 45689999999998765432211 1234578999999999975 2458999999999999999999 9999965
Q ss_pred cccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCC
Q 011808 244 AEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323 (477)
Q Consensus 244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP 323 (477)
... . ...+....... ... ........+.++.+||.+||+.||
T Consensus 243 ~~~--------~--~~~i~~~~~~~--~~~--------------------------~~~~~~~~~~~~~~li~~~L~~dP 284 (434)
T 2rio_A 243 KYS--------R--ESNIIRGIFSL--DEM--------------------------KCLHDRSLIAEATDLISQMIDHDP 284 (434)
T ss_dssp TTT--------H--HHHHHHTCCCC--CCC--------------------------TTCCCHHHHHHHHHHHHHHTCSSG
T ss_pred chh--------h--HHHHhcCCCCc--ccc--------------------------cccccccchHHHHHHHHHHhhCCh
Confidence 431 1 11122111000 000 000011123578999999999999
Q ss_pred CCCCCHHHHhcCccCC
Q 011808 324 RKRITAAQALEHEYFR 339 (477)
Q Consensus 324 ~~Rpt~~e~L~h~~f~ 339 (477)
.+|||+.++|+||||+
T Consensus 285 ~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 285 LKRPTAMKVLRHPLFW 300 (434)
T ss_dssp GGSCCHHHHHTSGGGS
T ss_pred hhCCCHHHHHhCCccC
Confidence 9999999999999996
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=337.16 Aligned_cols=270 Identities=26% Similarity=0.413 Sum_probs=202.6
Q ss_pred ccceeEEeeecccCceEEEEEEEec-ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA-AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..+|++++.||+|+||.||+|++.. +..++..||||++..... ......+.+|+.+++.++||||+++++++.+....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 4569999999999999999998532 335789999999976543 33456788999999999999999999999877656
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~kl~Df 170 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV----ESEHQVKIGDF 170 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----EETTEEEECCC
T ss_pred eEEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE----cCCCCEEECcc
Confidence 7899999997 59999886543 368999999999999999999999999999999999999 56678999999
Q ss_pred ccceeecCCCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc---CCCcccHHHH
Q 011808 183 GLARIYQAPLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS---TQNPFQLDQL 258 (477)
Q Consensus 183 G~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~---~~~~~~~~~~ 258 (477)
|++......... .......+|..|+|||++.+.. ++.++|||||||++|+|++|..||....... ..........
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence 999876543321 1223345688899999998744 8899999999999999999999875321100 0000001111
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
..+...+. .......+...++.+.+||.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~------------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 250 TRLVNTLK------------------------------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHH------------------------------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHh------------------------------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11111111 01112234556788999999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=341.76 Aligned_cols=262 Identities=22% Similarity=0.359 Sum_probs=205.4
Q ss_pred ccceeEEeeecccCceEEEEEEEeccc--CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAA--NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
.++|++.+.||+|+||.||+|.+..+. .....||+|++..... ......+.+|+.+++.+ +||||+++++++.+..
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH-ADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC-hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 578999999999999999999876432 1235899999975432 22345678899999999 8999999999986543
Q ss_pred CceEEEEEeccCC-CHHHHHHhhhcc---------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC
Q 011808 102 DMSLYLAFDYAEY-DLYEIIRHHRDK---------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 102 ~~~~~lv~e~~~~-~L~~~l~~~~~~---------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~ 171 (477)
.+|+||||+.+ +|.+++...... ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 124 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---- 197 (333)
T 2i1m_A 124 --PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---- 197 (333)
T ss_dssp --SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE----
T ss_pred --ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE----
Confidence 68999999974 999998765321 13468999999999999999999999999999999999999
Q ss_pred CCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCC
Q 011808 172 EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQ 250 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~ 250 (477)
+.++.+||+|||++................+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~---- 272 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILV---- 272 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS----
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccch----
Confidence 66778999999999876544333334456678899999999874 48999999999999999998 9999976542
Q ss_pred CcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHH
Q 011808 251 NPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA 330 (477)
Q Consensus 251 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~ 330 (477)
...+..+..... ....+...+..+.+||.+||+.||.+|||+.
T Consensus 273 ----~~~~~~~~~~~~---------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 315 (333)
T 2i1m_A 273 ----NSKFYKLVKDGY---------------------------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQ 315 (333)
T ss_dssp ----SHHHHHHHHHTC---------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----hHHHHHHHhcCC---------------------------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHH
Confidence 122222222110 0112333467899999999999999999999
Q ss_pred HHhcC
Q 011808 331 QALEH 335 (477)
Q Consensus 331 e~L~h 335 (477)
+++++
T Consensus 316 ~l~~~ 320 (333)
T 2i1m_A 316 QICSF 320 (333)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=334.70 Aligned_cols=256 Identities=22% Similarity=0.311 Sum_probs=200.3
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..++|++.+.||+|+||.||+|++.....++..||||++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE--- 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC-HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS---
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC-chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---
Confidence 36899999999999999999999876555667899999976532 22345778899999999999999999998543
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~Df 157 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV----ASPECVKLGDF 157 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----EETTEEEECCC
T ss_pred CCEEEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE----CCCCcEEeCcc
Confidence 3589999998 68888887642 358999999999999999999999999999999999999 56678999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|++......... ......+++.|+|||++.+. .++.++|||||||++|+|++ |+.||...... +....+
T Consensus 158 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--------~~~~~~ 227 (281)
T 3cc6_A 158 GLSRYIEDEDYY-KASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENK--------DVIGVL 227 (281)
T ss_dssp CGGGCC----------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--------GHHHHH
T ss_pred CCCccccccccc-ccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChH--------HHHHHH
Confidence 999866543211 12234458899999999764 48999999999999999998 99999755421 112222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.... . ...+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 228 ~~~~-~---------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 228 EKGD-R---------------------------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHTC-C---------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCC-C---------------------------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 1110 0 01223346789999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=349.84 Aligned_cols=270 Identities=17% Similarity=0.164 Sum_probs=195.9
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC---------CCcHHHHHHHHHHHhcCCCCeeEEEEE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD---------GVSPTAIREIMLLREITHENVVKLVNV 96 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~~Ei~il~~l~hpnIv~l~~~ 96 (477)
++|++.+.||+|+||.||+|++.....++..+|||++....... .....+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 58999999999999999999987544568899999987653210 012345678888999999999999999
Q ss_pred EEcC--CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc
Q 011808 97 HINH--ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ 174 (477)
Q Consensus 97 ~~~~--~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~ 174 (477)
+.+. ....+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+..++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN--P 189 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS--T
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC--C
Confidence 8762 356899999999889998886532 689999999999999999999999999999999999994322 2
Q ss_pred ccEEEeecccceeecCCCCcc-----cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccC
Q 011808 175 GVVKIADFGLARIYQAPLKFL-----SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST 249 (477)
Q Consensus 175 ~~vkL~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~ 249 (477)
+.+||+|||+++.+....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~--- 265 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLK--- 265 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTT---
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCcccccc---
Confidence 379999999998764322111 11335679999999999875 489999999999999999999999964321
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
....+...........+..+.. .......+..+.+||.+||..||.+|||+
T Consensus 266 ----~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 316 (345)
T 2v62_A 266 ----DPVAVQTAKTNLLDELPQSVLK-------------------------WAPSGSSCCEIAQFLVCAHSLAYDEKPNY 316 (345)
T ss_dssp ----CHHHHHHHHHHHHHTTTHHHHH-------------------------HSCTTSCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred ----ccHHHHHHHHhhcccccHHHHh-------------------------hccccccHHHHHHHHHHHhhcCcccCCCH
Confidence 1111111111110000000000 00011456789999999999999999999
Q ss_pred HHHhcC
Q 011808 330 AQALEH 335 (477)
Q Consensus 330 ~e~L~h 335 (477)
.++++.
T Consensus 317 ~~l~~~ 322 (345)
T 2v62_A 317 QALKKI 322 (345)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=332.09 Aligned_cols=252 Identities=28% Similarity=0.458 Sum_probs=189.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC--CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG--DGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++|++.+.||+|+||.||+|++. +..||||+++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP- 79 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-----TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-----CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC-
Confidence 578999999999999999999853 778999998765433 234467788999999999999999999986643
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC---eecCCCCCCcEEEeccCC----Cc
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW---IIHRDLKPSNILVMGEGE----EQ 174 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDikp~NILl~~~~~----~~ 174 (477)
.+|+||||+. ++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||+..+.. .+
T Consensus 80 -~~~lv~e~~~~~~L~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 80 -NLCLVMEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred -ceEEEEEcCCCCCHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence 6899999997 57766663 236999999999999999999999999 999999999999954211 36
Q ss_pred ccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCccc
Q 011808 175 GVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQ 254 (477)
Q Consensus 175 ~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~ 254 (477)
+.+||+|||++........ ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 153 ~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------- 219 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDG-------- 219 (271)
T ss_dssp CCEEECCCCC-----------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCH--------
T ss_pred cceEEccCCcccccccccc----cCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------
Confidence 7899999999986554322 235679999999999874 489999999999999999999999976542
Q ss_pred HHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.... ....... .....+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 220 ~~~~---~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 266 (271)
T 3dtc_A 220 LAVA---YGVAMNK------------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD 266 (271)
T ss_dssp HHHH---HHHHTSC------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHH---HhhhcCC------------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1111 1111110 111234455678999999999999999999999987
Q ss_pred C
Q 011808 335 H 335 (477)
Q Consensus 335 h 335 (477)
|
T Consensus 267 ~ 267 (271)
T 3dtc_A 267 Q 267 (271)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=351.40 Aligned_cols=271 Identities=15% Similarity=0.171 Sum_probs=196.4
Q ss_pred cceeEEeeecccCceEEEEEEEeccc--CCCcEEEEEecccCCCCC---------CCcHHHHHHHHHHHhcCCCCeeEEE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAA--NRGKAIAIKKFKQSKDGD---------GVSPTAIREIMLLREITHENVVKLV 94 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~--~~~~~vaiK~~~~~~~~~---------~~~~~~~~Ei~il~~l~hpnIv~l~ 94 (477)
++|++.+.||+|+||.||+|.++.+. ..++.||||++....... ......++|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 38999999999999999999876431 136789999986543100 0111233455566677899999999
Q ss_pred EEEEcCC--CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCC
Q 011808 95 NVHINHA--DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE 172 (477)
Q Consensus 95 ~~~~~~~--~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~ 172 (477)
+++.... ..++||||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+.. +
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~--~ 188 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRFGSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY--K 188 (364)
T ss_dssp EEEEEEETTEEEEEEEEECEEEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES--S
T ss_pred eeeeeccCCcceEEEEEeCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec--C
Confidence 9987642 3568999999988999998764 346999999999999999999999999999999999999942 1
Q ss_pred CcccEEEeecccceeecCCCCcc-----cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 011808 173 EQGVVKIADFGLARIYQAPLKFL-----SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAK 247 (477)
Q Consensus 173 ~~~~vkL~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~ 247 (477)
.++.+||+|||+++.+....... .....+||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.+....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 56789999999998765432111 123455899999999998754 899999999999999999999999864321
Q ss_pred cCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC
Q 011808 248 STQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI 327 (477)
Q Consensus 248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp 327 (477)
.............. ++.+.. ........+.++.+||.+||..||.+||
T Consensus 268 -------~~~~~~~~~~~~~~----------~~~~~~---------------~~~~~~~~~~~~~~li~~cl~~~p~~RP 315 (364)
T 3op5_A 268 -------PKYVRDSKIRYREN----------IASLMD---------------KCFPAANAPGEIAKYMETVKLLDYTEKP 315 (364)
T ss_dssp -------HHHHHHHHHHHHHC----------HHHHHH---------------HHSCTTCCCHHHHHHHHHHHTCCTTCCC
T ss_pred -------HHHHHHHHHHhhhh----------HHHHHH---------------HhcccccCHHHHHHHHHHHhcCCCCCCC
Confidence 01110000000000 000000 0001134467899999999999999999
Q ss_pred CHHHHhcC
Q 011808 328 TAAQALEH 335 (477)
Q Consensus 328 t~~e~L~h 335 (477)
++.++++.
T Consensus 316 ~~~~l~~~ 323 (364)
T 3op5_A 316 LYENLRDI 323 (364)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99988763
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=341.53 Aligned_cols=262 Identities=21% Similarity=0.334 Sum_probs=205.4
Q ss_pred cccceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
..++|++.+.||+|+||.||+|.++. ...++..||||++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 35789999999999999999998763 123477899999975432 223346778999999999999999999986543
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcc-----cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDK-----VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
..|+||||+. ++|.+++...... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 102 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli----~~~~ 175 (322)
T 1p4o_A 102 --PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDF 175 (322)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE----CTTC
T ss_pred --ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE----cCCC
Confidence 6799999997 5999988764321 12357899999999999999999999999999999999999 6677
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCccc
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQ 254 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~ 254 (477)
.+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------- 246 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------- 246 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCH--------
Confidence 8999999999866543333333445678999999999874 48999999999999999999 8999976542
Q ss_pred HHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
......+.. ... ...+..++..+.+||.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~---~~~-------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~ 292 (322)
T 1p4o_A 247 EQVLRFVME---GGL-------------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292 (322)
T ss_dssp HHHHHHHHT---TCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHc---CCc-------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111111111 000 0123345678999999999999999999999998
Q ss_pred C
Q 011808 335 H 335 (477)
Q Consensus 335 h 335 (477)
|
T Consensus 293 ~ 293 (322)
T 1p4o_A 293 S 293 (322)
T ss_dssp H
T ss_pred H
Confidence 7
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=342.87 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=203.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecc----cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAA----ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHIN 99 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 99 (477)
.++|++.+.||+|+||.||+|++... ..++..||||+++.... ......+.+|+.+++.+ +||||+++++++.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc-HHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 47999999999999999999987531 13577899999975432 22345678899999999 89999999999865
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEE
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRDK-----------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILV 167 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl 167 (477)
. ..+|+||||+. ++|.+++...... ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 113 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 113 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp S--SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred C--CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 4 36899999997 5999998764311 12348999999999999999999999999999999999999
Q ss_pred eccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 011808 168 MGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEA 246 (477)
Q Consensus 168 ~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~ 246 (477)
+.++.+||+|||+++...............+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus 191 ----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 191 ----TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp ----CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ----cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 67778999999999876654333333344568899999999774 48999999999999999999 9999976542
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
.+....+.... ....+..++..+.+||.+||..||.+|
T Consensus 266 --------~~~~~~~~~~~----------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~R 303 (334)
T 2pvf_A 266 --------EELFKLLKEGH----------------------------------RMDKPANCTNELYMMMRDCWHAVPSQR 303 (334)
T ss_dssp --------HHHHHHHHHTC----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred --------HHHHHHHhcCC----------------------------------CCCCCccCCHHHHHHHHHHccCChhhC
Confidence 11111111110 011233456789999999999999999
Q ss_pred CCHHHHhcC
Q 011808 327 ITAAQALEH 335 (477)
Q Consensus 327 pt~~e~L~h 335 (477)
||+.+++++
T Consensus 304 ps~~ell~~ 312 (334)
T 2pvf_A 304 PTFKQLVED 312 (334)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999977
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=352.50 Aligned_cols=257 Identities=22% Similarity=0.374 Sum_probs=191.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||+|+++....++..||||+++.... ......+.+|+.++++++||||+++++++.+. ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS--KP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--Cc
Confidence 4689999999999999999998775545678899999976432 22345678999999999999999999998654 36
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg 192 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFG 192 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEECCC-
T ss_pred eEEEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE----cCCCCEEECcCc
Confidence 899999996 6999888754 3468999999999999999999999999999999999999 677889999999
Q ss_pred cceeecCCCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
+++........ .......+++.|+|||++.+. .++.++|||||||++|||++ |+.||.+... .+.+..+
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~i 263 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKAV 263 (373)
T ss_dssp ---------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHHH
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH
Confidence 99876543211 112223447789999999874 48999999999999999998 9999976542 1111111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.... ....+..++..+.+||.+||+.||.+||++.++++.
T Consensus 264 ~~~~----------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 264 DEGY----------------------------------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp HTTE----------------------------------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCC----------------------------------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHH
Confidence 1100 011223446789999999999999999999998864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=337.00 Aligned_cols=259 Identities=23% Similarity=0.355 Sum_probs=198.0
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
...+|++.+.||+|+||.||+|++..+......+|+|.+..... ......+.+|+.++++++||||+++++++... +.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC-HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-CC
Confidence 35679999999999999999998765545566799999875332 22345678899999999999999999987654 34
Q ss_pred eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
..|++|||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~kl~Df 172 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML----DEKFTVKVADF 172 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTCCEEECSC
T ss_pred ceEEEEeCCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE----CCCCCEEECcc
Confidence 67899999985 998888653 3468999999999999999999999999999999999999 67778999999
Q ss_pred ccceeecCCCC--cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHH
Q 011808 183 GLARIYQAPLK--FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 183 G~a~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|+++....... ........+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+.. +...
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--------~~~~ 243 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--------DITV 243 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--------THHH
T ss_pred cccccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--------HHHH
Confidence 99986643221 1122344568899999999774 48999999999999999999 67777655421 1111
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.+... .....+...+..+.+||.+||+.||.+|||+.++++.
T Consensus 244 ~~~~~----------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 244 YLLQG----------------------------------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHTT----------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcC----------------------------------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11110 0011233456789999999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=342.74 Aligned_cols=270 Identities=25% Similarity=0.391 Sum_probs=207.7
Q ss_pred ccceeEEeeecccCceEEEEEEEec-ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA-AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++++.||+|+||.||+|+++. +..++..||||++.... ......+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 4789999999999999999998532 23578899999987542 22345678899999999999999999999877777
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~----~~~~~~kl~Df 171 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV----ESEAHVKIADF 171 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----EETTEEEECCG
T ss_pred eEEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE----CCCCCEEEccc
Confidence 8999999995 68998887643 258999999999999999999999999999999999999 66678999999
Q ss_pred ccceeecCCCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccC---CCcccHHHH
Q 011808 183 GLARIYQAPLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST---QNPFQLDQL 258 (477)
Q Consensus 183 G~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~---~~~~~~~~~ 258 (477)
|++......... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||........ .........
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence 999876543221 122334568889999999874 489999999999999999999999975432100 000000011
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..+...+. .......+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~------------------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 251 SRLLELLE------------------------------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHH------------------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhh------------------------------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11111111 111122345567889999999999999999999999766
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=332.12 Aligned_cols=253 Identities=24% Similarity=0.401 Sum_probs=205.2
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..++|++.+.||+|+||.||+|.++. ++..||||++.... .....+.+|+.+++.++||||+++++++.+. .
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 82 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--P 82 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGG---GTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred cccceeEEeecCCCCceeEEEeEecC---CCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--C
Confidence 46889999999999999999998764 58899999997533 2346778999999999999999999998654 4
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~~l~Df 155 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV----GENHLVKVADF 155 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE----CGGGCEEECCC
T ss_pred CEEEEEEcCCCCcHHHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE----cCCCCEEEccC
Confidence 6899999998 69999987643 3468999999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|++........ .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.. .+...
T Consensus 156 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---------~~~~~ 224 (288)
T 3kfa_A 156 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------QVYEL 224 (288)
T ss_dssp CGGGTSCSSSS-EEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---------GHHHH
T ss_pred ccceeccCCcc-ccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------HHHHH
Confidence 99986654322 233445678899999999874 48999999999999999999 99999765421 11111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.... .....+..++..+.+||.+||..||.+|||++++++.
T Consensus 225 ~~~~---------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 225 LEKD---------------------------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHTT---------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hhcc---------------------------------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 1110 0111234456789999999999999999999999764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=333.90 Aligned_cols=251 Identities=27% Similarity=0.425 Sum_probs=203.8
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEc--
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHIN-- 99 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 99 (477)
..+..+|++++.||+|+||.||+|+++. ++..||||++.... ..+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFD 77 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETT---TCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred chhccccceeeeeccCCceEEEEEEEcC---CCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence 3567899999999999999999998753 68899999997543 256689999999999999999998854
Q ss_pred ------------CCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEE
Q 011808 100 ------------HADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNIL 166 (477)
Q Consensus 100 ------------~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NIL 166 (477)
.....+|+||||+.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil 154 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEE
Confidence 223468999999995 9999987653 347899999999999999999999999999999999999
Q ss_pred EeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 011808 167 VMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEA 246 (477)
Q Consensus 167 l~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~ 246 (477)
+ +.++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 155 ~----~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~- 225 (284)
T 2a19_B 155 L----VDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS- 225 (284)
T ss_dssp E----EETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH-
T ss_pred E----cCCCCEEECcchhheecccccc---ccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH-
Confidence 9 5667899999999987654322 2334679999999999874 48999999999999999999998874211
Q ss_pred ccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCC
Q 011808 247 KSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326 (477)
Q Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 326 (477)
. ....+... ..+...+..+.+||.+||..||.+|
T Consensus 226 ----------~---~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~l~~dp~~R 259 (284)
T 2a19_B 226 ----------K---FFTDLRDG---------------------------------IISDIFDKKEKTLLQKLLSKKPEDR 259 (284)
T ss_dssp ----------H---HHHHHHTT---------------------------------CCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred ----------H---HHHHhhcc---------------------------------cccccCCHHHHHHHHHHccCChhhC
Confidence 1 11111000 0122345778999999999999999
Q ss_pred CCHHHHhcCccCC
Q 011808 327 ITAAQALEHEYFR 339 (477)
Q Consensus 327 pt~~e~L~h~~f~ 339 (477)
||+.++++|.|..
T Consensus 260 ps~~e~l~~l~~~ 272 (284)
T 2a19_B 260 PNTSEILRTLTVW 272 (284)
T ss_dssp CCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHH
Confidence 9999999998864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.39 Aligned_cols=245 Identities=24% Similarity=0.441 Sum_probs=198.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++++.||+|+||.||+|.++ +..||||+++... ..+.+.+|+.+|++++||||+++++++.... ..
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 261 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GG 261 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-----CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-Cc
Confidence 578999999999999999999753 6789999997643 4568889999999999999999999986543 36
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill----~~~~~~kl~DfG 334 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV----SEDNVAKVSDFG 334 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTSCEEECCCT
T ss_pred eEEEEEecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE----CCCCCEEEeeCC
Confidence 899999997 59999998653 2247899999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+++...... ....+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.+.. +.+..+.
T Consensus 335 ~a~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~ 400 (450)
T 1k9a_A 335 LTKEASSTQ-----DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPRVE 400 (450)
T ss_dssp TCEECC-----------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--------THHHHHH
T ss_pred Ccccccccc-----cCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHH
Confidence 998543321 123458899999999874 48999999999999999998 99999865421 1111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
. +.....|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 401 ~----------------------------------~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 401 K----------------------------------GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp T----------------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c----------------------------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1 0111234556788999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=334.85 Aligned_cols=261 Identities=27% Similarity=0.460 Sum_probs=192.7
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
..+++|++.+.||+|+||.||+|.+.. ++..||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETT---TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ccccceEEEEeecCCCCceEEEEEEcC---CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 347899999999999999999998654 6889999999764322 223456778999999999999999999997644
Q ss_pred CceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.+++||||+.+ +|.+++..... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 106 --~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~----~~~~~~kl~ 178 (310)
T 2wqm_A 106 --ELNIVLELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI----TATGVVKLG 178 (310)
T ss_dssp --EEEEEEECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEEC
T ss_pred --cEEEEEecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE----cCCCCEEEE
Confidence 78999999985 88888876432 24568999999999999999999999999999999999999 667789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+... ....+..
T Consensus 179 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~ 248 (310)
T 2wqm_A 179 DLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKM-------NLYSLCK 248 (310)
T ss_dssp CC--------------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---C-------CHHHHHH
T ss_pred eccceeeecCCCc--cccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccch-------hHHHHHH
Confidence 9999986543221 12335679999999999874 489999999999999999999999975432 1111111
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.......+ .......+.++.+||.+||..||.+|||+.+++++
T Consensus 249 ~~~~~~~~--------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 249 KIEQCDYP--------------------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHTTCSC--------------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhcccCC--------------------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 11111000 01123346789999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=334.02 Aligned_cols=254 Identities=20% Similarity=0.354 Sum_probs=198.3
Q ss_pred ccceeEEe-eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIG-KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~-~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++.+ .||+|+||.||+|.+.. ...+..||||+++...........+.+|+.+++.++||||+++++++.. .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQM-KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---E 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEEC-SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---S
T ss_pred chhhhhccCccccccCeeeEeeeecC-CCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC---C
Confidence 46899999 99999999999997653 3467899999998765444445678899999999999999999999833 3
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~----~~~~~~kl~Df 161 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL----VTQHYAKISDF 161 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----EETTEEEECCC
T ss_pred CcEEEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE----eCCCcEEEccC
Confidence 5799999998 6898888763 368999999999999999999999999999999999999 56678999999
Q ss_pred ccceeecCCCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHH
Q 011808 183 GLARIYQAPLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 183 G~a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|++.......... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+. ..+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~ 231 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------SEVTA 231 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHHH
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCH---------HHHHH
Confidence 9998765433221 112234578899999997644 8899999999999999999 9999976542 11111
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.... .. ....+..++..+.+||.+||+.||.+|||+.++++
T Consensus 232 ~~~~---~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 232 MLEK---GE------------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHT---TC------------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHc---CC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 00 01123445688999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=335.58 Aligned_cols=258 Identities=24% Similarity=0.364 Sum_probs=193.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++++.||+|+||.||+|++......+..||||+++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence 57899999999999999999987654344457999999765432 234567788999999999999999999987643
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili----~~~~~~kl~Df 165 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL----ATRDLVKIGDF 165 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----EETTEEEECCC
T ss_pred -ceeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE----cCCCCEEEccc
Confidence 789999998 69999887643 358999999999999999999999999999999999999 56678999999
Q ss_pred ccceeecCCCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHH
Q 011808 183 GLARIYQAPLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 183 G~a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|++.......... ......+|..|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+. .+.+..
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~ 236 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHK 236 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHH
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHH
Confidence 9998765432211 12234557889999999774 48899999999999999999 9999976542 122221
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+.. ... ....+..++..+.+||.+||..||.+|||+.+++++
T Consensus 237 ~~~---~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 237 IDK---EGE------------------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHT---SCC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHc---cCC------------------------------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 111 000 011233456789999999999999999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=346.35 Aligned_cols=262 Identities=15% Similarity=0.167 Sum_probs=198.0
Q ss_pred cceeEEeeecccCceEEEEEEEecccC-----CCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeE--------
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAAN-----RGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK-------- 92 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~-------- 92 (477)
++|++.+.||+|+||.||+|+++.+.. .+..||||++... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 799999999999999999998764211 4789999998754 25678999999999999987
Q ss_pred -------EEEEEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcE
Q 011808 93 -------LVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNI 165 (477)
Q Consensus 93 -------l~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NI 165 (477)
+++++... +..+|+||||++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 115 ~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQ-DKYRFLVLPSLGRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCSCCCCCEEEEET-TTEEEEEEECCCEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred CccCccchhhccccC-CcEEEEEecCCCcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 56666542 45889999999889999998652 24799999999999999999999999999999999999
Q ss_pred EEeccCCCcc--cEEEeecccceeecCCCCcc-----cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCC
Q 011808 166 LVMGEGEEQG--VVKIADFGLARIYQAPLKFL-----SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK 238 (477)
Q Consensus 166 Ll~~~~~~~~--~vkL~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~ 238 (477)
|+ +.++ .+||+|||+++.+....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+
T Consensus 191 l~----~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 191 FV----DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp EE----ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSC
T ss_pred EE----cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCC
Confidence 99 4455 89999999998665322111 11334789999999999874 4899999999999999999999
Q ss_pred CCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHh
Q 011808 239 PLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318 (477)
Q Consensus 239 ~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~ 318 (477)
.||...... ...+......+.......... .......+..+.+||.+|
T Consensus 266 ~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~ 313 (352)
T 2jii_A 266 LPWTNCLPN-------TEDIMKQKQKFVDKPGPFVGP-------------------------CGHWIRPSETLQKYLKVV 313 (352)
T ss_dssp CTTGGGTTC-------HHHHHHHHHHHHHSCCCEECT-------------------------TSCEECCCHHHHHHHHHH
T ss_pred CCcccCCcC-------HHHHHHHHHhccCChhhhhhh-------------------------ccccCCCcHHHHHHHHHH
Confidence 999765421 122222222111111110000 000113467899999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 011808 319 LEYDPRKRITAAQALEH 335 (477)
Q Consensus 319 L~~dP~~Rpt~~e~L~h 335 (477)
|+.||.+|||++++++.
T Consensus 314 l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 314 MALTYEEKPPYAMLRNN 330 (352)
T ss_dssp HTCCTTCCCCHHHHHHH
T ss_pred HhCChhhCCCHHHHHHH
Confidence 99999999999998765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=334.98 Aligned_cols=253 Identities=15% Similarity=0.282 Sum_probs=196.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccC----CCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAAN----RGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
.++|++.+.||+|+||.||+|+++.+.. .+..||+|++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 5789999999999999999998875321 12579999986543 23456788999999999999999999998764
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCC----Ccc
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGE----EQG 175 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~----~~~ 175 (477)
. ..|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+
T Consensus 85 ~--~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 D--ENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp T--CCEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred C--CCEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 4 6789999998 69999987643 24899999999999999999999999999999999999954432 112
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccccCCCccc
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKSTQNPFQ 254 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~PF~~~~~~~~~~~~~ 254 (477)
.+||+|||++...... ....+|+.|+|||++.+...++.++|||||||++|+|++| .+||...+
T Consensus 159 ~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--------- 223 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--------- 223 (289)
T ss_dssp EEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---------
T ss_pred eeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc---------
Confidence 3999999998654321 2245688999999998755689999999999999999995 55554432
Q ss_pred HHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 255 LDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
......+.... ...+...+..+.+||.+||+.||.+|||+.++++
T Consensus 224 ~~~~~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 268 (289)
T 4fvq_A 224 SQRKLQFYEDR-----------------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIR 268 (289)
T ss_dssp HHHHHHHHHTT-----------------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHhhcc-----------------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11111111110 0122333567899999999999999999999998
Q ss_pred C
Q 011808 335 H 335 (477)
Q Consensus 335 h 335 (477)
|
T Consensus 269 ~ 269 (289)
T 4fvq_A 269 D 269 (289)
T ss_dssp H
T ss_pred H
Confidence 8
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=359.21 Aligned_cols=252 Identities=24% Similarity=0.420 Sum_probs=204.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
..+|++.++||+|+||.||+|+++. ++..||||+++.... ....+.+|+.+|++++||||+++++++.+. ..
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~ 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PP 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGG---GTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcC---CCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecC--Cc
Confidence 4679999999999999999998764 578999999976432 356788999999999999999999998654 36
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll----~~~~~~kl~DFG 363 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV----GENHLVKVADFG 363 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CGGGCEEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE----CCCCcEEEeecc
Confidence 899999998 69999997643 2468999999999999999999999999999999999999 677889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+++...... ........+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.+.. .+....
T Consensus 364 ~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---------~~~~~~ 432 (495)
T 1opk_A 364 LSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------QVYELL 432 (495)
T ss_dssp CEECCTTCC-EECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---------GHHHHH
T ss_pred cceeccCCc-eeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---------HHHHHH
Confidence 998765322 2223344557899999999874 48999999999999999999 99999865521 111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.. ......+..++..+.+||.+||+.||.+|||+.++++.
T Consensus 433 ~~---------------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 433 EK---------------------------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp HT---------------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hc---------------------------------CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 10 01112344567889999999999999999999999763
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=336.20 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=191.7
Q ss_pred CCccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEE
Q 011808 19 GEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVH 97 (477)
Q Consensus 19 ~~~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 97 (477)
......+++|++.+.||+|+||.||+|+++. ++..||||++....... .....+.+|+.+++.++||||+++++++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 27 SREGTQFGPYRLRRLVGRGGMGDVYEAEDTV---RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp -------CCEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCCcEeccEEEEEEEcCCCCeeEEEEEEcC---CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 3455678999999999999999999998654 68899999997654322 2235677899999999999999999999
Q ss_pred EcCCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc
Q 011808 98 INHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 98 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~ 176 (477)
... ..+|++|||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 104 ~~~--~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~----~~~~~ 172 (309)
T 2h34_A 104 EID--GQLYVDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV----SADDF 172 (309)
T ss_dssp EET--TEEEEEEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSC
T ss_pred eeC--CeEEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE----cCCCC
Confidence 764 378999999985 999888764 368999999999999999999999999999999999999 66678
Q ss_pred EEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHH
Q 011808 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~ 256 (477)
+||+|||++........ .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... .
T Consensus 173 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~ 241 (309)
T 2h34_A 173 AYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQL---------S 241 (309)
T ss_dssp EEECSCCC-----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------H
T ss_pred EEEecCccCcccccccc-ccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchH---------H
Confidence 99999999976543221 122345679999999999874 488999999999999999999999976441 1
Q ss_pred HHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-CHHHHhc
Q 011808 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-TAAQALE 334 (477)
Q Consensus 257 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-t~~e~L~ 334 (477)
.+..... ...+. ....+...+..+.+||.+||+.||++|| |+++++.
T Consensus 242 ~~~~~~~---~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 242 VMGAHIN---QAIPR----------------------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHH---SCCCC----------------------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHhc---cCCCC----------------------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 1111111 11000 0112344567899999999999999999 6776664
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=342.79 Aligned_cols=263 Identities=24% Similarity=0.339 Sum_probs=199.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH--AD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 102 (477)
.++|++++.||+|+||.||+|+++. ++..||||++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLH---DGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecC---CCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 3679999999999999999998754 68899999986532 22345677899999999999999999998632 34
Q ss_pred ceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|+||||+.+ +|.+++..... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~----~~~~~~kl~d 177 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL----GDEGQPVLMD 177 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTSCEEECC
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----cCCCCEEEEe
Confidence 578999999985 99988876532 24579999999999999999999999999999999999999 6677899999
Q ss_pred cccceeecCCCCcc-------cCCCeeeccccccchhhcCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCc
Q 011808 182 FGLARIYQAPLKFL-------SENGVVVTIWYRAPELLLGAK--HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252 (477)
Q Consensus 182 FG~a~~~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~--~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~ 252 (477)
||++.......... ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.......
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---- 253 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---- 253 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT----
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc----
Confidence 99987543211000 001234589999999997643 26889999999999999999999996422110
Q ss_pred ccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 011808 253 FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332 (477)
Q Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~ 332 (477)
+.+...... . .....+...+..+.+||.+||+.||.+|||+.++
T Consensus 254 ---~~~~~~~~~--~-------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 297 (317)
T 2buj_A 254 ---DSVALAVQN--Q-------------------------------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297 (317)
T ss_dssp ---SCHHHHHHC--C---------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---chhhHHhhc--c-------------------------------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 011111100 0 0001123346789999999999999999999999
Q ss_pred hcCcc
Q 011808 333 LEHEY 337 (477)
Q Consensus 333 L~h~~ 337 (477)
+++-.
T Consensus 298 l~~L~ 302 (317)
T 2buj_A 298 LSQLE 302 (317)
T ss_dssp HHHHH
T ss_pred HHHhh
Confidence 98843
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=333.36 Aligned_cols=257 Identities=21% Similarity=0.305 Sum_probs=201.8
Q ss_pred ccceeEEe-eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIG-KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~-~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|.+++ .||+|+||.||+|.++. ..++..||||+++... .......+.+|+.+++.++||||+++++++.. .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRM-RKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---E 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---S
T ss_pred HHHhhhhhccccccCceeEEEeEecc-CCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---C
Confidence 46788887 99999999999998653 2457889999997643 22334567889999999999999999999843 2
Q ss_pred eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+++||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~kl~Df 154 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL----VNRHYAKISDF 154 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----EETTEEEECCC
T ss_pred CcEEEEEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE----cCCCCEEECcc
Confidence 58999999985 888887643 3468999999999999999999999999999999999999 56678999999
Q ss_pred ccceeecCCCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHH
Q 011808 183 GLARIYQAPLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 183 G~a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|++.......... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+... .+....
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~ 225 (287)
T 1u59_A 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAF 225 (287)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHH
T ss_pred cceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHH
Confidence 9998765432221 12234458899999999764 48999999999999999998 9999976542 111111
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
+.. .. ....+..++..+.+||.+||..||.+|||+.++++|.+
T Consensus 226 i~~----~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 226 IEQ----GK------------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHT----TC------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred Hhc----CC------------------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111 00 01133455788999999999999999999999999865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=354.89 Aligned_cols=250 Identities=22% Similarity=0.385 Sum_probs=200.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||+|.++ .+..||||+++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~ 256 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EP 256 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET----TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECS---SS
T ss_pred hHHeEEEEEcccCCceEEEEEEEC----CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC---Cc
Confidence 478999999999999999999864 36789999997643 235688899999999999999999999852 35
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill----~~~~~~kl~DFG 329 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV----SASLVCKIADFG 329 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE----CTTCCEEECSTT
T ss_pred cEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE----CCCCcEEEeeCC
Confidence 799999997 699999976432 258889999999999999999999999999999999999 677889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+++...... ........+++.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+. .+.+..+.
T Consensus 330 ~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~ 399 (454)
T 1qcf_A 330 LARVIEDNE-YTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALE 399 (454)
T ss_dssp GGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHHH
T ss_pred CceEcCCCc-eeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence 998654321 1112233457889999999764 48999999999999999999 9999986542 22222222
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
... ....+..+++.+.+||.+||..||++|||+++++..
T Consensus 400 ~~~----------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~ 438 (454)
T 1qcf_A 400 RGY----------------------------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSV 438 (454)
T ss_dssp HTC----------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC----------------------------------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 111 011234456889999999999999999999998753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=337.32 Aligned_cols=256 Identities=29% Similarity=0.424 Sum_probs=198.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcE--EEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKA--IAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 101 (477)
.++|++.+.||+|+||.||+|+++. ++.. ++||.++.... ......+.+|+.+++++ +||||+++++++.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred HHHccceeeeecCCCceEEEEEEcc---CCcccceeeeeeccccc-hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 5899999999999999999998765 4554 59998875432 23345678899999999 8999999999997654
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhc-----------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEec
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRD-----------KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMG 169 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~ 169 (477)
.+|+||||+. ++|.+++..... .....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 100 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~-- 175 (327)
T 1fvr_A 100 --YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV-- 175 (327)
T ss_dssp --EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred --ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE--
Confidence 7899999997 599999876431 123468999999999999999999999999999999999999
Q ss_pred cCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccc
Q 011808 170 EGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKS 248 (477)
Q Consensus 170 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~ 248 (477)
+.++.+||+|||+++...... ......+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus 176 --~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~-- 247 (327)
T 1fvr_A 176 --GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-- 247 (327)
T ss_dssp --CGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred --cCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcH--
Confidence 677789999999997432211 12223458899999999764 48999999999999999998 9999976542
Q ss_pred CCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC
Q 011808 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT 328 (477)
Q Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt 328 (477)
. .+...+... .....+...+..+.+||.+||..||.+|||
T Consensus 248 ------~----~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 287 (327)
T 1fvr_A 248 ------A----ELYEKLPQG------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPS 287 (327)
T ss_dssp ------H----HHHHHGGGT------------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred ------H----HHHHHhhcC------------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence 1 122221110 011123345678999999999999999999
Q ss_pred HHHHhcCc
Q 011808 329 AAQALEHE 336 (477)
Q Consensus 329 ~~e~L~h~ 336 (477)
+++++++-
T Consensus 288 ~~ell~~L 295 (327)
T 1fvr_A 288 FAQILVSL 295 (327)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999873
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=345.93 Aligned_cols=258 Identities=16% Similarity=0.138 Sum_probs=197.4
Q ss_pred ccceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC---CCCeeEEEEEEEc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT---HENVVKLVNVHIN 99 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~ 99 (477)
.++|.+.++||+|+||.||+|.++. ...++..||||+++.. ....+.+|+.+++.++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 3679999999999999999995322 2346889999998653 2456778888888886 9999999999876
Q ss_pred CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc-------C
Q 011808 100 HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE-------G 171 (477)
Q Consensus 100 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~-------~ 171 (477)
.. ..|+||||+. ++|.+++..........+++..++.++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 139 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 139 QN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred CC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 54 6799999997 699999987554445679999999999999999999999999999999999999431 1
Q ss_pred CCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCC
Q 011808 172 EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~ 251 (477)
...+.+||+|||+++.+............+||+.|+|||++.+.. |+.++|||||||++|||+||+.||........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~-- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence 126889999999998654332233344567899999999998854 89999999999999999999999964432100
Q ss_pred cccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHH
Q 011808 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ 331 (477)
Q Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e 331 (477)
... . .......++.+.+||.+||+.+|.+|++..+
T Consensus 294 --~~~--------------~-----------------------------~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~ 328 (365)
T 3e7e_A 294 --KPE--------------G-----------------------------LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLD 328 (365)
T ss_dssp --EEC--------------S-----------------------------CCTTCSSHHHHHHHHHHHHCCCCTTCCCCHH
T ss_pred --eec--------------h-----------------------------hccccCcHHHHHHHHHHHcCCCCCCcchHHH
Confidence 000 0 0000012356779999999999999977665
Q ss_pred HhcCcc
Q 011808 332 ALEHEY 337 (477)
Q Consensus 332 ~L~h~~ 337 (477)
.|.+.+
T Consensus 329 ~l~~~l 334 (365)
T 3e7e_A 329 LLRQKL 334 (365)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 555543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=350.53 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=191.9
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
..|++.+.||+|+||.||+|++.........||||.++... .......+.+|+.++++++||||+++++++.... ...
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS-SCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-CCe
Confidence 35889999999999999999886543445679999987533 2234467789999999999999999999875433 367
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 167 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~~~~kL~DFG~ 238 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML----DEKFTVKVADFGL 238 (373)
T ss_dssp EEEEECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEECCC--
T ss_pred EEEEECCCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE----CCCCCEEEeeccc
Confidence 89999998 5999988653 2358899999999999999999999999999999999999 6777899999999
Q ss_pred ceeecCCCCc--ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 185 ARIYQAPLKF--LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 185 a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
++.+...... .......+|+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+... ....+
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--------~~~~~ 309 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYL 309 (373)
T ss_dssp -------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--------HHHHH
T ss_pred cccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--------HHHHH
Confidence 9865432211 112334567899999999874 48999999999999999999 788887654211 11111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.. + .....+..++..+.+||.+||+.||++|||+.+++++
T Consensus 310 ~~--~--------------------------------~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 310 LQ--G--------------------------------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HT--T--------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hc--C--------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 0 0011234456789999999999999999999999876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=327.49 Aligned_cols=250 Identities=23% Similarity=0.421 Sum_probs=200.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||+|.+. ++..||||++..... ....+.+|+.+++.++||||+++++++.+.. .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--P 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--S
T ss_pred hhheeeeeEecCCCceeEEEEEec----CCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--C
Confidence 478999999999999999999864 367899999976543 2357889999999999999999999986643 6
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|++|||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili----~~~~~~kl~dfg 149 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV----GENQVIKVSDFG 149 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE----CGGGCEEECCTT
T ss_pred eEEEEeCCCCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE----CCCCCEEEcccc
Confidence 899999997 58988887642 368999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++....... ........+++.|+|||++.+. .++.++|||||||++|+|++ |+.||...+. ......+.
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i~ 219 (267)
T 3t9t_A 150 MTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDIS 219 (267)
T ss_dssp GGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHH
T ss_pred ccccccccc-ccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHHh
Confidence 998654321 1122334557889999999864 48999999999999999999 8999976541 12222211
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
. .. ....+...+..+.+||.+||+.||.+|||+.+++++
T Consensus 220 ~----~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 220 T----GF------------------------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp T----TC------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c----CC------------------------------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1 00 011233446789999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=346.44 Aligned_cols=276 Identities=22% Similarity=0.307 Sum_probs=203.4
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..++|++.+.||+|+||.||+|+++ ++..||||++........ ...+.+|+.+++.++||||+++++++.+..
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 100 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTPT-- 100 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCS----SSCCEEEEECCC-----C-CCHHHHHHHGGGTCCCTTBCCCCEEECCSS--
T ss_pred HhhccccceeEecCCCcEEEEEEec----CCCEEEEEEeccccCchH-HHHHHHHHHHHHhccCCCccceEEEEecCC--
Confidence 3578999999999999999999633 588999999976554332 236789999999999999999999987644
Q ss_pred eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC---CeecCCCCCCcEEEeccCCCcccEEE
Q 011808 104 SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN---WIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 104 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..++||||+.+ +|.+++..... ....+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~----~~~~~~kl 175 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVV 175 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE----CTTCCEEE
T ss_pred ceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE----CCCCCEEe
Confidence 57899999984 88888876432 244599999999999999999999999 99999999999999 67778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..............+.+
T Consensus 176 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~- 252 (326)
T 3uim_A 176 GDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV- 252 (326)
T ss_dssp CCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH-
T ss_pred ccCccccccCccccc-ccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH-
Confidence 999999876543222 223355899999999997744 89999999999999999999999964332111111111110
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
...+... .... .....+....+...+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 253 --~~~~~~~---~~~~------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 253 --KGLLKEK---KLEA------------------LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp --TTTTSSC---CSTT------------------SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred --HHHhhch---hhhh------------------hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 0000000 0000 00001111112222356889999999999999999999999865
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.63 Aligned_cols=246 Identities=23% Similarity=0.413 Sum_probs=191.5
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
..++|++.+.||+|+||.||+|.+ ++..||||+++... ..+.+.+|+.+++.++||||+++++++.... .
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 88 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-G 88 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---
T ss_pred ChhhceEEeEEecCCCceEEEEEE-----cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-C
Confidence 368999999999999999999975 37889999997532 3567889999999999999999999876533 3
Q ss_pred eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+.+ +|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~~l~Df 161 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV----SEDNVAKVSDF 161 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTSCEEECCC
T ss_pred ceEEEEecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE----eCCCcEEEeec
Confidence 67999999985 99999876532 247899999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
|++....... ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...... +...
T Consensus 162 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~-- 225 (278)
T 1byg_A 162 GLTKEASSTQ-----DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVP-- 225 (278)
T ss_dssp CC-----------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--------GHHH--
T ss_pred cccccccccc-----cCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHH--
Confidence 9998654321 223458899999999764 48999999999999999998 99999765421 1111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.+... .....+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 226 --~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 226 --RVEKG------------------------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp --HHTTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHhcC------------------------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 11110 011133455688999999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=331.56 Aligned_cols=262 Identities=27% Similarity=0.417 Sum_probs=195.8
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHh--cCCCCeeEEEEEEEcC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE--ITHENVVKLVNVHINH 100 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~ 100 (477)
.+.++|++++.||+|+||.||+|++ ++..||||++... ......+|.+++.. ++||||+++++++...
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW-----QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTS 74 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE-----CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence 3578999999999999999999975 4788999998653 23455667777776 7999999999987543
Q ss_pred --CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhh--------hCCeecCCCCCCcEEEec
Q 011808 101 --ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH--------SNWIIHRDLKPSNILVMG 169 (477)
Q Consensus 101 --~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH--------~~givHrDikp~NILl~~ 169 (477)
....+|+||||+. ++|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+|||+
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill-- 146 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV-- 146 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE--
T ss_pred cCCCceeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE--
Confidence 3456899999998 589888843 36899999999999999999999 9999999999999999
Q ss_pred cCCCcccEEEeecccceeecCCCCcc--cCCCeeeccccccchhhcCCCC-----CCchhhHHHHHHHHHHHHhC-----
Q 011808 170 EGEEQGVVKIADFGLARIYQAPLKFL--SENGVVVTIWYRAPELLLGAKH-----YTSAVDMWAVGCIFAELLTL----- 237 (477)
Q Consensus 170 ~~~~~~~vkL~DFG~a~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~-----~~~~~DiwSlGvil~elltG----- 237 (477)
+.++.+||+|||+++......... .....+||+.|+|||++.+... ++.++|||||||++|||++|
T Consensus 147 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~ 224 (301)
T 3q4u_A 147 --KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224 (301)
T ss_dssp --CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred --cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcc
Confidence 677789999999998765433221 1233478999999999987532 34699999999999999999
Q ss_pred -----CCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHH
Q 011808 238 -----KPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY 312 (477)
Q Consensus 238 -----~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~ 312 (477)
..||........ ....+..+....... .. ++. ...+...+..+.
T Consensus 225 ~~~~~~~pf~~~~~~~~----~~~~~~~~~~~~~~~--~~------~~~-------------------~~~~~~~~~~l~ 273 (301)
T 3q4u_A 225 IVEDYKPPFYDVVPNDP----SFEDMRKVVCVDQQR--PN------IPN-------------------RWFSDPTLTSLA 273 (301)
T ss_dssp BCCCCCCTTTTTSCSSC----CHHHHHHHHTTSCCC--CC------CCG-------------------GGGGSHHHHHHH
T ss_pred ccccccccccccCCCCc----chhhhhHHHhccCCC--CC------CCh-------------------hhccCccHHHHH
Confidence 788865432211 112222211111000 00 000 001112235689
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 011808 313 DLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 313 dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+||.+||+.||.+|||+.++++.
T Consensus 274 ~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 274 KLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhhcChhhCCCHHHHHHH
Confidence 99999999999999999999853
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=337.41 Aligned_cols=257 Identities=23% Similarity=0.372 Sum_probs=194.5
Q ss_pred ccceeEEeeecccCceEEEEEEEeccc-CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAA-NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++.+.||+|+||.||+|+++.+. ..+..||||+++.... ......+.+|+.+++.++||||+++++++.+. .
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--K 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--S
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC--C
Confidence 468999999999999999999876432 2245799999975432 22344677899999999999999999998653 4
Q ss_pred eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+++||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~----~~~~~~kl~Df 191 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV----NSNLVCKVSDF 191 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEECCC
T ss_pred CcEEEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE----CCCCcEEECCC
Confidence 78999999985 888888764 2468999999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHH
Q 011808 183 GLARIYQAPLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 183 G~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|+++........ .......+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+... .+.+..
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~ 262 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKA 262 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHH
T ss_pred CcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHH
Confidence 999876542211 112223457889999999874 48999999999999999999 9999975542 111221
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+.... ....+..++..+.+||.+||+.||.+||++++++++
T Consensus 263 ~~~~~----------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 263 INDGF----------------------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHTTC----------------------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHCCC----------------------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11100 011233446789999999999999999999999876
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=354.71 Aligned_cols=264 Identities=19% Similarity=0.209 Sum_probs=200.9
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
+.+.++|+++++||+|+||.||+|++.. ++..||||++....... .+.+|+.+++.+.|.+++..+.++...
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~- 74 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVE- 74 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETT---TCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEE-
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECC---CCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEee-
Confidence 4567899999999999999999998654 68899999887654322 467899999999875444444443332
Q ss_pred CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 102 DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 102 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
....||||||++++|.+++... ...+++..++.|+.||+.||.|||++|||||||||+||||..+ +..+.+||+|
T Consensus 75 ~~~~~lvme~~g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~D 149 (483)
T 3sv0_A 75 GDYNVLVMDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIID 149 (483)
T ss_dssp TTEEEEEEECCCCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-GGTTCEEECC
T ss_pred CCEEEEEEECCCCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecC-CCCCeEEEEe
Confidence 3478999999999999998754 3469999999999999999999999999999999999999432 3567899999
Q ss_pred cccceeecCCCCc-----ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHH
Q 011808 182 FGLARIYQAPLKF-----LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256 (477)
Q Consensus 182 FG~a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~ 256 (477)
||+++.+...... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..... ...
T Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-----~~~ 223 (483)
T 3sv0_A 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-----KKQ 223 (483)
T ss_dssp CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-----HHH
T ss_pred CCcceeccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchh-----HHH
Confidence 9999877653321 122356789999999999875 48999999999999999999999998755321 122
Q ss_pred HHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 257 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.+..+........ .......++.++.+||.+||..||++||++.++++
T Consensus 224 ~~~~i~~~~~~~~------------------------------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 224 KYEKISEKKVATS------------------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHHHHHHSC------------------------------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhcccccc------------------------------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2222222110000 00112234678999999999999999999987765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=351.53 Aligned_cols=250 Identities=25% Similarity=0.411 Sum_probs=195.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||+|.++. +..||||+++.... ....+.+|+.+|+.++||||+++++++.+ ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECC----CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC---Cc
Confidence 4689999999999999999998753 56799999976432 24578899999999999999999999854 35
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill----~~~~~~kl~DfG 325 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV----GENLVCKVADFG 325 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCCC
T ss_pred eEEEehhhcCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE----CCCCCEEECCCc
Confidence 799999997 59999987543 2368999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+++...... ........++..|+|||++.+. .++.++|||||||++|||++ |+.||.+... .+.+..+.
T Consensus 326 ~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~ 395 (452)
T 1fmk_A 326 LARLIEDNE-YTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVE 395 (452)
T ss_dssp TTC---------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHH
T ss_pred cceecCCCc-eecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence 998764322 1122334457899999999864 48999999999999999999 9999986542 12222211
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.. .....+..++..+.+||.+||+.||++|||++++++.
T Consensus 396 ~~----------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~ 434 (452)
T 1fmk_A 396 RG----------------------------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 434 (452)
T ss_dssp TT----------------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC----------------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 10 0111234556789999999999999999999998864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=326.23 Aligned_cols=249 Identities=23% Similarity=0.407 Sum_probs=198.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++++.||+|+||.||+|++. ++..||||++..... ....+.+|+.+++.++||||+++++++.+. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQE---P 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---S
T ss_pred HHhhhheeeecCCCCeEEEEEEEc----CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcCC---C
Confidence 478999999999999999999854 467899999875432 346788999999999999999999987532 4
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.++||||+. ++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~kl~Dfg 154 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV----SDTLSCKIADFG 154 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTSCEEECCCT
T ss_pred cEEEEecCCCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE----cCCCCEEECCCc
Confidence 799999996 68988886532 1268999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
++........ .......+++.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+. .+.+..+.
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~ 224 (279)
T 1qpc_A 155 LARLIEDNEY-TAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLE 224 (279)
T ss_dssp TCEECSSSCE-ECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHH
T ss_pred ccccccCccc-ccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHHHHHHh
Confidence 9987654321 122334557889999999764 48999999999999999999 9999976542 11111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
. . .....+..++..+.+||.+||..||++|||++++++
T Consensus 225 ~----~------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 225 R----G------------------------------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp T----T------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c----c------------------------------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 0 001123445678999999999999999999999876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=328.50 Aligned_cols=257 Identities=24% Similarity=0.325 Sum_probs=198.1
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
-.|++.++||+|+||.||+|++..+...+..+|+|++..... ......+.+|+.+++.++||||+++++++.+... ..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG-LP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS-CC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC-Cc
Confidence 457788999999999999999876555666899999875332 2234567789999999999999999999876543 44
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+++|||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 99 ~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili----~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML----DESFTVKVADFGL 170 (298)
T ss_dssp EEEECCCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTCCEEECCTTS
T ss_pred EEEEecccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE----cCCCcEEeCcCCC
Confidence 88999986 7898888753 3468999999999999999999999999999999999999 6777899999999
Q ss_pred ceeecCCC--CcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccccCCCcccHHHHHHH
Q 011808 185 ARIYQAPL--KFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 185 a~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
++.+.... .........+++.|+|||++.+. .++.++|||||||++|+|++| .+||...+. ..+...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---------~~~~~~ 240 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---------FDLTHF 240 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---------GGHHHH
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCH---------HHHHHH
Confidence 97654322 11122334568999999999874 489999999999999999995 555554331 111111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..... ....+...+..+.+||.+||+.||.+|||+.++++.
T Consensus 241 ~~~~~---------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 241 LAQGR---------------------------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHTTC---------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcCC---------------------------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11110 011233456789999999999999999999998865
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=326.19 Aligned_cols=250 Identities=23% Similarity=0.382 Sum_probs=191.2
Q ss_pred CCCCccccccceeEE-eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHH-HhcCCCCeeEEE
Q 011808 17 NHGEKPEWLQQYNLI-GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLL-REITHENVVKLV 94 (477)
Q Consensus 17 ~~~~~~~~~~~Y~i~-~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~ 94 (477)
.......++++|.++ +.||+|+||.||+|+++. ++..||||++.. .....+|+.++ +.++||||++++
T Consensus 8 ~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~ 77 (299)
T 3m2w_A 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIV 77 (299)
T ss_dssp CCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEE
T ss_pred ccCcccccccchhhcCcccccCCCeEEEEEEEcC---CCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHH
Confidence 344556789999998 789999999999998764 688999999864 24677899988 566999999999
Q ss_pred EEEEc--CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC
Q 011808 95 NVHIN--HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 95 ~~~~~--~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~ 171 (477)
+++.. ..+..+|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+..+
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~- 153 (299)
T 3m2w_A 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK- 153 (299)
T ss_dssp EEEEEEETTEEEEEEEECCCCSCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS-
T ss_pred hhhhhhcCCCceEEEEEeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecC-
Confidence 99865 33557899999997 49999988743 3469999999999999999999999999999999999999432
Q ss_pred CCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCC
Q 011808 172 EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~ 251 (477)
..++.+||+|||++..... ..++.++|||||||++|+|++|+.||.+........
T Consensus 154 ~~~~~~kl~Dfg~a~~~~~-------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 208 (299)
T 3m2w_A 154 RPNAILKLTDFGFAKETTG-------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 208 (299)
T ss_dssp STTCCEEECCCTTCEECTT-------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C
T ss_pred CCCCcEEEecccccccccc-------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH
Confidence 1267899999999864321 237889999999999999999999997654211100
Q ss_pred cccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHH
Q 011808 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ 331 (477)
Q Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e 331 (477)
.. .. .+ ......+........+.++.+||.+||+.||.+|||+++
T Consensus 209 ~~-----------------------~~---------~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e 253 (299)
T 3m2w_A 209 GM-----------------------KT---------RI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 253 (299)
T ss_dssp CS-----------------------CC---------SS---CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HH-----------------------HH---------HH---hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHH
Confidence 00 00 00 000000000111345788999999999999999999999
Q ss_pred HhcCccCCC
Q 011808 332 ALEHEYFRI 340 (477)
Q Consensus 332 ~L~h~~f~~ 340 (477)
+|+||||+.
T Consensus 254 ~l~hp~~~~ 262 (299)
T 3m2w_A 254 FMNHPWIMQ 262 (299)
T ss_dssp HHTSHHHHT
T ss_pred HhcChhhcc
Confidence 999999973
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=349.05 Aligned_cols=255 Identities=16% Similarity=0.159 Sum_probs=190.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCC-CCe------------
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITH-ENV------------ 90 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~h-pnI------------ 90 (477)
...|.+.++||+|+||.||+|++.. +++.||||+++.... .....+.+.+|+.+++.+.| .|+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred ceeEEEecccccCCCEEEEEEEecC---CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 3458899999999999999998764 688999999874332 23446778899999999977 221
Q ss_pred ---------eEEEEEEEcCC---CceEEEEEeccCCCHHHHHHhhhc--ccCCCCCHHHHHHHHHHHHHHHHHhhhCCee
Q 011808 91 ---------VKLVNVHINHA---DMSLYLAFDYAEYDLYEIIRHHRD--KVNHTMNPYTVKSILWQLLNGLNYLHSNWII 156 (477)
Q Consensus 91 ---------v~l~~~~~~~~---~~~~~lv~e~~~~~L~~~l~~~~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~giv 156 (477)
..+..++.... ...++++|+++.++|.+++..... .....+++..+..++.||+.||.|||++||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 11111121111 234789999999999998864321 1123577888999999999999999999999
Q ss_pred cCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhc---------CCCCCCchhhHHHH
Q 011808 157 HRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLL---------GAKHYTSAVDMWAV 227 (477)
Q Consensus 157 HrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~---------~~~~~~~~~DiwSl 227 (477)
||||||+|||| +.++.+||+|||+++..... ....+| +.|+|||++. ....|+.++|||||
T Consensus 234 HrDiKp~NILl----~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 234 HTYLRPVDIVL----DQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CSCCCGGGEEE----CTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred cCCcccceEEE----ecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 99999999999 67777999999999865432 234567 9999999993 33458889999999
Q ss_pred HHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCC
Q 011808 228 GCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSP 307 (477)
Q Consensus 228 Gvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 307 (477)
||++|+|++|+.||.+.+....... + .......
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~~~~--------~---------------------------------------~~~~~~~ 336 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGGSEW--------I---------------------------------------FRSCKNI 336 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSCSGG--------G---------------------------------------GSSCCCC
T ss_pred HHHHHHHHHCCCCCCCcchhhhHHH--------H---------------------------------------HhhcccC
Confidence 9999999999999976543211100 0 0001234
Q ss_pred CchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 308 KSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 308 s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
+..+.+||.+||+.||.+|||+.++|+|+||+
T Consensus 337 ~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 337 PQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence 57899999999999999999999999999996
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=335.47 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=190.7
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc--CCCCeeEEEEEEEcC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI--THENVVKLVNVHINH 100 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~~~~~~~ 100 (477)
.+.++|++++.||+|+||.||+|+++ +..||||++.... .....+|.+++..+ +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-----GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-----TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-----CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 45689999999999999999999753 7899999986432 23455666666654 899999999998775
Q ss_pred CC--ceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC--------CeecCCCCCCcEEEec
Q 011808 101 AD--MSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN--------WIIHRDLKPSNILVMG 169 (477)
Q Consensus 101 ~~--~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------givHrDikp~NILl~~ 169 (477)
.. ..+|+||||+.+ +|.+++... .+++..++.++.||+.||.|||++ ||+||||||+|||+
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill-- 175 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV-- 175 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE--
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE--
Confidence 33 578999999974 999988653 589999999999999999999999 99999999999999
Q ss_pred cCCCcccEEEeecccceeecCCCCcc--cCCCeeeccccccchhhcCCCCCCc------hhhHHHHHHHHHHHHhC----
Q 011808 170 EGEEQGVVKIADFGLARIYQAPLKFL--SENGVVVTIWYRAPELLLGAKHYTS------AVDMWAVGCIFAELLTL---- 237 (477)
Q Consensus 170 ~~~~~~~vkL~DFG~a~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~------~~DiwSlGvil~elltG---- 237 (477)
+.++.+||+|||+++.+....... .....+||+.|+|||++.+.. ++. ++|||||||++|||+||
T Consensus 176 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 176 --KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp --CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred --CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcc
Confidence 667789999999998664432211 123457899999999998754 333 49999999999999999
Q ss_pred ------CCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchH
Q 011808 238 ------KPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311 (477)
Q Consensus 238 ------~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~ 311 (477)
..||........ ....+........ ....+ + ....+..++..+
T Consensus 253 ~~~~~~~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~------~-------------------~~~~~~~~~~~l 301 (337)
T 3mdy_A 253 GIVEEYQLPYHDLVPSDP----SYEDMREIVCIKK--LRPSF------P-------------------NRWSSDECLRQM 301 (337)
T ss_dssp TBCCCCCCTTTTTSCSSC----CHHHHHHHHTTSC--CCCCC------C-------------------GGGGGSHHHHHH
T ss_pred cccccccccHhhhcCCCC----chhhhHHHHhhhc--cCccc------c-------------------ccchhhHHHHHH
Confidence 555543322111 1111111111000 00000 0 000112234568
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 011808 312 YDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 312 ~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.+||.+||+.||.+|||+.++++|
T Consensus 302 ~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 302 GKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhhhhChhhCCCHHHHHHH
Confidence 899999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=362.10 Aligned_cols=247 Identities=20% Similarity=0.344 Sum_probs=193.9
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEec
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
++||+|+||.||+|.+.. ...+..||||+++...........+.+|+.+|++++||||+++++++.+. .+++||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~E~ 450 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQM-KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEM 450 (635)
T ss_dssp EEEEECSSEEEEEEEEEC-SSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEEC
T ss_pred CEeccCCCEEEEEEEEcC-CCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEEEc
Confidence 489999999999997653 24578999999987655445567888999999999999999999998643 47899999
Q ss_pred cC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 112 AE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 112 ~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+..
T Consensus 451 ~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl----~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 451 AELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL----VTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp CTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEECCTTHHHHTTC
T ss_pred cCCCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE----eCCCCEEEEEcCCcccccc
Confidence 98 5898888653 368999999999999999999999999999999999999 6667899999999987654
Q ss_pred CCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 191 PLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 191 ~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
.... .......+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+. .+....+ .. .
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i-~~---~ 588 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAML-EK---G 588 (635)
T ss_dssp -------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHH-HT---T
T ss_pred CccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-Hc---C
Confidence 3221 122234457889999999774 48999999999999999998 9999987652 1111111 11 0
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.....+..++.++.+||.+||+.||++|||++++++
T Consensus 589 ------------------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 589 ------------------------------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ------------------------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------------------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 011134456788999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=332.52 Aligned_cols=269 Identities=24% Similarity=0.393 Sum_probs=201.8
Q ss_pred ccceeEEeeecccCceEEEEEEEec-ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA-AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++++.||+|+||.||+|++.. +..++..||||++.... ......+.+|+.+++.++||||+++++++......
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 5679999999999999999998532 23568899999987532 33345778999999999999999999998776555
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli----~~~~~~kL~Df 189 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV----ENENRVKIGDF 189 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----EETTEEEECCC
T ss_pred ceEEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE----cCCCcEEEecC
Confidence 7899999997 59999987642 358999999999999999999999999999999999999 56678999999
Q ss_pred ccceeecCCCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc----CCCcccHHH
Q 011808 183 GLARIYQAPLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS----TQNPFQLDQ 257 (477)
Q Consensus 183 G~a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~----~~~~~~~~~ 257 (477)
|++.......... ......++..|+|||++.+.. ++.++|||||||++|+|+||..||....... .........
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 9998765433211 122334578899999998744 8899999999999999999999986431100 000000000
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
...+...+.. ......+..++..+.+||.+||..||.+|||+.++++
T Consensus 269 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 269 VFHLIELLKN------------------------------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHT------------------------------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhhc------------------------------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111111100 0011134456788999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=328.88 Aligned_cols=246 Identities=26% Similarity=0.421 Sum_probs=188.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||+|++. +..||||++... .....+.+|+.++++++||||+++++++.+ .
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~ 73 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-----AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN----P 73 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-----TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----T
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-----CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----C
Confidence 578999999999999999999753 678999998643 234577899999999999999999998753 3
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh---CCeecCCCCCCcEEEeccCCCcc-cEEE
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS---NWIIHRDLKPSNILVMGEGEEQG-VVKI 179 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDikp~NILl~~~~~~~~-~vkL 179 (477)
.|+||||+. ++|.+++..... ...+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++ .+||
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~~kl 147 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL----VAGGTVLKI 147 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEE----ETTTTEEEE
T ss_pred cEEEEEcCCCCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEE----eCCCCEEEE
Confidence 689999997 599888875421 1247889999999999999999999 899999999999999 4444 4899
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ...
T Consensus 148 ~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------~~~ 212 (307)
T 2eva_A 148 CDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGP---------AFR 212 (307)
T ss_dssp CCCCC-----------------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS---------HHH
T ss_pred cccccccccccc-----cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCcc---------HHH
Confidence 999999765432 1234579999999999874 4899999999999999999999999754321 111
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.......... ...+..++..+.+||.+||+.||.+|||+++++++
T Consensus 213 ~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 213 IMWAVHNGTR-------------------------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHTTCC-------------------------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCC-------------------------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1111111110 01223456789999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=357.56 Aligned_cols=250 Identities=25% Similarity=0.411 Sum_probs=200.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.++||+|+||.||+|.++. +..||||+++.... ....+.+|+.+|+.++||||+++++++.+ ..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT----TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC----CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee---cc
Confidence 4789999999999999999998753 56799999976432 34578899999999999999999999854 35
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+||||||+. ++|.+++.... ...+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll----~~~~~~kl~DFG 408 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV----GENLVCKVADFG 408 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCTT
T ss_pred ceEeeehhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE----cCCCcEEEcccc
Confidence 799999998 59999987543 2358999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+++.+.... ........++..|+|||++.+. .++.++|||||||++|||++ |+.||.+... .+.+..+.
T Consensus 409 ~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~ 478 (535)
T 2h8h_A 409 LARLIEDNE-YTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVE 478 (535)
T ss_dssp STTTCCCHH-HHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHH
T ss_pred cceecCCCc-eecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence 998654321 1112233457889999999864 48999999999999999999 9999986542 12222221
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.. .....+..++..+.+||.+||+.||++|||+++++..
T Consensus 479 ~~----------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 479 RG----------------------------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp TT----------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC----------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 10 0111234556789999999999999999999998864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=327.76 Aligned_cols=265 Identities=24% Similarity=0.336 Sum_probs=198.6
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC--CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD--GDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
|...+.||+|+||.||+|.+ ++..||||++..... .......+.+|+.+++.++||||+++++++.+.. .+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD--DL 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES-----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SC
T ss_pred cccCCccccCCCeEEEEEEE-----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC--ce
Confidence 44558999999999999973 478899999876432 2334567789999999999999999999986643 67
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|++|||+. ++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~kl~Dfg~ 179 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL----DEAFTAKISDFGL 179 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTCCEEECCCTT
T ss_pred EEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE----cCCCcEEEeeccc
Confidence 99999996 688888875432 3468999999999999999999999999999999999999 6777899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+................||+.|+|||++.+ .++.++|||||||++|+|++|..||.......... .+ ...
T Consensus 180 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-----~~---~~~ 249 (307)
T 2nru_A 180 ARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL-----DI---KEE 249 (307)
T ss_dssp CEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT-----HH---HHH
T ss_pred ccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH-----HH---HHH
Confidence 987654333333344568999999999876 37899999999999999999999998765332211 11 111
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+..... .+. .|.. ..+ ...+...+..+.+||.+||+.||.+|||+.+++++
T Consensus 250 ~~~~~~-~~~------~~~~------------~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 250 IEDEEK-TIE------DYID------------KKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHTTSC-CHH------HHSC------------SSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hhhhhh-hhh------hhcc------------ccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 100000 000 0000 000 00111223568899999999999999999999865
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=357.98 Aligned_cols=258 Identities=21% Similarity=0.318 Sum_probs=197.6
Q ss_pred cceeEEe-eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIG-KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~-~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|.+.+ .||+|+||.||+|.++.. .++..||||+++... .......+.+|+.+|+.++||||+++++++.+. .
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~ 409 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---A 409 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECS-SCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---S
T ss_pred cceeEcCcEEecCCCcEEEEEEEecC-CCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---C
Confidence 3456666 899999999999987642 356789999997653 233557888999999999999999999998653 4
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl----~~~~~vkL~DFG 481 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL----VNRHYAKISDFG 481 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEECCCS
T ss_pred eEEEEEeCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE----cCCCcEEEeecc
Confidence 899999998 5888887543 3468999999999999999999999999999999999999 666789999999
Q ss_pred cceeecCCCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
+++.+....... ......+++.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+. .+.+..+
T Consensus 482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i 552 (613)
T 2ozo_A 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFI 552 (613)
T ss_dssp TTTTCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--------HHHHHHH
T ss_pred CcccccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHHHH
Confidence 998664322211 11223446889999999864 48999999999999999998 9999987552 1222211
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh---cCccC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL---EHEYF 338 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L---~h~~f 338 (477)
.. . .....+..++.++.+||.+||+.||++|||+.+++ ++.|+
T Consensus 553 ~~----~------------------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 553 EQ----G------------------------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp HT----T------------------------------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred Hc----C------------------------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 11 0 01113445678899999999999999999999874 45554
Q ss_pred C
Q 011808 339 R 339 (477)
Q Consensus 339 ~ 339 (477)
.
T Consensus 599 ~ 599 (613)
T 2ozo_A 599 S 599 (613)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=332.29 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=194.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||+|+++. .+|+|+++...........+.+|+.+++.++||||+++++++.+.. .
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~ 103 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP--H 103 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS--C
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--c
Confidence 6899999999999999999997642 3999999876555544556678999999999999999999997654 6
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
++++|||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~----~-~~~~~l~Dfg 174 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY----D-NGKVVITDFG 174 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE----C---CCEECCCS
T ss_pred eEEEeecccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE----e-CCCEEEeecC
Confidence 899999997 5888887543 2368999999999999999999999999999999999999 3 4579999999
Q ss_pred cceeecCCCC---cccCCCeeeccccccchhhcC--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCc
Q 011808 184 LARIYQAPLK---FLSENGVVVTIWYRAPELLLG--------AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNP 252 (477)
Q Consensus 184 ~a~~~~~~~~---~~~~~~~~gt~~y~APE~l~~--------~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~ 252 (477)
++........ ........||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------ 248 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------ 248 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------
Confidence 9875432111 111223457999999999975 23478899999999999999999999976542
Q ss_pred ccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 011808 253 FQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332 (477)
Q Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~ 332 (477)
......+. ..... ...+...+.++.+||.+||..||.+|||+.++
T Consensus 249 --~~~~~~~~----~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l 293 (319)
T 2y4i_B 249 --EAIIWQMG----TGMKP-----------------------------NLSQIGMGKEISDILLFCWAFEQEERPTFTKL 293 (319)
T ss_dssp --HHHHHHHH----TTCCC-----------------------------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHH
T ss_pred --HHHHHHhc----cCCCC-----------------------------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 11111111 10000 00122346789999999999999999999999
Q ss_pred hcC
Q 011808 333 LEH 335 (477)
Q Consensus 333 L~h 335 (477)
++.
T Consensus 294 ~~~ 296 (319)
T 2y4i_B 294 MDM 296 (319)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=331.58 Aligned_cols=199 Identities=29% Similarity=0.422 Sum_probs=157.8
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHH--HHhcCCCCeeEEEEEEE---
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIML--LREITHENVVKLVNVHI--- 98 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~i--l~~l~hpnIv~l~~~~~--- 98 (477)
-+++|++++.||+|+||.||+|++ ++..||||++.... ...+..|..+ ++.++||||+++++++.
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-----DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred ChHHhheeeecccCCCeEEEEEEE-----CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 478999999999999999999964 47899999986532 2344444444 44589999999998653
Q ss_pred cCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhC---------CeecCCCCCCcEEEe
Q 011808 99 NHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSN---------WIIHRDLKPSNILVM 168 (477)
Q Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---------givHrDikp~NILl~ 168 (477)
......+|+||||+. ++|.+++... ..++..++.++.||+.||.|||+. ||+||||||+|||+
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill- 153 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV- 153 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE-
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE-
Confidence 233446899999996 6999988653 458889999999999999999999 99999999999999
Q ss_pred ccCCCcccEEEeecccceeecCCCC------cccCCCeeeccccccchhhcCC------CCCCchhhHHHHHHHHHHHHh
Q 011808 169 GEGEEQGVVKIADFGLARIYQAPLK------FLSENGVVVTIWYRAPELLLGA------KHYTSAVDMWAVGCIFAELLT 236 (477)
Q Consensus 169 ~~~~~~~~vkL~DFG~a~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~------~~~~~~~DiwSlGvil~ellt 236 (477)
+.++.+||+|||+++.+..... .......+||+.|+|||++.+. ..++.++|||||||++|||++
T Consensus 154 ---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 230 (336)
T 3g2f_A 154 ---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230 (336)
T ss_dssp ---CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT
T ss_pred ---cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh
Confidence 6677899999999987654221 1112234689999999999763 235678999999999999999
Q ss_pred CCCCCC
Q 011808 237 LKPLFQ 242 (477)
Q Consensus 237 G~~PF~ 242 (477)
|..||.
T Consensus 231 g~~p~~ 236 (336)
T 3g2f_A 231 RCTDLF 236 (336)
T ss_dssp TBGGGS
T ss_pred cCCcCC
Confidence 966553
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=326.97 Aligned_cols=260 Identities=24% Similarity=0.349 Sum_probs=196.8
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHh--cCCCCeeEEEEEEEcCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE--ITHENVVKLVNVHINHA 101 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~ 101 (477)
+.++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|+++++. ++||||+++++++....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ccccEEEEeeecCCCCcEEEEEEE-----cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 357899999999999999999975 3789999998643 23567789999887 78999999999987654
Q ss_pred C--ceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhh--------hCCeecCCCCCCcEEEecc
Q 011808 102 D--MSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH--------SNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 102 ~--~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH--------~~givHrDikp~NILl~~~ 170 (477)
. ..+|+||||+.+ +|.+++... .+++..++.++.||+.||.||| +.||+||||||+|||+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll--- 180 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--- 180 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---
T ss_pred CccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---
Confidence 3 268999999985 999988653 5899999999999999999999 8999999999999999
Q ss_pred CCCcccEEEeecccceeecCCCCcc--cCCCeeeccccccchhhcCCCC-----CCchhhHHHHHHHHHHHHhC------
Q 011808 171 GEEQGVVKIADFGLARIYQAPLKFL--SENGVVVTIWYRAPELLLGAKH-----YTSAVDMWAVGCIFAELLTL------ 237 (477)
Q Consensus 171 ~~~~~~vkL~DFG~a~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~-----~~~~~DiwSlGvil~elltG------ 237 (477)
+.++.+||+|||++.......... ......||+.|+|||++.+... ++.++|||||||++|+|++|
T Consensus 181 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 181 -KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp -CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred -CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 667789999999998776543221 2234568999999999976432 23689999999999999999
Q ss_pred ----CCCCCCcccccCCCcccHHHHHHHHHHhCCC-CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHH
Q 011808 238 ----KPLFQGAEAKSTQNPFQLDQLDKIFKILGHP-TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAY 312 (477)
Q Consensus 238 ----~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~ 312 (477)
..||........ . ...+...+... .... ++. .......+..+.
T Consensus 260 ~~~~~~p~~~~~~~~~----~---~~~~~~~~~~~~~~~~------~~~-------------------~~~~~~~~~~l~ 307 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDP----S---VEEMRKVVCEQKLRPN------IPN-------------------RWQSCEALRVMA 307 (342)
T ss_dssp CCCCCCTTTTTSCSSC----C---HHHHHHHHTTSCCCCC------CCG-------------------GGGTSHHHHHHH
T ss_pred ccccccCccccCcCcc----c---HHHHHHHHHHHHhCCC------Ccc-------------------cccchhHHHHHH
Confidence 677765432111 1 11222222110 0000 000 000111234688
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 011808 313 DLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 313 dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+||.+||+.||.+|||+.++++|
T Consensus 308 ~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 308 KIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhccChhhCCCHHHHHHH
Confidence 99999999999999999999977
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=364.85 Aligned_cols=285 Identities=25% Similarity=0.314 Sum_probs=200.4
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEc--
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHIN-- 99 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 99 (477)
...+++|++.+.||+|+||.||+|+++ .++..||||+++... .......+.+|+.+++.++||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~---~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQ---DTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCT---TTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEEC---CCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 345799999999999999999999755 368899999987542 22334567789999999999999999998754
Q ss_pred --CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc
Q 011808 100 --HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 100 --~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~ 176 (477)
......|+||||+. ++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||+..+ .....
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~-g~~~~ 162 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG-PQRLI 162 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECC-SSSCE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecC-CCcee
Confidence 22456799999996 699888876431 2358899999999999999999999999999999999999544 23446
Q ss_pred EEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHH
Q 011808 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~ 256 (477)
+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.....
T Consensus 163 vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-------- 230 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-------- 230 (676)
T ss_dssp EEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH--------
T ss_pred EEEcccccccccccccc---cccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchh--------
Confidence 99999999987654322 2345679999999999774 58999999999999999999999997542100
Q ss_pred HHHHHHHHhCCCCCC---CccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 257 QLDKIFKILGHPTPE---KWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 257 ~~~~i~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
.+...+...... .+........|. .............+..+.+||.+||.+||.+|||+++++
T Consensus 231 ---~~~~~i~~~~~~~~~~~~~l~g~~~~~-----------~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 231 ---QWHGKVREKSNEHIVVYDDLTGAVKFS-----------SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp ---HSSTTCC------CCSCCCCSSSCCCC-----------SSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred ---hhhhhhhcccchhhhhhhhhccccccc-----------cccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000000000000 000000000000 000001112223456789999999999999999999999
Q ss_pred cCccCC
Q 011808 334 EHEYFR 339 (477)
Q Consensus 334 ~h~~f~ 339 (477)
.|+||.
T Consensus 297 ~hp~F~ 302 (676)
T 3qa8_A 297 NVGCFQ 302 (676)
T ss_dssp CCTTHH
T ss_pred cCHHHH
Confidence 999996
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=355.14 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=200.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||+|.++.....+..||||+++... .......+.+|+.+++.++||||+++++++.+ ..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 464 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 464 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---Cc
Confidence 478999999999999999999987655567889999987533 22234577889999999999999999999843 25
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl----~~~~~vkL~DFG 536 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV----SSNDCVKLGDFG 536 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEECCCC
T ss_pred eEEEEEcCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE----eCCCCEEEEecC
Confidence 799999998 6898888754 2358999999999999999999999999999999999999 566789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+++........ ......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+... .+.+..+.
T Consensus 537 ~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--------~~~~~~i~ 606 (656)
T 2j0j_A 537 LSRYMEDSTYY-KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIE 606 (656)
T ss_dssp CCCSCCC-----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHH
T ss_pred CCeecCCCcce-eccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHH
Confidence 99876443221 22234557899999999764 58999999999999999997 9999986542 22222222
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
... ....+..++..+.+||.+||..||.+|||+.++++.
T Consensus 607 ~~~----------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 607 NGE----------------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HTC----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC----------------------------------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 110 011234456789999999999999999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=332.97 Aligned_cols=255 Identities=23% Similarity=0.246 Sum_probs=190.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC------CCCcHHHHHHHHHHHhcC---------CCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG------DGVSPTAIREIMLLREIT---------HEN 89 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~Ei~il~~l~---------hpn 89 (477)
.++|++++.||+|+||+||+|++ ++..||||++...... ......+.+|+.+++.++ |||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccchheeeecccCceEEEEEEe-----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 47899999999999999999985 4789999999865432 223367889999999886 888
Q ss_pred eeEEEEEEEcC----------------------------CCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHH
Q 011808 90 VVKLVNVHINH----------------------------ADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSIL 140 (477)
Q Consensus 90 Iv~l~~~~~~~----------------------------~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~ 140 (477)
|+++.+++... ....+|+||||+.+ ++++.+.. ..+++..++.++
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~ 167 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSIL 167 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHH
Confidence 88888875421 24579999999874 46655532 368999999999
Q ss_pred HHHHHHHHHhh-hCCeecCCCCCCcEEEeccCC----------------CcccEEEeecccceeecCCCCcccCCCeeec
Q 011808 141 WQLLNGLNYLH-SNWIIHRDLKPSNILVMGEGE----------------EQGVVKIADFGLARIYQAPLKFLSENGVVVT 203 (477)
Q Consensus 141 ~qil~aL~~LH-~~givHrDikp~NILl~~~~~----------------~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt 203 (477)
.||+.||.||| ++||+||||||+|||+..++. ....+||+|||+|+.... ...+||
T Consensus 168 ~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt 240 (336)
T 2vuw_A 168 HQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFC 240 (336)
T ss_dssp HHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECC
T ss_pred HHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEe
Confidence 99999999999 999999999999999965431 123899999999987653 235789
Q ss_pred cccccchhhcCCCCCCchhhHHHHHHH-HHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccc
Q 011808 204 IWYRAPELLLGAKHYTSAVDMWAVGCI-FAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHW 282 (477)
Q Consensus 204 ~~y~APE~l~~~~~~~~~~DiwSlGvi-l~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 282 (477)
+.|+|||++.+.. +.++|||||+++ .+++++|..||.+.. +.......+...........
T Consensus 241 ~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~---------- 301 (336)
T 2vuw_A 241 DVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVL-------WLHYLTDKMLKQMTFKTKCN---------- 301 (336)
T ss_dssp CCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHH-------HHHHHHHHHHHTCCCSSCCC----------
T ss_pred ecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchh-------hhhHHHHhhhhhhccCcccc----------
Confidence 9999999998744 889999998777 788899999985311 00111222222111110000
Q ss_pred cccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh-cCccCC
Q 011808 283 QSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL-EHEYFR 339 (477)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L-~h~~f~ 339 (477)
...+...++++.+||++||++| |++|+| +||||+
T Consensus 302 ------------------~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 302 ------------------TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp ------------------SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ------------------hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 0011123567999999999988 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=354.14 Aligned_cols=244 Identities=25% Similarity=0.359 Sum_probs=193.4
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC-
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD- 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~- 102 (477)
+.++|++++.||+|+||.||+|+++. .+++.||||++..... ......+.+|+.++++++||||+++++++.....
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRN--VNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGG--GTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcC--CCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 44899999999999999999998753 2578999999875322 2233466789999999999999999999876442
Q ss_pred --ceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 103 --MSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 103 --~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
..+||||||+++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.+ .+||
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll----~~~-~~kl 222 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML----TEE-QLKL 222 (681)
T ss_dssp SCEEEEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CSS-CEEE
T ss_pred CCceeEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEE----eCC-cEEE
Confidence 237999999985 6655443 268999999999999999999999999999999999999 332 7999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+++..... ...+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+......... .
T Consensus 223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~---~--- 288 (681)
T 2pzi_A 223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED---D--- 288 (681)
T ss_dssp CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTT---C---
T ss_pred EecccchhcccC------CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccccccc---c---
Confidence 999999876532 335679999999999763 48899999999999999999999875432111000 0
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
.....++.+.+||.+||++||.+||++.+++.|+|+.
T Consensus 289 -------------------------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 289 -------------------------------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -------------------------------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------------------------------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0001135688999999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=309.14 Aligned_cols=230 Identities=15% Similarity=0.070 Sum_probs=178.3
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
.+.++|++++.||+|+||.||+|++.. +++.||||++....... .....+.+|+.+++.++||||+++++++.+..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 104 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTA---LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA 104 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETT---TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecC---CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence 345789999999999999999998753 68999999998654432 23357788999999999999999999997753
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.+|+||||++ ++|.+++.. .....++..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 105 --~~~lv~e~~~g~~L~~~l~~-------~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll----~~~g~~kl~ 171 (286)
T 3uqc_A 105 --GGLVVAEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV----SIDGDVVLA 171 (286)
T ss_dssp --EEEEEEECCCEEEHHHHHTT-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----ETTSCEEEC
T ss_pred --cEEEEEEecCCCCHHHHHhc-------CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE----cCCCCEEEE
Confidence 7899999998 588888743 24566789999999999999999999999999999999 566778887
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
+++ |++ .++.++|||||||++|+|+||+.||.+.+.........
T Consensus 172 ~~~----------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~------ 215 (286)
T 3uqc_A 172 YPA----------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE------ 215 (286)
T ss_dssp SCC----------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC------
T ss_pred ecc----------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH------
Confidence 443 332 27889999999999999999999998765321100000
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
. ...............++..+.+||.+||++||.+| |+.++++.
T Consensus 216 ----------------~--------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 216 ----------------R--------------DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp ----------------B--------------CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred ----------------H--------------HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 0 00000000011234557889999999999999999 99999875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=290.96 Aligned_cols=187 Identities=16% Similarity=0.059 Sum_probs=127.1
Q ss_pred eecccCceEEEEEEEecccCCCcEEEEEecccCCCCC--------CCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCc
Q 011808 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD--------GVSPTAIREIMLLREI-THENVVKLVNVHINHADM 103 (477)
Q Consensus 33 ~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 103 (477)
.++.|++|.+..++... .|..++||++....... ...+.+.+|+++|+++ .|+||+++++++++. .
T Consensus 241 ~~~~~~~~~h~~~rr~~---fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYF---FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--Q 315 (569)
T ss_dssp C-C--------CCEEEE---ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--S
T ss_pred ccccCCccccccccccc---ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--C
Confidence 45667777766665443 58889999997654322 1224577899999999 799999999999764 4
Q ss_pred eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+||||||++| +|.++|... +.+++. .|+.||+.||+|||++|||||||||+|||| +.++.+||+||
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL----~~dg~vKL~DF 383 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV----DARQHARLIDF 383 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE----CTTSCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE----CCCCCEEEeec
Confidence 79999999995 999998763 356654 588999999999999999999999999999 67788999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL 240 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~P 240 (477)
|+|+....... .....+||+.|||||++.+. +..++|+||+|+++++|+++..+
T Consensus 384 GlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 384 GSIVTTPQDCS--WPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp TTEESCC---C--CSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred ccCeeCCCCCc--cccCceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence 99987654322 23347899999999999873 57789999999999888765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.5e-27 Score=246.97 Aligned_cols=187 Identities=18% Similarity=0.180 Sum_probs=136.1
Q ss_pred eEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCC------cHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 29 NLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV------SPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 29 ~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
...+.||+|+||.||+|.. .+..+++|+.......... .+.+.+|++++++++||||+++..++.+..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~- 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD- 412 (540)
T ss_dssp ---------CCEEEEEEEC-----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT-
T ss_pred CCCCEEeeCCCEEEEEEEE-----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC-
Confidence 3456899999999999942 4678899987553322211 234678999999999999994443333333
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..||||||++ ++|.+++.. +..++.||++||.|||++||+||||||+|||+ +. .+||+|
T Consensus 413 -~~~lVmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl----~~--~~kL~D 472 (540)
T 3en9_A 413 -NKRIMMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF----DK--DLYIID 472 (540)
T ss_dssp -TTEEEEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE----SS--SEEECC
T ss_pred -ccEEEEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE----CC--eEEEEE
Confidence 3599999997 688887643 56899999999999999999999999999999 44 799999
Q ss_pred cccceeecCCCCcc-----cCCCeeeccccccchhhcCC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 011808 182 FGLARIYQAPLKFL-----SENGVVVTIWYRAPELLLGA-KHYTSAVDMWAVGCIFAELLTLKPLF 241 (477)
Q Consensus 182 FG~a~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~elltG~~PF 241 (477)
||+++......... .....+||+.|||||++.+. ..|+..+|+||..+-..+.+.++.+|
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99999775432111 11246789999999999651 23777889999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=202.44 Aligned_cols=143 Identities=20% Similarity=0.157 Sum_probs=109.2
Q ss_pred eEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC----------------CcHHHHHHHHHHHhcCCCCeeE
Q 011808 29 NLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG----------------VSPTAIREIMLLREITHENVVK 92 (477)
Q Consensus 29 ~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~----------------~~~~~~~Ei~il~~l~hpnIv~ 92 (477)
.+.+.||+|+||.||+|++ . ++..||||+++....... ....+.+|+.+++.++| ++
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~-~---~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~ 165 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYS-E---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LA 165 (282)
T ss_dssp EEEEEEEECSSEEEEEEEE-T---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SS
T ss_pred EecCEeccCCCceEEEEEe-C---CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CC
Confidence 3449999999999999986 2 588999999975432111 13457789999999984 55
Q ss_pred EEEEEEcCCCceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC
Q 011808 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 93 l~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~ 171 (477)
+.+++.. ...|+||||+++ +|.+ +. ......++.||+.||.|||++||+||||||+|||+
T Consensus 166 v~~~~~~---~~~~lvmE~~~g~~L~~-l~-----------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---- 226 (282)
T 1zar_A 166 VPKVYAW---EGNAVLMELIDAKELYR-VR-----------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---- 226 (282)
T ss_dssp SCCEEEE---ETTEEEEECCCCEEGGG-CC-----------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE----
T ss_pred cCeEEec---cceEEEEEecCCCcHHH-cc-----------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE----
Confidence 5554433 245999999985 7655 21 12356799999999999999999999999999999
Q ss_pred CCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhc
Q 011808 172 EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLL 213 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~ 213 (477)
+ ++.+||+|||+++. +..++|||++.
T Consensus 227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 5 67899999999963 44578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-20 Score=180.35 Aligned_cols=138 Identities=22% Similarity=0.230 Sum_probs=104.0
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcE--EEEEecccCCCCCC----------------------CcHHHHHHHHHHH
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKA--IAIKKFKQSKDGDG----------------------VSPTAIREIMLLR 83 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~--vaiK~~~~~~~~~~----------------------~~~~~~~Ei~il~ 83 (477)
|++.+.||+|+||.||+|.+.. +|.. ||||+++....... ....+.+|+.+|+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~---~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF---DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE---TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC---CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 7899999999999999998743 5778 99999765421110 0125678999999
Q ss_pred hcCCCCe--eEEEEEEEcCCCceEEEEEeccCC------CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhh-hCC
Q 011808 84 EITHENV--VKLVNVHINHADMSLYLAFDYAEY------DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH-SNW 154 (477)
Q Consensus 84 ~l~hpnI--v~l~~~~~~~~~~~~~lv~e~~~~------~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~g 154 (477)
.+.|++| ..++++ . ..+|||||+++ .|.+.... .++..+..++.||+.+|.||| +.|
T Consensus 126 ~l~~~~i~~p~~~~~--~----~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY--M----KNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHHHTTCCCCCEEEE--E----TTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HHHhCCCCCCeEEEc--C----CCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 9987754 444442 2 34899999953 55544321 234567899999999999999 999
Q ss_pred eecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 155 IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 155 ivHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
|+||||||+|||+ +. .++|+|||+|...
T Consensus 192 ivHrDlkp~NILl----~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 LVHADLSEYNIMY----ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EECSSCSTTSEEE----SS--SEEECCCTTCEET
T ss_pred EEeCCCCHHHEEE----cC--cEEEEECcccccC
Confidence 9999999999999 44 7999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.2e-17 Score=164.61 Aligned_cols=140 Identities=16% Similarity=0.180 Sum_probs=96.7
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC------------CCcH--------HHHHHHHHHHhcCC
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD------------GVSP--------TAIREIMLLREITH 87 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~--------~~~~Ei~il~~l~h 87 (477)
|++.+.||+|+||.||+|.+. +|+.||||+++...... .... .+.+|...|.++.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~----~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE----KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT----TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEECC----CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 899999999999999999753 58999999986432110 0011 12346777777754
Q ss_pred CCe--eEEEEEEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcE
Q 011808 88 ENV--VKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNI 165 (477)
Q Consensus 88 pnI--v~l~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NI 165 (477)
.++ ...+++ .. .+|||||++|..+.. ......+..++.||+.+|.+||+.|||||||||.||
T Consensus 173 ~gv~vp~p~~~--~~----~~LVME~i~G~~L~~----------l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NI 236 (397)
T 4gyi_A 173 EGFPVPEPIAQ--SR----HTIVMSLVDALPMRQ----------VSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNI 236 (397)
T ss_dssp TTCSCCCEEEE--ET----TEEEEECCSCEEGGG----------CCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred cCCCCCeeeec--cC----ceEEEEecCCccHhh----------hcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHE
Confidence 443 223332 21 279999999732211 112234577899999999999999999999999999
Q ss_pred EEeccCCC------cccEEEeeccccee
Q 011808 166 LVMGEGEE------QGVVKIADFGLARI 187 (477)
Q Consensus 166 Ll~~~~~~------~~~vkL~DFG~a~~ 187 (477)
|+..+++. ...+.|+||+-+..
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EEeCCCCcccccccccceEEEEeCCccc
Confidence 99655321 12488999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=3.8e-11 Score=113.94 Aligned_cols=141 Identities=17% Similarity=0.131 Sum_probs=106.2
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 101 (477)
.++..|++...++.|+.+.||++.. .+..+++|+........ ...+.+|+.+++.+. +..+.++++++.+.
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-----~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~- 82 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHD- 82 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-----SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEET-
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-----CCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecC-
Confidence 4578899999999999999999852 36789999987532111 224678999999884 67788899887653
Q ss_pred CceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh----------------------------
Q 011808 102 DMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS---------------------------- 152 (477)
Q Consensus 102 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~---------------------------- 152 (477)
...|+|||+++| ++.+.+ .+......++.++..+|..||+
T Consensus 83 -~~~~lv~e~i~G~~l~~~~----------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T 3tm0_A 83 -GWSNLLMSEADGVLCSEEY----------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp -TEEEEEEECCSSEEHHHHC----------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred -CceEEEEEecCCeehhhcc----------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence 478999999998 444321 1112345778899999999998
Q ss_pred -------------------------------CCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 153 -------------------------------NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 153 -------------------------------~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
..++|+|+++.|||+ ++...+.|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~----~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV----KDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE----ETTEEEEECCCTTCE
T ss_pred ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEE----ECCcEEEEEEchhcc
Confidence 459999999999999 444456799999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=2.7e-10 Score=107.46 Aligned_cols=138 Identities=14% Similarity=0.072 Sum_probs=94.2
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCC--eeEEEEEEEcC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN--VVKLVNVHINH 100 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~ 100 (477)
..+..|.+....+.|..+.||++.. .++..+++|...... ...+.+|+.+++.+.+.+ +.+++.+..+.
T Consensus 17 ~~~~~~~~~~~~~gg~~~~v~~~~~----~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 17 ERLFGYDWAQQTIGCSDAAVFRLSA----QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TTTTTCEEEECSCTTSSCEEEEEEC----TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred HhcCCCceEecccCCCCceEEEEec----CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 4456777766656677799999852 246779999976431 124668999999885434 56688776543
Q ss_pred CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC--------------------------
Q 011808 101 ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW-------------------------- 154 (477)
Q Consensus 101 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g-------------------------- 154 (477)
...|++|||++|.... .. ..+ ...++.+++..|..||+..
T Consensus 88 --~~~~~v~e~i~G~~l~-~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (264)
T 1nd4_A 88 --GRDWLLLGEVPGQDLL-SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLV 153 (264)
T ss_dssp --SCEEEEEECCSSEETT-TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCC
T ss_pred --CCCEEEEEecCCcccC-cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCc
Confidence 3579999999974222 10 111 2245666667777777543
Q ss_pred --------------------------------eecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 155 --------------------------------IIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 155 --------------------------------ivHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
++|+|++|.|||+ +++..+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~----~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 154 DQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMV----ENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEE----ETTEEEEECCCTTCEE
T ss_pred cchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEE----ECCcEEEEEcchhccc
Confidence 9999999999999 4445567999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.00 E-value=3.1e-10 Score=110.27 Aligned_cols=187 Identities=20% Similarity=0.199 Sum_probs=114.0
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCC--eeEEEEEEEcCCC-ceEE
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THEN--VVKLVNVHINHAD-MSLY 106 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpn--Iv~l~~~~~~~~~-~~~~ 106 (477)
++.|+.|....||++. ..+++|+.... .....+.+|+.+|+.+ .+.. +.+++........ ...|
T Consensus 25 i~~~~~G~~n~v~~v~--------~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~ 92 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN--------RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF 92 (304)
T ss_dssp CCEEEECSSEEEEEST--------TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred eEecCCCCcceEEEEC--------CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence 4568999999999862 45888886432 2234677899999888 3332 3444443322211 2348
Q ss_pred EEEeccCCC-HHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------
Q 011808 107 LAFDYAEYD-LYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS--------------------------------- 152 (477)
Q Consensus 107 lv~e~~~~~-L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~--------------------------------- 152 (477)
+||++++|. +...... .++..+...++.+++..|..||+
T Consensus 93 ~vm~~i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 93 AGFTKIKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp EEEECCCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred EEEcccCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 899999973 3222111 35666677777777777777775
Q ss_pred -------------------------CCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCe---eec-
Q 011808 153 -------------------------NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV---VVT- 203 (477)
Q Consensus 153 -------------------------~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~---~gt- 203 (477)
..++|+|+++.|||+..+ ....+.|+||+.+...+........... .+.
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~--~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE--KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME 243 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT--TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHH
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC--CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHH
Confidence 247999999999999432 1456889999998764332111000000 000
Q ss_pred --------ccccc-chhhcCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 011808 204 --------IWYRA-PELLLGAKHYTSAVDMWAVGCIFAELLTLKPLF 241 (477)
Q Consensus 204 --------~~y~A-PE~l~~~~~~~~~~DiwSlGvil~elltG~~PF 241 (477)
..... |+.... .....+.|+++.++|.+.+|..+|
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00111 222211 122368999999999999998776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=3e-09 Score=105.76 Aligned_cols=146 Identities=14% Similarity=0.162 Sum_probs=101.1
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecc--cCCCCCCCcHHHHHHHHHHHhcC--CCCeeEEEEEEEcCCC-
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFK--QSKDGDGVSPTAIREIMLLREIT--HENVVKLVNVHINHAD- 102 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~- 102 (477)
..-++.|+.|.++.||++.. .+..+++|+.. ..... .....+.+|+.+++.+. +..+.+++.++.+...
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~-----~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~ 113 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT-----PGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI 113 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC-----SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred CceEEEcCCcccceEEEEEE-----CCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence 34577899999999999863 24578889876 32211 12235668999999996 4567888887755421
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh------------------------------
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS------------------------------ 152 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~------------------------------ 152 (477)
...|+||||++|..... .....+++.+...++.+++.+|..||+
T Consensus 114 g~~~~vme~v~G~~l~~------~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWD------QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK 187 (359)
T ss_dssp SSCEEEEECCCCBCCCC------TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred CCeEEEEEecCCeecCC------CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence 34689999999742210 011246788888999999999999997
Q ss_pred ----------------------------CCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 153 ----------------------------NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 153 ----------------------------~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
..++|+|+++.|||+..++ ...+.|+||+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~--~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE--PRVLAVLDWELSTL 248 (359)
T ss_dssp HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS--SCEEEECCCTTCEE
T ss_pred hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC--CcEEEEECcccccc
Confidence 3699999999999994321 13468999999865
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=2.5e-06 Score=82.65 Aligned_cols=72 Identities=17% Similarity=0.202 Sum_probs=49.4
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCC---CeeEEEEEEEcCCCceEEE
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE---NVVKLVNVHINHADMSLYL 107 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~~~~~~~l 107 (477)
++.++.|....||+. +..+++|+.... .....+.+|+.+|+.+.+. .|.+++.+... .....|+
T Consensus 24 v~~l~~G~~n~v~~v--------g~~~VlR~~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------NGDWVFRFPKSQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE--------TTTEEEEEESSH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEE
T ss_pred eeecCCCcceeEEEE--------CCEEEEEecCCc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEE
Confidence 456888999999987 345888875321 1234677899999999642 35566666542 2345689
Q ss_pred EEeccCCC
Q 011808 108 AFDYAEYD 115 (477)
Q Consensus 108 v~e~~~~~ 115 (477)
+|++++|.
T Consensus 91 v~e~i~G~ 98 (306)
T 3tdw_A 91 GYRKVQGQ 98 (306)
T ss_dssp EEECCCSE
T ss_pred EEeccCCe
Confidence 99999973
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=3.6e-05 Score=72.59 Aligned_cols=139 Identities=19% Similarity=0.211 Sum_probs=85.9
Q ss_pred ccceeEEeeecccCce-EEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYG-LVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g-~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 102 (477)
+..|+... +..|..+ .||+.... ..+..+++|+.... ....+.+|..+|+.+. +--+.+++.++.+.+
T Consensus 24 l~g~~~~~-~~~G~S~~~v~rl~~~---~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~- 93 (272)
T 4gkh_A 24 LYGYRWAR-DNVGQSGATIYRLYGK---PNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD- 93 (272)
T ss_dssp HTTCEEEE-EECSSSSCEEEEEECC---TTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred ccCCeEEE-ccCCCcCCeEEEEEec---CCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC-
Confidence 34455433 4445444 68887533 34667899986532 2345678999999884 334667777776543
Q ss_pred ceEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-----------------------------
Q 011808 103 MSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS----------------------------- 152 (477)
Q Consensus 103 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~----------------------------- 152 (477)
..|+|||+++| .+.+..... ......+..++...|..||.
T Consensus 94 -~~~lvme~l~G~~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (272)
T 4gkh_A 94 -DAWLLTTAIPGKTAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVD 163 (272)
T ss_dssp -EEEEEEECCCSEEHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCC
T ss_pred -eEEEEEEeeCCccccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhh
Confidence 67999999997 333332211 01122334444444444442
Q ss_pred -----------------------------CCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 153 -----------------------------NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 153 -----------------------------~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
..++|+|+.+.|||+ +..+.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~----~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 164 ASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIF----DEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEE----ETTEEEEECCCTTCEE
T ss_pred hhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEE----ECCeEEEEEECccccc
Confidence 127999999999999 4455667999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=5.1e-05 Score=76.07 Aligned_cols=78 Identities=17% Similarity=0.102 Sum_probs=48.3
Q ss_pred EEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC--C---CCCcHHHHHHHHHHHhcCC--C-CeeEEEEEEEcCC
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD--G---DGVSPTAIREIMLLREITH--E-NVVKLVNVHINHA 101 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~---~~~~~~~~~Ei~il~~l~h--p-nIv~l~~~~~~~~ 101 (477)
-++.||.|.++.||++.+.. .+..++||....... . .........|..+|+.+.. + .+.+++.+ +.+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~---~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~ 108 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE 108 (397)
T ss_dssp EEEECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT
T ss_pred EEEECCCCceEEEEEEEECC---CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC
Confidence 46789999999999996432 356799997643211 0 1123456779999888732 3 34456543 222
Q ss_pred CceEEEEEeccCC
Q 011808 102 DMSLYLAFDYAEY 114 (477)
Q Consensus 102 ~~~~~lv~e~~~~ 114 (477)
..++|||++++
T Consensus 109 --~~~lvmE~l~g 119 (397)
T 2olc_A 109 --MAVTVMEDLSH 119 (397)
T ss_dssp --TTEEEECCCTT
T ss_pred --ccEEEEEeCCC
Confidence 24799999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=0.00011 Score=72.42 Aligned_cols=86 Identities=8% Similarity=0.047 Sum_probs=52.0
Q ss_pred eEEeee-cccCceEEEEEEEecccC---CCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcC-C--CCeeEEEEEEEcC
Q 011808 29 NLIGKI-GEGTYGLVFLARIKAAAN---RGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREIT-H--ENVVKLVNVHINH 100 (477)
Q Consensus 29 ~i~~~l-G~G~~g~Vy~a~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~ 100 (477)
..++.| +.|....+|++....... .+..+++|....... .......+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345677 888899999886431000 156789998754320 0001124567888888773 2 3567777766443
Q ss_pred C-CceEEEEEeccCC
Q 011808 101 A-DMSLYLAFDYAEY 114 (477)
Q Consensus 101 ~-~~~~~lv~e~~~~ 114 (477)
. ....|++||+++|
T Consensus 103 ~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 DVLGTPFFLMDYVEG 117 (357)
T ss_dssp TTTSSCEEEEECCCC
T ss_pred CccCCceEEEEecCC
Confidence 2 1245789999986
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00035 Score=67.92 Aligned_cols=31 Identities=19% Similarity=0.295 Sum_probs=26.4
Q ss_pred CCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 153 NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 153 ~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
..++|+|+++.|||+ +.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~----~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLL----GENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEE----CGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEE----eCCCcEEEEehhhccc
Confidence 579999999999999 5456799999998753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0012 Score=63.38 Aligned_cols=68 Identities=18% Similarity=0.141 Sum_probs=41.4
Q ss_pred EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCCceEEEEE
Q 011808 31 IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENV-VKLVNVHINHADMSLYLAF 109 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~~~lv~ 109 (477)
++.|+.|....+|++ ..+++|+........ . ...+|+.+++.+..-++ .+++.+. .+ .-++++
T Consensus 23 i~~l~gG~tN~~~~~---------~~~vlR~~~~~~~~~--~-~r~~E~~~l~~l~~~g~~P~~~~~~--~~--~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---------GDLCLRIPGKGTEEY--I-NRANEAVAAREAAKAGVSPEVLHVD--PA--TGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE---------TTEEEEEECC----C--C-CHHHHHHHHHHHHHTTSSCCEEEEC--TT--TCCEEE
T ss_pred eeEcCCcccccccee---------eeEEEECCCCCccce--e-CHHHHHHHHHHHHHcCCCCceEEEE--CC--CCEEEE
Confidence 788999999999988 248888876532111 1 22458877777632222 4555543 22 126789
Q ss_pred ecc-CC
Q 011808 110 DYA-EY 114 (477)
Q Consensus 110 e~~-~~ 114 (477)
+|+ +|
T Consensus 87 e~i~~g 92 (301)
T 3dxq_A 87 RYIAGA 92 (301)
T ss_dssp ECCTTC
T ss_pred eecCCC
Confidence 999 65
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0025 Score=57.55 Aligned_cols=97 Identities=21% Similarity=0.126 Sum_probs=61.9
Q ss_pred CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhh-hCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCC
Q 011808 115 DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH-SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK 193 (477)
Q Consensus 115 ~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~ 193 (477)
+|.++|... +.+++|.++|.++.|.+.+|.-+- .+.-..+=+.|..|+| ..+|.|-+.+ ..+.
T Consensus 34 SL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l----~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 34 SLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV----WRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE----ETTSCEEECC-C----------
T ss_pred cHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE----ecCCceeccc-cccc-------
Confidence 688888765 568999999999999999988762 1222234455788888 4445565543 1110
Q ss_pred cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh
Q 011808 194 FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT 236 (477)
Q Consensus 194 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt 236 (477)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 -------~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -------AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred -------ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 0133467888764 235678899999999999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0027 Score=63.95 Aligned_cols=79 Identities=10% Similarity=0.031 Sum_probs=45.6
Q ss_pred hhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeee--ccccccchhhcCCCC--CCchhhHHH
Q 011808 151 HSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV--TIWYRAPELLLGAKH--YTSAVDMWA 226 (477)
Q Consensus 151 H~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~g--t~~y~APE~l~~~~~--~~~~~DiwS 226 (477)
+...++|+|+++.|||+ +.++ ++|+||+.+..-........ ... ...|++++....... -....++.+
T Consensus 230 ~~~~liHGDl~~~Nil~----~~~~-~~lID~e~a~~G~p~~Dla~---~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMV----TQDS-TQVIDPEFSFYGPMGFDIGA---YLGNLILAFFAQDGHATQENDRKEYKQWILR 301 (420)
T ss_dssp BCCEEECSCCSGGGEEE----CSSC-EEECCCTTCEEECHHHHHHH---HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEE----eCCC-CEEEeCcccccCchHHHHHH---HHHHHHHHHHhcccccccccchHHHHHHHHH
Confidence 45689999999999999 4333 99999998875332111000 000 234566665532110 112344557
Q ss_pred HHHHHHHHHhC
Q 011808 227 VGCIFAELLTL 237 (477)
Q Consensus 227 lGvil~elltG 237 (477)
+...+++.+++
T Consensus 302 ~~~~~~~~y~~ 312 (420)
T 2pyw_A 302 TIEQTWNLFNK 312 (420)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 77777776653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0013 Score=63.50 Aligned_cols=83 Identities=12% Similarity=0.137 Sum_probs=43.9
Q ss_pred ccccceeE-----EeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCC--eeEEEE
Q 011808 23 EWLQQYNL-----IGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN--VVKLVN 95 (477)
Q Consensus 23 ~~~~~Y~i-----~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~ 95 (477)
.++.+|.+ ++.|+.|....+|++... +..+++|....... ...+..|+.+++.|...+ +.+++.
T Consensus 14 ~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-----~g~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 14 NFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-----KDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp HHHTTBCCCCEEEEEEECC---EEEEEEEES-----SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred HHHHhCCCCcceEeeccCCCcccceEEEEeC-----CccEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 34455543 456777888999998532 23688998865311 124556788777763212 233332
Q ss_pred EEEc----CCCceEEEEEeccCC
Q 011808 96 VHIN----HADMSLYLAFDYAEY 114 (477)
Q Consensus 96 ~~~~----~~~~~~~lv~e~~~~ 114 (477)
.... ......+++|++++|
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G 107 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEG 107 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCC
T ss_pred CCCCCEEEEECCEEEEEEEeCCC
Confidence 1000 001356899999886
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0084 Score=57.81 Aligned_cols=73 Identities=14% Similarity=0.065 Sum_probs=53.8
Q ss_pred EEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC---CCCeeEEEEEEEcCCCceEE
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT---HENVVKLVNVHINHADMSLY 106 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~~~ 106 (477)
-++.|+.|.+..+|+... .+..+++|+.... ....+.+|+..|+.|. ...+.+++.+.... ...|
T Consensus 40 ~~~~l~gG~~n~~y~v~~-----~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~ 107 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-----EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSF 107 (312)
T ss_dssp EEEEECCSSSSEEEEEES-----SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEE
T ss_pred eeEEeCCccceeeeEEEE-----CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceE
Confidence 356789999999999852 3567889987643 2345677998888883 35677888776543 4689
Q ss_pred EEEeccCC
Q 011808 107 LAFDYAEY 114 (477)
Q Consensus 107 lv~e~~~~ 114 (477)
+|||++++
T Consensus 108 lvme~l~G 115 (312)
T 3jr1_A 108 LLLEALNK 115 (312)
T ss_dssp EEEECCCC
T ss_pred EEEEeccC
Confidence 99999986
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.019 Score=54.39 Aligned_cols=76 Identities=11% Similarity=0.165 Sum_probs=51.4
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-C--CCeeEEEEEEEcCCCc
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-H--ENVVKLVNVHINHADM 103 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~ 103 (477)
+..-++.+|.|..+.||++.. .+|+.|++|+...... .....+..|+..|+.|. . --+.+++.+ +..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l----~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~-- 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL----ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDR-- 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE----TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETT--
T ss_pred CeEEEEecCCCCCeEEEEEEE----CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEec--cCc--
Confidence 456678899999999999864 3588999998754332 22235667999998884 2 234555553 222
Q ss_pred eEEEEEeccCC
Q 011808 104 SLYLAFDYAEY 114 (477)
Q Consensus 104 ~~~lv~e~~~~ 114 (477)
+++||++.+
T Consensus 86 --~lv~e~l~~ 94 (288)
T 3f7w_A 86 --TLAMEWVDE 94 (288)
T ss_dssp --EEEEECCCC
T ss_pred --eEEEEeecc
Confidence 778888764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0078 Score=59.71 Aligned_cols=148 Identities=15% Similarity=0.169 Sum_probs=79.2
Q ss_pred EeeecccCceEEEEEEEecc----cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCceE
Q 011808 31 IGKIGEGTYGLVFLARIKAA----ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHADMSL 105 (477)
Q Consensus 31 ~~~lG~G~~g~Vy~a~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~ 105 (477)
++.|..|-...+|++..... ...+..+++|+.-.. ........+|..+++.|. +.-..+++.++. +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~---- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E---- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C----
Confidence 45676687888999864310 113468999986331 122345668999998883 333456666552 2
Q ss_pred EEEEeccCCCH---------------HHHHHh-hhc--ccCCCCC--HHHHHHHHHHHHH-------------------H
Q 011808 106 YLAFDYAEYDL---------------YEIIRH-HRD--KVNHTMN--PYTVKSILWQLLN-------------------G 146 (477)
Q Consensus 106 ~lv~e~~~~~L---------------~~~l~~-~~~--~~~~~l~--~~~~~~i~~qil~-------------------a 146 (477)
.+||||++|.. .+.|.+ |.. ....... ..++..++.++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 28899988611 111111 111 1111111 2345555544422 1
Q ss_pred HHHh----hh----CCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 147 LNYL----HS----NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 147 L~~L----H~----~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
+..| .. ..++|+|+.+.|||+..+++..+.+.|+||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 22 25999999999999964422346799999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0075 Score=60.94 Aligned_cols=75 Identities=15% Similarity=0.258 Sum_probs=48.3
Q ss_pred EEeeecccCceEEEEEEEecc----cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCC-eeEEEEEEEcCCCce
Q 011808 30 LIGKIGEGTYGLVFLARIKAA----ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN-VVKLVNVHINHADMS 104 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~ 104 (477)
-++.|+.|-...||++..... ...+..+++|+.... .....+.+|+.+++.|...+ ..++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T---
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C---
Confidence 456788888899999864321 012467999988431 11146668999998884333 356766542 2
Q ss_pred EEEEEeccCC
Q 011808 105 LYLAFDYAEY 114 (477)
Q Consensus 105 ~~lv~e~~~~ 114 (477)
.++++|++|
T Consensus 148 -g~v~e~l~G 156 (429)
T 1nw1_A 148 -GRLEEYIPS 156 (429)
T ss_dssp -EEEECCCCE
T ss_pred -CEEEEEeCC
Confidence 378899875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.77 E-value=0.014 Score=56.29 Aligned_cols=73 Identities=10% Similarity=0.103 Sum_probs=44.1
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCC--CeeEEEEEEEcC-----CCce
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHE--NVVKLVNVHINH-----ADMS 104 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~-----~~~~ 104 (477)
..|+ |....||++.. .+|..+++|....... ....+..|+.+++.+... .+.+++.. +. .+..
T Consensus 32 ~~l~-g~~n~~y~v~~----~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~ 101 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD----EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGF 101 (328)
T ss_dssp EEEC-CSSSEEEEECC----TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTE
T ss_pred Eeec-CcccceEEEEc----CCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCE
Confidence 4566 77888998742 2356799999863321 234566788888877321 23444432 11 0235
Q ss_pred EEEEEeccCC
Q 011808 105 LYLAFDYAEY 114 (477)
Q Consensus 105 ~~lv~e~~~~ 114 (477)
.+++|++++|
T Consensus 102 ~~~l~~~i~G 111 (328)
T 1zyl_A 102 YFAVFPSVGG 111 (328)
T ss_dssp EEEEEECCCC
T ss_pred EEEEEEecCC
Confidence 6889999986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.013 Score=56.76 Aligned_cols=37 Identities=30% Similarity=0.407 Sum_probs=27.8
Q ss_pred hCCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 152 ~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
...++|+|+.+.|||+..+......+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3579999999999999432111257899999988653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.30 E-value=0.019 Score=56.41 Aligned_cols=76 Identities=12% Similarity=0.157 Sum_probs=42.4
Q ss_pred EEeeecccCceEEEEEEEeccc-----CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCC-eeEEEEEEEcCCCc
Q 011808 30 LIGKIGEGTYGLVFLARIKAAA-----NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHEN-VVKLVNVHINHADM 103 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 103 (477)
-++.|+.|....+|++...... ..+..+++|+....... . .....|..+++.+...+ +.+++..+ ..
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--L-YNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--T-SCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--e-ecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 3567788888899998643200 01257889987543211 1 12346888888774323 44666544 22
Q ss_pred eEEEEEeccCC
Q 011808 104 SLYLAFDYAEY 114 (477)
Q Consensus 104 ~~~lv~e~~~~ 114 (477)
+++|+|++|
T Consensus 110 --~~v~e~i~G 118 (369)
T 3c5i_A 110 --GRIEEWLYG 118 (369)
T ss_dssp --EEEEECCCS
T ss_pred --cEEEEEecC
Confidence 678999886
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.16 E-value=0.063 Score=54.54 Aligned_cols=73 Identities=11% Similarity=0.100 Sum_probs=45.1
Q ss_pred EEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCe-eEEEEEEEcCCCceEEEE
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENV-VKLVNVHINHADMSLYLA 108 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~~~lv 108 (477)
-++.|+.|-...+|++.... .+..+++|+..... .... ...+|..+++.|...++ .++++++ .. .++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~---~~~~~vLRi~g~~~--~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v 179 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMS---KQAKYLIRLYGPKT--DEII-NREREKKISCILYNKNIAKKIYVFF--TN----GRI 179 (458)
T ss_dssp EEEEECC--CEEEEEEEETT---TTEEEEEEEECC-C--CSCS-CHHHHHHHHHHHTTSSSBCCEEEEE--TT----EEE
T ss_pred EEEEcCCCeEeEEEEEEECC---CCceEEEEECCCCh--hhhc-CHHHHHHHHHHHHhcCCCCCEEEEe--CC----eEE
Confidence 35678888889999986421 24678899875422 1111 12479999998864444 5677665 22 248
Q ss_pred EeccCC
Q 011808 109 FDYAEY 114 (477)
Q Consensus 109 ~e~~~~ 114 (477)
|+|++|
T Consensus 180 ~e~I~G 185 (458)
T 2qg7_A 180 EEFMDG 185 (458)
T ss_dssp EECCCS
T ss_pred EEeeCC
Confidence 999876
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.88 E-value=0.17 Score=50.84 Aligned_cols=76 Identities=9% Similarity=0.079 Sum_probs=45.9
Q ss_pred EEeeecccCceEEEEEEEecccCC----CcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCce
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANR----GKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHADMS 104 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 104 (477)
-++.|..|-...+|++.......+ +..+++|+..... .... ...+|..+++.+. +.-..++++.+ ..
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~--~~--- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFY-DSKVELDVFRYLSNINIAPNIIADF--PE--- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCC-CHHHHHHHHHHHHHTTSSCCEEEEE--TT---
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhc-CHHHHHHHHHHHHhcCCCCCEEEEc--CC---
Confidence 355677788889999875421111 5789999874422 1111 2347888888774 33345566543 22
Q ss_pred EEEEEeccCC
Q 011808 105 LYLAFDYAEY 114 (477)
Q Consensus 105 ~~lv~e~~~~ 114 (477)
++||+|++|
T Consensus 146 -~~I~efI~G 154 (424)
T 3mes_A 146 -GRIEEFIDG 154 (424)
T ss_dssp -EEEEECCCS
T ss_pred -CEEEEEeCC
Confidence 688999987
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.70 E-value=0.22 Score=49.55 Aligned_cols=33 Identities=24% Similarity=0.412 Sum_probs=26.7
Q ss_pred eecCCCCCCcEEEeccC--CCcccEEEeeccccee
Q 011808 155 IIHRDLKPSNILVMGEG--EEQGVVKIADFGLARI 187 (477)
Q Consensus 155 ivHrDikp~NILl~~~~--~~~~~vkL~DFG~a~~ 187 (477)
++|+|+.+.|||+..+. ++...++|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 78999999999996432 3456799999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=90.20 E-value=0.31 Score=47.14 Aligned_cols=32 Identities=22% Similarity=0.372 Sum_probs=26.7
Q ss_pred CCeecCCCCCCcEEEeccCCCcccEEEeecccceee
Q 011808 153 NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188 (477)
Q Consensus 153 ~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~ 188 (477)
..++|+|+.+.|||+ +.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~----~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLV----GNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEE----CGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEE----eCCCeEEEEECCCCeeC
Confidence 469999999999999 55567999999887654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.82 E-value=0.071 Score=54.24 Aligned_cols=63 Identities=11% Similarity=0.098 Sum_probs=16.9
Q ss_pred EEeeecccCceEEEEEEEecccCCCcEEEE------EecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEE
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAI------KKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHI 98 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~~~~vai------K~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 98 (477)
+.+.|| ||.||++.++. ....||+ |..+......+....+.+|..+++.++|+|+++.+.+..
T Consensus 146 l~~~lG---fG~v~~g~~~~---~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYK---KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC------------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccc---cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 455666 99999998753 2346787 666554444444456778999999999999999987653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 477 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-79 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-74 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-72 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-71 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-71 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-69 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-68 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-68 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-66 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-65 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-64 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-64 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-60 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-60 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-60 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-60 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-59 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-57 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-56 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-55 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-55 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-50 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-47 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-46 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-44 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-40 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-28 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 3e-79
Identities = 115/327 (35%), Positives = 176/327 (53%), Gaps = 32/327 (9%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y + KIG+GT+G VF AR + G+ +A+KK + +G TA+REI +L+ +
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHR---KTGQKVALKKVLMENEKEGFPITALREIKILQLLK 67
Query: 87 HENVVKLVNVHI------NHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSIL 140
HENVV L+ + N S+YL FD+ E+DL ++ + K + +K ++
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS----EIKRVM 123
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK--FLSEN 198
LLNGL Y+H N I+HRD+K +N+L+ GV+K+ADFGLAR +
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLARAFSLAKNSQPNRYT 179
Query: 199 GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258
VVT+WYR PELLLG + Y +D+W GCI AE+ T P+ QG + QL
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--------HQL 231
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP-AYDLLSK 317
I ++ G TPE WP + N ++ ++ K + + + + P A DL+ K
Sbjct: 232 ALISQLCGSITPEVWPNVDNYELYE----KLELVKGQKRKVKDRLKAYVRDPYALDLIDK 287
Query: 318 MLEYDPRKRITAAQALEHEYFRIEPLP 344
+L DP +RI + AL H++F +P+P
Sbjct: 288 LLVLDPAQRIDSDDALNHDFFWSDPMP 314
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 7e-74
Identities = 125/325 (38%), Positives = 185/325 (56%), Gaps = 33/325 (10%)
Query: 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFK---QSKDGDGVSPTAIREIMLLREIT 86
+ +GEG + V+ AR K N + +AIKK K +S+ DG++ TA+REI LL+E++
Sbjct: 2 KLDFLGEGQFATVYKARDK---NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 58
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
H N++ L++ + ++ L FD+ E DL II+ + + P +K+ + L G
Sbjct: 59 HPNIIGLLDAFGH--KSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQG 112
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
L YLH +WI+HRDLKP+N+L+ +E GV+K+ADFGLA+ + +P + + VVT WY
Sbjct: 113 LEYLHQHWILHRDLKPNNLLL----DENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWY 166
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266
RAPELL GA+ Y VDMWAVGCI AELL P G LDQL +IF+ LG
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--------DLDQLTRIFETLG 218
Query: 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326
PT E+WP + +LP + + + + LH + + DL+ + ++P R
Sbjct: 219 TPTEEQWPDMCSLPDY------VTFKSFPGIPLHHIFSAAGDD-LLDLIQGLFLFNPCAR 271
Query: 327 ITAAQALEHEYFRIEPLPGRNALVP 351
ITA QAL+ +YF P P +P
Sbjct: 272 ITATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 229 bits (583), Expect = 2e-72
Identities = 127/315 (40%), Positives = 188/315 (59%), Gaps = 30/315 (9%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+++Y+ + KIGEGTYG+V+ A+ G+ A+KK + K+ +G+ T IREI +L+E
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKEDEGIPSTTIREISILKE 56
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ H N+VKL +V H L L F++ + DL +++ + T KS L QLL
Sbjct: 57 LKHSNIVKLYDVI--HTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLL 110
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
NG+ Y H ++HRDLKP N+L+ EGE +KIADFGLAR + P++ +VT+
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGE----LKIADFGLARAFGIPVR--KYTHEIVTL 164
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
WYRAP++L+G+K Y++ +D+W+VGCIFAE++ PLF G + DQL +IF+I
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--------EADQLMRIFRI 216
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324
LG P + WP + LP + + + +E+ L DLLSKML+ DP
Sbjct: 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKG----LDES--GIDLLSKMLKLDPN 270
Query: 325 KRITAAQALEHEYFR 339
+RITA QALEH YF+
Sbjct: 271 QRITAKQALEHAYFK 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (578), Expect = 1e-71
Identities = 129/322 (40%), Positives = 194/322 (60%), Gaps = 30/322 (9%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
++ + + KIGEGTYG+V+ AR K G+ +A+KK + + +GV TAIREI LL+E
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIREISLLKE 57
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ H N+VKL++V H + LYL F++ DL + + + +KS L+QLL
Sbjct: 58 LNHPNIVKLLDVI--HTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLL 112
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
GL + HS+ ++HRDLKP N+L+ +G +K+ADFGLAR + P++ VVT+
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRT--YTHEVVTL 166
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
WYRAPE+LLG K+Y++AVD+W++GCIFAE++T + LF G ++DQL +IF+
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--------EIDQLFRIFRT 218
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324
LG P WP + ++P ++ K+ VVP + LLS+ML YDP
Sbjct: 219 LGTPDEVVWPGVTSMPDYK-----PSFPKWARQDFSKVVPPLDED-GRSLLSQMLHYDPN 272
Query: 325 KRITAAQALEHEYFR--IEPLP 344
KRI+A AL H +F+ +P+P
Sbjct: 273 KRISAKAALAHPFFQDVTKPVP 294
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 4e-71
Identities = 67/314 (21%), Positives = 120/314 (38%), Gaps = 21/314 (6%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
+ I ++G G G+VF K G +A K + IRE+ +L E
Sbjct: 8 FEKISELGAGNGGVVFKVSHK---PSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNS 63
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
+V + D + + ++ + + + + + + + ++ GL
Sbjct: 64 PYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGL 117
Query: 148 NYLHS-NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
YL + I+HRD+KPSNILV +G +K+ DFG++ + N V T Y
Sbjct: 118 TYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMA----NSFVGTRSY 169
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266
+PE L G HY+ D+W++G E+ + +AK + F +
Sbjct: 170 MSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSP-AYDLLSKMLEYDPRK 325
P P + + + Y N +P S D ++K L +P +
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288
Query: 326 RITAAQALEHEYFR 339
R Q + H + +
Sbjct: 289 RADLKQLMVHAFIK 302
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 5e-71
Identities = 110/376 (29%), Positives = 176/376 (46%), Gaps = 39/376 (10%)
Query: 13 TGTSNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVS 72
T G Y IG G++G+V+ A++ + G+ +AIKK Q K
Sbjct: 7 VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLC---DSGELVAIKKVLQDKR----- 58
Query: 73 PTAIREIMLLREITHENVVKLVNVHINHA----DMSLYLAFDYAEYDLYEIIRHHRDKVN 128
RE+ ++R++ H N+V+L + ++ L L DY +Y + RH+
Sbjct: 59 -FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-K 116
Query: 129 HTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY 188
T+ VK ++QL L Y+HS I HRD+KP N+L+ + V+K+ DFG A+
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT---AVLKLCDFGSAKQL 173
Query: 189 QAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248
+S + + +YRAPEL+ GA YTS++D+W+ GC+ AELL +P+F G
Sbjct: 174 VRGEPNVS---YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--- 227
Query: 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPK 308
+DQL +I K+LG PT E+ + + + + + V
Sbjct: 228 -----GVDQLVEIIKVLGTPTREQI------REMNPNYTEFKFPQIKAHPWTKVFRPRTP 276
Query: 309 SPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPS-QPGDKVVNYPTRPVD 367
A L S++LEY P R+T +A H +F L N +P+ + + N+ T+ +
Sbjct: 277 PEAIALCSRLLEYTPTARLTPLEACAHSFFD--ELRDPNVKLPNGRDTPALFNFTTQELS 334
Query: 368 SNTDFEGTTTLQPPQP 383
SN T L PP
Sbjct: 335 SNP--PLATILIPPHA 348
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 6e-69
Identities = 118/317 (37%), Positives = 168/317 (52%), Gaps = 29/317 (9%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
QQY + +IGEG YG VF AR N G+ +A+K+ + +G+ + IRE+ +LR +
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 86 T---HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQ 142
H NVV+L +V E+ ++ + + T+K +++Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV 202
LL GL++LHS+ ++HRDLKP NILV G +K+ADFGLARIY + VVV
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYSFQMAL---TSVVV 177
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262
T+WYRAPE+LL Y + VD+W+VGCIFAE+ KPLF+G+ +DQL KI
Sbjct: 178 TLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSS--------DVDQLGKIL 228
Query: 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYD 322
++G P E WP LP S Q + + + DLL K L ++
Sbjct: 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL--------GKDLLLKCLTFN 280
Query: 323 PRKRITAAQALEHEYFR 339
P KRI+A AL H YF+
Sbjct: 281 PAKRISAYSALSHPYFQ 297
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 1e-68
Identities = 119/316 (37%), Positives = 189/316 (59%), Gaps = 30/316 (9%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+Q+Y + KIGEGTYG VF A+ + + +A+K+ + D +GV +A+REI LL+E
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNR---ETHEIVALKRVRLDDDDEGVPSSALREICLLKE 57
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ H+N+V+L +V + ++L + ++ + D N ++P VKS L+QLL
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLV------FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
GL + HS ++HRDLKP N+L+ G +K+A+FGLAR + P++ S VVT+
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLARAFGIPVRCYSA--EVVTL 165
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK-PLFQGAEAKSTQNPFQLDQLDKIFK 263
WYR P++L GAK Y++++DMW+ GCIFAEL PLF G + DQL +IF+
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--------DQLKRIFR 217
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
+LG PT E+WP++ LP ++ ++ T+ ++ V L+ DLL +L+ +P
Sbjct: 218 LLGTPTEEQWPSMTKLPDYKPYPMY----PATTSLVNVVPKLNAT--GRDLLQNLLKCNP 271
Query: 324 RKRITAAQALEHEYFR 339
+RI+A +AL+H YF
Sbjct: 272 VQRISAEEALQHPYFS 287
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 8e-68
Identities = 107/330 (32%), Positives = 154/330 (46%), Gaps = 30/330 (9%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y + IGEG YG+V A +AIKK + +REI +L
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNV---NKVRVAIKKISPFEH-QTYCQRTLREIKILLRFR 64
Query: 87 HENVVKLVNVHINHA---DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
HEN++ + ++ +YL DLY++++ ++ + L+Q+
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQI 118
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPL-KFLSENGVVV 202
L GL Y+HS ++HRDLKPSN+L+ +KI DFGLAR+ V
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262
T WYRAPE++L +K YT ++D+W+VGCI AE+L+ +P+F G LDQL+ I
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH--------YLDQLNHIL 226
Query: 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYD 322
ILG P+ E + NL K N L S A DLL KML ++
Sbjct: 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD----SKALDLLDKMLTFN 282
Query: 323 PRKRITAAQALEHEYFRIEPLPGRNALVPS 352
P KRI QAL H Y P + +
Sbjct: 283 PHKRIEVEQALAHPYLEQYYDPSDEPIAEA 312
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 215 bits (549), Expect = 2e-66
Identities = 75/345 (21%), Positives = 129/345 (37%), Gaps = 57/345 (16%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
L Y++ ++G G +G+V +A G A K + D T +EI +
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHESD--KETVRKEIQTMSV 79
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+ H +V L + + D + + +++ +L+E + +K M+ + Q+
Sbjct: 80 LRHPTLVNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQV 133
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
GL ++H N +H DLKP NI+ + +K+ DFGL G T
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFT--TKRSNELKLIDFGLTAHLDPKQSVKVTTG---T 188
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
+ APE+ G K DMW+VG + LL+ F G + L +
Sbjct: 189 AEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKS 239
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
+ + ++ D + K+L DP
Sbjct: 240 CDWNMDDSAFSGIS-------------------------------EDGKDFIRKLLLADP 268
Query: 324 RKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDS 368
R+T QALEH + PGR++ +PS K+ + D+
Sbjct: 269 NTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDA 313
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 8e-66
Identities = 76/320 (23%), Positives = 126/320 (39%), Gaps = 55/320 (17%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
++ ++L+ +GEG YG V LA + +A+A+K + D +EI + +
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVDMKRAVDCPE-NIKKEICINKM 59
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ HENVVK YL +Y R + + M + QL+
Sbjct: 60 LNHENVVKFYGHR--REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLM 113
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
G+ YLH I HRD+KP N+L+ +E+ +KI+DFGLA +++ + N + T+
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
Y APELL + + VD+W+ G + +L + + P Q +K
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ--------PSDSCQEYSDWKE 221
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324
W + S LL K+L +P
Sbjct: 222 -KKTYLNPWKKID-------------------------------SAPLALLHKILVENPS 249
Query: 325 KRITAAQALEHEYFRIEPLP 344
RIT + ++ +PL
Sbjct: 250 ARITIPDIKKDRWYN-KPLK 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 6e-65
Identities = 75/316 (23%), Positives = 125/316 (39%), Gaps = 59/316 (18%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y ++ IG G+YG R K+ GK + K+ + + E+ LLRE+ H
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
N+V+ + I+ + +LY+ +Y E DL +I K ++ V ++ QL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLA 121
Query: 147 LNYLH-----SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
L H + ++HRDLKP+N+ + G+ VK+ DFGLARI F V
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQN----VKLGDFGLARILNHDTSFA--KAFV 175
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T +Y +PE + Y D+W++GC+ EL L P F Q + KI
Sbjct: 176 GTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKI 226
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
+ P ++ +++++ML
Sbjct: 227 REGKFRRIPYRYS----------------------------------DELNEIITRMLNL 252
Query: 322 DPRKRITAAQALEHEY 337
R + + LE+
Sbjct: 253 KDYHRPSVEEILENPL 268
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 2e-64
Identities = 107/318 (33%), Positives = 158/318 (49%), Gaps = 34/318 (10%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
Y + +G G YG V A G +AIKK + + + A RE+ LL+ +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDG---RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 86 THENVVKLVNVHINHAD----MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILW 141
HENV+ L++V YL + DL ++++H + + ++ +++
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK------LGEDRIQFLVY 128
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
Q+L GL Y+H+ IIHRDLKP N+ V E +KI DFGLAR + + G V
Sbjct: 129 QMLKGLRYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQADSEM-----TGYV 179
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
VT WYRAPE++L YT VD+W+VGCI AE++T K LF+G++ LDQL +I
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--------HLDQLKEI 231
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
K+ G P E L + + E S++ + A +LL KML
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPE---LEKKDFASILTNASPL-AVNLLEKMLVL 287
Query: 322 DPRKRITAAQALEHEYFR 339
D +R+TA +AL H YF
Sbjct: 288 DAEQRVTAGEALAHPYFE 305
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 2e-64
Identities = 73/318 (22%), Positives = 132/318 (41%), Gaps = 60/318 (18%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
+ +IG++G+G +G V+ A+ K A K + + + EI +L H
Sbjct: 14 WEIIGELGDGAFGKVYKAQNK---ETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDH 68
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
N+VKL++ + +L++ ++ + + ++ + ++ + Q L+ L
Sbjct: 69 PNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDAL 123
Query: 148 NYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYR 207
NYLH N IIHRDLK NIL G +K+ADFG++ ++ + + T ++
Sbjct: 124 NYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWM 177
Query: 208 APELLLG----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
APE+++ + Y D+W++G E+ ++P + L KI K
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--------PMRVLLKIAK 229
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
+ PTLA W S+ D L K LE +
Sbjct: 230 -------SEPPTLAQPSRWSSN-------------------------FKDFLKKCLEKNV 257
Query: 324 RKRITAAQALEHEYFRIE 341
R T +Q L+H + ++
Sbjct: 258 DARWTTSQLLQHPFVTVD 275
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 208 bits (530), Expect = 4e-64
Identities = 88/325 (27%), Positives = 149/325 (45%), Gaps = 35/325 (10%)
Query: 21 KPEWLQQ--YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIRE 78
EW Q Y L+ K+G G Y VF A + + +K K K RE
Sbjct: 28 VVEWGNQDDYQLVRKLGRGKYSEVFEAINI---TNNEKVVVKILKPVKKKK-----IKRE 79
Query: 79 IMLLREI-THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTV 136
I +L + N++ L ++ + + L F++ D ++ + T+ Y +
Sbjct: 80 IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDI 131
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
+ ++++L L+Y HS I+HRD+KP N+++ E +++ D+GLA Y ++
Sbjct: 132 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH---RKLRLIDWGLAEFYHPGQEY-- 186
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
N V + +++ PELL+ + Y ++DMW++GC+ A ++ K F D
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-------NYD 238
Query: 257 QLDKIFKILGHPTPEKWPTLANLPHWQ--SDSLHIQGRKYETNGLHSVVPLSPKSPAYDL 314
QL +I K+LG + N+ +D L RK +HS A D
Sbjct: 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298
Query: 315 LSKMLEYDPRKRITAAQALEHEYFR 339
L K+L YD + R+TA +A+EH YF
Sbjct: 299 LDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-62
Identities = 113/344 (32%), Positives = 164/344 (47%), Gaps = 37/344 (10%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
L++Y + IG G G+V A + +AIKK + + A RE++L++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 85 ITHENVVKLVNVHINHA----DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSIL 140
+ H+N++ L+NV +YL + + +L ++I+ D + +L
Sbjct: 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLL 125
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
+Q+L G+ +LHS IIHRDLKPSNI+V + KI DFGLAR
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL----KILDFGLARTAGTSFMM---TPY 178
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
VVT +YRAPE++LG Y VD+W+VGCI E++ K LF G + +DQ +K
Sbjct: 179 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRD--------YIDQWNK 229
Query: 261 IFKILGHPTPEKW----PTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPK---SPAYD 313
+ + LG P PE PT+ N + + K + L K S A D
Sbjct: 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289
Query: 314 LLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDK 357
LLSKML DP KRI+ AL+H Y + P P Q DK
Sbjct: 290 LLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDK 333
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (514), Expect = 6e-62
Identities = 74/328 (22%), Positives = 134/328 (40%), Gaps = 65/328 (19%)
Query: 20 EKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKF-KQSKDGDGVSPTAIRE 78
+ PE + ++ + +IG G++G V+ AR + +AIKK K + I+E
Sbjct: 11 DDPE--KLFSDLREIGHGSFGAVYFARDV---RNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 79 IMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKS 138
+ L+++ H N ++ ++ + + +L +Y +++ H+ + + +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAA 119
Query: 139 ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSEN 198
+ L GL YLHS+ +IHRD+K NIL+ E G+VK+ DFG A I N
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSASIMA------PAN 169
Query: 199 GVVVTIWYRAPELLLGA--KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
V T ++ APE++L Y VD+W++G EL KP ++
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-----------MN 218
Query: 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLS 316
+ ++ I + +P HW + +
Sbjct: 219 AMSALYHIAQNESPALQS-----GHWSEY-------------------------FRNFVD 248
Query: 317 KMLEYDPRKRITAAQALEHEYFRIEPLP 344
L+ P+ R T+ L+H + E P
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLRERPP 276
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 8e-61
Identities = 71/320 (22%), Positives = 136/320 (42%), Gaps = 65/320 (20%)
Query: 23 EW-LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK-DGDGVSPTAIREIM 80
+W L+ + + +G+G +G V+LAR K +A+K +++ + GV RE+
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREK---QSKFILALKVLFKAQLEKAGVEHQLRREVE 58
Query: 81 LLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSI 139
+ + H N+++L + +YL +YA +Y ++ + +
Sbjct: 59 IQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATY 111
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
+ +L N L+Y HS +IHRD+KP N+L+ G +KIADFG + + +
Sbjct: 112 ITELANALSYCHSKRVIHRDIKPENLLL----GSAGELKIADFGWSVHAPSSRRT----T 163
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
+ T+ Y PE++ G + + VD+W++G + E L KP F+ + +
Sbjct: 164 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYK 214
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
+I ++ P+ A DL+S++L
Sbjct: 215 RISRVEFTF-PDFVT----------------------------------EGARDLISRLL 239
Query: 320 EYDPRKRITAAQALEHEYFR 339
+++P +R + LEH +
Sbjct: 240 KHNPSQRPMLREVLEHPWIT 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-60
Identities = 75/328 (22%), Positives = 139/328 (42%), Gaps = 60/328 (18%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++Y KIG+G G V+ A G+ +AI++ + I EI+++RE
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDV---ATGQEVAIRQMNLQQQPK--KELIINEILVMREN 74
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
+ N+V ++ ++ L++ +Y + M+ + ++ + L
Sbjct: 75 KNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQ 127
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
L +LHSN +IHRD+K NIL+ G VK+ DFG S +V T +
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 181
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265
+ APE++ K Y VD+W++G + E++ +P + + L ++ I
Sbjct: 182 WMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNE-----------NPLRALYLIA 229
Query: 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK 325
+ TPE L + + S + D L++ L+ D K
Sbjct: 230 TNGTPE-------LQNPEKLS----------------------AIFRDFLNRCLDMDVEK 260
Query: 326 RITAAQALEHEYFRI-EPLPGRNALVPS 352
R +A + L+H++ +I +PL L+ +
Sbjct: 261 RGSAKELLQHQFLKIAKPLSSLTPLIAA 288
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 2e-60
Identities = 79/323 (24%), Positives = 126/323 (39%), Gaps = 56/323 (17%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
Y+ +G G + V LA K K +AIK + +G + EI +L +I
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDK---RTQKLVAIKCIAKKAL-EGKEGSMENEIAVLHKI 64
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
H N+V L +++ + LYL +L++ I +++Q+L
Sbjct: 65 KHPNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVL 117
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTI 204
+ + YLH I+HRDLKP N+L E+ + I+DFGL+++ + T
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDED-SKIMISDFGLSKMEDPGSVL---STACGTP 173
Query: 205 WYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264
Y APE+L K Y+ AVD W++G I LL P F ++I K
Sbjct: 174 GYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQILKA 224
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324
W ++ A D + ++E DP
Sbjct: 225 EYEFDSPYWDDIS-------------------------------DSAKDFIRHLMEKDPE 253
Query: 325 KRITAAQALEHEYFRIEPLPGRN 347
KR T QAL+H + + +N
Sbjct: 254 KRFTCEQALQHPWIAGDTALDKN 276
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-60
Identities = 112/328 (34%), Positives = 153/328 (46%), Gaps = 34/328 (10%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y + +G G YG V A G +A+KK + + RE+ LL+ + H
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDT---KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 88 ENVVKLVNVHIN----HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
ENV+ L++V +YL DL I++ + + V+ +++Q+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQI 130
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
L GL Y+HS IIHRDLKPSN+ V E +KI DFGLAR G V T
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDDE-----MTGYVAT 181
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
WYRAPE++L HY VD+W+VGCI AELLT + LF G + +DQL I +
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--------HIDQLKLILR 233
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
++G P E +++ Q K + V + A DLL KML D
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMN----FANVFIGANPLAVDLLEKMLVLDS 289
Query: 324 RKRITAAQALEHEYFRIEPLPGRNALVP 351
KRITAAQAL H YF P +
Sbjct: 290 DKRITAAQALAHAYFAQYHDPDDEPVAD 317
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 199 bits (506), Expect = 3e-60
Identities = 78/366 (21%), Positives = 143/366 (39%), Gaps = 67/366 (18%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
Y+++ ++G G +G+V KA G+ K D T EI ++ +
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYPLDKY--TVKNEISIMNQ 82
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+ H ++ L + + + L ++ +L++ I ++ M+ V + + Q
Sbjct: 83 LHHPKLINLHDAFED--KYEMVLILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQA 136
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
GL ++H + I+H D+KP NI+ E ++ VKI DFGLA T
Sbjct: 137 CEGLKHMHEHSIVHLDIKPENIMC--ETKKASSVKIIDFGLATKLNPDEIV---KVTTAT 191
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
+ APE++ + DMWA+G + LL+ F G + L+ L + +
Sbjct: 192 AEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKR 242
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
+ + + +SP+ A D + +L+ +P
Sbjct: 243 CDWEFDEDAFSS-----------------------------VSPE--AKDFIKNLLQKEP 271
Query: 324 RKRITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSNTDFEGTTTLQPPQP 383
RKR+T ALEH + + G ++ + S+ N + + E PQP
Sbjct: 272 RKRLTVHDALEHPWLK-----GDHSNLTSRIPSSRYNKIRQKIK-----EKYADWPAPQP 321
Query: 384 ASGPVP 389
A G +
Sbjct: 322 AIGRIA 327
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-59
Identities = 63/336 (18%), Positives = 121/336 (36%), Gaps = 58/336 (17%)
Query: 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLL 82
E ++Y + +G G +G+V + K K K +EI +L
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVET---SSKKTYMAKFVKVKGTDQV---LVKKEISIL 55
Query: 83 REITHENVVKLVNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILW 141
H N++ L + L + F++ D++E I + +N + S +
Sbjct: 56 NIARHRNILHLHESFES--MEELVMIFEFISGLDIFERINTSAFE----LNEREIVSYVH 109
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
Q+ L +LHS+ I H D++P NI+ +KI +FG AR + F
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRS--STIKIIEFGQARQLKPGDNFRLLFT-- 165
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
Y APE+ ++A DMW++G + LL+ F ++ I
Sbjct: 166 -APEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENI 215
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
E + ++ A D + ++L
Sbjct: 216 MNAEYTFDEEAFKEIS-------------------------------IEAMDFVDRLLVK 244
Query: 322 DPRKRITAAQALEHEYFRIEPLPGRNALVPSQPGDK 357
+ + R+TA++AL+H + + + ++ + +
Sbjct: 245 ERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRR 280
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 191 bits (487), Expect = 3e-58
Identities = 74/328 (22%), Positives = 123/328 (37%), Gaps = 70/328 (21%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-------GVSPTAIRE 78
+ Y +G G +V K K A+K + G + ++E
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHK---PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 59
Query: 79 IMLLREI-THENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTV 136
+ +LR++ H N+++L + + + +L FD + +L++ + T++
Sbjct: 60 VDILRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKV-----TLSEKET 112
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
+ I+ LL + LH I+HRDLKP NIL+ + +K+ DFG + K
Sbjct: 113 RKIMRALLEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDFGFSCQLDPGEKL-- 166
Query: 197 ENGVVVTIWYRAPELLLGA-----KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251
V T Y APE++ + Y VDMW+ G I LL P F +
Sbjct: 167 -REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK------ 219
Query: 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
Q+ L I +W +
Sbjct: 220 --QMLMLRMIMSGNYQFGSPEWDDYS-------------------------------DTV 246
Query: 312 YDLLSKMLEYDPRKRITAAQALEHEYFR 339
DL+S+ L P+KR TA +AL H +F+
Sbjct: 247 KDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-57
Identities = 60/316 (18%), Positives = 108/316 (34%), Gaps = 60/316 (18%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
+IG G++ V+ +A + + K E +L+ + H
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDT---ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH 67
Query: 88 ENVVKLVNV--HINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
N+V+ + + L + + M ++S Q+L
Sbjct: 68 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILK 123
Query: 146 GLNYLHSN--WIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
GL +LH+ IIHRDLK NI + G G VKI D GLA + +A V+ T
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGP---TGSVKIGDLGLATLKRASFA----KAVIGT 176
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
+ APE+ Y +VD++A G E+ T + + QN Q+ + +
Sbjct: 177 PEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSEC-----QNAAQIYR-----R 224
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
+ P + P+ +++ + +
Sbjct: 225 VTSGVKPASFDK----------------------------VAIPE--VKEIIEGCIRQNK 254
Query: 324 RKRITAAQALEHEYFR 339
+R + L H +F+
Sbjct: 255 DERYSIKDLLNHAFFQ 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-56
Identities = 72/316 (22%), Positives = 123/316 (38%), Gaps = 56/316 (17%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI----REIMLLR 83
Y+ ++G G + +V R K + G A K K+ + + RE+ +L+
Sbjct: 12 YDTGEELGSGQFAVVKKCREK---STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
EI H NV+ L V+ N + L + ++ + L Q+
Sbjct: 69 EIQHPNVITLHEVYEN--KTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQI 122
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
LNG+ YLHS I H DLKP NI+++ + +KI DFGLA +F + T
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 179
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
+ APE++ + DMW++G I LL+ F G + + L +
Sbjct: 180 PEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSA 230
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
+ E + + + A D + ++L DP
Sbjct: 231 VNYEFEDEYFSNTS-------------------------------ALAKDFIRRLLVKDP 259
Query: 324 RKRITAAQALEHEYFR 339
+KR+T +L+H + +
Sbjct: 260 KKRMTIQDSLQHPWIK 275
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 8e-56
Identities = 64/319 (20%), Positives = 116/319 (36%), Gaps = 60/319 (18%)
Query: 23 EW---LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
+W Q + +IG G++G V+ + +A+K + E+
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAPTPQQLQAFKNEV 55
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKS 138
+LR+ H N++ + L + + E LY + K +
Sbjct: 56 GVLRKTRHVNILLFMGYST---APQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLID 108
Query: 139 ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSEN 198
I Q G++YLH+ IIHRDLK +NI + E VKI DFGLA +
Sbjct: 109 IARQTAQGMDYLHAKSIIHRDLKSNNIFL----HEDLTVKIGDFGLATVKSRWSGSHQFE 164
Query: 199 GVVVTIWYRAPELLLGAK--HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
+ +I + APE++ Y+ D++A G + EL+T + + ++
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN-----------IN 213
Query: 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLS 316
D+I ++G P L+ + ++ L++
Sbjct: 214 NRDQIIFMVGR--GYLSPDLSKVRSNCPKAM------------------------KRLMA 247
Query: 317 KMLEYDPRKRITAAQALEH 335
+ L+ +R Q L
Sbjct: 248 ECLKKKRDERPLFPQILAS 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-55
Identities = 83/327 (25%), Positives = 126/327 (38%), Gaps = 69/327 (21%)
Query: 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK-DGDGVSPTAIREI 79
+PE + +GEG++ V LAR + AIK ++ + P RE
Sbjct: 6 RPE---DFKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKS 138
++ + H VKL + D LY YA+ +L + IR + + +
Sbjct: 60 DVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRF 112
Query: 139 ILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSEN 198
++++ L YLH IIHRDLKP NIL+ E ++I DFG A++ K N
Sbjct: 113 YTAEIVSALEYLHGKGIIHRDLKPENILL----NEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 199 GVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258
V T Y +PELL K + D+WA+GCI +L+ P F+ +
Sbjct: 169 SFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIF 219
Query: 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKM 318
KI K+ PEK+ A DL+ K+
Sbjct: 220 QKIIKLEYDF-PEKFF----------------------------------PKARDLVEKL 244
Query: 319 LEYDPRKRITAAQA------LEHEYFR 339
L D KR+ + H +F
Sbjct: 245 LVLDATKRLGCEEMEGYGPLKAHPFFE 271
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 187 bits (474), Expect = 1e-55
Identities = 91/348 (26%), Positives = 142/348 (40%), Gaps = 37/348 (10%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y L+ K+G G + V+LA+ +A+K + K + A EI LL+ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDM---VNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVND 68
Query: 88 ENVVKLVNVHINHADMSLYLAFDY-----------AEYDLYEIIRHHRDKVNHTMNPYTV 136
+ K ++ NH + L F++ E ++ + + + V
Sbjct: 69 ADNTKEDSMGANH-ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 137 KSILWQLLNGLNYLHSNW-IIHRDLKPSNILV--MGEGEEQGVVKIADFGLARIYQAPLK 193
K I QLL GL+Y+H IIH D+KP N+L+ + E +KIAD G A Y
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 194 FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253
+ T YR+PE+LLG + D+W+ C+ EL+T LF+ E S
Sbjct: 188 N-----SIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK-- 239
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANL-PHWQSDSLHIQGRKYETNGLHSVVPLSPKSP-- 310
D + +I ++LG + S L K + L V+ K
Sbjct: 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 299
Query: 311 ----AYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPGRNALVPSQP 354
D LS ML+ DPRKR A + H + + + L VP +
Sbjct: 300 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK-DTLGMEEIRVPDRE 346
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 8e-55
Identities = 65/320 (20%), Positives = 115/320 (35%), Gaps = 58/320 (18%)
Query: 25 LQQYNLIGK-IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI-MLL 82
+ Y + + +G G G V K + A+K + A RE+ +
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNK---RTQEKFALKMLQDCPK-------ARREVELHW 59
Query: 83 REITHENVVKLVNVHIN--HADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSI 139
R ++V++V+V+ N L + + + +L+ I+ D+ I
Sbjct: 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEI 116
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
+ + + YLHS I HRD+KP N+L ++K+ DFG A+ + +
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYT-SKRPNAILKLTDFGFAKETTSHNSLTT--- 172
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
T +Y APE+L + Y + DMW++G I LL P F L
Sbjct: 173 PCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH--------GLAISP 223
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
+ + E P W S L+ +L
Sbjct: 224 GMKTRIRMGQYEFPN-----PEWSEVS----------------------EEVKMLIRNLL 256
Query: 320 EYDPRKRITAAQALEHEYFR 339
+ +P +R+T + + H +
Sbjct: 257 KTEPTQRMTITEFMNHPWIM 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 176 bits (448), Expect = 1e-51
Identities = 68/325 (20%), Positives = 126/325 (38%), Gaps = 68/325 (20%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS----KDGDGVSPTAIREIM 80
+ +++ IG G +G V+ R + GK A+K + K G+ ++ +
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 59
Query: 81 LLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSI 139
L+ +V + H L D DL+ + H + ++
Sbjct: 60 LVSTGDCPFIVCMSYAF--HTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFY 112
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
+++ GL ++H+ ++++RDLKP+NIL+ +E G V+I+D GLA + +
Sbjct: 113 AAEIILGLEHMHNRFVVYRDLKPANILL----DEHGHVRISDLGLACDFSKK----KPHA 164
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
V T Y APE+L Y S+ D +++GC+ +LL F+ + K
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---------DKH 215
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
+I ++ E + SP+ LL +L
Sbjct: 216 EIDRMTLTMAVELPDSF-----------------------------SPE--LRSLLEGLL 244
Query: 320 EYDPRKRIT-----AAQALEHEYFR 339
+ D +R+ A + E +FR
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 5e-51
Identities = 59/312 (18%), Positives = 113/312 (36%), Gaps = 65/312 (20%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+++ L+ IG+G +G V L RG +A+K K + E ++ +
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGD-----YRGNKVAVKCIKNDATAQAF----LAEASVMTQ 56
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+ H N+V+L+ V + LY+ +Y L + +R V + + +
Sbjct: 57 LRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDV 112
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
+ YL N +HRDL N+LV E V K++DFGL + + +++ +
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLV----SEDNVAKVSDFGLTKEASS-----TQDTGKLP 163
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
+ + APE L K +++ D+W+ G + E+ + + D + ++ K
Sbjct: 164 VKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEK 215
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
P+ P Y+++ D
Sbjct: 216 GYKMDAPDGCP----------------------------------PAVYEVMKNCWHLDA 241
Query: 324 RKRITAAQALEH 335
R + Q E
Sbjct: 242 AMRPSFLQLREQ 253
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 8e-51
Identities = 69/335 (20%), Positives = 124/335 (37%), Gaps = 67/335 (20%)
Query: 21 KPEW---LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIR 77
K W + L K+G+G +G V++ +AIK K ++
Sbjct: 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPGTMSP---EAFLQ 61
Query: 78 EIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVK 137
E +++++ HE +V+L V +Y+ +Y + + + +
Sbjct: 62 EAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLL--DFLKGETGKYLRLPQLV 116
Query: 138 SILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSE 197
+ Q+ +G+ Y+ +HRDL+ +NILV E V K+ADFGLAR+ + ++ +
Sbjct: 117 DMAAQIASGMAYVERMNYVHRDLRAANILV----GENLVCKVADFGLARLIEDN-EYTAR 171
Query: 198 NGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257
G I + APE L +T D+W+ G + EL T + +
Sbjct: 172 QGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREV 223
Query: 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSK 317
LD++ + P P + P +DL+ +
Sbjct: 224 LDQVERGYRMPCPPECP----------------------------------ESLHDLMCQ 249
Query: 318 MLEYDPRKRITAAQALE--HEYFR---IEPLPGRN 347
+P +R T +YF + PG N
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-50
Identities = 60/325 (18%), Positives = 115/325 (35%), Gaps = 64/325 (19%)
Query: 19 GEKPEW---LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTA 75
+ EW + L+ ++G G +G V++ +A+K KQ
Sbjct: 3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGSMSP---DAF 55
Query: 76 IREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYT 135
+ E L++++ H+ +V+L V +Y+ +Y E + T+
Sbjct: 56 LAEANLMKQLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTI--NK 110
Query: 136 VKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195
+ + Q+ G+ ++ IHRDL+ +NILV + KIADFGLAR+ + ++
Sbjct: 111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDN-EYT 165
Query: 196 SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255
+ G I + APE + +T D+W+ G + E++T +
Sbjct: 166 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------- 217
Query: 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLL 315
+ + + + P+ P Y L+
Sbjct: 218 EVIQNLERGYRMVRPDNCP----------------------------------EELYQLM 243
Query: 316 SKMLEYDPRKRITAAQALE--HEYF 338
+ P R T ++F
Sbjct: 244 RLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-50
Identities = 77/319 (24%), Positives = 122/319 (38%), Gaps = 64/319 (20%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK--DGDGVSPTAIREIMLL 82
++ + L +G+G++G VFLA K + AIK K+ D V T + + +L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFK---KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 57
Query: 83 REITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILW 141
H + + +L+ +Y DL I+ H +
Sbjct: 58 LAWEHPFLTHMFCTFQT--KENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAA 110
Query: 142 QLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVV 201
+++ GL +LHS I++RDLK NIL+ + G +KIADFG+ + N
Sbjct: 111 EIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIADFGMCKENMLGDA--KTNTFC 164
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T Y APE+LLG + Y +VD W+ G + E+L + F G +++
Sbjct: 165 GTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHG------------QDEEEL 211
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
F + P P W A DLL K+
Sbjct: 212 FHSIRMDNPF-------YPRWLEKE------------------------AKDLLVKLFVR 240
Query: 322 DPRKRITAAQA-LEHEYFR 339
+P KR+ +H FR
Sbjct: 241 EPEKRLGVRGDIRQHPLFR 259
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-50
Identities = 55/324 (16%), Positives = 113/324 (34%), Gaps = 70/324 (21%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPT----AIREIMLL 82
QY + +G G +G V+ + +AIK ++ + D E++LL
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRV---SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 83 REIT--HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSIL 140
++++ V++L++ L L DL++ I + +S
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFF 116
Query: 141 WQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGV 200
WQ+L + + H+ ++HRD+K NIL+ +G +K+ DFG + +
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDT----VYTDF 169
Query: 201 VVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260
T Y PE + +++ + +W++G + +++ F+ E ++ +
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRGQV 221
Query: 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLE 320
F ++ S L+ L
Sbjct: 222 FF-------RQRVS----------------------------------SECQHLIRWCLA 240
Query: 321 YDPRKRITAAQALEHEYFRIEPLP 344
P R T + H + + LP
Sbjct: 241 LRPSDRPTFEEIQNHPWMQDVLLP 264
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (422), Expect = 8e-49
Identities = 65/319 (20%), Positives = 114/319 (35%), Gaps = 57/319 (17%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREI 85
+Y L +G G V LAR + +A+K + D RE +
Sbjct: 8 RYELGEILGFGGMSEVHLARDL---RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64
Query: 86 THENVVKLVNVHI--NHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQ 142
H +V + + A Y+ +Y + L +I+ M P ++
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIAD 119
Query: 143 LLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV 202
LN+ H N IIHRD+KP+NI++ VK+ DFG+AR +++ V+
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 203 -TIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T Y +PE G + D++++GC+ E+LT +P F G + +
Sbjct: 176 GTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQH 226
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321
+ P + L+ + ++ K L
Sbjct: 227 VREDPIPPSARHEGLS-------------------------------ADLDAVVLKALAK 255
Query: 322 DPRKRITAAQALEHEYFRI 340
+P R A + + R+
Sbjct: 256 NPENRYQTAAEMRADLVRV 274
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 8e-49
Identities = 67/332 (20%), Positives = 115/332 (34%), Gaps = 72/332 (21%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRG--KAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+G G +G V A + G +A+K K+ D + E+ ++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE-ALMSELKMMTQ 96
Query: 85 IT-HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVN-------------- 128
+ HEN+V L+ +YL F+Y Y DL +R R+K +
Sbjct: 97 LGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 129 ----HTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184
+ + + +Q+ G+ +L +HRDL N+LV VVKI DFGL
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV----THGKVVKICDFGL 210
Query: 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQG 243
AR + ++ + + + APE L YT D+W+ G + E+ +L + G
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 244 AEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVV 303
+ +K++ NG
Sbjct: 270 -----------IPVDANFYKLI------------------------------QNGFKMDQ 288
Query: 304 PLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335
P Y ++ +D RKR +
Sbjct: 289 PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-47
Identities = 59/313 (18%), Positives = 104/313 (33%), Gaps = 53/313 (16%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSP-TAIREIMLLR 83
+ L+ K+G+G++G+V A + + ++A+K K + IRE+ +
Sbjct: 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+ H N+++L V + + + + A + K T+ Q+
Sbjct: 67 SLDHRNLIRLYGVVL---TPPMKMVTELAPLGS---LLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
G+ YL S IHRDL N+L+ +VKI DFGL R
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKSTQNPFQLDQLDKIF 262
+ L + ++ A D W G E+ T + + G L KI
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------QILHKID 228
Query: 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYD 322
K E+ P + P Y+++ + +
Sbjct: 229 K-----EGERLPRPEDCP----------------------------QDIYNVMVQCWAHK 255
Query: 323 PRKRITAAQALEH 335
P R T +
Sbjct: 256 PEDRPTFVALRDF 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 2e-47
Identities = 67/316 (21%), Positives = 116/316 (36%), Gaps = 57/316 (18%)
Query: 23 EW---LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREI 79
++ ++ L IGEG +G V + N A+AIK K D V ++E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEA 59
Query: 80 MLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSI 139
+ +R+ H ++VKL+ V + +++ + +R ++++ ++
Sbjct: 60 LTMRQFDHPHIVKLIGVIT---ENPVWIIMELCTLGE---LRSFLQVRKYSLDLASLILY 113
Query: 140 LWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENG 199
+QL L YL S +HRD+ N+LV VK+ DFGL+R + + +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVKLGDFGLSRYMEDS-TYYKASK 168
Query: 200 VVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259
+ I + APE + + +TSA D+W G E+L Q D +
Sbjct: 169 GKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-------QGVKNNDVIG 220
Query: 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKML 319
+I P P P Y L++K
Sbjct: 221 RIENGERLPMPPNCP----------------------------------PTLYSLMTKCW 246
Query: 320 EYDPRKRITAAQALEH 335
YDP +R +
Sbjct: 247 AYDPSRRPRFTELKAQ 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (414), Expect = 3e-47
Identities = 67/321 (20%), Positives = 119/321 (37%), Gaps = 68/321 (21%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI-REIMLLR 83
LQ + ++ +G G++G V L R + + G+ A+K K+ E ++L
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSR---HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 59
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+TH ++++ + +++ DY E + K ++
Sbjct: 60 IVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEV 113
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
L YLHS II+RDLKP NIL+ ++ G +KI DFG A+ + T
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILL----DKNGHIKITDFGFAKYVPDV-----TYTLCGT 164
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
Y APE++ K Y ++D W+ G + E+L F + + + K
Sbjct: 165 PDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDS-----------NTMKTYEK 212
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
IL P + ++ DLLS+++ D
Sbjct: 213 ILNAELR--------FPPFFNED------------------------VKDLLSRLITRDL 240
Query: 324 RKRI-----TAAQALEHEYFR 339
+R+ H +F+
Sbjct: 241 SQRLGNLQNGTEDVKNHPWFK 261
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-47
Identities = 55/309 (17%), Positives = 110/309 (35%), Gaps = 59/309 (19%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+ + +IG G +GLV L +AIK ++ + I E ++ +++
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLS 58
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
H +V+L V + + L F++ E+ + + T+ + + G
Sbjct: 59 HPKLVQLYGVCLE--QAPICLVFEFMEHGC---LSDYLRTQRGLFAAETLLGMCLDVCEG 113
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWY 206
+ YL +IHRDL N LV E V+K++DFG+ R ++ S G + +
Sbjct: 114 MAYLEEACVIHRDLAARNCLV----GENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKW 168
Query: 207 RAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILG 266
+PE+ Y+S D+W+ G + E+ + + + S + ++ I
Sbjct: 169 ASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGFR 220
Query: 267 HPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKR 326
P + Y +++ + P R
Sbjct: 221 LYKPRLAS----------------------------------THVYQIMNHCWKERPEDR 246
Query: 327 ITAAQALEH 335
++ L
Sbjct: 247 PAFSRLLRQ 255
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 9e-47
Identities = 55/314 (17%), Positives = 118/314 (37%), Gaps = 62/314 (19%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
++G G +G V + K +A+K K + + + E +++++ + +V+
Sbjct: 14 ELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
++ + S L + AE L + ++ +R + + ++ Q+ G+ YL
Sbjct: 73 MIGICEAE---SWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE 124
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL-SENGVVVTIWYRAPE 210
+ +HRDL N+L++ Q KI+DFGL++ +A + ++ + + APE
Sbjct: 125 ESNFVHRDLAARNVLLV----TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 211 LLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKSTQNPFQLDQLDKIFKILGHPT 269
+ ++S D+W+ G + E + + ++G + + + K
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGERMGC 231
Query: 270 PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329
P P YDL++ YD R
Sbjct: 232 PAGCP----------------------------------REMYDLMNLCWTYDVENRPGF 257
Query: 330 AQ---ALEHEYFRI 340
A L + Y+ +
Sbjct: 258 AAVELRLRNYYYDV 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-46
Identities = 73/370 (19%), Positives = 137/370 (37%), Gaps = 81/370 (21%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK-DGDGVSPTAIREIMLLR 83
+ ++ + +G+GT+G V L R KA G+ A+K ++ + E +L+
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
H + L H + + + + + R + ++
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV------FTEERARFYGAEI 114
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
++ L YLHS +++RD+K N+++ ++ G +KI DFGL + + + T
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLML----DKDGHIKITDFGLCKEGISDGATM--KTFCGT 168
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
Y APE+L Y AVD W +G + E++ + F +++F+
Sbjct: 169 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN------------QDHERLFE 215
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
++ T LSP A LL+ +L+ DP
Sbjct: 216 LILMEEIRFPRT-----------------------------LSP--EAKSLLAGLLKKDP 244
Query: 324 RKRI-----TAAQALEHEYFR---IEPLPGRNALVPSQPGDKVVNYPTRPVDSNTD---F 372
++R+ A + +EH +F + + + L P +P V S D F
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP----------QVTSEVDTRYF 294
Query: 373 EGTTTLQPPQ 382
+ T Q
Sbjct: 295 DDEFTAQSIT 304
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (405), Expect = 4e-46
Identities = 61/315 (19%), Positives = 107/315 (33%), Gaps = 57/315 (18%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+ + IG G +G V +K R +AIK K + E ++ +
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR-DFLSEASIMGQ 83
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
H NV+ L V + + ++ E + D + +L +
Sbjct: 84 FDHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIA 138
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIY---QAPLKFLSENGVV 201
G+ YL +HRDL NILV V K++DFGL+R + + S G
Sbjct: 139 AGMKYLADMNYVHRDLAARNILV----NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKSTQNPFQLDQLDK 260
+ I + APE + + +TSA D+W+ G + E+++ + + + D ++
Sbjct: 195 IPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--------DVINA 245
Query: 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLE 320
I + P P P S + L+ +
Sbjct: 246 IEQDYRLPPPMDCP----------------------------------SALHQLMLDCWQ 271
Query: 321 YDPRKRITAAQALEH 335
D R Q +
Sbjct: 272 KDRNHRPKFGQIVNT 286
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 4e-46
Identities = 70/366 (19%), Positives = 132/366 (36%), Gaps = 69/366 (18%)
Query: 16 SNHGEKPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSK--DGDGVSP 73
+ H EK ++ + L+ +G G YG VFL R + + GK A+K K++ +
Sbjct: 15 TGHAEKVG-IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE 73
Query: 74 TAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNP 133
E +L I + ++ + +L+ +
Sbjct: 74 HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-----ERFTE 128
Query: 134 YTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK 193
+ V+ + +++ L +LH II+RD+K NIL+ + G V + DFGL++ + A
Sbjct: 129 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL----DSNGHVVLTDFGLSKEFVADET 184
Query: 194 FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253
+ + + + G + AVD W++G + ELLT F K
Sbjct: 185 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK------ 238
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYD 313
+ +I + + P ++ + A D
Sbjct: 239 --NSQAEISRRILKSEPPYPQEMS-------------------------------ALAKD 265
Query: 314 LLSKMLEYDPRKRI-----TAAQALEHEYFR---IEPLPGRNALVPSQPGDKVVNYPTRP 365
L+ ++L DP+KR+ A + EH +F+ + L + P +P
Sbjct: 266 LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKP----------V 315
Query: 366 VDSNTD 371
+ D
Sbjct: 316 IRDELD 321
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-46
Identities = 57/311 (18%), Positives = 113/311 (36%), Gaps = 61/311 (19%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
+ + ++G G +G+V + + +AIK K+ + I E ++ +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEGSMSE---DEFIEEAKVMMNL 56
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
+HE +V+L V +++ +Y + ++ ++ H + + +
Sbjct: 57 SHEKLVQLYGVCTK--QRPIFIITEYMANGC---LLNYLREMRHRFQTQQLLEMCKDVCE 111
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
+ YL S +HRDL N LV +QGVVK++DFGL+R ++ S G +
Sbjct: 112 AMEYLESKQFLHRDLAARNCLV----NDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVR 166
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKSTQNPFQLDQLDKIFKI 264
+ PE+L+ ++S D+WA G + E+ +L K ++ + + I +
Sbjct: 167 WSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQG 217
Query: 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPR 324
L P Y ++
Sbjct: 218 LRLYRPHLAS----------------------------------EKVYTIMYSCWHEKAD 243
Query: 325 KRITAAQALEH 335
+R T L +
Sbjct: 244 ERPTFKILLSN 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-46
Identities = 67/344 (19%), Positives = 124/344 (36%), Gaps = 59/344 (17%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGK-AIAIKKFKQSKDGDGVSPTAIREIMLLREI 85
++ I +G G +G V+ + K +AIK+ +++ + E ++ +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMASV 68
Query: 86 THENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLN 145
+ +V +L+ + + + + + + + + + + + Q+
Sbjct: 69 DNPHVCRLLGICLTSTVQLIT------QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 146 GLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIW 205
G+NYL ++HRDL N+LV + VKI DFGLA++ A K G V I
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 206 YRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265
+ A E +L + YT D+W+ G EL+T P+ +I IL
Sbjct: 179 WMALESILH-RIYTHQSDVWSYGVTVWELMTFGSK-----------PYDGIPASEISSIL 226
Query: 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRK 325
G P Y ++ K D
Sbjct: 227 ------------------------------EKGERLPQPPICTIDVYMIMVKCWMIDADS 256
Query: 326 RITAAQALEHEYFRIEPLPGRNALVPSQPGDKVVNYPTRPVDSN 369
R + + + ++ P R GD+ ++ P+ P DSN
Sbjct: 257 RPKFRELIIE-FSKMARDPQRY---LVIQGDERMHLPS-PTDSN 295
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-45
Identities = 57/314 (18%), Positives = 115/314 (36%), Gaps = 62/314 (19%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
++G G +G V + + +AIK KQ + +RE ++ ++ + +V+
Sbjct: 16 ELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVR 73
Query: 93 LVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLH 151
L+ V +L L + A L++ + R++ + V +L Q+ G+ YL
Sbjct: 74 LIGVCQ---AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLE 126
Query: 152 SNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVV-TIWYRAPE 210
+HRDL N+L++ + KI+DFGL++ A + + + + APE
Sbjct: 127 EKNFVHRDLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 211 LLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKSTQNPFQLDQLDKIFKILGHPT 269
+ + ++S D+W+ G E L+ + ++ + + + I +
Sbjct: 183 CINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKRMEC 233
Query: 270 PEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329
P + P Y L+S Y R
Sbjct: 234 PPECP----------------------------------PELYALMSDCWIYKWEDRPDF 259
Query: 330 A---QALEHEYFRI 340
Q + Y+ +
Sbjct: 260 LTVEQRMRACYYSL 273
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-45
Identities = 67/326 (20%), Positives = 118/326 (36%), Gaps = 57/326 (17%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
L IG+G +G V+ + RG+ +A+K F ++ EI +
Sbjct: 4 TIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSREERSWF---REAEIYQTVMLR 55
Query: 87 HENVVKLVNVHI--NHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
HEN++ + N L+L DY E+ L++ + + + + +
Sbjct: 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALST 109
Query: 144 LNGLNYLHSNW--------IIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFL 195
+GL +LH I HRDLK NILV + G IAD GLA + + +
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVRHDSATDTI 165
Query: 196 S--ENGVVVTIWYRAPELLLGAKH-----YTSAVDMWAVGCIFAELLTLKPLFQGAEAKS 248
N V T Y APE+L + + D++A+G +F E+ + E
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED-- 223
Query: 249 TQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPK 308
QL + P+ E+ + + +K N +
Sbjct: 224 -------YQLPYYDLVPSDPSVEEMRKV------------VCEQKLRPNIPNRWQSCEAL 264
Query: 309 SPAYDLLSKMLEYDPRKRITAAQALE 334
++ + + R+TA + +
Sbjct: 265 RVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 2e-44
Identities = 69/330 (20%), Positives = 110/330 (33%), Gaps = 71/330 (21%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
+ IGEG +G VF AR +A+K K+ D + RE L+ E
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA-DFQREAALMAE 72
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNHT------------- 130
+ N+VK + + + L F+Y Y DL E +R +
Sbjct: 73 FDNPNIVK--LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 131 ------MNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184
++ I Q+ G+ YL +HRDL N LV E VVKIADFGL
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV----GENMVVKIADFGL 186
Query: 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGA 244
+R + + ++ + I + PE + YT+ D+WA G + E+ +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYG------ 239
Query: 245 EAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVP 304
P+ +++ + P N P
Sbjct: 240 -----LQPYYGMAHEEVIYYVRDGNILACPE--NCP------------------------ 268
Query: 305 LSPKSPAYDLLSKMLEYDPRKRITAAQALE 334
Y+L+ P R +
Sbjct: 269 ----LELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (391), Expect = 1e-43
Identities = 68/321 (21%), Positives = 118/321 (36%), Gaps = 68/321 (21%)
Query: 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLR 83
L Q++ I +G G++G V L + K G A+K + K + E +L+
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 84 EITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQL 143
+ +VKL +++++ + + + + R R + + Q+
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARFYAAQI 150
Query: 144 LNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVT 203
+ YLHS +I+RDLKP N+L+ +QG +++ DFG A+ + + T
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFGFAKRVKGR-----TWTLCGT 201
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
APE++L K Y AVD WA+G + E+ P F DQ +I++
Sbjct: 202 PEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFA------------DQPIQIYE 248
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
+ S DLL +L+ D
Sbjct: 249 KIVSGKVRFPS-----------------------------HFSS--DLKDLLRNLLQVDL 277
Query: 324 RKRI-----TAAQALEHEYFR 339
KR H++F
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFA 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-43
Identities = 64/333 (19%), Positives = 115/333 (34%), Gaps = 63/333 (18%)
Query: 20 EKPEW---LQQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIKKFKQSKDGDGVSPT 74
+ +W + L +G G +G V A + +A+K K+
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 63
Query: 75 AIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHR---------- 124
+L+ H NVV L+ + + +L +R R
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123
Query: 125 -DKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183
D + + +Q+ G+ +L S IHRDL NIL+ E+ VVKI DFG
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFG 179
Query: 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQ 242
LAR ++ + + + + APE + + YT D+W+ G + E+ +L +
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP 238
Query: 243 GAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSV 302
G + ++ + L T + P
Sbjct: 239 G-----------VKIDEEFCRRLKEGTRMRAPD--------------------------- 260
Query: 303 VPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335
+P+ Y + +P +R T ++ +EH
Sbjct: 261 -YTTPE--MYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-43
Identities = 66/334 (19%), Positives = 112/334 (33%), Gaps = 68/334 (20%)
Query: 21 KPEW---LQQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIKKFKQSKDGDGVSPTA 75
+W + + +G G +G V A +A+K K S
Sbjct: 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE-AL 73
Query: 76 IREIMLLREIT-HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHRDKVNH---- 129
+ E+ +L + H N+V L+ + +Y Y DL +R RD
Sbjct: 74 MSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 130 ---------TMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180
++ + S +Q+ G+ +L S IHRDL NIL+ + KI
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT----HGRITKIC 187
Query: 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL 240
DFGLAR + ++ + + + + APE + YT D+W+ G EL +L
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGS- 245
Query: 241 FQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLH 300
+ + + K G
Sbjct: 246 ---------------------------------------SPYPGMPVDSKFYKMIKEGFR 266
Query: 301 SVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334
+ P + YD++ + DP KR T Q ++
Sbjct: 267 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 6e-43
Identities = 75/322 (23%), Positives = 122/322 (37%), Gaps = 66/322 (20%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
IGEG +G V ARIK AIK+ K+ D E+ +L ++
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEYASKDDHRDF-AGELEVLCKLG 68
Query: 87 -HENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHH-----------RDKVNHTMNP 133
H N++ L+ + LYLA +YA + +L + +R + T++
Sbjct: 69 HHPNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 134 YTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLK 193
+ + G++YL IHRDL NILV E V KIADFGL+R + +K
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSRGQEVYVK 182
Query: 194 FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253
+ + + + A E L YT+ D+W+ G + E+++L P+
Sbjct: 183 ---KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGT-----------PY 227
Query: 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYD 313
++++ L G PL+ YD
Sbjct: 228 CGMTCAELYEKL------------------------------PQGYRLEKPLNCDDEVYD 257
Query: 314 LLSKMLEYDPRKRITAAQALEH 335
L+ + P +R + AQ L
Sbjct: 258 LMRQCWREKPYERPSFAQILVS 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 150 bits (380), Expect = 1e-42
Identities = 54/300 (18%), Positives = 107/300 (35%), Gaps = 39/300 (13%)
Query: 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH 87
Y + +IGEG++G++F + +AIK + D +P E + +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNL---LNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAG 59
Query: 88 ENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGL 147
+ V + + L D L +++ + TV Q+L +
Sbjct: 60 CTGIPNV-YYFGQEGLHNVLVIDLLGPSLEDLLDLC----GRKFSVKTVAMAAKQMLARV 114
Query: 148 NYLHSNWIIHRDLKPSNILVM-GEGEEQGVVKIADFGLARIYQAP-----LKFLSENGVV 201
+H +++RD+KP N L+ + ++ + DFG+ + Y+ P + + + +
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T Y + LG + + D+ A+G +F L +QG +A K
Sbjct: 175 GTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--------TNKQKY 225
Query: 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKS-PAYDLLSKMLE 320
+I L + + +H L+ + P YD L +
Sbjct: 226 ERIGEKKQSTPLREL--CAGFPEEFYKY---------MHYARNLAFDATPDYDYLQGLFS 274
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-42
Identities = 77/335 (22%), Positives = 123/335 (36%), Gaps = 67/335 (20%)
Query: 20 EKPEW---LQQYNLIGKIGEGTYGLVFLARI----KAAANRGKAIAIKKFKQSKDGDGVS 72
E P W + L +GEG +G V LA K NR +A+K K +S
Sbjct: 4 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 63
Query: 73 PTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHR------- 124
M+ H+N++ + D LY+ +YA +L E ++ R
Sbjct: 64 DLISEMEMMKMIGKHKNIIN--LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121
Query: 125 ----DKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180
++ + S +Q+ G+ YL S IHRDL N+LV + V+KIA
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED----NVMKIA 177
Query: 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL 240
DFGLAR + + + + APE L + YT D+W+ G + E+ TL
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGS 236
Query: 241 FQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLH 300
P+ ++++FK+L P +N
Sbjct: 237 -----------PYPGVPVEELFKLLKEGHRMDKP--SNCT-------------------- 263
Query: 301 SVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335
+ Y ++ P +R T Q +E
Sbjct: 264 --------NELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (378), Expect = 2e-42
Identities = 64/318 (20%), Positives = 119/318 (37%), Gaps = 60/318 (18%)
Query: 20 EKPEW---LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAI 76
+W + K+G G YG V+ K +A+K K+ +
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKEDTMEV---EEFL 61
Query: 77 REIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTV 136
+E +++EI H N+V+L+ V + Y+ ++ Y + R+ ++ +
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLL--DYLRECNRQEVSAVVL 117
Query: 137 KSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLS 196
+ Q+ + + YL IHRDL N LV E +VK+ADFGL+R+ + +
Sbjct: 118 LYMATQISSAMEYLEKKNFIHRDLAARNCLV----GENHLVKVADFGLSRLMTGD-TYTA 172
Query: 197 ENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256
G I + APE L ++ D+WA G + E+ T P+
Sbjct: 173 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMS-----------PYPGI 220
Query: 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLS 316
L +++++L + P P Y+L+
Sbjct: 221 DLSQVYELLEKDYRMERP--EGCP----------------------------EKVYELMR 250
Query: 317 KMLEYDPRKRITAAQALE 334
+++P R + A+ +
Sbjct: 251 ACWQWNPSDRPSFAEIHQ 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-42
Identities = 57/305 (18%), Positives = 112/305 (36%), Gaps = 53/305 (17%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVK 92
IG G +G V+ + + A+K + D VS + E +++++ +H NV+
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 92
Query: 93 LVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS 152
L+ + + ++ S + Y ++ + H + Q+ G+ +L S
Sbjct: 93 LLGICL-RSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 153 NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP--LKFLSENGVVVTIWYRAPE 210
+HRDL N ++ +E+ VK+ADFGLAR ++ G + + + A E
Sbjct: 149 KKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 211 LLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKILGHPTP 270
L + +T+ D+W+ G + EL+T N F + + + P
Sbjct: 205 SLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTFDI--TVYLLQGRRLLQP 256
Query: 271 EKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA 330
E P P Y+++ K R + +
Sbjct: 257 EYCP----------------------------------DPLYEVMLKCWHPKAEMRPSFS 282
Query: 331 QALEH 335
+ +
Sbjct: 283 ELVSR 287
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (373), Expect = 2e-41
Identities = 59/322 (18%), Positives = 105/322 (32%), Gaps = 59/322 (18%)
Query: 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT 86
+Y L KIG G++G ++L AA G+ +AIK P E + + +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAA---GEEVAIKLECVKTK----HPQLHIESKIYKMMQ 60
Query: 87 HENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNG 146
+ + D + + L ++ K + TV + Q+++
Sbjct: 61 GGVGIPTIRWCGAEGDY-NVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISR 115
Query: 147 LNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQ-----APLKFLSENGVV 201
+ Y+HS IHRD+KP N L MG G++ +V I DFGLA+ Y+ + + +
Sbjct: 116 IEYIHSKNFIHRDVKPDNFL-MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 202 VTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261
T Y + LG + D+ ++G + + Q + K
Sbjct: 175 GTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPW--------QGLKAATKRQKY 225
Query: 262 FKILGHPTPEKWPTL-ANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLE 320
+I L P S L+
Sbjct: 226 ERISEKKMSTPIEVLCKGYP----------------------------SEFATYLNFCRS 257
Query: 321 YDPRKRITAA---QALEHEYFR 339
+ + Q + + R
Sbjct: 258 LRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 6e-41
Identities = 60/311 (19%), Positives = 111/311 (35%), Gaps = 54/311 (17%)
Query: 26 QQYNLIGKIGEGTYGLVFLARIKAAANR-GKAIAIKKFKQSKDGDGVSPTAIREIMLLRE 84
IG G +G V+ +K ++ + +AIK K + E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-DFLGEAGIMGQ 65
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+H N+++L V + M + EY + + + + + +L +
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIIT-----EYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR-IYQAPLKFLSENGVVVT 203
G+ YL + +HRDL NILV V K++DFGL+R + P + +G +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 204 IWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263
I + APE + K + A D+W+ G + E++T + + + I
Sbjct: 177 IRWTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNH-------EVMKAIND 228
Query: 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDP 323
PTP P S Y L+ + + +
Sbjct: 229 GFRLPTPMDCP----------------------------------SAIYQLMMQCWQQER 254
Query: 324 RKRITAAQALE 334
+R A +
Sbjct: 255 ARRPKFADIVS 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 7e-40
Identities = 60/331 (18%), Positives = 124/331 (37%), Gaps = 60/331 (18%)
Query: 23 EW---LQQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIKKFKQSKDGDGVSPTAIR 77
EW ++ + ++G+G++G+V+ K +AIK ++ +
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLN 72
Query: 78 EIMLLREITHENVVKLVNVHINHADMSLYLAFDYAEY-DLYEIIRHHR-----DKVNHTM 131
E +++E +VV+L+ V + + DL +R R + V
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130
Query: 132 NPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP 191
+ + + ++ +G+ YL++N +HRDL N +V E VKI DFG+ R
Sbjct: 131 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYET 186
Query: 192 LKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQN 251
+ ++ + + +PE L +T+ D+W+ G + E+ TL
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQ----------- 234
Query: 252 PFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPA 311
P+Q +++ + + P N P
Sbjct: 235 PYQGLSNEQVLRFVMEGGLLDKP--DNCP----------------------------DML 264
Query: 312 YDLLSKMLEYDPRKRITAAQALEHEYFRIEP 342
++L+ +Y+P+ R + + + +EP
Sbjct: 265 FELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 107 bits (269), Expect = 6e-28
Identities = 30/206 (14%), Positives = 59/206 (28%), Gaps = 36/206 (17%)
Query: 33 KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG--------DGVSPTAIREIMLLRE 84
+GEG VF + + +K K D +
Sbjct: 7 LMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 85 ITHENVVKLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLL 144
+ KL + + YA ++ K + + +L +L
Sbjct: 63 NEFRALQKLQGLAVPK---------VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMIL 113
Query: 145 NGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQAP--LKFLSENGVVV 202
+ + I+H DL N+LV EG + I DF + + L + +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEG-----IWIIDFPQSVEVGEEGWREILERDVRNI 168
Query: 203 TIWYRAPELLLGAKHYTSAVDMWAVG 228
++ + Y + D+ +
Sbjct: 169 ITYFS--------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 477 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.31 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.76 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.63 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.94 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.05 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.91 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=444.49 Aligned_cols=262 Identities=27% Similarity=0.411 Sum_probs=210.5
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
|+++|+++++||+|+||+||+|+++. +++.||||++...... ...+.+.+|+.+|+.++||||+++++++.+..
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-- 76 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGN-- 76 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETT--
T ss_pred CCcceEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc--
Confidence 68899999999999999999998764 6889999999765432 23346789999999999999999999998754
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|||||||. ++|.+++.. ...+++.+++.++.||++||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl----~~~~~~KL~DF 147 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL----DERDNLKISDF 147 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTCCEEECCC
T ss_pred eeEEEEeccCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE----CCCCCEEEccc
Confidence 7899999998 588887754 3479999999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+|+.+............+||+.|||||++.+...++.++|||||||++|||+||++||...... .......
T Consensus 148 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~--------~~~~~~~ 219 (271)
T d1nvra_ 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--------CQEYSDW 219 (271)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT--------SHHHHHH
T ss_pred hhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH--------HHHHHHH
Confidence 99997754433334456789999999999988665678899999999999999999999765421 1111111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
...... ......+++++.+||.+||++||.+|||++|+|+||||+.
T Consensus 220 --~~~~~~------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 220 --KEKKTY------------------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp --HTTCTT------------------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --hcCCCC------------------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 110000 0011234678999999999999999999999999999973
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-57 Score=440.32 Aligned_cols=289 Identities=42% Similarity=0.771 Sum_probs=230.1
Q ss_pred eEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC---CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 29 NLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG---DGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 29 ~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
+.+++||+|+||+||+|+++. +++.||||+++..... ......+.+|+.+|+.++|||||++++++.+.. .+
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~ 75 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NI 75 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CC
T ss_pred CcceEeccCcCeEEEEEEECC---CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--ce
Confidence 357899999999999998664 6899999999765432 223457889999999999999999999997654 68
Q ss_pred EEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccc
Q 011808 106 YLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLA 185 (477)
Q Consensus 106 ~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a 185 (477)
||||||+.+++...+... +..+++..++.+++||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 76 ~ivmE~~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli----~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL----DENGVLKLADFGLA 147 (299)
T ss_dssp EEEEECCSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCEEECCCGGG
T ss_pred eehhhhhcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe----cCCCccccccCccc
Confidence 999999998777766543 3468999999999999999999999999999999999999 77788999999999
Q ss_pred eeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 186 RIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 186 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
+....... .....+||+.|+|||++.+...|+.++|||||||++|||+||.+||.+.+ ..+.+..+++.+
T Consensus 148 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--------~~~~l~~i~~~~ 217 (299)
T d1ua2a_ 148 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--------DLDQLTRIFETL 217 (299)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHHH
T ss_pred cccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC--------HHHHHHHHHHhc
Confidence 86654322 23346789999999999877778999999999999999999999998776 677889999999
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCCCCCC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIEPLPG 345 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~~~~~ 345 (477)
+.+..+.|+.....+.+.... ......+.. .....+++++|||.+||++||++|||++|+|+||||+..+.|.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~-~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~ 290 (299)
T d1ua2a_ 218 GTPTEEQWPDMCSLPDYVTFK------SFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290 (299)
T ss_dssp CCCCTTTSSSTTSSTTCCCCC------CCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred CCCChhhccchhccchhhhhc------cCCCCChHH-hcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence 999988887665544332211 111111111 1234578899999999999999999999999999998766554
Q ss_pred CC
Q 011808 346 RN 347 (477)
Q Consensus 346 ~~ 347 (477)
..
T Consensus 291 ~~ 292 (299)
T d1ua2a_ 291 PG 292 (299)
T ss_dssp CS
T ss_pred CC
Confidence 33
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-57 Score=433.00 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=211.0
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+++|++++.||+|+||+||+|+++. +++.||||++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-- 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-- 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred hhHeEEEEEEecCCCcEEEEEEECC---CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC--
Confidence 6899999999999999999998764 688999999865432 2334567789999999999999999999997654
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+|||||. |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill----~~~~~~kl~DF 150 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL----GSAGELKIADF 150 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEECCC
T ss_pred EEEEEEeecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee----cCCCCEeeccc
Confidence 7899999998 5888888764 369999999999999999999999999999999999999 66778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+|+...... ....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+. .+.+..+.
T Consensus 151 G~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~ 217 (263)
T d2j4za1 151 GWSVHAPSSR----RTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS 217 (263)
T ss_dssp CSCSCCCCCC----CEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH
T ss_pred ceeeecCCCc----ccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHH
Confidence 9998654322 2335789999999999884 489999999999999999999999976542 22222221
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
... ..+|...++++.+||.+||++||.+|||++|+|+||||+.
T Consensus 218 ----~~~-------------------------------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 218 ----RVE-------------------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ----TTC-------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ----cCC-------------------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 111 1133445788999999999999999999999999999963
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=435.83 Aligned_cols=261 Identities=27% Similarity=0.466 Sum_probs=203.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++++.||+|+||+||+|+++. +++.||||++......+...+.+.+|+++|++++||||+++++++.+..+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred chhCEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence 5789999999999999999998764 6889999999876655445567889999999999999999999998776678
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC-----eecCCCCCCcEEEeccCCCcccEE
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW-----IIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g-----ivHrDikp~NILl~~~~~~~~~vk 178 (477)
+|+|||||. |+|.+++..... ....+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+|
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll----~~~~~vk 154 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL----DGKQNVK 154 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE----CTTSCEE
T ss_pred EEEEEecCCCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc----CCCCcEE
Confidence 999999998 599998876432 2457999999999999999999999876 9999999999999 6777899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+|+.+..... .....+||+.|+|||++.+. .|+.++|||||||++|||+||+.||.+.+. .+.+
T Consensus 155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~ 223 (269)
T d2java1 155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELA 223 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHH
T ss_pred EeeccceeecccCCC--ccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHH
Confidence 999999987654322 22346789999999999774 489999999999999999999999976542 2222
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..+... .. ...+...++++.+||.+||+.||.+|||++|+|+|||+
T Consensus 224 ~~i~~~---~~-------------------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 224 GKIREG---KF-------------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHT---CC-------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHcC---CC-------------------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 222211 00 01234457889999999999999999999999999995
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-56 Score=434.45 Aligned_cols=289 Identities=43% Similarity=0.794 Sum_probs=234.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|+++++||+|+||+||+|+++. +++.||||+++...........+.+|+++|++++||||++++++|.+.. .
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~--~ 75 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--K 75 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT--E
T ss_pred CCCCEeccEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc--c
Confidence 4789999999999999999998764 6889999999876655566778899999999999999999999998754 7
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+|+||||++++++.++.... ...+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~----~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI----NTEGAIKLADFGL 148 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEECSTTH
T ss_pred eeEEEeecCCchhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee----cccCcceeccCCc
Confidence 99999999998888776543 4479999999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
|+....... ......||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+ ..+.+..++..
T Consensus 149 a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~--------~~~~~~~i~~~ 218 (298)
T d1gz8a_ 149 ARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--------EIDQLFRIFRT 218 (298)
T ss_dssp HHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHH
T ss_pred ceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC--------HHHHHHHHHHh
Confidence 987654332 23446789999999999887777899999999999999999999998766 56788888888
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRIE 341 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~~ 341 (477)
.+.+....|......+.+...... ...... .......+.+++|||.+||++||.+|||++|+|+||||+.-
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~-~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 219 LGTPDEVVWPGVTSMPDYKPSFPK-----WARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTSCC-----CCCCCH-HHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCCCchhhcccccccccccccccc-----ccccch-hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 888887777766555443322111 011111 11223567889999999999999999999999999999743
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=434.50 Aligned_cols=256 Identities=27% Similarity=0.469 Sum_probs=210.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|+++++||+|+||+||+|+++. +++.||||+++..... ..+.+.+|+.+|+.++||||++++++|.+.. .
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGD--E 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTT---TCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--E
T ss_pred ccccEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECC--E
Confidence 3589999999999999999998654 6899999999765432 3467889999999999999999999998754 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+|||||. ++|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 92 ~~ivmEy~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl----~~~~~vkl~DFG 161 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL----GMDGSVKLTDFG 161 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCCT
T ss_pred EEEEEEecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE----CCCCcEeeccch
Confidence 899999998 577776654 269999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+|+.+..... .....+||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+ ..+.+..+..
T Consensus 162 ~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~~~~ 230 (293)
T d1yhwa1 162 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIAT 230 (293)
T ss_dssp TCEECCSTTC--CBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHH
T ss_pred hheeeccccc--cccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCC--------HHHHHHHHHh
Confidence 9997754332 23456789999999999874 58999999999999999999999997654 2233333322
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.. .+.. ..+..+++++++||.+||++||.+|||++|+|+||||+.
T Consensus 231 ~~-~~~~-------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 231 NG-TPEL-------------------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HC-SCCC-------------------------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred CC-CCCC-------------------------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 21 1111 122334688999999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=433.30 Aligned_cols=258 Identities=30% Similarity=0.457 Sum_probs=209.1
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
..++|++++.||+|+||+||+|+++. +++.||||++..... .......+.+|+++|++++||||++++++|.+.
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-- 80 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-- 80 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--
Confidence 35789999999999999999998764 688999999875432 233456788999999999999999999999765
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|+||||+. |+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+ ++++.+||+|
T Consensus 81 ~~~~ivmEy~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll----~~~~~vkl~D 151 (288)
T d1uu3a_ 81 EKLYFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL----NEDMHIQITD 151 (288)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTSCEEECC
T ss_pred CEEEEEEEccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc----CCCceEEecc
Confidence 47899999998 5888888764 379999999999999999999999999999999999999 7777899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+|+.+............+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+. .+.+..+
T Consensus 152 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i 222 (288)
T d1uu3a_ 152 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKI 222 (288)
T ss_dssp CTTCEECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred cccceecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHH
Confidence 9999987654443344556899999999999885 489999999999999999999999986542 2222222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHH------HhcC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQ------ALEH 335 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e------~L~h 335 (477)
.. .. ..+|...++++.+||.+||++||.+|||++| +++|
T Consensus 223 ~~----~~-------------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~H 267 (288)
T d1uu3a_ 223 IK----LE-------------------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267 (288)
T ss_dssp HT----TC-------------------------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred Hc----CC-------------------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcC
Confidence 11 00 1134456788999999999999999999988 5889
Q ss_pred ccCC
Q 011808 336 EYFR 339 (477)
Q Consensus 336 ~~f~ 339 (477)
|||+
T Consensus 268 pff~ 271 (288)
T d1uu3a_ 268 PFFE 271 (288)
T ss_dssp GGGT
T ss_pred CccC
Confidence 9996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-56 Score=433.78 Aligned_cols=263 Identities=29% Similarity=0.421 Sum_probs=197.9
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+.++|+++++||+|+||+||+|+++. +++.||||++....... ....+.+|+.+|+.++||||+++++++.+.
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-- 79 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKR---TQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESG-- 79 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETT---TCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred CCccceEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence 356779999999999999999998764 68899999997654432 234567899999999999999999999765
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|||||||. ++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||+... +.++.+||+|
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~-~~~~~vkl~D 153 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL-DEDSKIMISD 153 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS-STTCCEEECC
T ss_pred CEEEEEEeccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc-CCCceEEEec
Confidence 47899999998 6999998753 479999999999999999999999999999999999999543 3467899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+|+...... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.. ..+....+
T Consensus 154 FG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i 221 (307)
T d1a06a_ 154 FGLSKMEDPGS---VLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQI 221 (307)
T ss_dssp C---------------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHH
T ss_pred cceeEEccCCC---eeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHH
Confidence 99998765432 22346789999999999875 58999999999999999999999997654 22222222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
... ... .....+..+++++.+||.+||++||.+|||++|+|+||||+.
T Consensus 222 ~~~---~~~----------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 222 LKA---EYE----------------------------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HTT---CCC----------------------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred hcc---CCC----------------------------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 211 100 001123345788999999999999999999999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-55 Score=426.20 Aligned_cols=285 Identities=43% Similarity=0.797 Sum_probs=235.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|+++++||+|+||+||+|+++ +++.||||+++...........+.+|+.+|++++||||++++++|.+.. .
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~ 74 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--R 74 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--C
T ss_pred CCCceeccEEecCCCcEEEEEEeC----CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--c
Confidence 479999999999999999999864 5789999999877666666788999999999999999999999998754 6
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+|++|+++.+.++..+... ...+++..++.++.||+.||+|||+.|||||||||+|||+ +.++.+||+|||+
T Consensus 75 ~~i~~e~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll----~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI----NREGELKIADFGL 146 (286)
T ss_dssp EEEEEECCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEECCTTH
T ss_pred eeEEEEeehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE----cCCCCEEeccccc
Confidence 8999999999888777654 3579999999999999999999999999999999999999 6778899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
+........ ......+++.|+|||++.+...++.++|||||||++|||++|++||.+.+ ..+.+..++..
T Consensus 147 a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~--------~~~~~~~i~~~ 216 (286)
T d1ob3a_ 147 ARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--------EADQLMRIFRI 216 (286)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHH
T ss_pred ceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC--------HHHHHHHHHHh
Confidence 987654322 23345679999999999887778999999999999999999999998765 56778889999
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
++.+....|+.....+.+....... ............+..+.|||++||++||++|||++|+|+||||+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 217 LGTPNSKNWPNVTELPKYDPNFTVY------EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCC------CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred hCCCChhhccchhhhhhcccccccc------cCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 9999888887766655443221110 11111223455678899999999999999999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-56 Score=429.70 Aligned_cols=258 Identities=27% Similarity=0.459 Sum_probs=209.5
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
+.|++++.||+|+||+||+|+++. ++..||||+++... ....+.+.+|+++|++++|||||++++++.+.. .+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE---TSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC---CCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--eE
Confidence 569999999999999999998764 68899999997643 234457789999999999999999999998754 78
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|+|||||. |+|.+++... ...+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~lvmEy~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll----~~~~~~Kl~DFG~ 156 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF----TLDGDIKLADFGV 156 (288)
T ss_dssp EEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCCTT
T ss_pred EEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE----CCCCCEEEEechh
Confidence 99999998 5777776653 2469999999999999999999999999999999999999 6677899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLG----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|+....... .....+||+.|+|||++.+ ...|+.++|||||||++|||+||++||.+.+. .+.+..
T Consensus 157 a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--------~~~~~~ 226 (288)
T d2jfla1 157 SAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRVLLK 226 (288)
T ss_dssp CEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--------GGHHHH
T ss_pred hhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--------HHHHHH
Confidence 986543211 2234678999999999853 34589999999999999999999999987652 223333
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+... ..+. ...+...++++++||.+||++||.+|||++|+|+||||+.
T Consensus 227 i~~~---~~~~-----------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 227 IAKS---EPPT-----------------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHS---CCCC-----------------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHcC---CCCC-----------------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 3221 1100 0122345688999999999999999999999999999973
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-55 Score=438.74 Aligned_cols=268 Identities=24% Similarity=0.369 Sum_probs=216.6
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
...+++|+++++||+|+||.||+|+++. +|..||||++..... ...+.+.+|+.+|++++|||||+++++|.+..
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~---~g~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECCCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEcccch--hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4568899999999999999999998764 689999999975432 22456778999999999999999999998754
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.+|||||||. |+|.+++... ...+++.+++.++.||+.||.|||++|||||||||+|||+..+ .++.+||+
T Consensus 97 --~~~ivmE~~~gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~--~~~~vkL~ 168 (350)
T d1koaa2 97 --EMVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELKLI 168 (350)
T ss_dssp --EEEEEECCCCSCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TSCCEEEC
T ss_pred --EEEEEEEcCCCCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC--CCCeEEEe
Confidence 7999999998 6888888543 3469999999999999999999999999999999999999432 34679999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~ 260 (477)
|||+++.+..... ....+||+.|||||++.+. .|+.++|||||||++|+|++|+.||.+.+ ..+.+..
T Consensus 169 DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~ 236 (350)
T d1koaa2 169 DFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRN 236 (350)
T ss_dssp CCTTCEECCTTSC---EEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred ecchheecccccc---cceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHH
Confidence 9999987754332 2346779999999999884 48999999999999999999999998665 2333444
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
+.......+. .....+++++++||.+||++||++|||++|+|+||||+.
T Consensus 237 i~~~~~~~~~-------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~ 285 (350)
T d1koaa2 237 VKSCDWNMDD-------------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285 (350)
T ss_dssp HHHTCCCSCC-------------------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHhCCCCCCc-------------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 4332111111 111234678999999999999999999999999999985
Q ss_pred CCCCC
Q 011808 341 EPLPG 345 (477)
Q Consensus 341 ~~~~~ 345 (477)
...+.
T Consensus 286 ~~~~~ 290 (350)
T d1koaa2 286 GNAPG 290 (350)
T ss_dssp TTCCS
T ss_pred CCCCC
Confidence 54433
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=427.54 Aligned_cols=265 Identities=27% Similarity=0.400 Sum_probs=216.1
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC----CCcHHHHHHHHHHHhcCCCCeeEEEEEEE
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD----GVSPTAIREIMLLREITHENVVKLVNVHI 98 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 98 (477)
.+-++|++++.||+|+||+||+|+++. +|+.||||+++...... ...+.+.+|+.+|++++|||||+++++|.
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 356789999999999999999998764 68999999997654332 23467889999999999999999999997
Q ss_pred cCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccE
Q 011808 99 NHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVV 177 (477)
Q Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~v 177 (477)
+. ..+|||||||. |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+..++.....+
T Consensus 84 ~~--~~~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~v 156 (293)
T d1jksa_ 84 NK--TDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI 156 (293)
T ss_dssp CS--SEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCE
T ss_pred EC--CEEEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccce
Confidence 65 48999999998 5898988764 3699999999999999999999999999999999999997665556679
Q ss_pred EEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 178 KIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 178 kL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
||+|||+++....... .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+ ..+.
T Consensus 157 kl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~ 224 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDT--------KQET 224 (293)
T ss_dssp EECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH
T ss_pred EecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCC--------HHHH
Confidence 9999999987754332 2345679999999999874 58999999999999999999999998755 2222
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
+..+...- . . .....+...+..+++||++||++||.+|||++|+|+|||
T Consensus 225 ~~~i~~~~---~-~---------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 273 (293)
T d1jksa_ 225 LANVSAVN---Y-E---------------------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273 (293)
T ss_dssp HHHHHTTC---C-C---------------------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred HHHHHhcC---C-C---------------------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 22222110 0 0 011123345788999999999999999999999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|+.
T Consensus 274 ~~~ 276 (293)
T d1jksa_ 274 IKP 276 (293)
T ss_dssp TCC
T ss_pred cCC
Confidence 973
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-56 Score=424.07 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=206.6
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CCceE
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH--ADMSL 105 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~~ 105 (477)
|++.++||+|+||+||+|+++. ++..||+|++..........+.+.+|+++|++++|||||+++++|.+. .+..+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~---~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred EEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 4788899999999999998764 688999999977655444456778999999999999999999998753 34578
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCC--eecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNW--IIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++ ++++.+||+||
T Consensus 88 ~ivmE~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~---~~~~~~Kl~DF 159 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT---GPTGSVKIGDL 159 (270)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES---STTSCEEECCT
T ss_pred EEEEeCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee---CCCCCEEEeec
Confidence 99999998 5888888764 36999999999999999999999998 99999999999993 24578999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+|+..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+... . ..+.
T Consensus 160 Gla~~~~~~----~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--------~---~~~~ 222 (270)
T d1t4ha_ 160 GLATLKRAS----FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQN--------A---AQIY 222 (270)
T ss_dssp TGGGGCCTT----SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--------H---HHHH
T ss_pred CcceeccCC----ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCccc--------H---HHHH
Confidence 999864432 1234578999999999976 389999999999999999999999975431 1 2222
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFR 339 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~ 339 (477)
..+...... ..++...++++.+||.+||++||++|||++|+|+||||+
T Consensus 223 ~~i~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 223 RRVTSGVKP-----------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHTTTCCC-----------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHcCCCC-----------------------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 332221110 012233467899999999999999999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=432.53 Aligned_cols=256 Identities=25% Similarity=0.423 Sum_probs=213.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+++|++++.||+|+||+||+|+++. +++.||||++++... .......+.+|+.+|+.++||||++++++|.+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-- 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-- 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS--
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc--
Confidence 6789999999999999999998764 689999999975432 2334567889999999999999999999997754
Q ss_pred eEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+. |+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+||
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl----~~~g~vkl~DF 149 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML----DKDGHIKITDF 149 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEECCC
T ss_pred ccccceeccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe----cCCCCEEEeec
Confidence 8999999998 5888888764 379999999999999999999999999999999999999 77788999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+|+....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+. ...+..+.
T Consensus 150 G~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~ 218 (337)
T d1o6la_ 150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELIL 218 (337)
T ss_dssp TTCBCSCCTTC--CBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH
T ss_pred ccccccccCCc--ccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHh
Confidence 99986543322 33457899999999999885 489999999999999999999999987652 12222221
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCcc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALEHEY 337 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~h~~ 337 (477)
. .. ..+|...+++++|||.+||++||.+|++ +.++++|||
T Consensus 219 ~----~~-------------------------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 219 M----EE-------------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp H----CC-------------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred c----CC-------------------------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence 1 11 1134456789999999999999999994 999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|+.
T Consensus 264 f~~ 266 (337)
T d1o6la_ 264 FLS 266 (337)
T ss_dssp GTT
T ss_pred ccc
Confidence 973
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=424.37 Aligned_cols=288 Identities=42% Similarity=0.733 Sum_probs=231.2
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc---CCCCeeEEEEEEEc
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI---THENVVKLVNVHIN 99 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~ 99 (477)
...++|+++++||+|+||+||+|++.. .+++.||||+++...........+.+|+.+|+.| +||||++++++|..
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEEC--CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 346899999999999999999998754 2467899999977655555555667888887766 79999999999864
Q ss_pred ---CCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc
Q 011808 100 ---HADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 100 ---~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~ 176 (477)
..+..+|++|||+.++++.+..... ...+++..++.++.||+.||+|||++|||||||||+|||+ +..+.
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi----~~~~~ 154 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV----TSSGQ 154 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCC
T ss_pred cccccCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE----cCCCC
Confidence 2345789999999988777665533 4579999999999999999999999999999999999999 77778
Q ss_pred EEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHH
Q 011808 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLD 256 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~ 256 (477)
+||+|||+++...... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+ ..+
T Consensus 155 ~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~--------~~~ 222 (305)
T d1blxa_ 155 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSS--------DVD 222 (305)
T ss_dssp EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHH
T ss_pred eeecchhhhhhhcccc---cCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCC--------HHH
Confidence 9999999998654322 33456789999999999874 49999999999999999999999998776 567
Q ss_pred HHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 257 QLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 257 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
.+..+...++.+....|+.....+...-. . .............++.+.|||.+||++||++|||++|+|+||
T Consensus 223 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-------~-~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hp 294 (305)
T d1blxa_ 223 QLGKILDVIGLPGEEDWPRDVALPRQAFH-------S-KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294 (305)
T ss_dssp HHHHHHHHHCCCCGGGSCTTCSSCGGGSC-------C-CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHHHHHhhCCCchhcccccccchhhhhc-------c-ccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence 88889999988877766654433211100 0 001111223456678899999999999999999999999999
Q ss_pred cCC
Q 011808 337 YFR 339 (477)
Q Consensus 337 ~f~ 339 (477)
||+
T Consensus 295 ff~ 297 (305)
T d1blxa_ 295 YFQ 297 (305)
T ss_dssp GGT
T ss_pred hhc
Confidence 997
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=441.09 Aligned_cols=288 Identities=22% Similarity=0.332 Sum_probs=208.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
-++|+++++||+|+||+||+|+++. ++..||||+++... .......+.+|+.+|+.++|||||+++++|.+.. .
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~ 78 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--E 78 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETT---TTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS--E
T ss_pred ccCCEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--E
Confidence 4689999999999999999998764 68999999997643 2344567889999999999999999999998754 7
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
+|+||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++.+||+||
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl----~~~~~vkl~DF 149 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV----NSRGEIKLCDF 149 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE----CTTCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE----CCCCCEEEeeC
Confidence 899999998 5888888764 369999999999999999999997 499999999999999 67778999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+|+.+... .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+... .+...+.
T Consensus 150 Gla~~~~~~----~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~-------~~~~~~~ 217 (322)
T d1s9ja_ 150 GVSGQLIDS----MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE-------LELMFGC 217 (322)
T ss_dssp CCCHHHHHH----TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH-------HHHHC--
T ss_pred CCccccCCC----ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHH
Confidence 999866432 22356889999999999985 49999999999999999999999998755321 1111111
Q ss_pred HHhCCCCCC----CccccCCCccccccc---cccccccc-cCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 263 KILGHPTPE----KWPTLANLPHWQSDS---LHIQGRKY-ETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 263 ~~~~~~~~~----~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
...+..... .+........+.... ........ .............+.+++|||.+||++||.+|||++|+|+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 111111000 000000000000000 00000000 0000001111234678999999999999999999999999
Q ss_pred CccCC
Q 011808 335 HEYFR 339 (477)
Q Consensus 335 h~~f~ 339 (477)
||||+
T Consensus 298 Hpf~~ 302 (322)
T d1s9ja_ 298 HAFIK 302 (322)
T ss_dssp SHHHH
T ss_pred CHhhC
Confidence 99996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-55 Score=429.62 Aligned_cols=255 Identities=27% Similarity=0.471 Sum_probs=207.7
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+.|++++.||+|+||+||+|+++. ++..||||+++..... ....+.+.+|+.+|++++|||||++++++.+.. .
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--T 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--E
T ss_pred HhcEeeEEEecCCCeEEEEEEECC---CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC--E
Confidence 459999999999999999998764 6889999999765432 223456789999999999999999999998754 7
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
+|+|||||.++++..+... ...+++.+++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+
T Consensus 90 ~~iv~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl----~~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL----SEPGLVKLGDFGS 161 (309)
T ss_dssp EEEEEECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE----ETTTEEEECCCTT
T ss_pred EEEEEEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE----CCCCCEEEeeccc
Confidence 8999999997666554433 3479999999999999999999999999999999999999 6777899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGA--KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+.... ....+||+.|||||++.+. ..|+.++|||||||++|||++|+.||.+.+ ..+.+..+.
T Consensus 162 a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--------~~~~~~~i~ 227 (309)
T d1u5ra_ 162 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIA 227 (309)
T ss_dssp CBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHH
T ss_pred ccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH
Confidence 986543 2346789999999999753 358999999999999999999999997654 223333322
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
. ...+. ..+...++++.+||.+||++||.+|||++|+|+||||..
T Consensus 228 ~---~~~~~------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 228 Q---NESPA------------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp H---SCCCC------------------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred h---CCCCC------------------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 2 11110 112334678999999999999999999999999999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.9e-55 Score=435.93 Aligned_cols=262 Identities=25% Similarity=0.389 Sum_probs=213.3
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
..+++|++++.||+|+||+||+|+++. +++.||||+++..... ....+.+|+.+|++++|||||+++++|.+.
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-- 98 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFEDK-- 98 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEECS--
T ss_pred CcccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECCcchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence 457889999999999999999998764 6899999998764322 234667899999999999999999999764
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
..+|||||||+ ++|.+.+... ...+++.+++.++.||+.||.|||++|||||||||+||||.. ..++.+||+|
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~--~~~~~vkL~D 172 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET--KKASSVKIID 172 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS--TTCCCEEECC
T ss_pred CEEEEEEEcCCCChHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc--cCCCeEEEee
Confidence 47899999998 5887776543 346999999999999999999999999999999999999942 2457899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+|+.+..... ....+||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+ ..+.+..+
T Consensus 173 FGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i 240 (352)
T d1koba_ 173 FGLATKLNPDEI---VKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNV 240 (352)
T ss_dssp CTTCEECCTTSC---EEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHH
T ss_pred cccceecCCCCc---eeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH
Confidence 999998765322 2335679999999999874 49999999999999999999999998765 23344444
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.......+.. ....+++++.+||.+||++||.+|||++|+|+||||+.
T Consensus 241 ~~~~~~~~~~-------------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 241 KRCDWEFDED-------------------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp HHCCCCCCSS-------------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HhCCCCCCcc-------------------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 3322111111 22345688999999999999999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=425.75 Aligned_cols=300 Identities=38% Similarity=0.685 Sum_probs=232.0
Q ss_pred cccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 22 PEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 22 ~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
+.-+++|+++++||+|+||+||+|+++. +++.||||++......+.....+.+|+.+|+.++||||+++++++....
T Consensus 6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 6 CDEVSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp SCBGGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CCccCCEEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 4458999999999999999999998764 6899999999877776777788999999999999999999999986532
Q ss_pred ------CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 102 ------DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 102 ------~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
+..+|++|||+++.+...+... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl----~~~~ 154 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI----TRDG 154 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTS
T ss_pred ccccccCceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee----cCCC
Confidence 3458999999998887766543 3478999999999999999999999999999999999999 6777
Q ss_pred cEEEeecccceeecCCCC--cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 176 VVKIADFGLARIYQAPLK--FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
.+||+|||+++.+..... .......+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+
T Consensus 155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-------- 226 (318)
T d3blha1 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-------- 226 (318)
T ss_dssp CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------
T ss_pred cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--------
Confidence 899999999986653221 1223345789999999999887779999999999999999999999998765
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCcc-ccCCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHS-VVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~ 332 (477)
....+..+...++.+.++.+........+...... ......+.. ......++.++|||.+||++||++|+|++|+
T Consensus 227 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el 302 (318)
T d3blha1 227 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELV----KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302 (318)
T ss_dssp HHHHHHHHHHHHCCCCTTTSTTCCCC-------CC----SSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHHHHHHHhcCCCChhhccccchhhhhhhhccc----ccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 56777788888888887766655543322211100 000000000 0111235678899999999999999999999
Q ss_pred hcCccCCCCCCC
Q 011808 333 LEHEYFRIEPLP 344 (477)
Q Consensus 333 L~h~~f~~~~~~ 344 (477)
|+||||+..+.|
T Consensus 303 L~Hpff~~~p~p 314 (318)
T d3blha1 303 LNHDFFWSDPMP 314 (318)
T ss_dssp HHSGGGSSSSCC
T ss_pred HcChhhccCCCC
Confidence 999999866554
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-54 Score=423.95 Aligned_cols=253 Identities=26% Similarity=0.451 Sum_probs=209.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
+++|+++++||+|+||+||+|+++. +|+.||||+++.... .....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-- 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-- 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS--
T ss_pred hhHeEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC--
Confidence 5789999999999999999998764 689999999975432 2334567889999999999999999999997654
Q ss_pred eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.+|+||||+.| +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+||
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl----~~~g~vkL~DF 148 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL----DKNGHIKITDF 148 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE----CTTSCEEECCC
T ss_pred eeeeEeeecCCcccccccccc-----ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE----cCCCCEEEecC
Confidence 89999999985 666666553 368999999999999999999999999999999999999 77788999999
Q ss_pred ccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHH
Q 011808 183 GLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 183 G~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
|+|+..... ....+||+.|+|||++.+. .|+.++|||||||++|+|+||+.||.+.+. .+.+..+.
T Consensus 149 G~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~ 214 (316)
T d1fota_ 149 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKIL 214 (316)
T ss_dssp SSCEECSSC-----BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH
T ss_pred ccceEeccc-----cccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHH
Confidence 999876542 2346789999999999874 489999999999999999999999986552 22233322
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCcc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHEY 337 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~~ 337 (477)
.. . ..+|...++++.+||.+||++||.+|+ |++++|+|||
T Consensus 215 ~~----~-------------------------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 215 NA----E-------------------------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp HC----C-------------------------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred cC----C-------------------------------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence 21 0 112344568899999999999999996 8999999999
Q ss_pred CCC
Q 011808 338 FRI 340 (477)
Q Consensus 338 f~~ 340 (477)
|+.
T Consensus 260 f~~ 262 (316)
T d1fota_ 260 FKE 262 (316)
T ss_dssp GSS
T ss_pred ccc
Confidence 974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-54 Score=428.69 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=211.9
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.+++|++++.||+|+||+||+|+++. +|+.||||++..... .......+++|+.+|+.++||||+++++++.+..
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~---~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 114 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS- 114 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred CccCeEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-
Confidence 36899999999999999999998764 688999999865332 2334567889999999999999999999997654
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+|+||||+. ++|...+... ..+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|
T Consensus 115 -~~~~v~e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl----~~~g~ikL~D 184 (350)
T d1rdqe_ 115 -NLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTD 184 (350)
T ss_dssp -EEEEEEECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECC
T ss_pred -ccccccccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc----CCCCCEEeee
Confidence 7899999988 5888888664 369999999999999999999999999999999999999 6777899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+|+.+... ....+||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+ ....+..+
T Consensus 185 FG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i 250 (350)
T d1rdqe_ 185 FGFAKRVKGR-----TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKI 250 (350)
T ss_dssp CTTCEECSSC-----BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH
T ss_pred ceeeeecccc-----cccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcC--------HHHHHHHH
Confidence 9999977542 2346899999999999884 48999999999999999999999998654 22333333
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALEHE 336 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~h~ 336 (477)
... . ...+..+++++.+||++||++||.+|+ |++++|+||
T Consensus 251 ~~~----~-------------------------------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp 295 (350)
T d1rdqe_ 251 VSG----K-------------------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHC----C-------------------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred hcC----C-------------------------------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCc
Confidence 221 0 012344578899999999999999995 999999999
Q ss_pred cCCC
Q 011808 337 YFRI 340 (477)
Q Consensus 337 ~f~~ 340 (477)
||+.
T Consensus 296 ~f~~ 299 (350)
T d1rdqe_ 296 WFAT 299 (350)
T ss_dssp GGTT
T ss_pred cccC
Confidence 9973
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-53 Score=410.87 Aligned_cols=260 Identities=28% Similarity=0.410 Sum_probs=212.9
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCC-------cHHHHHHHHHHHhcC-CCCeeEEEE
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGV-------SPTAIREIMLLREIT-HENVVKLVN 95 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~-------~~~~~~Ei~il~~l~-hpnIv~l~~ 95 (477)
|.++|++++.||+|+||+||+|+++. +++.||||+++........ ...+.+|+.++++++ ||||+++++
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 77 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECC---CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence 57899999999999999999998764 6899999999876544322 235678999999996 999999999
Q ss_pred EEEcCCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc
Q 011808 96 VHINHADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ 174 (477)
Q Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~ 174 (477)
++.+. ..+||||||++ ++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||+ +.+
T Consensus 78 ~~~~~--~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill----~~~ 146 (277)
T d1phka_ 78 TYETN--TFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL----DDD 146 (277)
T ss_dssp EEECS--SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTT
T ss_pred ecccC--cceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE----cCC
Confidence 99764 48999999997 5999999763 379999999999999999999999999999999999999 777
Q ss_pred ccEEEeecccceeecCCCCcccCCCeeeccccccchhhcC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccC
Q 011808 175 GVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLG-----AKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST 249 (477)
Q Consensus 175 ~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~ 249 (477)
+.+||+|||+++.+..... ....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+
T Consensus 147 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---- 219 (277)
T d1phka_ 147 MNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---- 219 (277)
T ss_dssp CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred CCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC----
Confidence 8899999999998765332 234678999999999863 3447889999999999999999999998665
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
..+.+..+...-.... .......|+++++||.+||++||++|||+
T Consensus 220 ----~~~~~~~i~~~~~~~~-------------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~ 264 (277)
T d1phka_ 220 ----QMLMLRMIMSGNYQFG-------------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTA 264 (277)
T ss_dssp ----HHHHHHHHHHTCCCCC-------------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred ----HHHHHHHHHhCCCCCC-------------------------------CcccccCCHHHHHHHHHHccCChhHCcCH
Confidence 2233333322110000 01122456889999999999999999999
Q ss_pred HHHhcCccCC
Q 011808 330 AQALEHEYFR 339 (477)
Q Consensus 330 ~e~L~h~~f~ 339 (477)
+|+|+||||+
T Consensus 265 ~eil~h~~~~ 274 (277)
T d1phka_ 265 EEALAHPFFQ 274 (277)
T ss_dssp HHHTTSGGGC
T ss_pred HHHHcCHHHH
Confidence 9999999997
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-54 Score=425.97 Aligned_cols=283 Identities=34% Similarity=0.601 Sum_probs=224.8
Q ss_pred ceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEc----CCC
Q 011808 27 QYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHIN----HAD 102 (477)
Q Consensus 27 ~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~ 102 (477)
+|+.+++||+|+||+||+|+++. +++.||||+++...... .+|+.+|++++||||++++++|.. .+.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~------~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKRFK------NRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSSSC------CHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECC---CCCEEEEEEECccchHH------HHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 79999999999999999998764 68999999997654322 379999999999999999999864 234
Q ss_pred ceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCc-ccEEEee
Q 011808 103 MSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQ-GVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~-~~vkL~D 181 (477)
.++||||||+++++...+..... ....+++.+++.+++||+.||+|||++||+||||||+|||+ +.+ ..+||+|
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~-~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl----~~~~~~~kl~D 166 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL----DPDTAVLKLCD 166 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE----CTTTCCEEECC
T ss_pred eEEEEEEeccCCccHHHHHhhhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEE----ecCCCceeEec
Confidence 57899999999988777765332 24579999999999999999999999999999999999999 433 4799999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+++.+..... ....+||+.|+|||++.+...|+.++|||||||++|||++|++||...+ ..+++..+
T Consensus 167 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~--------~~~~l~~i 235 (350)
T d1q5ka_ 167 FGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--------GVDQLVEI 235 (350)
T ss_dssp CTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS--------HHHHHHHH
T ss_pred ccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC--------HHHHHHHH
Confidence 999987654332 2346789999999999877779999999999999999999999998766 56788888
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
++.++.+..+.+..... .+.. ..........+........++++.|||.+||++||++|||+.|+|+||||+.
T Consensus 236 ~~~~g~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 236 IKVLGTPTREQIREMNP--NYTE----FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HHHHCCCCHHHHHHHCC-----C----CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHhCCChHHhhhhhcc--chhh----ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 88888776554432211 0000 0001111122223344556788999999999999999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.6e-54 Score=427.84 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=208.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCC-CCCcHHHHH---HHHHHHhcCCCCeeEEEEEEEcC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDG-DGVSPTAIR---EIMLLREITHENVVKLVNVHINH 100 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~---Ei~il~~l~hpnIv~l~~~~~~~ 100 (477)
+++|+++++||+|+||.||+|+++. +|+.||||++...... ......+.+ |+.+++.++|||||+++++|.+.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred HHhCeeeeEEecCCCeEEEEEEECC---CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 6789999999999999999998764 6899999998643221 111223333 46677778899999999999775
Q ss_pred CCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 ADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
. .+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||
T Consensus 80 ~--~~~ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl----~~~g~iKl 148 (364)
T d1omwa3 80 D--KLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL----DEHGHVRI 148 (364)
T ss_dssp S--EEEEEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CSSSCEEE
T ss_pred C--EEEEEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE----cCCCcEEE
Confidence 4 7899999998 6899888764 368999999999999999999999999999999999999 77788999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+|+.+.... ....+||+.|+|||++.+...|+.++|||||||++|||+||+.||.+.... ...
T Consensus 149 ~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---------~~~ 215 (364)
T d1omwa3 149 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---------DKH 215 (364)
T ss_dssp CCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS---------CHH
T ss_pred eeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH---------HHH
Confidence 9999998765432 234678999999999976566999999999999999999999999865422 112
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCC-----HHHHhc
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRIT-----AAQALE 334 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt-----~~e~L~ 334 (477)
.+......... ..+..+++++.+||.+||++||.+||| ++++++
T Consensus 216 ~~~~~~~~~~~-------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 216 EIDRMTLTMAV-------------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHHSSSCCC-------------------------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHhcccCCC-------------------------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 22222221111 133456788999999999999999999 799999
Q ss_pred CccCCC
Q 011808 335 HEYFRI 340 (477)
Q Consensus 335 h~~f~~ 340 (477)
||||+.
T Consensus 265 Hp~f~~ 270 (364)
T d1omwa3 265 SPFFRS 270 (364)
T ss_dssp SGGGTT
T ss_pred CccccC
Confidence 999973
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=427.15 Aligned_cols=288 Identities=37% Similarity=0.609 Sum_probs=222.1
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA- 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 101 (477)
++-++|+++++||+|+||+||+|+++. +++.||||+++...........+.+|+++|+.++|||||+++++|...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 467899999999999999999998764 6899999999876555445567889999999999999999999997643
Q ss_pred ---CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 102 ---DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 102 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
...+|+||||++.+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 92 ~~~~~~~~lv~e~~~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~----~~~~~~k 161 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFMGTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELK 161 (346)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEE
T ss_pred ccccceEEEEEecccccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc----ccccccc
Confidence 235799999998888877654 369999999999999999999999999999999999999 7778899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||+|+...... ...+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+ ..+.+
T Consensus 162 l~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~--------~~~~~ 228 (346)
T d1cm8a_ 162 ILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--------HLDQL 228 (346)
T ss_dssp ECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred cccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC--------hHHHH
Confidence 99999998765432 345679999999999887778999999999999999999999998776 55667
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..+....+.++.+.+........+ .............+ .......++.+.|||.+||++||.+|||++|+|+||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f 304 (346)
T d1cm8a_ 229 KEIMKVTGTPPAEFVQRLQSDEAK---NYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304 (346)
T ss_dssp HHHHHHHCCCCHHHHHTCSCHHHH---HHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHhccCCCcHHHHhhhcchhhh---hhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 777777766654433221110000 00000000011111 11234567889999999999999999999999999999
Q ss_pred CC
Q 011808 339 RI 340 (477)
Q Consensus 339 ~~ 340 (477)
+.
T Consensus 305 ~~ 306 (346)
T d1cm8a_ 305 ES 306 (346)
T ss_dssp TT
T ss_pred Cc
Confidence 74
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=423.09 Aligned_cols=261 Identities=23% Similarity=0.349 Sum_probs=212.4
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
+++++|++++.||+|+||+||+|+++. +++.||||+++.... ....+.+|+++|+.++||||++++++|.+..
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~---~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~- 74 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESME- 74 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-
T ss_pred CCccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-
Confidence 578999999999999999999998764 688999999976432 2345678999999999999999999998754
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+|||||||. ++|.+++... ...+++.+++.|+.||+.||.|||++||+||||||+|||++.+ ....+||+|
T Consensus 75 -~~~lvmE~~~gg~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~--~~~~ikl~D 147 (321)
T d1tkia_ 75 -ELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKIIE 147 (321)
T ss_dssp -EEEEEECCCCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECC
T ss_pred -EEEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC--CceEEEEcc
Confidence 7999999998 5899888653 2369999999999999999999999999999999999999432 345799999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+++....... ....++|+.|+|||++.+. .|+.++|||||||++|+|++|..||.+.+ ..+.+..+
T Consensus 148 FG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------~~~~~~~i 215 (321)
T d1tkia_ 148 FGQARQLKPGDN---FRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENI 215 (321)
T ss_dssp CTTCEECCTTCE---EEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHH
T ss_pred cchhhccccCCc---ccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCC--------HHHHHHHH
Confidence 999987654322 2335679999999999874 48999999999999999999999998765 23333333
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
...-...+ ......++.++++||.+||++||.+|||++|+|+||||+.
T Consensus 216 ~~~~~~~~-------------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 216 MNAEYTFD-------------------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHTCCCCC-------------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HhCCCCCC-------------------------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 33211110 1112234678999999999999999999999999999963
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=405.59 Aligned_cols=288 Identities=40% Similarity=0.749 Sum_probs=233.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
+++|+++++||+|+||+||+|+++. +++.||||+++...........+.+|+.+|+.++||||+++++++.+.. .
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~ 75 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--K 75 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--E
T ss_pred CCCCEeeeEEecCcCeEEEEEEECC---CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc--c
Confidence 4799999999999999999998764 6889999999877666666778889999999999999999999997754 7
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
++++++++.+.++..+... ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||.
T Consensus 76 ~~iv~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli----~~~~~~kl~DFG~ 147 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI----NRNGELKLANFGL 147 (292)
T ss_dssp EEEEEECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCCTT
T ss_pred eeEEeeecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc----ccCCceeeeecch
Confidence 8999999997665555443 3478999999999999999999999999999999999999 6667899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKI 264 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~ 264 (477)
++........ .....+++.|+|||++.+...++.++|||||||++|||++|+.||..... ..+.+..+...
T Consensus 148 a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-------~~~~~~~~~~~ 218 (292)
T d1unla_ 148 ARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-------VDDQLKRIFRL 218 (292)
T ss_dssp CEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-------HHHHHHHHHHH
T ss_pred hhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC-------HHHHHHHHHhh
Confidence 9877654332 22345689999999998877789999999999999999999988643332 45667778888
Q ss_pred hCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 265 LGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.+.+....|+.....+.+...... .............++.+.|||++||++||.+|||++|+|+||||+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 219 LGTPTEEQWPSMTKLPDYKPYPMY------PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp HCCCCTTTCTTGGGSTTCCCCCCC------CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cCCCChhhhhhhhhcccccccccc------cccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 888888877766655544332111 1111122234456788999999999999999999999999999973
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=410.87 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=205.4
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC----CCcHHHHHHHHHHHhcC--CCCeeEEEEEE
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD----GVSPTAIREIMLLREIT--HENVVKLVNVH 97 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~il~~l~--hpnIv~l~~~~ 97 (477)
+-++|++.++||+|+||+||+|+++. +++.||||+++...... .....+.+|+.+|++++ ||||+++++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 45789999999999999999998764 68999999997654332 11223568999999996 89999999999
Q ss_pred EcCCCceEEEEEeccCC--CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcc
Q 011808 98 INHADMSLYLAFDYAEY--DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQG 175 (477)
Q Consensus 98 ~~~~~~~~~lv~e~~~~--~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~ 175 (477)
.+.. .+|+||||+.+ ++.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+. .+.+
T Consensus 79 ~~~~--~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~---~~~~ 148 (273)
T d1xwsa_ 79 ERPD--SFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID---LNRG 148 (273)
T ss_dssp ECSS--EEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---TTTT
T ss_pred eeCC--eEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe---cCCC
Confidence 7754 78999999874 777777653 3799999999999999999999999999999999999993 2346
Q ss_pred cEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccH
Q 011808 176 VVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 176 ~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~ 255 (477)
.+||+|||+|+..... .....+||+.|+|||++.+...++.++|||||||++|+|+||+.||.+.+
T Consensus 149 ~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------- 214 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------- 214 (273)
T ss_dssp EEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------
T ss_pred eEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------
Confidence 8999999999875433 22346789999999999876656788999999999999999999997532
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.+... ...++...++++.+||++||++||++|||++|+|+|
T Consensus 215 ----~i~~~-----------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 ----EIIRG-----------------------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----HHHHC-----------------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HHhhc-----------------------------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11110 011334567899999999999999999999999999
Q ss_pred ccCCC
Q 011808 336 EYFRI 340 (477)
Q Consensus 336 ~~f~~ 340 (477)
|||+.
T Consensus 256 p~~~~ 260 (273)
T d1xwsa_ 256 PWMQD 260 (273)
T ss_dssp GGGSS
T ss_pred HhhCC
Confidence 99974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=422.41 Aligned_cols=268 Identities=24% Similarity=0.368 Sum_probs=210.0
Q ss_pred CCccccccceeEEe-eecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEE
Q 011808 19 GEKPEWLQQYNLIG-KIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNV 96 (477)
Q Consensus 19 ~~~~~~~~~Y~i~~-~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 96 (477)
.++..++++|+++. .||+|+||+||+|+++. +++.||||+++. ...+.+|+.++.++ +||||++++++
T Consensus 4 ~~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~ 73 (335)
T d2ozaa1 4 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDV 73 (335)
T ss_dssp CBCSCGGGTEEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred CCCCCcccCEEEeeEEeeeccCeEEEEEEECC---CCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence 45667899999986 59999999999998764 688999999864 24677899987654 89999999999
Q ss_pred EEc--CCCceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCC
Q 011808 97 HIN--HADMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEE 173 (477)
Q Consensus 97 ~~~--~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~ 173 (477)
|.+ ..+..+|+|||||. |+|.+++.... ...+++.+++.|+.||+.||+|||++||+||||||+|||++.+ ..
T Consensus 74 ~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~-~~ 149 (335)
T d2ozaa1 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK-RP 149 (335)
T ss_dssp EEEEETTEEEEEEEEECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS-ST
T ss_pred EeecccCCCEEEEEEECCCCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccc-cc
Confidence 875 34567999999998 59999997642 3469999999999999999999999999999999999999543 34
Q ss_pred cccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcc
Q 011808 174 QGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPF 253 (477)
Q Consensus 174 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~ 253 (477)
.+.+||+|||+|+...... .....+||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+....
T Consensus 150 ~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---- 221 (335)
T d2ozaa1 150 NAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---- 221 (335)
T ss_dssp TCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------
T ss_pred cccccccccceeeeccCCC---ccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH----
Confidence 5679999999998765433 23446789999999999874 499999999999999999999999976553211
Q ss_pred cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 011808 254 QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQAL 333 (477)
Q Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L 333 (477)
...+...+.... + .+.......+++++.+||.+||++||++|||+.|+|
T Consensus 222 ----~~~~~~~i~~~~------------------------~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 270 (335)
T d2ozaa1 222 ----SPGMKTRIRMGQ------------------------Y---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270 (335)
T ss_dssp ----------CCCSCS------------------------S---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ----HHHHHHHHhcCC------------------------C---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 111111110000 0 000001123567899999999999999999999999
Q ss_pred cCccCC
Q 011808 334 EHEYFR 339 (477)
Q Consensus 334 ~h~~f~ 339 (477)
+||||.
T Consensus 271 ~hp~~~ 276 (335)
T d2ozaa1 271 NHPWIM 276 (335)
T ss_dssp HSHHHH
T ss_pred cCHHhh
Confidence 999996
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=415.42 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=209.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC-CCCCcHHHHHHHHHHH-hcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD-GDGVSPTAIREIMLLR-EITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~ 102 (477)
+++|+++++||+|+||+||+|+++. +++.||||++++... .......+++|+.++. .++||||+++++++.+..
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~---t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~- 76 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE- 76 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-
T ss_pred CCCeEEeeEEecCCCcEEEEEEECC---CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC-
Confidence 4789999999999999999998764 689999999975431 2334456677777665 689999999999997754
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEee
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIAD 181 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~D 181 (477)
.+||||||+. |+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 77 -~~yivmEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~----~~~~~~kl~D 146 (320)
T d1xjda_ 77 -NLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL----DKDGHIKIAD 146 (320)
T ss_dssp -EEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEECC
T ss_pred -ceeEEEeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee----cCCCceeccc
Confidence 7999999998 5898888764 368999999999999999999999999999999999999 7778899999
Q ss_pred cccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 182 FGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 182 FG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
||+++....... .....+||+.|+|||++.+. .|+.++|||||||++|+|+||+.||.+.+. ...+..+
T Consensus 147 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i 215 (320)
T d1xjda_ 147 FGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSI 215 (320)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred cchhhhcccccc--cccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence 999986554322 23446789999999999885 489999999999999999999999987652 2222222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHH-HHhcCccCCC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA-QALEHEYFRI 340 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~-e~L~h~~f~~ 340 (477)
.. +. ..+|..+++++.+||.+||++||.+|||+. ++++||||+.
T Consensus 216 ~~--~~---------------------------------~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 216 RM--DN---------------------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HH--CC---------------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred Hc--CC---------------------------------CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 11 10 113345578899999999999999999995 8999999973
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=403.91 Aligned_cols=258 Identities=24% Similarity=0.305 Sum_probs=202.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.++||+|+||+||+|+++ ..||||+++.........+.+.+|+.+|++++|||||++++++.. ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cE
Confidence 478999999999999999999632 359999998776666667788899999999999999999998643 25
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||++ |+|.+++... ...+++..+..++.||+.||+|||+++||||||||+|||| +.++.+||+|||
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl----~~~~~~Kl~DFG 149 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL----HEDLTVKIGDFG 149 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----ETTSSEEECCCC
T ss_pred EEEEEecCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE----cCCCCEEEcccc
Confidence 799999998 6999988754 3469999999999999999999999999999999999999 677789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGA--KHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
+|+...............||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+ ....+..+
T Consensus 150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~--------~~~~~~~~ 221 (276)
T d1uwha_ 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--------NRDQIIFM 221 (276)
T ss_dssp CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--------CHHHHHHH
T ss_pred ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC--------hHHHHHHH
Confidence 99876544333334456789999999999753 348999999999999999999999998654 22233322
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
....... +. ....+..+++++.+||.+||+.||.+|||+++++++-
T Consensus 222 ~~~~~~~-p~----------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 222 VGRGYLS-PD----------------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp HHHTSCC-CC----------------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhcCCCC-Cc----------------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 2221100 00 0113345578899999999999999999999999873
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-52 Score=413.22 Aligned_cols=288 Identities=28% Similarity=0.475 Sum_probs=215.2
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 103 (477)
.++|+++++||+|+||+||+|+++. +++.||||+++.. ....+.+|+.+|+.+. ||||++++++|......
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 5789999999999999999998764 6899999998643 2457789999999995 99999999999877777
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+|+||||+.+..+..+ ...+++..++.++.||+.||+|||++||+||||||+|||+.. ++..+||+|||
T Consensus 106 ~~~~v~e~~~~~~L~~~-------~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~---~~~~vkl~DFG 175 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQL-------YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH---EHRKLRLIDWG 175 (328)
T ss_dssp SEEEEEECCCSCBGGGT-------TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTTEEEECCGG
T ss_pred ceeEEEeecCCCcHHHH-------hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC---CCCeeeecccc
Confidence 89999999996433221 236999999999999999999999999999999999999942 34469999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+|+....... ....++|+.|+|||++.+...|+.++|||||||++|+|++|+.||..... ..++...+..
T Consensus 176 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~-------~~~~~~~i~~ 245 (328)
T d3bqca1 176 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-------NYDQLVRIAK 245 (328)
T ss_dssp GCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS-------HHHHHHHHHH
T ss_pred cceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch-------hHHHHHHHHH
Confidence 9987654332 34456799999999998877789999999999999999999999976543 3445555555
Q ss_pred HhCCCCCCCccccCCCcccccccccc--ccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccCCC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHI--QGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYFRI 340 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f~~ 340 (477)
.++.+....+........+....... ..................+++++|||++||++||.+|||++|+|+||||+.
T Consensus 246 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp HHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 55433222111111111000000000 000000001111122345788999999999999999999999999999973
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=409.98 Aligned_cols=293 Identities=35% Similarity=0.580 Sum_probs=218.2
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC-
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHA- 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 101 (477)
++-++|++++.||+|+||+||+|+++. +++.||||++.... .......+++|+.+|+.++||||+++++++....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNV---NKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETT---TCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECC---CCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 345789999999999999999998764 68999999997543 2233457788999999999999999999986543
Q ss_pred --CceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 102 --DMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 102 --~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
...+|+++++++++|.+++... .+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.+||
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl----~~~~~~kl 150 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKI 150 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEE
T ss_pred cccceEEEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE----CCCCCEEE
Confidence 2357888888889999998653 69999999999999999999999999999999999999 67778999
Q ss_pred eecccceeecCCCC-cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 180 ADFGLARIYQAPLK-FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 180 ~DFG~a~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
+|||+++....... .......+||+.|+|||++.....|+.++||||+||++|+|++|+.||.+.+ ..+..
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~--------~~~~~ 222 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH--------YLDQL 222 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHH
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC--------HHHHH
Confidence 99999987644322 1223456789999999999776678999999999999999999999998765 34555
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
......+..+.............+.. ...........+. ......++.+++||.+||++||.+|||++|+|+||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~ 298 (345)
T d1pmea_ 223 NHILGILGSPSQEDLNCIINLKARNY---LLSLPHKNKVPWN-RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298 (345)
T ss_dssp HHHHHHHCSCCHHHHHTCCCHHHHHH---HHTSCCCCCCCHH-HHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHHhhhccCCChhhhhhhhhhhhhcc---cccCCccCCCCHH-HhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 55555555443321111110000000 0000000000010 1223457789999999999999999999999999999
Q ss_pred CCC
Q 011808 339 RIE 341 (477)
Q Consensus 339 ~~~ 341 (477)
+..
T Consensus 299 ~~~ 301 (345)
T d1pmea_ 299 EQY 301 (345)
T ss_dssp TTT
T ss_pred ccC
Confidence 744
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=405.57 Aligned_cols=261 Identities=24% Similarity=0.410 Sum_probs=207.4
Q ss_pred cceeEEeeecccCceEEEEEEEecccCC--CcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANR--GKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHAD 102 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 102 (477)
++|++.++||+|+||+||+|+++..... ...||+|++..... ......+.+|+.+|+++ +|||||++++++.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~- 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-
Confidence 6899999999999999999998754322 34689998875443 33456788999999998 8999999999997654
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcc------------------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCC
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDK------------------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPS 163 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~ 163 (477)
.+|+|||||+ |+|.+++...+.. ....+++..++.++.||+.||.|||++|||||||||+
T Consensus 115 -~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 115 -PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp -SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred -eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 6899999998 6999999765421 1235899999999999999999999999999999999
Q ss_pred cEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 011808 164 NILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQ 242 (477)
Q Consensus 164 NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~ 242 (477)
|||+ +.++.+||+|||+|+...............||+.|||||++.+. .|+.++|||||||++|||+| |.+||.
T Consensus 194 Nill----~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 194 NVLV----THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp GEEE----ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cccc----ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999 67788999999999877655444445567889999999999874 48999999999999999998 899998
Q ss_pred CcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccC
Q 011808 243 GAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYD 322 (477)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~d 322 (477)
+.+. ...+.++...- .....|..+++++++||.+||+.|
T Consensus 269 ~~~~--------~~~~~~~~~~~---------------------------------~~~~~p~~~~~~l~~li~~cl~~d 307 (325)
T d1rjba_ 269 GIPV--------DANFYKLIQNG---------------------------------FKMDQPFYATEEIYIIMQSCWAFD 307 (325)
T ss_dssp TCCC--------SHHHHHHHHTT---------------------------------CCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCCH--------HHHHHHHHhcC---------------------------------CCCCCCCcCCHHHHHHHHHHcCCC
Confidence 6552 12233332211 111234456788999999999999
Q ss_pred CCCCCCHHHHhcC
Q 011808 323 PRKRITAAQALEH 335 (477)
Q Consensus 323 P~~Rpt~~e~L~h 335 (477)
|++|||++|+++|
T Consensus 308 P~~RPt~~ei~~~ 320 (325)
T d1rjba_ 308 SRKRPSFPNLTSF 320 (325)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhHCcCHHHHHHH
Confidence 9999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.4e-52 Score=398.52 Aligned_cols=265 Identities=25% Similarity=0.377 Sum_probs=202.1
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHA 101 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 101 (477)
.+.++|++++.||+|+||+||+|+++. +++.||||+++.....+ .....+.+|+++|+.++||||+++++++....
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence 456789999999999999999998764 68999999998765433 23456788999999999999999999987643
Q ss_pred --CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 102 --DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 102 --~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
...+|+||||++ ++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.++
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll----~~~~~~~ 151 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI----SATNAVK 151 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----ETTSCEE
T ss_pred CCCceEEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc----Cccccce
Confidence 346899999999 5788777654 379999999999999999999999999999999999999 6667799
Q ss_pred EeecccceeecCCCC-cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 179 IADFGLARIYQAPLK-FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 179 L~DFG~a~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
|+|||.+........ .......+||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+. .+.
T Consensus 152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~ 222 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSV 222 (277)
T ss_dssp ECCCTTCEECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHH
T ss_pred eehhhhhhhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCH--------HHH
Confidence 999999876543222 2233456789999999999874 489999999999999999999999986542 222
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEY 337 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~ 337 (477)
+..+... .+.+ .......+++.+.+||.+||++||.+||+..+.|.|+|
T Consensus 223 ~~~~~~~--~~~~-----------------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l 271 (277)
T d1o6ya_ 223 AYQHVRE--DPIP-----------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271 (277)
T ss_dssp HHHHHHC--CCCC-----------------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred HHHHHhc--CCCC-----------------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence 2222211 1110 01123345688999999999999999996555666777
Q ss_pred CC
Q 011808 338 FR 339 (477)
Q Consensus 338 f~ 339 (477)
.+
T Consensus 272 ~r 273 (277)
T d1o6ya_ 272 VR 273 (277)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=397.14 Aligned_cols=251 Identities=22% Similarity=0.392 Sum_probs=197.0
Q ss_pred eeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEEEec
Q 011808 32 GKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLAFDY 111 (477)
Q Consensus 32 ~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv~e~ 111 (477)
++||+|+||+||+|.++. ...++.||||+++...........+.+|+.+|++++|||||++++++.++ .+||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQM-KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEEC-SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEEEEEEC
T ss_pred CCcccCCCeEEEEEEEcc-CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEEEEEEc
Confidence 479999999999998764 24568899999976655444556788999999999999999999998653 46899999
Q ss_pred cC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecccceeecC
Q 011808 112 AE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARIYQA 190 (477)
Q Consensus 112 ~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~~~~ 190 (477)
++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 89 ~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill----~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 89 AELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL----VTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp CTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----EETTEEEECCCTTCEECCT
T ss_pred CCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc----cccCcccccchhhhhhccc
Confidence 98 5888888763 369999999999999999999999999999999999999 6777899999999987654
Q ss_pred CCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHHHhCCC
Q 011808 191 PLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFKILGHP 268 (477)
Q Consensus 191 ~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~~~~~~ 268 (477)
..... ......||+.|+|||++.+.. |+.++|||||||++|||+| |++||.+.+. .+ +...+...
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---------~~---~~~~i~~~ 226 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------SE---VTAMLEKG 226 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HH---HHHHHHTT
T ss_pred cccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCH---------HH---HHHHHHcC
Confidence 33222 223456799999999998744 8999999999999999998 8999986542 11 11221111
Q ss_pred CCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHH---hcCccC
Q 011808 269 TPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA---LEHEYF 338 (477)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~---L~h~~f 338 (477)
. ....|..+++++++||.+||+.||++|||++++ |+|+|+
T Consensus 227 ~------------------------------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 227 E------------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp C------------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C------------------------------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 0 111344567889999999999999999999998 466665
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=410.16 Aligned_cols=289 Identities=38% Similarity=0.589 Sum_probs=219.3
Q ss_pred ccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC--
Q 011808 23 EWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH-- 100 (477)
Q Consensus 23 ~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 100 (477)
++.++|+++++||+|+||+||+|+++. +++.||||+++...........+.+|+++|+.++||||+++++++...
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETT---TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 346899999999999999999998764 689999999987655444456778999999999999999999998643
Q ss_pred --CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEE
Q 011808 101 --ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVK 178 (477)
Q Consensus 101 --~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vk 178 (477)
....+|+++++++++|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi----~~~~~~k 161 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELK 161 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCEE
T ss_pred cccCceEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc----ccccccc
Confidence 2234677777777899988743 369999999999999999999999999999999999999 7778899
Q ss_pred EeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHH
Q 011808 179 IADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQL 258 (477)
Q Consensus 179 L~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~ 258 (477)
|+|||++..... ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+ .....
T Consensus 162 l~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~--------~~~~~ 228 (348)
T d2gfsa1 162 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--------HIDQL 228 (348)
T ss_dssp ECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHH
T ss_pred ccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC--------HHHHH
Confidence 999999976543 23346779999999999887778999999999999999999999998776 45666
Q ss_pred HHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCccC
Q 011808 259 DKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHEYF 338 (477)
Q Consensus 259 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~~f 338 (477)
..+....+.+..+.+......... .............+. ......+++++|||++||++||.+|||++|+|+||||
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f 304 (348)
T d2gfsa1 229 KLILRLVGTPGAELLKKISSESAR---NYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304 (348)
T ss_dssp HHHHHHHCCCCHHHHTTCCCHHHH---HHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHhcCCCChHHhhhccchhhh---hhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhh
Confidence 677777665544322211110000 000000000000011 1123567889999999999999999999999999999
Q ss_pred CCC
Q 011808 339 RIE 341 (477)
Q Consensus 339 ~~~ 341 (477)
+..
T Consensus 305 ~~~ 307 (348)
T d2gfsa1 305 AQY 307 (348)
T ss_dssp TTT
T ss_pred CCC
Confidence 854
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=413.37 Aligned_cols=292 Identities=36% Similarity=0.575 Sum_probs=215.6
Q ss_pred cccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcC---
Q 011808 24 WLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINH--- 100 (477)
Q Consensus 24 ~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--- 100 (477)
.+++|+++++||+|+||+||+|+++. ++..||||++............+.+|+.+|++++||||++++++|...
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~---t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~ 91 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETT---TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECC---CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc
Confidence 56899999999999999999998764 689999999987665544455778999999999999999999999754
Q ss_pred -CCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEE
Q 011808 101 -ADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKI 179 (477)
Q Consensus 101 -~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL 179 (477)
....+|+||||+.++++..+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 92 ~~~~~~~iv~Ey~~~~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~----~~~~~~kl 160 (355)
T d2b1pa1 92 EEFQDVYLVMELMDANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKI 160 (355)
T ss_dssp TTCCEEEEEEECCSEEHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEE
T ss_pred ccCceeEEEEeccchHHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc----ccccceee
Confidence 335899999999999887663 258999999999999999999999999999999999999 66778999
Q ss_pred eecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 180 ADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 180 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+|||+++...... .....++|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+ ......
T Consensus 161 ~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~--------~~~~~~ 228 (355)
T d2b1pa1 161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD--------YIDQWN 228 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred echhhhhcccccc---ccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCC--------HHHHHH
Confidence 9999988665432 23446789999999999884 58999999999999999999999998766 567777
Q ss_pred HHHHHhCCCCCCCccccCCC-ccccccccccccccc------cCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 011808 260 KIFKILGHPTPEKWPTLANL-PHWQSDSLHIQGRKY------ETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA 332 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~ 332 (477)
.+...++.+.++.|...... ............... .............++++.|||++||.+||++||||+|+
T Consensus 229 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el 308 (355)
T d2b1pa1 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308 (355)
T ss_dssp HHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 78777776655544332110 000000000000000 00000011111235678999999999999999999999
Q ss_pred hcCccCCCC
Q 011808 333 LEHEYFRIE 341 (477)
Q Consensus 333 L~h~~f~~~ 341 (477)
|+||||+..
T Consensus 309 L~Hpw~~~~ 317 (355)
T d2b1pa1 309 LQHPYINVW 317 (355)
T ss_dssp HTSTTTGGG
T ss_pred hcCcccCCC
Confidence 999999853
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-51 Score=394.92 Aligned_cols=252 Identities=25% Similarity=0.413 Sum_probs=203.7
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.++||+|+||+||+|+++. ++..||||+++.... ..+.+.+|+.+|++++|||||++++++.+.. .
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~ 87 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--P 87 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGG---GTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--S
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECC---CCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCC--e
Confidence 4689999999999999999998764 588999999975432 3467889999999999999999999997644 6
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. |+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl----~~~~~~Kl~DFG 160 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV----GENHLVKVADFG 160 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCCC
T ss_pred eEEEeecccCcchHHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE----CCCCcEEEcccc
Confidence 799999998 68888887643 3478999999999999999999999999999999999999 777889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
+|+....... .......|++.|+|||++.+. .|+.++|||||||++|||++|..||.... ....+ .+
T Consensus 161 ~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--------~~~~~---~~ 227 (287)
T d1opja_ 161 LSRLMTGDTY-TAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DLSQV---YE 227 (287)
T ss_dssp CTTTCCSSSS-EEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHH---HH
T ss_pred ceeecCCCCc-eeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcc--------hHHHH---HH
Confidence 9987654322 233456789999999999874 48999999999999999999766553322 12222 22
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.+... .....+..+++++.+||.+||+.||.+|||++++++
T Consensus 228 ~i~~~------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 228 LLEKD------------------------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcC------------------------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 22111 111234456788999999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-51 Score=398.49 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=193.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.++||+|+||+||+|+++.+......||||.+..... ....+.+.+|+.+|++++|||||++++++.+.. .
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST--P 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--S
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC--E
Confidence 4789999999999999999999876544556799999865433 233457889999999999999999999986644 6
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+|||||. |+|.+++... ...+++.++..++.||+.||.|||+++|+||||||+|||| +.++.+||+|||
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl----~~~~~~Kl~DFG 173 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV----NSNLVCKVSDFG 173 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEECCC-
T ss_pred EEEEEEecCCCcceeeeccc----cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE----CCCCcEEECCcc
Confidence 899999998 5787777653 3468999999999999999999999999999999999999 777889999999
Q ss_pred cceeecCCCCcc---cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHH
Q 011808 184 LARIYQAPLKFL---SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 184 ~a~~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
+++.+....... ......||+.|+|||++.+. .|+.++|||||||++|||+| |++||.+.+. .+.+.
T Consensus 174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--------~~~~~ 244 (299)
T d1jpaa_ 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTN--------QDVIN 244 (299)
T ss_dssp ----------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHH
T ss_pred cceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence 998765432221 22234578999999999874 58999999999999999998 8999986542 12222
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.+... .....+..++..+.+||.+||+.||.+|||++|++++
T Consensus 245 ~i~~~----------------------------------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 245 AIEQD----------------------------------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHTT----------------------------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHcC----------------------------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 22110 0111344567889999999999999999999998865
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-51 Score=388.88 Aligned_cols=249 Identities=23% Similarity=0.429 Sum_probs=191.8
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|+++++||+|+||+||+|+++ ++..||||+++.... ..+.+.+|++++++++||||+++++++.+.. .+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--~~ 75 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PI 75 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET----TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC----CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccCC--ce
Confidence 58999999999999999999865 367899999976432 3467889999999999999999999997644 67
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
|+||||+. |+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+
T Consensus 76 ~lv~E~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill----~~~~~~Kl~DFGl 147 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV----GENQVIKVSDFGM 147 (263)
T ss_dssp EEEEECCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE----CGGGCEEECSCC-
T ss_pred EEEEEecCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee----cCCCCeEecccch
Confidence 99999998 6888887654 2468899999999999999999999999999999999999 7788899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++........ ......||+.|+|||++.+.. |+.++|||||||++|||+| |.+||...+ ..+.+..+..
T Consensus 148 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~--------~~~~~~~i~~ 217 (263)
T d1sm2a_ 148 TRFVLDDQYT-SSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDIST 217 (263)
T ss_dssp ------------------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCC--------HHHHHHHHHH
T ss_pred heeccCCCce-eecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCC--------HHHHHHHHHh
Confidence 9876543322 233456799999999998754 9999999999999999999 566665433 1122222221
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
.. ....|..+++++.+||.+||+.||++|||++++++|
T Consensus 218 ~~----------------------------------~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 218 GF----------------------------------RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TC----------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC----------------------------------CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 10 111334456789999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=392.51 Aligned_cols=254 Identities=23% Similarity=0.421 Sum_probs=202.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|+++++||+|+||.||+|+++ ++..||||+++.... ..+.+.+|+.+|++++|||||++++++.+. .
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~ 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQE---P 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---S
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC----CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeeccC---C
Confidence 378999999999999999999864 467899999975432 345788999999999999999999987542 4
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. |+|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|||| +.++.+||+|||
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll----~~~~~~Kl~DFG 154 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV----SDTLSCKIADFG 154 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTSCEEECCCT
T ss_pred eEEEEEeCCCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee----ecccceeecccc
Confidence 689999998 67877665433 2368999999999999999999999999999999999999 777889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+|+.+..... .......||+.|+|||++.+. .|+.++|||||||++|||+|| .+||...+ ..+.+..+.
T Consensus 155 la~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--------~~~~~~~i~ 224 (272)
T d1qpca_ 155 LARLIEDNEY-TAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNLE 224 (272)
T ss_dssp TCEECSSSCE-ECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHH
T ss_pred ceEEccCCcc-ccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCC--------HHHHHHHHH
Confidence 9997754322 233446779999999999874 489999999999999999995 55554433 111122111
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc--CccCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE--HEYFR 339 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~--h~~f~ 339 (477)
.. .....|..+++++.+||.+||+.||++|||++++++ |+||.
T Consensus 225 ----~~------------------------------~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 225 ----RG------------------------------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ----TT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----hc------------------------------CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11 111234456788999999999999999999999998 78875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=401.46 Aligned_cols=265 Identities=28% Similarity=0.420 Sum_probs=212.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCC--CCCCcHHHHHHHHHHHhcCC-CCeeEEEEEEEcCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKD--GDGVSPTAIREIMLLREITH-ENVVKLVNVHINHA 101 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~ 101 (477)
+++|++++.||+|+||+||+|++.....+|+.||||+++.... .......+.+|+.+|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 6899999999999999999999876667899999999875432 12234456789999999976 89999999997754
Q ss_pred CceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEe
Q 011808 102 DMSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIA 180 (477)
Q Consensus 102 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~ 180 (477)
.++++|||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 103 --~~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill----~~~~~vkL~ 171 (322)
T d1vzoa_ 103 --KLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL----DSNGHVVLT 171 (322)
T ss_dssp --EEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEES
T ss_pred --ceeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee----cCCCCEEEe
Confidence 7899999998 58888887643 68899999999999999999999999999999999999 667789999
Q ss_pred ecccceeecCCCCcccCCCeeeccccccchhhcCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 181 DFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAK-HYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 181 DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|||+++.+..... .......|++.|+|||++.+.. .++.++|||||||+||+|++|+.||.+.+... ...
T Consensus 172 DFG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--------~~~ 242 (322)
T d1vzoa_ 172 DFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--------SQA 242 (322)
T ss_dssp CSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--------CHH
T ss_pred eccchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHH
Confidence 9999987654322 2234467899999999997643 47889999999999999999999998765322 222
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC-----CHHHHhc
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI-----TAAQALE 334 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp-----t~~e~L~ 334 (477)
.+........ ...+...++++.+||++||++||.+|+ |++|+|+
T Consensus 243 ~i~~~~~~~~-------------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 243 EISRRILKSE-------------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHHCC-------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHhcccCC-------------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 2222211111 113345678999999999999999999 5899999
Q ss_pred CccCCC
Q 011808 335 HEYFRI 340 (477)
Q Consensus 335 h~~f~~ 340 (477)
||||+.
T Consensus 292 Hpff~~ 297 (322)
T d1vzoa_ 292 HLFFQK 297 (322)
T ss_dssp SGGGTT
T ss_pred CHhhcC
Confidence 999973
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=392.45 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=204.2
Q ss_pred cceeEEee-ecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGK-IGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~-lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|.+.+. ||+|+||+||+|.++.. .++..||||+++.... ....+.+.+|+++|++++|||||++++++.++ .
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~-~~~~~vAvK~l~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~ 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---A 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred cCeEECCcEEecccCeEEEEEEEecC-CCcEEEEEEEEChhcC-HHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---e
Confidence 56888884 99999999999987642 3566899999975432 33456788999999999999999999998653 4
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill----~~~~~~Kl~DFG 154 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL----VNRHYAKISDFG 154 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----EETTEEEECCCT
T ss_pred EEEEEEeCCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee----ccCCceeeccch
Confidence 799999999 5888877543 3469999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCc-ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKF-LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
+++.+...... .......||+.|+|||++.+. .|+.++|||||||++|||+| |+.||.+.+. .+.+..+
T Consensus 155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~~~~i 225 (285)
T d1u59a_ 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFI 225 (285)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHHH
T ss_pred hhhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HHHHHHH
Confidence 99977553322 222345679999999999874 48999999999999999998 9999986542 1112111
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHH---hcCccC
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQA---LEHEYF 338 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~---L~h~~f 338 (477)
. .. .....|..+++++.+||.+||+.||++|||+.++ |+|.|+
T Consensus 226 ~----~~------------------------------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 226 E----QG------------------------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp H----TT------------------------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----cC------------------------------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 10 0112345567889999999999999999999877 678887
Q ss_pred C
Q 011808 339 R 339 (477)
Q Consensus 339 ~ 339 (477)
.
T Consensus 272 ~ 272 (285)
T d1u59a_ 272 S 272 (285)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=383.48 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=204.1
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSL 105 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~ 105 (477)
++|+++++||+|+||+||+|+++ ++..||||+++.... ....+.+|+.++++++||||+++++++.+. ..+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~ 74 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPI 74 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----TTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----CCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeC--Cce
Confidence 68999999999999999999864 477899999986543 346788999999999999999999998654 468
Q ss_pred EEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 106 YLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 106 ~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
++||||+. |+|.+++.... ..+++..++.++.||++||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill----~~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV----NDQGVVKVSDFGL 146 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE----CTTCCEEECCCSS
T ss_pred EEEEEccCCCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE----cCCCcEEECcchh
Confidence 99999998 67777766543 368999999999999999999999999999999999999 7778899999999
Q ss_pred ceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHHH
Q 011808 185 ARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIFK 263 (477)
Q Consensus 185 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~~ 263 (477)
++.+..... .......+|+.|+|||++.+.. |+.++|||||||++|||+| |+.||.+.+. .+....+..
T Consensus 147 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--------~~~~~~i~~ 216 (258)
T d1k2pa_ 147 SRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQ 216 (258)
T ss_dssp CCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHT
T ss_pred heeccCCCc-eeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCH--------HHHHHHHHh
Confidence 987654322 2334466799999999998744 8999999999999999998 8999986652 122222211
Q ss_pred HhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 264 ILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
. .....|...+.++.+||.+||+.||++|||++++|+|
T Consensus 217 ----~------------------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 217 ----G------------------------------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ----T------------------------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----C------------------------------CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1 1112344556789999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=387.38 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=193.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||.||+|++..+...+..||||.++.... ......+.+|+.+|++++||||+++++++.+ ..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---Ce
Confidence 3689999999999999999999876656677899999865432 3334567899999999999999999999853 35
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. |+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll----~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV----SSNDCVKLGDFG 153 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEECC--
T ss_pred EEEEEEeccCCcHHhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee----cCCCcEEEccch
Confidence 799999998 5777776653 3468999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+|+....... .......||+.|+|||++.+. .|+.++|||||||++|||+| |.+||.+.+.. +.+..+.
T Consensus 154 ~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--------~~~~~i~ 223 (273)
T d1mp8a_ 154 LSRYMEDSTY-YKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIE 223 (273)
T ss_dssp ------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHH
T ss_pred hheeccCCcc-eeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHH--------HHHHHHH
Confidence 9987654322 223345679999999999874 48999999999999999998 89999876532 2222221
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
. .. ....+..+++++.+||.+||..||.+|||+.++++|
T Consensus 224 ~---~~-------------------------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 224 N---GE-------------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp T---TC-------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c---CC-------------------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1 00 011344567889999999999999999999999876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=385.74 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=198.6
Q ss_pred cceeEEeeecccCceEEEEEEEecc--cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAA--ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHAD 102 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 102 (477)
++|++.++||+|+||.||+|+++.. ..+++.||||+++..... .....+++|+.++.++ +|+||+.+++++... +
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-T
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc-HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-C
Confidence 7899999999999999999998653 234578999999754332 2344667788888777 689999999987654 3
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEecc
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRDK-----------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGE 170 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~ 170 (477)
..+++|||||+ |+|.+++...... ....+++..+..++.||+.||.|||++|||||||||+||||
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl--- 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--- 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE---
Confidence 46899999998 7999998765421 12358999999999999999999999999999999999999
Q ss_pred CCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccccC
Q 011808 171 GEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKST 249 (477)
Q Consensus 171 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~PF~~~~~~~~ 249 (477)
+.++++||+|||+|+...............||+.|+|||++.+. .|+.++|||||||++|||+|| .+||.+...
T Consensus 168 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~--- 242 (299)
T d1ywna1 168 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--- 242 (299)
T ss_dssp -CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC---
T ss_pred -CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCH---
Confidence 77788999999999877655444455567889999999999874 489999999999999999986 578876542
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCH
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITA 329 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~ 329 (477)
...+..+...-. ....+..+++++++||.+||+.||++|||+
T Consensus 243 -----~~~~~~~~~~~~---------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 284 (299)
T d1ywna1 243 -----DEEFCRRLKEGT---------------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 284 (299)
T ss_dssp -----SHHHHHHHHHTC---------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -----HHHHHHHHhcCC---------------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCH
Confidence 122222222110 011334457889999999999999999999
Q ss_pred HHHhcC
Q 011808 330 AQALEH 335 (477)
Q Consensus 330 ~e~L~h 335 (477)
+|+++|
T Consensus 285 ~eil~~ 290 (299)
T d1ywna1 285 SELVEH 290 (299)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=388.14 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=197.6
Q ss_pred cceeEEeeecccCceEEEEEEEecccC-CCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAAN-RGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.+|+++++||+|+||+||+|+++.+.. ....||+|+++... .....+.+.+|+.++++++|||||++++++.+..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--- 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS---
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 569999999999999999998765321 12368999887543 3345668899999999999999999999997643
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
.+++++++. ++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll----~~~~~~kl~DFG 156 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV----KTPQHVKITDFG 156 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----EETTEEEECCCS
T ss_pred eeEEEEeccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee----CCCCCeEeeccc
Confidence 456666655 7888887764 3468999999999999999999999999999999999999 667789999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+|+.+.............||+.|+|||++.+. .|+.++|||||||++|||+| |.+||.+.+.. .+..++
T Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---------~~~~~i 226 (317)
T d1xkka_ 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------EISSIL 226 (317)
T ss_dssp HHHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---------GHHHHH
T ss_pred cceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---------HHHHHH
Confidence 99877654444344455679999999999875 49999999999999999998 89999865521 222222
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcCc
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEHE 336 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h~ 336 (477)
..-. ....|..+++++.+||.+||..||.+|||+.+++.|-
T Consensus 227 ~~~~---------------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 227 EKGE---------------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHTC---------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HcCC---------------------------------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 2110 0112344567899999999999999999999999884
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=381.44 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=196.8
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++.+.||+|+||+||+|+++. +..||||+++.... ..+.+.+|+.++++++|||||++++++.+. .
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~---~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE---P 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---S
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC----CCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEecC---C
Confidence 5899999999999999999998753 46799999975543 246788999999999999999999998442 4
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+++||||+. |+|..++.... ...+++.+++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll----~~~~~~kl~DfG 158 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV----GENLVCKVADFG 158 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCCC
T ss_pred eEEEEEecCCCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE----CCCCcEEEcccc
Confidence 689999998 56777765543 3369999999999999999999999999999999999999 777889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK-PLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~-~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+++.+..... .......||+.|+|||++.+. .++.++|||||||++|||++|. +||.+.. ..+.+..+.
T Consensus 159 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~--------~~~~~~~i~ 228 (285)
T d1fmka3 159 LARLIEDNEY-TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVE 228 (285)
T ss_dssp TTC---------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHH
T ss_pred hhhhccCCCc-eeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCC--------HHHHHHHHH
Confidence 9987643322 233446679999999999874 4899999999999999999965 4454333 122222221
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc--CccCCC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE--HEYFRI 340 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~--h~~f~~ 340 (477)
.. .....+..++.++.+||.+||+.||++|||+++++. |+||..
T Consensus 229 ~~----------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 229 RG----------------------------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TT----------------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred hc----------------------------------CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 11 011134455788999999999999999999999988 888863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=380.27 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=193.8
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCC-CCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGD-GVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
++|++++.||+|+||.||+|+++........||||+++...... ...+.+.+|+.+|++++||||+++++++.+. .
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---P 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---S
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---c
Confidence 67999999999999999999887655556689999997665433 3346788999999999999999999999653 4
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+++||||+. +++.+.+.... ..+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll----~~~~~vkl~DfG 156 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL----ATRDLVKIGDFG 156 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----EETTEEEECCCT
T ss_pred hheeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc----ccccceeeccch
Confidence 689999998 68887776643 359999999999999999999999999999999999999 566789999999
Q ss_pred cceeecCCCCcc-cCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHH
Q 011808 184 LARIYQAPLKFL-SENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKI 261 (477)
Q Consensus 184 ~a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i 261 (477)
+++.+....... ......++..|+|||++.+. .++.++|||||||++|||+| |..||.+.+. .+.+..+
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--------~~~~~~i 227 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKI 227 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHH
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--------HHHHHHH
Confidence 999775433222 22334568899999999874 48999999999999999998 8999986652 2222222
Q ss_pred HHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 262 FKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
.. .. .....+..+++++.+||.+||+.||++|||++++++
T Consensus 228 ~~---~~------------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 228 DK---EG------------------------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HT---SC------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Hh---CC------------------------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11 11 111133455688999999999999999999999863
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=377.07 Aligned_cols=256 Identities=23% Similarity=0.388 Sum_probs=190.9
Q ss_pred ccceeEEeeecccCceEEEEEEEecccC-CCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAAN-RGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 103 (477)
.+.|++.++||+|+||.||+|.++.+.. ....||||+++..... .....+++|+.+|++++|||||++++++.+..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~-- 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK-- 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh-HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC--
Confidence 3679999999999999999998875322 2357999999754332 23446789999999999999999999986644
Q ss_pred eEEEEEeccCC-CHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeec
Q 011808 104 SLYLAFDYAEY-DLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DF 182 (477)
.++++|||+.+ .+.+.+... ...+++.++..++.||+.||.|||+++|+||||||+|||| +.++.+||+||
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl----~~~~~~Kl~DF 154 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV----NSNLVCKVSDF 154 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEECCC
T ss_pred ceEEEEEecccCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE----CCCCeEEEccc
Confidence 68999999985 666666543 3469999999999999999999999999999999999999 77788999999
Q ss_pred ccceeecCCCC-cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCcccccCCCcccHHHHHH
Q 011808 183 GLARIYQAPLK-FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPL-FQGAEAKSTQNPFQLDQLDK 260 (477)
Q Consensus 183 G~a~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~P-F~~~~~~~~~~~~~~~~~~~ 260 (477)
|+++.+..... ........||+.|+|||++.+. .|+.++|||||||++|||+++..| |.+.+ ..+
T Consensus 155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~---------~~~--- 221 (283)
T d1mqba_ 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELS---------NHE--- 221 (283)
T ss_dssp CC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---------HHH---
T ss_pred chhhcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCC---------HHH---
Confidence 99987654322 2223345679999999999874 599999999999999999996554 44332 111
Q ss_pred HHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 261 IFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 261 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
++..+... .....+..++..+.+||.+||+.||++|||+.++++
T Consensus 222 ~~~~i~~~------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 222 VMKAINDG------------------------------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHTT------------------------------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHhcc------------------------------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 22222111 111233445678999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-48 Score=380.17 Aligned_cols=260 Identities=26% Similarity=0.368 Sum_probs=203.8
Q ss_pred ccceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++|++++.||+|+||+||+|+++. ...++..||||+++.... ......+.+|+.+|++++||||+++++++.+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-- 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAVG-- 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-hHHHHHHHHHHHHHHhcCCCCcccceeeeccC--
Confidence 3679999999999999999999864 234567899999875432 23345688999999999999999999999764
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhc-------------------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCC
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRD-------------------KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKP 162 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp 162 (477)
..++++|||+. ++|.+++..... .....+++..+..++.||+.||+|||+++||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 36899999998 689998865321 1123488999999999999999999999999999999
Q ss_pred CcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCC-CCC
Q 011808 163 SNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK-PLF 241 (477)
Q Consensus 163 ~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~-~PF 241 (477)
+|||| +.++.+||+|||+|+...............+|+.|+|||++.+. .|+.++|||||||++|||++|. +||
T Consensus 169 ~NILl----d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 169 RNCLV----GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp GGEEE----CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cceEE----CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCC
Confidence 99999 77788999999999876554444444456789999999999874 4999999999999999999985 678
Q ss_pred CCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhccc
Q 011808 242 QGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321 (477)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~ 321 (477)
.+.+. .+.+..+. .... ...|..+++++.+||.+||+.
T Consensus 244 ~~~~~--------~e~~~~v~----~~~~------------------------------~~~p~~~~~~~~~li~~cl~~ 281 (301)
T d1lufa_ 244 YGMAH--------EEVIYYVR----DGNI------------------------------LACPENCPLELYNLMRLCWSK 281 (301)
T ss_dssp TTSCH--------HHHHHHHH----TTCC------------------------------CCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCH--------HHHHHHHH----cCCC------------------------------CCCCccchHHHHHHHHHHcCC
Confidence 76542 22222221 1100 113445568899999999999
Q ss_pred CCCCCCCHHHHhc
Q 011808 322 DPRKRITAAQALE 334 (477)
Q Consensus 322 dP~~Rpt~~e~L~ 334 (477)
||++|||+.|+++
T Consensus 282 ~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 282 LPADRPSFCSIHR 294 (301)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhHCcCHHHHHH
Confidence 9999999999964
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=370.51 Aligned_cols=246 Identities=23% Similarity=0.428 Sum_probs=193.5
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
.++|++++.||+|+||.||+|+++ +..||||+++.+. ..+.+.+|+.++++++||||+++++++.+.. ..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~ 75 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GG 75 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---C
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-----CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-Cc
Confidence 578999999999999999999863 6789999997532 3467889999999999999999999886533 35
Q ss_pred EEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeecc
Q 011808 105 LYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFG 183 (477)
Q Consensus 105 ~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG 183 (477)
+|+||||+. |+|.+++..... ..+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~----~~~~~~kl~dfg 148 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV----SEDNVAKVSDFG 148 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTSCEEECCCC
T ss_pred EEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee----cCCCCEeecccc
Confidence 799999997 689999876532 258999999999999999999999999999999999999 777889999999
Q ss_pred cceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccCCCcccHHHHHHHH
Q 011808 184 LARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAKSTQNPFQLDQLDKIF 262 (477)
Q Consensus 184 ~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~~~~~~~~~~~~~~i~ 262 (477)
+++..... .....+|+.|+|||++.+. .++.++|||||||++|||+| |++||...+.. +. .
T Consensus 149 ~s~~~~~~-----~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--------~~----~ 210 (262)
T d1byga_ 149 LTKEASST-----QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DV----V 210 (262)
T ss_dssp C-----------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--------GH----H
T ss_pred cceecCCC-----CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--------HH----H
Confidence 99865432 2234568999999999874 48999999999999999998 78988765422 11 1
Q ss_pred HHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 263 KILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
..+.. +....++...++.+++||.+||..||.+|||+.+++++
T Consensus 211 ~~i~~------------------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 211 PRVEK------------------------------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHTT------------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHc------------------------------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 11111 11122345567889999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=374.76 Aligned_cols=263 Identities=29% Similarity=0.459 Sum_probs=204.4
Q ss_pred ccc---ccceeEEeeecccCceEEEEEEEeccc----CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEE
Q 011808 22 PEW---LQQYNLIGKIGEGTYGLVFLARIKAAA----NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKL 93 (477)
Q Consensus 22 ~~~---~~~Y~i~~~lG~G~~g~Vy~a~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l 93 (477)
++| .++|++.+.||+|+||.||+|++.... .++..||||+++.... ......+.+|+..+.++ +|||||++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC-hHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 456 489999999999999999999876432 2345899999976543 22345677899999888 89999999
Q ss_pred EEEEEcCCCceEEEEEeccC-CCHHHHHHhhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCC
Q 011808 94 VNVHINHADMSLYLAFDYAE-YDLYEIIRHHRDK-----------VNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLK 161 (477)
Q Consensus 94 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDik 161 (477)
++++.+. ..+|+||||+. |+|.+++...... ....+++.+++.++.||+.||.|||+++|||||||
T Consensus 85 ~~~~~~~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK 162 (299)
T d1fgka_ 85 LGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 162 (299)
T ss_dssp EEEECSS--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred ccccccC--CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeec
Confidence 9999764 47899999998 6899998765321 13468999999999999999999999999999999
Q ss_pred CCcEEEeccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 011808 162 PSNILVMGEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPL 240 (477)
Q Consensus 162 p~NILl~~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~P 240 (477)
|+|||+ +.++.+||+|||+++...............+|+.|+|||++.+. .|+.++|||||||++|||++ |.+|
T Consensus 163 p~NiLl----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p 237 (299)
T d1fgka_ 163 ARNVLV----TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSP 237 (299)
T ss_dssp GGGEEE----CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccceee----cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCC
Confidence 999999 77788999999999977665444444556789999999999874 59999999999999999998 7999
Q ss_pred CCCcccccCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcc
Q 011808 241 FQGAEAKSTQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLE 320 (477)
Q Consensus 241 F~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~ 320 (477)
|.+.+. .. ++..+.... ....|..+++.+.+||.+||+
T Consensus 238 ~~~~~~---------~~---~~~~i~~~~------------------------------~~~~p~~~~~~l~~li~~cl~ 275 (299)
T d1fgka_ 238 YPGVPV---------EE---LFKLLKEGH------------------------------RMDKPSNCTNELYMMMRDCWH 275 (299)
T ss_dssp STTCCH---------HH---HHHHHHTTC------------------------------CCCCCSSCCHHHHHHHHHHTC
T ss_pred CCCCCH---------HH---HHHHHHcCC------------------------------CCCCCccchHHHHHHHHHHcc
Confidence 976542 12 222221111 111344557889999999999
Q ss_pred cCCCCCCCHHHHhc
Q 011808 321 YDPRKRITAAQALE 334 (477)
Q Consensus 321 ~dP~~Rpt~~e~L~ 334 (477)
+||.+|||+.|+++
T Consensus 276 ~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 276 AVPSQRPTFKQLVE 289 (299)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CCHhHCcCHHHHHH
Confidence 99999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=373.58 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=208.7
Q ss_pred cceeEEeeecccCceEEEEEEEec--ccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKA--AANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHAD 102 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 102 (477)
++|++.++||+|+||.||+|+++. ...++..||||+++.... ......+.+|+.+++.+ +|||||++++++.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~- 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-
Confidence 899999999999999999998753 235677999999976443 22345678899999999 6999999999997644
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhc-------------ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEe
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRD-------------KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVM 168 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~ 168 (477)
.+|++||||. ++|.+++..... .....+++..+..++.||+.||+|||+++||||||||+|||+
T Consensus 101 -~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~- 178 (311)
T d1t46a_ 101 -PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL- 178 (311)
T ss_dssp -SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred -EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc-
Confidence 6899999998 688888876432 123368999999999999999999999999999999999999
Q ss_pred ccCCCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccc
Q 011808 169 GEGEEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLT-LKPLFQGAEAK 247 (477)
Q Consensus 169 ~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ellt-G~~PF~~~~~~ 247 (477)
+..+.+||+|||+++..............+||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+...
T Consensus 179 ---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~- 253 (311)
T d1t46a_ 179 ---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV- 253 (311)
T ss_dssp ---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-
T ss_pred ---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCH-
Confidence 66778999999999987665555555667899999999999874 58999999999999999998 6777765542
Q ss_pred cCCCcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCC
Q 011808 248 STQNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRI 327 (477)
Q Consensus 248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rp 327 (477)
.+.+.++...- .....+...++.+.+||.+||+.||.+||
T Consensus 254 -------~~~~~~~i~~~---------------------------------~~~~~~~~~~~~l~~Li~~cl~~dP~~RP 293 (311)
T d1t46a_ 254 -------DSKFYKMIKEG---------------------------------FRMLSPEHAPAEMYDIMKTCWDADPLKRP 293 (311)
T ss_dssp -------SHHHHHHHHHT---------------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred -------HHHHHHHHhcC---------------------------------CCCCCcccccHHHHHHHHHHcCCChhHCc
Confidence 23333333221 11113344567899999999999999999
Q ss_pred CHHHHhc
Q 011808 328 TAAQALE 334 (477)
Q Consensus 328 t~~e~L~ 334 (477)
|++++++
T Consensus 294 s~~~il~ 300 (311)
T d1t46a_ 294 TFKQIVQ 300 (311)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-47 Score=368.01 Aligned_cols=266 Identities=20% Similarity=0.252 Sum_probs=200.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCce
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMS 104 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 104 (477)
-++|++++.||+|+||+||+|+++. +++.||||++...... ..+.+|+++++.++|+|++.++..+... ...
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~ 77 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDY 77 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECC---CCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec-CCE
Confidence 4689999999999999999998764 6889999998764432 2467899999999877766655544433 347
Q ss_pred EEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccc
Q 011808 105 LYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGL 184 (477)
Q Consensus 105 ~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~ 184 (477)
.++||||+++++...+... ...+++..+..++.||+.||+|||++||+||||||+|||+... +.+..+||+|||+
T Consensus 78 ~~ivme~~~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~-~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 78 NVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG-KKGNLVYIIDFGL 152 (299)
T ss_dssp EEEEEECCCCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG-GGTTCEEECCCSS
T ss_pred EEEEEEEcCCchhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccccc-CCCceeeeeccCc
Confidence 8999999999998877654 3469999999999999999999999999999999999998543 3456799999999
Q ss_pred ceeecCCCCc-----ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHH
Q 011808 185 ARIYQAPLKF-----LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLD 259 (477)
Q Consensus 185 a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~ 259 (477)
|+.+...... ......+||+.|+|||++.+. .|+.++|||||||++|||+||..||...........+.. ..
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~--~~ 229 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER--IS 229 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH--HH
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH--hh
Confidence 9987543321 223456789999999999874 489999999999999999999999987653322111110 00
Q ss_pred HHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHH---HHhcCc
Q 011808 260 KIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA---QALEHE 336 (477)
Q Consensus 260 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~---e~L~h~ 336 (477)
. ..+..+. ......+++++.+||.+||..||++||+++ ++|+|.
T Consensus 230 ~--~~~~~~~-------------------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 230 E--KKMSTPI-------------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp H--HHHHSCH-------------------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred c--ccCCCCh-------------------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0 0000000 012234567899999999999999999987 557787
Q ss_pred cCC
Q 011808 337 YFR 339 (477)
Q Consensus 337 ~f~ 339 (477)
|.+
T Consensus 277 ~~~ 279 (299)
T d1ckia_ 277 FHR 279 (299)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=370.68 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=199.1
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREI-THENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 103 (477)
.++|++.++||+|+||+||+|+++.+ .....||||.++..... ...+.+.+|+.+|.++ +|||||++++++.+..
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~-~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-- 84 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-- 84 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEET-TEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCC-CeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC--
Confidence 46999999999999999999998752 12235788887644332 2345788999999999 7999999999998754
Q ss_pred eEEEEEeccC-CCHHHHHHhhh-----------cccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC
Q 011808 104 SLYLAFDYAE-YDLYEIIRHHR-----------DKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 104 ~~~lv~e~~~-~~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~ 171 (477)
.+|+||||+. |+|.+++.... ......+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---- 160 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---- 160 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE----
Confidence 7999999999 79999886531 1224579999999999999999999999999999999999999
Q ss_pred CCcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCcccccCC
Q 011808 172 EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLK-PLFQGAEAKSTQ 250 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~-~PF~~~~~~~~~ 250 (477)
+.++.+||+|||+++...... ......||..|+|||.+.+.. |+.++|||||||++|||++|. +||.+.+.
T Consensus 161 ~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~---- 232 (309)
T d1fvra_ 161 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---- 232 (309)
T ss_dssp CGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----
T ss_pred cCCCceEEccccccccccccc---cccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCH----
Confidence 777889999999998654322 223456799999999998754 899999999999999999965 67865542
Q ss_pred CcccHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHH
Q 011808 251 NPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAA 330 (477)
Q Consensus 251 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~ 330 (477)
..+...+... .....+..+++++.+||.+||+.||++|||+.
T Consensus 233 --------~~~~~~i~~~------------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ 274 (309)
T d1fvra_ 233 --------AELYEKLPQG------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 274 (309)
T ss_dssp --------HHHHHHGGGT------------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred --------HHHHHHHHhc------------------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 1222222110 01113445578899999999999999999999
Q ss_pred HHhcC
Q 011808 331 QALEH 335 (477)
Q Consensus 331 e~L~h 335 (477)
++++|
T Consensus 275 eil~~ 279 (309)
T d1fvra_ 275 QILVS 279 (309)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99988
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=370.32 Aligned_cols=260 Identities=21% Similarity=0.348 Sum_probs=206.6
Q ss_pred ccceeEEeeecccCceEEEEEEEecc--cCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAA--ANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++|++.++||+|+||+||+|.++.. ...+..||||+++.... ......+.+|+.++++++||||+++++++....
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~- 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ- 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC-hHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC-
Confidence 38999999999999999999987642 22457899999975432 223346789999999999999999999986543
Q ss_pred ceEEEEEeccC-CCHHHHHHhhhc-----ccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCccc
Q 011808 103 MSLYLAFDYAE-YDLYEIIRHHRD-----KVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGV 176 (477)
Q Consensus 103 ~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~ 176 (477)
.+++||||+. |+|.+++..... .....+++..+..++.||+.||.|||+++|+||||||+|||+ +.+++
T Consensus 97 -~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl----d~~~~ 171 (308)
T d1p4oa_ 97 -PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDFT 171 (308)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE----CTTCC
T ss_pred -ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee----cCCce
Confidence 6799999998 688888765431 112357889999999999999999999999999999999999 77889
Q ss_pred EEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccccCCCcccH
Q 011808 177 VKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTL-KPLFQGAEAKSTQNPFQL 255 (477)
Q Consensus 177 vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG-~~PF~~~~~~~~~~~~~~ 255 (477)
+||+|||+++.+.............||+.|+|||++.+. .++.++|||||||++|||+|| .+||.+.+. .
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--------~ 242 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------E 242 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------H
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 999999999877654444444556789999999999874 489999999999999999998 588876542 2
Q ss_pred HHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 256 DQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 256 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
..+..+.+ .. ....+..++..+.+||.+||+.||.+|||+.++++
T Consensus 243 ~~~~~i~~----~~------------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 243 QVLRFVME----GG------------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHHHT----TC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHh----CC------------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22222211 00 01123455678999999999999999999999998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=367.87 Aligned_cols=255 Identities=22% Similarity=0.344 Sum_probs=195.4
Q ss_pred eEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCceEEEE
Q 011808 29 NLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENVVKLVNVHINHADMSLYLA 108 (477)
Q Consensus 29 ~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~lv 108 (477)
.+.++||+|+||+||+|++..+..+...||||+++... .......+.+|+++|++++||||+++++++...+ ..+++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-CceEEE
Confidence 34678999999999999987654445679999987533 2334467889999999999999999999986543 478999
Q ss_pred EeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccCCCcccEEEeeccccee
Q 011808 109 FDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEGEEQGVVKIADFGLARI 187 (477)
Q Consensus 109 ~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~~ 187 (477)
||||. ++|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+|||| ++++.+||+|||+++.
T Consensus 108 ~E~~~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl----~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML----DEKFTVKVADFGLARD 179 (311)
T ss_dssp EECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTCCEEECSSGGGCC
T ss_pred EEEeecCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE----CCCCCEEEecccchhh
Confidence 99999 5777766543 3457788899999999999999999999999999999999 7778899999999987
Q ss_pred ecCCCCc--ccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHHHHHHHHHh
Q 011808 188 YQAPLKF--LSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQLDKIFKIL 265 (477)
Q Consensus 188 ~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~~~~i~~~~ 265 (477)
....... .......||+.|+|||++.+. .++.++|||||||++|||+||..||..... ..+....+..
T Consensus 180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~-------~~~~~~~i~~-- 249 (311)
T d1r0pa_ 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITVYLLQ-- 249 (311)
T ss_dssp TTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHT--
T ss_pred ccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHc--
Confidence 6543221 122345679999999999874 489999999999999999998777754321 0111111110
Q ss_pred CCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 011808 266 GHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALEH 335 (477)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~h 335 (477)
+.....|..+++++.+||.+||+.||++|||+.|+++|
T Consensus 250 --------------------------------g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 250 --------------------------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp --------------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------------CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01112344567889999999999999999999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.2e-46 Score=371.40 Aligned_cols=297 Identities=28% Similarity=0.395 Sum_probs=205.2
Q ss_pred cceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-----------CCCeeEEE
Q 011808 26 QQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-----------HENVVKLV 94 (477)
Q Consensus 26 ~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~ 94 (477)
++|+++++||+|+||+||+|+++. +++.||||+++.... ....+.+|+.+++.++ |+||++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~---~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 469999999999999999998764 689999999975431 2345678999888875 58899999
Q ss_pred EEEEcCCCceEEEEEeccC--CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh-CCeecCCCCCCcEEEeccC
Q 011808 95 NVHINHADMSLYLAFDYAE--YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS-NWIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 95 ~~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDikp~NILl~~~~ 171 (477)
+++........+++++++. +.......... ...+++..++.++.||+.||.|||+ .||+||||||+|||+..++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred EEeeeccccceeeeeeeccccccccccccccc---ccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence 9987654445566665544 44444443322 4578999999999999999999998 8999999999999995432
Q ss_pred C--CcccEEEeecccceeecCCCCcccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccC
Q 011808 172 E--EQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKST 249 (477)
Q Consensus 172 ~--~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~ 249 (477)
. ....++|+|||.+...... ....+||+.|+|||++.+. .|+.++|||||||++++|++|+.||...+....
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cccccceeeEeecccccccccc-----cccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 2 2235999999999865432 2346789999999999874 489999999999999999999999986553322
Q ss_pred CCcccHHHHHHHHHHhCCCCCCCccccCCCccccccc-cccccccccCCC------CccccCCCCCchHHHHHHHhcccC
Q 011808 250 QNPFQLDQLDKIFKILGHPTPEKWPTLANLPHWQSDS-LHIQGRKYETNG------LHSVVPLSPKSPAYDLLSKMLEYD 322 (477)
Q Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~------~~~~~p~~~s~~~~dli~~~L~~d 322 (477)
.. ..+.+...+..++..+.+.+........+.... ............ .........++.+.|||.+||++|
T Consensus 238 ~~--~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 238 TK--DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp -C--HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cc--hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 22 556667777777765433221110000000000 000000000000 001112223567899999999999
Q ss_pred CCCCCCHHHHhcCccCC
Q 011808 323 PRKRITAAQALEHEYFR 339 (477)
Q Consensus 323 P~~Rpt~~e~L~h~~f~ 339 (477)
|.+|||++|+|+||||+
T Consensus 316 P~~Rpta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLK 332 (362)
T ss_dssp TTTCBCHHHHHTCGGGT
T ss_pred hhHCcCHHHHhcCcccC
Confidence 99999999999999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.2e-45 Score=353.55 Aligned_cols=261 Identities=18% Similarity=0.245 Sum_probs=201.4
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCCc
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITH-ENVVKLVNVHINHADM 103 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~ 103 (477)
-++|+++++||+|+||+||+|+++. +++.||||++...... ..+.+|+++++.+.| +||+.+++++... .
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG--L 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEET--T
T ss_pred CCceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecC--C
Confidence 4689999999999999999998764 6899999998654432 245678999999965 8999999988664 4
Q ss_pred eEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC-CCcccEEEeec
Q 011808 104 SLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG-EEQGVVKIADF 182 (477)
Q Consensus 104 ~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~-~~~~~vkL~DF 182 (477)
..|+||||++++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||+.... ...+.+||+||
T Consensus 75 ~~~~vme~~~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred ccEEEEEecCCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccc
Confidence 78999999999999988764 34689999999999999999999999999999999999995432 23567999999
Q ss_pred ccceeecCCCC-----cccCCCeeeccccccchhhcCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccCCCcccHHH
Q 011808 183 GLARIYQAPLK-----FLSENGVVVTIWYRAPELLLGAKHYTSAVDMWAVGCIFAELLTLKPLFQGAEAKSTQNPFQLDQ 257 (477)
Q Consensus 183 G~a~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~elltG~~PF~~~~~~~~~~~~~~~~ 257 (477)
|+|+.+..... .......+||+.|||||++.+. .++.++|||||||++|||+||+.||.+..... ....
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~-----~~~~ 224 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQK 224 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-----HHHH
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchh-----HHHH
Confidence 99997654321 1223356789999999999874 59999999999999999999999998655321 1112
Q ss_pred HHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 011808 258 LDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEYDPRKRITAAQALE 334 (477)
Q Consensus 258 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~dP~~Rpt~~e~L~ 334 (477)
...+.......+. ......+++++.+||..|+..+|++||+.+.+.+
T Consensus 225 ~~~i~~~~~~~~~------------------------------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 225 YERIGEKKQSTPL------------------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHHHHHHSCH------------------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHhccCCCCh------------------------------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 2222111100000 0012334578999999999999999998776543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=358.66 Aligned_cols=267 Identities=24% Similarity=0.317 Sum_probs=191.3
Q ss_pred ccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHH--HHHHHHhcCCCCeeEEEEEEEcCCC
Q 011808 25 LQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIR--EIMLLREITHENVVKLVNVHINHAD 102 (477)
Q Consensus 25 ~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~--Ei~il~~l~hpnIv~l~~~~~~~~~ 102 (477)
.++|.+.++||+|+||.||+|++ +|..||||+++... .....+ |+..++.++||||+++++++.+...
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-----~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence 46899999999999999999974 47899999986532 233444 4555567899999999999976543
Q ss_pred --ceEEEEEeccC-CCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhh--------CCeecCCCCCCcEEEeccC
Q 011808 103 --MSLYLAFDYAE-YDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHS--------NWIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 103 --~~~~lv~e~~~-~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~--------~givHrDikp~NILl~~~~ 171 (477)
..+|+||||+. |+|.+++.+. .+++..+..++.|++.||.|||+ +|||||||||+||||
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---- 141 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---- 141 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE----
T ss_pred cceEEEEEEecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE----
Confidence 46899999998 6999998753 58899999999999999999996 599999999999999
Q ss_pred CCcccEEEeecccceeecCCCCcc--cCCCeeeccccccchhhcCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 011808 172 EEQGVVKIADFGLARIYQAPLKFL--SENGVVVTIWYRAPELLLGAK-----HYTSAVDMWAVGCIFAELLTLKPLFQGA 244 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~-----~~~~~~DiwSlGvil~elltG~~PF~~~ 244 (477)
+.++.+||+|||+++......... .....+||+.|+|||++.+.. .++.++|||||||++|||+||.+||...
T Consensus 142 ~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~ 221 (303)
T d1vjya_ 142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence 777889999999998775533221 233467899999999997632 1567899999999999999999988654
Q ss_pred ccccCCCcc---cHHHHHHHHHHhCCCCCCCccccCCCccccccccccccccccCCCCccccCCCCCchHHHHHHHhccc
Q 011808 245 EAKSTQNPF---QLDQLDKIFKILGHPTPEKWPTLANLPHWQSDSLHIQGRKYETNGLHSVVPLSPKSPAYDLLSKMLEY 321 (477)
Q Consensus 245 ~~~~~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dli~~~L~~ 321 (477)
......... .......+...+...... +. ++ ....+......+.+||.+||+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--p~---~~-------------------~~~~~~~~~~~l~~li~~cl~~ 277 (303)
T d1vjya_ 222 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLR--PN---IP-------------------NRWQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCC--CC---CC-------------------GGGGGCHHHHHHHHHHHTTCCS
T ss_pred cccccchhhcccccchHHHHHHHHhccccC--CC---CC-------------------cccCChHHHHHHHHHHHHHccc
Confidence 422110000 001111111111100000 00 00 0000111123478999999999
Q ss_pred CCCCCCCHHHHhcC
Q 011808 322 DPRKRITAAQALEH 335 (477)
Q Consensus 322 dP~~Rpt~~e~L~h 335 (477)
||++|||+.|++++
T Consensus 278 dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 278 NGAARLTALRIKKT 291 (303)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999999764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.4e-24 Score=195.62 Aligned_cols=166 Identities=16% Similarity=0.069 Sum_probs=118.6
Q ss_pred eeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCC-----------C-----cHHHHHHHHHHHhcCCCCee
Q 011808 28 YNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDG-----------V-----SPTAIREIMLLREITHENVV 91 (477)
Q Consensus 28 Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~-----------~-----~~~~~~Ei~il~~l~hpnIv 91 (477)
|.+.++||+|+||+||+|++. +|+.||||+++....... . .....+|...+.++.|.+++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~----~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~ 77 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVP 77 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSC
T ss_pred chhCCEeeeCcceEEEEEECC----CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcc
Confidence 568899999999999999763 488999998764322100 0 11234588899999999999
Q ss_pred EEEEEEEcCCCceEEEEEeccCCCHHHHHHhhhcccCCCCCHHHHHHHHHHHHHHHHHhhhCCeecCCCCCCcEEEeccC
Q 011808 92 KLVNVHINHADMSLYLAFDYAEYDLYEIIRHHRDKVNHTMNPYTVKSILWQLLNGLNYLHSNWIIHRDLKPSNILVMGEG 171 (477)
Q Consensus 92 ~l~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDikp~NILl~~~~ 171 (477)
..+++. . .+++|||+++... ..+++..+..++.||+.+|.|||++||+||||||+|||++
T Consensus 78 ~~~~~~--~----~~lvme~~~~~~~-----------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~--- 137 (191)
T d1zara2 78 KVYAWE--G----NAVLMELIDAKEL-----------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS--- 137 (191)
T ss_dssp CEEEEE--T----TEEEEECCCCEEG-----------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---
T ss_pred eEEEec--C----CEEEEEeeccccc-----------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee---
Confidence 988753 2 2799999997422 1245556788999999999999999999999999999994
Q ss_pred CCcccEEEeecccceeecCCCCcccCCCeeecccccc------chhhcCCCCCCchhhHHHHHHHH
Q 011808 172 EEQGVVKIADFGLARIYQAPLKFLSENGVVVTIWYRA------PELLLGAKHYTSAVDMWAVGCIF 231 (477)
Q Consensus 172 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~gt~~y~A------PE~l~~~~~~~~~~DiwSlGvil 231 (477)
++ .++|+|||.|.....+.. ..|.. .|.+. +.|+.++|+||+.--+
T Consensus 138 -~~-~~~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 138 -EE-GIWIIDFPQSVEVGEEGW----------REILERDVRNIITYFS--RTYRTEKDINSAIDRI 189 (191)
T ss_dssp -TT-EEEECCCTTCEETTSTTH----------HHHHHHHHHHHHHHHH--HHHCCCCCHHHHHHHH
T ss_pred -CC-CEEEEECCCcccCCCCCc----------HHHHHHHHHHHHHHHc--CCCCCcccHHHHHHHH
Confidence 32 389999999976543211 11211 12222 3478899999986443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.31 E-value=2.9e-06 Score=77.55 Aligned_cols=86 Identities=12% Similarity=0.060 Sum_probs=58.6
Q ss_pred ccccccceeEEeeecccCceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEc
Q 011808 21 KPEWLQQYNLIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHIN 99 (477)
Q Consensus 21 ~~~~~~~Y~i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 99 (477)
...+++.|++++..+-++.+.||+.. .++..++||......... ...+.+|+.+++.+. +--+.+++.+..+
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~-----~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~ 81 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLV-----GENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEE-----CSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEE-----eCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEec
Confidence 34567899998887666678999874 245667888876543322 224567888888773 3345677776654
Q ss_pred CCCceEEEEEeccCCC
Q 011808 100 HADMSLYLAFDYAEYD 115 (477)
Q Consensus 100 ~~~~~~~lv~e~~~~~ 115 (477)
. ...|+||++++|.
T Consensus 82 ~--~~~~lv~~~l~G~ 95 (263)
T d1j7la_ 82 D--GWSNLLMSEADGV 95 (263)
T ss_dssp T--TEEEEEEECCSSE
T ss_pred C--CceEEEEEecccc
Confidence 3 4679999999873
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.76 E-value=0.00014 Score=70.40 Aligned_cols=78 Identities=17% Similarity=0.099 Sum_probs=47.1
Q ss_pred EEeeecccCceEEEEEEEecccCCCcEEEEEecccC-----CCCCCCcHHHHHHHHHHHhc-CC--CCeeEEEEEEEcCC
Q 011808 30 LIGKIGEGTYGLVFLARIKAAANRGKAIAIKKFKQS-----KDGDGVSPTAIREIMLLREI-TH--ENVVKLVNVHINHA 101 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~~~Ei~il~~l-~h--pnIv~l~~~~~~~~ 101 (477)
-.+.||.|....||++.+. .+++.++||.-... ........+...|...|+.+ .+ ..+.+++.+ +.+
T Consensus 30 ~~~eig~G~~N~vfrV~~~---~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~ 104 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQ---EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE 104 (392)
T ss_dssp EEEECCSSSSEEEEEEEC-------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT
T ss_pred eEEEeCCCceEeEEEEEeC---CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCC
Confidence 3567999999999998643 34678899864321 11122234556788888877 22 345666654 232
Q ss_pred CceEEEEEeccCC
Q 011808 102 DMSLYLAFDYAEY 114 (477)
Q Consensus 102 ~~~~~lv~e~~~~ 114 (477)
..+++||++++
T Consensus 105 --~~~lvmE~L~~ 115 (392)
T d2pula1 105 --MAVTVMEDLSH 115 (392)
T ss_dssp --TTEEEECCCTT
T ss_pred --CCEEEEeccCC
Confidence 23789999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.63 E-value=0.00021 Score=64.33 Aligned_cols=76 Identities=12% Similarity=0.013 Sum_probs=47.4
Q ss_pred ceeEEeeecccC-ceEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC--CCCeeEEEEEEEcCCCc
Q 011808 27 QYNLIGKIGEGT-YGLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT--HENVVKLVNVHINHADM 103 (477)
Q Consensus 27 ~Y~i~~~lG~G~-~g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~ 103 (477)
.+++... ..|. -+.||+... ..+..+++|....... ..+.+|+.+++.+. .-.+.+++.+..+. .
T Consensus 12 g~~~~~~-~~G~s~~~v~r~~~----~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~ 79 (255)
T d1nd4a_ 12 GYDWAQQ-TIGCSDAAVFRLSA----QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEA--G 79 (255)
T ss_dssp TCEEEEC-SCTTSSCEEEEEEC----TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--S
T ss_pred CCceEEc-CCcccCCeEEEEEe----CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccc--c
Confidence 3455443 4444 467898753 3466788897654322 23567888888773 23356677665543 3
Q ss_pred eEEEEEeccCC
Q 011808 104 SLYLAFDYAEY 114 (477)
Q Consensus 104 ~~~lv~e~~~~ 114 (477)
..+++|++++|
T Consensus 80 ~~~~v~~~i~G 90 (255)
T d1nd4a_ 80 RDWLLLGEVPG 90 (255)
T ss_dssp CEEEEEECCSS
T ss_pred ceEEEEEeeec
Confidence 67899999976
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.94 E-value=0.0021 Score=61.85 Aligned_cols=75 Identities=15% Similarity=0.249 Sum_probs=48.5
Q ss_pred EEeeecccCceEEEEEEEeccc----CCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCce
Q 011808 30 LIGKIGEGTYGLVFLARIKAAA----NRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREIT-HENVVKLVNVHINHADMS 104 (477)
Q Consensus 30 i~~~lG~G~~g~Vy~a~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 104 (477)
-++.|+.|-.-.+|++...... .....|.++++-.. . ......+|..+++.+. +.-..++++++. +
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--- 116 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---E-TESHLVAESVIFTLLSERHLGPKLYGIFS--G--- 116 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---C-CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T---
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C---
Confidence 3567888888899999764321 23456777776422 1 2234567999999884 433457777662 2
Q ss_pred EEEEEeccCC
Q 011808 105 LYLAFDYAEY 114 (477)
Q Consensus 105 ~~lv~e~~~~ 114 (477)
.+|++|+.|
T Consensus 117 -g~I~efi~g 125 (395)
T d1nw1a_ 117 -GRLEEYIPS 125 (395)
T ss_dssp -EEEECCCCE
T ss_pred -ceEEEEecc
Confidence 678888875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.05 E-value=0.012 Score=54.53 Aligned_cols=68 Identities=9% Similarity=0.124 Sum_probs=39.7
Q ss_pred eEEEEEEEecccCCCcEEEEEecccCCCCCCCcHHHHHHHHHHHhcCCCCe--eEEEEE---EEcCCCceEEEEEeccCC
Q 011808 40 GLVFLARIKAAANRGKAIAIKKFKQSKDGDGVSPTAIREIMLLREITHENV--VKLVNV---HINHADMSLYLAFDYAEY 114 (477)
Q Consensus 40 g~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~---~~~~~~~~~~lv~e~~~~ 114 (477)
-.||++.. .+|..|++|+.+.... ....+..|+..+..|....| +..+.. .....+...+.+++++.|
T Consensus 36 N~vy~v~~----~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQD----EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECC----TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEc----CCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 57998853 3588899999865422 34567778888877742221 111110 000113467888888875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.91 E-value=0.007 Score=55.85 Aligned_cols=30 Identities=27% Similarity=0.346 Sum_probs=25.3
Q ss_pred CCeecCCCCCCcEEEeccCCCcccEEEeecccce
Q 011808 153 NWIIHRDLKPSNILVMGEGEEQGVVKIADFGLAR 186 (477)
Q Consensus 153 ~givHrDikp~NILl~~~~~~~~~vkL~DFG~a~ 186 (477)
.|+||+|+.++||++ +.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~----~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFF----LGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEE----ETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhc----ccccceeEecccccc
Confidence 479999999999999 455556899999885
|